PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fick, A; Lang, I; Schafer, V; Seher, A; Trebing, J; Weisenberger, D; Wajant, H				Fick, Andrea; Lang, Isabell; Schaefer, Viktoria; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Wajant, Harald			Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED CELL-DEATH; SKELETAL-MUSCLE; MULTIPLE PATHWAYS; GENE-EXPRESSION; KAPPA-B; TNF; RECEPTOR; PROLIFERATION; REGENERATION	To perform highly sensitive cellular binding studies with TNF-like weak inducer of apoptosis (TWEAK), we developed a bioluminescent variant of soluble TWEAK (GpL-FLAG-TNC-TWEAK) by fusing it genetically to the C terminus of the luciferase of Gaussia princeps (GpL). Equilibrium binding studies on human (HT1080 and HT29) and murine (Renca and B16) cell lines at 37 degrees C revealed high affinities of human TWEAK from 53 to 112 pM. The dissociation rate constant of the TWEAK-Fn14 interaction was between 0.48 x 10(-3) s(-1) (HT29) and 0.58 x 10(-3) s(-1) (HT1080) for the human molecules, and the association rate constant obtained was 3.3 x 10(6) M-1 s(-1) for both cell lines. It has been shown previously that oligomerization of soluble TWEAK trimers results in enhanced Fn14-mediated activation of the classical NF kappa B pathway. Binding studies with GpL-FLAG-TNC-TWEAK trimers oligomerized by help of a FLAG tag-specific antibody gave no evidence for a major increase in Fn14 occupancy by oligomerized ligand despite strongly enhanced induction of the NF kappa B target IL8. Thus, aggregated complexes of soluble TWEAK and Fn14 have a higher intrinsic activity to stimulate the classical NF kappa B pathway and qualitatively differ from isolated trimeric TWEAK-Fn14 complexes. Furthermore, determination of IL8 induction as a function of occupied activated receptors revealed that the intrinsic capability of TNFR1 to stimulate the classical NF kappa B pathway and IL8 production was similar to 100-fold higher than Fn14. Thus, although similar to 25 activated TNFR1 trimers were sufficient to trigger half-maximal IL8 production, more than 2500 cell-bound oligomerized TWEAK trimers were required to elicit a similar response.	[Fick, Andrea; Lang, Isabell; Schaefer, Viktoria; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, D-97070 Wurzburg, Germany	University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 487];  [Wa 1025/19-2];  [Wa 1025/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	This work was supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, Project B7) and Grants Wa 1025/19-2 and Wa 1025/21-1.	Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu JX, 2011, NEPHROLOGY, V16, P426, DOI 10.1111/j.1440-1797.2011.01449.x; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Michaelson JS, 2009, RESULTS PROBL CELL D, V49, P145, DOI 10.1007/400_2008_18; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Mueller AM, 2005, J NEUROIMMUNOL, V159, P55, DOI 10.1016/j.jneuroim.2004.10.001; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597	41	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					484	495		10.1074/jbc.M111.287656	http://dx.doi.org/10.1074/jbc.M111.287656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081603	Green Published, hybrid			2022-12-25	WOS:000298682400047
J	Hou, XH; Tashima, Y; Stanley, P				Hou, Xinghua; Tashima, Yuko; Stanley, Pamela			Galactose Differentially Modulates Lunatic and Manic Fringe Effects on Delta1-induced NOTCH Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE REPEATS; O-FUCOSE; GLYCOSYLATION MUTANTS; LIGAND-BINDING; MOUSE NOTCH1; PATHWAY; PROTEIN; GENES; SITES; BETA-4GALACTOSYLTRANSFERASE-1	NOTCH signaling induced by Delta1 (DLL1) and Jagged1 (JAG1) NOTCH ligands is modulated by the beta 3N-acetylglucosaminyl transferase Fringe. LFNG (Lunatic Fringe) and MFNG (Manic Fringe) transfer N-acetylglucosamine (GlcNAc) to O-fucose attached to EGF-like repeats of NOTCH receptors. In co-culture NOTCH signaling assays, LFNG generally enhances DLL1-induced, but inhibits JAG1-induced, NOTCH signaling. In mutant Chinese hamster ovary (CHO) cells that do not add galactose (Gal) to the GlcNAc transferred by Fringe, JAG1-induced NOTCH signaling is not inhibited by LFNG or MFNG. In mouse embryos lacking B4galt1, NOTCH signaling is subtly reduced during somitogenesis. Here we show that DLL1-induced NOTCH signaling in CHO cells was enhanced by LFNG, but this did not occur in either Lec8 or Lec20 CHO mutants lacking Gal on O-fucose glycans. Lec20 mutants corrected with a B4galt1 cDNA became responsive to LFNG. By contrast, MFNG promoted DLL1-induced NOTCH signaling better in the absence of Gal than in its presence. This effect was reversed in Lec8 cells corrected by expression of a UDP-Gal transporter cDNA. The MFNG effect was abolished by a DDD to DDA mutation that inactivates MFNG GlcNAc transferase activity. The binding of soluble NOTCH ligands and NOTCH1/EGF1-36 generally reflected changes in NOTCH signaling caused by LFNG and MFNG. Therefore, the presence of Gal on O-fucose glycans differentially affects DLL1-induced NOTCH signaling modulated by LFNG versus MFNG. Gal enhances the effect of LFNG but inhibits the effect of MFNG on DLL1-induced NOTCH signaling, with functional consequences for regulating the strength of NOTCH signaling.	[Hou, Xinghua; Tashima, Yuko; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health [RO1 95022]; NCI; Albert Einstein Cancer Center [PO1 13330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Albert Einstein Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 95022 from the NCI (to P. S.) and Albert Einstein Cancer Center Grant PO1 13330.	Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen JH, 2006, GENE EXPR PATTERNS, V6, P376, DOI 10.1016/j.modgep.2005.09.009; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; Luther KB, 2009, J BIOL CHEM, V284, P3294, DOI 10.1074/jbc.M805502200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; RUSSO RN, 1990, J BIOL CHEM, V265, P3324; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Stanley P, 2009, IMMUNOL REV, V230, P201, DOI 10.1111/j.1600-065X.2009.00791.x; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	39	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					474	483		10.1074/jbc.M111.317578	http://dx.doi.org/10.1074/jbc.M111.317578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081605	Green Published, hybrid			2022-12-25	WOS:000298682400046
J	Christianson, SJ; Brand, CL; Wilkinson, GS				Christianson, Sarah J.; Brand, Cara L.; Wilkinson, Gerald S.			Reduced Polymorphism Associated with X Chromosome Meiotic Drive in the Stalk-Eyed Fly Teleopsis dalmanni	PLOS ONE			English	Article							SEXUALLY SELECTED TRAIT; SEX-RATIO POLYMORPHISM; DROSOPHILA-SIMULANS; NATURAL-POPULATIONS; SEGREGATION DISTORTION; REPRODUCTIVE ISOLATION; GENETIC-VARIATION; DNA POLYMORPHISM; BACKGROUND SELECTION; CENTROMERIC REGION	Sex chromosome meiotic drive has been suggested as a cause of several evolutionary genetic phenomena, including genomic conflicts that give rise to reproductive isolation between new species. In this paper we present a population genetic analysis of X chromosome drive in the stalk-eyed fly, Teleopsis dalmanni, to determine how this natural polymorphism influences genetic diversity. We analyzed patterns of DNA sequence variation at two X-linked regions (comprising 1325 bp) approximately 50 cM apart and one autosomal region (comprising 921 bp) for 50 males, half of which were collected in the field from one of two allopatric locations and the other half were derived from lab-reared individuals with known brood sex ratios. These two populations are recently diverged but exhibit partial postzygotic reproductive isolation, i.e. crosses produce sterile hybrid males and fertile females. We find no nucleotide or microsatellite variation on the drive X chromosome, whereas the same individuals show levels of variation at autosomal regions that are similar to field-collected flies. Furthermore, one field-caught individual collected 10 years previously had a nearly identical X haplotype to the drive X, and is over 2% divergent from other haplotypes sampled from the field. These results are consistent with a selective sweep that has removed genetic variation from much of the drive X chromosome. We discuss how this finding may relate to the rapid evolution of postzygotic reproductive isolation that has been documented for these flies.	[Christianson, Sarah J.; Brand, Cara L.; Wilkinson, Gerald S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Christianson, SJ (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	wilkinso@umd.edu	Wilkinson, Gerald S./E-4424-2011	Wilkinson, Gerald S./0000-0001-7799-8444	NSF [DEB-0077878, DEB-0343617, DEB-0444886]; University of Maryland; Division Of Environmental Biology [0952260] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Maryland; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by NSF (http://www.nsf.gov/) grants DEB-0077878, DEB-0343617, and DEB-0444886 to GSW. Additional financial support came from an NSF predoctoral fellowship, a University of Maryland Graduate School Fellowship and a University of Maryland Dissertation Fellowship to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADE M, 1994, P NATL ACAD SCI USA, V91, P4658, DOI 10.1073/pnas.91.11.4658; AGUADE M, 1989, GENETICS, V122, P607; Andolfatto P, 2001, GENETICS, V158, P657; Babcock CS, 1996, MOL BIOL EVOL, V13, P297, DOI 10.1093/oxfordjournals.molbev.a025589; Baker RH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001121; Baker RH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-361; Bastide H, 2011, MOL BIOL EVOL, V28, P2461, DOI 10.1093/molbev/msr074; Beckenbach AT, 1996, EVOLUTION, V50, P787, DOI 10.1111/j.1558-5646.1996.tb03888.x; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Birge LM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-227; Capillon C, 1999, EVOLUTION, V53, P506, DOI [10.2307/2640786, 10.1111/j.1558-5646.1999.tb03785.x]; Carvalho AB, 1999, HEREDITY, V83, P221, DOI 10.1038/sj.hdy.6886100; Carvalho AB, 1997, GENETICS, V146, P891; Cazemajor M, 1997, GENETICS, V147, P635; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Christianson SJ, 2005, EVOLUTION, V59, P849, DOI 10.1554/04-291; CURTSINGER JW, 1980, GENETICS, V94, P445; DECARVALHO AB, 1989, HEREDITY, V62, P425, DOI 10.1038/hdy.1989.58; DECARVALHO AB, 1993, HEREDITY, V71, P546, DOI 10.1038/hdy.1993.174; Dermitzakis ET, 2000, GENETICS, V154, P687; Derome N, 2008, MOL BIOL EVOL, V25, P409, DOI 10.1093/molbev/msm269; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; EDWARDS AW, 1961, HEREDITY, V16, P291, DOI 10.1038/hdy.1961.35; Fay JC, 2000, GENETICS, V155, P1405; Fisher R.A., 1958, GENETICAL THEORY NAT; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; FU YX, 1993, GENETICS, V133, P693; Gershenson S, 1928, GENETICS, V13, P488; Glinka S, 2003, GENETICS, V165, P1269; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall DW, 2004, EVOLUTION, V58, P925; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HAUSCHTECKJUNGEN E, 1990, GENETICA, V83, P31; HUDSON RR, 1987, GENETICS, V116, P153; HURST LD, 1991, GENETICS, V128, P841; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; JAMES AC, 1990, GENETICS, V126, P651; Jensen MA, 2002, GENETICS, V160, P493; Johns PM, 2005, P ROY SOC B-BIOL SCI, V272, P2097, DOI 10.1098/rspb.2005.3183; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2000, GENETICS, V155, P1415; Kingan SB, 2010, GENETICS, V184, P253, DOI 10.1534/genetics.109.109587; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI [10.2307/2406613, 10.1111/j.1558-5646.1967.tb03408.x]; Lande R, 1999, GENET RES, V74, P245, DOI 10.1017/S0016672399004218; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARTINCAMPOS JM, 1992, GENETICS, V130, P805; McDermott SR, 2010, PHILOS T R SOC B, V365, P1265, DOI 10.1098/rstb.2009.0264; MERCOT H, 1995, J EVOLUTION BIOL, V8, P283, DOI 10.1046/j.1420-9101.1995.8030283.x; MIYASHITA NT, 1990, GENETICS, V125, P407; Montchamp-Moreau C, 2002, GENETICS, V162, P1221; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Palopoli MF, 1996, GENETICS, V143, P1675; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000463; Presgraves DC, 1997, GENETICS, V147, P1169; Quesada H, 2003, GENETICS, V165, P895; Reed FA, 2005, EVOLUTION, V59, P1280, DOI 10.1111/j.0014-3820.2005.tb01778.x; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STALKER HD, 1961, GENETICS, V46, P177; STEPHAN W, 1992, GENETICS, V132, P1039, DOI 10.1093/genetics/132.4.1039; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; Sturtevant AH, 1936, GENETICS, V21, P473; TAJIMA F, 1989, GENETICS, V123, P585; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilkinson GS, 2006, J EVOLUTION BIOL, V19, P1851, DOI 10.1111/j.1420-9101.2006.01169.x; Wilkinson GS, 2003, GENETICA, V117, P37, DOI 10.1023/A:1022360531703; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Wilkinson GS, 1998, NATURE, V391, P276, DOI 10.1038/34640; Wolfenbarger LL, 2001, EVOLUTION, V55, P103; Wright TF, 2004, GENET RES, V84, P27, DOI 10.1017/S0016672304006986	81	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27254	10.1371/journal.pone.0027254	http://dx.doi.org/10.1371/journal.pone.0027254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087274	gold, Green Published			2022-12-25	WOS:000297349700024
J	Wolting, CD; Griffiths, EK; Sarao, R; Prevost, BC; Wybenga-Groot, LE; McGlade, CJ				Wolting, Cheryl D.; Griffiths, Emily K.; Sarao, Renu; Prevost, Brittany C.; Wybenga-Groot, Leanne E.; McGlade, C. Jane			Biochemical and Computational Analysis Of LNX1 Interacting Proteins	PLOS ONE			English	Article							ADENOVIRUS RECEPTOR CAR; E3 UBIQUITIN LIGASE; JUNCTIONAL CELL-ADHESION; PDZ-DOMAIN; BINDING DOMAIN; ACTIVE ZONE; P21-ACTIVATED KINASES; FINGER STRUCTURE; PTP-BL; NUMB	PDZ (Post-synaptic density, 95 kDa, Discs large, Zona Occludens-1) domains are protein interaction domains that bind to the carboxy-terminal amino acids of binding partners, heterodimerize with other PDZ domains, and also bind phosphoinositides. PDZ domain containing proteins are frequently involved in the assembly of multi-protein complexes and clustering of transmembrane proteins. LNX1 (Ligand of Numb, protein X 1) is a RING (Really Interesting New Gene) domain-containing E3 ubiquitin ligase that also includes four PDZ domains suggesting it functions as a scaffold for a multiprotein complex. Here we use a human protein array to identify direct LNX1 PDZ domain binding partners. Screening of 8,000 human proteins with isolated PDZ domains identified 53 potential LNX1 binding partners. We combined this set with LNX1 interacting proteins identified by other methods to assemble a list of 220 LNX1 interacting proteins. Bioinformatic analysis of this protein list was used to select interactions of interest for future studies. Using this approach we identify and confirm six novel LNX1 binding partners: KCNA4, PAK6, PLEKHG5, PKC-alpha1, TYK2 and PBK, and suggest that LNX1 functions as a signalling scaffold.	[Wolting, Cheryl D.; Prevost, Brittany C.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wolting, Cheryl D.; Griffiths, Emily K.; Sarao, Renu; Prevost, Brittany C.; Wybenga-Groot, Leanne E.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wolting, CD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	jmcglade@sickkids.ca			Canadian Institutes of Health Research [MOP-121669]; Canadian Cancer Society [020228]; National Cancer Institute of Canada; Terry Fox Foundation; NSERC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Terry Fox Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Canadian Institutes of Health Research (MOP-121669) and the Canadian Cancer Society (#020228) to Dr. McGlade. Dr. Wolting was supported by a studentship from the National Cancer Institute of Canada, and Dr. Griffiths was supported by a Terry Fox Foundation Fellowship with funds from the Canadian Cancer Society, Dr. Wybeng-Groot was supported by a fellowship from the Canadian Institutes of Health Research, and Dr. Prevost by an NSERC PGSM studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruester V, 2004, J VIROL, V78, P10310, DOI 10.1128/JVI.78.19.10310-10319.2004; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bork P, 2002, BIOINFORMATICS, V18, pS64, DOI 10.1093/bioinformatics/18.suppl_2.S64; Borrell-Pages M, 2000, MOL BIOL CELL; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gross C, 2001, FEBS LETT, V496, P101, DOI 10.1016/S0014-5793(01)02401-2; Higa S, 2007, BIOCHEM BIOPH RES CO, V354, P686, DOI 10.1016/j.bbrc.2007.01.036; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mori H, 2004, GENES CELLS, V9, P811, DOI 10.1111/j.1365-2443.2004.00765.x; Nie J, 2004, J BIOL CHEM, V279, P20807, DOI 10.1074/jbc.M311396200; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; PHILIPSON LH, 1993, GENOMICS, V15, P463, DOI 10.1006/geno.1993.1094; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tajima M, 2003, GENES CELLS, V8, P759, DOI 10.1046/j.1365-2443.2003.00673.x; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; van den Berk LCJ, 2007, BIOCHEMISTRY-US, V46, P13629, DOI 10.1021/bi700954e; Wang P, 2000, EUR J BIOCHEM, V267, P3116, DOI 10.1046/j.1432-1327.2000.01318.x; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Wolting C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-338; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xie Y, 2001, BIOCHEM GENET, V39, P117, DOI 10.1023/A:1010269908398; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zegers M, 2008, INT REV CEL MOL BIO, V267, P253, DOI 10.1016/S1937-6448(08)00606-0; Zheng D, 2010, MOL BIOL REP, V37, P2431, DOI 10.1007/s11033-009-9754-5; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	61	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26248	10.1371/journal.pone.0026248	http://dx.doi.org/10.1371/journal.pone.0026248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087225	Green Submitted, gold, Green Published			2022-12-25	WOS:000297349700006
J	Chung, U; Mack, L; Yun, JI; Kim, SH				Chung, Uran; Mack, Liz; Yun, Jin I.; Kim, Soo-Hyung			Predicting the Timing of Cherry Blossoms in Washington, DC and Mid-Atlantic States in Response to Climate Change	PLOS ONE			English	Article							BUD-BURST; DORMANCY INDUCTION; TREE PHENOLOGY; TEMPERATURE; GROWTH; MODELS; PHOTOPERIOD; RESOLUTION; BUDBURST; EARLIER	Cherry blossoms, an icon of spring, are celebrated in many cultures of the temperate region. For its sensitivity to winter and early spring temperatures, the timing of cherry blossoms is an ideal indicator of the impacts of climate change on tree phenology. Here, we applied a process-based phenology model for temperate deciduous trees to predict peak bloom dates (PBD) of flowering cherry trees (Prunus x yedoensis 'Yoshino' and Prunus serrulata 'Kwanzan') in the Tidal Basin, Washington, DC and the surrounding Mid-Atlantic States in response to climate change. We parameterized the model with observed PBD data from 1991 to 2010. The calibrated model was tested against independent datasets of the past PBD data from 1951 to 1970 in the Tidal Basin and more recent PBD data from other locations (e.g., Seattle, WA). The model performance against these independent data was satisfactory (Yoshino: r(2) = 0.57, RMSE = 6.6 days, bias = 0.9 days and Kwanzan: r(2) = 0.76, RMSE = 5.5 days, bias = -2.0 days). We then applied the model to forecast future PBD for the region using downscaled climate projections based on IPCC's A1B and A2 emissions scenarios. Our results indicate that PBD at the Tidal Basin are likely to be accelerated by an average of five days by 2050 s and 10 days by 2080 s for these cultivars under a mid-range (A1B) emissions scenario projected by ECHAM5 general circulation model. The acceleration is likely to be much greater (13 days for 2050 s and 29 days for 2080s) under a higher (A2) emissions scenario projected by CGCM2 general circulation model. Our results demonstrate the potential impacts of climate change on the timing of cherry blossoms and illustrate the utility of a simple process-based phenology model for developing adaptation strategies to climate change in horticulture, conservation planning, restoration and other related disciplines.	[Chung, Uran; Mack, Liz; Kim, Soo-Hyung] Univ Washington, Ctr Urban Hort, Sch Forest Resources, Coll Environm, Seattle, WA 98195 USA; [Yun, Jin I.] Kyung Hee Univ, Dept Ecosyst Engn, Yongin, South Korea; [Chung, Uran] Seoul Natl Univ, Natl Ctr Agrometeorol, Seoul, South Korea	University of Washington; University of Washington Seattle; Kyung Hee University; Seoul National University (SNU)	Chung, U (corresponding author), Univ Washington, Ctr Urban Hort, Sch Forest Resources, Coll Environm, Seattle, WA 98195 USA.	soohkim@u.washington.edu	Kim, Soo-Hyung/A-3012-2009	Kim, Soo-Hyung/0000-0003-3879-4080	Rural Development Administration, Republic of Korea [PJ006403]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Cooperative Research Program for Agricultural Science & Technology Development (Project No. PJ006403), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; CANNELL MGR, 1985, J APPL ECOL, V22, P931, DOI 10.2307/2403241; Cesaraccio C, 2004, AGR FOREST METEOROL, V126, P1, DOI 10.1016/j.agrformet.2004.03.002; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chung U, 2009, CLIMATIC CHANGE, V93, P447, DOI 10.1007/s10584-008-9504-z; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Granhus A, 2009, TREE PHYSIOL, V29, P497, DOI 10.1093/treephys/tpn039; Havens K, 2008, USING PHENOLOGY ENGA; Heide OM, 2008, SCI HORTIC-AMSTERDAM, V115, P309, DOI 10.1016/j.scienta.2007.10.005; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Heide OM, 2003, TREE PHYSIOL, V23, P931, DOI 10.1093/treephys/23.13.931; Henebry GM, 2010, EOS, V91, P3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Jefferson RM, 1977, JAPANESE FLOWERING C; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165, DOI 10.1093/treephys/26.9.1165; McClellan A., 2005, CHERRY BLOSSOM FESTI; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2007, AM J BOT, V94, P1470, DOI 10.3732/ajb.94.9.1470; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; Oh S. D., 2004, FRUIT TREE PHYSL REL; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pooler Margaret R., 1999, Journal of Environmental Horticulture, V17, P189; Primack RB, 2009, BIOL CONSERV, V142, P1943, DOI 10.1016/j.biocon.2009.03.016; Ramirez J, 2010, 1 CIATCGIAR; RETTA A, 1991, AGRON J, V83, P757, DOI 10.2134/agronj1991.00021962008300040021x; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Roh MS, 2007, SCI HORTIC-AMSTERDAM, V114, P121, DOI 10.1016/j.scienta.2007.06.005; Rutishauser T, 2003, THESIS U BERN; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Seeley SD, 1996, MODELLING CLIMATIC R, P361; Seino H., 1993, J AGR METEOROL, V48, P379, DOI DOI 10.2480/AGRMET.48.379; Thompson R, 2008, HOLOCENE, V18, P95, DOI 10.1177/0959683607085599; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; WMO, 1989, 10 WMO WCDP, P1011; 정재은, 2005, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V7, P148; Yun Jin, 2006, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V8, P68; Zavalloni C, 2006, J AM SOC HORTIC SCI, V131, P601, DOI 10.21273/JASHS.131.5.601	44	47	50	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27439	10.1371/journal.pone.0027439	http://dx.doi.org/10.1371/journal.pone.0027439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087317	gold, Green Published			2022-12-25	WOS:000297347700054
J	Tio, M; Toh, J; Fang, WR; Blanco, J; Udolph, G				Tio, Murni; Toh, Joanne; Fang, Wanru; Blanco, Jorge; Udolph, Gerald			Asymmetric Cell Division and Notch Signaling Specify Dopaminergic Neurons in Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; LATERAL INHIBITION; GENE-EXPRESSION; MOSAIC ANALYSIS; FATE DECISIONS; NUMB; NEUROGENESIS; SPECIFICATION; MELANOGASTER	In Drosophila, dopaminergic (DA) neurons can be found from mid embryonic stages of development till adulthood. Despite their functional involvement in learning and memory, not much is known about the developmental as well as molecular mechanisms involved in the events of DA neuronal specification, differentiation and maturation. In this report we demonstrate that most larval DA neurons are generated during embryonic development. Furthermore, we show that loss of function (l-o-f) mutations of genes of the apical complex proteins in the asymmetric cell division (ACD) machinery, such as inscuteable and bazooka result in supernumerary DA neurons, whereas l-o-f mutations of genes of the basal complex proteins such as numb result in loss or reduction of DA neurons. In addition, when Notch signaling is reduced or abolished, additional DA neurons are formed and conversely, when Notch signaling is activated, less DA neurons are generated. Our data demonstrate that both ACD and Notch signaling are crucial mechanisms for DA neuronal specification. We propose a model in which ACD results in differential Notch activation in direct siblings and in this context Notch acts as a repressor for DA neuronal specification in the sibling that receives active Notch signaling. Our study provides the first link of ACD and Notch signaling in the specification of a neurotransmitter phenotype in Drosophila. Given the high degree of conservation between Drosophila and vertebrate systems, this study could be of significance to mechanisms of DA neuronal differentiation not limited to flies.	[Tio, Murni; Toh, Joanne; Fang, Wanru; Blanco, Jorge; Udolph, Gerald] Inst Med Biol, Singapore, Singapore; [Blanco, Jorge; Udolph, Gerald] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Tio, M (corresponding author), Inst Med Biol, Singapore, Singapore.	gerald.udolph@imb.a-star.edu.sg			NICHD	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Buescher and X. H. Yang for advice and critical comments on the manuscript. We are very grateful to M. Rosbash (Per), B.W. Lu (dTH) and Lee C. Y. for sharing antibodies and fly stocks. We thank the Bloomington Drosophila stock center and VDRC for providing the fly stocks. We used monoclonal antibodies obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Binor E, 2005, DEV NEUROSCI-BASEL, V27, P306, DOI 10.1159/000086710; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; CABRERA CV, 1990, DEVELOPMENT, V110, P733; CamposOrtega JA, 1996, NEURON, V17, P1, DOI 10.1016/S0896-6273(00)80274-3; Cardona A, 2010, J NEUROSCI, V30, P7538, DOI 10.1523/JNEUROSCI.0186-10.2010; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dye CA, 1998, DEVELOPMENT, V125, P1845; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HORNYKIEWICZ O, 1992, CLIN NEUROL NEUROSUR, V94, pS9; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lacin H, 2009, DEVELOPMENT, V136, P3257, DOI 10.1242/dev.037242; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LIU X, 1992, J NEUROSCI, V12, P2735; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Mahler J, 2010, J NEUROSCI, V30, P16621, DOI 10.1523/JNEUROSCI.4769-10.2010; Matsuzaki F, 2000, CURR OPIN NEUROBIOL, V10, P38, DOI 10.1016/S0959-4388(99)00052-5; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Rath P, 2002, EMBO REP, V3, P660, DOI 10.1093/embo-reports/kvf134; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stagg SB, 2011, DEVELOPMENT, V138, P2171, DOI 10.1242/dev.056507; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Udolph G, 2010, NOTCH SIGNALING GENE; Udolph G, 2009, DEV BIOL, V336, P156, DOI 10.1016/j.ydbio.2009.09.030; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	62	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26879	10.1371/journal.pone.0026879	http://dx.doi.org/10.1371/journal.pone.0026879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073214	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200021
J	Worodria, W; Anderson, J; Cattamanchi, A; Davis, JL; den Boon, S; Andama, A; Yoo, SD; Joloba, M; Huang, L; Kato-Maeda, M				Worodria, William; Anderson, Jillian; Cattamanchi, Adithya; Davis, J. Lucian; den Boon, Saskia; Andama, Alfred; Yoo, Samuel D.; Joloba, Moses; Huang, Laurence; Kato-Maeda, Midori			The Role of Speciation in Positive Lowenstein-Jensen Culture Isolates from a High Tuberculosis Burden Country	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM COMPLEX; POLYMERASE GENE RPOB; NONTUBERCULOUS MYCOBACTERIA; PCR ASSAY; IDENTIFICATION; DISEASE; DIFFERENTIATION; BACTEREMIA; INFECTION; DIAGNOSIS	Objective: To determine the need for routine speciation of positive Lowenstein-Jensen mycobacterial cultures in HIV-infected patients suspected of having pulmonary tuberculosis at Mulago Hospital in Kampala, Uganda. Methods: Sputum and bronchoalveolar lavage Lowenstein-Jensen mycobacterial culture isolates from consecutive, HIV-infected patients admitted to Mulago Hospital with 2 weeks or more of cough were subjected to IS6110 PCR and rpoB genetic analysis to determine the presence of Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM). Results: Eighty (100%) mycobacterial cultures from 65 patients were confirmed to be members of MTBC. Subsequent analysis of the cultures from 54 patients by PCR and sequence analyses to identify co-infection with NTM confirmed the presence of MTBC as well as the presence of Micrococcus luteus (n = 4), Janibacter spp. (n = 1) and six cultures had organisms that could not be identified. Conclusions: Presumptive diagnosis of tuberculosis on the basis of a positive Lowenstein-Jensen culture is sufficient in HIV-infected Ugandans suspected of having tuberculosis. Routine molecular confirmation of positive Lowenstein-Jensen cultures is unnecessary in this low resource setting.	[Worodria, William; Andama, Alfred; Yoo, Samuel D.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Worodria, William; Andama, Alfred; Yoo, Samuel D.] Mulago Natl Referral & Teaching Hosp, Dept Med, Kampala, Uganda; [Worodria, William; Cattamanchi, Adithya; Davis, J. Lucian; den Boon, Saskia; Andama, Alfred; Yoo, Samuel D.; Huang, Laurence] Univ Calif San Francisco, Makerere Univ, San Francisco Res Collaborat, Kampala, Uganda; [Anderson, Jillian; Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence; Kato-Maeda, Midori] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Curry Int TB Ctr, San Francisco, CA USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA USA; [Joloba, Moses] Makerere Univ, Sch Biomed Sci, Dept Microbiol, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University	Worodria, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	worodria@yahoo.com	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019; Davis, J. Lucian/AAC-8376-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Joloba, Moses/0000-0002-0334-9983	National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases at the National Institutes of Health; Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from the National Heart, Lung, and Blood Institute and from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health; and was also funded by the Netherlands-African Partnership for Capacity Development and Clinical Interventions Against Poverty-Related Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afghani B, 1996, BIOCHEM MOL MED, V57, P14, DOI 10.1006/bmme.1996.0003; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; Corbett EL, 1999, AM J RESP CRIT CARE, V159, P94, DOI 10.1164/ajrccm.159.1.9803048; Eaton T, 1995, TUBERCLE LUNG DIS, V76, P570, DOI 10.1016/0962-8479(95)90536-7; GILKS CF, 1995, J ACQ IMMUN DEF SYND, V8, P195; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; Kim BJ, 2004, J CLIN MICROBIOL, V42, P1308, DOI 10.1128/JCM.42.3.1308-1312.2004; Kim BJ, 2001, J CLIN MICROBIOL, V39, P2102, DOI 10.1128/JCM.39.6.2102-2109.2001; Loubinoux J, 2005, J CLIN MICROBIOL, V43, P3564, DOI 10.1128/JCM.43.7.3564-3566.2005; Mawak Jd, 2006, Ghana Med J, V40, P132; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Ngamlert K, 2009, TROP MED INT HEALTH, V14, P748, DOI 10.1111/j.1365-3156.2009.02284.x; Nunes Elizabete Abrantes, 2008, J. bras. pneumol., V34, P822, DOI 10.1590/S1806-37132008001000011; OKELLO DO, 1990, J INFECT DIS, V162, P208, DOI 10.1093/infdis/162.1.208; Pettipher CA, 2001, CLIN INFECT DIS, V33, P2068, DOI 10.1086/323979; Shenai S, 2010, INT J TUBERC LUNG D, V14, P1001; Smith KJ, 1999, BRIT J DERMATOL, V141, P558; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Thrash JC, 2011, J BACTERIOL, V193, P584, DOI 10.1128/JB.01298-10; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; *WHO, 2007, WHOHTMSTB200740; WILSON ML, 1995, J CLIN MICROBIOL, V33, P2516, DOI 10.1128/JCM.33.9.2516-2518.1995	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27017	10.1371/journal.pone.0027017	http://dx.doi.org/10.1371/journal.pone.0027017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073241	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200029
J	Yabas, M; Godfrey, DI; Goodnow, CC; Hoyne, GF				Yabas, Mehmet; Godfrey, Dale I.; Goodnow, Christopher C.; Hoyne, Gerard F.			Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells	PLOS ONE			English	Article							NATURAL-KILLER; FUNCTIONALLY DISTINCT; CYTOKINE PRODUCTION; HOMEOSTASIS; CD1D; RIBONUCLEOPROTEIN; IDENTIFICATION; ACTIVATION; MATURATION; PRECURSOR	Natural killer T (NKT) cells represent an important regulatory T cell subset that develops in the thymus and contains immature (NK1.1(lo)) and mature (NK1.1(hi)) cell subsets. Here we show in mice that an inherited mutation in heterogeneous ribonucleoprotein L-like protein (hnRNPLL(thunder)), that shortens the survival of conventional T cells, has no discernible effect on NKT cell development, homeostasis or effector function. Thus, Hnrpll deficiency effectively increases the NKT:T cell ratio in the periphery. However, Hnrpll mutation disrupts CD45RA, RB and RC exon silencing of the Ptprc mRNA in both NKT and conventional T cells, and leads to a comparably dramatic shift to high molecular weight CD45 isoforms. In addition, Hnrpll mutation has a cell intrinsic effect on the expression of the developmentally regulated cell surface marker NK1.1 on NKT cells in the thymus and periphery but does not affect cell numbers. Therefore our results highlight both overlapping and divergent roles for hnRNPLL between conventional T cells and NKT cells. In both cell subsets it is required as a trans-acting factor to regulate alternative splicing of the Ptprc mRNA, but it is only required for survival of conventional T cells.	[Yabas, Mehmet; Goodnow, Christopher C.; Hoyne, Gerard F.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Australian National University; John Curtin School of Medical Research; University of Melbourne	Yabas, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia.	Chris.Goodnow@anu.edu.au; Gerard.Hoyne@nd.edu.au	Yabas, Mehmet/D-9513-2012; Goodnow, Christopher C/V-8108-2018; Hoyne, Gerard/M-5406-2013	Yabas, Mehmet/0000-0002-3462-5389; Goodnow, Christopher C/0000-0001-5296-6155; Hoyne, Gerard/0000-0002-7370-9139; Godfrey, Dale/0000-0002-3009-5472	National Institutes of Health (NIH) [BAA NIAID-DAIT-07-35]; Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC) [219167]; JDRF [7-2006-327]; Ministry of National Education, Republic of Turkey; NHMRC; Australian Research Council (ARC)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC)(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); JDRF(Juvenile Diabetes Research Foundation); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This work was supported by the National Institutes of Health (NIH) contract BAA NIAID-DAIT-07-35; Juvenile Diabetes Research Foundation/National Health and Medical Research Council (JDRF/NHMRC) Special Program Grant 219167 and JDRF Program Grant 7-2006-327. Dr. Yabas was supported by a postgraduate award from the Ministry of National Education, Republic of Turkey, Dr. Godfrey by an NHMRC Principal Research Fellowship and Dr. Goodnow by an Australian Research Council (ARC) Federation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mcnab FW, 2007, J IMMUNOL, V179, P6630, DOI 10.4049/jimmunol.179.10.6630; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wu ZP, 2010, J IMMUNOL, V185, P231, DOI 10.4049/jimmunol.0903625; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004	33	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26440	10.1371/journal.pone.0026440	http://dx.doi.org/10.1371/journal.pone.0026440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073166	Green Published, gold			2022-12-25	WOS:000297198200013
J	Zhu, YG; Ji, F; Shang, H; Zhu, Q; Wang, PX; Xu, CC; Deng, Y; Peng, DH; Ruan, LF; Sun, M				Zhu, Yiguang; Ji, Fang; Shang, Hui; Zhu, Qian; Wang, Pengxia; Xu, Chengchen; Deng, Yun; Peng, Donghai; Ruan, Lifang; Sun, Ming			Gene Clusters Located on Two Large Plasmids Determine Spore Crystal Association (SCA) in Bacillus thuringiensis Subsp finitimus Strain YBT-020	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TOXIN-CODING PLASMID; PROTEIN GENES; EXOSPORIUM; ISRAELENSIS; GERMINATION; PBTOXIS; CLONING	Crystals in Bacillus thuringiensis are usually formed in the mother cell compartment during sporulation and are separated from the spores after mother cell lysis. In a few strains, crystals are produced inside the exosporium and are associated with the spores after sporulation. This special phenotype, named 'spore crystal association' (SCA), typically occurs in B. thuringiensis subsp. finitimus. Our aim was to identify genes determining the SCA phenotype in B. thuringiensis subsp. finitimus strain YBT-020. Plasmid conjugation experiments indicated that the SCA phenotype in this strain was tightly linked with two large plasmids (pBMB26 and pBMB28). A shuttle bacterial artificial chromosome (BAC) library of strain YBT-020 was constructed. Six fragments from BAC clones were screened from this library and discovered to cover the full length of pBMB26; four others were found to cover pBMB28. Using fragment complementation testing, two fragments, each of approximately 35 kb and located on pBMB26 and pBMB28, were observed to recover the SCA phenotype in an acrystalliferous mutant, B. thuringiensis strain BMB171. Furthermore, deletion analysis indicated that the crystal protein gene cry26Aa from pBMB26, along with five genes from pBMB28, were indispensable to the SCA phenotype. Gene disruption and frame-shift mutation analyses revealed that two of the five genes from pBMB28, which showed low similarity to crystal proteins, determined the location of crystals inside the exosporium. Gene disruption revealed that the three remaining genes, similar to spore germination genes, contributed to the stability of the SCA phenotype in strain YBT-020. Our results thus identified the genes determining the SCA phenotype in B. thuringiensis subsp. finitimus.	[Zhu, Yiguang; Shang, Hui; Zhu, Qian; Wang, Pengxia; Xu, Chengchen; Deng, Yun; Peng, Donghai; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Beijing, Peoples R China; [Ji, Fang] Jianghan Univ, Sch Med, Wuhan, Peoples R China	Huazhong Agricultural University; Jianghan University	Zhu, YG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Beijing, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	National Natural Science Foundation of China [30870066, 30470026]; National High Technology Research and Development Program (863 Program) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Agriculture; Ministry of Forestry [2006-4-41]; China National Fundamental Fund of Personnel Training [J0730649]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Forestry; China National Fundamental Fund of Personnel Training	This study was supported by the National Natural Science Foundation of China (30870066 and 30470026), National High Technology Research and Development Program (863 Program) of China grants 2011AA10A203 and 2006AA02Z174, the National Basic Research Program (973) of China (2009CB118902), Genetically Modified Organisms Breeding Major Projects of China grant 2009ZX08009-032B, and China 948 Program of Ministry of Agriculture (2011) and Ministry of Forestry (2006-4-41), and China National Fundamental Fund of Personnel Training (J0730649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoarrahem MM, 2009, APPL ENVIRON MICROB, V75, P6410, DOI 10.1128/AEM.00962-09; ANDRUP L, 1993, J BACTERIOL, V175, P6530, DOI 10.1128/jb.175.20.6530-6536.1993; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aronson A, 2002, CELL MOL LIFE SCI, V59, P417, DOI 10.1007/s00018-002-8434-6; Bailey-Smith K, 2005, J BACTERIOL, V187, P3800, DOI 10.1128/JB.187.11.3800-3806.2005; BAUM JA, 1994, J BACTERIOL, V176, P2835, DOI 10.1128/JB.176.10.2835-2845.1994; BAUM JA, 1991, J BACTERIOL, V173, P5280, DOI 10.1128/jb.173.17.5280-5289.1991; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; DEBRO L, 1986, J BACTERIOL, V165, P258, DOI 10.1128/jb.165.1.258-268.1986; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; GERHARDT P, 1964, J BACTERIOL, V88, P1774, DOI 10.1128/JB.88.6.1774-1789.1964; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; HANNAY CL, 1961, J BIOPHYS BIOCHEM CY, V9, P285, DOI 10.1083/jcb.9.2.285; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hernandez-Soto A, 2009, APPL ENVIRON MICROB, V75, P4661, DOI 10.1128/AEM.00409-09; Ji F, 2009, FEMS MICROBIOL LETT, V300, P11, DOI 10.1111/j.1574-6968.2009.01743.x; Jv Shou-yong, 2007, Weishengwu Xuebao, V47, P88; Kim HS, 2003, CURR MICROBIOL, V46, P33, DOI 10.1007/s00284-002-3801-y; Liu XY, 2010, J BIOL CHEM, V285, P39191, DOI 10.1074/jbc.M110.148387; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; LopezMeza JE, 1996, APPL ENVIRON MICROB, V62, P1306, DOI 10.1128/AEM.62.4.1306-1310.1996; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shao ZZ, 2001, APPL ENVIRON MICROB, V67, P5362, DOI 10.1128/AEM.67.12.5362-5369.2001; SHORT JA, 1974, J GEN MICROBIOL, V84, P261, DOI 10.1099/00221287-84-2-261; Steichen CT, 2007, MOL MICROBIOL, V64, P359, DOI 10.1111/j.1365-2958.2007.05658.x; Stein C, 2006, APPL ENVIRON MICROB, V72, P1771, DOI 10.1128/AEM.72.3.1771-1776.2006; Vidal-Quist JC, 2009, J MICROBIOL BIOTECHN, V19, P749, DOI 10.4014/jmb.0810.595; Wojciechowska JA, 1999, FEBS LETT, V453, P46, DOI 10.1016/S0014-5793(99)00650-X; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025; Zhu YG, 2011, J BACTERIOL, V193, P2379, DOI 10.1128/JB.00267-11	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27164	10.1371/journal.pone.0027164	http://dx.doi.org/10.1371/journal.pone.0027164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076131	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200043
J	Sawides, L; de Gracia, P; Dorronsoro, C; Webster, MA; Marcos, S				Sawides, Lucie; de Gracia, Pablo; Dorronsoro, Carlos; Webster, Michael A.; Marcos, Susana			Vision Is Adapted to the Natural Level of Blur Present in the Retinal Image	PLOS ONE			English	Article							NEURAL COMPENSATION; ADAPTATION	Background: The image formed by the eye's optics is inherently blurred by aberrations specific to an individual's eyes. We examined how visual coding is adapted to the optical quality of the eye. Methods and Findings: We assessed the relationship between perceived blur and the retinal image blur resulting from high order aberrations in an individual's optics. Observers judged perceptual blur in a psychophysical two-alternative forced choice paradigm, on stimuli viewed through perfectly corrected optics (using a deformable mirror to compensate for the individual's aberrations). Realistic blur of different amounts and forms was computer simulated using real aberrations from a population. The blur levels perceived as best focused were close to the levels predicted by an individual's high order aberrations over a wide range of blur magnitudes, and were systematically biased when observers were instead adapted to the blur reproduced from a different observer's eye. Conclusions: Our results provide strong evidence that spatial vision is calibrated for the specific blur levels present in each individual's retinal image and that this adaptation at least partly reflects how spatial sensitivity is normalized in the neural coding of blur.	[Sawides, Lucie; de Gracia, Pablo; Dorronsoro, Carlos; Marcos, Susana] CSIC, Inst Opt, E-28006 Madrid, Spain; [Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes); Nevada System of Higher Education (NSHE); University of Nevada Reno	Sawides, L (corresponding author), CSIC, Inst Opt, Serrano 121, E-28006 Madrid, Spain.	lucie@io.cfmac.csic.es	Sawides, Lucie/O-1431-2016; Dorronsoro, Carlos/AAC-8003-2019; Dorronsoro, Carlos/A-2297-2011; De Gracia, Pablo/B-2786-2017	Sawides, Lucie/0000-0002-8918-8753; Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128; Webster, Michael/0000-0001-8262-7525; De Gracia, Pablo/0000-0003-4319-2797	Ministerio de Ciencia e Innovacion (MICINN) [FIS2008-02065]; Consejo Superior de Investigaciones Cientificas (CSIC); European Heads of Research Councils-European Science Foundation EUROHORCs-ESF [EURYI-05-102-ES];  [EY-10834]; NATIONAL EYE INSTITUTE [R29EY010834, R01EY010834] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); European Heads of Research Councils-European Science Foundation EUROHORCs-ESF; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the following: Ministerio de Ciencia e Innovacion (MICINN), Formacion de Personal Investigador (FPI) Predoctoral Fellowship to LS; Consejo Superior de Investigaciones Cientificas (CSIC) I3P Predoctoral Fellowship to PdG; EY-10834 to MW; MICINN FIS2008-02065 and EURYI-05-102-ES (European Heads of Research Councils-European Science Foundation EUROHORCs-ESF) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Chen L, 2007, J VISION, V7, DOI 10.1167/7.10.9; DEGRACIA P, 2010, VISION RES, V15; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; Elliott SL, 2011, J VISION, V11, DOI 10.1167/11.2.7; Goodman J. W., 1996, INTRO FOURIER OPTICS; Jung GH, 2010, J VISION, V10, DOI 10.1167/10.5.7; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marcos S, 2009, J MOD OPTIC, V56, P2181, DOI 10.1080/09500340902927074; Marcos S, 2008, J VISION, V8, DOI 10.1167/8.13.1; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; Pesudovs K, 2005, J REFRACT SURG, V21, P144; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Rossi EA, 2010, J VISION, V10, DOI 10.1167/10.12.11; Sabesan R, 2010, INVEST OPHTH VIS SCI, V51, P3835, DOI 10.1167/iovs.09-4558; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817	20	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27031	10.1371/journal.pone.0027031	http://dx.doi.org/10.1371/journal.pone.0027031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073247	Green Published, gold			2022-12-25	WOS:000297154900067
J	Lechardeur, D; Cesselin, B; Liebl, U; Vos, MH; Fernandez, A; Brun, C; Gruss, A; Gaudu, P				Lechardeur, Delphine; Cesselin, Benedicte; Liebl, Ursula; Vos, Marten H.; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe			Discovery of Intracellular Heme-binding Protein HrtR, Which Controls Heme Efflux by the Conserved HrtB-HrtA Transporter in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON RESPONSE REGULATOR; STAPHYLOCOCCUS-AUREUS; CORYNEBACTERIUM-DIPHTHERIAE; RESPIRATION CAPACITY; 2-COMPONENT SYSTEM; CYTOCHROME BD; TETR FAMILY; TOXICITY; BACTERIA; GROWTH	Most commensal and food bacteria lack heme biosynthesis genes. For several of these, the capture of environmental heme is a means of activating aerobic respiration metabolism. Our previous studies in the Gram-positive bacterium Lactococcus lactis showed that heme exposure strongly induced expression of a single operon, called here hrtRBA, encoding an ortholog of the conserved membrane hrt (heme-regulated transporter) and a unique transcriptional regulator that we named HrtR. We show that HrtR expressed as a fusion protein is a heme-binding protein. Heme iron interaction with HrtR is non-covalent, hexacoordinated, and involves two histidines, His-72 and His-149. HrtR specifically binds a 15-nt palindromic sequence in the hrtRBA promoter region, which is needed for hrtRBA repression. HrtR-DNA binding is abolished by heme addition, which activates expression of the HrtB-HrtA (HrtBA) transporter in vitro and in vivo. The use of HrtR as an intracellular heme sensor appears to be conserved among numerous commensal bacteria, in contrast with numerous Gram-positive pathogens that use an extracellular heme-sensing system, HssRS, to regulate hrt. Finally, we show for the first time that HrtBA permease controls heme toxicity by its direct and specific efflux. The use of an intracellular heme sensor to control heme efflux constitutes a novel paradigm for bacterial heme homeostasis.	[Lechardeur, Delphine; Cesselin, Benedicte; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe] INRA, UMR1319, Inst Micalis, UMR1319 Micalis, F-78352 Jouy En Josas, France; [Lechardeur, Delphine; Cesselin, Benedicte; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Liebl, Ursula; Vos, Marten H.] Ecole Polytech, Lab Opt & Biosci, CNRS, UMR7645, F-91128 Palaiseau, France; [Liebl, Ursula; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lechardeur, D (corresponding author), INRA, UMR1319, Inst Micalis, UMR1319 Micalis, Batiment 222, F-78352 Jouy En Josas, France.	delphine.lechardeur@jouy.inra.fr	GAUDU, Philippe/AAE-9696-2022; GAUDU, Philippe/AFE-8376-2022	Gruss, Alexandra/0000-0001-7426-5229; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388	French "Agence Nationale de la Recherche"	French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported in part by the "StrepRespire" project by the French "Agence Nationale de la Recherche" and Chr. Hansen.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; Bibb LA, 2010, J BACTERIOL, V192, P4606, DOI 10.1128/JB.00525-10; Brugna M, 2010, FEBS J, V277, P2663, DOI [10.1111/j.1742-464X.2010.07677.x, 10.1111/j.1742-4658.2010.07677.x]; Christel Garrigues Johansen E., 2006, NAT REV MICROBIOL, V4, pc3; Christel Garrigues Johansen E., 2006, NAT REV MICROBIOL, V4, pc2; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Hoier E., 2010, TECHNOLOGY CHEESEMAK, P193; KANEKO T, 1990, APPL ENVIRON MICROB, V56, P2644, DOI 10.1128/AEM.56.9.2644-2649.1990; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Marletta MA, 2006, ACS CHEM BIOL, V1, P73, DOI 10.1021/cb600110g; Miller J.H., 1972, EXPT MOL GENETICS; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Routh MD, 2009, BBA-PROTEINS PROTEOM, V1794, P844, DOI 10.1016/j.bbapap.2008.12.001; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Stauff DL, 2008, J BACTERIOL, V190, P3588, DOI 10.1128/JB.01921-07; Stauff DL, 2007, J BIOL CHEM, V282, P26111, DOI 10.1074/jbc.M703797200; Stauff DL, 2009, CONTRIB MICROBIOL, V16, P120, DOI 10.1159/000219376; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Vido K, 2004, J BACTERIOL, V186, P1648, DOI 10.1128/JB.186.6.1648-1657.2004; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x	40	63	68	8	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4752	4758		10.1074/jbc.M111.297531	http://dx.doi.org/10.1074/jbc.M111.297531			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22084241	Green Published, hybrid			2022-12-25	WOS:000300608500036
J	Herker, E; Ott, M				Herker, Eva; Ott, Melanie			Emerging Role of Lipid Droplets in Host/Pathogen Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; CORE PROTEIN; DENGUE VIRUS; MYCOBACTERIUM-TUBERCULOSIS; APOLIPOPROTEIN-E; DIACYLGLYCEROL ACYLTRANSFERASE; VIRAL REPLICATION; SCHWANN-CELLS; TRIACYLGLYCEROL	Lipid droplets (LDs) are highly dynamic cell organelles involved in energy homeostasis and membrane trafficking. Here, we review how select pathogens interact with LDs. Several RNA viruses use host LDs at different steps of their life cycle. Some intracellular bacteria and parasites usurp host LDs or encode their own lipid biosynthesis machinery, thus allowing production of LDs independently of their host. Although many mechanistic details of host/pathogen LD interactions are unknown, a picture emerges in which the unique cellular architecture and energy stored in LDs are important in the replication of diverse pathogens.	[Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R56 AI085056, P30 DK026743]; Gladstone Institutes; Hellman Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); Hellman Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56 AI085056 and P30 DK026743 (to the UCSF Liver Center). This work was also supported by the Gladstone Institutes and the Hellman Family Foundation. This is the second article in the Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coffey CM, 2006, J VIROL, V80, P8422, DOI 10.1128/JVI.02601-05; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Palacpac NMQ, 2004, BIOCHEM BIOPH RES CO, V321, P1062, DOI 10.1016/j.bbrc.2004.07.070; Palacpac NMQ, 2004, J CELL SCI, V117, P1469, DOI 10.1242/jcs.00988; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parr RD, 2006, J VIROL, V80, P2842, DOI 10.1128/JVI.80.6.2842-2854.2006; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Sabahi A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-117; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Scollard DM, 2006, CLIN INFECT DIS, V43, pE19, DOI 10.1086/505222; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanigawa K, 2008, FEMS MICROBIOL LETT, V289, P72, DOI 10.1111/j.1574-6968.2008.01369.x; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Unterstab G, 2010, VIROLOGY, V399, P322, DOI 10.1016/j.virol.2010.01.011; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vielemeyer O, 2004, MOL BIOCHEM PARASIT, V135, P195, DOI 10.1016/j.molbiopara.2003.08.017; Virchow R., 1863, KRANKHAFTEN GESCHWUL; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang ZQ, 2010, INT J OBESITY, V34, P1355, DOI 10.1038/ijo.2010.77; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	100	68	69	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2280	2287		10.1074/jbc.R111.300202	http://dx.doi.org/10.1074/jbc.R111.300202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090026	Green Published, hybrid			2022-12-25	WOS:000300292300003
J	Hill-Burns, EM; Factor, SA; Zabetian, CP; Thomson, G; Payami, H				Hill-Burns, Erin M.; Factor, Stewart A.; Zabetian, Cyrus P.; Thomson, Glenys; Payami, Haydeh			Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region	PLOS ONE			English	Article							HAPLOTYPES; METAANALYSIS; IMPUTATION; GENETICS; SNCA	Parkinson's disease (PD) was recently found to be associated with HLA in a genome-wide association study (GWAS). Followup GWAS's replicated the PD-HLA association but their top hits differ. Do the different hits tag the same locus or is there more than one PD-associated variant within HLA? We show that the top GWAS hits are not correlated with each other (0.00 <= r(2)<= 0.15). Using our GWAS (2000 cases, 1986 controls) we conducted step-wise conditional analysis on 107 SNPs with P, 10 23 for PD-association; 103 dropped-out, four remained significant. Each SNP, when conditioned on the other three, yielded P-SNP1 = 5610 24, P-SNP2 = 5610 24, P-SNP3 = 4610 23 and P-SNP4 = 0.025. The four SNPs were not correlated (0.01 <= r(2)<= 0.20). Haplotype analysis (excluding rare SNP2) revealed increasing PD risk with increasing risk alleles from OR = 1.27, P = 5610 23 for one risk allele to OR = 1.65, P = 4610 28 for three. Using additional 843 cases and 856 controls we replicated the independent effects of SNP1 (Pconditioned-on-SNP4 = 0.04) and SNP4 (Pconditioned-on-SNP1 = 0.04); SNP2 and SNP3 could not be replicated. In pooled GWAS and replication, SNP1 had ORconditioned-on-SNP4 = 1.23, Pconditioned-on-SNP4 = 6610 27; SNP4 had ORconditioned-on-SNP1 = 1.18, Pconditioned-on-SNP1 = 3610 23; and the haplotype with both risk alleles had OR = 1.48, P = 2x10(-12). Genotypic OR increased with the number of risk alleles an individual possessed up to OR = 1.94, P = 2610 211 for individuals who were homozygous for the risk allele at both SNP1 and SNP4. SNP1 is a variant in HLA-DRA and is associated with HLA-DRA, DRB5 and DQA2 gene expression. SNP4 is correlated (r(2) = 0.95) with variants that are associated with HLA-DQA2 expression, and with the top HLA SNP from the IPDGC GWAS (r(2) = 0.60). Our findings suggest more than one PD-HLA association; either different alleles of the same gene, or separate loci.	[Hill-Burns, Erin M.; Payami, Haydeh] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Factor, Stewart A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Zabetian, Cyrus P.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Zabetian, Cyrus P.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Thomson, Glenys] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	State University of New York (SUNY) System; Wadsworth Center; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of California System; University of California Berkeley	Hill-Burns, EM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	hpayami@wadsworth.org	Payami, Haydeh/ABE-1944-2020	Payami, Haydeh/0000-0001-9084-5338; Zabetian, Cyrus/0000-0002-7739-4306	National Institute of Neurological Disorders And Stroke (NINDS) [R01 NS36960, R01 NS067469]; Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative; Department of Veterans Affairs [I01BX000531]; Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas; National Institute of Allergy and Infectious Disease [AI40076]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067469, R01NS036960] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000531] Funding Source: NIH RePORTER	National Institute of Neurological Disorders And Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative; Department of Veterans Affairs(US Department of Veterans Affairs); Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Study was supported by grants from the National Institute of Neurological Disorders And Stroke (NINDS R01 NS36960 and R01 NS067469 to HP), the Edmond J. Safra Michael J. Fox Foundation Global Genetic Consortium Initiative (HP), the Department of Veterans Affairs ('I01BX000531 to CZ), The Close to a Cure Foundation: A Fund for Parkinson's Research of Foundation for the Carolinas (SF), and the National Institute of Allergy and Infectious Disease (AI40076, GT). Funding support for the replication dataset was provided by the National Institute of Neurological Disorders and Stroke (Foroud/Myers, PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benkler M, 2009, INT J NEUROSCI, V119, P2133, DOI 10.3109/00207450903178786; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes AJ, 1997, EUR NEUROL, V38, P13, DOI 10.1159/000113471; Lin DY, 2007, AM J HUM GENET, V80, P577, DOI 10.1086/512201; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neter J, 1996, APPL LINEAR STAT MOD, P52; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; PAYAMI H, 1989, AM J HUM GENET, V45, P541; PAYAMI H, 1987, AM J HUM GENET, V41, P331; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puschmann A, 2011, PARKINSONISM RELAT D, V17, P376, DOI 10.1016/j.parkreldis.2011.03.008; Rohn TT, 2010, PLOS ONE, V6; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x	29	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27109	10.1371/journal.pone.0027109	http://dx.doi.org/10.1371/journal.pone.0027109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096524	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800027
J	Wang, XL; Xu, HB; Alvarez, X; Pahar, B; Moroney-Rasmussen, T; Lackner, AA; Veazey, RS				Wang, Xiaolei; Xu, Huanbin; Alvarez, Xavier; Pahar, Bapi; Moroney-Rasmussen, Terri; Lackner, Andrew A.; Veazey, Ronald S.			Distinct Expression Patterns of CD69 in Mucosal and Systemic Lymphoid Tissues in Primary SIV Infection of Rhesus Macaques	PLOS ONE			English	Article							CD4(+) T-CELLS; SIMIAN-IMMUNODEFICIENCY-VIRUS; GASTROINTESTINAL-TRACT; IMMUNE ACTIVATION; HIV-INFECTION; IN-VIVO; DEPLETION; SELECTION; PATHOGENESIS; REPLICATION	Although the intestinal tract plays a major role in early human immunodeficiency virus (HIV) infection, the role of immune activation and viral replication in intestinal tissues is not completely understood. Further, increasing evidence suggests the early leukocyte activation antigen CD69 may be involved in the development or regulation of important T cell subsets, as well as a major regulatory molecule of immune responses. Using the simian immunodeficiency virus (SIV) rhesus macaque model, we compared expression of CD69 on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-infected macaques throughout infection. In uninfected macaques, the majority of intestinal lamina propria CD4+ T cells had a memory (CD95+) phenotype and co-expressed CD69, and essentially all intestinal CCR5+ cells co-expressed CD69. In contrast, systemic lymphoid tissues had far fewer CD69+ T cells, and many had a naive phenotype. Further, marked, selective depletion of intestinal CD4+ CD69+ T cells occurred in early SIV infection, and this depletion persisted throughout infection. Markedly increased levels of CD8+CD69+ T cells were detected after SIV infection in virtually all tissues, including the intestine. Further, confocal microscopy demonstrated selective, productive infection of CD3+CD69+ T cells in the intestine in early infection. Combined, these results indicate CD69+CD4+ T cells are a major early target for viral infection, and their rapid loss by direct infection may have profound effects on intestinal immune regulation in HIV infected patients.	[Wang, Xiaolei; Xu, Huanbin; Alvarez, Xavier; Pahar, Bapi; Moroney-Rasmussen, Terri; Lackner, Andrew A.; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA	Tulane University	Wang, XL (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	rveazey@tulane.edu	Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X	National Institutes of Health [AI49080, AI084793, RR000164]; Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049080, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants AI49080, AI084793, and RR000164, and a Faculty Enhancement Grant from Tulane University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Douek Daniel, 2007, Top HIV Med, V15, P114; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Veazey Ronald, 2003, AIDS Rev, V5, P245; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2007, FUTURE HIV THERAPY, V1, P103; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Zeigler SF, 1994, STEM CELLS, V12, P456	32	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27207	10.1371/journal.pone.0027207	http://dx.doi.org/10.1371/journal.pone.0027207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096538	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800038
J	Fullwood, MJ; Lee, J; Lin, LF; Li, GL; Huss, M; Ng, P; Sung, WK; Shenolikar, S				Fullwood, Melissa J.; Lee, Joanne; Lin, Lifang; Li, Guoliang; Huss, Mikael; Ng, Patrick; Sung, Wing-Kin; Shenolikar, Shirish			Next-Generation Sequencing of Apoptotic DNA Breakpoints Reveals Association with Actively Transcribed Genes and Gene Translocations	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; DOUBLE-STRAND BREAKS; FRAGMENTATION FACTOR; CLUSTER REGION; HORIZONTAL TRANSFER; ACTINOMYCIN-D; NUCLEAR-DNA; CLEAVAGE; IDENTIFICATION; BIOLOGY	DNA fragmentation is a well-recognized hallmark of apoptosis. However, the precise DNA sequences cleaved during apoptosis triggered by distinct mechanisms remain unclear. We used next-generation sequencing of DNA fragments generated in Actinomycin D-treated human HL-60 leukemic cells to generate a high-throughput, global map of apoptotic DNA breakpoints. These data highlighted that DNA breaks are non-random and show a significant association with active genes and open chromatin regions. We noted that transcription factor binding sites were also enriched within a fraction of the apoptotic breakpoints. Interestingly, extensive apoptotic cleavage was noted within genes that are frequently translocated in human cancers. We speculate that the non-random fragmentation of DNA during apoptosis may contribute to gene translocations and the development of human cancers.	[Fullwood, Melissa J.; Lin, Lifang] Duke NUS Grad Med Sch Singapore, A STAR Duke NUS Neurosci Partnership, Singapore, Singapore; [Fullwood, Melissa J.; Lee, Joanne; Li, Guoliang; Sung, Wing-Kin] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Fullwood, Melissa J.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Huss, Mikael; Ng, Patrick] 1st Base Pte Ltd, Singapore, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, Singapore, Singapore; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; Duke University	Fullwood, MJ (corresponding author), Duke NUS Grad Med Sch Singapore, A STAR Duke NUS Neurosci Partnership, Singapore, Singapore.	Shirish.shenolikar@duke-nus.edu.sg	Li, Guoliang/D-8014-2012; Fullwood, Melissa/G-5713-2011	Li, Guoliang/0000-0003-1601-6640; Fullwood, Melissa/0000-0003-0321-7865; Sung, Wing-Kin/0000-0001-7806-7086; Huss, Mikael/0000-0003-0839-2451	Duke-NUS; Singapore Ministry of Education [T1]; Lee Kwan Yew Postdoctoral Fellowship; L'Oreal for Women in Science Fellowship	Duke-NUS; Singapore Ministry of Education(Ministry of Education, Singapore); Lee Kwan Yew Postdoctoral Fellowship; L'Oreal for Women in Science Fellowship	This study was supported by Duke-NUS funds to S.S. and a Singapore Ministry of Education grant (T1) to M.J.F. M.J.F. is supported by a Lee Kwan Yew Postdoctoral Fellowship and a L'Oreal for Women in Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boyle AP, 2011, GENOME RES; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Di Filippo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005010; Didenko VV, 1996, J CELL BIOL, V135, P1369, DOI 10.1083/jcb.135.5.1369; Dullea RG, 1999, CANCER RES, V59, P3712; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Futami T, 2005, J BIOL CHEM, V280, P826, DOI 10.1074/jbc.M409948200; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gogusev J, 2002, CANCER GENET CYTOGEN, V138, P95, DOI 10.1016/S0165-4608(02)00589-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Holmgren L, 2010, BIOCHEM BIOPH RES CO, V396, P147, DOI 10.1016/j.bbrc.2010.04.026; Hsieh SY, 2003, BRIT J CANCER, V88, P210, DOI 10.1038/sj.bjc.6600695; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huebner K, 1998, ANNU REV GENET, V32, P7, DOI 10.1146/annurev.genet.32.1.7; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Liu HS, 2009, BIOCHEM J, V422, P543, DOI 10.1042/BJ20090342; Liu QY, 2003, CELL DEATH DIFFER, V10, P278, DOI 10.1038/sj.cdd.4401146; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Mirault ME, 2006, AM J HUM GENET, V79, P779, DOI 10.1086/507791; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; MIYASHITA T, 1995, CELL, V80, P293; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sim SP, 2001, J BIOL CHEM, V276, P31590, DOI 10.1074/jbc.M103962200; Stanulla M, 1997, LEUKEMIA, V11, P490, DOI 10.1038/sj.leu.2400632; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Stanulla M, 2001, HUM MOL GENET, V10, P2481, DOI 10.1093/hmg/10.22.2481; Stenman G, 2010, CELL CYCLE, V9, P2986, DOI 10.4161/cc.9.15.12515; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Turan T, 2006, INT J GYNECOL CANCER, V16, P1432, DOI 10.1111/j.1525-1438.2006.00606.x; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Winter DB, 1998, NUCLEIC ACIDS RES, V26, P4422, DOI 10.1093/nar/26.19.4422; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yan B, 2006, ONCOGENE, V25, P5370, DOI 10.1038/sj.onc.1209535; Yan B, 2006, P NATL ACAD SCI USA, V103, P1504, DOI 10.1073/pnas.0507779103; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2011, NUCL ACIDS RES	69	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26054	10.1371/journal.pone.0026054	http://dx.doi.org/10.1371/journal.pone.0026054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087219	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700002
J	Jourdan, M; Deutz, NEP; Cynober, L; Aussel, C				Jourdan, Marion; Deutz, Nicolaas E. P.; Cynober, Luc; Aussel, Christian			Features, Causes and Consequences of Splanchnic Sequestration of Amino Acid in Old Rats	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; WHOLE-BODY; ADIPOSE-TISSUE; DIETARY RESTRICTION; ISOTOPE ENRICHMENT; DRAINED VISCERA; METABOLIC FLUX; ELDERLY-MEN; IN-VIVO; LEUCINE	Rationale: In elderly subjects, splanchnic extraction of amino acids (AA) increases during meals in a process known as splanchnic sequestration of amino acids (SSAA). This process potentially contributes to the age-related progressive decline in muscle mass via reduced peripheral availability of dietary AA. SSAA mechanisms are unknown but may involve an increased net utilization of ingested AA in the splanchnic area. Objectives: Using stable isotope methodology in fed adult and old rats to provide insight into age-related SSAA using three hypotheses: 1) an increase in protein synthesis in the gut and/or the liver, 2) an increase in AA oxidation related to an increased ureagenesis, and 3) Kupffer cell (KC) activation consequently to age-related low-grade inflammation. Findings: Splanchnic extraction of Leu (SPELeu) was doubled in old rats compared to adult rats and was not changed after KC inactivation. No age-related effects on gut and liver protein synthesis were observed, but urea synthesis was lower in old rats and negatively correlated to liver Arg utilization. Net whole-body protein synthesis and arterial AA levels were lower in old rats and correlated negatively with SPELeu. Conclusion: SSAA is not the consequence of age-related alterations in ureagenesis, gut or liver protein synthesis or of KC activity. However, SSAA may be related to reduced net whole-body protein synthesis and consequently to the reduced lean body mass that occurs during aging.	[Jourdan, Marion; Cynober, Luc; Aussel, Christian] Paris Descartes Univ, Lab Biol Nutr EA 4466, Paris, France; [Deutz, Nicolaas E. P.] Maastricht Univ, Dept Surg, Maastricht, Netherlands; [Cynober, Luc] Cochin Hosp APHP, Paris, France; [Cynober, Luc] Hotel Dieu Hosp APHP, Paris, France; [Aussel, Christian] Henri Mondor Hosp APHP, PUI, Nutr Unit, Creteil, France	UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Jourdan, M (corresponding author), Paris Descartes Univ, Lab Biol Nutr EA 4466, Paris, France.	christian.aussel@erx.aphp.fr	Cynober, Luc/ABB-2368-2020; Deutz, Nicolaas E/J-5200-2012	Deutz, Nicolaas/0000-0001-5845-6447	French Ministry of Research and Technology [EA 2498]; Ajinomoto Inc.; ESPEN-ABBOTT	French Ministry of Research and Technology; Ajinomoto Inc.; ESPEN-ABBOTT	This program was supported by a grant from the French Ministry of Research and Technology (2002-2005 four-year contract/EA 2498) and an unrestricted grant from Ajinomoto Inc. Marion Jourdan was supported by an ESPEN-ABBOTT fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2009, AGE, V31, P155, DOI 10.1007/s11357-009-9092-5; BARRETT EJ, 1987, BIOCHEM J, V245, P223, DOI 10.1042/bj2450223; Beliveau CG, 1993, BIOCHEM J, V292, P241; Boirie Y, 1997, AM J CLIN NUTR, V65, P489; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; BORKAN GA, 1977, HUM BIOL, V49, P495; Bruins MJ, 2000, J NUTR, V130, P3003, DOI 10.1093/jn/130.12.3003; BRUN C, 1951, J LAB CLIN MED, V37, P955; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; CYNOBER L, 2004, ENCY BIOL CHEM, P90; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630; Felgines C, 1999, JPEN-PARENTER ENTER, V23, P32, DOI 10.1177/014860719902300132; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4; FRICK GP, 1981, J BIOL CHEM, V256, P2618; FRICK GP, 1988, J BIOL CHEM, V263, P3245; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jefferson LS, 2001, J NUTR, V131, p2460S, DOI 10.1093/jn/131.9.2460S; Jourdan M, 2008, AM J PHYSIOL-REG I, V294, pR748, DOI 10.1152/ajpregu.00291.2007; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kumagai K, 2007, TOXICOLOGY, V241, P106, DOI 10.1016/j.tox.2007.08.090; Lochs H, 1987, Beitr Infusionther Klin Ernahr, V17, P167; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X; MERRY BJ, 1992, EXP GERONTOL, V27, P191, DOI 10.1016/0531-5565(92)90043-Y; Morais JA, 1997, AM J CLIN NUTR, V66, P880, DOI 10.1093/ajcn/66.4.880; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; NAIR KS, 1992, AM J PHYSIOL, V263, pE928, DOI 10.1152/ajpendo.1992.263.5.E928; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Pailla K, 2001, CLIN NUTR, V20, P313, DOI 10.1054/clnu.2001.0421; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; RAO TI, 1982, J NEUROSCI RES, V7, P387, DOI 10.1002/jnr.490070404; ROSENBLATT J, 1992, AM J PHYSIOL, V263, pE584, DOI 10.1152/ajpendo.1992.263.3.E584; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; SCHAUDER P, 1987, SCAND J CLIN LAB INV, V47, P447; SHINNICK FL, 1976, BIOCHIM BIOPHYS ACTA, V437, P477, DOI 10.1016/0304-4165(76)90016-7; Tenhave GAM, 1996, LAB ANIM-UK, V30, P347, DOI 10.1258/002367796780739862; Timmerman KL, 2008, CURR OPIN CLIN NUTR, V11, P45, DOI 10.1097/MCO.0b013e3282f2a592; TOURIAN A, 1969, J CELL PHYSIOL, V73, P159, DOI 10.1002/jcp.1040730210; Van Eijk HMH, 2007, J CHROMATOGR B, V856, P48, DOI 10.1016/j.jchromb.2007.05.020; van Eijk HMH, 1999, ANAL BIOCHEM, V271, P8, DOI 10.1006/abio.1999.4112; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693	54	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27002	10.1371/journal.pone.0027002	http://dx.doi.org/10.1371/journal.pone.0027002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087243	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700013
J	Riegel, AK; Busch, R; Segal, S; Fox, JA; Eltzschig, HK; Shernan, SK				Riegel, Ann K.; Busch, Raila; Segal, Scott; Fox, John A.; Eltzschig, Holger K.; Shernan, Stanton K.			Evaluation of Transmitral Pressure Gradients in the Intraoperative Echocardiographic Diagnosis of Mitral Stenosis after Mitral Valve Repair	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HALF-TIME; PULMONARY EMBOLECTOMY; 3D ECHOCARDIOGRAPHY; REGURGITATION; AREA; EMBOLISM; RECURRENCE; ANESTHESIA; SURGERY	Objective: Acute mitral stenosis (MS) following mitral valve (MV) repair is a rare but severe complication. We hypothesize that intraoperative echocardiography can be utilized to diagnose iatrogenic MS immediately after MV repair. Methods: The medical records of 552 consecutive patients undergoing MV repair at a single institution were reviewed. Post-cardiopulmonary bypass peak and mean transmitral pressure gradients (TMPG), and pressure half time (PHT) were obtained from intraoperative transesophageal echocardiographic (TEE) examinations in each patient. Results: Nine patients (9/552 = 1.6%) received a reoperation for primary MS, prior to hospital discharge. Interestingly, all of these patients already showed intraoperative post-CPB mean and peak TMPGs that were significantly higher compared to values for those who did not: 10.7 +/- 4.8 mmHg vs 2.9 +/- 1.6 mmHg; p<0.0001 and 22.9 +/- 7.9 mmHg vs 7.6 +/- 3.7 mmHg; p<0.0001, respectively. However, PHT varied considerably (87 +/- 37 ms; range: 20-439 ms) within the entire population, and only weakly predicted the requirement for reoperation (113 +/- 56 vs. 87 +/- 37 ms, p = 0.034). Receiver operating characteristic curves showed strong discriminating ability for mean gradients (AUC = 0.993) and peak gradients (area under the curve, AUC = 0.996), but poor performance for PHT (AUC = 0.640). A value of >= 7 mmHg for mean, and >= 17 mmHg for peak TMPG, best separated patients who required reoperation for MS from those who did not. Conclusions: Intraoperative TEE diagnosis of a peak TMPG >= 17 mmHg or mean TMPG >= 7 mmHg immediately following CPB are suggestive of clinically relevant MS after MV repair.	[Riegel, Ann K.; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA; [Busch, Raila] Univ Hosp Greifswald, Dept Cardiol Angiol Pneumol & Intens Care Med, Greifswald, Germany; [Segal, Scott] Tufts Med Ctr, Dept Anesthesiol, Boston, MA USA; [Fox, John A.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of Colorado System; University of Colorado Denver; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Riegel, AK (corresponding author), Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA.	holger.eltzschig@ucdenver.edu; sshernan@partners.org	Segal, Scott/S-4157-2019	Segal, Scott/0000-0002-7647-6422	Brigham and Women's Hospital, Boston, MA	Brigham and Women's Hospital, Boston, MA	Departmental funding, Brigham and Women's Hospital, Boston, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Chu JW, 2008, J AM SOC ECHOCARDIOG, V21, P1006, DOI 10.1016/j.echo.2008.05.010; Cohn LH, 2002, ADV CARDIOL, V39, P153; Eltzschig HK, 2004, NEW ENGL J MED, V350, P2424, DOI 10.1056/NEJM200406033502323; Eltzschig HK, 2003, J CARDIOTHOR VASC AN, V17, P422, DOI 10.1016/S1053-0770(03)00145-9; Eltzschig HK, 2003, NEW ENGL J MED, V348, P319, DOI 10.1056/NEJMra021276; Eltzschig HK, 2002, ANESTHESIOLOGY, V97, P1627, DOI 10.1097/00000542-200212000-00041; Eltzschig HK, 2002, ANAESTHESIST, V51, P81; Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015; Eltzschig Holger K, 2005, J Am Soc Echocardiogr, V18, P1221; Felbinger TW, 2003, CAN J ANAESTH, V50, P480, DOI 10.1007/BF03021060; FERNANDEZ J, 1992, ANN THORAC SURG, V54, P440, DOI 10.1016/0003-4975(92)90433-5; Firstenberg MS, 2001, J HEART VALVE DIS, V10, P49; Flameng W, 2003, CIRCULATION, V107, P1609, DOI 10.1161/01.CIR.0000058703.26715.9D; HATLE L, 1979, CIRCULATION, V60, P1096, DOI 10.1161/01.CIR.60.5.1096; Ibrahim MF, 2002, ANN THORAC SURG, V73, P34, DOI 10.1016/S0003-4975(01)03305-7; Kouris Nikos, 2005, Eur J Echocardiogr, V6, P435; Mannaerts HFJ, 2004, EUR HEART J, V25, P2073, DOI 10.1016/j.ehj.2004.10.001; Maslow A, 2011, J CARDIOTHOR VASC AN, V25, P486, DOI 10.1053/j.jvca.2010.04.006; Maslow A, 2011, J CARDIOTHOR VASC AN, V25, P221, DOI 10.1053/j.jvca.2010.11.022; Memtsoudis SG, 2006, ANESTH ANALG, V102, P1653, DOI 10.1213/01.ane.0000216412.83790.29; Mergner D, 2005, ANAESTHESIST, V54, P427, DOI 10.1007/s00101-005-0846-x; Mohan JC, 2004, AM HEART J, V148, P703, DOI 10.1016/j.ahj.2003.12.043; Mohan JC, 2002, J AM COLL CARDIOL, V40, P1809, DOI 10.1016/S0735-1097(02)02487-7; Muehrcke DD, 1997, ANN THORAC SURG, V63, P1718, DOI 10.1016/S0003-4975(97)00271-3; Muratori M, 2001, J HEART VALVE DIS, V10, P65; Nowak M, 2006, ANAESTHESIST, V55, P337, DOI 10.1007/s00101-006-0992-9; Nowak M, 2005, ECHOCARDIOGRAP UNPUB; Nowak M, 2008, J CLIN ANESTH, V20, P136, DOI 10.1016/j.jclinane.2007.06.026; Nowak M, 2006, ANESTHESIOLOGY, V104, P1346, DOI 10.1097/00000542-200606000-00042; Poh KK, 2006, INT J CARDIOL, V108, P177, DOI 10.1016/j.ijcard.2005.04.027; RIFKIN RD, 1995, J AM COLL CARDIOL, V26, P458, DOI 10.1016/0735-1097(95)80023-A; Rosenberger P, 2005, J CLIN ANESTH, V17, P146, DOI 10.1016/j.jclinane.2004.12.009; Rosenberger P, 2005, ANN THORAC SURG, V79, P1092, DOI 10.1016/j.athoracsur.2004.04.103; Rosenberger P, 2005, ANESTH ANALG, V100, P292, DOI 10.1213/01.ANE.0000141274.42848.40; Rosenberger P, 2004, ANN THORAC SURG, V78, P862, DOI 10.1016/j.athoracsur.2004.02.069; Rosenberger P, 2004, ANESTH ANALG, V99, P12, DOI 10.1213/01.ANE.0000117284.25696.64; Russo A, 2008, J AM COLL CARDIOL, V51, P1203, DOI 10.1016/j.jacc.2007.10.058; Schlosshan D, 2011, JACC-CARDIOVASC IMAG, V4, P580, DOI 10.1016/j.jcmg.2010.12.009; Shernan SK, 2007, CRIT CARE MED, V35, pS372, DOI 10.1097/01.CCM.0000270248.34274.AB; Singh P, 2009, ECHOCARDIOGR-J CARD, V26, P980, DOI 10.1111/j.1540-8175.2009.01022.x; Tanaka K, 2003, J CARDIOVASC SURG, V44, P59; THOMAS JD, 1988, CIRCULATION, V78, P980, DOI 10.1161/01.CIR.78.4.980; Umana JP, 1998, ANN THORAC SURG, V66, P1640, DOI 10.1016/S0003-4975(98)00828-5; Williams ML, 2009, ANN THORAC SURG, V88, P1197, DOI 10.1016/j.athoracsur.2009.06.022; Zamorano J, 2004, EUR HEART J, V25, P2086, DOI 10.1016/j.ehj.2004.09.041; Zhao LP, 2007, J THORAC CARDIOV SUR, V133, P1257, DOI 10.1016/j.jtcvs.2006.12.048	48	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26559	10.1371/journal.pone.0026559	http://dx.doi.org/10.1371/journal.pone.0026559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087230	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700007
J	Shepard, ELC; Lambertucci, SA; Vallmitjana, D; Wilson, RP				Shepard, Emily L. C.; Lambertucci, Sergio A.; Vallmitjana, Diego; Wilson, Rory P.			Energy Beyond Food: Foraging Theory Informs Time Spent in Thermals by a Large Soaring Bird	PLOS ONE			English	Article							MARGINAL VALUE THEOREM; ANDEAN CONDOR; MIGRATION; FLIGHT; PERFORMANCE; MOVEMENT; PATTERNS; BEHAVIOR; SEA	Current understanding of how animals search for and exploit food resources is based on microeconomic models. Although widely used to examine feeding, such constructs should inform other energy-harvesting situations where theoretical assumptions are met. In fact, some animals extract non-food forms of energy from the environment, such as birds that soar in updraughts. This study examined whether the gains in potential energy (altitude) followed efficiency-maximising predictions in the world's heaviest soaring bird, the Andean condor (Vultur gryphus). Animal-attached technology was used to record condor flight paths in three-dimensions. Tracks showed that time spent in patchy thermals was broadly consistent with a strategy to maximise the rate of potential energy gain. However, the rate of climb just prior to leaving a thermal increased with thermal strength and exit altitude. This suggests higher rates of energetic gain may not be advantageous where the resulting gain in altitude would lead to a reduction in the ability to search the ground for food. Consequently, soaring behaviour appeared to be modulated by the need to reconcile differing potential energy and food energy distributions. We suggest that foraging constructs may provide insight into the exploitation of non-food energy forms, and that non-food energy distributions may be more important in informing patterns of movement and residency over a range of scales than previously considered.	[Shepard, Emily L. C.; Vallmitjana, Diego; Wilson, Rory P.] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales; [Lambertucci, Sergio A.; Vallmitjana, Diego] Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina	Swansea University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Shepard, ELC (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales.	e.l.c.shepard@swansea.ac.uk		Shepard, Emily/0000-0001-7325-6398; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Leverhulme Early Career Fellowship; National Geographic Society [W133-10]; Wingate scholarship; Fundacion Banco Bilbao Vizcaya Argentaria [BIOCON-08-126]	Leverhulme Early Career Fellowship(Leverhulme Trust); National Geographic Society(National Geographic Society); Wingate scholarship; Fundacion Banco Bilbao Vizcaya Argentaria	Funding was provided through a Leverhulme Early Career Fellowship (to ES) and a National Geographic Society/Waitt Grant (W133-10), with additional support from a Wingate scholarship (to ES). Fieldwork was conducted in collaboration with Fundacion Banco Bilbao Vizcaya Argentaria project BIOCON-08-126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akos Z, 2008, P NATL ACAD SCI USA, V105, P4139, DOI 10.1073/pnas.0707711105; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Bradbury T., 2000, METEOROLOGY FLIGHT P; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Houston DC, 1974, AFR J ECOL, V12, P63, DOI [10.1111/j.1365-2028.1974.tb00107.x, DOI 10.1111/J.1365-2028.1974.TB00107.X]; JONES FRH, 1979, J CONSEIL, V38, P331; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Leshem Y, 1998, IBIS, V140, P41, DOI 10.1111/j.1474-919X.1998.tb04539.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; MCGAHAN J, 1973, J EXP BIOL, V58, P225; MCNAIR JN, 1982, AM NAT, V119, P511, DOI 10.1086/283929; PALADINES OL, 1964, J NUTR, V82, P145, DOI 10.1093/jn/82.1.145; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Stephens D., 2007, FORAGING BEHAV ECOLO; Tsoar A, 2011, P NATL ACAD SCI US; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; White C.M., 1994, NEW WORLD VULTURES G; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Wilson RP, 2011, P ROY SOC B IN PRESS	31	56	56	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27375	10.1371/journal.pone.0027375	http://dx.doi.org/10.1371/journal.pone.0027375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087301	Green Published, gold			2022-12-25	WOS:000297349700036
J	Zhao, RM; Dai, H; Qiu, S; Li, T; He, YW; Ma, YB; Chen, ZY; Wu, YL; Li, WX; Cao, ZJ				Zhao, Ruiming; Dai, Hui; Qiu, Su; Li, Tian; He, Yawen; Ma, Yibao; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			SdPI, The First Functionally Characterized Kunitz-Type Trypsin Inhibitor from Scorpion Venom	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; TRANSCRIPTOME ANALYSIS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; LYCHAS-MUCRONATUS; TOXIN SEQUENCES; NEUROTOXIN; CLONING; CONKUNITZIN-S1; PANCREATITIS	Background: Kunitz-type venom peptides have been isolated from a wide variety of venomous animals. They usually have protease inhibitory activity or potassium channel blocking activity, which by virtue of the effects on predator animals are essential for the survival of venomous animals. However, no Kunitz-type peptides from scorpion venom have been functionally characterized. Principal Findings: A new Kunitz-type venom peptide gene precursor, SdPI, was cloned and characterized from a venom gland cDNA library of the scorpion Lychas mucronatus. It codes for a signal peptide of 21 residues and a mature peptide of 59 residues. The mature SdPI peptide possesses a unique cysteine framework reticulated by three disulfide bridges, different from all reported Kunitz-type proteins. The recombinant SdPI peptide was functionally expressed. It showed trypsin inhibitory activity with high potency (K(i) = 1.6 x 10(-7) M) and thermostability. Conclusions: The results illustrated that SdPI is a potent and stable serine protease inhibitor. Further mutagenesis and molecular dynamics simulation revealed that SdPI possesses a serine protease inhibitory active site similar to other Kunitz-type venom peptides. To our knowledge, SdPI is the first functionally characterized Kunitz-type trypsin inhibitor derived from scorpion venom, and it represents a new class of Kunitz-type venom peptides.	[Zhao, Ruiming; Dai, Hui; Qiu, Su; Li, Tian; He, Yawen; Ma, Yibao; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Zhao, RM (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Zhao, Ruiming/C-1817-2017; Ma, Yibao/H-3849-2016	Ma, Yibao/0000-0002-3270-8893	National Natural Sciences Foundation of China [30971500, 31071942]; Major State Basic Research Development Program of China [2010CB529800, 2010CB530100]; China Specific Project for Developing New Drugs [2009ZX09103-612]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); China Specific Project for Developing New Drugs	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 30971500 and 31071942) and the Major State Basic Research Development Program of China (Nos. 2010CB529800 and 2010CB530100), and the China Specific Project for Developing New Drugs (No. 2009ZX09103-612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Barbar E, 2001, BIOCHEMISTRY-US, V40, P9734, DOI 10.1021/bi010483z; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Brillard-Bourdet M, 2006, BIOCHEM J, V400, P467, DOI 10.1042/BJ20060437; Cao ZJ, 2005, IUBMB LIFE, V57, P513, DOI 10.1080/15216540500149870; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; Hoogerwerf WA, 2005, CURR OPIN PHARMACOL, V5, P578, DOI 10.1016/j.coph.2005.06.007; Kozlov S A, 2009, Bioorg Khim, V35, P789; Lewis R. J., 2009, V46, P45, DOI 10.1007/978-3-540-87895-7_2; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Minagawa S, 2008, COMP BIOCHEM PHYS B, V150, P240, DOI 10.1016/j.cbpb.2008.03.010; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; STRYDOM DJ, 1973, NATURE-NEW BIOL, V243, P88; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; VINCENT JP, 1974, EUR J BIOCHEM, V42, P505, DOI 10.1111/j.1432-1033.1974.tb03365.x; Wang GJ, 2009, WORLD J GASTROENTERO, V15, P1427, DOI 10.3748/wjg.15.1427; Wu WL, 2007, PEPTIDES, V28, P2306, DOI 10.1016/j.peptides.2007.10.009; YI H, BMC STRUCT BIOL, V11, P3; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	35	35	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27548	10.1371/journal.pone.0027548	http://dx.doi.org/10.1371/journal.pone.0027548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087336	gold, Green Published, Green Submitted			2022-12-25	WOS:000297349700058
J	Ellis, L; Lehet, K; Ramakrishnan, S; Adelaiye, R; Miles, KM; Wang, D; Liu, S; Atadja, P; Carducci, MA; Pili, R				Ellis, Leigh; Lehet, Kristin; Ramakrishnan, Swathi; Adelaiye, Remi; Miles, Kiersten M.; Wang, Dan; Liu, Song; Atadja, Peter; Carducci, Michael A.; Pili, Roberto			Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PROSTATE-CANCER; MAMMALIAN TARGET; C-MYC; ANGIOGENESIS; COMBINATION; VORINOSTAT; CARCINOMA; RAPAMYCIN; PROTEINS	Specific inhibitors towards Histone Deacetylases (HDACs) and Mammalian Target of Rapamycin Complex 1 (mTORC1) have been developed and demonstrate potential as treatments for patients with advanced and/or metastatic and castrate resistant prostate cancer (PCa). Further, deregulation of HDAC expression and mTORC1 activity are documented in PCa and provide rational targets to create new therapeutic strategies to treat PCa. Here we report the use of the c-Myc adenocarcinoma cell line from the c-Myc transgenic mouse with prostate cancer to evaluate the in vitro and in vivo antitumor activity of the combination of the HDAC inhibitor panobinostat with the mTORC1 inhibitor everolimus. Panobinostat/everolimus combination treatment resulted in significantly greater antitumor activity in mice bearing androgen sensitive Myc-CaP and castrate resistant Myc-CaP tumors compared to single treatments. We identified that panobinostat/everolimus combination resulted in enhanced anti-tumor activity mediated by decreased tumor growth concurrent with augmentation of p21 and p27 expression and the attenuation of angiogenesis and tumor proliferation via androgen receptor, c-Myc and HIF-1 alpha signaling. Also, we observed altered expression of microRNAs associated with these three transcription factors. Overall, our results demonstrate that low dose concurrent panobinostat/everolimus combination therapy is well tolerated and results in greater anti-tumor activity compared to single treatments in tumor bearing immuno-competent mice. Finally, our results suggest that response of selected miRs could be utilized to monitor panobinostat/everolimus in vivo activity.	[Ellis, Leigh; Lehet, Kristin; Ramakrishnan, Swathi; Adelaiye, Remi; Miles, Kiersten M.; Pili, Roberto] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Genitourinary Program, Buffalo, NY 14263 USA; [Wang, Dan; Liu, Song] Roswell Pk Canc Inst, Dept Bioinformat, Buffalo, NY 14263 USA; [Atadja, Peter] Novartis Biomed Res Inst, Shanghai, Peoples R China; [Carducci, Michael A.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Johns Hopkins University; Johns Hopkins Medicine	Ellis, L (corresponding author), Roswell Pk Canc Inst, Grace Canc Drug Ctr, Genitourinary Program, Buffalo, NY 14263 USA.	Roberto.pili@roswellpark.org	Ramakrishnan, Swathi/O-5054-2019; Carducci, Michael/R-8164-2019	Adelaiye-Ogala, Remi/0000-0002-6581-7359	Department of Defense [PC040800]; National Cancer Institute [P50CA58236]; NCI [P30CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056, P50CA058236, P30CA006973] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the Department of Defense-PC040800 (to LE) and the National Cancer Institute-P50CA58236 (to RP and MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In vivo bioluminescence imaging studies were performed through the Shared Tumor imaging Resource at Roswell Park Cancer Institute supported by NCI P30CA16056 (Trump, DL). We kindly thank past and present members of the Pili laboratory for insightful discussions.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Atadja P, 2004, CANCER RES, V64, P689, DOI 10.1158/0008-5472.CAN-03-2043; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradley D, 2009, CANCER-AM CANCER SOC, V115, P5541, DOI 10.1002/cncr.24597; Chiong E, 2011, CLIN CANCER RES, V17, P2863, DOI 10.1158/1078-0432.CCR-09-3202; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Ellis L, 2011, PROSTATE; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Ellis L, 2010, PHARMACEUTICALS, V3, P2441, DOI 10.3390/ph3082441; Ellis L, 2009, BLOOD, V114, P380, DOI 10.1182/blood-2008-10-182758; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Emmenegger U, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.tps246; Evren S, 2010, PROSTATE, V70, P1429, DOI 10.1002/pros.21178; Garcia JA, 2008, MOL CANCER THER, V7, P1347, DOI 10.1158/1535-7163.MCT-07-2408; Glaser KB, 2003, MOL CANCER THER, V2, P151; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurel B, 2008, ADV ANAT PATHOL, V15, P319, DOI 10.1097/PAP.0b013e31818a5c19; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hao Y, 2011, CANC INVEST; Hwang JJ, 2010, J UROLOGY, V184, P2557, DOI 10.1016/j.juro.2010.07.035; Iacopino F, 2008, INT J ONCOL, V32, P1293; Jans J, 2010, UROLOGY, V75, P786, DOI 10.1016/j.urology.2009.08.024; Kaarbo M, 2010, CELL ONCOL, V32, P11, DOI 10.3233/CLO-2009-0487; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Nguyen DM, 2004, CLIN CANCER RES, V10, P1813, DOI 10.1158/1078-0432.CCR-0901-3; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pesta M, 2010, ANTICANCER RES, V30, P3579; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rai JS, 2010, UROL ONCOL-SEMIN ORI, V28, P134, DOI 10.1016/j.urolonc.2009.03.023; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Tessel MA, 2010, CURR OPIN ONCOL, V22, P592, DOI 10.1097/CCO.0b013e32833ea80c; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Wang LG, 2008, INT J ONCOL, V33, P375, DOI 10.3892/ijo_00000018; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Wedel S, 2011, LIFE SCI, V88, P418, DOI 10.1016/j.lfs.2010.12.017; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Wu Y, 2010, ANTICANCER RES, V30, P3895; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246	59	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27178	10.1371/journal.pone.0027178	http://dx.doi.org/10.1371/journal.pone.0027178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087262	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700026
J	Juneja, J; Cushman, I; Casey, PJ				Juneja, Juhi; Cushman, Ian; Casey, Patrick J.			G12 Signaling through c-Jun NH2-Terminal Kinase Promotes Breast Cancer Cell Invasion	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; LEUCINE-ZIPPER PROTEIN; STRESS FIBER FORMATION; SERUM RESPONSE FACTOR; TERMINAL KINASE; COUPLED RECEPTORS; REGULATED KINASE; LYSOPHOSPHATIDIC ACID; TRANSCRIPTION FACTORS; SCAFFOLDING PROTEIN	Signaling through the heterotrimeric G protein, G12, via Rho induces a striking increase in breast cancer cell invasion. In this study, evidence is provided that the c-Jun NH2-terminal kinase (JNK) is a key downstream effector of G12 on this pathway. Expression of constitutively-active G alpha 12 or activation of G12 signaling by thrombin leads to increased JNK and c-Jun phosphorylation. Pharmacologic inhibition of JNK or knockdown of JNK expression by siRNA significantly decreases G12-induced JNK activation as well as the ability of breast cancer cells to invade a reconstituted basement membrane. Furthermore, expression of dominant-negative Rho or treatment of cells with an inhibitor of the Rho kinase, ROCK, reduces G12-induced JNK and c-Jun activation, and ROCK inhibitor treatment also inhibits G12-induced cellular invasion. JNK knockdown or ROCK inhibitor treatment has no effect on activation of Rho by G12. Taken together, our data indicate that JNK activation is required for G12-induced invasion of breast cancer cells and that JNK is downstream of Rho and ROCK on this pathway. This study implicates a G12-stimulated mitogen-activated protein kinase cascade in cancer cell invasion, and supports a role for JNK in cancer progression.	[Juneja, Juhi; Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	Duke University; National University of Singapore	Juneja, J (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	patrick.casey@duke.edu		Casey, Patrick/0000-0002-7366-9309	National Institutes of Health (USA); National Medical Research Council (Singapore); Human Frontier Science Program Fellowship	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council (Singapore)(National Medical Research Council, Singapore); Human Frontier Science Program Fellowship(Human Frontier Science Program)	This work was supported by grants from the National Institutes of Health (USA) and National Medical Research Council (Singapore) (to P.J.C.) and a Human Frontier Science Program Fellowship (to J.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Dermott JM, 2004, ONCOGENE, V23, P226, DOI 10.1038/sj.onc.1207009; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2011, NEOPLASIA, V13, P358, DOI 10.1593/neo.101622; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Malchinkhuu E, 2005, ONCOGENE, V24, P6676, DOI 10.1038/sj.onc.1208805; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Meigs TE, 2005, J BIOL CHEM, V280, P18049, DOI 10.1074/jbc.M500445200; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shimada K, 2007, AM J PATHOL, V171, P1003, DOI 10.2353/ajpath.2007.070010; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tabu K, 2007, MOL CANCER RES, V5, P1099, DOI 10.1158/1541-7786.MCR-07-0096; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26085	10.1371/journal.pone.0026085	http://dx.doi.org/10.1371/journal.pone.0026085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087220	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700003
J	Andersson, EA; Harder, MN; Pilgaard, K; Pisinger, C; Stancakova, A; Kuusisto, J; Grarup, N; Faerch, K; Poulsen, P; Witte, DR; Jorgensen, T; Vaag, A; Laakso, M; Pedersen, O; Hansen, T				Andersson, Ehm A.; Harder, Marie N.; Pilgaard, Kasper; Pisinger, Charlotta; Stancakova, Alena; Kuusisto, Johanna; Grarup, Niels; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Jorgensen, Torben; Vaag, Allan; Laakso, Markku; Pedersen, Oluf; Hansen, Torben			The Birth Weight Lowering C-Allele of rs900400 Near LEKR1 and CCNL1 Associates with Elevated Insulin Release following an Oral Glucose Challenge	PLOS ONE			English	Article							RISK GENOTYPES; TYPE-2	Background and Aim: The first genome-wide association study on birth weight was recently published and the most significant associated birth weight lowering variant was the rs900400 C-allele located near LEKR1 and CCNL1. We aimed to replicate the association with birth weight in the Danish Inter99 study and furthermore to evaluate associations between rs900400 and indices of insulin secretion and insulin sensitivity obtained by oral glucose tolerance tests in adults from the Danish Inter99 study and the Finnish, Metabolic Syndrome in Men (METSIM) sample. Methods: For 4,744 of 6,784 Inter99 participants, midwife journals were traced through the Danish State Archives and association of rs900400 with birth weight was examined. Associations between rs900400 and fasting serum insulin, fasting plasma glucose, insulinogenic index, homeostasis model assessment of insulin resistance (HOMA-IR) and disposition index were studied in 5,484 Danish and 6,915 Finnish non-diabetic individuals and combined in meta-analyses. Results: The C-allele of rs900400 was associated with a 22.1 g lower birth weight ([-41.3; -3.0], P = 0.024) per allele. Moreover, in combined analyses of the Danish Inter99 study and the Finnish METSIM study we found that the birth weight lowering allele was associated with increased insulin release measured by the insulinogenic index (beta = 2.25% [0.59; 3.91], P = 0.008) and with an increased disposition index (beta = 1.76% [0.04; 3.49], P = 0.05). Conclusion: The birth weight lowering effect of the C-allele of rs900400 located near LEKR1 and CCNL1 was replicated in the Danish population. Furthermore the C-allele was associated with increased insulin response following oral glucose stimulation in a meta-analysis based on Danish and Finnish non-diabetic individuals.	[Andersson, Ehm A.; Harder, Marie N.; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Pilgaard, Kasper; Faerch, Kristine; Poulsen, Pernille; Witte, Daniel R.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pisinger, Charlotta; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; University of Southern Denmark	Andersson, EA (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	marie.harder@sund.ku.dk	Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Stancakova, Alena/AAN-6723-2020; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Stancakova, Alena/0000-0002-1375-0252; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830; Vaag, Allan Arthur/0000-0002-3690-2191; Pilgaard, Kasper Ascanius/0000-0003-2079-5229; Pisinger, Charlotta/0000-0002-7970-3168; Faerch, Kristine/0000-0002-6127-0448	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Strategic Research Council, Hagedorn Research Institute; Novo Nordisk Foundation Center for Basic Metabolic Research; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health Sciences	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); Danish Strategic Research Council, Hagedorn Research Institute(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health Sciences	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP). The Inter99 was initiated by T. Jorgensen (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T. F. Thomsen. The Steering Committee comprises the former two and C. Pisinger. The study was financially supported by research grants from the Danish Strategic Research Council, Hagedorn Research Institute, the Novo Nordisk Foundation Center for Basic Metabolic Research, the PhD School of Molecular Metabolism University of Southern Denmark and the Copenhagen Graduate School of Health Sciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Dusatkova P, 2011, J PEDIATR ENDOCR MET, V24, P187, DOI 10.1515/JPEM.2011.083; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Freathy RM, NAT GENET; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kilpelaeinen TO, 2011, AM J CLIN NUTR, V93, P851, DOI 10.3945/ajcn.110.000828; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Pilgaard K, J DEV ORIGINS HLTH D, P1; Pulizzi N, 2009, DIABETOLOGIA, V52, P825, DOI 10.1007/s00125-009-1291-1; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Who, 1999, TECH REP SER WHO; Zhao JH, 2009, DIABETES, V58, P2414, DOI 10.2337/db09-0506	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27096	10.1371/journal.pone.0027096	http://dx.doi.org/10.1371/journal.pone.0027096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073261	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200033
J	Vizcaychipi, MP; Lloyd, DG; Wan, YJ; Palazzo, MG; Maze, M; Ma, DQ				Vizcaychipi, Marcela P.; Lloyd, Dafydd G.; Wan, Yanjie; Palazzo, Mark G.; Maze, Mervyn; Ma, Daqing			Xenon Pretreatment May Prevent Early Memory Decline after Isoflurane Anesthesia and Surgery in Mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; HEAT-SHOCK-PROTEIN; CARDIOPULMONARY BYPASS; PERIPHERAL INFECTION; DORSAL HIPPOCAMPUS; CEREBRAL-ISCHEMIA; NEONATAL ASPHYXIA; RATS; BRAIN; INJURY	Postoperative cognitive decline (POCD) is a common complication following surgery, but its aetiology remains unclear. We hypothesized that xenon pretreatment prevents POCD by suppressing the systemic inflammatory response or through an associated protective signaling pathway involving heat shock protein 72 (Hsp72) and PI3-kinase. Twenty-four hours after establishing long-term memory using fear conditioning training, C57BL/6 adult male mice (n = 12/group) received one of the following treatments: 1) no treatment group (control); 2) 1.8% isoflurane anesthesia; 3) 70% xenon anesthesia; 4) 1.8% isoflurane anesthesia with surgery of the right hind leg tibia that was pinned and fractured; or 5) pretreatment with 70% xenon for 20 minutes followed immediately by 1.8% isoflurane anesthesia with the surgery described above. Assessments of hippocampal-dependent memory were performed on days 1 and 7 after treatment. Hsp72 and PI3-kinase in hippocampus, and plasma IL-1 beta, were measured using western blotting and ELISA respectively, from different cohorts on day 1 after surgery. Isoflurane induced memory deficit after surgery was attenuated by xenon pretreatment. Xenon pretreatment prevented the memory deficit typically seen on day 1 (P = 0.04) but not on day 7 (P = 0.69) after surgery under isoflurane anesthesia, when compared with animals that underwent surgery without pretreatment. Xenon pretreatment modulated the expression of Hsp72 (P = 0.054) but had no significant effect on PI3-kinase (P = 0.54), when compared to control. Xenon pretreatment also reduced the plasma level increase of IL-1 beta induced by surgery (P = 0.028). Our data indicated that surgery and/or Isoflurane induced memory deficit was attenuated by xenon pretreatment. This was associated with a reduction in the plasma level of IL-1 beta and an upregulation of Hsp72 in the hippocampus.	[Vizcaychipi, Marcela P.; Lloyd, Dafydd G.; Palazzo, Mark G.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Surg & Canc, London, England; [Wan, Yanjie] Gongli Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA	Imperial College London; University of California System; University of California San Francisco	Vizcaychipi, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Surg & Canc, London, England.	d.ma@imperial.ac.uk	Ma, Daqing/GLT-2735-2022; Vizcaychipi, Marcela/H-5487-2011	Ma, Daqing/0000-0003-1235-0537; Vizcaychipi, Marcela/0000-0001-7894-873X; Ma, Daqing/0000-0002-0688-2097	Joint Research Committee of Chelsea; Westminster Medical School; Chelsea and Westminster Hospital NHS Foundation Trust; Charing Cross Hospital; Imperial College Healthcare NHS Trust	Joint Research Committee of Chelsea; Westminster Medical School; Chelsea and Westminster Hospital NHS Foundation Trust; Charing Cross Hospital; Imperial College Healthcare NHS Trust	This work was supported in part by grants from the Joint Research Committee of Chelsea and Westminster Medical School, the Chelsea and Westminster Hospital NHS Foundation Trust and the Charing Cross Hospital, Imperial College Healthcare NHS Trust to Marcela P. Vizcaychipi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adori C, 2005, NEUROBIOL DIS, V19, P427, DOI 10.1016/j.nbd.2005.01.015; Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Cattano D, 2008, CAN J ANAESTH, V55, P429, DOI 10.1007/BF03016309; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clark JA, 2005, J CARDIOTHOR VASC AN, V19, P488, DOI 10.1053/j.jvca.2005.05.007; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Harry LE, 2008, J ORTHOP RES, V26, P1238, DOI 10.1002/jor.20649; Hein M, 2008, ACTA ANAESTH SCAND, V52, P1194, DOI 10.1111/j.1399-6576.2008.01757.x; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Kelly S, 2002, ANN NEUROL, V52, P160, DOI 10.1002/ana.10264; Kitahata H, 2008, ANESTH ANALG, V107, P755, DOI 10.1213/ane.0b013e31817f0e61; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Saravanan P, 2009, BRIT J ANAESTH, V103, P805, DOI 10.1093/bja/aep297; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Valentim AM, 2008, BRIT J ANAESTH, V101, P434, DOI 10.1093/bja/aen228; Vizcaychipi MP, 2011, ANESTHESIOLOGY, V114, P891, DOI 10.1097/ALN.0b013e31820ad3ce; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xu X, 2008, NEUROSCIENCE, V154, P1002, DOI 10.1016/j.neuroscience.2008.04.013; Yang YL, 1999, AM J PHYSIOL-HEART C, V276, pH1961, DOI 10.1152/ajpheart.1999.276.6.H1961; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	42	32	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26394	10.1371/journal.pone.0026394	http://dx.doi.org/10.1371/journal.pone.0026394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073162	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000009
J	Lee, SO; Andey, T; Jin, UH; Kim, K; Sachdeva, M; Safe, S				Lee, S-O; Andey, T.; Jin, U-H; Kim, K.; Sachdeva, M.; Safe, S.			The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53	ONCOGENE			English	Article						TR3; Nur77; NR4A1; mTORC1; c-DIMs; lung cancer	INDUCED B-ALPHA; NUR77; ACTIVATION; APOPTOSIS; PROTECTOR; PATHWAY; TARGET; GENES; NR4A2; BCL-2	The orphan nuclear receptor TR3 (NR41A and Nur77) is overexpressed in most lung cancer patients and is a negative prognostic factor for patient survival. The function of TR3 was investigated in non-small-cell lung cancer A549 and H460 cells, and knockdown of TR3 by RNA interference (siTR3) inhibited cancer cell growth and induced apoptosis. The prosurvival activity of TR3 was due, in part, to formation of a p300/TR3/specificity protein 1 complex bound to GC-rich promoter regions of survivin and other Sp-regulated genes (mechanism 1). However, in p53 wild-type A549 and H460 cells, siTR3 inhibited the mTORC1 pathway, and this was due to activation of p53 and induction of the p53-responsive gene sestrin 2, which subsequently activated the mTORC1 inhibitor AMP-activated protein kinase alpha (AMPK alpha) (mechanism 2). This demonstrates that the pro-oncogenic activity of TR3 in lung cancer cells was due to inhibition of p53 and activation of mTORC1. 1,1-Bis(3'-indolyl)-1-(p-hydroxyphenyl) methane (DIM-C-pPhOH) is a recently discovered inhibitor of TR3, which mimics the effects of siTR3. DIM-C-pPhOH inhibited growth and induced apoptosis in lung cancer cells and lung tumors in murine orthotopic and metastatic models, and this was accompanied by decreased expression of survivin and inhibition of mTORC1 signaling, demonstrating that inactivators of TR3 represent a novel class of mTORC1 inhibitors. Oncogene (2012) 31, 3265-3276; doi:10.1038/onc.2011.504; published online 14 November 2011	[Safe, S.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Lee, S-O; Jin, U-H; Kim, K.; Safe, S.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Andey, T.; Sachdeva, M.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut, Tallahassee, FL 32307 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; State University System of Florida; Florida A&M University	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Vet Res Bldg 410, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu		Sachdeva, Mandip/0000-0001-9192-8143; Kim, Kyounghyun/0000-0002-7240-2768; Lee, Syng-Ook/0000-0002-8958-8634	National Institutes of Health [R01-CA124998]; Texas AM AgriLife; NATIONAL CANCER INSTITUTE [R01CA124998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AM AgriLife; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (R01-CA124998) and the Texas A&M AgriLife.	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chen LL, 2011, GUT, V60, P534, DOI 10.1136/gut.2010.224071; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lee SO, 2009, MOL CANCER RES, V7, P1169, DOI 10.1158/1541-7786.MCR-08-0473; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; MARUYAMA K, 1995, CANCER LETT, V96, P117, DOI 10.1016/0304-3835(95)03921-I; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	35	83	85	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	27					3265	3276		10.1038/onc.2011.504	http://dx.doi.org/10.1038/onc.2011.504			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22081070	Green Accepted, Bronze			2022-12-25	WOS:000306113400006
J	Zwaenepoel, O; Tzenaki, N; Vergetaki, A; Makrigiannakis, A; Vanhaesebroeck, B; Papakonstanti, EA				Zwaenepoel, Olivier; Tzenaki, Niki; Vergetaki, Aikaterini; Makrigiannakis, Antonis; Vanhaesebroeck, Bart; Papakonstanti, Evangelia A.			Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110 delta isoform of PI 3-kinase	FASEB JOURNAL			English	Article						nucleus; CSF-1R; p110 delta; PI3K; Rab5	COLONY-STIMULATING FACTOR; FACTOR-I RECEPTOR; FMS PROTOONCOGENE PRODUCT; SMALL GTPASE RAB5; C-FMS; KINASE INHIBITOR; GROWTH-FACTOR; AUTOANTIGEN EEA1; EXPRESSION; CANCER	Colony stimulating factor-1 (CSF-1) and its receptor (CSF-1R) are key regulators of macrophage biology, and their elevated expression in cancer cells has been linked to poor prognosis. CSF-1Rs are thought to function at the plasma membrane. We show here that functional CSF-1Rs are present at the nuclear envelope of various cell types, including primary macrophages, human cancer cell lines, and primary human carcinomas. In response to CSF-1, added to intact cells or isolated nuclei, nucleus-associated CSF-1R became phosphorylated and triggered the phosphorylation of Akt and p27 inside the nucleus. Extracellularly added CSF-1 was also found to colocalize with nucleus-associated CSF-1Rs. All these activities were found to depend selectively on the activity of the p110 delta isoform of phosphoinositide 3-kinase (PI3K). This finding was related to the p110 delta-dependent translocation of exogenous CSF-1 to the nucleus-associated CSF-1Rs, correlating with a prominent role of p110 delta in activation of the Rab5 GTPase, a key regulator of the endocytic trafficking. siRNA-silencing of Rab5a phenocopied p110 delta inactivation and nuclear CSF-1 signaling. Our work demonstrates for the first time the presence of functional nucleus-associated CSF-1Rs, which are activated by extracellular CSF-1 by a mechanism that involves p110 delta and Rab5 activity. These findings may have important implications in cancer development.-Zwaenepoel, O., Tzenaki, N., Vergetaki A., Makrigiannakis, A., Vanhaesebroeck, B., Papakonstanti, E. A. Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110 delta isoform of PI 3-kinase. FASEB J. 26, 691-706 (2012). www.fasebj.org	[Zwaenepoel, Olivier; Tzenaki, Niki; Papakonstanti, Evangelia A.] Univ Crete, Dept Biochem, Sch Med, GR-71110 Iraklion, Greece; [Vergetaki, Aikaterini; Makrigiannakis, Antonis] Univ Crete, Dept Obstet & Gynecol, Sch Med, GR-71110 Iraklion, Greece; [Vanhaesebroeck, Bart] Univ London, Ctr Cell Signalling, Barts Canc Inst, London, England	University of Crete; University of Crete; University of London; Queen Mary University London	Papakonstanti, EA (corresponding author), Univ Crete, Dept Biochem, Sch Med, GR-71110 Iraklion, Greece.	epapak@med.uoc.gr		Makrigiannakis, Antonis/0000-0002-8475-1500; Papakonstanti, Evangelia/0000-0002-7119-6026	European Reintegration Grant [MERG-CT-2006-044916]; Research Committee of the University of Crete [KA 2564, KA 2999, KA 3001]	European Reintegration Grant; Research Committee of the University of Crete	The authors thank Christian Rommel, Thomas Ruckle, and Montserrat Camps (Merck, Geneva, Switzerland) and Kevan Shokat (University of California, San Francisco, California, USA) for pharmacological agents. The authors are also grateful to E. Richard Stanley (Albert Einstein College of Medicine, New York, NY, USA) for providing MacCsf1r<SUP>+/+</SUP> and MacCsf1r<SUP>-/-</SUP> cell lines; Guangpu Li (University of Oklahoma, Norman, OK, USA) for the pGEX/R5BD construct; Jozsef Konya (University of Debrecen, Debrecen, Hungary) for Caski, Hela, and C33-A cell lines; Ines Koch (Charite University Hospital, Berlin, Germany) for CAOV3, OVCAR3, and ES2 cell lines; and Nicholas Pavlidis (Medical School, University of Ioannina, Ioannina, Greece) for the breast cancer tissue. O.Z. is supported by European Reintegration Grant (MERG-CT-2006-044916). N.T. is supported by the Research Committee of the University of Crete (KA 2999). This work was supported by the European Reintegration grant (MERG-CT-2006-044916) awarded to E. P. and by the Research Committee of the University of Crete (KA 2564, KA 2999, KA 3001).	Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; BROCK TG, 1994, J BIOL CHEM, V269, P22059; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CAO H, 1995, ENDOCRINOLOGY, V136, P3163, DOI 10.1210/en.136.7.3163; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Cress AE, 2000, BIOTECHNIQUES, V29, P776, DOI 10.2144/00294st03; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GUILBERT LJ, 1986, J BIOL CHEM, V261, P4024; Huang H, 2008, BIOORG MED CHEM LETT, V18, P2355, DOI 10.1016/j.bmcl.2008.02.070; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Illig CR, 2008, BIOORG MED CHEM LETT, V18, P1642, DOI 10.1016/j.bmcl.2008.01.059; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; KACINSKI BM, 1989, YALE J BIOL MED, V62, P379; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Martelli AM, 2004, PHARMACOL THERAPEUT, V101, P47, DOI 10.1016/j.pharmthera.2003.10.003; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Murayama T, 1999, CIRCULATION, V99, P1740, DOI 10.1161/01.CIR.99.13.1740; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Okkenhaug K, 2002, SCIENCE, V297, P1031; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Patch RJ, 2007, BIOORG MED CHEM LETT, V17, P6070, DOI 10.1016/j.bmcl.2007.09.057; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; RETTENMIER CW, 1986, J CLIN INVEST, V77, P1740, DOI 10.1172/JCI112496; RETTENMIER CW, 1985, SCIENCE, V228, P320, DOI 10.1126/science.2580348; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smalley TL, 2007, BIOORG MED CHEM LETT, V17, P6257, DOI 10.1016/j.bmcl.2007.09.009; STANLEY ER, 1978, NATURE, V274, P168, DOI 10.1038/274168a0; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; STUURMAN N, 1990, J BIOL CHEM, V265, P5460; TANG RP, 1992, J CELL BIOCHEM, V50, P350, DOI 10.1002/jcb.240500403; Toy EP, 2009, NEOPLASIA, V11, P136, DOI 10.1593/neo.81150; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wall MJ, 2008, BIOORG MED CHEM LETT, V18, P2097, DOI 10.1016/j.bmcl.2008.01.088; Wesche J, 2000, BIOCHEMISTRY-US, V39, P15091, DOI 10.1021/bi001831k; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171	59	8	8	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					691	706		10.1096/fj.11-189753	http://dx.doi.org/10.1096/fj.11-189753			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22084313				2022-12-25	WOS:000300485700021
J	Mamenko, M; Zaika, O; Ilatovskaya, DV; Staruschenko, A; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg; Ilatovskaya, Daria V.; Staruschenko, Alexander; Pochynyuk, Oleh			Angiotensin II Increases Activity of the Epithelial Na+ Channel (ENaC) in Distal Nephron Additively to Aldosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; SODIUM-CHANNEL; OPEN PROBABILITY; LIDDLE SYNDROME; AT(1) RECEPTOR; GAMMA-SUBUNIT; TRPV4 CHANNEL; BETA-SUBUNIT; RAT-KIDNEY; HYPERTENSION	Dietary salt intake controls epithelial Na+ channel (ENaC)mediated Na+ reabsorption in the distal nephron by affecting status of the renin-angiotensin-aldosterone system (RAAS). Whereas regulation of ENaC by aldosterone is generally accepted, little is known about whether other components of RAAS, such as angiotensin II (Ang II), have nonredundant to aldosterone-stimulatory actions on ENaC. We combined patch clamp electrophysiology and immunohistochemistry in freshly isolated split-opened distal nephrons of mice to determine the mechanism and molecular signaling pathway of Ang II regulation of ENaC. We found that Ang II acutely increases ENaC P-o, whereas prolonged exposure to Ang II also induces translocation of alpha-ENaC toward the apical membrane in situ. Ang II actions on ENaC P-o persist in the presence of saturated mineralocorticoid status. Moreover, aldosterone fails to stimulate ENaC acutely, suggesting that Ang II and aldosterone have different time frames of ENaC activation. AT(1) but not AT(2) receptors mediate Ang II actions on ENaC. Unlike its effect in vasculature, Ang II did not increase [ Ca2+](i) in split-opened distal nephrons as demonstrated using ratiometric Fura-2-based microscopy. However, application of Ang II to mpkCCD(c14) cells resulted in generation of reactive oxygen species, as probed with fluorescent methods. Consistently, inhibiting NADPH oxidase with apocynin abolished Ang II-mediated increases in ENaC P-o in murine distal nephron. Therefore, we concluded that Ang II directly regulates ENaC activity in the distal nephron, and this effect complements regulation of ENaC by aldosterone. We propose that stimulation of AT(1) receptors with subsequent activation of NADPH oxidase signaling pathway mediates Ang II actions on ENaC.	[Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Ilatovskaya, Daria V.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Ilatovskaya, Daria V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	University of Texas System; University of Texas Health Science Center Houston; Medical College of Wisconsin; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715; Ilatovskaya, Daria/0000-0003-4832-4170; Staruschenko, Alexander/0000-0002-5190-8356	American Heart Association [SDG2230391]; American Society of Nephrology; National Institutes of Health, American Diabetes Association [1-10-BS-168, R01HL108880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health, American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by American Heart Association Grant SDG2230391 (to O. P.), a in part Carl W. Gottschalk research scholar grant from the American Society of Nephrology (to O. P.), National Institutes of Health Grant American Diabetes Association Grant 1-10-BS-168 (to A. S.), and R01HL108880 (to A. S.).	Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Beutler KT, 2003, HYPERTENSION, V41, P1143, DOI 10.1161/01.HYP.0000066129.12106.E2; BRAAM B, 1993, AM J PHYSIOL, V264, pF891, DOI 10.1152/ajprenal.1993.264.5.F891; Brooks HL, 2002, HYPERTENSION, V39, P470, DOI 10.1161/hy02t2.102959; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170, DOI 10.1152/ajprenal.1997.273.1.F170; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Khawaja Z, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/143471; Knepper MA, 2003, ANN NY ACAD SCI, V986, P562, DOI 10.1111/j.1749-6632.2003.tb07254.x; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Ozono R, 1997, HYPERTENSION, V30, P1238, DOI 10.1161/01.HYP.30.5.1238; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Schild L, 2001, ADV EXP MED BIOL, V502, P305; Schild L, 1996, NEPHROLOGIE, V17, P395; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yue P, 2011, KIDNEY INT, V79, P423, DOI 10.1038/ki.2010.380; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	51	103	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					660	671		10.1074/jbc.M111.298919	http://dx.doi.org/10.1074/jbc.M111.298919			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086923	Green Published, hybrid			2022-12-25	WOS:000298682400064
J	Dang, CW; Wang, Y; Zhang, DB; Yao, Q; Chen, KP				Dang, Chunwang; Wang, Yong; Zhang, Debao; Yao, Qin; Chen, Keping			A Genome-Wide Survey on Basic Helix-Loop-Helix Transcription Factors in Giant Panda	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; FACTOR FAMILY; DNA	The giant panda (Ailuropoda melanoleuca) is a critically endangered mammalian species. Studies on functions of regulatory proteins involved in developmental processes would facilitate understanding of specific behavior in giant panda. The basic helix-loop-helix (bHLH) proteins play essential roles in a wide range of developmental processes in higher organisms. bHLH family members have been identified in over 20 organisms, including fruit fly, zebrafish, mouse and human. Our present study identified 107 bHLH family members being encoded in giant panda genome. Phylogenetic analyses revealed that they belong to 44 bHLH families with 46, 25, 15, 4, 11 and 3 members in group A, B, C, D, E and F, respectively, while the remaining 3 members were assigned into "orphan''. Compared to mouse, the giant panda does not encode seven bHLH proteins namely Beta3a, Mesp2, Sclerax, S-Myc, Hes5 (or Hes6), EBF4 and Orphan 1. These results provide useful background information for future studies on structure and function of bHLH proteins in the regulation of giant panda development.	[Dang, Chunwang; Zhang, Debao; Yao, Qin; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Provinc, Peoples R China; [Wang, Yong] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu Provinc, Peoples R China	Jiangsu University; Jiangsu University	Dang, CW (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Provinc, Peoples R China.	ywang@ujs.edu.cn			Scientific Research Promotion Fund for the Talents of Jiangsu University [09JDG029]; Jiangsu Sci-Tech Support Project - Agriculture [BE2008379]	Scientific Research Promotion Fund for the Talents of Jiangsu University; Jiangsu Sci-Tech Support Project - Agriculture	This work was supported by Scientific Research Promotion Fund for the Talents of Jiangsu University (No. 09JDG029) and Jiangsu Sci-Tech Support Project - Agriculture (No. BE2008379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; LEDENT V, 2002, GENOME BIOL, V3, pR30; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liu WY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/682095; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Satou Y, 2003, DEV GENES EVOL, V213, P213, DOI 10.1007/s00427-003-0319-7; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao YQ, 2010, DNA CELL BIOL, V29, P41, DOI 10.1089/dna.2009.0909; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wan QH, 2003, ELECTROPHORESIS, V24, P1353, DOI 10.1002/elps.200390174; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Wang Y, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4001; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; Wang Yong, 2010, Yichuan, V32, P307, DOI 10.3724/SP.J.1005.2010.00307; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Zheng X, 2009, MAMM GENOME, V20, P236, DOI 10.1007/s00335-009-9176-7	25	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26878	10.1371/journal.pone.0026878	http://dx.doi.org/10.1371/journal.pone.0026878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096504	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800015
J	Wu, HY; Chen, LH; Zhou, QL; Zhang, WZ				Wu, Hongyu; Chen, Lihe; Zhou, Qiaoling; Zhang, Wenzheng			AF17 Facilitates Dot1a Nuclear Export and Upregulates ENaC-Mediated Na plus Transport in Renal Collecting Duct Cells	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; HISTONE H3; MINERALOCORTICOID RECEPTOR; SUBCELLULAR-LOCALIZATION; NONCOORDINATE REGULATION; MEMBRANE TOPOLOGY; SUBUNIT PROTEINS; ALDOSTERONE; ALPHA; KIDNEY	Our previous work in 293T cells and AF17(-/-) mice suggests that AF17 upregulates expression and activity of the epithelial Na(+) channel (ENaC), possibly by relieving Dot1a-AF9-mediated repression. However, whether and how AF17 directly regulates Dot1a cellular distribution and ENaC function in renal collecting duct cells remain unaddressed. Here, we report our findings in mouse cortical collecting duct M-1 cells that overexpression of AF17 led to preferential distribution of Dot1a in the cytoplasm. This effect could be blocked by nuclear export inhibitor leptomycin B. siRNA-mediated depletion of AF17 caused nuclear accumulation of Dot1a. AF17 overexpression elicited multiple effects that are reminiscent of aldosterone action. These effects include 1) increased mRNA and protein expression of the three ENaC subunits (alpha, beta and gamma) and serum- and glucocorticoid inducible kinase 1, as revealed by real-time RT-qPCR and immunoblotting analyses; 2) impaired Dot1a-AF9 interaction and H3 K79 methylation at the alpha ENaC promoter without affecting AF9 binding to the promoter, as evidenced by chromatin immunoprecipitation; and 3) elevated ENaC-mediated Na+ transport, as analyzed by measurement of benzamil-sensitive intracellular [Na(+)] and equivalent short circuit current using single-cell fluorescence imaging and an epithelial Volt-ohmmeter, respectively. Knockdown of AF17 elicited opposite effects. However, combination of AF17 overexpression or depletion with aldosterone treatment did not cause an additive effect on mRNA expression of the ENaC subunits. Taken together, we conclude that AF17 promotes Dot1a nuclear export and upregulates basal, but not aldosterone-stimulated ENaC expression, leading to an increase in ENaC-mediated Na(+) transport in renal collecting duct cells.	[Wu, Hongyu; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Zhou, Qiaoling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University	Wu, HY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA.	wenzheng.zhang@uth.tmc.edu	Chen, Lihe/N-3186-2018	Chen, Lihe/0000-0002-6207-6364	American Heart Association [0865271F]; American Society of Nephrology; National Institutes of Health [R01 DK080236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by American Heart Association Beginning Grant-in-Aid 0865271F (to WZ), American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to WZ), and National Institutes of Health grants R01 DK080236 (to WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chang CT, 2007, NEPHROL DIAL TRANSPL, V22, P722, DOI 10.1093/ndt/gfl668; CHEN L, J AM SOC NEPHROL, V22, P1076; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; May A, 1997, J AM SOC NEPHROL, V8, P1813; MCENEANEY V, MOL CELL ENDOCRINOL, V325, P8; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nishi M, 2001, MOL ENDOCRINOL, V15, P1077, DOI 10.1210/me.15.7.1077; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; PAN YJ, 1982, HYPERTENSION, V4, P279, DOI 10.1161/01.HYP.4.2.279; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; PERLEWITZ A, NUCL ACIDS RES, V38, P5746; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; POINDEXTER BJ, 2005, J BURNS WOUNDS, V4, P128; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; RENARD S, 1994, J BIOL CHEM, V269, P12981; RENARD S, 1995, PFLUG ARCH EUR J PHY, V430, P299, DOI 10.1007/BF00373903; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; SCHNERMANN JB, 1998, KIDNEY PHYSL; Sheldon C, 2004, PFLUG ARCH EUR J PHY, V449, P307, DOI 10.1007/s00424-004-1344-8; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang S, 2009, J MEMBRANE BIOL, V227, P77, DOI 10.1007/s00232-008-9145-1; Waseem TV, 2007, BRAIN RES BULL, V73, P135, DOI 10.1016/j.brainresbull.2007.03.002; Weisz OA, 2003, AM J PHYSIOL-RENAL, V285, pF833, DOI 10.1152/ajprenal.00088.2003; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2004, AM J PHYSIOL-RENAL, V286, pF1171, DOI 10.1152/ajprenal.00043.2003; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27429	10.1371/journal.pone.0027429	http://dx.doi.org/10.1371/journal.pone.0027429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087315	Green Submitted, gold, Green Published			2022-12-25	WOS:000297349700044
J	Aachoui, Y; Ghosh, SK				Aachoui, Youssef; Ghosh, Swapan K.			Extracellular Matrix from Porcine Small Intestinal Submucosa (SIS) as Immune Adjuvants	PLOS ONE			English	Article							INFLAMMATORY DENDRITIC CELLS; VACCINE; ACTIVATION; GENERATION; BIOLOGY; PROTEIN; DANGER; GROWTH; REPAIR	Porcine small intestinal submucosa (SIS) of Cook Biotech is licensed and widely used for tissue remodeling in humans. SIS was shown to be highly effective as an adjuvant in model studies with prostate and ovarian cancer vaccines. However, SIS adjuvanticity relative to alum, another important human-licensed adjuvant, has not yet been delineated in terms of activation of innate immunity via inflammasomes and boosting of antibody responses to soluble proteins and hapten-protein conjugates. We used ovalbumin, and a hapten-protein conjugate, phthalate-keyhole limpet hemocyanin. The evaluation of SIS was conducted in BALB/c and C57BL/6 mice using both intraperitoneal and subcutaneous routes. Inflammatory responses were studied by microarray profiling of chemokines and cytokines and by qPCR of inflammasomes-related genes. Results showed that SIS affected cytokine and chemokines microenvironments such as up-regulation of IL-4 and CD30-ligand and activation of chemotactic factors LIX and KC (neutrophil chemotactic factors), MCP-1 (monocytes chemotactic factors), MIP 1-alpha (macrophage chemotactic factor) and lymphotactin, as well as, growth factors like M-CSF. SIS also promoted gene expression of Nod-like receptors (NLR) and associated downstream effectors. However, in contrast to alum, SIS had no effects on pro-inflammatory cytokines (IL-6, IL-1 beta, TNF-alpha) or NLRP3, but it appeared to promote both Th1 and Th2 responses under different conditions. Lastly, it was as effective as alum in engendering a lasting and specific antibody response, primarily of IgG1 type.	[Aachoui, Youssef; Ghosh, Swapan K.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University	Ghosh, SK (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	sghosh@indstate.edu			Cook Biotech; Fraternal Order of Eagles; graduate school of Indiana State University	Cook Biotech; Fraternal Order of Eagles; graduate school of Indiana State University	The work was supported by grants from Cook Biotech, and the Fraternal Order of Eagles and the graduate school of Indiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachoui Y, 2011, CELL IMMUNOL; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054; Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Badylak, 1996, Patent No. 5516533; Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349; Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; Coombe D, 1998, IMMUNOL CELL BIOL, V76, P114; Crapo PM, 2010, ACTA BIOMATER, V6, P2091, DOI 10.1016/j.actbio.2009.10.048; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; GHOSH SK, 1984, J IMMUNOL, V133, P1677; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; KNOPP BP, 1995, UROLOGY, V46, P396, DOI 10.1016/S0090-4295(99)80227-1; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lim So-Yon, 2006, J Immune Based Ther Vaccines, V4, P6, DOI 10.1186/1476-8518-4-6; Lim SY, 2003, IMMUNOLOGY, V110, P482, DOI 10.1111/j.1365-2567.2003.01765.x; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Rosen Michael, 2005, Surg Innov, V12, P227, DOI 10.1177/155335060501200307; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; STANLEY ER, 1994, STEM CELLS, V12, P15; Suckow MA, 2008, ANTICANCER RES, V28, P2529; Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wang HB, 2008, J LEUKOCYTE BIOL, V83, P817, DOI 10.1189/jlb.0607392; Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	45	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27083	10.1371/journal.pone.0027083	http://dx.doi.org/10.1371/journal.pone.0027083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087247	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700015
J	Trinko, R; Gan, GL; Gao, XB; Sears, RM; Guarnieri, DJ; DiLeone, RJ				Trinko, Richard; Gan, Geliang; Gao, Xiao-Bing; Sears, Robert M.; Guarnieri, Douglas J.; DiLeone, Ralph J.			Erk1/2 Mediates Leptin Receptor Signaling in the Ventral Tegmental Area	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; PROOPIOMELANOCORTIN NEURONS; INDUCED ANOREXIA; ARCUATE NUCLEUS; FOOD-INTAKE; INSULIN; HYPOTHALAMUS; EXPRESSION; RAT; TRANSCRIPTION-3	Leptin acts on the ventral tegmental area (VTA) to modulate neuronal function and feeding behavior in rats and mice. To identify the intracellular effectors of the leptin receptor (Lepr), downstream signal transduction events were assessed for regulation by direct leptin infusion. Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) and phosphorylated extracellular signal-regulated kinase-1 and -2 (pERK1/2) were increased in the VTA while phospho-AKT (pAKT) was unaffected. Pretreatment of brain slices with the mitogen-activated protein kinase kinase -1 and -2 (MEK1/2) inhibitor U0126 blocked the leptin-mediated decrease in firing frequency of VTA dopamine neurons. The anorexigenic effects of VTA-administered leptin were also blocked by pretreatment with U0126, which effectively blocked phosphorylation of ERK1/2 but not STAT3. These data demonstrate that pERK1/2 may have a critical role in mediating both the electrophysiogical and behavioral effects of leptin receptor signaling in the VTA.	[Trinko, Richard; Sears, Robert M.; Guarnieri, Douglas J.; DiLeone, Ralph J.] Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat,Ribicoff Res Facil, New Haven, CT 06520 USA; [Gan, Geliang; Gao, Xiao-Bing] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA	Yale University; Yale University	Trinko, R (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat,Ribicoff Res Facil, New Haven, CT 06520 USA.	ralph.dileone@yale.edu	Gao, Xiao-Bing/C-3121-2011	Gao, Xiao-Bing/0000-0002-2035-4936; , robert/0000-0001-5688-1853; DiLeone, Ralph/0000-0002-4770-2590	National Institutes of Health (NIH) [DK076964]; State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076964] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grant DK076964 to R.J.D. and the State of Connecticut, Department of Mental Health and Addiction Services (R.J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Baskin DG, 2000, REGUL PEPTIDES, V92, P9, DOI 10.1016/S0167-0115(00)00143-9; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Carvalheira JBC, 2005, OBES RES, V13, P48, DOI 10.1038/oby.2005.7; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Johansson A, 2008, PEPTIDES, V29, P1588, DOI 10.1016/j.peptides.2008.04.018; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; Lindblom J, 2005, MOL BRAIN RES, V133, P37, DOI 10.1016/j.molbrainres.2004.09.025; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Morton GJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE202, DOI 10.1152/ajpendo.90865.2008; Muroya S, 2004, EUR J NEUROSCI, V19, P1524, DOI 10.1111/j.1460-9568.2004.03255.x; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Wang JH, 2008, NEUROSCIENCE, V156, P89, DOI 10.1016/j.neuroscience.2008.04.079; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	32	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27180	10.1371/journal.pone.0027180	http://dx.doi.org/10.1371/journal.pone.0027180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076135	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200047
J	Fernandez-Martos, CM; Gonzalez-Fernandez, C; Gonzalez, P; Maqueda, A; Arenas, E; Rodriguez, FJ				Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Gonzalez, Pau; Maqueda, Alfredo; Arenas, Ernest; Javier Rodriguez, Francisco			Differential Expression of Wnts after Spinal Cord Contusion Injury in Adult Rats	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SIGNALING CONTROLS; INFLAMMATORY RESPONSES; ALZHEIMERS-DISEASE; STEM-CELLS; BRAIN; LITHIUM; REGENERATION; ACTIVATION	Background: Spinal cord injury is a major cause of disability that has no clinically accepted treatment. Functional decline following spinal cord injury is caused by mechanical damage, secondary cell death, reactive gliosis and a poor regenerative capacity of damaged axons. Wnt proteins are a family of secreted glycoproteins that play key roles in different developmental processes although little is known of the expression patterns and functions of Wnts in the adult central nervous system in normal or diseased states. Findings: Using qRT-PCR analysis, we demonstrate that mRNA encoding most Wnt ligands and soluble inhibitors are constitutively expressed in the healthy adult spinal cord. Strikingly, contusion spinal cord injury induced a time-dependent increase in Wnt mRNA expression from 6 hours until 28 days post-injury, and a narrow peak in the expression of soluble Wnt inhibitors between 1 and 3 days post-injury. These results are consistent with the increase in the migration shift, from day 1 to 7, of the intracellular Wnt signalling component, Dishevelled-3. Moreover, after an initial decrease by 1 day, we also found an increase in phosphorylation of the Wnt co-receptor, low-density lipoprotein receptor-related protein 6, and an increase in active beta-catenin protein, both of which suffer a dramatic change, from a homogeneous expression pattern in the grey matter to a disorganized injury-induced pattern. Conclusions: Our results suggest a role for Wnts in spinal cord homeostasis and injury. We demonstrate that after injury Wnt signalling is activated via the Wnt/beta-catenin and possibly other pathways. These findings provide an important foundation to further address the function of individual Wnt proteins in vivo and the pathophysiology of spinal cord injury.	[Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Gonzalez, Pau; Maqueda, Alfredo; Javier Rodriguez, Francisco] HNP, Lab Neurol Mol, Toledo, Spain; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Unit, MBB, Stockholm, Sweden	Karolinska Institutet	Fernandez-Martos, CM (corresponding author), HNP, Lab Neurol Mol, Toledo, Spain.	fjrodriguez@sescam.jccm.es	González, Carlos/AAG-9659-2019; Fernandez-Martos, Carmen/J-7770-2014; Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Arenas, Ernest/AAO-5231-2020	González, Carlos/0000-0002-3415-0723; Fernandez-Martos, Carmen/0000-0002-6387-4456; Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Arenas, Ernest/0000-0003-0197-6577; Maqueda Fernandez, Alfredo/0000-0002-0117-5422	Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) [PI2008-39]; Fondode Investigaciones Sanitarias (FIS) [PI08-1475]; Fondo Europeo de Desarrollo Regional (FEDER); FISCAM [MOV-2009_JI-06]	Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM); Fondode Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); FISCAM	This work was supported by: Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM; Grant PI2008-39) and Fondode Investigaciones Sanitarias (FIS; Grant PI08-1475 with Fondo Europeo de Desarrollo Regional (FEDER) co-funding). Carlos Gonzalez-Fernandez was supported by FISCAM (MOV-2009_JI-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam SY, 2007, CURR ALZHEIMER RES, V4, P21; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bian QM, 2007, BRAIN RES, V1184, P270, DOI 10.1016/j.brainres.2007.09.054; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V318, P79, DOI 10.1124/jpet.106.102863; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Eftekharpour E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E18; Eto M, 2005, CIRCULATION, V112, P1316, DOI 10.1161/CIRCULATIONAHA.105.564112; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fernandez CM, 2009, BIOCHIM BIOPHYS ACTA, V1803, P1131; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim H, 2010, NEUROBIOL A IN PRESS; Knafo S, 2008, BRIT J NEUROSURG, V22, P3, DOI 10.1080/02688690701593595; Komiya Yuko, 2008, Organogenesis, V4, P68; Kubo F, 2008, DEV GROWTH DIFFER, V50, P245, DOI [10.1111/j.1440-169X.2008.01033.x, 10.1111/j.1440-169x.2008.01033.x]; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; Lei ZN, 2008, NEUROSCI LETT, V435, P108, DOI 10.1016/j.neulet.2008.02.031; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Pishvaian Michael J., 2007, Cancer Biomarkers, V3, P263; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Preston E, 2001, J NEUROTRAUM, V18, P83, DOI 10.1089/089771501750055794; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Rosenberg SS, 2009, GENE DEV, V23, P1487, DOI 10.1101/gad.1824009; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Suh HI, 2011, ACTA NEUROC IN PRESS; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Yick LW, 2004, J NEUROTRAUM, V21, P932, DOI 10.1089/neu.2004.21.932; Yin Zong-Sheng, 2007, Neurol Res, V29, P847, DOI 10.1179/016164107X223539; Yin ZS, 2008, NEUROL RES, V30, P480, DOI 10.1179/174313208X284133; Zenzmaier C, 2009, J NEUROCHEM, V110, P653, DOI 10.1111/j.1471-4159.2009.06158.x; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	100	66	79	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27000	10.1371/journal.pone.0027000	http://dx.doi.org/10.1371/journal.pone.0027000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073235	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900059
J	Tonione, MA; Reeder, N; Moritz, CC				Tonione, Maria A.; Reeder, Natalie; Moritz, Craig C.			High Genetic Diversity Despite the Potential for Stepping-Stone Colonizations in an Invasive Species of Gecko on Moorea, French Polynesia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HEMIDACTYLUS GECKOS; MITOCHONDRIAL-DNA; HOUSE GECKOS; BIOLOGICAL INVASION; GUINEA ISLANDS; CANE TOAD; EVOLUTION; GEKKONIDAE; BIOGEOGRAPHY	Invasive species often have reduced genetic diversity, but the opposite can be true if there have been multiple introductions and genetic admixture. Reduced diversity is most likely soon after establishment, in remote locations, when there is lower propagule pressure and with stepping-stone colonizations. The common house gecko (Hemidactylus frenatus) was introduced to Moorea, French Polynesia in the remote eastern Pacific within the last two decades and accordingly is expected to exhibit low diversity. In contrast, we show that H. frenatus on Moorea has exceptionally high genetic diversity, similar to that near the native range in Asia and much higher than reported for other Pacific island reptiles. The high diversity in this recently founded population likely reflects extensive genetic admixture in source population(s) and a life history that promotes retention of diversity. These observations point to the importance of understanding range-wide dynamics of genetic admixture in highly invasive species.	[Tonione, Maria A.; Moritz, Craig C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Reeder, Natalie] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California Berkeley; California State University System; San Francisco State University	Tonione, MA (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	riatoni@berkeley.edu	Tonione, Maria/ABB-8483-2021	Tonione, Maria/0000-0001-7447-213X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research is a component of the Moorea Biocode Project, supported by the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Arnold EN, 2008, ZOOL SCR, V37, P619, DOI 10.1111/j.1463-6409.2008.00351.x; Austin CC, 1999, NATURE, V397, P113, DOI 10.1038/16365; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Bansal R, 2010, MOL PHYLOGENET EVOL, V57, P459, DOI 10.1016/j.ympev.2010.06.008; Bauer AM, 2010, MOL PHYLOGENET EVOL, V57, P343, DOI 10.1016/j.ympev.2010.06.014; Brown W. C., 1957, Copeia, V1957, P39, DOI 10.2307/1440508; Bruna EM, 1996, P ROY SOC B-BIOL SCI, V263, P681, DOI 10.1098/rspb.1996.0102; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Carranza S, 2006, MOL PHYLOGENET EVOL, V38, P531, DOI 10.1016/j.ympev.2005.07.012; Case Ted J., 1992, P91; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; CASE TJ, 1994, ECOLOGY, V75, P464, DOI 10.2307/1939550; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Dame EA, 2006, ANIM BEHAV, V71, P1165, DOI 10.1016/j.anbehav.2005.10.009; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Estoup A, 2010, MOL ECOL RESOUR, V10, P886, DOI 10.1111/j.1755-0998.2010.02882.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng J, 2007, ZOOL SCI, V24, P656, DOI 10.2108/zsj.24.656; Fisher RN, 1997, EVOLUTION, V51, P906, DOI 10.1111/j.1558-5646.1997.tb03672.x; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Harris DJ, 2004, AMPHIBIA-REPTILIA, V25, P451; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoskin C, 2010, AUSTRAL ECOLOGY; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; INEICH I, 1988, Atoll Research Bulletin, P1; Jesus J, 2005, MOL PHYLOGENET EVOL, V34, P480, DOI 10.1016/j.ympev.2004.11.006; Jesus J, 2006, HERPETOL J, V16, P291; Joly S, 2006, SYST BIOL, V55, P623, DOI 10.1080/10635150600863109; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; McKeown S, 1996, FIELD GUIDE REPTILES; Meyer CP, 2004, MALACOLOGIA, V46, P127; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1111/j.1095-8312.1993.tb00882.x; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2004, MRMODELTEST 2 0; Ota Hidetoshi, 2006, Current Herpetology, V25, P97, DOI 10.3105/1345-5834(2006)25[97:COTGDD]2.0.CO;2; Peacock MM, 2009, MOL ECOL, V18, P3603, DOI 10.1111/j.1365-294X.2009.04308.x; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Pritchard JK, 2000, GENETICS, V155, P945; Rato C, 2011, MOL PHYLOGENET EVOL, V58, P365, DOI 10.1016/j.ympev.2010.12.004; Rato C, 2010, MOL PHYLOGENET EVOL, V56, P962, DOI 10.1016/j.ympev.2010.04.033; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thulin CG, 2006, MOL ECOL, V15, P3947, DOI 10.1111/j.1365-294X.2006.03084.x; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vences M, 2004, BIOL J LINN SOC, V83, P115, DOI 10.1111/j.1095-8312.2004.00370.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8; Yamamoto Yurie, 2006, Current Herpetology, V25, P39, DOI 10.3105/1345-5834(2006)25[39:LFSSBA]2.0.CO;2; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	73	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26874	10.1371/journal.pone.0026874	http://dx.doi.org/10.1371/journal.pone.0026874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073211	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900048
J	Hirata, H; Wen, H; Kawakami, Y; Naganawa, Y; Ogino, K; Yamada, K; Saint-Amant, L; Low, SE; Cui, WW; Zhou, WB; Sprague, SM; Asakawa, K; Muto, A; Kawakami, K; Kuwada, JY				Hirata, Hiromi; Wen, Hua; Kawakami, Yu; Naganawa, Yuriko; Ogino, Kazutoyo; Yamada, Kenta; Saint-Amant, Louis; Low, Sean E.; Cui, Wilson W.; Zhou, Weibin; Sprague, Shawn M.; Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi; Kuwada, John Y.			Connexin 39.9 Protein Is Necessary for Coordinated Activation of Slow-twitch Muscle and Normal Behavior in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARVAL ZEBRAFISH; SKELETAL-MUSCLE; LENS DEVELOPMENT; RELAXED MUTANTS; TOUCH RESPONSE; SPINAL-CORD; GENE; EXPRESSION; GAP; EMBRYOS	In many tissues and organs, connexin proteins assemble between neighboring cells to form gap junctions. These gap junctions facilitate direct intercellular communication between adjoining cells, allowing for the transmission of both chemical and electrical signals. In rodents, gap junctions are found in differentiating myoblasts and are important for myogenesis. Although gap junctions were once believed to be absent from differentiated skeletal muscle in mammals, recent studies in teleosts revealed that differentiated muscle does express connexins and is electrically coupled, at least at the larval stage. These findings raised questions regarding the functional significance of gap junctions in differentiated muscle. Our analysis of gap junctions in muscle began with the isolation of a zebrafish motor mutant that displayed weak coiling at day 1 of development, a behavior known to be driven by slow-twitch muscle (slow muscle). We identified a missense mutation in the gene encoding Connexin 39.9. In situ hybridization found connexin 39.9 to be expressed by slow muscle. Paired muscle recordings uncovered that wild-type slow muscles are electrically coupled, whereas mutant slow muscles are not. The further examination of cellular activity revealed aberrant, arrhythmic touch-evoked Ca2+ transients in mutant slow muscle and a reduction in the number of muscle fibers contracting in response to touch in mutants. These results indicate that Connexin 39.9 facilitates the spreading of neuronal inputs, which is irregular during motor development, beyond the muscle cells and that gap junctions play an essential role in the efficient recruitment of slow muscle fibers.	[Hirata, Hiromi; Ogino, Kazutoyo; Yamada, Kenta] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi; Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi; Kawakami, Yu; Naganawa, Yuriko] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Hirata, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Ibaraki 5670047, Japan; [Wen, Hua] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Saint-Amant, Louis; Low, Sean E.] Univ Montreal, Dept Pathol & Biol Cellulaire, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada; [Low, Sean E.; Cui, Wilson W.; Zhou, Weibin; Sprague, Shawn M.; Kuwada, John Y.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Cui, Wilson W.; Kuwada, John Y.] Univ Michigan, Program Cell & Mol Biol, Ann Arbor, MI 48109 USA; [Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Nagoya University; Japan Science & Technology Agency (JST); Oregon Health & Science University; Universite de Montreal; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hirata, H (corresponding author), Natl Inst Genet, Frontier Res Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	hihirata@lab.nig.ac.jp	Kawakami, Koichi/AAF-1380-2019; Asakawa, Kazuhide/ABD-2065-2020; Kuwada, John Y/B-1447-2009; Muto, Akira/E-2580-2015	Asakawa, Kazuhide/0000-0003-0628-1176; Muto, Akira/0000-0003-4276-1775; Hirata, Hiromi/0000-0002-3769-7441	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks); Takeda Science Foundation; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS018205, R01NS018205] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700477] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks); Takeda Science Foundation(Takeda Science Foundation (TSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks), by the Takeda Science Foundation and by a career development award from the Human Frontier Science Program (to H. H.).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Araya R, 2003, CELL COMMUN ADHES, V10, P451, DOI 10.1080/15419060390263038; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Ashworth R, 2001, DEV BRAIN RES, V129, P169, DOI 10.1016/S0165-3806(01)00198-5; Bahary N, 2004, METHOD CELL BIOL, V77, P305; Belluardo N, 2005, CELL TISSUE RES, V320, P299, DOI 10.1007/s00441-005-1087-7; Buckingham SD, 2004, J EXP BIOL, V207, P841, DOI 10.1242/jeb.00839; Budick SA, 2000, J EXP BIOL, V203, P2565; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Chatterjee B, 2005, DEV DYNAM, V233, P890, DOI 10.1002/dvdy.20426; Cheng SH, 2004, J BIOL CHEM, V279, P36993, DOI 10.1074/jbc.M401355200; Cheng SH, 2003, DEV DYNAM, V228, P709, DOI 10.1002/dvdy.10436; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Downes GB, 2006, J NEUROBIOL, V66, P437, DOI 10.1002/neu.20226; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; FELSENFELD AL, 1990, DEVELOPMENT, V108, P443; Fero K, 2011, NEUROMETHODS, V52, P249, DOI 10.1007/978.1.60761.922.2_12; Gates MA, 1999, GENOME RES, V9, P334; Gerhart SV, 2009, FEBS LETT, V583, P3419, DOI 10.1016/j.febslet.2009.09.054; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Granato M, 1996, DEVELOPMENT, V123, P399; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; Hirata H, 2004, DEVELOPMENT, V131, P5457, DOI 10.1242/dev.01410; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; Johnston I.A., 1983, P36; KALDERON N, 1977, J CELL BIOL, V75, P788, DOI 10.1083/jcb.75.3.788; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Luna VM, 2006, J GEN PHYSIOL, V128, P89, DOI 10.1085/jgp.200609501; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Naganawa Y, 2011, DEV BIOL, V355, P194, DOI 10.1016/j.ydbio.2011.04.027; Nakano Y, 2010, DEVELOPMENT, V137, P1689, DOI 10.1242/dev.047464; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ogino K, 2011, J BIOL CHEM, V286, P806, DOI 10.1074/jbc.M110.125500; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Proulx A, 1997, DEV GENET, V20, P133, DOI 10.1002/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8; Randall, 1978, FISH PHYSIOL, P361; RASH JE, 1973, DEV BIOL, V30, P166, DOI 10.1016/0012-1606(73)90055-9; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Saint-Amant L, 2008, DEV NEUROBIOL, V68, P45, DOI 10.1002/dneu.20569; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sohl G, 2003, CELL COMMUN ADHES, V10, P27, DOI 10.1080/15419060390220468; von Maltzahn J, 2004, J CELL SCI, V117, P5381, DOI 10.1242/jcs.01413; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	62	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1080	1089		10.1074/jbc.M111.308205	http://dx.doi.org/10.1074/jbc.M111.308205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22075003	Green Published, hybrid			2022-12-25	WOS:000299170300024
J	Chang, TW; Lin, YM; Wang, CF; Liao, YD				Chang, Ting-Wei; Lin, Yu-Ming; Wang, Chiu-Feng; Liao, You-Di			Outer Membrane Lipoprotein Lpp Is Gram-negative Bacterial Cell Surface Receptor for Cationic Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOST-DEFENSE; HUMAN SKIN; MECHANISMS; RESISTANCE; INFECTION; PATHOGENS; PROTEINS; SMAP-29; BINDING	Antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms. Here we demonstrate that the outer membrane lipoprotein, Lpp, of Enterobacteriaceae interacts with and promotes susceptibility to the bactericidal activities of AMPs. The oligomeric Lpp was specifically recognized by several cationic alpha-helical AMPs, including SMAP-29, CAP-18, and LL-37; AMP-mediated bactericidal activities were blocked by anti-Lpp antibody blocking. Blebbing of the outer membrane and increase in membrane permeability occurred in association with the coordinate internalization of Lpp and AMP. Interestingly, the specific binding of AMP to Lpp was resistant to divalent cations and salts, which were able to inhibit the bactericidal activities of some AMPs. Furthermore, using His-tagged Lpp as a ligand, we retrieved several characterized AMPs, including SMAP-29 and hRNase 7, from a peptide library containing crude mammalian cell lysates. Overall, this study explores a new mechanism and target of antimicrobial activity and provides a novel method for screening of antimicrobials for use against drug-resistant bacteria.	[Chang, Ting-Wei; Lin, Yu-Ming; Wang, Chiu-Feng; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Program Mol Med, Sch Life Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ydliao@ibms.sinica.edu.tw	Liao, You-Di/S-7018-2018	Liao, You-Di/0000-0001-5527-4736	Academia Sinica and National Science Council [NSC 98-2311-B-001-017-MY3]	Academia Sinica and National Science Council	This work was supported by Academia Sinica and National Science Council Grant NSC 98-2311-B-001-017-MY3.	Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Cowles CE, 2011, MOL MICROBIOL, V79, P1168, DOI 10.1111/j.1365-2958.2011.07539.x; De Pascale G, 2010, CHEMBIOCHEM, V11, P1325, DOI 10.1002/cbic.201000067; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; INOUYE M, 1974, P NATL ACAD SCI USA, V71, P2396, DOI 10.1073/pnas.71.6.2396; INOUYE M, 1972, J BIOL CHEM, V247, P8154; INOUYE S, 1976, J BACTERIOL, V127, P555, DOI 10.1128/JB.127.1.555-563.1976; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; MIZUSHIMA S, 1975, BIOCHIM BIOPHYS ACTA, V375, P44, DOI 10.1016/0005-2736(75)90071-1; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Shepard BD, 2002, MICROBES INFECT, V4, P215, DOI 10.1016/S1286-4579(01)01530-1; Shin SY, 2001, BIOCHEM BIOPH RES CO, V285, P1046, DOI 10.1006/bbrc.2001.5280; Shu W, 2000, J MOL BIOL, V299, P1101, DOI 10.1006/jmbi.2000.3776; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	34	44	46	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					418	428		10.1074/jbc.M111.290361	http://dx.doi.org/10.1074/jbc.M111.290361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084237	Green Published, hybrid			2022-12-25	WOS:000298682400040
J	Stewart, EV; Lloyd, SJA; Burg, JS; Nwosu, CC; Lintner, RE; Daza, R; Russ, C; Ponchner, K; Nusbaum, C; Espenshade, PJ				Stewart, Emerson V.; Lloyd, S. Julie-Ann; Burg, John S.; Nwosu, Christine C.; Lintner, Robert E.; Daza, Riza; Russ, Carsten; Ponchner, Karen; Nusbaum, Chad; Espenshade, Peter J.			Yeast Sterol Regulatory Element-binding Protein (SREBP) Cleavage Requires Cdc48 and Dsc5, a Ubiquitin Regulatory X Domain-containing Subunit of the Golgi Dsc E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DEGRADATION; GENE; COMPLEX; UBX2; EXPRESSION; MUTATIONS; MECHANISM; EFFICIENT	Schizosaccharomyces pombe Sre1 is a membrane-bound transcription factor that controls adaptation to hypoxia. Like its mammalian homolog, sterol regulatory element-binding protein (SREBP), Sre1 activation requires release from the membrane. However, in fission yeast, this release occurs through a strikingly different mechanism that requires the Golgi Dsc E3 ubiquitin ligase complex and the proteasome. The mechanistic details of Sre1 cleavage, including the link between the Dsc E3 ligase complex and proteasome, are not well understood. Here, we present results of a genetic selection designed to identify additional components required for Sre1 cleavage. From the selection, we identified two new components of the fission yeast SREBP pathway: Dsc5 and Cdc48. The AAA(ATPase associated with diverse cellular activities) ATPase Cdc48 and Dsc5, a ubiquitin regulatory X domain-containing protein, interact with known Dsc complex components and are required for SREBP cleavage. These findings provide a mechanistic link between the Dsc E3 ligase complex and the proteasome in SREBP cleavage and add to a growing list of similarities between the Dsc E3 ligase and membrane E3 ligases involved in endoplasmic reticulum-associated degradation.	[Stewart, Emerson V.; Lloyd, S. Julie-Ann; Burg, John S.; Nwosu, Christine C.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Lintner, Robert E.; Daza, Riza; Russ, Carsten; Ponchner, Karen; Nusbaum, Chad] Broad Inst Massachusetts Inst Technol & Harvard, Genome Sequencing & Anal Program, Cambridge, MA 02141 USA	Johns Hopkins University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Daza, Riza M./HCH-4047-2022	Lintner, Robert/0000-0002-4379-7799	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077588 (to P. J. E.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hartmann-Petersen R, 2003, INT J BIOCHEM CELL B, V35, P629, DOI 10.1016/S1357-2725(02)00393-X; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thompson J. F., 2010, CURR PROTOC MOL BIOL, V10, DOI DOI 10.1002/0471142727.MB0710S92; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x	39	41	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					672	681		10.1074/jbc.M111.317370	http://dx.doi.org/10.1074/jbc.M111.317370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086920	Green Published, hybrid			2022-12-25	WOS:000298682400065
J	Hirahatake, KM; Meissen, JK; Fiehn, O; Adams, SH				Hirahatake, Kristin M.; Meissen, John K.; Fiehn, Oliver; Adams, Sean H.			Comparative Effects of Fructose and Glucose on Lipogenic Gene Expression and Intermediary Metabolism in HepG2 Liver Cells	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; HEXOSAMINE BIOSYNTHESIS; INSULIN-RESISTANCE; DIETARY FRUCTOSE; HEPATIC LIPOGENESIS; RAT HEPATOCYTES; MESSENGER-RNA; HEALTHY-MEN; CARBOHYDRATE; DISEASE	Consumption of large amounts of fructose or sucrose increases lipogenesis and circulating triglycerides in humans. Although the underlying molecular mechanisms responsible for this effect are not completely understood, it is possible that as reported for rodents, high fructose exposure increases expression of the lipogenic enzymes fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC-1) in human liver. Since activation of the hexosamine biosynthesis pathway (HBP) is associated with increases in the expression of FAS and ACC-1, it raises the possibility that HBP-related metabolites would contribute to any increase in hepatic expression of these enzymes following fructose exposure. Thus, we compared lipogenic gene expression in human-derived HepG2 cells after incubation in culture medium containing glucose alone or glucose plus 5 mM fructose, using the HBP precursor 10 mM glucosamine (GlcN) as a positive control. Cellular metabolite profiling was conducted to analyze differences between glucose and fructose metabolism. Despite evidence for the active uptake and metabolism of fructose by HepG2 cells, expression of FAS or ACC-1 did not increase in these cells compared with those incubated with glucose alone. Levels of UDP-N-acetylglucosamine (UDP-GlcNAc), the end-product of the HBP, did not differ significantly between the glucose and fructose conditions. Exposure to 10 mM GlcN for 10 minutes to 24 hours resulted in 8-fold elevated levels of intracellular UDP-GlcNAc (P<0.001), as well as a 74-126% increase in FAS (P<0.05) and 49-95% increase in ACC-1 (P<0.01) expression above controls. It is concluded that in HepG2 liver cells cultured under standard conditions, sustained exposure to fructose does not result in an activation of the HBP or increased lipogenic gene expression. Should this scenario manifest in human liver in vivo, it would suggest that high fructose consumption promotes triglyceride synthesis primarily through its action to provide lipid precursor carbon and not by activating lipogenic gene expression.	[Hirahatake, Kristin M.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Meissen, John K.; Fiehn, Oliver] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Meissen, John K.; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Adams, Sean H.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Hirahatake, KM (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	sean.h.adams@ars.usda.gov	ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319	United States Department of Agriculture (USDA)-Agricultural Research Service [5306-51530-016-00D, 5306-51530-019-00]; Diabetes Action and Research Education Fund	United States Department of Agriculture (USDA)-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Diabetes Action and Research Education Fund	This work was funded in part by the following: intramural United States Department of Agriculture (USDA)-Agricultural Research Service Projects 5306-51530-016-00D and 5306-51530-019-00 and a pilot grant from the Diabetes Action and Research Education Fund (to SHA). USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Adams SH, 2008, ENDOCRINOLOGY, V149, P3002, DOI 10.1210/en.2007-1812; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bray GA, 2004, AM J CLIN NUTR, V79, P537; BRUCKDORFER KR, 1972, BIOCHEM J, V129, P439, DOI 10.1042/bj1290439; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; DeHaven JE, 2001, DIABETES, V50, P2419, DOI 10.2337/diabetes.50.11.2419; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; HERS HG, 1952, BIOCHIM BIOPHYS ACTA, V8, P416, DOI 10.1016/0006-3002(52)90067-X; HERZBERG GR, 1982, CAN J PHYSIOL PHARM, V60, P912, DOI 10.1139/y82-128; Jijakli H, 2003, J BIOL CHEM, V278, P4531, DOI 10.1074/jbc.M206730200; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; Kazumi T, 1997, ENDOCR J, V44, P239, DOI 10.1507/endocrj.44.239; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Le KA, 2008, DIABETES METAB, V34, P82, DOI 10.1016/j.diabet.2007.08.004; Malaisse WJ, 2002, MOL CELL BIOCHEM, V241, P103, DOI 10.1023/A:1020818810935; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; MENDELOFF AI, 1953, METABOLISM, V2, P450; Moreno-Aliaga MJ, 2007, J MOL ENDOCRINOL, V38, P537, DOI 10.1677/JME-06-0034; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Nagata R, 2004, J BIOL CHEM, V279, P29031, DOI 10.1074/jbc.M309449200; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Rumberger JM, 2003, J BIOL CHEM, V278, P28547, DOI 10.1074/jbc.M302793200; Sage AT, 2010, AM J PHYSIOL-ENDOC M, V298, pE499, DOI 10.1152/ajpendo.00507.2009; Scruel O, 1997, MOL CELL BIOCHEM, V175, P263, DOI 10.1023/A:1006834010660; SHAFRIR E, 1975, ISRAEL J MED SCI, V11, P738; SPENCE JT, 1982, EUR J BIOCHEM, V128, P15; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; WINDER WW, 1975, P SOC EXP BIOL MED, V148, P1150, DOI 10.3181/00379727-148-38706	40	35	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26583	10.1371/journal.pone.0026583	http://dx.doi.org/10.1371/journal.pone.0026583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096489	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900005
J	Yamauchi, Y; Izumi, Y; Kawamura, M; Nakatsuka, S; Yashiro, H; Tsukada, N; Inoue, M; Asakura, K; Nomori, H				Yamauchi, Yoshikane; Izumi, Yotaro; Kawamura, Masafumi; Nakatsuka, Seishi; Yashiro, Hideki; Tsukada, Norimasa; Inoue, Masanori; Asakura, Keisuke; Nomori, Hiroaki			Percutaneous Cryoablation of Pulmonary Metastases from Colorectal Cancer	PLOS ONE			English	Article							ACUTE LUNG INJURY; RADIOFREQUENCY ABLATION; SURGICAL-TREATMENT; RESECTION; TUMORS; CRYOTHERAPY; EXPERIENCE; MODEL; PNEUMOTHORAX; CANDIDATES	Objective: To evaluate the safety and efficacy of cryoablation for metastatic lung tumors from colorectal cancer. Methods: The procedures were performed on 24 patients (36-82 years of age, with a median age of 62; 17 male patients, 7 female patients) for 55 metastatic tumors in the lung, during 30 sessions. The procedural safety, local progression free interval, and overall survival were assessed by follow-up computed tomographic scanning performed every 3-4 months. Results: The major complications were pneumothorax, 19 sessions (63%), pleural effusion, 21 sessions (70%), transient and self-limiting hemoptysis, 13 sessions (43%) and tract seeding, 1 session (3%). The 1- and 3-year local progression free intervals were 90.8% and 59%, respectively. The 3-years local progression free intervals of tumors <= 15 mm in diameter was 79.8% and that of tumors >15 mm was 28.6% (p = 0.001; log-rank test). The 1- and 3-year overall survival rates were 91% and 59.6%, respectively. Conclusion: The results indicated that percutaneous cryoablation is a feasible treatment option. The local progression free interval was satisfactory at least for tumors that were <= 15 mm in diameter.	[Yamauchi, Yoshikane; Izumi, Yotaro; Tsukada, Norimasa; Asakura, Keisuke; Nomori, Hiroaki] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Nakatsuka, Seishi; Yashiro, Hideki; Inoue, Masanori] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Kawamura, Masafumi] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan	Keio University; Keio University; Teikyo University	Yamauchi, Y (corresponding author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	yoshikaney@2004.jukuin.keio.ac.jp	Yamauchi, Yoshikane/I-1952-2019	Yamauchi, Yoshikane/0000-0002-3374-2399; Asakura, Keisuke/0000-0002-4491-3456	Japanese Ministry of Education, Culture, Sports, Science and Technology [21591823, 22591374]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants (#21591823 and #22591374) to MK and to SN respectively, from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge BK, 2006, J ENDOUROL, V20, P1101, DOI 10.1089/end.2006.20.1101; Bahn DK, 2002, UROLOGY, V60, P3, DOI 10.1016/S0090-4295(02)01678-3; Chapman WC, 2000, ARCH SURG-CHICAGO, V135, P667, DOI 10.1001/archsurg.135.6.667; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Deygas N, 2001, CHEST, V120, P26, DOI 10.1378/chest.120.1.26; Dupuy DE, 2000, AM J ROENTGENOL, V174, P57, DOI 10.2214/ajr.174.1.1740057; Fernando HC, 2005, J THORAC CARDIOV SUR, V129, P639, DOI 10.1016/j.jtcvs.2004.10.019; Girard P, 1996, J CLIN ONCOL, V14, P2047, DOI 10.1200/JCO.1996.14.7.2047; Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65; Hiraki T, 2007, J VASC INTERV RADIOL, V18, P1264, DOI 10.1016/j.jvir.2007.06.027; Hruby G, 2008, BJU INT, V102, P723, DOI 10.1111/j.1464-410X.2008.07735.x; Izumi Y, 2005, ANN THORAC SURG, V79, P318, DOI 10.1016/j.athoracsur.2003.09.082; Kawamura M, 2006, J THORAC CARDIOV SUR, V131, P1007, DOI 10.1016/j.jtcvs.2005.12.051; Kelly H, 2005, J CLIN ONCOL, V23, P4553, DOI 10.1200/JCO.2005.17.749; Lee FT, 1997, RADIOLOGY, V202, P624, DOI 10.1148/radiology.202.3.9051005; MCAFEE MK, 1992, ANN THORAC SURG, V53, P780, DOI 10.1016/0003-4975(92)91435-C; MCCORMACK PM, 1992, ARCH SURG-CHICAGO, V127, P1403; Moorjani V, 2001, EUR J CARDIO-THORAC, V20, P502, DOI 10.1016/S1010-7940(01)00815-6; Nakatsuka S, 2010, CRYOBIOLOGY, V61, P317, DOI 10.1016/j.cryobiol.2010.10.157; Okumura S, 1996, J THORAC CARDIOV SUR, V112, P867, DOI 10.1016/S0022-5223(96)70085-5; Permpongkosol S, 2007, J VASC INTERV RADIOL, V18, P283, DOI 10.1016/j.jvir.2006.12.008; Regnard JF, 1998, ANN THORAC SURG, V66, P214, DOI 10.1016/S0003-4975(98)00269-0; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Sakurai J, 2007, J VASC INTERV RADIOL, V18, P141, DOI 10.1016/j.jvir.2006.10.011; Seifert JK, 1999, WORLD J SURG, V23, P1019, DOI 10.1007/s002689900617; Shiono S, 2005, ANN THORAC SURG, V80, P1040, DOI 10.1016/j.athoracsur.2004.12.033; SHIROUZU K, 1995, CANCER, V76, P393, DOI 10.1002/1097-0142(19950801)76:3<393::AID-CNCR2820760308>3.0.CO;2-8; THOMFORD NR, 1965, J THORAC CARDIOV SUR, V49, P357, DOI 10.1016/S0022-5223(19)33271-4; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Wang HW, 2005, RADIOLOGY, V235, P289, DOI 10.1148/radiol.2351030747; Washington K, 2001, J SURG RES, V95, P1, DOI 10.1006/jsre.2000.5976; Yamagami T, 2006, J VASC INTERV RADIOL, V17, P1625, DOI 10.1097/01.RVI.0000236607.05698.4A; Yamakado K, 2009, ONCOL REP, V22, P885, DOI 10.3892/or_00000513	33	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27086	10.1371/journal.pone.0027086	http://dx.doi.org/10.1371/journal.pone.0027086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096520	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800025
J	Boras-Granic, K; VanHouten, J; Hiremath, M; Wysolmerski, J				Boras-Granic, Kata; VanHouten, Joshua; Hiremath, Minoti; Wysolmerski, John			Parathyroid Hormone-Related Protein Is Not Required for Normal Ductal or Alveolar Development in the Post-Natal Mammary Gland	PLOS ONE			English	Article							BREAST-CANCER; BRANCHING MORPHOGENESIS; TRANSGENIC MICE; SIGNALING PATHWAYS; LACZ EXPRESSION; CELL FATE; OVEREXPRESSION; DIFFERENTIATION; COMMITMENT; MAINTAINS	PTHrP is necessary for the formation of the embryonic mammary gland and, in its absence, the embryonic mammary bud fails to form the neonatal duct system. In addition, PTHrP is produced by the breast during lactation and contributes to the regulation of maternal calcium homeostasis during milk production. In this study, we examined the role of PTHrP during post-natal mammary development. Using a PTHrP-lacZ transgenic mouse, we surveyed the expression of PTHrP in the developing post-natal mouse mammary gland. We found that PTHrP expression is restricted to the basal cells of the gland during pubertal development and becomes expressed in milk secreting alveolar cells during pregnancy and lactation. Based on the previous findings that overexpression of PTHrP in cap and myoepithelial cells inhibited ductal elongation during puberty, we predicted that ablation of native PTHrP expression in the post-natal gland would result in accelerated ductal development. To address this hypothesis, we generated two conditional models of PTHrP-deficiency specifically targeted to the postnatal mammary gland. We used the MMTV-Cre transgene to ablate the floxed PTHrP gene in both luminal and myoepithelial cells and a tetracycline-regulated K14-tTA;tetO-Cre transgene to target PTHrP expression in just myoepithelial and cap cells. In both models of PTHrP ablation, we found that mammary development proceeds normally despite the absence of PTHrP. We conclude that PTHrP signaling is not required for normal ductal or alveolar development.	[Boras-Granic, Kata; VanHouten, Joshua; Wysolmerski, John] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hiremath, Minoti] Boise State Univ, Dept Biol, Boise, ID 83725 USA	Yale University; Idaho; Boise State University	Boras-Granic, K (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	john.wysolmerski@yale.edu			National Institutes of Health [DK05501, DK077565, CA153702]; Yale Diabetes and Endocrine Research Center (NIH) [P30DK45735]; Yale Core Center for Musculoskeletal Disease (NIH) [P30AR46032]; NATIONAL CANCER INSTITUTE [R01CA153702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK055501, R01DK077565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Diabetes and Endocrine Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Core Center for Musculoskeletal Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants: DK05501, DK077565 and CA153702 from the National Institutes of Health. Support was also provided by core facilities funded by the Yale Diabetes and Endocrine Research Center (NIH P30DK45735) and the Yale Core Center for Musculoskeletal Disease (NIH P30AR46032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtari M, 2008, CANCER BIOL THER, V7, P3, DOI 10.4161/cbt.7.1.5163; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chen XS, 2006, J BONE MINER RES, V21, P113, DOI 10.1359/JBMR.051005; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; Dewar R, 2011, ARCH PATHOL LAB MED, V135, P422, DOI 10.1043/2010-0336-CP.1; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; Dunbar ME, 2001, J ENDOCRINOL, V171, P403, DOI 10.1677/joe.0.1710403; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; EDWARDS RC, 1995, EUR J CANCER, V31A, P334, DOI 10.1016/0959-8049(94)00451-A; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; Fleming NI, 2009, CANCER RES, V69, P7473, DOI 10.1158/0008-5472.CAN-09-0194; Foley J, 2001, DEVELOPMENT, V128, P513; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; LI J, 2008, J BONE MINER RES, pS1016; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Shen XL, 2004, EXP CELL RES, V294, P420, DOI 10.1016/j.yexcr.2003.11.028; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Visvader JE, 2011, COLD SPRING HARB PER, V3; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539; WYSOLMERSKI JJ, 1994, P NATL ACAD SCI USA, V91, P1133, DOI 10.1073/pnas.91.3.1133; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788; WYSOLMERSKI JJ, 2008, PRIMER METABOLIC BON, P127	35	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27278	10.1371/journal.pone.0027278	http://dx.doi.org/10.1371/journal.pone.0027278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087279	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700026
J	Bulut, G; Fallen, S; Beauchamp, EM; Drebing, LE; Sun, JF; Berry, DL; Kallakury, B; Crum, CP; Toretsky, JA; Schlegel, R; Uren, A				Bulut, Guelay; Fallen, Shannon; Beauchamp, Elspeth M.; Drebing, Lauren E.; Sun, Junfeng; Berry, Deborah L.; Kallakury, Bhaskar; Crum, Christopher P.; Toretsky, Jeffrey A.; Schlegel, Richard; Ueren, Aykut			Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice	PLOS ONE			English	Article							EPIGENETIC INACTIVATION; SQUAMOUS CARCINOGENESIS; UTERINE CERVIX; RODENT DIETS; WNT PATHWAY; SFRP GENES; CANCER; CARCINOMA; TRANSFORMATION; E6	Human papilloma virus (HPV) is the principal etiological agent of cervical cancer in women, and its DNA is present in virtually all of these tumors. However, exposure to the high-risk HPV types alone is insufficient for tumor development. Identifying specific collaborating factors that will lead to cervical cancer remains an unanswered question, especially because millions of women are exposed to HPV. Our earlier work using an in vitro model indicated that activation of the canonical Wnt pathway in HPV-positive epithelial cells was sufficient to induce anchorage independent growth. We therefore hypothesized that constitutive activation of this pathway might function as the "second hit." To address this possibility, we developed two double-transgenic (DT) mouse models, K14-E7/Delta N87 beta cat and K14-HPV16/Delta N87 beta cat that express either the proteins encoded by the E7 oncogene or the HPV16 early region along with constitutively active beta-catenin, which was expressed by linking it to the keratin-14 (K14) promoter. We initiated tumor formation by treating all groups with estrogen for six months. Invasive cervical cancer was observed in 11% of the K14-Delta N87 beta cat mice, expressing activated beta-catenin and in 50% of the animals expressing the HPV16 E7 oncogene. In double-transgenic mice, coexpression of beta-catenin and HPV16 E7 induced invasive cervical cancer at about 7 months in 94% of the cases. We did not observe cervical cancer in any group unless the mice were treated with estrogen. In the second model, K14-HPV16 mice suffered cervical dysplasias, but this phenotype was not augmented in HPV16/Delta N87 beta cat mice. In summary, the phenotypes of the K14-E7/Delta N87 beta cat mice support the hypothesis that activation of the Wnt/beta-catenin pathway in HPV-associated premalignant lesions plays a functional role in accelerating cervical carcinogenesis.	[Bulut, Guelay; Fallen, Shannon; Beauchamp, Elspeth M.; Drebing, Lauren E.; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Sun, Junfeng] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Kallakury, Bhaskar; Schlegel, Richard] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Crum, Christopher P.] Harvard Univ, Dept Pathol, Boston, MA 02115 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Georgetown University; Harvard University	Fallen, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu	BULUT, GULAY/J-3180-2012		National Institutes of Health (NIH) [CA108641]; Cancer Center [P30 CA051008]; NIH ARRA [1G20 RR025828-01]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008, R01CA108641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR025828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NIH ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants from the National Institutes of Health (NIH) CA108641 (to AU), Cancer Center Support Grant P30 CA051008 for use of Shared Resources (H&E and IHC stainings) and NIH ARRA Grant 1G20 RR025828-01 for use of Rodent Barrier Facility Equipment (between 7/20/2009 to 7/19/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Barcroft JD, 2002, THEORY PRACTICE HIST; Brake T, 2003, CANCER RES, V63, P8173; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Elson DA, 2000, CANCER RES, V60, P1267; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Jensen MN, 2007, LAB ANIM-UK, V41, P1, DOI 10.1258/002367707779399428; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; LAMBERT PF, 1993, P NATL ACAD SCI USA, V90, P5583, DOI 10.1073/pnas.90.12.5583; Lee J, 2008, GYNECOL ONCOL, V109, P270, DOI 10.1016/j.ygyno.2008.01.034; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Polakis P, 2000, GENE DEV, V14, P1837; Rampias T, 2010, MOL CANCER RES, V8, P433, DOI 10.1158/1541-7786.MCR-09-0345; Riley RR, 2003, CANCER RES, V63, P4862; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Shinohara A, 2001, GYNECOL ONCOL, V82, P450, DOI 10.1006/gyno.2001.6298; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Uren A, 2004, PEDIATR BLOOD CANCER, V43, P243, DOI 10.1002/pbc.20124; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Wolf JK, 2003, CANCER-AM CANCER SOC, V98, P2064, DOI 10.1002/cncr.11682	31	48	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27243	10.1371/journal.pone.0027243	http://dx.doi.org/10.1371/journal.pone.0027243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087269	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700030
J	Galbo, T; Olsen, GS; Quistorff, B; Nishimura, E				Galbo, Thomas; Olsen, Grith Skytte; Quistorff, Bjorn; Nishimura, Erica			Free Fatty Acid-Induced PP2A Hyperactivity Selectively Impairs Hepatic Insulin Action on Glucose Metabolism	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHATASE 2A; RESISTANCE; INHIBITION; AKT; PHOSPHORYLATION; ACTIVATION; CELLS; LIVER; OBESE	In type 2 Diabetes (T2D) free fatty acids (FFAs) in plasma are increased and hepatic insulin resistance is "selective", in the sense that the insulin-mediated decrease of glucose production is blunted while insulin's effect on stimulating lipogenesis is maintained. We investigated the molecular mechanisms underlying this pathogenic paradox. Primary rat hepatocytes were exposed to palmitate for twenty hours. To establish the physiological relevance of the in vitro findings, we also studied insulin-resistant Zucker Diabetic Fatty (ZDF) rats. While insulin-receptor phosphorylation was unaffected, activation of Akt and inactivation of the downstream targets Glycogen synthase kinase 3 alpha (Gsk3 alpha and Forkhead box O1 (FoxO1) was inhibited in palmitate-exposed cells. Accordingly, dose-response curves for insulin-mediated suppression of the FoxO1-induced gluconeogenic genes and for de novo glucose production were right shifted, and insulin-stimulated glucose oxidation and glycogen synthesis were impaired. In contrast, similar to findings in human T2D, the ability of insulin to induce triglyceride (TG) accumulation and transcription of the enzymes that catalyze de novo lipogenesis and TG assembly was unaffected. Insulin-induction of these genes could, however, be blocked by inhibition of the atypical PKCs (aPKCs). The activity of the Akt-inactivating Protein Phosphatase 2A (PP2A) was increased in the insulin-resistant cells. Furthermore, inhibition of PP2A by specific inhibitors increased insulin-stimulated activation of Akt and phosphorylation of FoxO1 and Gsk3 alpha. Finally, PP2A mRNA levels were increased in liver, muscle and adipose tissue, while PP2A activity was increased in liver and muscle tissue in insulin-resistant ZDF rats. In conclusion, our findings indicate that FFAs may cause a selective impairment of insulin action upon hepatic glucose metabolism by increasing PP2A activity.	[Galbo, Thomas; Olsen, Grith Skytte; Nishimura, Erica] Novo Nordisk AS, Dept Insulin Biol, Diabet Res Unit, Malov, Denmark; [Galbo, Thomas; Quistorff, Bjorn] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark	Novo Nordisk; University of Copenhagen	Galbo, T (corresponding author), Novo Nordisk AS, Dept Insulin Biol, Diabet Res Unit, Malov, Denmark.	tgbo@novonordisk.com		Nishimura, Erica/0000-0001-5741-3648	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	TG is funded by a grant from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation. BQ is employed by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Basu R, 2004, AM J PHYSIOL-ENDOC M, V287, pE55, DOI 10.1152/ajpendo.00549.2003; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Federici M, 2004, CIRCULATION, V109, P399, DOI 10.1161/01.CIR.0000109498.77895.6F; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fernandez JJ, 2002, CURR MED CHEM, V9, P229, DOI 10.2174/0929867023371247; Guenin S, 2008, INT J ONCOL, V32, P49; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mistafa O, 2010, J BIOL CHEM, V285, P27900, DOI 10.1074/jbc.M110.117093; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; NORDLIE RC, 1968, J BIOL CHEM, V243, P1140; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Passonneau Lowry, 1972, FLEXIBLE SYSTEM ENZY; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TERRETTAZ J, 1983, ENDOCRINOLOGY, V112, P1346, DOI 10.1210/endo-112-4-1346; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	41	36	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27424	10.1371/journal.pone.0027424	http://dx.doi.org/10.1371/journal.pone.0027424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087313	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700052
J	Karlocai, MR; Toth, K; Watanabe, M; Ledent, C; Juhasz, G; Freund, TF; Magloczky, Z				Karlocai, Maria R.; Toth, Kinga; Watanabe, Masahiko; Ledent, Catherine; Juhasz, Gabor; Freund, Tamas F.; Magloczky, Zsofia			Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy	PLOS ONE			English	Article							PERISOMATIC INHIBITORY INPUT; TEMPORAL-LOBE EPILEPSY; ENDOCANNABINOID SYSTEM; DENTATE GYRUS; IMMUNOREACTIVE INTERNEURONS; SYNAPTIC REORGANIZATION; MEDIATED INHIBITION; GRANULE CELLS; MODEL; GABA	The endocannabinoid system plays a central role in retrograde synaptic communication and may control the spread of activity in an epileptic network. Using the pilocarpine model of temporal lobe epilepsy we examined the expression pattern of the Type 1 cannabinoid receptor (CB1-R) in the hippocampi of CD1 mice at survival times of 2 hours, 1 day, 3 days and 2 months (acute, latent and chronic phases). Based on the behavioral signs of the acute seizures, animals were classified as "weakly'' or "strongly'' epileptic using the modified Racine scale. Mice of the weak group had mild seizures, whereas seizures in the strong group were frequent with intense motor symptoms and the majority of these animals developed sclerosis in the chronic phase. In control samples the most intense staining of CB1-R-positive fibers was found in the molecular layer of the dentate gyrus and in str. pyramidale of the cornu Ammonis. In weak animals no significant changes were seen at any survival time compared to controls. In strong animals, however, in the acute phase, a massive reduction in CB1-R-stained terminals occurred in the hippocampus. In the latent phase CB1-R immunoreactivity gradually recovered. In the chronic phase, CB1-immunostaining in sclerotic samples was stronger throughout the hippocampus. Quantitative electron microscopic analysis showed an increase in the number of CB1-R-positive terminals in the dentate gyrus. Moreover, the number of immunogold particles significantly increased in GABAergic terminals. Our results suggest a proconvulsive downregulation of CB1 receptors in the acute phase most probably due to receptor internalization, followed by compensatory upregulation and sprouting in the chronic phase of epilepsy. In conclusion, the changes in CB1 receptor expression pattern revealed in this study are associated with the severity of hippocampal injury initiated by acute seizures that ultimately leads to sclerosis in the vulnerable regions in the chronic phase.	[Karlocai, Maria R.; Toth, Kinga; Freund, Tamas F.; Magloczky, Zsofia] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Ledent, Catherine] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Juhasz, Gabor] Eotvos Lorand Univ, Inst Biol, Res Grp Prote, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University; Universite Libre de Bruxelles; Eotvos Lorand University	Karlocai, MR (corresponding author), Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.	karlocai.rita@koki.hu	WATANABE, Masahiko/A-4055-2012; Juhász, Gábor/I-7781-2017; Karlocai, Rita/ABD-9391-2021; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Juhász, Gábor/0000-0002-0849-6931; Karlocai, Rita/0000-0002-2110-8825; Watanabe, Masahiko/0000-0001-5037-7138	EC [LSH-CT-2006-037315, NS030549]; Hungarian Scientific Research Fund [NKTH-OTKA CNK 77793]; National Development Agency [TAMOP 4.2.1./B-09/1/KMR.2010.0003]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN	EC(European CommissionEuropean Commission Joint Research Centre); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the following: EPICURE FP6 EC LSH-CT-2006-037315, NS030549, and Hungarian Scientific Research Fund (NKTH-OTKA CNK 77793) and National Development Plan of the National Development Agency (TAMOP 4.2.1./B-09/1/KMR.2010.0003) for G.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010683; Cadas H, 1996, J NEUROSCI, V16, P3934; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Corsellis JAN, 1976, GREENFIELDS NEUROPAT, P771; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Coutts AA, 2001, J NEUROSCI, V21, P2425; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; da Costa NM, 2009, J NEUROSCI METH, V180, P77, DOI 10.1016/j.jneumeth.2009.03.001; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Engel J, 1996, CAN J NEUROL SCI, V23, P167, DOI 10.1017/S0317167100038464; Falenski KW, 2007, NEUROSCIENCE, V146, P1232, DOI 10.1016/j.neuroscience.2007.01.065; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 2003, NEURON, V38, P362, DOI 10.1016/S0896-6273(03)00262-9; Fujiwara-Tsukamoto Y, 2003, NEUROSCIENCE, V119, P265, DOI 10.1016/S0306-4522(03)00102-7; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; GALLYAS F, 1980, STAIN TECHNOL, V55, P299, DOI 10.3109/10520298009067258; GASS P, 1995, NEUROSCIENCE, V65, P27, DOI 10.1016/0306-4522(95)92049-P; Goffin K, 2011, BRAIN, V134, P1033, DOI 10.1093/brain/awq385; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Green RC, 1991, EPILEPSY BEHAV, P345; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kathmann M, 1999, N-S ARCH PHARMACOL, V359, P466, DOI 10.1007/PL00005377; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; KEELER MH, 1967, DIS NERV SYST, V28, P474; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; LEITE JP, 1995, EPILEPSY RES, V20, P93, DOI 10.1016/0920-1211(94)00070-D; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Lourenco J, 2011, J NEUROSCI, V31, P3243, DOI 10.1523/JNEUROSCI.3512-10.2011; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Lutz B, 2002, PROSTAG LEUKOTR ESS, V66, P123, DOI 10.1054/plef.2001.0342; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Magloczky Z, 1997, NEUROSCIENCE, V76, P377, DOI 10.1016/S0306-4522(96)00440-X; MAGLOCZKY Z, 1995, NEUROSCIENCE, V66, P847, DOI 10.1016/0306-4522(94)00613-A; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matyas F, 2004, HIPPOCAMPUS, V14, P460, DOI 10.1002/hipo.10191; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; NADLER JV, 1980, BRAIN RES, V182, P1; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; Sullivan JM, 1999, J NEUROPHYSIOL, V82, P1286, DOI 10.1152/jn.1999.82.3.1286; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Toth K, 2007, NEUROSCIENCE, V144, P495, DOI 10.1016/j.neuroscience.2006.09.039; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wittner L, 2005, BRAIN, V128, P138, DOI 10.1093/brain/awh339; Wittner L, 2002, NEUROSCIENCE, V115, P961, DOI 10.1016/S0306-4522(02)00264-6; Wittner L, 2001, NEUROSCIENCE, V108, P587, DOI 10.1016/S0306-4522(01)00446-8; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010	87	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27196	10.1371/journal.pone.0027196	http://dx.doi.org/10.1371/journal.pone.0027196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076136	Green Submitted, gold, Green Published			2022-12-25	WOS:000297198200048
J	Wright, H; Cohen, A; Sonmez, K; Yochum, G; McWeeney, S				Wright, Hollis; Cohen, Aaron; Soenmez, Kemal; Yochum, Gregory; McWeeney, Shannon			Occupancy Classification of Position Weight Matrix-Inferred Transcription Factor Binding Sites	PLOS ONE			English	Article							NETWORKS	Background: Computational prediction of Transcription Factor Binding Sites (TFBS) from sequence data alone is difficult and error-prone. Machine learning techniques utilizing additional environmental information about a predicted binding site (such as distances from the site to particular chromatin features) to determine its occupancy/functionality class show promise as methods to achieve more accurate prediction of true TFBS in silico. We evaluate the Bayesian Network (BN) and Support Vector Machine (SVM) machine learning techniques on four distinct TFBS data sets and analyze their performance. We describe the features that are most useful for classification and contrast and compare these feature sets between the factors. Results: Our results demonstrate good performance of classifiers both on TFBS for transcription factors used for initial training and for TFBS for other factors in cross-classification experiments. We find that distances to chromatin modifications (specifically, histone modification islands) as well as distances between such modifications to be effective predictors of TFBS occupancy, though the impact of individual predictors is largely TF specific. In our experiments, Bayesian network classifiers outperform SVM classifiers. Conclusions: Our results demonstrate good performance of machine learning techniques on the problem of occupancy classification, and demonstrate that effective classification can be achieved using distances to chromatin features. We additionally demonstrate that cross-classification of TFBS is possible, suggesting the possibility of constructing a generalizable occupancy classifier capable of handling TFBS for many different transcription factors.	[Wright, Hollis; Cohen, Aaron; Soenmez, Kemal; McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Yochum, Gregory] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Biostat, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Wright, H (corresponding author), Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	wrighth@ohsu.edu	Sonmez, Kemal/ABF-3992-2020	Sonmez, Kemal/0000-0002-2816-6438; McWeeney, Shannon/0000-0001-8333-6607	National Library of Medicine [T15 LM007088]; National Institutes of Health, National Center for Research Resources [5UL1RR024140]; National Institutes of Health, National Cancer Institute [5 P30 CA069533-13]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was primarily supported by a National Library of Medicine pre-doctoral fellowship (T15 LM007088) to Dr. Wright, and National Institutes of Health, National Center for Research Resources (5UL1RR024140 to Dr. McWeeney); National Institutes of Health, National Cancer Institute (5 P30 CA069533-13 to Dr. McWeeney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen Y, 2007, PLOS COMPUT BIOL, V3; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins PJ, 2007, PLOS GENET, V3, P2247, DOI 10.1371/journal.pgen.0030208; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hall M., 1998, THESIS U WAIKATO HAM; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; R Core Team, 2021, R LANG ENV STAT COMP; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roulet E, 1998, In Silico Biol, V1, P21; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Witten I. H., 2005, DATA MINING PRACTICA; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Won KJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r7; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26160	10.1371/journal.pone.0026160	http://dx.doi.org/10.1371/journal.pone.0026160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073148	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200005
J	Munro, JB; Heraty, JM; Burks, RA; Hawks, D; Mottern, J; Cruaud, A; Rasplus, JY; Jansta, P				Munro, James B.; Heraty, John M.; Burks, Roger A.; Hawks, David; Mottern, Jason; Cruaud, Astrid; Rasplus, Jean-Yves; Jansta, Petr			A Molecular Phylogeny of the Chalcidoidea (Hymenoptera)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; PERILAMPIDAE HYMENOPTERA; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; WASPS HYMENOPTERA; CLASSIFICATION; INSECTA; GENUS; 28S; EVOLUTION	Chalcidoidea (Hymenoptera) are extremely diverse with more than 23,000 species described and over 500,000 species estimated to exist. This is the first comprehensive phylogenetic analysis of the superfamily based on a molecular analysis of 18S and 28S ribosomal gene regions for 19 families, 72 subfamilies, 343 genera and 649 species. The 56 outgroups are comprised of Ceraphronoidea and most proctotrupomorph families, including Mymarommatidae. Data alignment and the impact of ambiguous regions are explored using a secondary structure analysis and automated (MAFFT) alignments of the core and pairing regions and regions of ambiguous alignment. Both likelihood and parsimony approaches are used to analyze the data. Overall there is no impact of alignment method, and few but substantial differences between likelihood and parsimony approaches. Monophyly of Chalcidoidea and a sister group relationship between Mymaridae and the remaining Chalcidoidea is strongly supported in all analyses. Either Mymarommatoidea or Diaprioidea are the sister group of Chalcidoidea depending on the analysis. Likelihood analyses place Rotoitidae as the sister group of the remaining Chalcidoidea after Mymaridae, whereas parsimony nests them within Chalcidoidea. Some traditional family groups are supported as monophyletic (Agaonidae, Eucharitidae, Encyrtidae, Eulophidae, Leucospidae, Mymaridae, Ormyridae, Signiphoridae, Tanaostigmatidae and Trichogrammatidae). Several other families are paraphyletic (Perilampidae) or polyphyletic (Aphelinidae, Chalcididae, Eupelmidae, Eurytomidae, Pteromalidae, Tetracampidae and Torymidae). Evolutionary scenarios discussed for Chalcidoidea include the evolution of phytophagy, egg parasitism, sternorrhynchan parasitism, hypermetamorphic development and heteronomy.	[Munro, James B.; Heraty, John M.; Burks, Roger A.; Hawks, David; Mottern, Jason; Cruaud, Astrid] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Rasplus, Jean-Yves] INRA, Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Jansta, Petr] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	University of California System; University of California Riverside; INRAE; Institut de Recherche pour le Developpement (IRD); Charles University Prague	Munro, JB (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	john.heraty@ucr.edu	Jansta, Petr/R-9124-2017; Munro, James B./C-5489-2009; Rasplus, Jean-Yves/O-2873-2017	Jansta, Petr/0000-0001-6409-3603; Munro, James B./0000-0003-3067-6434; Rasplus, Jean-Yves/0000-0001-8614-6665	National Science Foundation [TOL EF-0341149, PEET DEB-0730616]; @-Speed-Id; ANR BioFigs;  [MSM0021620828]	National Science Foundation(National Science Foundation (NSF)); @-Speed-Id; ANR BioFigs(French National Research Agency (ANR)); 	Funding was provided by National Science Foundation grants TOL EF-0341149 and PEET DEB-0730616 to JMH, @-Speed-Id and ANR BioFigs to JYR, and MSM0021620828 to PJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke DP, 1961, DEP AGR TECHNICAL SE, V5, P1; Ashmead W.H., 1904, MEM CARNEGIE MUS, V1, P225, DOI DOI 10.5962/BHL.TITLE.10341; Banks JC, 2006, MOL PHYLOGENET EVOL, V41, P690, DOI 10.1016/j.ympev.2006.06.001; Boucek Z., 1988, P11; BOUCEK Z, 1981, Tijdschrift voor Entomologie, V124, P149; BOUCEK Z, 1987, SYST ENTOMOL, V12, P407, DOI 10.1111/j.1365-3113.1987.tb00212.x; BOUCEK Z, 1974, ENTOMOLOGY S, V23, P1; Boucek Z, 1997, ANNOTATED KEYS GENER; BOUCEK Z, 1988, AUSTR CHALCIDOIDEA H; Boucek Z, 1997, ANNOTATED KEYS GENER; Burks BD, 1979, ORMYRIDAE CATALOG HY, P1198; Burks RA, 2011, CLADISTICS, V27, P581, DOI 10.1111/j.1096-0031.2011.00358.x; CAMPBELL B, 2000, HYMENOPTERA EVOLUTIO, P57; Castro LR, 2006, INVERTEBR SYST, V20, P603, DOI 10.1071/IS06002; Chen Y, 2004, MOL PHYLOGENET EVOL, V31, P300, DOI 10.1016/S1055-7903(03)00282-3; COMPERE HAROLD, 1961, JOUR ENT SOC SOUTHERN AFRICA, V24, P17; COPLAND MJW, 1973, J ENTOMOL SER A, V48, P25; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; DARLING DC, 1992, SYST ENTOMOL, V17, P331, DOI 10.1111/j.1365-3113.1992.tb00554.x; Darling DC, 1997, ANNOTATED KEYS GENER, P794; Deans AR, 2006, SYST ENTOMOL, V31, P517, DOI 10.1111/j.1365-3113.2006.00327.x; Delucchi V, 1962, SCI ZOOLOGIQUE, V110, P363; DELVARE G., 1992, MEM AM ENTOMOL INST, V53, P119; Delvare G., 1992, MEM AM ENTOMOL I, V53, P1; DESANTIS L, 1946, REV MUSEO PLATA, V5, P1; Desjardins CA, 2007, MOL PHYLOGENET EVOL, V45, P454, DOI 10.1016/j.ympev.2007.08.004; Domenichini G., 1954, Bollettino di Zoologia Agraria e Bachicoltura Parma, V20, P95; Erdos J, 1964, FAUNA HUNG, V73, P1; FERRIERE C, 1965, HYMENOPTERA APHELINI; Gates M, 2008, U CALIFORNIA PUBLICA, V127, P1; Gauld ID, 1995, HYMENOPTERA COSTA RI, P185; Gauthier N, 2000, SYST ENTOMOL, V25, P521, DOI 10.1046/j.1365-3113.2000.00134.x; Ghesquiere J., 1955, Memoires de la Societe Entomologique de Belgique, V27, P217; Gibson G., 1990, Chalcid Forum, P7; Gibson G. A. P., 2003, Phylogenetics and classification of Cleonyminae (Hymenoptera: Chalcidoidea: Pteromalidae); Gibson G. A. P, 1989, MEMOIRS ENTOMOLOGICA, V149, P1, DOI [10.4039/entm121149fv, DOI 10.4039/ENTM121149FV]; GIBSON GAP, 1986, CAN ENTOMOL, V118, P205, DOI 10.4039/Ent118205-3; Gibson GAP, 1999, ZOOL SCR, V28, P125, DOI 10.1046/j.1463-6409.1999.00015.x; Gibson GAP, 2000, J NAT HIST, V34, P2293, DOI 10.1080/002229300750037901; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Gibson GAP, 1993, HYMENOPTERA WORLD ID; Gibson Gary A.P., 2008, Zootaxa, V1730, P1; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; Gillespie JJ, 2005, J MOL EVOL, V61, P114, DOI 10.1007/s00239-004-0246-x; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Girault A. A., 1915, Memoirs of the Queensland Museum, V4; Goloboff PA, 2003, TREE ANAL USING NEW; Goloboff P, 2008, CLADISTICS, V24, P91; Gordh G, 1979, ENCYRTIDAE CATALOG H; Graham M. W. R. de V., 1969, Bull. Br. Mus. nat. Hist. Ent., V16, P1; Grimaldi David, 2005, pi; Grissell E.E., 1995, Memoirs on Entomology International, V2, P1; Grissell EE, 1997, ANNOTATED KEYS GENER; Gumovsky Alex V., 2005, Entomological Problems, V35, P123; Gumovsky AV, 2002, PARASITIC WASPS EVOL; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; HANSON P, 1992, J NAT HIST, V26, P1333, DOI 10.1080/00222939200770761; Hanson P, 1997, ANNOTATED KEYS GENER; HAYAT M, 1994, ORIENT INSECTS, V28, P81; HAYAT M, 1983, SYST ENTOMOL, V8, P63, DOI 10.1111/j.1365-3113.1983.tb00467.x; Hayat M., 1998, MEM ENTOMOL INT, V13, P1; Hayat M, 1985, ORIENT INSECTS, V19, p[226, 163]; HEDQVIST K-J, 1971, Entomologisk Tidskrift, V92, P237; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Heraty J. M., 2007, Journal of the Entomological Society of Ontario, V138, P33; Heraty J. M., 2003, P 21 S PLANT BIOL LO, P277; Heraty J. M, 2002, MEM AM ENTOMOL I, V68, P1; HERATY JM, 1984, SYST ENTOMOL, V9, P309, DOI 10.1111/j.1365-3113.1984.tb00056.x; Heraty JM, 1997, SYST ENTOMOL, V22, P45, DOI 10.1046/j.1365-3113.1997.d01-26.x; Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Heraty JM, 2009, ZOOTAXA, P1; HUBER J T, 1986, Entomography, V4, P185; Huber JT, 2008, J HYMENOPT RES, V17, P175; Huber JT, 2006, J NAT HIST, V40, P1909, DOI 10.1080/00222930601046428; Huber JT, 1997, ANNOTATED KEYS GENER; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khan MY, 1980, SCI ENV ALIGARH, V2, P59; LaSalle J, 1997, SYST ENTOMOL, V22, P131, DOI 10.1046/j.1365-3113.1997.d01-38.x; LASALLE J, 1985, J NEW YORK ENTOMOL S, V93, P1261; LASALLE J, 1987, CONTRIBUTIONS AM ENT, V23, P1; Letsch HO, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-146; LINARES AR, 1991, J MOL BIOL, V219, P381, DOI 10.1016/0022-2836(91)90178-9; Lotfalizadeh H, 2007, ZOOL J LINN SOC-LOND, V151, P441, DOI 10.1111/j.1096-3642.2007.00308.x; Masner L, 1995, PROCTOTRUPOID FAMILI, P209; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; MERCET RICARDO GARCIA, 1929, EOS, V5, P111; Miller M, 2010, CIPRES PORTALS, P2009; Mottern JL, 2011, SYST ENTOMOL, V36, P267, DOI 10.1111/j.1365-3113.2010.00557.x; Muesebeck CFW, 1951, AGR MONOGRAPH; Narendran T. C, 1989, ORIENTAL CHALCIDIDAE; NIKOLSKAYA MN, 1966, OPREDELITELI FAUNE S, V91, P1; Noyes J.S., 1990, Chalcid Forum, P6; Noyes John S., 2000, Memoirs of the American Entomological Institute (Gainesville), V62, P1; Noyes JS, 2011, UNIVERSAL CHALCIDOID; Noyes JS, 1997, ANNOTATED KEYS GENER; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; Parker HL, 1924, ANN SOC ENTOMOLOGIQU, V93, P1; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pedata P.A., 1991, Redia, V74, P343; Pfeiffer W, 2010, 9 IEEE INT WORKSH HI; Pinto J, 2003, ENCY INSECTS, P546; Poinar G, 2011, ZOOKEYS, P461, DOI 10.3897/zookeys.130.1241; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rosen D., 1990, ARMORED SCALE INSECT; Schauff M.E., 1984, Memoirs of the Entomological Society of Washington, P1; Schauff ME, 1997, ANNOTATED KEYS GENER; Schmidt AR, 2010, P NATL ACAD SCI USA, V107, P7329, DOI 10.1073/pnas.1000948107; Schulmeister S, 2003, BIOL J LINN SOC, V79, P245, DOI 10.1046/j.1095-8312.2003.00233.x; SHAFEE S A, 1978, Journal of Zoological Research (Aligarh), V2, P42; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; STAGE G I, 1986, Contributions in Science (Los Angeles), P1; Stamatakis A, 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L., 1990, MOL SYSTEMATICS; Swofford DL, 2002, PAUP VERSION 4 0 U 1; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Triapitzin VA, 1973, ENTOMOLOGICAL REV, V57, P287; Trjapitzin V.A., 1989, Opredeliteli po Faune SSSR, V158, P1; Trjapitzin V.A, 1973, ENTOMOL REV, V52, P118; VIGGIANI G, 1984, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V41, P149; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wijesekara G. A. W., 1997, Contributions of the American Entomological Institute, V29, P1; WOOLLEY JB, 1988, SYST ENTOMOL, V13, P465, DOI 10.1111/j.1365-3113.1988.tb00256.x; Woolley JB, 1997, ANNOTATED KEYS GENER; Woolley JB, 1997, ANNOTATED KEYS GENER; YASNOSH V A, 1976, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V55, P114; YOSHIMOTO CM, 1975, CAN ENTOMOL, V107, P499, DOI 10.4039/Ent107499-5	134	116	124	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27023	10.1371/journal.pone.0027023	http://dx.doi.org/10.1371/journal.pone.0027023			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22087244	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000022
J	Sulmon, C; Gouesbet, G; Ramel, F; Cabello-Hurtado, F; Penno, C; Bechtold, N; Couee, I; El Amrani, A				Sulmon, Cecile; Gouesbet, Gwenola; Ramel, Fanny; Cabello-Hurtado, Francisco; Penno, Christophe; Bechtold, Nicole; Couee, Ivan; El Amrani, Abdelhak			Carbon Dynamics, Development and Stress Responses in Arabidopsis: Involvement of the APL4 Subunit of ADP-Glucose Pyrophosphorylase (Starch Synthesis)	PLOS ONE			English	Article							SUGAR-INDUCED TOLERANCE; SUCROSE-INDUCED TOLERANCE; GENOME-WIDE ANALYSIS; GENE-EXPRESSION MAP; OXIDATIVE STRESS; HERBICIDE ATRAZINE; SINGLET OXYGEN; SOLUBLE SUGARS; THALIANA; PLANTS	An Arabidopsis thaliana T-DNA insertional mutant was identified and characterized for enhanced tolerance to the singlet-oxygen-generating herbicide atrazine in comparison to wild-type. This enhanced atrazine tolerance mutant was shown to be affected in the promoter structure and in the regulation of expression of the APL4 isoform of ADP-glucose pyrophosphorylase, a key enzyme of the starch biosynthesis pathway, thus resulting in decrease of APL4 mRNA levels. The impact of this regulatory mutation was confirmed by the analysis of an independent T-DNA insertional mutant also affected in the promoter of the APL4 gene. The resulting tissue-specific modifications of carbon partitioning in plantlets and the effects on plantlet growth and stress tolerance point out to specific and non-redundant roles of APL4 in root carbon dynamics, shoot-root relationships and sink regulations of photosynthesis. Given the effects of exogenous sugar treatments and of endogenous sugar levels on atrazine tolerance in wild-type Arabidopsis plantlets, atrazine tolerance of this apl4 mutant is discussed in terms of perception of carbon status and of investment of sugar allocation in xenobiotic and oxidative stress responses.	[Sulmon, Cecile; Gouesbet, Gwenola; Ramel, Fanny; Cabello-Hurtado, Francisco; Penno, Christophe; Couee, Ivan; El Amrani, Abdelhak] Univ Rennes 1, Ctr Natl Rech Sci, ECOBIO, UMR 6553, Rennes, France; [Bechtold, Nicole] Ctr Versailles Grignon, Inst Natl Rech Agron, Unite Genet & Ameliorat Plantes, Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; INRAE	Sulmon, C (corresponding author), Univ Rennes 1, Ctr Natl Rech Sci, ECOBIO, UMR 6553, Rennes, France.	cecile.sulmon-maisonneuve@univ-rennes1.fr	Sulmon, Cécile/AAC-3611-2019; Gouesbet, Gwenola/C-4790-2009; Couee, Ivan/D-9201-2012	Sulmon, Cécile/0000-0003-3989-9853; Gouesbet, Gwenola/0000-0002-5223-7240; Couee, Ivan/0000-0002-1117-0043; penno, christophe/0000-0002-7698-5278	Ministere de l'Enseignement Superieur et de la Recherche (France); Centre National de la Recherche Scientifique, France; Rennes Metropole (France) local council	Ministere de l'Enseignement Superieur et de la Recherche (France); Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS)); Rennes Metropole (France) local council	This work was supported in part by fellowships (to F.R. and to C.S.) from the Ministere de l'Enseignement Superieur et de la Recherche (France, www.recherche.gouv.fr) and by grants from the Environnement-Vie-Societe and Ingenierie Ecologique programmes (Centre National de la Recherche Scientifique, France; www.cnrs.fr) and from Rennes Metropole (France; www.rennes-metropole.fr) local council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbacher RA, 2000, P 9 SWISS PLANT CELL, P51; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; De Prado R, 2000, PESTIC BIOCHEM PHYS, V67, P114, DOI 10.1006/pest.2000.2484; Devic M, 1997, PLANT PHYSIOL BIOCH, V35, P331; FREAR DS, 1970, PHYTOCHEMISTRY, V9, P2123, DOI 10.1016/S0031-9422(00)85377-7; Fritzius T, 2001, PLANT PHYSIOL, V126, P883, DOI 10.1104/pp.126.2.883; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Hummel I, 2004, GENE, V342, P199, DOI 10.1016/j.gene.2004.08.024; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; LICHTENTHALER H. K., 1983, BIOCHEM SOC T, V11, P591, DOI [DOI 10.1042/BST0110591, 10.1042/BST0110591]; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; LIN TP, 1988, PLANT PHYSIOL, V88, P1175, DOI 10.1104/pp.88.4.1175; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; NEUHAUS HE, 1990, PLANTA, V182, P445, DOI [10.1007/BF02411398, 10.1007/BF00197565]; Ohkama-Ohtsu N, 2004, PLANT PHYSIOL, V136, P3209, DOI 10.1104/pp.104.047068; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Owen W.J., 2000, METABOLISM AGROCHEMI, P211; Paul MJ, 2010, PLANT SIGNAL BEHAV, V5, P386, DOI 10.4161/psb.5.4.10792; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; PREISS J, 1982, ANNU REV PLANT PHYS, V33, P431, DOI 10.1146/annurev.pp.33.060182.002243; PREISS J, 1997, MOL APPROACH PRIMARY, P81; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Ramel F, 2009, ANN BOT-LONDON, V104, P1323, DOI 10.1093/aob/mcp243; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Sahrawy M, 2004, J EXP BOT, V55, P2495, DOI 10.1093/jxb/erh257; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Sulmon C, 2006, PLANT CELL REP, V25, P489, DOI 10.1007/s00299-005-0062-9; Sulmon C, 2004, PLANT SCI, V167, P913, DOI 10.1016/j.plantsci.2004.05.036; Sulmon C, 2007, J PLANT PHYSIOL, V164, P1083, DOI 10.1016/j.jplph.2006.11.005; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Sun JD, 1999, PLANT PHYSIOL, V119, P267, DOI 10.1104/pp.119.1.267; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tsai HL, 2009, PLANT PHYSIOL, V151, P1582, DOI 10.1104/pp.109.144196; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1997, PLANT J, V11, P1121, DOI 10.1046/j.1365-313X.1997.11051121.x; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Windsor B, 2003, NAT BIOTECHNOL, V21, P428, DOI 10.1038/nbt809; Wingler A, 2000, PLANT PHYSIOL, V124, P105, DOI 10.1104/pp.124.1.105; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	63	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26855	10.1371/journal.pone.0026855	http://dx.doi.org/10.1371/journal.pone.0026855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073207	gold, Green Published			2022-12-25	WOS:000297197000002
J	Green, TC; Black, R; Serrano, JMG; Budman, SH; Butler, SF				Green, Traci C.; Black, Ryan; Serrano, Jill M. Grimes; Budman, Simon H.; Butler, Stephen F.			Typologies of Prescription Opioid Use in a Large Sample of Adults Assessed for Substance Abuse Treatment	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; HUMAN-IMMUNODEFICIENCY-VIRUS; ADDICTION SEVERITY INDEX; LATENT CLASS ANALYSIS; NONMEDICAL USE; DRUG-USE; ILLICIT USE; SELF-REPORTS; SEEKING TREATMENT; COLLEGE-STUDENTS	Background: As a population, non-medical prescription opioid users are not well-defined. We aimed to derive and describe typologies of prescription opioid use and nonmedical use using latent class analysis in an adult population being assessed for substance abuse treatment. Methods: Latent class analysis was applied to data from 26,314 unique respondents, aged 18-70, self-reporting past month use of a prescription opioid out of a total of 138,928 cases (18.9%) collected by the Addiction Severity Index-Multimedia Version (ASI-MV (R)), a national database for near real-time prescription opioid abuse surveillance. Data were obtained from November 2005 through December 2009. Substance abuse treatment, criminal justice, and public assistance programs in the United States submitted data to the ASI-MV database (n = 538). Six indicators of the latent classes derived from responses to the ASI-MV, a version of the ASI modified to collect prescription opioid abuse and chronic pain experience. The latent class analysis included respondent home ZIP code random effects to account for nesting of respondents within ZIP code. Results: A four-class adjusted latent class model fit best and defined clinically interpretable and relevant subgroups: Use as prescribed, Prescribed misusers, Medically healthy abusers, and Illicit users. Classes varied on key variables, including race/ethnicity, gender, concurrent substance abuse, duration of prescription opioid abuse, mental health problems, and ASI composite scores. Three of the four classes (81% of respondents) exhibited high potential risk for fatal opioid overdose; 18.4% exhibited risk factors for blood-borne infections. Conclusions: Multiple and distinct profiles of prescription opioid use were detected, suggesting a range of use typologies at differing risk for adverse events. Results may help clinicians and policy makers better focus overdose and blood-borne infection prevention efforts and intervention strategies for prescription opioid abuse reduction.	[Green, Traci C.] Brown Med Sch, Providence, RI USA; [Green, Traci C.] Rhode Isl Hosp, Providence, RI USA; [Black, Ryan; Serrano, Jill M. Grimes; Budman, Simon H.; Butler, Stephen F.] Inflexxion Inc, Needham, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Green, TC (corresponding author), Brown Med Sch, Providence, RI USA.	traci.c.green@gmail.com	Butler, Stephen/AAK-7902-2020	Butler, Stephen/0000-0002-6132-5883	National Research Service from the National Institute on Drug Abuse [5F31DA023862]; Lifespan/Tufts/Brown Center for AIDS Research [NIAID P30AI042853]; King Pharmaceuticals(R), Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023862] Funding Source: NIH RePORTER	National Research Service from the National Institute on Drug Abuse; Lifespan/Tufts/Brown Center for AIDS Research; King Pharmaceuticals(R), Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a National Research Service Award grant (TCG) from the National Institute on Drug Abuse (5F31DA023862) and by a 2009 Developmental grant to TCG from Lifespan/Tufts/Brown Center for AIDS Research (NIAID P30AI042853). The writing of this paper was funded in part by an unrestricted grant to Inflexxion, Inc. from King Pharmaceuticals, Inc., which was acquired by Pfizer, Inc. in March 2011. JGS and SFB, who are employees of Inflexxion, were paid consultants to King Pharmaceuticals, Inc., in connection with the development of this manuscript. The views expressed in this paper are those of the authors and do not necessarily represent the views of Pfizer Pharmaceuticals, Inc. The funding sources had no part in the conception, design, data analysis, interpretation, writing, editing, or decision to publish this manuscript.	Agrawal A, 2007, ADDICTION, V102, P94, DOI 10.1111/j.1360-0443.2006.01630.x; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Boyd CJ, 2006, DRUG ALCOHOL DEPEN, V81, P37, DOI 10.1016/j.drugalcdep.2005.05.017; Butler SF, 2004, PAIN, V112, P65, DOI 10.1016/j.pain.2004.07.026; Butler SF, 2008, J PAIN, V9, P360, DOI 10.1016/j.jpain.2007.11.014; Butler SF, 2008, PHARMACOEPIDEM DR S, V17, P1142, DOI 10.1002/pds.1659; Carise D, 2007, AM J PSYCHIAT, V164, P1750, DOI 10.1176/appi.ajp.2007.07050252; CHAISSON RE, 1987, AM J PUBLIC HEALTH, V77, P169, DOI 10.2105/AJPH.77.2.169; Chitwood DD, 2003, J PSYCHOACTIVE DRUGS, V35, P445, DOI 10.1080/02791072.2003.10400491; Connors GJ, 2003, ADDICTION, V98, P21, DOI 10.1046/j.1359-6357.2003.00585.x; Daniulaityte R, 2006, J DRUG ISSUES, V36, P787, DOI 10.1177/002204260603600402; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dasgupta N, 2010, AM J LIFESTYLE MED, V4, P32, DOI 10.1177/1559827609348462; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Delucchi KL, 2004, DRUG ALCOHOL DEPEN, V74, P235, DOI 10.1016/j.drugalcdep.2003.12.014; Des Jarlais DC, 2007, ADDICTION, V102, P778, DOI 10.1111/j.1360-0443.2007.01764.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Draus PJ, 2006, SUBST USE MISUSE, V41, P1111, DOI 10.1080/10826080500411577; FDA, 2011, QUEST ANSW FDA REQ R; Ghandour LA, 2008, INT J METH PSYCH RES, V17, P89, DOI 10.1002/mpr.232; Girion L, 2011, DRUG DEATHS NOW OUTN; Goodman FDC, 2005, AM J HEALTH-SYST PH, V62, P2604, DOI 10.2146/ajhp040618; GOSSOP M, 1992, J ROY SOC MED, V85, P469; Gossop M, 1992, BR J ADDICT, V87; Grau LE, 2007, AM J ADDICTION, V16, P166, DOI 10.1080/10550490701375293; Green TC, 2008, DISTINGUISHING SIGNS, P979; Green TC, 2009, DRUG ALCOHOL DEPEN, V103, P65, DOI 10.1016/j.drugalcdep.2009.03.014; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Havens JR, 2011, DRUG ALCOHOL DEPEN, V115, P107, DOI 10.1016/j.drugalcdep.2010.11.003; Havens Jennifer R, 2008, J Opioid Manag, V4, P63; Havens JR, 2008, CHARACTERIZING OPIOI; HENDRIKS VM, 1989, J SUBST ABUSE TREAT, V6, P133, DOI 10.1016/0740-5472(89)90041-X; Hickman M, 2008, ADDICTION, V103, P1060, DOI 10.1111/j.1360-0443.2008.02134.x; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Jamison RN, 2000, J PAIN SYMPTOM MANAG, V19, P53, DOI 10.1016/S0885-3924(99)00144-X; Kochanek KD, 2011, DEATHS PRELIMINARY D; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lord S, 2003, J AM PHARM ASSOC, V49, P519, DOI DOI 10.1331/JAPHA.2009.08027; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; MARMOR M, 1987, AIDS, V1, P39; McCabe SE, 2005, J SUBST ABUSE TREAT, V28, P225, DOI 10.1016/j.jsat.2004.12.009; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; McCabe SE, 2005, DRUG ALCOHOL DEPEN, V77, P37, DOI 10.1016/j.drugalcdep.2004.07.005; McCabe SE, 2005, ADDICT BEHAV, V30, P789, DOI 10.1016/j.addbeh.2004.08.024; McCabe SE, 2007, ADDICT BEHAV, V32, P562, DOI 10.1016/j.addbeh.2006.05.022; McCabe SE, 2007, J ADOLESCENT HEALTH, V40, P76, DOI 10.1016/j.jadohealth.2006.07.016; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; McCabe SE, 2009, DRUG ALCOHOL DEPEN, V102, P63, DOI 10.1016/j.drugalcdep.2009.01.007; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; McNees E, 2008, EXPLORATORY PROFILE; Monga N, 2007, DRUG ALCOHOL DEPEN, V88, P1, DOI 10.1016/j.drugalcdep.2006.08.029; Morasco BJ, 2011, PAIN, V152, P488, DOI 10.1016/j.pain.2010.10.009; Muthen B., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; Muthen L.K., 2013, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1532-5415.2004.52225.X; Neale J, 2003, DRUG ALCOHOL DEPEN, V71, P57, DOI 10.1016/S0376-8716(03)00053-X; NSDUH, 2007, 2007 NAT SURV DRUG U; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Office of Applied Studies, 2004, RES 2003 NAT SURV DR; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Passik Steven D, 2006, J Pain Palliat Care Pharmacother, V20, P5; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2007, TRENDS UNINTENTIONAL; Paulozzi LJ, 2008, TRENDS UNINTENTIONAL; Potter JS, 2004, DRUG ALCOHOL DEPEN, V76, P213, DOI 10.1016/j.drugalcdep.2004.05.001; Razak MH, 2003, JAIDS-J ACQ IMM DEF, V33, P259, DOI 10.1097/00126334-200306010-00023; Secades-Villa R, 2003, ADDICT BEHAV, V28, P1175, DOI 10.1016/S0306-4603(02)00219-8; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Simoni-Wastila Linda, 2006, Am J Geriatr Pharmacother, V4, P380, DOI 10.1016/j.amjopharm.2006.10.002; Solbergsdottir E, 2004, J ADDICT DIS, V23, P29, DOI 10.1300/J069v23n01_03; Stohler R, 2000, EUR ADDICT RES, V6, P154, DOI 10.1159/000019019; Substance Abuse and Mental Health Services Administration, 2008, TREATM EP DAT SET TE; Teter CJ, 2005, J AM COLL HEALTH, V53, P253, DOI 10.3200/JACH.53.6.253-262; Tetrault JM, 2008, ADDICTION, V103, P258, DOI 10.1111/j.1360-0443.2007.02056.x; [United States Department of Health and Human Services Substance Abuse and Mental Health Services Administration OoAS], 2009, ICPSR30462V1 US DEP; Wang CL, 2005, AIDS, V19, P935, DOI 10.1097/01.aids.0000171407.30866.22; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; Wisniewski AM, 2008, J ADDICT DIS, V27, P1, DOI 10.1300/J069v27n01_01; Wu LT, 2010, DRUG ALCOHOL DEPEN, V112, P69, DOI 10.1016/j.drugalcdep.2010.05.013; Yacoubian GS, 2002, J DRUG EDUC, V32, P261, DOI 10.2190/FAW4-6GNP-Q6N7-V5MB	82	49	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27244	10.1371/journal.pone.0027244	http://dx.doi.org/10.1371/journal.pone.0027244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22087270	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900094
J	Hornstra, HM; Priestley, RA; Georgia, SM; Kachur, S; Birdsell, DN; Hilsabeck, R; Gates, LT; Samuel, JE; Heinzen, RA; Kersh, GJ; Keim, P; Massung, RF; Pearson, T				Hornstra, Heidie M.; Priestley, Rachael A.; Georgia, Shalamar M.; Kachur, Sergey; Birdsell, Dawn N.; Hilsabeck, Remy; Gates, Lauren T.; Samuel, James E.; Heinzen, Robert A.; Kersh, Gilbert J.; Keim, Paul; Massung, Robert F.; Pearson, Talima			Rapid Typing of Coxiella burnetii	PLOS ONE			English	Article							AMPLIFICATION MUTATION ASSAY; PCR; GENE	Coxiella burnetii has the potential to cause serious disease and is highly prevalent in the environment. Despite this, epidemiological data are sparse and isolate collections are typically small, rare, and difficult to share among laboratories as this pathogen is governed by select agent rules and fastidious to culture. With the advent of whole genome sequencing, some of this knowledge gap has been overcome by the development of genotyping schemes, however many of these methods are cumbersome and not readily transferable between institutions. As comparisons of the few existing collections can dramatically increase our knowledge of the evolution and phylogeography of the species, we aimed to facilitate such comparisons by extracting SNP signatures from past genotyping efforts and then incorporated these signatures into assays that quickly and easily define genotypes and phylogenetic groups. We found 91 polymorphisms (SNPs and indels) among multispacer sequence typing (MST) loci and designed 14 SNP-based assays that could be used to type samples based on previously established phylogenetic groups. These assays are rapid, inexpensive, real-time PCR assays whose results are unambiguous. Data from these assays allowed us to assign 43 previously untyped isolates to established genotypes and genomic groups. Furthermore, genotyping results based on assays from the signatures provided here are easily transferred between institutions, readily interpreted phylogenetically and simple to adapt to new genotyping technologies.	[Hornstra, Heidie M.; Georgia, Shalamar M.; Kachur, Sergey; Birdsell, Dawn N.; Hilsabeck, Remy; Gates, Lauren T.; Keim, Paul; Pearson, Talima] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Priestley, Rachael A.; Kersh, Gilbert J.; Massung, Robert F.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA; [Samuel, James E.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA; [Heinzen, Robert A.] NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA	Northern Arizona University; Centers for Disease Control & Prevention - USA; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Translational Genomics Research Institute	Hornstra, HM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	rfm2@cdc.gov; talima.pearson@nau.edu	Pearson, Talima/O-7840-2019	Pearson, Talima/0000-0003-3696-041X	U.S. Department of Homeland Security ST CB Division	U.S. Department of Homeland Security ST CB Division	This work was supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EURO SURVEILL; Archie James W., 1996, P153, DOI 10.1016/B978-012618030-5/50008-3; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Cha R S, 1992, PCR Methods Appl, V2, P14; Cruz RE, 2010, J CLIN MICROBIOL, V48, P3081, DOI 10.1128/JCM.00634-10; DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Easterday WR, 2005, BIOTECHNIQUES, V38, P731, DOI 10.2144/05385ST03; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; HENDRIX LR, 1991, J GEN MICROBIOL, V137, P269, DOI 10.1099/00221287-137-2-269; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; WAAG DM, 2007, Q FEVER MED ASPECTS	21	65	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26201	10.1371/journal.pone.0026201	http://dx.doi.org/10.1371/journal.pone.0026201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073151	gold, Green Submitted, Green Published			2022-12-25	WOS:000297154900015
J	Nauta, ST; Deckers, JW; Akkerhuis, M; Lenzen, M; Simoons, ML; van Domburg, RT				Nauta, Sjoerd T.; Deckers, Jaap W.; Akkerhuis, Martijn; Lenzen, Mattie; Simoons, Maarten L.; van Domburg, Ron T.			Changes in Clinical Profile, Treatment, and Mortality in Patients Hospitalised for Acute Myocardial Infarction between 1985 and 2008	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; RANDOMIZED-TRIAL; THROMBOLYTIC THERAPY; HEART-FAILURE; TRENDS; SURVIVAL; OUTCOMES; DISEASE; DEATH	Objectives: To quantify the impact of the implementation of treatment modalities into clinical practice since 1985, on outcome of patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Methods: All consecutive patients admitted for STEMI or NSTEMI at the Thoraxcenter between 1985 and 2008 were included. Baseline characteristics, pharmacological and invasive treatment modalities, and survival status were collected. The study population was categorised in three groups of patients: those hospitalised between 1985-1990, 1990-2000, and 2000-2008. Results: We identified 14,434 patients hospitalised for myocardial infarction (MI). Both STEMI and NSTEMI patients were increasingly treated with the current guideline based therapy. In STEMI, at 30 days following admission, cumulative mortality rate decreased from 17% in 1985-1990 to 13% in 1990-2000, and to 6% in 2000-2008. Adjusted 30-day and three-year mortality in the last period was 80% and 68% lower than in 1985, respectively. In NSTEMI, at 30 days following admission, cumulative mortality rate decreased from 6% in 1985-1990 to 4% in 1990-2000, and to 2% in 2000-2008. Adjusted 30-day and three-year mortality in the last period was 78% and 49% lower than in 1985, respectively. For patients admitted between 2000 and 2008, 3 year survival of STEMI and NSTEMI patients was 87% and 88%, respectively. Conclusions: Our results indicate substantial improvements in acute-and long-term survival in patients hospitalised for MI, related to improved acute-as well as long-term treatment. Early medical evaluation in suspected MI and intensive early hospital treatment both remain warranted in the future.	[Nauta, Sjoerd T.; Deckers, Jaap W.; Akkerhuis, Martijn; Lenzen, Mattie; Simoons, Maarten L.; van Domburg, Ron T.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Nauta, ST (corresponding author), Erasmus MC, Dept Cardiol, Rotterdam, Netherlands.	j.deckers@erasmusmc.nl			Erasmus Medical Center, Rotterdam	Erasmus Medical Center, Rotterdam	The Erasmus Medical Center, Rotterdam, was the only source of funding for the present study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Arciero TJ, 2004, AM J MED, V117, P228, DOI 10.1016/j.amjmed.2004.04.008; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Chew DP, 2010, HEART, V96, P1201, DOI 10.1136/hrt.2009.184853; Cleland JGF, 1997, EUR HEART J, V18, P41; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; GRIJSEELS EWM, 1995, EUR HEART J, V16, P325; Grijseels EWM, 1996, EUR HEART J, V17, P89; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Hirsch A, 2007, LANCET, V369, P827, DOI 10.1016/S0140-6736(07)60410-3; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; PEDERSEN TR, 1994, LANCET, V344, P1383; Reiner JS, 1996, CIRCULATION, V94, P2441, DOI 10.1161/01.CIR.94.10.2441; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; SIMOONS ML, 1993, LANCET, V342, P1523, DOI 10.1016/S0140-6736(05)80089-3; SIMOONS ML, 1985, LANCET, V2, P578; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	29	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26917	10.1371/journal.pone.0026917	http://dx.doi.org/10.1371/journal.pone.0026917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073220	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900053
J	Ni, L; Zhou, CQ; Duan, QL; Lv, JG; Fu, XN; Xia, Y; Wang, DW				Ni, Li; Zhou, Changqing; Duan, Quanlu; Lv, Jiagao; Fu, Xiangning; Xia, Yong; Wang, Dao Wen			beta-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CHANNEL RYANODINE RECEPTOR; CELL-DEATH; BETA(1)-ADRENERGIC STIMULATION; PKA PHOSPHORYLATION; APOPTOSIS; DYSFUNCTION; ACTIVATION; DISEASE	Background: Long-term beta-adrenergic receptor (beta-AR) blockade reduces mortality in patients with heart failure. Chronic sympathetic hyperactivity in heart failure causes sustained beta-AR activation, and this can deplete Ca(2+) in endoplasmic reticulum (ER) leading to ER stress and subsequent apoptosis. We tested the effect of beta-AR blockers on ER stress pathway in experimental model of heart failure. Methods and Results: ER chaperones were markedly increased in failing hearts of patients with end-stage heart failure. In Sprague-Dawley rats, cardiac hypertrophy and heart failure was induced by abdominal aortic constriction or isoproterenol subcutaneous injection. Oral beta-AR blockers treatment was performed in therapy groups. Cardiac remodeling and left ventricular function were analyzed in rats failing hearts. After 4 or 8 weeks of banding, rats developed cardiac hypertrophy and failure. Cardiac expression of ER chaperones was significantly increased. Similar to the findings above, sustained isoproterenol infusion for 2 weeks induced cardiac hypertrophy and failure with increased ER chaperones and apoptosis in hearts. beta-AR blockers treatment markedly attenuated these pathological changes and reduced ER stress and apoptosis in failing hearts. On the other hand, beta-AR agonist isoproterenol induced ER stress and apoptosis in cultured cardiomyocytes. beta-AR blockers largely prevented ER stress and protected myocytes against apoptosis. And beta-AR blockade significantly suppressed the overactivation of CaMKII in isoproterenol-stimulated cardiomyocytes and failing hearts in rats. Conclusions: Our results demonstrated that ER stress occurred in failing hearts and this could be reversed by beta-AR blockade. Alleviation of ER stress may be an important mechanism underlying the therapeutic effect of beta-AR blockers on heart failure.	[Ni, Li; Zhou, Changqing; Duan, Quanlu; Lv, Jiagao; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Fu, Xiangning] Huazhong Univ Sci & Technol, Dept Cardiothorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xia, Yong] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med,Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Ohio; Ohio State University	Ni, L (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	yong.xia@osumc.edu; dwwang@tjh.tjmu.edu.cn		Wang, Dao Wen/0000-0002-9774-3980	National Basic Research Program (973) of China [2007CB512004]; National Natural Science Foundation of China [30770882, 81000097]; National Institutes of Health [HL77575, HL86965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a National Basic Research Program (973) of China (2007CB512004) and National Natural Science Foundation of China (30770882 and 81000097). Y.X. was supported by National Institutes of Health Grants HL77575 and HL86965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH1689, DOI 10.1152/ajpheart.00538.2007; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; BRISTOW MR, 1997, AM J CARDIOL, V80, P26; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Marano G, 2002, J HYPERTENS, V20, P763, DOI 10.1097/00004872-200204000-00036; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vatner DE, 2001, CIRC RES, V88, P645, DOI 10.1161/hh0701.089951; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; [No title captured]	37	51	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27294	10.1371/journal.pone.0027294	http://dx.doi.org/10.1371/journal.pone.0027294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073308	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900097
J	Tauber, JM; Vanlandingham, PA; Zhang, B				Tauber, John M.; Vanlandingham, Phillip A.; Zhang, Bing			Elevated Levels of the Vesicular Monoamine Transporter and a Novel Repetitive Behavior in the Drosophila Model of Fragile X Syndrome	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONGITUDINAL IQ CHANGES; MOUSE MODEL; MESSENGER-RNA; SYNAPTIC PLASTICITY; COURTSHIP BEHAVIOR; AUTISTIC BEHAVIOR; GENE; IDENTIFICATION; FMRP	Fragile X Syndrome (FXS) is characterized by mental impairment and autism in humans, and it often features hyperactivity and repetitive behaviors. The mechanisms for the disease, however, remain poorly understood. Here we report that the dfmr1 mutant in the Drosophila model of FXS grooms excessively, which may be regulated differentially by two signaling pathways. Blocking metabotropic glutamate receptor signaling enhances grooming in dfmr1 mutant flies, whereas blocking the vesicular monoamine transporter (VMAT) suppresses excessive grooming. dfmr1 mutant flies also exhibit elevated levels of VMAT mRNA and protein. These results suggest that enhanced monoamine signaling correlates with repetitive behaviors and hyperactivity associated with FXS.	[Tauber, John M.; Vanlandingham, Phillip A.; Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Tauber, JM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	bing@ou.edu			University of Oklahoma; NIH [RO1 NS060878]; Vad Foundation Award for Outstanding Undergraduate Thesis; Division Of Integrative Organismal Systems [0822236, 1025556] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878] Funding Source: NIH RePORTER	University of Oklahoma; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vad Foundation Award for Outstanding Undergraduate Thesis; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by internal funds from the University of Oklahoma (to B.Z.) and in part by an NIH grant (RO1 NS060878 to B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Yong Q. Zhang and Kendal Broadie for providing the w; dfmr1<SUP>83M</SUP>/TM6B, Tb stock, and Dr. Thomas Jongens for providing the w; dfmr1<SUP>3</SUP>/TM6C, Sb, wild-type rescue (Control) and frameshift rescue (FS) stocks. We also thank Dr. David Krantz for his advice on the use of acetic acid in dissolving reserpine and for providing the antibody to dVMAT, Drs. Michael Tranfaglia, Randy Hewes, Rosemary Knapp, and David McCauley for constructive comments on the manuscript, Dr. Lauren Ritterhouse for assistance in the statistical analysis of the data, Logan Cox for assistance on fly husbandry, and Emily Kumimoto, Rod Kumimoto, and Sunetra Das for their instruction and assistance with RNA isolation and real-time PCR. The MPEP drug was a generous gift of Dr. Michael Tranfaglia from the FRAXA Research Foundation. J.M.T. received the inaugural Vad Foundation Award for Outstanding Undergraduate Thesis for this research. We wish to thank Dr. Vijay Vad and his Foundation for his support.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Boyle L, 2010, AM J MED GENET C, V154C, P469, DOI 10.1002/ajmg.c.30277; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Choi CH, 2011, BRAIN RES, V1380, P106, DOI 10.1016/j.brainres.2010.11.032; Choi CH, 2010, BIOGERONTOLOGY, V11, P347, DOI 10.1007/s10522-009-9259-6; Coffee B, 2009, AM J HUM GENET, V85, P503, DOI 10.1016/j.ajhg.2009.09.007; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Cook D, 2010, J NEUROSCI, V30, P7121, DOI 10.1523/JNEUROSCI.1298-10.2010; Cordeiro L, 2011, J NEURODEV DISORD, V3, P57, DOI 10.1007/s11689-010-9067-y; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Gabis LV, 2011, J CHILD NEUROL; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; HAGERMAN RJ, 1989, AM J MED GENET, V33, P513, DOI 10.1002/ajmg.1320330422; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2; Harris SW, 2008, AM J MENT RETARD, V113, P427, DOI 10.1352/2008.113:427-438; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Hong A, 2011, J MOL NEUROSCI; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Inoue SB, 2002, CURR BIOL, V12, P1331, DOI 10.1016/S0960-9822(02)01036-9; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Larson J, 2005, J NEUROSCI, V25, P9460, DOI 10.1523/JNEUROSCI.2638-05.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Moon J, 2006, BEHAV NEUROSCI, V120, P1367, DOI 10.1037/0735-7044.120.6.1367; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Moss J, 2009, J AUTISM DEV DISORD, V39, P572, DOI 10.1007/s10803-008-0655-6; Pan L, 2008, MOL CELL NEUROSCI, V37, P747, DOI 10.1016/j.mcn.2008.01.003; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; Repicky S, 2009, J NEUROPHYSIOL, V101, P672, DOI 10.1152/jn.90953.2008; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Tessier CR, 2008, DEVELOPMENT, V135, P1547, DOI 10.1242/dev.015867; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; WrightTalamante C, 1996, AM J MED GENET, V64, P350, DOI 10.1002/(SICI)1096-8628(19960809)64:2<350::AID-AJMG23>3.0.CO;2-D; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	59	41	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27100	10.1371/journal.pone.0027100	http://dx.doi.org/10.1371/journal.pone.0027100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087250	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900077
J	Yu, D; Zhan, XH; Zhao, XF; Williams, MS; Carey, GB; Smith, E; Scott, D; Zhu, J; Guo, Y; Cherukuri, S; Civin, CI; Zhan, X				Yu, D.; Zhan, X. H.; Zhao, X. F.; Williams, M. S.; Carey, G. B.; Smith, E.; Scott, D.; Zhu, J.; Guo, Y.; Cherukuri, S.; Civin, C. I.; Zhan, X.			Mice deficient in MIM expression are predisposed to lymphomagenesis	ONCOGENE			English	Article						MIM; I-BAR; chemokine; B cells; lymphoma	MISSING-IN-METASTASIS; SUPPRESSOR 1 MTSS1; B-CELL LYMPHOMA; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; DOWN-REGULATION; BLADDER-CANCER; SONIC HEDGEHOG; ACTIN; GENE	Missing in metastasis (MIM) is a member of newly emerged inverse Bin-Amphiphysin-Rvs (BAR) domain protein family and a putative metastasis suppressor. Although reduced MIM expression has been associated with bladder, breast and gastric cancers, evidence for the role of MIM in tumor progression remains scarce and controversial. Herein we characterized a MIM knockout mouse strain and observed that MIM-deficient mice often developed enlarged spleens. Autopsy and histological analysis revealed that nearly 78% of MIM(-/-) mice developed tumors with features similar to diffuse large B lymphoma during a period from 1 to 2 years. MIM(-/-) mice also exhibited abnormal distribution of B cells in lymphoid organs with decrease in the spleen but increase in the bone marrow and the peripheral blood. Furthermore, the bone marrow of MIM(-/-) mice contained a higher percentage of pre-B2 cells but fewer immature B-cells than wild-type mice. In response to CXCL13, a B-cell chemokine released from splenic stromal cells, MIM-deficient B-cells did not undergo chemotaxis or morphological changes in response to the chemokine and also did not internalize CXCR5, the receptor of CXCL13. Microarray analyses demonstrated that MIM is the only member of the I-BAR domain family that was highly expressed in human B cells. However, low or absent MIM expression was common in either primary B-cell malignancies or established B-cell acute lymphocytic leukemia or lymphomas. Thus, our data demonstrate for the first time an important role for MIM in B-cell development and suggest that predisposition of MIM-null mice to lymphomagenesis may involve aberrant interactions between B lineage cells and the lymphoid microenvironment. Oncogene (2012) 31, 3561-3568; doi:10.1038/onc.2011.509; published online 14 November 2011	[Yu, D.; Zhan, X. H.; Williams, M. S.; Carey, G. B.; Smith, E.; Zhan, X.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhao, X. F.; Zhan, X.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Williams, M. S.; Carey, G. B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Scott, D.] Univ Hlth Sci, Res Dept Med Uniformed Serv, Bethesda, MD USA; [Zhu, J.] Nantong Univ, Affiliated Hosp, Dept Gen Surg, Nantong, Peoples R China; [Guo, Y.; Cherukuri, S.; Civin, C. I.] Univ Maryland, Sch Med, Dept Pediat & Physiol, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Zhan, X.] Univ Maryland, Sch Med, Marlene Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nantong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhan, X (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	xzhan@som.umaryland.edu			NATIONAL CANCER INSTITUTE [R01CA113809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113809-05] Funding Source: Medline; NIAID NIH HHS [R01 AI070823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bodenstine TM, 2008, CANCER MICROENVIRON, V1, P1, DOI 10.1007/s12307-008-0001-8; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gribben JG, 2010, CURR OPIN ONCOL, V22, P424, DOI 10.1097/CCO.0b013e32833d5938; Karnoub Antoine E, 2006, Breast Dis, V26, P75; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Lindemann RK, 2008, CANCER RES, V68, P961, DOI 10.1158/0008-5472.CAN-07-5500; Lipp M, 2004, NAT IMMUNOL, V5, P12, DOI 10.1038/ni0104-12; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Liu W, 2011, DEVELOPMENT, V138, P2035, DOI 10.1242/dev.058800; Loberg RD, 2005, INT J ONCOL, V26, P1699; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; Mahadevan D, 2005, MOL CANCER THER, V4, P1867, DOI 10.1158/1535-7163.MCT-05-0146; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Nixdorf S, 2004, CANCER LETT, V215, P209, DOI 10.1016/j.canlet.2004.05.002; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Quinones GA, 2010, CELL CYCLE, V9, P2522, DOI 10.4161/cc.9.13.12123; Rolink Antonius G, 2004, Methods Mol Biol, V271, P271; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Su Y, 2008, J IMMUNOL, V181, P1153, DOI 10.4049/jimmunol.181.2.1153; Wang D, 2011, J GASTROINTEST SURG, V15, P1205, DOI 10.1007/s11605-011-1546-2; Wang Y, 2007, CANCER INVEST, V25, P79, DOI 10.1080/07357900701205457; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Yu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020845; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370	44	26	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	30					3561	3568		10.1038/onc.2011.509	http://dx.doi.org/10.1038/onc.2011.509			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22081072	Green Accepted			2022-12-25	WOS:000306844100008
J	Cai, LF; Pan, CG; Xu, L; Shui, Y; Liu, KL; Jiang, SB				Cai, Lifeng; Pan, Chungen; Xu, Liang; Shui, Yuan; Liu, Keliang; Jiang, Shibo			Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combination	FASEB JOURNAL			English	Article						peptide; gp41; TLT; T20; T1144	VIRUS TYPE-1 GP41; PEPTIDE INHIBITOR; MEMBRANE-FUSION; ENFUVIRTIDE; RESISTANT; REPLICATION; DESIGN; TARGET; IDENTIFICATION; GLYCOPROTEIN	We previously reported that the combinatorial use of T20 and T1144, the first and next generations of HIV fusion inhibitors, containing different functional domains resulted in synergistic anti-HIV-1 effect, but this effect diminished when T20 and T1144 were covalently linked together. To elucidate the mechanism underlying this synergistic anti-HIV-1 effect, we studied the interactions between T20 and T1144 either in a mixture state or in a covalently linked state. T20 alone in solution was largely featureless, while T1144 alone was in alpha-helical trimeric conformation. When mixed in solution, T20 and T1144 showed a loose and transient interaction, with a moderate 10% alpha-helical content increase, but this interaction was greatly enhanced in the linked state, and T20 and T1144 showed similar to 100% alpha-helical content. These results suggested that the loose and transient interaction between T20 and T1144 may destabilize the T1144 trimer, which makes its otherwise shielded binding sites more accessible to N-terminal heptad repeat (NHR) and increases its associating rate, thus increasing its anti-HIV-1 potency against the temporarily exposed target in NHR and causing the synergistic anti-HIV-1 effect. However, the strong interaction between T20 and T1144 in the covalently linked state may shield their NHR-binding sites, resulting in reduction of the synergistic effect.-Cai, L., Pan, C., Xu, L., Shui, Y., Liu, K., Jiang, S. Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 ef-fect resulting from their combination. FASEB J. 26, 1018 -1026 (2012). www.fasebj.org	[Cai, Lifeng; Pan, Chungen; Shui, Yuan; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Cai, Lifeng; Xu, Liang; Liu, Keliang] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Pan, Chungen] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Minist Educ,Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Minist Educ,Minist Hlth,Key Lab Med Mol Virol, Shanghai 200433, Peoples R China	New York Blood Center; Academy of Military Medical Sciences - China; Sun Yat Sen University; Fudan University	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.	keliangliu@yahoo.com; sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Xu, Liang/0000-0001-8946-8280	U.S. National Institutes of Health [AI046221]; National Natural Science Foundation of China [81072581, 81173098]; National Science and Technology Major Project of Original New Drug Research Key Technology grant [2009ZX09301-002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of Original New Drug Research Key Technology grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by U.S. National Institutes of Health grant AI046221 to S.J., National Natural Science Foundation of China grants 81072581 to L. C. and 81173098 to S.J., and National Science and Technology Major Project of Original New Drug Research Key Technology grant 2009ZX09301-002 to K.L.	Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Cai LF, 2009, ANTIMICROB AGENTS CH, V53, P2444, DOI 10.1128/AAC.00150-09; CASE DA, 2004, AMBER 8; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Delmedico M, 2006, 13 C RETR OPP INF DE; Dong MX, 2010, EUR J MED CHEM, V45, P4096, DOI 10.1016/j.ejmech.2010.05.070; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Liu J, 2010, J VIROL, V84, P201, DOI 10.1128/JVI.01558-09; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2008, BIOORGAN MED CHEM, V16, P9184, DOI 10.1016/j.bmc.2008.09.018; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Pan CG, 2011, J BIOL CHEM, V286, P28425, DOI 10.1074/jbc.M111.241992; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Pan C, 2009, AIDS, V23, P639, DOI 10.1097/QAD.0b013e328325a4cd; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; WILD C, 1994, P NATL ACAD SCI USA, V91, P12676, DOI 10.1073/pnas.91.26.12676; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537	29	15	16	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1018	1026		10.1096/fj.11-195289	http://dx.doi.org/10.1096/fj.11-195289			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22085645	Green Published			2022-12-25	WOS:000300949300007
J	Peterson, JM; Aja, S; Wei, ZK; Wong, GW				Peterson, Jonathan M.; Aja, Susan; Wei, Zhikui; Wong, G. William			CTRP1 Protein Enhances Fatty Acid Oxidation via AMP-activated Protein Kinase (AMPK) Activation and Acetyl-CoA Carboxylase (ACC) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; CONSERVED LYSINE RESIDUES; MICE LACKING ADIPONECTIN; C1Q/TNF FAMILY-MEMBERS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; T-CADHERIN; COLLAGENOUS DOMAIN; GLUCOSE-METABOLISM; MALONYL-COA	We previously described the adipokine CTRP1, which has up-regulated expression following exposure to the anti-diabetic drug rosiglitazone and increased circulating levels in adiponectin-null mice (Wong, G. W., Krawczyk, S. A., Kitidis-Mitrokostas, C., Revett, T., Gimeno, R., and Lodish, H. F. (2008) Biochem. J. 416, 161-177). Although recombinant CTRP1 lowers blood glucose in mice, its physiological function, mechanisms of action, and roles in metabolic stress remain unknown. Here, we show that circulating levels of CTRP1 are strikingly reduced in diet-induced obese mice. Overexpressing CTRP1 in transgenic mice improved insulin sensitivity and decreased high-fat diet-induced weight gain. Reduced adiposity resulted from enhanced fatty acid oxidation and energy expenditure, effects mediated by AMP-activated protein kinase (AMPK). In skeletal muscle of transgenic mice, AMPK alpha and its downstream target, acetyl-CoA carboxylase (ACC), were hyperphosphorylated, indicative of AMPK activation and ACC inhibition. Inactivation of ACC promotes mitochondrial fat oxidation. Consistent with the direct effect of CTRP1 on AMPK signaling, recombinant CTRP1 administration acutely stimulated muscle AMPK alpha and ACC phosphorylation in vivo. In isolated soleus muscle, recombinant CTRP1 activated AMPK signaling to increase fatty acid oxidation ex vivo, an effect abrogated by an AMPK inhibitor. These results provide the first in vivo evidence that CTRP1 is a novel regulator of fatty acid metabolism.	[Peterson, Jonathan M.; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Peterson, Jonathan M.; Aja, Susan; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, R01DK084171, P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center (DRTC); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G.W.W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center (DRTC) Grant P60DK079637.; Supported by National Institutes of Health National Research Service Award F32DK084607.; Supported by American Heart Association Fellowship PRE3790034.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; HA J, 1994, J BIOL CHEM, V269, P22162; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaushik VK, 2001, AM J PHYSIOL-ENDOC M, V281, pE335, DOI 10.1152/ajpendo.2001.281.2.E335; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lusk G, 1928, ELEMENTS SCI NUTR; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P481, DOI 10.1042/bst0230481; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Spranger J, 2006, DIABETES, V55, P141, DOI 10.2337/diabetes.55.1.141; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	55	121	127	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1576	1587		10.1074/jbc.M111.278333	http://dx.doi.org/10.1074/jbc.M111.278333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086915	hybrid, Green Published			2022-12-25	WOS:000299170300071
J	Clifton, LA; Johnson, CL; Solovyova, AS; Callow, P; Weiss, KL; Ridley, H; Le Brun, AP; Kinane, CJ; Webster, JRP; Holt, SA; Lakey, JH				Clifton, Luke A.; Johnson, Christopher L.; Solovyova, Alexandra S.; Callow, Phil; Weiss, Kevin L.; Ridley, Helen; Le Brun, Anton P.; Kinane, Christian J.; Webster, John R. P.; Holt, Stephen A.; Lakey, Jeremy H.			Low Resolution Structure and Dynamics of a Colicin-Receptor Complex Determined by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING DOMAINS; TOXIN T DOMAIN; OUTER-MEMBRANE; CRYSTAL-STRUCTURES; RECOGNITION SITE; OMPF PORIN; PROTEIN; TRANSLOCATION; BINDING; INSERTION	Proteins that translocate across cell membranes need to overcome a significant hydrophobic barrier. This is usually accomplished via specialized protein complexes, which provide a polar transmembrane pore. Exceptions to this include bacterial toxins, which insert into and cross the lipid bilayer itself. We are studying the mechanism by which large antibacterial proteins enter Escherichia coli via specific outer membrane proteins. Here we describe the use of neutron scattering to investigate the interaction of colicin N with its outer membrane receptor protein OmpF. The positions of lipids, colicin N, and OmpF were separately resolved within complex structures by the use of selective deuteration. Neutron reflectivity showed, in real time, that OmpF mediates the insertion of colicin N into lipid monolayers. This data were complemented by Brewster Angle Microscopy images, which showed a lateral association of OmpF in the presence of colicin N. Small angle neutron scattering experiments then defined the three-dimensional structure of the colicin N-OmpF complex. This revealed that colicin N unfolds and binds to the OmpF-lipid interface. The implications of this unfolding step for colicin translocation across membranes are discussed.	[Johnson, Christopher L.; Solovyova, Alexandra S.; Ridley, Helen; Le Brun, Anton P.; Lakey, Jeremy H.] Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Clifton, Luke A.; Kinane, Christian J.; Webster, John R. P.; Holt, Stephen A.] Rutherford Appleton Lab, ISIS Spallat Neutron Source, Didcot OX11 0QX, Oxon, England; [Callow, Phil] Inst Laue Langevin, F-38042 Grenoble, France; [Weiss, Kevin L.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA	Newcastle University - UK; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Institut Laue-Langevin (ILL); United States Department of Energy (DOE); Oak Ridge National Laboratory	Lakey, JH (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Jeremy.Lakey@ncl.ac.uk	Le Brun, Anton P/A-2604-2010; webster, john/GYU-7651-2022; Weiss, Kevin/I-4669-2013; Holt, Stephen A/E-4662-2011	Le Brun, Anton P/0000-0003-2431-6985; Weiss, Kevin/0000-0002-6486-8007; Holt, Stephen A/0000-0003-3189-8047; Kinane, Christy/0000-0002-1185-0719; Lakey, Jeremy/0000-0003-4646-9085; Clifton, Luke/0000-0001-8754-362X; Solovyova, Alexandra/0000-0002-5682-7037	Wellcome Trust [080342]; ISIS [RB910077]; Institut Laue-Langevin; Office of Biological and Environmental Research; LLC [DE-AC05-00OR22725]	Wellcome Trust(Wellcome TrustEuropean Commission); ISIS; Institut Laue-Langevin; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LLC	This work was supported by Wellcome Trust Grant 080342, ISIS Grant RB910077, and the Institut Laue-Langevin. The research at Oak Ridge National Laboratory's Center for Structural Molecular Biology was supported by the Office of Biological and Environmental Research, using facilities supported by the United States Department of Energy, managed by UT-Battelle, LLC under contract DE-AC05-00OR22725.	Anderluh G, 2003, J BIOL CHEM, V278, P21860, DOI 10.1074/jbc.M300411200; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; Baboolal TG, 2008, STRUCTURE, V16, P371, DOI 10.1016/j.str.2007.12.023; Bainbridge G, 1998, FEBS LETT, V432, P117, DOI 10.1016/S0014-5793(98)00846-1; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; BULLOCK JO, 1986, BIOCHIM BIOPHYS ACTA, V856, P101, DOI 10.1016/0005-2736(86)90015-5; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Cisneros DA, 2006, ANGEW CHEM INT EDIT, V45, P3252, DOI 10.1002/anie.200504506; Clifton LA, 2008, J PHYS CHEM B, V112, P15907, DOI 10.1021/jp806016h; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARGENT B, 1988, J MOL BIOL, V201, P497, DOI 10.1016/0022-2836(88)90632-8; Dover LG, 2000, BIOCHEMISTRY-US, V39, P8632, DOI 10.1021/bi000160n; ElKouhen R, 1996, J BACTERIOL, V178, P5316, DOI 10.1128/jb.178.17.5316-5319.1996; Evans LJA, 1996, BIOCHEMISTRY-US, V35, P13180, DOI 10.1021/bi960990u; Evans LJA, 1996, BIOCHEMISTRY-US, V35, P15143, DOI 10.1021/bi9615497; Evans LJA, 1996, J MOL BIOL, V255, P559, DOI 10.1006/jmbi.1996.0047; Fridd SL, 2002, BIOCHIMIE, V84, P477, DOI 10.1016/S0300-9084(02)01418-9; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Gokce I, 2000, J MOL BIOL, V304, P621, DOI 10.1006/jmbi.2000.4232; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; HOENGER A, 1993, J STRUCT BIOL, V111, P212, DOI 10.1006/jsbi.1993.1051; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Jakes KS, 2010, MOL MICROBIOL, V75, P567, DOI 10.1111/j.1365-2958.2009.06966.x; Jakes KS, 1998, P NATL ACAD SCI USA, V95, P4321, DOI 10.1073/pnas.95.8.4321; Jaroslawski S, 2009, MOL MICROBIOL, V74, P1211, DOI 10.1111/j.1365-2958.2009.06926.x; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lad MD, 2007, BIOPHYS J, V92, P3575, DOI 10.1529/biophysj.106.097774; LAKEY JH, 1985, BIOCHIM BIOPHYS ACTA, V817, P208, DOI 10.1016/0005-2736(85)90022-7; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; LAKEY JH, 1991, EUR J BIOCHEM, V196, P599, DOI 10.1111/j.1432-1033.1991.tb15855.x; Lu JR, 1998, J CHEM SOC FARADAY T, V94, P995, DOI 10.1039/a707853f; McConlogue CW, 1997, LANGMUIR, V13, P7158, DOI 10.1021/la970898e; Mo Y, 2008, J PHYS CHEM B, V112, P13349, DOI 10.1021/jp801266r; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Osickova A, 2010, MOL MICROBIOL, V75, P1550, DOI 10.1111/j.1365-2958.2010.07077.x; Penfold J, 2002, CURR OPIN COLLOID IN, V7, P139, DOI 10.1016/S1359-0294(02)00015-8; PENFOLD J, 1987, J PHYS E SCI INSTRUM, V20, P1411, DOI 10.1088/0022-3735/20/11/024; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; SCHINDLER H, 1981, P NATL ACAD SCI-BIOL, V78, P2302, DOI 10.1073/pnas.78.4.2302; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Stora T, 1999, ANGEW CHEM INT EDIT, V38, P389, DOI 10.1002/(SICI)1521-3773(19990201)38:3<389::AID-ANIE389>3.0.CO;2-U; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; TREWHELLA J, 1983, BIOPHYS J, V42, P233, DOI 10.1016/S0006-3495(83)84391-4; TREWHELLA J, 1986, EMBO J, V5, P3045, DOI 10.1002/j.1460-2075.1986.tb04604.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Watanabe Y, 2005, PROTEIN J, V24, P167, DOI 10.1007/s10930-005-7840-7; Watanabe Y, 1999, JPN J APPL PHYS 1, V38, P180, DOI 10.7567/JJAPS.38S1.180; Webster J, 2006, PHYSICA B, V385-86, P1164, DOI 10.1016/j.physb.2006.05.400; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151	67	48	48	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					337	346		10.1074/jbc.M111.302901	http://dx.doi.org/10.1074/jbc.M111.302901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081604	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000298682400033
J	Filosto, S; Ashfaq, M; Chung, S; Fry, W; Goldkorn, T				Filosto, Simone; Ashfaq, Majid; Chung, Samuel; Fry, William; Goldkorn, Tzipora			Neutral Sphingomyelinase 2 Activity and Protein Stability Are Modulated by Phosphorylation of Five Conserved Serines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; CIGARETTE-SMOKE; INDUCED APOPTOSIS; OXIDATIVE STRESS; CERAMIDE; EXPRESSION; NSMASE2; INFLAMMATION; ACTIVATION	We previously presented that the neutral sphingomyelinase 2 (nSMase2) is the only SMase activated in human airway epithelial (HAE) cells following exposure to oxidative stress (ox-stress), yielding ceramide accumulation and thereby inducing apoptosis. Furthermore, we reported that nSMase2 is a phospho-protein in which the level of phosphorylation controls nSMase2 activation induced by ox-stress. Here we identify five specific serines that are phosphorylated in nSMase2 and demonstrate that their phosphorylation controls the nSMase2 activity upon ox-stress exposure in an interdependent manner. Furthermore, we show that the nSMase2 protein stability and thus its level of expression is also post-translationally regulated by these five serine phosphorylation sites. This study provides initial structure/function insights regarding nSMase2 phosphorylation sites and offers some new links for future studies aiming to fully elucidate nSMase2 regulatory machinery.	[Filosto, Simone; Ashfaq, Majid; Chung, Samuel; Fry, William; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis	Goldkorn, T (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Rm 6321,451 E Hlth Sci Dr, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu	Chung, Samuel/H-9472-2019	Chung, Samuel/0000-0002-4988-0606; Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-related Disease Research Program (TRDRP) [17RT-0131, 20FT-0087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program (TRDRP)(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-71871 and HL-66189 (to T. G.). This work was also supported by Tobacco-related Disease Research Program (TRDRP) Grants 17RT-0131 (to T. G.) and 20FT-0087 (to S. F.).	Barak A, 2001, INVEST OPHTH VIS SCI, V42, P247; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Filosto S, 2011, AM J RESP CELL MOL, V44, P350, DOI 10.1165/rcmb.2009-0422OC; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Goldkorn T, 1998, J CELL SCI, V111, P3209; Goldkorn T., 2001, CLIN APPL IMMUNOLOGY, V1, P173; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Luberto C, 1999, LIPIDS, V34, pS5, DOI 10.1007/BF02562221; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Robinson CB, 1991, METHODS CELL SCI, V13, P95; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z	34	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					514	522		10.1074/jbc.M111.315481	http://dx.doi.org/10.1074/jbc.M111.315481			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074919	Green Published, hybrid			2022-12-25	WOS:000298682400050
J	Helsen, CW; Glover, JR				Helsen, Christopher W.; Glover, John R.			Insight into Molecular Basis of Curing of [PSI+] Prion by Overexpression of 104-kDa Heat Shock Protein (Hsp104)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OLIGOPEPTIDE REPEATS; GENETIC-VARIATION; STRUCTURAL BASIS; YEAST; SUP35; MECHANISM; CHAPERONE; HSP70; DISAGGREGATION	Yeast prions are a powerful model for understanding the dynamics of protein aggregation associated with a number of human neurodegenerative disorders. The AAA+ protein disaggregase Hsp104 can sever the amyloid fibrils produced by yeast prions. This action results in the propagation of "seeds" that are transmitted to daughter cells during budding. Overexpression of Hsp104 eliminates the [PSI+] prion but not other prions. Using biochemical methods we identified Hsp104 binding sites in the highly charged middle domain of Sup35, the protein determinant of [PSI+]. Deletion of a short segment of the middle domain (amino acids 129-148) diminishes Hsp104 binding and strongly affects the ability of the middle domain to stimulate the ATPase activity of Hsp104. In yeast, [PSI+] maintained by Sup35 lacking this segment, like other prions, is propagated by Hsp104 but cannot be cured by Hsp104 overexpression. These results provide new insight into the enigmatic specificity of Hsp104-mediated curing of yeast prions and sheds light on the limitations of the ability of Hsp104 to eliminate aggregates produced by other aggregation-prone proteins.	[Helsen, Christopher W.; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Glover, JR (corresponding author), Rm 5302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	john.glover@utoronto.ca			Canadian Institutes of Health Research [MOP-86754]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by Canadian Institutes of Health Research Operating Grant MOP-86754 (to J. R. G.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hara H, 2003, GENES CELLS, V8, P925, DOI 10.1111/j.1365-2443.2003.00694.x; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Jensen MA, 2001, GENETICS, V159, P527; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lee DH, 2010, BIOCHEM BIOPH RES CO, V391, P1056, DOI 10.1016/j.bbrc.2009.12.018; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 2001, BIOCHEM SOC SYMP, V68, P35; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SMIRNOV MN, 1967, BIOCHEM BIOPH RES CO, V27, P299, DOI 10.1016/S0006-291X(67)80096-2; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Toombs JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021953; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	71	71	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					542	556		10.1074/jbc.M111.302869	http://dx.doi.org/10.1074/jbc.M111.302869			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081611	Green Published, hybrid			2022-12-25	WOS:000298682400053
J	Herod, MR; Jones, DM; McLauchlan, J; McCormick, CJ				Herod, Morgan R.; Jones, Daniel M.; McLauchlan, John; McCormick, Christopher J.			Increasing Rate of Cleavage at Boundary between Non-structural Proteins 4B and 5A Inhibits Replication of Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 SERINE-PROTEASE; RNA REPLICATION; SUBSTRATE-SPECIFICITY; MEMBRANE ASSOCIATION; SYNTHETIC PEPTIDES; VIRAL REPLICATION; NS4B PROTEIN; POLYPROTEIN; NS5A; PRODUCTS	In hepatitis C virus, non-structural proteins are cleaved from the viral polyprotein by viral encoded proteases. Although proteolytic processing goes to completion, the rate of cleavage differs between different boundaries, primarily due to the sequence at these positions. However, it is not known whether slow cleavage is important for viral replication or a consequence of restrictions on sequences that can be tolerated at the cleaved ends of non-structural proteins. To address this question, mutations were introduced into the NS4B side of the NS4B5A boundary, and their effect on replication and polyprotein processing was examined in the context of a subgenomic replicon. Single mutations that modestly increased the rate of boundary processing were phenotypically silent, but a double mutation, which further increased the rate of boundary cleavage, was lethal. Rescue experiments relying on viral RNA polymerase-induced error failed to identify second site compensatory mutations. Use of a replicon library with codon degeneracy did allow identification of second site compensatory mutations, some of which fell exclusively within the NS5A side of the boundary. These mutations slowed boundary cleavage and only enhanced replication in the context of the original lethal NS4B double mutation. Overall, the data indicate that slow cleavage of the NS4B5A boundary is important and identify a previously unrecognized role for NS4B5A-containing precursors requiring them to exist for a minimum finite period of time.	[Herod, Morgan R.; McCormick, Christopher J.] Southampton Gen Hosp, Sir Henry Wellcome Labs, Div Infect Inflammat & Immun, Sch Med, Southampton SO16 6YD, Hants, England; [Jones, Daniel M.; McLauchlan, John] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G11 5JR, Lanark, Scotland	University of Southampton; University of Glasgow	McCormick, CJ (corresponding author), Southampton Gen Hosp, Sir Henry Wellcome Labs, Div Infect Inflammat & Immun, Sch Med, MP814, Southampton SO16 6YD, Hants, England.	cjm@soton.ac.uk		Herod, Morgan/0000-0002-8626-6787; McCormick, Christopher/0000-0002-6155-9161	Medical Research Council [G0701215]; Royal Society; Medical Research Council [MC_U130184143] Funding Source: researchfish; MRC [MC_U130184143, G0701215] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0701215 and a Royal Society research grant.	Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beyer BM, 2001, PROTEINS, V43, P82, DOI 10.1002/1097-0134(20010501)43:2<82::AID-PROT1020>3.3.CO;2-W; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, J VIROL, V78, P12085, DOI 10.1128/JVI.78.21.12085-12089.2004; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Gouttenoire J, 2009, J VIROL, V83, P11378, DOI 10.1128/JVI.01122-09; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kim JE, 1999, ARCH VIROL, V144, P329, DOI 10.1007/s007050050507; Kim SY, 2000, ANAL BIOCHEM, V284, P42, DOI 10.1006/abio.2000.4662; KOLYKHALOV AA, 1994, J VIROL, V68, P7525, DOI 10.1128/JVI.68.11.7525-7533.1994; Kusov Y, 1999, J VIROL, V73, P9867, DOI 10.1128/JVI.73.12.9867-9878.1999; Landro JA, 1997, BIOCHEMISTRY-US, V36, P9340, DOI 10.1021/bi963054n; LIN C, 1994, J VIROL, V68, P5063, DOI 10.1128/JVI.68.8.5063-5073.1994; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; McCormick CJ, 2006, J GEN VIROL, V87, P635, DOI 10.1099/vir.0.81553-0; McCormick CJ, 2006, J GEN VIROL, V87, P93, DOI 10.1099/vir.0.81180-0; McCormick CJ, 2002, J GEN VIROL, V83, P383, DOI 10.1099/0022-1317-83-2-383; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; MIZUSHIMA H, 1994, J VIROL, V68, P6215, DOI 10.1128/JVI.68.10.6215-6222.1994; Paredes AM, 2008, J VIROL, V82, P10671, DOI 10.1128/JVI.00875-08; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Steinkuhler C, 1996, J VIROL, V70, P6694; TANJI Y, 1994, J VIROL, V68, P8418, DOI 10.1128/JVI.68.12.8418-8422.1994; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Towner JS, 1998, J VIROL, V72, P7191, DOI 10.1128/JVI.72.9.7191-7200.1998; VanKuppeveld FJM, 1996, J VIROL, V70, P7632, DOI 10.1128/JVI.70.11.7632-7640.1996; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997	54	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					568	580		10.1074/jbc.M111.311407	http://dx.doi.org/10.1074/jbc.M111.311407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084249	Green Published, hybrid			2022-12-25	WOS:000298682400055
J	Yu, FY; Jiao, Y; Zhu, YH; Wang, Y; Zhu, JD; Cui, XY; Liu, YJ; He, YH; Park, EY; Zhang, HY; Lv, XB; Ma, KL; Su, FX; Park, JH; Song, EW				Yu, Fengyan; Jiao, Yu; Zhu, Yinghua; Wang, Ying; Zhu, Jingde; Cui, Xiuying; Liu, Yujie; He, Yinghua; Park, Eun-Young; Zhang, Hongyu; Lv, Xiaobin; Ma, Kelong; Su, Fengxi; Park, Jong Hoon; Song, Erwei			MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; CPG METHYLATION; EPIGENETIC INACTIVATION; EXPRESSION; TRANSCRIPTION; BINDING; MIR-34; SITE; DEMETHYLATION; ACTIVATION	Tumor-initiating cells (T-ICs), a subpopulation of cancer cells with stem cell-like properties, are related to tumor relapse and metastasis. Our previous studies identified a distinct profile of microRNA (miRNA) expression in breast T-ICs (BT-ICs), and the dysregulated miRNAs contribute to the self-renewal and tumorigenesis of these cells. However, the underlying mechanisms for miRNA dysregulation in BT-ICs remain obscure. In the present study, we demonstrated that the expression and function of miR-34c were reduced in the BT-ICs of MCF-7 and SK-3rd cells, a breast cancer cell line enriched for BT-ICs. Ectopic expression of miR-34c reduced the self-renewal of BT-ICs, inhibited epithelial-mesenchymal transition, and suppressed migration of the tumor cells via silencing target gene Notch4. Furthermore, we identified a single hypermethylated CpG site in the promoter region of miR-34c gene that contributed to transcriptional repression of miR-34c in BT-ICs by reducing DNA binding activities of Sp1. Therefore, miR-34c reduction in BT-ICs induced by a single hypermethylated CpG site in the promoter region promotes self-renewal and epithelial-mesenchymal transition of BT-ICs.	[Park, Eun-Young; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Yu, Fengyan; Wang, Ying; Liu, Yujie; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Jiao, Yu; Zhu, Yinghua; Song, Erwei] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China; [Zhu, Jingde; He, Yinghua; Zhang, Hongyu; Ma, Kelong] Shanghai Jiao Tong Univ, Canc Epigenet & Gene Therapy Grp, Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Cui, Xiuying; Lv, Xiaobin] Sun Yat Sen Univ, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China	Sookmyung Women's University; Sun Yat Sen University; Sun Yat Sen University; Shanghai Jiao Tong University; Sun Yat Sen University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, 52 Hyochangwonro, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr; songerwei02@yahoo.com.cn	Lv, Xiao-Bin/T-7607-2019		Natural Science Foundation of China [30921140312, 30831160515, 30830110, 30973396, 30972785]; Ministry of Science and Technology of China [2010CB912800, 2011CB504203, 2009CB521706, 2009CB825606, 2009CB825607]; Public Health Administration of China; Ministry of Health of China [2011ZX09102-010-02]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University [KLB09001]; HuoYingdong Educational Foundation [121042]; National Research Foundation of Korea [2011-0001382]; Korea government	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Public Health Administration of China; Ministry of Health of China; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University; HuoYingdong Educational Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by Grant 30921140312 from the A3 program of the Natural Science Foundation of China; 973 Projects 2010CB912800, 2011CB504203, 2009CB521706, 2009CB825606, and 2009CB825607 from the Ministry of Science and Technology of China; Grants 30831160515, 30830110, 30973396, and 30972785 from the Natural Science Foundation of China; a Clinical Key Project of the Public Health Administration of China; Grant 2011ZX09102-010-02 for the Development of Important New Drugs from the Ministry of Health of China; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University; Young Teacher Grant 121042 from the HuoYingdong Educational Foundation; and National Research Foundation of Korea Grant 2011-0001382 funded by the Korea government.	BENHATTAR J, 1988, GENE, V65, P219, DOI 10.1016/0378-1119(88)90458-1; Cai KM, 2010, INT J MOL MED, V25, P565, DOI 10.3892/ijmm_00000378; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Furuta T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-39; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu Y, 2009, CLIN IMMUNOL, V130, P213, DOI 10.1016/j.clim.2008.08.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Norton L, 2011, ONCOLOGY-NY, V25, P30; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; ROBERTSON KD, 1995, MOL CELL BIOL, V15, P6150; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Torng PL, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-120; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Xu J, 2002, CELL RES, V12, P177, DOI 10.1038/sj.cr.7290124; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang H, 2004, CELL RES, V14, P283, DOI 10.1038/sj.cr.7290229; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	45	113	119	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					465	473		10.1074/jbc.M111.280768	http://dx.doi.org/10.1074/jbc.M111.280768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074923	Green Published, hybrid			2022-12-25	WOS:000298682400045
J	Zheng, Y; Asara, JM; Tyner, AL				Zheng, Yu; Asara, John M.; Tyner, Angela L.			Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-TUMOR KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; CANCER-CELLS; GASTROINTESTINAL-TRACT; PROSTATE-CANCER; GENE-EXPRESSION; E-CADHERIN; BRK; SRC	Protein-tyrosine kinase 6 (PTK6) is a non-myristoylated intracellular tyrosine kinase evolutionarily related to Src kinases. Aberrant PTK6 expression and intracellular localization have been detected in human prostate tumors. In the PC3 prostate cancer cell line, the pool of endogenous activated PTK6, which is phosphorylated on tyrosine residue 342, is localized at the membrane. Expression of ectopic membrane-targeted PTK6 led to dramatic morphology changes and formation of peripheral adhesion complexes in PC3 cells. Peripheral adhesion complex formation was dependent upon PTK6 kinase activity. We demonstrated that p130 CRK-associated substrate (p130CAS) is a novel direct substrate of PTK6, and it works as a crucial adapter protein in inducing peripheral adhesion complexes. Activation of ERK5 downstream of p130CAS was indispensable for this process. Knockdown of endogenous PTK6 led to reduced cell migration and p130CAS phosphorylation, whereas knockdown of p130CAS attenuated oncogenic signaling induced by membrane-targeted PTK6, including ERK5 and AKT activation. Expression of membrane-targeted PTK6 promoted cell migration, which could be impaired by knockdown of p130CAS or ERK5. Our study reveals a novel function for PTK6 at the plasma membrane and suggests that the PTK6-p130CAS-ERK5 signaling cascade plays an important role in cancer cell migration and invasion.	[Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Asara, John M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	atyner@uic.edu		Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [DK044525, DK068503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068503, R01DK044525, R55DK044525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044525 and DK068503 (to A. L. T.).	American Cancer Society, 2010, CANC FACTS FIG 2010; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Brauer PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014789; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Fromont G, 2007, PROSTATE, V67, P268, DOI 10.1002/pros.20516; Grille SJ, 2003, CANCER RES, V63, P2172; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Ko S, 2009, BIOCHEM BIOPH RES CO, V384, P236, DOI 10.1016/j.bbrc.2009.04.103; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; LEE ST, 1993, ONCOGENE, V8, P3403; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Locatelli A, 2011, J BIOL CHEM, V286, P21062, DOI 10.1074/jbc.M110.211409; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; PATCH LA, 1995, J CELL SCI, V108, P1371; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rasband W., 2006, IMAGEJ; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Serfas MS, 2003, ONCOL RES, V13, P409; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Shin DS, 2008, J COMB CHEM, V10, P20, DOI 10.1021/cc7001217; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	62	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					148	158		10.1074/jbc.M111.298117	http://dx.doi.org/10.1074/jbc.M111.298117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084245	Green Published, hybrid			2022-12-25	WOS:000298682400017
J	Han, HM; Liu, QJ; He, W; Ong, K; Liu, XL; Gao, B				Han, Huamin; Liu, Qingjun; He, Wen; Ong, Kristy; Liu, Xiaoli; Gao, Bin			An Efficient Vector System to Modify Cells Genetically	PLOS ONE			English	Article							RETROVIRALLY TRANSDUCED CELLS; FLUORESCENCE-BASED SELECTION; EMBRYONIC STEM-CELLS; METABOLIC BIOTINYLATION; IN-VIVO; DENDRITIC CELLS; SURFACE PROTEINS; MAMMALIAN-CELLS; FLOW-CYTOMETRY; GENE-TRANSFER	The transfer of foreign genes into mammalian cells has been essential for understanding the functions of genes and mechanisms of genetic diseases, for the production of coding proteins and for gene therapy applications. Currently, the identification and selection of cells that have received transferred genetic material can be accomplished by methods, including drug selection, reporter enzyme detection and GFP imaging. These methods may confer antibiotic resistance, or be disruptive, or require special equipment. In this study, we labeled genetically modified cells with a cell surface biotinylation tag by co-transfecting cells with BirA, a biotin ligase. The modified cells can be quickly isolated for downstream applications using a simple streptavidin bead method. This system can also be used to screen cells expressing two sets of genes from separate vectors.	[Han, Huamin; Liu, Qingjun; He, Wen; Gao, Bin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China; [Han, Huamin; He, Wen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ong, Kristy] UCL Inst Child Hlth, London, England; [Liu, Xiaoli] Epigen Biotec Ltd, Beijing, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of London; University College London; Chinese Academy of Sciences; Institute of Microbiology, CAS	Han, HM (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China.	bgao2004@gmail.com	Liu, Xiaoli/HGE-7614-2022		Ministry of Health [2008ZX10003-012, 2009ZX10004-305]; Innovative Research Group of the National Natural Science Foundation of China (NSFC) [81021003]	Ministry of Health; Innovative Research Group of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Project of "Eleventh Five-year Plan" of Ministry of Health (grants 2008ZX10003-012, 2009ZX10004-305). BG is a principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGNIS C, 1995, LEUKEMIA, V9, pS61; Barat B, 2007, BIOMOL ENG, V24, P283, DOI 10.1016/j.bioeng.2007.02.003; Beausejour CM, 2001, CANCER GENE THER, V8, P669, DOI 10.1038/sj.cgt.7700358; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Byun HM, 2005, BIOCHEM BIOPH RES CO, V332, P518, DOI 10.1016/j.bbrc.2005.04.155; Chang Lung-Ji, 2002, Methods Mol Med, V69, P303; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; CHUNG HM, 2007, STEM CELLS DEV, V16, P537; David R, 2005, STEM CELLS, V23, P477, DOI 10.1634/stemcells.2004-0177; Fehse B, 1997, HUM GENE THER, V8, P1815, DOI 10.1089/hum.1997.8.15-1815; FISHER PB, 1999, NUCLEIC ACIDS RES, V27, P4775; Fontanellas A, 1999, J GENE MED, V1, P322; Giaretta I, 2000, HAEMATOLOGICA, V85, P680; Gotoh H, 2007, GENE, V389, P146, DOI 10.1016/j.gene.2006.10.019; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Kawahara M, 2004, BIOCHEM BIOPH RES CO, V315, P132, DOI 10.1016/j.bbrc.2004.01.030; Kawahara M, 2004, J IMMUNOL METHODS, V284, P187, DOI 10.1016/j.jim.2003.10.007; Kawahara M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng032; Kawahara M, 2002, J BIOSCI BIOENG, V93, P399, DOI 10.1263/jbb.93.399; Kawahara M, 2007, BBA-GEN SUBJECTS, V1770, P206, DOI 10.1016/j.bbagen.2006.10.014; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Liu Qingjun, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1888; Locke P, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt63; LU YA, 2011, J NEUROINFLAMMATION, V8; Lundqvist A, 2002, MED ONCOL, V19, P197, DOI 10.1385/MO:19:4:197; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Millington M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006461; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Nakamura M, 2005, ONCOLOGY-BASEL, V68, P163, DOI 10.1159/000086770; Nesbeth D, 2006, MOL THER, V13, P814, DOI 10.1016/j.ymthe.2005.09.016; Parrott MB, 2000, MOL THER, V1, P96, DOI 10.1006/mthe.1999.0011; Parrott MB, 2001, BIOCHEM BIOPH RES CO, V281, P993, DOI 10.1006/bbrc.2001.4437; PODDA S, 1992, P NATL ACAD SCI USA, V89, P9676, DOI 10.1073/pnas.89.20.9676; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; Tirat A, 2006, INT J BIOL MACROMOL, V39, P66, DOI 10.1016/j.ijbiomac.2006.01.012; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Wang B, 2006, VACCINE, V24, P3477, DOI 10.1016/j.vaccine.2006.02.025; Ward M, 1996, CLIN CANCER RES, V2, P873; Wei K, 1996, J BIOL CHEM, V271, P3812, DOI 10.1074/jbc.271.7.3812; Wu Y, 2010, INT J CANCER, V126, P2373, DOI 10.1002/ijc.24932; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001; YEYATI PL, 1995, HUM GENE THER, V6, P975, DOI 10.1089/hum.1995.6.8-975; Yoshikawa T, 2001, BIOTECHNOL BIOENG, V74, P435, DOI 10.1002/bit.1134	47	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26380	10.1371/journal.pone.0026380	http://dx.doi.org/10.1371/journal.pone.0026380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096482	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900003
J	Lawhon, SD; Khare, S; Rossetti, CA; Everts, RE; Galindo, CL; Luciano, SA; Figueiredo, JF; Nunes, JES; Gull, T; Davidson, GS; Drake, KL; Garner, HR; Lewin, HA; Baumler, AJ; Adams, LG				Lawhon, Sara D.; Khare, Sangeeta; Rossetti, Carlos A.; Everts, Robin E.; Galindo, Cristi L.; Luciano, Sarah A.; Figueiredo, Josely F.; Nunes, Jairo E. S.; Gull, Tamara; Davidson, George S.; Drake, Kenneth L.; Garner, Harold R.; Lewin, Harris A.; Baeumler, Andreas J.; Adams, Leslie Garry			Role of SPI-1 Secreted Effectors in Acute Bovine Response to Salmonella enterica Serovar Typhimurium: A Systems Biology Analysis Approach	PLOS ONE			English	Article							EPITHELIAL-CELLS; MOLECULAR CHARACTERIZATION; BAYESIAN FRAMEWORK; EXPRESSION DATA; RHO GTPASES; WILD-TYPE; INFECTION; INVASION; INTERFERON; SOPB	Salmonella enterica Serovar Typhimurium (S. Typhimurium) causes enterocolitis with diarrhea and polymorphonuclear cell (PMN) influx into the intestinal mucosa in humans and calves. The Salmonella Type III Secretion System (T3SS) encoded at Pathogenicity Island I translocates Salmonella effector proteins SipA, SopA, SopB, SopD, and SopE2 into epithelial cells and is required for induction of diarrhea. These effector proteins act together to induce intestinal fluid secretion and transcription of C-X-C chemokines, recruiting PMNs to the infection site. While individual molecular interactions of the effectors with cultured host cells have been characterized, their combined role in intestinal fluid secretion and inflammation is less understood. We hypothesized that comparison of the bovine intestinal mucosal response to wild type Salmonella and a SipA, SopABDE2 effector mutant relative to uninfected bovine ileum would reveal heretofore unidentified diarrhea-associated host cellular pathways. To determine the coordinated effects of these virulence factors, a bovine ligated ileal loop model was used to measure responses to wild type S. Typhimurium (WT) and a Delta sipA, sopABDE2 mutant (MUT) across 12 hours of infection using a bovine microarray. Data were analyzed using standard microarray analysis and a dynamic Bayesian network modeling approach (DBN). Both analytical methods confirmed increased expression of immune response genes to Salmonella infection and novel gene expression. Gene expression changes mapped to 219 molecular interaction pathways and 1620 gene ontology groups. Bayesian network modeling identified effects of infection on several interrelated signaling pathways including MAPK, Phosphatidylinositol, mTOR, Calcium, Toll-like Receptor, CCR3, Wnt, TGF-beta, and Regulation of Actin Cytoskeleton and Apoptosis that were used to model of host-pathogen interactions. Comparison of WT and MUT demonstrated significantly different patterns of host response at early time points of infection (15 minutes, 30 minutes and one hour) within phosphatidylinositol, CCR3, Wnt, and TGF-b signaling pathways and the regulation of actin cytoskeleton pathway.	[Lawhon, Sara D.; Khare, Sangeeta; Rossetti, Carlos A.; Luciano, Sarah A.; Figueiredo, Josely F.; Nunes, Jairo E. S.; Gull, Tamara; Adams, Leslie Garry] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Sch, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Davidson, George S.] Sandia Natl Labs, Computat Comp & Math Ctr, Albuquerque, NM 87185 USA; [Drake, Kenneth L.] Serologix LLC, Austin, TX USA; [Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Davis	Lawhon, SD (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	gadams@cvm.tamu.edu	LEWIN, HARRIS/HGC-6543-2022; Khare, SangeetA/Q-5470-2019; Lawhon, Sara D./G-5147-2011; Baumler, Andreas J/H-2301-2011	LEWIN, HARRIS/0000-0002-1043-7287; Khare, SangeetA/0000-0002-9496-6636; Lawhon, Sara D./0000-0001-9154-8909; Baumler, Andreas J/0000-0001-9152-7809	National Institute of Allergy and Infectious Disease [1 R01 A144170-01-A1, 1 R01 AI076246 01-A2]; USDA [2002-35204-12247]; Public Health Service [AI060933]; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076246, K08AI060933] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA(United States Department of Agriculture (USDA)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants to AJB and LGA from the National Institute of Allergy and Infectious Disease (1 R01 A144170-01-A1, 1 R01 AI076246 01-A2 and USDA 2002-35204-12247). Additionally, SDL received support from the Public Health Service Grant (AI060933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: KD is employed by Seralogix, LLC where his primary role is Chief Technology Officer. Seralogix is a bioinformatics research and services company commercializing computational systems biology software tools that are being sponsored by the National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute. KD participated in conducting certain genomic data processing involving pathway analyses and modeling that helped to provide a more system level perspective of host immune response to the Texas A&M University researchers. Data were processed by KD, utilizing Seralogix's proprietary computational pipeline for biological systems analysis. The relation between Seralogix and Texas A&M University, College of Veterinary Medicine is strictly on a collaborative (mutually beneficial) research basis with no financial arrangements, commitments or interests. KD's motivation is to see his computational tools produce results that contribute to the improved understanding of host response to pathogen invasions (an objective of his National Health Institute research grants). KD contributed to the interpretation of the analysis results provided to the Texas A&M University researchers. Seralogix has no ownership of the data, nor results produced by their tools. RE is currently employed by Sequenom Inc. SK is currently employed by the United States Food and Drug Administration. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Bakowski MA, 2007, CELL MICROBIOL, V9, P2839, DOI 10.1111/j.1462-5822.2007.01000.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cronin Maureen, 2004, Clin Chem, V50, P1464, DOI 10.1373/clinchem.2004.035675; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; FRANCIS CL, 1992, MOL MICROBIOL, V6, P3077, DOI 10.1111/j.1365-2958.1992.tb01765.x; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; GALAN JE, 1992, J BACTERIOL, V174, P4338; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gerold G, 2007, SEMIN IMMUNOL, V19, P41, DOI 10.1016/j.smim.2006.12.003; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2008, J INFECT DEV COUNTR, V2, P438, DOI 10.3855/jidc.158; Guiney DG, 2005, CURR TOP MICROBIOL, V289, P131; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; JONES BD, 1994, INFECT IMMUN, V62, P3745, DOI 10.1128/IAI.62.9.3745-3752.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; Kim H, 2002, BIOTECHNIQUES, V33, P924, DOI 10.2144/02334mt06; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; LIPINSKI M, 1980, EUR J IMMUNOL, V10, P246, DOI 10.1002/eji.1830100405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Murphy KP, 1999, MODELING GENE EXPRES; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2007, INFECT IMMUN, V75, P4342, DOI 10.1128/IAI.01571-06; Reis BP, 2003, VET MICROBIOL, V97, P269, DOI 10.1016/j.vetmic.2003.09.019; Rossetti CA, 2011, RES VET SCI, V91, P40, DOI 10.1016/j.rvsc.2010.09.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santos RL, 2003, BRAZ J MED BIOL RES, V36, P3, DOI 10.1590/S0100-879X2003000100002; Santos RL, 2002, AM J VET RES, V63, P1145, DOI 10.2460/ajvr.2002.63.1145; Santos RL, 2002, J INFECT DIS, V186, P372, DOI 10.1086/341509; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Santos RL, 2001, INFECT IMMUN, V69, P4610, DOI 10.1128/IAI.69.7.4610-4617.2001; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Schlumberger MC, 2003, J BIOL CHEM, V278, P27149, DOI 10.1074/jbc.M302475200; Simon R, 2007, J INTERF CYTOK RES, V27, P317, DOI 10.1089/jir.2006.0141; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Takeuchi A, 1972, Nihon Ishikai Zasshi, V67, P725; Tam MA, 2008, CELL MICROBIOL, V10, P1517, DOI 10.1111/j.1462-5822.2008.01144.x; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; VIRELIZIER JL, 1978, J IMMUNOL, V120, P1616; VIRELIZIER JL, 1981, ARCH FR PEDIATR, V38, P77; Weil MR, 2002, BIOTECHNIQUES, V32, P1310, DOI 10.2144/02326mt01; WINTER SE, 2009, INFECT IMMUN; Zhang SP, 2003, INFECT IMMUN, V71, P4795, DOI 10.1128/IAI.71.8.4795-4803.2003; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; 2010, CTR DIS CONTROL PREV, V59, P418; 2008, CTR DIS CONTROL PREV, V57, P366	77	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26869	10.1371/journal.pone.0026869	http://dx.doi.org/10.1371/journal.pone.0026869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096503	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900013
J	Veselkin, E; Kondratyev, M; Lurie, Y; Ron, E; Santo, M; Reif, S; Elashvili, I; Bar, L; Lederkremer, GZ				Veselkin, Elena; Kondratyev, Maria; Lurie, Yoav; Ron, Efrat; Santo, Moshe; Reif, Shimon; Elashvili, Irma; Bar, Lana; Lederkremer, Gerardo Z.			A Secreted Form of the Asialoglycoprotein Receptor, sH2a, as a Novel Potential Noninvasive Marker for Liver Fibrosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; DIAGNOSTIC-ACCURACY; VIRAL-HEPATITIS; EXPRESSION; MECHANISMS; PREDICTION; BIOMARKERS; DISEASE; TESTS; INDEX	Background and Aim: The human asialoglycoprotein receptor is a membrane heterooligomer expressed exclusively in hepatocytes. A soluble secreted form, sH2a, arises, not by shedding at the cell surface, but by intracellular cleavage of its membrane-bound precursor, which is encoded by an alternatively spliced form of the receptor H2 subunit. Here we determined and report that sH2a, present at constant levels in serum from healthy individuals is altered upon liver fibrosis, reflecting the status of hepatocyte function. Methods: We measured sH2a levels in serum using a monoclonal antibody and an ELISA assay that we developed, comparing with routine liver function markers. We compared blindly pretreatment serum samples from a cohort of 44 hepatitis C patients, which had METAVIR-scored biopsies, with 28 healthy individuals. Results: sH2a levels varied minimally for the healthy individuals (150 +/- 21 ng/ml), whereas the levels deviated from this normal range increasingly in correlation with fibrosis stage. A simple algorithm combining sH2a levels with those of alanine aminotransferase allowed prediction of fibrosis stage, with a very high area under the ROC curve of 0.86. Conclusions: sH2a has the potential to be a uniquely sensitive and specific novel marker for liver fibrosis and function.	[Veselkin, Elena; Kondratyev, Maria; Ron, Efrat; Lederkremer, Gerardo Z.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Lurie, Yoav; Santo, Moshe; Reif, Shimon; Elashvili, Irma; Bar, Lana] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, Liver Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Veselkin, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il		Lederkremer, Gerardo/0000-0002-9857-7152	Israel Science Foundation; Israel Cancer Association; Israeli Ministry of Health	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israeli Ministry of Health	GZL received financial support from the Ramot research fund, the Israel Science Foundation, the Israel Cancer Association and the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BENYAIR R, 2011, WORLD J GAS IN PRESS; Bissell DM, 2004, GASTROENTEROLOGY, V127, P1847, DOI 10.1053/j.gastro.2004.10.012; BURGESS JB, 1992, HEPATOLOGY, V15, P702, DOI 10.1002/hep.1840150425; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; DRICKAMER K, 1991, CELL, V67, P1029, DOI 10.1016/0092-8674(91)90278-7; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Gressner OA, 2007, CLIN CHIM ACTA, V381, P107, DOI 10.1016/j.cca.2007.02.038; Higuchi H, 2003, CURR MOL MED, V3, P483, DOI 10.2174/1566524033479528; Ishii H, 1998, J GASTROENTEROL, V33, P920, DOI 10.1007/s005350050203; Jarcuska P, 2010, CLIN CHIM ACTA, V411, P1009, DOI 10.1016/j.cca.2010.04.009; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kokudo N, 2002, WORLD J SURG, V26, P1342, DOI 10.1007/s00268-002-6262-3; KUDO M, 1991, J NUCL MED, V32, P1177; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; PIMSTONE NR, 1994, HEPATOLOGY, V20, P917, DOI 10.1002/hep.1840200421; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Rossi Enrico, 2007, Clin Biochem Rev, V28, P3; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Takemoto R, 2009, J DIGEST DIS, V10, P145, DOI 10.1111/j.1751-2980.2009.00377.x; Thuluvath PJ, 2006, AM J GASTROENTEROL, V101, P1497, DOI 10.1111/j.1572-0241.2005.00304.x; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Trere D, 1999, BRIT J CANCER, V81, P404, DOI 10.1038/sj.bjc.6690708	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							se27210	10.1371/journal.pone.0027210	http://dx.doi.org/10.1371/journal.pone.0027210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096539	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900025
J	Baskaran, P; Heckler, EJ; van den Akker, F; Beuve, A				Baskaran, Padmamalini; Heckler, Erin J.; van den Akker, Focco; Beuve, Annie			Identification of Residues in the Heme Domain of Soluble Guanylyl Cyclase that are Important for Basal and Stimulated Catalytic Activity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NITRIC-OXIDE; ACTIVATION; BINDING; NO; MECHANISM; SENSITIVITY; INSIGHTS; MOIETY; SENSOR	Nitric oxide signals through activation of soluble guanylyl cyclase (sGC), a heme-containing heterodimer. NO binds to the heme domain located in the N-terminal part of the beta subunit of sGC resulting in increased production of cGMP in the catalytic domain located at the C-terminal part of sGC. Little is known about the mechanism by which the NO signaling is propagated from the receptor domain (heme domain) to the effector domain (catalytic domain), in particular events subsequent to the breakage of the bond between the heme iron and Histidine 105 (H105) of the b subunit. Our modeling of the heme-binding domain as well as previous homologous heme domain structures in different states point to two regions that could be critical for propagation of the NO activation signal. Structure-based mutational analysis of these regions revealed that residues T110 and R116 in the alpha F helix-beta 1 strand, and residues I41 and R40 in the alpha B-alpha C loop mediate propagation of activation between the heme domain and the catalytic domain. Biochemical analysis of these heme mutants allows refinement of the map of the residues that are critical for heme stability and propagation of the NO/YC-1 activation signal in sGC.	[Baskaran, Padmamalini; Heckler, Erin J.; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University	Baskaran, P (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	focco.vandenakker@case.edu; annie.beuve@umdnj.edu		Heckler, Erin/0000-0002-9156-1318	National Institutes of Health [GM067640, HL075329]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM067640 (to AB) and HL075329 (to FvdA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskaran P, 2011, BIOCHEMISTRY-US, V50, P4291, DOI 10.1021/bi2004087; Capece L, 2008, BIOCHEMISTRY-US, V47, P9416, DOI 10.1021/bi800682k; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Knipp M, 2011, J INORG BIOCHEM, V105, P1405, DOI 10.1016/j.jinorgbio.2011.07.009; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin F, 2010, J BIOL CHEM; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Mergia Evanthia, 2009, V191, P33, DOI 10.1007/978-3-540-68964-5_3; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olea C, 2010, PROTEIN SCI, V19, P881, DOI 10.1002/pro.357; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; YUEN PST, 1994, J BIOL CHEM, V269, P791	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26976	10.1371/journal.pone.0026976	http://dx.doi.org/10.1371/journal.pone.0026976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096512	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800020
J	Kasera, R; Singh, BP; Lavasa, S; Prasad, KN; Sahoo, RC; Singh, AB				Kasera, Ramkrashan; Singh, Bhanu Pratap; Lavasa, Sakuntala; Prasad, Komerla N.; Sahoo, Ramesh C.; Singh, Anand B.			Kidney Bean: A Major Sensitizer among Legumes in Asthma and Rhinitis Patients from India	PLOS ONE			English	Article							FOOD ALLERGY; PREVALENCE; CHILDREN; PROTEINS; UTILITY; POLLEN; PEANUT; EGG	Background: The prevalence of IgE mediated food allergies has increased over the last two decades. Food allergy has been reported to be fatal in highly sensitive individuals. Legumes are important food allergens but their prevalence may vary among different populations. The present study identifies sensitization to common legumes among Indian population, characterizes allergens of kidney bean and establishes its cross reactivity with other legumes. Methodology: Patients (n = 355) with history of legume allergy were skin prick tested (SPT) with 10 legumes. Specific IgE (sIgE) and total IgE were estimated in sera by enzyme-linked immunosorbent assay. Characterization of kidney bean allergens and their cross reactivity was investigated by immunobiochemical methods. Identification of major allergens of kidney bean was carried out by mass spectrometry. Principal Findings: Kidney bean exhibited sensitization in 78 (22.0%) patients followed by chickpea 65 (18.0%) and peanut 53 (15%). SPT positive patients depicted significantly elevated sIgE levels against different legumes (r = 0.85, p<0.0001). Sera from 30 kidney bean sensitive individuals exhibited basophil histamine release (16-54%) which significantly correlated with their SPT (r = 0.83, p<0.0001) and sIgE (r = 0.99, p<0.0001). Kidney bean showed eight major allergens of 58, 50, 45, 42, 40, 37, 34 and 18 kDa on immunoblot and required 67.3 +/- 2.51 ng of homologous protein for 50% IgE inhibition. Inhibition assays revealed extensive cross reactivity among kidney bean, peanut, black gram and pigeon pea. nLC-MS/MS analysis identified four allergens of kidney bean showing significant matches with known proteins namely lectin (phytohemagglutinin), phaseolin, alpha-amylase inhibitor precursor and group 3 late embryogenesis abundant protein. Conclusion/Significance: Among legumes, kidney bean followed by chick pea and peanut are the major allergic triggers in asthma and rhinitis patients in India. Kidney bean showed eight major allergens and cross reacted with other legumes. A combination of SPT, sIgE and histamine release assay is helpful in allergy diagnosis.	[Kasera, Ramkrashan; Singh, Bhanu Pratap; Singh, Anand B.] Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Lavasa, Sakuntala] USLavasa Med & Res Ctr, Chandigarh, India; [Prasad, Komerla N.] Bangalore Allergy Ctr, Bangalore, Karnataka, India; [Kasera, Ramkrashan; Singh, Bhanu Pratap] Univ Pune, Pune, Maharashtra, India; [Sahoo, Ramesh C.] Manipal Med Coll, Mangalore, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University; Manipal Academy of Higher Education (MAHE)	Kasera, R (corresponding author), Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	singha49@hotmail.com	Kasera, Ramkrashan/D-3727-2012		Indian Council of Medical Research, Delhi, India	Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR))	The study is funded by Indian Council of Medical Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Asero R, 2009, CURR OPIN ALLERGY CL, V9, P379, DOI 10.1097/ACI.0b013e32832d9049; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Budde IK, 2001, INT ARCH ALLERGY IMM, V126, P277, DOI 10.1159/000049524; Crespo JF, 2003, ALLERGY, V58, P98, DOI 10.1034/j.1398-9995.2003.02170.x; Eggesbo M, 2001, ALLERGY, V56, P403, DOI 10.1034/j.1398-9995.2001.056005403.x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Gupta SK, 1996, LUNG INDIA, V14, P60; Ibanez M D, 2003, Allergol Immunopathol (Madr), V31, P151; Kluh I, 2005, PHYTOCHEMISTRY, V66, P31, DOI 10.1016/j.phytochem.2004.11.001; Kukreja N, 2009, FEMS IMMUNOL MED MIC, V56, P32, DOI 10.1111/j.1574-695X.2009.00542.x; Kumar R, 2007, IMMUNOBIOLOGY, V212, P141, DOI 10.1016/j.imbio.2006.11.006; Kumari D, 2006, ALLERGY, V61, P104, DOI 10.1111/j.1398-9995.2006.00990.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mari A, 2003, CLIN EXP ALLERGY, V33, P1429, DOI 10.1046/j.1365-2222.2003.01783.x; Misra A, 2008, IMMUNOPHARM IMMUNOT, V30, P529, DOI 10.1080/08923970802135294; Nowak-Wegrzyn A, 2006, MED CLIN N AM, V90, P97, DOI 10.1016/j.mcna.2005.08.012; O'Cualain RDM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-286; ORANJE AP, 1992, ACTA DERM-VENEREOL, P41; Osterballe M, 2009, PEDIAT ALLERG IMM-UK, V20, P686, DOI 10.1111/j.1399-3038.2008.00842.x; Pascual CY, 1999, J ALLERGY CLIN IMMUN, V103, P154, DOI 10.1016/S0091-6749(99)70539-7; Patil SP, 2001, ANN ALLERG ASTHMA IM, V87, P140, DOI 10.1016/S1081-1206(10)62209-0; Penard-Morand C, 2005, ALLERGY, V60, P1165, DOI 10.1111/j.1398-9995.2005.00860.x; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Rouge P, 2011, ALLERGY, V66, P301, DOI 10.1111/j.1398-9995.2010.02466.x; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sanchez-Monge R, 2000, J ALLERGY CLIN IMMUN, V106, P955, DOI 10.1067/mai.2000.109912; Sandin DI, 1999, ALLERGY, V54, P1209, DOI 10.1034/j.1398-9995.1999.00299.x; Sato S, 2011, INT ARCH ALLERGY IMM, V155, P96, DOI 10.1159/000327490; Shaikh WA, 1990, BOMBAY HOSP J, V32, P31; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Sharma S, 2006, CLIN EXP ALLERGY, V36, P1019, DOI 10.1111/j.1365-2222.2006.02525.x; Sharman Jyotsna, 2000, Indian Journal of Pediatrics, V67, P713, DOI 10.1007/BF02723925; Sicherer SH, 2009, ANNU REV MED, V60, P261, DOI 10.1146/annurev.med.60.042407.205711; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; SINGH AB, 1992, ASIAN PAC J ALLERGY, V10, P103; Singh AK, 2006, ALLERGY, V61, P491, DOI 10.1111/j.1398-9995.2006.01049.x; SINGH BP, 1992, BIOCHEM INT, V27, P477; Spiewak R, 2000, ANN AGR ENV MED, V7, P55; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014	43	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27193	10.1371/journal.pone.0027193	http://dx.doi.org/10.1371/journal.pone.0027193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096535	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800035
J	Wang, SS; Lu, YN; Rothman, N; Abdou, AM; Cerhan, JR; De Roos, A; Davis, S; Severson, RK; Cozen, W; Chanock, SJ; Bernstein, L; Morton, LM; Hartge, P				Wang, Sophia S.; Lu, Yani; Rothman, Nathaniel; Abdou, Amr M.; Cerhan, James R.; De Roos, Anneclaire; Davis, Scott; Severson, Richard K.; Cozen, Wendy; Chanock, Stephen J.; Bernstein, Leslie; Morton, Lindsay M.; Hartge, Patricia			Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; POOLED ANALYSIS; SUN EXPOSURE; POLYMORPHISMS; IL10	Genetic variations in human leukocyte antigens (HLA) are critical in host responses to infections, transplantation, and immunological diseases. We previously identified associations with non-Hodgkin lymphoma (NHL) and the HLA-DRB1*01:01 allele and extended ancestral haplotype (AH) 8.1 (HLA-A*01-B*08-DR*03-TNF-308A). To illuminate how HLA alleles and haplotypes may influence NHL etiology, we examined potential interactions between HLA-DRB1*01:01 and AH 8.1, and a wide range of NHL risk factors among 685 NHL cases and 646 controls from a United States population-based case-control study. We calculated odds ratios and 95% confidence intervals by HLA allele or haplotype status, adjusted for sex, age, race and study center for NHL and two major subtypes using polychotomous unconditional logistic regression models. The previously reported elevation in NHL risk associated with exposures to termite treatment and polychlorinated biphenyls were restricted to individuals who did not possess HLA-DRB1*01:01. Previous associations for NHL and DLBCL with decreased sun exposure, higher BMI, and autoimmune conditions were statistically significant only among those with AH 8.1, and null among those without AH 8.1. Our results suggest that NHL risk factors vary in their association based on HLA-DRB1*01:01 and AH 8.1 status. Our results further suggest that certain NHL risk factors may act through a common mechanism to alter NHL risk. Finally, control participants with either HLA-DRB1*01:01 or AH 8.1 reported having a family history of NHL twice as likely as those who did not have either allele or haplotype, providing the first empirical evidence that HLA associations may explain some of the well-established relationship between family history and NHL risk.	[Wang, Sophia S.; Lu, Yani; Bernstein, Leslie] Beckman Res Inst & City Hope, Div Canc Etiol, Dept Populat Sci, Duarte, CA USA; [Rothman, Nathaniel; Chanock, Stephen J.; Morton, Lindsay M.; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA; [Abdou, Amr M.] Natl Res Ctr, Dept Microbiol & Immunol, Cairo, Egypt; [Cerhan, James R.] Mayo Clin, Div Epidemiol, Coll Med, Rochester, MN USA; [De Roos, Anneclaire; Davis, Scott] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Severson, Richard K.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Karmanos Canc Inst, Detroit, MI USA; [Cozen, Wendy] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA	City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Mayo Clinic; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Southern California	Wang, SS (corresponding author), Beckman Res Inst & City Hope, Div Canc Etiol, Dept Populat Sci, Duarte, CA USA.	sowang@coh.org	Morton, Lindsay M/B-5234-2015; Morton, Lindsay/AAE-7495-2022	Morton, Lindsay M/0000-0001-9767-2310; Morton, Lindsay/0000-0001-9767-2310; Abdou, Amr/0000-0002-3373-2406; WANG, SOPHIA/0000-0003-2597-9393; Cerhan, James/0000-0002-7482-178X	National Institutes of Health (NHI) National Cancer Institute (NCI) [HHSN261200800001E]; Public Health Service (PHS) [N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, N02-PC-71105]; NIH, National Cancer Institute, Center for Cancer Research; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010, N01PC065064, N01PC067009, N01PC067008] Funding Source: NIH RePORTER	National Institutes of Health (NHI) National Cancer Institute (NCI); Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences)	The NCI-SEER study was supported by the Intramural Research Program of the National Institutes of Health (NHI) National Cancer Institute (NCI), and by Public Health Service (PHS) contracts N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, and N02-PC-71105. HLA typing for the study was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E and in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AM, 2010, LEUKEMIA, V24, P1055, DOI 10.1038/leu.2010.17; Anderson LA, 2009, INT J CANCER, V125, P398, DOI 10.1002/ijc.24287; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Colt JS, 2009, BLOOD, V113, P1899, DOI 10.1182/blood-2008-04-153858; Colt JS, 2005, EPIDEMIOLOGY, V16, P516, DOI 10.1097/01.ede.0000164811.25760.f1; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; De Roos AJ, 2005, CANCER RES, V65, P11214, DOI 10.1158/0008-5472.CAN-05-1755; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; Devlin JF, 2003, GROUND WATER, V41, P316, DOI 10.1111/j.1745-6584.2003.tb02600.x; Gathany AH, 2009, CANCER CAUSE CONTROL, V20, P1291, DOI 10.1007/s10552-009-9348-5; Hurley MTJHC, 2002, IHWG TECHNICAL MANUA; Kricker A, 2008, INT J CANCER, V122, P144, DOI 10.1002/ijc.23003; Morton LM, 2008, BLOOD, V112, P5150, DOI 10.1182/blood-2008-01-133587; Morton LM, 2005, CANCER EPIDEM BIOMAR, V14, P925, DOI 10.1158/1055-9965.EPI-04-0693; Morton LM, 2005, LANCET ONCOL, V6, P469, DOI 10.1016/S1470-2045(05)70214-X; Percy C., INT CLASSIFICATION D; Purdue MP, 2007, CANCER CAUSE CONTROL, V18, P989, DOI 10.1007/s10552-007-9039-z; Purdue MP, 2010, AM J EPIDEMIOL, V172, P58, DOI 10.1093/aje/kwq117; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Wang SS, 2007, CANCER RES, V67, P5042, DOI 10.1158/0008-5472.CAN-06-4752; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Willett EV, 2008, INT J CANCER, V122, P2062, DOI 10.1002/ijc.23344	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26949	10.1371/journal.pone.0026949	http://dx.doi.org/10.1371/journal.pone.0026949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096508	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800017
J	Floden, AM; Watt, JA; Brissette, CA				Floden, Angela M.; Watt, John A.; Brissette, Catherine A.			Borrelia burgdorferi Enolase Is a Surface-Exposed Plasminogen Binding Protein	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ALPHA-ENOLASE; STREPTOCOCCUS-PNEUMONIAE; IDENTIFICATION; EXPRESSION; FIBRONECTIN; RECEPTOR; ISOLATE; AUTOANTIBODIES; PENETRATION	Borrelia burgdorferi is the causative agent of Lyme disease, the most commonly reported arthropod-borne disease in the United States. B. burgdorferi is a highly invasive bacterium, yet lacks extracellular protease activity. In order to aid in its dissemination, B. burgdorferi binds plasminogen, a component of the hosts' fibrinolytic system. Plasminogen bound to the surface of B. burgdorferi can then be activated to the protease plasmin, facilitating the bacterium's penetration of endothelial cell layers and degradation of extracellular matrix components. Enolases are highly conserved proteins with no sorting sequences or lipoprotein anchor sites, yet many bacteria have enolases bound to their outer surfaces. B. burgdorferi enolase is both a cytoplasmic and membrane associated protein. Enolases from other pathogenic bacteria are known to bind plasminogen. We confirmed the surface localization of B. burgdorferi enolase by in situ protease degradation assay and immunoelectron microscopy. We then demonstrated that B. burgdorferi enolase binds plasminogen in a dose-dependent manner. Lysine residues were critical for binding of plasminogen to enolase, as the lysine analog eaminocaproic acid significantly inhibited binding. Ionic interactions did not play a significant role in plasminogen binding by enolase, as excess NaCl had no effects on the interaction. Plasminogen bound to recombinant enolase could be converted to active plasmin. We conclude that B. burgdorferi enolase is a moonlighting cytoplasmic protein which also associates with the bacterial outer surface and facilitates binding to host plasminogen.	[Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol, Grand Forks, ND 58201 USA; [Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Immunol, Grand Forks, ND 58201 USA; [Watt, John A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Anat, Grand Forks, ND 58201 USA; [Watt, John A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Cell Biol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks; University of North Dakota Grand Forks	Floden, AM (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol, Grand Forks, ND 58201 USA.	catherine.brissette@med.und.edu		Brissette, Catherine/0000-0003-0792-1403	ND EPSCoR [UND0014095]	ND EPSCoR	ND EPSCoR (UND0014095; www.ndepscor.nodak.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P671, DOI 10.1006/jaut.1998.0239; Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Castellino FJ, 1997, CIBA F SYMP, V212, P46; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; Eroles P, 1997, MICROBIOL-SGM, V143, P313, DOI 10.1099/00221287-143-2-313; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Haile WB, 2006, CELL MICROBIOL, V8, P1349, DOI 10.1111/j.1462-5822.2006.00717.x; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hara H, 2000, MICROBIOL IMMUNOL, V44, P349, DOI 10.1111/j.1348-0421.2000.tb02505.x; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LOTTENBERG R, 1987, INFECT IMMUN, V55, P1914, DOI 10.1128/IAI.55.8.1914-1918.1987; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Nowalk AJ, 2006, PROTEOMICS, V6, P2121, DOI 10.1002/pmic.200500187; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Zuckert WR, 2007, CURRENT PROTOCOLS MI, p12C1111	63	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27502	10.1371/journal.pone.0027502	http://dx.doi.org/10.1371/journal.pone.0027502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087329	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700053
J	Fuji, N; Suzuki, A; Lupisan, S; Sombrero, L; Galang, H; Kamigaki, T; Tamaki, R; Saito, M; Aniceto, R; Olveda, R; Oshitani, H				Fuji, Naoko; Suzuki, Akira; Lupisan, Socorro; Sombrero, Lydia; Galang, Hazel; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Aniceto, Rapunzel; Olveda, Remigio; Oshitani, Hitoshi			Detection of Human Rhinovirus C Viral Genome in Blood among Children with Severe Respiratory Infections in the Philippines	PLOS ONE			English	Article							IDENTIFIED HUMAN RHINOVIRUS; TISSUE TROPISM; HRV-C; CLINICAL-FEATURES; GENETIC DIVERSITY; PROTOTYPE STRAINS; SPECIES C; RECOMBINATION; DETERMINANTS; ILLNESS	Human rhinovirus (HRV) C was recently identified as the third species of HRV using a molecular technique. Infections caused by previously identified HRVs (A and B) are thought to be limited to the respiratory tract; however, pathogenesis of HRVC is still largely unknown. A total of 816 nasopharyngeal swabs from hospitalized children with severe respiratory infections in the Philippines (May 2008-May 2009) were tested for HRV by reverse transcription polymerase chain reaction (RT-PCR), and 243 samples (29.8%) were positive for HRV. Among these patients, serum samples were also tested to determine whether specific HRV species were associated with viremia. Only 30 serum samples (12.3%) were positive for HRV. However, the HRV positive rates were different among HRV species, 3% (4/135) for HRVA, 0% (0/25) for HRVB, and 31% (26/83) for HRVC, and were the highest on 2 days after the onset of symptoms. These results suggest that HRVC may have a different pathogenicity and can more commonly cause viremia than HRVA and HRVB. Serum positive rates for HRV are affected by age, i.e., higher positive rates for those aged 1 year or more. HRVC that were detected from serum exhibited the same level of sequence diversity as those positive only for nasopharyngeal samples in phylogenetic analysis. However, all HRVA which were detected from serum were clustered in a monophyletic clade based on their 5' non-coding region (NCR) sequences, which is closely related with a certain HRVC genotype (A2) in 5'-NCR. This finding suggests that the 5'NCR region may be associated with viremia.	[Fuji, Naoko; Suzuki, Akira; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Suzuki, Akira; Kamigaki, Taro; Tamaki, Raita; Saito, Mariko; Aniceto, Rapunzel; Oshitani, Hitoshi] Tohoku RITM Collaborating Res Ctr Emerging & Reem, Muntinlupa, Metro Manila, Philippines; [Lupisan, Socorro; Sombrero, Lydia; Olveda, Remigio] Res Inst Trop Med, Muntinlupa, Metro Manila, Philippines; [Aniceto, Rapunzel] Eastern Visayas Reg Med Ctr, Leyte, Tacloban, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Fuji, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019	Suzuki, Akira/0000-0002-8223-0314	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by a grant-in-aid for The Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministries of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Calvo C, 2010, PEDIATR INFECT DIS J, V29, P717, DOI 10.1097/INF.0b013e3181d7a708; Cheung PKM, 2005, J MED VIROL, V77, P414, DOI 10.1002/jmv.20470; CHO CT, 1982, INFECT IMMUN, V37, P720, DOI 10.1128/IAI.37.2.720-727.1982; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; GREGG I, 1972, BRIT MED J, V3, P824, DOI 10.1136/bmj.3.5830.824-c; Han TH, 2009, ARCH VIROL, V154, P987, DOI 10.1007/s00705-009-0383-z; Harvala H, 2005, J GEN VIROL, V86, P1897, DOI 10.1099/vir.0.80603-0; Harvala H, 2002, J GEN VIROL, V83, P1697, DOI 10.1099/0022-1317-83-7-1697; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MCKAY HW, 1963, AM J PUBLIC HEALTH N, V53, P274, DOI 10.2105/AJPH.53.2.274; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Miller EK, 2009, J CLIN VIROL, V46, P85, DOI 10.1016/j.jcv.2009.06.007; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Pallansch M. A., 2007, ENTEROVIRUSES POLIOV, P839; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016; RONALD B, 2007, RHINOVIRUSES, P895; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Sandager MM, 2008, VIROLOGY, V372, P35, DOI 10.1016/j.virol.2007.10.020; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Tapparel C, 2009, J CLIN VIROL, V45, P157, DOI 10.1016/j.jcv.2009.03.014; URQUHART GE, 1970, BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5726.28; URQUHART GE, 1972, J CLIN PATHOL, V25, P443, DOI 10.1136/jcp.25.5.443; *WHO, 1990, MAN YOUNG CHILDR AC; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC	37	46	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27247	10.1371/journal.pone.0027247	http://dx.doi.org/10.1371/journal.pone.0027247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087272	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700022
J	Lan, WX; Wang, ZH; Yang, ZZ; Zhu, J; Ying, TL; Jiang, XW; Zhang, XM; Wu, HM; Liu, ML; Tan, XS; Cao, CY; Huang, ZX				Lan, Wenxian; Wang, Zhonghua; Yang, Zhongzheng; Zhu, Jing; Ying, Tianlei; Jiang, Xianwang; Zhang, Xu; Wu, Houming; Liu, Maili; Tan, Xiangshi; Cao, Chunyang; Huang, Zhong-Xian			Conformational Toggling of Yeast Iso-1-Cytochrome c in the Oxidized and Reduced States	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR COOA; MITOCHONDRIAL CYTOCHROME-C; GATED ELECTRON-TRANSFER; CIRCULAR-DICHROISM; FERRICYTOCHROME-C; LIGAND-EXCHANGE; MET80X MUTANTS; ALKALINE FORM; AXIAL LIGAND; HEME	To convert cyt c into a peroxidase-like metalloenzyme, the P71H mutant was designed to introduce a distal histidine. Unexpectedly, its peroxidase activity was found even lower than that of the native, and that the axial ligation of heme iron was changed to His71/His18 in the oxidized state, while to Met80/His18 in the reduced state, characterized by UV-visible, circular dichroism, and resonance Raman spectroscopy. To further probe the functional importance of Pro71 in oxidation state dependent conformational changes occurred in cyt c, the solution structures of P71H mutant in both oxidation states were determined. The structures indicate that the half molecule of cyt c (aa 50-102) presents a kind of "zigzag riveting ruler" structure, residues at certain positions of this region such as Pro71, Lys73 can move a big distance by altering the tertiary structure while maintaining the secondary structures. This finding provides a molecular insight into conformational toggling in different oxidation states of cyt c that is principle significance to its biological functions in electron transfer and apoptosis. Structural analysis also reveals that Pro71 functions as a key hydrophobic patch in the folding of the polypeptide of the region (aa 50-102), to prevent heme pocket from the solvent.	[Lan, Wenxian; Yang, Zhongzheng; Zhu, Jing; Wu, Houming; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Wang, Zhonghua; Ying, Tianlei; Tan, Xiangshi; Huang, Zhong-Xian] Fudan Univ, Dept Chem, Biol Chem Lab, Shanghai 200433, Peoples R China; [Jiang, Xianwang; Zhang, Xu; Liu, Maili] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Fudan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Lan, WX (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn; zxhuang@fudan.edu.cn	Zhang, Xu/B-4753-2015; 应, 天雷/P-5396-2019; Liu, Maili/A-8543-2011	应, 天雷/0000-0002-9597-2843; Liu, Maili/0000-0002-9359-915X	National Basic Research Program of China [2009CB918600, 2011CB966300]; National Science Foundation of China [20921091, 30430180]; Science and Technology Commission of Shanghai Municipality, China [08PJ1411700]; State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS [T152902]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS(Chinese Academy of Sciences)	This work was supported partially by the National Basic Research Program of China under No. 2009CB918600 and 2011CB966300, by the National Science Foundation of China under No. 20921091 and No. 30430180, by Pujiang talents awards from Science and Technology Commission of Shanghai Municipality, China under No. 08PJ1411700 and by the funding from State Key laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, CAS, under No. T152902. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; AYERS PW, 2006, J CHEM PHYS, V124; Baddam S, 2006, INORG CHEM, V45, P6338, DOI 10.1021/ic0603712; Baistrocchi P, 1996, BIOCHEMISTRY-US, V35, P13788, DOI 10.1021/bi961110e; BANCI L, 1989, INORG CHEM, V28, P4650, DOI 10.1021/ic00325a023; Banci L, 1997, BIOCHEMISTRY-US, V36, P8992, DOI 10.1021/bi963025c; Bandi S, 2008, J AM CHEM SOC, V130, P7540, DOI 10.1021/ja801941r; Bandi S, 2007, BIOCHEMISTRY-US, V46, P10643, DOI 10.1021/bi700992y; BARKER PD, 1992, J AM CHEM SOC, V114, P3619, DOI 10.1021/ja00036a006; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BERGHUIS AM, 1992, J MOL BIOL, V223, P959, DOI 10.1016/0022-2836(92)90255-I; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; CUTLER RL, 1987, PROTEIN ENG, V1, P95, DOI 10.1093/protein/1.2.95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; Feinberg BA, 1998, BIOCHEMISTRY-US, V37, P13091, DOI 10.1021/bi981037n; FERRER JC, 1993, J AM CHEM SOC, V115, P7505; GAO Y, 1990, BIOCHEMISTRY-US, V29, P6994, DOI 10.1021/bi00482a007; HAWKINS BK, 1994, J AM CHEM SOC, V116, P3111, DOI 10.1021/ja00086a046; Hay S, 2005, BIOCHEMISTRY-US, V44, P431, DOI 10.1021/bi0492298; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KAMINSKY LS, 1973, BIOCHEMISTRY-US, V12, P2215, DOI 10.1021/bi00736a006; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LOOZE Y, 1978, INT J PEPT PROT RES, V12, P233; LOUIE GV, 1988, J MOL BIOL, V199, P295, DOI 10.1016/0022-2836(88)90315-4; MACURA S, 1982, J MAGN RESON, V47, P351, DOI 10.1016/0022-2364(82)90128-7; Mines GA, 1996, CHEM BIOL, V3, P491, DOI 10.1016/S1074-5521(96)90097-6; Moore G. R., 1990, CYTOCHROMES C EVOLUT, P1; MURPHY ME, THESIS U BRIT COLUMB, P96; Nakajima H, 2001, J BIOL CHEM, V276, P37895; Nakajima H, 2001, J BIOL CHEM, V276, P7055, DOI 10.1074/jbc.M003972200; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; PIELAK GJ, 1988, EUR J BIOCHEM, V177, P167, DOI 10.1111/j.1432-1033.1988.tb14359.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; RAPHAEL AL, 1989, PROTEINS, V6, P338, DOI 10.1002/prot.340060316; Reynolds MF, 1998, J AM CHEM SOC, V120, P9080, DOI 10.1021/ja981146p; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; Santucci R, 1997, J INORG BIOCHEM, V68, P211, DOI 10.1016/S0162-0134(97)00100-1; Schejter A, 1996, J AM CHEM SOC, V118, P477, DOI 10.1021/ja9529448; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone GG, 2005, J AM CHEM SOC, V127, P92, DOI 10.1021/ja045719b; STELLWAGEN E, 1974, BIOCHEM BIOPH RES CO, V60, P371, DOI 10.1016/0006-291X(74)90214-9; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; Vogel KM, 1999, BIOCHEMISTRY-US, V38, P2679, DOI 10.1021/bi982375r; Wallace CJA, 1997, BIOCHEMISTRY-US, V36, P14733, DOI 10.1021/bi971595m; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; WUTTKE DS, 1993, PROTEIN ENG, V3, P555; Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51; Ying TL, 2010, CHEM COMMUN, V46, P3541, DOI 10.1039/b926261j; Ying TL, 2009, CHEM COMMUN, P4512, DOI 10.1039/b904347k; Zheng JW, 2000, BIOPOLYMERS, V57, P77, DOI 10.1002/(SICI)1097-0282(2000)57:2<77::AID-BIP4>3.0.CO;2-Y	61	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27219	10.1371/journal.pone.0027219	http://dx.doi.org/10.1371/journal.pone.0027219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087268	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700020
J	Liu, XP; Liu, JH				Liu, Xi-Peng; Liu, Jian-Hua			Characterization of Family IV UDG from Aeropyrum pernix and Its Application in Hot-Start PCR by Family B DNA Polymerase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; URACIL RECOGNITION; GLYCOSYLASE; ENDONUCLEASE; PROCESSIVITY; SPECIFICITY; EXPRESSION; HYPOXANTHINE; DEAMINATION	Recombinant uracil-DNA glycosylase (UDG) from Aeropyrum pernix (A. pernix) was expressed in E. coli. The biochemical characteristics of A. pernix UDG (ApeUDG) were studied using oligonucleotides carrying a deoxyuracil (dU) base. The optimal temperature range and pH value for dU removal by ApeUDG were 55-65 degrees C and pH 9.0, respectively. The removal of dU was inhibited by the divalent ions of Zn, Cu, Co, Ni, and Mn, as well as a high concentration of NaCl. The opposite base in the complementary strand affected the dU removal by ApeUDG as follows: U/C approximate to U/G>U/T approximate to U/AP approximate to U/->U/U approximate to U/I>U/A. The phosphorothioate around dU strongly inhibited dU removal by ApeUDG. Based on the above biochemical characteristics and the conservation of amino acid residues, ApeUDG was determined to belong to the IV UDG family. ApeUDG increased the yield of PCR by Pfu DNA polymerase via the removal of dU in amplified DNA. Using the dU-carrying oligonucleotide as an inhibitor and ApeUDG as an activator of Pfu DNA polymerase, the yield of undesired DNA fragments, such as primer-dimer, was significantly decreased, and the yield of the PCR target fragment was increased. This strategy, which aims to amplify the target gene with high specificity and yield, can be applied to all family B DNA polymerases.	[Liu, Xi-Peng; Liu, Jian-Hua] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, XP (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	jianhualiudl@sjtu.edu.cn			National High Technology Research and Development Program of China [2006AA02Z108]; National Basic Research Program of China [2005CB724301, 2007CB914504, 2009CB118906]; National Science Foundation of China [30700131, 30870512]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National High Technology Research and Development Program of China (Grant No. 2006AA02Z108), the National Basic Research Program of China (Grant Nos. 2005CB724301, 2007CB914504, and 2009CB118906), and the National Science Foundation of China (Grant Nos. 30700131 and 30870512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes WM, 2002, MOL CELL PROBE, V16, P167, DOI 10.1006/mcpr.2002.0407; Bjornberg O, 2003, J BIOL CHEM, V278, P20667, DOI 10.1074/jbc.M213010200; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640; Davidson JF, 2003, NUCLEIC ACIDS RES, V31, P4702, DOI 10.1093/nar/gkg667; Emptage K, 2008, J MOL BIOL, V383, P762, DOI 10.1016/j.jmb.2008.08.018; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Gill S, 2007, J MOL BIOL, V372, P855, DOI 10.1016/j.jmb.2007.07.015; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Hitchcock TM, 2004, NUCLEIC ACIDS RES, V32, P4071, DOI 10.1093/nar/gkh747; Hogrefe HH, 2002, P NATL ACAD SCI USA, V99, P596, DOI 10.1073/pnas.012372799; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Kaboev OK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e94; KAIJALAINEN S, 1993, NUCLEIC ACIDS RES, V21, P2959, DOI 10.1093/nar/21.12.2959; Kainz P, 2000, BIOTECHNIQUES, V28, P278, DOI 10.2144/00282st04; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kermekchiev MB, 2003, NUCLEIC ACIDS RES, V31, P6139, DOI 10.1093/nar/gkg813; Kiyonari S, 2008, J BIOL CHEM, V283, P24185, DOI 10.1074/jbc.M802837200; Kiyonari S, 2009, NUCLEIC ACIDS RES, V37, P6439, DOI 10.1093/nar/gkp720; Lee HW, 2011, J BIOL CHEM, V286, P31282, DOI 10.1074/jbc.M111.249524; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu XP, 2010, PROTEIN EXPRES PURIF, V70, P1, DOI 10.1016/j.pep.2009.10.006; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mansfield C, 2003, FEBS LETT, V540, P171, DOI 10.1016/S0014-5793(03)00257-6; Moretti T, 1998, BIOTECHNIQUES, V25, P716; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Nilsson J, 1997, BIOTECHNIQUES, V22, P744, DOI 10.2144/97224rr04; Parker JB, 2008, BIOCHEMISTRY-US, V47, P8614, DOI 10.1021/bi800854g; Pavlov AR, 2002, P NATL ACAD SCI USA, V99, P13510, DOI 10.1073/pnas.202127199; Sakai T, 2008, DNA REPAIR, V7, P663, DOI 10.1016/j.dnarep.2008.01.006; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SHARKEY DJ, 1994, BIO-TECHNOL, V12, P506, DOI 10.1038/nbt0594-506; Shuttleworth G, 2004, J MOL BIOL, V337, P621, DOI 10.1016/j.jmb.2004.01.021; VARSHNEY U, 1988, J BIOL CHEM, V263, P7776; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Yang HJ, 2000, J BACTERIOL, V182, P1272, DOI 10.1128/JB.182.5.1272-1279.2000	39	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27248	10.1371/journal.pone.0027248	http://dx.doi.org/10.1371/journal.pone.0027248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087273	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700023
J	Seronello, S; Montanez, J; Presleigh, K; Barlow, M; Park, SB; Choi, J				Seronello, Scott; Montanez, Jessica; Presleigh, Kristen; Barlow, Miriam; Park, Seung Bum; Choi, Jinah			Ethanol and Reactive Species Increase Basal Sequence Heterogeneity of Hepatitis C Virus and Produce Variants with Reduced Susceptibility to Antivirals	PLOS ONE			English	Article							INTERFERON-ALPHA; RNA REPLICATION; OXIDATIVE STRESS; DNA-DAMAGE; NONSTRUCTURAL PROTEIN; HEPATOMA-CELLS; IRON DEPLETION; CYCLOSPORINE-A; ALCOHOL; RESISTANCE	Hepatitis C virus (HCV) exhibits a high level of genetic variability, and variants with reduced susceptibility to antivirals can occur even before treatment begins. In addition, alcohol decreases efficacy of antiviral therapy and increases sequence heterogeneity of HCV RNA but how ethanol affects HCV sequence is unknown. Ethanol metabolism and HCV infection increase the level of reactive species that can alter cell metabolism, modify signaling, and potentially act as mutagen to the viral RNA. Therefore, we investigated whether ethanol and reactive species affected the basal sequence variability of HCV RNA in hepatocytes. Human hepatoma cells supporting a continuous replication of genotype 1b HCV RNA (Con1, AJ242652) were exposed to ethanol, acetaldehyde, hydrogen peroxide, or L-buthionine-S,R-sulfoximine (BSO) that decreases intracellular glutathione as seen in patients. Then, NS5A region was sequenced and compared with genotype 1b HCV sequences in the database. Ethanol and BSO elevated nucleotide and amino acid substitution rates of HCV RNA by 4-18 folds within 48 hrs which were accompanied by oxidative RNA damage. Iron chelator and glutathione ester decreased both RNA damage and mutation rates. Furthermore, infectious HCV and HCV core gene were sufficient to induce oxidative RNA damage even in the absence of ethanol or BSO. Interestingly, the dn/ds ratio and percentage of sites undergoing positive selection increased with ethanol and BSO, resulting in an increased detection of NS5A variants with reduced susceptibility to interferon alpha, cyclosporine, and ribavirin and others implicated in immune tolerance and modulation of viral replication. Therefore, alcohol is likely to synergize with virus-induced oxidative/nitrosative stress to modulate the basal mutation rate of HCV. Positive selection induced by alcohol and reactive species may contribute to antiviral resistance.	[Seronello, Scott; Montanez, Jessica; Presleigh, Kristen; Barlow, Miriam; Park, Seung Bum; Choi, Jinah] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced	Seronello, S (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	jchoi@ucmerced.edu	Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433; Park, Seung Bum/0000-0003-2834-9071	UC-Merced; NIH [1R56AI083353-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083353] Funding Source: NIH RePORTER	UC-Merced; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by start up funds and faculty research grants to J.C. from UC-Merced and an NIH grant #1R56AI083353-01A1 (http://projectreporter.nih.gov/project_info_details.cfm?aid = 8130414&icde = 10161487). Partial sequencing was donated by Eddy Rubin, director of the DOE Joint Genome Institute, through the sequencing quota allocated to the UC Merced Genome Biology course (BIS 142) in Spring 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2001, REV MED VIROL, V11, P87, DOI 10.1002/rmv.303; Barbaro G, 1999, J HEPATOL, V30, P774, DOI 10.1016/S0168-8278(99)80128-7; Bebenek K, 1999, MUTAT RES-FUND MOL M, V429, P149, DOI 10.1016/S0027-5107(99)00119-0; BELOQUI O, 1993, J INTERFERON RES, V13, P279, DOI 10.1089/jir.1993.13.279; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Burlando B, 2003, CELL PHYSIOL BIOCHEM, V13, P147, DOI 10.1159/000071865; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Carriere M, 2006, J VIRAL HEPATITIS, V13, P633, DOI 10.1111/j.1365-2893.2006.00737.x; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Choi J, 2006, FREE RADICAL BIO MED, V41, P1488, DOI 10.1016/j.freeradbiomed.2006.08.008; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Cromie SL, 1996, J HEPATOL, V25, P821, DOI 10.1016/S0168-8278(96)80284-4; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Doreswamy K, 2004, J ANDROL, V25, P996; Duan H, 2010, VACCINE, V28, P4138, DOI 10.1016/j.vaccine.2010.04.024; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Eysseric H, 1997, ALCOHOL, V14, P111, DOI 10.1016/S0741-8329(96)00112-7; Fargion S, 1997, EUR J GASTROEN HEPAT, V9, P497, DOI 10.1097/00042737-199705000-00016; Feld JJ, 2011, GASTROENTEROLOGY, V140, P830, DOI 10.1053/j.gastro.2010.09.010; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Filipowicz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015492; Fong TL, 1998, J HEPATOL, V28, P369, DOI 10.1016/S0168-8278(98)80308-5; Fontana RJ, 2000, HEPATOLOGY, V31, P730, DOI 10.1002/hep.510310325; Forman HJ, 1997, OXIDATIVE STRESS SIG; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Gentile I, 2009, J CLIN APHERESIS, V24, P190, DOI 10.1002/jca.20210; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Haviryaji KSG, 1997, NEUROCHEM RES, V22, P699, DOI 10.1023/A:1027302126493; Hofmann WP, 2005, J CLIN VIROL, V32, P86, DOI 10.1016/j.jcv.2004.08.004; Huang H, 2007, P NATL ACAD SCI USA, V104, P18666, DOI 10.1073/pnas.0708423104; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Hwang DR, 2005, J VIROL METHODS, V129, P170, DOI 10.1016/j.jviromet.2005.05.026; Kamiya H, 2009, FREE RADICAL BIO MED, V46, P1703, DOI 10.1016/j.freeradbiomed.2009.04.005; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kohashi T, 2006, J VIRAL HEPATITIS, V13, P582, DOI 10.1111/j.1365-2893.2006.00739.x; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Kuroki M, 2009, J VIROL, V83, P2338, DOI 10.1128/JVI.01840-08; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Look MP, 1999, ANTIVIR RES, V43, P113, DOI 10.1016/S0166-3542(99)00041-8; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Noguchi T, 2008, VIROLOGY, V375, P424, DOI 10.1016/j.virol.2008.02.009; Osada S, 2006, J GASTROEN HEPATOL, V21, P988, DOI 10.1111/j.1440-1746.2006.04223.x; OSHITA M, 1994, HEPATOLOGY, V20, P1115; Pawlotsky JM, 2003, CURR OPIN INFECT DIS, V16, P587, DOI 10.1097/00001432-200312000-00012; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; Rispeter K, 2000, VIRUS GENES, V21, P179, DOI 10.1023/A:1008135413215; Romero-Gomez M, 2001, DIGEST LIVER DIS, V33, P698, DOI 10.1016/S1590-8658(01)80048-7; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sata M, 1996, J VIRAL HEPATITIS, V3, P143, DOI 10.1111/j.1365-2893.1996.tb00005.x; SAWADA M, 1993, ALCOHOL ALCOHOLISM, V28, P85, DOI 10.1093/alcalc/28.Supplement_1B.85; Seronello S, 2007, FREE RADICAL BIO MED, V43, P869, DOI 10.1016/j.freeradbiomed.2007.05.036; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Sherman KE, 1999, HEPATOLOGY, V30, P265, DOI 10.1002/hep.510300131; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Takahashi K, 2001, J GASTROEN HEPATOL, V16, P416, DOI 10.1046/j.1440-1746.2001.02462.x; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Thomson M, 2001, GASTROENTEROLOGY, V121, P1226, DOI 10.1053/gast.2001.28669; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; TSUKAMOTO S, 1989, ALCOHOL ALCOHOLISM, V24, P101, DOI 10.1093/oxfordjournals.alcalc.a044872; Tsutsumi T, 2003, HEPATOLOGY, V38, P820, DOI 10.1053/jhep.2003.50399; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026; Zhang T, 2003, HEPATOLOGY, V38, P57, DOI 10.1053/jhep.2003.50295; Zubkova I, 2009, VACCINE, V27, P2594, DOI 10.1016/j.vaccine.2009.02.045	75	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27436	10.1371/journal.pone.0027436	http://dx.doi.org/10.1371/journal.pone.0027436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087316	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700045
J	Chauvigne, F; Plummer, S; Lesne, L; Cravedi, JP; Dejucq-Rainsford, N; Fostier, A; Jegou, B				Chauvigne, Francois; Plummer, Simon; Lesne, Laurianne; Cravedi, Jean-Pierre; Dejucq-Rainsford, Nathalie; Fostier, Alexis; Jegou, Bernard			Mono-(2-ethylhexyl) Phthalate Directly Alters the Expression of Leydig Cell Genes and CYP17 Lyase Activity in Cultured Rat Fetal Testis	PLOS ONE			English	Article							IN-UTERO EXPOSURE; REPRODUCTIVE-TRACT; DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION; TESTOSTERONE SYNTHESIS; DI(N-BUTYL) PHTHALATE; POSTNATAL-DEVELOPMENT; PROGRAMMING WINDOW; DIBUTYL PHTHALATE; STEROIDOGENESIS	Exposure to phthalates in utero alters fetal rat testis gene expression and testosterone production, but much remains to be done to understand the mechanisms underlying the direct action of phthalate within the fetal testis. We aimed to investigate the direct mechanisms of action of mono-(2-ethylhexyl) phthalate (MEHP) on the rat fetal testis, focusing on Leydig cell steroidogenesis in particular. We used an in vitro system based on the culture for three days, with or without MEHP, of rat fetal testes obtained at 14.5 days post-coitum. Exposure to MEHP led to a dose-dependent decrease in testosterone production. Moreover, the production of 5 alpha-dihydrotestosterone (5 alpha-DHT) (-68%) and androstenedione (-54%) was also inhibited by 10 mu M MEHP, whereas 17 alpha-hydroxyprogesterone (17 alpha-OHP) production was found to increase (+41%). Testosterone synthesis was rescued by the addition of androstenedione but not by any of the other precursors used. Thus, the hormone data suggested that steroidogenesis was blocked at the level of the 17,20 lyase activity of the P450c17 enzyme (CYP17), converting 17 alpha-OHP to androstenedione. The subsequent gene expression and protein levels supported this hypothesis. In addition to Cyp17a1, microarray analysis showed that several other genes important for testes development were affected by MEHP. These genes included those encoding insulin-like factor 3 (INSL3), which is involved in controlling testicular descent, and Inha, which encodes the alpha subunit of inhibin B. These findings indicate that under in vitro conditions known to support normal differentiation of the fetal rat testis, the exposure to MEHP directly inhibits several important Leydig cell factors involved in testis function and that the Cyp17a1 gene is a specific target to MEHP explaining the MEHP-induced suppression of steroidogenesis observed.	[Chauvigne, Francois; Lesne, Laurianne; Dejucq-Rainsford, Nathalie; Jegou, Bernard] IRSET, INSERM, U625, Rennes, France; [Plummer, Simon] CXR Biosci Ltd, Dundee, Scotland; [Fostier, Alexis] SCRIBE, INRA, UR1037, Rennes, France; [Cravedi, Jean-Pierre] INRA Toxalim, UMR 1331, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chauvigne, F (corresponding author), IRSET, INSERM, U625, Rennes, France.	bernard.jegou@inserm.fr	Chauvigne, Francois/D-6854-2017; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Jégou, Bernard/I-4742-2015; Lesne, Laurianne/AAD-6180-2019	Chauvigne, Francois/0000-0001-5571-7517; Lesne, Laurianne/0000-0003-3165-9986; JEGOU, Bernard/0000-0003-0623-3609; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	INSERM (Institut National de la Sante et de la Recherche Medicale); Ministere de l'Enseignement Superieur et de la Recherche; European Union [212844]; European Council;  [ANR-06PNRA-008-05];  [ANR-07 SEST 019]	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Union(European Commission); European Council; ; 	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale), Ministere de l'Enseignement Superieur et de la Recherche, and grants from the European Union (DEER for Developmental Effects of Environment on Reproductive Health, grant number [212844]), the European Council for Plasticizers and Intermediates, and by ANR-06PNRA-008-05 (PLAST-IMPACT), ANR-07 SEST 019 (PHTALATESTIS) and Centre Regional d'Innovation et de Transfert de Technologies Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ATSDR, 2002, TOX PROF DIETH PHTHA; Bae SH, 2001, BIOCHEM J, V353, P689, DOI 10.1042/0264-6021:3530689; Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Chen J, 2009, TALANTA, V80, P826, DOI 10.1016/j.talanta.2009.07.066; Clewell RA, 2010, TOXICOL IN VITRO, V24, P327, DOI 10.1016/j.tiv.2009.08.003; Fan JJ, 2010, ENDOCRINOLOGY, V151, P3348, DOI 10.1210/en.2010-0010; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; FOSTIER A, 1986, FISH PHYSIOL BIOCHEM, V2, P87, DOI 10.1007/BF02264076; Friry-Santini C, 2007, TOXICOL SCI, V97, P81, DOI 10.1093/toxsci/kfm022; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; HABERT R, 1991, MOL CELL ENDOCRINOL, V82, P199, DOI 10.1016/0303-7207(91)90032-N; Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Janulis L, 2000, PROSTATE, V43, P195, DOI 10.1002/(SICI)1097-0045(20000515)43:3<195::AID-PROS5>3.0.CO;2-#; Jegou B, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P445; Johnson KJ, 2007, BIOL REPROD, V77, P978, DOI 10.1095/biolreprod.107.062950; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Lague E, 2008, ENDOCRINOLOGY, V149, P4688, DOI 10.1210/en.2008-0310; Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049; Lassurguere J, 2003, TOXICOL SCI, V73, P160, DOI 10.1093/toxsci/kfg065; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Majdic G, 1997, ENDOCRINOLOGY, V138, P2136, DOI 10.1210/en.138.5.2136; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403; Miller WL, 1997, STEROIDS, V62, P133, DOI 10.1016/S0039-128X(96)00172-9; Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062; ROYO T, 1993, J LIPID RES, V34, P867; Schiffler B, 2001, J BIOL CHEM, V276, P36225, DOI 10.1074/jbc.M102320200; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233; Suna S, 2007, TOXICOL LETT, V173, P107, DOI 10.1016/j.toxlet.2007.06.015; Svechnikov K, 2008, REPROD TOXICOL, V25, P485, DOI 10.1016/j.reprotox.2008.05.057; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Travert C, 2000, MOL CELL BIOCHEM, V213, P51, DOI 10.1023/A:1007178532236; Vinggaard AM, 2002, TOXICOL SCI, V69, P344, DOI 10.1093/toxsci/69.2.344; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wilson JD, 2001, REPROD FERT DEVELOP, V13, P673, DOI 10.1071/RD01074; Zhang GQ, 1998, J LIPID RES, V39, P2406; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	53	44	49	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27172	10.1371/journal.pone.0027172	http://dx.doi.org/10.1371/journal.pone.0027172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087261	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700025
J	Cocklin, R; Goebl, M				Cocklin, Ross; Goebl, Mark			Nutrient Sensing Kinases PKA and Sch9 Phosphorylate the Catalytic Domain of the Ubiquitin-Conjugating Enzyme Cdc34	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; REGULATORY SUBUNIT; LIFE-SPAN; BUDDING YEAST; INHIBITOR SIC1; LIGASE COMPLEX; IN-VITRO; ACTIVATION	Cell division is controlled in part by the timely activation of the CDK, Cdc28, through its association with G1 and G2 cyclins. Cdc28 complexes are regulated in turn by the ubiquitin conjugating enzyme Cdc34 and SCF ubiquitin ligase complexes of the ubiquitin-proteasome system (UPS) to control the initiation of DNA replication. Here we demonstrate that the nutrient sensing kinases PKA and Sch9 phosphorylate S97 of Cdc34. S97 is conserved across species and restricted to the catalytic domain of Cdc34/Ubc7-like E2s. Cdc34-S97 phosphorylation is cell cycle regulated, elevated during active cell growth and division and decreased during cell cycle arrest. Cell growth and cell division are orchestrated to maintain cell size homeostasis over a wide range of nutrient conditions. Cells monitor changes in their environment through nutrient sensing protein kinases. Thus Cdc34 phosphorylation by PKA and Sch9 provides a direct tether between G1 cell division events and cell growth.	[Cocklin, Ross; Goebl, Mark] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Cocklin, R (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA.	mgoebl@iupui.edu			National Science Foundation [MCB-0091317]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB-0091317 to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Cocklin R, 2011, GENETICS, V187, P701, DOI 10.1534/genetics.110.125302; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOEBL MG, 1994, MOL CELL BIOL, V14, P3022, DOI 10.1128/MCB.14.5.3022; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; Harlow E., 1999, USING ANTIBODIES LAB; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hsieh CC, 2002, MECH AGEING DEV, V123, P1229, DOI 10.1016/S0047-6374(02)00036-2; Irniger S, 2000, GENETICS, V154, P1509; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lass A, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-7; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schweltzer K, 2005, YEAST, V22, P553, DOI 10.1002/yea.1234; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tripodi F, 2007, BIOCHEM BIOPH RES CO, V359, P921, DOI 10.1016/j.bbrc.2007.05.195; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaremberg V, 1996, EUR J BIOCHEM, V237, P136, DOI 10.1111/j.1432-1033.1996.0136n.x; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	69	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27099	10.1371/journal.pone.0027099	http://dx.doi.org/10.1371/journal.pone.0027099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087249	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700017
J	Lou, HY; Li, SL; Yang, YJ; Kang, LL; Zhang, X; Jin, WF; Wu, BL; Jin, L; Xu, SH				Lou, Haiyi; Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Jin, Wenfei; Wu, Bailin; Jin, Li; Xu, Shuhua			A Map of Copy Number Variations in Chinese Populations	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENETIC-MARKERS; ARRAY CGH; VARIANTS; GENOME; HAPLOTYPE; SCALE; NUCLEOTIDE; INFERENCE; ADMIXTURE	It has been shown that the human genome contains extensive copy number variations (CNVs). Investigating the medical and evolutionary impacts of CNVs requires the knowledge of locations, sizes and frequency distribution of them within and between populations. However, CNV study of Chinese minorities, which harbor the majority of genetic diversity of Chinese populations, has been underrepresented considering the same efforts in other populations. Here we constructed, to our knowledge, a first CNV map in seven Chinese populations representing the major linguistic groups in China with 1,440 CNV regions identified using Affymetrix SNP 6.0 Array. Considerable differences in distributions of CNV regions between populations and substantial population structures were observed. We showed that similar to 35% of CNV regions identified in minority ethnic groups are not shared by Han Chinese population, indicating that the contribution of the minorities to genetic architecture of Chinese population could not be ignored. We further identified highly differentiated CNV regions between populations. For example, a common deletion in Dong and Zhuang (44.4% and 50%), which overlaps two keratin-associated protein genes contributing to the structure of hair fibers, was not observed in Han Chinese. Interestingly, the most differentiated CNV deletion between HapMap CEU and YRI containing CCL3L1 gene reported in previous studies was also the highest differentiated regions between Tibetan and other populations. Besides, by jointly analyzing CNVs and SNPs, we found a CNV region containing gene CTDSPL were in almost perfect linkage disequilibrium between flanking SNPs in Tibetan while not in other populations except HapMap CHD. Furthermore, we found the SNP taggability of CNVs in Chinese populations was much lower than that in European populations. Our results suggest the necessity of a full characterization of CNVs in Chinese populations, and the CNV map we constructed serves as a useful resource in further evolutionary and medical studies.	[Lou, Haiyi; Jin, Wenfei; Jin, Li; Xu, Shuhua] Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China; [Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Wu, Bailin; Jin, Li] Fudan Univ, Minist Educ MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Shilin; Yang, Yajun; Kang, Longli; Zhang, Xin; Wu, Bailin; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wu, Bailin] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA USA; [Lou, Haiyi; Jin, Wenfei; Jin, Li; Xu, Shuhua] Chinese Acad Sci, Max Planck Soc CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Fudan University; Fudan University; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Lou, HY (corresponding author), Chinese Acad Sci, Key Lab Computat Biol, Shanghai, Peoples R China.	ljin007@gmail.com; xushua@picb.ac.cn	Jin, Wenfei/V-9944-2019; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Jin, Wenfei/H-5330-2011; XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020	Jin, Wenfei/0000-0002-0028-3739; Jin, Li/0000-0002-4546-2415; Jin, Wenfei/0000-0002-0028-3739; XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002	National Science Foundation of China [30971577, 31171218, 30890034]; Shanghai Rising-Star Program [11QA1407600]; Science Foundation of the Chinese Academy of Sciences [KSCX2-EW-Q-1-11, KSCX2-EW-R-01-05, KSCX2-EW-J-15-05]; Science and Technology Commission of Shanghai Municipality [09540704300]; Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Science Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology (MoST) International Cooperation Base of China; K.C. Wong Education Foundation, Hong Kong	Shuhua Xu was supported by the National Science Foundation of China (30971577, 31171218), Shanghai Rising-Star Program (11QA1407600), and Science Foundation of the Chinese Academy of Sciences (KSCX2-EW-Q-1-11; KSCX2-EW-R-01-05; KSCX2-EW-J-15-05). Li Jin was supported by the National Science Foundation of China (30890034) and the Science and Technology Commission of Shanghai Municipality (09540704300). This research was supported in part by the Ministry of Science and Technology (MoST) International Cooperation Base of China. Shuhua Xu is a Max-Planck Independent Junior Research Group Leader and a member of CAS Youth Innovation Promotion Association. Shuhua Xu also gratefully acknowledges the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armengol L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007230; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kang TW, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-492, 10.1186/1471-2164-9-92]; Kato M, 2009, HUM MOL GENET, V18, P3579; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Li J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007958; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruault M, 2003, GENOMICS, V81, P391, DOI 10.1016/S0888-7543(03)00025-9; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teo SM, 2011, J HUM GENET, V56, P524, DOI 10.1038/jhg.2011.52; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Xu SH, 2009, MOL BIOL EVOL, V26, P2197, DOI 10.1093/molbev/msp130; Xue FH, 2008, EUR J HUM GENET, V16, P705, DOI 10.1038/sj.ejhg.5201998; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	58	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27341	10.1371/journal.pone.0027341	http://dx.doi.org/10.1371/journal.pone.0027341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087296	gold, Green Submitted, Green Published			2022-12-25	WOS:000297347700043
J	Luo, PH; Lin, ML; Li, L; Yang, B; He, QJ				Luo, Peihua; Lin, Meili; Li, Lin; Yang, Bo; He, Qiaojun			The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article							ACID RECEPTOR-ALPHA; TRANS-RETINOIC ACID; GROWTH-FACTOR; APOPTOSIS; CANCER; ONCOLOGY; ANGIOGENESIS; DEGRADATION; EXPRESSION; LEUKEMIA	Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. Differentiated human NBs are associated with better outcome and lower stage; induction of differentiation is considered to be therapeutically advantageous. All-trans retinoic acid (ATRA) has been shown to induce the differentiation of neuroblastoma (NB) cell lines. The proteasome inhibitor bortezomib inhibits cell growth and angiogenesis in NBs. Here, we investigated the synergistic effect between bortezomib and ATRA in inducing NB cell differentiation in different NB cell lines. Bortezomib combined with ATRA had a significantly enhanced antiproliferative effect. This inhibition was characterized by a synergistic increase in neuronal differentiation. At the same time, the combination therapy showed little neuronal toxicity which was assessed in primary cultures of rat cerebellar granule cells by the MTT assay, PI staining. The combination of bortezomib and ATRA triggered increased differentiation through the activation of proteins, including RAR alpha, RAR beta, RAR gamma, p-JNK and p21, compared with ATRA treatment alone. Using JNK inhibitor SP600125 to block JNK-dependent activity, the combination therapy-induced neuronal differentiation was partially attenuated. In addition, p21 shRNA had no effect on the combination therapy-induced neuronal differentiation. The in vivo antitumor activities were examined in human NB cell xenografts and GFP-labeled human NB cell xenografts. Treatment of human NB cell CHP126-bearing nude mice with ATRA plus bortezomib resulted in more significant tumor growth inhibition than mice treated with either drug alone. These findings provide the rationale for the development of a new therapeutic strategy for NB based on the pharmacological combination of ATRA and bortezomib.	[Luo, Peihua; Lin, Meili; Li, Lin; Yang, Bo; He, Qiaojun] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Peoples R China	Zhejiang University	Luo, PH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310027, Peoples R China.	qiaojunhe@zju.edu.cn			National Natural Science Foundation of China [30572211, 307725911]; National Post-doctor Foundation of China [20090460104]; Zhejiang Provincial Foundation of National Science [Y2100618]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Post-doctor Foundation of China(China Postdoctoral Science Foundation); Zhejiang Provincial Foundation of National Science; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30572211 and 307725911), the National Post-doctor Foundation of China (No. 20090460104), the Zhejiang Provincial Foundation of National Science (Y2100618) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson PC, 2007, PEDIATR BLOOD CANCER, V49, P661, DOI 10.1002/pbc.21011; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horton TM, 2007, CLIN CANCER RES, V13, P1516, DOI 10.1158/1078-0432.CCR-06-2173; Karlsson J, 2007, ONCOGENE, V26, P6150, DOI 10.1038/sj.onc.1210439; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu Y, 2008, J NEUROCHEM, V106, P1104, DOI 10.1111/j.1471-4159.2008.05445.x; Luo PH, 2006, MOL CANCER THER, V5, P1; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marimpietri D, 2007, CLIN CANCER RES, V13, P3977, DOI 10.1158/1078-0432.CCR-06-2757; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; MARSHALL GM, 1995, ONCOGENE, V11, P485; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Nagai J, 2004, CANCER RES, V64, P7910, DOI 10.1158/0008-5472.CAN-04-1178; Nordstrom EK, 2005, J NEUROSCI, V25, P8451, DOI 10.1523/JNEUROSCI.2349-05.2005; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Perez-Juste G, 1999, ONCOGENE, V18, P5393, DOI 10.1038/sj.onc.1202906; Redova M, 2010, INT J MOL MED, V25, P271, DOI 10.3892/ijmm_00000341; Rocchi P, 2005, ONCOL REP, V13, P1139; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Wang DD, 2009, CELL MOL NEUROBIOL, V29, P391, DOI 10.1007/s10571-008-9331-9; Washio A, 2009, EXP CELL RES, V315, P3036, DOI 10.1016/j.yexcr.2009.07.006; Yang B, 2005, CLIN CANCER RES, V11, P2774, DOI 10.1158/1078-0432.CCR-04-2382; Zhang C, 2008, EUR J PHARM SCI, V33, P415, DOI 10.1016/j.ejps.2008.01.012; Zhang JW, 2002, J NEUROCHEM, V81, P307, DOI 10.1046/j.1471-4159.2002.00824.x; Zhang LA, 2010, CLIN CANCER RES, V16, P4478, DOI 10.1158/1078-0432.CCR-10-0859; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	39	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27298	10.1371/journal.pone.0027298	http://dx.doi.org/10.1371/journal.pone.0027298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087283	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700036
J	Sun, L; Tan, LJ; Lei, SF; Chen, XD; Li, X; Pan, R; Yin, F; Liu, QW; Yan, XF; Papasian, CJ; Deng, HW				Sun, Lu; Tan, Li-Jun; Lei, Shu-Feng; Chen, Xiang-Ding; Li, Xi; Pan, Rong; Yin, Fang; Liu, Quan-Wei; Yan, Xiao-Feng; Papasian, Christopher J.; Deng, Hong-Wen			Bivariate Genome-Wide Association Analyses of Femoral Neck Bone Geometry and Appendicular Lean Mass	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; HEXOKINASE-II; MINERAL DISTRIBUTION; RISK-ASSESSMENT; HIP GEOMETRY; STRENGTH; MUSCLE; FRACTURE; PROTEIN; ENERGY	Objective: Femoral neck geometric parameters (FNGPs), such as periosteal diameter (W), cross-sectional area (CSA), cortical thickness (CT), buckling ratio (BR), and section modulus (Z), are highly genetically correlated with body lean mass. However, the specific SNPs/genes shared by these phenotypes are largely unknown. Methods: To identify the specific SNPs/genes shared between FNGPs and appendicular lean mass (ALM), we performed an initial bivariate genome-wide association study (GWAS) by scanning similar to 690,000 SNPs in 1,627 unrelated Han Chinese adults (802 males and 825 females) and a follow-up replicate study in 2,286 unrelated US Caucasians. Results: We identified 13 interesting SNPs that may be important for both FNGPs and ALM. Two SNPs, rs681900 located in the HK2 (hexokinase 2) gene and rs11859916 in the UMOD (uromodulin) gene, were bivariately associated with FNGPs and ALM (p = 7.58610(-6) for ALM-BR and p = 2.93610(-6) for ALM-W, respectively). The associations were then replicated in Caucasians, with corresponding p values of 0.024 for rs681900 and 0.047 for rs11859916. Meta-analyses yielded combined p values of 3.05610(-6) and 2.31610(-6) for rs681900 and rs11859916, respectively. Our findings are consistent with previous biological studies that implicated HK2 and UMOD in both FNGPs and ALM. Our study also identified a group of 11 contiguous SNPs, which spanned a region of similar to 130 kb, were bivariately associated with FNGPs and ALM, with p values ranging from 3.06610(-7) to 4.60610(-6) for ALM-BR. The region contained two neighboring miRNA coding genes, MIR873 (MicroRNA873) and MIR876 (MicroRNA876). Conclusion: Our study implicated HK2, UMOD, MIR873 and MIR876, as pleiotropic genes underlying variation of both FNGPs and ALM, thus suggesting their important functional roles in co-regulating both FNGPs and ALM.	[Sun, Lu; Tan, Li-Jun; Lei, Shu-Feng; Chen, Xiang-Ding; Li, Xi; Pan, Rong; Yin, Fang; Liu, Quan-Wei; Yan, Xiao-Feng; Deng, Hong-Wen] Hunan Normal Univ, Lab Mol & Stat Genet, Coll Life Sci, Changsha, Hunan, Peoples R China; [Tan, Li-Jun; Deng, Hong-Wen] Tulane Univ, Ctr Bioinformat & Genom, Dept Biostat, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Orthoped Surg, Kansas City, MO 64108 USA; [Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Beijing Jiao Tong Univ, Coll Life Sci & Technol, Beijing, Peoples R China	Hunan Normal University; Tulane University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Shanghai for Science & Technology; Beijing Jiaotong University	Sun, L (corresponding author), Hunan Normal Univ, Lab Mol & Stat Genet, Coll Life Sci, Changsha, Hunan, Peoples R China.	hdeng2@tulane.edu	Tan, Li-Jun/AAO-1130-2020	Deng, Hong-Wen/0000-0002-0387-8818	Natural Science Foundation of China (NSFC) [30900810, 30771222, 31071097, 30600364]; NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative [30811120436]; NSFC/RGC [30731160618]; Shanghai Leading Academic Discipline Project [S30501]; Shanghai University of Science and Technology; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR057049, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR)); NSFC/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai University of Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the Natural Science Foundation of China (NSFC) (30900810, 30771222, 31071097, and 30600364), the NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), the NSFC/RGC Joint Research Scheme (30731160618), the Shanghai Leading Academic Discipline Project (S30501) and startup fund from Shanghai University of Science and Technology. HWD was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221) and the Franklin D. Dickson/Missouri Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; Beck T, 2003, OSTEOPOROSIS INT, V14, pS81, DOI 10.1007/s00198-003-1478-0; Beck TJ, 2001, J BONE MINER RES, V16, P1108, DOI 10.1359/jbmr.2001.16.6.1108; Bethesda, 1995, J GERONTOL A-BIOL, V50, P1; BRAITHWAITE SS, 1995, DIABETES, V44, P43, DOI 10.2337/diabetes.44.1.43; Carvalho M, 2002, BRAZ J MED BIOL RES, V35, P1165, DOI 10.1590/S0100-879X2002001000009; Chang PY, 1996, J BIOL CHEM, V271, P14834, DOI 10.1074/jbc.271.25.14834; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Crabtree N, 2000, BONE, V27, P151, DOI 10.1016/S8756-3282(00)00300-8; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Deng FY, 2007, J BONE MINER RES, V22, P808, DOI 10.1359/JBMR.070303; Ferretti JL, 2003, MECH AGEING DEV, V124, P269, DOI 10.1016/S0047-6374(02)00194-X; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Handoll HHG, 2007, J R SOC PROMO HEALTH, V127, P168, DOI 10.1177/1466424007079491; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; Izumi K, 2010, AM J MED GENET A, V152A, P2115, DOI 10.1002/ajmg.a.33511; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kim HJ, 2010, J BONE MINER RES, V25, P1771, DOI 10.1002/jbmr.60; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kochi Y, 2009, J AUTOIMMUN, V32, P158, DOI 10.1016/j.jaut.2009.02.020; Leidy HJ, 2007, OBESITY, V15, P421, DOI 10.1038/oby.2007.531; LIECHTY EA, 1991, PEDIATR RES, V30, P423, DOI 10.1203/00006450-199111000-00006; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Marcora S, 2006, RHEUMATOLOGY, V45, P1385, DOI 10.1093/rheumatology/kel127; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P460, DOI 10.1007/s00198-004-1820-1; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Movcessian S G, 1972, Vopr Biokhim Mozga, V7, P11; Okamoto Y, 2006, NEUROGENETICS, V7, P175, DOI 10.1007/s10048-006-0046-0; Palmer Christina G S, 2008, J Genet Couns, V17, P129, DOI 10.1007/s10897-007-9134-z; PEACOCK M, 1995, OSTEOPOROSIS INT, V5, P167, DOI 10.1007/BF02106096; PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3; Pulkkinen P, 2004, OSTEOPOROSIS INT, V15, P274, DOI 10.1007/s00198-003-1556-3; Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; STREFFER C, 1994, ADV EXP MED BIOL, V345, P327; Sun X, 2006, CALCIFIED TISSUE INT, V79, P43, DOI 10.1007/s00223-006-0041-3; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vestergaard H, 1995, J CLIN INVEST, V96, P2639, DOI 10.1172/JCI118329; Wu S, 2007, ANN HUM BIOL, V34, P344, DOI 10.1080/03014460701275749; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	47	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27325	10.1371/journal.pone.0027325	http://dx.doi.org/10.1371/journal.pone.0027325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087292	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700041
J	Kida, Y; Xia, ZX; Zheng, SJ; Mordwinkin, NM; Louie, SG; Zheng, SG; Feng, M; Shi, HB; Duan, ZP; Han, YP				Kida, Yujiro; Xia, Zanxian; Zheng, Sujun; Mordwinkin, Nicholas M.; Louie, Stan G.; Zheng, Song Guo; Feng, Min; Shi, Hongbo; Duan, Zhongping; Han, Yuan-Ping			Interleukin-1 as an Injury Signal Mobilizes Retinyl Esters in Hepatic Stellate Cells through Down Regulation of Lecithin Retinol Acyltransferase	PLOS ONE			English	Article							RAT-LIVER; T-CELLS; ACID; ACTIVATION; EXPRESSION; FIBROSIS; MICE; OLIGONUCLEOTIDES; METABOLISM; LIPOCYTES	Retinoids are mostly stored as retinyl esters in hepatic stellate cells (HSCs) through esterification of retinol and fatty acid, catalyzed by lecithin-retinol acyltransferase (LRAT). This study is designated to address how retinyl esters are mobilized in liver injury for tissue repair and wound healing. Initially, we speculated that acute inflammatory cytokines may act as injury signal to mobilize retinyl esters by down-regulation of LRAT in HSCs. By examining a panel of cytokines we found interleukin-1 (IL-1) can potently down-regulate mRNA and protein levels of LRAT, resulting in mobilization of retinyl esters in primary rat HSCs. To simulate the microenvironment in the space of Disse, HSCs were embedded in three-dimensional extracellular matrix, by which HSCs retaine quiescent phenotypes, indicated by up-regulation of LRAT and accumulation of lipid droplets. Upon IL-1 stimulation, LRAT expression went down together with mobilization of lipid droplets. Secreted factors from Kupffer cells were able to suppress LRAT expression in HSCs, which was neutralized by IL-1 receptor antagonist. To explore the underlying mechanism we noted that the stability of LRAT protein is not significantly regulated by IL-1, indicating the regulation is likely at transcriptional level. Indeed, we found that IL-1 failed to down-regulate recombinant LRAT protein expressed in HSCs by adenovirus, while transcription of endogenous LRAT was promptly decreased. Following liver damage, IL-1 was promptly elevated in a close pace with down-regulation of LRAT transcription, implying their causative relationship. After administration of IL-1, retinyl ester levels in the liver, as measured by LC/MS/MS, decreased in association with down-regulation of LRAT. Likewise, IL-1 receptor knockout mice were protected from injury-induced down-regulation of LRAT. In summary, we identified IL-1 as an injury signal to mobilize retinyl ester in HSCs through down-regulation of LRAT, implying a mechanism governing transition from hepatic injury to wound healing.	[Kida, Yujiro; Xia, Zanxian; Feng, Min] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Zheng, Sujun; Shi, Hongbo; Duan, Zhongping; Han, Yuan-Ping] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Mordwinkin, Nicholas M.; Louie, Stan G.] Univ So Calif, Sch Pharm, Los Angeles, CA USA; [Zheng, Song Guo] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Han, Yuan-Ping] Beijing Hepo Med Res Inst, Beijing, Peoples R China; [Han, Yuan-Ping] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; Capital Medical University; University of Southern California; University of Southern California; University of Southern California	Kida, Y (corresponding author), Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA.	duan2517@163.com.cn; yhan@surgery.usc.edu		Mordwinkin, Nicholas/0000-0002-3019-0170	National Institutes of Health [R01s, DK069418, AR051558, R01 AR059103]; Robert and May Wright Foundation; Chinese State Key Projects for Basic Research [2007CB512801]; American College of Rheumatology; Arthritis Foundation; National Natural Science Foundation of China [30728007]; Non-Parenchymal Liver Cell Core [R24AA12885]; USC Research Center for Alcoholic Liver and Pancreatic Diseases [P50AA11999]; Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases [P30 DK048522]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051558, R01AR059103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069418, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and May Wright Foundation; Chinese State Key Projects for Basic Research; American College of Rheumatology(General Electric); Arthritis Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Non-Parenchymal Liver Cell Core; USC Research Center for Alcoholic Liver and Pancreatic Diseases; Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is supported in part by National Institutes of Health Grants R01s, DK069418 and AR051558, as well as the Robert and May Wright Foundation to Y-PH. The study is also supported in part by the Chinese State Key Projects for Basic Research, No. 2007CB512801 to ZD. This work was partially supported by grants from the National Institutes of Health (R01 AR059103), the American College of Rheumatology (Within Our Reach), the Arthritis Foundation, and by an Outstanding Youth Scientist Investigator Award from the National Natural Science Foundation of China, 30728007, to SGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Dr. Hidekazu Tsukamoto for his advice and tissue share, Jiaohong Wang for isolation of liver cells, and Hongyun She for control adenovirus, which have been supported in part by Non-Parenchymal Liver Cell Core (R24AA12885) and USC Research Center for Alcoholic Liver and Pancreatic Diseases (P50AA11999). We also thank Drs. Akiko Maeda and Krzysztof Palczewski for providing anti-LRAT antibody. The qRT-PCR and LC/MS/MS analyses were performed at the Analytical-Metabolic-Instrumental Core of the Research Center for Liver Diseases (P30 DK048522).	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Hautekeete ML, 1998, ALCOHOL CLIN EXP RES, V22, P494, DOI 10.1111/j.1530-0277.1998.tb03678.x; Hellemans K, 2003, J LIPID RES, V44, P280, DOI 10.1194/jlr.M200376-JLR200; HENDRIKS HFJ, 1988, HEPATOLOGY, V8, P276, DOI 10.1002/hep.1840080215; Ho LJ, 2005, BIOCHEM PHARMACOL, V70, P200, DOI 10.1016/j.bcp.2005.04.039; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; JONES AL, 1984, J LIPID RES, V25, P1151; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Motomura K, 1997, J GASTROEN HEPATOL, V12, P887, DOI 10.1111/j.1440-1746.1997.tb00388.x; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; TIEGS G, J AUTOIMMUN, V34, P1; Wake K, 1980, Int Rev Cytol, V66, P303; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yamaguchi K, 2008, HEPATOLOGY, V47, P625, DOI 10.1002/hep.21988; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	34	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26644	10.1371/journal.pone.0026644	http://dx.doi.org/10.1371/journal.pone.0026644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073179	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200015
J	Lee, GA; Crawford, GW; Liu, L; Sasaki, Y; Chen, XX				Lee, Gyoung-Ah; Crawford, Gary W.; Liu, Li; Sasaki, Yuka; Chen, Xuexiang			Archaeological Soybean (Glycine max) in East Asia: Does Size Matter?	PLOS ONE			English	Article							GENETIC DIVERSITY; DOMESTICATION; CHINA; WILD; PATTERNS; ORIGINS; SOJA; AGRICULTURE; CALIBRATION; SEQUENCE	The recently acquired archaeological record for soybean from Japan, China and Korea is shedding light on the context in which this important economic plant became associated with people and was domesticated. This paper examines archaeological (charred) soybean seed size variation to determine what insight can be gained from a comprehensive comparison of 949 specimens from 22 sites. Seed length alone appears to represent seed size change through time, although the lengthxwidthxthickness product has the potential to provide better size change resolution. A widespread early association of small seeded soybean is as old as 9000-8600 cal BP in northern China and 7000 cal BP in Japan. Direct AMS radiocarbon dates on charred soybean seeds indicate selection resulted in large seed sizes in Japan by 5000 cal BP (Middle Jomon) and in Korea by 3000 cal BP (Early Mumun). Soybean seeds recovered in China from the Shang through Han periods are similar in length to the large Korean and Japanese specimens, but the overall size of the large Middle and Late Jomon, Early Mumun through Three Kingdom seeds is significantly larger than any of the Chinese specimens. The archaeological record appears to disconfirm the hypothesis of a single domestication of soybean and supports the view informed by recent phyologenetic research that soybean was domesticated in several locations in East Asia.	[Lee, Gyoung-Ah] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Crawford, Gary W.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Liu, Li] Stanford Univ, E Asian Languages & Cultures Stanford Archaeol Ct, Stanford, CA 94305 USA; [Sasaki, Yuka] Paleo Labo Co Ltd, Toda, Saitama, Japan; [Chen, Xuexiang] Shandong Univ, Dept Archaeol, Jinan 250100, Peoples R China	University of Oregon; University of Toronto; University Toronto Mississauga; Stanford University; Shandong University	Lee, GA (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	galee@uoregon.edu	Crawford, Gary W./A-4808-2008	Crawford, Gary W./0000-0002-3370-0527; Lee, Gyoung-Ah/0000-0001-7873-6841	Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History; La Trobe University; University of Oregon; Australian Research Council [DP0450025]; Social Sciences and Humanities Research Council of Canada [72022345]; Program of Introducing Talents of Discipline to Universities [111-2-09]; National Natural Science Foundation of China [40472087, 40772105]; National Science Foundation [BCS-99-11128]	Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History; La Trobe University; University of Oregon; Australian Research Council(Australian Research Council); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	GHL used the following funds for conducting sample collection and analysis listed in the paper: The Henry Luce/American Council of Learned Society Initiative on East and Southeast Asian Archaeology and Early History, La Trobe University Postdoctoral fellowship and the University of Oregon Junior Professor Development fund and Summer Research Award. The Australian Research Council (DP0450025) supported LL to conduct the Yiluo Archaeology Project. The Social Sciences and Humanities Research Council of Canada (grant 72022345) sponsored GWC to conduct the research at the Liangchenzhen and Shantaisi sites and the first phases of the archaeobotany research in the Yiluo valley, China. The Program of Introducing Talents of Discipline to Universities (111-2-09) supported XC and GWC to procure data from the Shang sites, China. The National Natural Science Foundation of China (grant 40472087, 40772105) supported JZ (University of Science and Technology of China) to conduct the excavation of the Jiahu site where the authors collected data. The National Science Foundation (award BCS-99-11128 to Anne Underhill, Yale University and Gary Feinman, Field Museum) sponsored GWC to collect data from Shandong, China. The University of Oregon Office of Research Grant helped DJK (University of Oregon) to establish the Archaeometry Facility, where some of the samples in this study were prepared for AMS dating. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Braadbaart F, 2004, VEG HIST ARCHAEOBOT, V14, P65; Braadbaart F, 2007, ECON BOT, V61, P137, DOI 10.1663/0013-0001(2007)61[137:CIMADO]2.0.CO;2; BROICH SL, 1981, EUPHYTICA, V30, P55, DOI 10.1007/BF00033659; Carlson JB, 2004, SOYBEANS IMPROVEMENT, P71; Carter T. E, 2004, SOYBEANS IMPROVEMENT, V3rd, DOI DOI 10.2134/AGRONMONOGR16.3ED.C8; Choi Duk-Hyang, 2004, NONGYE KAOGU, V3, p[225, 285]; Crawford G, 2005, CURR ANTHROPOL, V46, P309, DOI 10.1086/428788; Crawford G.W., 2006, E ASIA ARCHAEOLOGY, V3, P247; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; Crawford GW, 1983, PALEOETHNOBOTANY KAM; Dong YS, 2004, THEOR APPL GENET, V108, P931, DOI 10.1007/s00122-003-1503-x; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Gai J.Y., 2000, ACTA AGRONOMICA SINI, V26, P513, DOI DOI 10.3321/J.ISSN:0496-3490.2000.05.001; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Han Z, 1995, SHIJING YIZHU; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Harlan JR, 1992, CROPS MAN; He Deliang, 1999, KAOGU, V7, P59; Ho P-T, 1975, CRADLE E INQUIRY IND; Hunan Institute of Archaeology, 2006, PENGT BASH; Hymowitz T., 2004, SOYBEANS IMPROVEMENT, P97; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kirkbride J.H, 2003, FRUITS SEEDS GENERA; Kudo Y., 2010, B NATL MUS JPN HIST, V158, P1; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee G-A, 2003, THESIS U TORONTO TOR; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu L, 2002, J FIELD ARCHAEOL, V29, P75, DOI 10.2307/3181486; Liu L, 1987, KAOGU, V4, P365; Liu L, 2012, KAOGU IN PRESS, V12; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Luoyang Relics Team, 2002, LUOYANG ZAOJ; Nakayama S, 2009, B YAMANASHI PREFECTU, V3, P1; Obata H., 2007, JPN J HIST BOT, V15, P97, DOI [10.34596/hisbot.15.2_97, DOI 10.34596/HISBOT.15.2_97]; Obata H, 2011, CURRENT RES NEOLITHI, P1; Obata H, 2011, JOMON AGR PALEOETHNO; Qutob D, 2008, BOTANY, V86, P219, DOI 10.1139/B08-002; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rosen AM, 2007, BULL INDO PAC PRE HI, V27, P39; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rovner I, 2007, ECON BOT, V61, P154, DOI 10.1663/0013-0001(2007)61[154:CMANMF]2.0.CO;2; Sakamoto S, 2006, J FOSSIL RES, V39, P1; Sasaki Y., 2007, JAPANESE J HIST BOT, V15, P35; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shelach G, 2000, J WORLD PREHIST, V14, P363, DOI 10.1023/A:1011124209079; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M, CALIB 6 0; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; USDA ARS National Genetic Resources Program, 2011, TAX GLYC MAX L MERR; USDA ARS National Genetic Resources Program, 2011, TAX GLYC SOJ SIEB ZU; Vavilov NI, 2009, ORIGIN GEOGRAPHY CUL; Xu B, 1986, SOYBEAN SCI, V5, P123; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yang XY, 2005, J ARCHAEOL SCI, V32, P1045, DOI 10.1016/j.jas.2005.02.003; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zhang JZ, 1999, NATURE, V401, P366, DOI 10.1038/43865; Zhao T, 2004, SCI AGR SINICA, V37, P945; Zhao Z, 2004, DONGFANG KAOGU, V1, P210; Zhao Z, 2007, KEJI KAOGU, V2, P1; Zhao Z, 2010, PALAEOETHNOBOTANY TH, P90; Zhao Z, 2010, PALAEOETHNOBOTANY TH, P145; Zhao Z. J., 2005, ANTIQUITIES E ASIA A, P188; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887	69	114	124	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26720	10.1371/journal.pone.0026720	http://dx.doi.org/10.1371/journal.pone.0026720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073186	gold, Green Submitted, Green Published			2022-12-25	WOS:000297198200017
J	Mirkovic, B; Sosic, I; Gobec, S; Kos, J				Mirkovic, Bojana; Sosic, Izidor; Gobec, Stanislav; Kos, Janko			Redox-Based Inactivation of Cysteine Cathepsins by Compounds Containing the 4-Aminophenol Moiety	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; EXPRESSION; INHIBITORS; PHOSPHATASE; DISCOVERY; PROTEASES; ASSAY; MECHANISM; TOXICITY	Background: Redox cycling compounds have been reported to cause false positive inhibition of proteases in drug discovery studies. This kind of false positives can lead to unusually high hit rates in high-throughput screening campaigns and require further analysis to distinguish true from false positive hits. Such follow-up studies are both time and resource consuming. Methods and Findings: In this study we show that 5-aminoquinoline-8-ol is a time-dependent inactivator of cathepsin B with a k(inact)/K-I of 36.7 +/- 13.6 M(-1)s(-1) using enzyme kinetics. 5-Aminoquinoline-8-ol inhibited cathepsins H, L and B in the same concentration range, implying a non-specific mechanism of inhibition. Further analogues, 4-aminonaphthalene-1-ol and 4-aminophenol, also displayed time-dependent inhibition of cathepsin B with k(inact)/K-I values of 406.4 +/- 10.8 and 36.5 +/- 1.3 M(-1)s(-1). No inactivation occurred in the absence of either the amino or the hydroxyl group, suggesting that the 4-aminophenol moiety is a prerequisite for enzyme inactivation. Induction of redox oxygen species (ROS) by 4-aminophenols in various redox environments was determined by the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate. Addition of catalase to the assay buffer significantly abrogated the ROS signal, indicating that H2O2 is a component of the ROS induced by 4-aminophenols. Furthermore, using mass spectrometry, active site probe DCG-04 and isoelectric focusing we show that redox inactivation of cysteine cathepsins by 5-aminoquinoline-8-ol is active site directed and leads to the formation of sulfinic acid. Conclusions: In this study we report that compounds containing the 4-aminophenol moiety inactivate cysteine cathepsins through a redox-based mechanism and are thus likely to cause false positive hits in the screening assays for cysteine proteases.	[Mirkovic, Bojana; Kos, Janko] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Ljubljana, Slovenia; [Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Dept Med Chem, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Mirkovic, B (corresponding author), Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Ljubljana, Slovenia.	bojana.mirkovic@ffa.uni-lj.si		Sosic, Izidor/0000-0002-3370-4587; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [J4-4123]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (grant number J4-4123 [to J.K.]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann E, 2004, J MED CHEM, V47, P5833, DOI 10.1021/jm0493111; [Anonymous], EXPASY PROT SERV PRO; [Anonymous], UNIPROT UNIPROTKB; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bauer CG, 1996, ANAL CHEM, V68, P2453, DOI 10.1021/ac960218x; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; Bova MP, 2004, ARCH BIOCHEM BIOPHYS, V429, P30, DOI 10.1016/j.abb.2004.05.010; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Copeland R. A., 2005, EVALUATION ENZYME IN; Das J, 2007, ANAL CHEM, V79, P2790, DOI 10.1021/ac062291l; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; Du JQ, 2008, J BIOL CHEM, V283, P30205, DOI 10.1074/jbc.M803347200; Foreman BD, 2008, TOXICOL APPL PHARM, V230, P144, DOI 10.1016/j.taap.2008.02.014; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hallman MA, 2000, TOXICOLOGY, V156, P37, DOI 10.1016/S0300-483X(00)00326-7; Hamer I, 2009, BIOL CELL, V101, P31, DOI 10.1042/BC20080043; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; IWAHASHI H, 1988, BIOCHEM J, V251, P893, DOI 10.1042/bj2510893; Johnston PA, 2010, CURR OPIN CHEM BIOL, V15, P1; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; JOSEPHY PD, 1983, MOL PHARMACOL, V23, P461; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Markt P, 2008, J CHEM INF MODEL, V48, P1693, DOI 10.1021/ci800101j; Mirkovic B, 2011, CHEMMEDCHEM, V6, P1351, DOI 10.1002/cmdc.201100098; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ren WP, 1996, BIOCHEM J, V319, P793, DOI 10.1042/bj3190793; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Schweiger A, 1997, J IMMUNOL METHODS, V201, P165, DOI 10.1016/S0022-1759(96)00218-9; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Stirnimann G, 2010, SWISS MED WKLY, V140, P18, DOI 10.4414/smw.2010.13080; Tardito S, 2007, J MED CHEM, V50, P1916, DOI 10.1021/jm061174f; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Zager V, 2010, RADIOL ONCOL, V44, P42, DOI 10.2478/v10019-010-0010-3	47	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27197	10.1371/journal.pone.0027197	http://dx.doi.org/10.1371/journal.pone.0027197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073285	Green Submitted, gold, Green Published			2022-12-25	WOS:000297198200049
J	Schueler, C; Becker, HM; McKenna, R; Deitmer, JW				Schueler, Christina; Becker, Holger M.; McKenna, Robert; Deitmer, Joachim W.			Transport Activity of the Sodium Bicarbonate Cotransporter NBCe1 Is Enhanced by Different Isoforms of Carbonic Anhydrase	PLOS ONE			English	Article							PROTON-TRANSFER; CATALYTIC-PROPERTIES; HYDROPHOBIC POCKET; LACTATE TRANSPORT; KINETIC-ANALYSIS; XENOPUS OOCYTES; CHEMICAL RESCUE; O-18 EXCHANGE; BINDING-SITE; II BINDS	Transport metabolons have been discussed between carbonic anhydrase II (CAII) and several membrane transporters. We have now studied different CA isoforms, expressed in Xenopus oocytes alone and together with the electrogenic sodium bicarbonate cotransporter 1 (NBCe1), to determine their catalytic activity and their ability to enhance NBCe1 transport activity. pH measurements in intact oocytes indicated similar activity of CAI, CAII and CAIII, while in vitro CAIII had no measurable activity and CAI only 30% of the activity of CAII. All three CA isoforms increased transport activity of NBCe1, as measured by the transport current and the rate of intracellular sodium rise in oocytes. Two CAII mutants, altered in their intramolecular proton pathway, CAII-H64A and CAII-Y7F, showed significant catalytic activity and also enhanced NBCe1 transport activity. The effect of CAI, CAII, and CAII mutants on NBCe1 activity could be reversed by blocking CA activity with ethoxyzolamide (EZA, 10 mu M), while the effect of the less EZA-sensitive CAIII was not reversed. Our results indicate that different CA isoforms and mutants, even if they show little enzymatic activity in vitro, may display significant catalytic activity in intact cells, and that the ability of CA to enhance NBCe1 transport appears to depend primarily on its catalytic activity.	[Schueler, Christina; Deitmer, Joachim W.] TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, Kaiserslautern, Germany; [Becker, Holger M.] TU Kaiserslautern, FB Biol, AG Zool Membrantransport, Kaiserslautern, Germany; [McKenna, Robert] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Kaiserslautern; University of Kaiserslautern; State University System of Florida; University of Florida	Schueler, C (corresponding author), TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, Kaiserslautern, Germany.	christina.schueler@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020		Deutsche Forschungsgemeinschaft [DE 231/24-1]; Graduate School GRK 845; Landesschwerpunkt Membrantransport (RIMP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School GRK 845; Landesschwerpunkt Membrantransport (RIMP)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DE 231/24-1), by the Graduate School GRK 845 and by the Landesschwerpunkt Membrantransport (RIMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; An HQ, 2002, BIOCHEMISTRY-US, V41, P3235, DOI 10.1021/bi0120695; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; BEHRAVAN G, 1991, EUR J BIOCHEM, V198, P589, DOI 10.1111/j.1432-1033.1991.tb16054.x; BEHRAVAN G, 1990, EUR J BIOCHEM, V190, P351, DOI 10.1111/j.1432-1033.1990.tb15582.x; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Briganti F, 1997, BIOCHEMISTRY-US, V36, P10384, DOI 10.1021/bi970760v; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Budayova-Spano M, 2006, ACTA CRYSTALLOGR F, V62, P6, DOI 10.1107/S1744309105038248; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Duda D, 2001, BIOCHEMISTRY-US, V40, P1741, DOI 10.1021/bi002295z; Elder I, 2007, PROTEINS, V68, P337, DOI 10.1002/prot.21403; ENGBERG P, 1985, ARCH BIOCHEM BIOPHYS, V241, P628, DOI 10.1016/0003-9861(85)90589-2; ERIKSSON AE, 1993, PROTEINS, V16, P29, DOI 10.1002/prot.340160104; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; GRAMLICH TL, 1990, ARCH PATHOL LAB MED, V114, P415; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; JEFFERY S, 1980, BIOCHEM GENET, V18, P843, DOI 10.1007/BF00500117; JEWELL DA, 1991, BIOCHEMISTRY-US, V30, P1484, DOI 10.1021/bi00220a006; JONSSON BH, 1976, FEBS LETT, V64, P310, DOI 10.1016/0014-5793(76)80317-1; KARARLI T, 1985, J BIOL CHEM, V260, P3484; Kristensen JM, 2004, ACTA PHYSIOL SCAND, V182, P69, DOI 10.1111/j.1365-201X.2004.01297.x; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; LOGRASSO PV, 1991, BIOCHEMISTRY-US, V30, P8463, DOI 10.1021/bi00098a025; Loiselle FB, 2004, AM J PHYSIOL-CELL PH, V286, pC1423, DOI 10.1152/ajpcell.00382.2003; LONNERHOLM G, 1985, GASTROENTEROLOGY, V88, P1151; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Maupin CM, 2008, J AM CHEM SOC, V130, P11399, DOI 10.1021/ja802264j; ODOWD JJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P241, DOI 10.1016/0304-4165(88)90015-3; Piermarini PM, 2007, J BIOL CHEM, V282, P1409, DOI 10.1074/jbc.M608261200; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Scozzafava A, 2002, J MED CHEM, V45, P284, DOI 10.1021/jm010958k; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Sterling D, 2001, JOP, V2, P165; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2004, CRC ENZYM INHIB SER, P67; Swietach P, 2010, CARDIOVASC RES, V85, P729, DOI 10.1093/cvr/cvp343; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; TU CK, 1990, BIOCHEMISTRY-US, V29, P6400, DOI 10.1021/bi00479a009; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Weise A, 2007, J GEN PHYSIOL, V130, P203, DOI 10.1085/jgp.200709809; Weise A, 2011, CELL PHYSIOL BIOCHEM, V27, P79, DOI 10.1159/000325208; Wendel C, 2008, PFLUG ARCH EUR J PHY, V455, P885, DOI 10.1007/s00424-007-0351-y; Yamada H, 2011, CHANNELS, V5, P106, DOI 10.4161/chan.5.2.14341; Yu H, 2009, AM J PHYSIOL-GASTR L, V297, P1223	60	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27167	10.1371/journal.pone.0027167	http://dx.doi.org/10.1371/journal.pone.0027167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076132	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200044
J	Sunkara, LT; Achanta, M; Schreiber, NB; Bommineni, YR; Dai, G; Jiang, WY; Lamont, S; Lillehoj, HS; Beker, A; Teeter, RG; Zhang, GL				Sunkara, Lakshmi T.; Achanta, Mallika; Schreiber, Nicole B.; Bommineni, Yugendar R.; Dai, Gan; Jiang, Weiyu; Lamont, Susan; Lillehoj, Hyun S.; Beker, Ali; Teeter, Robert G.; Zhang, Guolong			Butyrate Enhances Disease Resistance of Chickens by Inducing Antimicrobial Host Defense Peptide Gene Expression	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SALMONELLA-ENTERITIDIS; CATHELICIDIN LL-37; MULTIPLE ROLES; IN-VITRO; CELLS; IDENTIFICATION; ANTIBACTERIAL; INHIBITORS	Host defense peptides (HDPs) constitute a large group of natural broad-spectrum antimicrobials and an important first line of immunity in virtually all forms of life. Specific augmentation of synthesis of endogenous HDPs may represent a promising antibiotic-alternative approach to disease control. In this study, we tested the hypothesis that exogenous administration of butyrate, a major type of short-chain fatty acids derived from bacterial fermentation of undigested dietary fiber, is capable of inducing HDPs and enhancing disease resistance in chickens. We have found that butyrate is a potent inducer of several, but not all, chicken HDPs in HD11 macrophages as well as in primary monocytes, bone marrow cells, and jejuna and cecal explants. In addition, butyrate treatment enhanced the antibacterial activity of chicken monocytes against Salmonella enteritidis, with a minimum impact on inflammatory cytokine production, phagocytosis, and oxidative burst capacities of the cells. Furthermore, feed supplementation with 0.1% butyrate led to a significant increase in HDP gene expression in the intestinal tract of chickens. More importantly, such a feeding strategy resulted in a nearly 10-fold reduction in the bacterial titer in the cecum following experimental infections with S. enteritidis. Collectively, the results indicated that butyrate-induced synthesis of endogenous HDPs is a phylogenetically conserved mechanism of innate host defense shared by mammals and aves, and that dietary supplementation of butyrate has potential for further development as a convenient antibiotic-alternative strategy to enhance host innate immunity and disease resistance.	[Sunkara, Lakshmi T.; Achanta, Mallika; Schreiber, Nicole B.; Bommineni, Yugendar R.; Dai, Gan; Jiang, Weiyu; Beker, Ali; Teeter, Robert G.; Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Lamont, Susan] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Lillehoj, Hyun S.] ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, USDA, Beltsville, MD USA	Oklahoma State University System; Oklahoma State University - Stillwater; Iowa State University; United States Department of Agriculture (USDA)	Sunkara, LT (corresponding author), Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA.	zguolon@okstate.edu	Zhang, Guolong/AAU-8197-2020; Sunkara, Lakshmi/B-8108-2014; Zhang, Guolong/HCI-5587-2022	Zhang, Guolong/0000-0003-4781-5816; Sunkara, Lakshmi/0000-0003-2023-5010; jiang, weiyu/0000-0001-6199-4289	US Department of Agriculture NIFA [2008-35204-04544]; Oklahoma Center for the Advancement of Science and Technology [HR07-113, AR07.2-087]; Oklahoma Agricultural Experiment Station [H-2811]	US Department of Agriculture NIFA; Oklahoma Center for the Advancement of Science and Technology; Oklahoma Agricultural Experiment Station	This work was supported by a US Department of Agriculture NIFA grant (2008-35204-04544), Oklahoma Center for the Advancement of Science and Technology grants HR07-113 and AR07.2-087, and Oklahoma Agricultural Experiment Station project H-2811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Evans EW, 1995, VET MICROBIOL, V47, P295, DOI 10.1016/0378-1135(95)00126-3; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Higgs R, 2005, IMMUNOGENETICS, V57, P90, DOI 10.1007/s00251-005-0777-3; Joseph J, 2004, ONCOGENE, V23, P6304, DOI 10.1038/sj.onc.1207852; Kaiser MG, 2002, POULTRY SCI, V81, P657, DOI 10.1093/ps/81.5.657; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEVISON ME, 1973, INFECT IMMUN, V8, P30, DOI 10.1128/IAI.8.1.30-35.1973; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Strominger JL, 2009, J IMMUNOL, V182, P6633, DOI 10.4049/jimmunol.0990038; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; van Dijk A, 2005, VET IMMUNOL IMMUNOP, V106, P321, DOI 10.1016/j.vetimm.2005.03.003; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Van Immerseel F, 2005, POULTRY SCI, V84, P1851, DOI 10.1093/ps/84.12.1851; Van Immerseel F, 2004, AVIAN DIS, V48, P384, DOI 10.1637/7094; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xie H, 2001, VET IMMUNOL IMMUNOP, V80, P225, DOI 10.1016/S0165-2427(01)00260-4; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	48	172	183	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27225	10.1371/journal.pone.0027225	http://dx.doi.org/10.1371/journal.pone.0027225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073293	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200052
J	Szczepankowska, AK; Prestel, E; Mariadassou, M; Bardowski, JK; Bidnenko, E				Szczepankowska, Agnieszka K.; Prestel, Eric; Mariadassou, Mahendra; Bardowski, Jacek K.; Bidnenko, Elena			Phylogenetic and Complementation Analysis of a Single-Stranded DNA Binding Protein Family from Lactococcal Phages Indicates a Non-Bacterial Origin	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; OB-FOLD; REPLICATION FORK; SSB; GENE; IDENTIFICATION; EVOLUTION; DOMAIN; RECOMBINATION; MIRABILIS	Background: The single-stranded-nucleic acid binding (SSB) protein superfamily includes proteins encoded by different organisms from Bacteria and their phages to Eukaryotes. SSB proteins share common structural characteristics and have been suggested to descend from an ancestor polypeptide. However, as other proteins involved in DNA replication, bacterial SSB proteins are clearly different from those found in Archaea and Eukaryotes. It was proposed that the corresponding genes in the phage genomes were transferred from the bacterial hosts. Recently new SSB proteins encoded by the virulent lactococcal bacteriophages (Orf14(bIL67)-like proteins) have been identified and characterized structurally and biochemically. Methodology/Principal Findings: This study focused on the determination of phylogenetic relationships between Orf14(bIL67)-like proteins and other SSBs. We have performed a large scale phylogenetic analysis and pairwise sequence comparisons of SSB proteins from different phyla. The results show that, in remarkable contrast to other phage SSBs, the Orf14(bIL67)-like proteins form a distinct, self-contained and well supported phylogenetic group connected to the archaeal SSBs. Functional studies demonstrated that, despite the structural and amino acid sequence differences from bacterial SSBs, Orf14(bIL67) protein complements the conditional lethal ssb-1 mutation of Escherichia coli. Conclusions/Significance: Here we identified for the first time a group of phages encoded SSBs which are clearly distinct from their bacterial counterparts. All methods supported the recognition of these phage proteins as a new family within the SSB superfamily. Our findings suggest that unlike other phages, the virulent lactococcal phages carry ssb genes that were not acquired from their hosts, but transferred from an archaeal genome. This represents a unique example of a horizontal gene transfer between Archaea and bacterial phages.	[Szczepankowska, Agnieszka K.; Prestel, Eric; Bidnenko, Elena] INRA, Inst Micalis, UMR1319, Jouy En Josas, France; [Szczepankowska, Agnieszka K.; Bardowski, Jacek K.] Inst Biochem & Biophys PAS, Dept Microbial Biochem, Warsaw, Poland; [Mariadassou, Mahendra] INRA, UR1077, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Szczepankowska, AK (corresponding author), INRA, Inst Micalis, UMR1319, Jouy En Josas, France.	elena.bidnenko@jouy.inra.fr	Szczepankowska, Agnieszka K/AAN-7311-2021; Szczepankowska, Agnieszka K/H-2488-2017	Szczepankowska, Agnieszka K/0000-0002-8733-3283; Szczepankowska, Agnieszka K/0000-0002-8733-3283	Institut National de la Recherche Agronomique (INRA), France; Ministry of Science and Higher Education (MSHE), Poland [INRA/26/2008]	Institut National de la Recherche Agronomique (INRA), France; Ministry of Science and Higher Education (MSHE), Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the joint research project between Institut National de la Recherche Agronomique (INRA), France, and the Ministry of Science and Higher Education (MSHE), Poland [number INRA/26/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abriouel H, 2011, INT J FOOD MICROBIOL, V144, P487, DOI 10.1016/j.ijfoodmicro.2010.11.006; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bendtsen JD, 2002, J VIROL, V76, P9695, DOI 10.1128/JVI.76.19.9695-9701.2002; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BIDNENKO E, 1995, J BACTERIOL, V177, P3824, DOI 10.1128/jb.177.13.3824-3829.1995; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Chang HW, 2008, INT J FOOD MICROBIOL, V126, P159, DOI 10.1016/j.ijfoodmicro.2008.05.013; CHASE JW, 1983, J MOL BIOL, V164, P193, DOI 10.1016/0022-2836(83)90075-X; Chedin F, 1998, TRENDS BIOCHEM SCI, V23, P273, DOI 10.1016/S0968-0004(98)01243-2; Chilukuri LN, 1997, MICROBIOL-SGM, V143, P1163, DOI 10.1099/00221287-143-4-1163; CHOI MY, 1995, J BIOL CHEM, V270, P22541, DOI 10.1074/jbc.270.38.22541; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; DEVRIES J, 1994, MICROBIOL-SGM, V140, P889, DOI 10.1099/00221287-140-4-889; DEVRIES J, 1994, EUR J BIOCHEM, V224, P613; Durmaz E, 2000, APPL ENVIRON MICROB, V66, P895, DOI 10.1128/AEM.66.3.895-903.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gascon I, 2000, J MOL BIOL, V296, P989, DOI 10.1006/jmbi.2000.3521; Gill EE, 2011, BIOESSAYS, V33, P248, DOI 10.1002/bies.201000091; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Gray MW, 2001, GENOME BIOL, V2; Guardino KM, 2009, INT J MOL SCI, V10, P2412, DOI 10.3390/ijms10052412; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haseltine CA, 2002, MOL MICROBIOL, V43, P1505, DOI 10.1046/j.1365-2958.2002.02807.x; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Kelly TJ, 1998, P NATL ACAD SCI USA, V95, P14634, DOI 10.1073/pnas.95.25.14634; Kerr ID, 2003, EMBO J, V22, P2561, DOI 10.1093/emboj/cdg272; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Labrie SJ, 2007, J BACTERIOL, V189, P1482, DOI 10.1128/JB.01111-06; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Lehnherr H, 1999, J BACTERIOL, V181, P6463, DOI 10.1128/JB.181.20.6463-6468.1999; Leipe DD, 1997, NUCLEIC ACIDS RES, V27, P3389; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; Moreira D, 2000, MOL MICROBIOL, V35, P1, DOI 10.1046/j.1365-2958.2000.01692.x; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Robbins JB, 2005, J BIOL CHEM, V280, P15325, DOI 10.1074/jbc.M412870200; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Sambrook J., 1989, MOL CLONING LAB MANU; Scaltriti E, 2009, MOL MICROBIOL, V73, P1156, DOI 10.1111/j.1365-2958.2009.06844.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Szczepanska AK, 2007, VIROLOGY, V363, P104, DOI 10.1016/j.virol.2007.01.023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theobald DL, 2005, J MOL BIOL, V354, P722, DOI 10.1016/j.jmb.2005.08.071; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tye BK, 2000, P NATL ACAD SCI USA, V97, P2399, DOI 10.1073/pnas.97.6.2399; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Xu H, 2010, NUCLEIC ACIDS RES, V38, P4821, DOI 10.1093/nar/gkq219	62	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26942	10.1371/journal.pone.0026942	http://dx.doi.org/10.1371/journal.pone.0026942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073223	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200024
J	Lavilla-Alonso, S; Abo-Ramadan, U; Halavaara, J; Escutenaire, S; Tatlisumak, T; Saksela, K; Kanerva, A; Hemminki, A; Pesonen, S				Lavilla-Alonso, Sergio; Abo-Ramadan, Usama; Halavaara, Juha; Escutenaire, Sophie; Tatlisumak, Turgut; Saksela, Kalle; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari			Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy	PLOS ONE			English	Article							COLON-CANCER CELLS; IN-VIVO; LIVER; DISSEMINATION; EXPRESSION; MICE	Development of new cancer treatments focuses increasingly on the relation of cancer tissue with its microenvironment. A major obstacle for the development of new anti-cancer therapies has been the lack of relevant animal models that would reproduce all the events involved in disease progression from the early-stage primary tumor until the development of mature metastatic tissue. To this end, we have developed a readily imageable mouse model of colorectal cancer featuring highly reproducible formation of spontaneous liver metastases derived from intrasplenic primary tumors. We optimized several experimental variables, and found that the correct choice of cell line and the genetic background, as well as the age of the recipient mice, were critical for establishing a useful model system. Among a panel of colorectal cancer cell lines tested, the epithelial carcinoma HT29 line was found to be the most suitable in terms of producing homogeneous tumor growth and metastases. In our hands, SCID mice at the age of 125 days or older were the most suitable in supporting consistent HT29 tumor growth after splenic implantation followed by reproducible metastasis to the liver. A magnetic resonance imaging (MRI) protocol was optimized for use with this mouse model, and demonstrated to be a powerful method for analyzing the antitumor effects of an experimental therapy. Specifically, we used this system to with success to verify by MRI monitoring the efficacy of an intrasplenically administered oncolytic adenovirus therapy in reducing visceral tumor load and development of liver metastases. In summary, we have developed a highly optimized mouse model for liver metastasis of colorectal cancer, which allows detection of the tumor load at the whole body level and enables an accurate timing of therapeutic interventions to target different stages of cancer progression and metastatic development.	[Lavilla-Alonso, Sergio; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland; [Lavilla-Alonso, Sergio; Escutenaire, Sophie; Kanerva, Anna; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Lavilla-Alonso, Sergio; Escutenaire, Sophie; Hemminki, Akseli; Pesonen, Sari] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Abo-Ramadan, Usama; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Halavaara, Juha] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland; [Halavaara, Juha] Jorvi Hosp, Dept Radiol, SF-02740 Espoo, Finland; [Lavilla-Alonso, Sergio; Saksela, Kalle] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Kanerva, Anna] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Lavilla-Alonso, S (corresponding author), Univ Helsinki, Haartman Inst, Transplantat Lab, Canc Gene Therapy Grp,Mol Canc Biol Program, Helsinki, Finland.	akseli.hemminki@helsinki.fi; sari.pesonen@helsinki.fi		Saksela, Kalle/0000-0003-0827-122X; Tatlisumak, Turgut/0000-0002-2430-8988	European Research Council; European Union [THERADPOX, APOTHERAPY]; Helsinki University Central Hospital; Sigrid Juselius Foundation; Academy of Finland; Emil Aaltonen Foundation; Finnish Cancer Society; Biocentrum Helsinki; University of Helsinki; Helsinki Biomedical Graduate School	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Helsinki University Central Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Cancer Society; Biocentrum Helsinki; University of Helsinki; Helsinki Biomedical Graduate School	Funding was provided by European Research Council, European Union grants THERADPOX and APOTHERAPY, Helsinki University Central Hospital, Sigrid Juselius Foundation, Academy of Finland, Emil Aaltonen Foundation, Finnish Cancer Society, Biocentrum Helsinki, Research Funds of the University of Helsinki, and Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Chiappa A, 2009, CRIT REV ONCOL HEMAT, V72, P65, DOI 10.1016/j.critrevonc.2008.11.003; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Ito K, 2010, CANCER J, V16, P103, DOI 10.1097/PPO.0b013e3181d7e8e5; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koike N, 2009, WORLD J GASTROENTERO, V15, P5805, DOI 10.3748/wjg.15.5805; Liu XY, 2006, CELL RES, V16, P740, DOI 10.1038/sj.cr.7310088; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Satoh Yuji, 2002, J Exp Ther Oncol, V2, P337, DOI 10.1046/j.1359-4117.2002.01050.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Thalheimer A, 2009, EUR SURG RES, V42, P195, DOI 10.1159/000205825; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Yamamoto N, 2003, CANCER RES, V63, P7785; Yu HK, 2004, CANCER RES, V64, P7092, DOI 10.1158/0008-5472.CAN-04-0364; Zechmann CM, 2007, NEOPLASIA, V9, P57, DOI 10.1593/neo.06688	23	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26810	10.1371/journal.pone.0026810	http://dx.doi.org/10.1371/journal.pone.0026810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073198	gold, Green Submitted, Green Published			2022-12-25	WOS:000297197000001
J	London, CA; Bear, MD; McCleese, J; Foley, KP; Paalangara, R; Inoue, T; Ying, WW; Barsoum, J				London, Cheryl A.; Bear, Misty D.; McCleese, Jennifer; Foley, Kevin P.; Paalangara, Reji; Inoue, Takayo; Ying, Weiwen; Barsoum, James			Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer	PLOS ONE			English	Article							MULTIPLE SIGNALING PATHWAYS; SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; CANINE OSTEOSARCOMA; TUMOR-GROWTH; HEAT-SHOCK-PROTEIN-90; CELLS; EXPRESSION; MACHINERY; APOPTOSIS	Background: The novel water soluble compound STA-1474 is metabolized to ganetespib (formerly STA-9090), a potent HSP90 inhibitor previously shown to kill canine tumor cell lines in vitro and inhibit tumor growth in the setting of murine xenografts. The purpose of the following study was to extend these observations and investigate the safety and efficacy of STA-1474 in dogs with spontaneous tumors. Methods and Findings: This was a Phase 1 trial in which dogs with spontaneous tumors received STA-1474 under one of three different dosing schemes. Pharmacokinetics, toxicities, biomarker changes, and tumor responses were assessed. Twenty-five dogs with a variety of cancers were enrolled. Toxicities were primarily gastrointestinal in nature consisting of diarrhea, vomiting, inappetence and lethargy. Upregulation of HSP70 protein expression was noted in both tumor specimens and PBMCs within 7 hours following drug administration. Measurable objective responses were observed in dogs with malignant mast cell disease (n = 3), osteosarcoma (n = 1), melanoma (n = 1) and thyroid carcinoma (n = 1), for a response rate of 24% (6/25). Stable disease (>10 weeks) was seen in 3 dogs, for a resultant overall biological activity of 36% (9/25). Conclusions: This study provides evidence that STA-1474 exhibits biologic activity in a relevant large animal model of cancer. Given the similarities of canine and human cancers with respect to tumor biology and HSP90 activation, it is likely that STA-1474 and ganetespib will demonstrate comparable anti-cancer activity in human patients.	[London, Cheryl A.; Bear, Misty D.; McCleese, Jennifer] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Foley, Kevin P.] GlaxoSmithKline, Translat Biol, Collegeville, PA USA; [Paalangara, Reji] Intervet Schering Plough Anim Hlth, Summit, NJ USA; [Inoue, Takayo] Synta Pharmaceut Corp, Drug Metab & Pharmacokinet, Lexington, MA USA; [Ying, Weiwen] Synta Pharmaceut Corp, Discovery Chem, Lexington, MA USA; [Barsoum, James] Theracrine Inc, Cambridge, MA USA	University System of Ohio; Ohio State University; Merck & Company	London, CA (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	london.20@osu.edu	London, Cheryl/E-6561-2012; Foley, Kevin/ABC-1041-2020	Foley, Kevin/0000-0001-5148-7689	Synta Pharmaceuticals Corp.; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	Synta Pharmaceuticals Corp.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This clinical trial was supported by funding from Synta Pharmaceuticals Corp. The funders contributed to the study design, pharmacokinetic analysis and preparation of manuscript, but had no role in the treatment and evaluation of dogs in this study.	Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bansal H, 2010, BLOOD; Beere H M, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.93.re1; Beloueche-Babari M, 2010, ONCOTARGET, V1, P185; Chun R, 2003, VET CLIN N AM-SMALL, V33, P491, DOI 10.1016/S0195-5616(03)00021-4; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dakappagari N, 2010, BIOMARKERS, V15, P31, DOI 10.3109/13547500903261347; Erlichman C, 2009, EXPERT OPIN INV DRUG, V18, P861, DOI 10.1517/13543780902953699; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; London CA, 2003, CLIN CANCER RES, V9, P2755; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; McDowell CL, 2009, INT J BIOL MACROMOL, V45, P310, DOI 10.1016/j.ijbiomac.2009.06.012; Mueller F, 2007, ANTICANCER RES, V27, P155; Neckers Len, 2005, Expert Opin Emerg Drugs, V10, P137, DOI 10.1517/14728214.10.1.137; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsuchida Y, 2001, MED PEDIATR ONCOL, V37, P1, DOI 10.1002/mpo.1154; Vastag B, 2006, NAT BIOTECHNOL, V24, P1307, DOI 10.1038/nbt1106-1307; Veterinary Co-operative Oncology Group, VET COMP ONCOL, V2, P195; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams CR, 2007, J UROLOGY, V178, P1528, DOI 10.1016/j.juro.2007.05.120; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yano M, 1996, JPN J CANCER RES, V87, P908, DOI 10.1111/j.1349-7006.1996.tb02119.x; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	38	37	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27018	10.1371/journal.pone.0027018	http://dx.doi.org/10.1371/journal.pone.0027018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073242	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000021
J	Ye, SQ; Fowler, TW; Pavlos, NJ; Ng, PY; Liang, K; Feng, YF; Zheng, MH; Kurten, R; Manolagas, SC; Zhao, HB				Ye, Shiqiao; Fowler, Tristan W.; Pavlos, Nathan J.; Ng, Pei Ying; Liang, Kai; Feng, Yunfeng; Zheng, Minghao; Kurten, Richard; Manolagas, Stavros C.; Zhao, Haibo			LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; M-CSF; NEURONAL MIGRATION; CLEAR ZONE; ORGANIZATION; PROTEIN; DIFFERENTIATION; PATHWAY; ACETYLHYDROLASE	Microtubule organization and lysosomal secretion are both critical for the activation and function of osteoclasts, highly specialized polykaryons that are responsible for bone resorption and skeletal homeostasis. Here, we have identified a novel interaction between microtubule regulator LIS1 and Plekhm1, a lysosome-associated protein implicated in osteoclast secretion. Decreasing LIS1 expression by shRNA dramatically attenuated osteoclast formation and function, as shown by a decreased number of mature osteoclasts differentiated from bone marrow macrophages, diminished resorption pits formation, and reduced level of CTx-I, a bone resorption marker. The ablated osteoclast formation in LIS1-depleted macrophages was associated with a significant decrease in macrophage proliferation, osteoclast survival and differentiation, which were caused by reduced activation of ERK and AKT by M-CSF, prolonged RANKL-induced JNK activation and declined expression of NFAT-c1, a master transcription factor of osteoclast differentiation. Consistent with its critical role in microtubule organization and dynein function in other cell types, we found that LIS1 binds to and colocalizes with dynein in osteoclasts. Loss of LIS1 led to disorganized microtubules and aberrant dynein function. More importantly, the depletion of LIS1 in osteoclasts inhibited the secretion of Cathepsin K, a crucial lysosomal hydrolase for bone degradation, and reduced the motility of osteoclast precursors. These results indicate that LIS1 is a previously unrecognized regulator of osteoclast formation, microtubule organization, and lysosomal secretion by virtue of its ability to modulate dynein function and Plekhm1.	[Ye, Shiqiao; Manolagas, Stavros C.; Zhao, Haibo] Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Ye, Shiqiao; Manolagas, Stavros C.; Zhao, Haibo] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Fowler, Tristan W.; Kurten, Richard] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Pavlos, Nathan J.; Ng, Pei Ying; Zheng, Minghao] Univ Western Australia, Sch Surg, Ctr Orthoped Res, Perth, WA 6009, Australia; [Liang, Kai] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA; [Feng, Yunfeng] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Western Australia; University of Arkansas System; University of Arkansas Medical Sciences; Washington University (WUSTL)	Ye, SQ (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA.	hzhao@uams.edu	Zhao, Haibo/ABG-9729-2021; Ye, Shiqiao/N-2873-2015	Ye, Shiqiao/0000-0003-1529-7102; ZHAO, HAIBO/0000-0003-0836-7555; Zheng, Minghao/0000-0003-1185-4768; Pavlos, Nathan/0000-0001-7003-188X; Feng, Yunfeng/0000-0001-9150-7795	National Institutes of Health [AR055694, P01 AG13918]; UAMS; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant AR055694, P01 AG13918 and UAMS Tobacco Settlement Funds provided by Arkansas Biosciences Institute to H Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechler ME, 2010, J CELL BIOL, V190, P45, DOI 10.1083/jcb.200908105; BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P287, DOI 10.1007/BF02554876; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunati AM, 1996, EUR J BIOCHEM, V240, P400, DOI 10.1111/j.1432-1033.1996.0400h.x; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Del Fattore A, 2008, J BONE MINER RES, V23, P380, DOI 10.1359/JBMR.071107; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Linder S, 2000, J CELL SCI, V113, P4165; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mulari MTK, 2003, EXP CELL RES, V285, P221, DOI 10.1016/S0014-4827(03)00033-8; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinholt FP, 1999, EXP CELL RES, V251, P477, DOI 10.1006/excr.1999.4585; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Tabata K, 2010, MOL BIOL CELL, V21, P4162, DOI 10.1091/mbc.E10-06-0495; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Vaananen HK, 2000, J CELL SCI, V113, P377; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; van Wesenbeeck L, 2004, J BONE MINER RES, V19, P183, DOI 10.1359/jbmr.2004.19.2.183; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Zhao HB, 2002, BIOCHEM BIOPH RES CO, V293, P1060, DOI 10.1016/S0006-291X(02)00326-1; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	57	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27285	10.1371/journal.pone.0027285	http://dx.doi.org/10.1371/journal.pone.0027285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073305	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000041
J	Gonzalez, JM; Dong, Z; Romero, R; Girardi, G				Gonzalez, Juan M.; Dong, Zhong; Romero, Roberto; Girardi, Guillermina			Cervical Remodeling/Ripening at Term and Preterm Delivery: The Same Mechanism Initiated by Different Mediators and Different Effector Cells	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASES; LEUKOCYTES; PREGNANCY; BIRTH; WOMEN; LABOR	Background: Premature cervical remodeling/ripening is believed to contribute to preterm delivery (PTD), the leading cause of perinatal morbidity and mortality. Despite considerable research, the causes of term and PTD remain unclear, and there is no effective treatment for PTD. We previously demonstrated that complement activation plays a causative role in cervical remodeling that leads to PTD in mice. Methodology/Principal Findings: Here we found that complement activation is not required for the physiological process that leads to term delivery in mice. Neither increased C3 cervical deposition nor increased C3a and C5a serum levels were observed at term. In addition, macrophages infiltration was found in PTD in contrast to term delivery were no leukocytes were found. Despite the different role of complement and different cellular effector cells, PTD and term delivery share a common dowsntream pathway characterized by increased metalloproteinases (MMPs) release and increased collagen degradation. However, different sources of MMPs were identified. Macrophages are the source of MMPs in PTD while cervical fibroblasts and columnar epithelial cells synthesize MMPs at term delivery. A dramatic diminution in serum progesterone levels precedes parturition at term but not in PTD, suggesting that progesterone withdrawal initiates cervical remodeling at term. On the other hand, MMPs release in PTD is triggered by C5a. Conclusion and Significance: In conclusion, preterm and term cervical remodeling occur through the same mechanism but they are initiated by different mediators and effector cells. That complement activation is required for PTD but not for the physiological process that leads to term delivery, suggests that complement is a potential specific biomarker and selective target to prevent PTD and thus avert neonatal mortality and morbidity.	[Gonzalez, Juan M.; Dong, Zhong; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Bethesda, MD 20892 USA; [Girardi, Guillermina] CUNY, York Coll, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); City University of New York (CUNY) System	Gonzalez, JM (corresponding author), NICHHD, Perinatol Res Branch, NIH, Bethesda, MD 20892 USA.	Guillermina.Girardi@ed.ac.uk	; Romero, Roberto/A-5268-2019	Girardi, Guillermina/0000-0002-5797-7731; Romero, Roberto/0000-0002-4448-5121	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; Medical Research Council [G1002033] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; MRC [G1002033] Funding Source: UKRI	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These studies were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher N, 2009, ACTA OBSTET GYN SCAN, V88, P502, DOI 10.1080/00016340902852898; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Choi SJ, 2009, EUR J OBSTET GYN R B, V142, P43, DOI 10.1016/j.ejogrb.2008.08.009; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Elimian A, 1998, OBSTET GYNECOL, V92, P72, DOI 10.1016/S0029-7844(98)00123-9; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; Holt R, 2011, ENDOCRINOLOGY, V152, P1036, DOI 10.1210/en.2010-1105; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004; Imada K, 1997, BIOL REPROD, V56, P575, DOI 10.1095/biolreprod56.3.575; Kelly RW, 2002, J REPROD IMMUNOL, V57, P217, DOI 10.1016/S0165-0378(02)00007-4; LIGGINS GC, 1978, SEMIN PERINATOL, V2, P261; Ludmir J, 2000, CLIN OBSTET GYNECOL, V43, P433, DOI 10.1097/00003081-200009000-00003; Lynch AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.044; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; Rodriguez HA, 2003, MOL HUM REPROD, V9, P807, DOI 10.1093/molehr/gag099; Russell WMS., 1959, MED J AUSTRALIA; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Timmons BC, 2006, BIOL REPROD, V74, P236, DOI 10.1095/biolreprod.105.044891; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Vaisbuch E, 2009, J MATERN-FETAL NEO M, V22, P905, DOI 10.1080/14767050902994663; Word RA, 2007, CERVICAL FUNCTION PR, P19	29	68	70	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26877	10.1371/journal.pone.0026877	http://dx.doi.org/10.1371/journal.pone.0026877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073213	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900050
J	Hawthorne, DJ; Dively, GP				Hawthorne, David J.; Dively, Galen P.			Killing Them with Kindness? In-Hive Medications May Inhibit Xenobiotic Efflux Transporters and Endanger Honey Bees	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; TRANSEPITHELIAL TRANSPORT; MALPIGHIAN TUBULES; INSECTICIDES; PESTICIDES; TOXICITY; VINBLASTINE; MECHANISMS	Background: Honey bees (Apis mellifera) have recently experienced higher than normal overwintering colony losses. Many factors have been evoked to explain the losses, among which are the presence of residues of pesticides and veterinary products in hives. Multiple residues are present at the same time, though most often in low concentrations so that no single product has yet been associated with losses. Involvement of a combination of residues to losses may however not be excluded. To understand the impact of an exposure to combined residues on honey bees, we propose a mechanism-based strategy, focusing here on Multi-Drug Resistance (MDR) transporters as mediators of those interactions. Methodology/Principal Findings: Using whole-animal bioassays, we demonstrate through inhibition by verapamil that the widely used organophosphate and pyrethroid acaricides coumaphos and tau-fluvalinate, and three neonicotinoid insecticides: imidacloprid, acetamiprid and thiacloprid are substrates of one or more MDR transporters. Among the candidate inhibitors of honey bee MDR transporters is the in-hive antibiotic oxytetracycline. Bees prefed oxytetracycline were significantly sensitized to the acaricides coumaphos and tau-fluvalinate, suggesting that the antibiotic may interfere with the normal excretion or metabolism of these pesticides. Conclusions/Significance: Many bee hives receive regular treatments of oxytetracycline and acaricides for prevention and treatment of disease and parasites. Our results suggest that seasonal co-application of these medicines to bee hives could increase the adverse effects of these and perhaps other pesticides. Our results also demonstrate the utility of a mechanism-based strategy. By identifying pesticides and apicultural medicines that are substrates and inhibitors of xenobiotic transporters we prioritize the testing of those chemical combinations most likely to result in adverse interactions.	[Hawthorne, David J.; Dively, Galen P.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Hawthorne, DJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	djh@umd.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain LJ, 1997, ENVIRON HEALTH PERSP, V105, P812, DOI 10.1289/ehp.97105812; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Callaghan A, 2002, ECOTOX ENVIRON SAFE, V52, P211, DOI 10.1006/eesa.2002.2186; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DELAPLANE KS, 1994, AM BEE J, V134, P259; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Frazier M, 2008, AM BEE J, V148, P521; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Lanning CL, 1996, TOXICOL LETT, V85, P127, DOI 10.1016/0378-4274(96)03654-5; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Leader JP, 2005, J EXP BIOL, V208, P4363, DOI 10.1242/jeb.01911; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sammataro D, 1998, BEEKEEPERS HDB, P190; Sanford MT, 2010, STOREYS GUIDE KEEPIN; Schrickx J, 2007, J VET PHARMACOL THER, V30, P25, DOI 10.1111/j.1365-2885.2007.00808.x; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; TSURUO T, 1981, CANCER RES, V41, P1967; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Winston M.L., 1991, BIOL HONEY BEE	39	63	65	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26796	10.1371/journal.pone.0026796	http://dx.doi.org/10.1371/journal.pone.0026796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073195	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900037
J	Keijzer, C; Slutter, B; van der Zee, R; Jiskoot, W; van Eden, W; Broere, F				Keijzer, Chantal; Slutter, Bram; van der Zee, Ruurd; Jiskoot, Wim; van Eden, Willem; Broere, Femke			PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity	PLOS ONE			English	Article							REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; N-TRIMETHYL CHITOSAN; SHOCK-PROTEIN HSP; DENDRITIC CELLS; INTRANASAL VACCINATION; MICROSPHERES PROLONGS; CHRONIC INFLAMMATION; ADJUVANT ARTHRITIS; MUCOSAL IMMUNITY	Development of vaccines in autoimmune diseases has received wide attention over the last decade. However, many vaccines showed limited clinical efficacy. To enhance vaccine efficacy in infectious diseases, biocompatible and biodegradable polymeric nanoparticles have gained interest as antigen delivery systems. We investigated in mice whether antigen-encapsulated PLGA (poly-lactic-co-glycolic acid), PLGA-TMC (N-trimethyl chitosan) or TMC-TPP (tri-polyphosphate) nanoparticles can also be used to modulate the immunological outcome after nasal vaccination. These three nanoparticles enhanced the antigen presentation by dendritic cells, as shown by increased in vitro and in vivo CD4(+) T-cell proliferation. However, only nasal PLGA nanoparticles were found to induce an immunoregulatory response as shown by enhanced Foxp3 expression in the nasopharynx associated lymphoid tissue and cervical lymph nodes. Nasal administration of OVA-containing PLGA particle resulted in functional suppression of an OVA-specific Th-1 mediated delayed-type hypersensitivity reaction, while TMC-TPP nanoparticles induced humoral immunity, which coincided with the enhanced generation of OVA-specific B-cells in the cervical lymph nodes. Intranasal treatment with Hsp70-mB29a peptide-loaded PLGA nanoparticles suppressed proteoglycan-induced arthritis, leading to a significant reduction of disease. We have uncovered a role for PLGA nanoparticles to enhance CD4(+) T-cell mediated immunomodulation after nasal application. The exploitation of this differential regulation of nanoparticles to modulate nasal immune responses can lead to innovative vaccine development for prophylactic or therapeutic vaccination in infectious or autoimmune diseases.	[Keijzer, Chantal; van der Zee, Ruurd; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Slutter, Bram; Jiskoot, Wim] LACDR, Div Drug Delivery Technol, Leiden, Netherlands	Utrecht University	Keijzer, C (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	Broere, femke/C-2675-2012; van der Zee, Ruurd/O-5256-2015	van der Zee, Ruurd/0000-0002-4331-2755; Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	European Union [TOLERAGE: HEALTH-F4-2008-202156]; TI Pharma Project [D5-106]; BSIK VIRGO consortium [03012]; Dutch Arthritis Association	European Union(European Commission); TI Pharma Project; BSIK VIRGO consortium(Ministry of Economic Affairs, Netherlands); Dutch Arthritis Association	This work was supported by grants from the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156, TI Pharma Project D5-106, BSIK VIRGO consortium grant no. 03012, and the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT REV IMMUNOL, V2, P629, DOI 10.1038/nm745; Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2; Broere F, 2009, MUCOSAL IMMUNOL, V2, P254, DOI 10.1038/mi.2009.2; Brownlie RJ, 2006, ARTHRITIS RHEUM-US, V54, P854, DOI 10.1002/art.21654; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Finnegan A, 1999, J IMMUNOL, V163, P5383; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; Hagenaars N, 2009, PHARM RES-DORDR, V26, P1353, DOI 10.1007/s11095-009-9845-y; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Hauet-Broere F, 2006, ANN RHEUM DIS, V65, P65, DOI 10.1136/ard.2006.058495; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jaganathan KS, 2006, VACCINE, V24, P4201, DOI 10.1016/j.vaccine.2006.01.011; Jin L, 2010, VACCINE, V28, P3312, DOI 10.1016/j.vaccine.2010.02.100; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Liu ZG, 2009, INT ARCH ALLERGY IMM, V150, P221, DOI 10.1159/000222674; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Marazuela EG, 2008, CLIN EXP ALLERGY, V38, P520, DOI 10.1111/j.1365-2222.2007.02922.x; Mestecky J, 2005, VACCINE, V23, P1800, DOI 10.1016/j.vaccine.2004.11.009; Metzler B, 1999, IMMUNOLOGY, V97, P257; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Rodriguez-Monroy MA, 2007, SCAND J IMMUNOL, V65, P276, DOI 10.1111/j.1365-3083.2006.01898.x; Shi FD, 1998, J NEUROL SCI, V155, P1, DOI 10.1016/S0022-510X(97)00232-3; Slutter B, 2010, VACCINE, V28, P6282, DOI 10.1016/j.vaccine.2010.06.121; Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011; Tanaka S, 1999, J IMMUNOL, V163, P5560; Tarkowski A, 1999, ARTHRITIS RHEUM, V42, P1628, DOI 10.1002/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T; Unger WWJ, 2003, J IMMUNOL, V171, P4592, DOI 10.4049/jimmunol.171.9.4592; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Waeckerle-Men Y, 2006, VACCINE, V24, P1847, DOI 10.1016/j.vaccine.2005.10.032; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Wieten L, 2009, THESIS ENSCHEDE; Wieten L, 2007, FEBS LETT, V581, P3716, DOI 10.1016/j.febslet.2007.04.082; Wu HY, 1996, IMMUNOLOGY, V88, P493, DOI 10.1046/j.1365-2567.1996.d01-690.x	44	61	65	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26684	10.1371/journal.pone.0026684	http://dx.doi.org/10.1371/journal.pone.0026684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073184	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900032
J	Lavandero, B; Figueroa, CC; Franck, P; Mendez, A				Lavandero, Blas; Figueroa, Christian C.; Franck, Pierre; Mendez, Angela			Estimating Gene Flow between Refuges and Crops: A Case Study of the Biological Control of Eriosoma lanigerum by Aphelinus mali in Apple Orchards	PLOS ONE			English	Article							LANDSCAPE COMPOSITION; POPULATION-GENETICS; MICROSATELLITE LOCI; HEMIPTERA APHIDIDAE; COMPUTER-PROGRAM; SPECIATION; DIVERSITY; HOMOPTERA; INVASION; INSECTS	Parasitoid disturbance populations in agroecosystems can be maintained through the provision of habitat refuges with host resources. However, specialized herbivores that feed on different host plants have been shown to form host-specialized races. Parasitoids may subsequently specialize on these herbivore host races and therefore prefer parasitizing insects from the refuge, avoiding foraging on the crop. Evidence is therefore required that parasitoids are able to move between the refuge and the crop and that the refuge is a source of parasitoids, without being an important source of herbivore pests. A North-South transect trough the Chilean Central Valley was sampled, including apple orchards and surrounding Pyracantha coccinea (M. Roem) (Rosales: Rosacea) hedges that were host of Eriosoma lanigerum (Hemiptera: Aphididae), a globally important aphid pest of cultivated apples. At each orchard, aphid colonies were collected and taken back to the laboratory to sample the emerging hymenopteran parasitoid Aphelinus mali (Hymenoptera: Aphelinidae). Aphid and parasitoid individuals were genotyped using species-specific microsatellite loci and genetic variability was assessed. By studying genetic variation, natural geographic barriers of the aphid pest became evident and some evidence for incipient host-plant specialization was found. However, this had no effect on the population-genetic features of its most important parasitoid. In conclusion, the lack of genetic differentiation among the parasitoids suggests the existence of a single large and panmictic population, which could parasite aphids on apple orchards and on P. coccinea hedges. The latter could thus comprise a suitable and putative refuge for parasitoids, which could be used to increase the effectiveness of biological control. Moreover, the strong geographical differentiation of the aphid suggests local reinfestations occur mainly from other apple orchards with only low reinfestation from P. cocinnea hedges. Finally, we propose that the putative refuge could act as a source of parasitoids without being a major source of aphids.	[Lavandero, Blas; Mendez, Angela] Univ Talca, Lab Interacciones Insecto Planta, Talca, Chile; [Franck, Pierre] INRA, Plantes Syst Culture Hort, Avignon, France; [Figueroa, Christian C.] Univ Austral Chile, Fac Ciencias, Inst Ecol & Evoluc, Valdivia, Chile	Universidad de Talca; INRAE; Universidad Austral de Chile	Lavandero, B (corresponding author), Univ Talca, Lab Interacciones Insecto Planta, Talca, Chile.	blavandero@utalca.cl	lavandero, blas/A-1340-2012; Méndez, Ángela/GRY-7666-2022; Figueroa, Christian C./A-1170-2008	Figueroa, Christian C./0000-0001-9218-5564; lavandero, blas/0000-0002-2423-7016; Franck, Pierre/0000-0002-1904-8325	International Foundation for Science [C/4023-2]; FONDECYT [11080013]	International Foundation for Science(International Foundation for Science); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by the International Foundation for Science Grant No C/4023-2 and FONDECYT (Project Number 11080013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P1471; Asante S. K., 1997, Plant Protection Quarterly, V12, P166; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Castaneda LE, 2010, BIOL J LINN SOC, V100, P237, DOI 10.1111/j.1095-8312.2010.01416.x; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cohen H, 1996, ENTOMOPHAGA, V41, P225, DOI 10.1007/BF02764248; Dobson AJ, 2002, INTRO GEN LINEAR MOL; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frantz AC, 2006, MOL ECOL, V15, P3191, DOI 10.1111/j.1365-294X.2006.03022.x; Fuentes-Contreras E, 2008, POPULATION, V101, P190; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hufbauer RA, 2004, MOL ECOL, V13, P337, DOI 10.1046/j.1365-294X.2003.02084.x; JAMES BD, 1982, ECOL ENTOMOL, V7, P277, DOI 10.1111/j.1365-2311.1982.tb00667.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lavandero B, 2009, B ENTOMOL RES, V99, P97, DOI 10.1017/S0007485308006196; Lavandero B, 2009, MOL ECOL RESOUR, V9, P302, DOI 10.1111/j.1755-0998.2008.02398.x; Lavandero B, 2010, INSECT SCI, V17, P549, DOI 10.1111/j.1744-7917.2010.01345.x; Marko V, 2008, J APPL ENTOMOL, V132, P26, DOI 10.1111/j.1439-0418.2007.01233.x; Moreno V, 2003, DINAMICA POBLACIONAL; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PENMAN DR, 1980, J ECON ENTOMOL, V73, P49, DOI 10.1093/jee/73.1.49; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandanayaka WRM, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.27; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WEBER DC, 1988, J ECON ENTOMOL, V81, P1170, DOI 10.1093/jee/81.4.1170; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x	40	25	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26694	10.1371/journal.pone.0026694	http://dx.doi.org/10.1371/journal.pone.0026694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073185	Green Published, gold			2022-12-25	WOS:000297154900033
J	Wang, KY; Guo, YM; Wang, F; Wang, ZR				Wang, Kaiyu; Guo, Yanmeng; Wang, Fei; Wang, Zuoren			Drosophila TRPA Channel Painless Inhibits Male-Male Courtship Behavior through Modulating Olfactory Sensation	PLOS ONE			English	Article							SEXUAL RECEPTIVITY; SOCIAL EXPERIENCE; MELANOGASTER; PHEROMONE; GENE; NOCICEPTION; AVOIDANCE; TASTE; FLY	The Drosophila melanogaster TRPA family member painless, expressed in a subset of multidendritic neurons embeding in the larval epidermis, is necessary for larval nociception of noxious heat or mechanical stimuli. However, the function of painless in adult flies remains largely unknown. Here we report that mutation of painless leads to a defect in male-male courtship behavior and alteration in olfaction sensitivity in adult flies. Specific downregulation of the expression of the Painless protein in the olfactory projection neurons (PNs) of the antennal lobes (ALs) resulted in a phenotype resembling that found in painless mutant flies, whereas overexpression of Painless in PNs of painless mutant males suppressed male-male courtship behavior. The downregulation of Painless exclusively during adulthood also resulted in male-male courtship behavior. In addition, mutation of the painless gene in flies caused changes in olfaction, suggesting a role for this gene in olfactory processing. These results indicate that functions of painless in the adult central nervous system of Drosophila include modulation of olfactory processing and inhibition of male-male courtship behavior.	[Wang, Kaiyu; Guo, Yanmeng; Wang, Fei; Wang, Zuoren] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Wang, Kaiyu; Guo, Yanmeng; Wang, Fei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, KY (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China.	ZuorenWang@ion.ac.cn		Wang, Fei/0000-0002-8646-2411	China 973 project [2011CBA00404]	China 973 project(National Basic Research Program of China)	This work was supported by the China 973 project (2011CBA00404) awarded to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barron AB, 2000, J INSECT PHYSIOL, V46, P439, DOI 10.1016/S0022-1910(99)00129-8; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; FERVEUR JF, 2007, COMPLEX CHEM MESSAGE, P397; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Inoshita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019770; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lacaille F, 2009, BEHAV GENET, V39, P554, DOI 10.1007/s10519-009-9286-8; Lin MQ, 1996, P NATL ACAD SCI USA, V93, P10446, DOI 10.1073/pnas.93.19.10446; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Villella A, 1997, GENETICS, V147, P1107; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451	38	17	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25890	10.1371/journal.pone.0025890	http://dx.doi.org/10.1371/journal.pone.0025890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073144	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900003
J	Nakaoka, H; Nishiyama, A; Saito, M; Ishikawa, F				Nakaoka, Hidenori; Nishiyama, Atsuya; Saito, Motoki; Ishikawa, Fuyuki			Xenopus laevis Ctc1-Stn1-Ten1 (xCST) Protein Complex Is Involved in Priming DNA Synthesis on Single-stranded DNA Template in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA-PRIMASE; TELOMERE MAINTENANCE; ACCESSORY PROTEIN; LENGTH REGULATION; CHROMOSOME ENDS; CELL-CYCLE; REPLICATION; RPA; ASSOCIATION; PROTECTION	The Ctc1-Stn1-Ten1 (CST) complex is an RPA (replication protein A)-like protein complex that binds to single-stranded (ss) DNA. It localizes at telomeres and is involved in telomere end protection in mammals and plants. It is also known to stimulate DNA polymerase alpha-primase in vitro. However, it is not known how CST accomplishes these functions in vivo. Here, we report the identification and characterization of Xenopus laevis CST complex (xCST). xCST showed ssDNA binding activity with moderate preference for G (guanine)-rich sequences. xStn1-immunodepleted Xenopus egg extracts supported chromosomal DNA replication in in vitro reconstituted sperm nuclei, suggesting that xCST is not a general replication factor. However, the immunodepletion or neutralization of xStn1 compromised DNA synthesis on ssDNA template. Because primed ssDNA template was replicated in xStn1-immunodepleted extracts as efficiently as in control ones, we conclude that xCST is involved in the priming step on ssDNA template. These results are consistent with the current model that CST is involved in telomeric C-strand synthesis through the regulation of DNA polymerase alpha-primase.	[Nakaoka, Hidenori; Nishiyama, Atsuya; Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Nishiyama, Atsuya/D-7894-2017; Ishikawa, Fuyuki/AAU-4056-2021	Nishiyama, Atsuya/0000-0002-8416-3776; Ishikawa, Fuyuki/0000-0002-5580-2305; Nakaoka, Hidenori/0000-0001-8465-5853	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).	Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; Flynn RL, 2010, CRIT REV BIOCHEM MOL, V45, P266, DOI 10.3109/10409238.2010.488216; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; GOULIAN M, 1990, J BIOL CHEM, V265, P13231; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; RIEDEL HD, 1982, NUCLEIC ACIDS RES, V10, P5621, DOI 10.1093/nar/10.18.5621; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Ueno M, 2010, BIOSCI BIOTECH BIOCH, V74, P1, DOI 10.1271/bbb.90682; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	37	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					619	627		10.1074/jbc.M111.263723	http://dx.doi.org/10.1074/jbc.M111.263723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086929	Green Published, hybrid			2022-12-25	WOS:000298682400060
J	Dai, LS; Tsai-Morris, CH; Sato, H; Villar, J; Kang, JH; Zhang, JB; Dufau, ML				Dai, Lisheng; Tsai-Morris, Chon-Hwa; Sato, Hisashi; Villar, Joaquin; Kang, Jung-Hoon; Zhang, Jiabao; Dufau, Maria L.			Testis-specific miRNA-469 Up-regulated in Gonadotropin-regulated Testicular RNA Helicase (GRTH/DDX25)-null Mice Silences Transition Protein 2 and Protamine 2 Messages at Sites within Coding Region IMPLICATIONS OF ITS ROLE IN GERM CELL DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MICRORNA BIOGENESIS; CHROMATOID BODY; SELF-RENEWAL; EXPRESSION; GRTH/DDX25; GENE; TRANSLATION; LET-7; DIFFERENTIATION	Gonadotropin-regulated testicular RNA helicase (GRTH/DDX25), a testis-specific member of the DEAD-box family, is an essential post-transcriptional regulator of spermatogenesis. Failure of expression of Transition protein 2 (TP2) and Protamine 2 (Prm2) proteins (chromatin remodelers, essential for spermatid elongation and completion of spermatogenesis) with preservation of their mRNA expression was observed in GRTH-null mice (azoospermic due to failure of spermatids to elongate). These were identified as target genes for the testis-specific miR-469, which is increased in the GRTH-null mice. Further analysis demonstrated that miR-469 repressed TP2 and Prm2 protein expression at the translation level with minor effect on mRNA degradation, through binding to the coding regions of TP2 and Prm2 mRNAs. The corresponding primary-microRNAs and the expression levels of Drosha and DGCR8 (both mRNA and protein) were increased significantly in the GRTH-null mice. miR-469 silencing of TP2 and Prm2 mRNA in pachytene spermatocytes and round spermatids is essential for their timely translation at later times of spermiogenesis, which is critical to attain mature sperm. Collectively, these studies indicate that GRTH, a multifunctional RNA helicase, acts as a negative regulator of miRNA-469 biogenesis and consequently their function during spermatogenesis.	[Dai, Lisheng; Tsai-Morris, Chon-Hwa; Sato, Hisashi; Villar, Joaquin; Kang, Jung-Hoon; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Dai, Lisheng; Zhang, Jiabao] Jilin Univ, Lab Anim Ctr, Coll Anim Sci & Vet Med, Changchun 130062, Jilin, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Jilin University	Dufau, ML (corresponding author), Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program through the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Bjork JK, 2010, DEVELOPMENT, V137, P3177, DOI 10.1242/dev.050955; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BUCCI LR, 1986, BIOL REPROD, V34, P195, DOI 10.1095/biolreprod34.1.195; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chieffi P, 2002, ONCOGENE, V21, P3644, DOI 10.1038/sj/onc/1205501; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Damestoy A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-22; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Jung YH, 2010, MOL HUM REPROD, V16, P804, DOI 10.1093/molehr/gaq058; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee EK, 2011, RNA BIOL, V8, P44, DOI 10.4161/rna.8.1.13863; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Qian ZR, 2009, MODERN PATHOL, V22, P431, DOI 10.1038/modpathol.2008.202; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Sato H., 2008, END SOC 90 ANN M SAN, pP1; Sato H, 2010, BBA-MOL CELL RES, V1803, P534, DOI 10.1016/j.bbamcr.2010.02.004; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsai-Morris CH, 2010, J ANDROL, V31, P45, DOI 10.2164/jandrol.109.008219; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	57	52	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44306	44318		10.1074/jbc.M111.282756	http://dx.doi.org/10.1074/jbc.M111.282756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086916	hybrid, Green Published			2022-12-25	WOS:000298645500002
J	Kloosterman, TG; Kuipers, OP				Kloosterman, Tomas G.; Kuipers, Oscar P.			Regulation of Arginine Acquisition and Virulence Gene Expression in the Human Pathogen Streptococcus pneumoniae by Transcription Regulators ArgR1 and AhrC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING PROTEIN; HISTIDINE TRIAD PROTEINS; BACILLUS-SUBTILIS; AMINO-ACIDS; DEIMINASE SYSTEM; GENOME SEQUENCE; CELL-SURFACE; RNA SR1; METABOLISM; PYOGENES	In this study, we investigated for the first time the transcriptional response of the human pathogen Streptococcus pneumoniae to fluctuating concentrations of arginine, an essential amino acid for this bacterium. By means of DNA microarray analyses, several operons and genes were found, the expression of which was affected by the concentration of arginine in the medium. Five of the identified operons were demonstrated to be directly repressed in the presence of high arginine concentrations via the concerted action of the ArgR-type regulators ArgR1 and AhrC. These ArgR1/AhrC targets encompass the putative amino acid transport genes artPQ, abpA, abpB, and aapA; the arginine biosynthetic genes argGH; and the virulence genes aliB and lmB/adcAII-phtD encoding an oligopeptide-binding lipoprotein and cell surface Zn2+-scavenging units, respectively. In addition, the data indicate that three of the amino acid transport genes encode an arginine ATP-binding cassette transporter unit required for efficient growth during arginine limitation. Instead of regulating arginine biosynthetic and catabolic genes as has been reported for other Gram-positive bacteria, our findings suggest that the physiological function of ArgR1/AhrC in S. pneumoniae is to ensure optimal uptake of arginine from the surrounding milieu.	[Kloosterman, Tomas G.; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9747 AG Groningen, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	European Union [HEALTH-F3-2009-222983]	European Union(European Commission)	Supported by the European Union-funded Pneumopath Project HEALTH-F3-2009-222983.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Barcelona-Andres B, 2002, J BACTERIOL, V184, P6289, DOI 10.1128/JB.184.22.6289-6300.2002; Belitsky, 2001, BACILLUS SUBTILIS IT, P203; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bringel F, 1997, J BACTERIOL, V179, P2697, DOI 10.1128/jb.179.8.2697-2706.1997; Bryan JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-607; CALOGERO S, 1994, J BACTERIOL, V176, P1234, DOI 10.1128/jb.176.5.1234-1241.1994; Canepa A, 2002, NEPHROL DIAL TRANSPL, V17, P413, DOI 10.1093/ndt/17.3.413; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; CURRIE GA, 1979, BRIT J CANCER, V39, P613, DOI 10.1038/bjc.1979.112; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Dennis CA, 2002, ACTA CRYSTALLOGR D, V58, P421, DOI 10.1107/S0907444901021692; Dong YQ, 2004, J BACTERIOL, V186, P2511, DOI 10.1128/JB.186.8.2511-2514.2004; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Griswold A, 2004, APPL ENVIRON MICROB, V70, P1321, DOI 10.1128/AEM.70.3.1321-1327.2004; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Larsen R, 2005, J BIOL CHEM, V280, P19319, DOI 10.1074/jbc.M413983200; Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004; Larsen R, 2005, THESIS U GRONINGEN G; Larsen R, 2008, APPL ENVIRON MICROB, V74, P4768, DOI 10.1128/AEM.00117-08; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Li W, 2009, FEMS MICROBIOL LETT, V292, P123, DOI 10.1111/j.1574-6968.2008.01476.x; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; Lu CD, 1999, J BACTERIOL, V181, P2459, DOI 10.1128/JB.181.8.2459-2464.1999; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Maarsingh H, 2008, EUR J PHARMACOL, V585, P375, DOI 10.1016/j.ejphar.2008.02.096; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Miller CM, 1997, MOL MICROBIOL, V26, P37, DOI 10.1046/j.1365-2958.1997.5441907.x; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Nicoloff H, 2004, J BACTERIOL, V186, P6059, DOI 10.1128/JB.186.18.6059-6069.2004; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Park SM, 1997, J BACTERIOL, V179, P5300, DOI 10.1128/jb.179.17.5300-5308.1997; Reyes ED, 2010, J BIOL CHEM, V285, P16521, DOI 10.1074/jbc.M110.119164; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Senechal H, 2010, FEMS MICROBIOL LETT, V305, P162, DOI 10.1111/j.1574-6968.2010.01921.x; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; Sethuraman R, 2006, NEUROCHEM RES, V31, P1127, DOI 10.1007/s11064-006-9133-8; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Sitkiewicz I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009785; Song JH, 2005, MOL CELLS, V19, P365; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Terao Y, 2002, INFECT IMMUN, V70, P993; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wahid RM, 2005, PEDIATR INT, V47, P196, DOI 10.1111/j.1442-200x.2005.02038.x; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	87	40	40	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44594	44605		10.1074/jbc.M111.295832	http://dx.doi.org/10.1074/jbc.M111.295832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22084243	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000298645500031
J	Wang, Y; Nie, M; Li, W; Ping, F; Hu, YY; Ma, LK; Gao, JS; Liu, JT				Wang, Ying; Nie, Min; Li, Wei; Ping, Fan; Hu, Yingying; Ma, Liangkun; Gao, Jinsong; Liu, Juntao			Association of Six Single Nucleotide Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-SECRETION; GENETIC-VARIANTS; TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2; COMMON VARIANTS; INCREASED RISK; TYPE-2; WOMEN; IGF2BP2	Background: To investigate whether the candidate genes that confer susceptibility to type 2 diabetes mellitus are also correlated with gestational diabetes mellitus (GDM) in pregnant Chinese women. Methodology/Principal Findings: In this study, 1764 unrelated pregnant women were recruited, of which 725 women had GDM and 1039 served as controls. Six single nucleotide polymorphisms (rs7754840 in CDKAL1, rs391300 in SRR, rs2383208 in CDKN2A/2B, rs4402960 in IGF2BP2, rs10830963 in MTNR1B, rs4607517 in GCK) were genotyped using TaqMan allelic discrimination assays. The genotype and allele distributions of each SNP between the GDM cases and controls and the combined effects of alleles for the risk of developing GDM were analyzed. We found that the rs4402960, rs2383208 and rs391300 were statistically associated with GDM (OR = 1.207, 95% CI = 1.029-1.417, p = 0.021; OR = 1.242, 95% CI = 1.077-1.432, p = 0.003; OR = 1.202, 95% CI = 1.020-1.416, P = 0.028, respectively). In addition, the effect was greater under a recessive model in rs391300 (OR = 1.820, 95% CI = 1.226-2.701, p = 0.003). Meanwhile, the joint effect of these three loci indicated an additive effect of multiple alleles on the risk of developing GDM with an OR of 1.196 per allele (p = 1.08 x 10(-4)). We also found that the risk alleles of rs2383208 (b = -0.085, p = 0.003), rs4402960 (b = -0.057, p = 0.046) and rs10830963 (b = -0.096, p = 0.001) were associated with HOMA-B, while rs7754840 was associated with decrease in insulin AUC during a 100 g OGTT given at the time of GDM diagnosis (b = -0.080, p = 0.007). Conclusions/Significance: Several risk alleles of type 2 diabetes were associated with GDM in pregnant Chinese women. The effects of these SNPs on GDM might be through the impairment of beta cell function and these risk loci contributed additively to the disease.	[Wang, Ying; Nie, Min; Li, Wei; Ping, Fan; Hu, Yingying] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrine,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China; [Wang, Ying] ShanXi Med Coll, Affiliated Hosp 2, Dept Endocrinol, Taiyuan, Shan Xi, Peoples R China; [Ma, Liangkun; Gao, Jinsong; Liu, Juntao] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wang, Y (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Key Lab Endocrine,Minist Hlth,Dept Endocrinol, Beijing 100730, Peoples R China.	nm_pumch@yahoo.com.cn			National Natural Science Foundation of China [81070630, 30672210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Project of National Natural Science Foundation of China (no. 81070630 and no. 30672210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2004, DIABETES CARE S1, V27, P380, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Chen Z, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-35; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fernandez-Mejia C, 2001, ENDOCRINOLOGY, V142, P1448, DOI 10.1210/en.142.4.1448; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; JASON YK, 2011, BMC MED GEN IN PRESS, V12, P82; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Lin Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-97; Linne Y, 2002, BJOG-INT J OBSTET GY, V109, P1227; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pascoe L, 2008, DIABETOLOGIA, V51, P1989, DOI 10.1007/s00125-008-1124-7; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; RYAN EA, 1995, DIABETES, V44, P506, DOI 10.2337/diabetes.44.5.506; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaat N, 2007, DIABETOLOGIA, V50, P972, DOI 10.1007/s00125-007-0623-2; Shaat N, 2006, DIABETOLOGIA, V49, P1545, DOI 10.1007/s00125-006-0258-8; Shaat N, 2005, DIABETOLOGIA, V48, P2544, DOI 10.1007/s00125-005-0035-0; Shaat N, 2007, CURR MED CHEM, V14, P569, DOI 10.2174/092986707780059643; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; TSAI FJ, 2010, PLOS ONE, V19, P6; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Watanabe RM, 2007, DIABETES, V56, P1481, DOI 10.2337/db06-1682; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Williams MA, 2003, J REPROD MED, V48, P955; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Xiang AH, 1999, DIABETES, V48, P848, DOI 10.2337/diabetes.48.4.848; XU M, 2010, PLOS ONE, V17, P5; Yang XL, 2002, DIABETES CARE, V25, P847, DOI 10.2337/diacare.25.5.847; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou Q, 2009, DIABETOLOGIA, V52, P2466, DOI 10.1007/s00125-009-1500-y	50	73	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26953	10.1371/journal.pone.0026953	http://dx.doi.org/10.1371/journal.pone.0026953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096510	Green Submitted, gold, Green Published			2022-12-25	WOS:000297553900016
J	Kibler, KV; Gomez, CE; Perdiguero, B; Wong, SM; Huynh, T; Holechek, S; Arndt, W; Jimenez, V; Gonzalez-Sanz, R; Denzler, K; Haddad, EK; Wagner, R; Sekaly, RP; Tartaglia, J; Pantaleo, G; Jacobs, BL; Esteban, M				Kibler, Karen V.; Gomez, Carmen E.; Perdiguero, Beatriz; Wong, Shukmei; Trung Huynh; Holechek, Susan; Arndt, William; Jimenez, Victoria; Gonzalez-Sanz, Ruben; Denzler, Karen; Haddad, Elias K.; Wagner, Ralf; Sekaly, Rafick P.; Tartaglia, James; Pantaleo, Giuseppe; Jacobs, Bertram L.; Esteban, Mariano			Improved NYVAC-Based Vaccine Vectors	PLOS ONE			English	Article							T-CELL RESPONSES; CLADE-C; GENE-EXPRESSION; VIRUS; MVA; IMMUNOGENICITY; ALVAC; DNA	While as yet there is no vaccine against HIV/AIDS, the results of the phase III Thai trial (RV144) have been encouraging and suggest that further improvements of the prime/boost vaccine combination of a poxvirus and protein are needed. With this aim, in this investigation we have generated derivatives of the candidate vaccinia virus vaccine vector NYVAC with potentially improved functions. This has been achieved by the re-incorporation into the virus genome of two host range genes, K1L and C7L, in conjunction with the removal of the immunomodulatory viral molecule B19, an antagonist of type I interferon action. These novel virus vectors, referred to as NYVAC-C-KC and NYVAC-C-KC-DB19R, have acquired relevant biological characteristics, giving higher levels of antigen expression in infected cells, replication-competency in human keratinocytes and dermal fibroblasts, activation of selective host cell signal transduction pathways, and limited virus spread in tissues. Importantly, these replication-competent viruses have been demonstrated to maintain a highly attenuated phenotype.	[Kibler, Karen V.; Wong, Shukmei; Trung Huynh; Holechek, Susan; Arndt, William; Denzler, Karen; Jacobs, Bertram L.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Gomez, Carmen E.; Perdiguero, Beatriz; Jimenez, Victoria; Gonzalez-Sanz, Ruben; Esteban, Mariano] Consejo Super Invest Cient, Ctr Nacl Biotecnol, Madrid, Spain; [Haddad, Elias K.; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Sekaly, Rafick P.] Univ Montreal, Montreal, PQ, Canada; [Wagner, Ralf] Univ Regensburg, Regensburg, Germany; [Tartaglia, James] Sanofi Pasteur, Swiftwater, PA USA; [Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	Arizona State University; Arizona State University-Tempe; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vaccine & Gene Therapy Institute of Florida; Universite de Montreal; University of Regensburg; Sanofi-Aventis; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kibler, KV (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	bjacobs@asu.edu; mesteban@cnb.csic.es	Esteban, Mariano/ABG-5375-2020; gonzalez, ruben/O-5088-2014; González, Rubén/N-7936-2019; Pantaleo, Giuseppe/K-6163-2016; Perdiguero, Beatriz/K-6587-2017; Gomez, Carmen Elena/K-1940-2014	Esteban, Mariano/0000-0003-0846-2827; Perdiguero, Beatriz/0000-0001-6276-7766; Gomez, Carmen Elena/0000-0002-5414-7935	Bill and Melinda Gates Foundation; Spanish grant [SAF2008-02036]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish grant(Spanish Government)	This study was conducted as part of the Poxvirus T cell Vaccine Discovery Consortium (PTVDC) as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill and Melinda Gates Foundation. Mariano Esteban was supported in part by a Spanish grant (SAF2008-02036). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JT is an employee of Sanofi Pasteur and as such, Sanofi Pasteur is considered by PLoS ONE to have contributed funding to this research.	ALCAMI A, 1995, J VIROL, V69, P4633; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Li ZQ, 2004, VACCINE, V22, P1486, DOI 10.1016/j.vaccine.2003.10.022; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; PAOLETTI E, 1994, DEV BIOL STAND, V82, P65; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Willis KL, 2009, VIROLOGY, V394, P73, DOI 10.1016/j.virol.2009.08.020	30	48	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e25674	10.1371/journal.pone.0025674	http://dx.doi.org/10.1371/journal.pone.0025674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096477	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800002
J	D'Osualdo, A; Weichenberger, CX; Wagner, RN; Godzik, A; Wooley, J; Reed, JC				D'Osualdo, Andrea; Weichenberger, Christian X.; Wagner, Roland N.; Godzik, Adam; Wooley, John; Reed, John C.			CARD8 and NLRP1 Undergo Autoproteolytic Processing through a ZU5-Like Domain	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HOMOLOGY DETECTION; ACTIVATION; PREDICTION; INFLAMMASOME; CASPASE-2; SERVER; FORMS	The "Function to Find Domain" (FIIND)-containing proteins CARD8 (Cardinal; Tucan) and NLRP1 (NALP1; NAC) are well known components of inflammasomes, multiprotein complexes responsible for activation of caspase-1, a regulator of inflammation and innate immunity. Although identified many years ago, the role of the FIIND is unknown. Here, we report that CARD8 and NLRP1 undergo autoproteolytic cleavage at a conserved SF/S motif within the FIIND. Using bioinformatics and computational modeling approaches, we detected striking structural similarity between the FIIND and the ZU5-UPA domain present in the autoproteolytic protein PIDD. This allowed us to generate a three-dimensional model and to gain insights in the molecular mechanism of the cleavage. Site-directed mutagenesis experiments revealed that the second serine of the SF/S motif is required for CARD8 and NLRP1 autoproteolysis. Furthermore, we discovered an important function for conserved glutamic acid and histidine residues, located in proximity of the cleavage site in regulating the autoprocessing efficiency. Altogether, these results identify a function for the FIIND and show that CARD8 and NLRP1 are ZU5-UPA domain-containing autoproteolytic proteins, thus suggesting a novel mechanism for regulating innate immune responses.	[D'Osualdo, Andrea; Weichenberger, Christian X.; Wagner, Roland N.; Godzik, Adam; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Weichenberger, Christian X.; Wooley, John] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Weichenberger, Christian X.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; European Academy of Bozen-Bolzano	D'Osualdo, A (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	reedoffice@sanfordburnham.org	Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Weichenberger, Christian X./0000-0002-2176-0274	National Institutes of Health (NIH) [AI-56324]; American-Italian Cancer Foundation; Austrian Science Fund (FWF) [J 3154] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056324] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Italian Cancer Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the National Institutes of Health (NIH) for generous support (AI-56324). Andrea D'Osualdo was supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bagnall RD, 2008, EUR J HUM GENET, V16, P619, DOI 10.1038/sj.ejhg.5201996; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1998, NAT STRUCT BIOL, V5, P249, DOI 10.1038/nsb0498-249; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Sun Y, 2008, PROTEIN SCI, V17, P494, DOI 10.1110/ps.073311808; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	34	107	110	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27396	10.1371/journal.pone.0027396	http://dx.doi.org/10.1371/journal.pone.0027396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087307	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700040
J	Meissner, M; Herrema, H; van Dijk, TH; Gerding, A; Havinga, R; Boer, T; Muller, M; Reijngoud, DJ; Groen, AK; Kuipers, F				Meissner, Maxi; Herrema, Hilde; van Dijk, Theo H.; Gerding, Albert; Havinga, Rick; Boer, Theo; Mueller, Michael; Reijngoud, Dirk-Jan; Groen, Albert K.; Kuipers, Folkert			Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; TYPE-2 DIABETES-MELLITUS; PERIPHERAL INSULIN SENSITIVITY; COLESEVELAM HYDROCHLORIDE; NUCLEAR RECEPTOR; GLYCEMIC CONTROL; CARBOHYDRATE-METABOLISM; DOUBLE-BLIND; FATTY-ACIDS; OB/OB MICE	Aims/Hypothesis: Bile acid sequestrants (BAS) reduce plasma glucose levels in type II diabetics and in murine models of diabetes but the mechanism herein is unknown. We hypothesized that sequestrant-induced changes in hepatic glucose metabolism would underlie reduced plasma glucose levels. Therefore, in vivo glucose metabolism was assessed in db/db mice on and off BAS using tracer methodology. Methods: Lean and diabetic db/db mice were treated with 2% (wt/wt in diet) Colesevelam HCl (BAS) for 2 weeks. Parameters of in vivo glucose metabolism were assessed by infusing [U-C-13]- glucose, [2-C-13]- glycerol, [1-H-2]- galactose and paracetamol for 6 hours, followed by mass isotopologue distribution analysis, and related to metabolic parameters as well as gene expression patterns. Results: Compared to lean mice, db/db mice displayed an almost 3-fold lower metabolic clearance rate of glucose (p = 0.0001), a similar to 300% increased glucokinase flux (p = 0.001) and a similar to 200% increased total hepatic glucose production rate (p = 0.0002). BAS treatment increased glucose metabolic clearance rate by similar to 37% but had no effects on glucokinase flux nor total hepatic or endogenous glucose production. Strikingly, BAS-treated db/db mice displayed reduced long-chain acylcarnitine content in skeletal muscle (p = 0.0317) but not in liver (p = 0.189). Unexpectedly, BAS treatment increased hepatic FGF21 mRNA expression 2-fold in lean mice (p = 0.030) and 3-fold in db/db mice (p = 0.002). Conclusions/Interpretation: BAS induced plasma glucose lowering in db/db mice by increasing metabolic clearance rate of glucose in peripheral tissues, which coincided with decreased skeletal muscle long-chain acylcarnitine content.	[Meissner, Maxi; Herrema, Hilde; Havinga, Rick; Groen, Albert K.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [van Dijk, Theo H.; Gerding, Albert; Boer, Theo; Reijngoud, Dirk-Jan; Groen, Albert K.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Herrema, Hilde; Mueller, Michael] Nutrigen Consortium TI Food & Nutr, Wageningen, Netherlands; [Herrema, Hilde; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands	University of Groningen; University of Groningen; Top Institute Food & Nutrition; Wageningen University & Research	Meissner, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.	meissner.maxi@gmail.com	Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Kuipers, Folkert/0000-0003-2518-737X; Meissner, Maxi/0000-0001-9422-4141; Herrema, Hilde/0000-0002-0112-6348; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Groningen Expert Center for Kids with Obesity (GECKO); DaiichiSankyo (Pirsipanny, NJ)	Groningen Expert Center for Kids with Obesity (GECKO); DaiichiSankyo (Pirsipanny, NJ)	This study was funded by an unrestricted research grant of the Groningen Expert Center for Kids with Obesity (GECKO) and DaiichiSankyo (Pirsipanny, NJ). Neither GECKO nor DaiichiSankyo took part in the data collection nor the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Bays HE, 2008, ARCH INTERN MED, V168, P1975, DOI 10.1001/archinte.168.18.1975; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; Cariou B, 2005, ENDOCRINOLOGY, V146, P981, DOI 10.1210/en.2004-1595; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chace DH, 2001, CLIN CHEM, V47, P1166; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Claudel T, 2002, J CLIN INVEST, V109, P961; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Davidson MH, 2007, EXPERT OPIN PHARMACO, V8, P2569, DOI 10.1517/14656566.8.15.2569; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Donovan JM, 2005, DIGEST DIS SCI, V50, P1232, DOI 10.1007/s10620-005-2765-8; Duran-Sandoval D, 2005, BIOCHIMIE, V87, P93, DOI 10.1016/j.biochi.2004.11.018; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Fonseca VA, 2008, DIABETES CARE, V31, P1479, DOI 10.2337/dc08-0283; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Freeman Jeffrey S, 2009, Cleve Clin J Med, V76 Suppl 5, pS12, DOI 10.3949/ccjm.76.s5.03; GARG A, 1994, ANN INTERN MED, V121, P416, DOI 10.7326/0003-4819-121-6-199409150-00004; GATES SC, 1978, CLIN CHEM, V24, P1663; Goldberg RB, 2008, ARCH INTERN MED, V168, P1531, DOI 10.1001/archinte.168.14.1531; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; Herrema H, 2009, HEPATOLOGY; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lefebvre P., 2009, PHYSIOL REV, P147; Matsuzaki Y, 2002, J GASTROEN HEPATOL, V17, P1133, DOI 10.1046/j.1440-1746.2002.02860.x; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Onishi T, 2002, J GASTROEN HEPATOL, V17, P697, DOI 10.1046/j.1440-1746.2002.02765.x; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; SHAFRIR E, 1992, DIABETES METAB REV, V8, P179, DOI 10.1002/dmr.5610080302; Shang Q, 2010, AM J PHYSIOL-GASTR L, V298, pG419, DOI 10.1152/ajpgi.00362.2009; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zieve FJ, 2007, CLIN THER, V29, P74, DOI 10.1016/j.clinthera.2007.01.003	52	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e24564	10.1371/journal.pone.0024564	http://dx.doi.org/10.1371/journal.pone.0024564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087215	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700001
J	Yokoyama, T; Tam, J; Kuroda, S; Scott, AW; Aaron, J; Larson, T; Shanker, M; Correa, AM; Kondo, S; Roth, JA; Sokolov, K; Ramesh, R				Yokoyama, Tomohisa; Tam, Justina; Kuroda, Shinji; Scott, Ailing W.; Aaron, Jesse; Larson, Tim; Shanker, Manish; Correa, Arlene M.; Kondo, Seiji; Roth, Jack A.; Sokolov, Konstantin; Ramesh, Rajagopal			EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONITORING AUTOPHAGY; QUANTUM DOTS; THERAPY; ANTIBODIES; LC3; MUTATIONS; CETUXIMAB; DELIVERY; LIGAND	Background: The epidermal growth factor receptor (EGFR) is overexpressed in 80% of non-small cell lung cancer (NSCLC) and is associated with poor survival. In recent years, EGFR-targeted inhibitors have been tested in the clinic for NSCLC. Despite the emergence of novel therapeutics and their application in cancer therapy, the overall survival rate of lung cancer patients remains 15%. To develop more effective therapies for lung cancer we have combined the anti-EGFR antibody (Clone 225) as a molecular therapeutic with hybrid plasmonic magnetic nanoparticles (NP) and tested on non-small cell lung cancer (NSCLC) cells. Methodology/Principal Findings: Cell viability was determined by trypan-blue assay. Cellular protein expression was determined by Western blotting. C225-NPs were detected by electron microscopy and confocal microscopy, and EGFR expression using immunocytochemistry. C225-NP exhibited a strong and selective antitumor effect on EGFR-expressing NSCLC cells by inhibiting EGFR-mediated signal transduction and induced autophagy and apoptosis in tumor cells. Optical images showed specificity of interactions between C225-NP and EGFR-expressing NSCLC cells. No binding of C225-NP was observed for EGFR-null NSCLC cells. C225-NP exhibited higher efficiency in induction of cell killing in comparison with the same amount of free C225 antibody in tumor cells with different levels of EGFR expression. Furthermore, in contrast to C225-NP, free C225 antibody did not induce autophagy in cells. However, the therapeutic efficacy of C225-NP gradually approached the level of free antibodies as the amount of C225 antibody conjugated per nanoparticle was decreased. Finally, attaching C225 to NP was important for producing the enhanced tumor cell killing as addition of mixture of free C225 and NP did not demonstrate the same degree of cell killing activity. Conclusions/Significance: We demonstrated for the first time the molecular mechanism of C225-NP induced cytotoxic effects in lung cancer cells that are not characteristic for free molecular therapeutics thus increasing efficacy of therapy against NSCLC.	[Yokoyama, Tomohisa; Kuroda, Shinji; Scott, Ailing W.; Shanker, Manish; Correa, Arlene M.; Roth, Jack A.; Ramesh, Rajagopal] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Tam, Justina; Aaron, Jesse; Larson, Tim; Sokolov, Konstantin] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kondo, Seiji] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Sokolov, Konstantin] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Grad Program Biomed Sci, Oklahoma City, OK USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yokoyama, T (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	kostia@mail.utexas.edu; rajagopal-ramesh@ouhsc.edu		Sokolov, Konstantin/0000-0002-0198-2005	National Cancer Institute [R01CA103830, RO3EB009182, P50CA070907, CA16672]; Joans Legacy: United against Lung Cancer; NATIONAL CANCER INSTITUTE [R01CA103830, P50CA070907, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB009182] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joans Legacy: United against Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by the National Cancer Institute grants R01CA103830, RO3EB009182, P50CA070907 (SPORE in Lung Cancer), CA16672, and The Joans Legacy: United against Lung Cancer. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaron J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2737351; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Baker CH, 2002, AM J PATHOL, V161, P929, DOI 10.1016/S0002-9440(10)64253-8; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; DeGrendele Heather, 2003, Clin Lung Cancer, V5, P83; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; GOOI HC, 1985, BIOSCIENCE REP, V5, P83; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Jablonski AE, 2010, J PHYS CHEM LETT, V1, P1312, DOI 10.1021/jz100248c; Ji XJ, 2007, J PHYS CHEM C, V111, P6245, DOI 10.1021/jp0702245; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kumar S, 2008, NAT PROTOC, V3, P314, DOI 10.1038/nprot.2008.1; Larabell CA, 2010, CURR OPIN STRUC BIOL, V20, P623, DOI 10.1016/j.sbi.2010.08.008; Larson TA, 2007, NANOTECHNOLOGY, V18, P325; Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f; Ma LL, 2011, LANGMUIR, V27, P7681, DOI 10.1021/la200659z; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Milas L, 2004, INT J RADIAT ONCOL, V58, P966, DOI 10.1016/j.ijrobp.2003.08.035; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Poon Z, 2010, ANGEW CHEM INT EDIT, V49, P7266, DOI 10.1002/anie.201003445; Ramesh R, 2003, CANCER RES, V63, P5105; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Sokolov K, 2003, CANCER RES, V63, P1999; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; VEALE D, 1989, CANCER RES, V49, P1313; Wang AZ, 2008, CHEMMEDCHEM, V3, P1311, DOI 10.1002/cmdc.200800091; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941	39	79	81	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e25507	10.1371/journal.pone.0025507	http://dx.doi.org/10.1371/journal.pone.0025507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087216	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700002
J	Dalton, T; Dowd, SE; Wolcott, RD; Sun, Y; Watters, C; Griswold, JA; Rumbaugh, KP				Dalton, Trevor; Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan; Watters, Chase; Griswold, John A.; Rumbaugh, Kendra P.			An In Vivo Polymicrobial Biofilm Wound Infection Model to Study Interspecies Interactions	PLOS ONE			English	Article							AERUGINOSA SWARMING MOTILITY; DIABETIC FOOT ULCER; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MUTANS; MULTISPECIES BIOFILMS; TWITCHING MOTILITY; MOUSE MODEL; VIRULENCE; CELL; FLAGELLA	Chronic wound infections are typically polymicrobial; however, most in vivo studies have focused on monospecies infections. This project was designed to develop an in vivo, polymicrobial, biofilm-related, infected wound model in order to study multispecies biofilm dynamics and in relation to wound chronicity. Multispecies biofilms consisting of both Gram negative and Gram positive strains, as well as aerobes and anaerobes, were grown in vitro and then transplanted onto the wounds of mice. These in vitro-to-in vivo multi-species biofilm transplants generated polymicrobial wound infections, which remained heterogeneous with four bacterial species throughout the experiment. We observed that wounded mice given multispecies biofilm infections displayed a wound healing impairment over mice infected with a single-species of bacteria. In addition, the bacteria in the polymicrobial wound infections displayed increased antimicrobial tolerance in comparison to those in single species infections. These data suggest that synergistic interactions between different bacterial species in wounds may contribute to healing delays and/or antibiotic tolerance.	[Dalton, Trevor; Watters, Chase; Griswold, John A.; Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Dalton, Trevor; Watters, Chase; Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Lubbock, TX 79430 USA; [Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan] Res & Testing Lab, Lubbock, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Dalton, T (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA.	kendra.rumbaugh@ttuhsc.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Griswold, John/0000-0002-0578-0646	American Diabetes Association [1-08-RA-165]	American Diabetes Association(American Diabetes Association)	This study was supported by American Diabetes Association research grant #1-08-RA-165 to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Burn Association, BURN INC TREATM US 2; American Diabetes Association, DAT 2011 NAT DIAB FA; BJORNSON HS, 1982, SURGERY, V92, P720; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; BROOK I, 1985, INFECT IMMUN, V50, P929, DOI 10.1128/IAI.50.3.929-931.1985; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; [Center for Disease Control Center U.S. Department of Health and Human Services Centers for Disease Control and Prevention], 2002, NAT EST GEN INF DIAB; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Cunningham AB, 2006, BIOFILMS HYPERTEXTBO; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gurjala AN, 2010, ADV WOUND CARE-SER, V1, P305, DOI 10.1089/awc.2009.0094; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Huelves L, 2007, MICROB PATHOGENESIS, V43, P114, DOI 10.1016/j.micpath.2007.05.005; INGHAM HR, 1977, LANCET, V2, P1252; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Mastropaolo MD, 2005, INFECT IMMUN, V73, P6055, DOI 10.1128/IAI.73.9.6055-6063.2005; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MERGENHAGEN SE, 1958, J INFECT DIS, V103, P33, DOI 10.1093/infdis/103.1.33; Nakagami G, 2008, WOUND REPAIR REGEN, V16, P30, DOI 10.1111/j.1524-475X.2007.00329.x; National Institute of General Medical Sciences, 2007, FACT SHEET TRAUM SHO; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Potokar TS, 2008, BURNS, V34, P3, DOI 10.1016/j.burns.2007.09.004; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8; Rickard AH, 2010, J APPL MICROBIOL, V108, P1509, DOI 10.1111/j.1365-2672.2009.04554.x; Rumbaugh K.P., 2010, BIOFILM INFECT; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Sun Y, 2009, J Wound Care, V18, P426; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Sun Y, 2010, INVEST OPHTH VIS SCI, V51, P1511, DOI 10.1167/iovs.09-4237; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Watters C, 2010, PSEUDOMONAS AERUGINO; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709; Xie Q, 2008, ORAL MICROBIOL IMMUN, V23, P459, DOI 10.1111/j.1399-302X.2008.00450.x; Zolfaghar I, 2003, INFECT IMMUN, V71, P5389, DOI 10.1128/IAI.71.9.5389-5393.2003	56	218	223	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27317	10.1371/journal.pone.0027317	http://dx.doi.org/10.1371/journal.pone.0027317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076151	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200065
J	Kirkby, JA; Blythe, HI; Drieghe, D; Liversedge, SP				Kirkby, Julie A.; Blythe, Hazel I.; Drieghe, Denis; Liversedge, Simon P.			Reading Text Increases Binocular Disparity in Dyslexic Children	PLOS ONE			English	Article							VERGENCE EYE-MOVEMENTS; MONOCULAR OCCLUSION; COORDINATION; PERCEPTION	Children with developmental dyslexia show reading impairment compared to their peers, despite being matched on IQ, socio-economic background, and educational opportunities. The neurological and cognitive basis of dyslexia remains a highly debated topic. Proponents of the magnocellular theory, which postulates abnormalities in the M-stream of the visual pathway cause developmental dyslexia, claim that children with dyslexia have deficient binocular coordination, and this is the underlying cause of developmental dyslexia. We measured binocular coordination during reading and a non-linguistic scanning task in three participant groups: adults, typically developing children, and children with dyslexia. A significant increase in fixation disparity was observed for dyslexic children solely when reading. Our study casts serious doubts on the claims of the magnocellular theory. The exclusivity of increased fixation disparity in dyslexics during reading might be a result of the allocation of inadequate attentional and/or cognitive resources to the reading process, or suboptimal linguistic processing per se.	[Kirkby, Julie A.] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England; [Blythe, Hazel I.; Drieghe, Denis; Liversedge, Simon P.] Univ Southampton, Sch Psychol, Southampton, Hants, England	Bournemouth University; University of Southampton	Kirkby, JA (corresponding author), Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England.	jkirkby@bournemouth.ac.uk		Drieghe, Denis/0000-0001-9630-8410; Kirkby, Julie/0000-0001-6502-0676	Leverhulme Trust [F/00 180/W]; Economic and Social Research Council; Biotechnology and Biological Sciences Research Council [519168]; Economic and Social Research Council [RES-000-22-3398]	Leverhulme Trust(Leverhulme Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	J.A.K. was supported by the Leverhulme Trust. H.I.B. was supported by an Economic and Social Research Council Postdoctoral Fellowship. S.P.L. was supported by Biotechnology and Biological Sciences Research Council grant (519168), Economic and Social Research Council grant (RES-000-22-3398) and Leverhulme Trust grant (F/00 180/W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Boden C, 2007, PSYCHOL BULL, V133, P346, DOI 10.1037/0033-2909.133.2.346; BURT P, 1980, SCIENCE, V208, P615, DOI 10.1126/science.7367885; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; CORNELISSEN P, 1992, DEV MED CHILD NEUROL, V34, P296; Erkelens CJ, 2001, VISION RES, V41, P3497, DOI 10.1016/S0042-6989(01)00004-9; FENDER D, 1967, J OPT SOC AM, V57, P819, DOI 10.1364/JOSA.57.000819; GALABURDA AM, 1993, CURR OPIN NEUROBIOL, V3, P237, DOI 10.1016/0959-4388(93)90216-L; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GALABURDA AM, 1993, NEUROL CLIN, V11, P161, DOI 10.1016/S0733-8619(18)30175-0; Heller D, 1999, CURRENT OCULOMOTOR RESEARCH, P341; Hendriks AW, 1996, ACTA PSYCHOL, V92, P131, DOI 10.1016/0001-6918(95)00011-9; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; Jaschinski W, 2004, KLIN MONATSBL AUGENH, V221, P854, DOI 10.1055/s-2004-813712; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; Ramus F, 2001, Dyslexia, V7, P197, DOI 10.1002/dys.205; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Rayner K, 2009, PERCEPTION, V38, P895, DOI 10.1068/ldmk-ray; Sheliga BM, 2006, VISION RES, V46, P3723, DOI 10.1016/j.visres.2006.04.020; Snowling M., 2000, DYSLEXIA; Snowling M.J., 1995, J RES READ, V18, P132, DOI DOI 10.1111/J.1467-9817.1995.TB00079.X; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; STEIN J, 1985, LANCET, V2, P69; Stein JF, 2000, BRAIN, V123, P164, DOI 10.1093/brain/123.1.164; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Wechsler D., 2009, WECHSLER INDIVIDUAL, V3rd; Wechsler D., 1999, WECHSLER ABBREVIATED	34	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27105	10.1371/journal.pone.0027105	http://dx.doi.org/10.1371/journal.pone.0027105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073266	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200034
J	Sborgi, L; Verma, A; Munoz, V; de Alba, E				Sborgi, Lorenzo; Verma, Abhinav; Munoz, Victor; de Alba, Eva			Revisiting the NMR Structure of the Ultrafast Downhill Folding Protein gpW from Bacteriophage lambda	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SIMULATIONS; FIELD	GpW is a 68-residue protein from bacteriophage lambda that participates in virus head morphogenesis. Previous NMR studies revealed a novel alpha+beta fold for this protein. Recent experiments have shown that gpW folds in microseconds by crossing a marginal free energy barrier (i.e., downhill folding). These features make gpW a highly desirable target for further experimental and computational folding studies. As a step in that direction, we have re-determined the high-resolution structure of gpW by multidimensional NMR on a construct that eliminates the purification tags and unstructured C-terminal tail present in the prior study. In contrast to the previous work, we have obtained a full manual assignment and calculated the structure using only unambiguous distance restraints. This new structure confirms the alpha+beta topology, but reveals important differences in tertiary packing. Namely, the two alpha-helices are rotated along their main axis to form a leucine zipper. The beta-hairpin is orthogonal to the helical interface rather than parallel, displaying most tertiary contacts through strand 1. There also are differences in secondary structure: longer and less curved helices and a hairpin that now shows the typical right-hand twist. Molecular dynamics simulations starting from both gpW structures, and calculations with CS-Rosetta, all converge to our gpW structure. This confirms that the original structure has strange tertiary packing and strained secondary structure. A comparison of NMR datasets suggests that the problems were mainly caused by incomplete chemical shift assignments, mistakes in NOE assignment and the inclusion of ambiguous distance restraints during the automated procedure used in the original study. The new gpW corrects these problems, providing the appropriate structural reference for future work. Furthermore, our results are a cautionary tale against the inclusion of ambiguous experimental information in the determination of protein structures.	[Sborgi, Lorenzo; Verma, Abhinav; Munoz, Victor; de Alba, Eva] Consejo Super Invest Cient, Ctr Invest Biol, Madrid, Spain; [Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University System of Maryland; University of Maryland College Park	Sborgi, L (corresponding author), Consejo Super Invest Cient, Ctr Invest Biol, Madrid, Spain.	vmunoz@cib.csic.es; dealbae@cib.csic.es			Spanish Ministry of Science and Innovation [BFU2008-03278, BFU2008-03237, CSD2009-00088]; Marie Curie Excellence Award [MEXT-CT-2006-04233]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Excellence Award(European Commission)	This work was supported by the grants BFU2008-03278 (to E.d.A.), BFU2008-03237 (to V.M.) and Consolider-Ingenio 2010 program grant CSD2009-00088 (to V.M. and E.d.A.) from the Spanish Ministry of Science and Innovation, and from Marie Curie Excellence Award MEXT-CT-2006-04233 (to V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bruscolini P, 2011, J AM CHEM SOC, V133, P5372, DOI 10.1021/ja110884m; Cavanagh J., PROTEIN NMR SPECTROS; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Sancho D, 2008, J COMPUT CHEM, V29, P1684, DOI 10.1002/jcc.20924; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; *DELANO SCI LLC, 2004, PYMOL MOL GRAPH SYST; Fung A, 2008, J AM CHEM SOC, V130, P7489, DOI 10.1021/ja801401a; GARRETT DS, 1991, J MAGN RESON, V95, P216; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maxwell KL, 2001, J MOL BIOL, V308, P9, DOI 10.1006/jmbi.2001.4582; Maxwell KL, 2000, J BIOL CHEM, V275, P18879, DOI 10.1074/jbc.M001178200; Moseley HNB, 1999, CURR OPIN STRUC BIOL, V9, P635, DOI 10.1016/S0959-440X(99)00019-6; Munoz V, 2008, HFSP J, V2, P342, DOI 10.2976/1.2988030; Murialdo H, 2003, BIOCHEM CELL BIOL, V81, P307, DOI 10.1139/O03-059; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273	25	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26409	10.1371/journal.pone.0026409	http://dx.doi.org/10.1371/journal.pone.0026409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22087227	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200010
J	Eiserhardt, WL; Bjorholm, S; Svenning, JC; Rangel, TF; Balslev, H				Eiserhardt, Wolf L.; Bjorholm, Stine; Svenning, Jens-Christian; Rangel, Thiago F.; Balslev, Henrik			Testing the Water-Energy Theory on American Palms (Arecaceae) Using Geographically Weighted Regression	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; LATITUDINAL GRADIENT; DIVERSITY PATTERNS; GLOBAL PATTERNS; SCALE VARIATION; CLIMATE; DETERMINANTS; PTERIDOPHYTE; EXPLANATION; ECOLOGY	Water and energy have emerged as the best contemporary environmental correlates of broad-scale species richness patterns. A corollary hypothesis of water-energy dynamics theory is that the influence of water decreases and the influence of energy increases with absolute latitude. We report the first use of geographically weighted regression for testing this hypothesis on a continuous species richness gradient that is entirely located within the tropics and subtropics. The dataset was divided into northern and southern hemispheric portions to test whether predictor shifts are more pronounced in the less oceanic northern hemisphere. American palms (Arecaceae, n = 547 spp.), whose species richness and distributions are known to respond strongly to water and energy, were used as a model group. The ability of water and energy to explain palm species richness was quantified locally at different spatial scales and regressed on latitude. Clear latitudinal trends in agreement with water-energy dynamics theory were found, but the results did not differ qualitatively between hemispheres. Strong inherent spatial autocorrelation in local modeling results and collinearity of water and energy variables were identified as important methodological challenges. We overcame these problems by using simultaneous autoregressive models and variation partitioning. Our results show that the ability of water and energy to explain species richness changes not only across large climatic gradients spanning tropical to temperate or arctic zones but also within megathermal climates, at least for strictly tropical taxa such as palms. This finding suggests that the predictor shifts are related to gradual latitudinal changes in ambient energy (related to solar flux input) rather than to abrupt transitions at specific latitudes, such as the occurrence of frost.	[Eiserhardt, Wolf L.; Bjorholm, Stine; Svenning, Jens-Christian; Balslev, Henrik] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Rangel, Thiago F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil	Aarhus University; Universidade Federal de Goias	Eiserhardt, WL (corresponding author), Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	henrik.balslev@biology.au.dk	Balslev, Henrik/J-9191-2013; Rangel, Thiago F/H-8708-2012; Svenning, Jens-Christian/C-8977-2012; Balslev, Hendrik/AAE-4071-2020; Eiserhardt, Wolf L./D-7677-2011	Balslev, Henrik/0000-0002-7101-7120; Rangel, Thiago F/0000-0002-2001-7382; Svenning, Jens-Christian/0000-0002-3415-0862; Eiserhardt, Wolf L./0000-0002-8136-5233	Danish Council for Independent Research - Natural Sciences [272-07-0242, 10-083348]; European Community [212631]; faculty of Natural Sciences at the University of Aarhus	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); European Community(European Commission); faculty of Natural Sciences at the University of Aarhus	This work was supported by the Danish Council for Independent Research - Natural Sciences (grant# 272-07-0242 to JCS, #10-083348 to HB) and the European Community (FP7 grant #212631 to HB). The faculty of Natural Sciences at the University of Aarhus supported SB's PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; [Anonymous], 2010, R LANG ENV STAT COMP; Balslev H, 2011, BOT REV IN PRESS, DOI [10.1007/s12229-12011-19084-x, DOI 10.1007/S12229-12011-19084-X]; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Bickford SA, 2006, GLOBAL ECOL BIOGEOGR, V15, P588, DOI 10.1111/j.1466-8238.2006.00250.x; Bjorholm S, 2006, BOT J LINN SOC, V151, P113, DOI 10.1111/j.1095-8339.2006.00527.x; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brunsdon C, 2001, INT J CLIMATOL, V21, P455, DOI 10.1002/joc.614; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dransfield J., 2008, GENERA PALMARUM; Eiserhardt WL, 2011, ANN BOT IN PRESS; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Foody GM, 2005, GLOBAL ECOL BIOGEOGR, V14, P99, DOI 10.1111/j.1466-822X.2005.00142.x; Foody GM, 2004, GLOBAL ECOL BIOGEOGR, V13, P315, DOI 10.1111/j.1466-822X.2004.00097.x; Foody GM, 2003, REMOTE SENS ENVIRON, V88, P283, DOI 10.1016/j.rse.2003.08.004; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; HENDERSON A, 1995, FIELD GUIDE PALMS AM; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Jetz W, 2005, GLOBAL ECOL BIOGEOGR, V14, P97, DOI 10.1111/j.1466-822X.2004.00129.x; Keil P, 2008, INSECT CONSERV DIVER, V1, P142, DOI 10.1111/j.1752-4598.2008.00019.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2006, ECOGRAPHY, V29, P21, DOI 10.1111/j.2005.0906-7590.04203.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kreft H, 2010, ECOGRAPHY, V33, P408, DOI 10.1111/j.1600-0587.2010.06434.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lyons SK, 2002, ECOLOGY, V83, P47; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Salm Rodolfo, 2007, Acta Amaz., V37, P17, DOI 10.1590/S0044-59672007000100002; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Svenning JC, 2009, ECOGRAPHY, V32, P13, DOI 10.1111/j.1600-0587.2008.05732.x; Terribile LC, 2009, ACTA OECOL, V35, P163, DOI 10.1016/j.actao.2008.09.006; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; [No title captured]; [No title captured]	56	27	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27027	10.1371/journal.pone.0027027	http://dx.doi.org/10.1371/journal.pone.0027027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073244	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000023
J	Fottrell, E; Kahn, K; Tollman, S; Byass, P				Fottrell, Edward; Kahn, Kathleen; Tollman, Stephen; Byass, Peter			Probabilistic Methods for Verbal Autopsy Interpretation: InterVA Robustness in Relation to Variations in A Priori Probabilities	PLOS ONE			English	Article							SOUTH-AFRICA; DEATH; TRANSITION; MORTALITY; MODEL	Background: InterVA is a probabilistic method for interpreting verbal autopsy (VA) data. It uses a priori approximations of probabilities relating to diseases and symptoms to calculate the probability of specific causes of death given reported symptoms recorded in a VA interview. The extent to which InterVA's ability to characterise a population's mortality composition might be sensitive to variations in these a priori probabilities was investigated. Methods: A priori InterVA probabilities were changed by 1, 2 or 3 steps on the logarithmic scale on which the original probabilities were based. These changes were made to a random selection of 25% and 50% of the original probabilities, giving six model variants. A random sample of 1,000 VAs from South Africa, were used as a basis for experimentation and were processed using the original InterVA model and 20 random instances of each of the six InterVA model variants. Rank order of cause of death and cause-specific mortality fractions (CSMFs) from the original InterVA model and the mean, maximum and minimum results from the 20 randomly modified InterVA models for each of the six variants were compared. Results: CSMFs were functionally similar between the original InterVA model and the models with modified a priori probabilities such that even the CSMFs based on the InterVA model with the greatest degree of variation in the a priori probabilities would not lead to substantially different public health conclusions. The rank order of causes were also similar between all versions of InterVA. Conclusion: InterVA is a robust model for interpreting VA data and even relatively large variations in a priori probabilities do not affect InterVA-derived results to a great degree. The original physician-derived a priori probabilities are likely to be sufficient for the global application of InterVA in settings without routine death certification.	[Fottrell, Edward; Kahn, Kathleen; Tollman, Stephen; Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, Umea, Sweden; [Fottrell, Edward] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England; [Kahn, Kathleen; Tollman, Stephen; Byass, Peter] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa	Umea University; University of London; University College London; University of Witwatersrand	Fottrell, E (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, Dept Publ Hlth & Clin Med, Umea, Sweden.	Edward.Fottrell@epiph.umu.se		Tollman, Stephen/0000-0003-0744-7588; Byass, Peter/0000-0001-5474-4361; Kahn, Kathleen/0000-0003-3339-3931; Fottrell, Edward/0000-0003-0518-7161	FAS; Swedish Council for Working Life and Social Research [2006-1512]; Wellcome Trust, UK; University of the Witwatersrand and Medical Research Council, South Africa;  [058893/Z/99/A];  [069683/Z/02/Z];  [085477/Z/08/Z]	FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand and Medical Research Council, South Africa; ; ; 	This work was undertaken with support from FAS, the Swedish Council for Working Life and Social Research (grant 2006-1512) (www.fas.se). The Agincourt health and socio-demographic surveillance system, including conduct of verbal autopsies, is funded by The Wellcome Trust, UK (www.wellcome.ac.uk) (grant numbers 058893/Z/99/A, 069683/Z/02/Z and 085477/Z/08/Z) and the University of the Witwatersrand and Medical Research Council, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P32, DOI 10.1080/14034950310015086; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Byass P, 2007, PLOS MED, V4, P1715, DOI 10.1371/journal.pmed.0040333; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Fottrell E, 2010, TROP MED INT HEALTH, V15, P1256, DOI 10.1111/j.1365-3156.2010.02601.x; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Hounton S, 2008, TROP MED INT HEALTH, V13, P14, DOI 10.1111/j.1365-3156.2008.02083.x; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; King G, 2008, STAT SCI, V23, P78, DOI 10.1214/07-STS247; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327	15	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27200	10.1371/journal.pone.0027200	http://dx.doi.org/10.1371/journal.pone.0027200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073287	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000031
J	Di Fulvio, M; Frondorf, K; Henkels, KM; Grunwald, WC; Cool, D; Gomez-Cambronero, J				Di Fulvio, Mauricio; Frondorf, Kathleen; Henkels, Karen M.; Grunwald, William C., Jr.; Cool, David; Gomez-Cambronero, Julian			Phospholipase D2 (PLD2) Shortens the Time Required for Myeloid Leukemic Cell Differentiation MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTOR SP1; EARLY GROWTH RESPONSE-1; C-FES; HL-60 CELLS; HL60 CELLS; GRANULOCYTIC DIFFERENTIATION; TYROSINE KINASE; S6 KINASE; HUMAN NEUTROPHILS	Cell differentiation is compromised in acute leukemias. We report that mammalian target of rapamycin (mTOR) and S6 kinase (S6K) are highly expressed in the undifferentiated promyelomonocytic leukemic HL-60 cell line, whereas PLD2 expression is minimal. The expression ratio of PLD2 to mTOR (or to S6K) is gradually inverted upon in vitro induction of differentiation toward the neutrophilic phenotype. We present three ways that profoundly affect the kinetics of differentiation as follows: (i) simultaneous overexpression of mTOR (or S6K), (ii) silencing of mTOR via dsRNA-mediated interference or inhibition with rapamycin, and (iii) PLD2 overexpression. The last two methods shortened the time required for differentiation. By determining how PLD2 participates in cell differentiation, we found that PLD2 interacts with and activates the oncogene Fes/Fps, a protein-tyrosine kinase known to be involved in myeloid cell development. Fes activity is elevated with PLD2 overexpression, phosphatidic acid or phosphatidylinositol bisphosphate. Co-immunoprecipitation indicates a close PLD2-Fes physical interaction that is negated by a Fes-R483K mutant that incapacitates its Src homology 2 domain. All these suggest for the first time the following mechanism: mTOR/S6K down-regulation -> PLD2 overexpression -> PLD2/Fes association -> phosphatidic acid-led activation of Fes kinase -> granulocytic differentiation. Differentiation shortening could have a clinical impact on reducing the time of return to normalcy of the white cell counts after chemotherapy in patients with acute promyelocytic leukemia.	[Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Grunwald, William C., Jr.; Cool, David] Wright State Univ, Dept Pharmacol & Toxicol, Sch Med, Dayton, OH 45435 USA	Wright State University Dayton; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; Research Challenge (Ohio Board of Regents) [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Challenge (Ohio Board of Regents); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.). This work was also supported by Research Challenge 668372 (Ohio Board of Regents) (to J. G.-C.).	Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bechoua S, 2001, J BIOL CHEM, V276, P31752, DOI 10.1074/jbc.M101265200; Bettoun DJ, 2004, J STEROID BIOCHEM, V89-90, P195, DOI 10.1016/j.jsbmb.2004.03.087; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; BORELLINI F, 1990, MOL CELL BIOL, V10, P5541, DOI 10.1128/MCB.10.10.5541; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Chen F, 2004, CANCER RES, V64, P5425, DOI 10.1158/0008-5472.CAN-04-0806; COLLINS SJ, 1987, BLOOD, V70, P1233; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Di Fulvio M, 2005, J LEUKOCYTE BIOL, V77, P999, DOI 10.1189/jlb.1104684; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; El Marjou M, 2000, LEUKEMIA, V14, P2118; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Guillemain I, 1998, BBA-MOL CELL RES, V1405, P161, DOI 10.1016/S0167-4889(98)00107-4; Hackenmiller R, 2002, DEV BIOL, V245, P255, DOI 10.1006/dbio.2002.0643; Haigh J, 1996, CELL GROWTH DIFFER, V7, P931; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Horn JM, 2001, BBA-MOL CELL BIOL L, V1530, P97, DOI 10.1016/S1388-1981(00)00172-4; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Izuhara K, 1996, BLOOD, V88, P3910, DOI 10.1182/blood.V88.10.3910.bloodjournal88103910; JANICKBUCKNER D, 1991, FASEB J, V5, P320, DOI 10.1096/fasebj.5.3.2001792; Jiang H, 2001, J IMMUNOL, V166, P2627, DOI 10.4049/jimmunol.166.4.2627; KHARBANDA S, 1991, J CLIN INVEST, V88, P571, DOI 10.1172/JCI115341; Kim J, 2003, J BIOL CHEM, V278, P14978, DOI 10.1074/jbc.M212118200; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Liu J, 2001, INT J ONCOL, V18, P863; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MANFREDINI R, 1993, J EXP MED, V178, P381, DOI 10.1084/jem.178.2.381; Manfredini R, 1997, BLOOD, V89, P135, DOI 10.1182/blood.V89.1.135.135_135_145; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MATSUHISA T, 1995, BLOOD CELL MOL DIS, V21, P42, DOI 10.1006/bcmd.1995.0007; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Meier KE, 1999, BBA-MOL CELL BIOL L, V1439, P199, DOI 10.1016/S1388-1981(99)00095-5; MEYER PA, 1990, ENVIRON HEALTH PERSP, V88, P179, DOI 10.2307/3431071; Nakamura M, 1998, J LEUKOCYTE BIOL, V63, P781, DOI 10.1002/jlb.63.6.781; Nakashima S, 1998, BBA-LIPID LIPID MET, V1389, P173, DOI 10.1016/S0005-2760(97)00153-7; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ohguchi K, 1999, BBA-MOL CELL BIOL L, V1439, P215, DOI 10.1016/S1388-1981(99)00096-7; Rao J, 1998, J CELL PHYSIOL, V175, P121, DOI 10.1002/(SICI)1097-4652(199805)175:2<121::AID-JCP1>3.0.CO;2-Q; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Redina OE, 1998, BIOCHEM J, V331, P845, DOI 10.1042/bj3310845; RYVES WJ, 1994, CARCINOGENESIS, V15, P2501, DOI 10.1093/carcin/15.11.2501; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; SODDU S, 1994, BLOOD, V83, P2230, DOI 10.1182/blood.V83.8.2230.bloodjournal8382230; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2003, INT J MOL MED, V11, P547; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tsolmon S, 2009, PLANTA MED, V75, P49, DOI 10.1055/s-0028-1088370; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada O, 2008, J LEUKOCYTE BIOL, V83, P1240, DOI 10.1189/jlb.1207848; Yates KE, 1996, STEM CELLS, V14, P117, DOI 10.1002/stem.140117; Yoshimura S, 1996, BIOCHEM BIOPH RES CO, V225, P494, DOI 10.1006/bbrc.1996.1201; YU G, 1989, J BIOL CHEM, V264, P10276	75	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					393	407		10.1074/jbc.M111.259465	http://dx.doi.org/10.1074/jbc.M111.259465			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22094461	hybrid, Green Published			2022-12-25	WOS:000298682400038
J	Mancarella, S; Wang, YJ; Deng, XX; Landesberg, G; Scalia, R; Panettieri, RA; Mallilankaraman, K; Tang, XD; Madesh, M; Gill, DL				Mancarella, Salvatore; Wang, Youjun; Deng, Xiaoxiang; Landesberg, Gavin; Scalia, Rosario; Panettieri, Reynold A.; Mallilankaraman, Karthik; Tang, Xiang D.; Madesh, Muniswamy; Gill, Donald L.			Hypoxia-induced Acidosis Uncouples the STIM-Orai Calcium Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CA2+ CHANNELS; INFLUX; DOMAINS; BINDING; BORATE	The endoplasmic reticulum Ca2+-sensing STIM proteins mediate Ca2+ entry signals by coupling to activate plasma membrane Orai channels. We reveal that STIM-Orai coupling is rapidly blocked by hypoxia and the ensuing decrease in cytosolic pH. In smooth muscle cells or HEK293 cells coexpressing STIM1 and Orai1, acute hypoxic conditions rapidly blocked store-operated Ca2+ entry and the Orai1-mediated Ca2+ release-activated Ca2+ current (I-CRAC). Hypoxia-induced blockade of Ca2+ entry and I-CRAC was reversed by NH4+-induced cytosolic alkalinization. Hypoxia and acidification both blocked I-CRAC induced by the short STIM1 Orai-activating region. Although hypoxia induced STIM1 translocation into junctions, it did not dissociate the STIM1-Orai1 complex. However, both hypoxia and cytosolic acidosis rapidly decreased Forster resonance energy transfer (FRET) between STIM1-YFP and Orai1-CFP. Thus, although hypoxia promotes STIM1 junctional accumulation, the ensuing acidification functionally uncouples the STIM1-Orai1 complex providing an important mechanism protecting cells from Ca2+ overload under hypoxic stress conditions.	[Mancarella, Salvatore; Wang, Youjun; Deng, Xiaoxiang; Mallilankaraman, Karthik; Madesh, Muniswamy; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Landesberg, Gavin; Scalia, Rosario] Temple Univ, Sch Med, Dept Physiol, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Panettieri, Reynold A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Nankai University	Mancarella, S (corresponding author), Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA.	mancas@temple.edu; dgill@temple.edu	panettieri, reynold/AAG-9485-2019; Wang, Youjun/H-4016-2013	Wang, Youjun/0000-0003-0961-1716; Scalia, Rosario/0000-0002-1829-943X; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [AI058173, HL086699, DK043442]; NHLBI [F32HL105066]; National Natural Science Foundation of China [30871011]; Project "973" [2010CB945001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699, F32HL105066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project "973"(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058173 (to D. L. G.), HL086699 (to M. M.), DK043442 (to R. S.), and NHLBI Postdoctoral Fellowship F32HL105066 (to S. M.). This work was also supported by National Natural Science Foundation of China Grant 30871011 (to X. D. T.) and Project "973" Grant 2010CB945001 (to X. D. T.).	Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; JAMESKRACKE MR, 1992, J CELL PHYSIOL, V151, P596, DOI 10.1002/jcp.1041510320; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Mancarella S, 2009, CURR BIOL, V19, pR950, DOI 10.1016/j.cub.2009.08.051; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Quayle JM, 2006, AM J PHYSIOL-HEART C, V291, pH71, DOI 10.1152/ajpheart.01107.2005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shimoda LA, 2011, AM J PHYSIOL-CELL PH, V300, pC951, DOI 10.1152/ajpcell.00512.2010; Smani T, 2002, CARDIOVASC RES, V53, P97, DOI 10.1016/S0008-6363(01)00422-9; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2011, NAT CHEM BIOL, V7, P488, DOI 10.1038/nchembio.619; Tao Z, 2008, J PHYS CHEM A, V112, P1511, DOI 10.1021/jp710176z; Thorne GD, 2004, CELL CALCIUM, V36, P201, DOI 10.1016/j.ceca.2004.02.018; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wray S, 2004, MOL CELL BIOCHEM, V263, P163, DOI 10.1023/B:MCBI.0000041858.78005.d2; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; YUAN XJ, 1993, AM J PHYSIOL, V264, pL116, DOI 10.1152/ajplung.1993.264.2.L116; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	54	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44788	44798		10.1074/jbc.M111.303081	http://dx.doi.org/10.1074/jbc.M111.303081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22084246	hybrid, Green Published			2022-12-25	WOS:000298645500048
J	Biswas, S; Nyman, JS; Alvarez, J; Chakrabarti, A; Ayres, A; Sterling, J; Edwards, J; Rana, T; Johnson, R; Perrien, DS; Lonning, S; Shyr, Y; Matrisian, LM; Mundy, GR				Biswas, Swati; Nyman, Jeffry S.; Alvarez, JoAnn; Chakrabarti, Anwesa; Ayres, Austin; Sterling, Julie; Edwards, James; Rana, Tapasi; Johnson, Rachelle; Perrien, Daniel S.; Lonning, Scott; Shyr, Yu; Matrisian, Lynn M.; Mundy, Gregory R.			Anti-Transforming Growth Factor beta Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone	PLOS ONE			English	Article							I RECEPTOR KINASE; TGF-BETA; OSTEOCLAST DIFFERENTIATION; SKELETAL COMPLICATIONS; DOUBLE-BLIND; EXPRESSION; PAMIDRONATE; INHIBITION; CELLS; PTHRP	Breast cancer often metastasizes to bone causing osteolytic bone resorption which releases active TGF beta. Because TGF beta favors progression of breast cancer metastasis to bone, we hypothesized that treatment using anti-TGF beta antibody may reduce tumor burden and rescue tumor-associated bone loss in metastatic breast cancer. In this study we have tested the efficacy of an anti-TGF beta antibody 1D11 preventing breast cancer bone metastasis. We have used two preclinical breast cancer bone metastasis models, in which either human breast cancer cells or murine mammary tumor cells were injected in host mice via left cardiac ventricle. Using several in vivo, in vitro and ex vivo assays, we have demonstrated that anti-TGF beta antibody treatment have significantly reduced tumor burden in the bone along with a statistically significant threefold reduction in osteolytic lesion number and tenfold reduction in osteolytic lesion area. A decrease in osteoclast numbers (p = 0.027) in vivo and osteoclastogenesis ex vivo were also observed. Most importantly, in tumor-bearing mice, anti-TGF beta treatment resulted in a twofold increase in bone volume (p<0.01). In addition, treatment with anti-TGF beta antibody increased the mineral-to-collagen ratio in vivo, a reflection of improved tissue level properties. Moreover, anti-TGF beta antibody directly increased mineralized matrix formation in calverial osteoblast (p = 0.005), suggesting a direct beneficial role of anti-TGF beta antibody treatment on osteoblasts. Data presented here demonstrate that anti-TGF beta treatment may offer a novel therapeutic option for tumor-induced bone disease and has the dual potential for simultaneously decreasing tumor burden and rescue bone loss in breast cancer to bone metastases. This approach of intervention has the potential to reduce skeletal related events (SREs) in breast cancer survivors.	[Biswas, Swati; Rana, Tapasi] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Chakrabarti, Anwesa; Ayres, Austin; Sterling, Julie; Edwards, James; Johnson, Rachelle; Perrien, Daniel S.; Mundy, Gregory R.] Vanderbilt Univ, Sch Med, Ctr Bone Biol, Nashville, TN 37212 USA; [Nyman, Jeffry S.; Perrien, Daniel S.] Vanderbilt Univ, Sch Med, Dept Orthoped, Nashville, TN 37212 USA; [Perrien, Daniel S.] Vanderbilt Univ, Sch Med, Inst Imaging Sci, Nashville, TN 37212 USA; [Biswas, Swati; Matrisian, Lynn M.; Mundy, Gregory R.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Alvarez, JoAnn; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Lonning, Scott] Genzyme Corp, Framingham, MA 01701 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Sanofi-Aventis; Genzyme Corporation	Biswas, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	swati.biswas@vanderbilt.edu	Nyman, Jeffry/L-5736-2013; Perrien, Daniel S/AAH-3889-2020	Perrien, Daniel/0000-0002-5488-3932; Nyman, Jeffry/0000-0001-7403-7605	NIH [PO1 CA040035, U54 CA126505]; NCI; NATIONAL CANCER INSTITUTE [T32CA009592, P01CA040035, U54CA126505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work presented here has been funded by the PO1 CA040035 (NIH) grants awarded to the late Dr. Gregory R. Mundy (current PIs Matrisian and Elefteriou), U54 CA126505 (NIH) awarded to Dr. Lynn Matrisian (Dr. Mundy, project leader), and the Vanderbilt Breast Spore Program (NCI) awarded to Dr. Carlos Arteaga. Dr. Biswas was a BIRCWH fellow (2007-2010) whose work was supported by the Building Interdisciplinary Research Careers in Women's Health (BIRCWH) career development award (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genzyme has provided us with the anti-TGF beta antibody and was involved in study design as a follow up of their preliminary finding with this antibody. They have not taken part in acquiring or analyzing the data presented here.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Baselga J, 2008, BIOMARKERS, V13, P217, DOI [10.1080/13547500701676019, 10.1080/13547500701676019 ]; Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0; Berenson JR, 1998, ONCOLOGY-NY, V12, P1573; BERENSON JR, 1998, ONCOLOGY WILLISTON P, V12, P1579; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; COLEMAN RE, CANC TREAT REV, V36, P615; DASCH JR, 1989, J IMMUNOL, V142, P1536; DJULBEGOVIC B, 2002, COCHRANE DB SYST REV; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Hortobagyi GN, 1996, SEMIN ONCOL, V23, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JEMAL A, CANC EPIDEMIOL BIOMA, V19, P1893; Kanis John A., 2000, Cancer, V88, P3022, DOI 10.1002/1097-0142(20000615)88:12+<3022::AID-CNCR19>3.0.CO;2-R; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khanna AK, 2004, CIRCULATION, V110, P3822, DOI 10.1161/01.CIR.0000150400.15354.7D; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Michigami T, 2002, BREAST CANCER RES TR, V75, P249, DOI 10.1023/A:1019905111666; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; MUNDY GR, 1978, NATURE, V275, P132, DOI 10.1038/275132a0; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; PFEILSCHIFTER J, 1990, ENDOCRINOLOGY, V127, P69, DOI 10.1210/endo-127-1-69; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Theriault RL, 1999, J CLIN ONCOL, V17, P846, DOI 10.1200/JCO.1999.17.3.846; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	53	64	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27090	10.1371/journal.pone.0027090	http://dx.doi.org/10.1371/journal.pone.0027090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096521	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900020
J	Apaldetti, C; Martinez, RN; Alcober, OA; Pol, D				Apaldetti, Cecilia; Martinez, Ricardo N.; Alcober, Oscar A.; Pol, Diego			A New Basal Sauropodomorph (Dinosauria: Saurischia) from Quebrada del Barro Formation (Marayes-El Carrizal Basin), Northwestern Argentina	PLOS ONE			English	Article							UPPER ELLIOT FORMATION; ISCHIGUALASTO FORMATION; EVOLUTION; PROSAUROPODA; YUNNAN; YOUNG; SKULL	Background: Argentinean basal sauropodomorphs are known by several specimens from different basins; Ischigualasto, El Tranquilo, and Mogna. The Argentinean record is diverse and includes some of the most primitive known sauropodomorphs such as Panphagia and Chromogisaurus, as well as more derived forms, including several massospondylids. Until now, the Massospondylidae were the group of basal sauropodomorphs most widely spread around Pangea with a record in almost all continents, mostly from the southern hemisphere, including the only record from Antarctica. Methodology/Principal Finding: We describe here a new basal sauropodomorph, Leyesaurus marayensis gen. et sp. nov., from the Quebrada del Barro Formation, an Upper Triassic-Lower Jurassic unit that crops out in northwestern Argentina. The new taxon is represented by a partial articulated skeleton that includes the skull, vertebral column, scapular and pelvic girdles, and hindlimb. Leyesaurus is diagnosed by a set of unique features, such as a sharply acute angle (50 degrees) formed by the ascending process of the maxilla and the alveolar margin, a straight ascending process of the maxilla with a longitudinal ridge on its lateral surface, noticeably bulging labial side of the maxillary teeth, greatly elongated cervical vertebrae, and proximal articular surface of metatarsal III that is shelf-like and medially deflected. Phylogenetic analysis recovers Leyesaurus as a basal sauropodomorph, sister taxon of Adeopapposaurus within the Massospondylidae. Moreover, the results suggest that massospondylids achieved a higher diversity than previously thought. Conclusions/Significance: Our phylogenetic results differ with respect to previous analyses by rejecting the massospondylid affinities of some taxa from the northern hemisphere (e. g., Seitaad, Sarahsaurus). As a result, the new taxon Leyesaurus, coupled with other recent discoveries, suggests that the diversity of massospondylids in the southern hemisphere was higher than in other regions of Pangea. Finally, the close affinities of Leyesaurus with the Lower Jurassic Massospondylus suggest a younger age for the Quebrada del Barro Formation than previously postulated.	[Apaldetti, Cecilia; Martinez, Ricardo N.; Alcober, Oscar A.] Univ Nacl San Juan, Museo Ciencias Nat, San Juan, Argentina; [Apaldetti, Cecilia; Pol, Diego] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Pol, Diego] Museo Paleontol Egidio Feruglio, Trelew, Argentina	Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Apaldetti, C (corresponding author), Univ Nacl San Juan, Museo Ciencias Nat, San Juan, Argentina.	capaldetti@unsj.edu.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA); Jurassic Foundation	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA); Jurassic Foundation	This work was supported by Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; Consejo de Investigaciones de Ciencia TecnologA-a y Arte (CICITCA), and the Jurassic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Attridge J., 1963, South African Journal of Science, V59, P242; Bai Z.-Q., 1990, YUXIWENBO, V1, P14; Barrett PM, 2007, ZOOL J LINN SOC-LOND, V150, P319, DOI 10.1111/j.1096-3642.2007.00290.x; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Barrett PM, 2004, S AFR J SCI, V100, P501; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bergmann F. A. J., 1948, REV MINERA GEOLOGIA, V19, P3; Bodenbender G, 1912, AN MIN AGR SECC GEOL, V8, P9; BONAPARTE J F, 1979, Ameghiniana, V16, P173; BONAPARTE J F, 1978, Ameghiniana, V15, P327; Bonaparte J.F., 1972, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Bonaparte Jose F., 1995, Ameghiniana, V32, P341; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Borrello A.V., 1946, REV SOC GEOL ARGENT, V1, P167; Bossi GE, 1978, ACTA GEOL LILLOANA 1, V1, P41; Bossi GE, 1975, 4 C GEOL ARG, V1; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Fedak TJ, 2007, SPEC PAP PALAEONTOL, P245; Flores M., 1969, 4 JORN GEOL ARG ACT, P311; Galton P.M., 1990, P320; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2001, Revue de Paleobiologie, V20, P435; Galton PM, 2000, NEUES JAHRB GEOL P-A, V216, P233; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Kellner AWA, 2000, AN ACAD BRAS CIENC, V72, P509, DOI 10.1590/S0001-37652000000400005; Knoll F, 2010, GEOL MAG, V147, P814, DOI 10.1017/S001675681000018X; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; Leal LA, 2004, ZOOTAXA, P1; Lu Junchang, 2007, Memoir of the Fukui Prefectural Dinosaur Museum, V6, P1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Martin R. A., 1999, Journal of Vertebrate Paleontology, V19, p61A; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; OLSEN PE, 1987, SCIENCE, V237, P1025, DOI 10.1126/science.3616622; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pol Diego, 2007, Historical Biology, V19, P125, DOI 10.1080/08912960601140085; Pol D, 2007, SPEC PAP PALAEONTOL, P223; Rassmuss J, 1922, GEOLOGIA HIDROLOGI B, V32, P7; Rowe TB, 2011, P ROY SOC B-BIOL SCI, V278, P1044, DOI 10.1098/rspb.2010.1867; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2004, Postilla, V230, P1; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x; YOUNG C. C., 1947, PALEONTOL SINICA NEW SER, V12, P1; Young C. C., 1942, Bulletin of the Geological Society of China, V22, P63; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1; Yrigoyen M, 1970, ACT 4 JORN GEOL ARG, P2; Yrigoyen M, 1974, 1 C ARG PAL BIOESTR; ZHANG Y, 1994, COMPLETE OSTEOLOGY P	71	60	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26964	10.1371/journal.pone.0026964	http://dx.doi.org/10.1371/journal.pone.0026964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096511	gold, Green Published			2022-12-25	WOS:000297350800019
J	Han, L; Ma, QY; Li, JH; Liu, H; Li, W; Ma, GD; Xu, QH; Zhou, S; Wu, EX				Han, Liang; Ma, Qingyong; Li, Junhui; Liu, Han; Li, Wei; Ma, Guodong; Xu, Qinhong; Zhou, Shuang; Wu, Erxi			High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; KINASE; ACTIVATION; PROTEIN	Multiple lines of evidence suggest that a large portion of pancreatic cancer patients suffer from either hyperglycemia or diabetes, both of which are characterized by high blood glucose level. However, the underlying biological mechanism of this phenomenon is largely unknown. In the present study, we demonstrated that the proliferative ability of two human pancreatic cancer cell lines, BxPC-3 and Panc-1, was upregulated by high glucose in a concentration-dependent manner. Furthermore, the promoting effect of high glucose levels on EGF transcription and secretion but not its receptors in these PC cell lines was detected by using an EGF-neutralizing antibody and RT-PCR. In addition, the EGFR transactivation is induced by high glucose levels in concentration- and time-dependent manners in PC cells in the presence of the EGF-neutralizing antibody. These results suggest that high glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Our findings may provide new insight on the links between high glucose level and PC in terms of the molecular mechanism and reveal a novel therapeutic strategy for PC patients who simultaneously suffer from either diabetes or hyperglycemia.	[Han, Liang; Ma, Qingyong; Li, Junhui; Liu, Han; Li, Wei; Ma, Guodong; Xu, Qinhong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China; [Zhou, Shuang; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	Xi'an Jiaotong University; North Dakota State University Fargo	Han, L (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China.	qyma56@mail.xjtu.edu.cn		Wu, Erxi/0000-0002-1680-3639; Zhou, Shuang/0000-0002-2403-7161	National Natural Scientific Foundation of China [81172360, 30900705]; 13115 major project of Shaanxi province [2010ZDKG-49]; ND EPSCoR; Centers of Biomedical Research Excellence (COBRE); NIH from the National Center for Research Resources (NCRR) [P20 RR020151]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); 13115 major project of Shaanxi province; ND EPSCoR; Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Natural Scientific Foundation of China (No. 81172360 (to QM), No. 30900705 (to JL)), a 13115 major project of Shaanxi province 2010ZDKG-49 (to QM), ND EPSCoR (to EW), and Pilot Project Grant (to EW) from the Centers of Biomedical Research Excellence (COBRE) grant NIH P20 RR020151 from the National Center for Research Resources (NCRR). NCRR is a component of the National Institutes of Health (NIH). The contents of this report are solely the responsibility of the authors and do not necessarily reflect the official views of the NIH or NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2003, HYPERTENSION, V41, P781, DOI 10.1161/01.HYP.0000049426.61176.DF; Carpenter G, 2000, SCI STKE, V2000, pE1; Cartwright Thomas, 2008, Cancer Control, V15, P308; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Georgopoulos NT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013621; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greco S, 2003, J CELL PHYSIOL, V196, P370, DOI 10.1002/jcp.10313; Gschwind A, 2002, CANCER RES, V62, P6329; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Lee E, 2010, CANCER LETT, V290, P43, DOI 10.1016/j.canlet.2009.08.022; Li JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017385; Liu H, 2011, MOL CELL BIOCHEM, V347, P95, DOI 10.1007/s11010-010-0617-0; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10; Najafov A, 2010, P NATL ACAD SCI USA, V107, P19135, DOI 10.1073/pnas.1014047107; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Saad S, 2005, KIDNEY INT, V68, P985, DOI 10.1111/j.1523-1755.2005.00492.x; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Suzuki K, 2007, PROSTATE CANCER P D, V10, P384, DOI 10.1038/sj.pcan.4500976; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; WAHL MI, 1987, CLIN PHYSIOL BIOCH, V5, P130; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Yamamoto M, 1999, INT J CANCER, V83, P98, DOI 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565	33	88	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27074	10.1371/journal.pone.0027074	http://dx.doi.org/10.1371/journal.pone.0027074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087246	Green Submitted, gold, Green Published			2022-12-25	WOS:000297349700015
J	Eller-Vainicher, C; Chiodini, I; Santi, I; Massarotti, M; Pietrogrande, L; Cairoli, E; Beck-Peccoz, P; Longhi, M; Galmarini, V; Gandolini, G; Bevilacqua, M; Grossi, E				Eller-Vainicher, Cristina; Chiodini, Iacopo; Santi, Ivana; Massarotti, Marco; Pietrogrande, Luca; Cairoli, Elisa; Beck-Peccoz, Paolo; Longhi, Matteo; Galmarini, Valter; Gandolini, Giorgio; Bevilacqua, Maurizio; Grossi, Enzo			Recognition of Morphometric Vertebral Fractures by Artificial Neural Networks: Analysis from GISMO Lombardia Database	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DEFORMITY INDEX SDI; OSTEOPOROTIC FRACTURE; POSTMENOPAUSAL WOMEN; RISK-FACTOR; CLASSIFICATION; METAANALYSIS; PREDICTION; REGRESSION; WELL	Background: It is known that bone mineral density (BMD) predicts the fracture's risk only partially and the severity and number of vertebral fractures are predictive of subsequent osteoporotic fractures (OF). Spinal deformity index (SDI) integrates the severity and number of morphometric vertebral fractures. Nowadays, there is interest in developing algorithms that use traditional statistics for predicting OF. Some studies suggest their poor sensitivity. Artificial Neural Networks (ANNs) could represent an alternative. So far, no study investigated ANNs ability in predicting OF and SDI. The aim of the present study is to compare ANNs and Logistic Regression (LR) in recognising, on the basis of osteoporotic risk-factors and other clinical information, patients with SDI >= 1 and SDI >= 5 from those with SDI = 0. Methodology: We compared ANNs prognostic performance with that of LR in identifying SDI >= 1/SDI >= 5 in 372 women with postmenopausal-osteoporosis (SDI >= 1, n = 176; SDI = 0, n = 196; SDI >= 5, n = 51), using 45 variables (44 clinical parameters plus BMD). ANNs were allowed to choose relevant input data automatically (TWIST-system-Semeion). Among 45 variables, 17 and 25 were selected by TWIST-system-Semeion, in SDI >= 1 vs SDI = 0 (first) and SDI >= 5 vs SDI = 0 (second) analysis. In the first analysis sensitivity of LR and ANNs was 35.8% and 72.5%, specificity 76.5% and 78.5% and accuracy 56.2% and 75.5%, respectively. In the second analysis, sensitivity of LR and ANNs was 37.3% and 74.8%, specificity 90.3% and 87.8%, and accuracy 63.8% and 81.3%, respectively. Conclusions: ANNs showed a better performance in identifying both SDI >= 1 and SDI >= 5, with a higher sensitivity, suggesting its promising role in the development of algorithm for predicting OF.	[Eller-Vainicher, Cristina; Chiodini, Iacopo; Cairoli, Elisa; Beck-Peccoz, Paolo] Ca Granda Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Endocrinol & Diabetol Unit, Dept Med Sci, Milan, Italy; [Santi, Ivana] Ist Geriatr Azienda Serv Persona Ist Milanesi Mar, Milan, Italy; [Massarotti, Marco] Ist Ricovero & Cura Carattere Sci Humanitas, Milan, Italy; [Pietrogrande, Luca] Univ Milan, Orthoped Clin, Dipartimento Med Chirurg & Odontoiatria San Paolo, Milan, Italy; [Longhi, Matteo] Ist Ricovero & Cura Carattere Sci Ist Ortoped Gal, Unit Reumathol, Milan, Italy; [Galmarini, Valter] Azienda Osped Fatebenefratelli & Oftalm, Milan, Italy; [Gandolini, Giorgio] Ist Ricovero & Cura Carattere Sci Don Gnocchi, Milan, Italy; [Bevilacqua, Maurizio] Univ Milan, Endocrinol & Diabet Unit, Luigi Sacco Hosp Vialba, Milan, Italy; [Grossi, Enzo] San Donato Milanese, Bracco Med Dept, Milan, Italy; [Grossi, Enzo] Semeion Res Ctr, Rome, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Luigi Sacco Hospital; Bracco	Eller-Vainicher, C (corresponding author), Ca Granda Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci, Endocrinol & Diabetol Unit, Dept Med Sci, Milan, Italy.	eller.vainicher@gmail.com	Iacopo, Chiodini/W-9911-2019; Grossi, Enzo/AAF-7765-2020; Cairoli, Elisa/AAB-7010-2019	Iacopo, Chiodini/0000-0001-7594-3300; Cairoli, Elisa/0000-0001-8767-6385; Massarotti, Marco/0000-0001-9603-2098				Agenzia Italiana per il Farmaco, 79 AIFA; Andriulli A, 2003, DIGEST LIVER DIS, V35, P222, DOI 10.1016/S1590-8658(03)00057-4; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; Buscema M, 2005, ARTIF INTELL MED, V34, P279, DOI 10.1016/j.artmed.2004.12.001; Buscema M, 2004, EXPERT SYST, V21, P63, DOI 10.1111/j.1468-0394.2004.00264.x; Buscema M, 2007, COMPUT INTEL NEUROSC, V35021, P1; Caocci G, 2010, EXP HEMATOL, V38, P426, DOI 10.1016/j.exphem.2010.02.012; Crans GG, 2005, BONE, V37, P175, DOI 10.1016/j.bone.2005.04.003; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Laet C, 2005, OSTEOPOROSIS INT, V16, P313, DOI 10.1007/s00198-004-1689-z; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Di Monaco M, 2011, AM J PHYS MED REHAB, V90, P1, DOI 10.1097/PHM.0b013e31820174e8; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Garrett IR, 1999, J BONE MINER RES, V14, pS180; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007/s001980070078; Genant HK, 2007, OSTEOPOROSIS INT, V18, P69, DOI 10.1007/s00198-006-0199-6; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Guglielmi G, 2009, EUR J RADIOL, V69, P173, DOI 10.1016/j.ejrad.2007.09.040; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2002, BONE, V30, P251, DOI 10.1016/S8756-3282(01)00653-6; Kerkeni S, 2009, OSTEOPOROSIS INT, V20, P1547, DOI 10.1007/s00198-008-0832-7; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lim LS, 2009, J AM GERIATR SOC, V57, P855, DOI 10.1111/j.1532-5415.2009.02195.x; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Melton LJ, 2006, OSTEOPOROSIS INT, V17, P978, DOI 10.1007/s00198-006-0106-1; MINNE HW, 1988, BONE MINER, V3, P335; Morelli V, 2010, EUR J CLIN INVEST, V40, P803, DOI 10.1111/j.1365-2362.2010.02330.x; Mussolino ME, 2006, ANN EPIDEMIOL, V16, P395, DOI 10.1016/j.annepidem.2005.06.051; National Institute on Alcohol Abuse and Alcoholism U.S. Dept of Health and Human Services, 2005, DESCR STAND DRINKS C; Nilsson J, 2006, J THORAC CARDIOV SUR, V132, P12, DOI 10.1016/j.jtcvs.2005.12.055; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Rejnmark L, 2006, J BONE MINER RES, V21, P163, DOI 10.1359/JBMR.051003; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Rumelhart D.E., 1988, PARALLEL DISTRIBUTED, V1, DOI [10.1016/B978-1-4832-1446-7.50010-8, DOI 10.1016/B978-1-4832-1446-7.50010-8]; Snow PB, 2001, CANCER, V91, P1673, DOI 10.1002/1097-0142(20010415)91:8+<1673::AID-CNCR1182>3.0.CO;2-T; Sornay-Rendu E, 2010, J BONE MINER RES, V25, P2101, DOI 10.1002/jbmr.106; TREMOLLIERES FA, 2010, SCIENCE, V25, P1002; Varenna M, 2001, OSTEOPOROSIS INT, V12, P296, DOI 10.1007/s001980170119; WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Levels, 2004, ASSESSMENT OSTEOPORO; Zadeh LA, 1997, FUZZY SET SYST, V90, P111, DOI 10.1016/S0165-0114(97)00077-8	49	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27277	10.1371/journal.pone.0027277	http://dx.doi.org/10.1371/journal.pone.0027277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076144	Green Published, gold			2022-12-25	WOS:000297198200058
J	Li, ZW; Potts-Kant, EN; Garantziotis, S; Foster, WM; Hollingsworth, JW				Li, Zhuowei; Potts-Kant, Erin N.; Garantziotis, Stavros; Foster, W. Michael; Hollingsworth, John W.			Hyaluronan Signaling during Ozone-Induced Lung Injury Requires TLR4, MyD88, and TIRAP	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; AIRWAY HYPERRESPONSIVENESS; CUTTING EDGE; MOUSE LUNG; MICE; INFLAMMATION; MORTALITY; SUSCEPTIBILITY; EXPOSURE; ASTHMA	Ozone exposure is associated with exacerbation of reactive airways disease. We have previously reported that the damage-associated molecular pattern, hyaluronan, is required for the complete biological response to ambient ozone and that hyaluronan fragments signal through toll-like receptor 4 (TLR4). In this study, we further investigated the role of TLR4 adaptors in ozone-induced airway hyperresponsiveness (AHR) and the direct response to hyaluronan fragments (HA). Using a murine model of AHR, C57BL/6J, TLR4(-/-), MyD88(-/-), and TIRAP(-/-) mice were characterized for AHR after exposure to either ozone (1 ppmx3 h) or HA fragments. Animals were characterized for AHR with methacholine challenge, cellular inflammation, lung injury, and production of pro-inflammatory cytokines. Ozone-exposed C57BL/6J mice developed cellular inflammation, lung injury, pro-inflammatory cytokines, and AHR, while mice deficient in TLR4, MyD88 or TIRAP demonstrated both reduced AHR and reduced levels of pro-inflammatory cytokines including TNF alpha, IL-1 beta, MCP-1, IL-6 and KC. The level of hyaluronan was increased after inhalation of ozone in each strain of mice. Direct challenge of mice to hyaluronan resulted in AHR in C57BL/6J mice, but not in TLR4(-/-), MyD88(-/-), or TIRAP(-/-) mice. HA-induced cytokine production in wild-type mice was significantly reduced in TLR4(-/-), MyD88(-/-), or TIRAP(-/-) mice. In conclusion, our findings support that ozone-induced airway hyperresponsiveness is dependent on the HA-TLR4-MyD88-TIRAP signaling pathway.	[Li, Zhuowei; Potts-Kant, Erin N.; Foster, W. Michael; Hollingsworth, John W.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Hollingsworth, John W.] Duke Univ, Dept Immunol, Durham, NC USA; [Garantziotis, Stavros] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Li, ZW (corresponding author), Duke Univ, Dept Med, Durham, NC 27710 USA.	john.hollingsworth@duke.edu	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X	National Institute of Environmental Health Sciences [ES016126, ES020426]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, ZIAES102605, R21ES020426] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (ES016126, ES020426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Auten RL, 2009, AM J RESP CRIT CARE, V180, P1218, DOI 10.1164/rccm.200901-0116OC; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bauer AK, 2011, ENVIRON HEALTH PERSP, V119, P1091, DOI 10.1289/ehp.1003326; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Chang HH, 2010, INT J ENV RES PUB HE, V7, P2866, DOI 10.3390/ijerph7072866; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; DeLorme MP, 2002, J TOXICOL ENV HEAL A, V65, P1453, DOI 10.1080/00984100290071432; Foster WM, 2010, AM J PHYSIOL-LUNG C, V299, pL345, DOI 10.1152/ajplung.00067.2010; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; GRYPARIS A, 2004, AM J RESP CRIT CARE, V28, P28; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Leu SW, 2011, J IMMUNOL, V186, P556, DOI 10.4049/jimmunol.1001630; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li ZW, 2010, J IMMUNOL, V185, P6891, DOI 10.4049/jimmunol.1000283; Lukacs Nicholas W., 2007, V14, P68, DOI 10.1159/000107055; Matsumoto K, 1999, EUR RESPIR J, V14, P1088, DOI 10.1183/09031936.99.14510889; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003-0373OC; Que LG, 2011, J APPL PHYSL; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Williams MA, 2007, BIOMARK INSIGHTS, V2, P226; Wood LG, 2011, CLIN EXP ALLERGY, V41, P640, DOI 10.1111/j.1365-2222.2010.03669.x; Wu ZX, 2008, RESP PHYSIOL NEUROBI, V164, P300, DOI 10.1016/j.resp.2008.07.019; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	50	52	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27137	10.1371/journal.pone.0027137	http://dx.doi.org/10.1371/journal.pone.0027137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073274	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200038
J	Lisso, J; Schroder, F; Fisahn, J; Mussig, C				Lisso, Janina; Schroeder, Florian; Fisahn, Joachim; Muessig, Carsten			NFX1-LIKE2 (NFXL2) Suppresses Abscisic Acid Accumulation and Stomatal Closure in Arabidopsis thaliana	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; DROUGHT STRESS TOLERANCE; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; HYDROGEN-PEROXIDE; GENE-EXPRESSION; WATER-STRESS; ABA; INTERACTS; UBIQUITIN	The NFX1-LIKE1 (NFXL1) and NFXL2 genes were identified as regulators of salt stress responses. The NFXL1 protein is a nuclear factor that positively affects adaptation to salt stress. The nfxl1-1 loss-of-function mutant displayed reduced survival rates under salt and high light stress. In contrast, the nfxl2-1 mutant, defective in the NFXL2 gene, and NFXL2-antisense plants exhibited enhanced survival under these conditions. We show here that the loss of NFXL2 function results in abscisic acid (ABA) overaccumulation, reduced stomatal conductance, and enhanced survival under drought stress. The nfxl2-1 mutant displayed reduced stomatal aperture under all conditions tested. Fusicoccin treatment, exposition to increasing light intensities, and supply of decreasing CO2 concentrations demonstrated full opening capacity of nfxl2-1 stomata. Reduced stomatal opening presumably is a consequence of elevated ABA levels. Furthermore, seedling growth, root growth, and stomatal closure were hypersensitive to exogenous ABA. The enhanced ABA responses may contribute to the improved drought stress resistance of the mutant. Three NFXL2 splice variants were cloned and named NFXL2-78, NFXL2-97, and NFXL2-100 according to the molecular weight of the putative proteins. Translational fusions to the green fluorescent protein suggest nuclear localisation of the NFXL2 proteins. Stable expression of the NFXL2-78 splice variant in nfxl2-1 plants largely complemented the mutant phenotype. Our data show that NFXL2 controls ABA levels and suppresses ABA responses. NFXL2 may prevent unnecessary and costly stress adaptation under favourable conditions.	[Lisso, Janina; Schroeder, Florian; Fisahn, Joachim; Muessig, Carsten] Univ Potsdam, Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society; University of Potsdam	Lisso, J (corresponding author), Univ Potsdam, Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	muessig@uni-potsdam.de			Deutsche Forschungsgemeinschaft [MU 1738/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (MU 1738/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Berger D, 2000, GENE DEV, V14, P1119; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Johansson M, 2011, PLANT PHYSIOL, V155, P2108, DOI 10.1104/pp.110.167155; Jubany-Mari T, 2010, PLANT PHYSIOL BIOCH, V48, P351, DOI 10.1016/j.plaphy.2010.01.021; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katzenellenbogen RA, 2009, J VIROL, V83, P6446, DOI 10.1128/JVI.02556-08; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lisso J, 2006, FEBS LETT, V580, P4851, DOI 10.1016/j.febslet.2006.07.079; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luna CM, 2005, J EXP BOT, V56, P417, DOI 10.1093/jxb/eri039; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mussig C, 2010, PLANT BIOLOGY, V12, P381, DOI 10.1111/j.1438-8677.2009.00303.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muschak M, 1999, PLANTA, V209, P104, DOI 10.1007/s004250050611; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; SONG ZM, 1994, J EXP MED, V180, P1763, DOI 10.1084/jem.180.5.1763; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Xu M, 2010, J VIROL, V84, P11461, DOI 10.1128/JVI.00538-10; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	77	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26982	10.1371/journal.pone.0026982	http://dx.doi.org/10.1371/journal.pone.0026982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073231	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000018
J	Liu, JX; Qin, W; Nan, JF; Li, J; Yuan, K; Zhao, L; Zeng, F; Sun, JB; Yu, DH; Dong, MH; Liu, P; von Deneen, KM; Gong, QY; Liang, FR; Tian, J				Liu, Jixin; Qin, Wei; Nan, Jiaofen; Li, Jing; Yuan, Kai; Zhao, Ling; Zeng, Fang; Sun, Jinbo; Yu, Dahua; Dong, Minghao; Liu, Peng; von Deneen, Karen M.; Gong, Qiyong; Liang, Fanrong; Tian, Jie			Gender-Related Differences in the Dysfunctional Resting Networks of Migraine Suffers	PLOS ONE			English	Article							STRUCTURAL CORTICAL NETWORKS; GRAPH-THEORETICAL ANALYSIS; GREY-MATTER CHANGES; QUALITY-OF-LIFE; SEX-DIFFERENCES; CONNECTIVITY PATTERNS; ANATOMICAL NETWORKS; BRAIN NETWORKS; YOUNG-ADULTS; HEADACHE	Background: Migraine shows gender-specific incidence and has a higher prevalence in females. However, little is known about gender-related differences in dysfunctional brain organization, which may account for gender-specific vulnerability and characteristics of migraine. In this study, we considered gender-related differences in the topological property of resting functional networks. Methodology/Principal Findings: Data was obtained from 38 migraine patients (18 males and 20 females) and 38 healthy subjects (18 males and 20 females). We used the graph theory analysis, which becomes a powerful tool in investigating complex brain networks on a whole brain scale and could describe functional interactions between brain regions. Using this approach, we compared the brain functional networks between these two groups, and several network properties were investigated, such as small-worldness, network resilience, nodal centrality, and interregional connections. In our findings, these network characters were all disrupted in patients suffering from chronic migraine. More importantly, these functional damages in the migraine-affected brain had a skewed balance between males and females. In female patients, brain functional networks showed worse resilience, more regions exhibited decreased nodal centrality, and more functional connections revealed abnormalities than in male patients. Conclusions: These results indicated that migraine may have an additional influence on females and lead to more dysfunctional organization in their resting functional networks.	[Liu, Jixin; Qin, Wei; Nan, Jiaofen; Li, Jing; Yuan, Kai; Sun, Jinbo; Yu, Dahua; Dong, Minghao; Liu, Peng; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Zeng, Fang; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Peoples R China; [Gong, Qiyong] Sichuan Univ, HMRRC, Dept Radiol, Ctr Med Imaging,W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Sichuan University; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	chinwei@mail.xidian.edu.cn; lfr@cdutcm.edu.cn; tian@ieee.org	Yu, Dahua/N-7242-2013; Tian, Jie/H-1190-2011; Dong, Minghao/A-6425-2014; tian, jie/M-6336-2013; Yuan, Kai/M-9403-2013; Life, PAM/M-9552-2013; Yuan, Kai/I-4150-2016; JinBo, Sun/GLT-2082-2022; 秦, 伟/J-9770-2016; Gong, Qiyong/W-3052-2019	Yu, Dahua/0000-0001-7850-7512; Tian, Jie/0000-0003-0498-0432; Dong, Minghao/0000-0002-0190-6985; Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Gong, Qiyong/0000-0002-5912-4871; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 30901900, 81001504, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Chinese Academy of Sciences [KGCX2-YW-129]; Inner Mongolia University of Science and Technology [2010NC030, 2010NC037]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences(Chinese Academy of Sciences); Inner Mongolia University of Science and Technology	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 30901900, 81001504, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171, the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129, and the Innovation Fund Project of Inner Mongolia University of Science and Technology Nos. 2010NC030 and 2010NC037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2011, CEREB CORTE IN PRESS; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao Y, 2002, NEUROLOGY, V59, P72, DOI 10.1212/WNL.59.1.72; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; Detsky ME, 2006, JAMA-J AM MED ASSOC, V296, P1274, DOI 10.1001/jama.296.10.1274; Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081; Filippi M, 2008, NEUROL SCI, V29, pS336, DOI 10.1007/s10072-008-1011-5; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gong G, 2011, NEUROSCIENT IN PRESS; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gur RC, 1999, J NEUROSCI, V19, P4065; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton C, 2009, COGNITION SEX DIFFER, V51, P965; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Kang DH, 2010, KOREAN J PAIN, V23, P159, DOI 10.3344/kjp.2010.23.3.159; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Salat DH, 2002, CEREB CORTEX, V12, P494, DOI 10.1093/cercor/12.5.494; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Stovner LJ, 2006, EUR J NEUROL, V13, P333, DOI 10.1111/j.1468-1331.2006.01184.x; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Welch KMA, 1998, NEUROLOGY, V51, P1465, DOI 10.1212/WNL.51.5.1465; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	73	46	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27049	10.1371/journal.pone.0027049	http://dx.doi.org/10.1371/journal.pone.0027049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073251	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900010
J	Ouvrier, A; Alves, G; Damon-Soubeyrand, C; Marceau, G; Cadet, R; Janny, L; Brugnon, F; Kocer, A; Pommier, A; Lobaccaro, JMA; Drevet, JR; Saez, F				Ouvrier, Aurelia; Alves, Georges; Damon-Soubeyrand, Christelle; Marceau, Geoffroy; Cadet, Remi; Janny, Laurent; Brugnon, Florence; Kocer, Ayhan; Pommier, Aurelien; Lobaccaro, Jean-Marc A.; Drevet, Joel R.; Saez, Fabrice			Dietary Cholesterol-Induced Post-Testicular Infertility	PLOS ONE			English	Article							LIVER-X-RECEPTORS; HOMEOSTASIS; LXR; EXPRESSION; CAVEOLAE; OBESITY; LIPIDS; BETA; MICE	This work shows that an overload of dietary cholesterol causes complete infertility in dyslipidemic male mice (the Liver X Receptor-deficient mouse model). Infertility resulted from post-testicular defects affecting the fertilizing potential of spermatozoa. Spermatozoa of cholesterol-fed lxr-/- animals were found to be dramatically less viable and motile, and highly susceptible to undergo a premature acrosome reaction. We also provide evidence, that this lipid-induced infertility is associated with the accelerated appearance of a highly regionalized epididymal phenotype in segments 1 and 2 of the caput epididymidis that was otherwise only observed in aged LXR-deficient males. The epididymal epithelial phenotype is characterized by peritubular accumulation of cholesteryl ester lipid droplets in smooth muscle cells lining the epididymal duct, leading to their transdifferentiation into foam cells that eventually migrate through the duct wall, a situation that resembles the inflammatory atherosclerotic process. These findings establish the high level of susceptibility of epididymal sperm maturation to dietary cholesterol overload and could partly explain reproductive failures encountered by young dyslipidemic men as well as ageing males wishing to reproduce.	[Ouvrier, Aurelia; Damon-Soubeyrand, Christelle; Cadet, Remi; Kocer, Ayhan; Drevet, Joel R.; Saez, Fabrice] Univ Blaise Pascal, Equipe Epididyme & Maturat Gametes, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Alves, Georges; Damon-Soubeyrand, Christelle; Pommier, Aurelien; Lobaccaro, Jean-Marc A.] Univ Blaise Pascal, Equipe LXR Oxysterols & Tissus Steroidogenes, UnivUMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Alves, Georges; Damon-Soubeyrand, Christelle; Pommier, Aurelien; Lobaccaro, Jean-Marc A.] Univ Blaise Pascal, Ctr Rech Nutr Humaine Auvergne CRNH, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Marceau, Geoffroy] Univ Blaise Pascal, Equipe Implicat & Metab & Mol Retinoides Dev Huma, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France; [Janny, Laurent; Brugnon, Florence] Univ Clermont 1, EA 975, Clermont Ferrand, France; [Janny, Laurent; Brugnon, Florence] CECOS, CHU Estaing, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Ouvrier, A (corresponding author), Univ Blaise Pascal, Equipe Epididyme & Maturat Gametes, UMR GReD Genet Reprod & Dev, Clermont Univ,INSERM U931,CNRS 6247, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; Drevet, Joël/W-2692-2019; LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Brugnon, Florence/X-9423-2019	Drevet, Joël/0000-0003-3077-6558; Lobaccaro, Jean-Marc/0000-0001-9890-2392; Brugnon, Florence/0000-0002-8402-8734; MARCEAU, GEOFFROY/0000-0003-4713-7162				ABE K, 1983, ARCH HISTOL JAPON, V46, P51, DOI 10.1679/aohc.46.51; Bakos HW, 2010, INT J ANDROL, P1; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Dondorp W, 2010, HUM REPROD, V25, P578, DOI 10.1093/humrep/dep458; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; El-Hajjaji FZ, 2011, BBA-MOL BASIS DIS, V1812, P974, DOI 10.1016/j.bbadis.2011.02.004; Fielding CJ, 2001, ADV DRUG DELIVER REV, V49, P251, DOI 10.1016/S0169-409X(01)00140-5; Frenoux JM, 2004, J MOL ENDOCRINOL, V33, P361, DOI 10.1677/jme.1.01515; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hassan HH, 2006, CAN J CARDIOL, V22, p35B, DOI 10.1016/S0828-282X(06)70985-0; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; KRUTSKIKH A, ENDOCRINOLOGY, V152, P689, DOI DOI 10.1210/EN.2007-1805; Ledger WL, 2009, REPROD BIOMED ONLINE, V18, pS11, DOI 10.1016/S1472-6483(10)60442-7; Mouzat K, 2007, J BIOL CHEM, V282, P4693, DOI 10.1074/jbc.M606718200; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Ouvrier A, 2009, J LIPID RES, V50, P1766, DOI 10.1194/jlr.M800657-JLR200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Reyland ME, 2000, J BIOL CHEM, V275, P36637, DOI 10.1074/jbc.M006456200; Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Saez F, 2007, ASIAN J ANDROL, V9, P574, DOI 10.1111/j.1745-7262.2007.00301.x; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; SSS, SSSSS; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Vukovic Irena, 2006, Exp Clin Cardiol, V11, P123; Zappalla FR, 2009, ENDOCRIN METAB CLIN, V38, P171, DOI 10.1016/j.ecl.2008.11.006	34	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26966	10.1371/journal.pone.0026966	http://dx.doi.org/10.1371/journal.pone.0026966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073227	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900055
J	Ben Khalifa, N; Tyteca, D; Marinangeli, C; Depuydt, M; Collet, JF; Courtoy, PJ; Renauld, JC; Constantinescu, S; Octave, JN; Kienlen-Campard, P				Ben Khalifa, Naouel; Tyteca, Donatienne; Marinangeli, Claudia; Depuydt, Mathieu; Collet, Jean-Francois; Courtoy, Pierre J.; Renauld, Jean-Christophe; Constantinescu, Stefan; Octave, Jean-Noel; Kienlen-Campard, Pascal			Structural features of the KPI domain control APP dimerization, trafficking, and processing	FASEB JOURNAL			English	Article						Alzheimer; APP; dimerization; BiFC; beta-amyloid	AMYLOID PRECURSOR PROTEIN; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; BETA-PROTEIN; GAMMA-SECRETASE; LIVING CELLS; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; INHIBITOR DOMAIN	The two major isoforms of human APP, APP695 and APP751, differ by the presence of a Kunitz-type protease inhibitor (KPI) domain in the extracellular region. APP processing and function is thought to be regulated by homodimerization. We used bimolecular fluorescence complementation (BiFC) to study dimerization of different APP isoforms and mutants. APP751 was found to form significantly more homodimers than APP695. Mutation of dimerization motifs in the TM domain did not affect fluorescence complementation, but native folding of KPI is critical for APP751 homodimerization. APP751 and APP695 dimers were mostly localized at steady state in the Golgi region, suggesting that most of the APP751 and 695 dimers are in the secretory pathway. Mutation of the KPI led to the retention of the APP homodimers in the endoplasmic reticulum. We finally showed that APP751 is more efficiently processed through the nonamyloidogenic pathway than APP695. These findings provide new insight on the particular role of KPI domain in APP dimerization. The correlation observed between dimerization, subcellular localization, and processing suggests that dimerization acts as an efficient regulator of APP trafficking in the secretory compartments that has major consequences on its processing.-Ben Khalifa, N., Tyteca, D., Marinangeli, C., Depuydt, M., Collet, J.-F., Courtoy, P. J., Renauld, J.-C., Constantinescu, S. N., Octave, J.-N., Kienlen-Campard, P. Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB J. 26, 855-867 (2012). www.fasebj.org	[Ben Khalifa, Naouel; Marinangeli, Claudia; Octave, Jean-Noel; Kienlen-Campard, Pascal] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Tyteca, Donatienne; Collet, Jean-Francois; Courtoy, Pierre J.; Renauld, Jean-Christophe; Constantinescu, Stefan] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Depuydt, Mathieu; Collet, Jean-Francois] Walloon Excellence Life Sci & Biotechnol Welbio, Brussels, Belgium; [Renauld, Jean-Christophe; Constantinescu, Stefan] Ludwig Inst Canc Res, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO; Ludwig Institute for Cancer Research	Kienlen-Campard, P (corresponding author), Catholic Univ Louvain, Inst Neuroscience IoNS, UCL5410,Av Hippocrate 54, B-1200 Brussels, Belgium.	pascal.kienlen-campard@uclouvain.be	Collet, Jean Francois/F-2105-2010; Renauld, Jean-Christophe/B-7268-2012	Collet, Jean-Francois/0000-0001-8069-7036; Constantinescu, Stefan N./0000-0002-8599-2699; Depuydt, Matthieu/0000-0002-4069-3521; Kienlen-Campard, Pascal/0000-0003-1086-2942; Renauld, Jean-Christophe/0000-0003-1736-2131	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FNS-FNRS); Neurodegeneration and Inflamation (DIANE) Program of Excellence Region Wallonne; Region Bruxelloise; Loterie Nationale; Interuniversity Attraction Pole Programme-Belgian Science Policy [P6/05, P6/43]; Foundation for Research on Alzheimer Disease; Fonds Speciaux de Recherches	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FNS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Neurodegeneration and Inflamation (DIANE) Program of Excellence Region Wallonne; Region Bruxelloise(Innoviris); Loterie Nationale; Interuniversity Attraction Pole Programme-Belgian Science Policy(Belgian Federal Science Policy Office); Foundation for Research on Alzheimer Disease; Fonds Speciaux de Recherches	The authors thank L. El Haylani for excellent technical support; T. Lac, M. Lemaire, B. Tasiaux, and Y. Marchand for technical or typing assistance. The authors gratefully acknowledge B. de Strooper (Katholieke Universiteit Leuven-Vlaams Instituut voor Biotechnologie, Leuven, Belgium) for providing the APP-knockout MEF cells and Carmela R. Abraham (Boston University, Boston, MA, USA) for the YFP fusion plasmids. This work was supported by grants from Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FNS-FNRS; to J.F.C.), Neurodegeneration and Inflamation (DIANE) Program of Excellence Region Wallonne (to P.J.C. and J.N.O.), Region Bruxelloise, Loterie Nationale (to P.J.C.), the Interuniversity Attraction Pole Programme-Belgian Science Policy (network P6/05, to J.F.C.; and P6/43, to J.N.O. and P. K. C.), the Foundation for Research on Alzheimer Disease (SAO-FRMA; to P. K. C.), and Fonds Speciaux de Recherches (to P. K. C.). J.F.C. and S.N.C. are research associates of the FRS-FNRS. M. D. is a research fellow of the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture.	Akman G, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-12; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben Khalifa N, 2010, CELL ADHES MIGR, V4, P268, DOI 10.4161/cam.4.2.11476; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Chang JY, 2000, FEBS LETT, V473, P183, DOI 10.1016/S0014-5793(00)01515-5; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOJOBORI T, 1994, PHILOS T ROY SOC B, V344, P411, DOI 10.1098/rstb.1994.0080; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Ho LB, 1996, J BIOL CHEM, V271, P30929, DOI 10.1074/jbc.271.48.30929; Huysseune S, 2009, FASEB J, V23, P4158, DOI 10.1096/fj.09-140012; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; JACOBSEN JS, 1991, NEUROBIOL AGING, V12, P585, DOI 10.1016/0197-4580(91)90090-7; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; MARKS CB, 1987, SCIENCE, V235, P1370, DOI 10.1126/science.2435002; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Menendez-Gonzalez M, 2005, NEURODEGENER DIS, V2, P277, DOI 10.1159/000092315; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; NEVE RL, 1990, NEURON, V5, P329, DOI 10.1016/0896-6273(90)90169-G; Octave JN, 1995, ACTA NEUROL BELG, V95, P197; Octave JN, 1995, REV NEUROSCIENCE, V6, P287; Octave JN, 2000, J BIOL CHEM, V275, P1525, DOI 10.1074/jbc.275.3.1525; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Santos SF, 2009, J NEUROSCI, V29, P4708, DOI 10.1523/JNEUROSCI.4917-08.2009; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; TANZI RE, 1993, MOL BRAIN RES, V18, P246, DOI 10.1016/0169-328X(93)90196-V; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	64	33	34	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					855	867		10.1096/fj.11-190207	http://dx.doi.org/10.1096/fj.11-190207			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22085646				2022-12-25	WOS:000300485700036
J	Lambrecht, JA; Flynn, JM; Downs, DM				Lambrecht, Jennifer A.; Flynn, Jeffrey M.; Downs, Diana M.			Conserved YjgF Protein Family Deaminates Reactive Enamine/Imine Intermediates of Pyridoxal 5 '-Phosphate (PLP)-dependent Enzyme Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE O-SULFATE; YJGF/YER057C/UK114 FAMILY; CRYSTAL-STRUCTURE; THREONINE DEAMINASE; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; BIOLOGICAL-RESEARCH; MEMBER; DEGRADATION; PATHWAY	The YjgF/YER057c/UK114 family of proteins is conserved in all domains of life, suggesting that the role of these proteins arose early and was maintained throughout evolution. Metabolic consequences of lacking this protein in Salmonella enterica and other organisms have been described, but the biochemical function of YjgF remained unknown. This work provides the first description of a conserved biochemical activity for the YjgF protein family. Our data support the conclusion that YjgF proteins have enamine/imine deaminase activity and accelerate the release of ammonia from reactive enamine/imine intermediates of the pyridoxal 5'-phosphate-dependent threonine dehydratase (IlvA). Results from structure-guided mutagenesis experiments suggest that YjgF lacks a catalytic residue and that it facilitates ammonia release by positioning a critical water molecule in the active site. YjgF is renamed RidA (reactive intermediate/imine deaminase A) to reflect the conserved activity of the protein family described here. This study, combined with previous physiological studies on yjgF mutants, suggests that intermediates of pyridoxal 5'-phosphate-mediated reactions may have metabolic consequences in vivo that were previously unappreciated. The conservation of the RidA/YjgF family suggests that reactive enamine/imine metabolites are of concern to all organisms.	[Lambrecht, Jennifer A.; Flynn, Jeffrey M.; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health from the USPHS [R01 GM095837]; National Institutes of Health [T32 GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM095837 from the USPHS (to D. M. D.).; Supported by a Molecular Biosciences Training Grant from the National Institutes of Health (T32 GM07215).	Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; Chargaff E., 1943, J BIOL CHEM, V151, P273; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; DATTA P, 1978, EUR J BIOCHEM, V91, P527, DOI 10.1111/j.1432-1033.1978.tb12706.x; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Davis L, 1972, ENZYMES, P33; Deaconescu AM, 2002, PROTEINS, V48, P431, DOI 10.1002/prot.10151; Deriu D, 2003, ACTA CRYSTALLOGR D, V59, P1676, DOI 10.1107/S0907444903014306; DUNATHAN HC, 1971, ADV ENZYMOL RAMB, V35, P79; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; FELDBERG RS, 1971, EUR J BIOCHEM, V21, P438, DOI 10.1111/j.1432-1033.1971.tb01490.x; FELDBERG RS, 1970, SCIENCE, V170, P1414, DOI 10.1126/science.170.3965.1414; FLAVIN M, 1964, BIOCHEMISTRY-US, V3, P885, DOI 10.1021/bi00895a004; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; He ZG, 1998, J BACTERIOL, V180, P2502, DOI 10.1128/JB.180.9.2502-2506.1998; HILLEBRAND GG, 1979, BIOCHEMISTRY-US, V18, P1751, DOI 10.1021/bi00576a018; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; LI RS, 1995, ANAL BIOCHEM, V230, P37, DOI 10.1006/abio.1995.1434; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; Manjasetty BA, 2004, PROTEINS, V54, P797, DOI 10.1002/prot.10619; Miyakawa T, 2006, PROTEINS, V62, P557, DOI 10.1002/prot.20778; Orii C, 2004, EUR J BIOCHEM, V271, P3248, DOI 10.1111/j.1432-1033.2004.04258.x; Park HS, 2000, J BACTERIOL, V182, P573, DOI 10.1128/JB.182.3.573-580.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Sawers G, 1998, ARCH MICROBIOL, V171, P1, DOI 10.1007/s002030050670; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; Takenaka S, 2000, ARCH MICROBIOL, V174, P265, DOI 10.1007/s002030000203; Takenaka S, 2009, FEMS MICROBIOL LETT, V298, P93, DOI 10.1111/j.1574-6968.2009.01699.x; Thakur KG, 2010, PROTEINS, V78, P773, DOI 10.1002/prot.22623; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; Volz K, 1999, PROTEIN SCI, V8, P2428; WOOD WA, 1949, J BIOL CHEM, V181, P171; ZARLENGO MH, 1968, J BIOL CHEM, V243, P186; Zelyas NJ, 2008, J BACTERIOL, V190, P7957, DOI 10.1128/JB.00698-08; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	45	85	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3454	3461		10.1074/jbc.M111.304477	http://dx.doi.org/10.1074/jbc.M111.304477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22094463	Green Published, hybrid			2022-12-25	WOS:000300295100050
J	Jeffries, O; Tian, LJ; McClafferty, H; Shipston, MJ				Jeffries, Owen; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.			An Electrostatic Switch Controls Palmitoylation of the Large Conductance Voltage- and Calcium-activated Potassium (BK) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; MEMBRANE INTERACTIONS; NEURONAL DEVELOPMENT; DEPENDENT REGULATION; PLASMA-MEMBRANE; CSS-PALM; PHOSPHORYLATION; TRANSFERASES; TRAFFICKING	Protein palmitoylation is a major dynamic posttranslational regulator of protein function. However, mechanisms that control palmitoylation are poorly understood. In many proteins, palmitoylation occurs at cysteine residues juxtaposed to membrane-anchoring domains such as transmembrane helices, sites of irreversible lipid modification, or hydrophobic and/or polybasic domains. In particular, polybasic domains represent an attractive mechanism to dynamically control protein palmitoylation, as the function of these domains can be dramatically influenced by protein phosphorylation. Here we demonstrate that a polybasic domain immediately upstream of palmitoylated cysteine residues within an alternatively spliced insert in the C terminus of the large conductance calcium- and voltage-activated potassium channel is an important determinant of channel palmitoylation and function. Mutation of basic amino acids to acidic residues within the polybasic domain results in inhibition of channel palmitoylation and a significant right-shift in channel half maximal voltage for activation. Importantly, protein kinase A-dependent phosphorylation of a single serine residue within the core of the polybasic domain, which results in channel inhibition, also reduces channel palmitoylation. These data demonstrate the key role of the polybasic domain in controlling stress-regulated exon palmitoylation and suggests that phosphorylation controls the domain by acting as an electrostatic switch.	[Jeffries, Owen; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100	Wellcome Trust; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust program grant (to M.J.S.).; Recipient of a Biotechnology and Biological Sciences Research Council doctoral training grant PhD studentship.	Belanger C, 2001, FEBS LETT, V499, P59, DOI 10.1016/S0014-5793(01)02513-3; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; KIM JY, 1994, J BIOL CHEM, V269, P28214; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	38	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1468	1477		10.1074/jbc.M111.224840	http://dx.doi.org/10.1074/jbc.M111.224840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084244	Green Published, hybrid			2022-12-25	WOS:000299170300060
J	Durcan, TM; Kontogiannea, M; Bedard, N; Wing, SS; Fon, EA				Durcan, Thomas M.; Kontogiannea, Maria; Bedard, Nathalie; Wing, Simon S.; Fon, Edward A.			Ataxin-3 Deubiquitination Is Coupled to Parkin Ubiquitination via E2 Ubiquitin-conjugating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACHADO-JOSEPH DISEASE; POLYUBIQUITIN CHAINS; PROTEIN LIGASE; DEGRADATION; MECHANISMS; MITOPHAGY; ACTIVATION; PROTEASOME; STABILITY; PROMOTES	We reported previously that parkin, a Parkinson disease-associated E3 ubiquitin-ligase interacts with ataxin-3, a deubiquitinating enzyme associated with Machado-Joseph disease. Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells. Moreover, ataxin-3-dependent deubiquitination of parkin required the catalytic cysteine 14 in ataxin-3, although the precise mechanism remained unclear. We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub. Moreover, within this complex, the transfer of Ub from the E2 is diverted away from parkin and onto ataxin-3, further explaining how ataxin-3 deubiquitination is coupled to parkin ubiquitination. Taken together, our findings reveal an unexpected convergence upon the E2 Ub-conjugating enzyme in the regulation of an E3/deubiquitinating enzyme pair, with important implications for the function of parkin and ataxin-3, two proteins responsible for closely related neurodegenerative diseases.	[Durcan, Thomas M.; Kontogiannea, Maria; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Durcan, Thomas M.; Kontogiannea, Maria; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Bedard, Nathalie; Wing, Simon S.] McGill Univ, Ctr Hlth, Polypeptide Lab, Dept Med,Res Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Dept Neurol & Neurosurg, Rm MPO36,3801 Univ St, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca	Wing, Simon/D-2589-2012	Wing, Simon/0000-0001-8394-7563	Canadian Institutes of Health Research (CIHR) [MOP-84345, MOP-82734]; National Ataxia Foundation; Parkinson's Disease Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Ataxia Foundation; Parkinson's Disease Foundation	This work was supported in part by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-84345 (to E. A. F.).; Supported by fellowships from the National Ataxia Foundation and the Parkinson's Disease Foundation.; Supported by a CIHR Operating Grant MOP-82734.	Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; Durcan TM, 2011, AUTOPHAGY, V7, P233, DOI 10.4161/auto.7.2.14224; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Klein C, 2009, MOVEMENT DISORD, V24, P2042, DOI 10.1002/mds.22675; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	36	51	52	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					531	541		10.1074/jbc.M111.288449	http://dx.doi.org/10.1074/jbc.M111.288449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081612	Green Published, hybrid			2022-12-25	WOS:000298682400052
J	Wang, L; Lin, JP; Zhou, Z; Huo, RF; Shen, BH; Sun, Y; Li, NL				Wang, Li; Lin, Jinpiao; Zhou, Zhou; Huo, Rongfen; Shen, Baihua; Sun, Yue; Li, Ningli			Up-Regulation of Th17 Cells May Underlie Inhibition of Treg Development Caused by Immunization with Activated Syngeneic T Cells	PLOS ONE			English	Article							IN-VIVO; DENDRITIC CELLS; MEDIATED SUPPRESSION; IMMUNE-RESPONSES; TUMOR-IMMUNITY; CANCER; GROWTH; DIFFERENTIATION; LINEAGE; T(H)17	Background: Our previous work showed that mice immunized with attenuated activated syngeneic T cells (aTCV) led to damping Treg function which resulted in enhancing anti-tumor immunity. It is well known that DC plays a very important role in controlling Th cell differentiation; whether DC involves Treg attenuation in immunized mice remained unknown. In this study, we provided evidence that increased mature DC (mDC) after immunization with aTCV skewed Th17 differentiation, which resulted in inhibition of Treg differentiation through IL-6 signaling pathway. Principal Findings: In the present study, we found that the frequency of mDCs increased dramatically in the immunized mice accompanied by lower Treg cells compared to the controls. Moreover, both DCs and serum derived from the immunized mice suppressed Treg differentiation in vitro, respectively. mDCs generated from bone marrow precursor cells in vitro strongly inhibited Treg development and simultaneously drove Th17 differentiation with elevated IL-6 production. However, PD-L1, a potent Treg inducer did not show effect on Treg down-regulation. Assay with transwell systems showed that cell-cell contact was necessary for IL-6 production to a threshold to activate Th17 transcriptional factor ROR gamma t and to inhibit Treg counterpart Foxp3. Conclusions: Our results implicate up-regulated Th17 development might be one of mechanisms of enhancing anti-tumor immunity induced by immunization with aTCV, which provide a novel insight in numerous mechanisms responsible for antitumor immunity.	[Wang, Li; Lin, Jinpiao; Zhou, Zhou; Huo, Rongfen; Shen, Baihua; Sun, Yue; Li, Ningli] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Wang, Li] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	ninglixiaoxue57@yahoo.com.cn			National Natural Science Foundation of China [30872990 1/4 CE11072468]; National Basic Research Program of China [2010CB529103]; Science and Technology Commission of Shanghai Municipality [10JC1408300]; Shanghai Municipal Education [J50207]; Shanghai Health Bureau [2010036]; Shanghai Jiao Tong University School of Medicine [YBPY2009009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education(Shanghai Municipal Education Commission (SHMEC)); Shanghai Health Bureau; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grant No. 30872990 1/4 CE11072468), National Basic Research Program of China (Grant No. 2010CB529103), Science and Technology Commission of Shanghai Municipality (10JC1408300), Shanghai Municipal Education J50207 and Shanghai Health Bureau (2010036), Shanghai Jiao Tong University School of Medicine (YBPY2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Canderan G, 2010, IMMUNOTHERAPY-UK, V2, P21, DOI [10.2217/imt.09.83, 10.2217/IMT.09.83]; Cao Q, 2007, CELL RES, V17, P627, DOI 10.1038/cr.2007.46; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Langroudi L, 2010, INT IMMUNOPHARMACOL, V10, P1055, DOI 10.1016/j.intimp.2010.06.005; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Litzinger MT, 2007, BLOOD, V110, P3192, DOI 10.1182/blood-2007-06-094615; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Onizuka S, 1999, CANCER RES, V59, P3128; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vissers JLM, 2001, J LEUKOCYTE BIOL, V69, P785; Wang L, 2006, CELL RES, V16, P702, DOI 10.1038/sj.cr.7310083; Yamamoto M, 2009, ONCOL REP, V22, P337, DOI 10.3892/or_00000442; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2009, INT IMMUNOPHARMACOL, V9, P593, DOI 10.1016/j.intimp.2009.01.026; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27289	10.1371/journal.pone.0027289	http://dx.doi.org/10.1371/journal.pone.0027289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087281	gold, Green Published, Green Submitted			2022-12-25	WOS:000297349700027
J	Fang, F; Hoglund, CO; Arck, P; Lundholm, C; Langstrom, N; Lichtenstein, P; Lekander, M; Almqvist, C				Fang, Fang; Hoglund, Caroline Olgart; Arck, Petra; Lundholm, Cecilia; Langstrom, Niklas; Lichtenstein, Paul; Lekander, Mats; Almqvist, Catarina			Maternal Bereavement and Childhood Asthma-Analyses in Two Large Samples of Swedish Children	PLOS ONE			English	Article							REGULATORY T-CELLS; PRENATAL STRESS; GENDER-DIFFERENCES; NATIONWIDE; RISK; EXPRESSION; PREGNANCY; COHORT; ATOPY; LIFE	Background: Prenatal factors such as prenatal psychological stress might influence the development of childhood asthma. Methodology and Principal Findings: We assessed the association between maternal bereavement shortly before and during pregnancy, as a proxy for prenatal stress, and the risk of childhood asthma in the offspring, based on two samples of children 1-4 (n = 426 334) and 7-12 (n = 493 813) years assembled from the Swedish Medical Birth Register. Exposure was maternal bereavement of a close relative from one year before pregnancy to child birth. Asthma event was defined by a hospital contact for asthma or at least two dispenses of inhaled corticosteroids or montelukast. In the younger sample we calculated hazards ratios (HRs) of a first-ever asthma event using Cox models and in the older sample odds ratio (ORs) of an asthma attack during 12 months using logistic regression. Compared to unexposed boys, exposed boys seemed to have a weakly higher risk of first-ever asthma event at 1-4 years (HR: 1.09; 95% confidence interval [CI]: 0.98, 1.22) as well as an asthma attack during 12 months at 7-12 years (OR: 1.10; 95% CI: 0.96, 1.24). No association was suggested for girls. Boys exposed during the second trimester had a significantly higher risk of asthma event at 1-4 years (HR: 1.55; 95% CI: 1.19, 2.02) and asthma attack at 7-12 years if the bereavement was an older child (OR: 1.58; 95% CI: 1.11, 2.25). The associations tended to be stronger if the bereavement was due to a traumatic death compared to natural death, but the difference was not statistically significant. Conclusions/Significance: Our results showed some evidence for a positive association between prenatal stress and childhood asthma among boys but not girls.	[Fang, Fang; Lundholm, Cecilia; Langstrom, Niklas; Lichtenstein, Paul; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Resp Med Unit, Dept Med Solna, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hoglund, Caroline Olgart; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Arck, Petra] Univ Hosp Hamburg Eppendorf, Lab Expt Fetomaternal Med, Dept Obstet & Fetal Med, Hamburg, Germany; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Almqvist, Catarina] Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stockholm University; Karolinska Institutet; Karolinska University Hospital	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	catarina.almqvist@ki.se	Arck, Petra C/D-7094-2013; Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287; Fang, Fang/0000-0002-3310-6456; Arck, Petra/0000-0002-2932-926X; Lundholm, Cecilia/0000-0002-6546-3650	Stockholm County Council; Karolinska Institutet; Swedish Research Council (SIMSAM) [80748301]; Centre for Allergy Research; Hjarnfonden; Swedish Heart Lung Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council (SIMSAM)(Swedish Research Council); Centre for Allergy Research; Hjarnfonden; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grants from the Swedish Research Council (SIMSAM grant number 80748301), Centre for Allergy Research and the Strategic Research Program in Epidemiology at Karolinska Institutet. Fang Fang was partially supported by a postdoctoral fellowship from Hjarnfonden. Caroline Olgart Hoglund was supported by the Karolinska Institutet and the Swedish Heart Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Dolznig H, 2004, METH MOLEC MED, V105, P323; Hoglund CO, 2006, CLIN EXP ALLERGY, V36, P982, DOI 10.1111/j.1365-2222.2006.02529.x; Holt PG, 2009, J EXP MED, V206, P2861, DOI 10.1084/jem.20092469; Joachim RA, 2008, AM J PATHOL, V173, P1379, DOI 10.2353/ajpath.2008.080105; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2008, EPILEPSY RES, V81, P52, DOI 10.1016/j.eplepsyres.2008.04.014; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Li J, 2009, PEDIATRICS, V123, P1102, DOI 10.1542/peds.2008-1734; Loisel DA, 2011, J ALLERGY CLIN IMMUN, V128, P524, DOI 10.1016/j.jaci.2011.06.016; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; Pincus-Knackstedt MK, 2006, J IMMUNOL, V177, P8484, DOI 10.4049/jimmunol.177.12.8484; Rieger M, 2004, ANN NY ACAD SCI, V1032, P228, DOI 10.1196/annals.1314.026; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sausenthaler S, 2009, J INVEST ALLERG CLIN, V19, P481; Solano ME, J REPROD IM IN PRESS; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Uekert SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1375, DOI 10.1016/j.jaci.2006.09.008; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Virk J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011523; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; vonMutius E, 1996, THORAX, V51, pS3, DOI 10.1136/thx.51.Suppl_1.S3; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wright RJ, 2004, J ALLERGY CLIN IMMUN, V113, P1051, DOI 10.1016/j.jaci.2004.03.032; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright RJ, 2007, PAEDIATR PERINAT EP, V21, P8, DOI 10.1111/j.1365-3016.2007.00879.x; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	35	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27202	10.1371/journal.pone.0027202	http://dx.doi.org/10.1371/journal.pone.0027202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087265	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700029
J	Yang, DC; Tsai, CC; Liao, YF; Fu, HC; Tsay, HJ; Huang, TF; Chen, YH; Hung, SC				Yang, Der-Chih; Tsai, Chih-Chien; Liao, Yun-Feng; Fu, Hui-Chuan; Tsay, Huey-Jen; Huang, Tung-Fu; Chen, Yau-Hung; Hung, Shih-Chieh			Twist Controls Skeletal Development and Dorsoventral Patterning by Regulating Runx2 in Zebrafish	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTORS; OSTEOBLAST DIFFERENTIATION; BONE-DEVELOPMENT; GENE-EXPRESSION; EMBRYO; ISOFORM; MODELS; MOUSE; ONSET	Background: Twist1a and twist1b are the principal components of twists that negatively regulate a number of cellular signaling events. Expression of runx2 and downstream targets is essential for skeletal development and ventral organizer formation and specification in early vertebrate embryos, but what controls ventral activity of maternal runx2 and how twists function in zebrafish embryogenesis still remain unclear. Methodology/Principal Findings: By studying the loss of twist induced by injection of morpholino-oligonucleotide in zebrafish, we found that twist1a and twist1b, but not twist2 or twist3, were required for proper skeletal development and dorsoventral patterning in early embryos. Overexpression of twist1a or twist1b following mRNA injection resulted in deteriorated skeletal development and formation of typical dorsalized embryos, whereas knockdown of twist1a and twist1b led to the formation of abnormal embryos with enhanced skeletal formation and typical ventralized patterning. Overexpression of twist1a or twist1b decreased the expression of runx2b, whereas twist1a and twist1b knockdown increased runx2b expression. We have further demonstrated that phenotypes induced by twist1a and twist1b knockdown were rescued by runx2b knockdown. Conclusions/Significance: Together, these results suggest that twist1a and twist1b control skeletal development and dorsoventral patterning by regulating runx2b in zebrafish and provide potential targets for the treatment of diseases or syndromes associated with decreased skeletal development.	[Yang, Der-Chih; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Chih-Chien; Tsay, Huey-Jen; Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Pharmaol, Taipei 112, Taiwan; Natl Yang Ming Univ, Dept Neurosci, Taipei 112, Taiwan; [Huang, Tung-Fu] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Liao, Yun-Feng; Fu, Hui-Chuan; Chen, Yau-Hung] Tamkang Univ, Dept Chem, Taipei, Taiwan; [Yang, Der-Chih; Tsai, Chih-Chien; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Tung-Fu; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tamkang University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	yauhung@mail.tku.edu.tw; hungsc@vghtpe.gov.tw			National Science Council [100-2313-B-032-001]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from the National Science Council (100-2313-B-032-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen YH, 2009, BONE, V44, P777, DOI 10.1016/j.bone.2009.01.374; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MVC, 2008, NAT CELL BIOL, V10, P346, DOI 10.1038/ncb1697; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Frajese G V, 2005, J Endocrinol Invest, V28, P3; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kelly C, 2000, DEVELOPMENT, V127, P3899; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2004, DEV CELL, V6, P317, DOI 10.1016/S1534-5807(04)00069-3; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Miraoui H, 2010, J CELL BIOCHEM, V110, P1147, DOI 10.1002/jcb.22628; Mullins MC, 1996, DEVELOPMENT, V123, P81; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schilling TF, 1997, DEVELOPMENT, V124, P2945; SIMPSON P, 1983, GENETICS, V105, P615; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	35	20	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27324	10.1371/journal.pone.0027324	http://dx.doi.org/10.1371/journal.pone.0027324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087291	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700040
J	Bellanger, C; Dubanet, L; Lise, MC; Fauchais, AL; Bordessoule, D; Jauberteau, MO; Troutaud, D				Bellanger, Cynthia; Dubanet, Lydie; Lise, Marie-Claude; Fauchais, Anne-Laure; Bordessoule, Dominique; Jauberteau, Marie-Odile; Troutaud, Danielle			Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SURVIVAL; LYMPHOCYTES; SORTILIN; PATHWAY; EPRATUZUMAB; ACTIVATION; P75(NTR); ANTIBODY; RECEPTOR	Background: Diffuse large B-cell lymphoma (DLBCL) is a common and often fatal malignancy. Immunochemotherapy, a combination of rituximab to standard chemotherapy, has resulted in improved survival. However a substantial proportion of patients still fail to reach sustained remission. We have previously demonstrated that autocrine brain-derived neurotrophic factor (BDNF) production plays a function in human B cell survival, at least partly via sortilin expression. As neurotrophin receptor (Trks) signaling involved activation of survival pathways that are inhibited by rituximab, we speculated that neurotrophins may provide additional support for tumour cell survival and therapeutic resistance in DLBCL. Methodology/Principal Findings: In the present study, we used two DLBCL cell lines, SUDHL4 and SUDHL6, known to be respectively less and more sensitive to rituximab. We found by RT-PCR, western blotting, cytometry and confocal microscopy that both cell lines expressed, in normal culture conditions, BDNF and to a lesser extent NGF, as well as truncated TrkB and p75(NTR)/sortilin death neurotrophin receptors. Furthermore, BDNF secretion was detected in cell supernatants. NGF and BDNF production and Trk receptor expression, including TrkA, are regulated by apoptotic conditions (serum deprivation or rituximab exposure). Indeed, we show for the first time that rituximab exposure of DLBCL cell lines induces NGF secretion and that differences in rituximab sensitivity are associated with differential expression patterns of neurotrophins and their receptors (TrkA). Finally, these cells are sensitive to the Trk-inhibitor, K252a, as shown by the induction of apoptosis. Furthermore, K252a exhibits additive cytotoxic effects with rituximab. Conclusions/Significance: Collectively, these data strongly suggest that a neurotrophin axis, such NGF/TrkA pathway, may contribute to malignant cell survival and rituximab resistance in DLBCL.	[Bellanger, Cynthia; Dubanet, Lydie; Lise, Marie-Claude; Fauchais, Anne-Laure; Jauberteau, Marie-Odile; Troutaud, Danielle] Univ Limoges, EA3842, Limoges, France; [Bordessoule, Dominique] Univ Limoges, CNRS, UMR 6101, Limoges, France; [Bordessoule, Dominique] CHU Limoges, Serv Hematol Clin, Limoges, France	Universite de Limoges; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; CHU Limoges	Bellanger, C (corresponding author), Univ Limoges, EA3842, Limoges, France.	danielle.troutaud@unilim.fr		Troutaud, Danielle/0000-0002-2619-5059; Fauchais, Anne Laure/0000-0002-0489-8570; Jauberteau, Marie-Odile/0000-0002-8811-8948	Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne); CORC (Comite d'Orientation Recherche Cancer en Limousin)	Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne); CORC (Comite d'Orientation Recherche Cancer en Limousin)	This work and C.B. were supported by Ligue Nationale Contre le Cancer (Comite Departemental de La Haute-Vienne) and CORC (Comite d'Orientation Recherche Cancer en Limousin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram M, 2009, J IMMUNOL, V182, P4705, DOI 10.4049/jimmunol.0802814; Akil H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025097; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Carnahan J, 2007, MOL IMMUNOL, V44, P1331, DOI 10.1016/j.molimm.2006.05.007; Coiffier B, 2007, ONCOGENE, V26, P3603, DOI 10.1038/sj.onc.1210376; Coiffier B, 2002, ANTI-CANCER DRUG, V13, pS43, DOI 10.1097/00001813-200211002-00007; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Paepe P, 2007, LEUKEMIA, V21, P37, DOI 10.1038/sj.leu.2404449; Dechant G, 2001, CELL TISSUE RES, V305, P229, DOI 10.1007/s004410100378; Fauchais AL, 2008, J IMMUNOL, V181, P3027, DOI 10.4049/jimmunol.181.5.3027; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; Lyu MA, 2010, NEOPLASIA, V12, P366, DOI 10.1593/neo.91960; Melamed I, 1996, EUR J IMMUNOL, V26, P1985, DOI 10.1002/eji.1830260903; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sniderhan LF, 2009, EXP HEMATOL, V37, P1295, DOI 10.1016/j.exphem.2009.08.005; Stein R, 2004, CLIN CANCER RES, V10, P2868, DOI 10.1158/1078-0432.CCR-03-0493; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tervonen TA, 2006, EUR J NEUROSCI, V24, P1277, DOI 10.1111/j.1460-9568.2006.05010.x; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Verdier M, 2006, CYTOM PART A, V69A, P999, DOI 10.1002/cyto.a.20310; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27213	10.1371/journal.pone.0027213	http://dx.doi.org/10.1371/journal.pone.0027213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076137	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200050
J	Benitez, BA; Alvarado, D; Cai, YF; Mayo, K; Chakraverty, S; Norton, J; Morris, JC; Sands, MS; Goate, A; Cruchaga, C				Benitez, Bruno A.; Alvarado, David; Cai, Yefei; Mayo, Kevin; Chakraverty, Sumitra; Norton, Joanne; Morris, John C.; Sands, Mark S.; Goate, Alison; Cruchaga, Carlos			Exome-Sequencing Confirms DNAJC5 Mutations as Cause of Adult Neuronal Ceroid-Lipofuscinosis	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; KUFS-DISEASE; CSP-ALPHA; AUTOSOMAL-DOMINANT; SYNAPTIC VESICLES; ONSET; PALMITOYLATION; DEFICIENCY; PREDICTION; CHAPERONE	We performed whole-exome sequencing in two autopsy-confirmed cases and an elderly unaffected control from a multigenerational family with autosomal dominant neuronal ceroid lipofuscinosis (ANCL). A novel single-nucleotide variation (c.344T>G) in the DNAJC5 gene was identified. Mutational screening in an independent family with autosomal dominant ANCL found an in-frame single codon deletion (c.346_348 delCTC) resulting in a deletion of p.Leu116del. These variants fulfill all genetic criteria for disease-causing mutations: they are found in unrelated families with the same disease, exhibit complete segregation between the mutation and the disease, and are absent in healthy controls. In addition, the associated amino acid substitutions are located in evolutionarily highly conserved residues and are predicted to functionally affect the encoded protein (CSP alpha). The mutations are located in a cysteine-string domain, which is required for membrane targeting/binding, palmitoylation, and oligomerization of CSP alpha. We performed a comprehensive in silico analysis of the functional and structural impact of both mutations on CSP alpha. We found that these mutations dramatically decrease the affinity of CSP alpha for the membrane. We did not identify any significant effect on palmitoylation status of CSP alpha. However, a reduction of CSP alpha membrane affinity may change its palmitoylation and affect proper intracellular sorting. We confirm that CSP alpha has a strong intrinsic aggregation propensity; however, it is not modified by the mutations. A complementary disease-network analysis suggests a potential interaction with other NCLs genes/pathways. This is the first replication study of the identification of DNAJC5 as the disease-causing gene for autosomal dominant ANCL. The identification of the novel gene in ANCL will allow us to gain a better understanding of the pathological mechanism of ANCLs and constitutes a great advance toward the development of new molecular diagnostic tests and may lead to the development of potential therapies.	[Benitez, Bruno A.; Cai, Yefei; Mayo, Kevin; Chakraverty, Sumitra; Norton, Joanne; Goate, Alison; Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Alvarado, David; Sands, Mark S.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Morris, John C.; Goate, Alison] Washington Univ, Dept Neurol, St Louis, MO USA; [Sands, Mark S.; Goate, Alison; Cruchaga, Carlos] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Goate, Alison] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Benitez, BA (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	cruchagac@psychiatry.wustl.edu	Benitez, Bruno A./E-7116-2014; Cruchaga, Carlos/ABF-4065-2020	Benitez, Bruno A./0000-0002-2699-3878; Cruchaga, Carlos/0000-0002-0276-2899; Goate, Alison/0000-0002-0576-2472	NIH [1P30NS069329-01, P50AG005681]; Barnes-Jewish Hospital Foundation; Hope Center for Neurological Disorders; Danforth Foundation Challenge at Washington University; NCI Cancer Center [P30 CA91842]; ICTS/CTSA [UL1RR024992]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Hope Center for Neurological Disorders; Danforth Foundation Challenge at Washington University; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants: NIH (1P30NS069329-01, P50AG005681), the Barnes-Jewish Hospital Foundation. This work was also supported by pilot funding from the Hope Center for Neurological Disorders and the Danforth Foundation Challenge at Washington University. We thank the Genome Technology Access Center in the Department of Genetics for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1RR024992 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Hawkins-Salsbury JA, 2011, HUM MOL GENET, V20, pR54, DOI 10.1093/hmg/ddr112; Heinonen O, 2000, MOL GENET METAB, V69, P123, DOI 10.1006/mgme.2000.2961; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Josephson SA, 2001, J NEUROL SCI, V188, P51, DOI 10.1016/S0022-510X(01)00546-9; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Mastrogiacomo A, 1998, FEBS LETT, V436, P85, DOI 10.1016/S0014-5793(98)01092-8; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ramadan H, 2007, NEUROLOGY, V68, P387, DOI 10.1212/01.wnl.0000252825.85947.2f; Ranjan R, 1998, J NEUROSCI, V18, P956; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Sadzot B, 2000, J NEUROL, V247, P447, DOI 10.1007/s004150070174; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schuierer S, 2010, BIOINFORMATICS, V26, P1922, DOI 10.1093/bioinformatics/btq307; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Sleat DE, 2009, MOL CELL PROTEOMICS, V8, P1708, DOI 10.1074/mcp.M900122-MCP200; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2007, STRUCTURE, V15, P139, DOI 10.1016/j.str.2006.12.007; Tartaglia GG, 2010, J MOL BIOL, V402, P919, DOI 10.1016/j.jmb.2010.08.013; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; van Diggelen OP, 2001, ANN NEUROL, V50, P269, DOI 10.1002/ana.1103; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Virmani T, 2005, NEUROBIOL DIS, V20, P314, DOI 10.1016/j.nbd.2005.03.012; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	65	82	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26741	10.1371/journal.pone.0026741	http://dx.doi.org/10.1371/journal.pone.0026741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073189	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200019
J	Miyazaki, M; Schroder, E; Edelmann, SE; Hughes, ME; Kornacker, K; Balke, CW; Esser, KA				Miyazaki, Mitsunori; Schroder, Elizabeth; Edelmann, Stephanie E.; Hughes, Michael E.; Kornacker, Karl; Balke, C. William; Esser, Karyn A.			Age-Associated Disruption of Molecular Clock Expression in Skeletal Muscle of the Spontaneously Hypertensive Rat	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; INSULIN-RESISTANCE; CIRCADIAN CLOCK; SOLEUS MUSCLES; GENE-EXPRESSION; IN-VIVO; DISEASE; CELLS; MOUSE; TRANSCRIPTION	It is well known that spontaneously hypertensive rats (SHR) develop muscle pathologies with hypertension and heart failure, though the mechanism remains poorly understood. Woon et al. (2007) linked the circadian clock gene Bmal1 to hypertension and metabolic dysfunction in the SHR. Building on these findings, we compared the expression pattern of several core-clock genes in the gastrocnemius muscle of aged SHR (80 weeks; overt heart failure) compared to aged-matched control WKY strain. Heart failure was associated with marked effects on the expression of Bmal1, Clock and Rora in addition to several non-circadian genes important in regulating skeletal muscle phenotype including Mck, Ttn and Mef2c. We next performed circadian time-course collections at a young age (8 weeks; pre-hypertensive) and adult age (22 weeks; hypertensive) to determine if clock gene expression was disrupted in gastrocnemius, heart and liver tissues prior to or after the rats became hypertensive. We found that hypertensive/hypertrophic SHR showed a dampening of peak Bmal1 and Reverb expression in the liver, and the clock-controlled gene Pgc1 alpha in the gastrocnemius. In addition, the core-clock gene Clock and the muscle-specific, clock-controlled gene Myod1, no longer maintained a circadian pattern of expression in gastrocnemius from the hypertensive SHR. These findings provide a framework to suggest a mechanism whereby chronic heart failure leads to skeletal muscle pathologies; prolonged dysregulation of the molecular clock in skeletal muscle results in altered Clock, Pgc1 alpha and Myod1 expression which in turn leads to the mis-regulation of target genes important for mechanical and metabolic function of skeletal muscle.	[Miyazaki, Mitsunori; Schroder, Elizabeth; Edelmann, Stephanie E.; Esser, Karyn A.] Univ Kentucky, Ctr Muscle Biol, Dept Physiol, Lexington, KY 40536 USA; [Hughes, Michael E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Kornacker, Karl] Ohio State Univ, Div Sensory Biophys, Columbus, OH 43210 USA; [Balke, C. William] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Balke, C. William] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Kentucky; Yale University; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miyazaki, M (corresponding author), Univ Kentucky, Ctr Muscle Biol, Dept Physiol, Lexington, KY 40536 USA.	eschr0@uky.edu	Miyazaki, Mitsunori/AAM-8598-2021	Miyazaki, Mitsunori/0000-0001-7824-2091	NIAMS [R01AR055246]; NIEHS [RC1ES018636]; American Heart Association [0825668D]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018636] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01AR055246 from NIAMS, RC1ES018636 from NIEHS, and a postdoctoral fellowship provided by the American Heart Association to Mitsunori Miyazaki (0825668D), http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; AMEEN M, 1991, ANN NY ACAD SCI, V639, P550, DOI 10.1111/j.1749-6632.1991.tb17348.x; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; ANDREWS JL, P NATL ACAD SCI US, V107, P19090; ATRAKCHI A, 1994, AM J PHYSIOL, V267, pC827, DOI 10.1152/ajpcell.1994.267.3.C827; Bortolotto SK, 1999, AM J PHYSIOL-CELL PH, V276, pC628, DOI 10.1152/ajpcell.1999.276.3.C628; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Cabassi A, 2001, HYPERTENSION, V37, P698, DOI 10.1161/01.HYP.37.2.698; CAPALDO B, 1991, METABOLISM, V40, P1320, DOI 10.1016/0026-0495(91)90036-V; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Geyer C., 2003, STAT 5102 NOTES NONP; GRAY SD, 1994, AM J PHYSIOL, V267, pR735, DOI 10.1152/ajpregu.1994.267.3.R735; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6; Harridge SDR, 1996, EUR HEART J, V17, P896; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; HULMAN S, 1993, METABOLISM, V42, P14, DOI 10.1016/0026-0495(93)90165-K; Kobayashi N, 2005, ARTERIOSCL THROM VAS, V25, P2114, DOI 10.1161/01.ATV.0000178993.13222.f2; Lampert E, 1996, J AM COLL CARDIOL, V28, P980, DOI 10.1016/S0735-1097(96)00272-0; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; LIPKIN DP, 1988, INT J CARDIOL, V20, P161; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lunde PK, 2001, ACTA PHYSIOL SCAND, V171, P277, DOI 10.1046/j.1365-201x.2001.00830.x; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; PICKAR JG, 1994, AM J PHYSIOL, V267, pC836, DOI 10.1152/ajpcell.1994.267.3.C836; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; RUDIC RD, 2005, PERIPHERAL CLOCKS RE, P524; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sullivan MJ, 1997, MED SCI SPORT EXER, V29, P860, DOI 10.1097/00005768-199707000-00004; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vissing K, 2005, J APPL PHYSIOL, V99, P164, DOI 10.1152/japplphysiol.01172.2004; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	54	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27168	10.1371/journal.pone.0027168	http://dx.doi.org/10.1371/journal.pone.0027168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076133	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200045
J	Tsuei, DJ; Lee, PH; Peng, HY; Lu, SL; Su, DS; Jeng, YM; Hsu, HC; Hsu, SH; Wu, JF; Ni, YH; Chang, MH				Tsuei, Daw-Jen; Lee, Po-Huang; Peng, Hsiao-Yu; Lu, Shau-Lin; Su, De-Shiuan; Jeng, Yung-Ming; Hsu, Hey-Chi; Hsu, Shu-Hao; Wu, Jia-Feng; Ni, Yen-Hsuan; Chang, Mei-Hwei			Male Germ Cell-Specific RNA Binding Protein RBMY: A New Oncogene Explaining Male Predominance in Liver Cancer	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ANDROGEN-RECEPTOR; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTIONAL ACTIVITY; GENDER DISPARITY; EXPRESSION; SAM68; TESTOSTERONE; VACCINATION; REPEATS	Male gender is a risk factor for the development of hepatocellular carcinoma (HCC) but the mechanisms are not fully understood. The RNA binding motif gene on the Y chromosome (RBMY), encoding a male germ cell-specific RNA splicing regulator during spermatogenesis, is aberrantly activated in human male liver cancers. This study investigated the in vitro oncogenic effect and the possible mechanism of RBMY in human hepatoma cell line HepG2 and its in vivo effect with regards to the livers of human and transgenic mice. RBMY expression in HepG2 cells was knocked down by RNA interference and the cancer cell phenotype was characterized by soft-agar colony formation and sensitivity to hydrogenperoxide-induced apoptosis. The results revealed that RBMY knockdown reduced the transformation and anti-apoptotic efficiency of HepG2 cells. The expression of RBMY, androgen receptor (AR) and its inhibitory variant AR45, AR-targeted genes insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) was analyzed by quantitative RT-PCR. Up-regulation of AR45 variant and reduction of IGF-1 and IGFBP-3 expression was only detected in RBMY knockdown cells. Moreover, RBMY positive human male HCC expressed lower level of AR45 as compared to RBMY negative HCC tissues. The oncogenic properties of RBMY were further assessed in a transgenic mouse model. Liver-specific RBMY transgenic mice developed hepatic pre-cancerous lesions, adenoma, and HCC. RBMY also accelerated chemical carcinogen-induced hepatocarcinogenesis in transgenic mice. Collectively, these findings suggest that Y chromosome-specific RBMY is likely involved in the regulation of androgen receptor activity and contributes to male predominance of HCC.	[Tsuei, Daw-Jen; Peng, Hsiao-Yu; Lu, Shau-Lin; Su, De-Shiuan; Hsu, Shu-Hao; Wu, Jia-Feng; Ni, Yen-Hsuan; Chang, Mei-Hwei] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Lee, Po-Huang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei, Taiwan; [Jeng, Yung-Ming; Hsu, Hey-Chi] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pathol, Taipei, Taiwan; [Chang, Mei-Hwei] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsuei, DJ (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan.	changmh@ntu.edu.tw	Wu, Jia-Feng/H-8125-2019	Wu, Jia-Feng/0000-0001-6343-1658; JENG, YUNG-MING/0000-0002-3878-4491; HSU, SHU-HAO/0000-0002-9444-4192; LEE, PO-HUANG/0000-0001-5831-035X; Chang, Mei Hwei/0000-0002-3648-9261; Ni, Yen-Hsuan/0000-0002-1158-5249	National Health Research Institute of Taiwan [NHRI-EX93-117BN, NHRI-EX95 (96, 97, 98)-9418BI]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants NHRI-EX93-117BN, NHRI-EX95 (96, 97, 98)-9418BI from the National Health Research Institute of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens-Fath I, 2005, FEBS J, V272, P74, DOI 10.1111/j.1432-1033.2004.04395.x; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang MH, 2000, JAMA-J AM MED ASSOC, V284, P3040, DOI 10.1001/jama.284.23.3040; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Dreumont N, 2010, J CELL SCI, V123, P40, DOI 10.1242/jcs.055889; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Kanda T, 2008, J VIROL, V82, P11066, DOI 10.1128/JVI.01300-08; KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Peng LH, 2006, ENDOCRINOLOGY, V147, P4599, DOI 10.1210/en.2006-0560; Prieto Jesus, 2008, J Hepatol, V48, P380, DOI 10.1016/j.jhep.2007.11.007; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Ruggieri A, 2010, INT J CANCER, V127, P499, DOI 10.1002/ijc.25298; Tsuei DJ, 2004, ONCOGENE, V23, P5815, DOI 10.1038/sj.onc.1207773; Tsuei DJ, 2002, J MED VIROL, V68, P513, DOI 10.1002/jmv.10240; Venables JP, 1999, HUM MOL GENET, V8, P959, DOI 10.1093/hmg/8.6.959; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Yu MW, 2000, J NATL CANCER I, V92, P2023, DOI 10.1093/jnci/92.24.2023	33	25	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26948	10.1371/journal.pone.0026948	http://dx.doi.org/10.1371/journal.pone.0026948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073224	Green Submitted, gold, Green Published			2022-12-25	WOS:000297198200025
J	Dass, SAH; Vasudevan, A; Dutta, D; Soh, LJT; Sapolsky, RM; Vyas, A				Dass, Shantala Arundathi Hari; Vasudevan, Anand; Dutta, Deborah; Soh, Linda Jing Ting; Sapolsky, Robert Morris; Vyas, Ajai			Protozoan Parasite Toxoplasma gondii Manipulates Mate Choice in Rats by Enhancing Attractiveness of Males	PLOS ONE			English	Article							NORWAY RATS; FEMALE MICE; BEHAVIOR; INFECTION; COLORATION; EVOLUTION; PATTERN; FITNESS; SEX	Females in various species typically avoid males infected with parasites, while parasite-free males advertise their status through conspicuous phenotypic traits. This process selects for heritable resistance and reduces direct exposure of the female to parasites. Coevolving parasites are likely to attempt to circumvent this obstacle. In this paper, we demonstrate a case of parasitic manipulation of host mate choice. We report that Toxoplasma gondii, a sexually transmitted infection of brown rats, enhances sexual attractiveness of infected males. Thus under some evolutionary niches, parasites can indeed manipulate host sexual signaling to their own advantage.	[Dass, Shantala Arundathi Hari; Vasudevan, Anand; Dutta, Deborah; Soh, Linda Jing Ting; Vyas, Ajai] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sapolsky, Robert Morris] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University	Dass, SAH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	avyas@ntu.edu.sg	Vyas, Ajai/A-2223-2011; Vasudevan, Anand/J-8983-2019	Vyas, Ajai/0000-0002-2592-6796; Vasudevan, Anand/0000-0002-7890-3782; dutta, deborah/0000-0003-2445-7139; Hari Dass, Shantala/0000-0002-1852-4641	Nanyang Technological University, Singapore; Stanley Medical Research Institute; National Institute of Health, USA [AI41014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041014] Funding Source: NIH RePORTER	Nanyang Technological University, Singapore(Nanyang Technological University); Stanley Medical Research Institute; National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by Nanyang Technological University, Singapore, through its Nanyang Assistant Professorship program; Stanley Medical Research Institute and National Institute of Health, USA (grant AI41014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able DJ, 1996, P NATL ACAD SCI USA, V93, P2229, DOI 10.1073/pnas.93.5.2229; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Arantes TP, 2009, EXP PARASITOL, V123, P190, DOI 10.1016/j.exppara.2009.07.003; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BERDOY M, 1995, PARASITOLOGY, V111, P403, DOI 10.1017/S0031182000065902; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Dawkins R., 1982, pi; Dawson RD, 2006, NATURWISSENSCHAFTEN, V93, P597, DOI 10.1007/s00114-006-0146-6; Deaton R, 2009, BEHAV PROCESS, V80, P1, DOI 10.1016/j.beproc.2008.07.010; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Ehman KD, 2002, PARASITOLOGY, V125, P461, DOI 10.1017/S003118200200224X; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Fisher RA, 1915, EUGEN REV, V7, P184; Gutierrez J, 2010, VET PARASITOL, V172, P8, DOI 10.1016/j.vetpar.2010.04.035; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P398, DOI 10.1016/S0003-3472(82)80051-1; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P410, DOI 10.1016/S0003-3472(82)80052-3; McLachlan A, 1999, ANIM BEHAV, V57, P1199, DOI 10.1006/anbe.1999.1087; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MOLLER AP, 1990, EVOLUTION, V44, P771, DOI 10.1111/j.1558-5646.1990.tb03804.x; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; MOLLER AP, 1991, ANIM BEHAV, V41, P723, DOI 10.1016/S0003-3472(05)80909-1; Moore J., 2002, PARASITES BEHAV ANIM; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Poulin R, 1998, PARASITOLOGY, V116, pS3, DOI 10.1017/S0031182000084894; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	44	60	62	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27229	10.1371/journal.pone.0027229	http://dx.doi.org/10.1371/journal.pone.0027229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073295	Green Published, gold			2022-12-25	WOS:000297154900092
J	Bortolussi, G; Zentilin, L; Baj, G; Giraudi, P; Bellarosa, C; Giacca, M; Tiribelli, C; Muro, AF				Bortolussi, Giulia; Zentilin, Lorena; Baj, Gabriele; Giraudi, Pablo; Bellarosa, Cristina; Giacca, Mauro; Tiribelli, Claudio; Muro, Andres F.			Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer	FASEB JOURNAL			English	Article						kernicterus; phototherapy; UGT1A1	UDP-GLUCURONOSYLTRANSFERASE DEFICIENCY; INDUCED CEREBELLAR HYPOPLASIA; GUNN RAT; UGT1 LOCUS; EDA EXON; HYPERBILIRUBINEMIA; MICE; FIBRONECTIN; KERNICTERUS; GENOME	Crigler-Najjar type I (CNI) syndrome is a recessively inherited disorder characterized by severe unconjugated hyperbilirubinemia caused by uridine diphosphoglucuronosyltransferase 1A1 (UGT1A1) deficiency. The disease is lethal due to bilirubin-induced neurological damage unless phototherapy is applied from birth. However, treatment becomes less effective during growth, and liver transplantation is required. To investigate the pathophysiology of the disease and therapeutic approaches in mice, we generated a mouse model by introducing a premature stop codon in the UGT1a1 gene, which results in an inactive enzyme. Homozygous mutant mice developed severe jaundice soon after birth and died within 11 d, showing significant cerebellar alterations. To rescue neonatal lethality, newborns were injected with a single dose of adeno-associated viral vector 9 (AAV9) expressing the human UGT1A1. Gene therapy treatment completely rescued all AAV-treated mutant mice, accompanied by lower plasma bilirubin levels and normal brain histology and motor coordination. Our mouse model of CNI reproduces genetic and phenotypic features of the human disease. We have shown, for the first time, the full recovery of the lethal effects of neonatal hyperbilirubinemia. We believe that, besides gene-addition-based therapies, our mice could represent a very useful model to develop and test novel technologies based on gene correction by homologous recombination.-Bortolussi, G., Zentilin, L., Baj, G., Giraudi, P., Bellarosa, C., Giacca, M., Tiribelli, C., Muro, A. F. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. FASEB J. 26, 1052-1063 (2012). www.fasebj.org	[Bortolussi, Giulia; Zentilin, Lorena; Giacca, Mauro; Muro, Andres F.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Baj, Gabriele] Univ Trieste, Dept Life Sci, Ctr Neurosci, Basic Res & Integrat Neurosci BRAIN, Trieste, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy; [Giraudi, Pablo; Bellarosa, Cristina; Tiribelli, Claudio] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste	Muro, AF (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34149 Trieste, Italy.	muro@icgeb.org	Muro, Andrés F/K-3156-2016; Giacca, Mauro/J-9287-2016; Baj, Gabriele/H-4228-2012; Tiribelli, Claudio/A-4716-2014	Muro, Andrés F/0000-0002-9628-0494; Giacca, Mauro/0000-0003-2927-7225; Baj, Gabriele/0000-0002-2625-9454; Bortolussi, Giulia/0000-0001-9470-0902; Tiribelli, Claudio/0000-0001-6596-7595	Telethon [GGP10051]; Friuli-Venezia Giulia Regional Grant	Telethon(Fondazione Telethon); Friuli-Venezia Giulia Regional Grant	This work was supported by Telethon (GGP10051) and by Friuli-Venezia Giulia Regional Grant to AFM. The authors thank M. Dappas and M. Zotti for help with AAV preparation, M. Sturnega and S. Artico for help with animal care, E. Tongiorgi for microscope resources, M. Rossi for help in determination of Ugt1a1 activity, and the integrants of the Mouse Molecular Genetics Group for critical reading of the manuscript.	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Chauhan AK, 2005, BEHAV BRAIN RES, V161, P31, DOI 10.1016/j.bbr.2005.02.020; Chowdhury J. R., 1986, BILE PIGMENTS JAUNDI, P317; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; CRIGLER JF, 1952, PEDIATRICS, V10, P169; DOBBS RH, 1975, ARCH DIS CHILD, V50, P833, DOI 10.1136/adc.50.11.833; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; DOUMAS BT, 1985, CLIN CHEM, V31, P1779; Emi Y, 2002, ARCH BIOCHEM BIOPHYS, V405, P163, DOI 10.1016/S0003-9861(02)00351-X; Flageul M, 2009, J GENE MED, V11, P689, DOI 10.1002/jgm.1343; Fonnum F, 2000, TOXICOL LETT, V112, P9, DOI 10.1016/S0378-4274(99)00246-5; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; GORDON ER, 1984, J BIOL CHEM, V259, P5500; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; Iyanagi T, 1998, BBA-MOL BASIS DIS, V1407, P173, DOI 10.1016/S0925-4439(98)00044-1; Jia Z, 2005, MOL THER, V12, P860, DOI 10.1016/j.ymthe.2005.04.023; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; KEINO H, 1989, NEUROSCI RES, V6, P209, DOI 10.1016/0168-0102(89)90060-6; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Miranda PSM, 2009, CURR GENE THER, V9, P72; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Ogura T, 2006, J GENE MED, V8, P990, DOI 10.1002/jgm.916; Pacak Christina A, 2008, Genet Vaccines Ther, V6, P13, DOI 10.1186/1479-0556-6-13; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; Seppen J, 2006, MOL THER, V13, P1085, DOI 10.1016/j.ymthe.2006.01.014; Shapiro SM, 2006, CLIN PERINATOL, V33, P387, DOI 10.1016/j.clp.2006.03.010; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strauss KA, 2006, EUR J PEDIATR, V165, P306, DOI 10.1007/s00431-005-0055-2; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; Yamamura H, 1993, Nagoya J Med Sci, V55, P11; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001	38	53	57	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1052	1063		10.1096/fj.11-195461	http://dx.doi.org/10.1096/fj.11-195461			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22094718	Green Published, hybrid			2022-12-25	WOS:000300949300010
J	Colom, B; Poitelon, Y; Huang, WL; Woodfin, A; Averill, S; Del Carro, U; Zambroni, D; Brain, SD; Perretti, M; Ahluwalia, A; Priestley, JV; Chavakis, T; Imhof, BA; Feltri, ML; Nourshargh, S				Colom, Bartomeu; Poitelon, Yannick; Huang, Wenlong; Woodfin, Abigail; Averill, Sharon; Del Carro, Ubaldo; Zambroni, Desiree; Brain, Susan D.; Perretti, Mauro; Ahluwalia, Amrita; Priestley, John V.; Chavakis, Triantafyllos; Imhof, Beat A.; Feltri, M. Laura; Nourshargh, Sussan			Schwann cell-specific JAM-C-deficient mice reveal novel expression and functions for JAM-C in peripheral nerves	FASEB JOURNAL			English	Article						adhesion molecules; tight junctions; peripheral nerves	JUNCTIONAL-ADHESION-MOLECULE; MYELINATED AXONS; TRANSENDOTHELIAL MIGRATION; IMMUNOGLOBULIN SUPERFAMILY; TIGHT JUNCTIONS; IN-VIVO; RECEPTOR; PROTEINS; INTEGRIN; GROWTH	Junctional adhesion molecule-C (JAM-C) is an adhesion molecule expressed at junctions between adjacent endothelial and epithelial cells and implicated in multiple inflammatory and vascular responses. In addition, we recently reported on the expression of JAM-C in Schwann cells (SCs) and its importance for the integrity and function of peripheral nerves. To investigate the role of JAM-C in neuronal functions further, mice with a specific deletion of JAM-C in SCs (JAM-C SC KO) were generated. Compared to wild-type (WT) controls, JAM-C SC KO mice showed electrophysiological defects, muscular weakness, and hypersensitivity to mechanical stimuli. In addressing the underlying cause of these defects, nerves from JAM-C SC KO mice were found to have morphological defects in the paranodal region, exhibiting increased nodal length as compared to WTs. The study also reports on previously undetected expressions of JAM-C, namely on perineural cells, and in line with nociception defects of the JAM-C SC KO animals, on finely myelinated sensory nerve fibers. Collectively, the generation and characterization of JAM-C SC KO mice has provided unequivocal evidence for the involvement of SC JAM-C in the fine organization of peripheral nerves and in modulating multiple neuronal responses.-Colom, B., Poitelon, Y., Huang, W., Woodfin, A., Averill, S., Del Carro, U., Zambroni, D., Brain, S. D., Perretti, M., Ahluwalia, A., Priestley, J. V., Chavakis, T., Imhof, B. A., Feltri, M. L., Nourshargh, S. Schwann cell-specific JAM-C-deficient mice reveal novel expression and functions for JAM-C in peripheral nerves. FASEB J. 26, 1064-1076 (2012). www.fasebj.org	[Colom, Bartomeu; Woodfin, Abigail; Perretti, Mauro; Ahluwalia, Amrita; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Huang, Wenlong; Averill, Sharon; Priestley, John V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, London EC1M 6BQ, England; [Poitelon, Yannick; Del Carro, Ubaldo; Zambroni, Desiree; Feltri, M. Laura] Ist Sci San Raffaele, Dept Genet & Cell Biol, I-20132 Milan, Italy; [Poitelon, Yannick; Del Carro, Ubaldo; Zambroni, Desiree; Feltri, M. Laura] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Brain, Susan D.] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Brain, Susan D.] Kings Coll London, Ctr Integrat Biomed, London WC2R 2LS, England; [Chavakis, Triantafyllos] Univ Dresden, Dept Med, Dresden, Germany; [Chavakis, Triantafyllos] Univ Dresden, Dept Physiol, Dresden, Germany; [Imhof, Beat A.] Ctr Med Univ Geneva, Geneva, Switzerland	University of London; Queen Mary University London; University of London; Queen Mary University London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; King's College London; University of London; King's College London; Technische Universitat Dresden; Technische Universitat Dresden; University of Geneva	Nourshargh, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk	Zambroni, Desiree/AAN-4003-2020; Del Carro, Ubaldo/AAO-3457-2020; Feltri, Maria Laura/J-5286-2018; Colom, Bartomeu/AAA-7539-2019; Colom, Bartomeu/A-6905-2013; Brain, Susan/L-3681-2013; Chavakis, Triantafyllos/ABE-8845-2020; Huang, Wenlong/P-2025-2016	Zambroni, Desiree/0000-0003-4027-1094; Del Carro, Ubaldo/0000-0003-3301-5412; Nourshargh, Sussan/0000-0001-5677-1806; Colom, Bartomeu/0000-0001-6256-6462; Brain, Susan/0000-0002-9684-8342; Poitelon, Yannick/0000-0001-9868-1569; AHLUWALIA, Amrita/0000-0001-7626-6399	Wellcome Trust [081172/Z/06/Z]; Swiss National Science Foundation [310030-120184]; Deutsche Forschungsgemeinschaft; Center for Regenerative Therapies Dresden; U.S. National Institute of Neurological Disorders and Stroke [R01NS045630]; Telethon Italia [GGP08021]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045630] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Regenerative Therapies Dresden; U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon Italia(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Wellcome Trust (081172/Z/06/Z to S.N.). The study was also supported by the Swiss National Science Foundation (310030-120184 to B. A. I.), the Deutsche Forschungsgemeinschaft and the Center for Regenerative Therapies Dresden (to T. C.), the U.S. National Institute of Neurological Disorders and Stroke (R01NS045630 to M. L. F.), and Telethon Italia (GGP08021 to M. L. F.). The authors thank Stefania Saccucci for superb technical assistance.	Alanne MH, 2009, J HISTOCHEM CYTOCHEM, V57, P523, DOI 10.1369/jhc.2009.951681; Angelow S, 2007, AM J PHYSIOL-RENAL, V293, pF166, DOI 10.1152/ajprenal.00087.2007; Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Betanzos A, 2009, BIOL CELL, V101, P441, DOI 10.1042/BC20080130; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Cao T, 2000, J IMMUNOL, V164, P5424, DOI 10.4049/jimmunol.164.10.5424; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fullerton JM, 2010, BIOL PSYCHIAT, V67, P478, DOI 10.1016/j.biopsych.2009.10.022; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Inoue H, 1997, EUR J PHARMACOL, V333, P231, DOI 10.1016/S0014-2999(97)01040-6; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Keiper T, 2005, FASEB J, V19, P2078, DOI 10.1096/fj.05-4196fje; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Morris AP, 2006, CELL COMMUN ADHES, V13, P233, DOI 10.1080/15419060600877978; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Ody C, 2007, LEUKEMIA, V21, P1285, DOI 10.1038/sj.leu.2404689; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Palmer G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2223; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Praetor A, 2009, BLOOD, V113, P1919, DOI 10.1182/blood-2008-06-159574; Priestley JV, 2002, CAN J PHYSIOL PHARM, V80, P495, DOI 10.1139/y02-034; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sandri C, 1977, Prog Brain Res, V46, P1; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; Scherer SS, 1995, J NEUROSCI, V15, P8281; SCHNAPP B, 1976, NEUROSCIENCE, V1, P459, DOI 10.1016/0306-4522(76)90097-X; Shagdarsuren E, 2009, ARTERIOSCL THROM VAS, V29, P1161, DOI 10.1161/ATVBAHA.109.187898; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; THOMAS PK, 1963, J ANAT, V97, P35; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vonlaufen A, 2006, J PATHOL, V209, P540, DOI 10.1002/path.2007; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Zimmerli C, 2009, J IMMUNOL, V182, P4728, DOI 10.4049/jimmunol.0803892	52	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1064	1076		10.1096/fj.11-196220	http://dx.doi.org/10.1096/fj.11-196220			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22090315	Green Published, hybrid			2022-12-25	WOS:000300949300011
J	Hu, XY; Laragione, T; Sun, L; Koshy, S; Jones, KR; Ismailov, II; Yotnda, P; Horrigan, FT; Gulko, PS; Beeton, C				Hu, Xueyou; Laragione, Teresina; Sun, Liang; Koshy, Shyny; Jones, Karlie R.; Ismailov, Iskander I.; Yotnda, Patricia; Horrigan, Frank T.; Gulko, Percio S.; Beeton, Christine			KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; CA2+-ACTIVATED K+ CHANNEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; JOINT DESTRUCTION; KV1.3 CHANNELS; EXPRESSION; CLASSIFICATION; PROLIFERATION	Fibroblast-like synoviocytes (FLS) play important roles in the pathogenesis of rheumatoid arthritis (RA). Potassium channels have regulatory roles in many cell functions. We have identified the calcium-and voltage-gated KCa1.1 channel (BK, Maxi-K, Slo1, KCNMA1) as the major potassium channel expressed at the plasma membrane of FLS isolated from patients with RA (RA-FLS). We further show that blocking this channel perturbs the calcium homeostasis of the cells and inhibits the proliferation, production of VEGF, IL-8, and pro-MMP-2, and migration and invasion of RA-FLS. Our findings indicate a regulatory role of KCa1.1 channels in RA-FLS function and suggest this channel as a potential target for the treatment of RA.	[Hu, Xueyou; Sun, Liang; Koshy, Shyny; Jones, Karlie R.; Ismailov, Iskander I.; Horrigan, Frank T.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Laragione, Teresina; Gulko, Percio S.] Feinstein Inst Med Res, Lab Expt Rheumatol, Ctr Genom & Human Genet, Manhasset, NY 11030 USA; [Yotnda, Patricia] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Northwell Health; Baylor College of Medicine	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Mail Stop BCM335,Rm S409A, Houston, TX 77030 USA.	beeton@bcm.edu	; Sun, Liang/D-4857-2018	Beeton, Christine/0000-0002-2500-5874; Sun, Liang/0000-0002-7817-5121	Baylor College of Medicine; Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health [M01RR018535]; National Institutes of Health, NIAID [AI084981, AI54348]; NINDS [NS042901]; NIAMS [AR059838, AR0426213]; National Institutes of Health [NCRR S10RR024574, NIAID AI036211, NCI P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054348, R56AI084981, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042901] Funding Source: NIH RePORTER	Baylor College of Medicine; Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Baylor College of Medicine (to F. T. H. and C. B.), the Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health Grant M01RR018535 (to P. S. G.) and National Institutes of Health, NIAID Grants AI084981 (to C. B.) and AI54348 (to P. S. G.), NINDS Grant NS042901 (to F. T. H.), NIAMS Grants AR059838 (to C. B.), and AR0426213 (to P. S. G.)). The Baylor College of Medicine Cytometry and Cell Sorting Core is supported by National Institutes of Health Grants NCRR S10RR024574, NIAID AI036211, and NCI P30CA125123.	Abeles AM, 2006, BULL HOSP JT DIS, V64, P20; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brenner R, 1996, J NEUROSCI, V16, P1827; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; GALLAGHER RT, 1977, NEW ZEAL J AGR RES, V20, P431, DOI 10.1080/00288233.1977.10427356; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P145, DOI 10.1186/ar79; Gregersen P. K., 2006, RHEUMATOID ARTHRITIS; Gulko P. S., 2001, SAMTERS IMMUNOLOGIC; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Laragione T, 2008, ARTHRITIS RHEUM-US, V58, P2296, DOI 10.1002/art.23610; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Laragione T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2476; Large RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1180, DOI 10.1152/ajpcell.00028.2010; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meyer LH, 2006, BEST PRACT RES CL RH, V20, P969, DOI 10.1016/j.berh.2006.06.005; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pattacini L, 2007, RHEUMATOLOGY, V46, P1252, DOI 10.1093/rheumatology/kem092; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Striano P, 2009, EXPERT OPIN INV DRUG, V18, P1875, DOI 10.1517/13543780903369341; Tolboom TCA, 2005, ARTHRITIS RHEUM-US, V52, P1999, DOI 10.1002/art.21118; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921	43	35	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4014	4022		10.1074/jbc.M111.312264	http://dx.doi.org/10.1074/jbc.M111.312264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22074915	Green Published, hybrid			2022-12-25	WOS:000300410900035
J	Speicher, T; Kohler, UA; Chouker, A; Werner, S; Weiland, T; Wendel, A				Speicher, Tobias; Koehler, Ulrike A.; Chouker, Alexander; Werner, Sabine; Weiland, Timo; Wendel, Albrecht			Fructose Protects Murine Hepatocytes from Tumor Necrosis Factor-induced Apoptosis by Modulating JNK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC DEPLETION; CANCER-PATIENTS; PHASE-I; C-JUN; TNF; ACTIVATION; KINASE; LIVER; ATP; TRANSDUCTION	Fructose-induced hepatic ATP depletion prevents TNF-induced apoptosis, whereas it contrarily enhances CD95-induced hepatocyte apoptosis in vitro and in vivo. By contrast, transformed liver cells are not protected against TNF due to metabolic alterations, allowing selective tumor targeting. We analyzed the molecular mechanisms by which fructose modulates cytokine-induced apoptosis. A release of adenosine after fructose-induced ATP depletion, followed by a cAMP response, was demonstrated. Likewise, cAMP and adenosine mimicked per se the modulation by fructose of CD95- and TNF-induced apoptosis. The effects of fructose on cytokine-induced apoptosis were sensitive to inhibition of protein kinase A. Fructose prevented the pro-apoptotic, sustained phase of TNF-induced JNK signaling and thereby blocked bid-mediated activation of the intrinsic mitochondrial apoptosis pathway in a PKA-dependent manner. We explain the dichotomal effects of fructose on CD95- and TNF-induced cell death by the selective requirement of JNK signaling for the latter. These findings provide a mechanistic rationale for the protection of hepatocytes from TNF-induced cell death by pharmacological doses of fructose.	[Speicher, Tobias; Koehler, Ulrike A.; Weiland, Timo; Wendel, Albrecht] Univ Konstanz, Fac Biol, Chair Biochem Pharmacol, D-78457 Constance, Germany; [Chouker, Alexander] Klinikum Grosshadern, Dept Anesthesiol, D-81377 Munich, Germany; [Speicher, Tobias; Werner, Sabine] Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Konstanz; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wendel, A (corresponding author), Univ Konstanz, Fac Biol, Chair Biochem Pharmacol, M667, D-78457 Constance, Germany.	albrecht.wendel@uni-konstanz.de	Chouker, Alexander/H-2490-2017	Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft; International Research Training Group [1331]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Research Training Group	This study was supported in part by a fellowship of the Deutsche Forschungsgemeinschaft-funded International Research Training Group 1331 ( to Marcel Leist and A. W.).	Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Hui HX, 2009, PANCREAS, V38, P706, DOI 10.1097/MPA.0b013e3181a7c6e5; Khan N, 2011, Mymensingh Med J, V20, P332; Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975; Lee JD, 2005, J NUCL MED, V46, P1753; LEIST M, 1994, J IMMUNOL, V153, P1778; Lejeune FJ, 2006, B CANC, V93, pE90; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Lucas R, 2005, CURR CANCER DRUG TAR, V5, P381, DOI 10.2174/1568009054863627; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MAENPAA PH, 1968, SCIENCE, V161, P1253, DOI 10.1126/science.161.3847.1253; Minor T, 2000, LIVER TRANSPLANT, V6, P196, DOI 10.1016/S1527-6465(00)80011-8; Moser G. H., 1989, AM J PHYSIOL, V256, P799; Palmer T. M., 2008, BR J PHARM S, V153, P127; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; Speicher T, 2010, J HEPATOL, V53, P896, DOI 10.1016/j.jhep.2010.05.024; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; Taeger G, 2008, INT J HYPERTHER, V24, P193, DOI 10.1080/02656730701868387; Thiel M, 1997, INFECT IMMUN, V65, P2136, DOI 10.1128/IAI.65.6.2136-2144.1997; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wahjudi PN, 2010, CLIN BIOCHEM, V43, P198, DOI 10.1016/j.clinbiochem.2009.08.028; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87	26	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1837	1846		10.1074/jbc.M111.266742	http://dx.doi.org/10.1074/jbc.M111.266742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22086922	hybrid, Green Published			2022-12-25	WOS:000299321000025
J	Bilyy, RO; Shkandina, T; Tomin, A; Munoz, LE; Franz, S; Antonyuk, V; Kit, YY; Zirngibl, M; Furnrohr, BG; Janko, C; Lauber, K; Schiller, M; Schett, G; Stoika, RS; Herrmann, M				Bilyy, Rostyslav O.; Shkandina, Tanya; Tomin, Andriy; Munoz, Luis E.; Franz, Sandra; Antonyuk, Volodymyr; Kit, Yuriy Ya.; Zirngibl, Matthias; Fuernrohr, Barbara G.; Janko, Christina; Lauber, Kirsten; Schiller, Martin; Schett, Georg; Stoika, Rostyslav S.; Herrmann, Martin			Macrophages Discriminate Glycosylation Patterns of Apoptotic Cell-derived Microparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ME SIGNAL; FIND-ME; CLEARANCE; SURFACE; MACROPINOCYTOSIS; RECOGNITION; RECEPTOR; ACID	Inappropriate clearance of apoptotic remnants is considered to be the primary cause of systemic autoimmune diseases, like systemic lupus erythematosus. Here we demonstrate that apoptotic cells release distinct types of subcellular membranous particles (scMP) derived from the endoplasmic reticulum (ER) or the plasma membrane. Both types of scMP exhibit desialylated glycotopes resulting from surface exposure of immature ER-derived glycoproteins or from surface-borne sialidase activity, respectively. Sialidase activity is activated by caspase-dependent mechanisms during apoptosis. Cleavage of sialidase Neu1 by caspase 3 was shown to be directly involved in apoptosis-related increase of surface sialidase activity. ER-derived blebs possess immature mannosidic glycoepitopes and are prioritized by macrophages during clearance. Plasma membrane-derived blebs contain nuclear chromatin (DNA and histones) but not components of the nuclear envelope. Existence of two immunologically distinct types of apoptotic blebs may provide new insights into clearance-related diseases.	[Bilyy, Rostyslav O.; Munoz, Luis E.; Franz, Sandra; Zirngibl, Matthias; Fuernrohr, Barbara G.; Janko, Christina; Schett, Georg; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol & Rheumatol, D-91054 Erlangen, Germany; [Bilyy, Rostyslav O.; Shkandina, Tanya; Tomin, Andriy; Antonyuk, Volodymyr; Kit, Yuriy Ya.; Stoika, Rostyslav S.] Natl Acad Sci Ukraine, Inst Cell Biol, UA-79005 Lvov, Ukraine; [Lauber, Kirsten] Univ Munich, Dept Radiat Oncol, D-81377 Munich, Germany; [Schiller, Martin] Univ Heidelberg, Dept Med 5, D-69120 Heidelberg, Germany	University of Erlangen Nuremberg; National Academy of Sciences Ukraine; Institute of Cell Biology of NASU; University of Munich; Ruprecht Karls University Heidelberg	Herrmann, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol & Rheumatol, Krankenhausstr 12, D-91054 Erlangen, Germany.	martin.herrmann@UK-Erlangen.de	Antonyuk, Volodymyr/AAD-4457-2019; Dumych, Tetiana/H-9450-2018; herrmann, martin/AAT-9836-2020; Munoz, Luis E/E-7725-2010; Bilyy, Rostyslav/A-9777-2010; Bilyy, Rostyslav/AAH-9636-2020; Herrmann, Martin/A-9597-2013	Dumych, Tetiana/0000-0002-8489-5600; Munoz, Luis E/0000-0002-5395-804X; Bilyy, Rostyslav/0000-0002-2344-1349; Bilyy, Rostyslav/0000-0002-2344-1349; Herrmann, Martin/0000-0002-0258-2484; Franz, Sandra/0000-0002-3449-2723; Tomin, Andriy/0000-0001-8921-6366; Janko, Christina/0000-0001-5705-6329; Kit, Yuriy/0000-0002-5995-4381; Stoika, Rostyslav/0000-0001-5719-2187	German-Ukrainian Grant [UKR08/035]; NASU; WUBMRC; Ukraine; intramural grant ELAN [M3-09.03.18.1]; DFG [GRK-SFB643]; K&R Wucherpfennigstiftung	German-Ukrainian Grant; NASU; WUBMRC; Ukraine; intramural grant ELAN; DFG(German Research Foundation (DFG)); K&R Wucherpfennigstiftung	This work was supported by German-Ukrainian Grant UKR08/035 (to R. B. and M. H.), Grants from NASU, WUBMRC, and the President of Ukraine (to R. B.), by an intramural grant ELAN M3-09.03.18.1 (to L. E. M.), by the DFG (GRK-SFB643), and the K&R Wucherpfennigstiftung (to M. H.). Confocal microscopy was done at the Nikon Imaging Center at the University of Heidelberg.	Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Bilyy RO, 2003, CYTOM PART A, V56A, P89, DOI 10.1002/cyto.a.10089; Bilyy R, 2007, AUTOIMMUNITY, V40, P249, DOI 10.1080/08916930701358867; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Franz S, 2006, CYTOM PART A, V69A, P230, DOI 10.1002/cyto.a.20206; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nakano V, 2006, ANAEROBE, V12, P238, DOI 10.1016/j.anaerobe.2006.07.003; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Tomin A., 2011, P SOC PHOTO-OPT INS, V8087; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WARNER TG, 1979, BIOCHEMISTRY-US, V18, P2783, DOI 10.1021/bi00580a014	28	61	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					496	503		10.1074/jbc.M111.273144	http://dx.doi.org/10.1074/jbc.M111.273144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074924	Green Published, hybrid			2022-12-25	WOS:000298682400048
J	Chow, SS; Van Petegem, F; Accili, EA				Chow, Sarah S.; Van Petegem, Filip; Accili, Eric A.			Energetics of Cyclic AMP Binding to HCN Channel C Terminus Reveal Negative Cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CHANNEL; PACEMAKER CHANNELS; CAMP MODULATION; LIGHT-SCATTERING; STRUCTURAL BASIS; SINOATRIAL NODE; LIGAND-BINDING; PROTEINS; VOLTAGE; CRYSTALLIZATION	Cyclic AMP binds to the HCN channel C terminus and variably stabilizes its open state. Using isothermal titration calorimetry, we show that cAMP binds to one subunit of tetrameric HCN2 and HCN4 C termini with high affinity (similar to 0.12 mu M) and subsequently with low affinity (similar to 1 mu M) to the remaining three subunits. Changes induced by high affinity binding already exist in both a constrained HCN2 tetramer and the unconstrained HCN1 tetramer. Natural "preactivation" of HCN1 may explain both the smaller effect of cAMP on stabilizing its open state and the opening of unliganded HCN1, which occurs as though already disinhibited.	[Chow, Sarah S.; Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Accili, EA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	eaaccili@mail.ubc.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes for Health Research (CIHR); Tier II Canada Research Chair	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier II Canada Research Chair	This work was supported by operating funds from the Canadian Institutes for Health Research (CIHR) (to E. A. A. and F. V. P.).; The recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed. Tel.: 604-822-6900; Fax: 604-822-6048, E-mail: eaaccili@mail.ubc.ca.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Habel JE, 2001, ACTA CRYSTALLOGR D, V57, P254, DOI 10.1107/S0907444900015225; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; ZULAUF M, 1992, J CRYST GROWTH, V122, P102, DOI 10.1016/0022-0248(92)90232-8	35	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					600	606		10.1074/jbc.M111.269563	http://dx.doi.org/10.1074/jbc.M111.269563			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084239	hybrid, Green Published			2022-12-25	WOS:000298682400058
J	Yoshida, A; Wei, DD; Nomura, W; Izawa, S; Inoue, Y				Yoshida, Aya; Wei, Dandan; Nomura, Wataru; Izawa, Shingo; Inoue, Yoshiharu			Reduction of Glucose Uptake through Inhibition of Hexose Transporters and Enhancement of Their Endocytosis by Methylglyoxal in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR INTERNALIZATION; INDUCED DEGRADATION; PHOSPHOLIPASE-C; KINASE CASCADE; BETA-ARRESTIN; YEAST; PROTEIN; UBIQUITINATION; EXPRESSION; PATHWAY	Diabetes mellitus is characterized by an impairment of glucose uptake even though blood glucose levels are increased. Methylglyoxal is derived from glycolysis and has been implicated in the development of diabetes mellitus, because methylglyoxal levels in blood and tissues are higher in diabetic patients than in healthy individuals. However, it remains to be elucidated whether such factors are a cause, or consequence, of diabetes. Here, we show that methylglyoxal inhibits the activity of mammalian glucose transporters using recombinant Saccharomyces cerevisiae cells genetically lacking all hexose transporters but carrying cDNA for human GLUT1 or rat GLUT4. We found that methylglyoxal inhibits yeast hexose transporters also. Glucose uptake was reduced in a stepwise manner following treatment with methylglyoxal, i.e. a rapid reduction within 5 min, followed by a slow and gradual reduction. The rapid reduction was due to the inhibitory effect of methylglyoxal on hexose transporters, whereas the slow and gradual reduction seemed due to endocytosis, which leads to a decrease in the amount of hexose transporters on the plasma membrane. We found that Rsp5, a HECT-type ubiquitin ligase, is responsible for the ubiquitination of hexose transporters. Intriguingly, Plc1 (phospholipase C) negatively regulated the endocytosis of hexose transporters in an Rsp5-dependent manner, although the methylglyoxal-induced endocytosis of hexose transporters occurred irrespective of Plc1. Meanwhile, the internalization of hexose transporters following treatment with methylglyoxal was delayed in a mutant defective in protein kinase C.	[Yoshida, Aya; Wei, Dandan; Nomura, Wataru; Izawa, Shingo; Inoue, Yoshiharu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Kyoto 6110011, Japan	Kyoto University	Inoue, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Kyoto 6110011, Japan.	y_inoue@kais.kyoto-u.ac.jp		Izawa, Shingo/0000-0002-4920-2450	Ministry of Education, Science, Sports and Culture of Japan; Institution of Fermentation, Osaka, Japan; Grants-in-Aid for Scientific Research [23380202] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institution of Fermentation, Osaka, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan and grants from Institution of Fermentation, Osaka, Japan (to Y. I.).	Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Inoue Y, 2011, SEMIN CELL DEV BIOL, V22, P278, DOI 10.1016/j.semcdb.2011.02.002; Izawa S, 2004, J BIOL CHEM, V279, P35469, DOI 10.1074/jbc.M403692200; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kasahara T, 2003, BIOCHEM J, V372, P247, DOI 10.1042/BJ20030044; Kasahara T, 1996, BIOCHEM J, V315, P177, DOI 10.1042/bj3150177; Kasahara T, 1997, BBA-BIOMEMBRANES, V1324, P111, DOI 10.1016/S0005-2736(96)00217-9; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Lagunas R., 1993, FEMS MICROBIOL REV, V10, P229; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753-8764.2004; Maeta K, 2005, J BIOL CHEM, V280, P253, DOI 10.1074/jbc.M408061200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Powers T, 2010, ENZYMES, V27, P177, DOI 10.1016/S1874-6047(10)27010-5; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Thorens B., 1996, AM J PHYSIOL, V270, pG541; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Turk Z, 2010, PHYSIOL RES, V59, P147, DOI 10.33549/physiolres.931585; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892	62	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					701	711		10.1074/jbc.M111.322222	http://dx.doi.org/10.1074/jbc.M111.322222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22094464	Green Published, hybrid			2022-12-25	WOS:000298682400068
J	Steinbach, K; McDonald, CL; Reindl, M; Schweigreiter, R; Bandtlow, C; Martin, R				Steinbach, Karin; McDonald, Claire L.; Reindl, Markus; Schweigreiter, Ruediger; Bandtlow, Christine; Martin, Roland			Nogo-Receptors NgR1 and NgR2 Do Not Mediate Regulation of CD4 T Helper Responses and CNS Repair in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; B-LYMPHOCYTE STIMULATOR; MULTIPLE-SCLEROSIS; AXONAL REGENERATION; NEURITE OUTGROWTH; FUNCTIONAL LIGAND; CELL-ADHESION; IDENTIFICATION; INFLAMMATION; DISEASE	Myelin-associated inhibition of axonal regrowth after injury is considered one important factor that contributes to regeneration failure in the adult central nervous system (CNS). Blocking strategies targeting this pathway have been successfully applied in several nerve injury models, including experimental autoimmune encephalomyelitis (EAE), suggesting myelin-associated inhibitors (MAIs) and functionally related molecules as targets to enhance regeneration in multiple sclerosis. NgR1 and NgR2 were identified as interaction partners for the myelin proteins Nogo-A, MAG and OMgp and are probably mediating their growth-inhibitory effects on axons, although the in vivo relevance of this pathway is currently under debate. Recently, alternative functions of MAIs and NgRs in the regulation of immune cell migration and T cell differentiation have been described. Whether and to what extent NgR1 and NgR2 are contributing to Nogo and MAG-related inhibition of neuroregeneration or immunomodulation during EAE is currently unknown. Here we show that genetic deletion of both receptors does not promote functional recovery during EAE and that NgR1 and NgR2-mediated signals play a minor role in the development of CNS inflammation. Induction of EAE in Ngr1/2-double mutant mice resulted in indifferent disease course and tissue damage when compared to WT controls. Further, the development of encephalitogenic CD4(+) Th1 and Th17 responses was unchanged. However, we observed a slightly increased leukocyte infiltration into the CNS in the absence of NgR1 and NgR2, indicating that NgRs might be involved in the regulation of immune cell migration in the CNS. Our study demonstrates the urgent need for a more detailed knowledge on the multifunctional roles of ligands and receptors involved in CNS regeneration failure.	[Steinbach, Karin; Martin, Roland] Inst Neuroimmunol & Clin MS Res, Hamburg, Germany; [McDonald, Claire L.; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Schweigreiter, Ruediger; Bandtlow, Christine] Innsbruck Med Univ, Dept Neurobiochem, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Steinbach, K (corresponding author), Inst Neuroimmunol & Clin MS Res, Hamburg, Germany.	roland.martin@usz.ch	Reindl, Markus/ABE-5880-2020	McDonald, Claire/0000-0002-0583-742X; Reindl, Markus/0000-0003-2817-1402; Martin, Roland/0000-0002-0982-1329	Gemeinnuetzige Hertie-Stiftung; Austrian Research Foundation (FWF) [W1206]; Novartis	Gemeinnuetzige Hertie-Stiftung; Austrian Research Foundation (FWF)(Austrian Science Fund (FWF)); Novartis(Novartis)	This work was supported by a research grant of the Gemeinnuetzige Hertie-Stiftung (Grant No. 1.01.1/ 08/ 001); the Gemeinnuetzige Hertie-Stiftung supports the The Institute for Neuroimmunology and Clinical Multiple Sclerosis (MS) Research as well. Claire McDonald is enrolled in the graduate program SPIN that is supported by the Austrian Research Foundation (FWF W1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author has read the journal's policy and may have a conflict of interest related to the work reported in the submitted manuscript.; It may be seen as a conflict that the corresponding author has previously received remuneration for consulting or advisory function to companies developing or marketing treatments for MS (Biogen, Merck Serono, Teva, Sanofi-Aventis); however, none of these were directly related to the work reported here. The corresponding author (in his prior function as director of the Institute for Neuroimmunology and Clinical MS Research) has received unrestricted grant support by Novartis, which is developing an anti-Nogo antibody for the treatment of spinal cord injury, but, due to largely negative results, the data - although not directly addressing this issue - are negative if anything for the efforts of Novartis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; MCDONALD CL, J NEUROINFLAMMATION, V8, P113; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schanda Kathrin, 2011, BMC Res Notes, V4, P6, DOI 10.1186/1756-0500-4-6; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; TALLANTYRE EC, MULT SCLER, V16, P406; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.wnl.0000316195.52001.e1; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Worter V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005218; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786; YANG Y, ANN NEUROL, V67, P498; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zhang L, 2009, J NEUROSCI, V29, P6348, DOI 10.1523/JNEUROSCI.5040-08.2009; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26341	10.1371/journal.pone.0026341	http://dx.doi.org/10.1371/journal.pone.0026341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096481	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000297553900002
J	Abdou, M; Peng, C; Huang, JH; Zyaan, O; Wang, S; Li, S; Wang, J				Abdou, Mohamed; Peng, Cheng; Huang, Jianhua; Zyaan, Ola; Wang, Sheng; Li, Sheng; Wang, Jian			Wnt Signaling Cross-Talks with JH Signaling by Suppressing Met and gce Expression	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; BEETLE TRIBOLIUM-CASTANEUM; STATUS-QUO ACTION; DROSOPHILA-MELANOGASTER; BROAD-COMPLEX; METHOPRENE-TOLERANT; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; MUTANT DROSOPHILA; WNT/BETA-CATENIN	Juvenile hormone (JH) plays key roles in controlling insect growth and metamorphosis. However, relatively little is known about the JH signaling pathways. Until recent years, increasing evidence has suggested that JH modulates the action of 20-hydroxyecdysone (20E) by regulating expression of broad (br), a 20E early response gene, through Met/Gce and Kr-h1. To identify other genes involved in JH signaling, we designed a novel Drosophila genetic screen to isolate mutations that derepress JH-mediated br suppression at early larval stages. We found that mutations in three Wnt signaling negative regulators in Drosophila, Axin (Axn), supernumerary limbs (slmb), and naked cuticle (nkd), caused precocious br expression, which could not be blocked by exogenous JHA. A similar phenotype was observed when armadillo (arm), the mediator of Wnt signaling, was overexpressed. qRT-PCR revealed that Met, gce and Kr-h1expression was suppressed in the Axn, slmb and nkd mutants as well as in arm gain-of-function larvae. Furthermore, ectopic expression of gce restored Kr-h1 expression but not Met expression in the arm gain-of-function larvae. Taken together, we conclude that Wnt signaling cross-talks with JH signaling by suppressing transcription of Met and gce, genes that encode for putative JH receptors. The reduced JH activity further induces down-regulation of Kr-h1expression and eventually derepresses br expression in the Drosophila early larval stages.	[Abdou, Mohamed; Peng, Cheng; Huang, Jianhua; Zyaan, Ola; Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Wang, Sheng; Li, Sheng] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Abdou, M (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jianwang@umd.edu	Wang, Sheng/Q-3708-2016; Zyaan, Ola/D-5964-2017; Abdou, Mohamed A/D-6024-2017; Zyaan, Ola/F-6939-2018	Wang, Sheng/0000-0002-5625-403X; Zyaan, Ola/0000-0001-8200-3261; Abdou, Mohamed A/0000-0002-2285-7246; Zyaan, Ola/0000-0001-8200-3261	National Science Foundation [IOS1021767]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (IOS1021767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; ALTARATZ M, 1991, MOL CELL ENDOCRINOL, V81, P205, DOI 10.1016/0303-7207(91)90219-I; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Crossgrove K, 1996, DEV BIOL, V180, P745, DOI 10.1006/dbio.1996.0343; DIBELLO PR, 1991, GENETICS, V129, P385; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P1198, DOI 10.1016/j.ibmb.2007.07.011; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Wang L, 2007, J BONE MINER RES, V22, P1988, DOI 10.1359/JBMR.070806; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou XF, 2002, DEVELOPMENT, V129, P2259	50	18	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26772	10.1371/journal.pone.0026772	http://dx.doi.org/10.1371/journal.pone.0026772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087234	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700010
J	Aparicio, F; Aparicio-Sanchis, R; Gadea, J; Sanchez-Navarro, JA; Pallas, V; Murguia, JR				Aparicio, Frederic; Aparicio-Sanchis, Rafael; Gadea, Jose; Angel Sanchez-Navarro, Jesus; Pallas, Vicente; Ramon Murguia, Jose			A Plant Virus Movement Protein Regulates the Gcn2p Kinase in Budding Yeast	PLOS ONE			English	Article							CELL-TO-CELL; NECROTIC-RINGSPOT-VIRUS; MESSENGER-RNA TRANSLATION; MOSAIC-VIRUS; BINDING DOMAIN; COAT PROTEIN; MODEL HOST; EXPRESSION; PHOSPHORYLATION; EIF2-ALPHA	Virus life cycle heavily depends on their ability to command the host machinery in order to translate their genomes. Animal viruses have been shown to interfere with host translation machinery by expressing viral proteins that either maintain or inhibit eIF2 alpha function by phosphorylation. However, this interference mechanism has not been described for any plant virus yet. Prunnus necrotic ringspot virus (PNRSV) is a serious pathogen of cultivated stone fruit trees. The movement protein (MP) of PNRSV is necessary for the cell-to-cell movement of the virus. By using a yeast-based approach we have found that overexpression of the PNRSV MP caused a severe growth defect in yeast cells. cDNA microarrays analysis carried out to characterise at the molecular level the growth interference phenotype reported the induction of genes related to amino acid deprivation suggesting that expression of MP activates the GCN pathway in yeast cells. Accordingly, PNRSV MP triggered activation of the Gcn2p kinase, as judged by increased eIF2 alpha phosphorylation. Activation of Gcn2p by MP expression required a functional Tor1p kinase, since rapamycin treatment alleviated the yeast cell growth defect and blocked eIF2 alpha phosphorylation triggered by MP expression. Overall, these findings uncover a previously uncharacterised function for PNRSV MP viral protein, and point out at Tor1p and Gcn2p kinases as candidate susceptibility factors for plant viral infections.	[Aparicio, Frederic; Aparicio-Sanchis, Rafael; Gadea, Jose; Angel Sanchez-Navarro, Jesus; Pallas, Vicente; Ramon Murguia, Jose] Inst Biol Mol & Celular Plantas UPV CSIC, Dept Stress Biol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Aparicio, F (corresponding author), Inst Biol Mol & Celular Plantas UPV CSIC, Dept Stress Biol, Valencia, Spain.	muribajo@ibmcp.upv.es	APARICIO, FREDERIC/R-2008-2018; Vacas, José Gadea/S-2446-2019; Sánchez-Navarro, Jesus Angel/K-8787-2014; Murguia, Jose R./H-4419-2015; Pallas, Vicente/N-1317-2014	APARICIO, FREDERIC/0000-0002-1586-9978; Vacas, José Gadea/0000-0002-3612-7914; Sánchez-Navarro, Jesus Angel/0000-0002-3320-2827; Murguia, Jose R./0000-0001-9364-4603; Pallas, Vicente/0000-0003-4954-989X; Aparicio-Sanchis, Rafael/0000-0001-9993-7722	Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana) [GV/2007/064, GV/2011/003]	Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants GV/2007/064 (Proyecto para grupos de investigacion emergentes) and (GV/2011/003) (Prometeo Project) from Conselleria d'Empresa, Universitat i Ciencia (Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Aparicio F, 2003, VIROLOGY, V313, P213, DOI 10.1016/S0042-6822(03)00284-8; Aparicio F, 2002, VIRUS GENES, V25, P75, DOI 10.1023/A:1020126309692; Bilgin DD, 2003, DEV CELL, V4, P651, DOI 10.1016/S1534-5807(03)00125-4; Boevink P, 2005, PLANT PHYSIOL, V138, P1815, DOI 10.1104/pp.105.066761; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Curin M, 2007, PLANT PHYSIOL, V143, P801, DOI 10.1104/pp.106.091488; Di Terlizzi B, 2001, ARCH VIROL, V146, P825, DOI 10.1007/s007050170151; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fernandez-Calvino L, 2011, RECENT ADV PLANT VIR, P470; Fiore N, 2008, ARCH VIROL, V153, P909, DOI 10.1007/s00705-008-0066-1; Halford NG, 2006, ADV BOT RES, V43, P93, DOI 10.1016/S0065-2296(05)43002-5; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Herranz MC, 2005, VIROLOGY, V339, P31, DOI 10.1016/j.virol.2005.05.020; Herranz MC, 2004, J GEN VIROL, V85, P761, DOI 10.1099/vir.0.19534-0; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kaido M, 2007, MOL PLANT MICROBE IN, V20, P671, DOI 10.1094/MPMI-20-6-0671; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lageix S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-134; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Martinez-Gil L, 2009, J VIROL, V83, P5535, DOI 10.1128/JVI.00393-09; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Menacho-Marquez M, 2007, CELL CYCLE, V6, P2302, DOI 10.4161/cc.6.18.4668; Mink G.I., 1992, Advances in Disease Vector Research, V9, P261; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Pallas V, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P75; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qian WJ, 1996, J BIOL CHEM, V271, P13202, DOI 10.1074/jbc.271.22.13202; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; SanchezNavarro JA, 1997, ARCH VIROL, V142, P749, DOI 10.1007/s007050050116; Sasaki N, 2009, MOL PLANT PATHOL, V10, P161, DOI 10.1111/j.1364-3703.2008.00517.x; Schepetilnikov M, 2011, EMBO J, V30, P1343, DOI 10.1038/emboj.2011.39; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Steffensen L, 2006, EUKARYOT CELL, V5, P248, DOI 10.1128/EC.5.2.248-261.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Waigmann E, 2004, CRIT REV PLANT SCI, V23, P195, DOI 10.1080/07352680490452807; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Zhang YH, 2003, PLANTA, V217, P668, DOI 10.1007/s00425-003-1025-4; Zhang YH, 2008, J EXP BOT, V59, P3131, DOI 10.1093/jxb/ern169	47	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27409	10.1371/journal.pone.0027409	http://dx.doi.org/10.1371/journal.pone.0027409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087310	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700042
J	Jiang, H; Lu, Y; Yuan, L; Liu, JH				Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai			Regulation of Interleukin-10 Receptor Ubiquitination and Stability by Beta-TrCP-Containing Ubiquitin E3 Ligase	PLOS ONE			English	Article							INTERFERON-ALPHA RECEPTOR; T-CELLS; DOWN-REGULATION; I INTERFERON; IL-10; DEGRADATION; PHOSPHORYLATION; EXPRESSION; PATHWAY; GROWTH	Interleukin-10 (IL-10) initiates potent anti-inflammatory effects via activating its cell surface receptor, composed of IL-10R1 and IL-10R2 subunits. The level of IL-10R1 is a major determinant of the cells' responsiveness to IL-10. Here, via a series of biochemical analyses using 293T cells reconstituted with IL-10R1, we identify the latter as a novel substrate of beta TrCP-containing ubiquitin E3 ligase. Within the intracellular tail of IL-10R1, a canonical ((318)DpSGFGpS) and a slightly deviated ((369)DpSGICLQEP) beta TrCP recognition motif can additively recruit beta TrCP in a phosphorylation-dependent manner. beta TrCP recruitment leads to ubiquitination, endocytosis and degradation of IL-10R1, subsequently reducing the cellular responsiveness to IL-10. Our study uncovers a novel negative regulatory mechanism that may potentially affect IL-10 function in target cells under physiological or pathological conditions.	[Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Animals Dis Study, Nanjing 210008, Peoples R China; [Jiang, Hui; Lu, Yi; Yuan, Liang; Liu, Jianghuai] Natl Resource Ctr Mutant Mice, Nanjing, Peoples R China; [Liu, Jianghuai] Wenzhou Med Coll, Sch Life Sci, Zhejiang Key Lab Technol & Applicat Model Organis, Wenzhou, Peoples R China	Nanjing University; Wenzhou Medical University	Jiang, H (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Animals Dis Study, Nanjing 210008, Peoples R China.	liujianghuai@nju.edu.cn		Liu, Jianghuai/0000-0002-2382-9140; Jiang, Hui/0000-0003-1170-0224	National Natural Science Foundation of China [30971512, 31071231]; Chinese Ministry of Science and Technology [2010CB945100, 2011CB944104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China grants (www.nsfc.gov.cn) #30971512 and #31071231 to JL; and Chinese Ministry of Science and Technology 973 grants (www.most.gov.cn) #2010CB945100 and #2011CB944104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Belouzard S, 2006, EMBO J, V25, P932, DOI 10.1038/sj.emboj.7600989; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DELPRETE G, 1993, J IMMUNOL, V150, P353; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Groux H, 1998, J IMMUNOL, V160, P3188; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Gruber SG, 2008, EUR J IMMUNOL, V38, P3365, DOI 10.1002/eji.200837718; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; HuangFu WC, 2008, FEBS LETT, V582, P3206, DOI 10.1016/j.febslet.2008.08.013; HuangFu WC, 2010, PIGM CELL MELANOMA R, V23, P838, DOI 10.1111/j.1755-148X.2010.00770.x; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Joss A, 2000, EUR J IMMUNOL, V30, P1683, DOI 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Langer JA, 2004, CYTOKINE GROWTH F R, V15, P33, DOI 10.1016/j.cytogfr.2003.10.001; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qian J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002065; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Santin AD, 2000, J VIROL, V74, P4729, DOI 10.1128/JVI.74.10.4729-4737.2000; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Wei SHY, 2006, J INTERF CYTOK RES, V26, P281, DOI 10.1089/jir.2006.26.281; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	71	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27464	10.1371/journal.pone.0027464	http://dx.doi.org/10.1371/journal.pone.0027464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087322	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700049
J	Shu, XS; Geng, H; Li, LL; Ying, JM; Ma, CH; Wang, YJ; Poon, FF; Wang, X; Ying, Y; Yeo, W; Srivastava, G; Tsao, SW; Yu, J; Sung, JJY; Huang, S; Chan, ATC; Tao, Q				Shu, Xing-sheng; Geng, Hua; Li, Lili; Ying, Jianming; Ma, Chunhong; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Srivastava, Gopesh; Tsao, Sai Wah; Yu, Jun; Sung, Joseph J. Y.; Huang, Shi; Chan, Anthony T. C.; Tao, Qian			The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/beta-Catenin Signaling and Is Frequently Silenced in Multiple Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC-CANCER; CYCLIN D1; GENE; INACTIVATION; METHYLATION; CARCINOMA; NASOPHARYNGEAL; PATHWAY; TARGET	Background: PRDM (PRDI-BF1 and RIZ domain containing) proteins are zinc finger proteins involved in multiple cellular regulations by acting as epigenetic modifiers. We studied a recently identified PRDM member PRDM5 for its epigenetic abnormality and tumor suppressive functions in multiple tumorigeneses. Methodology/Principal Findings: Semi-quantitative RT-PCR showed that PRDM5 was broadly expressed in human normal tissues, but frequently silenced or downregulated in multiple carcinoma cell lines due to promoter CpG methylation, including 80% (4/5) nasopharyngeal, 44% (8/18) esophageal, 76% (13/17) gastric, 50% (2/4) cervical, and 25% (3/12) hepatocellular carcinoma cell lines, but not in any immortalized normal epithelial cell lines. PRDM5 expression could be restored by 5-aza-2'-deoxycytidine demethylation treatment in silenced cell lines. PRDM5 methylation was frequently detected by methylation-specific PCR (MSP) in multiple primary tumors, including 93% (43/46) nasopharyngeal, 58% (25/43) esophageal, 88% (37/42) gastric and 63% (29/46) hepatocellular tumors. PRDM5 was further found a stress-responsive gene, but its response was impaired when the promoter was methylated. Ectopic PRDM5 expression significantly inhibited tumor cell clonogenicity, accompanied by the inhibition of TCF/beta-catenin-dependent transcription and downregulation of CDK4, TWIST1 and MDM2 oncogenes, while knocking down of PRDM5 expression lead to increased cell proliferation. ChIP assay showed that PRDM5 bound to its target gene promoters and suppressed their transcription. An inverse correlation between the expression of PRDM5 and activated beta-catenin was also observed in cell lines. Conclusions/Significance: PRDM5 functions as a tumor suppressor at least partially through antagonizing aberrant WNT/beta-catenin signaling and oncogene expression. Frequent epigenetic silencing of PRDM5 is involved in multiple tumorigeneses, which could serve as a tumor biomarker.	[Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Dept Clin Oncol, Canc Epigenet Lab, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Shu, Xing-sheng; Geng, Hua; Li, Lili; Wang, Yajun; Poon, Fan Fong; Wang, Xian; Ying, Ying; Yeo, Winnie; Chan, Anthony T. C.; Tao, Qian] CUHK Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Ying, Jianming] Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; [Ying, Jianming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Ma, Chunhong] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Srivastava, Gopesh] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai Wah] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Shi] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Shandong University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Central South University	Shu, XS (corresponding author), Chinese Univ Hong Kong, Dept Clin Oncol, Canc Epigenet Lab, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China.	qtao@clo.cuhk.edu.hk	Tao, Qian/T-4743-2018; Yeo, Winnie/R-4792-2018; Yu, Jun/D-8569-2015; Li, Lili/Q-5750-2018; Sung, Joseph J. Y./R-3203-2018; Chan, Anthony Tak Cheung/R-3940-2018	Tao, Qian/0000-0001-5383-4808; Yeo, Winnie/0000-0002-0863-8469; Yu, Jun/0000-0001-5008-2153; Li, Lili/0000-0002-0292-5889; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Anthony Tak Cheung/0000-0002-6912-8091; Wang, Xian/0000-0003-0041-7589	Research Grants Council of Hong Kong (GRF) [473908]; National Natural Science Foundation of China (NSFC) [30928012]	Research Grants Council of Hong Kong (GRF)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Research Grants Council of Hong Kong (GRF #473908) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the National Natural Science Foundation of China (NSFC #30928012) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Du Y, 2001, CANCER RES, V61, P8094; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Esteller M, 2000, CANCER RES, V60, P4366; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kim KC, 2003, CANCER BIOL THER, V2, P491, DOI 10.4161/cbt.2.5.629; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Sato N, 2003, CANCER RES, V63, P3735; Senyuk V, 2005, CANCER RES, V65, P7603, DOI 10.1158/0008-5472.CAN-05-0412; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Yang XH, 1999, GENOMICS, V61, P319, DOI 10.1006/geno.1999.5967; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yu J, 2009, CANCER-AM CANCER SOC, V115, P49, DOI 10.1002/cncr.23989; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	35	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27346	10.1371/journal.pone.0027346	http://dx.doi.org/10.1371/journal.pone.0027346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087297	Green Published, gold			2022-12-25	WOS:000297349700034
J	Torres, R; Drummond, H; Velando, A				Torres, Roxana; Drummond, Hugh; Velando, Alberto			Parental Age and Lifespan Influence Offspring Recruitment: A Long-Term Study in a Seabird	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BREEDING EXPERIENCE; LIVED BIRD; SENESCENCE; PERFORMANCE; EVOLUTION; DECLINE; HISTORY; QUALITY; SPERM	Recent studies of wild populations provide compelling evidence that survival and reproduction decrease with age because of senescence, a decline in functional capacities at old ages. However, in the wild, little is known about effects of parental senescence on offspring quality. We used data from a 21-year study to examine the role of parental age on offspring probability of recruitment in a long-lived bird, the blue-footed booby (Sula nebouxii). Offspring probability of recruiting into the breeding population varied over the life of parents and effects age were similar in mothers and fathers. Offspring recruitment was high when parents were roughly 6-12 years old and low before and after then. Effects of parental age on offspring recruitment varied with lifespan (parental age at last reproduction) and previous breeding experience. Offspring recruitment from young and old parents with long reproductive lifespans was greater than that of offspring from parents with short lifespans at young and old ages. For parents with little previous breeding experience recruitment of offspring decreased with their hatch date, but experienced parents were no similarly affected. We found evidence of terminal effects on offspring recruitment in young parents but not in older parents, suggesting that senescence is more likely a gradual process of deterioration than a process of terminal illness. Failure to recruit probably reflects mortality during the first years after independence but also during the fledgling transition to full independence. Our results show effects of parental age and quality on offspring viability in a long-lived wild vertebrate and support the idea that wild populations are composed of individuals of different quality, and that this individual heterogeneity can influence the dynamics of age-structured populations.	[Torres, Roxana; Drummond, Hugh] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico; [Velando, Alberto] Univ Vigo, Dept Ecoloxia & Biol Anim, Vigo 36310, Spain	Universidad Nacional Autonoma de Mexico; Universidade de Vigo	Torres, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico.	avelando@uvigo.es	Velando, Alberto/B-1701-2009	Velando, Alberto/0000-0001-8909-0724	Universidad Nacional Autonoma de Mexico [IN228309]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [4722-N9407, D112-903581, PCCNCNA-031528, 34500-V, CO1-47599, 81823]; Spanish Ministerio de Ciencia y Tecnologia [CGL2009-10883-C02-01]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study was supported by the Universidad Nacional Autonoma de Mexico (IN228309), the Consejo Nacional de Ciencia y Tecnologia (CONACYT 4722-N9407, D112-903581, PCCNCNA-031528, 34500-V, CO1-47599, 81823), and the Spanish Ministerio de Ciencia y Tecnologia (CGL2009-10883-C02-01). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2007, EVOL ECOL RES, V9, P355; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; [Anonymous], 2006, SAS MIXED MODELS; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Baudisch A, 2005, P NATL ACAD SCI USA, V102, P8263, DOI 10.1073/pnas.0502155102; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Bennett P. M., 2002, OX ECOL EV; Bouwhuis S, 2010, J EVOLUTION BIOL, V23, P636, DOI 10.1111/j.1420-9101.2009.01929.x; Bouwhuis S, 2009, P ROY SOC B-BIOL SCI, V276, P2769, DOI 10.1098/rspb.2009.0457; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coulson JC, 2001, J AVIAN BIOL, V32, P146, DOI 10.1034/j.1600-048X.2001.320207.x; Crespin L, 2006, J ANIM ECOL, V75, P228, DOI 10.1111/j.1365-2656.2006.01035.x; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; DAAN S, 1990, BEHAVIOUR, V114, P83, DOI 10.1163/156853990X00068; Daunt F, 1999, P ROY SOC B-BIOL SCI, V266, P1489, DOI 10.1098/rspb.1999.0805; Descamps S, 2008, OIKOS, V117, P1406, DOI 10.1111/j.0030-1299.2008.16545.x; Drummond H, 2003, AM NAT, V161, P794, DOI 10.1086/375170; Fitzgerald C, 1998, YALE J BIOL MED, V71, P367; GUERRA M, 1995, BEHAVIOUR, V132, P479, DOI 10.1163/156853995X00162; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kern S, 2001, EVOLUTION, V55, P1822, DOI 10.1111/j.0014-3820.2001.tb00831.x; Kim SY, 2011, J EVOLUTION BIOL, V24, P295, DOI 10.1111/j.1420-9101.2010.02165.x; Kim SY, 2007, BEHAV ECOL, V18, P1132, DOI 10.1093/beheco/arm091; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Komdeur J, 1996, BEHAV ECOL, V7, P417, DOI 10.1093/beheco/7.4.417; Lynch M., 1998, GENETICS ANAL QUANTI; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moore PJ, 2003, P ROY SOC B-BIOL SCI, V270, pS192, DOI 10.1098/rsbl.2003.0051; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Nelson B., 1978, SULIDAE GANNETS BOOB; Nikola T, 2004, EVOL ECOL, V18, P187, DOI 10.1023/B:EVEC.0000021090.51851.bd; Nilsson J-A, 1999, P 22 INT ORN C DURB, P234; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; OSORIOBERISTAIN M, 1993, AUK, V110, P234; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; Rattiste K, 2004, P ROY SOC B-BIOL SCI, V271, P2059, DOI 10.1098/rspb.2004.2832; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reid JM, 2010, J ANIM ECOL, V79, P851, DOI 10.1111/j.1365-2656.2010.01669.x; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; SAS Institute, 1999, SAS ONL DOC VERS 8; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Torres R, 1999, J ANIM ECOL, V68, P1133, DOI 10.1046/j.1365-2656.1999.00357.x; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Velando A, 2000, ANIM BEHAV, V60, P181, DOI 10.1006/anbe.2000.1445; Velando A, 2011, J EVOLUTION BIOL, V24, P693, DOI 10.1111/j.1420-9101.2010.02201.x; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; Waskar M, 2005, AGE, V27, P201, DOI 10.1007/s11357-005-2914-1; West-Eberhard Mary Jane, 2003, pi; White J, 2008, P NATL ACAD SCI USA, V105, P13947, DOI 10.1073/pnas.0803067105; Williams G. C., 1966, P307; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; Yilmaz M, 2008, BIOGERONTOLOGY, V9, P163, DOI 10.1007/s10522-008-9125-y	77	38	38	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27245	10.1371/journal.pone.0027245	http://dx.doi.org/10.1371/journal.pone.0027245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087271	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700021
J	Dong, CH; Della-Morte, D; Wang, LY; Cabral, D; Beecham, A; McClendon, MS; Luca, CC; Blanton, SH; Sacco, RL; Rundek, T				Dong, Chuanhui; Della-Morte, David; Wang, Liyong; Cabral, Digna; Beecham, Ashley; McClendon, Mark S.; Luca, Corneliu C.; Blanton, Susan H.; Sacco, Ralph L.; Rundek, Tatjana			Association of the Sirtuin and Mitochondrial Uncoupling Protein Genes with Carotid Plaque	PLOS ONE			English	Article							NORTHERN MANHATTAN; BLOOD-PRESSURE; PRINCIPAL-COMPONENTS; CARIBBEAN HISPANICS; ANGIOTENSIN-II; METABOLISM; MECHANISMS; OBESITY; MICE; POLYMORPHISMS	Objective: Sirtuins (SIRTs) and mitochondrial uncoupling proteins (UCPs) have been implicated in cardiovascular diseases through the control of reactive oxygen species production. This study sought to investigate the association between genetic variants in the SIRT and UCP genes and carotid plaque. Methods: In a group of 1018 stroke-free subjects from the Northern Manhattan Study with high-definition carotid ultrasonography and genotyping, we investigated the associations of 85 single nucleotide polymorphisms (SNPs) in the 11 SIRT and UCP genes with the presence and number of carotid plaques, and evaluated interactions of SNPs with sex, smoking, diabetes and hypertension as well as interactions between SNPs significantly associated with carotid plaque. Results: Overall, 60% of subjects had carotid plaques. After adjustment for demographic and vascular risk factors, T-carriers of the SIRT6 SNP rs107251 had an increased risk for carotid plaque (odds ratio, OR = 1.71, 95% CI = 1.23-2.37, Bonferroni-corrected p = 0.03) and for a number of plaques (rate ratio, RR = 1.31, 1.18-1.45, Bonferroni-corrected p = 1.4x10(-5)), whereas T-carriers of the UCP5 SNP rs5977238 had an decreased risk for carotid plaque (OR = 0.49, 95% CI = 0.32-0.74, Bonferroni-corrected p = 0.02) and plaque number (RR = 0.64, 95% CI = 0.52-0.78, Bonferroni-corrected p = 4.9x10(-4)). Some interactions with a nominal p <= 0.01 were found between sex and SNPs in the UCP1 and UCP3 gene; between smoking, diabetes, hypertension and SNPs in UCP5 and SIRT5; and between SNPs in the UCP5 gene and the UCP1, SIRT1, SIRT3, SIRT5, and SIRT6 genes in association with plaque phenotypes. Conclusion: We observed significant associations between genetic variants in the SIRT6 and UCP5 genes and atherosclerotic plaque. We also found potential effect modifications by sex, smoking and vascular risk factors of the SIRT/UCP genes in the associations with atherosclerotic plaque. Further studies are needed to validate our observations.	[Dong, Chuanhui; Della-Morte, David; Cabral, Digna; McClendon, Mark S.; Luca, Corneliu C.; Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Wang, Liyong; Beecham, Ashley; Blanton, Susan H.; Sacco, Ralph L.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, John T McDonald Dept Human Genet, Miami, FL 33136 USA; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Della-Morte, David] IRCCS San Raffaele Pisana, Dept Lab Med & Adv Biotechnol, Rome, Italy	University of Miami; University of Miami; University of Miami; IRCCS San Raffaele Pisana	Dong, CH (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	TRundek@med.miami.edu	Blanton, Susan Halloran/ABF-1323-2021; Sacco, Ralph/Y-9278-2019; Della-Morte, David/K-1011-2018	Luca, Corneliu/0000-0001-8435-222X; DELLA MORTE, DAVID/0000-0002-4054-5318	National Institute of Neurologic Disorders and Stroke (NINDS) [R01 NS NS40807, R01 NS047655, K24 NS062737]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040807, K24NS062737, R01NS047655, R01NS065114] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R01 NS NS40807 (Dr. Sacco), R01 NS047655 (Dr. Rundek); and K24 NS062737 (Dr. Rundek) from the National Institute of Neurologic Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUR J, 2010, SIRTUINS OXIDATIV PA, P2; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Camins A, 2010, BBA-GENE REGUL MECH, V1799, P740, DOI 10.1016/j.bbagrm.2010.06.005; Cha MH, 2008, J KOREAN MED SCI, V23, P776, DOI 10.3346/jkms.2008.23.5.776; Cha MH, 2007, METABOLISM, V56, P806, DOI 10.1016/j.metabol.2007.01.023; Chen H, 2008, BRAIN RES, V1228, P81, DOI 10.1016/j.brainres.2008.06.067; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; de Parre TJLV, 2008, CARDIOVASC RES, V77, P425, DOI 10.1093/cvr/cvm003; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Dong CH, 2010, STROKE, V41, P2750, DOI 10.1161/STROKEAHA.110.596981; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Guo P, 2006, J HYPERTENS, V24, P1097, DOI 10.1097/01.hjh.0000226200.73065.5d; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Hunt KJ, 2002, STROKE, V33, P2775, DOI 10.1161/01.STR.0000043827.03966.EF; JIA JJ, 2009, MOL BIOL REP; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Labayen I, 2009, PEDIATR RES, V66, P350, DOI 10.1203/PDR.0b013e3181b1bd35; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Potente M, 2010, CIRC RES, V106, P1316, DOI 10.1161/CIRCRESAHA.110.219352; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos KS, 2007, MUTAT RES-FUND MOL M, V621, P18, DOI 10.1016/j.mrfmmm.2006.12.009; Rodriguez AM, 2004, INT J OBESITY, V28, P500, DOI 10.1038/sj.ijo.0802588; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2009, J AM COLL CARDIOL, V54, P2303, DOI 10.1016/j.jacc.2009.07.047; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Ungvari Z, 2008, FRONT BIOSCI-LANDMRK, V13, P5056, DOI 10.2741/3064; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Wolkow CA, 2006, AGEING RES REV, V5, P196, DOI 10.1016/j.arr.2006.03.007; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	56	50	53	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27157	10.1371/journal.pone.0027157	http://dx.doi.org/10.1371/journal.pone.0027157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087257	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700022
J	Vivet-Boudou, V; Isel, C; Sleiman, M; Smyth, R; Ben Gaied, N; Barhoum, P; Laumond, G; Bec, G; Gotte, M; Mak, J; Aubertin, AM; Burger, A; Marquet, R				Vivet-Boudou, Valerie; Isel, Catherine; Sleiman, Marwan; Smyth, Redmond; Ben Gaied, Nouha; Barhoum, Patrick; Laumond, Geraldine; Bec, Guillaume; Goette, Matthias; Mak, Johnson; Aubertin, Anne-Marie; Burger, Alain; Marquet, Roland			8-Modified-2 '-Deoxyadenosine Analogues Induce Delayed Polymerization Arrest during HIV-1 Reverse Transcription	PLOS ONE			English	Article							NUCLEOSIDE ANALOGS; NONNUCLEOSIDE INHIBITORS; ANTIRETROVIRAL THERAPY; PURINE NUCLEOSIDES; DRUG-RESISTANCE; EXCISION; TYPE-1; POTENT; REPLICATION; ENTECAVIR	The occurrence of resistant viruses to any of the anti-HIV-1 compounds used in the current therapies against AIDS underlies the urge for the development of new drug targets and/or new drugs acting through novel mechanisms. While all anti-HIV-1 nucleoside analogues in clinical use and in clinical trials rely on ribose modifications for activity, we designed nucleosides with a natural deoxyribose moiety and modifications of position 8 of the adenine base. Such modifications might induce a steric clash with helix alpha H in the thumb domain of the p66 subunit of HIV-1 RT at a distance from the catalytic site, causing delayed chain termination. Eleven new 2'-deoxyadenosine analogues modified on position 8 of the purine base were synthesized and tested in vitro and in cell-based assays. In this paper we demonstrate for the first time that chemical modifications on position 8 of 2'-deoxyadenosine induce delayed chain termination in vitro, and also inhibit DNA synthesis when incorporated in a DNA template strand. Furthermore, one of them had moderate anti-HIV-1 activity in cell-culture. Our results constitute a proof of concept indicating that modification on the base moiety of nucleosides can induce delayed polymerization arrest and inhibit HIV-1 replication.	[Vivet-Boudou, Valerie; Isel, Catherine; Sleiman, Marwan; Barhoum, Patrick; Bec, Guillaume; Marquet, Roland] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France; [Smyth, Redmond; Mak, Johnson] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Ben Gaied, Nouha; Burger, Alain] Univ Nice Sophia Antipolis, CNRS, Inst Chim Nice, Lab Chim Mol Bioact & Aromes, Nice, France; [Laumond, Geraldine; Aubertin, Anne-Marie] Univ Strasbourg, INSERM, Fac Med, Virol Lab, Strasbourg, France; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Burnet Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University	Vivet-Boudou, V (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France.	v.vivet@ibmc-cnrs.unistra.fr; c.isel@ibmc-cnrs.unistra.fr	Isel, Catherine/AAH-2174-2020; mak, johnson/S-2457-2019; Isel, Catherine/B-9406-2015; mak, johnson/H-4605-2014; Burger, Alain F/B-9586-2009; Smyth, Redmond/AAP-1637-2020	Isel, Catherine/0000-0002-8014-7525; mak, johnson/0000-0002-5229-5707; Isel, Catherine/0000-0001-7258-869X; mak, johnson/0000-0002-5229-5707; LAUMOND, Geraldine/0000-0003-1867-0734; Smyth, Redmond/0000-0002-1580-0671; Sleiman, Marwan/0000-0003-4457-8069; Marquet, Roland/0000-0002-4209-3976	Agence Nationale de Recherche sur le Sida, SIDACTION; University of Strasbourg	Agence Nationale de Recherche sur le Sida, SIDACTION(ANRS); University of Strasbourg	The work was supported by the Agence Nationale de Recherche sur le Sida, SIDACTION and the University of Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Hoyos AJ, 2010, VIRUSES-BASEL, V2, P372, DOI 10.3390/v2020372; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2009, J MED CHEM, V52, P5356, DOI 10.1021/jm801176e; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; Capek P, 2006, ORG BIOMOL CHEM, V4, P2278, DOI 10.1039/b604010a; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; El Safadi Y, 2010, J MED CHEM, V53, P1534, DOI 10.1021/jm901758f; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Fukushima K, 2008, HEPATOL RES, V38, P842, DOI 10.1111/j.1872-034X.2008.00332.x; Gaied NB, 2005, NUCLEIC ACIDS RES, V33, P1031, DOI 10.1093/nar/gki253; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lindberg J, 2002, EUR J BIOCHEM, V269, P1670, DOI 10.1046/j.1432-1327.2002.02811.x; LONG RA, 1967, J ORG CHEM, V32, P2751, DOI 10.1021/jo01284a024; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; Marquez VE, 2006, ANTIVIR RES, V71, P268, DOI 10.1016/j.antiviral.2006.04.012; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; MIZRAHI V, 1994, J BIOL CHEM, V269, P19245; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Ohrui Hiroshi, 2001, Current Drug Targets - Infectious Disorders, V1, P1, DOI 10.2174/1568005013343218; Pomerantz RJ, 2003, NAT MED, V9, P867, DOI 10.1038/nm0703-867; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAGI G, 1994, J MED CHEM, V37, P1307, DOI 10.1021/jm00035a010; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Skalka AM, 1993, COLD SPRING HARBOR M, V23, P492; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; VANAERSCHOT AA, 1993, J MED CHEM, V36, P2938, DOI 10.1021/jm00072a013; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10	41	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27456	10.1371/journal.pone.0027456	http://dx.doi.org/10.1371/journal.pone.0027456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087320	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700055
J	Gu, BA; Kale, SD; Wang, QH; Wang, DH; Pan, QN; Cao, H; Meng, YL; Kang, ZS; Tyler, BM; Shan, WX				Gu, Biao; Kale, Shiv D.; Wang, Qinhu; Wang, Dinghe; Pan, Qiaona; Cao, Hua; Meng, Yuling; Kang, Zhensheng; Tyler, Brett M.; Shan, Weixing			Rust Secreted Protein Ps87 Is Conserved in Diverse Fungal Pathogens and Contains a RXLR-like Motif Sufficient for Translocation into Plant Cells	PLOS ONE			English	Article							EFFECTOR PROTEINS; FLAX RUST; AVIRULENCE PROTEINS; DISEASE RESISTANCE; OOMYCETE; BACTERIAL; GENOMICS; DELIVERY; SEQUENCE; GENES	Background: Effector proteins of biotrophic plant pathogenic fungi and oomycetes are delivered into host cells and play important roles in both disease development and disease resistance response. How obligate fungal pathogen effectors enter host cells is poorly understood. The Ps87 gene of Puccinia striiformis encodes a protein that is conserved in diverse fungal pathogens. Ps87 homologs from a clade containing rust fungi are predicted to be secreted. The aim of this study is to test whether Ps87 may act as an effector during Puccinia striiformis infection. Methodology/Principal Findings: Yeast signal sequence trap assay showed that the rust protein Ps87 could be secreted from yeast cells, but a homolog from Magnaporthe oryzae that was not predicted to be secreted, could not. Cell re-entry and protein uptake assays showed that a region of Ps87 containing a conserved RXLR-like motif [K/R]RLTG was confirmed to be capable of delivering oomycete effector Avr1b into soybean leaf cells and carrying GFP into soybean root cells. Mutations in the Ps87 motif (KRLTG) abolished the protein translocation ability. Conclusions/Significance: The results suggest that Ps87 and its secreted homologs could utilize similar protein translocation machinery as those of oomycete and other fungal pathogens. Ps87 did not show direct suppression activity on plant defense responses. These results suggest Ps87 may represent an "emerging effector" that has recently acquired the ability to enter plant cells but has not yet acquired the ability to alter host physiology.	[Gu, Biao; Wang, Dinghe; Meng, Yuling; Kang, Zhensheng; Shan, Weixing] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Kale, Shiv D.; Tyler, Brett M.] Viginia Bioinformat Inst, Blacksburg, VA USA; [Wang, Qinhu; Pan, Qiaona; Cao, Hua] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Gu, Biao; Wang, Qinhu; Wang, Dinghe; Pan, Qiaona; Cao, Hua; Meng, Yuling; Kang, Zhensheng; Shan, Weixing] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Shan, WX (corresponding author), NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	btyler@vbi.vt.edu; wxshan@nwsuaf.edu.cn	Wang, Qinhu/AAD-4793-2021; Zhao, jing/B-7349-2008; Gu, Biao/AAT-8220-2021; Pan, Qiaona/AAI-4570-2021; Wang, Qinhu/I-6274-2012	Wang, Qinhu/0000-0003-1251-073X; Wang, Qinhu/0000-0003-1251-073X; Shan, Weixing/0000-0001-7286-4041; Kang, Zhensheng/0000-0001-5575-0122	China Agriculture Research System [CARS-10]; National Natural Science Foundation of China [30971881]; Ministry of Education of China [B07049]; National Research Initiative of the USDA National Institute of Food and Agriculture [2007-35319-18100]; Virginia Bioinformatics Institute (BMT); U.S. National Science Foundation	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National Research Initiative of the USDA National Institute of Food and Agriculture; Virginia Bioinformatics Institute (BMT); U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by China Agriculture Research System (grant number #CARS-10), National Natural Science Foundation of China (grant number #30971881) and the 111 Project from Ministry of Education of China (grant number #B07049) (WS), and in part by the National Research Initiative of the USDA National Institute of Food and Agriculture, grant number #2007-35319-18100 (BMT), and funds from the Virginia Bioinformatics Institute (BMT). SDK was supported in part by a U.S. National Science Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Gan PHP, 2010, PLANT SIGNAL BEHAV, V5, P1272, DOI 10.4161/psb.5.10.13013; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2002, CAN J PLANT PATHOL, V24, P6, DOI 10.1080/07060660109506963; Kamoun S, 1998, PHYTOPATHOLOGY, V88, P1315, DOI 10.1094/PHYTO.1998.88.12.1315; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S3; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang Y, 2011, MOL PLANT PATHOL, V12, P187, DOI 10.1111/j.1364-3703.2010.00659.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zhang YH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	37	57	65	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27217	10.1371/journal.pone.0027217	http://dx.doi.org/10.1371/journal.pone.0027217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076138	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200051
J	Costa, NR; Paulo, P; Caffrey, T; Hollingsworth, MA; Santos-Silva, F				Costa, Natalia R.; Paulo, Paula; Caffrey, Thomas; Hollingsworth, Michael A.; Santos-Silva, Filipe			Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MULTIPLE-MYELOMA CELLS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; BETA-CATENIN; RNA INTERFERENCE; CIRCULATING GALECTIN-3; TUMOR PROGRESSION; EPITHELIAL MUCIN; EPISIALIN MUC1	Background: Gastric carcinoma is the second leading cause of cancer-associated death worldwide. The high mortality associated with this disease is in part due to limited knowledge about gastric carcinogenesis and a lack of available therapeutic and prevention strategies. MUC1 is a high molecular weight transmembrane mucin protein expressed at the apical surface of most glandular epithelial cells and a major component of the mucus layer above gastric mucosa. Overexpression of MUC1 is found in approximately 95% of human adenocarcinomas, where it is associated with oncogenic activity. The role of MUC1 in gastric cancer progression remains to be clarified. Methodology: We downregulated MUC1 expression in a gastric carcinoma cell line by RNA interference and studied the effects on cellular proliferation (MTT assay), apoptosis (TUNEL assay), migration (migration assay), invasion (invasion assay) and aggregation (aggregation assay). Global gene expression was evaluated by microarray analysis to identify alterations that are regulated by MUC1 expression. In vivo assays were also performed in mice, in order to study the tumorigenicity of cells with and without MUC1 downregulation in MKN45 gastric carcinoma cell line. Results: Downregulation of MUC1 expression increased proliferation and apoptosis as compared to controls, whereas cell-cell aggregation was decreased. No significant differences were found in terms of migration and invasion between the downregulated clones and the controls. Expression of TCN1, KLK6, ADAM29, LGAL4, TSPAN8 and SHPS-1 was found to be significantly different between MUC1 downregulated clones and the control cells. In vivo assays have shown that mice injected with MUC1 downregulated cells develop smaller tumours when compared to mice injected with the control cells. Conclusions: These results indicate that MUC1 downregulation alters the phenotype and tumorigenicity of MKN45 gastric carcinoma cells and also the expression of several molecules that can be involved in tumorigenic events. Therefore, MUC1 should be further studied to better clarify its potential as a novel therapeutic target for gastric cancer.	[Costa, Natalia R.; Paulo, Paula; Santos-Silva, Filipe] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Caffrey, Thomas; Hollingsworth, Michael A.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Santos-Silva, Filipe] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; University of Nebraska System; University of Nebraska Medical Center; Universidade do Porto	Costa, NR (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	fsilva@ipatimup.pt	Santos-Silva, Filipe/J-4535-2013; Paulo, Paula/F-1441-2016	Santos-Silva, Filipe/0000-0001-7143-1025; Paulo, Paula/0000-0001-8387-2127; Costa, Natalia Rios/0000-0002-1858-2438; Costa, Maria/0000-0001-5798-6470; Caffrey, Thomas/0000-0001-6707-8468	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [POCTI/SAU-IMI/56895/2004, PTDC/SAU-OBD/65616/2006, SFRH/BD/21693/2005, SFRH/BD/36961/2007]; Fundacao Luso-Americana (FLAD)	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fundacao Luso-Americana (FLAD)	This work was supported by grants from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, Projects POCTI/SAU-IMI/56895/2004 and PTDC/SAU-OBD/65616/2006 and fellowships SFRH/BD/21693/2005 and SFRH/BD/36961/2007 and Fundacao Luso-Americana (FLAD). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Benjamin JBE, 2010, CLIN CHIM ACTA, V411, P2067, DOI 10.1016/j.cca.2010.09.003; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Chaturvedi R, 2005, INT J ONCOL, V26, P1169; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Guang W, 2009, INT J BIOCHEM CELL B, V41, P1354, DOI 10.1016/j.biocel.2008.12.004; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Hattrup CL, 2008, BREAST CANCER-BASIC, V1, P57; Hayashi T, 2001, DIGESTION, V63, P87, DOI 10.1159/000051917; Henkhaus RS, 2008, BIOL CHEM, V389, P757, DOI 10.1515/BC.2008.087; Heuze-Vourc'h N, 2009, J CELL MOL MED, V13, P4014, DOI 10.1111/j.1582-4934.2009.00763.x; Huang Lei, 2010, Genes Cancer, V1, P239; Inagaki Y, 2011, ANTICANCER RES, V31, P535; Kawano T, 2008, INT J ONCOL, V33, P153; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KLINGE CM, 2011, MOL CANC THER; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Li Q, 2004, BIOCHEM BIOPH RES CO, V315, P471, DOI 10.1016/j.bbrc.2004.01.075; Li XJ, 2005, CANCER BIOL THER, V4, P968, DOI 10.4161/cbt.4.9.1913; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Lillehoj EP, 2007, BBA-MOL CELL RES, V1773, P1028, DOI 10.1016/j.bbamcr.2007.04.009; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nath D, 1999, IMMUNOLOGY, V98, P213; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Rahn JJ, 2005, CLIN EXP METASTAS, V22, P475, DOI 10.1007/s10585-005-3098-x; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Regimbald LH, 1996, CANCER RES, V56, P4244; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; SATELLI A, 2010, INT J CANC; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Wang QF, 2008, CANCER LETT, V269, P127, DOI 10.1016/j.canlet.2008.04.035; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Xu Y, 2009, BIOLOGICALS, V37, P18, DOI 10.1016/j.biologicals.2008.08.002; Ye Q, 2011, LAB INVEST, V91, P778, DOI 10.1038/labinvest.2011.12; Yonezawa S, 1997, PATHOL INT, V47, P813, DOI 10.1111/j.1440-1827.1997.tb03713.x; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Yuan Z, 2007, BIOCHEM BIOPH RES CO, V362, P740, DOI 10.1016/j.bbrc.2007.08.074; Yuan ZL, 2009, J SURG RES, V157, pE39, DOI 10.1016/j.jss.2008.09.005; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	62	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26970	10.1371/journal.pone.0026970	http://dx.doi.org/10.1371/journal.pone.0026970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073229	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900056
J	Lowe, PK; Bruno, JF; Selig, ER; Spencer, M				Lowe, Phillip K.; Bruno, John F.; Selig, Elizabeth R.; Spencer, Matthew			Empirical Models of Transitions between Coral Reef States: Effects of Region, Protection, and Environmental Change	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHASE-SHIFTS; CLIMATE-CHANGE; MARINE; COMMUNITIES; MANAGEMENT; PATTERNS; FUTURE; CONSERVATION; SENSITIVITY	There has been substantial recent change in coral reef communities. To date, most analyses have focussed on static patterns or changes in single variables such as coral cover. However, little is known about how community-level changes occur at large spatial scales. Here, we develop Markov models of annual changes in coral and macroalgal cover in the Caribbean and Great Barrier Reef (GBR) regions. We analyzed reef surveys from the Caribbean and GBR (1996-2006). We defined a set of reef states distinguished by coral and macroalgal cover, and obtained Bayesian estimates of the annual probabilities of transitions between these states. The Caribbean and GBR had different transition probabilities, and therefore different rates of change in reef condition. This could be due to differences in species composition, management or the nature and extent of disturbances between these regions. We then estimated equilibrium probability distributions for reef states, and coral and macroalgal cover under constant environmental conditions. In both regions, the current distributions are close to equilibrium. In the Caribbean, coral cover is much lower and macroalgal cover is higher at equilibrium than in the GBR. We found no evidence for differences in transition probabilities between the first and second halves of our survey period, or between Caribbean reefs inside and outside marine protected areas. However, our power to detect such differences may have been low. We also examined the effects of altering transition probabilities on the community state equilibrium, along a continuum from unfavourable (e.g., increased sea surface temperature) to favourable (e.g., improved management) conditions. Both regions showed similar qualitative responses, but different patterns of uncertainty. In the Caribbean, uncertainty was greatest about effects of favourable changes, while in the GBR, we are most uncertain about effects of unfavourable changes. Our approach could be extended to provide risk analysis for management decisions.	[Lowe, Phillip K.; Spencer, Matthew] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Selig, Elizabeth R.] Conservat Int, Sci & Knowledge Div, Arlington, VA USA	University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; Conservation International	Lowe, PK (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	m.spencer@liverpool.ac.uk						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; ANDERSON TW, 1957, ANN MATH STAT, V28, P89, DOI 10.1214/aoms/1177707039; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2011, REEFS RISK REVISITED; Carr MH, 2003, ECOL APPL, V13, pS90; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Efron B., 1994, INTRO BOOTSTRAP; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Freckleton RP, AM NATURALI IN PRESS; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garthwaite P., 2002, STAT INFERENCE; Gelman A., 2004, BAYESIAN DATA ANAL; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Graham NAJ, 2011, CORAL REEFS IN PRESS; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P435, DOI 10.1098/rspb.2002.2230; Hill MF, 2004, AM NAT, V164, pE46, DOI 10.1086/422340; Himes AH, 2007, OCEAN COAST MANAGE, V50, P329, DOI 10.1016/j.ocecoaman.2006.09.005; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huntington BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012327; Jackson JBC, 2010, PHILOS T R SOC B, V365, P3765, DOI 10.1098/rstb.2010.0278; KNOWLTON N, 1992, AM ZOOL, V32, P674; Logofet DO, 2000, ECOL MODEL, V126, P285, DOI 10.1016/S0304-3800(00)00269-6; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P1, DOI 10.1016/0304-3800(94)00042-G; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Melbourne-Thomas J, ENV MODELLI IN PRESS; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Queenborough SA, METHODS ECO IN PRESS; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rogers CS, 2006, MAR ECOL PROG SER, V306, P103, DOI 10.3354/meps306103; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Solow AR, 2006, J APPL ECOL, V43, P185, DOI 10.1111/j.1365-2664.2005.01127.x; Steneck RS, 1988, P 6 INT COR REEF S T; Tanner JE, 2009, ECOLOGY, V90, P506, DOI 10.1890/08-0399.1; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Tanner JE, 1996, ECOLOGY, V77, P108, DOI 10.2307/2265660; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; USHER MB, 1979, J ANIM ECOL, V48, P413, DOI 10.2307/4170; *WDPA CONS, 2005, WORLD DAT PROT AR 20; West, 1970, STUDIES VEGETATIONAL, P117; Wilkinson Clive, 2000, P21; Wing SR, 2001, CORAL REEFS, V20, P1; Wolanski E, 2005, ESTUAR COAST SHELF S, V64, P504, DOI 10.1016/j.ecss.2005.03.017; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	74	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26339	10.1371/journal.pone.0026339	http://dx.doi.org/10.1371/journal.pone.0026339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073157	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900018
J	Shimo, K; Ueno, T; Younger, J; Nishihara, M; Inoue, S; Ikemoto, T; Taniguchi, S; Ushida, T				Shimo, Kazuhiro; Ueno, Takefumi; Younger, Jarred; Nishihara, Makoto; Inoue, Shinsuke; Ikemoto, Tatsunori; Taniguchi, Shinichirou; Ushida, Takahiro			Visualization of Painful Experiences Believed to Trigger the Activation of Affective and Emotional Brain Regions in Subjects with Low Back Pain	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-TRIAL FMRI; HUMAN PULVINAR; CORTICAL REPRESENTATION; CATASTROPHIC THINKING; SOMATOSENSORY CORTEX; NEURAL RESPONSES; FUNCTIONAL MRI; MUSCLE PAIN	In the management of clinical low back pain (LBP), actual damage to lower back areas such as muscles, intervertebral discs etc. are normally targeted for therapy. However, LBP may involve not only sensory pain, but also underlying affective pain which may also play an important role overall in painful events. Therefore we hypothesized that visualization of a painful event may trigger painful memories, thus provoking the affective dimension of pain. The present study investigated neural correlates of affect processing in subjects with LBP (n = 11) and subjects without LBP (n = 11) through the use of virtual LBP stimuli. Whole brain functional magnetic resonance imaging (MRI) was performed for all subjects while they were shown a picture of a man carrying luggage in a half-crouching position. All subjects with LBP reported experiencing discomfort and 7 LBP subjects reported experiencing pain. In contrast to subjects without LBP, subjects with LBP displayed activation of the cortical area related to pain and emotions: the insula, supplementary motor area, premotor area, thalamus, pulvinar, posterior cingulate cortex, hippocampus, fusiform, gyrus, and cerebellum. These results suggest that the virtual LBP stimuli caused memory retrieval of unpleasant experiences and therefore may be associated with prolonged chronic LBP conditions.	[Shimo, Kazuhiro; Nishihara, Makoto; Inoue, Shinsuke; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Aichi, Japan; [Ueno, Takefumi] Kyushu Univ, Dept Neuropsychiat, Fukuoka 812, Japan; [Younger, Jarred] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Ikemoto, Tatsunori] NPO Pain Med Res Informat Ctr, Kochi, Japan; [Taniguchi, Shinichirou; Ushida, Takahiro] Kochi Med Sch, Dept Orthopaed Surg, Kochi, Japan	Aichi Medical University; Kyushu University; Stanford University; Kochi University	Shimo, K (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Aichi, Japan.	ushidat-koc@umin.ac.jp	Ikemoto, Tatsunori/E-3839-2018	Ikemoto, Tatsunori/0000-0002-4521-7639	Ministry of Health, Labour, and Welfare	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Clark RE, 2007, J NEUROSCI, V27, P6647, DOI 10.1523/JNEUROSCI.0913-07.2007; Cotton PL, 2007, J NEUROPHYSIOL, V98, P1600, DOI 10.1152/jn.00419.2007; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hsieh JC, 1996, PAIN, V64, P303, DOI 10.1016/0304-3959(95)00129-8; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Korotkov A, 2002, NEUROSCI LETT, V335, P119, DOI 10.1016/S0304-3940(02)01181-3; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Peyron R, 2007, NEUROPHYSIOL CLIN, V37, P249, DOI 10.1016/j.neucli.2007.07.002; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Qiu YH, 2006, CEREB CORTEX, V16, P1289, DOI 10.1093/cercor/bhj071; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Ruehle BS, 2006, J NEUROSCI, V26, P5492, DOI 10.1523/JNEUROSCI.2059-05.2006; Sander K, 2007, HUM BRAIN MAPP, V28, P1007, DOI 10.1002/hbm.20333; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Smith AT, 2009, J NEUROPHYSIOL, V101, P917, DOI 10.1152/jn.90963.2008; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 2005, PAIN, V113, P310, DOI 10.1016/j.pain.2004.11.003; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Talairach J., 1988, COPLANAR STEREOTAXIC; Ushicla T, 2008, NEUROSCI LETT, V439, P7, DOI 10.1016/j.neulet.2008.04.085; Ushida T, 2005, BRAIN TOPOGR, V18, P27, DOI 10.1007/s10548-005-7898-8; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	56	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26681	10.1371/journal.pone.0026681	http://dx.doi.org/10.1371/journal.pone.0026681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073183	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900031
J	Geurts, N; Martens, E; Verhenne, S; Lays, N; Thijs, G; Magez, S; Cauwe, B; Li, S; Heremans, H; Opdenakker, G; Van den Steen, PE				Geurts, Nathalie; Martens, Erik; Verhenne, Sebastien; Lays, Natacha; Thijs, Greet; Magez, Stefan; Cauwe, Benedicte; Li, Sandra; Heremans, Hubertine; Opdenakker, Ghislain; Van den Steen, Philippe E.			Insufficiently Defined Genetic Background Confounds Phenotypes in Transgenic Studies As Exemplified by Malaria Infection in Tlr9 Knockout Mice	PLOS ONE			English	Article							ACTIVATES DENDRITIC CELLS; MURINE CEREBRAL MALARIA; TOLL-LIKE RECEPTORS; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSES; B-CELLS; C57BL/6 MICE; MOUSE; SUSCEPTIBILITY; RESISTANCE	The use of genetically modified mice, i.e. transgenic as well as gene knockout (KO) and knock-in mice, has become an established tool to study gene function in many animal models for human diseases. However, a gene functions in a particular genomic context. This implies the importance of a well-defined homogenous genetic background for the analysis and interpretation of phenotypes associated with genetic mutations. By studying a Plasmodium chabaudi chabaudi AS (PcAS) malaria infection in mice bearing a TLR9 null mutation, we found an increased susceptibility to infection, i.e. higher parasitemia levels and increased mortality. However, this was not triggered by the deficient TLR9 gene itself. Instead, this disease phenotype was dependent on the heterogeneous genetic background of the mice, which appeared insufficiently defined as determined by single nucleotide polymorphism (SNP) analysis. Hence, it is of critical importance to study gene KO phenotypes on a homogenous genetic background identical to that of their wild type (WT) control counterparts. In particular, to avoid problems related to an insufficiently defined genetic background, we advocate that for each study involving genetically modified mice, at least a detailed description of the origin and genetic background of both the WT control and the altered strain of mice is essential.	[Geurts, Nathalie; Martens, Erik; Verhenne, Sebastien; Lays, Natacha; Thijs, Greet; Cauwe, Benedicte; Li, Sandra; Heremans, Hubertine; Opdenakker, Ghislain; Van den Steen, Philippe E.] Univ Louvain, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium; [Magez, Stefan] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium	KU Leuven; Vrije Universiteit Brussel	Geurts, N (corresponding author), Univ Louvain, Rega Inst Med Res, Immunobiol Lab, Louvain, Belgium.	Philippe.VandenSteen@rega.kuleuven.be	Opdenakker, Ghislain/Q-3130-2017; Martens, Erik/F-9214-2015; Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/V-8562-2019; Cauwe, Bénédicte/B-9959-2012; Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021	Opdenakker, Ghislain/0000-0003-1714-2294; Martens, Erik/0000-0002-7947-6567; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968	Fund for Scientific Research-Flanders (FWO-Vlaanderen); 'Geconcerteerde OnderzoeksActies' (GOA); Research Fund of the University of Leuven [CREA 09/023]	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); 'Geconcerteerde OnderzoeksActies' (GOA); Research Fund of the University of Leuven	This study was supported by The Fund for Scientific Research-Flanders (FWO-Vlaanderen), the 'Geconcerteerde OnderzoeksActies' (GOA 2007-2011) and a CREA-grant (CREA 09/023) from the Research Fund of the University of Leuven. NG is a research assistant of the FWO-Vlaanderen and PVDS is a Research Professor of the Research Fund of the University of Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanmori BD, 1996, PARASITE IMMUNOL, V18, P193, DOI 10.1046/j.1365-3024.1996.d01-80.x; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Basu M, 2010, INFECT GENET EVOL, V10, P686, DOI 10.1016/j.meegid.2010.03.008; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Chang KH, 2004, BLOOD, V103, P3727, DOI 10.1182/blood-2003-08-2887; *CLEA JAP, 2011, JAP MOUS RAT STRAIN; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban Cevayir, 2010, Allergology International, V59, P115, DOI 10.2332/allergolint.10-RAI-0194; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2002, GENES IMMUN, V3, P177, DOI 10.1038/sj.gene.6363841; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gowda DC, 2007, TRENDS PARASITOL, V23, P596, DOI 10.1016/j.pt.2007.09.003; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Griffith JW, 2007, J INFECT DIS, V196, P1553, DOI 10.1086/522865; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; *JACKS LAB, 2007, BREED STRAT MAINT CO; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jepson A, 1997, BRIT MED J, V315, P96, DOI 10.1136/bmj.315.7100.96; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Langhorne J, 2002, CHEM IMMUNOL, V80, P204; Lepenies B, 2008, MED MICROBIOL IMMUN, V197, P39, DOI 10.1007/s00430-007-0057-y; Li C, 2001, MED MICROBIOL IMMUN, V189, P115, DOI 10.1007/s430-001-8017-8; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Lyke KE, 2011, TISSUE ANTIGENS, V77, P562, DOI 10.1111/j.1399-0039.2011.01661.x; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Sanford LP, 2000, METH MOL B, V158, P217; Sanni LA, 2004, INFECT IMMUN, V72, P3054, DOI 10.1128/IAI.72.5.3054-3058.2004; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Stevens JC, 2007, TRENDS MOL MED, V13, P512, DOI 10.1016/j.molmed.2007.10.001; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Taylor-Robinson AW, 2010, EXP PARASITOL, V126, P406, DOI 10.1016/j.exppara.2010.01.028; TAYLORROBINSON AW, 1994, INFECT IMMUN, V62, P2490, DOI 10.1128/IAI.62.6.2490-2498.1994; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yoshida S, 2010, INFECT IMMUN, V78, P595, DOI 10.1128/IAI.00877-09; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94	80	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27131	10.1371/journal.pone.0027131	http://dx.doi.org/10.1371/journal.pone.0027131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096530	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900024
J	Kiedrowski, MR; Kavanaugh, JS; Malone, CL; Mootz, JM; Voyich, JM; Smeltzer, MS; Bayles, KW; Horswill, AR				Kiedrowski, Megan R.; Kavanaugh, Jeffrey S.; Malone, Cheryl L.; Mootz, Joe M.; Voyich, Jovanka M.; Smeltzer, Mark S.; Bayles, Kenneth W.; Horswill, Alexander R.			Nuclease Modulates Biofilm Formation in Community-Associated Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							GENE REGULATOR AGR; EXTRACELLULAR DNA; BACTERIAL-CONTAMINATION; COMPUTER KEYBOARDS; HEMATOGENOUS OSTEOMYELITIS; PLASMA-PROTEINS; SARA MUTANTS; IN-VITRO; VIRULENCE; RELEASE	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging contributor to biofilm-related infections. We recently reported that strains lacking sigma factor B (sigB) in the USA300 lineage of CA-MRSA are unable to develop a biofilm. Interestingly, when spent media from a USA300 sigB mutant was incubated with other S. aureus strains, biofilm formation was inhibited. Following fractionation and mass spectrometry analysis, the major anti-biofilm factor identified in the spent media was secreted thermonuclease (Nuc). Considering reports that extracellular DNA (eDNA) is an important component of the biofilm matrix, we investigated the regulation and role of Nuc in USA300. The expression of the nuc gene was increased in a sigB mutant, repressed by glucose supplementation, and was unaffected by the agr quorum-sensing system. A FRET assay for Nuc activity was developed and confirmed the regulatory results. A USA300 nuc mutant was constructed and displayed an enhanced biofilm-forming capacity, and the nuc mutant also accumulated more high molecular weight eDNA than the WT and regulatory mutant strains. Inactivation of nuc in the USA300 sigB mutant background partially repaired the sigB biofilm-negative phenotype, suggesting that nuc expression contributes to the inability of the mutant to form biofilm. To test the generality of the nuc mutant biofilm phenotypes, the mutation was introduced into other S. aureus genetic backgrounds and similar increases in biofilm formation were observed. Finally, using multiple S. aureus strains and regulatory mutants, an inverse correlation between Nuc activity and biofilm formation was demonstrated. Altogether, our findings confirm the important role for eDNA in the S. aureus biofilm matrix and indicates Nuc is a regulator of biofilm formation.	[Kiedrowski, Megan R.; Kavanaugh, Jeffrey S.; Malone, Cheryl L.; Mootz, Joe M.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Voyich, Jovanka M.] Montana State Univ, Dept Vet Microbiol, Bozeman, MT 59717 USA; [Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Bayles, Kenneth W.] Univ Nebraska, Nebraska Med Ctr, Dept Pathol, Omaha, NE 68182 USA	University of Iowa; Montana State University System; Montana State University Bozeman; University of Arkansas System; University of Arkansas Medical Sciences; University of Nebraska System; University of Nebraska Medical Center	Kiedrowski, MR (corresponding author), Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu	; Smeltzer, Mark/M-2009-2018	Kiedrowski, Megan/0000-0003-4610-182X; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases [AI083211, AI074087]; National Institute of Health-National Center for Research Resources [P20RR020185]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, R13AI074087, R01AI090046] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to MSS from the National Institute of Allergy and Infectious Diseases (AI083211, ARH, KWB and AI074087) and JMV was supported by the National Institute of Health-National Center for Research Resources grant (P20RR020185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderson G, 2009, AM J INFECT CONTROL, V37, P507, DOI 10.1016/j.ajic.2008.10.032; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; ARNONE A, 1971, J BIOL CHEM, V246, P2302; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baranovskii AG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P587, DOI 10.1023/B:BIRY.0000033731.50496.01; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Beer D, 2006, PEDIATR INFECT DIS J, V25, P1074, DOI 10.1097/01.inf.0000242649.27400.94; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Brady RRW, 2007, ANN ROY COLL SURG, V89, P656, DOI 10.1308/003588407X209347; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat James E., 2007, V391, P127; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Cuatrecasas P, 1968, Brookhaven Symp Biol, V21, P172; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS A, 1977, J BIOL CHEM, V252, P6544; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; DEWEZ B, 1993, EUR J CLIN CHEM CLIN, V31, P793; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DYKE KGH, 1966, LANCET, V1, P835; Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; FUCHS S, 1967, J BIOL CHEM, V242, P4768; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; GOODMAN SD, 2011, MUCOSAL IMMUNOLOGY; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Haque NZ, 2007, INT J ANTIMICROB AG, V30, P72, DOI 10.1016/j.ijantimicag.2007.02.007; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; HEINS JN, 1967, J BIOL CHEM, V242, P1016; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; KLEVENS RM, 2007, United States Jama, V298, P1763; Kourbatova EV, 2005, AM J INFECT CONTROL, V33, P385, DOI 10.1016/j.ajic.2005.06.006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagae-Wiens PRS, 2007, J CLIN MICROBIOL, V45, P3478, DOI 10.1128/JCM.01477-07; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; LEE SP, 1994, ANAL BIOCHEM, V220, P377, DOI 10.1006/abio.1994.1353; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Motta RHL, 2007, INFECT CONT HOSP EP, V28, P185, DOI 10.1086/510867; NADANO D, 1993, CLIN CHEM, V39, P448; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schultz M, 2003, INFECT CONT HOSP EP, V24, P302, DOI 10.1086/502200; Seybold U, 2007, INFECTION, V35, P190, DOI 10.1007/s15010-007-6058-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMELTZER MS, 1993, INFECT IMMUN, V61, P919, DOI 10.1128/IAI.61.3.919-925.1993; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; TANIUCHI H, 1966, J BIOL CHEM, V241, P4366; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; VAUDAUX PE, 1995, INFECT IMMUN, V63, P585, DOI 10.1128/IAI.63.2.585-590.1995; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williams Christa, 2009, Clin Lab Sci, V22, P34	89	169	176	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26714	10.1371/journal.pone.0026714	http://dx.doi.org/10.1371/journal.pone.0026714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096493	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900007
J	Rheindt, FE; Szekely, T; Edwards, SV; Lee, PLM; Burke, T; Kennerley, PR; Bakewell, DN; Alrashidi, M; Kosztolanyi, A; Weston, MA; Liu, WT; Lei, WP; Shigeta, Y; Javed, S; Zefania, S; Kupper, C				Rheindt, Frank E.; Szekely, Tamas; Edwards, Scott V.; Lee, Patricia L. M.; Burke, Terry; Kennerley, Peter R.; Bakewell, David N.; Alrashidi, Monif; Kosztolanyi, Andras; Weston, Michael A.; Liu, Wei-Ting; Lei, Wei-Pan; Shigeta, Yoshimitsu; Javed, Salim; Zefania, Sama; Kuepper, Clemens			Conflict between Genetic and Phenotypic Differentiation: The Evolutionary History of a 'Lost and Rediscovered' Shorebird	PLOS ONE			English	Article							CONSERVED MICROSATELLITE MARKERS; CHARADRIUS-ALEXANDRINUS; POPULATION-STRUCTURE; LINKED LOCI; INFERENCE; PHYLOGENY; KENTISH; AMPLIFICATION; DIVERGENCE; MORPHOLOGY	Understanding and resolving conflicts between phenotypic and genetic differentiation is central to evolutionary research. While phenotypically monomorphic species may exhibit deep genetic divergences, some morphologically distinct taxa lack notable genetic differentiation. Here we conduct a molecular investigation of an enigmatic shorebird with a convoluted taxonomic history, the White-faced Plover (Charadrius alexandrinus dealbatus), widely regarded as a subspecies of the Kentish Plover (C. alexandrinus). Described as distinct in 1863, its name was consistently misapplied in subsequent decades until taxonomic clarification ensued in 2008. Using a recently proposed test of species delimitation, we reconfirm the phenotypic distinctness of dealbatus. We then compare three mitochondrial and seven nuclear DNA markers among 278 samples of dealbatus and alexandrinus from across their breeding range and four other closely related plovers. We fail to find any population genetic differentiation between dealbatus and alexandrinus, whereas the other species are deeply diverged at the study loci. Kentish Plovers join a small but growing list of species for which low levels of genetic differentiation are accompanied by the presence of strong phenotypic divergence, suggesting that diagnostic phenotypic characters may be encoded by few genes that are difficult to detect. Alternatively, gene expression differences may be crucial in producing different phenotypes whereas neutral differentiation may be lagging behind.	[Rheindt, Frank E.; Edwards, Scott V.; Alrashidi, Monif; Kuepper, Clemens] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rheindt, Frank E.; Edwards, Scott V.; Alrashidi, Monif; Kuepper, Clemens] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Lee, Patricia L. M.] Swansea Univ, Dept Biosci, Inst Environm Sustainabil, Swansea, W Glam, Wales; [Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Bakewell, David N.] Whimbrel Cottage, Eye, Suffolk, England; [Alrashidi, Monif] Univ Hail, Dept Biol, Coll Sci, Hail, Saudi Arabia; [Kosztolanyi, Andras] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Weston, Michael A.] Deakin Univ, Sch Life & Environm Sci, Fac Sci & Technol, Burwood, Vic, Australia; [Liu, Wei-Ting] Tunghai Univ, Taiwan Wader Study Grp, Dept Environm Sci, Taichung 40704, Taiwan; [Lei, Wei-Pan] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Shigeta, Yoshimitsu] Yamashina Inst Ornithol, Bird Migrat Res Ctr, Div Avian Conservat, Abiko, Chiba, Japan; [Javed, Salim] Environm Agcy, Biodivers Management Sect, Abu Dhabi, U Arab Emirates; [Zefania, Sama] Univ Antananarivo, Dept Anim Biol, Antananarivo, Madagascar	Harvard University; Harvard University; University of Bath; Swansea University; University of Sheffield; University Ha'il; Eotvos Lorand University; Deakin University; Tunghai University; Beijing Normal University; University Antananarivo	Rheindt, FE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	frankrheindt@yahoo.com.au	Kosztolanyi, Andras/B-8008-2016; Szekely, Tamas/I-7089-2016; Lee, Patricia/N-4157-2013; GenePool, The/D-8812-2012; Burke, Terry/B-3196-2011; Küpper, Clemens/D-8116-2011; Javed, Salim/AAV-7507-2020; Rheindt, Frank/D-7826-2014; Edwards, Scott V./D-9071-2018	Kosztolanyi, Andras/0000-0002-9109-5871; Szekely, Tamas/0000-0003-2093-0056; Lee, Patricia/0000-0002-8489-9206; Burke, Terry/0000-0003-3848-1244; Küpper, Clemens/0000-0002-1507-8033; Rheindt, Frank/0000-0001-8946-7085; Edwards, Scott V./0000-0003-2535-6217; Lei, Weipan/0000-0001-7616-7200	National Geographic Society [8403-08]; Natural Environmental Research Council [MGF184]; German Academic Exchange Service (DAAD); Hungarian Scientific Research Fund (OTKA) [K81953]; National Natural Science Foundation of China-Guangdong [U0833005]; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010001, NBAF010003] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NBAF010001] Funding Source: researchfish	National Geographic Society(National Geographic Society); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Natural Science Foundation of China-Guangdong(National Natural Science Foundation of China (NSFC)National Natural Science Foundation of Guangdong Province); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for fieldwork was provided by the National Geographic Society (8403-08). Genetic analyses were funded by the Natural Environmental Research Council (MGF184). FER and CK were supported by postdoctoral fellowships of German Academic Exchange Service (DAAD). AK was supported by the Hungarian Scientific Research Fund (OTKA, K81953 to Adam Miklosi). LW was supported by the National Natural Science Foundation of China-Guangdong Joint Fund (Grant No. U0833005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alstrom P, 2008, MOL PHYLOGENET EVOL, V47, P960, DOI 10.1016/j.ympev.2007.12.007; Avise John C., 1994, pi; Blomqvist D, 2002, NATURE, V419, P613, DOI 10.1038/nature01104; Brooks TM, 2010, NATURE, V467, P540, DOI 10.1038/467540a; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Darwin C., 1859, ORIGIN SPECIES MEANS; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk WC, 2007, CONSERV GENET, V8, P1287, DOI 10.1007/s10592-006-9278-7; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Grant P. R., 2008, WHY SPECIES MULTIPLY; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Hartert E, 1915, IBIS, V57, P526, DOI [10.1111/j.1474-919X.1915.tb08204.x, DOI 10.1111/J.1474-919X.1915.TB08204.X]; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kennerley PR, 2008, FORKTAIL, P63; Kupper C, 2010, MOL ECOL, V19, P5172, DOI 10.1111/j.1365-294X.2010.04867.x; Kupper C, 2009, AUK, V126, P839, DOI 10.1525/auk.2009.08174; Kupper C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-502; Kupper C, 2007, MOL ECOL NOTES, V7, P35, DOI 10.1111/j.1471-8286.2006.01517.x; Lee PLM, 2008, MOL ECOL RESOUR, V8, P551, DOI 10.1111/j.1471-8286.2007.02042.x; Magallon S., 2009, TIMETREE LIFE, P133; Mayr G, 2011, ZOOL J LINN SOC-LOND, V161, P916, DOI 10.1111/j.1096-3642.2010.00654.x; Olsson U, 2005, MOL PHYLOGENET EVOL, V36, P261, DOI 10.1016/j.ympev.2005.01.012; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Piersma T., 1996, HDB BIRDS WORLD, P384; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pritchard JK, 2000, GENETICS, V155, P945; Rheindt FE, 2008, MOL PHYLOGENET EVOL, V48, P150, DOI 10.1016/j.ympev.2008.04.016; Rheindt FE, 2009, ZOOL SCR, V38, P143, DOI 10.1111/j.1463-6409.2008.00369.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saitoh T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-35; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swinhoe R, 1863, P ZOOL SOC LOND, V1863, P259; Swinhoe R, 1870, P ZOOL SOC LOND, V1870, P136; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szekely T, 2006, BIOSCIENCE, V56, P801, DOI 10.1641/0006-3568(2006)56[801:SCEABS]2.0.CO;2; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Uy JAC, 2009, AM NAT, V174, P244, DOI 10.1086/600084; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang ZS, 2003, EVOLUTION, V57, P2852; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	55	40	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26995	10.1371/journal.pone.0026995	http://dx.doi.org/10.1371/journal.pone.0026995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096515	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000297350800022
J	Blom, EJ; Ridder, ANJA; Lulko, AT; Roerdink, JBTM; Kuipers, OP				Blom, Evert-Jan; Ridder, Anja N. J. A.; Lulko, Andrzej T.; Roerdink, Jos B. T. M.; Kuipers, Oscar P.			Time-Resolved Transcriptomics and Bioinformatic Analyses Reveal Intrinsic Stress Responses during Batch Culture of Bacillus subtilis	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEOME; CANNIBALISM; STARVATION; RESISTANCE; SEQUENCE; GENOME; DEATH; TOOL; IDENTIFICATION	We have determined the time-resolved transcriptome of the model gram-positive organism B. subtilis during growth in a batch fermentor on rich medium. DNA microarrays were used to monitor gene transcription using 10-minute intervals at 40 consecutive time points. From the growth curve and analysis of all gene expression levels, we identified 4 distinct growth phases and one clear transition point: a lag phase, an exponential growth phase, the transition point and the very clearly separated early and late stationary growth phases. The gene expression profiles suggest the occurrence of stress responses at specific times although no external stresses were applied. The first one is a small induction of the SigB regulon that occurs at the transition point. Remarkably, a very strong response is observed for the SigW regulon, which is highly upregulated at the onset of the late stationary phase. Bioinformatic analyses that were performed on our data set suggest several novel putative motifs for regulator binding. In addition, the expression profiles of several genes appeared to correlate with the oxygen concentration. This data set of the expression profiles of all B. subtilis genes during the entire growth curve on rich medium constitutes a rich repository that can be further mined by the scientific community.	[Blom, Evert-Jan; Ridder, Anja N. J. A.; Lulko, Andrzej T.; Kuipers, Oscar P.] Univ Groningen, Dept Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	University of Groningen; University of Groningen	Blom, EJ (corresponding author), Keygene NV, Wageningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Roerdink, Jos B.T.M/B-3631-2008	Kuipers, Oscar/0000-0001-5596-7735; 	Netherlands Organisation for Scientific Research; NWO-BMI [050.50.206]; Center IOP Genomics; NWO Molecule to Cell	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO-BMI(Netherlands Organization for Scientific Research (NWO)); Center IOP Genomics; NWO Molecule to Cell	This study was supported by a grant from The Netherlands Organisation for Scientific Research and industrial partners in the NWO-BMI project number 050.50.206 on Computational Genomics of Prokaryotes. In addition, this study was supported by the Center IOP Genomics and NWO Molecule to Cell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2006, J BACTERIOL, V188, P5299, DOI 10.1128/JB.00084-06; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banse AV, 2008, P NATL ACAD SCI USA, V105, P15547, DOI 10.1073/pnas.0805203105; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Becher D, 2011, PROTEOMICS, V11, P2971, DOI 10.1002/pmic.201100090; Beier L, 2002, J BACTERIOL, V184, P3232, DOI 10.1128/JB.184.12.3232-3241.2002; Bernhardt J, 2003, GENOME RES, V13, P224, DOI 10.1101/gr.905003; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; Blom EJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-535; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Butcher BG, 2006, MOL MICROBIOL, V60, P765, DOI 10.1111/j.1365-2958.2006.05131.x; Chandramohan L, 2009, J BACTERIOL, V191, P4103, DOI 10.1128/JB.00314-09; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gaballa A, 2003, MICROBIOL-SGM, V149, P3413, DOI 10.1099/mic.0.26225-0; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rudrappa T, 2007, PLANTA, V226, P283, DOI 10.1007/s00425-007-0480-8; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Wolff S, 2007, J CHROMATOGR B, V849, P129, DOI 10.1016/j.jchromb.2006.09.029; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092	42	30	31	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27160	10.1371/journal.pone.0027160	http://dx.doi.org/10.1371/journal.pone.0027160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087258	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700017
J	Clavijo, G; Doremus, T; Ravallec, M; Mannucci, MA; Jouan, V; Volkoff, AN; Darboux, I				Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle			Multigenic Families in Ichnovirus: A Tissue and Host Specificity Study through Expression Analysis of Vankyrins from Hyposoter didymator Ichnovirus	PLOS ONE			English	Article							CAMPOLETIS-SONORENSIS ICHNOVIRUS; POLYDNAVIRUS INDUCES APOPTOSIS; GENE FAMILY; IN-VITRO; SPODOPTERA-FRUGIPERDA; IMMUNE-RESPONSE; CELLS; SEQUENCE; GENOME; VIRUS	The viral ankyrin (vankyrin) gene family is represented in all polydnavirus (PDVs) genomes and encodes proteins homologous to I-kappaBs, inhibitors of NF-kappaB transcription factors. The structural similarities led to the hypothesis that vankyrins mimic eukaryotic factors to subvert important physiological pathways in the infected host. Here, we identified nine vankyrin genes in the genome of the Hyposoter didymator Ichnovirus (HdIV). Time-course gene expression experiments indicate that all members are expressed throughout parasitism of Spodoptera frugiperda, as assessed using RNA extracted from whole larvae. To study tissue and/or species specificity transcriptions, the expression of HdIV vankyrin genes were compared between HdIV-injected larvae of S. frugiperda and S. littoralis. The transcriptional profiles were similar in the two species, including the largely predominant expression of Hd27-vank1 in all tissues examined. However, in various insect cell lines, the expression patterns of HdIV vankyrins differed according to species. No clear relationship between vankyrin expression patterns and abundance of vankyrin-bearing genomic segments were found in the lepidopteran cell lines. Moreover, in these cells, the amount of vankyrin-bearing genomic segments differed substantially between cytosol and nuclei of infected cells, implying the existence of an unexpected step regulating the copy number of HdIV segments in cell nuclei. Our in vitro results reveal a host-specific transcriptional profile of vankyrins that may be related to the success of parasitism in different hosts. In Spodoptera hosts, the predominant expression of Hd27-vank1 suggests that this protein might have pleiotropic functions during parasitism of these insect species.	[Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle] INRA, UMR Divers Genomes & Interact Microorganismes Ins, F-34060 Montpellier, France; [Clavijo, Gabriel; Doremus, Tristan; Ravallec, Marc; Mannucci, Marie-Anne; Jouan, Veronique; Volkoff, Anne-Nathalie; Darboux, Isabelle] Univ Montpellier 2, UMR Divers Genomes & Interact Microorganismes Ins, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Clavijo, G (corresponding author), INRA, UMR Divers Genomes & Interact Microorganismes Ins, F-34060 Montpellier, France.	darboux@supagro.inra.fr		Darboux, Isabelle/0000-0003-4990-8856; Volkoff, Anne-Nathalie/0000-0002-7211-1370	French Agency for National Research [ANR-09-BLAN-0243-02]; French National Institute for Agricultural Research (INRA); University of Montpellier	French Agency for National Research; French National Institute for Agricultural Research (INRA); University of Montpellier	This study was supported by the French Agency for National Research (grant number ANR-09-BLAN-0243-02) and G. Clavijo's post-doctoral position was supported by grants from the French National Institute for Agricultural Research (INRA) and University of Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beliveau C, 2003, J INSECT PHYSIOL, V49, P501, DOI 10.1016/S0022-1910(03)00055-6; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; COHEN S, BIOCH BIOPHYS ACTA; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Falabella P, 2007, J GEN VIROL, V88, P92, DOI 10.1099/vir.0.82306-0; Friedman R, 2006, INFECT GENET EVOL, V6, P315, DOI 10.1016/j.meegid.2005.10.001; Galibert L, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-48; GOODWIN RH, 1978, IN VITRO CELL DEV B, V14, P485; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; KRELL PJ, 1982, J VIROL, V43, P859, DOI 10.1128/JVI.43.3.859-870.1982; Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kroemer JA, 2006, J VIROL, V80, P12219, DOI 10.1128/JVI.01187-06; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; PROVOST B, 2011, INSECT BIOCH MOL BIO; Rasoolizadeh A, 2009, J GEN VIROL, V90, P1505, DOI 10.1099/vir.0.008664-0; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; STOLTZ DB, 1988, J GEN VIROL, V69, P903, DOI 10.1099/0022-1317-69-4-903; STOLTZ DB, 1979, CAN J MICROBIOL, V25, P207, DOI 10.1139/m79-032; Stoltz D, 2007, J GEN VIROL, V88, P2977, DOI 10.1099/vir.0.83118-0; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; SUMMERS MD, 1995, P NATL ACAD SCI USA, V92, P29, DOI 10.1073/pnas.92.1.29; Tanaka K, 2007, VIROLOGY, V363, P26, DOI 10.1016/j.virol.2006.11.034; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Volkoff AN, 1999, VIROLOGY, V263, P349, DOI 10.1006/viro.1999.9929; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Zhang GM, 2004, J BIOL CHEM, V279, P41580, DOI 10.1074/jbc.M406865200	38	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27522	10.1371/journal.pone.0027522	http://dx.doi.org/10.1371/journal.pone.0027522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087334	Green Published, gold			2022-12-25	WOS:000297349700056
J	Yamanaka, A; Mulyatno, KC; Susilowati, H; Hendrianto, E; Ginting, AP; Sary, DD; Rantam, FA; Soegijanto, S; Konishi, E				Yamanaka, Atsushi; Mulyatno, Kris C.; Susilowati, Helen; Hendrianto, Eryk; Ginting, Amor P.; Sary, Dian D.; Rantam, Fedik A.; Soegijanto, Soegeng; Konishi, Eiji			Displacement of the Predominant Dengue Virus from Type 2 to Type 1 with a Subsequent Genotype Shift from IV to I in Surabaya, Indonesia 2008-2010	PLOS ONE			English	Article							SEROTYPE-SPECIFIC DIFFERENCES; GUANGDONG PROVINCE; MOLECULAR CHARACTERIZATION; HEMORRHAGIC-FEVER; EASTER-ISLAND; EVOLUTION; EPIDEMIC; OUTBREAK; THAILAND; BANGKOK	Indonesia has annually experienced approximately 100,000 reported cases of dengue fever (DF) and dengue hemorrhagic fever (DHF) in recent years. However, epidemiological surveys of dengue viruses (DENVs) have been limited in this country. In Surabaya, the second largest city, a single report indicated that dengue virus type 2 (DENV2) was the predominant circulating virus in 2003-2005. We conducted three surveys in Surabaya during: (i) April 2007, (ii) June 2008 to April 2009, and (iii) September 2009 to December 2010. A total of 231 isolates were obtained from dengue patients and examined by PCR typing. We found that the predominant DENV shifted from type 2 to type 1 between October and November 2008. Another survey using wild-caught mosquitoes in April 2009 confirmed that dengue type 1 virus (DENV1) was the predominant type in Surabaya. Phylogenetic analyses of the nucleotide sequences of the complete envelope gene of DENV1 indicated that all 22 selected isolates in the second survey belonged to genotype IV and all 17 selected isolates in the third survey belonged to genotype I, indicating a genotype shift between April and September 2009. Furthermore, in December 2010, isolates were grouped into a new clade of DENV1 genotype I, suggesting clade shift between September and December 2010. According to statistics reported by the Surabaya Health Office, the proportion of DHF cases among the total number of dengue cases increased about three times after the type shift in 2008. In addition, the subsequent genotype shift in 2009 was associated with the increased number of total dengue cases. This indicates the need for continuous surveillance of circulating viruses to predict the risk of DHF and DF.	[Yamanaka, Atsushi; Mulyatno, Kris C.; Susilowati, Helen; Hendrianto, Eryk; Ginting, Amor P.; Sary, Dian D.; Rantam, Fedik A.; Soegijanto, Soegeng] Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia; [Yamanaka, Atsushi; Konishi, Eiji] Kobe Univ, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan; [Konishi, Eiji] Kobe Univ, Dept Int Hlth, Grad Sch Hlth, Kobe, Hyogo 657, Japan; [Konishi, Eiji] Mahidol Univ, BIKEN Endowed Dept Dengue Vaccine Dev, Fac Trop Med, Bangkok, Thailand	Airlangga University; Kobe University; Kobe University; Mahidol University	Yamanaka, A (corresponding author), Airlangga Univ, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Inst Trop Dis, Surabaya, Indonesia.	paradios99@yahoo.co.jp	Abdul Rantam, Fedik/GSO-2120-2022; Mulyatno, Kris Cahyo/GSE-4955-2022; Hendrianto, Eryk/H-7407-2015	Abdul Rantam, Fedik/0000-0001-8182-1465; Mulyatno, Kris Cahyo/0000-0001-8926-3031; Soegijanto, Soegeng/0000-0002-9470-8223; Yamanaka, Atsushi/0000-0002-2757-2792; Hendrianto, Eryk/0000-0001-9723-8098; SUSILOWATI, HELEN/0000-0002-3358-5231	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan	This work was supported in part by a grant-in-aid through the Program of Founding Research Centers for Emerging and Re-emerging Infectious Diseases, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The "BIKEN Endowed Department of Dengue Vaccine Development" was endowed from The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan to Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.	Aryati, 2006, THESIS AIRLANGGA U S; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Corwin AL, 2001, T ROY SOC TROP MED H, V95, P257, DOI 10.1016/S0035-9203(01)90229-9; Dash P. K., 2010, EPIDEMIOL INFECT, V30, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunham EJ, 2007, J MOL EVOL, V64, P656, DOI 10.1007/s00239-006-0278-5; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Guzman MG, 2000, LANCET, V355, P1902, DOI 10.1016/S0140-6736(00)02303-5; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HOTTA S, 1970, Kobe Journal of Medical Sciences, V16, P235; Ito M, 2007, J TRAVEL MED, V14, P233, DOI 10.1111/j.1708-8305.2007.00130.x; Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Nukui Y, 2006, EMERG INFECT DIS, V12, P343, DOI 10.3201/eid1202.050733; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Perret C, 2003, EMERG INFECT DIS, V9, P1465, DOI 10.3201/eid0911.020788; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Sittisombut N, 1997, AM J TROP MED HYG, V57, P100, DOI 10.4269/ajtmh.1997.57.100; SUMARMO, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P269; Susilowati A, 1999, DENGUE B, V23; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; van Peenen P F, 1978, Southeast Asian J Trop Med Public Health, V9, P25; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Zhang FuChun, 2007, Dengue Bulletin, V31, P10; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617	47	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27322	10.1371/journal.pone.0027322	http://dx.doi.org/10.1371/journal.pone.0027322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087290	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700039
J	Bakhtiarizadeh, MR; Ebrahimi, M; Ebrahimie, E				Bakhtiarizadeh, Mohammad Reza; Ebrahimi, Mansour; Ebrahimie, Esmaeil			Discovery of EST-SSRs in Lung Cancer: Tagged ESTs with SSRs Lead to Differential Amino Acid and Protein Expression Patterns in Cancerous Tissues	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; GENOME-WIDE ANALYSIS; MICROSATELLITE INSTABILITY; ENZYME THERMOSTABILITY; LINKAGE ANALYSIS; TANDEM REPEATS; MARKERS; FEATURES; FREQUENCY; ABUNDANCE	Tandem repeats are found in both coding and non-coding sequences of higher organisms. These sequences can be used in cancer genetics and diagnosis to unravel the genetic basis of tumor formation and progression. In this study, a possible relationship between SSR distributions and lung cancer was studied by comparative analysis of EST-SSRs in normal and lung cancerous tissues. While the EST-SSR distribution was similar between tumorous tissues, this distribution was different between normal and tumorous tissues. Trinucleotides tandem repeats were highly different; the number of trinucleotides in ESTs of lung cancer was 3 times higher than normal tissue. Significant negative correlation between normal and cancerous tissue showed that cancerous tissue generates different types of trinucleotides. GGC and CGC were the more frequent expressed trinucleotides in cancerous tissue, but these SSRs were not expressed in normal tissue. Similar to the EST level, the expression pattern of EST-SSRs-derived amino acids was significantly different between normal and cancerous tissues. Arg, Pro, Ser, Gly, and Lys were the most abundant amino acids in cancerous tissues, and Leu, Cys, Phe, and His were significantly more abundant in normal tissues than in cancerous tissues. Next, the putative functions of triplet SSR-containing genes were analyzed. In cancerous tissue, EST-SSRs produce different types of proteins. Chromodomain helicase DNA binding proteins were one of the major protein products of EST-SSRs in the cancerous library, while these proteins were not produced from EST-SSRs in normal tissue. For the first time, the findings of this study confirmed that EST-SSRs in normal lung tissues are different than in unhealthy tissues, and tagged ESTs with SSRs cause remarkable differences in amino acid and protein expression patterns in cancerous tissue. We suggest that EST-SSRs and EST-SSRs differentially expressed in cancerous tissue may be suitable candidate markers for lung cancer diagnosis and prediction.	[Bakhtiarizadeh, Mohammad Reza] Univ Tehran, Dept Anim Sci, Karaj, Iran; [Ebrahimi, Mansour] Univ Qom, Dept Biol, Qom, Iran; [Ebrahimi, Mansour] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Tehran; University of Adelaide	Bakhtiarizadeh, MR (corresponding author), Univ Tehran, Dept Anim Sci, Karaj, Iran.	esmaeil.ebrahimie@adelaide.edu.au	ebrahimi, mansour/D-9950-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567	Shiraz University; Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University	Shiraz University; Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University	This study has been supported by Shiraz University grant of Esmaeil Ebrahimie and Bioinformatics Research Group of Qom University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alvarez A, 2007, CURR OPIN UROL, V17, P341, DOI 10.1097/MOU.0b013e3282c8c72b; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Demokan Semra, 2002, Pathology and Oncology Research, V8, P138; Deng Shun-sheng, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P468; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Edwards SF, 2009, MOL CARCINOGEN, V48, P336, DOI 10.1002/mc.20534; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grossman J, 2008, J ADDICT NURS, V19, P1, DOI 10.1080/10884600801896918; Haddad LA, 1998, GENE, V223, P369, DOI 10.1016/S0378-1119(98)00242-X; Janatova M, 2004, Prague Med Rep, V105, P111; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Madsen BE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-410; Miao XX, 2008, GENET RES, V90, P151, DOI 10.1017/S0016672308009221; Miller LD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1662; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Ndifon W, 2006, B MATH BIOL, V68, P1747, DOI 10.1007/s11538-005-9029-9; Nelson PS, 1998, GENOMICS, V47, P12, DOI 10.1006/geno.1997.5035; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Oda S, 2005, SURG TODAY, V35, P1005, DOI 10.1007/s00595-005-3125-1; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Riar DS, 2011, J HERED, V102, P17, DOI 10.1093/jhered/esq103; Rich SS, 2008, J CARDIOVASC TRANSL, V1, P21, DOI 10.1007/s12265-007-9003-z; Schiemann U, 2004, DIGESTION, V69, P166, DOI 10.1159/000078223; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Slate J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-52; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Tahrokh E, 2011, GENES GENOM, V33, P565, DOI 10.1007/s13258-011-0057-6; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tinelli A, 2010, MINI-REV MED CHEM, V10, P1356, DOI 10.2174/138955710793564098; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Venkatesan RN, 2006, DNA REPAIR, V5, P294, DOI 10.1016/j.dnarep.2005.10.012; Vergara D, 2010, CURR CANCER DRUG TAR, V10, P107, DOI 10.2174/156800910790980269; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Vivekanandan P, 2008, EXPERT REV PROTEOMIC, V5, P45, DOI 10.1586/14789450.5.1.45; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Wen Mingfu, 2010, BMC Res Notes, V3, P42, DOI 10.1186/1756-0500-3-42; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262	55	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27118	10.1371/journal.pone.0027118	http://dx.doi.org/10.1371/journal.pone.0027118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073269	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200035
J	Shmelkov, E; Nadas, A; Swetnam, J; Zolla-Pazner, S; Cardozo, T				Shmelkov, Evgeny; Nadas, Arthur; Swetnam, James; Zolla-Pazner, Susan; Cardozo, Timothy			Indirect Detection of an Epitope-Specific Response to HIV-1 gp120 Immunization in Human Subjects	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; HUMAN MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; GENETIC SUBTYPES; TRIAL; THAILAND; INFECTION; NEUTRALIZATION; DOMAIN	A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a result of vaccination of human subjects with the surface envelope glycoprotein (gp120) of HIV-1 has not previously been documented. Here, we used computational analysis to assess the epitope-specific responses of human subjects, which were immunized with recombinant gp120 immunogens in the VAX003 and VAX004 clinical trials. Our computational methodology-a variation of sieve analysis-compares the occurrence of specific nAb targeted conformational 3D epitopes on viruses from infected individuals who received vaccination to the occurrence of matched epitopes in the viruses infecting placebo subjects. We specifically studied seven crystallographically defined nAb targeted conformational epitopes in the V3 loop, an immunogenic region of gp120. Of the six epitopes present in the immunogens and targeted by known monoclonal neutralizing antibodies, only the one targeted by the anti-V3 nAb 2219 exhibited a significant reduction in occurrence in vaccinated subjects compared to the placebo group. This difference occurred only in the VAX003 Thailand cohort. No difference was seen between vaccinated and placebo groups for the occurrence of an epitope that was not present in the immunogen. Thus, it can be theorized that a specific 2219-like human neutralizing antibody immune response to AIDSVAX immunization occurred in the VAX003 cohort, and that this response protected subjects from a narrow subset of HIV-1 viruses circulating in Thailand in the 1990s and bearing the conformational epitope targeted by the neutralizing antibody 2219.	[Shmelkov, Evgeny; Swetnam, James; Cardozo, Timothy] NYUSoM, Dept Pharmacol, New York, NY USA; [Nadas, Arthur] NYUSoM, Dept Environm Med, New York, NY USA; [Zolla-Pazner, Susan] NYUSoM, Dept Pathol, New York, NY USA; [Zolla-Pazner, Susan] Vet Affairs Med Ctr, New York, NY USA	New York University; New York University; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Shmelkov, E (corresponding author), NYUSoM, Dept Pharmacol, New York, NY USA.	cardot01@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	Bill and Melinda Gates Foundation [38631]; NIH [DP2 OD004631, R01 AI084119, AI36085, HL59725, AI27742]; NSF [0333389]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742, R01AI084119] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from the Bill and Melinda Gates Foundation (#38631; http://www.gatesfoundation.org/Pages/home.aspx); the NIH (http://www.nih.gov/), including DP2 OD004631(TC), R01 AI084119 (TC), AI36085 (SZP), HL59725 (SZP), and AI27742 (NYU Center for AIDS Research); the NSF (http://www.nsf.gov/), including #0333389 training support for ES; and research funds from the Department of Veterans Affairs (http://www.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 2011, VACCINE; Albrecht H, 2003, AIDS Clin Care, V15, P42; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Cardozo T, 2009, AIDS RES HUM RETROV, V25, P441, DOI 10.1089/aid.2008.0188; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; GILBERT P, 2011, SIEVE ANAL HIV SEQUE, P5; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; OU CY, 1992, AIDS RES HUM RETROV, V8, P1471, DOI 10.1089/aid.1992.8.1471; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Swetnam J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015994; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27279	10.1371/journal.pone.0027279	http://dx.doi.org/10.1371/journal.pone.0027279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076145	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200059
J	Fu, XM; Wang, P; Zhu, BT				Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting			Characterization of the Estradiol-Binding Site Structure of Human Protein Disulfide Isomerase (PDI)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TARGET-CELLS; ESTROGEN-RECEPTOR; HORMONE-BINDING; HIV-1 ENTRY; INHIBITORS; GLYCOPROTEIN-120; CHAPERONE; DOMAIN; BONDS	Background: Earlier studies showed that 17 beta-estradiol (E-2), an endogenous female sex hormone, can bind to human protein disulfide isomerase (PDI), a protein folding catalyst for disulfide bond formation and rearrangement. This binding interaction can modulate the intracellular levels of E-2 and its biological actions. However, the structure of PDI's E-2-binding site is still unclear at present, which is the focus of this study. Methodology/Principal Findings: The E-2-binding site structure of human PDI was studied by using various biochemical approaches coupled with radiometric receptor-binding assays, site-directed mutagenesis, and molecular computational modeling. Analysis of various PDI protein fragments showed that the [H-3]E-2-binding activity is not associated with the single b or b' domain but is associated with the b-b' domain combination. Computational docking analyses predicted that the E-2-binding site is located in a hydrophobic pocket composed mainly of the b' domain and partially of the b domain. A hydrogen bond, formed between the 3-hydroxyl group of E-2 and His256 of PDI is critical for the binding interaction. This binding model was jointly confirmed by a series of detailed experiments, including site-directed mutagenesis of the His256 residue coupled with selective modifications of the ligand structures to alter the binding interaction. Conclusions/Significance: The results of this study elucidated the structural basis for the PDI-E-2 binding interaction and the reservoir role of PDI in modulating the intracellular E-2 levels. The identified PDI E-2-binding site is quite different from its known peptide binding sites. Given that PDI is a potential therapeutic target for cancer chemotherapy and HIV prevention and that E-2 can inhibit PDI activity in vitro, the E-2-binding site structure of human PDI determined here offers structural insights which may aid in the rational design of novel PDI inhibitors.	[Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Fu, Xin-Miao] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing 100871, Peoples R China; [Fu, Xin-Miao] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China	University of Kansas; University of Kansas Medical Center; Peking University; Peking University	Fu, XM (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904	National Institutes of Health [CA97109]; KU Endowment; NATIONAL CANCER INSTITUTE [R01CA097109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by a grant from the National Institutes of Health (CA97109). The other part is from KU Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Fu XM, 2010, BIOCHEM J, V429, P157, DOI 10.1042/BJ20091954; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Fu XM, 2008, J STEROID BIOCHEM, V112, P127, DOI 10.1016/j.jsbmb.2008.09.005; Fu XM, 2010, BIOCHEMISTRY; GABBARD RB, 1983, STEROIDS, V41, P791, DOI 10.1016/0039-128X(83)90054-5; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; Khan MM SS, 2010, ACS CHEM BIOL; KITAGAWA S, 1987, J BIOL CHEM, V262, P3903; Klett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009507; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; SITIA R, 2004, SCI STKE, pPE27; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yoshiro M, 1997, J FERMENT BIOENG, V84, P588; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	40	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27185	10.1371/journal.pone.0027185	http://dx.doi.org/10.1371/journal.pone.0027185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073283	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000030
J	Hammerschlag-Peyer, CM; Yeager, LA; Araujo, MS; Layman, CA				Hammerschlag-Peyer, Caroline M.; Yeager, Lauren A.; Araujo, Marcio S.; Layman, Craig A.			A Hypothesis-Testing Framework for Studies Investigating Ontogenetic Niche Shifts Using Stable Isotope Ratios	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; TROPHIC POSITION; SIZE; DIET; DELTA-C-13; PREDATION; ECOLOGY; MODELS; VARIABILITY; DELTA-N-15	Ontogenetic niche shifts occur across diverse taxonomic groups, and can have critical implications for population dynamics, community structure, and ecosystem function. In this study, we provide a hypothesis-testing framework combining univariate and multivariate analyses to examine ontogenetic niche shifts using stable isotope ratios. This framework is based on three distinct ontogenetic niche shift scenarios, i.e., (1) no niche shift, (2) niche expansion/reduction, and (3) discrete niche shift between size classes. We developed criteria for identifying each scenario, as based on three important resource use characteristics, i.e., niche width, niche position, and niche overlap. We provide an empirical example for each ontogenetic niche shift scenario, illustrating differences in resource use characteristics among different organisms. The present framework provides a foundation for future studies on ontogenetic niche shifts, and also can be applied to examine resource variability among other population sub-groupings (e.g., by sex or phenotype).	[Hammerschlag-Peyer, Caroline M.; Yeager, Lauren A.; Araujo, Marcio S.; Layman, Craig A.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA	State University System of Florida; Florida International University	Hammerschlag-Peyer, CM (corresponding author), Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA.	cpeye001@fiu.edu	Yeager, Lauren/F-8237-2011; Araujo, Marcio Silva/G-9485-2011	Yeager, Lauren/0000-0002-6623-0752; Araujo, Marcio Silva/0000-0003-3533-744X	National Science Foundation [0746164, 0842196]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Florida International University	National Science Foundation(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Florida International University	The authors would like to thank their funding agencies, National Science Foundation (OCE #0746164, DEB #0842196; www.nsf.gov/) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br/), and Florida International University Dissertation Year Fellowship (gradschool.fiu.edu/Fellowships.html) for their financial support. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R., 2008, MODEL BASED INFERENC; Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boveri MB, 2002, VERHANDLUNGEN INT VE, V28, P1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Claessen D, 2002, ECOLOGY, V83, P1660, DOI 10.2307/3071986; Cotter PA, 2006, COMP BIOCHEM PHYS A, V145, P158, DOI 10.1016/j.cbpa.2006.06.001; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Faunce CH, 2007, B MAR SCI, V80, P473; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; GROSSMAN GD, 1980, OECOLOGIA, V47, P233, DOI 10.1007/BF00346826; Hammerschlag N, 2009, MARINE ECOLOGY EVOLU, V31, P364; Hammerschlag-Peyer CM, B MARINE SC IN PRESS; Hentschel BT, 1998, ECOLOGY, V79, P1357, DOI 10.1890/0012-9658(1998)079[1357:IVICIO]2.0.CO;2; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JONES D, 1986, J ECON ENTOMOL, V79, P1156, DOI 10.1093/jee/79.5.1156; Keast A., 1977, Evolutionary Biol, V10, P333; Kieckbusch DK, 2004, B MAR SCI, V74, P271; KIRKPATRICK M, 1984, ECOLOGY, V65, P1874, DOI 10.2307/1937785; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; Layman CA, BIOL REV CA IN PRESS; Layman CA, 2008, ECOLOGY, V89, P2358, DOI 10.1890/08-0167.1; Layman CA, 2007, B MAR SCI, V80, P513; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MINNS CK, 1995, CAN J FISH AQUAT SCI, V52, P1499, DOI 10.1139/f95-144; Mueller-Lupp T, 2003, BOREAS, V32, P292, DOI 10.1080/03009480310001984; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; OLSON MH, 1995, ECOLOGY, V76, P1758, DOI 10.2307/1940708; Olson MH, 1996, ECOLOGY, V77, P179, DOI 10.2307/2265667; Persson L., 1988, P203; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Quevedo M, 2006, J FISH BIOL, V69, P141, DOI 10.1111/j.1095-8649.2006.01072.x; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; ROUNICK JS, 1986, BIOSCIENCE, V36, P171, DOI 10.2307/1310304; Royall R., 1997, STAT EVIDENCE LIKELI; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; STEIN R A, 1988, P161; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Sweeting CJ, 2005, FUNCT ECOL, V19, P777, DOI 10.1111/j.1365-2435.2005.01019.x; Taylor MD, 2010, MAR FRESHWATER RES, V61, P302, DOI 10.1071/MF09014; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 1979, PREDATOR PREY SYSTEM, P311; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Yeager LA, 2011, AQUAT ECOL, V45, P267, DOI 10.1007/s10452-011-9352-1; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060	66	71	74	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27104	10.1371/journal.pone.0027104	http://dx.doi.org/10.1371/journal.pone.0027104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073265	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000027
J	Alkan, Y; Biswal, BB; Alvarez, TL				Alkan, Yelda; Biswal, Bharat B.; Alvarez, Tara L.			Differentiation between Vergence and Saccadic Functional Activity within the Human Frontal Eye Fields and Midbrain Revealed through fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PREFRONTAL CORTEX; ANTERIOR CINGULATE; NEURAL CONTROL; CEREBELLAR CONTRIBUTIONS; VOLITIONAL SACCADES; RETINAL DISPARITY; OCULOMOTOR VERMIS; ADAPTIVE-CONTROL; GAZE-SHIFTS	Purpose: Eye movement research has traditionally studied solely saccade and/or vergence eye movements by isolating these systems within a laboratory setting. While the neural correlates of saccadic eye movements are established, few studies have quantified the functional activity of vergence eye movements using fMRI. This study mapped the neural substrates of vergence eye movements and compared them to saccades to elucidate the spatial commonality and differentiation between these systems. Methodology: The stimulus was presented in a block design where the 'off' stimulus was a sustained fixation and the 'on' stimulus was random vergence or saccadic eye movements. Data were collected with a 3T scanner. A general linear model (GLM) was used in conjunction with cluster size to determine significantly active regions. A paired t-test of the GLM beta weight coefficients was computed between the saccade and vergence functional activities to test the hypothesis that vergence and saccadic stimulation would have spatial differentiation in addition to shared neural substrates. Results: Segregated functional activation was observed within the frontal eye fields where a portion of the functional activity from the vergence task was located anterior to the saccadic functional activity (z > 2.3; p < 0.03). An area within the midbrain was significantly correlated with the experimental design for the vergence but not the saccade data set. Similar functional activation was observed within the following regions of interest: the supplementary eye field, dorsolateral prefrontal cortex, ventral lateral prefrontal cortex, lateral intraparietal area, cuneus, precuneus, anterior and posterior cingulates, and cerebellar vermis. The functional activity from these regions was not different between the vergence and saccade data sets assessed by analyzing the beta weights of the paired t-test (p > 0.2). Conclusion: Functional MRI can elucidate the differences between the vergence and saccade neural substrates within the frontal eye fields and midbrain.	[Alkan, Yelda; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA	New Jersey Institute of Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center	Alkan, Y (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	bbiswal@gmail.com; tara.l.alvarez@njit.edu		Lauwereyns, Jan/0000-0003-0551-2550; Alvarez, Tara/0000-0002-8797-1613	NSF [BES-044713]; NIH [5R01NS049176, 5R01AG032088-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by NSF CAREER BES-044713 to TLA, NIH 5R01NS049176 and NIH 5R01AG032088-02 to BBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2005, EXP BRAIN RES, V164, P92, DOI 10.1007/s00221-004-2213-6; Alkan Y, 2011, VISUAL NEUROSCIENCE, V28; Alvarez TL, 2010, VISION RES, V50, P2163, DOI 10.1016/j.visres.2010.08.018; Alvarez TL, 2010, VISION RES; Alvarez TL, 2010, OPTOM VIS SCI; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bababekova Y, 2011, OPTOMETRY VISION SCI, V88, P795, DOI 10.1097/OPX.0b013e3182198792; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Berns G S, 1999, J Neurosci, V19, pRC17; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Biswal B, 2011, J NEUROL SCI, V301, P9, DOI 10.1016/j.jns.2010.11.018; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Ciuffreda KJ, EYE MOVEMENT BASICS, P36; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; Coubard OA, 2008, GRAEF ARCH CLIN EXP, V246, P521, DOI 10.1007/s00417-007-0714-2; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dean HL, 2006, J NEUROSCI, V26, P1117, DOI 10.1523/JNEUROSCI.2497-05.2006; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; ENRIGHT JT, 1984, J PHYSIOL-LONDON, V350, P9, DOI 10.1113/jphysiol.1984.sp015186; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P441, DOI 10.1098/rspb.1989.0031; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Ferraina S, 2009, J NEUROSCI, V29, P11461, DOI 10.1523/JNEUROSCI.1305-09.2009; Fukushima K, 2002, NATURE, V419, P157, DOI 10.1038/nature00953; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gavrilescu M, 2008, HUM BRAIN MAPP, V29, P1040, DOI 10.1002/hbm.20446; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hasebe H, 1999, NEUROIMAGE, V10, P200, DOI 10.1006/nimg.1999.0453; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Howarth PA, 2011, OPHTHAL PHYSL OPT, V31, P111, DOI 10.1111/j.1475-1313.2011.00822.x; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Kojima Y, 2010, J NEUROSCI, V30, P3715, DOI 10.1523/JNEUROSCI.4953-09.2010; Kumar AN, 2005, J NEUROPHYSIOL, V93, P2797, DOI 10.1152/jn.00858.2004; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; Matsuda T, 2004, PSYCHIAT RES-NEUROIM, V131, P147, DOI 10.1016/j.pscychresns.2003.12.007; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MAYS LE, 1984, J NEUROPHYSIOL, V52, P743, DOI 10.1152/jn.1984.52.4.743; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Missimer JH, 2010, J MAGN RESON IMAGING, V31, P821, DOI 10.1002/jmri.22122; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Nybakken GE, 2002, NEURORADIOLOGY, V44, P403, DOI 10.1007/s00234-001-0722-6; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Quigley MA, 2002, AM J NEURORADIOL, V23, P49; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Rosano C, 2002, CEREB CORTEX, V12, P107, DOI 10.1093/cercor/12.2.107; Rosenthal CR, 2008, PROG BRAIN RES, V171, P419, DOI 10.1016/S0079-6123(08)00661-4; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; Schall JD, 2007, COGN AFFECT BEHAV NE, V7, P396, DOI 10.3758/CABN.7.4.396; Schendan HE, 2008, CEREB CORTEX, V18, P1695, DOI 10.1093/cercor/bhm197; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Semmlow JL, 2002, CAH PSYCHOL COGN, V21, P343; Semmlow JL, 2007, J EYE MOVEMENT RES, V1; Semmlow JL, 2009, J EYE MOVEMENT RES, V2; Serra A, 2011, CURR OPIN NEUROL, V24, P32, DOI 10.1097/WCO.0b013e328341eebd; Takagi M, 2003, PROG BRAIN RES, V142, P19; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; van Broekhoven PCA, 2009, CEREBELLUM, V8, P403, DOI 10.1007/s12311-009-0116-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; van Leeuwen AF, 1998, VISION RES, V38, P3943, DOI 10.1016/S0042-6989(98)00092-3; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Vernet M, 2009, J VISION, V9, DOI 10.1167/9.7.2; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zee D S, 1992, Baillieres Clin Neurol, V1, P455; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624; ZHANG Y, 1992, J NEUROPHYSIOL, V67, P944, DOI 10.1152/jn.1992.67.4.944; ZHANG Y, 1991, EXP BRAIN RES, V84, P525	103	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25866	10.1371/journal.pone.0025866	http://dx.doi.org/10.1371/journal.pone.0025866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073141	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900001
J	Gowrishankar, G; Zitzmann-Kolbe, S; Junutula, A; Reeves, R; Levi, J; Srinivasan, A; Bruus-Jensen, K; Cyr, J; Dinkelborg, L; Gambhir, SS				Gowrishankar, Gayatri; Zitzmann-Kolbe, Sabine; Junutula, Anitha; Reeves, Robert; Levi, Jelena; Srinivasan, Ananth; Bruus-Jensen, Kjerstin; Cyr, John; Dinkelborg, Ludger; Gambhir, Sanjiv S.			GLUT 5 Is Not Over-Expressed in Breast Cancer Cells and Patient Breast Cancer Tissues	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; FRUCTOSE TRANSPORTER; PET; PROLIFERATION; F-18-FDG; FAMILY; TUMORS; LUNG	F18 2-Fluoro 2-deoxyglucose (FDG) has been the gold standard in positron emission tomography (PET) oncologic imaging since its introduction into the clinics several years ago. Seeking to complement FDG in the diagnosis of breast cancer using radio labeled fructose based analogs, we investigated the expression of the chief fructose transporter-GLUT 5 in breast cancer cells and human tissues. Our results indicate that GLUT 5 is not over-expressed in breast cancer tissues as assessed by an extensive immunohistochemistry study. RT-PCR studies showed that the GLUT 5 mRNA was present at minimal amounts in breast cancer cell lines. Further knocking down the expression of GLUT 5 in breast cancer cells using RNA interference did not affect the fructose uptake in these cell lines. Taken together these results are consistent with GLUT 5 not being essential for fructose uptake in breast cancer cells and tissues.	[Gowrishankar, Gayatri; Junutula, Anitha; Reeves, Robert; Levi, Jelena; Gambhir, Sanjiv S.] Dept Radiol, Mol Imaging Program, Div Nucl Med, Stanford, CA USA; [Zitzmann-Kolbe, Sabine; Srinivasan, Ananth; Bruus-Jensen, Kjerstin; Cyr, John; Dinkelborg, Ludger] Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany; [Gambhir, Sanjiv S.] Dept Bioengn & Mat Sci & Engn, Stanford, CA USA	Bayer AG; Bayer Healthcare Pharmaceuticals	Gowrishankar, G (corresponding author), Dept Radiol, Mol Imaging Program, Div Nucl Med, Stanford, CA USA.	sgambhir@stanford.edu			Bayer Schering Pharma AG; Bayer Schering Pharma	Bayer Schering Pharma AG(Bayer AG); Bayer Schering Pharma(Bayer AG)	This study was funded by the authors' collaborators at Bayer Schering Pharma AG. These collaborators also participated in the study design and in the scientific discussions during the course of the study.; The study was funded by Bayer Schering Pharma. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alavi A, 2004, SEMIN NUCL MED, V34, P56, DOI 10.1053/j.semnuclmed.2003.09.007; Avril N, 2000, J CLIN ONCOL, V18, P3495, DOI 10.1200/JCO.2000.18.20.3495; BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X; Buck AK, 2003, J NUCL MED, V44, P1426; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Chan KK, 2004, J CELL BIOCHEM, V93, P1134, DOI 10.1002/jcb.20270; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Grover-McKay M, 1998, Pathol Oncol Res, V4, P115; JAMES DE, 1994, J CELL BIOL, V126, P1123, DOI 10.1083/jcb.126.5.1123; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Jung CY, 1998, EXP PHYSIOL, V83, P267, DOI 10.1113/expphysiol.1998.sp004112; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Keshari KR, 2009, J AM CHEM SOC, V131, P17591, DOI 10.1021/ja9049355; Kostakoglu L, 2003, J NUCL MED, V44, P224; Lazar V, 1999, J CLIN ENDOCR METAB, V84, P3228, DOI 10.1210/jc.84.9.3228; Levi J, 2007, BIOCONJUGATE CHEM, V18, P628, DOI 10.1021/bc060184s; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Trayner BJ, 2009, BIOORGAN MED CHEM, V17, P5488, DOI 10.1016/j.bmc.2009.06.034; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7; 1996, P NATL ACAD SCI US, V93, P15522	25	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26902	10.1371/journal.pone.0026902	http://dx.doi.org/10.1371/journal.pone.0026902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073218	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900052
J	Leite, TKM; Fonseca, RMC; de Franca, NM; Parra, EJ; Pereira, RW				Leite, Tailce K. M.; Fonseca, Romulo M. C.; de Franca, Nanci M.; Parra, Esteban J.; Pereira, Rinaldo W.			Genomic Ancestry, Self-Reported "Color'' and Quantitative Measures of Skin Pigmentation in Brazilian Admixed Siblings	PLOS ONE			English	Article							GENETIC ANCESTRY; ASSOCIATION; SLC24A5; AGREEMENT; ADMIXTURE; INFERENCE; RISK	A current concern in genetic epidemiology studies in admixed populations is that population stratification can lead to spurious results. The Brazilian census classifies individuals according to self-reported "color'', but several studies have demonstrated that stratifying according to "color'' is not a useful strategy to control for population structure, due to the dissociation between self-reported "color'' and genomic ancestry. We report the results of a study in a group of Brazilian siblings in which we measured skin pigmentation using a reflectometer, and estimated genomic ancestry using 21 Ancestry Informative Markers (AIMs). Self-reported "color'', according to the Brazilian census, was also available for each participant. This made it possible to evaluate the relationship between self-reported "color'' and skin pigmentation, self-reported "color'' and genomic ancestry, and skin pigmentation and genomic ancestry. We observed that, although there were significant differences between the three "color'' groups in genomic ancestry and skin pigmentation, there was considerable dispersion within each group and substantial overlap between groups. We also saw that there was no good agreement between the "color'' categories reported by each member of the sibling pair: 30 out of 86 sibling pairs reported different "color'', and in some cases, the sibling reporting the darker "color'' category had lighter skin pigmentation. Socioeconomic status was significantly associated with self-reported "color'' and genomic ancestry in this sample. This and other studies show that subjective classifications based on self-reported "color'', such as the one that is used in the Brazilian census, are inadequate to describe the population structure present in recently admixed populations. Finally, we observed that one of the AIMs included in the panel (rs1426654), which is located in the known pigmentation gene SLC24A5, was strongly associated with skin pigmentation in this sample.	[Leite, Tailce K. M.; Fonseca, Romulo M. C.; de Franca, Nanci M.; Pereira, Rinaldo W.] Univ Catolica Brasilia, Programa Pos Grad Educ Fis, Brasilia, DF, Brazil; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Pereira, Rinaldo W.] Univ Catolica Brasilia, Programa Pos Grad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; University of Toronto; University Toronto Mississauga; Universidade Catolica de Brasilia	Leite, TKM (corresponding author), Univ Catolica Brasilia, Programa Pos Grad Educ Fis, Brasilia, DF, Brazil.	rinaldo.pereira@catolica.edu.br	Leite, Tailce/AAI-2666-2021; Fonseca, Romulo MC/G-3206-2012; genomicas, ciencias/D-9871-2013; Pereira, Rinaldo W/B-9255-2011	Fonseca, Romulo MC/0000-0002-2097-7498; Pereira, Rinaldo W/0000-0003-3704-2848; Leite, Tailce/0000-0002-4251-729X; parra, esteban J/0000-0002-2057-8577	National Counsel of Technological and Scientific Development - CNPq - Brazil [MCT/CNPq-02/2006-Universal- 475438/2006-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB)	National Counsel of Technological and Scientific Development - CNPq - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB)	This study was supported by grants from the following Brazilian agencies: National Counsel of Technological and Scientific Development - CNPq - Brazil (process id: MCT/CNPq-02/2006-Universal- 475438/2006-0), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Pro-Reitoria de Pos-graduacao e Pesquisa - Universidade Catolica de Brasilia (PRPGP - UCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Associacao Brasileira das Empresas de Pesquisa (ABEP), 2003, CRIT CLASS EC BRAS; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dimisianos G, 2009, EXP DERMATOL, V18, P175, DOI 10.1111/j.1600-0625.2008.00758.x; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Fonseca RMC, 2011, JOINT BONE IN PRESS, DOI 101016/jjbspin201105007; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gravlee CC, 2005, AM J PUBLIC HEALTH, V95, P2191, DOI 10.2105/AJPH.2005.065615; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; IBGE-Instituto Brasileiro de Geografia e Estatisticas, 2000, CENS DEM 2000 CAR GE; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lins TC, 2011, J EPIDEMIOL, DOI 102188/jeaJE20100164; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Parra EJ, 2007, CLIN GENET, V71, P359, DOI 10.1111/j.1399-0004.2007.00780.x; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruiz-Narvaez EA, 2010, BREAST CANCER RES TR, V123, P525, DOI 10.1007/s10549-010-0775-5; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Viera AJ, 2005, FAM MED, V37, P360	41	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27162	10.1371/journal.pone.0027162	http://dx.doi.org/10.1371/journal.pone.0027162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073278	gold, Green Published			2022-12-25	WOS:000297154900082
J	Perveen, R; Funk, K; Thuma, J; Ridge, SW; Cao, YY; Akkerman, JWN; Chen, XZ; Akbar, H				Perveen, Rehana; Funk, Kevin; Thuma, Jean; Ridge, Shelli Wulf; Cao, Yanyan; Akkerman, Jan Willem N.; Chen, Xiaozhuo; Akbar, Huzoor			A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-alpha-D-glucopyranose Mimics the Antiplatelet Actions of Insulin	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PLATELET ACTIVATION; SIGNALING PATHWAYS; P2Y(12) RECEPTOR; IN-VIVO; INHIBITION; AGGREGATION; HYPERACTIVITY; INFLAMMATION; RESISTANCE	Background: We have shown that 1,2,3,4,6-penta-O-galloyl-alpha-D-glucopyranose (alpha-PGG), an orally effective hypoglycemic small molecule, binds to insulin receptors and activates insulin-mediated glucose transport. Insulin has been shown to bind to its receptors on platelets and inhibit platelet activation. In this study we tested our hypothesis that if insulin possesses anti-platelet properties then insulin mimetic small molecules should mimic antiplatelet actions of insulin. Principal Findings: Incubation of human platelets with insulin or alpha-PGG induced phosphorylation of insulin receptors and IRS-1 and blocked ADP or collagen induced aggregation. Pre-treatment of platelets with alpha-PGG inhibited thrombin-induced release of P-selectin, secretion of ATP and aggregation. Addition of ADP or thrombin to platelets significantly decreased the basal cyclic AMP levels. Pre-incubation of platelets with alpha-PGG blocked ADP or thrombin induced decrease in platelet cyclic AMP levels but did not alter the basal or PGE(1) induced increase in cAMP levels. Addition of alpha-PGG to platelets blocked agonist induced rise in platelet cytosolic calcium and phosphorylation of Akt. Administration of alpha-PGG (20 mg kg(-1)) to wild type mice blocked ex vivo platelet aggregation induced by ADP or collagen. Conclusions: These data suggest that alpha-PGG inhibits platelet activation, at least in part, by inducing phosphorylation of insulin receptors leading to inhibition of agonist induced: (a) decrease in cyclic AMP; (b) rise in cytosolic calcium; and (c) phosphorylation of Akt. These findings taken together with our earlier reports that alpha-PGG mimics insulin signaling suggest that inhibition of platelet activation by alpha-PGG mimics antiplatelet actions of insulin.	[Perveen, Rehana; Funk, Kevin; Thuma, Jean; Ridge, Shelli Wulf; Chen, Xiaozhuo; Akbar, Huzoor] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Cao, Yanyan; Chen, Xiaozhuo; Akbar, Huzoor] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Akkerman, Jan Willem N.] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands	University System of Ohio; Ohio University; University System of Ohio; Ohio University; Utrecht University; Utrecht University Medical Center	Perveen, R (corresponding author), Baqai Med Univ, Karachi, Pakistan.	akbar@ohio.edu			Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee; Higher Education Commission of Pakistan; OUCOM	Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); OUCOM	This research was supported in part by the Ohio University College of Osteopathic Medicine (OUCOM) The Research & Scholarly Affairs Committee. RP was a post-doctoral trainee funded by the Higher Education Commission of Pakistan. SWR, a 2nd year medical student was a recipient of an OUCOM summer research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KC, 1994, BIOCHEM PHARMACOL, V48, P1909, DOI 10.1016/0006-2952(94)90589-4; Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; AKBAR H, 1993, AM J HYPERTENS, V6, P857; Akbar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022117; Angiolillo DJ, 2006, J THROMB HAEMOST, V4, P2563, DOI 10.1111/j.1538-7836.2006.02209.x; Angiolillo DJ, 2006, J AM COLL CARDIOL, V48, P298, DOI 10.1016/j.jacc.2006.03.038; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Biondi-Zoccai GGL, 2003, J AM COLL CARDIOL, V41, P1071, DOI 10.1016/S0735-1097(03)00088-3; Cao YY, 2011, APOPTOSIS, V16, P902, DOI 10.1007/s10495-011-0614-0; Cattaneo M, 2007, J THROMB HAEMOST, V5, P577, DOI 10.1111/j.1538-7836.2007.02356.x; Colwell JA, 2003, DIABETES CARE, V26, P2181, DOI 10.2337/diacare.26.7.2181; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; FALCON C, 1988, BIOCHEM BIOPH RES CO, V157, P1190, DOI 10.1016/S0006-291X(88)81000-3; Ferreira IA, 2006, ARTERIOSCL THROM VAS, V26, P417, DOI 10.1161/01.ATV.0000199519.37089.a0; Ferreira IA, 2005, J BIOL CHEM, V280, P32625, DOI 10.1074/jbc.M507221200; Ferreira IA, 2004, J BIOL CHEM, V279, P3254, DOI 10.1074/jbc.M305474200; Ferroni P, 2004, J THROMB HAEMOST, V2, P1282, DOI 10.1111/j.1538-7836.2004.00836.x; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; HAJEK AS, 1979, J CLIN INVEST, V63, P1060, DOI 10.1172/JCI109375; HARTMANN K, 1989, J RECEPTOR RES, V9, P181, DOI 10.3109/10799898909066053; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; HUZOOR A, 1993, P NATL ACAD SCI USA, V90, P868; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Li Y, 2001, AM J PHYSIOL-HEART C, V280, pH1480, DOI 10.1152/ajpheart.2001.280.4.H1480; Li YS, 2005, BIOCHEM BIOPH RES CO, V336, P430, DOI 10.1016/j.bbrc.2005.08.103; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; LOPEZAPARICIO P, 1992, BIOCHEM BIOPH RES CO, V186, P517, DOI 10.1016/S0006-291X(05)80838-1; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Orchard TJ, 1998, INT J EPIDEMIOL, V27, P976, DOI 10.1093/ije/27.6.976; Quinton TM, 2004, J THROMB HAEMOST, V2, P978, DOI 10.1111/j.1538-7836.2004.00741.x; Ren YL, 2006, J MED CHEM, V49, P2829, DOI 10.1021/jm060087k; Schlein M, 2001, BIOCHEMISTRY-US, V40, P13520, DOI 10.1021/bi015672w; TROVATI M, 1994, DIABETES, V43, P1015, DOI 10.2337/diabetes.43.8.1015; TROVATI M, 1988, DIABETES, V37, P780, DOI 10.2337/diabetes.37.6.780; Trovati M, 1998, DIABETOLOGIA, V41, P609, DOI 10.1007/s001250050958; Turk Z, 1996, HORM METAB RES, V28, P95, DOI 10.1055/s-2007-979136; Vericel E, 2004, DIABETES, V53, P1046, DOI 10.2337/diabetes.53.4.1046; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Westerbacka J, 2002, ARTERIOSCL THROM VAS, V22, P167, DOI 10.1161/hq0102.101546; WINOCOUR PD, 1992, DIABETES, V41, P26, DOI 10.2337/diab.41.2.S26; WINOCOUR PD, 1992, EUR J CLIN INVEST, V22, P19, DOI 10.1111/j.1365-2362.1992.tb01930.x; Yngen M, 2004, DIABETOLOGIA, V47, P537, DOI 10.1007/s00125-004-1352-4; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	46	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26238	10.1371/journal.pone.0026238	http://dx.doi.org/10.1371/journal.pone.0026238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073153	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900016
J	Li, WZ; Liu, QP; Pang, Y; Jin, JH; Wang, HG; Cao, HY; Li, Z; Wang, X; Ma, B; Chi, Y; Wang, RJ; Kondo, A; Gu, JG; Taniguchi, N				Li, Wenzhe; Liu, Qingping; Pang, Yue; Jin, Jinhua; Wang, Huiguo; Cao, Hongyu; Li, Zhi; Wang, Xu; Ma, Biao; Chi, Yan; Wang, Renjun; Kondo, Akihiro; Gu, Jianguo; Taniguchi, Naoyuki			Core Fucosylation of mu Heavy Chains Regulates Assembly and Intracellular Signaling of Precursor B Cell Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-B; ALPHA-1,6-FUCOSYL-TRANSFERASE-DEFICIENT MICE; BCR; REPERTOIRE; FUCOSE; OLIGOSACCHARIDES; GLYCOSYLATION; ABNORMALITIES; EXPRESSION; PHENOTYPE	alpha 1,6-Fucosyltransferase (Fut8) knock-out (Fut8(-/-)) mice showed an abnormality in pre-B cell generation. Membrane assembly of pre-BCR is a crucial checkpoint for pre-B cell differentiation and proliferation in both humans and mice. The assembly of pre-BCR on the cell surface was substantially blocked in the Fut8-knockdown pre-B cell line, 70Z/3-KD cells, and then completely restored by re-introduction of the Fut8 gene to 70Z/3-KD (70Z/3-KD-re) cells. Moreover, loss of alpha 1,6-fucosylation (also called core fucosylation) of mu HC was associated with the suppression of the interaction between mu HC and lambda 5. In contrast to Fut8(+/+) CD19(+) CD43(-) cells, the subpopulation expressing the mu HC center dot lambda 5 complex in the Fut8(-/-) CD19(+) CD43(-) cell fraction was decreased. The pre-BCR-mediated tyrosine phosphorylation of CD79a and activation of Btk were attenuated in Fut8-KD cells, and restored in 70Z/3-KD-re cells. The frequency of CD19(low)-CD43(-) cells (pre-B cell enriched fraction) was also reduced in Fut8(-/-) bone marrow cells, and then the levels of IgM, IgG, and IgA of 12-week-old Fut8(-/-) mice sera were significantly lower than those of Fut8(-/-) mice. Our results suggest that the core fucosylation of mu HC mediates the assembly of pre-BCR to regulate pre-BCR intracellular signaling and pre-B cell proliferation.	[Li, Wenzhe; Liu, Qingping; Pang, Yue; Jin, Jinhua; Wang, Huiguo; Cao, Hongyu; Wang, Xu; Ma, Biao; Chi, Yan; Wang, Renjun] Dalian Univ Technol, Coll Life Sci & Technol, Inst Immunol, Liaoning 116622, Peoples R China; [Li, Zhi] Dalian Cent Hosp, Clin Lab, Dalian 116003, Liaoning, Peoples R China; [Kondo, Akihiro] Osaka Univ, Grad Sch Med, Dept Mol Diagnost & Informat, Suita, Osaka 5650871, Japan; [Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Dalian University of Technology; Osaka University; Tohoku Medical & Pharmaceutical University; RIKEN	Li, WZ (corresponding author), Dalian Univ Technol, Coll Life Sci & Technol, Inst Immunol, 10 Xuefu Ave, Liaoning 116622, Peoples R China.	liwenzhe46@hotmail.com	Taniguchi, Naoyuki/I-4182-2014; Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; Chi, Yan/0000-0001-9736-4983	National Nature Science Foundation of China [30972675]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM); Science and Technology Planning Project of Dalian City, China [2010J21DW011]; Grants-in-Aid for Scientific Research [21591667] Funding Source: KAKEN	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Planning Project of Dalian City, China; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Nature Science Foundation of China Grant 30972675, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM), and Science and Technology Planning Project of Dalian City, China, Grant 2010J21DW011.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569; Espeli M, 2006, SEMIN IMMUNOL, V18, P56, DOI 10.1016/j.smim.2005.11.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Granados EL, 2002, J CLIN INVEST, V110, P1029, DOI 10.1172/JCI200215658; Haimovich J, 2010, MOL IMMUNOL, V48, P351, DOI 10.1016/j.molimm.2010.07.005; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Ishida H, 2002, BIOSCI BIOTECH BIOCH, V66, P1002, DOI 10.1271/bbb.66.1002; Kawano Y, 2006, J IMMUNOL, V177, P2242, DOI 10.4049/jimmunol.177.4.2242; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Li WZ, 2006, GLYCOBIOLOGY, V16, P1007, DOI 10.1093/glycob/cwl023; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; RABINOVICH E, 1993, J BIOL CHEM, V268, P24145; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stubbs HJ, 1996, BIOCHEMISTRY-US, V35, P937, DOI 10.1021/bi9513719; tenBoekel E, 1997, IMMUNITY, V7, P357; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; Uozumi N, 1996, J BIOCHEM, V120, P385; Wang F, 2003, ANAL BIOCHEM, V314, P266, DOI 10.1016/S0003-2697(02)00693-0; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; WRIGHT JF, 1990, J BIOL CHEM, V265, P10506; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	38	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2500	2508		10.1074/jbc.M111.303123	http://dx.doi.org/10.1074/jbc.M111.303123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22084235	Green Published, hybrid			2022-12-25	WOS:000300292300024
J	Rey, O; Chang, WH; Bikle, D; Rozengurt, N; Young, SH; Rozengurt, E				Rey, Osvaldo; Chang, Wenhan; Bikle, Daniel; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique			Negative Cross-talk between Calcium-sensing Receptor and beta-Catenin Signaling Systems in Colonic Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; EXTRACELLULAR CA2+-SENSING RECEPTOR; NEONATAL SEVERE HYPERPARATHYROIDISM; GASTROINTESTINAL-TRACT; COLORECTAL-CANCER; STEM-CELLS; INTESTINAL POLYPOSIS; RISK-FACTORS; AKT KINASE	Here, we examined the role of the extracellular Ca2+-sensing receptor (CaSR) in the control of colonic epithelial cell proliferation in vivo and changes in beta-catenin triggered by CaSR stimulation in human colonic epithelial cells in vitro. The in vivo studies, using a novel Casr intestinal-specific knock-out mouse, indicate that the genetic ablation of the Casr leads to hyperproliferation of colonic epithelial cells, expansion of the proliferative zone, changes in crypt structure, and enhanced beta-catenin nuclear localization. The in vitro results indicate that stimulation of the CaSR, by Ca2+ or by the calcimimetic R-568, produced a striking and time-dependent decrease in the phosphorylation of beta-catenin at Ser-552 and Ser-675, two amino acid residues that promote beta-catenin transcriptional activity. The reduced phosphorylation of beta-catenin coincided with a decline in its nuclear localization and a marked redistribution to the plasma membrane. Furthermore, CaSR stimulation promoted a down-regulation of beta-catenin-mediated transcriptional activation. These studies demonstrate that signaling pathways emanating from the CaSR control colonic epithelial cell proliferation in vivo and suggest that the mechanism involves regulation of beta-catenin phosphorylation.	[Rey, Osvaldo; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE Digest Dis Res Ctr,Mol Biol I, Los Angeles, CA 90095 USA; [Rey, Osvaldo; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Chang, Wenhan; Bikle, Daniel] Univ Calif San Francisco, Endocrine Res Unit, Dept Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Rey, O (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE Digest Dis Res Ctr,Mol Biol I, 900 Veteran Ave,Warren Hall,Rm 11-115, Los Angeles, CA 90095 USA.	orey@mednet.ucla.edu		Rey, Osvaldo/0000-0003-1575-9864	National Institutes of Health [K22CA128883, K22CA128883-03S1, RO1-AG21353, RO1AR050023, RO1 AR055924, RO1DK054793, RO1DK56930, RO1DK55003, P30DK41301]; Veteran Affairs Merit Review; NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023, R01AR055924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056930, R01DK055003, R01DK054793, P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Review(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA128883 (to O. R.), K22CA128883-03S1 (to O. R.), RO1-AG21353 (to W. C.), RO1AR050023 (to D. B.), RO1 AR055924 (to D. B.), RO1DK054793 (to D. B.), RO1DK56930 (to E. R.), RO1DK55003 (to E. R.), and P30DK41301 (to E. R.). This work was also supported by Veteran Affairs Merit Review (to D. B.) and Veteran Affairs Merit Review (to E. R.).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P1011; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, AM J KIDNEY DIS, V25, P506, DOI 10.1016/0272-6386(95)90118-3; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; Chakrabarty S, 2003, CANCER RES, V63, P67; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Eastwood GL, 1995, J CLIN GASTROENTEROL, V21, pS1; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fox J, 1999, J PHARMACOL EXP THER, V290, P473; GADBOIS DM, 1992, P NATL ACAD SCI USA, V89, P8626, DOI 10.1073/pnas.89.18.8626; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Geibel JP, 2009, ANNU REV PHYSIOL, V71, P205, DOI 10.1146/annurev.physiol.010908.163128; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Grau MV, 2007, JNCI-J NATL CANCER I, V99, P129, DOI 10.1093/jnci/djk016; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; Hizaki K, 2011, MODERN PATHOL, V24, P876, DOI 10.1038/modpathol.2011.10; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Holt PR, 1997, CANCER EPIDEM BIOMAR, V6, P131; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kallay E, 2000, CANCER DETECT PREV, V24, P127; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; LIPKIN M, 1984, CANCER RES, V44, P4201; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Quarles LD, 2003, CURR OPIN NEPHROL HY, V12, P349, DOI 10.1097/00041552-200307000-00002; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Rey O, 2000, J VIROL, V74, P4912, DOI 10.1128/JVI.74.10.4912-4918.2000; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rozengurt E, 2002, EUR J SURG, V168, P23; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sheinin Y, 2000, J HISTOCHEM CYTOCHEM, V48, P595, DOI 10.1177/002215540004800503; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; TERPSTRA OT, 1987, GASTROENTEROLOGY, V92, P704, DOI 10.1016/0016-5085(87)90021-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vezzoli G, 2009, CURR PHARM BIOTECHNO, V10, P302, DOI 10.2174/138920109787847475; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699	69	56	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1158	1167		10.1074/jbc.M111.274589	http://dx.doi.org/10.1074/jbc.M111.274589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094462	Green Published, hybrid			2022-12-25	WOS:000299170300031
J	Gustafsson, C; Edso, JR; Cohn, M				Gustafsson, Cecilia; Edso, Jenny Rhodin; Cohn, Marita			Rap1 Binds Single-stranded DNA at Telomeric Double- and Single-stranded Junctions and Competes with Cdc13 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LENGTH REGULATION; HUMAN-CHROMOSOMES; CELL-CYCLE; IN-VITRO; YEAST; END; SITES; REPLICATION; RECOGNITION	The ends of eukaryotic chromosomes are protected by specialized telomere chromatin structures. Rap1 and Cdc13 are essential for the formation of functional telomere chromatin in budding yeast by binding to the double-stranded part and the single-stranded 3' overhang, respectively. We analyzed the binding properties of Saccharomyces castellii Rap1 and Cdc13 to partially single-stranded oligonucleotides, mimicking the junction of the double- and single-stranded DNA (ds-ss junction) at telomeres. We determined the optimal and the minimal DNA setup for a simultaneous binding of Rap1 and Cdc13 at the ds-ss junction. Remarkably, Rap1 is able to bind to a partially single-stranded binding site spanning the ds-ss junction. The binding over the ds-ss junction is anchored in a single double-stranded hemi-site and is stabilized by a sequence-independent interaction of Rap1 with the single-stranded 3' overhang. Thus, Rap1 is able to switch between a sequence-specific and a nonspecific binding mode of one hemi-site. At a ds-ss junction configuration where the two binding sites partially overlap, Rap1 and Cdc13 are competing for the binding. These results shed light on the end protection mechanisms and suggest that Rap1 and Cdc13 act together to ensure the protection of both the 3' and the 5' DNA ends at telomeres.	[Gustafsson, Cecilia; Edso, Jenny Rhodin; Cohn, Marita] Lund Univ, Dept Biol, Genet Grp, SE-22362 Lund, Sweden	Lund University	Cohn, M (corresponding author), Lund Univ, Dept Biol, Genet Grp, Biol Bldg A,Solvegatan 35, SE-22362 Lund, Sweden.	marita.cohn@biol.lu.se		Cohn, Marita/0000-0002-3370-2864	Jorgen Lindstrom Foundation; Royal Physiographic Society in Lund; Carl Trygger Foundation; Swedish Research Council	Jorgen Lindstrom Foundation; Royal Physiographic Society in Lund; Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Jorgen Lindstrom Foundation, the Royal Physiographic Society in Lund, the Carl Trygger Foundation, and the Swedish Research Council.	BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Del Vescovo V, 2004, J MOL BIOL, V338, P877, DOI 10.1016/j.jmb.2004.03.047; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Qi HY, 2000, GENE DEV, V14, P1777; Rhodin Edso Jenny, 2011, Genome Integr, V2, P2, DOI 10.1186/2041-9414-2-2; Rhodin J, 2006, J MOL BIOL, V355, P335, DOI 10.1016/j.jmb.2005.10.078; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Stansel RM, 2001, EMBO J, V20, P5532; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wahlin J, 2000, NUCLEIC ACIDS RES, V28, P2292, DOI 10.1093/nar/28.12.2292; Wahlin J, 2002, YEAST, V19, P241, DOI 10.1002/yea.816; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Yanez GH, 2005, BIOCHEM BIOPH RES CO, V328, P49, DOI 10.1016/j.bbrc.2004.12.134	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45174	45185		10.1074/jbc.M111.300517	http://dx.doi.org/10.1074/jbc.M111.300517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22075002	Green Published, hybrid			2022-12-25	WOS:000298645500083
J	Beggs, KT; Tyndall, JDA; Mercer, AR				Beggs, Kyle T.; Tyndall, Joel D. A.; Mercer, Alison R.			Honey Bee Dopamine and Octopamine Receptors Linked to Intracellular Calcium Signaling Have a Close Phylogenetic and Pharmacological Relationship	PLOS ONE			English	Article							DROSOPHILA MUSHROOM BODIES; MESSENGER-RNA LOCALIZATION; PROTEIN COUPLED RECEPTORS; APIS-MELLIFERA BRAIN; FUNCTIONAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; NEUROHORMONE GPCRS; TYRAMINE RECEPTOR; MELANOGASTER	Background: Three dopamine receptor genes have been identified that are highly conserved among arthropod species. One of these genes, referred to in honey bees as Amdop2, shows a close phylogenetic relationship to the a-adrenergic-like octopamine receptor family. In this study we examined in parallel the functional and pharmacological properties of AmDOP2 and the honey bee octopamine receptor, AmOA1. For comparison, pharmacological properties of the honey bee dopamine receptors AmDOP1 and AmDOP3, and the tyramine receptor AmTYR1, were also examined. Methodology/Principal Findings: Using HEK293 cells heterologously expressing honey bee biogenic amine receptors, we found that activation of AmDOP2 receptors, like AmOA1 receptors, initiates a rapid increase in intracellular calcium levels. We found no evidence of calcium signaling via AmDOP1, AmDOP3 or AmTYR1 receptors. AmDOP2- and AmOA1-mediated increases in intracellular calcium were inhibited by 10 mu M edelfosine indicating a requirement for phospholipase C-beta activity in this signaling pathway. Edelfosine treatment had no effect on AmDOP2-or AmOA1-mediated increases in intracellular cAMP. The synthetic compounds mianserin and epinastine, like cis-(Z)-flupentixol and spiperone, were found to have significant antagonist activity on AmDOP2 receptors. All 4 compounds were effective antagonists also on AmOA1 receptors. Analysis of putative ligand binding sites offers a possible explanation for why epinastine acts as an antagonist at AmDOP2 receptors, but fails to block responses mediated via AmDOP1. Conclusions/Significance: Our results indicate that AmDOP2, like AmOA1, is coupled not only to cAMP, but also to calcium-signalling and moreover, that the two signalling pathways are independent upstream of phospholipase C-beta activity. The striking similarity between the pharmacological properties of these 2 receptors suggests an underlying conservation of structural properties related to receptor function. Taken together, these results strongly support phylogenetic analyses indicating that the AmDOP2 and AmOA1 receptor genes are immediate paralogs.	[Beggs, Kyle T.; Mercer, Alison R.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Tyndall, Joel D. A.] Univ Otago, Sch Pharm, Dunedin, New Zealand	University of Otago; University of Otago	Beggs, KT (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	alison.mercer@stonebow.otago.ac.nz	tyndall, joel/C-2803-2008	tyndall, joel/0000-0003-0783-1635; Mercer, Alison/0000-0001-8110-4247	Royal Society of New Zealand [UOO0615]	Royal Society of New Zealand(Royal Society of New Zealand)	This research was supported by a grant from the Royal Society of New Zealand Marsden Fund (UOO0615, http://marsden.rsnz.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldauf SL, 2003, TRENDS GENET, V19, P345, DOI 10.1016/S0168-9525(03)00112-4; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Barbas D, 2006, J NEUROCHEM, V96, P414, DOI 10.1111/j.1471-4159.2005.03561.x; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Blenau W, 1998, J NEUROCHEM, V70, P15; Clark MC, 2006, COMP BIOCHEM PHYS B, V143, P294, DOI 10.1016/j.cbpb.2005.11.017; Clark MC, 2007, COMP BIOCHEM PHYS B, V146, P9, DOI 10.1016/j.cbpb.2006.08.018; Degen J, 2000, BRIT J PHARMACOL, V130, P587, DOI 10.1038/sj.bjp.0703338; Enan EE, 2005, INSECT BIOCHEM MOLEC, V35, P309, DOI 10.1016/j.ibmb.2004.12.007; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Feng GP, 1996, J NEUROSCI, V16, P3925; FISER A, METHODS ENZYMOLOGY D, V374; GANTZ I, 1992, J BIOL CHEM, V267, P20840; Gerber S, 2006, INSECT BIOCHEM MOLEC, V36, P749, DOI 10.1016/j.ibmb.2006.07.003; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mustard JA, 2005, ARCH INSECT BIOCHEM, V59, P103, DOI 10.1002/arch.20065; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Ohta H, 2009, INSECT BIOCHEM MOLEC, V39, P342, DOI 10.1016/j.ibmb.2009.01.011; Ohtani A, 2006, INSECT MOL BIOL, V15, P763, DOI 10.1111/j.1365-2583.2006.00676.x; Ono H, 2004, INSECT BIOCHEM MOLEC, V34, P1247, DOI 10.1016/j.ibmb.2004.08.009; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; POWIS G, 1992, CANCER RES, V52, P2835; Reale V, 1997, J NEUROSCI, V17, P6545; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; VERNIER P, 1995, TRENDS PHARMACOL SCI, V16, P375, DOI 10.1016/S0165-6147(00)89078-1	44	66	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26809	10.1371/journal.pone.0026809	http://dx.doi.org/10.1371/journal.pone.0026809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096499	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900009
J	Leung, JWC; Wong, WT; Koon, HW; Mo, FM; Tam, S; Huang, Y; Vanhoutte, PM; Chung, SSM; Chung, SK				Leung, Justin Wai-Chung; Wong, Wing Tak; Koon, Hon Wai; Mo, Fong Ming; Tam, Sidney; Huang, Yu; Vanhoutte, Paul M.; Chung, Stephen Sum Man; Chung, Sookja Kim			Transgenic Mice Over-Expressing ET-1 in the Endothelial Cells Develop Systemic Hypertension with Altered Vascular Reactivity	PLOS ONE			English	Article							SMALL ARTERY STRUCTURE; BLOOD-PRESSURE; NITRIC-OXIDE; OVEREXPRESSING ENDOTHELIN-1; POTENTIAL ROLE; KNOCKOUT MICE; RATS; RECEPTOR; ANTAGONIST; GENE	Endothelin-1 (ET-1) is a potent vasoconstrictor involved in the regulation of vascular tone and implicated in hypertension. However, the role of small blood vessels endothelial ET-1 in hypertension remains unclear. The present study investigated the effect of chronic over-expression of endothelial ET-1 on arterial blood pressure and vascular reactivity using transgenic mice approach. Transgenic mice (TET-1) with endothelial ET-1 over-expression showed increased in ET-1 level in the endothelial cells of small pulmonary blood vessels. Although TET-1 mice appeared normal, they developed mild hypertension which was normalized by the ETA receptor (BQ123) but not by ETB receptor (BQ788) antagonist. Tail-cuff measurements showed a significant elevation of systolic and mean blood pressure in conscious TET-1 mice. The mice also exhibited left ventricular hypertrophy and left axis deviation in electrocardiogram, suggesting an increased peripheral resistance. The ionic concentrations in the urine and serum were normal in 8-week old TET-1 mice, indicating that the systemic hypertension was independent of renal function, although, higher serum urea levels suggested the occurrence of kidney dysfunction. The vascular reactivity of the aorta and the mesenteric artery was altered in the TET-1 mice indicating that chronic endothelial ET-1 up-regulation leads to vascular tone imbalance in both conduit and resistance arteries. These findings provide evidence for the role of spatial expression of ET-1 in the endothelium contributing to mild hypertension was mediated by ETA receptors. The results also suggest that chronic endothelial ET-1 over-expression affects both cardiac and vascular functions, which, at least in part, causes blood pressure elevation.	[Leung, Justin Wai-Chung; Koon, Hon Wai; Mo, Fong Ming; Chung, Sookja Kim] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Wing Tak; Huang, Yu] Chinese Univ Hong Kong, Inst Vasc Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Wong, Wing Tak; Huang, Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Tam, Sidney] Univ Hong Kong, Dept Clin Biochem, Hong Kong, Hong Kong, Peoples R China; [Vanhoutte, Paul M.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Chung, Stephen Sum Man] United Int Coll, Div Sci & Technol, Zhuhai, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; Beijing Normal University - Hong Kong Baptist University United International College; University of Hong Kong	Leung, JWC (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	skchung@hkucc.hku.hk	Huang, Yu/K-2866-2017; Wong, Wing Tak Jack/Q-4512-2018	Huang, Yu/0000-0002-1277-6784; Wong, Wing Tak Jack/0000-0002-4514-3780; Leung, Justin Wai Chung/0000-0003-4601-390X	Hong Kong Research Grant Council [HKU 7220/02M]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084256] Funding Source: NIH RePORTER	Hong Kong Research Grant Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present work was supported by a research grant from the Hong Kong Research Grant Council (HKU 7220/02M) to SKC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Amiri F, 2008, J HYPERTENS, V26, P1102, DOI 10.1097/HJH.0b013e3282fc2184; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Chan TSK, 1995, EUR J BIOCHEM, V234, P819, DOI 10.1111/j.1432-1033.1995.819_a.x; DAY R, 1995, AM J HYPERTENS, V8, P294, DOI 10.1016/0895-7061(95)96213-4; dUscio LV, 1997, HYPERTENSION, V30, P905, DOI 10.1161/01.HYP.30.4.905; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gustafsson E, 2001, J CELL SCI, V114, P671; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Ho MCY, 2001, FASEB J, V15, P618, DOI 10.1096/fj.99-1022com; Hocher B, 2000, AM J RESP CELL MOL, V23, P19, DOI 10.1165/ajrcmb.23.1.4030; Hocher B, 1997, J CLIN INVEST, V99, P1380, DOI 10.1172/JCI119297; Iglarz M, 1998, EUR J PHARMACOL, V359, P69, DOI 10.1016/S0014-2999(98)00616-5; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LARIVIERE R, 1993, HYPERTENSION, V21, P916, DOI 10.1161/01.HYP.21.6.916; Leung JWC, 2004, J CARDIOVASC PHARM, V44, pS293, DOI 10.1097/01.fjc.0000166277.70538.b0; Li JS, 1998, AM J HYPERTENS, V11, P554, DOI 10.1016/S0895-7061(97)00405-6; LIU JJ, 1994, CLIN EXP PHARMACOL P, V21, P49, DOI 10.1111/j.1440-1681.1994.tb02435.x; LUSCHER TF, 1993, HYPERTENSION, V21, P752, DOI 10.1161/01.HYP.21.6.752; MANSOOR AM, 1995, BIOCHEM BIOPH RES CO, V215, P981, DOI 10.1006/bbrc.1995.2560; MCMAHON EG, 1991, J CARDIOVASC PHARM, V17, pS29, DOI 10.1097/00005344-199100177-00009; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; SCHIFFRIN EL, 1995, BRIT J PHARMACOL, V115, P1377, DOI 10.1111/j.1476-5381.1995.tb16626.x; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P769, DOI 10.1161/01.HYP.25.4.769; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P1135, DOI 10.1161/01.HYP.25.6.1135; Schmetterer L, 1998, BRIT J PHARMACOL, V124, P930, DOI 10.1038/sj.bjp.0701923; Sharifi AM, 1998, J CARDIOVASC PHARM, V31, pS309, DOI 10.1097/00005344-199800001-00086; Shindo T, 2002, J MOL MED, V80, P105, DOI 10.1007/s00109-001-0284-4; Tharaux PL, 1999, CIRCULATION, V99, P2185, DOI 10.1161/01.CIR.99.16.2185; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZACHARIAH PK, 1988, J CLIN PHARMACOL, V28, P843, DOI 10.1002/j.1552-4604.1988.tb03226.x	37	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26994	10.1371/journal.pone.0026994	http://dx.doi.org/10.1371/journal.pone.0026994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096514	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900017
J	Hogel, H; Rantanen, K; Jokilehto, T; Grenman, R; Jaakkola, PM				Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Grenman, Reidar; Jaakkola, Panu M.			Prolyl Hydroxylase PHD3 Enhances the Hypoxic Survival and G1 to S Transition of Carcinoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR; CYCLE PROGRESSION; TUMOR-GROWTH; HIF-ALPHA; RETINOBLASTOMA PROTEIN; NEURONAL APOPTOSIS; EXPRESSION; CANCER; OXYGEN; ARREST	Hypoxia restricts cell proliferation and cell cycle progression at the G1/S interface but at least a subpopulation of carcinoma cells can escape the restriction. In carcinoma hypoxia may in fact select for cells with enhanced hypoxic survival and increased aggressiveness. The cellular oxygen sensors HIF proline hydroxylases (PHDs) adapt the cellular functions to lowered environmental oxygen tension. PHD3 isoform has shown the strongest hypoxic upregulation among the family members. We detected a strong PHD3 mRNA expression in tumors of head and neck squamous cell carcinoma (HNSCC). The PHD3 expression associated with expression of hypoxic marker gene. Using siRNA in cell lines derived from HNSCC we show that specific inhibition of PHD3 expression in carcinoma cells caused reduced cell survival in hypoxia. The loss of PHD3, but not that of PHD2, led to marked cell number reduction. Although caspase-3 was activated at early hypoxia no induction of apoptosis was detected. However, hypoxic PHD3 inhibition caused a block in cell cycle progression. Cell population in G1 phase was increased and the population in S phase reduced demonstrating a block in G1 to S transition under PHD3 inhibition. In line with this, the level of hyperphosphorylated retinoblastoma protein Rb was reduced by PHD3 knock-down in hypoxia. PHD3 loss led to increase in cyclin-dependent kinase inhibitor p27 expression but not that of p21 or p16. The data demonstrated that increased PHD3 expression under hypoxia enhances cell cycle progression and survival of carcinoma cells.	[Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Jaakkola, Panu M.] Turku Univ, Turku Ctr Biotechnol, Turku, Finland; [Hogel, Heidi; Rantanen, Krista; Jokilehto, Terhi; Jaakkola, Panu M.] Abo Akad Univ, Turku, Finland; [Grenman, Reidar] Turku Univ, Dept Med Biochem, Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Jaakkola, Panu M.] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Hogel, H (corresponding author), Turku Univ, Turku Ctr Biotechnol, Turku, Finland.	panjaa@utu.fi	Högel, Heidi/A-1814-2019; Jaakkola, Panu M/B-4355-2012	Högel, Heidi/0000-0001-6592-5723; Jaakkola, Panu/0000-0002-2365-4985	Academy of Finland [200462]; Emil Aaltonen Foundation; Turku University Hospital [EVO13031]; Turku University Foundation	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Turku University Hospital; Turku University Foundation	This study was supported by The Academy of Finland (grant 200462), Emil Aaltonen Foundation, Turku University Hospital (EVO13031) and The Turku University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMELLEM O, 1991, CELL PROLIFERAT, V24, P127, DOI 10.1111/j.1365-2184.1991.tb01144.x; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Baba M, 2003, ONCOGENE, V22, P2728, DOI 10.1038/sj.onc.1206373; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; GRENMAN R, 1992, ARCH OTOLARYNGOL, V118, P542; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heikkinen PT, 2010, CANCER RES, V70, P5984, DOI 10.1158/0008-5472.CAN-09-3777; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Jokilehto T, 2010, EXP CELL RES, V316, P1169, DOI 10.1016/j.yexcr.2010.02.012; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; LUDLOW JW, 1993, ONCOGENE, V8, P331; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Oncomine, ONC; PETTERSEN EO, 1983, BRIT J CANCER, V48, P809, DOI 10.1038/bjc.1983.271; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rantanen K, 2008, MOL BIOL CELL, V19, P2231, DOI 10.1091/mbc.E07-11-1124; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Schlisio S, 2009, J CELL MOL MED, V13, P4104, DOI 10.1111/j.1582-4934.2009.00881.x; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SPIRO IJ, 1984, INT J RADIAT ONCOL, V10, P1275, DOI 10.1016/0360-3016(84)90332-8; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029; Zygmunt A, 2002, EXP CELL RES, V278, P53, DOI 10.1006/excr.2002.5564	53	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27112	10.1371/journal.pone.0027112	http://dx.doi.org/10.1371/journal.pone.0027112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087251	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700016
J	Hummelen, R; Macklaim, JM; Bisanz, JE; Hammond, JA; McMillan, A; Vongsa, R; Koenig, D; Gloor, GB; Reid, G				Hummelen, Ruben; Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Vongsa, Rebecca; Koenig, David; Gloor, Gregory B.; Reid, Gregor			Vaginal Microbiome and Epithelial Gene Array in Post-Menopausal Women with Moderate to Severe Dryness	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION; BACTERIAL VAGINOSIS; EXPRESSION; DIVERSITY; DATABASE; IMPACT; FLORA	After menopause, many women experience vaginal dryness and atrophy of tissue, often attributed to the loss of estrogen. An understudied aspect of vaginal health in women who experience dryness due to atrophy is the role of the resident microbes. It is known that the microbiota has an important role in healthy vaginal homeostasis, including maintaining the pH balance and excluding pathogens. The objectives of this study were twofold: first to identify the microbiome of postmenopausal women with and without vaginal dryness and symptoms of atrophy; and secondly to examine any differences in epithelial gene expression associated with atrophy. The vaginal microbiome of 32 post-menopausal women was profiled using Illumina sequencing of the V6 region of the 16S rRNA gene. Sixteen subjects were selected for follow-up sampling every two weeks for 10 weeks. In addition, 10 epithelial RNA samples (6 healthy and 4 experiencing vaginal dryness) were acquired for gene expression analysis by Affymetrix Human Gene array. The microbiota abundance profiles were relatively stable over 10 weeks compared to previously published data on premenopausal women. There was an inverse correlation between Lactobacillus ratio and dryness and an increased bacterial diversity in women experiencing moderate to severe vaginal dryness. In healthy participants, Lactobacillus iners and L. crispatus were generally the most abundant, countering the long-held view that lactobacilli are absent or depleted in menopause. Vaginal dryness and atrophy were associated with down-regulation of human genes involved in maintenance of epithelial structure and barrier function, while those associated with inflammation were up-regulated consistent with the adverse clinical presentation.	[Hummelen, Ruben; Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Hummelen, Ruben] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Macklaim, Jean M.; Bisanz, Jordan E.; Hammond, Jo-Anne; McMillan, Amy; Gloor, Gregory B.; Reid, Gregor] Univ Western Ontario, London, ON, Canada; [Vongsa, Rebecca; Koenig, David] Kimberly Clark Inc, Corp Res & Engn Microbial Control, Neenah, WI USA	Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; Western University (University of Western Ontario); Kimberly-Clark	Hummelen, R (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	gregor@uwo.ca	Hummelen, Ruben/ABG-5746-2021; Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380; Bisanz, Jordan/0000-0002-8649-1706	Kimberly Clark Corporation, USA	Kimberly Clark Corporation, USA	The study was funded by a grant-in-aid from Kimberly Clark Corporation, USA. Two Kimberly Clark scientists (BV, DK) provided input into the study design with GR, but had no role in data collection or decision to publish. They provided at the other authors' request some statistical analysis and input into the manuscript, but no content or data was altered as a result of their corporate positions. Rather, they were true scientific collaborators.	Agresti L, 2002, CATEGORICAL DATA ANA, P600; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Burton JP, 2002, J INFECT DIS, V186, P1770, DOI 10.1086/345761; Cheng XL, 2009, J BIOL CHEM, V284, P30897, DOI 10.1074/jbc.M109.011213; Cotreau MM, 2007, MATURITAS, V58, P366, DOI 10.1016/j.maturitas.2007.09.009; Lara LAD, 2009, J SEX MED, V6, P3097, DOI 10.1111/j.1743-6109.2009.01407.x; Dahn A, 2008, MICROBES INFECT, V10, P620, DOI 10.1016/j.micinf.2008.02.007; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Heinemann C, 2005, CAN J MICROBIOL, V51, P777, DOI [10.1139/w05-070, 10.1139/W05-070]; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Ibe C, 2010, J SEX MED, V7, P1042, DOI 10.1111/j.1743-6109.2009.01692.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Kim S, 2009, EXP DERMATOL, V18, P1016, DOI 10.1111/j.1600-0625.2009.00894.x; Kirjavainen P.K., 2008, INT J PROBIOTICS, V3, P99; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mac Bride MB, 2010, MAYO CLIN PROC, V85, P87, DOI 10.4065/mcp.2009.0413; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Magurran A E, 1988, ECOLOGICAL DIVERSITY; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Puthenedam M, 2011, INFLAMM BOWEL DIS, V17, P260, DOI 10.1002/ibd.21443; R Core Team, 2021, R LANG ENV STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Simon JA, 2009, MENOPAUSE, V16, P73, DOI 10.1097/gme.0b013e31817b614a; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Sturdee DW, 2010, CLIMACTERIC, V13, P509, DOI 10.3109/13697137.2010.522875; Ting AY, 2004, BIOL REPROD, V71, P1397, DOI 10.1095/biolreprod.104.030023; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411	39	114	125	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26602	10.1371/journal.pone.0026602	http://dx.doi.org/10.1371/journal.pone.0026602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073175	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900007
J	Jia, CY; Li, HH; Zhu, XC; Dong, YW; Fu, D; Zhao, QL; Wu, W; Wu, XZ				Jia, Cheng You; Li, Hui Hui; Zhu, Xu Chao; Dong, Yi Wei; Fu, Da; Zhao, Qian Lei; Wu, Wei; Wu, Xing Zhong			MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; PROTEIN-KINASE-C; MICRORNA-223; EXPRESSION; DIFFERENTIATION; METASTASIS; BIOGENESIS; MECHANISM; PATHWAY; CANCER	To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1 receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type 3'UTR(3'untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn't contain the 39UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223 suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by targeting IGF-1R.	[Jia, Cheng You; Li, Hui Hui; Zhu, Xu Chao; Dong, Yi Wei; Fu, Da; Zhao, Qian Lei; Wu, Wei; Wu, Xing Zhong] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China	Fudan University	Jia, CY (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China.	xz_wu@shmu.edu.cn	Jia, Chengyou/AAV-1153-2021; ravegnini, gloria/K-1330-2016; Fu, Da/F-1763-2013	ravegnini, gloria/0000-0002-7774-402X; Wu, Xing Zhong/0000-0003-3506-5544	National Natural Science Foundation of China [30570414, 30970641, 31170767]; State Key Laboratory of Medical Neurobiology; Fudan University; National Key Basic Research Program of China [2012CB822104]; Shanghai Leading Academic Discipline [B110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Medical Neurobiology; Fudan University; National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by grants from The National Natural Science Foundation of China (30570414, 30970641, 31170767), the Opening Project of State Key Laboratory of Medical Neurobiology, Fudan University, National Key Basic Research Program of China (2012CB822104), and the Shanghai Leading Academic Discipline Project (B110). The funders had no role in the study design, data analysis, collection and decision to publish.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; PARK S, HAEMATOLOGICA, V95, P819; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SCHERR M, METHODS MOL BIOL, V614, P175; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wu LH, 2010, BRAIN PATHOL, V20, P1042, DOI 10.1111/j.1750-3639.2010.00410.x; Wu XZ, 2006, CELL BIOL INT, V30, P672, DOI 10.1016/j.cellbi.2006.04.009; WU XZ, 1991, CHINESE MED J-PEKING, V104, P32; Wu XZ, 2004, INT J CANCER, V110, P504, DOI 10.1002/ijc.20127; WU XZ, 1989, LEUKEMIA RES, V13, P869, DOI 10.1016/0145-2126(89)90039-8; Wu XZ, 1996, CHINESE MED J-PEKING, V109, P295; XU Y, J BIOL CHEM, V285, P34439; Zheng J, 2009, CLIN CHIM ACTA, V405, P119, DOI 10.1016/j.cca.2009.04.017	30	117	124	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27008	10.1371/journal.pone.0027008	http://dx.doi.org/10.1371/journal.pone.0027008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073238	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900063
J	Riyahi, TY; Frese, F; Steinert, M; Omosigho, NN; Glockner, G; Eichinger, L; Orabi, B; Williams, RSB; Noegel, AA				Riyahi, Tanja Y.; Frese, Frederike; Steinert, Michael; Omosigho, Napoleon N.; Gloeckner, Gernot; Eichinger, Ludwig; Orabi, Benoit; Williams, Robin S. B.; Noegel, Angelika A.			RpkA, a Highly Conserved GPCR with a Lipid Kinase Domain, Has a Role in Phagocytosis and Anti-Bacterial Defense	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; PHOSPHOINOSITIDE METABOLISM; INTRACELLULAR GROWTH; PHAGOSOME MATURATION; LEGIONNAIRES-DISEASE; DRINKING-WATER; SOCIAL AMEBAS; VALPROIC ACID; HELA-CELLS	RpkA (Receptor phosphatidylinositol kinase A) is an unusual seven-helix transmembrane protein of Dictyostelium discoideum with a G protein coupled receptor (GPCR) signature and a C-terminal lipid kinase domain (GPCR-PIPK) predicted as a phosphatidylinositol-4-phosphate 5-kinase. RpkA-homologs are present in all so far sequenced Dictyostelidae as well as in several other lower eukaryotes like the oomycete Phytophthora, and in the Legionella host Acanthamoeba castellani. Here we show by immunofluorescence that RpkA localizes to endosomal membranes and is specifically recruited to phagosomes. RpkA interacts with the phagosomal protein complex V-ATPase as proteins of this complex co-precipitate with RpkA-GFP as well as with the GST-tagged PIPK domain of RpkA. Loss of RpkA leads to a defect in phagocytosis as measured by yeast particle uptake. The uptake of the pathogenic bacterium Legionella pneumophila was however unaltered whereas its intracellular replication was significantly enhanced in rpkA(-). The difference between wild type and rpkA(-) was even more prominent when L. hackeliae was used. When we investigated the reason for the enhanced susceptibility for L. pneumophila of rpkA(-) we could not detect a difference in endosomal pH but rpkA(-) showed depletion of phosphoinositides (PIP and PIP2) when we compared metabolically labeled phosphoinositides from wild type and rpkA(-). Furthermore rpkA(-) exhibited reduced nitrogen starvation tolerance, an indicator for a reduced autophagy rate. Our results indicate that RpkA is a component of the defense system of D. discoideum as well as other lower eukaryotes.	[Riyahi, Tanja Y.; Omosigho, Napoleon N.; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Inst Biochem 1, Fac Med, CMMC,Cologne Excellence Cluster Cellular Stress R, Cologne, Germany; [Frese, Frederike; Steinert, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Orabi, Benoit; Williams, Robin S. B.] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham, Surrey, England	University of Cologne; Braunschweig University of Technology; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of London; Royal Holloway University London	Riyahi, TY (corresponding author), Univ Cologne, Inst Biochem 1, Fac Med, CMMC,Cologne Excellence Cluster Cellular Stress R, Cologne, Germany.	noegel@uni-koeln.de	Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021; Williams, Robin/G-6807-2011	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117; 	Deutsche Forschungsgemeinschaft (DFG) [SFB 670]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG), in particular SFB 670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bakthavatsalam D, 2007, CURR BIOL, V17, P892, DOI 10.1016/j.cub.2007.04.029; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Boulais J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.80; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Burden LM, 1999, BIOCHEMISTRY-US, V38, P15141, DOI 10.1021/bi991571a; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Clarke M, 2002, J CELL SCI, V115, P2893; Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DREYFUS LA, 1987, MICROB PATHOGENESIS, V3, P45, DOI 10.1016/0882-4010(87)90036-2; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fischer M, 2006, FEBS LETT, V580, P2495, DOI 10.1016/j.febslet.2006.03.082; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Heidel A, 2011, GENOME RES; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Kular G, 1997, BIOCHEM J, V325, P299, DOI 10.1042/bj3250299; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lu H, 2005, CELL MICROBIOL, V7, P995, DOI 10.1111/j.1462-5822.2005.00528.x; Marciano-Cabral F, 2010, J WATER HEALTH, V8, P71, DOI 10.2166/wh.2009.129; Marston Barbara J., 1997, Archives of Internal Medicine, V157, P1709, DOI 10.1001/archinte.157.15.1709; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Pawolleck N, 2009, METHODS MOL BIOL, V571, P283, DOI 10.1007/978-1-60761-198-1_19; Peracino B, 2010, J CELL SCI, V123, P4039, DOI 10.1242/jcs.072124; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Ruiz-Trillo I, 2004, CURR BIOL, V14, pR946, DOI 10.1016/j.cub.2004.10.037; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SCHOPOHL D, 1992, J BIOL CHEM, V267, P2400; Schreiner T, 2002, EUKARYOT CELL, V1, P906, DOI 10.1128/EC.1.6.906-914.2002; Shevchuk O, 2009, INT J MED MICROBIOL, V299, P489, DOI 10.1016/j.ijmm.2009.03.006; Shina MC, 2010, J BIOL CHEM, V285, P9249, DOI 10.1074/jbc.M109.083725; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Swanson MS, 2002, TRAFFIC, V3, P170, DOI 10.1034/j.1600-0854.2002.030302.x; Temesvari LA, 1996, J CELL SCI, V109, P1479; Thomas JM, 2011, ENVIRON SCI TECHNOL, V45, P860, DOI 10.1021/es102876y; Tung SM, 2010, CELL MICROBIOL, V12, P765, DOI 10.1111/j.1462-5822.2010.01432.x; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Valster RM, 2010, APPL ENVIRON MICROB, V76, P7144, DOI 10.1128/AEM.00926-10; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wienke D, 2006, EUR J CELL BIOL, V85, P991, DOI 10.1016/j.ejcb.2006.04.010; WILKINSON HW, 1985, J CLIN MICROBIOL, V22, P488, DOI 10.1128/JCM.22.4.488-489.1985; Xu XH, 2007, EUKARYOT CELL, V6, P899, DOI 10.1128/EC.00104-06; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	73	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27311	10.1371/journal.pone.0027311	http://dx.doi.org/10.1371/journal.pone.0027311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073313	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900098
J	Wang, YC; Pinto, JR; Solis, RS; Dweck, D; Liang, JS; Diaz-Perez, Z; Ge, Y; Walker, JW; Potter, JD				Wang, Yingcai; Pinto, Jose Renato; Solis, Raquel Sancho; Dweck, David; Liang, Jingsheng; Diaz-Perez, Zoraida; Ge, Ying; Walker, Jeffery W.; Potter, James D.			Generation and Functional Characterization of Knock-in Mice Harboring the Cardiac Troponin I-R21C Mutation Associated with Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MOUSE MODEL; LIGHT-CHAIN; PHOSPHORYLATION; GENE; MUSCLE; SITE; SUSCEPTIBILITY; TROPOMYOSIN; AFFINITY	The R21C substitution in cardiac troponin I (cTnI) is the only identified mutation within its unique N-terminal extension that is associated with hypertrophic cardiomyopathy (HCM) in man. Particularly, this mutation is located in the consensus sequence for beta-adrenergic-activated protein kinase A (PKA)-mediated phosphorylation. The mechanisms by which this mutation leads to heart disease are still unclear. Therefore, we generated cTnI knock-in mouse models carrying an R21C mutation to evaluate the resultant functional consequences. Measuring the in vivo levels of incorporated mutant and WT cTnI, and their basal phosphorylation levels by top-down mass spectrometry demonstrated: 1) a dominant-negative effect such that, the R21C+/- hearts incorporated 24.9% of the mutant cTnI within the myofilament; and 2) the R21C mutation abolished the in vivo phosphorylation of Ser(23)/Ser(24) in the mutant cTnI. Adult heterozygous (R21C+/-) and homozygous (R21C+/-) mutant mice activated the fetal gene program and developed a remarkable degree of cardiac hypertrophy and fibrosis. Investigation of cardiac skinned fibers isolated from WT and heterozygous mice revealed that the WT cTnI was completely phosphorylated at Ser(23)/Ser(24) unless the mice were pre-treated with propranolol. After propranolol treatment (-PKA), the pCa-tension relationships of all three mice (i. e. WT, R21C+/-, and R21C+/-) were essentially the same. However, after treatment with propranolol and PKA, the R21C cTnI mutation reduced (R21C+/-) or abolished (R21C+/-) the well known decrease in the Ca2+ sensitivity of tension that accompanies Ser(23)/Ser(24) cTnI phosphorylation. Altogether, the combined effects of the R21C mutation appear to contribute toward the development of HCM and suggest that another physiological role for the phosphorylation of Ser(23)/Ser(24) in cTnI is to prevent cardiac hypertrophy.	[Wang, Yingcai; Pinto, Jose Renato; Dweck, David; Liang, Jingsheng; Diaz-Perez, Zoraida; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Solis, Raquel Sancho; Ge, Ying; Walker, Jeffery W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53706 USA; [Solis, Raquel Sancho; Ge, Ying; Walker, Jeffery W.] Univ Wisconsin, Sch Med & Publ Hlth, Human Prote Program, Madison, WI 53706 USA; [Walker, Jeffery W.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Arizona	Potter, JD (corresponding author), 1600 NW 10th Ave,R-189, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976	National Institutes of these advances, there is a lack of information in the literature Health [HL042325, RO1 HL081386, 1K99HL103840-01]; JE King Grant [10KN-13]; Wisconsin Partnership Fund for a Healthy Future; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R00HL103840, R37HL042325, R01HL081386, K99HL103840] Funding Source: NIH RePORTER	National Institutes of these advances, there is a lack of information in the literature Health; JE King Grant; Wisconsin Partnership Fund for a Healthy Future; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of these advances, there is a lack of information in the literature Health Grants HL042325 (to J. D. P.), RO1 HL081386 (to J. W. W.), 1K99HL103840-01 and J&E King Grant 10KN-13 (to J. R. P.), the Wisconsin Partnership Fund for a Healthy Future, and an American Heart Association Scientist Development Grant (to Y. G.).	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Day SM, 2007, J MOL MED, V85, P911, DOI 10.1007/s00109-007-0181-6; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Huang XP, 1999, CIRC RES, V84, P1; JAQUET K, 1995, EUR J BIOCHEM, V231, P486, DOI 10.1111/j.1432-1033.1995.tb20722.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Marian AJ, 1998, ANN MED, V30, P24; Marston SB, 2003, CIRC RES, V93, P1170, DOI 10.1161/01.RES.0000105088.06696.17; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Monasky MM, 2010, J MOL CELL CARDIOL, V48, P1023, DOI 10.1016/j.yjmcc.2010.03.004; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Wang YC, 2007, FASEB J, V21, P2205, DOI 10.1096/fj.06-7538com; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	50	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2156	2167		10.1074/jbc.M111.294306	http://dx.doi.org/10.1074/jbc.M111.294306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22086914	hybrid, Green Published			2022-12-25	WOS:000299321000055
J	Langelueddecke, C; Roussa, E; Fenton, RA; Wolff, NA; Lee, WK; Thevenod, F				Langelueddecke, Christian; Roussa, Eleni; Fenton, Robert A.; Wolff, Natascha A.; Lee, Wing-Kee; Thevenod, Frank			Lipocalin-2 (24p3/Neutrophil Gelatinase-associated Lipocalin (NGAL)) Receptor Is Expressed in Distal Nephron and Mediates Protein Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; ISCHEMIA-REPERFUSION INJURY; RAT-KIDNEY; CONVOLUTED TUBULE; HUMAN TRANSFERRIN; METAL COMPLEXES; IRON; CADMIUM; METALLOTHIONEIN; TRANSPORT	In the kidney, bulk reabsorption of filtered proteins occurs in the proximal tubule via receptor-mediated endocytosis (RME) through the multiligand receptor complex megalin-cubilin. Other mechanisms and nephron sites for RME of proteins are unclear. Recently, the secreted protein 24p3 (lipocalin-2, neutrophil gelatinase-associated lipocalin (NGAL)), which is expressed in the distal nephron, has been identified as a sensitive biomarker of kidney damage. A high-affinity receptor for 24p3 (24p3R) that is involved in endocytotic iron delivery has also been cloned. We investigated the localization of 24p3R in rodent kidney and its role in RME of protein-metal complexes and albumin. Immunostaining of kidney tissue showed expression of 24p3R in apical membranes of distal tubules and collecting ducts, but not of proximal tubule. The differential expression of 24p3R in these nephron segments was confirmed in the respective cell lines. CHO cells transiently transfected with 24p3R or distal tubule cells internalized submicromolar concentrations of fluorescence-coupled proteins transferrin, albumin, or metallothionein (MT) as well as the toxic cadmium-MT (Cd-7(2+)-MT) complex, which caused cell death. Uptake of MT or transferrin and Cd-7(2+)-MT toxicity were prevented by picomolar concentrations of 24p3. An EC50 of 123 +/- 50 nM was determined for binding of MT to 24p3R by microscale thermophoresis. Hence, 24p3R binds proteins filtered by the kidney with high affinity and may contribute to RME of proteins, including 24p3, and to Cd-7(2+)-MT toxicity in distal nephron segments.	[Thevenod, Frank] Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Fac Hlth, D-58453 Witten, Germany; [Roussa, Eleni] Univ Freiburg, Inst Anat & Cell Biol 2, D-79104 Freiburg, Germany; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	Witten Herdecke University; University of Freiburg; Aarhus University	Thevenod, F (corresponding author), Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Fac Hlth, Stockumer Str 12, D-58453 Witten, Germany.	frank.thevenod@uni-wh.de	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Lee, Wing-Kee/0000-0002-7352-4679	Deutsche Forschungsgemeinschaft [TH345/11-1]; ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University); Lundbeck foundation; Danish Medical Research Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University); Lundbeck foundation(Lundbeckfonden); Danish Medical Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant TH345/11-1 and ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University) (to F. T.).; Supported by the Lundbeck foundation and Danish Medical Research Foundation.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; AISEN P, 1978, J BIOL CHEM, V253, P1930; ANDERSEN O, 1984, ENVIRON HEALTH PERSP, V54, P249, DOI 10.2307/3429813; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; BOYLAN JW, 1979, KIDNEY INT, V16, P247, DOI 10.1038/ki.1979.127; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; BREMNER I, 1987, PROG FOOD NUTR SCI, V11, P1; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; CORTNEY MA, 1970, J CLIN INVEST, V49, P1, DOI 10.1172/JCI106208; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Erfurt C, 2003, AM J PHYSIOL-CELL PH, V285, pC1367, DOI 10.1152/ajpcell.00217.2003; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; GALASKE RG, 1979, KIDNEY INT, V16, P394, DOI 10.1038/ki.1979.142; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; GIROLAMI JP, 1989, TOXICOLOGY, V55, P117, DOI 10.1016/0300-483X(89)90179-0; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Klassen RB, 2004, AM J PHYSIOL-RENAL, V287, pF393, DOI 10.1152/ajprenal.00233.2003; LAUWERYS R, 1989, TOXICOL LETT, V46, P13, DOI 10.1016/0378-4274(89)90113-6; LEBER PD, 1970, AM J PHYSIOL, V219, P358, DOI 10.1152/ajplegacy.1970.219.2.358; Lee WK, 2011, TOXICOL SCI, V121, P343, DOI 10.1093/toxsci/kfr071; Liu ZM, 2011, J BIOL CHEM, V286, P20606, DOI 10.1074/jbc.M110.216549; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Maack T., 1992, KIDNEY PHYSL PATHOPH, P3005; MADSEN KM, 1982, KIDNEY INT, V21, P354, DOI 10.1038/ki.1982.29; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; PERRIN DD, 1971, BIOCHIM BIOPHYS ACTA, V230, P96, DOI 10.1016/0304-4165(71)90057-2; ROY AK, 1972, J HISTOCHEM CYTOCHEM, V20, P89, DOI 10.1177/20.2.89; Sabolic I, 2010, BIOMETALS, V23, P897, DOI 10.1007/s10534-010-9351-z; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; STRAUS W, 1964, J HISTOCHEM CYTOCHEM, V12, P470, DOI 10.1177/12.6.470; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; THEVENOD F, 1988, AM J PHYSIOL, V255, pG429, DOI 10.1152/ajpgi.1988.255.4.G429; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574; Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	62	74	76	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					159	169		10.1074/jbc.M111.308296	http://dx.doi.org/10.1074/jbc.M111.308296			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084236	Green Published, hybrid			2022-12-25	WOS:000298682400018
J	Tondo, ML; Musumeci, MA; Delprato, ML; Ceccarelli, EA; Orellano, EG				Laura Tondo, Maria; Musumeci, Matias A.; Laura Delprato, Maria; Ceccarelli, Eduardo A.; Orellano, Elena G.			Structural-Functional Characterization and Physiological Significance of Ferredoxin-NADP(+) Reductase from Xanthomonas axonopodis pv. citri	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATALYTIC EFFICIENCY; RHODOBACTER-CAPSULATUS; SUPEROXIDE STRESS; NADP+ REDUCTASE; SOXRS RESPONSE; BINDING-SITE; PLANT; GENE; OXIDOREDUCTASE	Xanthomonas axonopodis pv. citri is a phytopathogen bacterium that causes severe citrus canker disease. Similar to other phytopathogens, after infection by this bacterium, plants trigger a defense mechanism that produces reactive oxygen species. Ferredoxin-NADP(+) reductases (FNRs) are redox flavoenzymes that participate in several metabolic functions, including the response to reactive oxygen species. Xanthomonas axonopodis pv. citri has a gene (fpr) that encodes for a FNR (Xac-FNR) that belongs to the subclass I bacterial FNRs. The aim of this work was to search for the physiological role of this enzyme and to characterize its structural and functional properties. The functionality of Xac-FNR was tested by cross-complementation of a FNR knockout Escherichia coli strain, which exhibit high susceptibility to agents that produce an abnormal accumulation of O-center dot(2)-. Xac-FNR was able to substitute for the FNR in E. coli in its antioxidant role. The expression of fpr in X. axonopodis pv. citri was assessed using semiquantitative RT-PCR and Western blot analysis. A 2.2-fold induction was observed in the presence of the superoxide-generating agents methyl viologen and 2,3-dimethoxy-1,4-naphthoquinone. Structural and functional studies showed that Xac-FNR displayed different functional features from other subclass I bacterial FNRs. Our analyses suggest that these differences may be due to the unusual carboxy-terminal region. We propose a further classification of subclass I bacterial FNRs, which is useful to determine the nature of their ferredoxin redox partners. Using sequence analysis, we identified a ferredoxin (XAC1762) as a potential substrate of Xac-FNR. The purified ferredoxin protein displayed the typical broad UV-visible spectrum of [4Fe-4S] clusters and was able to function as substrate of Xac-FNR in the cytochrome c reductase activity. Our results suggest that Xac-FNR is involved in the oxidative stress response of Xanthomonas axonopodis pv. citri and performs its biological function most likely through the interaction with ferredoxin XAC1762.	[Laura Tondo, Maria; Musumeci, Matias A.; Laura Delprato, Maria; Ceccarelli, Eduardo A.; Orellano, Elena G.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Tondo, ML (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina.	ceccarelli@ibr.gov.ar; orellano@ibr.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306; Tondo, Maria Laura/0000-0002-0160-1882; Musumeci, Matias/0000-0003-2358-1365	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2007 01-00645]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 252, 112-2009-01-00873]; University of Rosario, Argentina [BIO187, BIO162]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Rosario, Argentina	This work was supported by grants PICT-2007 01-00645, Agencia Nacional de Promocion Cientifica y Tecnologica to EAC, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); PIP 252 to EAC and 112-2009-01-00873 to EGO from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (www.conicet.gov.ar); BIO187 to EAC and BIO162 to EGO from the University of Rosario, Argentina (www.unr.edu.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY MA, 1956, ARCH BIOCHEM BIOPHYS, V65, P475, DOI 10.1016/0003-9861(56)90207-7; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; BASTIAENS PIH, 1992, BIOCHEMISTRY-US, V31, P7061, DOI 10.1021/bi00146a006; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; Bittel C, 2003, FEBS LETT, V553, P408, DOI 10.1016/S0014-5793(03)01075-5; Bortolotti A, 2009, BBA-PROTEINS PROTEOM, V1794, P199, DOI 10.1016/j.bbapap.2008.09.013; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Carrillo N, 1987, TOPICS PHOTOSYNTHESI, V8, P527; Catalano-Dupuy DL, 2006, BIOCHEMISTRY-US, V45, P13899, DOI 10.1021/bi061152v; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CENTENO F, 1992, BIOCHEMISTRY-US, V31, P8473, DOI 10.1021/bi00151a013; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; EDMONDSO.DE, 1971, BIOCHEMISTRY-US, V10, P113; Fukuyama K, 2006, HDB METALLOPROTEINS, P543; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; ISAS JM, 1994, J BIOL CHEM, V269, P19404; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Jung YS, 1999, J BIOL CHEM, V274, P2978, DOI 10.1074/jbc.274.5.2978; Khan KK, 1997, EUR J BIOCHEM, V244, P361, DOI 10.1111/j.1432-1033.1997.00361.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Medina M, 2004, PHOTOSYNTH RES, V79, P113, DOI 10.1023/B:PRES.0000015386.67746.2c; Milani M, 2007, J MOL BIOL, V367, P501, DOI 10.1016/j.jmb.2007.01.005; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Musumeci MA, 2011, BIOCHEMISTRY-US, V50, P2111, DOI 10.1021/bi101772a; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nascimento AS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-69; Nogues I, 2005, BIOCHEMISTRY-US, V44, P11730, DOI 10.1021/bi0508183; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; ORELLANO EG, 1993, J BIOL CHEM, V268, P19267; Paladini DH, 2009, BIOCHEMISTRY-US, V48, P5760, DOI 10.1021/bi9004232; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Piubelli L, 2000, J BIOL CHEM, V275, P10472, DOI 10.1074/jbc.275.14.10472; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; RITCHIE SW, 1994, PLANT MOL BIOL, V26, P679, DOI 10.1007/BF00013753; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHIN M, 1965, J BIOL CHEM, V240, P1405; Tondo M.L., 2008, FLAVINS FLAVOPROTEIN, P255; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	56	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27124	10.1371/journal.pone.0027124	http://dx.doi.org/10.1371/journal.pone.0027124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096528	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800029
J	Singh, T; Sharma, SD; Katiyar, SK				Singh, Tripti; Sharma, Som D.; Katiyar, Santosh K.			Grape Proanthocyanidins Induce Apoptosis by Loss of Mitochondrial Membrane Potential of Human Non-Small Cell Lung Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							DEPENDENT KINASES; CYCLE CONTROL; BCL-2 FAMILY; INHIBIT; GROWTH; PROTEIN; DEATH; ACTIVATION; BERBERINE; THERAPY	Lung cancer remains the leading cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) represents approximately 80% of total lung cancer cases. The use of non-toxic dietary phytochemicals can be considered as a chemotherapeutic strategy for the management of the NSCLC. Here, we report that grape seed proanthocyanidins (GSPs) induce apoptosis of NSCLC cells, A549 and H1299, in vitro which is mediated through increased expression of pro-apoptotic protein Bax, decreased expression of anti-apoptotic proteins Bcl2 and Bcl-xl, disruption of mitochondrial membrane potential, and activation of caspases 9, 3 and poly (ADP-ribose) polymerase (PARP). Pre-treatment of A549 and H1299 cells with the caspase-3 inhibitor (z-DEVD-fmk) significantly blocked the GSPs-induced apoptosis of these cells confirmed that GSPs-induced apoptosis is mediated through activation of caspases-3. Treatments of A549 and H1299 cells with GSPs resulted in an increase in G1 arrest. G0/G1 phase of the cell cycle is known to be controlled by cyclin dependent kinases (Cdk), cyclin-dependent kinase inhibitors (Cdki) and cyclins. Our western blot analyses showed that GSPs-induced G1 cell cycle arrest was mediated through the increased expression of Cdki proteins (Cip1/p21 and Kip1/p27), and a simultaneous decrease in the levels of Cdk2, Cdk4, Cdk6 and cyclins. Further, administration of 50, 100 or 200 mg GSPs/kg body weight of mice by oral gavage (5 d/week) markedly inhibited the growth of s.c. A549 and H1299 lung tumor xenografts in athymic nude mice, which was associated with the induction of apoptotic cell death, increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3 in tumor xenograft cells. Based on the data obtained in animal study, human equivalent dose of GSPs was calculated, which seems affordable and attainable. Together, these results suggest that GSPs may represent a potential therapeutic agent for the non-small cell lung cancer.	[Singh, Tripti; Sharma, Som D.; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Singh, T (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			Veterans Administration Merit Review Award	Veterans Administration Merit Review Award(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; America Cancer Society, 2011, CANC FACTS FIG; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Facino RM, 1996, PLANTA MED, V62, P495, DOI 10.1055/s-2006-957956; Ferrigno D, 2000, LUNG CANCER-J IASLC, V29, P91, DOI 10.1016/S0169-5002(00)00112-4; Fischer P M, 2001, Curr Opin Drug Discov Devel, V4, P623; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; GRANA X, 1995, ONCOGENE, V11, P211; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Maziak DE, 2004, ANN THORAC SURG, V77, P1484, DOI 10.1016/j.athoracsur.2003.07.017; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; WRIGHT SC, 1994, FASEB J, V8, P654, DOI 10.1096/fasebj.8.9.8005393; Ye X, 1999, MOL CELL BIOCHEM, V196, P99, DOI 10.1023/A:1006926414683; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0	41	70	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27444	10.1371/journal.pone.0027444	http://dx.doi.org/10.1371/journal.pone.0027444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087318	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700046
J	Yang, DR; Liu, NAL; Zuo, CH; Lei, SH; Wu, XJ; Zhou, F; Liu, C; Zhu, HZ				Yang, Darong; Liu, Nianli; Zuo, Chaohui; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Liu, Chen; Zhu, Haizhen			Innate Host Response in Primary Human Hepatocytes with Hepatitis C Virus Infection	PLOS ONE			English	Article							INDUCED APOPTOSIS; IMMUNE-RESPONSES; ADAPTER PROTEIN; RIG-I; REPLICATION; DISRUPTION; CULTURE; TRAIL	Background and Aim: The interaction between hepatitis C virus (HCV) and innate antiviral defense systems in primary human hepatocytes is not well understood. The objective of this study is to examine how primary human hepatocytes response to HCV infection. Methods: An infectious HCV isolate JFH1 was used to infect isolated primary human hepatocytes. HCV RNA or NS5A protein in the cells was detected by real-time PCR or immunofluorescence staining respectively. Apoptosis was examined with flow cytometry. Mechanisms of HCV-induced IFN-beta expression and apoptosis were determined. Results: Primary human hepatocytes were susceptible to JFH1 virus and released infectious virus. IFN-alpha inhibited viral RNA replication in the cells. IFN-b and interferon-stimulated genes were induced in the cells during acute infection. HCV infection induced apoptosis of primary human hepatocytes through the TRAIL-mediated pathway. Silencing RIG-I expression in primary human hepatocytes inhibited IFN-beta and TRAIL expression and blocked apoptosis of the cells, which facilitated viral RNA replication in the cells. Moreover, HCV NS34A protein inhibited viral induced IFN-beta expression in primary human hepatocytes. Conclusion: Innate host response is intact in HCV-infected primary human hepatocytes. RIG-I plays a key role in the induction of IFN and TRAIL by viruses and apoptosis of primary human hepatocytes via activation of the TRAIL-mediated pathway. HCV NS34A protein appears to be capable of disrupting the innate antiviral host responses in primary human hepatocytes. Our study provides a novel mechanism by which primary human hepatocytes respond to natural HCV infection.	[Yang, Darong; Liu, Nianli; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Zhu, Haizhen] Hunan Univ, Dept Mol Med, Coll Biol, Changsha 410082, Hunan, Peoples R China; [Yang, Darong; Liu, Nianli; Lei, Shoahua; Wu, Xinjiao; Zhou, Fei; Zhu, Haizhen] Hunan Univ, State Key Lab Chem Biosensesing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Zuo, Chaohui; Zhu, Haizhen] Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Zuo, Chaohui; Zhu, Haizhen] Hunan Univ, Res Ctr Canc Prevent & Treatment, Changsha 410082, Hunan, Peoples R China; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Hunan University; Hunan University; Hunan University; State University System of Florida; University of Florida	Yang, DR (corresponding author), Hunan Univ, Dept Mol Med, Coll Biol, Changsha 410082, Hunan, Peoples R China.	zhuhaizhen69@yahoo.com	Lei, Shaohua/GPS-5028-2022; Yang, Darong/HHZ-5465-2022	Yang, Darong/0000-0002-5343-9047	National Grand Program on Key Infectious Disease [2009ZX10004-312]; Program for New Century Excellent Talents in University [NCET-09-0339]; Key Scientific and Technical Innovation Program of Hunan [2010TD2012];  [NIH-DK002958]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002958] Funding Source: NIH RePORTER	National Grand Program on Key Infectious Disease; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Scientific and Technical Innovation Program of Hunan; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Grand Program on Key Infectious Disease (2009ZX10004-312), Program for New Century Excellent Talents in University (NCET-09-0339), Key Scientific and Technical Innovation Program of Hunan (2010TD2012) to HZ and grant NIH-DK002958 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Balfe Peter, 2009, J Hepatol, V51, P609, DOI 10.1016/j.jhep.2009.06.014; Banaudha K, 2010, HEPATOLOGY, V51, P1922, DOI 10.1002/hep.23616; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Berg CP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-213; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Clarke P, 2003, APOPTOSIS, V8, P141, DOI 10.1023/A:1022966508671; Eksioglu EA, 2011, PLOS ONE, pe21186; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Jouan L, 2010, J HEPATOL, V52, P167, DOI 10.1016/j.jhep.2009.11.011; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Stiffler JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006661; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017; Zhu Haizhen, 2009, V510, P373, DOI 10.1007/978-1-59745-394-3_28; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	37	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27552	10.1371/journal.pone.0027552	http://dx.doi.org/10.1371/journal.pone.0027552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087337	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700059
J	Yen, P; Finley, SD; Engel-Stefanini, MO; Popel, AS				Yen, Phillip; Finley, Stacey D.; Engel-Stefanini, Marianne O.; Popel, Aleksander S.			A Two-Compartment Model of VEGF Distribution in the Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CAPILLARY BASEMENT-MEMBRANE; SKELETAL-MUSCLE; ISOFORM EXPRESSION; COMPARTMENT MODEL; BLOOD-VOLUME; PLASMA VEGF; ANGIOGENESIS; RECEPTOR-1; BIOLOGY	Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis - the growth of new microvessels from existing microvasculature. Angiogenesis is a complex process involving numerous molecular species, and to better understand it, a systems biology approach is necessary. In vivo preclinical experiments in the area of angiogenesis are typically performed in mouse models; this includes drug development targeting VEGF. Thus, to quantitatively interpret such experimental results, a computational model of VEGF distribution in the mouse can be beneficial. In this paper, we present an in silico model of VEGF distribution in mice, determine model parameters from existing experimental data, conduct sensitivity analysis, and test the validity of the model. The multiscale model is comprised of two compartments: blood and tissue. The model accounts for interactions between two major VEGF isoforms (VEGF(120) and VEGF(164)) and their endothelial cell receptors VEGFR-1, VEGFR-2, and co-receptor neuropilin-1. Neuropilin-1 is also expressed on the surface of parenchymal cells. The model includes transcapillary macromolecular permeability, lymphatic transport, and macromolecular plasma clearance. Simulations predict that the concentration of unbound VEGF in the tissue is approximately 50-fold greater than in the blood. These concentrations are highly dependent on the VEGF secretion rate. Parameter estimation was performed to fit the simulation results to available experimental data, and permitted the estimation of VEGF secretion rate in healthy tissue, which is difficult to measure experimentally. The model can provide quantitative interpretation of preclinical animal data and may be used in conjunction with experimental studies in the development of pro- and anti-angiogenic agents. The model approximates the normal tissue as skeletal muscle and includes endothelial cells to represent the vasculature. As the VEGF system becomes better characterized in other tissues and cell types, the model can be expanded to include additional compartments and vascular elements.	[Yen, Phillip; Finley, Stacey D.; Engel-Stefanini, Marianne O.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Yen, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	sdfinley@jhu.edu	Popel, Aleksander S/A-6724-2009	Popel, Aleksander/0000-0002-6706-9235; Yen, Phillip/0000-0002-0234-7791; Finley, Stacey/0000-0001-6901-3692	National Institutes of Health (NIH) [R01 HL101200, R01 CA138264]; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL101200 and R01 CA138264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; CUTHBERTSON RA, 1986, INVEST OPHTH VIS SCI, V27, P1653; Daly T, 2009, VEGF BINDING FUSION; Ee LC, 2000, AM J PHYSIOL-GASTR L, V279, pG325, DOI 10.1152/ajpgi.2000.279.2.G325; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; GARLICK DG, 1970, AM J PHYSIOL, V219, P1595, DOI 10.1152/ajplegacy.1970.219.6.1595; Gibson JG, 1937, J CLIN INVEST, V16, P317, DOI 10.1172/JCI100860; Haas TL, 1997, MICROVASC RES, V53, P113, DOI 10.1006/mvre.1996.1999; Hagstrom L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/137817; Hernandez N, 1999, ANAT REC, V256, P425; HICKS P, 1983, NEUROBIOL AGING, V4, P69, DOI 10.1016/0197-4580(83)90057-X; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Hoff J, 2000, LAB ANIMAL, V29, P47; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; Kleinheinz J, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-17; Leighl NB, 2010, J THORAC ONCOL, V5, P1054, DOI 10.1097/JTO.0b013e3181e2f7fb; LEUENBERGER PM, 1970, DOC OPHTHALMOL, V28, P191, DOI 10.1007/BF00153877; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; MAN M, 1975, BIOCHEM BIOPH RES CO, V66, P9, DOI 10.1016/S0006-291X(75)80287-7; MATHIEUCOSTELLO O, 1989, RESP PHYSIOL, V76, P289, DOI 10.1016/0034-5687(89)90070-4; MAYROVITZ HN, 1992, MICROVASC RES, V43, P46, DOI 10.1016/0026-2862(92)90005-A; Medeiros A, 2008, BRAZ J MED BIOL RES, V41, P812, DOI 10.1590/S0100-879X2008000900012; MENDEZ J, 1977, J APPL PHYSIOL, V42, P731, DOI 10.1152/jappl.1977.42.5.731; Nakamura M, 2002, PATHOL INT, V52, P331, DOI 10.1046/j.1440-1827.2002.01367.x; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; North Central Cancer Treatment Group, 2007, PHAS 2 TRIAL VEGF TR; Olewniczak Slawomir, 2003, Polish Journal of Pathology, V54, P53; Olewniczak Slawomir, 2002, Polish Journal of Pathology, V53, P183; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; PODRAZKY V, 1966, EXPERIENTIA, V22, P792, DOI 10.1007/BF01897416; Qutub AA, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P316; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; SASSEN A, 1968, EXPERIENTIA, V24, P1203, DOI 10.1007/BF02146620; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; SHEFF MF, 1982, J PHYSIOL-LONDON, V328, P507, DOI 10.1113/jphysiol.1982.sp014280; SHER J, 1976, ACTA NEUROL SCAND, V54, P45, DOI 10.1111/j.1600-0404.1976.tb07619.x; Soukup T, 2002, ACTA HISTOCHEM, V104, P399, DOI 10.1078/0065-1281-00660; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Stefanini MO, 2011, MATH MED BIOL; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Testa U, 2008, J CARDIOVASC MED, V9, P1190, DOI 10.2459/JCM.0b013e3283117d37; THOMAS FC, 1994, MATH PROGRAM, V67, P189; Tokunaga T, 1998, ONCOL REP, V5, P1115; Truskey G. A., 2004, TRANSPORT PHENOMENA; van der Meer SFT, 2011, ANN ANAT, V193, P56, DOI 10.1016/j.aanat.2010.08.004; van Patot MCT, 2005, J APPL PHYSIOL, V98, P1626, DOI 10.1152/japplphysiol.00589.2004; Vempati P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-59; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Wachsberger PR, 2007, INT J RADIAT ONCOL, V67, P1526, DOI 10.1016/j.ijrobp.2006.11.011; Wagatsuma A, 2005, EXP PHYSIOL, V90, P403, DOI 10.1113/expphysiol.2004.029769; WASSMER B, 1988, COMP BIOCHEM PHYS B, V91, P179, DOI 10.1016/0305-0491(88)90132-0; Wong LE, 2009, J APPL PHYSIOL, V106, P1660, DOI 10.1152/japplphysiol.91233.2008; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Wu FTH, 2009, METHOD ENZYMOL, V467, P461, DOI 10.1016/S0076-6879(09)67018-X; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097	78	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27514	10.1371/journal.pone.0027514	http://dx.doi.org/10.1371/journal.pone.0027514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087332	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700055
J	Araujo-Palomares, CL; Richthammer, C; Seiler, S; Castro-Longoria, E				Araujo-Palomares, Cynthia L.; Richthammer, Corinna; Seiler, Stephan; Castro-Longoria, Ernestina			Functional Characterization and Cellular Dynamics of the CDC-42-RAC - CDC-24 Module in Neurospora crassa	PLOS ONE			English	Article							FUNGUS USTILAGO-MAYDIS; INVASIVE FILAMENTOUS GROWTH; RHO-TYPE GTPASE; CANDIDA-ALBICANS; ASPERGILLUS-NIDULANS; GENOME SEQUENCE; EXCHANGE FACTOR; HYPHAL GROWTH; PENICILLIUM-MARNEFFEI; SEPTUM FORMATION	Rho-type GTPases are key regulators that control eukaryotic cell polarity, but their role in fungal morphogenesis is only beginning to emerge. In this study, we investigate the role of the CDC-42 - RAC - CDC-24 module in Neurospora crassa. rac and cdc-42 deletion mutants are viable, but generate highly compact colonies with severe morphological defects. Double mutants carrying conditional and loss of function alleles of rac and cdc-42 are lethal, indicating that both GTPases share at least one common essential function. The defects of the GTPase mutants are phenocopied by deletion and conditional alleles of the guanine exchange factor (GEF) cdc-24, and in vitro GDP-GTP exchange assays identify CDC-24 as specific GEF for both CDC-42 and RAC. In vivo confocal microscopy shows that this module is organized as membrane-associated cap that covers the hyphal apex. However, the specific localization patterns of the three proteins are distinct, indicating different functions of RAC and CDC-42 within the hyphal tip. CDC-42 localized as confined apical membrane-associated crescent, while RAC labeled a membrane-associated ring excluding the region labeled by CDC42. The GEF CDC-24 occupied a strategic position, localizing as broad apical membrane-associated crescent and in the apical cytosol excluding the Spitzenkorper. RAC and CDC-42 also display distinct localization patterns during branch initiation and germ tube formation, with CDC-42 accumulating at the plasma membrane before RAC. Together with the distinct cellular defects of rac and cdc-42 mutants, these localizations suggest that CDC-42 is more important for polarity establishment, while the primary function of RAC may be maintaining polarity. In summary, this study identifies CDC-24 as essential regulator for RAC and CDC-42 that have common and distinct functions during polarity establishment and maintenance of cell polarity in N. crassa.	[Araujo-Palomares, Cynthia L.; Castro-Longoria, Ernestina] Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Richthammer, Corinna; Seiler, Stephan] Univ Gottingen, Inst Mikrobiol & Genet, Gottingen, Germany	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Gottingen	Araujo-Palomares, CL (corresponding author), Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	sseiler@gwdg.de; ecastro@cicese.mx	Castro-Longoria, Ernestina/GYV-4776-2022	Araujo Palomares, Cynthia Lizzeth/0000-0002-5007-8426	SEP-CONACyT [CB-2006-1-61524]; Deutsche Forschungsgesellschaft [SE1054/3-2, SE1054/4-1]; CONACyT	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a SEP-CONACyT grant (CB-2006-1-61524) to Dr. Castro-Longoria and the grants SE1054/3-2 and SE1054/4-1 from the Deutsche Forschungsgesellschaft to Dr. Seiler. We also thank CONACyT for a grant to Dr. Araujo-Palomares. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Banuett F, 2008, FUNGAL GENET BIOL, V45, pS3, DOI 10.1016/j.fgb.2008.05.012; Bardiya N, 2008, GENETICS, V178, P593, DOI 10.1534/genetics.107.079384; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bohmer C, 2008, J CELL SCI, V121, P143, DOI 10.1242/jcs.014449; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Boyce KJ, 2005, MOL MICROBIOL, V55, P1487, DOI 10.1111/j.1365-2958.2005.04485.x; Boyce KJ, 2003, J CELL SCI, V116, P1249, DOI 10.1242/jcs.00319; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Dunkler A, 2007, EUKARYOT CELL, V6, P844, DOI 10.1128/EC.00201-06; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Frieser SH, 2011, MOL BIOL CELL, V22, P3253, DOI 10.1091/mbc.E11-04-0314; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2011, MOL MICROBIOL, V79, P1123, DOI 10.1111/j.1365-2958.2010.07525.x; Harris SD, 2009, FUNGAL GENET BIOL, V46, pS82, DOI 10.1016/j.fgb.2008.07.023; Hazan I, 2002, EUKARYOT CELL, V1, P856, DOI 10.1128/EC.1.6.856-864.2002; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hlubek A, 2008, MOL MICROBIOL, V68, P615, DOI 10.1111/j.1365-2958.2008.06177.x; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Hope H, 2010, MOL MICROBIOL, V76, P1572, DOI 10.1111/j.1365-2958.2010.07186.x; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kwon MJ, 2011, MOL MICROBIOL, V79, P1151, DOI 10.1111/j.1365-2958.2010.07524.x; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; Ridley AJ, 2001, J CELL SCI, V114, P2713; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Virag A, 2007, MOL MICROBIOL, V66, P1579, DOI 10.1111/j.1365-2958.2007.06021.x; Vogel H.J., 1956, MICROB GENET B, V13, P42; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Wendland J, 2001, GENETICS, V157, P601; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339	55	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27148	10.1371/journal.pone.0027148	http://dx.doi.org/10.1371/journal.pone.0027148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087253	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700019
J	Zuo, LJ; Zhang, CK; Wang, F; Li, CSR; Zhao, HY; Lu, LG; Zhang, XY; Lu, L; Zhang, HP; Zhang, FY; Krystal, JH; Luo, XG				Zuo, Lingjun; Zhang, Clarence K.; Wang, Fei; Li, Chiang-Shan R.; Zhao, Hongyu; Lu, Lingeng; Zhang, Xiang-Yang; Lu, Lin; Zhang, Heping; Zhang, Fengyu; Krystal, John H.; Luo, Xingguang			A Novel, Functional and Replicable Risk Gene Region for Alcohol Dependence Identified by Genome-Wide Association Study	PLOS ONE			English	Article							POLYMORPHISMS; EXPRESSION; FINGER	Several genome-wide association studies (GWASs) reported tens of risk genes for alcohol dependence, but most of them have not been replicated or confirmed by functional studies. The present study used a GWAS to search for novel, functional and replicable risk gene regions for alcohol dependence. Associations of all top-ranked SNPs identified in a discovery sample of 681 African-American (AA) cases with alcohol dependence and 508 AA controls were retested in a primary replication sample of 1,409 European-American (EA) cases and 1,518 EA controls. The replicable associations were then subjected to secondary replication in a sample of 6,438 Australian family subjects. A functional expression quantitative trait locus (eQTL) analysis of these replicable risk SNPs was followed-up in order to explore their cis-acting regulatory effects on gene expression. We found that within a 90 Mb region around PHF3-PTP4A1 locus in AAs, a linkage disequilibrium (LD) block in PHF3-PTP4A1 formed the only peak associated with alcohol dependence at p<10(-4). Within this block, 30 SNPs associated with alcohol dependence in AAs (1.6x10(-5) <= p <= 0.050) were replicated in EAs (1.3x10(-3)<= p <= 0.038), and 18 of them were also replicated in Australians (1.8x10(-3)<= p <= 0.048). Most of these risk SNPs had strong cis-acting regulatory effects on PHF3-PTP4A1 mRNA expression across three HapMap samples. The distributions of -log(p) values for association and functional signals throughout this LD block were highly consistent across AAs, EAs, Australians and three HapMap samples. We conclude that the PHF3-PTP4A1 region appears to harbor a causal locus for alcohol dependence, and proteins encoded by PHF3 and/or PTP4A1 might play a functional role in the disorder.	[Zuo, Lingjun; Wang, Fei; Li, Chiang-Shan R.; Krystal, John H.; Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Zuo, Lingjun; Krystal, John H.; Luo, Xingguang] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Zhang, Clarence K.; Zhao, Hongyu; Lu, Lingeng; Zhang, Heping] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Peoples R China; [Zhang, Xiang-Yang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Zhang, Fengyu] NIMH, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; China Medical University; Baylor College of Medicine; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zuo, LJ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Lingjun.Zuo@yale.edu; Xingguang.Luo@yale.edu	Zhang, He/GXN-0028-2022; Zhang, Fengyu/M-1396-2019; Li, Chiang-Shan Ray/J-2813-2016	Zhang, Fengyu/0000-0001-8504-0770; Li, Chiang-Shan Ray/0000-0002-9393-1212	National Institute on Drug Abuse (NIDA) [K01 DA029643, K24 DA017899, R01 DA016750, K02 DA026990, R01 DA013423]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA016015, R21 AA020319, R21 AA018004, K24 AA013736, R01 AA11330, R01 AA017535, P50 AA012870, U10 AA008401]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Award [17616]; Department of Veterans Affairs through VA Alcohol Research Center; VA National Center for PTSD; Depression REAP; National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) [U01 HG004422, U01HG004438]; GENEVA Coordinating Center [U01 HG004446]; National Cancer Institute [P01 CA089392]; NIH [HHSN268200782096C]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004422, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870, R21AA018004, R01AA011330, R01AA016015, R01AA017535, K24AA013736, U10AA008401, R21AA020319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017899, K01DA029643, R01DA013423, K02DA026990, R01DA016750] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Alliance for Research on Schizophrenia and Depression (NARSAD) Award; Department of Veterans Affairs through VA Alcohol Research Center(US Department of Veterans Affairs); VA National Center for PTSD; Depression REAP; National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GENEVA Coordinating Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institute on Drug Abuse (NIDA) grants K01 DA029643, K24 DA017899, R01 DA016750 and K02 DA026990, National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants R01 AA016015, R21 AA020319, R21 AA018004, K24 AA013736, R01 AA11330, R01 AA017535, and P50 AA012870 and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Award 17616 (L.Z.). This work also received support from the Department of Veterans Affairs through its support of the VA Alcohol Research Center, the VA National Center for PTSD, and the Depression REAP. The authors thank National Institutes of Health GWAS Data Repository, the Contributing Investigator(s) (Drs. Bierut and Edenberg) who contributed the phenotype and genotype data (SAGE and COGA) from his/her original study, and the primary funding organization that supported the contributing study. Funding support for SAGE and COGA was provided through the National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) Grant U01 HG004422 and U01HG004438; the GENEVA Coordinating Center (U01 HG004446); the National Institute on Alcohol Abuse and Alcoholism (U10 AA008401); the National Institute on Drug Abuse (R01 DA013423); the National Cancer Institute (P01 CA089392); and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Johns Hopkins University Center for Inherited Disease Research or at deCODE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Chang YT, 2002, MOL PSYCHIATR, V7, P828, DOI 10.1038/sj.mp.4001110; Chen XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016002; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019210; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Li TK, 2007, ADDICTION, V102, P1522, DOI 10.1111/j.1360-0443.2007.01911.x; Lind PA, 2009, PSYCHIAT GENET, V19, P117, DOI 10.1097/YPG.0b013e32832a4f7b; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; McHugh RK, 2010, DRUG ALCOHOL DEPEN, V108, P1, DOI 10.1016/j.drugalcdep.2009.11.017; Mosing MA, 2010, TWIN RES HUM GENET, V13, P398, DOI 10.1375/twin.13.4.398; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuo L, 2011, NEUROPSYCHOPHARMACOL, DOI [10.1038/npp.2011.1229, DOI 10.1038/NPP.2011.1229]; Zuo LJ, 2007, BIOL PSYCHIAT, V62, P616, DOI 10.1016/j.biopsych.2006.12.004	28	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26726	10.1371/journal.pone.0026726	http://dx.doi.org/10.1371/journal.pone.0026726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22096494	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700009
J	Ratelade, J; Bennett, JL; Verkman, AS				Ratelade, Julien; Bennett, Jeffrey L.; Verkman, A. S.			Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema	PLOS ONE			English	Article							INSENSITIVE WATER CHANNEL; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; ANTIBODY; SPECTRUM; IMMUNOGLOBULIN; CONSEQUENCES; LOCALIZATION; PERMEABILITY; DISTINCTION	The pathogenesis of neuromyelitis optica (NMO) involves binding of IgG autoantibodies (NMO-IgG) to aquaporin-4 (AQP4) on astrocytes in the central nervous system (CNS). We studied the in vivo processing in mice of a recombinant monoclonal human NMO-IgG that binds strongly to mouse AQP4. Following intravenous administration, serum [NMO-IgG] decreased with t(1/2) similar to 18 hours in wildtype mice and similar to 41 hours in AQP4 knockout mice. NMO-IgG was localized to AQP4-expressing cell membranes in kidney (collecting duct), skeletal muscle, trachea (epithelial cells) and stomach (parietal cells). NMO-IgG was seen on astrocytes in the area postrema in brain, but not elsewhere in brain, spinal cord, optic nerve or retina. Intravenously administered NMO-IgG was also seen in brain following mechanical disruption of the blood-brain barrier. Selective cellular localization was not found for control (non-NMO) IgG, or for NMO-IgG in AQP4 knockout mice. NMO-IgG injected directly into brain parenchyma diffused over an area of similar to 5 mm(2) over 24 hours and targeted astrocyte foot-processes. Our data establish NMO-IgG pharmacokinetics and tissue distribution in mice. The rapid access of serum NMO-IgG to AQP4 in peripheral organs but not the CNS indicates that restricted antibody access cannot account for the absence of NMO pathology in peripheral organs.	[Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ratelade, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409	Guthy-Jackson Charitable Foundation; National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, RC1DK086125, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	Guthy-Jackson Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Guthy-Jackson Charitable Foundation (ASV, JLB), grants EY13574, EB00415, DK35124, HL73856, DK86125 and DK72517 from the National Institutes of Health (ASV) and grant RG4320 from the National Multiple Sclerosis Society (JLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bonnan M, 2009, MULT SCLER J, V15, P487, DOI 10.1177/1352458508100837; Brabb T, 1997, J IMMUNOL, V159, P497; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Burgoon MP, 1999, J NEUROIMMUNOL, V94, P204, DOI 10.1016/S0165-5728(98)00243-4; Chan KH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-50; Crane JM, 2010, NEUROSCIENCE, V168, P892, DOI 10.1016/j.neuroscience.2009.08.034; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; FRIGERI A, 1995, J CELL SCI, V108, P2993; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Popescu BFG, 2011, NEUROLOGY, V76, P1229, DOI 10.1212/WNL.0b013e318214332c; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schoderboeck L, 2009, NEUROBIOL DIS, V35, P368, DOI 10.1016/j.nbd.2009.05.026; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; VERKMAN AS, 2011, ACTA PHARM SIN; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG448, DOI 10.1152/ajpgi.2000.279.2.G448; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yang BX, 2000, AM J PHYSIOL-CELL PH, V278, pC1108, DOI 10.1152/ajpcell.2000.278.6.C1108; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com	41	66	72	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27412	10.1371/journal.pone.0027412	http://dx.doi.org/10.1371/journal.pone.0027412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076159	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200073
J	Zanin, M; Del Pozo, F; Boccaletti, S				Zanin, Massimiliano; Del Pozo, Francisco; Boccaletti, Stefano			Computation Emerges from Adaptive Synchronization of Networking Neurons	PLOS ONE			English	Article								The activity of networking neurons is largely characterized by the alternation of synchronous and asynchronous spiking sequences. One of the most relevant challenges that scientists are facing today is, then, relating that evidence with the fundamental mechanisms through which the brain computes and processes information, as well as with the arousal (or progress) of a number of neurological illnesses. In other words, the problem is how to associate an organized dynamics of interacting neural assemblies to a computational task. Here we show that computation can be seen as a feature emerging from the collective dynamics of an ensemble of networking neurons, which interact by means of adaptive dynamical connections. Namely, by associating logical states to synchronous neuron's dynamics, we show how the usual Boolean logics can be fully recovered, and a universal Turing machine can be constructed. Furthermore, we show that, besides the static binary gates, a wider class of logical operations can be efficiently constructed as the fundamental computational elements interact within an adaptive network, each operation being represented by a specific motif. Our approach qualitatively differs from the past attempts to encode information and compute with complex systems, where computation was instead the consequence of the application of control loops enforcing a desired state into the specific system's dynamics. Being the result of an emergent process, the computation mechanism here described is not limited to a binary Boolean logic, but it can involve a much larger number of states. As such, our results can enlighten new concepts for the understanding of the real computing processes taking place in the brain.	[Zanin, Massimiliano; Del Pozo, Francisco; Boccaletti, Stefano] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain; [Zanin, Massimiliano] Innaxis Fdn & Res Inst, Madrid, Spain	Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Zanin, M (corresponding author), Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain.	massimiliano.zanin@ctb.upm.es	Boccaletti, Stefano/U-7603-2019; POZO GUERRERO, FRANCISCO DEL/H-6668-2015	Boccaletti, Stefano/0000-0002-5758-7012; POZO GUERRERO, FRANCISCO DEL/0000-0001-9919-9125; Zanin, Massimiliano/0000-0002-5839-0393				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartee, 1991, COMPUTER ARCHITECTUR; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Breakspear M, 2004, J COMPUT NEUROSCI, V16, P49, DOI 10.1023/B:JCNS.0000004841.66897.7d; Ditto WL, 2010, CHAOS, V20; Fries P, 2002, J NEUROSCI, V22, P3739; HAYES S, 1993, PHYS REV LETT, V70, P3031, DOI 10.1103/PhysRevLett.70.3031; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Murali K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.025201; Pikovsky AS, 1984, RADIOPHYS QUANTUM EL, V27; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sinha S, 1998, PHYS REV LETT, V81, P2156, DOI 10.1103/PhysRevLett.81.2156; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wernick W, 1942, T AM MATH SOC, V51, P117, DOI 10.2307/1989982	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26467	10.1371/journal.pone.0026467	http://dx.doi.org/10.1371/journal.pone.0026467			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073167	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200014
J	Elschot, M; Nijsen, JFW; Dam, AJ; de Jong, HWAM				Elschot, Mattijs; Nijsen, Johannes Franciscus Wilhelmus; Dam, Alida Johanna; de Jong, Hugo Wilhelmus Antonius Maria			Quantitative Evaluation of Scintillation Camera Imaging Characteristics of Isotopes Used in Liver Radioembolization	PLOS ONE			English	Article							HOLMIUM-LOADED MICROSPHERES; Y-90 MICROSPHERES; SCATTER CORRECTION; HO-166; THERAPY; SPECT; MALIGNANCIES; BIODISTRIBUTION; QUANTIFICATION; RADIOTHERAPY	Background: Scintillation camera imaging is used for treatment planning and post-treatment dosimetry in liver radioembolization (RE). In yttrium-90 (90Y) RE, scintigraphic images of technetium-99m (99mTc) are used for treatment planning, while 90Y Bremsstrahlung images are used for post-treatment dosimetry. In holmium-166 (166Ho) RE, scintigraphic images of 166Ho can be used for both treatment planning and post-treatment dosimetry. The aim of this study is to quantitatively evaluate and compare the imaging characteristics of these three isotopes, in order that imaging protocols can be optimized and RE studies with varying isotopes can be compared. Methodology/Principal Findings: Phantom experiments were performed in line with NEMA guidelines to assess the spatial resolution, sensitivity, count rate linearity, and contrast recovery of 99mTc, 90Y and 166Ho. In addition, Monte Carlo simulations were performed to obtain detailed information about the history of detected photons. The results showed that the use of a broad energy window and the high-energy collimator gave optimal combination of sensitivity, spatial resolution, and primary photon fraction for 90Y Bremsstrahlung imaging, although differences with the medium-energy collimator were small. For 166Ho, the high-energy collimator also slightly outperformed the medium-energy collimator. In comparison with 99mTc, the image quality of both 90Y and 166Ho is degraded by a lower spatial resolution, a lower sensitivity, and larger scatter and collimator penetration fractions. Conclusions/Significance: The quantitative evaluation of the scintillation camera characteristics presented in this study helps to optimize acquisition parameters and supports future analysis of clinical comparisons between RE studies.	[Elschot, Mattijs; Nijsen, Johannes Franciscus Wilhelmus; Dam, Alida Johanna; de Jong, Hugo Wilhelmus Antonius Maria] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands; [Dam, Alida Johanna] Gelre Hosp, Dept Med Technol, Gelderland, Netherlands	Utrecht University; Utrecht University Medical Center; Gelre Hospitals	Elschot, M (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands.	m.elschot@umcutrecht.nl	Nijsen, Frank/C-2839-2018; Elschot, Mattijs/AAD-4362-2021	Nijsen, Frank/0000-0001-7625-2253; Elschot, Mattijs/0000-0002-8056-9103	University Medical Center Utrecht	University Medical Center Utrecht	This work received funding from the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYOUTH JE, 1994, PHYS MED BIOL, V39, P265, DOI 10.1088/0031-9155/39/2/004; Bult W, 2009, Q J NUCL MED MOL IM, V53, P325; CLARKE LP, 1992, J NUCL MED, V33, P161; Da Silva AJ, 2001, J NUCL MED, V42, P772; de Wit TC, 2006, PHYS MED BIOL, V51, P4773, DOI 10.1088/0031-9155/51/19/004; Fabbri C, 2009, CANCER BIOTHER RADIO, V24, P145, DOI 10.1089/cbr.2008.0543; Flamen P, 2008, PHYS MED BIOL, V53, P6591, DOI 10.1088/0031-9155/53/22/019; Gates VL, 2011, J NUCL MED, V52, P72, DOI 10.2967/jnumed.110.080986; Gulec SA, 2007, ARCH SURG-CHICAGO, V142, P675, DOI 10.1001/archsurg.142.7.675; Hendricks JS, 2005, LAUR052675 LOS AL NA; Ho S, 1997, BRIT J RADIOL, V70, P823, DOI 10.1259/bjr.70.836.9486047; Ho S, 1997, EUR J NUCL MED, V24, P293, DOI 10.1007/BF01728766; Ito S, 2009, ANN NUCL MED, V23, P257, DOI 10.1007/s12149-009-0233-9; Kennedy AS, 2010, CANCER J, V16, P163, DOI 10.1097/PPO.0b013e3181d7e8cf; Knesaurek K, 2010, TECHNOL CANCER RES T, V9, P253, DOI 10.1177/153303461000900304; Koch W, 2008, MED RADIOL DIAGN IMA, P75, DOI 10.1007/978-3-540-35423-9_8; Lhommel R, 2010, EUR J NUCL MED MOL I, V37, P1654, DOI 10.1007/s00259-010-1470-9; Lhommel R, 2009, EUR J NUCL MED MOL I, V36, P1696, DOI 10.1007/s00259-009-1210-1; Mansberg R, 2007, EUR J NUCL MED MOL I, V34, P1887, DOI 10.1007/s00259-007-0536-9; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; Minarik D, 2009, PHYS MED BIOL, V54, P5873, DOI 10.1088/0031-9155/54/19/014; National Electrical Manufacturers Association, 2007, NEMA STAND PUBL NU 1; Nijsen JFW, 2004, RADIOLOGY, V231, P491, DOI 10.1148/radiol.2312030594; Nijsen JFW, 1999, EUR J NUCL MED, V26, P699, DOI 10.1007/s002590050440; Rault E, 2010, MED PHYS, V37, P2943, DOI 10.1118/1.3431998; Sabet A, 2011, J NUCL MED, V52, P1063, DOI 10.2967/jnumed.110.083626; Salem R, 2008, AM J CLIN ONCOL-CANC, V31, P431, DOI 10.1097/COC.0b013e318168ef65; Seevinck PR, 2008, MAGN RESON MED, V60, P1466, DOI 10.1002/mrm.21785; Seppenwoolde JH, 2005, MAGN RESON MED, V53, P76, DOI 10.1002/mrm.20320; Shcherbinin S, 2008, PHYS MED BIOL, V53, P4595, DOI 10.1088/0031-9155/53/17/009; SHEN S, 1994, J NUCL MED, V35, P1381; Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70; SORENSON JA, 1975, J NUCL MED, V16, P284; Vandervoort E, 2007, PHYS MED BIOL, V52, P1527, DOI 10.1088/0031-9155/52/5/020; Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8; Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Walrand S, 2010, J NUCL MED, V51, P1969, DOI 10.2967/jnumed.110.080093; Zeintl J, 2010, J NUCL MED, V51, P921, DOI 10.2967/jnumed.109.071571	39	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26174	10.1371/journal.pone.0026174	http://dx.doi.org/10.1371/journal.pone.0026174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073149	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000007
J	Gole, L; Riviere, C; Hayakawa, Y; Rieu, JP				Gole, Laurent; Riviere, Charlotte; Hayakawa, Yoshinori; Rieu, Jean-Paul			A Quorum-Sensing Factor in Vegetative Dictyostelium Discoideum Cells Revealed by Quantitative Migration Analysis	PLOS ONE			English	Article							PERSISTENT RANDOM MOTION; EUKARYOTIC CELLS; AMEBOID CELLS; MOTILITY; CHEMOTAXIS; DYNAMICS; EXTENSION; MOVEMENT; STRATEGY; ADHESION	Background: Many cells communicate through the production of diffusible signaling molecules that accumulate and once a critical concentration has been reached, can activate or repress a number of target genes in a process termed quorum sensing (QS). In the social amoeba Dictyostelium discoideum, QS plays an important role during development. However little is known about its effect on cell migration especially in the growth phase. Methods and Findings: To investigate the role of cell density on cell migration in the growth phase, we use multisite timelapse microscopy and automated cell tracking. This analysis reveals a high heterogeneity within a given cell population, and the necessity to use large data sets to draw reliable conclusions on cell motion. In average, motion is persistent for short periods of time (t <= 5min), but normal diffusive behavior is recovered over longer time periods. The persistence times are positively correlated with the migrated distances. Interestingly, the migrated distance decreases as well with cell density. The adaptation of cell migration to cell density highlights the role of a secreted quorum sensing factor (QSF) on cell migration. Using a simple model describing the balance between the rate of QSF generation and the rate of QSF dilution, we were able to gather all experimental results into a single master curve, showing a sharp cell transition between high and low motile behaviors with increasing QSF. Conclusion: This study unambiguously demonstrates the central role played by QSF on amoeboid motion in the growth phase.	[Gole, Laurent; Riviere, Charlotte; Rieu, Jean-Paul] Univ Lyon 1, CNRS, Lab Phys Matiere Condense & Nanostruct, UMR 5586, F-69622 Villeurbanne, France; [Hayakawa, Yoshinori] Tohoku Univ, Ctr Informat Technol Educ, Sendai, Miyagi 980, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Tohoku University	Gole, L (corresponding author), Univ Lyon 1, CNRS, Lab Phys Matiere Condense & Nanostruct, UMR 5586, F-69622 Villeurbanne, France.	jean-paul.rieu@univ-lyon1.fr		Riviere, Charlotte/0000-0002-5048-5662	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported financially by the French Ministere de l'Enseignement Superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Campos D, 2010, J THEOR BIOL, V267, P526, DOI 10.1016/j.jtbi.2010.09.022; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Delanoe-Ayari H, 2008, CELL MOTIL CYTOSKEL, V65, P314, DOI 10.1002/cm.20262; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Gomer RH, 2011, DEV GROWTH DIFFER, V53, P482, DOI 10.1111/j.1440-169X.2010.01248.x; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Gruver JS, 2010, BIOPHYS J, V99, P367, DOI 10.1016/j.bpj.2010.03.073; Hickson J, 2009, CLIN EXP METASTAS, V26, P67, DOI 10.1007/s10585-008-9177-z; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Kolbinger A, 2005, EUKARYOT CELL, V4, P991, DOI 10.1128/EC.4.6.991-998.2005; Kruppa M, 2009, MYCOSES, V52, P1, DOI 10.1111/j.1439-0507.2008.01626.x; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Maeda Y, 2005, INT REV CYTOL, V244, P287, DOI 10.1016/S0074-7696(05)44007-3; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; Potdar AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009636; POTEL MJ, 1979, J CELL SCI, V36, P281; Rappel WJ, 2002, BIOPHYS J, V83, P1361, DOI 10.1016/S0006-3495(02)73906-4; Ray S, 2011, CELL SIGNAL, V23, P335, DOI 10.1016/j.cellsig.2010.09.017; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Soll DR, 2002, J MUSCLE RES CELL M, V23, P659, DOI 10.1023/A:1024459124427; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Tang L, 2002, P NATL ACAD SCI USA, V99, P1371, DOI 10.1073/pnas.022516099; Tang L, 2001, J BIOL CHEM, V276, P27663, DOI 10.1074/jbc.M102205200; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Van Haastert PJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006814; VanHaastert PJM, 1996, J CELL BIOL, V134, P1543, DOI 10.1083/jcb.134.6.1543; Viswanathan GM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011111; Whitney TJ, 2010, GENET MOL RES, V9, P394, DOI 10.4238/vol9-1gmr752	42	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26901	10.1371/journal.pone.0026901	http://dx.doi.org/10.1371/journal.pone.0026901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073217	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000015
J	Chuck, CP; Chow, HF; Wan, DCC; Wong, KB				Chuck, Chi-Pang; Chow, Hak-Fun; Wan, David Chi-Cheong; Wong, Kam-Bo			Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; IDENTIFICATION; VIRUSES; PROTEINASE; INHIBITOR; GENOME; RATES; HKU1	Background: Coronaviruses (CoVs) can be classified into alphacoronavirus (group 1), betacoronavirus (group 2), and gammacoronavirus (group 3) based on diversity of the protein sequences. Their 3C-like protease (3CL(pro)), which catalyzes the proteolytic processing of the polyproteins for viral replication, is a potential target for anti-coronaviral infection. Methodology/Principal Findings: Here, we profiled the substrate specificities of 3CL(pro) from human CoV NL63 (group 1), human CoV OC43 (group 2a), severe acute respiratory syndrome coronavirus (SARS-CoV) (group 2b) and infectious bronchitis virus (IBV) (group 3), by measuring their activity against a substrate library of 1968 of variants with single substitutions at P5 to P3' positions. The results were correlated with structural properties like side chain volume, hydrophobicity, and secondary structure propensities of substituting residues. All 3CL(pro) prefer Gln at P1 position, Leu at P2 position, basic residues at P3 position, small hydrophobic residues at P4 position, and small residues at P1' and P2' positions. Despite 3CL(pro) from different groups of CoVs share many similarities in substrate specificities, differences in substrate specificities were observed at P4 positions, with IBV 3CL(pro) prefers P4-Pro and SARS-CoV 3CL(pro) prefers P4-Val. By combining the most favorable residues at P3 to P5 positions, we identified super-active substrate sequences 'VARLQ down arrow SGF' that can be cleaved efficiently by all 3CL(pro) with relative activity of 1.7 to 3.2, and 'VPRLQ down arrow SGF' that can be cleaved specifically by IBV 3CL(pro) with relative activity of 4.3. Conclusions/Significance: The comprehensive substrate specificities of 3CL(pro) from each of the group 1, 2a, 2b, and 3 CoVs have been profiled in this study, which may provide insights into a rational design of broad-spectrum peptidomimetic inhibitors targeting the proteases.	[Chuck, Chi-Pang; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chow, Hak-Fun] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wan, David Chi-Cheong] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chuck, CP (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; Chow, Hak-Fun/A-9925-2008; Wan, David C/H-3335-2014	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chow, Hak-Fun/0000-0002-7621-0851; 	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government [09080282]	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government (project number: 09080282) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; BEAUDETTE F. R., 1937, Journal of the American Veterinary Medical Association, V90, P51; Binn L N, 1974, Proc Annu Meet U S Anim Health Assoc, P359; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; CHEEVER FS, 1949, J EXP MED, V90, P181, DOI 10.1084/jem.90.3.181; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Ignjatovic J, 2000, REV SCI TECH OIE, V19, P493, DOI 10.20506/rst.19.2.1228; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lee S, 2008, BIOPHYS CHEM, V134, P185, DOI 10.1016/j.bpc.2008.02.009; Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007; Lin CW, 2004, FEBS LETT, V574, P131, DOI 10.1016/j.febslet.2004.08.017; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; TYRRELL DA, 1966, LANCET, V1, P76; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324; Zhao Q, 2008, J VIROL, V82, P8647, DOI 10.1128/JVI.00298-08; Zhu LL, 2011, ANTIVIR RES, V92, P204, DOI 10.1016/j.antiviral.2011.08.001	38	44	45	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27228	10.1371/journal.pone.0027228	http://dx.doi.org/10.1371/journal.pone.0027228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073294	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900012
J	Qi, F; Wang, C; Liu, YL; Kaleem, I; Li, Q; Li, C				Qi, Feng; Wang, Chao; Liu, Yanli; Kaleem, Imdad; Li, Qian; Li, Chun			Transcriptional Profiling of Protein Expression Related Genes of Pichia pastoris under Simulated Microgravity	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; BIOSYNTHESIS; GLYCYRRHIZIN; DISPLAY; REVEALS; GROWTH; PCR	The physiological responses and transcription profiling of Pichia pastoris GS115 to simulated microgravity (SMG) were substantially changed compared with normal gravity (NG) control. We previously reported that the recombinant P. pastoris grew faster under SMG than NG during methanol induction phase and the efficiencies of recombinant enzyme production and secretion were enhanced under SMG, which was considered as the consequence of changed transcriptional levels of some key genes. In this work, transcriptiome profiling of P. pastoris cultured under SMG and NG conditions at exponential and stationary phases were determined using next-generation sequencing (NGS) technologies. Four categories of 141 genes function as methanol utilization, protein chaperone, RNA polymerase and protein transportation or secretion classified according to Gene Ontology (GO) were chosen to be analyzed on the basis of NGS results. And 80 significantly changed genes were weighted and estimated by Cluster 3.0. It was found that most genes of methanol metabolism (85% of 20 genes) and protein transportation or secretion (82.2% of 45 genes) were significantly up-regulated under SMG. Furthermore the quantity and fold change of up-regulated genes in exponential phase of each category were higher than those of stationary phase. The results indicate that the up-regulated genes of methanol metabolism and protein transportation or secretion mainly contribute to enhanced production and secretion of the recombinant protein under SMG.	[Qi, Feng; Wang, Chao; Liu, Yanli; Kaleem, Imdad; Li, Qian; Li, Chun] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Li, Chun] Shihezi Univ, Sch Chem & Chem Engn, Shihezi, Peoples R China; [Qi, Feng] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China	Beijing Institute of Technology; Shihezi University; Tianjin University Science & Technology	Qi, F (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	lichun@bit.edu.cn	Li, Chun/B-3292-2013	Qi, Feng/0000-0001-6349-179X	Natural Science Foundation of China [20976014]; Natural Science Foundation of Beijing [2112035]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work is supported by Natural Science Foundation of China (20976014) and Natural Science Foundation of Beijing (2112035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PW, 2004, MICROGRAVITY SCI TEC, V15, P39, DOI 10.1007/BF02870967; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Demain AL, 2001, CHEM REC, V1, P333, DOI 10.1002/tcr.1018; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang A, 2000, LETT APPL MICROBIOL, V31, P39; Feng SJ, 2006, J MOL CATAL B-ENZYM, V43, P63, DOI 10.1016/j.molcatb.2006.06.016; Gill RT, 1999, APPL ENVIRON MICROB, V65, P5386; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Johanson K, 2006, BIOTECHNOL BIOENG, V93, P1050, DOI 10.1002/bit.20810; Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4; Lee EJ, 2006, ANAL BIOCHEM, V357, P299, DOI 10.1016/j.ab.2006.06.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Qi F, 2011, J CHEM TECHNOL BIOT, V86, P505, DOI 10.1002/jctb.2541; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Sambrook J, 2001, MOL CLONING LAB MANU; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Sreekrishna K, 1997, GENE, V190, P55, DOI 10.1016/S0378-1119(96)00672-5; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	24	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26613	10.1371/journal.pone.0026613	http://dx.doi.org/10.1371/journal.pone.0026613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073176	gold, Green Submitted, Green Published			2022-12-25	WOS:000297154900027
J	Liu, XL; Song, YX; Lu, HJ; Tang, B; Piao, XY; Hou, N; Peng, S; Jiang, N; Yin, JG; Liu, MY; Chen, QJ				Liu, Xiaolei; Song, Yanxia; Lu, Huijun; Tang, Bin; Piao, Xianyu; Hou, Nan; Peng, Shuai; Jiang, Ning; Yin, Jigang; Liu, Mingyuan; Chen, Qijun			Transcriptome of Small Regulatory RNAs in the Development of the Zoonotic Parasite Trichinella spiralis	PLOS ONE			English	Article							ENDOGENOUS SIRNAS; GENE-EXPRESSION; MICRORNAS; IDENTIFICATION; DROSOPHILA; 21U-RNAS; PATHWAY; PLANT; PIWI; BIOGENESIS	Background: Trichinella spiralis is a parasite with unique features. It is a multicellular organism but with an intracellular parasitization and development stage. T. spiralis is the helminthic pathogen that causes zoonotic trichinellosis and afflicts more than 10 million people worldwide, whereas the parasite's biology, especially the developmental regulation is largely unknown. In other organisms, small non-coding RNAs, such as microRNAs (miRNA) and small interfering RNAs (siRNA) execute post-transcriptional regulation by translational repression or mRNA degradation, and a large number of miRNAs have been identified in diverse species. In T. spiralis, the profile of small non-coding RNAs and their function remains poorly understood. Methodology and Principal Findings: Here, the transcriptional profiles of miRNA and siRNA in three developmental stages of T. spiralis in the rat host were investigated, and compared by high-throughput cDNA sequencing technique ("RNA-seq"). 5,443,641 unique sequence tags were obtained. Of these, 21 represented conserved miRNAs related to 13 previously identified metazoan miRNA families and 213 were novel miRNAs so far unique to T. spiralis. Some of these miRNAs exhibited stage-specific expression. Expression of miRNAs was confirmed in three stages of the life cycle by qRT-PCR and northern blot analysis. In addition, endogenous siRNAs (endo-siRNAs) were found mainly derived from natural antisense transcripts (NAT) and transposable elements (TE) in the parasite. Conclusions and Significance: We provide evidence for the presence of miRNAs and endo-siRNAs in T. spiralis. The miRNAs accounted for the major proportion of the small regulatory RNA population of T. spiralis, while fewer endogenous siRNAs were found. The finding of stage-specific expression patterns of the miRNAs in different developmental stages of T. spiralis suggests that miRNAs may play important roles in parasite development. Our data provide a basis for further understanding of the molecular regulation and functional evolution of miRNAs in parasitic nematodes.	[Liu, Xiaolei; Song, Yanxia; Lu, Huijun; Tang, Bin; Peng, Shuai; Jiang, Ning; Yin, Jigang; Liu, Mingyuan; Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Piao, Xianyu; Hou, Nan; Chen, Qijun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China; [Song, Yanxia] Jilin Univ, Affiliated Hosp 1, Biol Therapy Ctr, Changchun 130023, Peoples R China	Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College; Jilin University	Liu, XL (corresponding author), Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China.	liumy@jlu.edu.cn; cqj@jlu.edu.cn	yin, jigang/GWV-1397-2022		National Natural Science Foundation of China (NSFC) [30625029, 30825033, 31030064, 30950110328, 81070311]; Institute of Pathogen Biology, CAMS [2008IPB204]; national science and technology specific projects [2008ZX-10004-011, 2008ZX10401]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology, CAMS; national science and technology specific projects	This study was supported by the National Natural Science Foundation of China (NSFC 30625029, 30825033, 31030064, 30950110328, 81070311), the intramural grant from Institute of Pathogen Biology, CAMS (2008IPB204), and the national science and technology specific projects (2008ZX-10004-011, 2008ZX10401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MX, 2011, EXP PARASITOL, V128, P116, DOI 10.1016/j.exppara.2011.02.019; Chen MX, 2011, PARASITOL RES; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cucher M, 2011, INT J PARASITOL, V41, P439, DOI 10.1016/j.ijpara.2010.11.010; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; DESPOMMIER DD, 1977, PARASITOLOGY, V74, P109, DOI 10.1017/S0031182000047570; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Friedlander MR, 2009, P NATL ACAD SCI USA, V106, P11546, DOI 10.1073/pnas.0905222106; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu MY, 2001, PARASITE, V8, pS34, DOI 10.1051/parasite/200108s2034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998c; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wakelin D, 1996, INT J PARASITOL, V26, P471, DOI 10.1016/0020-7519(96)89377-5; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Zarlenga DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/pnas.0602466103; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	63	14	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2011	6	11							e26448	10.1371/journal.pone.0026448	http://dx.doi.org/10.1371/journal.pone.0026448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849UN	22096484	Green Submitted, Green Published, gold			2022-12-25	WOS:000297150900012
J	Sassi, Y; Abi-Gerges, A; Fauconnier, J; Mougenot, N; Reiken, S; Haghighi, K; Kranias, EG; Marks, AR; Lacampagne, A; Engelhardt, S; Hatem, SN; Lompre, AM; Hulot, JS				Sassi, Yassine; Abi-Gerges, Aniella; Fauconnier, Jeremy; Mougenot, Nathalie; Reiken, Steven; Haghighi, Kobra; Kranias, Evangelia G.; Marks, Andrew R.; Lacampagne, Alain; Engelhardt, Stefan; Hatem, Stephane N.; Lompre, Anne-Marie; Hulot, Jean-Sebastien			Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes	FASEB JOURNAL			English	Article						cyclic nucleotides; MRP proteins; phosphodiesterases	SIGNAL-TRANSDUCTION; CELLULAR EXPORT; CA2+ CHANNELS; HEART; RESISTANCE; TRANSPORTER; EPAC; PUMP; ATP; COMPARTMENTATION	Recent studies indicate that members of the multidrug-resistance protein (MRP) family belonging to ATP binding cassette type C (ABCC) membrane proteins extrude cyclic nucleotides from various cell types. This study aimed to determine whether MRP proteins regulate cardiac cAMP homeostasis. Here, we demonstrate that MRP4 is the predominant isoform present at the plasma membrane of cardiacmyocytes and that it mediates the efflux of cAMP in these cells. MRP4-deficient mice displayed enhanced cardiac myocyte cAMP formation, contractility, and cardiac hypertrophy at 9 mo of age, an effect that was compensated transiently by increased phosphodiesterase expression at young age. These findings suggest that cAMP extrusion via MRP4 acts together with phosphodiesterases to control cAMP levels in cardiac myocytes.-Sassi, Y., Abi-Gerges, A., Fauconnier, J., Mougenot, N., Reiken, S., Haghighi, K., Kranias, E. G., Marks, A. R., Lacampagne, A., Engelhardt, S., Hatem, S. N., Lompre, A.-M., Hulot, J. S. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. FASEB J. 26, 1009-1017 (2012). www.fasebj.org	[Hulot, Jean-Sebastien] Univ Paris 06, Fac Med Pitie Salpetriere, INSERM, UMR S 956, F-75013 Paris, France; [Sassi, Yassine; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmakol & Toxikol, Munich, Germany; [Fauconnier, Jeremy; Lacampagne, Alain] Univ Montpellier, INSERM, U1046, F-34059 Montpellier, France; [Mougenot, Nathalie] Univ Paris 06, INSERM, IFR CMV 14, F-75013 Paris, France; [Reiken, Steven; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Haghighi, Kobra; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Hulot, Jean-Sebastien] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Technical University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Columbia University; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai	Hulot, JS (corresponding author), Univ Paris 06, Fac Med Pitie Salpetriere, INSERM, UMR S 956, 91 Bvd Hop, F-75013 Paris, France.	jean-sebastien.hulot@psl.aphp.fr	Lacampagne, Alain/S-3719-2016; Hulot, Jean-Sébastien/A-2278-2016; Hatem, Stephane/D-1016-2017; Abi-Gerges, Aniella/AAH-5250-2020; LOMPRE, Anne-Marie/H-2872-2013; Engelhardt, Stefan/AAA-9329-2019	Lacampagne, Alain/0000-0003-0264-1787; Hulot, Jean-Sébastien/0000-0001-5463-6117; Abi-Gerges, Aniella/0000-0001-9974-4023; Engelhardt, Stefan/0000-0001-5378-8661; Sassi, Yassine/0000-0002-7807-1728; hatem, stephane/0000-0002-9790-0755	Agence Nationale de la Recherche (ANR) [09JCJC0112]; Fondation de France [2006005606]; Fondation Leducq through CAERUS network [05CVD03]; U.S. National Institutes of Health [NIH HL26057, HL64018]; French Ministere de l'Education Nationale et de la Recherche Scientifique (MENRS); Fondation pour la Recherche Medicale (FRM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL026057, R37HL026057, R01HL064018] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation de France(Fondation de France); Fondation Leducq through CAERUS network(Leducq Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministere de l'Education Nationale et de la Recherche Scientifique (MENRS); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Prof. Piet Borst (NKI-Amsterdam, Amsterdam, The Netherlands) for helpful discussions and Dr. Chen Yan (University of Rochester, Rochester, NY, USA) for providing the PDE3A antibody. This work was supported by grants from the Agence Nationale de la Recherche (ANR; 09JCJC0112) and Fondation de France (2006005606) to J.S.H., by the Fondation Leducq through the CAERUS network (research agreement 05CVD03 to A.-M. L., A. R. M., and E. G. K.), and by the U.S. National Institutes of Health (grants NIH HL26057 and HL64018). Y.S. is the recipient of a Ph.D. fellowship from the French Ministere de l'Education Nationale et de la Recherche Scientifique (MENRS) and from Fondation pour la Recherche Medicale (FRM). J.S.H, S.N.H., A.-M. L. and S. E. were involved in the development of the overall study design. Y.S. planned and performed most of the experiments; A. A. G. assisted in in vitro experiments; J.F. performed the evaluation in isolated cardiac myocytes with the help of Y.S. and A. L.; Y.S., J.S.H., and N.M. performed the in vivo evaluations in mice; S. R. performed the RyR2 immunoblots. J.S.H, Y.S., S.N.H., and A.-M. L wrote the manuscript with the help of A. R. M., S. E., and A. L.; A. R. M., E. G. K., K. H., and S.N.H. assisted in conceptual aspects of the studies and interpretation of the data. All authors discussed results and contributed intellectually to the manuscript.	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Abi-Gerges A, 2009, CIRC RES, V105, P784, DOI 10.1161/CIRCRESAHA.109.197947; Akanuma S, 2010, J PHARMACOL EXP THER, V333, P912, DOI 10.1124/jpet.109.165332; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Boixel C, 2001, CIRC RES, V89, P607, DOI 10.1161/hh1901.096702; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Bristow MR, 1998, LANCET, V352, P8; Cazorla O, 2009, P NATL ACAD SCI USA, V106, P14144, DOI 10.1073/pnas.0812536106; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; Dazert P, 2003, AM J PATHOL, V163, P1567, DOI 10.1016/S0002-9440(10)63513-4; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Wolf CJF, 2007, FEBS J, V274, P439, DOI 10.1111/j.1742-4658.2006.05591.x; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Feldman DS, 2005, NAT CLIN PRACT CARD, V2, P475, DOI 10.1038/ncpcardio0309; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; GAUDIN C, 1995, J CLIN INVEST, V95, P1676, DOI 10.1172/JCI117843; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; HAMET P, 1989, J BIOL CHEM, V264, P12364; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Henaff M, 2001, FASEB J, V15, P99, DOI 10.1096/fj.01-0389fje; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; KAPOOR A K, 1977, Indian Journal of Physiology and Pharmacology, V21, P133; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Mendez M, 2005, AM J PHYSIOL-HEART C, V288, pH2111, DOI 10.1152/ajpheart.00838.2004; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; MOVSESIAN MA, 1991, J CLIN INVEST, V88, P15, DOI 10.1172/JCI115272; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ostrom RS, 2000, J BIOL CHEM, V275, P11735, DOI 10.1074/jbc.275.16.11735; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Rodriguez MR, 2011, GASTROENTEROLOGY, V140, P1292, DOI 10.1053/j.gastro.2010.12.053; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Takahashi K, 2002, HEART VESSELS, V16, P249, DOI 10.1007/s003800200032; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	51	50	52	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1009	1017		10.1096/fj.11-194027	http://dx.doi.org/10.1096/fj.11-194027			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22090316	Green Published			2022-12-25	WOS:000300949300006
J	Khanduja, JS; Muniyappa, K				Khanduja, Jasbeer Singh; Muniyappa, K.			Functional Analysis of DNA Replication Fork Reversal Catalyzed by Mycobacterium tuberculosis RuvAB Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RUVA; MIGRATION IN-VITRO; HOLLIDAY JUNCTION; BRANCH MIGRATION; CRYSTAL-STRUCTURE; LAGGING-STRAND; RECOMBINATIONAL REPAIR; HUMAN HLTF; REGRESSION; COMPLEX	Initially discovered in Escherichia coli, RuvAB proteins are ubiquitous in bacteria and play a dual role as molecular motor proteins responsible for branch migration of the Holliday junction(s) and reversal of stalled replication forks. Despite mounting genetic evidence for a crucial role of RuvA and RuvB proteins in reversal of stalled replication forks, the mechanistic aspects of this process are still not fully understood. Here, we elucidate the ability of Mycobacterium tuberculosis RuvAB (MtRuvAB) complex to catalyze the reversal of replication forks using a range of DNA replication fork substrates. Our studies show that MtRuvAB, unlike E. coli RuvAB, is able to drive replication fork reversal via the formation of Holliday junction intermediates, suggesting that RuvAB-catalyzed fork reversal involves concerted unwinding and annealing of nascent leading and lagging strands. We also demonstrate the reversal of replication forks carrying hemi-replicated DNA, indicating that MtRuvAB complex-catalyzed fork reversal is independent of symmetry at the fork junction. The fork reversal reaction catalyzed by MtRuvAB is coupled to ATP hydrolysis, is processive, and culminates in the formation of an extended reverse DNA arm. Notably, we found that sequence heterology failed to impede the fork reversal activity of MtRuvAB. We discuss the implications of these results in the context of recognition and processing of varied types of replication fork structures by RuvAB proteins.	[Khanduja, Jasbeer Singh; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			European Community [CSI_LTB LSHP-CT-2007-037235]; Department of Biotechnology, New Delhi under the "Centre of Excellence" in research on mycobacteria; J. C. Bose National Fellowship	European Community(European Commission); Department of Biotechnology, New Delhi under the "Centre of Excellence" in research on mycobacteria; J. C. Bose National Fellowship	This work was supported by European Community Grant CSI_LTB LSHP-CT-2007-037235, the Department of Biotechnology, New Delhi, under the "Centre of Excellence" in research on mycobacteria, and a J. C. Bose National Fellowship (to K. M.).	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Carr AM, 2002, SCIENCE, V297, P557, DOI 10.1126/science.1075456; Chamberlain D, 1998, J MOL BIOL, V284, P385, DOI 10.1006/jmbi.1998.2177; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Dennis C, 2004, EMBO J, V23, P2413, DOI 10.1038/sj.emboj.7600249; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Grompone G, 2004, EMBO REP, V5, P607, DOI 10.1038/sj.embor.7400167; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hiom K, 1996, GENES CELLS, V1, P443, DOI 10.1046/j.1365-2443.1996.d01-253.x; HIOM K, 1995, CELL, V80, P787, DOI 10.1016/0092-8674(95)90357-7; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; IWASAKI H, 1992, GENE DEV, V6, P2214, DOI 10.1101/gad.6.11.2214; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Khanduja JS, 2009, BIOCHEMISTRY-US, V48, P27, DOI 10.1021/bi8016526; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MULLER B, 1993, J BIOL CHEM, V268, P17179; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PARSONS CA, 1995, EMBO J, V14, P5736, DOI 10.1002/j.1460-2075.1995.tb00260.x; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; PARSONS CA, 1993, J MOL BIOL, V232, P397, DOI 10.1006/jmbi.1993.1399; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Prabu JR, 2009, BBA-PROTEINS PROTEOM, V1794, P1001, DOI 10.1016/j.bbapap.2009.04.003; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Rafferty JB, 1998, J MOL BIOL, V278, P105, DOI 10.1006/jmbi.1998.1697; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHIBA T, 1991, P NATL ACAD SCI USA, V88, P8445, DOI 10.1073/pnas.88.19.8445; SHURVINTON CE, 1984, MOL GEN GENET, V194, P322, DOI 10.1007/BF00383535; Skalka A., 1974, MECHANISMS RECOMBINA, P421; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Svoboda DL, 1995, P NATL ACAD SCI USA, V92, P11975, DOI 10.1073/pnas.92.26.11975; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	78	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1345	1360		10.1074/jbc.M111.304741	http://dx.doi.org/10.1074/jbc.M111.304741			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094465	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000299170300049
J	Jelen, S; Wacker, S; Aponte-Santamaria, C; Skott, M; Rojek, A; Johanson, U; Kjellbom, P; Nielsen, S; de Groot, BL; Rutzler, M				Jelen, Sabina; Wacker, Soeren; Aponte-Santamaria, Camilo; Skott, Martin; Rojek, Aleksandra; Johanson, Urban; Kjellbom, Per; Nielsen, Soren; de Groot, Bert L.; Ruetzler, Michael			Aquaporin-9 Protein Is the Primary Route of Hepatocyte Glycerol Uptake for Glycerol Gluconeogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL SOLUTE CHANNEL; RAT HEPATOCYTES; MOLECULAR CHARACTERIZATION; TETRACYCLINE RESISTANCE; WATER PERMEABILITY; LIVER; EXPRESSION; CLONING; PHOSPHORYLATION; SELECTIVITY	It has been hypothesized that aquaporin-9 (AQP9) is part of the unknown route of hepatocyte glycerol uptake. In a previous study, leptin receptor-deficient wild-type mice became diabetic and suffered from fasting hyperglycemia whereas isogenic AQP9(-/-) knock-out mice remained normoglycemic. The reason for this improvement in AQP9(-/-) mice was not established before. Here, we show increased glucose output (by 123% +/- 36% S. E.) in primary hepatocyte culture when 0.5 mM extracellular glycerol was added. This increase depended on AQP9 because it was absent in AQP9(-/-) cells. Likewise, the increase was abolished by 25 mu M HTS13286 (IC50 similar to 2 mu M), a novel AQP9 inhibitor, which we identified in a small molecule library screen. Similarly, AQP9 deletion or chemical inhibition eliminated glycerol-enhanced glucose output in perfused liver preparations. The following control experiments suggested inhibitor specificity to AQP9: (i) HTS13286 affected solute permeability in cell lines expressing AQP9, but not in cell lines expressing AQPs 3, 7, or 8. (ii) HTS13286 did not influence lactate-and pyruvate-dependent hepatocyte glucose output. (iii) HTS13286 did not affect glycerol kinase activity. Our experiments establish AQP9 as the primary route of hepatocyte glycerol uptake for gluconeogenesis and thereby explain the previously observed, alleviated diabetes in leptin receptor-deficient AQP9(-/-) mice.	[Jelen, Sabina; Skott, Martin; Rojek, Aleksandra; Nielsen, Soren; Ruetzler, Michael] Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, DK-8000 Aarhus C, Denmark; [Wacker, Soeren; Aponte-Santamaria, Camilo; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Johanson, Urban; Kjellbom, Per] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, S-22100 Lund, Sweden	Aarhus University; Max Planck Society; Lund University	Nielsen, S (corresponding author), Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, Wilhelm Meyers Alle, DK-8000 Aarhus C, Denmark.	sn@ana.au.dk; mrr@ana.au.dk	Rutzler, Michael/ABE-7914-2020; Johanson, Urban/D-4344-2015; Johanson, Urban/AHE-8231-2022	Rutzler, Michael/0000-0001-5597-8880; Johanson, Urban/0000-0001-8862-128X; Johanson, Urban/0000-0001-8862-128X; Aponte-Santamaria, Camilo/0000-0002-8427-6965	Lundbeck Foundation [R17A1742]; Marie Curie Research Training Network; Nordic Research Grant for Water Imbalance Related Disorders; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; The Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Marie Curie Research Training Network(European Commission); Nordic Research Grant for Water Imbalance Related Disorders; European Drug Initiative on Channels and Transporters; The Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by Lundbeck Foundation Grant R17A1742, a Marie Curie Research Training Network grant, a Nordic Research Grant for Water Imbalance Related Disorders, and European Drug Initiative on Channels and Transporters Grant HEALTH-F4-2007-201924. The Water and Salt Research Center was established and funded by The Danish National Research Foundation.	Andersen B, 1999, BIOCHEM J, V342, P545, DOI 10.1042/0264-6021:3420545; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BUBLITZ C, 1954, J BIOL CHEM, V211, P951; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; DANG LX, 1995, J AM CHEM SOC, V117, P6954, DOI 10.1021/ja00131a018; Detmers FJM, 2006, J BIOL CHEM, V281, P14207, DOI 10.1074/jbc.M513072200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HILLEN W, 1983, J MOL BIOL, V169, P707, DOI 10.1016/S0022-2836(83)80166-1; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Ibu J O, 1986, Scand J Gastroenterol Suppl, V124, P75; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Klokkers J, 2009, AM J PHYSIOL-RENAL, V297, pF693, DOI 10.1152/ajprenal.00136.2009; Koyama Y, 1997, J BIOL CHEM, V272, P30329, DOI 10.1074/jbc.272.48.30329; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; LI CC, 1983, J CELL PHYSIOL, V117, P230, DOI 10.1002/jcp.1041170214; Ma TH, 1997, BIOCHEM BIOPH RES CO, V240, P324, DOI 10.1006/bbrc.1997.7664; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Morinaga T, 2002, BIOCHEM BIOPH RES CO, V294, P630, DOI 10.1016/S0006-291X(02)00536-3; NEWSHOLME EA, 1967, BIOCHIM BIOPHYS ACTA, V132, P338, DOI 10.1016/0005-2744(67)90153-2; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Phillips JW, 2002, EUR J BIOCHEM, V269, P792, DOI 10.1046/j.0014-2956.2001.02687.x; PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SESTOFT L, 1975, BIOCHIM BIOPHYS ACTA, V375, P462, DOI 10.1016/0005-2736(75)90360-0; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Westergaard N, 1998, BBA-MOL CELL RES, V1402, P261, DOI 10.1016/S0167-4889(98)00016-0	35	83	91	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44319	44325		10.1074/jbc.M111.297002	http://dx.doi.org/10.1074/jbc.M111.297002			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081610	hybrid, Green Published			2022-12-25	WOS:000298645500003
J	Abbasi, K; DuBois, KN; Dacks, JB; Field, MC				Abbasi, Kanwal; DuBois, Kelly N.; Dacks, Joel B.; Field, Mark C.			A Novel Rho-Like Protein TbRHP Is Involved in Spindle Formation and Mitosis in Trypanosomes	PLOS ONE			English	Article							AFRICAN TRYPANOSOME; GTPASE FAMILY; LOWE SYNDROME; LIFE-CYCLE; CELL-CYCLE; BRUCEI; CYTOKINESIS; GENOME; HOMOLOG; CRUZI	Background: In animals and fungi Rho subfamily small GTPases are involved in signal transduction, cytoskeletal function and cellular proliferation. These organisms typically possess multiple Rho paralogues and numerous downstream effectors, consistent with the highly complex contributions of Rho proteins to cellular physiology. By contrast, trypanosomatids have a much simpler Rho-signaling system, and the Trypanosoma brucei genome contains only a single divergent Rho-related gene, TbRHP (Tb927.10.6240). Further, only a single RhoGAP-like protein (Tb09.160.4180) is annotated, contrasting with the >70 Rho GAP proteins from Homo sapiens. We wished to establish the function(s) of TbRHP and if Tb09.160.4180 is a potential GAP for this protein. Methods/Findings: TbRHP represents an evolutionarily restricted member of the Rho GTPase clade and is likely trypanosomatid restricted. TbRHP is expressed in both mammalian and insect dwelling stages of T. brucei and presents with a diffuse cytoplasmic location and is excluded from the nucleus. RNAi ablation of TbRHP results in major cell cycle defects and accumulation of multi-nucleated cells, coinciding with a loss of detectable mitotic spindles. Using yeast two hybrid analysis we find that TbRHP interacts with both Tb11.01.3180 (TbRACK), a homolog of Rho-kinase, and the sole trypanosome RhoGAP protein Tb09.160.4180, which is related to human OCRL. Conclusions: Despite minimization of the Rho pathway, TbRHP retains an important role in spindle formation, and hence mitosis, in trypanosomes. TbRHP is a partner for TbRACK and an OCRL-related trypanosome Rho-GAP.	[Abbasi, Kanwal; DuBois, Kelly N.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Cambridge; University of Alberta	Abbasi, K (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Dacks, Joel/AAE-3308-2021; Field, Mark/AAD-6455-2021	Dacks, Joel/0000-0003-4520-5694; Field, Mark/0000-0002-4866-2885	Wellcome Trust; Commonwealth Scholarships scheme	Wellcome Trust(Wellcome TrustEuropean Commission); Commonwealth Scholarships scheme	Funding for this work was from the Wellcome Trust and the Commonwealth Scholarships scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Allen CL, 2007, MOL BIOCHEM PARASIT, V156, P175, DOI 10.1016/j.molbiopara.2007.07.020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Castagnetti S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000512; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; de Melo LDB, 2004, BIOCHEM BIOPH RES CO, V323, P1009, DOI 10.1016/j.bbrc.2004.08.197; De Melo LDB, 2006, BIOCHEM BIOPH RES CO, V345, P617, DOI 10.1016/j.bbrc.2006.04.075; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGSTLER M, 2007, TRYPANOSOMES GENOME; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Field MC, 2008, TRENDS PARASITOL, V24, P253, DOI 10.1016/j.pt.2008.03.005; Field MC, 2005, TRENDS PARASITOL, V21, P447, DOI 10.1016/j.pt.2005.08.008; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Loovers HM, 2007, TRAFFIC, V8, P618, DOI 10.1111/j.1600-0854.2007.00546.x; Loovers HM, 2003, J BIOL CHEM, V278, P5652, DOI 10.1074/jbc.M208396200; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Nepomuceno-Silva JL, 2004, GENE, V327, P221, DOI 10.1016/j.gene.2003.11.010; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Ploubidou A, 1999, J CELL SCI, V112, P4641; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Swan LE, 2010, P NATL ACAD SCI USA, V107, P3511, DOI 10.1073/pnas.0914658107; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Vlahou G, 2006, EUR J CELL BIOL, V85, P947, DOI 10.1016/j.ejcb.2006.04.011; Wherlock M, 2002, J CELL SCI, V115, P239; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26890	10.1371/journal.pone.0026890	http://dx.doi.org/10.1371/journal.pone.0026890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096505	gold, Green Published, Green Submitted			2022-12-25	WOS:000297553900014
J	Wantia, N; Rodriguez, N; Cirl, C; Ertl, T; Durr, S; Layland, LE; Wagner, H; Miethke, T				Wantia, Nina; Rodriguez, Nuria; Cirl, Christine; Ertl, Tanja; Duerr, Susanne; Layland, Laura E.; Wagner, Hermann; Miethke, Thomas			Toll-Like Receptors 2 and 4 Regulate the Frequency of IFN gamma-Producing CD4(+) T-Cells during Pulmonary Infection with Chlamydia pneumoniae	PLOS ONE			English	Article							MYD88-DEFICIENT DENDRITIC CELLS; IN-VIVO; ACTIVATION; TLR2; MACROPHAGES; ENDOTOXIN; INNATE; ALPHA	TLR2 and TLR4 are crucial for recognition of Chlamydia pneumoniae in vivo, since infected TLR2/4 double-deficient mice are unable to control the infection as evidenced by severe loss of body weight and progressive lethal pneumonia. Unexpectedly, these mice display higher pulmonary levels of the protective cytokine IFN gamma than wild type mice. We show here, that antigen-specific CD4(+) T-cells are responsible for the observed IFN gamma-secretion in vivo and their frequency is higher in TLR2/4 double-deficient than in wild type mice. The capacity of TLR2/4 double-deficient dendritic cells to re-stimulate CD4(+) T-cells did not differ from wild type dendritic cells. However, the frequency of CD4(+)CD25(+)Foxp3(+) T-cells was considerably higher in wild type compared to TLR2/4 double-deficient mice and was inversely related to the number of IFN gamma-secreting CD4(+) effector T-cells. Despite increased IFN gamma-levels, at least one IFN gamma-mediated response, protective NO-secretion, could not be induced in the absence of TLR2 and 4. In summary, CD4(+)CD25(+)Foxp3(+) regulatory T-cells fail to expand in the absence of TLR2 and TLR4 during pulmonary infection with C. pneumoniae, which in turn enhances the frequency of CD4(+)IFN gamma(+) effector T-cells. Failure of IFN gamma to induce NO in TLR2/4 double-deficient cells represents one possible mechanism why TLR2/4 double-deficient mice are unable to control pneumonia caused by C. pneumoniae and succumb to the infection.	[Wantia, Nina; Rodriguez, Nuria; Cirl, Christine; Ertl, Tanja; Duerr, Susanne; Layland, Laura E.; Wagner, Hermann; Miethke, Thomas] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany	Technical University of Munich	Wantia, N (corresponding author), Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany.	Thomas.Miethke@mikrobio.med.tum.de			Bayerische Forschungsstiftung, FORINGEN [VA5]	Bayerische Forschungsstiftung, FORINGEN	The work was supported by the Bayerische Forschungsstiftung, FORINGEN, Project VA5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; da Costa CUP, 2004, EUR J IMMUNOL, V34, P2874, DOI 10.1002/eji.200425101; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Rodriguez N, 2005, J IMMUNOL, V174, P4836, DOI 10.4049/jimmunol.174.8.4836; Rodriguez N, 2008, J LEUKOCYTE BIOL, V84, P1585, DOI 10.1189/jlb.0508304; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rothfuchs AG, 2004, J IMMUNOL, V172, P2407, DOI 10.4049/jimmunol.172.4.2407; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SUMMERSGILL JT, 1995, INFECT IMMUN, V63, P2801, DOI 10.1128/IAI.63.7.2801-2803.1995; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200	23	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26101	10.1371/journal.pone.0026101	http://dx.doi.org/10.1371/journal.pone.0026101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096480	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800004
J	Rostami, E; Krueger, F; Zoubak, S; Dal Monte, O; Raymont, V; Pardini, M; Hodgkinson, CA; Goldman, D; Risling, M; Grafman, J				Rostami, Elham; Krueger, Frank; Zoubak, Serguei; Dal Monte, Olga; Raymont, Vanessa; Pardini, Matteo; Hodgkinson, Colin A.; Goldman, David; Risling, Marten; Grafman, Jordan			BDNF Polymorphism Predicts General Intelligence after Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GENE; FACTOR VAL66MET POLYMORPHISM; TRKB MESSENGER-RNA; BIPOLAR DISORDER; CONFERS SUSCEPTIBILITY; MOLECULAR-CLONING; APOLIPOPROTEIN-E; CANDIDATE GENES; HUMAN-MEMORY; ASSOCIATION	Neuronal plasticity is a fundamental factor in cognitive outcome following traumatic brain injury. Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays an important role in this process. While there are many ways to measure cognitive outcome, general cognitive intelligence is a strong predictor of everyday decision-making, occupational attainment, social mobility and job performance. Thus it is an excellent measure of cognitive outcome following traumatic brain injury (TBI). Although the importance of the single-nucleotide polymorphisms polymorphism on cognitive function has been previously addressed, its role in recovery of general intelligence following TBI is unknown. We genotyped male Caucasian Vietnam combat veterans with focal penetrating TBI (pTBI) (n = 109) and non-head injured controls (n = 38) for 7 BDNF single-nucleotide polymorphisms. Subjects were administrated the Armed Forces Qualification Test (AFQT) at three different time periods: pre-injury on induction into the military, Phase II (10-15 years post-injury, and Phase III (30-35 years post-injury). Two single-nucleotide polymorphisms, rs7124442 and rs1519480, were significantly associated with post-injury recovery of general cognitive intelligence with the most pronounced effect at the Phase II time point, indicating lesion-induced plasticity. The genotypes accounted for 5% of the variance of the AFQT scores, independently of other significant predictors such as pre-injury intelligence and percentage of brain volume loss. These data indicate that genetic variations in BDNF play a significant role in lesion-induced recovery following pTBI. Identifying the underlying mechanism of this brain-derived neurotrophic factor effect could provide insight into an important aspect of post-traumatic cognitive recovery.	[Rostami, Elham; Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Dal Monte, Olga] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, NIH, Bethesda, MD USA; [Zoubak, Serguei; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Zoubak, Serguei] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Ophtalmol & Genet, Genoa, Italy; [Pardini, Matteo] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Zoubak, Serguei] Henry Jackson Fdn Adv Mil Med, Rockville, MD USA; [Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ USA; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Karolinska Institutet; George Mason University; George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Uniformed Services University of the Health Sciences - USA; University of Genoa; University of Genoa; Kessler Institute for Rehabilitation; Johns Hopkins University; Imperial College London	Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	jgrafman@kesslerfoundation.org	Goldman, David/F-9772-2010; Pardini, Matteo/F-8414-2010; Majid, Salma/AAT-2616-2020; Dal Monte, Olga/P-3759-2018	Goldman, David/0000-0002-1724-5405; Pardini, Matteo/0000-0002-4740-1982; Majid, Salma/0000-0002-1724-5405; Dal Monte, Olga/0000-0002-7823-4769; Hodgkinson, Colin/0000-0002-5365-8119; Grafman, Jordan H./0000-0001-8645-4457	U.S. National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research and Material Command; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study). No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Conner JM, 1997, J NEUROSCI, V17, P2295; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Domschke K, 2010, INT J NEUROPSYCHOPH, V13, P93, DOI 10.1017/S1461145709000030; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Faul MXL, 2010, TRAUMATIC BRAIN INJU, P1; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayashi M, 2001, BRAIN RES, V918, P191, DOI 10.1016/S0006-8993(01)03002-5; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kadish I, 2009, J ALZHEIMERS DIS, V18, P429, DOI 10.3233/JAD-2009-1157; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kaufman A.S., 2006, ASSESSING ADOLESCENT, V3rd; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kolb B, 1995, BRAIN PLASTICITY BEH; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lemos C, 2010, CEPHALALGIA, V30, P1375, DOI 10.1177/0333102410368443; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Liu LX, 2008, PSYCHIAT GENET, V18, P267, DOI 10.1097/YPG.0b013e3283060f59; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Luikart BW, 2006, PROG BRAIN RES, V157, P15, DOI 10.1016/S0079-6123(06)57002-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Nishimura K, 2007, BIOCHEM BIOPH RES CO, V356, P200, DOI 10.1016/j.bbrc.2007.02.135; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Resnick SM, 2003, J NEUROSCI, V23, P3295; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ronnlund M, 2006, INTELLIGENCE, V34, P63, DOI 10.1016/j.intell.2005.06.004; Ryan JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P311, DOI 10.1016/S0887-6177(99)00019-0; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Seitz RJ, 2005, ACT NEUR S, V93, P65; Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Szczepankiewicz A, 2009, INT ARCH ALLERGY IMM, V149, P343, DOI 10.1159/000205580; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P13, DOI 10.1159/000075333; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 1998, ANN NEUROL, V44, P143, DOI 10.1002/ana.410440125; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D, 1958, MEASUREMENT APPRAISA; Wechsler D., 1939, MEASUREMENT ADULT IN; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xiromerisiou G, 2007, NEUROSCI LETT, V415, P59, DOI 10.1016/j.neulet.2006.12.038	97	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27389	10.1371/journal.pone.0027389	http://dx.doi.org/10.1371/journal.pone.0027389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087305	Green Submitted, Green Published, gold			2022-12-25	WOS:000297349700038
J	Marban, C; Su, T; Ferrari, R; Li, B; Vatakis, D; Pellegrini, M; Zack, JA; Rohr, O; Kurdistani, SK				Marban, Celine; Su, Trent; Ferrari, Roberto; Li, Bing; Vatakis, Dimitrios; Pellegrini, Matteo; Zack, Jerome A.; Rohr, Olivier; Kurdistani, Siavash K.			Genome-Wide Binding Map of the HIV-1 Tat Protein to the Human Genome	PLOS ONE			English	Article							REPRESSES TRANSCRIPTION; EXPRESSION; GENE; INCREASES; SEQUENCES; KINASE; ETS-1	The HIV-1 Trans-Activator of Transcription (Tat) protein binds to multiple host cellular factors and greatly enhances the level of transcription of the HIV genome. While Tat's control of viral transcription is well-studied, much less is known about the interaction of Tat with the human genome. Here, we report the genome-wide binding map of Tat to the human genome in Jurkat T cells using chromatin immunoprecipitation combined with next-generation sequencing. Surprisingly, we found that similar to 53% of the Tat target regions are within DNA repeat elements, greater than half of which are Alu sequences. The remaining target regions are located in introns and distal intergenic regions; only similar to 7% of Tat-bound regions are near transcription start sites (TSS) at gene promoters. Interestingly, Tat binds to promoters of genes that, in Jurkat cells, are bound by the ETS1 transcription factor, the CBP histone acetyltransferase and/or are enriched for histone H3 lysine 4 tri-methylation (H3K4me3) and H3K27me3. Tat binding is associated with genes enriched with functions in T cell biology and immune response. Our data reveal that Tat's interaction with the host genome is more extensive than previously thought, with potentially important implications for the viral life cycle.	[Marban, Celine; Rohr, Olivier] Univ Strasbourg, Inst Virol, Strasbourg, France; [Marban, Celine; Su, Trent; Ferrari, Roberto; Li, Bing; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Su, Trent] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Vatakis, Dimitrios; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA USA; [Pellegrini, Matteo; Zack, Jerome A.; Kurdistani, Siavash K.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Rohr, Olivier] Inst Univ France IUF, Paris, France; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Institut Universitaire de France; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Marban, C (corresponding author), Univ Strasbourg, Inst Virol, Strasbourg, France.	olivier.rohr@unistra.fr; skurdistani@mednet.ucla.edu	Ferrari, Roberto/O-8143-2015; Vatakis, Dimitrios/AAD-1257-2020; Li, Bing/B-7056-2013	Ferrari, Roberto/0000-0002-0453-0899; Vatakis, Dimitrios/0000-0002-7255-0226; Pellegrini, Matteo/0000-0001-9355-9564; Kurdistani, Siavash/0000-0003-3295-3511; ROHR, Olivier/0000-0001-8992-2025	Agence Nationale de Recherche sur le Sida; Howard Hughes Medical Institute; National Institutes of Health (NIH); California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Marban was supported in part by a fellowship from the Agence Nationale de Recherche sur le Sida. This work was also supported by a Howard Hughes Medical Institute award, and a National Institutes of Health (NIH) Innovator award as well as a California Institute for Regenerative Medicine grant to Dr. Kurdistani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Caldwell RL, 2000, J IMMUNOL, V165, P7035, DOI 10.4049/jimmunol.165.12.7035; CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372; Carroll IR, 1998, MOL IMMUNOL, V35, P1171, DOI 10.1016/S0161-5890(98)00107-2; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JANG KL, 1992, J ACQ IMMUN DEF SYND, V5, P1142; Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601	25	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26894	10.1371/journal.pone.0026894	http://dx.doi.org/10.1371/journal.pone.0026894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073215	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200022
J	Ruby, MA; Nomura, DK; Hudak, CSS; Barber, A; Casida, JE; Krauss, RM				Ruby, Maxwell A.; Nomura, Daniel K.; Hudak, Carolyn S. S.; Barber, Anne; Casida, John E.; Krauss, Ronald M.			Acute Overactive Endocannabinoid Signaling Induces Glucose Intolerance, Hepatic Steatosis, and Novel Cannabinoid Receptor 1 Responsive Genes	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; CB1 RECEPTOR; INSULIN-RESISTANCE; OVERWEIGHT PATIENTS; METABOLIC SYNDROME; RIMONABANT; ACTIVATION; SYSTEM; ANTAGONIST; BLOCKADE	Endocannabinoids regulate energy balance and lipid metabolism by stimulating the cannabinoid receptor type 1 (CB1). Genetic deletion and pharmacological antagonism have shown that CB1 signaling is necessary for the development of obesity and related metabolic disturbances. However, the sufficiency of endogenously produced endocannabinoids to cause hepatic lipid accumulation and insulin resistance, independent of food intake, has not been demonstrated. Here, we show that a single administration of isopropyl dodecylfluorophosphonate (IDFP), perhaps the most potent pharmacological inhibitor of endocannabinoid degradation, increases hepatic triglycerides (TG) and induces insulin resistance in mice. These effects involve increased CB1 signaling, as they are mitigated by pre-administration of a CB1 antagonist (AM251) and in CB1 knockout mice. Despite the strong physiological effects of CB1 on hepatic lipid and glucose metabolism, little is known about the downstream targets responsible for these effects. To elucidate transcriptional targets of CB1 signaling, we performed microarrays on hepatic RNA isolated from DMSO (control), IDFP and AM251/IDFP-treated mice. The gene for the secreted glycoprotein lipocalin 2 (lcn2), which has been implicated in obesity and insulin resistance, was among those most responsive to alterations in CB1 signaling. The expression pattern of IDFP mice segregated from DMSO mice in hierarchal cluster analysis and AM251 pre-administration reduced (>50%) the majority (303 of 533) of the IDFP induced alterations. Pathway analysis revealed that IDFP altered expression of genes involved in lipid, fatty acid and steroid metabolism, the acute phase response, and amino acid metabolism in a CB1-dependent manner. PCR confirmed array results of key target genes in multiple independent experiments. Overall, we show that acute IDFP treatment induces hepatic TG accumulation and insulin resistance, at least in part through the CB1 receptor, and identify novel cannabinoid responsive genes.	[Ruby, Maxwell A.; Barber, Anne; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA; [Nomura, Daniel K.; Hudak, Carolyn S. S.; Casida, John E.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Ruby, MA (corresponding author), Childrens Hosp, Oakland Res Inst, Dept Atherosclerosis Res, 747 52nd St, Oakland, CA 94609 USA.	rkrauss@chori.org		Ruby, Maxwell/0000-0003-4790-590X	Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; Sanofi-Aventis	Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute; Sanofi-Aventis(Sanofi-Aventis)	This work was supported by the Department of Atherosclerosis Research at Children's Hospital Oakland Research Institute (R.M.K.). J.E.C. acknowledges the University of California Berkeley William Muriece Hoskins Chair in Chemical and Molecular Entomology. The microarrays were funded by Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Croci T, 2003, BRIT J PHARMACOL, V140, P115, DOI 10.1038/sj.bjp.0705412; De Gottardi A, 2010, LIVER INT, V30, P1482, DOI 10.1111/j.1478-3231.2010.02298.x; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; HOLLISTER LE, 1974, CLIN PHARMACOL THER, V16, P297; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; MELLER D, 1981, CAN MED ASSOC J, V124, P745; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Segall Y, 2003, TOXICOL SCI, V76, P131, DOI 10.1093/toxsci/kfg216; Seifert J, 2001, B ENVIRON CONTAM TOX, V67, P463, DOI 10.1007/s001280146; Shobha T R, 2000, J Assoc Physicians India, V48, P1197; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Taschler U, 2011, J BIOL CHEM; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueyama J, 2008, TOXICOL LETT, V182, P42, DOI 10.1016/j.toxlet.2008.08.004; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; ZADIK Z, 1983, J TOXICOL-CLIN TOXIC, V20, P381, DOI 10.3109/15563658308990606; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	62	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26415	10.1371/journal.pone.0026415	http://dx.doi.org/10.1371/journal.pone.0026415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073164	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000297198200011
J	Sun, L; Li, DL; Zhao, M; He, X; Yu, XJ; Miao, Y; Wang, H; Ren, J; Zang, WJ				Sun, Lei; Li, Dong-Ling; Zhao, Mei; He, Xi; Yu, Xiao-Jiang; Miao, Yi; Wang, Hao; Ren, Jun; Zang, Wei-Jin			The Role of Muscarinic Receptors in the Beneficial Effects of Adenosine against Myocardial Reperfusion Injury in Rats	PLOS ONE			English	Article							REDUCES INFARCT SIZE; NERVOUS-SYSTEM; HEART-FAILURE; NITRIC-OXIDE; A(1); ACTIVATION; ACETYLCHOLINE; ISCHEMIA	Adenosine, a catabolite of ATP, displays a wide variety of effects in the heart including regulation of cardiac response to myocardial ischemia and reperfusion injury. Nonetheless, the precise mechanism of adenosine-induced cardioprotection is still elusive. Isolated Sprague-Dawley rat hearts underwent 30 min global ischemia and 120 min reperfusion using a Langendorff apparatus. Both adenosine and acetylcholine treatment recovered the post-reperfusion cardiac function associated with adenosine and muscarinic receptors activation. Simultaneous administration of adenosine and acetylcholine failed to exert any additive protective effect, suggesting a shared mechanism between the two. Our data further revealed a cross-talk between the adenosine and acetylcholine receptor signaling in reperfused rat hearts. Interestingly, the selective M-2 muscarinic acetylcholine receptor antagonist methoctramine significantly attenuated the cardioprotective effect of adenosine. In addition, treatment with adenosine upregulated the expression and the maximal binding capacity of muscarinic acetylcholine receptor, which were inhibited by the selective A(1) adenosine receptor antagonist 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) and the nitric oxide synthase inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME). These data suggested a possible functional coupling between the adenosine and muscarinic receptors behind the observed cardioprotection. Furthermore, nitric oxide was found involved in triggering the response to each of the two receptor agonist. In summary, there may be a cross-talk between the adenosine and muscarinic receptors in ischemic/reperfused myocardium with nitric oxide synthase might serve as the distal converging point. In addition, adenosine contributes to the invigorating effect of adenosine on muscarinic receptor thereby prompting to regulation of cardiac function. These findings argue for a potentially novel mechanism behind the adenosine-mediated cardioprotection.	[Sun, Lei; Li, Dong-Ling; Zhao, Mei; He, Xi; Yu, Xiao-Jiang; Miao, Yi; Wang, Hao; Zang, Wei-Jin] Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China; [Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA	Xi'an Jiaotong University; University of Wyoming	Sun, L (corresponding author), Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China.	zwj@mail.xjtu.edu.cn	Ren, Jun/ACG-5366-2022; lei, sun/HGE-2755-2022; He, Xijing/AAE-7424-2021	Ren, Jun/0000-0002-0275-0783; He, Xijing/0000-0002-0465-5376	National Natural Science Foundation of China [30930105, 30873058, 30910238]; National Basic Research Program of China (973 Program) [2007CB512005]; CMB [F510000/G16916404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); CMB	This work was supported by the National Natural Science Foundation of China (No. 30930105; No. 30873058; No. 30910238), the National Basic Research Program of China (973 Program, No. 2007CB512005) and CMB Distinguished Professorships Award (No. F510000/G16916404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINKLEY PF, 1993, J AM COLL CARDIOL, V21, P655, DOI 10.1016/0735-1097(93)90098-L; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; Donato M, 2007, J CARDIOVASC PHARM, V49, P287, DOI 10.1097/FJC.0b013e31803c55fe; Fenton RA, 2007, J CELL PHYSIOL, V213, P785, DOI 10.1002/jcp.21149; Headrick JP, 2011, BBA-BIOMEMBRANES, V1808, P1413, DOI 10.1016/j.bbamem.2010.11.016; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kin H, 2005, CARDIOVASC RES, V67, P124, DOI 10.1016/j.cardiores.2005.02.015; McIntosh VJ, 2011, J CARDIOVAS IN PRESS; Mustafa S Jamal, 2009, Handb Exp Pharmacol, P161, DOI 10.1007/978-3-540-89615-9_6; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Peart J, 2000, AM J PHYSIOL-HEART C, V279, pH2166, DOI 10.1152/ajpheart.2000.279.5.H2166; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; Sroka K, 2004, Z KARDIOL, V93, P768, DOI 10.1007/s00392-004-0137-6; Sun L, 2011, J PHARMACOL SCI, V115, P205, DOI 10.1254/jphs.10231FP; Tsuboi M, 2003, HEART VESSELS, V18, P26, DOI 10.1007/s003800300004; Xi L, 2008, CIRCULATION, V118, pS32, DOI 10.1161/CIRCULATIONAHA.107.752865; Xu J, 1999, J CARDIOVASC PHARM, V34, P904, DOI 10.1097/00005344-199912000-00020; Xu ZL, 2005, CARDIOVASC RES, V65, P803, DOI 10.1016/j.cardiores.2004.12.004; YAO ZH, 1993, CIRC RES, V73, P1193, DOI 10.1161/01.RES.73.6.1193	20	13	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25618	10.1371/journal.pone.0025618	http://dx.doi.org/10.1371/journal.pone.0025618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073139	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200001
J	Yount, NY; Cohen, SE; Kupferwasser, D; Waring, AJ; Ruchala, P; Sharma, S; Wasserman, K; Jung, CL; Yeaman, MR				Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Waring, Alan J.; Ruchala, Piotr; Sharma, Shantanu; Wasserman, Karlman; Jung, Chun-Ling; Yeaman, Michael R.			Context Mediates Antimicrobial Efficacy of Kinocidin Congener Peptide RP-1	PLOS ONE			English	Article							PLATELET MICROBICIDAL PROTEIN-1; MOLECULAR-DYNAMICS SIMULATIONS; SOLID-STATE NMR; STAPHYLOCOCCUS-AUREUS; CANDIDA-ALBICANS; LIPID-BILAYERS; MEMBRANE; MECHANISMS; SUSCEPTIBILITY; CONFORMATION	Structure-mechanism relationships are key determinants of host defense peptide efficacy. These relationships are influenced by anatomic, physiologic and microbiologic contexts. Structure-mechanism correlates were assessed for the synthetic peptide RP-1, modeled on microbicidal domains of platelet kinocidins. Antimicrobial efficacies and mechanisms of action against susceptible ((S)) or resistant ((R)) Salmonella typhimurium (ST), Staphylococcus aureus (SA), and Candida albicans (CA) strain pairs were studied at pH 7.5 and 5.5. Although RP-1 was active against all study organisms, it exhibited greater efficacy against bacteria at pH 7.5, but greater efficacy against CA at pH 5.5. RP-1 de-energized SA and CA, but caused hyperpolarization of ST in both pH conditions. However, RP-1 permeabilized ST(S) and CA strains at both pH, whereas permeabilization was modest for ST(R) or SA strain at either pH. Biochemical analysis, molecular modeling, and FTIR spectroscopy data revealed that RP-1 has indistinguishable net charge and backbone trajectories at pH 5.5 and 7.5. Yet, concordant with organism-specific efficacy, surface plasmon resonance, and FTIR, molecular dynamics revealed modest helical order increases but greater RP-1 avidity and penetration of bacterial than eukaryotic lipid systems, particularly at pH 7.5. The present findings suggest that pH- and target-cell lipid contexts influence selective antimicrobial efficacy and mechanisms of RP-1 action. These findings offer new insights into selective antimicrobial efficacy and context-specificity of antimicrobial peptides in host defense, and support design strategies for potent anti-infective peptides with minimal concomitant cytotoxicity.	[Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Yeaman, Michael R.] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Infect Dis, Torrance, CA USA; [Yount, Nannette Y.; Cohen, Samuel E.; Kupferwasser, Deborah; Waring, Alan J.; Wasserman, Karlman; Yeaman, Michael R.] Univ Calif Los Angeles Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst Harbor, Torrance, CA USA; [Cohen, Samuel E.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Wasserman, Karlman] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Pulm Crit Care Med, Torrance, CA USA; [Waring, Alan J.; Ruchala, Piotr; Jung, Chun-Ling; Yeaman, Michael R.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Waring, Alan J.] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Irvine, CA 92717 USA; [Sharma, Shantanu] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Waring, Alan J.; Yeaman, Michael R.] Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Mol Med, Torrance, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Yount, NY (corresponding author), Los Angeles Cty Harbor Univ Calif Los Angeles Med, Div Infect Dis, Torrance, CA USA.	MRYeaman@ucla.edu		Yount, Nannette/0000-0002-7079-5211; RUCHALA, PIOTR/0000-0002-5574-2779	National Institute of Health [AI-39001, AI-48031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048031, R29AI039001, R01AI039001] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in-part by National Institute of Health grants AI-39001 and AI-48031 (MY). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Bayer AS, 2006, J BACTERIOL, V188, P211, DOI 10.1128/JB.188.1.211-222.2006; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Dorn A, 2005, J BIOMOL SCREEN, V10, P339, DOI 10.1177/1087057104272045; Elmore DE, 2010, BIOCHEM MOL BIOL EDU, V38, P216, DOI 10.1002/bmb.20396; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; FU Y, 2005, SSD1 IS INTEGRAL ANT; Gautier R, 2004, NUCLEIC ACIDS RES, V32, pW508, DOI 10.1093/nar/gkh388; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Guyton A., 2005, TXB MED PHYSL, P1104; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harrick N.J., 1967, INTERNAL REFLECTION; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; HESS M, 2008, J CHEM THEORY COMPUT, V4; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Katzif S, 2003, INFECT IMMUN, V71, P4304, DOI 10.1128/IAI.71.8.4304-4312.2003; Kauppine J, 1981, APPL SPECTROSC, V35, P272; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; Slack M, 2006, J BIOMOL SCREEN, V11, P57, DOI 10.1177/1087057105282712; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; WAUGH A, 2007, NATOMY PHYSL HLTH IL; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Xiong YQ, 2006, ANTIMICROB AGENTS CH, V50, P3786, DOI 10.1128/AAC.00038-06; Yamaguchi S, 2002, BIOCHEMISTRY-US, V41, P9852, DOI 10.1021/bi0257991; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeaman MR, 2005, ASM NEWS, V71, P21; Yeaman MR, 2004, ANTIMICROB AGENTS CH, V48, P3051, DOI 10.1128/AAC.48.8.3051-3056.2004; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Yeaman MR, 2002, ANTIMICROB AGENTS CH, V46, P3883, DOI 10.1128/AAC.46.12.3883-3891.2002; YEAMAN MR, 2009, EFFICACY INTRAVENOUS; Yount NY, 2007, BBA-BIOMEMBRANES, V1768, P598, DOI 10.1016/j.bbamem.2006.11.011; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Yount NY, 2004, ANTIMICROB AGENTS CH, V48, P4395, DOI 10.1128/AAC.48.11.4395-4404.2004; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X; Zurgil N, 2000, BIOCHEM BIOPH RES CO, V268, P155, DOI 10.1006/bbrc.1999.1934	52	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26727	10.1371/journal.pone.0026727	http://dx.doi.org/10.1371/journal.pone.0026727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073187	gold, Green Published, Green Accepted			2022-12-25	WOS:000297198200018
J	Carvalho, RN; Bopp, SK; Lettieri, T				Carvalho, Raquel N.; Bopp, Stephanie K.; Lettieri, Teresa			Transcriptomics Responses in Marine Diatom Thalassiosira pseudonana Exposed to the Polycyclic Aromatic Hydrocarbon Benzo[a]pyrene	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; CELL-DEATH; DIHYDRODIOL DEHYDROGENASE; PROTEOMIC ANALYSIS; DNA; PROTEIN; GENOME; STRESS; BENZO<A>PYRENE; ECOTOXICOLOGY	Diatoms are unicellular, photosynthetic, eukaryotic algae with a ubiquitous distribution in water environments and they play an important role in the carbon cycle. Molecular or morphological changes in these species under ecological stress conditions are expected to serve as early indicators of toxicity and can point to a global impact on the entire ecosystem. Thalassiosira pseudonana, a marine diatom and the first with a fully sequenced genome has been selected as an aquatic model organism for ecotoxicological studies using molecular tools. A customized DNA microarray containing probes for the available gene sequences has been developed and tested to analyze the effects of a common pollutant, benzo(a)pyrene (BaP), at a sub-lethal concentration. This approach in diatoms has helped to elucidate pathway/metabolic processes involved in the mode of action of this pollutant, including lipid metabolism, silicon metabolism and stress response. A dose-response of BaP on diatoms has been made and the effect of this compound on the expression of selected genes was assessed by quantitative real time-PCR. Up-regulation of the long-chain acyl-CoA synthetase and the anti-apoptotic transmembrane Bax inhibitor, as well as down-regulation of silicon transporter 1 and a heat shock factor was confirmed at lower concentrations of BaP, but not the heat-shock protein 20. The study has allowed the identification of molecular biomarkers to BaP to be later on integrated into environmental monitoring for water quality assessment.	[Carvalho, Raquel N.; Bopp, Stephanie K.; Lettieri, Teresa] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Rural Water & Ecosyst Resources Unit, Ispra, Varese, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Carvalho, RN (corresponding author), European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Rural Water & Ecosyst Resources Unit, Ispra, Varese, Italy.	Teresa.Lettieri@jrc.ec.europa.eu		Lettieri, Teresa/0000-0002-3363-9666; Bopp, Stephanie/0000-0003-1082-8007	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Commission. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barhoumi R, 2000, TOXICOL SCI, V53, P264, DOI 10.1093/toxsci/53.2.264; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bopp SK, 2007, GENE, V396, P293, DOI 10.1016/j.gene.2007.03.013; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Burczynski ME, 1999, CANCER RES, V59, P607; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Carvalho RN, 2011, AQUAT TOXICOL, V101, P244, DOI 10.1016/j.aquatox.2010.10.004; Davis AK, 2006, EUKARYOT CELL, V5, P1157, DOI 10.1128/EC.00042-06; De Stefano L, 2008, ACTA BIOMATER, V4, P126, DOI 10.1016/j.actbio.2007.09.003; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Garcia-Reyero N, 2011, ENVIRON TOXICOL CHEM, V30, P265, DOI 10.1002/etc.401; Garcia-Reyero N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-308; GLATT HR, 1979, NATURE, V277, P319, DOI 10.1038/277319a0; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; HESSE S, 1982, CARCINOGENESIS, V3, P757, DOI 10.1093/carcin/3.7.757; Hooven LA, 2008, TOXICOLOGY, V249, P1, DOI 10.1016/j.tox.2008.03.019; JERNSTROM B, 1994, BIOPHYS CHEM, V49, P185, DOI 10.1016/0301-4622(93)E0087-L; Jimenez M, 2002, ENVIRON TOXICOL CHEM, V21, P787, DOI 10.1897/1551-5028(2002)021<0787:TCTBAP>2.0.CO;2; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Lorrain S, 2004, PLANT CELL, V16, P2217, DOI 10.1105/tpc.104.022038; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neff JM, 2005, INTEGR ENVIRON ASSES, V1, P22, DOI 10.1897/IEAM_2004a-016.1; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3; Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Tekpli X, 2010, TOXICOL APPL PHARM, V243, P68, DOI 10.1016/j.taap.2009.11.014; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2012, ENVIRON MICROBIOL, V14, P67, DOI 10.1111/j.1462-2920.2011.02468.x; Tonon T, 2005, PLANT PHYSIOL, V138, P402, DOI 10.1104/pp.104.054528; Van Aggelen G, 2010, ENVIRON HEALTH PERSP, V118, P1, DOI 10.1289/ehp.0900985; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P664, DOI 10.1897/07-192.1; Watanabe N, 2009, INT J MOL SCI, V10, P3149, DOI 10.3390/ijms10073149; Williams TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002126	40	43	43	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26985	10.1371/journal.pone.0026985	http://dx.doi.org/10.1371/journal.pone.0026985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073232	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000019
J	O'Brien, HE; Gong, YC; Fung, P; Wang, PW; Guttman, DS				O'Brien, Heath E.; Gong, Yunchen; Fung, Pauline; Wang, Pauline W.; Guttman, David S.			Use of Low-Coverage, Large-Insert, Short-Read Data for Rapid and Accurate Generation of Enhanced-Quality Draft Pseudomonas Genome Sequences	PLOS ONE			English	Article							SYRINGAE; REVEALS; ANNOTATIONS; REPERTOIRE; VIRULENCE; PATHOGEN	Next-generation genomic technology has both greatly accelerated the pace of genome research as well as increased our reliance on draft genome sequences. While groups such as the Genomics Standards Consortium have made strong efforts to promote genome standards there is a still a general lack of uniformity among published draft genomes, leading to challenges for downstream comparative analyses. This lack of uniformity is a particular problem when using standard draft genomes that frequently have large numbers of low-quality sequencing tracts. Here we present a proposal for an "enhanced-quality draft'' genome that identifies at least 95% of the coding sequences, thereby effectively providing a full accounting of the genic component of the genome. Enhanced-quality draft genomes are easily attainable through a combination of small-and large-insert next-generation, paired-end sequencing. We illustrate the generation of an enhanced-quality draft genome by re-sequencing the plant pathogenic bacterium Pseudomonas syringae pv. phaseolicola 1448A ( Pph 1448A), which has a published, closed genome sequence of 5.93 Mbp. We use a combination of Illumina paired-end and mate-pair sequencing, and surprisingly find that de novo assemblies with 100x paired-end coverage and mate-pair sequencing with as low as low as 2-5x coverage are substantially better than assemblies based on higher coverage. The rapid and low-cost generation of large numbers of enhanced-quality draft genome sequences will be of particular value for microbial diagnostics and biosecurity, which rely on precise discrimination of potentially dangerous clones from closely related benign strains.	[O'Brien, Heath E.; Wang, Pauline W.; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Gong, Yunchen; Fung, Pauline; Wang, Pauline W.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	O'Brien, HE (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	heath.obrien@utoronto.ca	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869	Natural Sciences & Engineering Research Council (NSERC) of Canada; Canada Research Chairs Program	Natural Sciences & Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by grants from the Natural Sciences & Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) and the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to DSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dondoshansky I., 2000, BLASTCLUST BLAST SCO; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Yahara T, 2010, CURR OPIN ENV SUST, V2, P43, DOI 10.1016/j.cosust.2010.03.008	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27199	10.1371/journal.pone.0027199	http://dx.doi.org/10.1371/journal.pone.0027199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073286	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900088
J	Wheaton, BJ; Callaway, JK; Ek, CJ; Dziegielewska, KM; Saunders, NR				Wheaton, Benjamin J.; Callaway, Jennifer K.; Ek, C. Joakim; Dziegielewska, Katarzyna M.; Saunders, Norman R.			Spontaneous Development of Full Weight-Supported Stepping after Complete Spinal Cord Transection in the Neonatal Opossum, Monodelphis domestica	PLOS ONE			English	Article							SHORT-TAILED OPOSSUM; SUPRASPINAL AXONS; LOCOMOTOR FUNCTION; GAIT ANALYSIS; CONNECTIONS; RECOVERY; GROWTH; INJURY; LESION; GRAY	Spinal cord trauma in the adult nervous system usually results in permanent loss of function below the injury level. The immature spinal cord has greater capacity for repair and can develop considerable functionality by adulthood. This study used the marsupial laboratory opossum Monodelphis domestica, which is born at a very early stage of neural development. Complete spinal cord transection was made in the lower-thoracic region of pups at postnatal-day 7 (P7) or P28, and the animals grew to adulthood. Injury at P7 resulted in a dense neuronal tissue bridge that connected the two ends of the cord; retrograde neuronal labelling indicated that supraspinal and propriospinal innervation spanned the injury site. This repair was associated with pronounced behavioural recovery, coordinated gait and an ability to use hindlimbs when swimming. Injury at P28 resulted in a cyst-like cavity encased in scar tissue forming at the injury site. Using retrograde labelling, no labelled brainstem or propriospinal neurons were found above the lesion, indicating that detectable neuronal connectivity had not spanned the injury site. However, these animals could use their hindlimbs to take weight-supporting steps but could not use their hindlimbs when swimming. White matter, demonstrated by Luxol Fast Blue staining, was present in the injury site of P7- but not P28-injured animals. Overall, these studies demonstrated that provided spinal injury occurs early in development, regrowth of supraspinal innervation is possible. This repair appears to lead to improved functional outcomes. At older ages, even without detectable axonal growth spanning the injury site, substantial development of locomotion was still possible. This outcome is discussed in conjunction with preliminary findings of differences in the local propriospinal circuits following spinal cord injury (demonstrated with fluororuby labelling), which may underlie the weight bearing locomotion observed in the apparent absence of axons bridging the lesion site in P28-injured Monodelphis.	[Wheaton, Benjamin J.; Callaway, Jennifer K.; Ek, C. Joakim; Dziegielewska, Katarzyna M.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Melbourne	Wheaton, BJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Wheaton, Benjamin/0000-0003-0619-4777; Saunders, Norman/0000-0001-6660-7639	Victorian Neurotrauma Initiative Grant Body [DP049]	Victorian Neurotrauma Initiative Grant Body	This work was supported by the Victorian Neurotrauma Initiative Grant Body (Grant 11 #DP049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; FADEM BH, 1982, LAB ANIM SCI, V32, P405; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; HOWLAND DR, 1995, EXP NEUROL, V135, P108, DOI 10.1006/exnr.1995.1071; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Lane MA, 2004, RESPONSE DEV NERVOUS; Migliavacca A, 1930, ARCH ITAL BIOL, V83, P109; NICHOLLS JG, 1994, PROG BRAIN RES, V103, P263; Oswald-Cruz E, 1968, BRAIN OPOSSUM DIDELP; QIN YQ, 1993, DEV BRAIN RES, V75, P75, DOI 10.1016/0165-3806(93)90067-K; ROBINSON GA, 1986, EXP BRAIN RES, V62, P373, DOI 10.1007/BF00238857; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1995, CLIN EXP PHARMACOL P, V22, P518, DOI 10.1111/j.1440-1681.1995.tb02060.x; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; STELZNER DJ, 1975, EXP NEUROL, V46, P156, DOI 10.1016/0014-4886(75)90039-4; STELZNER DJ, 1979, BRAIN RES, V172, P407, DOI 10.1016/0006-8993(79)90575-4; Stolp HB, 2009, NEUROSCI LETT, V451, P232, DOI 10.1016/j.neulet.2009.01.021; TREHERNE JM, 1992, P NATL ACAD SCI USA, V89, P431, DOI 10.1073/pnas.89.1.431; VANDEBERG JL, 1999, UFAW HDB CARE MANAGE, P193; Wang XM, 1998, J COMP NEUROL, V398, P83; Wang XM, 1998, EXP NEUROL, V151, P50, DOI 10.1006/exnr.1998.6795; Wang XM, 1996, J COMP NEUROL, V371, P104; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; WOODWARD SKA, 1993, J EXP BIOL, V176, P77	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26826	10.1371/journal.pone.0026826	http://dx.doi.org/10.1371/journal.pone.0026826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073202	Green Published, gold			2022-12-25	WOS:000297154900009
J	Cassera, MB; Hazleton, KZ; Merino, EF; Obaldia, N; Ho, MC; Murkin, AS; DePinto, R; Gutierrez, JA; Almo, SC; Evans, GB; Babu, YS; Schramm, VL				Cassera, Maria B.; Hazleton, Keith Z.; Merino, Emilio F.; Obaldia, Nicanor, III; Ho, Meng-Chiao; Murkin, Andrew S.; DePinto, Richard; Gutierrez, Jemy A.; Almo, Steven C.; Evans, Gary B.; Babu, Yarlagadda S.; Schramm, Vern L.			Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model	PLOS ONE			English	Article							MALARIA PARASITES; PLASMA-MEMBRANE; IN-VITRO; METABOLISM; INHIBITORS; ENZYME; SUSCEPTIBILITY; HYPOXANTHINE; ARTEMISININ; COMBINATION	Plasmodium falciparum causes most of the one million annual deaths from malaria. Drug resistance is widespread and novel agents against new targets are needed to support combination-therapy approaches promoted by the World Health Organization. Plasmodium species are purine auxotrophs. Blocking purine nucleoside phosphorylase (PNP) kills cultured parasites by purine starvation. DADMe-Immucillin-G (BCX4945) is a transition state analogue of human and Plasmodium PNPs, binding with picomolar affinity. Here, we test BCX4945 in Aotus primates, an animal model for Plasmodium falciparum infections. Oral administration of BCX4945 for seven days results in parasite clearance and recrudescence in otherwise lethal infections of P. falciparum in Aotus monkeys. The molecular action of BCX4945 is demonstrated in crystal structures of human and P. falciparum PNPs. Metabolite analysis demonstrates that PNP blockade inhibits purine salvage and polyamine synthesis in the parasites. The efficacy, oral availability, chemical stability, unique mechanism of action and low toxicity of BCX4945 demonstrate potential for combination therapies with this novel antimalarial agent.	[Cassera, Maria B.; Hazleton, Keith Z.; Merino, Emilio F.; Ho, Meng-Chiao; Murkin, Andrew S.; Gutierrez, Jemy A.; Almo, Steven C.; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Obaldia, Nicanor, III] Gorgas Mem Inst Hlth Studies, Malaria Drug & Vaccine Evaluat Ctr, Panama City, Panama; [DePinto, Richard] Waters Corp, Parsippany, NJ USA; [Evans, Gary B.] Ind Res Ltd, Carbohydrate Chem Grp, Lower Hutt, New Zealand; [Babu, Yarlagadda S.] BioCryst Pharmaceut Inc, Dept Biol Sci, Birmingham, AL USA; [Murkin, Andrew S.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	Yeshiva University; Albert Einstein College of Medicine; Instituto Conmemorativo Gorgas de Estudios de la Salud; Waters Corporation; Callaghan Innovation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Cassera, MB (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	vern.schramm@einstein.yu.edu	Cassera, Maria/L-1572-2013; Ho, Meng-Chiao/H-2448-2015; Evans, Gary/B-8343-2011; Obaldia, Nicanor/K-4042-2019; Evans, Gary/I-4123-2019; Hazleton, Keith Z./AAD-3979-2019; Obaldia, Nicanor/AAV-1084-2021; Obaldia, Nicanor T/O-8460-2015; Murkin, Andrew/K-3146-2012	Ho, Meng-Chiao/0000-0002-5424-4524; Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Hazleton, Keith Z./0000-0003-4098-3411; Obaldia, Nicanor/0000-0002-3711-9449; Murkin, Andrew/0000-0002-2559-4605	NIH [AI049512, GM41916]; Albert Einstein College of Medicine; Medicines for Malaria; New Zealand Foundation for Research, Science Technology [BCX4945, C08X0209]; BioCryst Pharmaceuticals, Inc. [BCX4945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041916, T32GM007288, R01GM041916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Medicines for Malaria; New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); BioCryst Pharmaceuticals, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided primarily by NIH grant AI049512 (V. L. S.) and by the Albert Einstein College of Medicine. Early portions of the Aotus study were supported by Medicines for Malaria. The original synthesis of DADMe-Immucillin-G (BCX4945) by G. B. E. was supported by research contract C08X0209 from the New Zealand Foundation for Research, Science & Technology and NIH grant GM41916 (V. L. S.). BioCryst Pharmaceuticals, Inc., provided BCX4945 used for the Aotus study. Waters Corporation provided gratis access to a UPLC-ms instrument and technical help from R. D. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2010, BLOOD, V116, P886, DOI 10.1182/blood-2010-02-272039; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; BITONTI AJ, 1989, P NATL ACAD SCI USA, V86, P651, DOI 10.1073/pnas.86.2.651; BUNGENER W, 1968, Z TROPENMED PARASIT, V19, P185; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Clark K, 2010, AMINO ACIDS, V38, P633, DOI 10.1007/s00726-009-0424-7; *CLINICALTRIAL, 2010, NCT00985127 CLINICAL; Collaborative-Computational-ProjectG, 1994, ACTA CRYSTALLOGRAP D, V50, P760; Deng H, 2004, J AM CHEM SOC, V126, P9516, DOI 10.1021/ja049296p; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; EARLE WC, 1932, J LAB CLIN MED, V17, P1124; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Edwards AA, 2009, BIOCHEMISTRY-US, V48, P5226, DOI 10.1021/bi9005896; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Farthing D, 2007, J CHROMATOGR B, V854, P158, DOI 10.1016/j.jchromb.2007.04.013; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Haider N, 2005, MOL BIOCHEM PARASIT, V142, P224, DOI 10.1016/j.molbiopara.2005.04.004; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; Huser H, 1970, ATLAS COMP PRIMATE H; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; LAMBERT JDH, 1991, REGUL TOXICOL PHARM, V14, P189, DOI 10.1016/0273-2300(91)90006-H; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; OBALDIA N, 1991, LAB ANIM, V25, P133, DOI 10.1258/002367791781082603; Pascale RM, 2002, ALCOHOL, V27, P193, DOI 10.1016/S0741-8329(02)00227-6; PEGG AE, 1988, CANCER RES, V48, P759; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pukrittayakamee S, 1997, EUR J CLIN PHARMACOL, V52, P487, DOI 10.1007/s002280050323; Quashie NB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-95; Ringia EAT, 2005, CURR TOP MED CHEM, V5, P1237, DOI 10.2174/156802605774463088; Sajiki H, 2005, SYNLETT, P1385, DOI 10.1055/s-2005-868489; SCHREIBER G, 1986, INT J PRIMATOL, V7, P521, DOI 10.1007/BF02736659; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; TAYLOR DW, 1979, J PARASITOL, V65, P267, DOI 10.2307/3280160; TENG R, 2008, NMR BIOMED, V22, P292; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TITULAER HAC, 1991, INT J PHARMACEUT, V69, P83, DOI 10.1016/0378-5173(91)90213-8; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	49	52	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26916	10.1371/journal.pone.0026916	http://dx.doi.org/10.1371/journal.pone.0026916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096507	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900015
J	Costion, C; Ford, A; Cross, H; Crayn, D; Harrington, M; Lowe, A				Costion, Craig; Ford, Andrew; Cross, Hugh; Crayn, Darren; Harrington, Mark; Lowe, Andrew			Plant DNA Barcodes Can Accurately Estimate Species Richness in Poorly Known Floras	PLOS ONE			English	Article							CONSERVATION; DIVERSITY; GENUS; IDENTIFICATION; TREES	Background: Widespread uptake of DNA barcoding technology for vascular plants has been slow due to the relatively poor resolution of species discrimination (similar to 70%) and low sequencing and amplification success of one of the two official barcoding loci, matK. Studies to date have mostly focused on finding a solution to these intrinsic limitations of the markers, rather than posing questions that can maximize the utility of DNA barcodes for plants with the current technology. Methodology/Principal Findings: Here we test the ability of plant DNA barcodes using the two official barcoding loci, rbcLa and matK, plus an alternative barcoding locus, trnH-psbA, to estimate the species diversity of trees in a tropical rainforest plot. Species discrimination accuracy was similar to findings from previous studies but species richness estimation accuracy proved higher, up to 89%. All combinations which included the trnH-psbA locus performed better at both species discrimination and richness estimation than matK, which showed little enhanced species discriminatory power when concatenated with rbcLa. The utility of the trnH-psbA locus is limited however, by the occurrence of intraspecific variation observed in some angiosperm families to occur as an inversion that obscures the monophyly of species. Conclusions/Significance: We demonstrate for the first time, using a case study, the potential of plant DNA barcodes for the rapid estimation of species richness in taxonomically poorly known areas or cryptic populations revealing a powerful new tool for rapid biodiversity assessment. The combination of the rbcLa and trnH-psbA loci performed better for this purpose than any two-locus combination that included matK. We show that although DNA barcodes fail to discriminate all species of plants, new perspectives and methods on biodiversity value and quantification may overshadow some of these shortcomings by applying barcode data in new ways.	[Costion, Craig; Cross, Hugh; Lowe, Andrew] Univ Adelaide, Australian Ctr Ecol & Evolutionary Biol, Adelaide, SA, Australia; [Costion, Craig; Crayn, Darren; Harrington, Mark] James Cook Univ, Australian Trop Herbarium, Cairns, Qld, Australia; [Ford, Andrew] Trop Forest Res Ctr, CSIRO Ecosyst Sci, Atherton, Qld, Australia; [Cross, Hugh; Lowe, Andrew] State Herbarium S Australia, Dept Environm & Nat Resources, Adelaide, SA, Australia	University of Adelaide; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Costion, C (corresponding author), Univ Adelaide, Australian Ctr Ecol & Evolutionary Biol, Adelaide, SA, Australia.	ccostion@googlemail.com; andrew.lowe@adelaide.edu.au	Crayn, Darren M/A-7386-2011; Ford, Andrew J/D-3761-2011	Crayn, Darren M/0000-0001-6614-4216; Lowe, Andrew/0000-0003-1139-2516	University of Adelaide	University of Adelaide	This study was supported by an Australian Postgraduate Fees Waiver Scholarship under the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonants P., 2010, Bulletin OEPP, V40, P30, DOI 10.1111/j.1365-2338.2009.02350.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Cross H.B., 2010, 50 YEARS INVASION EC; DU ZY, 2011, J SYST EVOL IN PRESS; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jackson RB, 1999, P NATL ACAD SCI USA, V96, P11387, DOI 10.1073/pnas.96.20.11387; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lowe AJ, 2011, IAWA J, V32, P251, DOI 10.1163/22941932-90000055; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533	36	70	77	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26841	10.1371/journal.pone.0026841	http://dx.doi.org/10.1371/journal.pone.0026841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096501	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000297553900011
J	Tharad, M; Samuchiwal, SK; Bhalla, K; Ghosh, A; Kumar, K; Kumar, S; Ranganathan, A				Tharad, Megha; Samuchiwal, Sachin Kumar; Bhalla, Kuhulika; Ghosh, Anamika; Kumar, Krishan; Kumar, Sushil; Ranganathan, Anand			A Three-Hybrid System to Probe In Vivo Protein-Protein Interactions: Application to the Essential Proteins of the RD1 Complex of M. tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL ACTIVATOR; PATHOGENIC MYCOBACTERIA; VIRULENCE DETERMINANT; ESAT-6-CFP-10 COMPLEX; INFECTION; GRANULOMA; 2-HYBRID; ESAT-6; SECRETION	Background: Protein-protein interactions play a crucial role in enabling a pathogen to survive within a host. In many cases the interactions involve a complex of proteins rather than just two given proteins. This is especially true for pathogens like M. tuberculosis that are able to successfully survive the inhospitable environment of the macrophage. Studying such interactions in detail may help in developing small molecules that either disrupt or augment the interactions. Here, we describe the development of an E. coli based bacterial three-hybrid system that can be used effectively to study ternary protein complexes. Methodology/Principal Findings: The protein-protein interactions involved in M. tuberculosis pathogenesis have been used as a model for the validation of the three-hybrid system. Using the M. tuberculosis RD1 encoded proteins CFP10, ESAT6 and Rv3871 for our proof-of-concept studies, we show that the interaction between the proteins CFP10 and Rv3871 is strengthened and stabilized in the presence of ESAT6, the known heterodimeric partner of CFP10. Isolating peptide candidates that can disrupt crucial protein-protein interactions is another application that the system offers. We demonstrate this by using CFP10 protein as a disruptor of a previously established interaction between ESAT6 and a small peptide HCL1; at the same time we also show that CFP10 is not able to disrupt the strong interaction between ESAT6 and another peptide SL3. Conclusions/Significance: The validation of the three-hybrid system paves the way for finding new peptides that are stronger binders of ESAT6 compared even to its natural partner CFP10. Additionally, we believe that the system offers an opportunity to study tri-protein complexes and also perform a screening of protein/peptide binders to known interacting proteins so as to elucidate novel tri-protein complexes.	[Tharad, Megha; Samuchiwal, Sachin Kumar; Bhalla, Kuhulika; Ghosh, Anamika; Kumar, Krishan; Kumar, Sushil; Ranganathan, Anand] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Tharad, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi, India.	anand@icgeb.res.in	Samuchiwal, Sachin/AAL-2904-2021; Bhalla, Kuhulika/P-3280-2019; KUMAR, SUSHIL/T-8493-2017	Bhalla, Kuhulika/0000-0002-6608-2120; KUMAR, SUSHIL/0000-0001-8481-9221; SAMUCHIWAL, SACHIN/0000-0001-6232-5650; KUMAR, KRISHAN/0000-0003-3957-2084	Council for Scientific and Industrial Research (CSIR), India; International Centre for Genetic Engineering and Biotechnology (ICGEB); Department of Biotechnology (DBT), Government of India [BT/PR7760/Med/14/1104/2006]	Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); International Centre for Genetic Engineering and Biotechnology (ICGEB); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	MT was funded by a fellowship from the Council for Scientific and Industrial Research (CSIR), India. The work was funded by internal grants of the International Centre for Genetic Engineering and Biotechnology (ICGEB) and a grant provided by the Department of Biotechnology (DBT), Government of India, Grant no. BT/PR7760/Med/14/1104/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff EA, 2002, ANGEW CHEM INT EDIT, V41, P2327, DOI 10.1002/1521-3773(20020703)41:13<2327::AID-ANIE2327>3.0.CO;2-U; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Callahan B, 2010, J BACTERIOL, V192, P326, DOI 10.1128/JB.01032-09; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Chang Y, 2009, PROTEIN SCI, V18, P2316, DOI 10.1002/pro.242; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chopra S, 2003, CHEM BIOL, V10, P917, DOI 10.1016/j.chembiol.2003.09.007; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; DOVE SL, 1997, LETT NAT, V386, P627; Firestine SM, 2000, NAT BIOTECHNOL, V18, P544, DOI 10.1038/75414; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kumar K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007615; Licitra JE, 1996, P NATL ACAD SCI USA, V93, P12817; Loregian A, 2005, J CELL PHYSIOL, V204, P750, DOI 10.1002/jcp.20356; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Miller J.H., 1972, EXPT MOL GENETICS; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rao A, 2005, J BIOL CHEM, V280, P23605, DOI 10.1074/jbc.M503056200; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sperandio Olivier, 2008, Open Biochem J, V2, P29, DOI 10.2174/1874091X00802010029; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Tirode F, 1997, J BIOL CHEM, V272, P22995, DOI 10.1074/jbc.272.37.22995; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO Media centre, 2010, TUB; Zhang J, 1996, ANAL BIOCHEM, V242, P68, DOI 10.1006/abio.1996.0429	46	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27503	10.1371/journal.pone.0027503	http://dx.doi.org/10.1371/journal.pone.0027503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087330	gold, Green Published, Green Submitted			2022-12-25	WOS:000297349700054
J	Kallio, H; Tolvanen, M; Janis, J; Pan, PW; Laurila, E; Kallioniemi, A; Kilpinen, S; Tuominen, VJ; Isola, J; Valjakka, J; Pastorekova, S; Pastorek, J; Parkkila, S				Kallio, Heini; Tolvanen, Martti; Janis, Janne; Pan, Pei-wen; Laurila, Eeva; Kallioniemi, Anne; Kilpinen, Sami; Tuominen, Vilppu J.; Isola, Jorma; Valjakka, Jarkko; Pastorekova, Silvia; Pastorek, Jaromir; Parkkila, Seppo			Characterization of Non-Specific Cytotoxic Cell Receptor Protein 1: A New Member of the Lectin-Type Subfamily of F-Box Proteins	PLOS ONE			English	Article							NCCRP-1; GENE; EXPRESSION; (NCCRP)-1; BINDING; CLONING; FAMILY; IX	Our previous microarray study showed that the non-specific cytotoxic cell receptor protein 1 (Nccrp1) transcript is significantly upregulated in the gastric mucosa of carbonic anhydrase IX (CA IX)-deficient (Car9(-/-)) mice. In this paper, we aimed to characterize human NCCRP1 and to elucidate its relationship to CA IX. Recombinant NCCRP1 protein was expressed in Escherichia coli, and a novel polyclonal antiserum was raised against the purified full-length protein. Immunocytochemistry showed that NCCRP1 is expressed intracellularly, even though it has previously been described as a transmembrane protein. Using bioinformatic analyses, we identified orthologs of NCCRP1 in 35 vertebrate genomes, and up to five paralogs per genome. These paralogs are FBXO genes whose protein products are components of the E3 ubiquitin ligase complexes. NCCRP1 proteins have no signal peptides or transmembrane domains. NCCRP1 has mainly been studied in fish and was thought to be responsible for the cytolytic function of nonspecific cytotoxic cells (NCCs). Our analyses showed that in humans, NCCRP1 mRNA is expressed in tissues containing squamous epithelium, whereas it shows a more ubiquitous tissue expression pattern in mice. Neither human nor mouse NCCRP1 expression is specific to immune tissues. Silencing CA9 using siRNAs did not affect NCCRP1 levels, indicating that its expression is not directly regulated by CA9. Interestingly, silencing NCCRP1 caused a statistically significant decrease in the growth of HeLa cells. These studies provide ample evidence that the current name, "non-specific cytotoxic cell receptor protein 1," is not appropriate. We therefore propose that the gene name be changed to FBXO50.	[Kallio, Heini; Tolvanen, Martti; Pan, Pei-wen; Laurila, Eeva; Kallioniemi, Anne; Tuominen, Vilppu J.; Isola, Jorma; Valjakka, Jarkko; Parkkila, Seppo] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kallio, Heini; Pan, Pei-wen; Kallioniemi, Anne; Parkkila, Seppo] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Kilpinen, Sami] MediSapiens Ltd, Helsinki, Finland; [Pastorek, Jaromir; Parkkila, Seppo] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava, Slovakia	Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland; Slovak Academy of Sciences	Kallio, H (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	heini.kallio@uta.fi	Pastorek, Jaromir/AAR-2647-2020; Pastorekova, Silvia/C-6685-2018; Jänis, Janne/B-7326-2014	Kilpinen, Sami/0000-0003-3444-2539; Kallioniemi, Anne/0000-0003-3552-8158; Tolvanen, Martti/0000-0003-3434-7646; Laurila, Eeva/0000-0003-0090-4547; Kallio, Heini M.L./0000-0003-4345-1787; Parkkila, Seppo/0000-0001-7323-8536	Tampere University Hospital; Sigrid Juselius Foundation; Academy of Finland	Tampere University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by the Competitive Research Funding of the Tampere University Hospital and by grants from the Sigrid Juselius Foundation and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bootorabi Fatemeh, 2008, BMC Biochemistry, V9, P32, DOI 10.1186/1471-2091-9-32; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cuesta A, 2005, DEV COMP IMMUNOL, V29, P637, DOI 10.1016/j.dci.2004.11.003; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans DL, 1998, CELL IMMUNOL, V187, P19, DOI 10.1006/cimm.1998.1310; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gut MO, 2002, GASTROENTEROLOGY, V123, P1889, DOI 10.1053/gast.2002.37052; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ishimoto Y, 2004, FISH SHELLFISH IMMUN, V16, P163, DOI 10.1016/S1050-4648(03)00059-7; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jaso-Friedmann L, 2002, J MOL EVOL, V54, P386, DOI 10.1007/s00239-001-0027-8; Jaso-Friedmann L, 1997, MOL IMMUNOL, V34, P955, DOI 10.1016/S0161-5890(97)00086-2; Jaso-Friedmann L, 2001, DEV COMP IMMUNOL, V25, P701, DOI 10.1016/S0145-305X(01)00031-3; Kallio H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-397; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 2004, CANC THER, V2, P245; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reimers K, 2006, J COMP PHYSIOL B, V176, P599, DOI 10.1007/s00360-006-0083-x; Sakata H, 2005, COMP BIOCHEM PHYS C, V140, P287, DOI 10.1016/j.cca.2005.02.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yoshida Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2623, DOI 10.1271/bbb.70074; Zhang L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-78	34	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27152	10.1371/journal.pone.0027152	http://dx.doi.org/10.1371/journal.pone.0027152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087255	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700021
J	Wei, QZ; Condie, BG				Wei, Qiaozhi; Condie, Brian G.			A Focused In Situ Hybridization Screen Identifies Candidate Transcriptional Regulators of Thymic Epithelial Cell Development and Function	PLOS ONE			English	Article							3RD PHARYNGEAL POUCH; HOMEOBOX GENE; MOUSE EMBRYO; EXPRESSION; MICE; DIFFERENTIATION; ENDODERM; MORPHOGENESIS; ABNORMALITIES; NKX2.6	Background: Thymic epithelial cells (TECs) are necessary for normal T cell development. Currently, one transcription factor, Foxn1 is known to be necessary for the progression of fetal TEC differentiation. However, some aspects of fetal TEC differentiation occur in Foxn1 mutants, suggesting the existence of additional transcriptional regulators of TEC differentiation. The goal of this study was to identify some of the additional candidate transcription factors that may be involved in the specification and/or differentiation of TECs during fetal development. Methodology/Principal Findings: We identified candidate fetal TEC transcriptional regulators via data and text mining. From our data mining we selected the transcription factors Foxg1, Isl1, Gata3, Nkx2-5, Nkx2- 6 and Sox2 for further studies. Whole mount in situ hybridizations confirmed the expression of these transcription factors within subdomains of the third pharyngeal pouch from E9.5-E10.5. By E11.5 days Foxg1 and Isl1 transcripts were the only mRNAs from this group of genes detected exclusively within the thymus domain of the third pouch. Based on this initial in situ hybridization analysis, we focused on defining the expression of Foxg1 and Isl1 during multiple stages of thymus development and TEC differentiation. We found that Foxg1 and Isl1 are specifically expressed in differentiating TECs during fetal and postnatal stages of thymus development. In addition, we found differential expression of Islet1 and Foxn1 within the fetal and postnatal TEC population. Conclusions/Significance: Our studies have identified two developmental transcription factors that are excellent candidate regulators of thymic epithelial cell specification and differentiation during fetal development. Our results suggest that Foxg1 and Isl1 may play a role in the regulation of TEC differentiation during fetal and postnatal stages. Our results also demonstrate heterogeneity of TECs marked by the differential expression of transcription factors, potentially providing new insights into the regulation of TEC differentiation.	[Wei, Qiaozhi; Condie, Brian G.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Wei, QZ (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	bcondie@uga.edu			University of Georgia; NICHD	University of Georgia; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 39.4D5 anti-ISL1 monoclonal antibody developed by Dr. Thomas Jessell was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Baird AM, 2000, J IMMUNOL, V165, P3680, DOI 10.4049/jimmunol.165.7.3680; Biben C, 1998, MECH DEVELOP, V73, P125, DOI 10.1016/S0925-4773(98)00037-9; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Chung YC, 2011, GENE EXPR PATTERNS, V11, P84, DOI 10.1016/j.gep.2010.09.007; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dupe V, 1999, DEVELOPMENT, V126, P5051; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Friedrichs M, 2008, DEV BIOL, V318, P203, DOI 10.1016/j.ydbio.2008.03.032; Garces A, 2000, J NEUROSCI, V20, P4992; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2010, DEV BIOL, V339, P141, DOI 10.1016/j.ydbio.2009.12.026; Grevellec A, 2010, SEMIN CELL DEV BIOL, V21, P325, DOI 10.1016/j.semcdb.2010.01.022; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Grigorieva IV, 2010, J CLIN INVEST, V120, P2144, DOI 10.1172/JCI42021; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hidaka K, 2010, STEM CELLS DEV, V19, P1735, DOI 10.1089/scd.2009.0466; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Kist R, 2007, GENESIS, V45, P460, DOI 10.1002/dvg.20295; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Manaia A, 2000, DEVELOPMENT, V127, P643; Manley NR, 2004, DEV BIOL, V276, P301, DOI 10.1016/j.ydbio.2004.08.030; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nikolova M, 1997, MECH DEVELOP, V69, P215, DOI 10.1016/S0925-4773(97)00174-3; Ohnemus S, 2002, MECH DEVELOP, V119, P127, DOI 10.1016/S0925-4773(02)00345-3; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Parmar H, 2001, GENESIS, V31, P57, DOI 10.1002/gene.10005; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Rizzoti K, 2007, DEVELOPMENT, V134, P3437, DOI 10.1242/dev.007906; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Sultana DA, 2009, BLOOD, V113, P2976, DOI 10.1182/blood-2008-06-164921; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanaka M, 2000, MOL CELL BIOL, V20, P2874, DOI 10.1128/MCB.20.8.2874-2879.2000; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Urbanski WM, 2009, GENESIS, V47, P842, DOI 10.1002/dvg.20575; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei Q, 2011, J VIS EXP, V10, pe2797; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xu PX, 2002, DEVELOPMENT, V129, P3033; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yu T, 2009, J COMP NEUROL, V512, P613, DOI 10.1002/cne.21918; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229; Zou D, 2006, DEV BIOL, V293, P499, DOI 10.1016/j.ydbio.2005.12.015	59	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26795	10.1371/journal.pone.0026795	http://dx.doi.org/10.1371/journal.pone.0026795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087235	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700010
J	Hou, M; Liu, YH; Zhu, LJ; Sun, B; Guo, M; Buren, J; Li, XN				Hou, Miao; Liu, Yanhua; Zhu, Lijun; Sun, Bin; Guo, Mei; Buren, Jonas; Li, Xiaonan			Neonatal Overfeeding Induced by Small Litter Rearing Causes Altered Glucocorticoid Metabolism in Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; OBESE ZUCKER RATS; ADIPOSE-TISSUE; CORTISOL METABOLISM; EXPRESSION; CHILDREN; LEPTIN; LIVER; MODEL; MICE	Elevated glucocorticoid (GC) activity may be involved in the development of the metabolic syndrome. Tissue GC exposure is determined by the tissue-specific GC-activating enzyme 11 beta-hydroxysteriod dehydrogenase type 1 (11 beta-HSD1) and the GC-inactivating enzyme 5 alpha-reductase type 1 (5 alpha R1), as well as 5 beta-reductase (5 beta R). Our aim was to study the effects of neonatal overfeeding induced by small litter rearing on the expression of GC-regulating enzymes in adipose tissue and/or liver and on obesity-related metabolic disturbances during development. Male Sprague-Dawley rat pup litters were adjusted to litter sizes of three (small litters, SL) or ten (normal litters, NL) on postnatal day 3 and then given standard chow from postnatal week 3 onward (W3). Small litter rearing induced obesity, hyperinsulinemia, and higher circulating corticosterone in adults. 11 beta-HSD1 expression and enzyme activity in retroperitoneal, but not in epididymal, adipose tissue increased with postnatal time and peaked at W5/W6 in both groups before declining. From W8, 11 beta-HSD1 expression and enzyme activity levels in retroperitoneal fat persisted at significantly higher levels in SL compared to NL rats. Hepatic 11 beta-HSD1 enzyme activity in SL rats was elevated from W3 to W16 compared to NL rats. Hepatic 5 alpha R1 and 5 beta R expression was higher in SL compared to NL rats after weaning until W6, whereupon expression decreased in the SL rats and remained similar to that in NL rats. In conclusion, small litter rearing in rats induced peripheral tissue-specific alterations in 11 beta-HSD1 expression and activity and 5 alpha R1 and 5 beta R expression during puberty, which could contribute to elevated tissue-specific GC exposure and aggravate the development of metabolic dysregulation in adults.	[Hou, Miao; Liu, Yanhua; Zhu, Lijun; Li, Xiaonan] Nanjing Med Univ, Dept Children Hlth Care, Nanjing Childrens Hosp, Nanjing, Peoples R China; [Sun, Bin] Nanjing Med Univ, Dept Gen Surg, Nanjing Childrens Hosp, Nanjing, Peoples R China; [Guo, Mei; Li, Xiaonan] Nanjing Med Univ, Pediat Res Inst, Nanjing, Peoples R China; [Buren, Jonas] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Umea University	Hou, M (corresponding author), Nanjing Med Univ, Dept Children Hlth Care, Nanjing Childrens Hosp, Nanjing, Peoples R China.	xnli@njmu.edu.cn	liu, yan/HCI-5542-2022	Buren, Jonas/0000-0001-5846-9002	Natural Science Foundation of the Jiangsu Health Department of China; Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China	Natural Science Foundation of the Jiangsu Health Department of China; Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China	This work was supported by the Natural Science Foundation of the Jiangsu Health Department of China (2009) and the Scientific Research Foundation for Returned Overseas Scholars of the Ministry of Education of China (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2007, CLIN ENDOCRINOL, V66, P459, DOI 10.1111/j.1365-2265.2007.02763.x; Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Barat P, 2007, ENDOCRINOLOGY, V148, P4836, DOI 10.1210/en.2007-0597; Baudrand R, 2010, OBES SURG, V20, P77, DOI 10.1007/s11695-009-9937-0; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Buren J, 2007, ENDOCRINOLOGY, V148, P2716, DOI 10.1210/en.2006-0897; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; Campino C, 2010, ENDOCRINE, V37, P106, DOI 10.1007/s12020-009-9269-9; Chen HC, 2002, J LIPID RES, V43, P986; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Dieudonne MN, 2006, J STEROID BIOCHEM, V99, P189, DOI 10.1016/j.jsbmb.2006.01.007; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; GUSTAFSSON JA, 1974, J BIOL CHEM, V249, P711; Ishii-Yonemoto T, 2010, AM J PHYSIOL-ENDOC M, V298, pE930, DOI 10.1152/ajpendo.00320.2009; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; Li X, 2007, INT J OBESITY, V31, P820, DOI 10.1038/sj.ijo.0803470; Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409; LIVINGSTONE D, 2009, J ENDOCRINOL; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Metges CC, 2009, ADV EXP MED BIOL, V646, P105, DOI 10.1007/978-1-4020-9173-5_11; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Nyirenda MJ, 2009, DIABETES, V58, P2873, DOI 10.2337/db09-0873; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Stimson R H, 2007, Minerva Endocrinol, V32, P141; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6; Tomlinson JW, 2008, DIABETES, V57, P2652, DOI 10.2337/db08-0495; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596; Wiegand S, 2007, EUR J ENDOCRINOL, V157, P319, DOI 10.1530/EJE-07-0193; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Zhu LJ, 2010, J CLIN ENDOCR METAB, V95, P3300, DOI 10.1210/jc.2009-2708	49	36	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e25726	10.1371/journal.pone.0025726	http://dx.doi.org/10.1371/journal.pone.0025726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073140	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200002
J	Liu, YT; Gibson, J; Wheeler, J; Kwee, LC; Santiago-Turla, CM; Akafo, SK; Lichter, PR; Gaasterland, DE; Moroi, SE; Challa, P; Herndon, LW; Girkin, CA; Budenz, DL; Richards, JE; Allingham, RR; Hauser, MA				Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Santiago-Turla, Cecile M.; Akafo, Stephen K.; Lichter, Paul R.; Gaasterland, Douglas E.; Moroi, Sayoko E.; Challa, Pratap; Herndon, Leon W.; Girkin, Christopher A.; Budenz, Donald L.; Richards, Julia E.; Allingham, R. Rand; Hauser, Michael A.			GALC Deletions Increase the Risk of Primary Open-Angle Glaucoma: The Role of Mendelian Variants in Complex Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME-WIDE ASSOCIATION; NORMAL-TENSION GLAUCOMA; KRABBE-DISEASE; COMMON VARIANTS; GENE; SUSCEPTIBILITY; IDENTIFICATION; LEUKODYSTROPHY; MUTATIONS	DNA copy number variants (CNVs) have been reported in many human diseases including autism and schizophrenia. Primary Open Angle Glaucoma (POAG) is a complex adult-onset disorder characterized by progressive optic neuropathy and vision loss. Previous studies have identified rare CNVs in POAG; however, their low frequencies prevented formal association testing. We present here the association between POAG risk and a heterozygous deletion in the galactosylceramidase gene (GALC). This CNV was initially identified in a dataset containing 71 Caucasian POAG cases and 478 ethnically matched controls obtained from dbGAP (study accession phs000126.v1.p1.) (p = 0.017, fisher's exact test). It was validated with array comparative genomic hybridization (arrayCGH) and realtime PCR, and replicated in an independent POAG dataset containing 959 cases and 1852 controls (p = 0.021, OR (odds ratio) = 3.5, 95% CI 21.1-12.0). Evidence for association was strengthened when the discovery and replication datasets were combined (p = 0.002; OR = 5.0, 95% CI 1.6-16.4). Several deletions with different endpoints were identified by array CGH of POAG patients. Homozygous deletions that eliminate GALC enzymatic activity cause Krabbe disease, a recessive Mendelian disorder of childhood displaying bilateral optic neuropathy and vision loss. Our findings suggest that heterozygous deletions that reduce GALC activity are a novel mechanism increasing risk of POAG. This is the first report of a statistically-significant association of a CNV with POAG risk, contributing to a growing body of evidence that CNVs play an important role in complex, inherited disorders. Our findings suggest an attractive biomarker and potential therapeutic target for patients with this form of POAG.	[Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Liu, Yutao; Gibson, Jason; Wheeler, Joshua; Kwee, Lydia Coulter; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Santiago-Turla, Cecile M.; Challa, Pratap; Herndon, Leon W.; Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Eye, Durham, NC 27710 USA; [Akafo, Stephen K.] Univ Ghana, Sch Med, Dept Surg, Unit Ophthalmol, Korle Bu, Ghana; [Lichter, Paul R.; Moroi, Sayoko E.; Richards, Julia E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Gaasterland, Douglas E.] Eye Doctors Washington, Chevy Chase, MD USA; [Girkin, Christopher A.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35294 USA; [Budenz, Donald L.] Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA	Duke University; Duke University; Duke University; University of Ghana; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; Bascom Palmer Eye Institute	Liu, YT (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	yutao.liu@duke.edu		Girkin, Chris/0000-0002-9676-4499; Lichter, Paul/0000-0001-8394-4813; Girkin, Christopher/0000-0002-5781-7682; Moroi, Sayoko E/0000-0002-0418-0657	National Institutes of Health (NIH) [R01EY013315, R01EY019126, R03EY014939, R01EY015543, R01EY011671, R01EY09580]; Glaucoma Research Foundation; National Glaucoma Research of American Health Assistance Foundation; Research to Prevent Blindness; Glaucoma Foundation; Duke University NCRR/NIH [1 UL1 RR024128-01]; Duke Center for Human Genetics; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009580, R03EY014939, R01EY019126, P30EY005722, R01EY015543, R01EY011671, R01EY013315] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation; National Glaucoma Research of American Health Assistance Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Glaucoma Foundation; Duke University NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Duke Center for Human Genetics; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by National Institutes of Health (NIH) grants R01EY013315 (MAH), R01EY019126 (MAH), R03EY014939 (RRA), R01EY015543 (RRA), R01EY011671 (JER), R01EY09580 (JER), the Glaucoma Research Foundation (YL), National Glaucoma Research of American Health Assistance Foundation (YL), Research to Prevent Blindness (JER) and The Glaucoma Foundation (YL). This study was also supported in part by Duke University's CTSA grant 1 UL1 RR024128-01 from NCRR/NIH, as well as the research infrastructure of the Duke Center for Human Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2009, MOL VIS, V15, P1594; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; BROWNSTEIN S, 1978, ARCH OPHTHALMOL-CHIC, V96, P864, DOI 10.1001/archopht.1978.03910050466015; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Davis L, 2011, INVEST OPHTHALMOL VI; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Fraser CR, 2009, AM J CLIN PATHOL, V132, P928, DOI 10.1309/AJCPWQ0I0DGXBMHO; Fuse N, 2010, TOHOKU J EXP MED, V221, P1, DOI 10.1620/tjem.221.1; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Libby RT, 2005, ANNU REV GENOM HUM G, V6, P15, DOI 10.1146/annurev.genom.6.080604.162209; LIU Y, 2011, EXP EYE RES; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; LUZI P, 1995, GENOMICS, V26, P407, DOI 10.1016/0888-7543(95)80230-J; LUZI P, 1995, HUM MOL GENET, V4, P2335, DOI 10.1093/hmg/4.12.2335; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Manni G, 2008, PROG BRAIN RES, V173, P25, DOI 10.1016/S0079-6123(08)01103-5; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RAFI MA, 1995, HUM MOL GENET, V4, P1285, DOI 10.1093/hmg/4.8.1285; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	39	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27134	10.1371/journal.pone.0027134	http://dx.doi.org/10.1371/journal.pone.0027134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073273	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200037
J	Murdoch, BM; Murdoch, GK; Settles, M; McKay, S; Williams, JL; Moore, SS				Murdoch, Brenda M.; Murdoch, Gordon K.; Settles, Matthew; McKay, Stephanie; Williams, John L.; Moore, Stephen S.			Genome-Wide Scan Identifies Loci Associated with Classical BSE Occurrence	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PRION PROTEIN; INCUBATION PERIOD; CATTLE; GENE; MICE; CJD	Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease that is invariably fatal in cattle and has been implicated as a significant human health risk. Sequence variations in the coding region of the prion gene (PRNP) have been associated with acquired transmissible spongiform encephalopathy (TSE) susceptibility in mammals; however, this is not the case in cattle. It has been hypothesized that genes, in addition to the prion gene, contribute to genetic susceptibility of acquired TSEs. Accordingly, genetic studies of classical BSE in cattle identified loci other than PRNP that are associated with disease incidence. The objective of this study was to utilize a genome-wide association study to test for genetic loci associated with classical BSE. The samples include 143 BSE affected (case) and 173 unaffected half sib (control) animals collected in the mid 1990s in Southern England. The data analysis identifies loci on two different chromosomes associated with BSE disease occurrence. Most notable is a single nucleotide polymorphism on chromosome 1 at 29.15 Mb that is associated with BSE disease (p = 3.09E-05). Additionally, a locus on chromosome 14, within a cluster of SNPs showed a trend toward significance (p = 5.24E-05). It is worth noting that in a human vCJD study markers on human chromosome 8, a region with shared synteny to the region identified on cattle chromosome 14, were associated with disease. Further, our candidate genes appear to have plausible biological relevance with the known etiology of TSE disease. One of the candidate genes is hypothetical gene LOC521010, similar to FK506 binding protein 2 located on chromosome 1 at 29.32 Mb. This gene encodes a protein that is a member of the immunophilin protein family and is involved in basic cellular processes including protein folding. The chromosomal regions identified in this study and candidate genes within these regions merit further investigation.	[Murdoch, Brenda M.; Moore, Stephen S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Murdoch, Brenda M.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Settles, Matthew] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [McKay, Stephanie] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Williams, John L.] Polo Univ, Lodi, Italy	University of Alberta; Washington State University; Idaho; University of Idaho; University of Missouri System; University of Missouri Columbia	Murdoch, BM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	brenda_murdoch@wsu.edu	Settles, Matthew L/F-2031-2011; Moore, Stephen S/F-5285-2013	Settles, Matthew L/0000-0002-3424-1086; Moore, Stephen/0000-0002-9758-166X; McKay, Stephanie/0000-0003-1434-3111; Williams, John/0000-0001-5188-7957; Murdoch, Brenda M/0000-0001-8675-3473	PrioNet Canada; Alberta Prion Research Institute [200500696]	PrioNet Canada; Alberta Prion Research Institute	The authors would like to thank the PrioNet Canada and Alberta Prion Research Institute (200500696) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2006, J ANIM SCI, V84, P259, DOI 10.2527/2006.842259x; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Hernandez-Sanchez J, 2002, MAMM GENOME, V13, P164, DOI 10.1007/BF02684022; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moreno CR, 2008, GENETICS, V179, P723, DOI 10.1534/genetics.108.088146; Moreno CR, 2003, GENETICS, V165, P2085; Murdoch BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012786; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhang C, 2004, GENETICS, V167, P1863, DOI 10.1534/genetics.104.026401	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26819	10.1371/journal.pone.0026819	http://dx.doi.org/10.1371/journal.pone.0026819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073200	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200020
J	Qin, A; Cheng, TS; Lin, Z; Pavlos, NJ; Jiang, Q; Xu, JK; Dai, KR; Zheng, MH				Qin, An; Cheng, Tak S.; Lin, Zhen; Pavlos, Nathan J.; Jiang, Qing; Xu, Jiake; Dai, Ke R.; Zheng, Ming H.			Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and Function	PLOS ONE			English	Article							VACUOLAR PROTON PUMP; AUTOSOMAL RECESSIVE OSTEOPETROSIS; RESORPTION IN-VITRO; BONE-RESORPTION; H+-ATPASE; EXTRACELLULAR ACIDIFICATION; GRANULAR ACIDIFICATION; ESSENTIAL COMPONENT; GENE-EXPRESSION; MEMBRANE-FUSION	Vacuolar-type H+-ATPases (V-ATPases) are macromolecular proton pumps that acidify intracellular cargos and deliver protons across the plasma membrane of a variety of specialized cells, including bone-resorbing osteoclasts. Extracellular acidification is crucial for osteoclastic bone resorption, a process that initiates the dissolution of mineralized bone matrix. While the importance of V-ATPases in osteoclastic resorptive function is well-defined, whether V-ATPases facilitate additional aspects of osteoclast function and/or formation remains largely obscure. Here we report that the V-ATPase accessory subunit Ac45 participates in both osteoclast formation and function. Using a siRNA-based approach, we show that targeted suppression of Ac45 impairs intracellular acidification and endocytosis, both are prerequisite for osteoclastic bone resorptive function in vitro. Interestingly, we find that knockdown of Ac45 also attenuates osteoclastogenesis owing to a reduced fusion capacity of osteoclastic precursor cells. Finally, in an effort to gain more detailed insights into the functional role of Ac45 in osteoclasts, we attempted to generate osteoclast-specific Ac45 conditional knockout mice using a Cathepsin K-Cre-LoxP system. Surprisingly, however, insertion of the neomycin cassette in the Ac45-Flox(Neo) mice resulted in marked disturbances in CNS development and ensuing embryonic lethality thus precluding functional assessment of Ac45 in osteoclasts and peripheral bone tissues. Based on these unexpected findings we propose that, in addition to its canonical function in V-ATPase-mediated acidification, Ac45 plays versatile roles during osteoclast formation and function.	[Qin, An; Dai, Ke R.] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China; [Qin, An; Cheng, Tak S.; Lin, Zhen; Pavlos, Nathan J.; Zheng, Ming H.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Perth, WA 6009, Australia; [Lin, Zhen] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg, Div Orthopaed, Guangzhou, Guangdong, Peoples R China; [Jiang, Qing; Zheng, Ming H.] Nanjing Univ, Model Anim Res Ctr, Australian China Joint Ctr Bone & Joint Res, Nanjing 210008, Peoples R China; [Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing 210008, Peoples R China; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Dai, Ke R.] Shanghai Jiao Tong Univ, Chinese Acad Sci, Inst Hlth Sci, Orthopaed Cellular & Mol Biol Lab,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of Western Australia; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Nanjing University; Nanjing University; University of Western Australia; Chinese Academy of Sciences; Shanghai Jiao Tong University	Qin, A (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China.	krdai@163.com; minghao.zheng@uwa.edu.au		/0000-0002-2151-3433; Pavlos, Nathan/0000-0001-7003-188X; Xu, Jiake/0000-0003-2021-8309; Zheng, Minghao/0000-0003-1185-4768	National Health and Medical Research Council of Australia (NHMRC) [APP572670]; Key Disciplines of Shanghai Municipal Education Commission of China [J50206]; Guangdong Natural Science Foundation [9451008004002071]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Key Disciplines of Shanghai Municipal Education Commission of China; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by grants awarded by the National Health and Medical Research Council of Australia (NHMRC) to Dr. Zheng and Dr. Xu (APP572670), grants awarded by the Key Disciplines of Shanghai Municipal Education Commission of China to Dr. Dai (J50206), and grants awarded by Guangdong Natural Science Foundation to Dr. Lin (9451008004002071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; Drose S, 1997, J EXP BIOL, V200, P1; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Forgac M, 2000, J EXP BIOL, V203, P71; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Getlawi F, 1996, NEUROSCI LETT, V219, P13, DOI 10.1016/S0304-3940(96)13151-7; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Holthuis JCM, 1999, EUR J BIOCHEM, V262, P484, DOI 10.1046/j.1432-1327.1999.00396.x; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Ishizuka H, 2011, J BONE MINER RES, V26, P169, DOI 10.1002/jbmr.199; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2010, MOL BIOL CELL, V21, P3330, DOI 10.1091/mbc.E10-04-0274; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; LAITALA T, 1994, J CLIN INVEST, V93, P2311, DOI 10.1172/JCI117235; Laitala-Leinonen T, 1999, J CELL SCI, V112, P3657; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; PALMGREN MG, 1991, ANAL BIOCHEM, V192, P316, DOI 10.1016/0003-2697(91)90542-2; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Schoonderwoert VTG, 2002, MOL MEMBR BIOL, V19, P67, DOI 10.1080/09687680110112910; Scimeca JC, 2003, HUM MUTAT, V21, P151, DOI 10.1002/humu.10165; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUNDQUIST K, 1990, BIOCHEM BIOPH RES CO, V168, P309, DOI 10.1016/0006-291X(90)91709-2; SUNDQUIST KT, 1994, J BONE MINER RES, V9, P1575; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Vaananen HK, 2000, J CELL SCI, V113, P377; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu J, 2003, J CELL BIOCHEM, V88, P1256, DOI 10.1002/jcb.10477; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	59	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27155	10.1371/journal.pone.0027155	http://dx.doi.org/10.1371/journal.pone.0027155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22087256	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200040
J	Chadha, SS; Bn, S; Reddy, K; Jaju, J; Ph, V; Rao, S; Parmar, M; Satyanarayana, S; Sachdeva, KS; Wilson, N; Harries, AD				Chadha, Sarabjit S.; Bn, Sharath; Reddy, Kishore; Jaju, Jyothi; Ph, Vishnu; Rao, Sreenivas; Parmar, Malik; Satyanarayana, Srinath; Sachdeva, Kuldeep Singh; Wilson, Nevin; Harries, Anthony D.			Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, India	PLOS ONE			English	Article							TUBERCULOSIS	Background: Revised National TB Control Programme (RNTCP), Andhra Pradesh, India. There is limited information on whether MDR-TB suspects are identified, undergo diagnostic assessment and are initiated on treatment according to the programme guidelines. Objectives: To assess i) using the programme definition, the number and proportion of MDR-TB suspects in a large cohort of TB patients on first-line treatment under RNTCP ii) the proportion of these MDR-TB suspects who underwent diagnosis for MDR-TB and iii) the number and proportion of those diagnosed as MDR-TB who were successfully initiated on treatment. Methods: A retrospective cohort analysis, by reviewing RNTCP records and reports, was conducted in four districts of Andhra Pradesh, India, among patients registered for first line treatment during October 2008 to December 2009. Results: Among 23,999 TB patients registered for treatment there were 559 (2%) MDR-TB suspects (according to programme definition) of which 307 (55%) underwent diagnosis and amongst these 169 (55%) were found to be MDR-TB. Of the MDR-TB patients, 112 (66%) were successfully initiated on treatment. Amongst those eligible for MDR-TB services, significant proportions are lost during the diagnostic and treatment initiation pathway due to a variety of operational challenges. The programme needs to urgently address these challenges for effective delivery and utilisation of the MDR-TB services.	[Chadha, Sarabjit S.; Satyanarayana, Srinath; Wilson, Nevin] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Bn, Sharath; Jaju, Jyothi; Parmar, Malik] World Hlth Org, Off WHO Representat India, New Delhi, India; [Reddy, Kishore; Ph, Vishnu] State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Rao, Sreenivas] Govt Andhra Pradesh, State TB Off, Directorate Hlth, Hyderabad, Andhra Pradesh, India; [Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India	World Health Organization	Chadha, SS (corresponding author), Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India.	schadha@theunion.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551; Wilson, Nevin/0000-0002-0191-8855	Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France; Operational Research Unit, Medecins sans Frontieres, Brussels	Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France; Operational Research Unit, Medecins sans Frontieres, Brussels	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union against Tuberculosis and Lung Disease, Paris, France and the Operational Research Unit, Medecins sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CENTR TUB DIV, 2010, DOTS PLUS GUID DIR G; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; CHAN M, 2009, MDR TB OVERCOMING RE; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; *STOP T PARTN WHO, 2006, GLOB PLAN STOP TB 20; *WHO GEN, 2010, WHOHTMTB201003; *WHO GEN, 2008, WHOHTMTB2008402; *WHO GEN, 2003, TREATM TUB GUID NAT	11	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26659	10.1371/journal.pone.0026659	http://dx.doi.org/10.1371/journal.pone.0026659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073182	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900008
J	Denkel, LA; Horst, SA; Rouf, SF; Kitowski, V; Bohm, OM; Rhen, M; Jager, T; Bange, FC				Denkel, Luisa A.; Horst, Sarah A.; Rouf, Syed Fazle; Kitowski, Vera; Bohm, Oliver M.; Rhen, Mikael; Jager, Timo; Bange, Franz-Christoph			Methionine Sulfoxide Reductases Are Essential for Virulence of Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; STAPHYLOCOCCUS-AUREUS; R-SULFOXIDE; MYCOBACTERIUM-SMEGMATIS; EXPRESSION; DAMAGE; GENES; MSRA; MACROPHAGES	Production of reactive oxygen species represents a fundamental innate defense against microbes in a diversity of host organisms. Oxidative stress, amongst others, converts peptidyl and free methionine to a mixture of methionine-S-(Met-S-SO) and methionine-R-sulfoxides (Met-R-SO). To cope with such oxidative damage, methionine sulfoxide reductases MsrA and MsrB are known to reduce MetSOs, the former being specific for the S-form and the latter being specific for the R-form. However, at present the role of methionine sulfoxide reductases in the pathogenesis of intracellular bacterial pathogens has not been fully detailed. Here we show that deletion of msrA in the facultative intracellular pathogen Salmonella ( S.) enterica serovar Typhimurium increased susceptibility to exogenous H(2)O(2), and reduced bacterial replication inside activated macrophages, and in mice. In contrast, a Delta msrB mutant showed the wild type phenotype. Recombinant MsrA was active against free and peptidyl Met-S-SO, whereas recombinant MsrB was only weakly active and specific for peptidyl Met-R-SO. This raised the question of whether an additional Met-R-SO reductase could play a role in the oxidative stress response of S. Typhimurium. MsrC is a methionine sulfoxide reductase previously shown to be specific for free Met-R-SO in Escherichia (E.) coli. We tested a Delta msrC single mutant and a Delta msrB Delta msrC double mutant under various stress conditions, and found that MsrC is essential for survival of S. Typhimurium following exposure to H(2)O(2), as well as for growth in macrophages, and in mice. Hence, this study demonstrates that all three methionine sulfoxide reductases, MsrA, MsrB and MsrC, facilitate growth of a canonical intracellular pathogen during infection. Interestingly MsrC is specific for the repair of free methionine sulfoxide, pointing to an important role of this pathway in the oxidative stress response of Salmonella Typhimurium.	[Denkel, Luisa A.; Horst, Sarah A.; Rouf, Syed Fazle; Kitowski, Vera; Bange, Franz-Christoph] Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [Bohm, Oliver M.; Jager, Timo] Mol Links Sachsen Anhalt Gesell Beschrankter Haft, Magdeburg, Germany; [Rouf, Syed Fazle; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Hannover Medical School; Karolinska Institutet	Denkel, LA (corresponding author), Hannover Med Sch, Dept Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany.	bange.franz@mh-hannover.de	Denkel, Luisa/AIC-3404-2022	Rouf, Syed Fazle/0000-0003-3776-5018; Denkel, Luisa/0000-0003-4005-1315	International Research Training Group [1273]; German Research Foundation; Swedish Medical Research Council; German Research Foundation (Deutsche Forschungsgemeinschaft)	International Research Training Group; German Research Foundation(German Research Foundation (DFG)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the International Research Training Group 1273 funded by the German Research Foundation to SAH, LAD, and SFR. MR was supported by the Swedish Medical Research Council. Publication fee for this study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bong SM, 2010, J BIOL CHEM, V285, P25044, DOI 10.1074/jbc.M110.103119; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; EJIRI SI, 1979, J BACTERIOL, V139, P161, DOI 10.1128/JB.139.1.161-164.1979; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Gruez A, 2010, J BIOL CHEM, V285, P25033, DOI 10.1074/jbc.M110.134528; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mintz KP, 2002, MICROBIOL-SGM, V148, P3695, DOI 10.1099/00221287-148-11-3695; Moskovitz J, 2002, BIOCHEM BIOPH RES CO, V290, P62, DOI 10.1006/bbrc.2001.6171; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Singh VK, 2001, MICROBIOL-SGM, V147, P3037, DOI 10.1099/00221287-147-11-3037; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	39	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26974	10.1371/journal.pone.0026974	http://dx.doi.org/10.1371/journal.pone.0026974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073230	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900057
J	Mothe, AJ; Zahir, T; Santaguida, C; Cook, D; Tator, CH				Mothe, Andrea J.; Zahir, Tasneem; Santaguida, Carlo; Cook, Douglas; Tator, Charles H.			Neural Stem/Progenitor Cells from the Adult Human Spinal Cord Are Multipotent and Self-Renewing and Differentiate after Transplantation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM-CULTURE; PROGENITOR CELLS; IN-VITRO; GROWTH-FACTOR; HUMAN BRAIN; HUMAN NEUROSPHERES; PRECURSOR CELLS; RADIAL GLIA	Neural stem/progenitor cell (NSPC) transplantation is a promising therapy for spinal cord injury (SCI). However, little is known about NSPC from the adult human spinal cord as a donor source. We demonstrate for the first time that multipotent and self-renewing NSPC can be cultured, passaged and transplanted from the adult human spinal cord of organ transplant donors. Adult human spinal cord NSPC require an adherent substrate for selection and expansion in EGF (epidermal growth factor) and FGF2 (fibroblast growth factor) enriched medium. NSPC as an adherent monolayer can be passaged for at least 9 months and form neurospheres when plated in suspension culture. In EGF/FGF2 culture, NSPC proliferate and primarily express nestin and Sox2, and low levels of markers for differentiating cells. Leukemia inhibitory factor (LIF) promotes NSPC proliferation and significantly enhances GFAP expression in hypoxia. In differentiating conditions in the presence of serum, these NSPC show multipotentiality, expressing markers of neurons, astrocytes, and oligodendrocytes. Dibutyryl cyclic AMP (dbcAMP) significantly enhances neuronal differentiation. We transplanted the multipotent NSPC into SCI rats and show that the xenografts survive, are post-mitotic, and retain the capacity to differentiate into neurons and glia. Together, these findings reveal that multipotent self-renewing NSPC cultured and passaged from adult human spinal cords of organ transplant donors, respond to exogenous factors that promote selective differentiation, and survive and differentiate after transplantation into the injured spinal cord.	[Mothe, Andrea J.] Univ Toronto, Toronto Western Hosp, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mothe, AJ (corresponding author), Univ Toronto, Toronto Western Hosp, Div Genet & Dev, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada.	amothe@uhnres.utoronto.ca		Mothe, Andrea/0000-0002-1062-1025	AOSpine North America; Physicians' Services Inc. Foundation [09-34]; Canadian Paraplegic Association (ON branch); Christopher and Dana Reeve Foundation [TA1-0402-2]	AOSpine North America; Physicians' Services Inc. Foundation; Canadian Paraplegic Association (ON branch); Christopher and Dana Reeve Foundation	This work was supported by AOSpine North America Young Investigator Research Grant (no grant#), Physicians' Services Inc. Foundation (grant# 09-34), the Canadian Paraplegic Association (ON branch)(no grant#), and the Christopher and Dana Reeve Foundation (grant# TA1-0402-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson E, 2007, PHYSIOL BEHAV, V92, P60, DOI 10.1016/j.physbeh.2007.05.056; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barami K, 2001, NEUROL RES, V23, P260, DOI 10.1179/016164101101198406; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dervan AG, 2003, J COMP NEUROL, V458, P293, DOI 10.1002/cne.10594; Dromard C, 2008, J NEUROSCI RES, V86, P1916, DOI 10.1002/jnr.21646; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Klassen H, 2004, J NEUROSCI RES, V77, P334, DOI 10.1002/jnr.20183; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Lopez-Toledano MA, 2004, J HISTOCHEM CYTOCHEM, V52, P1177, DOI 10.1369/jhc.3A6244.2004; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.0.CO;2-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rao Mahendra S., 2009, V549, P3, DOI 10.1007/978-1-60327-931-4_1; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rivlin A S, 1978, Surg Neurol, V10, P38; Roy NS, 2004, NAT BIOTECHNOL, V22, P297, DOI 10.1038/nbt944; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Studer L, 2000, J NEUROSCI, V20, P7377; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; Weiss S, 1996, J NEUROSCI, V16, P7599; WOLSWIJK G, 1991, GLIA, V4, P495, DOI 10.1002/glia.440040509; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	70	64	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27079	10.1371/journal.pone.0027079	http://dx.doi.org/10.1371/journal.pone.0027079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073257	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900071
J	Niu, S; Shingle, DL; Garbarino-Pico, E; Kojima, S; Gilbert, M; Green, CB				Niu, Shuang; Shingle, Danielle L.; Garbarino-Pico, Eduardo; Kojima, Shihoko; Gilbert, Misty; Green, Carla B.			The Circadian Deadenylase Nocturnin Is Necessary for Stabilization of the iNOS mRNA in Mice	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; POSTTRANSCRIPTIONAL REGULATION; COMPLEX; IDENTIFICATION; LIPOPOLYSACCHARIDE; TRANSLATION; INVOLVEMENT; EXPRESSION; MECHANISM; ENDOTOXIN	Nocturnin is a member of the CCR4 deadenylase family, and its expression is under circadian control with peak levels at night. Because it can remove poly(A) tails from mRNAs, it is presumed to play a role in post-transcriptional control of circadian gene expression, but its target mRNAs are not known. Here we demonstrate that Nocturnin expression is acutely induced by the endotoxin lipopolysaccharide (LPS). Mouse embryo fibroblasts (MEFs) lacking Nocturnin exhibit normal patterns of acute induction of TNF alpha and iNOS mRNAs during the first three hours following LPS treatment, but by 24 hours, while TNFa mRNA levels are indistinguishable from WT cells, iNOS message is significantly reduced 20-fold. Accordingly, analysis of the stability of the mRNAs showed that loss of Nocturnin causes a significant decrease in the half-life of the iNOS mRNA (t(1/2) = 3.3 hours in Nocturnin knockout MEFs vs. 12.4 hours in wild type MEFs), while having no effect on the TNFa message. Furthermore, mice lacking Nocturnin lose the normal nighttime peak of hepatic iNOS mRNA, and have improved survival following LPS injection. These data suggest that Nocturnin has a novel stabilizing activity that plays an important role in the circadian response to inflammatory signals.	[Niu, Shuang; Shingle, Danielle L.; Garbarino-Pico, Eduardo; Kojima, Shihoko; Gilbert, Misty; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Shingle, Danielle L.; Kojima, Shihoko; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Niu, S (corresponding author), Stanford Med Sch, Dept Pediat, Palo Alto, CA USA.	Carla.Green@UTSouthwestern.edu		Kojima (xiao dao zhi bao zi), Shihoko/0000-0001-9579-7830; Garbarino Pico, Eduardo/0000-0002-2931-2038	National Institutes of Health [R01 GM076626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM076626 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Baggs Julie E, 2006, Methods Mol Biol, V317, P243; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Franco-Molina MA, 2004, INT IMMUNOPHARMACOL, V4, P1577, DOI 10.1016/j.intimp.2004.06.014; Garbarino-Pico E, 2007, COLD SPRING HARB SYM, V72, P145, DOI 10.1101/sqb.2007.72.022; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GELLER DA, 1995, J IMMUNOL, V155, P4890; Gilbert MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017051; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 1996, MOL BRAIN RES, V37, P157, DOI 10.1016/0169-328X(95)00307-E; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; HRUSHESKY WJM, 1994, J EXP MED, V180, P1059, DOI 10.1084/jem.180.3.1059; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Keene JD, 2007, COLD SPRING HARB SYM, V72, P157, DOI 10.1101/sqb.2007.72.013; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kitade H, 1996, HEPATOLOGY, V23, P797, DOI 10.1002/hep.510230421; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kuo SM, 2005, J NUTR, V135, P2411, DOI 10.1093/jn/135.10.2411; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Netea MG, 2001, EUR J IMMUNOL, V31, P2529, DOI 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Soderberg M, 2002, MOL PHARMACOL, V62, P423, DOI 10.1124/mol.62.2.423; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Xu J., 2005, CURR PROT MOL BIOL, V28, P28; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	48	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26954	10.1371/journal.pone.0026954	http://dx.doi.org/10.1371/journal.pone.0026954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073225	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900054
J	Utani, K; Okamoto, A; Shimizu, N				Utani, Koh-ichi; Okamoto, Atsushi; Shimizu, Noriaki			Generation of Micronuclei during Interphase by Coupling between Cytoplasmic Membrane Blebbing and Nuclear Budding	PLOS ONE			English	Article							EXTRACHROMOSOMALLY AMPLIFIED DNA; GENE AMPLIFICATION; DOUBLE MINUTES; CANCER-CELLS; HL-60 CELLS; MOLECULAR-MECHANISMS; MYC GENES; S PHASE; C-MYC; CHROMATIN	Micronucleation, mediated by interphase nuclear budding, has been repeatedly suggested, but the process is still enigmatic. In the present study, we confirmed the previous observation that there are lamin B1-negative micronuclei in addition to the positive ones. A large cytoplasmic bleb was found to frequently entrap lamin B1-negative micronuclei, which were connected to the nucleus by a thin chromatin stalk. At the bottom of the stalk, the nuclear lamin B1 structure appeared broken. Chromatin extrusion through lamina breaks has been referred to as herniation or a blister of the nucleus, and has been observed after the expression of viral proteins. A cell line in which extrachromosomal double minutes and lamin B1 protein were simultaneously visualized in different colors in live cells was established. By using these cells, time-lapse microscopy revealed that cytoplasmic membrane blebbing occurred simultaneously with the extrusion of nuclear content, which generated lamin B1-negative micronuclei during interphase. Furthermore, activation of cytoplasmic membrane blebbing by the addition of fresh serum or camptothecin induced nuclear budding within 1 to 10 minutes, which suggested that blebbing might be the cause of the budding. After the induction of blebbing, the frequency of lamin-negative micronuclei increased. The budding was most frequent during S phase and more efficiently entrapped small extrachromosomal chromatin than the large chromosome arm. Based on these results, we suggest a novel mechanism in which cytoplasmic membrane dynamics pulls the chromatin out of the nucleus through the lamina break. Evidence for such a mechanism was obtained in certain cancer cell lines including human COLO 320 and HeLa. The mechanism could significantly perturb the genome and influence cancer cell phenotypes.	[Utani, Koh-ichi; Okamoto, Atsushi; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan	Hiroshima University	Utani, K (corresponding author), NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA.	shimizu@hiroshima-u.ac.jp		Utani, Koichi/0000-0002-8065-3161	Japan Society for the Promotion of Science [17370002, 21657051]; Ministry of Education, Science, Sports and Culture of Japan [19038016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) [grant number 17370002] and a Grant-in-Aid for Challenging Exploratory Research [grant number 21657051] both from the Japan Society for the Promotion of Science to NS and a Grant-in-Aid for Scientific Research on Priority Areas - Nuclear dynamics [grant number 19038016] from the Ministry of Education, Science, Sports and Culture of Japan to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cimini D, 2002, J CELL SCI, V115, P507; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DIXON SJ, 1987, J CELL PHYSIOL, V132, P215, DOI 10.1002/jcp.1041320205; DIXON SJ, 1987, J CELL PHYSIOL, V132, P473, DOI 10.1002/jcp.1041320309; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2009, MUTAT RES-REV MUTAT, V681, P111, DOI 10.1016/j.mrrev.2008.11.003; FOISY S, 1988, BIOCHEM BIOPH RES CO, V156, P205, DOI 10.1016/S0006-291X(88)80825-8; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Hagmann J, 1999, J CELL BIOCHEM, V73, P488, DOI 10.1002/(SICI)1097-4644(19990615)73:4<488::AID-JCB7>3.0.CO;2-P; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Hoyt CC, 2004, J VIROL, V78, P6360, DOI 10.1128/JVI.78.12.6360-6369.2004; Itoh N, 1998, J CELL SCI, V111, P3275; Kanda T, 2000, J CELL BIOCHEM, P107; LEVAN A, 1978, HEREDITAS, V88, P81; Lindberg HK, 2007, MUTAT RES-FUND MOL M, V617, P33, DOI 10.1016/j.mrfmmm.2006.12.002; Machesky LM, 2009, CANCER CELL, V16, P5, DOI 10.1016/j.ccr.2009.06.009; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Paulin LM, 1996, CHROMOSOMA, V104, P367; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; SHIMIZU N, 1991, J BIOL CHEM, V266, P12157; Shimizu N, 2005, NUCLEIC ACIDS RES, V33, P6296, DOI 10.1093/nar/gki946; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; SHIMIZU N, 1994, CANCER RES, V54, P3561; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Shimizu N, 2011, MUTAGENESIS, V26, P119, DOI 10.1093/mutage/geq053; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tanaka T, 2000, J CELL SCI, V113, P697; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651	47	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27233	10.1371/journal.pone.0027233	http://dx.doi.org/10.1371/journal.pone.0027233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073297	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900093
J	Wang, CK; Simon, A; Jessen, CM; Oliveira, CLP; Mack, L; Braunewell, KH; Ames, JB; Pedersen, JS; Hofmann, A				Wang, Conan K.; Simon, Anne; Jessen, Christian M.; Oliveira, Cristiano L. P.; Mack, Lynsey; Braunewell, Karl-Heinz; Ames, James B.; Pedersen, Jan Skov; Hofmann, Andreas			Divalent Cations and Redox Conditions Regulate the Molecular Structure and Function of Visinin-Like Protein-1	PLOS ONE			English	Article							NEURONAL CALCIUM SENSOR-1; GUANYLYL CYCLASE; DNA-BINDING; IN-VITRO; VILIP-1; SCATTERING; IDENTIFICATION; LOCALIZATION; DIMERIZATION; EXPRESSION	The NCS protein Visinin-like Protein 1 (VILIP-1) transduces calcium signals in the brain and serves as an effector of the non-retinal receptor guanylyl cyclases (GCs) GC-A and GC-B, and nicotinic acetyl choline receptors (nAchR). Analysis of the quaternary structure of VILIP-1 in solution reveals the existence of monomeric and dimeric species, the relative contents of which are affected but not exclusively regulated by divalent metal ions and Redox conditions. Using small-angle X-ray scattering, we have investigated the low resolution structure of the calcium-bound VILIP-1 dimer under reducing conditions. Scattering profiles for samples with high monomeric and dimeric contents have been obtained. The dimerization interface involves residues from EF-hand regions EF3 and EF4. Using monolayer adsorption experiments, we show that myristoylated and unmyristoylated VILIP-1 can bind lipid membranes. The presence of calcium only marginally improves binding of the protein to the monolayer, suggesting that charged residues at the protein surface may play a role in the binding process. In the presence of calcium, VILIP-1 undergoes a conformational re-arrangement, exposing previously hidden surfaces for interaction with protein partners. We hypothesise a working model where dimeric VILIP-1 interacts with the membrane where it binds membrane-bound receptors in a calcium-dependent manner.	[Wang, Conan K.; Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Brisbane, Qld 4111, Australia; [Simon, Anne] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France; [Jessen, Christian M.] Univ Sao Paulo, Dept Expt Phys, Complex Fluids Grp, Sao Paulo, Brazil; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov] Univ Aarhus, Dept Chem, Aarhus, Denmark; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov] Univ Aarhus, iNANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark; [Mack, Lynsey; Hofmann, Andreas] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Braunewell, Karl-Heinz] So Res Inst, Dept Biochem & Mol Biol, Mol & Cellular Neurosci Lab, Birmingham, AL 35255 USA; [Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Griffith University; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade de Sao Paulo; Aarhus University; Aarhus University; University of Edinburgh; University of California System; University of California Davis	Wang, CK (corresponding author), Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Brisbane, Qld 4111, Australia.	conan.wang@griffith.edu.au	Hofmann, Andreas/M-9870-2019; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008; SIMON, Anne/D-6046-2011; Jessen, Christian/B-5238-2012; Hofmann, Andreas/B-9515-2008; Wang, Conan K/D-1481-2010; Oliveira, Cristiano L P/B-4403-2008	Hofmann, Andreas/0000-0003-4408-5467; Pedersen, Jan Skov/0000-0002-7768-0206; Hofmann, Andreas/0000-0003-4408-5467; Wang, Conan K/0000-0002-7973-7632; Oliveira, Cristiano L P/0000-0002-3426-6507	Fundacao Bial; Rebecca Cooper Foundation; National Institutes of Health [EY012347]; National Health and Medical Research Council [37677]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	Fundacao Bial(Bial Foundation); Rebecca Cooper Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in parts by Fundacao Bial, the Rebecca Cooper Foundation (AH), and National Institutes of Health (grant EY012347, J.B.A.). C. W. is supported by an National Health and Medical Research Council postdoctoral training fellowship (37677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Brackmann M, 2006, NEURONAL CALCIUM SEN, P115; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 2006, CALCIUM BINDING PROT, V1, P12; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; COX JA, 1994, J BIOL CHEM, V269, P32807; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Hofmann A, 2002, BIOINFORMATICS, V18, P209, DOI 10.1093/bioinformatics/18.1.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabbani N, 2002, J NEUROSCI, V22, P8476; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mahloogi H, 2003, CANCER RES, V63, P4997; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; Meyer T, 1999, NAT CELL BIOL, V1, pE93, DOI 10.1038/12090; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Permyakov SE, 2007, J PROTEOME RES, V6, P1855, DOI 10.1021/pr070015x; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Spilker C, 1997, NEUROSCI LETT, V225, P126, DOI 10.1016/S0304-3940(97)00201-2; Spilker C, 2002, J NEUROSCI, V22, P7331; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vogel A, 2007, BBA-BIOMEMBRANES, V1768, P3171, DOI 10.1016/j.bbamem.2007.08.024; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001	43	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26793	10.1371/journal.pone.0026793	http://dx.doi.org/10.1371/journal.pone.0026793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073194	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900036
J	Zwolinska, AK; Whiting, AH; Beekman, C; Sedivy, JM; Marine, JC				Zwolinska, A. K.; Whiting, A. Heagle; Beekman, C.; Sedivy, J. M.; Marine, J-C			Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency	ONCOGENE			English	Article						nucleostemin; c-Myc; p53; lymphoma; transgenic mice	TARGETED HOMOLOGOUS RECOMBINATION; RIBOSOMAL-PROTEIN L23; CELL-CYCLE ARREST; C-MYC; STEM-CELLS; IN-VIVO; GENE-EXPRESSION; DNA-DAMAGE; TRANSCRIPTIONAL REGULATION; INDUCED LYMPHOMAGENESIS	Nucleostemin (NS), a nucleolar GTPase, is highly expressed in stem/progenitor cells and in most cancer cells. However, little is known about the regulation of its expression. Here, we identify the NS gene as a novel direct transcriptional target of the c-Myc oncoprotein. We show that Myc overexpression enhances NS transcription in cultured cells and in pre-neoplastic B cells from El-myc transgenic mice. Consistent with NS being downstream of Myc, NS expression parallels that of Myc in a large panel of human cancer cell lines. Using chromatin immunoprecipitation we show that c-Myc binds to a well-conserved E-box in the NS promoter. Critically, we show NS haploinsufficiency profoundly delays Myc-induced cancer formation in vivo. NS+/- El-myc transgenic mice have much slower rates of B-cell lymphoma development, with life spans twice that of their wild-type littermates. Moreover, we demonstrate that NS is essential for the proliferation of Myc-overexpressing cells in cultured cells and in vivo: impaired lymphoma development was associated with a drastic decrease of c-Myc-induced proliferation of pre-tumoural B cells. Finally, we provide evidence that in cell culture NS controls cell proliferation independently of p53 and that NS haploinsufficiency significantly delays lymphomagenesis in p53-deficient mice. Together these data indicate that NS functions downstream of Myc as a rate-limiting regulator of cell proliferation and transformation, independently from its putative role within the p53 pathway. Targeting NS is therefore expected to compromise early tumour development irrespectively of the p53 status. Oncogene (2012) 31, 3311-3321; doi: 10.1038/onc.2011.507; published online 14 November 2011	[Zwolinska, A. K.; Marine, J-C] VIB KULeuven, Lab Mol Canc Biol, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zwolinska, A. K.; Beekman, C.; Marine, J-C] VIB UGent, Lab Mol Canc Biol, Dept Biomed Mol Biol, Ghent, Belgium; [Whiting, A. Heagle; Sedivy, J. M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Brown University	Marine, JC (corresponding author), VIB KULeuven, Lab Mol Canc Biol, Dept Mol & Dev Genet, Campus Gasthuisberg,Herestr 49,Box 602, B-3000 Louvain, Belgium.	JeanChristophe.Marine@cme.vib-kuleuven.be	Marine, Jean-Christophe/K-3292-2016; Marine, Jean Christophe/J-2237-2015	Marine, Jean-Christophe/0000-0003-2433-9837; Heagle Whiting, Amy/0000-0003-4392-1451	NIH [R01 GM041690]; COBRE [P20 RR015578];  [T32 GM007601]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, R01GM041690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG016694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Geconcerteerde Onderzoeksacties (GOA, University Ghent, Belgium). A K Zwolinska is a recipient of a FWO fellowship. Work in the Sedivy lab was supported by grant R01 GM041690 from the NIH. A Whiting was supported in part by training grant T32 GM007601. The Genomics Core Facility at Brown University was supported in part by the COBRE grant P20 RR015578.	ADAMS JM, 1986, CURR TOP MICROBIOL, V132, P1; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ASKEW DS, 1991, ONCOGENE, V6, P1915; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Bernardi R, 2003, NAT MED, V9, P24, DOI 10.1038/nm0103-24; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Han CX, 2005, INT J MOL MED, V16, P205; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7036, DOI 10.1073/pnas.91.15.7036; Izumi H, 2001, J CELL SCI, V114, P1533; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jafarnejad SM, 2008, CELL PROLIFERAT, V41, P28, DOI 10.1111/j.1365-2184.2007.00505.x; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Liu SJ, 2004, WORLD J GASTROENTERO, V10, P1246; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; Mai S, 1996, CHROMOSOME RES, V4, P365, DOI 10.1007/BF02257272; Malakootian M, 2010, MOL CARCINOGEN, V49, P818, DOI 10.1002/mc.20658; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marine JC, 2010, CANCER CELL, V18, P399, DOI 10.1016/j.ccr.2010.10.026; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; PROUTY SM, 1993, ONCOGENE, V8, P899; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schorl C, 2003, MOL BIOL CELL, V14, P823, DOI 10.1091/mbc.E02-10-0649; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang X, 2005, PNAS, V102, P13969; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	70	16	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	28					3311	3321		10.1038/onc.2011.507	http://dx.doi.org/10.1038/onc.2011.507			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	973NT	22081066	Green Accepted			2022-12-25	WOS:000306367600001
J	Cao, PX; Sun, WY; Kramp, K; Zheng, MH; Salom, D; Jastrzebska, B; Jin, H; Palczewski, K; Feng, ZY				Cao, Pengxiu; Sun, Wenyu; Kramp, Kristopher; Zheng, Maohua; Salom, David; Jastrzebska, Beata; Jin, Hui; Palczewski, Krzysztof; Feng, Zhaoyang			Light-sensitive coupling of rhodopsin and melanopsin to G(i/o) and G(q) signal transduction in Caenorhabditis elegans	FASEB JOURNAL			English	Article						optogenetics; G-protein signaling	OPTICAL CONTROL; HETEROLOGOUS EXPRESSION; NEURAL ACTIVITY; RECEPTOR; PATHWAY; IDENTIFICATION; ACTIVATION; G(Q)ALPHA; BEHAVIOR; GENE	Activation of G-protein-coupled receptors (GPCRs) initiates signal transduction cascades that affect many physiological responses. The worm Caenorhabditis elegans expresses >1000 of these receptors along with their cognate heterotrimeric G proteins. Here, we report properties of 9-cis-retinal regenerated bovine opsin [(b)isoRho] and human melanopsin [(h)Mo], two light-activated, heterologously expressed GPCRs in the nervous system of C. elegans with various genetically engineered alterations. Profound transient photoactivation of G(i/o) signaling by (b)isoRho led to a sudden and transient loss of worm motility dependent on cyclic adenosine monophosphate, whereas transient photoactivation of G(q) signaling by (h)Mo enhanced worm locomotion dependent on phospholipase C beta. These transgenic C. elegans models provide a unique way to study the consequences of G(i/o) and G(q) signaling in vivo with temporal and spatial precision and, by analogy, their relationship to human neuromotor function.-Cao, P., Sun, W., Kramp, K., Zheng, M., Salom, D., Jastrzebska, B., Jin, H., Palczewski, K., Feng, Z. Light-sensitive coupling of rhodopsin and melanopsin to G(i/o) and G(q) signal transduction in Caenorhabditis elegans. FASEB J. 26, 480-491 (2012). www.fasebj.org	[Palczewski, Krzysztof; Feng, Zhaoyang] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Sun, Wenyu; Salom, David; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH USA; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Dept Physiol, Coll Med, Xian 710049, Peoples R China	Case Western Reserve University; Xi'an Jiaotong University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; zxf17@case.edu	Cao, Pengxiu/I-5378-2012; Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; CAO, PENGXIU/0000-0002-5900-5645; Kramp, Kristopher/0000-0003-2121-9274; Salom, David/0000-0002-3208-1509	U.S. National Institutes of Health [GM083241, EY008061, EY009339, P30 EY11373]; Mt. Sinai Health Care Foundation; National Institute of General Medical Sciences [GM074945]; Polgenix, Inc.; NATIONAL EYE INSTITUTE [R01EY009339, R01EY008061, P30EY011373, R29EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241, U54GM074945] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mt. Sinai Health Care Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Polgenix, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. T. Webster for critical comments on the manuscript. This research was supported in part by grants GM083241 (to Z.F.), EY008061, EY009339 and P30 EY11373 (to K. P., co-principal investigator) from the U.S. National Institutes of Health, and Mt. Sinai Health Care Foundation Scholars Program in the Basic Science (to Z.F.). Research was also supported by a U54 award to the New York SGX Research Center for Structural Genomics (NYSGXRC) from the National Institute of General Medical Sciences (GM074945; principal investigator: Stephen K. Burley) under a contract to Polgenix, Inc. D. S. and W. S. are employees of Polgenix, Inc. K.P. is CSO at Polgenix, Inc. P.C., K.K., B.J., H.J., and Z.F. report no conflicts of interest. The Z.F. laboratory received support from Polgenix, Inc.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bastiani Carol, 2006, WormBook, P1; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Cho SW, 2005, MOL CELLS, V19, P149; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Darby C, 2001, INFECT IMMUN, V69, P6271, DOI 10.1128/IAI.69.10.6271-6275.2001; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA; Korswagen HC, 1997, GENE DEV, V11, P1493, DOI 10.1101/gad.11.12.1493; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OKKEMA PG, 1993, GENETICS, V135, P385; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Salom D, 2012, FASEB J, V26, P492, DOI 10.1096/fj.11-197780; Salom D, 2008, BIOCHEMISTRY-US, V47, P13296, DOI 10.1021/bi8018527; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Yabe T, 2005, DEVELOPMENT, V132, P3197, DOI 10.1242/dev.01909; Yau DM, 2003, P NATL ACAD SCI USA, V100, P14748, DOI 10.1073/pnas.2533143100; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang SJ, 2011, J NEUROSCI METH, V197, P315, DOI 10.1016/j.jneumeth.2011.02.014	60	20	23	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					480	491		10.1096/fj.11-197798	http://dx.doi.org/10.1096/fj.11-197798			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22090313	Green Published			2022-12-25	WOS:000300485700002
J	Latypov, RF; Hogan, S; Lau, H; Gadgil, H; Liu, DJ				Latypov, Ramil F.; Hogan, Sabine; Lau, Hollis; Gadgil, Himanshu; Liu, Dingjiang			Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY FOLDED STATE; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; GLOBULAR-PROTEINS; MOLTEN-GLOBULE; STABILITY; DOMAIN; MECHANISM; NMR; CLASSIFICATION	Understanding the underlying mechanisms of Fc aggregation is an important prerequisite for developing stable and efficacious antibody-based therapeutics. In our study, high resolution two-dimensional nuclear magnetic resonance (NMR) was employed to probe structural changes in the IgG1 Fc. A series of H-1-N-15 heteronuclear single-quantum correlation NMR spectra were collected between pH 2.5 and 4.7 to assess whether unfolding of C(H)2 domains precedes that of C(H)3 domains. The same pH range was subsequently screened in Fc aggregation experiments that utilized molecules of IgG1 and IgG2 subclasses with varying levels of C(H)2 glycosylation. In addition, differential scanning calorimetry data were collected over a pH range of 3-7 to assess changes in C(H)2 and C(H)3 thermostability. As a result, compelling evidence was gathered that emphasizes the importance of C(H)2 stability in determining the rate and extent of Fc aggregation. In particular, we found that Fc domains of the IgG1 subclass have a lower propensity to aggregate compared with those of the IgG2 subclass. Our data for glycosylated, partially deglycosylated, and fully deglycosylated molecules further revealed the criticality of CH2 glycans in modulating Fc aggregation. These findings provide important insights into the stability of Fc-based therapeutics and promote better understanding of their acid-induced aggregation process.	[Latypov, Ramil F.; Hogan, Sabine; Lau, Hollis; Gadgil, Himanshu] Amgen Inc, Drug Prod Dev, Seattle, WA 98119 USA; [Liu, Dingjiang] Amgen Inc, Drug Prod Dev, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Latypov, RF (corresponding author), Amgen Inc, Drug Prod Dev, 1201 Amgen Ct W, Seattle, WA 98119 USA.	rlatypov@amgen.com						Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chen S, 2010, PROTEIN SCI, V19, P1191, DOI 10.1002/pro.396; Chen XY, 2009, GLYCOBIOLOGY, V19, P240, DOI 10.1093/glycob/cwn120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fahrner R L, 2001, Biotechnol Genet Eng Rev, V18, P301; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Koren E., 2002, Current Pharmaceutical Biotechnology, V3, P349, DOI 10.2174/1389201023378175; Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003; LILIE H, 1995, FEBS LETT, V362, P43, DOI 10.1016/0014-5793(95)00203-L; Liu D, 2007, BIOMOL NMR ASSIGN, V1, P233, DOI 10.1007/s12104-007-9065-5; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Nakamura S, 2011, BIOCHEMISTRY-US, V50, P3116, DOI 10.1021/bi101806b; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Stackhouse N, 2011, J PHARM SCI-US, V100, P5115, DOI 10.1002/jps.22710; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; TAO MH, 1989, J IMMUNOL, V143, P2595; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; TISCHENKO VM, 1982, EUR J BIOCHEM, V126, P517, DOI 10.1111/j.1432-1033.1982.tb06811.x; Uversky VN, 1998, J MOL BIOL, V278, P879, DOI 10.1006/jmbi.1998.1741; Uversky VN, 1998, P NATL ACAD SCI USA, V95, P5480, DOI 10.1073/pnas.95.10.5480; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002	52	116	127	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1381	1396		10.1074/jbc.M111.297697	http://dx.doi.org/10.1074/jbc.M111.297697			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084250	Green Published, hybrid			2022-12-25	WOS:000299170300052
J	Wang, C; Yu, J; Huo, L; Wang, L; Feng, W; Wang, CC				Wang, Chao; Yu, Jiang; Huo, Lin; Wang, Lei; Feng, Wei; Wang, Chih-chen			Human Protein-disulfide Isomerase Is a Redox-regulated Chaperone Activated by Oxidation of Domain a '	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE DOMAINS; PROLYL 4-HYDROXYLASE; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; BINDING SITE; PDI FAMILY; DEGRADATION; SUBUNIT; SYSTEM; REGION	Protein-disulfide isomerase (PDI), with domains arranged as abb'xa'c, is a key enzyme and chaperone localized in the endoplasmic reticulum (ER) catalyzing oxidative folding and preventing misfolding/aggregation of proteins. It has been controversial whether the chaperone activity of PDI is redox-regulated, and the molecular basis is unclear. Here, we show that both the chaperone activity and the overall conformation of human PDI are redox-regulated. We further demonstrate that the conformational changes are triggered by the active site of domain a', and the minimum redox-regulated cassette is located in b'xa'. The structure of the reduced bb'xa' reveals for the first time that domain a' packs tightly with both domain b' and linker x to form one compact structural module. Oxidation of domain a' releases the compact conformation and exposes the shielded hydrophobic areas to facilitate its high chaperone activity. Thus, the study unequivocally provides mechanistic insights into the redox-regulated chaperone activity of human PDI.	[Wang, Chao; Huo, Lin; Wang, Lei; Feng, Wei; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Yu, Jiang] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong University of Science & Technology	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn; chihwang@sun5.ibp.ac.cn	HUO, LIN/A-6673-2012; Yu, Jiang/C-6980-2012; Wang, Chao/AGP-7000-2022; FENG, WEI/C-8966-2012	Wang, Chao/0000-0002-3048-8559; Wang, Lei/0000-0002-5071-5800	National Major Basic Research Program of China [2011CB910303, 2011CB910503]; National Natural Science Foundation of China [31000351, 31070657]; Chinese Academy of Sciences [KSCX2-YW-R-154, KSCX2-EW-J-3]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Major Basic Research Program of China Grants 2011CB910303 and 2011CB910503, National Natural Science Foundation of China Grants 31000351 and 31070657, and Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-154 and KSCX2-EW-J-3.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAI H, 1994, J BIOL CHEM, V269, P24550; Cho K, 2011, ANTIOXID REDOX SIGN, V15, P621, DOI 10.1089/ars.2010.3756; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee SO, 2010, EMBO J, V29, P363, DOI 10.1038/emboj.2009.359; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SITIA R, 2004, SCI STKE, pPE27; Sun XX, 2000, BBA-PROTEIN STRUCT M, V1481, P45, DOI 10.1016/S0167-4838(00)00122-9; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Walker AK, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/317340; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	56	95	97	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1139	1149		10.1074/jbc.M111.303149	http://dx.doi.org/10.1074/jbc.M111.303149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22090031	hybrid, Green Published			2022-12-25	WOS:000299170300029
J	Xie, T; Ren, RB; Zhang, YY; Pang, YX; Yan, CY; Gong, XQ; He, Y; Li, WQ; Miao, D; Hao, Q; Deng, HT; Wang, ZX; Wu, JW; Yan, NE				Xie, Tian; Ren, Ruobing; Zhang, Yuan-yuan; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng			Molecular Mechanism for Inhibition of a Critical Component in the Arabidopsis thaliana Abscisic Acid Signal Transduction Pathways, SnRK2.6, by Protein Phosphatase ABI1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; KINASE; ABA; STRESS; IDENTIFICATION; ACTIVATION; REGULATORS; INTERACTS; REVEALS; DROUGHT	Subclass III SnRK2s (SnRK2.6/2.3/2.2) are the key positive regulators of abscisic acid (ABA) signal transduction in Arabidopsis thaliana. The kinases, activated by ABA or osmotic stress, phosphorylate stress-related transcription factors and ion channels, which ultimately leads to the protection of plants from dehydration or high salinity. In the absence of stressors, SnRK2s are subject to negative regulation by group A protein phosphatase type 2Cs (PP2C), whereas the underlying molecular mechanism remains to be elucidated. Here we report the crystal structure of the kinase domain of SnRK2.6 at 2.6-angstrom resolution. Structure-guided biochemical analyses identified two distinct interfaces between SnRK2.6 and ABI1, a member of group A PP2Cs. Structural modeling suggested that the two interfaces lock SnRK2.6 and ABI1 in an orientation such that the activation loop of SnRK2.6 is posited to the catalytic site of ABI1 for dephosphorylation. These studies revealed the molecular basis for PP2Cs-mediated inhibition of SnRK2s and provided important insights into the downstream signal transduction of ABA.	[Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Hao, Qi; Wu, Jia-Wei; Yan, Nieng] Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Hao, Qi; Yan, Nieng] State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng] Sch Med, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng] Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Yuan-yuan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, JW (corresponding author), Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China.	jiaweiwu@tsinghua.edu.cn; nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; wang, zhixin/GZH-2500-2022	Ren, Ruobing/0000-0003-4517-7216; Yan, Chuangye/0000-0001-9338-8048; Deng, Haiteng/0000-0001-9496-1280; Xie, Tian/0000-0002-5445-664X	National Natural Science Foundation of China [91017011, 31070644]; Tsinghua University; Yuyuan Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University; Yuyuan Foundation	This work was supported by Projects 91017011 and 31070644 of the National Natural Science Foundation of China, Tsinghua University 985 Phase II funds, and the Yuyuan Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2007, CURRENT PROTOCOLS PR, V50, P291; FEDOROFF NV, 2002, SCI STKE, pRE10; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gong XQ, 2010, PROTEINS, V78, P3150, DOI 10.1002/prot.22831; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schroeder JI, 2006, CELL, V126, P1023, DOI 10.1016/j.cell.2006.09.001; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vlad F, 2010, PLANT J, V63, P778, DOI 10.1111/j.1365-313X.2010.04281.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	45	46	57	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					794	802		10.1074/jbc.M111.313106	http://dx.doi.org/10.1074/jbc.M111.313106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090030	hybrid, Green Published			2022-12-25	WOS:000298682400076
J	Airavaara, M; Pletnikova, O; Doyle, ME; Zhang, YE; Troncoso, JC; Liu, QR				Airavaara, Mikko; Pletnikova, Olga; Doyle, Maire E.; Zhang, Yong E.; Troncoso, Juan C.; Liu, Qing-Rong			Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONS IN-VIVO; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; NUCLEUS-ACCUMBENS; HUMAN BRAIN; BDNF GENES; EXPRESSION; SURVIVAL; MOUSE; IMMUNOREACTIVITY	Primate-specific genes and isoforms could provide insight into human brain diseases. Our bioinformatic analysis revealed that there are possibly five isoforms of human GDNF gene with different pre- and pro-regions by inter- and intra-exon splicing. By using TaqMan primer probe sets, designed between exons, we verified the expression of all isoforms. Furthermore, a novel GDNFOS gene was found to be transcribed from the opposite strand of GDNF gene. GDNFOS gene has four exons that are spliced into different isoforms. GDNFOS1 and GDNFOS2 are long noncoding RNAs, and GDNFOS3 encodes a protein of 105 amino acids. To study human GDNF and GDNFOS regulation in neurodegenerative diseases, the protein and mRNA levels were measured by Western blot and RT-quantitative PCR, respectively, in postmortem middle temporal gyrus (MTG) of Alzheimer disease (AD) and Huntington disease (HD) patients in comparison with those of normal controls. In the MTG of AD patients, the mature GDNF peptide was down-regulated; however, the transcript of GDNF isoform from human exon 2 was up-regulated, whereas that of the conserved isoform from exon 1 remained unchanged in comparison with those of normal controls. In contrast, the mature GDNF peptide and the isoform mRNA levels were not changed in the MTG of HD. The findings of novel GDNF and GDNFOS isoforms and differences in tissue expression patterns dysregulated in AD brains may further reveal the role of endogenous GDNF in human brain diseases.	[Liu, Qing-Rong] NIDA, Behav Neurosci Branch, IRP, NIH,DHSS, Baltimore, MD 21224 USA; [Airavaara, Mikko] NIDA, Neural Protect & Regenerat Sect, IRP, NIH,DHSS, Baltimore, MD 21224 USA; [Pletnikova, Olga; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21205 USA; [Doyle, Maire E.] Johns Hopkins Med Inst, Div Endocrinol, Baltimore, MD 21224 USA; [Zhang, Yong E.] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, QR (corresponding author), NIDA, Behav Neurosci Branch, IRP, NIH,DHSS, 251 Bayview Blvd,Ste 200, Baltimore, MD 21224 USA.	qliu@intra.nida.nih.gov	Zhang, Yong E./AAC-8610-2019; Liu, Qing-Rong/A-3059-2012; Zhang, Yong/A-7855-2011	Zhang, Yong E./0000-0003-3770-2383; Liu, Qing-Rong/0000-0001-8477-6452; Airavaara, Mikko/0000-0002-2026-1609	National Institutes of Health NIDA; Johns Hopkins University Alzheimer's Disease Research Center (NIA) [P50AG051460]; Huntington's Research Center without Walls (NINDS) [PO1NS16375]; Integrated Islet Distribution Program; NIDDK; JDRF; Alzheimer's Association [IIRG-09-134090]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375] Funding Source: NIH RePORTER	National Institutes of Health NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins University Alzheimer's Disease Research Center (NIA); Huntington's Research Center without Walls (NINDS); Integrated Islet Distribution Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NIDA intramural research program. This work was also supported by the Johns Hopkins University Alzheimer's Disease Research Center (NIA P50AG051460), the Huntington's Research Center without Walls (NINDS PO1NS16375), the Integrated Islet Distribution Program, funded by the NIDDK and the JDRF.; Supported by a Juvenile Diabetes Research Foundation career award from the Sanford Project (Sioux Falls, SD).; Recipient of a grant from the Alzheimer's Association (IIRG-09-134090).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Airavaara M, 2011, ADDICT BIOL, V16, P261, DOI 10.1111/j.1369-1600.2010.00281.x; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Backman CM, 2006, MOL CELL ENDOCRINOL, V252, P160, DOI 10.1016/j.mce.2006.03.013; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bradley LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009752; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Chlocco MJ, 2007, PARKINSONISM RELAT D, V13, pS321, DOI 10.1016/S1353-8020(08)70024-5; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Farhi J, 2010, FERTIL STERIL, V93, P2565, DOI 10.1016/j.fertnstert.2009.09.047; Fromont-Hankard G, 2002, ARCH PATHOL LAB MED, V126, P432; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Grimm L, 1998, HUM MOL GENET, V7, P1873, DOI 10.1093/hmg/7.12.1873; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Hunot S, 1996, J NEURAL TRANSM, V103, P1043, DOI 10.1007/BF01291789; Immonen T, 2008, EXP NEUROL, V210, P793, DOI 10.1016/j.expneurol.2007.12.018; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kondo S, 2003, EUR J IMMUNOL, V33, P2233, DOI 10.1002/eji.200323458; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Little M, 2010, CURR TOP DEV BIOL, V90, P193, DOI 10.1016/S0070-2153(10)90005-7; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lonka-Nevalaita L, 2010, J NEUROSCI, V30, P11403, DOI 10.1523/JNEUROSCI.5888-09.2010; Lucini C, 2008, EUR J HISTOCHEM, V52, P69; Martinelli PM, 2002, HISTOCHEM CELL BIOL, V118, P337, DOI 10.1007/s00418-002-0452-9; Matsushita N, 1997, GENE, V203, P149, DOI 10.1016/S0378-1119(97)00506-4; Mwangi S, 2008, GASTROENTEROLOGY, V134, P727, DOI 10.1053/j.gastro.2007.12.033; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oh-hashi K, 2009, MOL CELL BIOCHEM, V323, P1, DOI 10.1007/s11010-008-9958-3; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; Trok K, 1996, NEUROSCIENCE, V71, P231, DOI 10.1016/0306-4522(95)00412-2; Troncoso JC, 1998, ANN NEUROL, V43, P673, DOI 10.1002/ana.410430519; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wang J, 2010, J NEUROSCI, V30, P14502, DOI 10.1523/JNEUROSCI.3909-10.2010; Wang Y, 1997, J NEUROSCI, V17, P4341; Watanabe Y, 2009, GASTROENTEROLOGY, V136, P2149, DOI 10.1053/j.gastro.2009.02.085; Williams LR, 1996, J PHARMACOL EXP THER, V277, P1140; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179	55	82	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45093	45102		10.1074/jbc.M111.310250	http://dx.doi.org/10.1074/jbc.M111.310250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081608	hybrid, Green Published			2022-12-25	WOS:000298645500076
J	Lindstedt, F; Johansson, B; Martinsen, S; Kosek, E; Fransson, P; Ingvar, M				Lindstedt, Fredrik; Johansson, Bo; Martinsen, Sofia; Kosek, Eva; Fransson, Peter; Ingvar, Martin			Evidence for Thalamic Involvement in the Thermal Grill Illusion: An fMRI Study	PLOS ONE			English	Article							CENTRAL NEUROPATHIC PAIN; MEDIAL PREFRONTAL CORTEX; INSULAR CORTEX; LATERAL INHIBITION; PARADOXICAL HEAT; C-FIBERS; STIMULATION; MECHANISMS; BRAIN; UNPLEASANTNESS	Background: Perceptual illusions play an important role in untangling neural mechanisms underlying conscious phenomena. The thermal grill illusion (TGI) has been suggested as a promising model for exploring percepts involved in neuropathic pain, such as cold-allodynia (pain arising from contact with innocuous cold). The TGI is an unpleasant/painful sensation from touching juxtapositioned bars of cold and warm innocuous temperatures. Aim: To develop an MRI-compatible TGI-unit and explore the supraspinal correlates of the illusion, using fMRI, in a group of healthy volunteers. Methods: We constructed a TGI-thermode allowing the rapid presentation of warm(41 degrees C), cold(18 degrees C) and interleaved( 41 degrees C+ 18 degrees C = TGI) temperatures in an fMRI-environment. Twenty volunteers were tested. The affective-motivational ("unpleasantness") and sensory-disciminatory ("pain-intensity") dimensions of each respective stimulus were rated. Functional images were analyzed at a corrected alpha-level <0.05. Results: The TGI was rated as significantly more unpleasant and painful than stimulation with each of its constituent temperatures. Also, the TGI was rated as significantly more unpleasant than painful. Thermal stimulation versus neutral baseline revealed bilateral activations of the anterior insulae and fronto-parietal regions. Unlike its constituent temperatures the TGI displayed a strong activation of the right (contralateral) thalamus. Exploratory contrasts at a slightly more liberal threshold-level also revealed a TGI-activation of the right mid/anterior insula, correlating with ratings of unpleasantness(rho = 0.31). Conclusion/Significance: To the best of our knowledge, this is the first fMRI-study of the TGI. The activation of the anterior insula is consistent with this region's putative role in processing of homeostatically relevant feeling-states. Our results constitute the first neurophysiologic evidence of thalamic involvement in the TGI. Similar thalamic activity has previously been observed during evoked cold-allodynia in patients with central neuropathic pain. Our results further the understanding of the supraspinal correlates of the TGI-phenomenon and pave the way for future inquiries into if and how it may relate to neuropathic pain.	[Lindstedt, Fredrik; Martinsen, Sofia; Kosek, Eva; Fransson, Peter; Ingvar, Martin] Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Johansson, Bo] Somed AB, Horby, Sweden	Karolinska Institutet	Lindstedt, F (corresponding author), Karolinska Inst, Stockholm Brain Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Fransson, Peter/M-5679-2014	Fransson, Peter/0000-0002-1305-9875; Kosek, Eva/0000-0003-0488-8177; Ingvar, Martin/0000-0002-9041-5714	Osher foundation; Swedish Research Council [2009-2322]	Osher foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Osher foundation (www.osherfoundation.org) and the Swedish Research Council (www.vr.se), grant nr 2009-2322 (MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2000, J NEUROPHYSIOL, V84, P484, DOI 10.1152/jn.2000.84.1.484; BEKESY GV, 1962, J APPL PHYSIOL, V17, P1003, DOI 10.1152/jappl.1962.17.6.1003; BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8; Boettger MK, 2011, PAIN, V152, P123, DOI 10.1016/j.pain.2010.10.003; Bouhassira D, 2005, PAIN, V114, P160, DOI 10.1016/j.pain.2004.12.014; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; Craig AD, 2008, PAIN, V135, P215, DOI 10.1016/j.pain.2008.01.022; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Craig ADB, 1998, PAIN FORUM, V7, P1; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Davis KD, 2004, J NEUROPHYSIOL, V92, P1248, DOI 10.1152/jn.00084.2004; Defrin R, 2008, PAIN, V138, P577, DOI 10.1016/j.pain.2008.02.012; Dimitrova A, 2003, J NEUROPHYSIOL, V90, P1877, DOI 10.1152/jn.00053.2003; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016; Dunckley P, 2005, NEUROSCIENCE, V133, P533, DOI 10.1016/j.neuroscience.2005.02.041; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Finnerup NB, 2008, CURR OPIN ANESTHESIO, V21, P586, DOI 10.1097/ACO.0b013e32830a4c11; Fruhstorfer H, 2003, EUR J PAIN, V7, P63, DOI 10.1016/S1090-3801(02)00056-3; Graziano A, 2004, J NEUROSCI, V24, P248, DOI 10.1523/JNEUROSCI.4122-03.2004; GREENSPAN JD, 1993, SOMATOSENS MOT RES, V10, P467, DOI 10.3109/08990229309028851; Griffiths D, 2007, NEUROUROL URODYNAM, V26, P899, DOI 10.1002/nau.20488; HAMALAINEN H, 1982, BRAIN RES, V251, P77, DOI 10.1016/0006-8993(82)91275-6; Hatem SM, 2010, BRAIN, V133, P3409, DOI 10.1093/brain/awq244; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Kammers MPM, 2010, CURR BIOL, V20, P1819, DOI 10.1016/j.cub.2010.08.038; Kern D, 2008, PAIN, V139, P653, DOI 10.1016/j.pain.2008.07.001; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Kim JH, 2007, J NEUROSCI, V27, P4995, DOI 10.1523/JNEUROSCI.0716-07.2007; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; Lee JI, 2005, J NEUROPHYSIOL, V94, P1676, DOI 10.1152/jn.00343.2005; Leung AY, 2005, PAIN, V116, P26, DOI 10.1016/j.pain.2005.03.026; Li X, 2009, NEUROPHYSIOL CLIN, V39, P275, DOI 10.1016/j.neucli.2009.06.006; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; MAUGUIERE F, 1988, ARCH NEUROL-CHICAGO, V45, P1312, DOI 10.1001/archneur.1988.00520360030007; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Nasreddine ZS, 1997, NEUROLOGY, V48, P1196, DOI 10.1212/WNL.48.5.1196; Oshiro Y, 2009, J NEUROSCI, V29, P14924, DOI 10.1523/JNEUROSCI.5538-08.2009; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2000, PAIN, V84, P77, DOI 10.1016/S0304-3959(99)00190-6; Peyron R, 1998, BRAIN, V121, P345, DOI 10.1093/brain/121.2.345; Pinault D, 1998, EUR J NEUROSCI, V10, P3462, DOI 10.1046/j.1460-9568.1998.00362.x; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Ralston HJ, 2003, J COMP NEUROL, V459, P329, DOI 10.1002/cne.10614; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 2007, NEURON, V55, P339, DOI 10.1016/j.neuron.2007.07.019; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Thunberg T., 1896, UPPSALA L AKFOREN FO, V2, P489; Ushida T, 2005, BRAIN TOPOGR, V18, P27, DOI 10.1007/s10548-005-7898-8; Ushida Takahiro, 2010, Open Neuroimag J, V4, P182, DOI 10.2174/1874440001004010182; Veldhuijzen Dieuwke S, 2007, Curr Pain Headache Rep, V11, P183, DOI 10.1007/s11916-007-0189-1; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; VONBEKESY G, 1967, J GEN PHYSIOL, V50, P519, DOI 10.1085/jgp.50.3.519; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Weaver KE, 2009, J NEUROSCI, V29, P11424, DOI 10.1523/JNEUROSCI.3263-09.2009; Willis WD, 2002, J PAIN, V3, P79, DOI 10.1054/jpai.2002.122949	78	39	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27075	10.1371/journal.pone.0027075	http://dx.doi.org/10.1371/journal.pone.0027075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096519	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900019
J	Zeng, JY; Xiang, N; Jiang, L; Jones, G; Zheng, YM; Liu, BW; Zhang, SY				Zeng, Jinyao; Xiang, Ning; Jiang, Lei; Jones, Gareth; Zheng, Yongmei; Liu, Bingwan; Zhang, Shuyi			Moth Wing Scales Slightly Increase the Absorbance of Bat Echolocation Calls	PLOS ONE			English	Article							BUTTERFLIES; COLORS; INFORMATION; PREY	Coevolutionary arms races between predators and prey can lead to a diverse range of foraging and defense strategies, such as countermeasures between nocturnal insects and echolocating bats. Here, we show how the fine structure of wing scales may help moths by slightly increasing sound absorbance at frequencies typically used in bat echolocation. Using four widespread species of moths and butterflies, we found that moth scales are composed of honeycomb-like hollows similar to sound-absorbing material, but these were absent from butterfly scales. Micro-reverberation chamber experiments revealed that moth wings were more absorbent at the frequencies emitted by many echolocating bats (40-60 kHz) than butterfly wings. Furthermore, moth wings lost absorbance at these frequencies when scales were removed, which suggests that some moths have evolved stealth tactics to reduce their conspicuousness to echolocating bats. Although the benefits to moths are relatively small in terms of reducing their target strengths, scales may nonetheless confer survival advantages by reducing the detection distances of moths by bats by 5-6%.	[Zeng, Jinyao; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Jiang, Lei; Zheng, Yongmei] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Xiang, Ning] Rensselaer Polytech Inst, Sch Architecture, Troy, NY USA; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Liu, Bingwan] NE Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China	East China Normal University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Rensselaer Polytechnic Institute; University of Bristol; Northeast Forestry University - China	Zeng, JY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Jones, Gareth/0000-0002-1904-3735	CAS; National "985" Project; BBSRC; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish; BBSRC [BB/G530392/1] Funding Source: UKRI	CAS(Chinese Academy of Sciences); National "985" Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a CAS grant and the National "985" Project awarded to Shuyi Zhang, and a China Partnering award from the BBSRC to Gareth Jones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauert J., 2008, ACOUSTICS ENG TROY L; Brakefield PM, 2000, P ROY SOC B-BIOL SCI, V267, P1953, DOI 10.1098/rspb.2000.1235; BRUNTON CFA, 1995, P ROY SOC B-BIOL SCI, V260, P199, DOI 10.1098/rspb.1995.0080; Burghardt F, 2000, NATURWISSENSCHAFTEN, V87, P304, DOI 10.1007/s001140050726; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Culver S. J., 2000, BIOTIC RESPONSE GLOB; D'antonio P., 2009, ACOUSTIC ABSORBERS D; Denny M., 2007, BLIP PING BUZZ MAKIN; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; FULLARD JH, 1982, CAN J ZOOL, V60, P2572, DOI 10.1139/z82-330; Fullard JH, 1998, SPR HDB AUD, V10, P279; GHIRADELLA H, 1991, APPL OPTICS, V30, P3492, DOI 10.1364/AO.30.003492; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gopfert MC, 2002, P ROY SOC B-BIOL SCI, V269, P89, DOI 10.1098/rspb.2001.1646; Jones G, 2003, BAT ECOLOGY, P301; KINGSOLVER JG, 1983, AM NAT, V121, P32, DOI 10.1086/284038; Luo F, 2007, ZOOL STUD, V46, P622; MAA DY, 1975, SCI SINICA, V18, P55; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; ROEDER KD, 1963, BIOL BULL, V124, P200, DOI 10.2307/1539496; Sabine, 1922, COLLECTED PAPERS ACO; SCHROEDE.MR, 1965, J ACOUST SOC AM, V37, P409, DOI 10.1121/1.1909343; SIMMONS JA, 1989, J ACOUST SOC AM, V86, P1333, DOI 10.1121/1.398694; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; Veselka N, 2010, NATURE, V463, P939, DOI 10.1038/nature08737; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wang P, 1981, ICONOCRAPHIA HETEROC; Waters DA, 2003, PHYSIOL ENTOMOL, V28, P237, DOI 10.1111/j.1365-3032.2003.00355.x; Xiang N, 2003, J ACOUST SOC AM, V113, P2754, DOI 10.1121/1.1561498; Xiang N, 2001, J ACOUST SOC AM, V110, P1415, DOI 10.1121/1.1390334; XIANG N, 1993, APPL ACOUST, V38, P267, DOI 10.1016/0003-682X(93)90056-C; Yoshioka S, 2006, P ROY SOC B-BIOL SCI, V273, P129, DOI 10.1098/rspb.2005.3314	39	18	18	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27190	10.1371/journal.pone.0027190	http://dx.doi.org/10.1371/journal.pone.0027190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096534	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800034
J	Jacob, RE; Lamm, WJ				Jacob, Richard E.; Lamm, Wayne J.			Stable Small Animal Ventilation for Dynamic Lung Imaging to Support Computational Fluid Dynamics Models	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RESOLUTION; SIMULATIONS; MECHANICS; INJURY; CT	Pulmonary computational fluid dynamics models require that three-dimensional images be acquired over multiple points in the dynamic breathing cycle without breath holds or changes in ventilatory mechanics. With small animals, these requirements can result in long imaging times (similar to 90 minutes), over which lung mechanics, such as compliance, may gradually change if not carefully monitored and controlled. These changes, caused by derecruitment of parenchymal tissue, are manifested as an upward drift in peak inspiratory pressure (PIP) or by changes in the pressure waveform and/or lung volume over the course of the experiment. We demonstrate highly repeatable mechanical ventilation in anesthetized rats over a long duration for dynamic lung x-ray computed tomography (CT) imaging. We describe significant updates to a basic commercial ventilator that was acquired for these experiments. Key to achieving consistent results was the implementation of periodic deep breaths, or sighs, of extended duration to maintain lung recruitment. In addition, continuous monitoring of breath-to-breath pressure and volume waveforms and long-term trends in PIP and flow provide diagnostics of changes in breathing mechanics.	[Jacob, Richard E.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Lamm, Wayne J.] Univ Washington, Sch Med, Seattle, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle	Jacob, RE (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	Richard.jacob@pnnl.gov			PNNL through internal Laboratory Directed Research and Development (LDRD); National Heart, Lung, and Blood Institute [R01HL073598]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073598] Funding Source: NIH RePORTER	PNNL through internal Laboratory Directed Research and Development (LDRD); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by PNNL through internal Laboratory Directed Research and Development (LDRD) funding, and by Award Number R01HL073598 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate JHT, 2008, RESP PHYSIOL NEUROBI, V163, P54, DOI 10.1016/j.resp.2008.03.012; Carson JP, 2010, COMPUT MED IMAG GRAP, V34, P572, DOI 10.1016/j.compmedimag.2010.03.001; Carson JP, 2010, BIOMECH MODEL MECHAN, V9, P187, DOI 10.1007/s10237-009-0170-5; CILLEY RE, 1993, J PEDIATR SURG, V28, P488, DOI 10.1016/0022-3468(93)90253-H; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Einstein DR, 2008, ANAT REC, V291, P1628, DOI 10.1002/ar.20771; Ford NL, 2007, J APPL PHYSIOL, V102, P2046, DOI 10.1152/japplphysiol.00629.2006; GOTTLIEB SF, 1962, J APPL PHYSIOL, V17, P576; Hedlund Laurence W, 2002, ILAR J, V43, P159; Hedlund LW, 2000, MAGN RESON IMAGING, V18, P753, DOI 10.1016/S0730-725X(00)00154-5; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hu JC, 2004, ACAD RADIOL, V11, P961, DOI 10.1016/j.acra.2004.05.019; Kuprat AP, 2009, J COMPUT PHYS, V228, P619, DOI 10.1016/j.jcp.2008.09.030; Kyriazis A, 2010, IEEE T BIO-MED ENG, V57, P1745, DOI 10.1109/TBME.2010.2042596; Mai W, 2005, MAGN RESON MED, V53, P858, DOI 10.1002/mrm.20400; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; NICHOLAS TE, 1982, RESP PHYSIOL, V49, P315, DOI 10.1016/0034-5687(82)90119-0; Sera T, 2008, PHYS MED BIOL, V53, P4285, DOI 10.1088/0031-9155/53/16/005; Thiesse J, 2010, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; Walker MG, 2011, RESPIRATION, V81, P333, DOI 10.1159/000323609	20	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27577	10.1371/journal.pone.0027577	http://dx.doi.org/10.1371/journal.pone.0027577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087338	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700060
J	Xie, FL; Sun, GL; Stiller, JW; Zhang, BH				Xie, Fuliang; Sun, Guiling; Stiller, John W.; Zhang, Baohong			Genome-Wide Functional Analysis of the Cotton Transcriptome by Creating an Integrated EST Database	PLOS ONE			English	Article							GENETIC DIVERSITY; FLOWERING TIME; PLANT; IDENTIFICATION; MICRORNAS; DNA; ARABIDOPSIS; MAP; BIOGENESIS; SELECTION	A total of 28,432 unique contigs (25,371 in consensus contigs and 3,061 as singletons) were assembled from all 268,786 cotton ESTs currently available. Several in silico approaches [comparative genomics, Blast, Gene Ontology (GO) analysis, and pathway enrichment by Kyoto Encyclopedia of Genes and Genomes (KEGG)] were employed to investigate global functions of the cotton transcriptome. Cotton EST contigs were clustered into 5,461 groups with a maximum cluster size of 196 members. A total of 27,956 indel mutants and 149,616 single nucleotide polymorphisms (SNPs) were identified from consensus contigs. Interestingly, many contigs with significantly high frequencies of indels or SNPs encode transcription factors and protein kinases. In a comparison with six model plant species, cotton ESTs show the highest overall similarity to grape. A total of 87 cotton miRNAs were identified; 59 of these have not been reported previously from experimental or bioinformatics investigations. We also predicted 3,260 genes as miRNAs targets, which are associated with multiple biological functions, including stress response, metabolism, hormone signal transduction and fiber development. We identified 151 and 4,214 EST-simple sequence repeats (SSRs) from contigs and raw ESTs respectively. To make these data widely available, and to facilitate access to EST-related genetic information, we integrated our results into a comprehensive, fully downloadable web-based cotton EST database (www.leonxie.com).	[Xie, Fuliang; Sun, Guiling; Stiller, John W.; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Xie, FL (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Zhang, Baohong/O-4948-2016	Stiller, John/0000-0002-0668-8243	USDA; Cotton Incorporated	USDA(United States Department of Agriculture (USDA)); Cotton Incorporated(Cotton R&D Corp)	This work was supported partially by the USDA and the Cotton Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; delaHoz MPS, 1996, GENOME, V39, P112, DOI 10.1139/g96-015; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hattori J, 2005, GENOME, V48, P197, DOI [10.1139/g04-106, 10.1139/G04-106]; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; IAC, 1996, COTT REV WORLD SIT; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kantartzi SK, 2009, GENETICA, V136, P141, DOI 10.1007/s10709-008-9327-x; Krawczak M, 1999, ELECTROPHORESIS, V20, P1676, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1676::AID-ELPS1676>3.3.CO;2-4; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; RYCHLIK W, 1995, MOL BIOTECHNOL, V3, P129, DOI 10.1007/BF02789108; Schneider K, 2007, THEOR APPL GENET, V115, P601, DOI 10.1007/s00122-007-0591-4; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seki M, 1997, PLANT J, V12, P481, DOI 10.1046/j.1365-313X.1997.12020481.x; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venne LS, 2008, B ENVIRON CONTAM TOX, V80, P497, DOI 10.1007/s00128-008-9457-y; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	45	83	111	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26980	10.1371/journal.pone.0026980	http://dx.doi.org/10.1371/journal.pone.0026980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087239	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700011
J	Izzo, V; Pinelli, M; Tinto, N; Esposito, MV; Cola, A; Sperandeo, MP; Tucci, F; Cocozza, S; Greco, L; Sacchetti, L				Izzo, Valentina; Pinelli, Michele; Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sperandeo, Maria Pia; Tucci, Francesca; Cocozza, Sergio; Greco, Luigi; Sacchetti, Lucia			Improving the Estimation of Celiac Disease Sibling Risk by Non-HLA Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; MARKERS	Celiac Disease (CD) is a polygenic trait, and HLA genes explain less than half of the genetic variation. Through large GWAs more than 40 associated non-HLA genes were identified, but they give a small contribution to the heritability of the disease. The aim of this study is to improve the estimate of the CD risk in siblings, by adding to HLA a small set of non-HLA genes. One-hundred fifty-seven Italian families with a confirmed CD case and at least one other sib and both parents were recruited. Among 249 sibs, 29 developed CD in a 6 year follow-up period. All individuals were typed for HLA and 10 SNPs in non-HLA genes: CCR1/CCR3 (rs6441961), IL12A/SCHIP1 and IL12A (rs17810546 and rs9811792), TAGAP (rs1738074), RGS1 (rs2816316), LPP (rs1464510), OLIG3 (rs2327832), REL (rs842647), IL2/IL21 (rs6822844), SH2B3 (rs3184504). Three associated SNPs (in LPP, REL, and RGS1 genes) were identified through the Transmission Disequilibrium Test and a Bayesian approach was used to assign a score (BS) to each detected HLA+SNPs genotype combination. We then classified CD sibs as at low or at high risk if their BS was respectively < or >= median BS value within each HLA risk group. A larger number (72%) of CD sibs showed a BS >= the median value and had a more than two fold higher OR than CD sibs with a BS value < the median (O. R = 2.53, p = 0.047). Our HLA+SNPs genotype classification, showed both a higher predictive negative value (95% vs 91%) and diagnostic sensitivity (79% vs 45%) than the HLA only. In conclusion, the estimate of the CD risk by HLA+SNPs approach, even if not applicable to prevention, could be a precious tool to improve the prediction of the disease in a cohort of first degree relatives, particularly in the low HLA risk groups.	[Izzo, Valentina; Sperandeo, Maria Pia; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Izzo, Valentina; Sperandeo, Maria Pia; Tucci, Francesca; Greco, Luigi] Univ Naples Federico II, European Lab Food Induced Dis, Naples, Italy; [Pinelli, Michele; Cocozza, Sergio] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol L Califano, Naples, Italy; [Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sacchetti, Lucia] Scarl, CEINGE Adv Biotechnol, Naples, Italy; [Tinto, Nadia; Esposito, Maria Valeria; Cola, Arturo; Sacchetti, Lucia] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Izzo, V (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	ydongre@unina.it	Cocozza, Sergio/F-6488-2010; Tucci, Francesca/AAB-2184-2022; Pinelli, Michele/A-1584-2010	Tucci, Francesca/0000-0001-8798-8987; Pinelli, Michele/0000-0002-5927-1185	PREVENT-CD [EU-FP6-2005-FOOD4B, 036383]; CEINGE Regione Campania (DGRC), Italy [1901/2009]; Associazione Italiana Celiachia (AIC)	PREVENT-CD; CEINGE Regione Campania (DGRC), Italy; Associazione Italiana Celiachia (AIC)	This work was funded by the PREVENT-CD project: EU-FP6-2005-FOOD4B-contract no. 036383 and by CEINGE Regione Campania (DGRC 1901/2009) Italy. The authors thank Associazione Italiana Celiachia (AIC) for a supporting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Amundsen SS, 2010, GENES IMMUN, V11, P79, DOI 10.1038/gene.2009.67; Bonamico M, 2006, J PEDIATR GASTR NUTR, V42, P150, DOI 10.1097/01.mpg.0000189337.08139.83; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Dema B, 2009, J MED GENET, V46, P617, DOI 10.1136/jmg.2009.067041; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Liou HC, 2011, IMMUNOL CELL BIOL, V89, P27, DOI 10.1038/icb.2010.120; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Romanos J, 2009, J MED GENET, V46, P60, DOI 10.1136/jmg.2008.061457; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Son JS, 2011, BIOCHEM BIOPH RES CO, V407, P141, DOI 10.1016/j.bbrc.2011.02.126; THOMSON G, 1995, AM J HUM GENET, V57, P487; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	22	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26920	10.1371/journal.pone.0026920	http://dx.doi.org/10.1371/journal.pone.0026920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087237	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700012
J	Ouandaogo, ZG; Haouzi, D; Assou, S; Dechaud, H; Kadoch, IJ; De Vos, J; Hamamah, S				Ouandaogo, Zamalou Gisele; Haouzi, Delphine; Assou, Said; Dechaud, Herve; Kadoch, Issac Jacques; De Vos, John; Hamamah, Samir			Human Cumulus Cells Molecular Signature in Relation to Oocyte Nuclear Maturity Stage	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; GENE-EXPRESSION; GRANULOSA-CELLS; GROWTH-FACTOR; IN-VITRO; EMBRYO; TRANSCRIPTOME; MATURATION; PROFILES; RECEPTOR	The bi-directional communication between the oocyte and the surrounding cumulus cells (CCs) is crucial for the acquisition of oocyte competence. We investigated the transcriptomic profile of human CCs isolated from mature and immature oocytes under stimulated cycle. We used human Genome U133 Plus 2.0 microarrays to perform an extensive analysis of the genes expressed in human CCs obtained from patients undergoing intra-cytoplasmic sperm injection. CC samples were isolated from oocyte at germinal vesicle, stage metaphase I and stage metaphase II. For microarray analysis, we used eight chips for each CC category. Significance analysis of microarray multiclass was used to analyze the microarray data. Validation was performed by RT-qPCR using an independent cohort of CC samples. We identified differentially over-expressed genes between the three CC categories. This study revealed a specific signature of gene expression in CCs issued from MII oocyte compared with germinal vesicle and metaphase I. The CC gene expression profile, which is specific of MII mature oocyte, can be useful as predictors of oocyte quality.	[Ouandaogo, Zamalou Gisele; Haouzi, Delphine; Assou, Said; Dechaud, Herve; De Vos, John; Hamamah, Samir] Hop St Eloi, CHU Montpellier, Inst Res Biotherapy, INSERM U1040, Montpellier, France; [Ouandaogo, Zamalou Gisele; Assou, Said; Dechaud, Herve; De Vos, John; Hamamah, Samir] Univ Montpellier 1, UFR Med, Montpellier, France; [Dechaud, Herve; Hamamah, Samir] Hop Arnaud de Villeneuve, ART PGD Dept, CHU Montpellier, Montpellier, France; [Kadoch, Issac Jacques] Univ Montreal, Dept Obstet & Gynecol, Hop St Luc, CHUM, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montreal	Ouandaogo, ZG (corresponding author), Hop St Eloi, CHU Montpellier, Inst Res Biotherapy, INSERM U1040, Montpellier, France.	s-hamamah@chu-montpellier.fr	DE VOS, John/A-5703-2010	DE VOS, John/0000-0003-1880-4130; assou, said/0000-0001-6448-7995	Ferring company; Schering-Plough Pharmaceutical company; Vitrolife company; Ferring; Schering-Plough Pharmaceutical; Vitrolife; University Hospital of Montpellier	Ferring company(Ferring Pharmaceuticals); Schering-Plough Pharmaceutical company; Vitrolife company; Ferring(Ferring Pharmaceuticals); Schering-Plough Pharmaceutical; Vitrolife; University Hospital of Montpellier	This work was supported by Ferring, Schering-Plough Pharmaceutical and Vitrolife companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was funded by Ferring, Schering-Plough Pharmaceutical and Vitrolife. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We thank the University Hospital of Montpellier for its support and the ART/PGD teams for providing the samples.	Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Adriaenssens T, 2011, J ASSIST REPROD GEN, V28, P31, DOI 10.1007/s10815-010-9481-9; Adriaenssens T, 2009, BIOL REPROD, V80, P1015, DOI 10.1095/biolreprod.107.067462; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Duffy DM, 2005, HUM REPROD, V20, P1485, DOI 10.1093/humrep/deh784; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feuerstein P, 2007, HUM REPROD, V22, P3069, DOI 10.1093/humrep/dem336; Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Haouzi D, 2011, HUM REPROD, V26, P1440, DOI 10.1093/humrep/der075; Haouzi D, 2009, HUM REPROD, V24, P2868, DOI 10.1093/humrep/dep263; Higuchi T, 1999, MOL HUM REPROD, V5, P920, DOI 10.1093/molehr/5.10.920; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hogg K, 2010, ENDOCRINOLOGY, V151, P1247, DOI 10.1210/en.2009-0914; Johnson AL, 2008, ENDOCRINOLOGY, V149, P3187, DOI 10.1210/en.2007-1659; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Markosyan N, 2006, BIOL REPROD, V75, P868, DOI 10.1095/biolreprod.106.053769; Marteil G, 2009, REPROD BIOL, V9, P203, DOI 10.1016/S1642-431X(12)60027-8; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; McRae RS, 2005, ENDOCRINOLOGY, V146, P309, DOI 10.1210/en.2004-0999; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Segi E, 2003, BIOL REPROD, V68, P804, DOI 10.1095/biolreprod.102.003590; Tamba S, 2010, BIOCHIMIE, V92, P665, DOI 10.1016/j.biochi.2010.04.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Verbraak EJC, 2011, THERIOGENOLOGY, V75, P362, DOI 10.1016/j.theriogenology.2010.09.008; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	32	56	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27179	10.1371/journal.pone.0027179	http://dx.doi.org/10.1371/journal.pone.0027179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087263	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700027
J	Schuetz, A; Haule, A; Reither, K; Ngwenyama, N; Rachow, A; Meyerhans, A; Maboko, L; Koup, RA; Hoelscher, M; Geldmacher, C				Schuetz, Alexandra; Haule, Antelmo; Reither, Klaus; Ngwenyama, Njabulo; Rachow, Andrea; Meyerhans, Andreas; Maboko, Leonard; Koup, Richard A.; Hoelscher, Michael; Geldmacher, Christof			Monitoring CD27 Expression to Evaluate Mycobacterium Tuberculosis Activity in HIV-1 Infected Individuals In Vivo	PLOS ONE			English	Article							T-CELLS; PULMONARY TUBERCULOSIS; INFECTION; HIV; PREVALENCE; RESPONSES; GAMMA; CD4	The level of bacterial activity is only poorly defined during asymptomatic Mycobacterium tuberculosis (MTB) infection. The objective was to study the capacity of a new biomarker, the expression of the T cell maturation marker CD27 on MTB-specific CD4 T cells, to identify active tuberculosis (TB) disease in subjects from a MTB and HIV endemic region. The frequency and CD27 expression of circulating MTB-specific CD4 T cells was determined in 96 study participants after stimulation with purified protein derivative (PPD) using intracellular cytokine staining for IFNgamma (IFN gamma). Subjects were then stratified by their TB and HIV status. Within PPD responders, a CD27(-) phenotype was associated with active TB in HIV- (p = 0.0003) and HIV+ (p = 0.057) subjects, respectively. In addition, loss of CD27 expression preceded development of active TB in one HIV seroconverter. Interestingly, in contrast to HIV- subjects, MTB-specific CD4 T cell populations from HIV+ TB-asymptomatic subjects were often dominated by CD27(-) cells. These data indicate that down-regulation of CD27 on MTB-specific CD4 T cell could be used as a biomarker of active TB, potentially preceding clinical TB disease. Furthermore, these data are consistent with the hypothesis that late, chronic HIV infection is frequently associated with increased mycobacterial activity in vivo. The analysis of T cell maturation and activation markers might thus be a useful tool to monitor TB disease progression.	[Schuetz, Alexandra; Haule, Antelmo; Reither, Klaus; Rachow, Andrea; Maboko, Leonard] Referral Hosp, NIMR Mbeya Med Res Programme, Mbeya, Tanzania; [Reither, Klaus; Rachow, Andrea; Hoelscher, Michael; Geldmacher, Christof] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Ngwenyama, Njabulo; Koup, Richard A.; Geldmacher, Christof] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Meyerhans, Andreas] Univ Saarland, Inst Infect Med, Inst Virol, D-6650 Homburg, Germany	University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Saarland University	Schuetz, A (corresponding author), USAMC AFRIMS, Henry M Jackson Fdn Adv Mil Med, Walter Reed Program, Dept Retrovirol, Bangkok, Thailand.	alexandra.schuetz@afrims.org	Hoelscher, Michael/D-3436-2012; Meyerhans, Andreas/S-2559-2019; Meyerhans, Andreas/D-3382-2014	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317; Reither, Klaus/0000-0001-6195-8237	European Commission [ERBICA4-CT-2002-10035, SANTE/2004/078-545/130]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was supported by grants from the European Commission (DG XII, INCO-DC, ERBICA4-CT-2002-10035 and DG X, EuropeAID SANTE/2004/078-545/130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sester M, 2000, AIDS, V14, P2653, DOI 10.1097/00002030-200012010-00004; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735	16	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27284	10.1371/journal.pone.0027284	http://dx.doi.org/10.1371/journal.pone.0027284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087280	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700034
J	Yamaguchi, I; Ogawa, Y; Jimbo, Y; Nakao, H; Kotani, K				Yamaguchi, Ikuhiro; Ogawa, Yutaro; Jimbo, Yasuhiko; Nakao, Hiroya; Kotani, Kiyoshi			Reduction Theories Elucidate the Origins of Complex Biological Rhythms Generated by Interacting Delay-Induced Oscillations	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; EPILEPTIC SEIZURES; NEURONAL NETWORKS; CIRCADIAN-RHYTHM; MODEL; BIFURCATION; MULTISTABILITY; STIMULATION; STABILITY; RESPONSES	Time delay is known to induce sustained oscillations in many biological systems such as electroencephalogram (EEG) activities and gene regulations. Furthermore, interactions among delay-induced oscillations can generate complex collective rhythms, which play important functional roles. However, due to their intrinsic infinite dimensionality, theoretical analysis of interacting delay-induced oscillations has been limited. Here, we show that the two primary methods for finite-dimensional limit cycles, namely, the center manifold reduction in the vicinity of the Hopf bifurcation and the phase reduction for weak interactions, can successfully be applied to interacting infinite-dimensional delay-induced oscillations. We systematically derive the complex Ginzburg-Landau equation and the phase equation without delay for general interaction networks. Based on the reduced low-dimensional equations, we demonstrate that diffusive (linearly attractive) coupling between a pair of delay-induced oscillations can exhibit nontrivial amplitude death and multimodal phase locking. Our analysis provides unique insights into experimentally observed EEG activities such as sudden transitions among different phase-locked states and occurrence of epileptic seizures.	[Yamaguchi, Ikuhiro; Ogawa, Yutaro; Jimbo, Yasuhiko; Kotani, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan; [Nakao, Hiroya] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 152, Japan; [Nakao, Hiroya] JST, CREST, Kyoto, Japan	University of Tokyo; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Yamaguchi, I (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan.	kotani@k.u-tokyo.ac.jp	Nakao, Hiroya/B-9264-2015; Nakao, Hiroya/K-2771-2019	Nakao, Hiroya/0000-0003-3394-0392; Nakao, Hiroya/0000-0003-3394-0392; Yamaguchi, Ikuhiro/0000-0003-2875-6494	 [23240065];  [22684020];  [23680024]	; ; 	This study was supported in part by Grants-in-Aid for Scientific Research (23240065 to YJ, 22684020 to HN, and 23680024 to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON DG, 1990, PHYSICA D, V41, P403, DOI 10.1016/0167-2789(90)90007-C; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Campbell SA, 2006, PHYSICA D, V214, P101, DOI 10.1016/j.physd.2005.12.008; Campbell SA, 2005, NONLINEARITY, V18, P2827, DOI 10.1088/0951-7715/18/6/022; Censi F, 2000, MED BIOL ENG COMPUT, V38, P416, DOI 10.1007/BF02345011; Ermentrout B, 2009, SIAM J APPL DYN SYST, V8, P253, DOI 10.1137/080724010; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Forger DB, 2004, J THEOR BIOL, V230, P533, DOI 10.1016/j.jtbi.2004.04.041; Freeman WJ, 2003, CHAOS, V13, P1067, DOI 10.1063/1.1596553; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Golomb D, 1999, P NATL ACAD SCI USA, V96, P13480, DOI 10.1073/pnas.96.23.13480; Guckenheimer J, 2013, APPL MATH SCI, V42; Hale J.K., 1993, INTRO FUNCTIONAL DIF; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ito J, 2005, BIOL CYBERN, V92, P54, DOI 10.1007/s00422-004-0533-z; Izhikevich EM, 1998, PHYS REV E, V58, P905, DOI 10.1103/PhysRevE.58.905; Kim JW, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031907; Kim JW, 2009, J THEOR BIOL, V257, P527, DOI 10.1016/j.jtbi.2008.12.009; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kotani K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041904; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Loddenkemper T, 2001, J CLIN NEUROPHYSIOL, V18, P514, DOI 10.1097/00004691-200111000-00002; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Nakao H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036214; Ncube I, 2002, FIELDS I COMMUNICATI, V36, P179; PETROV V, 1992, J CHEM PHYS, V97, P6191, DOI 10.1063/1.463727; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Sano S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016207; Scheper TO, 1999, J NEUROSCI, V19, P40, DOI 10.1523/JNEUROSCI.19-01-00040.1999; Seidel H, 1998, PHYSICA D, V115, P145, DOI 10.1016/S0167-2789(97)00229-7; Shayer LP, 2000, SIAM J APPL MATH, V61, P673, DOI 10.1137/S0036139998344015; Sriram K, 2004, J THEOR BIOL, V231, P23, DOI 10.1016/j.jtbi.2004.04.006; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stone E, 2004, J NONLINEAR SCI, V14, P27, DOI 10.1007/s00332-003-0553-1; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; WISCHERT W, 1994, PHYS REV E, V49, P203, DOI 10.1103/PhysRevE.49.203; YAMAGUCHI Y, 1984, PHYSICA D, V11, P212, DOI 10.1016/0167-2789(84)90444-5; Yoshino K, 2002, BIOL CYBERN, V86, P483, DOI 10.1007/s00422-002-0314-5; Zucconi M, 2005, NEUROL SCI, V26, pS199, DOI 10.1007/s10072-005-0487-5	55	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26497	10.1371/journal.pone.0026497	http://dx.doi.org/10.1371/journal.pone.0026497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087228	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700006
J	Gonzalez, G; DaFonseca, S; Errazuriz, E; Coric, P; Souquet, F; Turcaud, S; Boulanger, P; Bouaziz, S; Hong, SS				Gonzalez, Gaelle; DaFonseca, Sandrina; Errazuriz, Elisabeth; Coric, Pascale; Souquet, Florence; Turcaud, Serge; Boulanger, Pierre; Bouaziz, Serge; Hong, Saw See			Characterization of a Novel Type of HIV-1 Particle Assembly Inhibitor Using a Quantitative Luciferase-Vpr Packaging-Based Assay	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BACULOVIRUS-INFECTED CELLS; BETULINIC ACID-DERIVATIVES; ALPHA-HELICAL STRUCTURE; GAG PRECURSOR; IN-VITRO; ADENOVIRUS DODECAHEDRON; VIRION INCORPORATION; FUSION PROTEINS; REGULATORY PROTEIN	The HIV-1 auxiliary protein Vpr and Vpr-fusion proteins can be copackaged with Gag precursor (Pr55Gag) into virions or membrane-enveloped virus-like particles (VLP). Taking advantage of this property, we developed a simple and sensitive method to evaluate potential inhibitors of HIV-1 assembly in a living cell system. Two proteins were coexpressed in recombinant baculovirus-infected Sf9 cells, Pr55Gag, which formed the VLP backbone, and luciferase fused to the N-terminus of Vpr (LucVpr). VLP-encapsidated LucVpr retained the enzymatic activity of free luciferase. The levels of luciferase activity present in the pelletable fraction recovered from the culture medium correlated with the amounts of extracellular VLP released by Sf9 cells assayed by conventional immunological methods. Our luciferase-based assay was then applied to the characterization of betulinic acid (BA) derivatives that differed from the leader compound PA-457 (or DSB) by their substituant on carbon-28. The beta-alanine-conjugated and lysine-conjugated DSB could not be evaluated for their antiviral potentials due to their high cytotoxicity, whereas two other compounds with a lesser cytotoxicity, glycine-conjugated and epsilon-NH-Boc-lysine-conjugated DSB, exerted a dose-dependent negative effect on VLP assembly and budding. A fifth compound with a low cytotoxicity, EP-39 (ethylene diamine-conjugated DSB), showed a novel type of antiviral effect. EP-39 provoked an aberrant assembly of VLP, resulting in nonenveloped, morula-like particles of 100-nm in diameter. Each morula was composed of nanoparticle subunits of 20-nm in diameter, which possibly mimicked transient intermediates of the HIV-1 Gag assembly process. Chemical cross-linking in situ suggested that EP-39 favored the formation or/and persistence of Pr55Gag trimers over other oligomeric species. EP-39 showed a novel type of negative effect on HIV-1 assembly, targeting the Pr55Gag oligomerisation. The biological effect of EP-39 underlined the critical role of the nature of the side chain at position 28 of BA derivatives in their anti-HIV-1 activity.	[Gonzalez, Gaelle; Errazuriz, Elisabeth] Univ Lyon 1, Fac Med, Ctr Commun Imagerie Laennec, F-69365 Lyon, France; [Gonzalez, Gaelle; DaFonseca, Sandrina; Boulanger, Pierre; Hong, Saw See] INRA, UMR 754, Lyon, France; [Coric, Pascale; Bouaziz, Serge] Univ Paris 05, UFR Sci Pharmaceut & Biol, CNRS, Lab Cristallog & RMN Biol,UMR 8015, Paris, France; [Souquet, Florence; Turcaud, Serge] Univ Paris 05, UFR Sci Pharmaceut & Biol, CNRS, Lab Synth & Struct Mol Interet Pharmacol,UMR 8638, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Gonzalez, G (corresponding author), Univ Lyon 1, Fac Med, Ctr Commun Imagerie Laennec, F-69365 Lyon, France.	serge.bouaziz@parisdescartes.fr; sawsee.hong@univ-lyon1.fr	Boulanger, Pierre/AFV-2750-2022; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Hong, Saw See/M-9818-2017	Bouaziz, Serge/0000-0001-7792-8307; Hong, Saw See/0000-0001-8871-0901; CORIC, Pascale/0000-0001-8484-1381	French AIDS foundation (SIDACTION) [A/19-3-01541]; Agence Nationale de Recherche sur le SIDA (ANRS) [DendrAde]; French Foundation for Cystic Fibrosis	French AIDS foundation (SIDACTION); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); French Foundation for Cystic Fibrosis	This work has been supported by the French AIDS foundation (SIDACTION-contract A/19-3-01541) and the Agence Nationale de Recherche sur le SIDA (ANRS, Grant DendrAde 2007-2008). SDF was the recipient of an ANRS fellowship, and GG was the recipient of a fellowship from the French Foundation for Cystic Fibrosis (Vaincre la Mucoviscidose). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Adamson CS, 2006, J VIROL, V80, P10957, DOI 10.1128/JVI.01369-06; Adamson CS, 2010, ANTIVIR RES, V85, P119, DOI 10.1016/j.antiviral.2009.09.009; Adamson CS, 2009, J VIROL, V83, P4884, DOI 10.1128/JVI.02659-08; Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alfadhli A, 2005, J VIROL, V79, P14498, DOI 10.1128/JVI.79.23.14498-14506.2005; Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; CARRIERE C, 1995, J VIROL, V69, P2366; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; CHAZAL N, 1995, J VIROL, V69, P365, DOI 10.1128/JVI.69.1.365-375.1995; Cimarelli A, 2002, CELL MOL LIFE SCI, V59, P1166, DOI 10.1007/s00018-002-8495-6; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DaFonseca S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-162; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Dorr CR, 2011, BIOORG MED CHEM LETT, V21, P542, DOI 10.1016/j.bmcl.2010.10.078; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; Fritz JV, 2010, J VIROL, V84, P1585, DOI 10.1128/JVI.01691-09; Gay B, 1998, VIROLOGY, V247, P160, DOI 10.1006/viro.1998.9237; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; Hong SS, 1997, EMBO J, V16, P2294, DOI 10.1093/emboj/16.9.2294; Huvent I, 1998, J GEN VIROL, V79, P1069, DOI 10.1099/0022-1317-79-5-1069; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; Jeong HJ, 1999, BIOORG MED CHEM LETT, V9, P1201, DOI 10.1016/S0960-894X(99)00165-1; Kanamoto T, 2001, ANTIMICROB AGENTS CH, V45, P1225, DOI 10.1128/AAC.45.4.1225-1230.2001; Kashiwada Y, 1996, J MED CHEM, V39, P1016, DOI 10.1021/jm950922q; Keller PW, 2011, J VIROL, V85, P1420, DOI 10.1128/JVI.01926-10; KLIKOVA M, 1995, J VIROL, V69, P1093, DOI 10.1128/JVI.69.2.1093-1098.1995; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; Kobinger GP, 1998, J VIROL, V72, P5441, DOI 10.1128/JVI.72.7.5441-5448.1998; Labrosse B, 1997, J VIROL, V71, P8230, DOI 10.1128/JVI.71.11.8230-8236.1997; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; LAVALLEE C, 1994, J VIROL, V68, P1926; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Li F, 2006, VIROLOGY, V356, P217, DOI 10.1016/j.virol.2006.07.023; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; LU YL, 1995, J VIROL, V69, P6873, DOI 10.1128/JVI.69.11.6873-6879.1995; MAHALINGAM S, 1995, P NATL ACAD SCI USA, V92, P3794, DOI 10.1073/pnas.92.9.3794; MAYAUX JF, 1994, P NATL ACAD SCI USA, V91, P3564, DOI 10.1073/pnas.91.9.3564; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller B, 2000, J VIROL, V74, P9727, DOI 10.1128/JVI.74.20.9727-9731.2000; Muriaux D, 2004, CURR PHARM DESIGN, V10, P3725, DOI 10.2174/1381612043382701; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Perrin-Tricaud C, 1999, VIROLOGY, V255, P20, DOI 10.1006/viro.1998.9573; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; ROYER M, 1992, J VIROL, V66, P3230, DOI 10.1128/JVI.66.5.3230-3235.1992; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; Royer M, 1997, J GEN VIROL, V78, P131, DOI 10.1099/0022-1317-78-1-131; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; Sakuragi S, 2006, MICROBES INFECT, V8, P1875, DOI 10.1016/j.micinf.2006.02.027; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Shvadchak V, 2009, BIOCHIMIE, V91, P916, DOI 10.1016/j.biochi.2009.04.014; Singh SP, 2000, J VIROL, V74, P10650, DOI 10.1128/JVI.74.22.10650-10657.2000; Soler F, 1996, J MED CHEM, V39, P1069, DOI 10.1021/jm950669u; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; TURCAUD S, 2011, J MED CHEM UNPUB; Votteler J, 2007, J VIROL, V81, P9572, DOI 10.1128/JVI.02803-06; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; WANG CT, 1994, VIROLOGY, V200, P524, DOI 10.1006/viro.1994.1215; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Yao Xiao-Jian, 2004, Retrovirology, V1, P21, DOI 10.1186/1742-4690-1-21; Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yuan XO, 2004, VIROLOGY, V324, P525, DOI 10.1016/j.virol.2004.04.009; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004; Zhou Jing, 2004, Retrovirology, V1, P15, DOI 10.1186/1742-4690-1-15; ZHOU X, 1994, J VIROL, V68, P2556	88	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27234	10.1371/journal.pone.0027234	http://dx.doi.org/10.1371/journal.pone.0027234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073298	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000297197000035
J	Shiramizo, SCPL; Marra, AR; Durao, MS; Paes, AT; Edmond, MB; dos Santos, OFP				Pereira Lima Shiramizo, Sandra Christina; Marra, Alexandre R.; Durao, Marcelino S.; Paes, Angela T.; Edmond, Michael B.; Pavao dos Santos, Oscar Fernando			Decreasing Mortality in Severe Sepsis and Septic Shock Patients by Implementing a Sepsis Bundle in a Hospital Setting	PLOS ONE			English	Article							GOAL-DIRECTED THERAPY; SURVIVING SEPSIS; CAMPAIGN GUIDELINES; MANAGEMENT; CARE; MULTICENTER; PROGRAM	Background: The Surviving Sepsis Campaign (SSC) guidelines for the management of severe sepsis (SS) and septic shock (SSh) have been recommended to reduce morbidity and mortality. Materials and Methods: A quasi-experimental study was conducted in a medical-surgical ICU. Multiple interventions to optimize SS and SSh shock patients' clinical outcomes were performed by applying sepsis bundles (6- and 24-hour) in May 2006. We compared bundle compliance and patient outcomes before (July 2005-April 2006) and after (May 2006-December 2009) implementation of the interventions. Results: A total of 564 SS and SSh patients were identified. Prior to the intervention, compliance with the 6 hour-sepsis resuscitation bundle was only 6%. After the intervention, compliance was as follows: 8.2% from May to December 2006, 9.3% in 2007, 21.1% in 2008 and 13.7% in 2009. For the 24 hour-management bundle, baseline compliance was 15.0%. After the intervention, compliance was 15.1% from May to December 2006, 21.4% in 2007, 27.8% in 2008 and 44.4% in 2009. The in-hospital mortality was 54.0% from July 2005 to April 2006, 41.1% from May to December 2006, 39.3% in 2007, 41.4% in 2008 and 16.2% in 2009. Conclusion: These results suggest reducing SS and SSh patient mortality is a complex process that involves multiple performance measures and interventions.	[Pereira Lima Shiramizo, Sandra Christina; Marra, Alexandre R.; Durao, Marcelino S.; Pavao dos Santos, Oscar Fernando] Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil; [Paes, Angela T.] IIEP, Dept Stat, Sao Paulo, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Dept Internal Med, Sch Med, Richmond, VA USA	Hospital Israelita Albert Einstein; Virginia Commonwealth University	Shiramizo, SCPL (corresponding author), Hosp Israelita Albert Einstein, Crit Care Unit, Sao Paulo, Brazil.	alexmarra@einstein.br	Paes, Angela T/B-7110-2014; Santos, Oscar Fernando Pavão dos/B-8761-2017; Shiramizo, Sandra/O-3359-2017	Santos, Oscar Fernando Pavão dos/0000-0002-8731-1201; Shiramizo, Sandra/0000-0002-8735-4930; Paes, Angela/0000-0002-7405-3442; Edmond, Michael/0000-0002-4144-8974				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; De Miguel-Yanes JM, 2009, AM J EMERG MED, V27, P668, DOI 10.1016/j.ajem.2008.05.010; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Durao MS, 2010, ANAESTH INTENS CARE, V38, P467, DOI 10.1177/0310057X1003800309; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x	22	52	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26790	10.1371/journal.pone.0026790	http://dx.doi.org/10.1371/journal.pone.0026790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073193	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000013
J	Carnero-Pardo, C; Espejo-Martinez, B; Lopez-Alcalde, S; Espinosa-Garcia, M; Saez-Zea, C; Hernandez-Torres, E; Navarro-Espigares, JL; Vilchez-Carrillo, R				Carnero-Pardo, Cristobal; Espejo-Martinez, Beatriz; Lopez-Alcalde, Samuel; Espinosa-Garcia, Maria; Saez-Zea, Carmen; Hernandez-Torres, Elisa; Luis Navarro-Espigares, Jose; Vilchez-Carrillo, Rosa			Diagnostic Accuracy, Effectiveness and Cost for Cognitive Impairment and Dementia Screening of Three Short Cognitive Tests Applicable to Illiterates	PLOS ONE			English	Article							MINI-MENTAL-STATE; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE; QUESTIONNAIRE; VALIDATION; BATTERY; TOOL	Background: Illiteracy, a universal problem, limits the utilization of the most widely used short cognitive tests. Our objective was to assess and compare the effectiveness and cost for cognitive impairment (CI) and dementia (DEM) screening of three short cognitive tests applicable to illiterates. Methods: Phase III diagnostic test evaluation study was performed during one year in four Primary Care centers, prospectively including individuals with suspicion of CI or DEM. All underwent the Eurotest, Memory Alteration Test (M@T), and Phototest, applied in a balanced manner. Clinical, functional, and cognitive studies were independently performed in a blinded fashion in a Cognitive Behavioral Neurology Unit, and the gold standard diagnosis was established by consensus of expert neurologists on the basis of these results. Effectiveness of tests was assessed as the proportion of correct diagnoses (diagnostic accuracy [DA]) and the kappa index of concordance (k) with respect to gold standard diagnoses. Costs were based on public prices at the time and hospital accounts. Results: The study included 139 individuals: 47 with DEM, 36 with CI, and 56 without CI. No significant differences in effectiveness were found among the tests. For DEM screening: Eurotest (k = 0.71 [0.59-0.83], DA = 0.87 [0.80-0.92]), M@T (k = 0.72 [0.60-0.84], DA = 0.87 [0.80-0.92]), Phototest (k = 0.70 [0.57-0.82], DA = 0.86 [0.79-0.91]). For CI screening: Eurotest (k = 0.67 [0.55-0.79]; DA = 0.83 [0.76-0.89]), M@T (k = 0.52 [0.37-0.67]; DA = 0.80 [0.72-0.86]), Phototest (k = 0.59 [0.46-0.72]; DA = 0.79 [0.71-0.86]). There were no differences in the cost of DEM screening, but the cost of CI screening was significantly higher with M@T (330.7 +/- 177.1(sic), mean +/- sd) than with Eurotest (294.1 +/- 195.0(sic)) or Phototest (296.0 +/- 196.5(sic)). Application time was shorter with Phototest (2.8 +/- 0.8 min) than with Eurotest (7.1 +/- 1.8 min) or M@T (6.8 +/- 2.2 min). Conclusions: Eurotest, M@T, and Phototest are equally effective. Eurotest and Phototest are both less expensive options but Phototest is the most efficient, requiring the shortest application time.	[Carnero-Pardo, Cristobal; Lopez-Alcalde, Samuel; Espinosa-Garcia, Maria; Saez-Zea, Carmen; Vilchez-Carrillo, Rosa] Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain; [Carnero-Pardo, Cristobal; Espinosa-Garcia, Maria] FIDYAN Neuroctr, Granada, Spain; [Espejo-Martinez, Beatriz] Complejo Hosp La Mancha Ctr, Serv Neurol, Alcazar De San Juan, Spain; [Saez-Zea, Carmen] Univ Jaen, Dept Psicol, Jaen, Spain; [Hernandez-Torres, Elisa; Luis Navarro-Espigares, Jose] Hosp Univ Virgen Nieves, Subdirecc Control Gest, Granada, Spain	Hospital Universitario Virgen de las Nieves; Universidad de Jaen; Hospital Universitario Virgen de las Nieves	Carnero-Pardo, C (corresponding author), Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain.	ccarnero@neurocenter.es	Carnero-Pardo, Cristóbal/I-6777-2018; García, María Espinosa/AAS-2903-2020; Navarro Espigares, Jose Luis/L-7643-2014	Carnero-Pardo, Cristóbal/0000-0003-3415-6727; Navarro Espigares, Jose Luis/0000-0003-3509-7810; Saez Zea, Carmen/0000-0003-3719-4948; HERNANDEZ-TORRES, ELISA/0000-0002-7266-7408	Carlos III National Health Research Institute [PI06/90034]	Carlos III National Health Research Institute	Funding was provided by the Carlos III National Health Research Institute (grant PI06/90034). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Boada M, 2002, NEUROLOGIA, V17, P317; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860; Carnero-Pardo C, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-15; Carnero-Pardo C, 2004, REV NEUROLOGIA, V39, P801, DOI 10.33588/rn.3909.2004095; Carnero-Pardo C, 2011, NEUROLOGIA, V26, P20, DOI 10.1016/j.nrl.2010.09.021; Carnero-Pardo C, 2004, REV NEUROLOGIA, V38, P201, DOI 10.33588/rn.3803.2003489; Carnero-Pardo C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-92; CARNEROPARDO C, 2011, NEUROLOGIA; CARNEROPARDO C, 2009, ALZH REAL INVEST DEM, V42, P14; CARNEROPARDO C, 2005, THESIS U GRANADA GRA; *CONS EC INN CIENC, 2001, CENS POBL; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; *EPT MON REP TEAM, 2010, REP 2010 REACH MARG; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gold MR, 1996, COST EFFECTIVENESS H; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Iturra-Mena Ann Mary, 2007, Rev. chil. neuro-psiquiatr., V45, P296; Kutner M., 2007, 2007480 NCES; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; MAHONEY F I, 1965, Md State Med J, V14, P61; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Prince M, 2000, INT J GERIATR PSYCH, V15, P14, DOI 10.1002/(SICI)1099-1166(200001)15:1<14::AID-GPS70>3.0.CO;2-8; Prince M, 2011, INT J GERIATR PSYCH, V26, P899, DOI 10.1002/gps.2622; Rami L, 2007, INT J GERIATR PSYCH, V22, P294, DOI 10.1002/gps.1672; Rami L, 2010, ARCH GERONTOL GERIAT, V50, P171, DOI 10.1016/j.archger.2009.03.005; Ridha B., 2010, PRACT NEUROL, V5, P298, DOI [10.1111/j.1474-7766.2005.00333.x, DOI 10.1111/J.1474-7766.2005.00333.X]; Robles A, 2002, NEUROLOGIA, V17, P17; Rosselli D, 2000, REV NEUROLOGIA, V30, P428, DOI 10.33588/rn.3005.99125; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Saez-Zea C, 2008, NEUROLOGIA, V23, P356; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043; *US FDA, 2003, STAT GUID REP RES ST; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	53	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27069	10.1371/journal.pone.0027069	http://dx.doi.org/10.1371/journal.pone.0027069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	849WB	22073256	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900070
J	Duchene, S; Archer, FI; Vilstrup, J; Caballero, S; Morin, PA				Duchene, Sebastian; Archer, Frederick I.; Vilstrup, Julia; Caballero, Susana; Morin, Phillip A.			Mitogenome Phylogenetics: The Impact of Using Single Regions and Partitioning Schemes on Topology, Substitution Rate and Divergence Time Estimation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; KILLER WHALE; GENE TREES; SPECIES TREES; MULTILOCUS PHYLOGENY; ORCINUS-ORCA; POPULATION; RESOLUTION; EVOLUTION; GENOME	The availability of mitochondrial genome sequences is growing as a result of recent technological advances in molecular biology. In phylogenetic analyses, the complete mitogenome is increasingly becoming the marker of choice, usually providing better phylogenetic resolution and precision relative to traditional markers such as cytochrome b (CYTB) and the control region (CR). In some cases, the differences in phylogenetic estimates between mitogenomic and single-gene markers have yielded incongruent conclusions. By comparing phylogenetic estimates made from different genes, we identified the most informative mitochondrial regions and evaluated the minimum amount of data necessary to reproduce the same results as the mitogenome. We compared results among individual genes and the mitogenome for recently published complete mitogenome datasets of selected delphinids (Delphinidae) and killer whales (genus Orcinus). Using Bayesian phylogenetic methods, we investigated differences in estimation of topologies, divergence dates, and clock-like behavior among genes for both datasets. Although the most informative regions were not the same for each taxonomic group (COX1, CYTB, ND3 and ATP6 for Orcinus, and ND1, COX1 and ND4 for Delphinidae), in both cases they were equivalent to less than a quarter of the complete mitogenome. This suggests that gene information content can vary among groups, but can be adequately represented by a portion of the complete sequence. Although our results indicate that complete mitogenomes provide the highest phylogenetic resolution and most precise date estimates, a minimum amount of data can be selected using our approach when the complete sequence is unavailable. Studies based on single genes can benefit from the addition of a few more mitochondrial markers, producing topologies and date estimates similar to those obtained using the entire mitogenome.	[Duchene, Sebastian; Caballero, Susana] Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Bogota, Colombia; [Archer, Frederick I.; Morin, Phillip A.] Natl Ocean & Atmospher Adm, Protected Resources Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Vilstrup, Julia] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark	Universidad de los Andes (Colombia); National Oceanic Atmospheric Admin (NOAA) - USA; University of Copenhagen	Duchene, S (corresponding author), Univ Los Andes, Lab Ecol Mol Vertebrados Acuat, Bogota, Colombia.	phillip.morin@noaa.gov	Morin, Phillip A/E-9515-2010; Vilstrup Mouatt, Julia T./N-4553-2017; Duchene, Sebastian/E-3527-2012	Vilstrup Mouatt, Julia T./0000-0001-6534-8452; Morin, Phillip/0000-0002-3279-1519; Duchene, Sebastian/0000-0002-2863-0907	Universidad de los Andes	Universidad de los Andes	Funding provided by Proyecto semilla Grant from Universidad de los Andes (www.uniandes.edu.co). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo C, 2010, BOOT BOOTSTRAP R S P, P2; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2008, BAYESIAN EVOLUTIONAR; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2010, MITOCHONDR DNA, V21, P138, DOI 10.3109/19401736.2010.494727; Ho SYW, 2010, SITESAMPLER V1 1; Ho SYW, 2005, MOL BIOL EVOL, V27, P7; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; Innan H, 2002, MOL BIOL EVOL, V19, P1122, DOI 10.1093/oxfordjournals.molbev.a004170; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Kass RE, 1995, J AM STAT ASSOC, V90, P13; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Lartillot N, 2008, PHILOS T R SOC LON B, V363, P9; LeDuc RG, 2008, BIOL LETT, V4, P3; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parsons KM, 2009, ANIM BEHAV, V77, P963, DOI 10.1016/j.anbehav.2009.01.018; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Pitman RL, 2007, J MAMMAL, V88, P43, DOI 10.1644/06-MAMM-A-118R1.1; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Posada D, 2008, MOL BIOL EVOL, V25, P3; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Rand DM, 2001, ANNU REV ECOL SYST, V32, P33; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Slatkin M, 2006, GENETICS, V172, P1979, DOI 10.1534/genetics.105.049593; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Venables W.N., 2002, MODERN APPL STAT S; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Viricel A, 2012, MAR MAMMAL SCI, V28, P37, DOI 10.1111/j.1748-7692.2010.00460.x; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	73	93	97	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27138	10.1371/journal.pone.0027138	http://dx.doi.org/10.1371/journal.pone.0027138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073275	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900011
J	Engelson, EJ; Buckner, FS; Van Voorhis, WC				Engelson, Erin J.; Buckner, Frederick S.; Van Voorhis, Wesley C.			An Essential Farnesylated Kinesin in Trypanosoma brucei	PLOS ONE			English	Article							FARNESYLTRANSFERASE INHIBITORS; EXPRESSION; ALIGNMENT; SYSTEM; POTENT	Kinesins are a family of motor proteins conserved throughout eukaryotes. In our present study we characterize a novel kinesin, Kinesin(CaaX), orthologs of which are only found in the kinetoplastids and not other eukaryotes. Kinesin(CaaX) has the CVIM amino acids at the C-terminus, and CVIM was previously shown to be an ideal signal for protein farnesylation in T. brucei. In this study we show Kinesin(CaaX) is farnesylated using radiolabeling studies and that farnesylation is dependent on the CVIM motif. Using RNA interference, we show Kinesin(CaaX) is essential for T. brucei proliferation. Additionally RNAi Kinesin(CaaX) depleted T. brucei are 4 fold more sensitive to the protein farneysltransferase (PFT) inhibitor LN-59, suggesting that Kinesin(CaaX) is a target of PFT inhibitors' action to block proliferation of T. brucei. Using tetracycline-induced exogenous tagged Kinesin(CaaX) and Kinesin(CVIMdeletion) (non-farnesylated Kinesin) expression lines in T. brucei, we demonstrate Kinesin(CaaX) is farnesylated in T. brucei cells and this farnesylation has functional effects. In cells expressing a CaaX-deleted version of Kinesin, the localization is more diffuse which suggests correct localization depends on farnesylation. Through our investigation of cell cycle, nucleus and kinetoplast quantitation and immunofluorescence assays an important role is suggested for Kinesin(CaaX) in the separation of nuclei and kinetoplasts during and after they have been replicated. Taken together, our work suggests Kinesin(CaaX) is a target of PFT inhibition of T. brucei cell proliferation and Kinesin(CaaX) functions through both the motor and farnesyl groups.	[Engelson, Erin J.; Buckner, Frederick S.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Engelson, Erin J.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Engelson, EJ (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	wesley@uw.edu	Buckner, Frederick/AAF-3938-2020	Buckner, Frederick/0000-0001-7796-6477	Molecular and Cellular Biology Program; University of Washington [R01CA52874, 1R01AI089441, 1R01AI080625]; NATIONAL CANCER INSTITUTE [R01CA052874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080625, R01AI089441] Funding Source: NIH RePORTER	Molecular and Cellular Biology Program; University of Washington(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of funding include the Molecular and Cellular Biology Program and the Royalty Research Fund at the University of Washington, R01CA52874, 1R01AI089441 and 1R01AI080625. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, HUM AFR TRYP NUMB NE; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Ayong L, 2011, MOL BIOCHEM PARASIT, V175, P162, DOI 10.1016/j.molbiopara.2010.11.007; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Buckner Frederick S, 2005, Curr Opin Investig Drugs, V6, P791; Buckner FS, 2000, J BIOL CHEM, V275, P21870, DOI 10.1074/jbc.M000975200; Buckner FS, 2002, BIOCHEM J, V367, P809, DOI 10.1042/BJ20020277; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Conner RJ, 1992, PROGRAMME CONTROL AF; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Fletcher S, 2008, J MED CHEM, V51, P5176, DOI 10.1021/jm800113p; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Kull FJ, 2002, J CELL SCI, V115, P15; Lawrence CJ, 2002, J MOL EVOL, V54, P42, DOI 10.1007/s00239-001-0016-y; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MICROBES INFECT, V3, P763, DOI 10.1016/S1286-4579(01)01432-0; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2010, PLOS, V11; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wood KW, 2008, CLIN CANCER RES, V14, P7588, DOI 10.1158/1078-0432.CCR-07-4443; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; World Health Organization, 2010, WHO AFR TRYP SLEEP S; Yokoyama K, 1997, MOL BIOCHEM PARASIT, V87, P61, DOI 10.1016/S0166-6851(97)00043-1; Yokoyama K, 1998, J BIOL CHEM, V273, P26497, DOI 10.1074/jbc.273.41.26497; Yokoyama K, 1998, MOL BIOCHEM PARASIT, V94, P87, DOI 10.1016/S0166-6851(98)00053-X; Yokoyama K, 2008, MOL BIOCHEM PARASIT, V157, P32, DOI 10.1016/j.molbiopara.2007.09.006	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26508	10.1371/journal.pone.0026508	http://dx.doi.org/10.1371/journal.pone.0026508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073170	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900023
J	Erwin, PM; Olson, JB; Thacker, RW				Erwin, Patrick M.; Olson, Julie B.; Thacker, Robert W.			Phylogenetic Diversity, Host-Specificity and Community Profiling of Sponge-Associated Bacteria in the Northern Gulf of Mexico	PLOS ONE			English	Article							RESTRICTION-FRAGMENT-LENGTH; IN-SITU HYBRIDIZATION; CYANOBACTERIUM OSCILLATORIA-SPONGELIAE; BARRIER-REEF SPONGE; MARINE SPONGES; MICROBIAL COMMUNITY; VERTICAL TRANSMISSION; CARIBBEAN SPONGE; POLYMORPHISM ANALYSIS; NITROGEN-FIXATION	Background: Marine sponges can associate with abundant and diverse consortia of microbial symbionts. However, associated bacteria remain unexamined for the majority of host sponges and few studies use phylogenetic metrics to quantify symbiont community diversity. DNA fingerprinting techniques, such as terminal restriction fragment length polymorphisms (T-RFLP), might provide rapid profiling of these communities, but have not been explicitly compared to traditional methods. Methodology/Principal Findings: We investigated the bacterial communities associated with the marine sponges Hymeniacidon heliophila and Haliclona tubifera, a sympatric tunicate, Didemnum sp., and ambient seawater from the northern Gulf of Mexico by combining replicated clone libraries with T-RFLP analyses of 16S rRNA gene sequences. Clone libraries revealed that bacterial communities associated with the two sponges exhibited lower species richness and lower species diversity than seawater and tunicate assemblages, with differences in species composition among all four source groups. T-RFLP profiles clustered microbial communities by source; individual T-RFs were matched to the majority (80.6%) of clone library sequences, indicating that T-RFLP analysis can be used to rapidly profile these communities. Phylogenetic metrics of community diversity indicated that the two sponge-associated bacterial communities include dominant and host-specific bacterial lineages that are distinct from bacteria recovered from seawater, tunicates, and unrelated sponge hosts. In addition, a large proportion of the symbionts associated with H. heliophila were shared with distant, conspecific host populations in the southwestern Atlantic (Brazil). Conclusions/Significance: The low diversity and species-specific nature of bacterial communities associated with H. heliophila and H. tubifera represent a distinctly different pattern from other, reportedly universal, sponge-associated bacterial communities. Our replicated sampling strategy, which included samples that reflect the ambient environment, allowed us to differentiate resident symbionts from potentially transient or prey bacteria. Pairing replicated clone library construction with rapid community profiling via T-RFLP analyses will greatly facilitate future studies of sponge-microbe symbioses.	[Erwin, Patrick M.; Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Tuscaloosa	Erwin, PM (corresponding author), CSIC, Ctr Adv Studies Blanes, Blanes, Girona, Spain.	thacker@uab.edu	Erwin, Patrick/E-9926-2016	Erwin, Patrick/0000-0001-9276-0020	Mississippi-Alabama Sea Grant Consortium; National Institute for Undersea Science and Technology; National Science Foundation [0209329, 0853089]; National Institutes of Health Centers for AIDS Research [P30 AI27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	Mississippi-Alabama Sea Grant Consortium; National Institute for Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Centers for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by grants from the Mississippi-Alabama Sea Grant Consortium (www.masgc.org) awarded to PME and the National Institute for Undersea Science and Technology (www.niust.org) awarded to RT. This material is based upon work supported by the National Science Foundation (www.nsf.gov) under Grant No. 0209329 awarded to RT and Grant No. 0853089 award to PME. This work has been facilitated by the infrastructure and resources provided by the National Institutes of Health Centers for AIDS Research Core Grant P30 AI27767 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson SA, 2010, FEMS MICROBIOL ECOL, V72, P328, DOI 10.1111/j.1574-6941.2010.00869.x; [Anonymous], IEEE T PATTERN ANAL; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Burja AM, 2001, HYDROBIOLOGIA, V461, P41, DOI 10.1023/A:1012713130404; CHESHIRE AC, 1991, MAR BIOL, V109, P13, DOI 10.1007/BF01320226; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Colwell RK, 2013, ESTIMATES STAT ESTIM; COX GC, 1985, MAR BIOL, V89, P149, DOI 10.1007/BF00392886; Diaz Maria Cristina, 1993, Scientia Marina, V57, P283; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Dobretsov S, 2005, MAR ECOL PROG SER, V297, P119, DOI 10.3354/meps297119; Dorigo U, 2005, WATER RES, V39, P2207, DOI 10.1016/j.watres.2005.04.007; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flatt P, 2005, MAR BIOL, V147, P761, DOI 10.1007/s00227-005-1614-9; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Friedrich AB, 1999, MAR BIOL, V134, P461, DOI 10.1007/s002270050562; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Henrikson AA, 1995, J EXP MAR BIOL ECOL, V194, P157, DOI 10.1016/0022-0981(95)00088-7; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2006, MAR BIOTECHNOL, V8, P373, DOI 10.1007/s10126-006-5152-3; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper J. N. A., 2002, SYSTEMA PORIFERA GUI, V1-2; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Ihara K, 1997, INT J SYST BACTERIOL, V47, P73, DOI 10.1099/00207713-47-1-73; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Lee EY, 2003, BIOMOL ENG, V20, P299, DOI 10.1016/S1389-0344(03)00034-0; Lee OO, 2006, MICROB ECOL, V52, P693, DOI 10.1007/s00248-006-9077-1; Lee OO, 2009, APPL ENVIRON MICROB, V75, P6147, DOI 10.1128/AEM.00023-09; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Lee OO, 2010, INT SOC MICROB ECOL, P1; Lemoine N, 2007, SERIE LIVROS MUSEU N, P239; Li ZY, 2007, WORLD J MICROB BIOT, V23, P1265, DOI 10.1007/s11274-007-9359-x; Li ZY, 2006, J EXP MAR BIOL ECOL, V329, P75, DOI 10.1016/j.jembe.2005.08.014; LITTLE FRANK J., 1963, TULANE STUD ZOOL, V11, P31; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Luter HM, 2010, APPL ENVIRON MICROB, V76, P5736, DOI 10.1128/AEM.00653-10; Lysek N, 2003, Z NATURFORSCH C, V58, P568; Manz W, 2000, J MICROBIOL METH, V40, P125, DOI 10.1016/S0167-7012(99)00103-7; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martinez-Garcia M, 2008, ENVIRON MICROBIOL, V10, P2991, DOI 10.1111/j.1462-2920.2008.01761.x; Martinez-Garcia M, 2007, ENVIRON MICROBIOL, V9, P521, DOI 10.1111/j.1462-2920.2006.01170.x; Martinez-Garcia M, 2007, MAR DRUGS, V5, P52, DOI 10.3390/md503052; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Moss C, 2003, MAR BIOL, V143, P99, DOI 10.1007/s00227-003-1060-5; Munchhoff J, 2007, ENVIRON MICROBIOL, V9, P890, DOI 10.1111/j.1462-2920.2006.01209.x; Olson JB, 2005, AQUAT MICROB ECOL, V39, P47, DOI 10.3354/ame039047; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; Rutzler Klaus, 2009, P285; SANTAVY DL, 1990, MAR ECOL PROG SER, V67, P73, DOI 10.3354/meps067073; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Sipkema D, 2010, MAR BIOL, V157, P627, DOI 10.1007/s00227-009-1347-2; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steindler L, 2002, SYMBIOSIS, V33, P263; Tait E, 2007, J EXP MAR BIOL ECOL, V342, P138, DOI 10.1016/j.jembe.2006.10.024; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Webster NS, 2008, ISME J, P1; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1978, MAR BIOL, V49, P169, DOI 10.1007/BF00387116; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; WILKINSON CR, 1987, SCIENCE, V236, P1654, DOI 10.1126/science.236.4809.1654; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Zhang R, 2008, FEMS MICROBIOL ECOL, V65, P169, DOI 10.1111/j.1574-6941.2008.00493.x	104	59	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26806	10.1371/journal.pone.0026806	http://dx.doi.org/10.1371/journal.pone.0026806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073197	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900039
J	Kariya, Y; Gu, JG				Kariya, Yoshinobu; Gu, Jianguo			N-Glycosylation of beta 4 Integrin Controls the Adhesion and Motility of Keratinocytes	PLOS ONE			English	Article							I-LIKE DOMAIN; ALPHA-6-BETA-4 INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; LIPID RAFTS; BIOLOGICAL FUNCTION; CARCINOMA INVASION; BISECTING GLCNAC; CELL-ADHESION; LAMININ-332; EXPRESSION	alpha 6 beta 4 integrin is an essential component of hemidesmosomes and modulates cell migration in wound healing and cancer invasion. To elucidate the role of N-glycosylation on beta 4 integrin, we investigated keratinocyte adhesion and migration through the re-expression of wild-type or N-glycosylation-defective beta 4 integrin (Delta N beta 4) in beta 4 integrin null keratinocytes. N-glycosylation of beta 4 integrin was not essential for the heterodimer formation of beta 4 integrin with alpha 6 integrin and its expression on a cell surface, but N-glycosylation was required for integrin-mediated cell adhesion and migration. Concomitantly with the reduction of beta 4 integrin in the membrane microdomain, the intracellular signals of Akt and ERK activation were decreased in cells expressing DN beta 4 integrin. Forced cross-linking of beta 4 integrin rescued the decreased ERK activation in Delta N beta 4 integrin-expressing cells to a similar extent in wild-type beta 4 integrin-expressing cells. Surprisingly, compared with cells expressing wild-type beta 4 integrin, an alternation in N-glycan structures expressed on epidermal growth factor receptor (EGFR), and the induction of a stronger association between EGFR and beta 4 integrin were observed in Delta N beta 4 integrin-expressing cells. These results clearly demonstrated that N-glycosylation on beta 4 integrin plays an essential role in keratinocyte cellular function by allowing the appropriate complex formation on cell surfaces.	[Kariya, Yoshinobu; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Kariya, Yoshinobu] Fukushima Med Univ Sch Med, Dept Biochem, Fukushima, Japan	Tohoku Medical & Pharmaceutical University; Fukushima Medical University	Kariya, Y (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan.	kariya@fmu.ac.jp; jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020		Japan Society for the Promotion of Science [21370059, 23651196]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Fukushima Medical University; Uehara Memorial Foundation of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukushima Medical University; Uehara Memorial Foundation of Japan(Uehara Memorial Foundation)	This work was partially supported by a Grant-in-Aid for Scientific Research No. 21370059 (JG) and for Challenging Exploratory Research No. 23651196 (JG) from the Japan Society for the Promotion of Science, and by the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Fukushima Medical University Research Project from Fukushima Medical University and the Uehara Memorial Foundation of Japan (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2009, MINI-REV MED CHEM, V9, P1284, DOI 10.2174/138955709789878114; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kariya Y, 2008, J BIOL CHEM, V283, P33036, DOI 10.1074/jbc.M804526200; Kim HI, 2008, CANCER PREV RES, V1, P385, DOI 10.1158/1940-6207.CAPR-08-0087; Ko MS, 2010, DERMATOL CLIN, V28, P1, DOI 10.1016/j.det.2009.10.001; Leitinger B, 2002, J CELL SCI, V115, P963; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Niessen CM, 1996, J CELL SCI, V109, P1695; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Soung YH, 2011, MOL CANCER THER, V10, P883, DOI 10.1158/1535-7163.MCT-10-1053; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	35	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27084	10.1371/journal.pone.0027084	http://dx.doi.org/10.1371/journal.pone.0027084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073258	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900072
J	Moftah, M; Aziz, SHA; Elramah, S; Favereaux, A				Moftah, Marie; Aziz, Sayeda H. Abdel; Elramah, Sara; Favereaux, Alexandre			Classification of Sharks in the Egyptian Mediterranean Waters Using Morphological and DNA Barcoding Approaches	PLOS ONE			English	Article							SQUALUS-ACANTHIAS; SPINY DOGFISH; IDENTIFICATION; NUCLEOTIDE; AMINO; PHYLOGENY; SPARIDAE; ATLANTIC; NUCLEAR; REGION	The identification of species constitutes the first basic step in phylogenetic studies, biodiversity monitoring and conservation. DNA barcoding, i.e. the sequencing of a short standardized region of DNA, has been proposed as a new tool for animal species identification. The present study provides an update on the composition of shark in the Egyptian Mediterranean waters off Alexandria, since the latest study to date was performed 30 years ago, DNA barcoding was used in addition to classical taxonomical methodologies. Thus, 51 specimen were DNA barcoded for a 667 bp region of the mitochondrial COI gene. Although DNA barcoding aims at developing species identification systems, some phylogenetic signals were apparent in the data. In the neighbor-joining tree, 8 major clusters were apparent, each of them containing individuals belonging to the same species, and most with 100% bootstrap value. This study is the first to our knowledge to use DNA barcoding of the mitochondrial COI gene in order to confirm the presence of species Squalus acanthias, Oxynotus centrina, Squatina squatina, Scyliorhinus canicula, Scyliorhinus stellaris, Mustelus mustelus, Mustelus punctulatus and Carcharhinus altimus in the Egyptian Mediterranean waters. Finally, our study is the starting point of a new barcoding database concerning shark composition in the Egyptian Mediterranean waters (Barcoding of Egyptian Mediterranean Sharks [BEMS], http://www.boldsystems.org/views/projectlist.php?&#Barcoding%20Fish%20%28FishBOL%29).	[Moftah, Marie] Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt; [Aziz, Sayeda H. Abdel; Elramah, Sara] Univ Alexandria, Fac Sci, Dept Oceanog, Alexandria, Egypt; [Elramah, Sara; Favereaux, Alexandre] Univ Bordeaux, IINS, UMR 5297, F-33000 Bordeaux, France; [Elramah, Sara; Favereaux, Alexandre] CNRS, IINS, UMR 5297, F-33000 Bordeaux, France	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Moftah, M (corresponding author), Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt.	alexandre.favereaux@u-bordeaux2.fr	Favereaux, Alexandre/C-9744-2016	Moftah, Marie/0000-0001-5179-9615; FAVEREAUX, Alexandre/0000-0003-0881-9224	Agence Universitaire de la Francophonie	Agence Universitaire de la Francophonie	SER received a travel funding by Agence Universitaire de la Francophonie to perform sequencing analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco M, 2008, J AGR FOOD CHEM, V56, P9868, DOI 10.1021/jf8015128; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Craig MT, 2001, MOL PHYLOGENET EVOL, V19, P121, DOI 10.1006/mpev.2000.0913; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heist EJ, 1999, FISH B-NOAA, V97, P53; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hong J, 1996, J MOL EVOL, V43, P602, DOI 10.1007/BF02202108; Hosny CF, 1981, THESIS; Iglesias SP, 2005, MOL PHYLOGENET EVOL, V34, P569, DOI 10.1016/j.ympev.2004.10.022; Kabasakal Hakan, 2009, Pan-American Journal of Aquatic Sciences, V4, P609; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAVERY S, 1992, AUST J MAR FRESH RES, V43, P97; Martin Andrew P., 1993, NOAA Technical Report NMFS, V115, P53; Mazhar FM, 1974, B I OCEAN FISH ARE, V4; Nei M, 1998, P NATL ACAD SCI USA, V95, P12390, DOI 10.1073/pnas.95.21.12390; Renon P, 2001, ELECTROPHORESIS, V22, P1534, DOI 10.1002/1522-2683(200105)22:8&lt;1534::AID-ELPS1534&gt;3.0.CO;2-D; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salaneck E, 2003, MOL BIOL EVOL, V20, P1271, DOI 10.1093/molbev/msg133; Stelbrink B, 2010, MOL PHYLOGENET EVOL, V54, P395, DOI 10.1016/j.ympev.2009.07.029; Stock DW, 1995, MOL MAR BIOL BIOTECH, V4, P284; Strauss R.E., 1990, P109; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	33	21	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27001	10.1371/journal.pone.0027001	http://dx.doi.org/10.1371/journal.pone.0027001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087242	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900060
J	Pires, MM; Prado, PI; Guimaraes, PR				Pires, Mathias M.; Prado, Paulo I.; Guimaraes, Paulo R., Jr.			Do Food Web Models Reproduce the Structure of Mutualistic Networks?	PLOS ONE			English	Article							BODY-SIZE; NESTEDNESS; PATTERNS; ARCHITECTURE; MODULARITY; RULES	Background: Simple models inspired by processes shaping consumer-resource interactions have helped to establish the primary processes underlying the organization of food webs, networks of trophic interactions among species. Because other ecological interactions such as mutualisms between plants and their pollinators and seed dispersers are inherently based in consumer-resource relationships we hypothesize that processes shaping food webs should organize mutualistic relationships as well. Methodology/Principal Findings: We used a likelihood-based model selection approach to compare the performance of food web models and that of a model designed for mutualisms, in reproducing the structure of networks depicting mutualistic relationships. Our results show that these food web models are able to reproduce the structure of most of the mutualistic networks and even the simplest among the food web models, the cascade model, often reproduce overall structural properties of real mutualistic networks. Conclusions/Significance: Based on our results we hypothesize that processes leading to feeding hierarchy, which is a characteristic shared by all food web models, might be a fundamental aspect in the assembly of mutualisms. These findings suggest that similar underlying ecological processes might be important in organizing different types of interactions.	[Pires, Mathias M.] Univ Sao Paulo, Inst Biociencias, Programa Pos Grad Ecol, Sao Paulo, Brazil; [Prado, Paulo I.; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pires, MM (corresponding author), Univ Sao Paulo, Inst Biociencias, Programa Pos Grad Ecol, Sao Paulo, Brazil.	prguima@usp.br	Prado, Paulo Inácio/AAN-6512-2021; Guimarães-Junior, Paulo R/M-1298-2016; Guimaraes, Paulo R./E-1915-2016; Pires, Mathias/I-4489-2012; Guimaraes, Paulo/B-1099-2008; Prado, Paulo I/G-3353-2012	Prado, Paulo Inácio/0000-0002-7174-5005; Guimaraes, Paulo R./0000-0001-9161-8305; Pires, Mathias/0000-0003-2500-4748; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/54567-6, 2009/054422-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; url:www.fapesp.org) grants 2009/54567-6 to MMP and 2009/054422-8 to PRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell C, 2011, P NATL ACAD SCI USA, V108, P197, DOI 10.1073/pnas.1008204108; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Chamberlain SA, 2009, FUNCT ECOL, V23, P196, DOI 10.1111/j.1365-2435.2008.01472.x; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2006, SFI S SCI C, P27; Dunne JA, 2009, PHILOS T R SOC B, V364, P1711, DOI 10.1098/rstb.2008.0219; Dupont YL, 2011, OIKOS, V120, P170, DOI 10.1111/j.1600-0706.2010.18699.x; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hartig F., 2011, ECOL LETT IN PRESS; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Idro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014001; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Montoya JM, 2003, ECOL LETT, V6, P587, DOI 10.1046/j.1461-0248.2003.00469.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; Royall R., 1997, STAT EVIDENCE LIKELI; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Takemoto K, 2010, J THEOR BIOL, V264, P782, DOI 10.1016/j.jtbi.2010.03.029; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J. N., 2005, INTERSPEC INTERACT; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zook AE, 2011, J THEOR BIOL, V271, P106, DOI 10.1016/j.jtbi.2010.11.045	52	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27280	10.1371/journal.pone.0027280	http://dx.doi.org/10.1371/journal.pone.0027280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073303	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900096
J	Vazquez, A; Markert, EK; Oltvai, ZN				Vazquez, Alexei; Markert, Elke K.; Oltvai, Zoltan N.			Serine Biosynthesis with One Carbon Catabolism and the Glycine Cleavage System Represents a Novel Pathway for ATP Generation	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; CELL-PROLIFERATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENOME-SCALE; CANCER-CELLS; TUMOR-CELLS; METABOLISM; LACTATE; PERFORMANCE	Previous experimental evidence indicates that some cancer cells have an alternative glycolysis pathway with net zero ATP production, implying that upregulation of glycolysis in these cells may not be related to the generation of ATP. Here we use a genome-scale model of human cell metabolism to investigate the potential metabolic alterations in cells using net zero ATP glycolysis. We uncover a novel pathway for ATP generation that involves reactions from serine biosynthesis, one-carbon metabolism and the glycine cleavage system, and show that the pathway is transcriptionally upregulated in an inducible murine model of Myc-driven liver tumorigenesis. This pathway has a predicted two-fold higher flux rate in cells using net zero ATP glycolysis than those using standard glycolysis and generates twice as much ATP with significantly lower rate of lactate - but higher rate of alanine secretion. Thus, in cells using the standard - or the net zero ATP glycolysis pathways a significant portion of the glycolysis flux is always associated with ATP generation, and the ratio between the flux rates of the two pathways determines the rate of ATP generation and lactate and alanine secretion during glycolysis.	[Vazquez, Alexei] Canc Inst New Jersey, Dept Radiat Oncol, Div Bioinformat & Surveillance, New Brunswick, NJ USA; [Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Markert, Elke K.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Oltvai, Zoltan N.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Institute for Advanced Study - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vazquez, A (corresponding author), Canc Inst New Jersey, Dept Radiat Oncol, Div Bioinformat & Surveillance, New Brunswick, NJ USA.	vazqueal@umdnj.edu			Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH) [NIAID U01 AI070499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070499] Funding Source: NIH RePORTER	Robert Wood Johnson (RWJ) Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AV was sponsored by the Robert Wood Johnson (RWJ) Foundation. This work has been supported in part by National Institutes of Health (NIH) grant NIAID U01 AI070499 to ZNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other external funding sources for this study.	Alberts B, 2008, MOL BIOL CELL; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BISMUT H, 1995, BIOCHEM J, V308, P761, DOI 10.1042/bj3080761; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; CURTHOYS NP, 1972, J BIOL CHEM, V247, P1965; EICHLER HG, 1981, BIOSCIENCE REP, V1, P101, DOI 10.1007/BF01117006; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; FRAME KK, 1990, BIOTECHNOL BIOENG, V36, P191, DOI 10.1002/bit.260360211; GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hou XY, 2002, CLIN PHYSIOL FUNCT I, V22, P226, DOI 10.1046/j.1475-097X.2002.00423.x; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; KIT S, 1955, CANCER RES, V15, P715; LEE B, 1983, P NATL ACAD SCI USA, V80, P622, DOI 10.1073/pnas.80.2.622; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mo ML, 2007, MOL BIOSYST, V3, P598, DOI 10.1039/b705597h; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; MUNYON WH, 1959, EXP CELL RES, V17, P490, DOI 10.1016/0014-4827(59)90069-2; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trabold O, 2003, WOUND REPAIR REGEN, V11, P504, DOI 10.1046/j.1524-475X.2003.11621.x; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019538; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; VOET D, 2006, FUNDAMENTALS BIOCH L; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; WILLIAMS R, 1993, J INVEST DERMATOL, V100, P834, DOI 10.1111/1523-1747.ep12476744; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	52	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25881	10.1371/journal.pone.0025881	http://dx.doi.org/10.1371/journal.pone.0025881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073143	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000297154900002
J	Burgoyne, JR; Haeussler, DJ; Kumar, V; Ji, YH; Pimental, DR; Zee, RS; Costello, CE; Lin, C; McComb, ME; Cohen, RA; Bachschmid, MM				Burgoyne, Joseph R.; Haeussler, Dagmar J.; Kumar, Vikas; Ji, Yuhan; Pimental, David R.; Zee, Rebecca S.; Costello, Cathrine E.; Lin, Cheng; McComb, Mark E.; Cohen, Richard A.; Bachschmid, Markus M.			Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis	FASEB JOURNAL			English	Article						growth factor signaling; high-fat high-glucose diet; oxidative post-translational modifications; reactive oxygen species; reactive nitrogen species	ACTIVATED PROTEIN-KINASE; H-RAS; S-GLUTATHIOLATION; PLASMA-MEMBRANE; PALMITATE TURNOVER; POLYBASIC DOMAIN; NAD(P)H OXIDASE; BETA-CELL; LOCALIZATION; MECHANISMS	Here we demonstrate a new paradigm in redox signaling, whereby oxidants resulting from metabolic stress directly alter protein palmitoylation by oxidizing reactive cysteine thiolates. In mice fed a high-fat, high-sucrose diet and in cultured endothelial cells (ECs) treated with high palmitate and high glucose (HPHG), there was decreased HRas palmitoylation on Cys181/184 (61 +/- 24% decrease for cardiac tissue and 38 +/- 7.0% in ECs). This was due to oxidation of Cys181/184, detected using matrix-assisted laser desorption/ionization time of flight (MALDI TOF)-TOF. Decrease in HRas palmitoylation affected its compartmentalization and Ras binding domain binding activity, with a shift from plasma membrane tethering to Golgi localization. Loss of plasma membrane-bound HRas decreased growth factor-stimulated ERK phosphorylation (84 +/- 8.6% decrease) and increased apoptotic signaling (24 +/- 6.5-fold increase) after HPHG treatment that was prevented by overexpressing wild-type but not C181/184S HRas. The essential role of HRas in metabolic stress was made evident by the similar effects of expressing an inactive dominant negative N17-HRas or a MEK inhibitor. Furthermore, the relevance of thiol oxidation was demonstrated by overexpressing manganese superoxide dismutase, which improved HRas palmitoylation and ERK phosphorylation, while lessening apoptosis in HPHG treated ECs.-Burgoyne, J. R., Haeussler, D. J., Kumar, V., Ji, Y., Pimental, D. R., Zee, R. S., Costello, C. E., Lin, C., McComb, M. E., Cohen, R. A., Bachschmid, M. M. Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis. FASEB J. 26, 832-841 (2012). www.fasebj.org	[Burgoyne, Joseph R.; Pimental, David R.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Unit, Boston, MA 02118 USA; [Ji, Yuhan; Costello, Cathrine E.; Lin, Cheng; McComb, Mark E.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Cardiovasc Prote Ctr, Boston, MA 02118 USA	Boston University; Boston University	Burgoyne, JR (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Unit, Boston, MA 02118 USA.	jrburgoy@bu.edu; bach@bu.edu	McComb, Mark E/I-3193-2014	/0000-0002-1070-6408; /0000-0002-4249-485X; Zee, Rebecca/0000-0002-4235-8778; Costello, Catherine/0000-0003-1594-5122; Burgoyne, Joseph/0000-0001-7325-7382; Bachschmid, Markus Michael/0000-0002-0748-5528	U.S. National Institutes of Health (NIH) [PO1-HL-068758, R37-HL-04017]; NIH [HL-007969-06A1]; National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services [HHSN268201000031C]; Wellcome Trust [085483/Z/08/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R01HL031607, R37HL104017, T32HL007969, K08HL004017] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) grants PO1-HL-068758 and R37-HL-04017 and NIH predoctoral training grant HL-007969-06A1, as well as by the National Heart, Lung, and Blood Institute, NIH, Department of Health and Human Services, under contract HHSN268201000031C. This work was also supported by a Sir Henry Wellcome postdoctoral fellowship from The Wellcome Trust (sponsor reference 085483/Z/08/Z; to J.R.B.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the awarding offices.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Baker TL, 2000, J BIOL CHEM, V275, P22037, DOI 10.1074/jbc.M001813200; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Charles RL, 2008, PROTEOM CLIN APPL, V2, P823, DOI 10.1002/prca.200780104; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Grines CL, 2002, CIRCULATION, V105, P1291, DOI 10.1161/hc1102.105595; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Haeussler DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023160; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Oeste CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015866; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Schreyer SA, 2003, ATHEROSCLEROSIS, V171, P49, DOI 10.1016/j.atherosclerosis.2003.07.010; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251	37	42	42	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					832	841		10.1096/fj.11-189415	http://dx.doi.org/10.1096/fj.11-189415			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22085642	Green Published			2022-12-25	WOS:000300485700034
J	Salom, D; Cao, PX; Sun, WY; Kramp, K; Jastrzebska, B; Jin, H; Feng, ZY; Palczewski, K				Salom, David; Cao, Pengxiu; Sun, Wenyu; Kramp, Kristopher; Jastrzebska, Beata; Jin, Hui; Feng, Zhaoyang; Palczewski, Krzysztof			Heterologous expression of functional G-protein-coupled receptors in Caenorhabditis elegans	FASEB JOURNAL			English	Article						native GPCR; purification; membrane proteins	RHODOPSIN MONOCLONAL-ANTIBODIES; STRUCTURAL GENOMICS; MEMBRANE-PROTEINS; LIGHT; PURIFICATION; ENVIRONMENT; ACTIVATION; BINDING	New strategies for expression, purification, functional characterization, and structural determination of membrane-spanning G-protein-coupled receptors (GPCRs) are constantly being developed because of their importance to human health. Here, we report a Caenorhabditis elegans heterologous expression system able to produce milligram amounts of functional native and engineered GPCRs. Both bovine opsin [(b)opsin] and human adenosine A(2A) subtype receptor [(h) A(2A)R] expressed in neurons or muscles of C. elegans were localized to cell membranes. Worms expressing these GPCRs manifested changes in motor behavior in response to light and ligands, respectively. With a newly devised protocol, 0.6-1 mg of purified homogenous 9-cis-retinal-bound bovine isorhodopsin [(b)isoRho] and ligand-bound (h) A(2A)R were obtained from C. elegans from one 10-L fermentation at low cost. Purified recombinant (b) isoRho exhibited its signature absorbance spectrum and activated its cognate G-protein transducin in vitro at a rate similar to native rhodopsin (Rho) obtained from bovine retina. Generally high expression levels of 11 native and mutant GPCRs demonstrated the potential of this C. elegans system to produce milligram quantities of high-quality GPCRs and possibly other membrane proteins suitable for detailed characterization.-Salom, D., Cao, P., Sun, W., Kramp, K., Jastrzebska, B., Jin, H., Feng, Z., Palczewski, K. Heterologous expression of functional G-protein-coupled receptors in Caenorhabditis elegans. FASEB J. 26, 492-502 (2012). www.fasebj.org	[Feng, Zhaoyang; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Salom, David; Sun, Wenyu; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH USA; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Dept Physiol, Coll Med, Xian 710049, Peoples R China	Case Western Reserve University; Xi'an Jiaotong University	Feng, ZY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	zxf17@case.edu; kxp65@case.edu	Cao, Pengxiu/I-5378-2012	Salom, David/0000-0002-3208-1509; CAO, PENGXIU/0000-0002-5900-5645; Kramp, Kristopher/0000-0003-2121-9274	U.S. National Institutes of Health [EY-008061, EY-009339, P30 EY-11373]; Mt. Sinai Health Care Foundation; National Institute of General Medical Sciences [GM074945]; Polgenix, Inc.; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mt. Sinai Health Care Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Polgenix, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. T. Webster, Jr., and members of the K. P. laboratory for critical comments on the manuscript. The authors thank Dr. I. Katsura (Graduate University for Advanced Studies, Mishima, Japan) for P<INF>H20</INF> DNA and M. H. Zheng for technical assistance. This research was supported in part by grants EY-008061, EY-009339, and P30 EY-11373 (to K. P.) from the U.S. National Institutes of Health, and Mt. Sinai Health Care Foundation Scholars Program in the Basic Science (to Z.F.). Research was also supported by a U54 award to the New York SGX Research Center for Structural Genomics (NYSGXRC) from the National Institute of General Medical Sciences (GM074945; principal investigator: Stephen K. Burley) under a contract to Polgenix, Inc. D. S. and W. S. are employees of Polgenix, Inc. K. P. is CSO at Polgenix Inc. P.C., K.K., B.J., H.J., and Z.F. report no conflicts of interest. The Z.F. laboratory received support from Polgenix, Inc.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Baker M, 2010, NATURE, V465, P823, DOI 10.1038/465823a; Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Klammt Christian, 2007, V375, P57; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lodowski DT, 2009, PHOTOCHEM PHOTOBIOL, V85, P425, DOI 10.1111/j.1751-1097.2008.00516.x; Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x; Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; O'Malley MA, 2007, J STRUCT BIOL, V159, P166, DOI 10.1016/j.jsb.2007.05.001; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OKKEMA PG, 1993, GENETICS, V135, P385; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panneels V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018478; Parrill AL, 2008, CHEMMEDCHEM, V3, P1021, DOI 10.1002/cmdc.200800070; Provasi D, 2010, BIOPHYS J, V98, P2347, DOI 10.1016/j.bpj.2010.01.047; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; Salom D.L.N., 2005, G PROTEIN COUPLED RE, P1; Salom D, 2008, BIOCHEMISTRY-US, V47, P13296, DOI 10.1021/bi8018527; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; Sprang SR, 2011, NATURE, V469, P172, DOI 10.1038/469172a; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Stiernagle Theresa, 2006, WormBook, P1; Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x; Vilaro MT, 2002, NEUROPHARMACOLOGY, V42, P60, DOI 10.1016/S0028-3908(01)00154-X; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Yabe T, 2005, DEVELOPMENT, V132, P3197, DOI 10.1242/dev.01909; Zhang SJ, 2011, J NEUROSCI METH, V197, P315, DOI 10.1016/j.jneumeth.2011.02.014	51	15	16	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					492	502		10.1096/fj.11-197780	http://dx.doi.org/10.1096/fj.11-197780			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22090314	Green Published			2022-12-25	WOS:000300485700003
J	Dodson, CA; Bayliss, R				Dodson, Charlotte A.; Bayliss, Richard			Activation of Aurora-A Kinase by Protein Partner Binding and Phosphorylation Are Independent and Synergistic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC SPINDLE; RESISTANT AURORA; STRUCTURAL BASIS; KINETIC BASIS; INHIBITORS; TPX2; MECHANISM; DISCOVERY; SUBSTRATE; MUTANTS	Protein kinases are activated by phosphorylation and by the binding of activator proteins. The interplay of these two factors is incompletely understood. We applied energetic analysis to this question and characterized the activation process of the serine/threonine kinase Aurora-A by phosphorylation and by its protein partner, targeting protein for Xenopus kinesin-like protein 2 (TPX2). We discovered that these two activators act synergistically and without a predefined order: each can individually increase the activity of Aurora-A, and the effect of both bound together is the exact sum of their individual contributions to catalysis. Unexpectedly, the unphosphorylated enzyme has catalytic activity that is increased 15-fold by the binding of TPX2 alone. The energetic contribution of phosphorylation to catalysis is 2-fold greater than that of TPX2 binding, which is independent of the phosphorylation state of the enzyme. Based on this analysis, we propose a revised, fluid model of Aurora-A activation in which the first step is a reduction in the mobility of the activation loop by either TPX2 binding or phosphorylation. Furthermore, our results suggest that unphosphorylated Aurora-A bound to the mitotic spindle by TPX2 is catalytically active and that the phosphorylation state of Aurora-A is an inaccurate surrogate for its activity. Extending this form of analysis will allow us to compare quantitatively the effects of the whole network of kinase-activating partners. Comparison with other kinases showed that kinetic characterization detects those kinases whose activation loops undergo a rearrangement upon phosphorylation and thus whose unphosphorylated state offers a distinct target for the development of Type II inhibitors.	[Dodson, Charlotte A.; Bayliss, Richard] Inst Canc Res, Div Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	richard.bayliss@le.ac.uk		Bayliss, Richard/0000-0003-0604-2773; Dodson, Charlotte/0000-0002-8403-726X	Royal Society; Cancer Research UK [C24461/A8032]; Institute of Cancer Research; National Health Service	Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); Institute of Cancer Research; National Health Service	This work was supported by a Royal Society University Research Fellowship (to R. B.) and Cancer Research UK Project Grant C24461/A8032 (to R. B.).; Mass spectrometry data acquisition and analysis were carried out by Angela Paul and Andrew Thompson at The Institute of Cancer Research Proteomics Core Facility. We thank Jessica Schmitt, Kathy Boxall, Wynne Aherne, Rosemary Burke, and Rob van Montfort in the Division of Cancer Therapeutics for practical advice and use of the Caliper EZ Reader system; Tim Sharpe (Department of Biochemistry, University of Cambridge) for helpful discussions; Mark Richards (The Institute of Cancer Research) for mutagenesis; and Clare Stace (The Institute of Cancer Research) for protein production. We acknowledge the Career Development Faculty Programme of The Institute of Cancer Research and National Health Service funding to the National Institute for Health Research Biomedical Research Centre.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fersht A. R., 1985, ENZYME STRUCTURE MEC, p[298, 303, 304, 350]; Hagopian JC, 2001, J BIOL CHEM, V276, P275, DOI 10.1074/jbc.M007337200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lew J, 2003, BIOCHEMISTRY-US, V42, P849, DOI 10.1021/bi0269761; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Saylor P, 1998, BIOCHEMISTRY-US, V37, P17875, DOI 10.1021/bi981775b; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stevenson LM, 2002, BIOCHEMISTRY-US, V41, P8528, DOI 10.1021/bi025812h; Toya M, 2011, NAT CELL BIOL, V13, P708, DOI 10.1038/ncb2242; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	26	72	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1150	1157		10.1074/jbc.M111.312090	http://dx.doi.org/10.1074/jbc.M111.312090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094468	Green Published, hybrid			2022-12-25	WOS:000299170300030
J	Mondejar, LG; Lupas, A; Schultz, A; Schultz, JE				Mondejar, Laura Garcia; Lupas, Andrei; Schultz, Anita; Schultz, Joachim E.			HAMP Domain-mediated Signal Transduction Probed with a Mycobacterial Adenylyl Cyclase as a Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SERINE CHEMORECEPTOR; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; LINKER REGION; HISTIDINE KINASE; PROTEINS; RECEPTOR; ENVZ; ASPARTATE; HELICES	HAMP domains, similar to 55 amino acid motifs first identified in histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatases, operate as signal mediators in two-component signal transduction proteins. A bioinformatics study identified a coevolving signal-accepting network of 10 amino acids in membrane-delimited HAMP proteins. To probe the functionality of this network we used a HAMP containing mycobacterial adenylyl cyclase, Rv3645, as a reporter enzyme in which the membrane anchor was substituted by the Escherichia coli chemotaxis receptor for serine (Tsr receptor) and the HAMP domain alternately with that from the protein Af1503 of the archaeon Archaeoglobus fulgidus or the Tsr receptor. In a construct with the Tsr-HAMP, cyclase activity was inhibited by serine, whereas in a construct with the HAMP domain from A. fulgidus, enzyme activity was not responsive to serine. Amino acids of the signal-accepting network were mutually swapped between both HAMP domains, and serine signaling was examined. The data biochemically tentatively established the functionality of the signal-accepting network. Based on a two-state gearbox model of rotation in HAMP domain-mediated signal propagation, we characterized the interaction between permanent and transient core residues in a coiled coil HAMP structure. The data are compatible with HAMP rotation in signal propagation but do not exclude alternative models for HAMP signaling. Finally, we present data indicating that the connector, which links the alpha-helices of HAMP domains, plays an important structural role in HAMP function.	[Mondejar, Laura Garcia; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Lupas, Andrei] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 766, TP B8]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 766, TP B8) and by institutional funds of the Max Planck Society.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Hammer A., 2004, THESIS EBERHARD KARL; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	26	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1022	1031		10.1074/jbc.M111.284067	http://dx.doi.org/10.1074/jbc.M111.284067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094466	Green Published, hybrid			2022-12-25	WOS:000299170300019
J	Tu, E; Ang, DKY; Hogan, TV; Read, S; Chia, CPZ; Gleeson, PA; van Driel, IR				Tu, Eric; Ang, Desmond K. Y.; Hogan, Thea V.; Read, Simon; Chia, Cheryl P. Z.; Gleeson, Paul A.; van Driel, Ian R.			A Convenient Model of Severe, High Incidence Autoimmune Gastritis Caused by Polyclonal Effector T Cells and without Perturbation of Regulatory T Cells	PLOS ONE			English	Article							ORGAN-SPECIFIC AUTOIMMUNITY; H,K-ATPASE ALPHA-SUBUNIT; ATPASE BETA-SUBUNIT; TCR TRANSGENIC MICE; H+,K+-ADENOSINE TRIPHOSPHATASE; PERNICIOUS-ANEMIA; NEONATAL THYMECTOMY; PARIETAL-CELLS; SELF-TOLERANCE; H+/K+-ATPASE	Autoimmune gastritis results from the breakdown of T cell tolerance to the gastric H(+)/K(+) ATPase. The gastric H(+)/K(+) ATPase is responsible for the acidification of gastric juice and consists of an alpha subunit (H/K alpha) and a beta subunit (H/K beta). Here we show that CD4(+) T cells from H/K alpha-deficient mice (H/K alpha(-/-)) are highly pathogenic and autoimmune gastritis can be induced in sublethally irradiated wildtype mice by adoptive transfer of unfractionated CD4(+) T cells from H/K alpha(-/-) mice. All recipient mice consistently developed the most severe form of autoimmune gastritis 8 weeks after the transfer, featuring hypertrophy of the gastric mucosa, complete depletion of the parietal and zymogenic cells, and presence of autoantibodies to H(+)/K(+) ATPase in the serum. Furthermore, we demonstrated that the disease significantly affected stomach weight and stomach pH of recipient mice. Depletion of parietal cells in this disease model required the presence of both H/K alpha and H/K beta since transfer of H/K alpha(-/-) CD4(+) T cells did not result in depletion of parietal cells in H/K alpha(-/-) or H/K beta(-/-) recipient mice. The consistency of disease severity, the use of polyclonal T cells and a specific T cell response to the gastric autoantigen make this an ideal disease model for the study of many aspects of organ-specific autoimmunity including prevention and treatment of the disease.	[Tu, Eric; Ang, Desmond K. Y.; Hogan, Thea V.; Read, Simon; Chia, Cheryl P. Z.; Gleeson, Paul A.; van Driel, Ian R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	University of Melbourne	Tu, E (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	ivd@unimelb.edu.au		van Driel, Ian/0000-0001-5371-120X; Gleeson, Paul/0000-0002-5336-6503; Hogan, Thea/0000-0002-3140-0192	National Health and Medical Research Council of Australia; University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	This work was supported by research grants from the National Health and Medical Research Council of Australia and the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderuccio F, 1997, AUTOIMMUNITY, V25, P167, DOI 10.3109/08916939709008023; Alderuccio F, 2000, INT IMMUNOL, V12, P343, DOI 10.1093/intimm/12.3.343; ALDERUCCIO F, 1993, J EXP MED, V178, P419, DOI 10.1084/jem.178.2.419; Allen S, 2005, J IMMUNOL, V175, P5759, DOI 10.4049/jimmunol.175.9.5759; Amedei A, 2003, J EXP MED, V198, P1147, DOI 10.1084/jem.20030530; Ang DKY, 2007, INT IMMUNOL, V19, P1135, DOI 10.1093/intimm/dxm087; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BARRETT SP, 1995, EUR J IMMUNOL, V25, P2686, DOI 10.1002/eji.1830250943; BARRETT SP, 1995, EUR J IMMUNOL, V25, P238, DOI 10.1002/eji.1830250139; Beggah AT, 1999, J BIOL CHEM, V274, P8217, DOI 10.1074/jbc.274.12.8217; Bergman MP, 2003, EUR J IMMUNOL, V33, P539, DOI 10.1002/immu.200310030; CALLAGHAN JM, 1993, AUTOIMMUNITY, V16, P289, DOI 10.3109/08916939309014648; Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917; Carmel R, 1996, ARCH INTERN MED, V156, P1097, DOI 10.1001/archinte.156.10.1097; D'Elios MM, 2001, GASTROENTEROLOGY, V120, P377, DOI 10.1053/gast.2001.21187; De Silva HD, 1999, IMMUNOLOGY, V96, P145; De Silva HD, 1998, IMMUNOLOGY, V93, P405; JONES CM, 1991, GASTROENTEROLOGY, V101, P287, DOI 10.1016/0016-5085(91)90002-3; Judd LM, 1999, AM J PHYSIOL-GASTR L, V277, pG209, DOI 10.1152/ajpgi.1999.277.1.G209; KARLSSON FA, 1988, J CLIN INVEST, V81, P475, DOI 10.1172/JCI113344; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laurie KL, 2002, J IMMUNOL, V169, P2361, DOI 10.4049/jimmunol.169.5.2361; Martinelli TM, 1996, GASTROENTEROLOGY, V110, P1791, DOI 10.1053/gast.1996.v110.pm8964405; McHugh RS, 2001, EUR J IMMUNOL, V31, P2094, DOI 10.1002/1521-4141(200107)31:7<2094::AID-IMMU2094>3.0.CO;2-S; Monteiro JP, 2008, J IMMUNOL, V181, P5895, DOI 10.4049/jimmunol.181.9.5895; Read S, 2007, GASTROENTEROLOGY, V133, P547, DOI 10.1053/j.gastro.2007.05.050; SAKAGUCHI S, 1994, J IMMUNOL, V152, P1471; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scarff KJ, 1997, IMMUNOLOGY, V92, P91, DOI 10.1046/j.1365-2567.1997.00302.x; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Silveira PA, 1999, J IMMUNOL, V162, P5106; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; SuriPayer E, 1996, J IMMUNOL, V157, P1799; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Zwar TA, 2006, J IMMUNOL, V176, P1609, DOI 10.4049/jimmunol.176.3.1609	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27153	10.1371/journal.pone.0027153	http://dx.doi.org/10.1371/journal.pone.0027153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096532	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800032
J	Fried, PJ; Elkin-Frankston, S; Rushmore, RJ; Hilgetag, CC; Valero-Cabre, A				Fried, Peter J.; Elkin-Frankston, Seth; Rushmore, Richard Jarrett; Hilgetag, Claus C.; Valero-Cabre, Antoni			Characterization of Visual Percepts Evoked by Noninvasive Stimulation of the Human Posterior Parietal Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CONCURRENT TMS-FMRI; CORTICAL EXCITABILITY; PHOSPHENE THRESHOLDS; SPATIAL ATTENTION; INTRAPARIETAL SULCUS; EXTRASTRIATE CORTEX; SUPERIOR COLLICULUS; LOW-FREQUENCY; MOTOR CORTEX	Phosphenes are commonly evoked by transcranial magnetic stimulation (TMS) to study the functional organization, connectivity, and excitability of the human visual brain. For years, phosphenes have been documented only from stimulating early visual areas (V1-V3) and a handful of specialized visual regions (V4, V5/MT+) in occipital cortex. Recently, phosphenes were reported after applying TMS to a region of posterior parietal cortex involved in the top-down modulation of visuo-spatial processing. In the present study, we systematically characterized parietal phosphenes to determine if they are generated directly by local mechanisms or emerge through indirect activation of other visual areas. Using technology developed in-house to record the subjective features of phosphenes, we found no systematic differences in the size, shape, location, or frame-of-reference of parietal phosphenes when compared to their occipital counterparts. In a second experiment, discrete deactivation by 1 Hz repetitive TMS yielded a double dissociation: phosphene thresholds increased at the deactivated site without producing a corresponding change at the non-deactivated location. Overall, the commonalities of parietal and occipital phosphenes, and our ability to independently modulate their excitability thresholds, lead us to conclude that they share a common neural basis that is separate from either of the stimulated regions.	[Fried, Peter J.; Elkin-Frankston, Seth; Rushmore, Richard Jarrett; Valero-Cabre, Antoni] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Hilgetag, Claus C.] Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, Hamburg, Germany; [Valero-Cabre, Antoni] Univ Paris 06, Inst Cerveau & Moelle, Paris, France	Boston University; University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Sorbonne Universite	Fried, PJ (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	rushmore@bu.edu; avalerocabre@gmail.com	Hilgetag, Claus C/L-7282-2013; Hilgetag, Claus C/AAH-1760-2020	Hilgetag, Claus C/0000-0003-2129-8910; Hilgetag, Claus C/0000-0003-2129-8910; Valero-Cabre, Antoni/0000-0002-5033-2279	Boston University, via the National Institutes of Health [MH020064-09]; Department of Anatomy and Neurobiology at Boston University School of Medicine; Spivak Foundation; National Institutes of Health [NSS062317]; FP6; ANR; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020064] Funding Source: NIH RePORTER	Boston University, via the National Institutes of Health; Department of Anatomy and Neurobiology at Boston University School of Medicine; Spivak Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP6(European Commission); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The contributions of PJF and SEF were funded through the Graduate Program in Neuroscience at Boston University, via the National Institutes of Health (MH020064-09) and the Department of Anatomy and Neurobiology at Boston University School of Medicine. The work of RJR and AVC was supported by the Spivak Foundation, the National Institutes of Health (NSS062317), and FP6& ANR project eraNET-NEURON BEYONDVIS (AV-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra J, 1998, ANN NEUROL, V44, P209, DOI 10.1002/ana.410440211; Antal A, 2006, CEPHALALGIA, V26, P865, DOI 10.1111/j.1468-2982.2006.01132.x; Aurora SK, 1998, NEUROLOGY, V50, P1111, DOI 10.1212/WNL.50.4.1111; BARKER AT, 1985, LANCET, V1, P1106; Bestmann S, 2007, CURR BIOL, V17, P134, DOI 10.1016/j.cub.2006.11.063; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Boulay C, 2005, EXP BRAIN RES, V167, P297, DOI 10.1007/s00221-005-0103-1; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2005, NEUROPSYCHOLOGIA, V43, P2041, DOI 10.1016/j.neuropsychologia.2005.03.020; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Elkin-Frankston S, 2011, J NEUROSCI METHODS; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Fierro B, 2003, NEUROLOGY, V61, P1446, DOI 10.1212/01.WNL.0000094823.74175.92; Fumal A, 2003, EXP BRAIN RES, V150, P332, DOI 10.1007/s00221-003-1423-7; Gerwig M, 2003, J NEUROL SCI, V215, P75, DOI 10.1016/S0022-510X(03)00228-4; Gothe J, 2002, BRAIN, V125, P479, DOI 10.1093/brain/awf045; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; HARTING JK, 1992, J COMP NEUROL, V324, P379, DOI 10.1002/cne.903240308; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 1999, NEUROPSYCHOLOGIA, V37, P191; Kammer T, 2005, EXP BRAIN RES, V160, P129, DOI 10.1007/s00221-004-1992-0; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; KIM D, 2007, NEUROL ASIA, V12, P84; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Mahaney KB, 2008, NEUROSURGERY, V63, P195, DOI 10.1227/01.NEU.0000313121.58694.4A; MARG E, 1991, OPTOMETRY VISION SCI, V68, P427, DOI 10.1097/00006324-199106000-00004; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; Marzi CA, 2009, EXP BRAIN RES, V192, P431, DOI 10.1007/s00221-008-1496-4; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Mullette-Gillman OA, 2008, CEREB CORTEX; Orban GA, 2006, NEUROPSYCHOLOGIA, V44, P2647, DOI 10.1016/j.neuropsychologia.2005.11.001; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Pascual-Leone A., 2002, HDB TRANSCRANIAL MAG; Pertzov Y, 2011, J NEUROSCI, V31, P1059, DOI 10.1523/JNEUROSCI.3721-10.2011; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; Rossi S, 2009, CLIN NEUROPHYSIOL; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Ruff CC, 2009, J COGNITIVE NEUROSCI, V21, P1146, DOI 10.1162/jocn.2009.21097; SANDERS MD, 1974, LANCET, V1, P707; Silvanto J, 2005, NAT NEUROSCI, V8, P143, DOI 10.1038/nn1379; Silvanto J, 2007, NEUROPSYCHOLOGIA, V45, P3346, DOI 10.1016/j.neuropsychologia.2007.06.008; Silvanto J, 2007, EUR J NEUROSCI, V25, P1874, DOI 10.1111/j.1460-9568.2007.05440.x; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Silvanto J, 2010, NEUROIMAGE, V50, P1683, DOI 10.1016/j.neuroimage.2010.01.021; Silvanto J, 2009, CEREB CORTEX, V19, P327, DOI 10.1093/cercor/bhn091; Stewart L, 1999, EEG CL N SU, P334; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Taylor PCJ, 2010, HUM BRAIN MAPP; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Vallar G, 1999, EXP BRAIN RES, V124, P281, DOI 10.1007/s002210050624; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	75	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27204	10.1371/journal.pone.0027204	http://dx.doi.org/10.1371/journal.pone.0027204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087266	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700018
J	Wang, RZ; Huang, WW; Chen, L; Ma, LN; Guo, CY; Liu, XQ				Wang, Renzhong; Huang, Wenwen; Chen, Liang; Ma, Linna; Guo, Chengyuan; Liu, Xiaoqiang			Anatomical and Physiological Plasticity in Leymus chinensis (Poaceae) along Large-Scale Longitudinal Gradient in Northeast China	PLOS ONE			English	Article							TRANSECT NECT; LEAF MORPHOLOGY; PROLINE ACCUMULATION; WATER-STRESS; DROUGHT; RESPONSES; CLIMATE; GROWTH; PLANTS; VARIABILITY	Background: Although it has been widely accepted that global changes will pose the most important constrains to plant survival and distribution, our knowledge of the adaptive mechanism for plant with large-scale environmental changes (e.g. drought and high temperature) remains limited. Methodology/Principal findings: An experiment was conducted to examine anatomical and physiological plasticity in Leymus chinensis along a large-scale geographical gradient from 115 degrees to 124 degrees E in northeast China. Ten sites selected for plant sampling at the gradient have approximately theoretical radiation, but differ in precipitation and elevation. The significantly increasing in leaf thickness, leaf mass per area, vessel and vascular diameters, and decreasing in stoma density and stoma index exhibited more obvious xerophil-liked traits for the species from the moist meadow grassland sites in contrast to that from the dry steppe and desert sites. Significant increase in proline and soluble sugar accumulation, K(+)/Na(+) for the species with the increasing of stresses along the gradient showed that osmotic adjustment was enhanced. Conclusion/Significance: Obvious xerophytic anatomical traits and stronger osmotic adjustment in stress conditions suggested that the plants have much more anatomical and physiological flexibilities than those in non-stress habitats along the large-scale gradient.	[Wang, Renzhong; Huang, Wenwen; Chen, Liang; Ma, Linna; Guo, Chengyuan; Liu, Xiaoqiang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Chen, Liang] Hubei Normal Univ, Coll Life Sci, Huangshi, Hubei, Peoples R China; [Liu, Xiaoqiang] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Hubei Normal University; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, RZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	wangrz@ibcas.ac.cn	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		National Scientific Foundation of China [31170304, 30970306, 31070228]; Chinese Academy of Sciences [KSCX2-EW-J-1]; State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN)	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN)	This work was supported by the National Scientific Foundation of China (31170304, 30970306, 31070228) and in part by Key Project of the Chinese Academy of Sciences (KSCX2-EW-J-1) and State Key Laboratory of Vegetation and Environmental Change, Institute of Botany (VEWALAN - project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Bandurska H, 2000, ACTA PHYSIOL PLANT, V22, P409, DOI 10.1007/s11738-000-0081-7; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; CALKIN HW, 1986, J EXP BOT, V37, P1054, DOI 10.1093/jxb/37.7.1054; CastroDiez P, 1997, TREES-STRUCT FUNCT, V11, P127, DOI 10.1007/s004680050068; Cellier F, 2000, J EXP BOT, V51, P299, DOI 10.1093/jexbot/51.343.299; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen L, 2009, AGR ECOSYST ENVIRON, V134, P46, DOI 10.1016/j.agee.2009.05.015; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; EBELL LF, 1965, PHYTOCHEMISTRY, V21, P227; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P301, DOI 10.1111/j.1365-3040.1992.tb00977.x; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Gullo MA, 1995, PLANT CELL ENVIRON, V18, P661; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Jackson RB, 2000, TRENDS PLANT SCI, V5, P482, DOI 10.1016/S1360-1385(00)01766-0; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; LI J.D., 1978, J NE NORMAL U, V1, P145; LU JM, 1994, J NORTHEST NORMAL U, V21, P79; Maroco JP, 2000, J ARID ENVIRON, V45, P119, DOI 10.1006/jare.2000.0638; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Paakkonen E, 1998, PLANT CELL ENVIRON, V21, P671, DOI 10.1046/j.1365-3040.1998.00303.x; Pena-Rojas K, 2005, FUNCT PLANT BIOL, V32, P117, DOI 10.1071/FP04137; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; Sobrado MA, 2007, NEW PHYTOL, V173, P584, DOI 10.1111/j.1469-8137.2006.01927.x; Villalba R, 1998, ECOLOGY, V79, P2624, DOI 10.1890/0012-9658(1998)079[2624:IOLSCV]2.0.CO;2; Wang RZ, 2008, J PLANT GROWTH REGUL, V27, P39, DOI 10.1007/s00344-007-9029-0; Wang RZ, 2004, DIVERS DISTRIB, V10, P65, DOI 10.1111/j.1472-4642.2004.00056.x; Wang RZ, 2003, J ARID ENVIRON, V54, P653, DOI 10.1006/jare.2002.1087; Wang RZ, 2003, GLOBAL ECOL BIOGEOGR, V12, P249, DOI 10.1046/j.1466-822X.2003.00027.x; Zhang Xin-Shi, 1997, Acta Botanica Sinica, V39, P785	35	32	42	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26209	10.1371/journal.pone.0026209	http://dx.doi.org/10.1371/journal.pone.0026209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087223	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700005
J	Lamb, TM; Goldsmith, CS; Bennett, L; Finch, KE; Bell-Pedersen, D				Lamb, Teresa M.; Goldsmith, Charles S.; Bennett, Lindsay; Finch, Katelyn E.; Bell-Pedersen, Deborah			Direct Transcriptional Control of a p38 MAPK Pathway by the Circadian Clock in Neurospora crassa	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OSMOTIC-STRESS; SACCHAROMYCES-CEREVISIAE; FUNGICIDE RESISTANCE; PHOTIC REGULATION; PHENYLPYRROLE FUNGICIDES; GLYCEROL ACCUMULATION; MOLECULAR-MECHANISM; TEMPORAL REGULATION; GENE-EXPRESSION	MAPK signal transduction pathways are important regulators of stress responses, cellular growth, and differentiation. In Neurospora, the circadian clock controls rhythms in phosphorylation of the p38-like MAPK (OS-2); however, the mechanism for this regulation is not known. We show that the WCC, a transcription factor and clock component, binds to the os-4 MAPKKK promoter in response to light and rhythmically in constant darkness, peaking in the subjective morning. Deletion of the WCC binding sites in the os-4 promoter disrupts both os-4 mRNA and OS-2 phosphorylation rhythms. The clock also indirectly regulates rhythmic expression of the histidyl-phosphotransferase gene, hpt-1, which peaks in the evening. Anti-phase expression of positive (OS-4) and negative (HPT-1) MAPK pathway regulators likely coordinate to enhance rhythmic MAPK activation to prepare cells to respond to osmotic stress during the day in the natural environment. Consistent with this idea, we show that wild type cells have a clock-dependent morning kinetic advantage in glycerol accumulation after salt stress as compared to evening treatment. Thus, circadian transcriptional control of MAPK pathway components leads to striking time-of-day-specific effects on the signaling status and physiological response of the pathway.	[Lamb, Teresa M.; Goldsmith, Charles S.; Bennett, Lindsay; Finch, Katelyn E.; Bell-Pedersen, Deborah] Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, Program Biol Filamentous Fungi,Interdisciplinary, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Lamb, TM (corresponding author), Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, Program Biol Filamentous Fungi,Interdisciplinary, College Stn, TX 77843 USA.	dpedersen@bio.tamu.edu	Bell-Pedersen, Deborah/H-8012-2016	Bell-Pedersen, Deborah/0000-0002-1639-8215	National Institute of Health [GM58529, NS39546]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health grants GM58529 and NS39546 to Dr. Bell-Pedersen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 1997, FEBS LETT, V403, P173, DOI 10.1016/S0014-5793(97)00048-3; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Banno S, 2007, CURR GENET, V51, P197, DOI 10.1007/s00294-006-0116-8; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Cha J, 2007, COLD SPRING HARB SYM, V72, P185, DOI 10.1101/sqb.2007.72.010; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Coogan AN, 2003, J NEUROSCI, V23, P3085; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Paula RM, 2008, CELL CYCLE, V7, P2630, DOI 10.4161/cc.7.17.6516; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap J., 2004, CHRONOBIOLOGY; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fujimura M, 2000, J PESTIC SCI, V25, P31; Fujimura M, 2003, BIOSCI BIOTECH BIOCH, V67, P186, DOI 10.1271/bbb.67.186; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2007, COLD SPRING HARB SYM, V72, P459, DOI 10.1101/sqb.2007.72.004; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hasegawa M, 2004, J BIOL CHEM, V279, P22738, DOI 10.1074/jbc.M401389200; Hayashi Y, 2003, J BIOL CHEM, V278, P25166, DOI 10.1074/jbc.M212726200; Hayashi Y, 2001, FEBS LETT, V491, P71, DOI 10.1016/S0014-5793(01)02153-6; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Irmler S, 2006, PESTIC BIOCHEM PHYS, V84, P25, DOI 10.1016/j.pestbp.2005.05.001; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Korotayev K, 2008, CELL SIGNAL, V20, P1221, DOI 10.1016/j.cellsig.2008.02.012; Kozma-Bognar L, 2008, CHEMBIOCHEM, V9, P2565, DOI 10.1002/cbic.200800385; Krantz M, 2006, CURR GENET, V49, P137, DOI 10.1007/s00294-005-0038-x; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Loros JJ, 2007, COLD SPRING HARB SYM, V72, P201, DOI 10.1101/sqb.2007.72.067; Loros JJ, 1998, CURR OPIN MICROBIOL, V1, P698, DOI 10.1016/S1369-5274(98)80118-5; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Nakaya M, 2003, BIOCHEM BIOPH RES CO, V305, P494, DOI 10.1016/S0006-291X(03)00791-5; Noguchi R, 2007, FUNGAL GENET BIOL, V44, P208, DOI 10.1016/j.fgb.2006.08.003; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Panda S, 2003, NOVART FDN SYMP, V253, P102; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Ripperger JA, 2000, GENE DEV, V14, P679; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P2856, DOI 10.1271/bbb.70410; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	73	30	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27149	10.1371/journal.pone.0027149	http://dx.doi.org/10.1371/journal.pone.0027149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087254	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700020
J	Kizil, C; Brand, M				Kizil, Caghan; Brand, Michael			Cerebroventricular Microinjection (CVMI) into Adult Zebrafish Brain Is an Efficient Misexpression Method for Forebrain Ventricular Cells	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; IN-VIVO; TRANSGENIC ZEBRAFISH; FIN REGENERATION; CAUDAL FIN; STEM-CELLS; NEUROGENESIS; PROLIFERATION; MORPHOLINOS	The teleost fish Danio rerio (zebrafish) has a remarkable ability to generate newborn neurons in its brain at adult stages of its lifespan-a process called adult neurogenesis. This ability relies on proliferating ventricular progenitors and is in striking contrast to mammalian brains that have rather restricted capacity for adult neurogenesis. Therefore, investigating the zebrafish brain can help not only to elucidate the molecular mechanisms of widespread adult neurogenesis in a vertebrate species, but also to design therapies in humans with what we learn from this teleost. Yet, understanding the cellular behavior and molecular programs underlying different biological processes in the adult zebrafish brain requires techniques that allow manipulation of gene function. As a complementary method to the currently used misexpression techniques in zebrafish, such as transgenic approaches or electroporation-based delivery of DNA, we devised a cerebroventricular microinjection (CVMI)-assisted knockdown protocol that relies on vivo morpholino oligonucleotides, which do not require electroporation for cellular uptake. This rapid method allows uniform and efficient knockdown of genes in the ventricular cells of the zebrafish brain, which contain the neurogenic progenitors. We also provide data on the use of CVMI for growth factor administration to the brain - in our case FGF8, which modulates the proliferation rate of the ventricular cells. In this paper, we describe the CVMI method and discuss its potential uses in zebrafish.	[Kizil, Caghan] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany; Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden	Kizil, C (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010; Kizil, Caghan/AFG-2073-2022; Kizil, Caghan/J-6923-2015	Brand, Michael/0000-0001-5711-6512; Kizil, Caghan/0000-0002-8164-9762; Kizil, Caghan/0000-0002-8164-9762	Deutsche Forschungsgemeinschaft [SFB-655]; European Union (ZF Health); Technical University of Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health)(European Commission); Technical University of Dresden	This work is supported by Deutsche Forschungsgemeinschaft SFB-655 (http://www.sfb655.de/START-EN/sonderforschungsbereich-655?set_language=en), The European Union (ZF Health) (http://zf-health.org), and Technical University of Dresden (www.tu-dresden.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Brand Michael, 2002, P7; Burket CT, 2008, TRANSGENIC RES, V17, P265, DOI 10.1007/s11248-007-9152-5; Carl M, 2002, DEVELOPMENT, V129, P4057; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Corey DR, 2001, GENOME BIOL, V2; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Golberg A, 2010, TECHNOL CANCER RES T, V9, P423, DOI 10.1177/153303461000900412; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Haugland R.P., 2002, HDB FLUORESCENT PROB; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2009, DEV BIOL, V325, P329, DOI 10.1016/j.ydbio.2008.09.032; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Li YF, 2008, BIOCONJUGATE CHEM, V19, P1464, DOI 10.1021/bc8001437; Mimoto MS, 2011, METHODS MOL BIOL, V770, P55, DOI 10.1007/978-1-61779-210-6_3; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; PAN YA, 2011, CSH PROTOCOLS; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Xiao DY, 2011, CELL BIOL INT, V35, P99, DOI 10.1042/CBI20100464; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	45	45	46	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27395	10.1371/journal.pone.0027395	http://dx.doi.org/10.1371/journal.pone.0027395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076157	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200071
J	Sanchez-Ruiz, Y; Valitutti, S; Dupre, L				Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic			Stepwise Maturation of Lytic Granules during Differentiation and Activation of Human CD8(+) T Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SECRETORY LYSOSOMES; PROTEIN; PERFORIN; CYTOTOXICITY; PURIFICATION; STIMULATION; BIOGENESIS; EXOCYTOSIS; ORGANELLES	During differentiation, cytotoxic T lymphocytes (CTL) acquire their killing potential through the biogenesis and maturation of lytic granules that are secreted upon target cell recognition. How lytic granule load in lytic molecules evolves during CTL differentiation and which subsets of lytic granules are secreted following activation remains to be investigated. We set up a flow cytometry approach to analyze single lytic granules isolated from primary human CTL according to their size and molecular content. During CTL in vitro differentiation, a relatively homogeneous population of lytic granules appeared through the progressive loading of Granzyme B, Perforin and Granzyme A within LAMP1(+) lysosomes. PMA/ionomycin-induced lytic granule exocytosis was preceded by a rapid association of the docking molecule Rab27a to approximately half of the lytic granules. Activated CTL were found to limit exocytosis by sparing lytic granules including some associated to Rab27a. Our study provides a quantification of key steps of lytic granule biogenesis and highlights the potential of flow cytometry to study organelle composition and dynamics.	[Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] CNRS, U5282, Toulouse, France; [Sanchez-Ruiz, Yovan; Valitutti, Salvatore; Dupre, Loic] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sanchez-Ruiz, Y (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	loic.dupre@inserm.fr	dupre, loic/L-8174-2014; Valitutti, Salvatore/M-2999-2014	dupre, loic/0000-0002-7278-6503; Valitutti, Salvatore/0000-0002-6432-4421	European Community [MEXT-CT-2005-025032]; "Ligue Contre le Cancer'' foundation; Comite regional Midi-Pyrenees	European Community(European Commission); "Ligue Contre le Cancer'' foundation; Comite regional Midi-Pyrenees	This work received financial support from the European Community (Marie Curie Excellence grant, contract MEXT-CT-2005-025032 to LD) and from the "Ligue Contre le Cancer'' foundation (grant from the "Comite regional Midi-Pyrenees'' to LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1990, J IMMUNOL, V144, P574; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CHATTOPADHYAY P, 2008, J LEUKOCYTE BIOL; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; Liu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012870; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MILLARD PJ, 1984, J IMMUNOL, V132, P3197; OLSEN I, 1990, EUR J IMMUNOL, V20, P2161, DOI 10.1002/eji.1830201003; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; WOLF ME, 1989, J NEUROSCI, V9, P106; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27057	10.1371/journal.pone.0027057	http://dx.doi.org/10.1371/journal.pone.0027057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073254	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200032
J	Mankoo, PK; Shen, RL; Schultz, N; Levine, DA; Sander, C				Mankoo, Parminder K.; Shen, Ronglai; Schultz, Nikolaus; Levine, Douglas A.; Sander, Chris			Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles	PLOS ONE			English	Article							PROPORTIONAL HAZARDS; VARIABLE SELECTION; CANCER; CHEMOTHERAPY; CELLS; DIFFERENTIATION; PROLIFERATION; RESISTANCE; REGRESSION; CARCINOMA	Background: Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas (TCGA) has provided rich molecular and genetic profiles from hundreds of primary surgical samples. These profiles confirm mutations of TP53 in similar to 100% of patients and an extraordinarily complex profile of DNA copy number changes with considerable patient-to-patient diversity. This raises the joint challenge of exploiting all new available datasets and reducing their confounding complexity for the purpose of predicting clinical outcomes and identifying disease relevant pathway alterations. We therefore set out to use multi-data type genomic profiles (mRNA, DNA methylation, DNA copy-number alteration and microRNA) available from TCGA to identify prognostic signatures for the prediction of progression-free survival (PFS) and overall survival (OS). Methodology/Principal Findings: We implemented a multivariate Cox Lasso model and median time-to-event prediction algorithm and applied it to two datasets integrated from the four genomic data types. We (1) selected features through cross-validation; (2) generated a prognostic index for patient risk stratification; and (3) directly predicted continuous clinical outcome measures, that is, the time to recurrence and survival time. We used Kaplan-Meier p-values, hazard ratios (HR), and concordance probability estimates (CPE) to assess prediction performance, comparing separate and integrated datasets. Data integration resulted in the best PFS signature (withheld data: p-value = 0.008; HR = 2.83; CPE = 0.72). Conclusions/Significance: We provide a prediction tool that inputs genomic profiles of primary surgical samples and generates patient-specific predictions for the time to recurrence and survival, along with outcome risk predictions. Using integrated genomic profiles resulted in information gain for prediction of outcomes. Pathway analysis provided potential insights into functional changes affecting disease progression. The prognostic signatures, if prospectively validated, may be useful for interpreting therapeutic outcomes for clinical trials that aim to improve the therapy for SeOvCa patients.	[Mankoo, Parminder K.; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Mankoo, PK (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	cancer-prognosis@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020	Levine, Douglas/0000-0003-1038-8232; Schultz, Nikolaus/0000-0002-0131-4904	National Institutes of Health [U24 CA143840]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health grant U24 CA143840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Causey MW, 2011, J SURG RES, V171, P615, DOI 10.1016/j.jss.2010.04.034; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Daemen A, 2009, GENOME MED, V1, DOI 10.1186/gm39; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; HELLER G, 1992, BIOMETRICS, V48, P101, DOI 10.2307/2532742; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; Noetzel E, 2008, Pathologe, V29 Suppl 2, P319, DOI 10.1007/s00292-008-1038-7; Ota T, 2007, REPROD SCI, V14, P605, DOI 10.1177/1933719107307781; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Peluso JJ, 2009, ENDOCRINOLOGY, V150, P4846, DOI 10.1210/en.2009-0730; Poroyo V, 2007, ATLAS GENET CYTOGENE, V11, P58; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Slovin SF, 2005, CLIN CANCER RES, V11, P8669, DOI 10.1158/1078-0432.CCR-05-1668; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Subramanian J, 2011, STAT MED, V30, P642, DOI 10.1002/sim.4106; Tai YT, 2009, BLOOD, V113, P4309, DOI 10.1182/blood-2008-10-183772; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P262, DOI 10.1016/j.bcp.2010.03.029; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Yu SYM, 2009, TUMOR BIOL, V30, P80, DOI 10.1159/000216843; Zangenberg M, 2009, EUR J HAEMATOL, V83, P439, DOI 10.1111/j.1600-0609.2009.01309.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	70	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e24709	10.1371/journal.pone.0024709	http://dx.doi.org/10.1371/journal.pone.0024709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073136	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000004
J	Buzzi, LI; Simonetta, SH; Parodi, AJ; Castro, OA				Buzzi, Lucila I.; Simonetta, Sergio H.; Parodi, Armando J.; Castro, Olga A.			The Two Caenorhabditis elegans UDP-Glucose: Glycoprotein Glucosyltransferase Homologues Have Distinct Biological Functions	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; CALRETICULIN; EXPRESSION; ENZYME; PURIFICATION; HOMOGENEITY; VIABILITY	The UDP-Glc: glycoprotein glucosyltransferase (UGGT) is the sensor of glycoprotein conformations in the glycoprotein folding quality control as it exclusively glucosylates glycoproteins not displaying their native conformations. Monoglucosylated glycoproteins thus formed may interact with the lectin-chaperones calnexin (CNX) and calreticulin (CRT). This interaction prevents premature exit of folding intermediates to the Golgi and enhances folding efficiency. Bioinformatic analysis showed that in C. elegans there are two open reading frames (F48E3.3 and F26H9.8 to be referred as uggt-1 and uggt-2, respectively) coding for UGGT homologues. Expression of both genes in Schizosaccharomyces pombe mutants devoid of UGGT activity showed that uggt-1 codes for an active UGGT protein (CeUGGT-1). On the other hand, uggt-2 coded for a protein (CeUGGT-2) apparently not displaying a canonical UGGT activity. This protein was essential for viability, although cnx/crt null worms were viable. We constructed transgenic worms carrying the uggt-1 promoter linked to the green fluorescent protein (GFP) coding sequence and found that CeUGGT-1 is expressed in cells of the nervous system. uggt-1 is upregulated under ER stress through the ire-1 arm of the unfolded protein response (UPR). Real-time PCR analysis showed that both uggt-1 and uggt-2 genes are expressed during the entire C. elegans life cycle. RNAi-mediated depletion of CeUGGT-1 but not of CeUGGT-2 resulted in a reduced lifespan and that of CeUGGT-1 and CeUGGT-2 in a developmental delay. We found that both CeUGGT1 and CeUGGT2 play a protective role under ER stress conditions, since 10 mu g/ml tunicamycin arrested development at the L2/L3 stage of both uggt-1(RNAi) and uggt-2(RNAi) but not of control worms. Furthermore, we found that the role of CeUGGT-2 but not CeUGGT-1 is significant in relieving low ER stress levels in the absence of the ire-1 unfolding protein response signaling pathway. Our results indicate that both C. elegans UGGT homologues have distinct biological functions.	[Buzzi, Lucila I.; Parodi, Armando J.; Castro, Olga A.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Simonetta, Sergio H.] Fdn Inst Leloir, Lab Genet & Mol Physiol, Buenos Aires, DF, Argentina; [Parodi, Armando J.; Castro, Olga A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Castro, Olga A.] Univ Buenos Aires, Sch Sci, Buenos Aires, DF, Argentina	Leloir Institute; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Buzzi, LI (corresponding author), Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina.	ocastro@leloir.org.ar			National Institutes of Health [GM-44500];  [PICT 2008-700];  [PIP 20080100567]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	Grants: PICT 2008-700 www.agencia.gov.ar and PIP 20080100567 www.conicet.gov.ar (both to Olga Castro). Howard Hughes Medical Institute, and National Institutes of Health grant GM-44500 to Armando Parodi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Guerin M, 2003, J BIOL CHEM, V278, P20540, DOI 10.1074/jbc.M300891200; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Lee D, 2007, J MOL BIOL, V372, P331, DOI 10.1016/j.jmb.2007.06.071; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Mello C, 1995, METHOD CELL BIOL, V48, P451; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Samuelson AV, 2007, COLD SPRING HARB SYM, V72, P489, DOI 10.1101/sqb.2007.72.068; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; WRIGHT A, 1965, BIOCHIM BIOPHYS ACTA, V104, P594, DOI 10.1016/0304-4165(65)90366-1; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122	34	20	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27025	10.1371/journal.pone.0027025	http://dx.doi.org/10.1371/journal.pone.0027025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073243	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900065
J	Hellman, M; Tossavainen, H; Rappu, P; Heino, J; Permi, P				Hellman, Maarit; Tossavainen, Helena; Rappu, Pekka; Heino, Jyrki; Permi, Perttu			Characterization of Intrinsically Disordered Prostate Associated Gene (PAGE5) at Single Residue Resolution by NMR Spectroscopy	PLOS ONE			English	Article							T-CELL RESPONSES; BACKBONE ASSIGNMENT; DNA-BINDING; WEB SERVER; PROTEINS; SEQUENCE; MELANOMA; N-15; PREDICTION; TESTIS	Background: The Cancer-Testis antigens (CTA) are proteins expressed in human germ line and certain cancer cells. CTAs form a large gene family, representing 10% of X-chromosomal genes. They have high potential for cancer-specific immunotherapy. However, their biological functions are currently unknown. Prostate associated genes (PAGE) are characterized as CTAs. PAGE5 is one of six proteins belonging to this protein family, also called CT16. Methodology/Principal findings: In this study we show, using bioinformatics, chromatographic and solution state NMR spectroscopic methods, that PAGE5 is an intrinsically disordered protein (IDP). Conclusion/Significance: The study stands out as the first time structural characterization of the PAGE family protein and introduces how solution state NMR spectroscopy can be effectively utilized for identification of molecular recognition regions (MoRF) in IDPs, known often as transiently populated secondary structures.	[Hellman, Maarit; Tossavainen, Helena; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland; [Rappu, Pekka; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Helsinki; University of Turku	Hellman, M (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland.	Perttu.Permi@helsinki.fi		Rappu, Pekka/0000-0002-5068-2842	Academy of Finland [122170, 133144, 127168]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland grants 122170 and 133144 to PP and 127168 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Atkinson RA, 1999, J BIOMOL NMR, V13, P83, DOI 10.1023/A:1008323420405; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Brinkmann U, 1998, P NATL ACAD SCI USA, V95, P10757, DOI 10.1073/pnas.95.18.10757; Chen ME, 1998, J BIOL CHEM, V273, P17618, DOI 10.1074/jbc.273.28.17618; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Goddard T.D., 2002, SPARKY 3; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; Hazy E, 2009, CHEMPHYSCHEM, V10, P1415, DOI 10.1002/cphc.200900205; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mantylahti S, 2011, J BIOMOL NMR, V49, P99, DOI 10.1007/s10858-011-9470-z; Mantylahti S, 2010, J BIOMOL NMR, V47, P171, DOI 10.1007/s10858-010-9421-0; Mantylahti S, 2009, J BIOMOL NMR, V45, P301, DOI 10.1007/s10858-009-9373-4; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Puttonen E, 2006, MAGN RESON CHEM, V44, P168; Rappu P, 2011, INT J CANCER, V128, P2382, DOI 10.1002/ijc.25571; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tossavainen H, 2004, J MAGN RESON, V170, P244, DOI 10.1016/j.jmr.2004.06.018; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vansteenkiste JF, 2008, P AM SOC CLIN ON S15, V26, P7501; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wirmer J, 2002, J BIOMOL NMR, V23, P47, DOI 10.1023/A:1015384805098; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zbilut JP, 2004, J PROTEOME RES, V3, P1243, DOI 10.1021/pr049883+; Zendman AJW, 2002, INT J CANCER, V99, P361, DOI 10.1002/ijc.10371; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	52	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26633	10.1371/journal.pone.0026633	http://dx.doi.org/10.1371/journal.pone.0026633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073178	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900029
J	Xiao, JH; Jia, JG; Murphy, RW; Huang, DW				Xiao, Jin-Hua; Jia, Jing-Guo; Murphy, Robert W.; Huang, Da-Wei			Rapid Evolution of the Mitochondrial Genome in Chalcidoid Wasps (Hymenoptera: Chalcidoidea) Driven by Parasitic Lifestyles	PLOS ONE			English	Article							TRANSFER-RNA GENES; MOLECULAR EVOLUTION; REARRANGEMENTS; SEQUENCE; FIG; DNA; PHYLOGENY; PROGRAM; INSECTA; DIPTERA	Among the Chalcidoids, hymenopteran parasitic wasps that have diversified lifestyles, a partial mitochondrial genome has been reported only from Nasonia. This genome had many unusual features, especially a dramatic reorganization and a high rate of evolution. Comparisons based on more mitochondrial genomic data from the same superfamily were required to reveal weather these unusual features are peculiar to Nasonia or not. In the present study, we sequenced the nearly complete mitochondrial genomes from the species Philotrypesis. pilosa and Philotrypesis sp., both of which were associated with Ficus hispida. The acquired data included all of the protein-coding genes, rRNAs, and most of the tRNAs, and in P. pilosa the control region. High levels of nucleotide divergence separated the two species. A comparison of all available hymenopteran mitochondrial genomes (including a submitted partial genome from Ceratosolen solmsi) revealed that the Chalcidoids had dramatic mitochondrial gene rearrangments, involved not only the tRNAs, but also several protein-coding genes. The AT-rich control region was translocated and inverted in Philotrypesis. The mitochondrial genomes also exhibited rapid rates of evolution involving elevated nonsynonymous mutations.	[Xiao, Jin-Hua; Jia, Jing-Guo; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Jia, Jing-Guo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Da-Wei] Hebei Univ, Coll Life Sci, Baoding, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hebei University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum	Xiao, JH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw619@gmail.com		Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [31090253, 30900137]; Chinese Academy of Sciences [KSCX2-EW-Z-2, KSCX2-YW-Z-0908]; Ministry of Science and Technology of the Republic of China [2006FY110500]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Sciences and Engineering Research Council [A3148]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); National Science Fund for Fostering Talents in Basic Research; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by National Natural Science Foundation of China (NSFC grant no. 31090253, 30900137), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-2, KSCX2-YW-Z-0908), by Program of Ministry of Science and Technology of the Republic of China (2006FY110500), by National Science Fund for Fostering Talents in Basic Research (Special subjects in animal taxonomy, NSFC-J0930004), and by a grant (No. O529YX5105) from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences. Manuscript preparation was supported by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences and by the National Sciences and Engineering Research Council (Discovery Grant A3148) to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; CROZIER RH, 1993, GENETICS, V133, P97; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jiang ZF, 2006, J EVOLUTION BIOL, V19, P1157, DOI 10.1111/j.1420-9101.2006.01087.x; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Xu W, 2006, J MOL EVOL, V63, P375, DOI 10.1007/s00239-005-0246-5; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	30	41	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26645	10.1371/journal.pone.0026645	http://dx.doi.org/10.1371/journal.pone.0026645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073180	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900030
J	Bailey, AR; Hou, HY; Obregon, DF; Tian, J; Zhu, YY; Zou, Q; Nikolic, WV; Bengtson, M; Mori, T; Murphy, T; Tan, J				Bailey, Antoinette R.; Hou, Huayan; Obregon, Demian F.; Tian, Jun; Zhu, Yuyan; Zou, Qiang; Nikolic, William V.; Bengtson, Michael; Mori, Takashi; Murphy, Tanya; Tan, Jun			Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-alpha : implications for autism	FASEB JOURNAL			English	Article						T cells; sAPP-alpha; transgenic mice	NERVE GROWTH-FACTOR; NEGATIVE SELECTION; CELL DEVELOPMENT; SPECTRUM DISORDERS; SECRETED FORMS; ACTIVE DOMAIN; RETT-SYNDROME; CHILDREN; RECEPTOR; DISEASE	Abnormalities in T-lymphocyte populations and function are observed in autism. Soluble amyloid precursor protein alpha (sAPP-alpha) is elevated in some patients with autism and is known to be produced by immune cells. In light of the well-established role of sAPP-alpha in proliferation, growth, and survival of neurons, we hypothesized an analogous role in the immune system. Thus, we explored whether sAPP-alpha could modulate immune development and function, especially aspects of the pinnacle cell of the adaptive arm of the immune system: the T cell. To do this, we generated mice overexpressing human sAPP-alpha and characterized elements of T-cell development, signal transduction, cytokine production, and innate/adaptive immune functions. Here, we report that transgenic sAPP-alpha-overexpressing (TgsAPP-alpha) mice displayed increased proportions of CD8(+) T cells, while effector memory T cells were decreased in the thymus. Overall apoptotic signal transduction was decreased in the thymus, an effect that correlated with dramatic elevations in Notch1 activation; while active-caspase-3/total-caspase-3 and Bax/Bcl-2 ratios were decreased. Greater levels of IFN-gamma, IL-2, and IL-4 were observed after ex vivo challenge of TgsAPP-alpha mouse splenocytes with T-cell mitogen. Finally, after immunization, splenocytes from TgsAPP-alpha mice displayed decreased levels IFN-gamma, IL-2, and IL-4, as well as suppressed ZAP70 activation, after recall antigen stimulation. Given elevated levels of circulating sAPP-alpha in some patients with autism, sAPP-alpha could potentially drive aspects of immune dysfunction observed in these patients, including dysregulated T-cell apoptosis, aberrant PI3K/AKT signaling, cytokine alterations, and impaired T-cell recall stimulation.-Bailey, A. R., Hou, H., Obregon, D. F., Tian, J., Zhu, Y., Zou, Q., Nikolic, W. V., Bengtson, M., Mori, T., Murphy, T., Tan, J. Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-alpha : implications for autism. FASEB J. 26, 1040-1051 (2012). www.fasebj.org	[Bailey, Antoinette R.; Hou, Huayan; Obregon, Demian F.; Tian, Jun; Zhu, Yuyan; Zou, Qiang; Bengtson, Michael; Tan, Jun] Univ S Florida, Coll Med, All Childrens Hosp, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr,Dep, Tampa, FL 33613 USA; [Murphy, Tanya] Univ S Florida, Coll Med, All Childrens Hosp, Rothman Ctr Neuropsychiat,Dept Pediat, Tampa, FL 33613 USA; [Nikolic, William V.] Univ Kragujevac, Fac Med, Dept Genet, Kragujevac, Serbia; [Mori, Takashi] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Univ, Kawagoe, Saitama, Japan	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Kragujevac; Saitama Medical University; Saitama Medical University; Saitama Medical University	Tan, J (corresponding author), Univ S Florida, Coll Med, Dept Psychiat & Neurosci, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, 3515 E Fletcher Ave, Tampa, FL 33613 USA.	jtan@hsc.usf.edu	Tan, Jun/I-5339-2012; Murphy, Tanya K/J-7079-2013; Nikolic, William/H-4672-2013	Nikolic, William/0000-0002-7670-6910	Silver Foundation; U.S. National Institutes of Health/National Institute of Mental Health [R21MH087849]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032432] Funding Source: NIH RePORTER	Silver Foundation; U.S. National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Silver Foundation and the U.S. National Institutes of Health/National Institute of Mental Health (R21MH087849, J.T.). J.T. holds the Sliver Chair in Developmental Neurobiology. T. M. holds the Rothman Chair for Neuropsychiatry. The authors particularly thank Steven Barger (University of Arkansas, Little Rock, AR, USA) for providing the sAPP-alpha DNA construct and Danielle T. Sutton for her helpful advice and discussion. The authors also thank Frank Fernandez for his support.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Ashwood P, 2004, AUTOIMMUN REV, V3, P557, DOI 10.1016/j.autrev.2004.07.036; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bullido MJ, 1996, BBA-MOL CELL RES, V1313, P54, DOI 10.1016/0167-4889(96)00015-8; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Denney DR, 1996, J AUTISM DEV DISORD, V26, P87, DOI 10.1007/BF02276236; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fiumara A, 1999, PEDIATR NEUROL, V21, P619, DOI 10.1016/S0887-8994(99)00053-3; FUKUYAMA R, 1994, MOL CHEM NEUROPATHOL, V23, P93, DOI 10.1007/BF02815403; Goines P, 2010, CURR OPIN NEUROL, V23, P111, DOI 10.1097/WCO.0b013e3283373514; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Gupta S, 1996, J AUTISM DEV DISORD, V26, P439, DOI 10.1007/BF02172828; Gupta S, 1998, J NEUROIMMUNOL, V85, P106, DOI 10.1016/S0165-5728(98)00021-6; Gupta S, 2010, J CLIN IMMUNOL, V30, pS90, DOI 10.1007/s10875-010-9402-9; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hong R, 2001, Chest Surg Clin N Am, V11, P295; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Luo JJ, 2001, J NEUROSCI RES, V63, P410, DOI 10.1002/1097-4547(20010301)63:5<410::AID-JNR1036>3.3.CO;2-2; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MONNING U, 1990, FEBS LETT, V277, P261, DOI 10.1016/0014-5793(90)80861-C; MONNING U, 1992, J BIOL CHEM, V267, P23950; Mostafa G. A., 1925, J CHILD NEUROL, V25, P328; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213; PLIOPLYS AV, 1994, NEUROPSYCHOBIOLOGY, V29, P12, DOI 10.1159/000119056; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; ROCH JM, 1993, ANN NY ACAD SCI, V695, P149, DOI 10.1111/j.1749-6632.1993.tb23044.x; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stern L, 2005, ANN ALLERG ASTHMA IM, V95, P558, DOI 10.1016/S1081-1206(10)61019-8; STUBBS EG, 1977, J AUTISM CHILD SCHIZ, V7, P49, DOI 10.1007/BF01531114; Suh YH, 1997, ARCH GERONTOL GERIAT, V24, P1, DOI 10.1016/S0167-4943(96)00721-2; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WARREN RP, 1990, IMMUNOL INVEST, V19, P245, DOI 10.3109/08820139009041839; WARREN RP, 1986, J AUTISM DEV DISORD, V16, P189, DOI 10.1007/BF01531729; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; YONK LJ, 1990, IMMUNOL LETT, V25, P341, DOI 10.1016/0165-2478(90)90205-5; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	57	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1040	1051		10.1096/fj.11-195438	http://dx.doi.org/10.1096/fj.11-195438			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22085641	Green Published			2022-12-25	WOS:000300949300009
J	Wang, HL; Cheng, XL; Sine, SM				Wang, Hai-Long; Cheng, Xiaolin; Sine, Steven M.			Intramembrane Proton Binding Site Linked to Activation of Bacterial Pentameric Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ALLOSTERIC TRANSMEMBRANE SITE; X-RAY-STRUCTURE; SINGLE-CHANNEL; LOOP; CYANOBACTERIA; POTENTIATION; SIMULATION; DOMAIN; CELLS	Prokaryotic orthologs of eukaryotic Cys-loop receptor channels recently emerged as structural and mechanistic surrogates to investigate this superfamily of intercellular signaling proteins. Here, we examine proton activation of the prokaryotic ortholog GLIC using patch clamp electrophysiology, mutagenesis, and molecular dynamics (MD) simulations. Whole-cell current recordings from human embryonic kidney (HEK) 293 cells expressing GLIC show half-maximal activation at pH 6, close to the pK(a) of histidine, implicating the three native His residues in proton sensing linked to activation. The mutation H235F abolishes proton activation, H277Y is without effect, and all nine mutations of His-127 prevent expression on the cell surface. In the GLIC crystal structure, His-235 on transmembrane (TM) alpha-helix 2, hydrogen bonds to the main chain carbonyl oxygen of Ile-259 on TM alpha-helix 3. MD simulations show that when His-235 is protonated, the hydrogen bond persists, and the channel remains in the open conformation, whereas when His-235 is deprotonated, the hydrogen bond dissociates, and the channel closes. Mutations of the proximal Tyr-263, which also links TM alpha-helices 2 and 3 via a hydrogen bond, alter proton sensitivity over a 1.5 pH unit range. MD simulations show that mutations of Tyr-263 alter the hydrogen bonding capacity of His-235. The overall findings show that His-235 in the TM region of GLIC is a novel proton binding site linked to channel activation.	[Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Cheng, Xiaolin] Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA; [Cheng, Xiaolin] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	Mayo Clinic; Mayo Clinic; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	sine@mayo.edu		Cheng, Xiaolin/0000-0002-7396-3225	National Institutes of Health [NS31744]; U.S. Department of Energy [FWP ERKJE84]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS31744 (to S.M.S.) and the Advanced Computing Program, U.S. Department of Energy Grant FWP ERKJE84 (to X.C.). This work also used resources of the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the U.S. Department of Energy.	BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; LEE NG, 1991, ONCOGENE, V6, P1161; Ma ZY, 2008, BIOCHEM BIOPH RES CO, V371, P437, DOI 10.1016/j.bbrc.2008.04.090; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; van der Straaten TA, 2005, MOL SIMULAT, V31, P151, DOI 10.1080/08927020412331308700; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	31	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6482	6489		10.1074/jbc.M111.305839	http://dx.doi.org/10.1074/jbc.M111.305839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22084238	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000300791800037
J	Ballester, LY; Capo-Velez, CM; Garcia-Beltran, WF; Ramos, FM; Vazquez-Rosa, E; Rios, R; Mercado, JR; Melendez, RI; Lasalde-Dominicci, JA				Ballester, Leomar Y.; Capo-Velez, Coral M.; Garcia-Beltran, Wilfredo F.; Ramos, Felix M.; Vazquez-Rosa, Edwin; Rios, Raymond; Mercado, Jose R.; Melendez, Roberto I.; Lasalde-Dominicci, Jose A.			Up-regulation of the Neuronal Nicotinic Receptor alpha 7 by HIV Glycoprotein 120 POTENTIAL IMPLICATIONS FOR HIV-ASSOCIATED NEUROCOGNITIVE DISORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN NEUROBLASTOMA-CELLS; SUB-SAHARAN AFRICA; COAT PROTEIN GP120; ACETYLCHOLINE-RECEPTOR; RISK-FACTORS; HIPPOCAMPAL-NEURONS; CHEMOKINE RECEPTORS; PRIMARY MACROPHAGES	Approximately 30-50% of the >30 million HIV-infected subjects develop neurological complications ranging from mild symptoms to dementia. HIV does not infect neurons, and the molecular mechanisms behind HIV-associated neurocognitive decline are not understood. There are several hypotheses to explain the development of dementia in HIV+ individuals, including neuroinflammation mediated by infected microglia and neuronal toxicity by HIV proteins. A key protein associated with the neurological complications of HIV, gp120, forms part of the viral envelope and can be found in the CSF of infected individuals. HIV-1-gp120 interacts with several receptors including CD4, CCR5, CXCR4, and nicotinic acetylcholine receptors (nAChRs). However, the role of nAChRs in HIV-associated neurocognitive disorder has not been investigated. We studied the effects of gp120(IIIB) on the expression and function of the nicotinic receptor alpha 7 (alpha 7-nAChR). Our results show that gp120, through activation of the CXCR4 chemokine receptor, induces a functional up-regulation of alpha 7-nAChRs. Because alpha 7-nAChRs have a high permeability to Ca2+, we performed TUNEL staining to investigate the effects of receptor up-regulation on cell viability. Our data revealed an increase in cell death, which was blocked by the selective antagonist alpha-bungarotoxin. The in vitro data are supported by RT-PCR and Western blot analysis, confirming a remarkable up-regulation of the alpha 7-nAChR in gp120-transgenic mice brains. Specifically, alpha 7-nAChR up-regulation is observed in mouse striatum, a region severely affected in HIV+ patients. In summary, CXCR4 activation induces up-regulation of alpha 7-nAChR, causing cell death, suggesting that alpha 7-nAChR is a previously unrecognized contributor to the neurotoxicity associated with HIV infection.	[Rios, Raymond; Mercado, Jose R.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Melendez, Roberto I.] Univ Puerto Rico, Dept Anat & Neurobiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico	Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, Rio Piedras, PR 00931 USA.	jlasalde@gmail.com		Melendez, Roberto/0000-0001-5262-9757	National Institutes of Health [SNRP-U54N54301]; Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health [2R25GM061151]; Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, T34GM007821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health; Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant SNRP-U54N54301.; Supported by Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health Program Grant 2R25GM061151.; Supported by the Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health program.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; BUZY J, 1992, BRAIN RES, V598, P10, DOI 10.1016/0006-8993(92)90161-2; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; Criado M, 1997, J NEUROSCI, V17, P6554; D'Hooge R, 1999, EUR J NEUROSCI, V11, P4398, DOI 10.1046/j.1460-9568.1999.00857.x; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403; Liu QH, 2000, P NATL ACAD SCI USA, V97, P4832, DOI 10.1073/pnas.090521697; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Misse D, 1999, BLOOD, V93, P2454, DOI 10.1182/blood.V93.8.2454.408k35_2454_2462; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Nieves DMT, 2007, J NEUROVIROL, V13, P315, DOI 10.1080/13550280701361508; Njamnshi AK, 2009, J NEUROL SCI, V285, P149, DOI 10.1016/j.jns.2009.06.043; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; SEGUELA P, 1993, J NEUROSCI, V13, P596; Stalmeijer EHB, 2004, J VIROL, V78, P2722, DOI 10.1128/JVI.78.6.2722-2728.2004; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Tyagi E, 2010, INNATE IMMUN-LONDON, V16, P3, DOI 10.1177/1753425909104680; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	52	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3079	3086		10.1074/jbc.M111.262543	http://dx.doi.org/10.1074/jbc.M111.262543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22084248	hybrid, Green Published			2022-12-25	WOS:000300295100014
J	Michaki, V; Guix, FX; Vennekens, K; Munck, S; Dingwall, C; Davis, JB; Townsend, DM; Tew, KD; Feiguin, F; De Strooper, B; Dotti, CG; Wahle, T				Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; Dingwall, Colin; Davis, John B.; Townsend, Danyelle M.; Tew, Kenneth D.; Feiguin, Fabian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina			Down-regulation of the ATP-binding Cassette Transporter 2 (Abca2) Reduces Amyloid-beta Production by Altering Nicastrin Maturation and Intracellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; LDL-DERIVED CHOLESTEROL; NIEMANN-PICK DISEASE; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; LIPID RAFTS; HIPPOCAMPAL-NEURONS; GLYCOSYLATED NICASTRIN; DEPENDENT CLEAVAGE; NERVOUS-SYSTEM	Clinical, pharmacological, biochemical, and genetic evidence support the notion that alteration of cholesterol homeostasis strongly predisposes to Alzheimer disease (AD). The ATP-binding cassette transporter-2 (Abca2), which plays a role in intracellular sterol trafficking, has been genetically linked to AD. It is unclear how these two processes are related. Here we demonstrate that down-regulation of Abca2 in mammalian cells leads to decreased amyloid-beta (A beta) generation. In vitro studies revealed altered gamma-secretase complex formation in Abca2 knock-out cells due to the altered levels, post-translational modification, and subcellular localization of Nicastrin. Reduced Abca2 levels in mammalian cells in vitro, in Drosophila melanogaster and in mice resulted in altered gamma-secretase processing of APP, and thus A beta generation, without affecting Notch cleavage.	[Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina] Katholieke Univ Leuven, LIND, B-3000 Louvain, Belgium; [Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.] Vlaams Inst Biotechnol, VIB11, B-3000 Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Dingwall, Colin] Kings Coll London, Div Pharmaceut Sci, London SE1 9NH, England; [Davis, John B.] GlaxoSmithKline Res & Dev Ltd, Neurosci Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England; [Townsend, Danyelle M.; Tew, Kenneth D.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Feiguin, Fabian] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of London; King's College London; GlaxoSmithKline; Medical University of South Carolina; International Center for Genetic Engineering & Biotechnology (ICGEB)	Dotti, CG (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium.	carlos.dotti@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; Feiguin, Fabian/ABC-2514-2020; Guix, Francesc/AAA-7462-2020; De Strooper, Bart/F-6507-2012; Dotti, Carlos G/I-5533-2015	De Strooper, Bart/0000-0001-5455-5819; Dotti, Carlos G/0000-0003-4052-1719; Guix Rafols, Francesc Xavier/0000-0001-5781-3799; Munck, Sebastian/0000-0002-5182-5358	Fund for Scientific Research Flanders (FWO); Federal Office for Scientific Affairs [IUAP P6/43/]; Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA); Flemish Government; Spanish Government [CSD2010-00064, SAF2010-14906]; Spanish Grant Beatriu de Pinos (AGAUR); European Molecular Biology Organization; Deutsche Forschungsgemeinschaft	Fund for Scientific Research Flanders (FWO)(FWO); Federal Office for Scientific Affairs; Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA); Flemish Government(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Grant Beatriu de Pinos (AGAUR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Fund for Scientific Research Flanders (FWO), Federal Office for Scientific Affairs (IUAP P6/43/), Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA), the Flemish Government (Methusalem grant), and Spanish Government Grants Ministerio de Ciencia e Innovacion Ingenio-Consolider CSD2010-00064 and Ministerio de Ciencia e Innovacion SAF2010-14906 (to C. G. D.).; Supported by the Spanish Grant Beatriu de Pinos (AGAUR).; Supported by European Molecular Biology Organization and Deutsche Forschungsgemeinschaft long-term fellowships. To whom correspondence may be addressed: Laboratory of Neuronal Differentiation, Center for Human Genetics and Leuven Institute for Neurodegenerative diseases (LIND), KU Leuven and Vlaams institute voor Biotechnologie, VIB11, Herestraat 49-bus 602, 3000 Leuven, Belgium. Tel.: 32-0-16-3-30525; Fax: 32-0-16-3-30939; E-mail: tina.wahle@med.kuleuven.be.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arawaka S, 2002, J NEUROCHEM, V83, P1065, DOI 10.1046/j.1471-4159.2002.01207.x; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Broccardo C, 2006, J NEUROCHEM, V97, P345, DOI 10.1111/j.1471-4159.2006.03714.x; Burns M, 2003, J NEUROSCI, V23, P5645; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chen ZJJ, 2004, FASEB J, V18, P1129, DOI 10.1096/fj.03-1490fje; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Davis W, 2004, BBA-MOL CELL BIOL L, V1683, P89, DOI 10.1016/j.bbalip.2004.04.009; Davis W, 2010, CURR ALZHEIMER RES, V7, P566, DOI 10.2174/156720510793499002; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dean M, 2001, J LIPID RES, V42, P1007; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; HIGGINS JJ, 1992, NEUROLOGY, V42, P2286, DOI 10.1212/WNL.42.12.2286; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mace S, 2005, NEUROBIOL DIS, V18, P119, DOI 10.1016/j.nbd.2004.09.011; Mack JT, 2008, EXPERT OPIN THER TAR, V12, P491, DOI 10.1517/14728222.12.4.491 ; Mack JT, 2007, CURR DRUG METAB, V8, P47, DOI 10.2174/138920007779315044; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rouyer O, 2009, CLIN TRANSPLANT, V23, P897, DOI 10.1111/j.1399-0012.2009.01013.x; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Schmitz G, 2001, FRONT BIOSCI, V6, pD505, DOI 10.2741/Schmitz; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stuven E, 2003, J BIOL CHEM, V278, P53112, DOI 10.1074/jbc.M300402200; Thaveau F, 2009, J SURG RES, V155, P65, DOI 10.1016/j.jss.2008.08.001; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wollmer MA, 2006, AM J MED GENET B, V141B, P534, DOI 10.1002/ajmg.b.30345; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Zhao LX, 2000, BIOCHEM J, V350, P865, DOI 10.1042/0264-6021:3500865	74	29	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1100	1111		10.1074/jbc.M111.288258	http://dx.doi.org/10.1074/jbc.M111.288258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086926	Green Published, hybrid			2022-12-25	WOS:000299170300026
J	Su, T; Chapin, SJ; Bryant, DM; Shewan, AM; Young, K; Mostov, KE				Su, Tao; Chapin, Steven J.; Bryant, David M.; Shewan, Annette M.; Young, Kitty; Mostov, Keith E.			Reduced Immunoglobulin A Transcytosis Associated with Immunoglobulin A Nephropathy and Nasopharyngeal Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; FREE SECRETORY COMPONENT; EPITHELIAL-CELLS; IGA NEPHROPATHY; RECEPTOR; POLYMORPHISMS; TRANSPORT; ENTRY	Polymeric IgA (pIgA) is transcytosed by the pIgA receptor (pIgR) across mucosal epithelial cells. After transcytosis to the apical surface, the extracellular, ligand-binding portion of the pIgR is proteolytically cleaved. A missense mutation in human pIgR, A580V, is associated with IgA nephropathy and nasopharyngeal carcinoma. We report that this mutation reduces the rate of transcytosis of pIgR and pIgA, and seemingly the rate of pIgR cleavage. We propose that the defects in pIgR trafficking caused by the A580V mutation may underlie the pathogenesis of both diseases.	[Su, Tao; Chapin, Steven J.; Bryant, David M.; Shewan, Annette M.; Young, Kitty; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mostov, KE (corresponding author), UCSF GH N212B,600 16th St, San Francisco, CA 94158 USA.	keith.mostov@ucsf.edu	Shewan, Annette/B-3251-2011; Su, Tao/T-4411-2019; Bryant, David/AAH-5620-2019	Shewan, Annette/0000-0003-4936-9207; Su, Tao/0000-0002-9148-6127; Bryant, David/0000-0003-2721-5012; mostov, keith/0000-0002-8123-6247	National Institutes of Health [R01AI25144]; Susan G. Komen Foundation; National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI25144 (to K. E. M.).; Supported by a Susan G. Komen Foundation postdoctoral fellowship.; Supported by a National Health and Medical Research Council C.J. Martin fellowship. Present address: School of Chemistry and Molecular Biosciences, the University of Queensland, St. Lucia, Queensland 4072, Australia.	Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; EIFFERT H, 1984, H-S Z PHYSIOL CHEM, V365, P1489, DOI 10.1515/bchm2.1984.365.2.1489; EMANCIPATOR SN, 1989, LAB INVEST, V60, P168; Fan Qin, 2005, Ai Zheng, V24, P915; Gan YJ, 1997, J VIROL, V71, P519, DOI 10.1128/JVI.71.1.519-526.1997; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hirunsatit R, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-3; Hughes GJ, 1997, FEBS LETT, V410, P443, DOI 10.1016/S0014-5793(97)00629-7; Hutt-Fletcher LM, 2007, J VIROL, V81, P7825, DOI 10.1128/JVI.00445-07; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Luton F, 2009, TRAFFIC, V10, P1128, DOI 10.1111/j.1600-0854.2009.00941.x; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Obara W, 2003, J HUM GENET, V48, P293, DOI 10.1007/s10038-003-0027-1; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; SIXBEY JW, 1992, SCIENCE, V255, P1578, DOI 10.1126/science.1312750; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615	20	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44921	44925		10.1074/jbc.M111.296731	http://dx.doi.org/10.1074/jbc.M111.296731			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086919	Green Published, hybrid			2022-12-25	WOS:000298645500060
J	Houck, SA; Landsbury, A; Clark, JI; Quinlan, RA				Houck, Scott A.; Landsbury, Andrew; Clark, John I.; Quinlan, Roy A.			Multiple Sites in alpha B-Crystallin Modulate Its Interactions with Desmin Filaments Assembled In Vitro	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; AGGREGATE FORMATION; A-CRYSTALLIN; DOMAIN; MYOPATHY; MUTATION; SEQUENCES; INSIGHTS; CELLS	The beta 3- and beta 8-strands and C-terminal residues 155-165 of alpha B-crystallin were identified by pin arrays as interaction sites for various client proteins including the intermediate filament protein desmin. Here we present data using 5 well-characterised alpha B-crystallin protein constructs with substituted beta 3- and beta 8-strands and with the C-terminal residues 155-165 deleted to demonstrate the importance of these sequences to the interaction of alpha B-crystallin with desmin filaments. We used electron microscopy of negatively stained samples to visualize increased interactions followed by sedimentation assays to quantify our observations. A low-speed sedimentation assay measured the ability of alpha B-crystallin to prevent the self-association of desmin filaments. A high-speed sedimentation assay measured alpha B-crystallin cosedimentation with desmin filaments. Swapping the beta 8-strand of alpha B-crystallin or deleting residues 155-165 increased the cosedimentation of alpha B-crystallin with desmin filaments, but this coincided with increased filament-filament interactions. In contrast, substitution of the beta 3-strand with the equivalent alpha A-crystallin sequences improved the ability of alpha B-crystallin to prevent desmin filament-filament interactions with no significant change in its cosedimentation properties. These data suggest that all three sequences (beta 3-strand, beta 8-strand and C-terminal residues 155-165) contribute to the interaction of alpha B-crystallin with desmin filaments. The data also suggest that the cosedimentation of alpha B-crystallin with desmin filaments does not necessarily correlate with preventing desmin filament-filament interactions. This important observation is relevant not only to the formation of the protein aggregates that contain both desmin and alpha B-crystallin and typify desmin related myopathies, but also to the interaction of alpha B-crystallin with other filamentous protein polymers.	[Houck, Scott A.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Landsbury, Andrew; Quinlan, Roy A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Quinlan, Roy A.] Univ Durham, Biophys Sci Inst, Durham, England	University of Washington; University of Washington Seattle; Durham University; University of Washington; University of Washington Seattle; Durham University	Houck, SA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	clarkji@u.washington.edu; r.a.quinlan@dur.ac.uk	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123	National Eye Institute [EY04542]; BBSRC [BB/E527898]; Leverhulme Trust [RF0546]; NATIONAL EYE INSTITUTE [R01EY004542, P30EY001730] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant EY04542 from the National Eye Institute (http://www.nei.nih.gov/), BBSRC (BB/E527898 http://www.bbsrc.ac.uk/) and Leverhulme Trust (RF0546: http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2007, INT J BIOCH CELL BIO; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hayes VH, 2008, J BIOL CHEM, V283, P10500, DOI 10.1074/jbc.M706453200; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Latham JC, 2009, ANAL CHEM, V81, P1865, DOI 10.1021/ac802327h; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Perng MD, 1999, J CELL SCI, V112, P2099; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Quinlan R, 1999, NAT MED, V5, P25, DOI 10.1038/4704; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Sokal R. R., 2012, BIOMETRY; Sreelakshmi Y, 2001, J PROTEIN CHEM, V20, P123, DOI 10.1023/A:1011077307262; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e25859	10.1371/journal.pone.0025859	http://dx.doi.org/10.1371/journal.pone.0025859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096479	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000297350800003
J	Krauss, J; Farzaneh-Far, R; Puterman, E; Na, B; Lin, J; Epel, E; Blackburn, E; Whooley, MA				Krauss, Jeffrey; Farzaneh-Far, Ramin; Puterman, Eli; Na, Beeya; Lin, Jue; Epel, Elissa; Blackburn, Elizabeth; Whooley, Mary A.			Physical Fitness and Telomere Length in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study	PLOS ONE			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; ARTERY-DISEASE; REPLICATIVE SENESCENCE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; QUANTITATIVE PCR; DNA-DAMAGE; EXERCISE	Background: Short telomere length (TL) is an independent predictor of mortality in patients with coronary heart disease (CHD). However, the relationship between physical fitness and TL has not been explored in these patients. Methods: In a cross sectional study of 944 outpatients with stable CHD, we performed exercise treadmill testing, assessed self-reported physical activity, and measured leukocyte TL using a quantitative PCR assay. We used generalized linear models to calculate mean TL (T/S ratio), and logistic regression models to compare the proportion of patients with short TL (defined as the lowest quartile), among participants with low, medium and high physical fitness, based on metabolic equivalent tasks achieved (METs). Results: 229 participants had low physical fitness (<5 METS), 334 had moderate physical fitness (5-7 METS), and 381 had high physical fitness (>7 METS). Mean +/- T/S ratio ranged from 0.86=0.21 (5349 +/- 3781 base pairs) in those with low physical fitness to 0.95 +/- 0.23 (5566 +/- 3829 base pairs) in those with high physical fitness (p<001). This association remained strong after adjustment for numerous patient characteristics, including measures of cardiac disease severity and physical inactivity (p = 0.005). Compared with participants with high physical fitness, those with low physical fitness had 2-fold greater odds of having TL in the lowest quartile (OR 2.39, 95% CI 1.60-3.55; p<.001). This association was similar after multivariable adjustment (OR 1.94, 95%CI, 1.18-3.20; p = 0.009). Self-reported physical inactivity was associated with shorter TL in unadjusted analyses, but not after multivariable adjustment. Conclusions: We found that worse objectively-assessed physical fitness is associated with shorter leukocyte telomere length in patients with CHD. The clinical implications of this association deserve further study.	[Krauss, Jeffrey] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Farzaneh-Far, Ramin] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Puterman, Eli; Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Na, Beeya; Whooley, Mary A.] Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; [Lin, Jue; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krauss, J (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	Mary.Whooley@ucsf.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348; Krauss, Jeffrey/0000-0001-6794-3052	American Federation for Aging Research; Department of Veterans Affairs; National Heart, Lung and Blood Institute; Robert Wood Johnson Foundation; Ischemia Research and Education Foundation	American Federation for Aging Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation	Jeffrey Krauss was funded by a Medical Student in Aging Research grant from the American Federation for Aging Research. The Heart and Soul Study was funded by the Department of Veterans Affairs, the National Heart, Lung and Blood Institute, the Robert Wood Johnson Foundation, the American Federation for Aging Research, and the Ischemia Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atturu G, 2010, EUR J VASC ENDOVASC; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Diaz VA, 2010, AM J CARDIOL, V106, P659, DOI 10.1016/j.amjcard.2010.04.018; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Fuster JJ, 2007, J HYPERTENS, V25, P2185, DOI 10.1097/HJH.0b013e3282ef6196; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Lin J, 2009, HDB NEUROSCIENCE BEH, P1280; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V348, P669, DOI 10.1016/j.bbrc.2006.07.103; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radak Z, 2005, BIOGERONTOLOGY, V6, P71, DOI 10.1007/s10522-004-7386-7; Rennie KL, 1998, PUBLIC HEALTH NUTR, V1, P265, DOI 10.1079/PHN19980043; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Shin YA, 2008, MECH AGEING DEV, V129, P254, DOI 10.1016/j.mad.2008.01.001; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Woo J, 2008, ARCH INTERN MED, V168, P2163, DOI 10.1001/archinte.168.19.2163; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	55	49	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26983	10.1371/journal.pone.0026983	http://dx.doi.org/10.1371/journal.pone.0026983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096513	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800021
J	Nagao, T; Oshikawa, G; Wu, N; Kurosu, T; Miura, O				Nagao, Toshikage; Oshikawa, Gaku; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu			DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ERYTHROPOIETIN RECEPTOR; JAK2 V617F; KINASE; PHOSPHORYLATION; PATHWAY; CELLS; CBL; CASPASE-2; NEOPLASMS	The cytoplasmic tyrosine kinase Jak2 plays a crucial role in cytokine receptor signaling in hematopoietic cells. The activated Jak2-V617F mutant is present in most cases of BCR/ABL-negative myeloproliferative neoplasms and constitutively activates downstream signals from homodimeric cytokine receptors, such as the erythropoietin receptor (EpoR). Here we examine the effects of DNA damage stress on Jak2 or Jak2-V617F and on induction of apoptosis in hematopoietic cells. Etoposide or doxorubicin dose-dependently decreased the expression level of Jak2 in UT7 or 32D cells expressing EpoR in the absence of Epo and that of exogenously expressed Jak2-V617F in UT7 cells when cotreated with the Jak2 inhibitor JakI-1 or AG490. Studies with pharmacological inhibitors and genetic manipulations further showed that downregulation of the PI3K/Akt pathway leading to the activation of GSK3 beta may be involved in downregulation of Jak2 or Jak2-V617F as well as in synergistic induction of Bax activation and apoptosis. The downregulation of Jak2 was inhibited by the proteasome inhibitor MG132 or by expression of both of loss-of-function mutants of c-Cbl and Cbl-b, E3 ubiquitin ligases which facilitated ubiquitination of Jak2-V617F when co-expressed in 293T cells. The pan-caspase inhibitor Boc-d-fmk also inhibited the Jak2 downregulation as well as appearance of a 100-kDa fragment that contained the N-terminal portion of Jak2 in response to DNA damage. Together, these data suggest that DNA damage stress with simultaneous inhibition of the kinase activity causes degradation of Jak2 or Jak2-V617F by caspase cleavage and proteasomal degradation through GSK3b activation, which is closely involved in synergistic induction of apoptosis in hematopoietic cells.	[Nagao, Toshikage; Oshikawa, Gaku; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Nagao, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science and Technology of Japan [21591194, 22591030]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 21591194 and 22591030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chen CL, 2006, MOL PHARMACOL, V70, P510, DOI 10.1124/mol.106.024059; Chin H, 1998, BLOOD, V91, P3734; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Haan S, 2009, ONCOGENE, V28, P3069, DOI 10.1038/onc.2009.155; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jin ZH, 2005, ONCOGENE, V24, P1973, DOI 10.1038/sj.onc.1208408; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; KOMATSU N, 1991, CANCER RES, V51, P341; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Kurosu T, 2007, ONCOGENE, V26, P2975, DOI 10.1038/sj.onc.1210117; Kurosu T, 2010, APOPTOSIS, V15, P608, DOI 10.1007/s10495-010-0457-0; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Makin G, 2003, TRENDS MOL MED, V9, P251, DOI 10.1016/S1471-4914(03)00084-4; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Verstovsek S, 2008, CLIN CANCER RES, V14, P788, DOI 10.1158/1078-0432.CCR-07-0524; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P1581, DOI 10.1016/S0960-894X(03)00135-5; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yun SI, 2009, APOPTOSIS, V14, P771, DOI 10.1007/s10495-009-0348-4	42	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27397	10.1371/journal.pone.0027397	http://dx.doi.org/10.1371/journal.pone.0027397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087308	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700041
J	Kim, HH; van den Heuvel, APJ; Schmidt, JW; Ross, SR				Kim, Hyoung H.; van den Heuvel, A. Pieter J.; Schmidt, John W.; Ross, Susan R.			Novel Common Integration Sites Targeted by Mouse Mammary Tumor Virus Insertion in Mammary Tumors Have Oncogenic Activity	PLOS ONE			English	Article							EPITHELIAL-CELLS; TCF7L2 VARIANT; MMTV; TUMORIGENESIS; RECEPTOR; GENES; IDENTIFICATION; PROLIFERATION; MORPHOGENESIS; TRANSCRIPTION	Non-acute transforming retroviruses like mouse mammary tumor virus (MMTV) cause cancer, at least in part, through integration near cellular genes involved in growth control, thereby de-regulating their expression. It is well-established that MMTV commonly integrates near and activates expression of members of the Wnt and Fgf pathways in mammary tumors. However, there are a significant number of tumors for which the proviral integration sites have not been identified. Here, we used high through-put screening to identify common integration sites (CISs) in MMTV-induced tumors from C3H/HeN and BALB/c mice. As expected, members of both the Wnt and Fgf families were identified in this screen. In addition, a number of novel CISs were found, including Tcf7l2, Antxr1/Tem8, and Arhgap18. We show here that expression of these three putative oncogenes in normal murine mammary gland cells altered their growth kinetics and caused their morphological transformation when grown in three dimensional cultures. Additionally, expression of Tcf7l2 and Antxr1/Tem8 sensitized cells to exogenous WNT ligand. As Tcf7l2, Antxr1/Tem8, and Arhgap18 have been associated with human breast and other cancers, these data demonstrate that MMTV-induced insertional mutation remains an important means for identifying genes involved in breast cancer.	[Kim, Hyoung H.; van den Heuvel, A. Pieter J.; Schmidt, John W.; Ross, Susan R.] Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kim, HH (corresponding author), Univ Penn, Dept Microbiol, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	rosss@mail.med.upenn.edu	Schmidt, John/H-5937-2019; van den Heuvel, Antonius PJ/J-8145-2012	Schmidt, John/0000-0003-0494-2436; Ross, Susan R/0000-0002-3094-3769	Public Health Services (PHS) [R01 CA114273, T32 AI7324]; NATIONAL CANCER INSTITUTE [R01CA114273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324] Funding Source: NIH RePORTER	Public Health Services (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Public Health Services (PHS) grant R01 CA114273 to SR. JS was supported by PHS Training Grant T32 AI7324 to the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Buggiano V, 2002, BREAST CANCER RES TR, V75, P191, DOI 10.1023/A:1019932516887; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P269, DOI 10.1007/s10911-008-9094-4; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Gattelli A, 2006, J VIROL, V80, P11409, DOI 10.1128/JVI.00234-06; Goode EL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-312; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katz E, 2005, J EXP MED, V201, P431, DOI 10.1084/jem.20041471; Maeda M, 2011, MOL BIOL CELL; MERLO GR, 1994, ONCOGENE, V9, P443; Merlo GR, 1996, EUR J CELL BIOL, V70, P97; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Naidu R, 2011, MED ONCOL; Nusse R, 1997, CELL, V89, P321, DOI 10.1016/S0092-8674(00)80210-X; Robertson ES, 2011, CANC ASS VI IN PRESS; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; St Croix B, 2000, SCIENCE, V289, P1197; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Tsedensodnom O, 2011, EXP CELL RES, V317, P920, DOI 10.1016/j.yexcr.2011.01.015; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Verma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022334; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	42	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27425	10.1371/journal.pone.0027425	http://dx.doi.org/10.1371/journal.pone.0027425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087314	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700053
J	Allendorph, GP; Read, JD; Kawakami, Y; Kelber, JA; Isaacs, MJ; Choe, S				Allendorph, George P.; Read, Jessica D.; Kawakami, Yasuhiko; Kelber, Jonathan A.; Isaacs, Michael J.; Choe, Senyon			Designer TGF beta Superfamily Ligands with Diversified Functionality	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVIN-A; BINDING-SPECIFICITY; CRYSTAL-STRUCTURE; GROWTH-FACTORS; RECEPTORS; DIFFERENTIATION; COMPLEX; PURIFICATION; KINASE	Transforming Growth Factor - beta (TGF beta) superfamily ligands, including Activins, Growth and Differentiation Factors (GDFs), and Bone Morphogenetic Proteins (BMPs), are excellent targets for protein-based therapeutics because of their pervasiveness in numerous developmental and cellular processes. We developed a strategy termed RASCH (Random Assembly of Segmental Chimera and Heteromer), to engineer chemically-refoldable TGF beta superfamily ligands with unique signaling properties. One of these engineered ligands, AB208, created from Activin-beta A and BMP-2 sequences, exhibits the refolding characteristics of BMP-2 while possessing Activin-like signaling attributes. Further, we find several additional ligands, AB204, AB211, and AB215, which initiate the intracellular Smad1-mediated signaling pathways more strongly than BMP-2 but show no sensitivity to the natural BMP antagonist Noggin unlike natural BMP-2. In another design, incorporation of a short N-terminal segment from BMP-2 was sufficient to enable chemical refolding of BMP-9, without which was never produced nor refolded. Our studies show that the RASCH strategy enables us to expand the functional repertoire of TGF beta superfamily ligands through development of novel chimeric TGF beta ligands with diverse biological and clinical values.	[Allendorph, George P.; Isaacs, Michael J.; Choe, Senyon] Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Allendorph, George P.; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Read, Jessica D.; Kelber, Jonathan A.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Gachon University; Salk Institute; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Allendorph, GP (corresponding author), Gachon Univ Med & Sci, Joint Ctr Biosci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	choe@salk.edu		Kelber, Jonathan/0000-0002-4606-1445; Kawakami, Yasuhiko/0000-0002-0043-9705	United States of America Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine; IFEZ; WCU, Korea	United States of America Defense Advanced Research Projects Agency; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); IFEZ; WCU, Korea	This work was supported by grants from the United States of America Defense Advanced Research Projects Agency (to SC), California Institute for Regenerative Medicine (to SC), IFEZ and WCU, Korea (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Blunk T, 2003, GROWTH FACTORS, V21, P71, DOI 10.1080/0897719031000148822; Bradley L, 2008, CELL MOL LIFE SCI, V65, P2119, DOI 10.1007/s00018-008-8077-3; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cui YZ, 2001, GENE DEV, V15, P2797; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; DERYNCK R, 2008, COLD SPRING HARBOR M, V50, P1114; Ejima D, 2006, PROTEIN EXPRES PURIF, V47, P45, DOI 10.1016/j.pep.2005.08.013; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; ISRAEL DI, 1996, GROWTH FACTORS, V13, P10; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kweon DH, 2004, BIOTECHNOL PROGR, V20, P277, DOI 10.1021/bp0341895; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Mellor SL, 2000, J CLIN ENDOCR METAB, V85, P4851, DOI 10.1210/jc.85.12.4851; Miyazono K, 2000, J CELL SCI, V113, P1101; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SONG K, 2010, J BIOL CHEM; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	53	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26402	10.1371/journal.pone.0026402	http://dx.doi.org/10.1371/journal.pone.0026402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073163	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200009
J	Ambruosi, B; Uranio, MF; Sardanelli, AM; Pocar, P; Martino, NA; Paternoster, MS; Amati, F; Dell'Aquila, ME				Ambruosi, Barbara; Uranio, Manuel Filioli; Sardanelli, Anna Maria; Pocar, Paola; Martino, Nicola Antonio; Paternoster, Maria Stefania; Amati, Francesca; Dell'Aquila, Maria Elena			In Vitro Acute Exposure to DEHP Affects Oocyte Meiotic Maturation, Energy and Oxidative Stress Parameters in a Large Animal Model	PLOS ONE			English	Article							NONESTERIFIED-FATTY-ACIDS; BOVINE GRANULOSA-CELLS; MONO-(2-ETHYLHEXYL) PHTHALATE; DEVELOPMENTAL COMPETENCE; DI(2-ETHYLHEXYL) PHTHALATE; MITOCHONDRIAL DISTRIBUTION; CHROMATIN CONFIGURATION; SUPEROXIDE-DISMUTASE; EMBRYO DEVELOPMENT; PORCINE OOCYTES	Phthalates are ubiquitous environmental contaminants because of their use in plastics and other common consumer products. Di-(2-ethylhexyl) phthalate (DEHP) is the most abundant phthalate and it impairs fertility by acting as an endocrine disruptor. The aim of the present study was to analyze the effects of in vitro acute exposure to DEHP on oocyte maturation, energy and oxidative status in the horse, a large animal model. Cumulus cell (CC) apoptosis and oxidative status were also investigated. Cumulus-oocyte complexes from the ovaries of slaughtered mares were cultured in vitro in presence of 0.12, 12 and 1200 mu M DEHP. After in vitro maturation (IVM), CCs were removed and evaluated for apoptosis (cytological assessment and TUNEL) and intracellular reactive oxygen species (ROS) levels. Oocytes were evaluated for nuclear chromatin configuration. Matured (Metaphase II stage; MII) oocytes were further evaluated for cytoplasmic energy and oxidative parameters. DEHP significantly inhibited oocyte maturation when added at low doses (0.12 mu M; P<0.05). This effect was related to increased CC apoptosis (P<0.001) and reduced ROS levels (P<0.0001). At higher doses (12 and 1200 mu M), DEHP induced apoptosis (P<0.0001) and ROS increase (P<0.0001) in CCs without affecting oocyte maturation. In DEHP-exposed MII oocytes, mitochondrial distribution patterns, apparent energy status (MitoTracker fluorescence intensity), intracellular ROS localization and levels, mt/ROS colocalization and total SOD activity did not vary, whereas increased ATP content (P<0.05), possibly of glycolytic origin, was found. Co-treatment with N-Acetyl-Cysteine reversed apoptosis and efficiently scavenged excessive ROS in DEHP-treated CCs without enhancing oocyte maturation. In conclusion, acute in vitro exposure to DEHP inhibits equine oocyte maturation without altering ooplasmic energy and oxidative stress parameters in matured oocytes which retain the potential to be fertilized and develop into embryos even though further studies are necessary to confirm this possibility.	[Ambruosi, Barbara; Uranio, Manuel Filioli; Martino, Nicola Antonio; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy; [Sardanelli, Anna Maria; Paternoster, Maria Stefania; Amati, Francesca] Univ Bari Aldo Moro, Dept Med Biochem Biol & Phys, Bari, Italy; [Pocar, Paola] Univ Milan, Dipartimento Patol Anim Igiene & Sanit Pubbl Vet, Milan, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Milan	Ambruosi, B (corresponding author), Univ Bari Aldo Moro, Dept Anim Prod, Bari, Italy.	m.filioliuranio@gmail.com	Sardanelli, Anna Maria/AAD-4745-2021; Martino, Nicola/AAP-9891-2020; POCAR, PAOLA/K-7293-2017; Martino, Nicola Antonio/N-4096-2014	Sardanelli, Anna Maria/0000-0002-8535-7601; POCAR, PAOLA/0000-0002-1362-001X; Martino, Nicola Antonio/0000-0001-6853-2757; Dell'Aquila, Maria Elena/0000-0003-3629-7005	University of Bari "Aldo Moro" - Italy [2007S75KSE_003]	University of Bari "Aldo Moro" - Italy	This work was supported by Progetto COFIN PRIN 2007 (2007S75KSE_003 Contributo d'Ateneo) University of Bari "Aldo Moro" - Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Anas MKI, 2003, REPROD TOXICOL, V17, P305, DOI 10.1016/S0890-6238(03)00014-5; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Bonilla E, 2010, REPROD TOXICOL, V30, P387, DOI 10.1016/j.reprotox.2010.04.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Dalman A, 2008, BIOFACTORS, V33, P149, DOI 10.1002/biof.5520330207; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; Dell'Aquila ME, 2008, MOL REPROD DEV, V75, P1229, DOI 10.1002/mrd.20869; Dell'Aquila Maria Elena, 2004, Reprod Biol Endocrinol, V2, P44, DOI 10.1186/1477-7827-2-44; Dell'Aquila ME, 2003, BIOL REPROD, V68, P2065, DOI 10.1095/biolreprod.102.009852; EIMANI H, 2005, YAKHTEH, V7, P56; European Food Safety Authority (EFSA), 2005, STAT SCI PAN FOOD AD; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Goudet G, 1997, BIOL REPROD, V57, P232, DOI 10.1095/biolreprod57.2.232; Goudet G, 1999, BIOL REPROD, V60, P1120, DOI 10.1095/biolreprod60.5.1120; Guixue Z, 2001, THERIOGENOLOGY, V55, P1733, DOI 10.1016/S0093-691X(01)00516-7; HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9; Hinrichs K, 2005, BIOL REPROD, V72, P1142, DOI 10.1095/biolreprod.104.036012; Hinrichs K, 2000, BIOL REPROD, V62, P1402, DOI 10.1095/biolreprod62.5.1402; Jorritsma R, 2004, ANIM REPROD SCI, V81, P225, DOI 10.1016/j.anireprosci.2003.10.005; KANDA T, 1990, BIOCHEM BIOPH RES CO, V168, P1053, DOI 10.1016/0006-291X(90)91136-G; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Komar CM, 2001, ENDOCRINOLOGY, V142, P4831, DOI 10.1210/en.142.11.4831; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9; Manojkumar V, 1998, VOX SANG, V75, P139, DOI 10.1159/000030975; Martinelli MI, 2006, HUM EXP TOXICOL, V25, P531, DOI 10.1191/0960327106het651oa; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mlynarcikova A, 2009, TOXICOL IN VITRO, V23, P371, DOI 10.1016/j.tiv.2008.12.017; Modina S, 2001, MARC MALPIG SYMP SER, V8, P241; *NAT TOX PROGR, 2006, NTP CERHR MON POT HU, P76; OEHHA, 2001, NO SIGN RISK LEV NSR; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Raval J, 2006, FREE RADICAL BIO MED, V41, P1645, DOI 10.1016/j.freeradbiomed.2006.07.023; Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022; Rogalska A, 2011, TOXICOL IN VITRO, V25, P1712, DOI 10.1016/j.tiv.2011.08.009; Santhosh A, 1998, INDIAN J MED RES, V108, P17; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; TAKAGI A, 1990, JPN J CANCER RES, V81, P213, DOI 10.1111/j.1349-7006.1990.tb02551.x; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; TREINEN KA, 1990, TOXICOL APPL PHARM, V106, P334, DOI 10.1016/0041-008X(90)90252-P; Ukeda H, 1999, BIOSCI BIOTECH BIOCH, V63, P485, DOI 10.1271/bbb.63.485; Valentini L, 2010, ANIM REPROD SCI, V117, P166, DOI 10.1016/j.anireprosci.2009.03.008; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Wakefield SL, 2008, AM J PHYSIOL-ENDOC M, V294, pE425, DOI 10.1152/ajpendo.00409.2007; Whitaker BD, 2010, REPROD DOMEST ANIM, V45, P755, DOI 10.1111/j.1439-0531.2009.01344.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yang MY, 2000, BIOL REPROD, V62, P1209, DOI 10.1095/biolreprod62.5.1209; Zhang WY, 2011, TOXICOL IN VITRO, V25, P979, DOI 10.1016/j.tiv.2011.03.009; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	65	76	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27452	10.1371/journal.pone.0027452	http://dx.doi.org/10.1371/journal.pone.0027452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076161	gold, Green Submitted, Green Published			2022-12-25	WOS:000297198200075
J	Aucher, W; Davison, S; Fouet, A				Aucher, Willy; Davison, Sophie; Fouet, Agnes			Characterization of the Sortase Repertoire in Bacillus anthracis	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-WALL ENVELOPE; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; SORTING MOTIF; PEPTIDOGLYCAN; SEQUENCE; PLASMID; SRTA; CAPSULE	LPXTG proteins, present in most if not all Gram-positive bacteria, are known to be anchored by sortases to the bacterial peptidoglycan. More than one sortase gene is often encoded in a bacterial species, and each sortase is supposed to specifically anchor given LPXTG proteins, depending of the sequence of the C-terminal cell wall sorting signal (cwss), bearing an LPXTG motif or another recognition sequence. B. anthracis possesses three sortase genes. B. anthracis sortase deleted mutant strains are not affected in their virulence. To determine the sortase repertoires, we developed a genetic screen using the property of the gamma phage to lyse bacteria only when its receptor, GamR, an LPXTG protein, is exposed at the surface. We identified 10 proteins that contain a cell wall sorting signal and are covalently anchored to the peptidoglycan. Some chimeric proteins yielded phage lysis in all sortase mutant strains, suggesting that cwss proteins remained surface accessible in absence of their anchoring sortase, probably as a consequence of membrane localization of yet uncleaved precursor proteins. For definite assignment of the sortase repertoires, we consequently relied on a complementary test, using a biochemical approach, namely immunoblot experiments. The sortase anchoring nine of these proteins has thus been determined. The absence of virulence defect of the sortase mutants could be a consequence of the membrane localization of the cwss proteins.	[Aucher, Willy; Davison, Sophie; Fouet, Agnes] Inst Pasteur, Unite Toxines, Dept Microbiol, Paris, France; [Aucher, Willy; Davison, Sophie; Fouet, Agnes] Inst Pasteur, Unite Pathogenie Bacterienne, Dept Microbiol, Paris, France; [Aucher, Willy] Inst Pasteur, Unite Genet Mol, CNRS, URA 2172, Paris, France; [Fouet, Agnes] INSERM, Inst Cochin, Team FRM Barriers & Pathogens, U1016, Paris, France; [Fouet, Agnes] CNRS, UMR 8104, Paris, France; [Fouet, Agnes] Univ Paris 05, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Aucher, W (corresponding author), Inst Pasteur, Unite Genet Mol, CNRS, URA 2172, Paris, France.	agnes.fouet@inserm.fr		Fouet, Agnes/0000-0001-7715-9157	Direction Generale a l'Armement; Agence Nationale de la Recherche [ANR-09-MIEN-010-02]	Direction Generale a l'Armement; Agence Nationale de la Recherche(French National Research Agency (ANR))	S. Davison was funded by the Direction Generale a l'Armement. This work was supported in part by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) through the project ANR-09-MIEN-010-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Davison S, 2005, J BACTERIOL, V187, P6742, DOI 10.1128/JB.187.19.6742-6749.2005; DAVISON S, 2007, CARACTERISATION PROT; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Egan SA, 2010, J PROTEOME RES, V9, P1088, DOI 10.1021/pr901025w; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HONSA ES, 2011, BIOMETALS; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Maniatis T., 1982, MOL CLONING LAB MANU; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Sambrook J., 2002, MOL CLONING LAB MANU; Sirard JC, 2000, INT J MED MICROBIOL, V290, P313; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; TRIEUCUOT P, 1987, FEMS MICROBIOL LETT, V48, P289, DOI 10.1111/j.1574-6968.1987.tb02558.x; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27411	10.1371/journal.pone.0027411	http://dx.doi.org/10.1371/journal.pone.0027411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076158	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200072
J	Girmatsion, Z; Biliczki, P; Takac, I; Schwerthelm, C; Hohnloser, SH; Ehrlich, JR				Girmatsion, Zenawit; Biliczki, Peter; Takac, Ina; Schwerthelm, Christin; Hohnloser, Stefan H.; Ehrlich, Joachim R.			N-Terminal Arginines Modulate Plasma-Membrane Localization of Kv7.1/KCNE1 Channel Complexes	PLOS ONE			English	Article							LONG QT SYNDROME; DELAYED RECTIFIER CURRENT; KCNQ1 POTASSIUM CHANNEL; I-KS; ATRIAL-FIBRILLATION; MINK; KVLQT1; PROTEINS; KCNE1; TRAFFICKING	Background and Objective: The slow delayed rectifier current (I(Ks)) is important for cardiac action potential termination. The underlying channel is composed of Kv7.1 alpha-subunits and KCNE1 beta-subunits. While most evidence suggests a role of KCNE1 transmembrane domain and C-terminus for the interaction, the N-terminal KCNE1 polymorphism 38G is associated with reduced I(Ks) and atrial fibrillation (a human arrhythmia). Structure-function relationship of the KCNE1 N-terminus for I(Ks) modulation is poorly understood and was subject of this study. Methods: We studied N-terminal KCNE1 constructs disrupting structurally important positively charged amino-acids (arginines) at positions 32, 33, 36 as well as KCNE1 constructs that modify position 38 including an N-terminal truncation mutation. Experimental procedures included molecular cloning, patch-clamp recording, protein biochemistry, real-time-PCR and confocal microscopy. Results: All KCNE1 constructs physically interacted with Kv7.1. I(Ks) resulting from co-expression of Kv7.1 with non-atrial fibrillation '38S' was greater than with any other construct. Ionic currents resulting from co-transfection of a KCNE1 mutant with arginine substitutions ('38G-3xA') were comparable to currents evoked from cells transfected with an N-terminally truncated KCNE1-construct ('Delta 1-38'). Western-blots from plasma-membrane preparations and confocal images consistently showed a greater amount of Kv7.1 protein at the plasma-membrane in cells co-transfected with the non-atrial fibrillation KCNE1-38S than with any other construct. Conclusions: The results of our study indicate that N-terminal arginines in positions 32, 33, 36 of KCNE1 are important for reconstitution of I(Ks). Furthermore, our results hint towards a role of these N-terminal amino-acids in membrane representation of the delayed rectifier channel complex.	[Girmatsion, Zenawit; Biliczki, Peter; Schwerthelm, Christin; Hohnloser, Stefan H.; Ehrlich, Joachim R.] Goethe Univ Frankfurt, Sect Electrophysiol, Div Cardiol, Frankfurt, Germany; [Takac, Ina] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Girmatsion, Z (corresponding author), Goethe Univ Frankfurt, Sect Electrophysiol, Div Cardiol, Frankfurt, Germany.	j.ehrlich@em.uni-frankfurt.de			Adolf-Messer Stiftung	Adolf-Messer Stiftung	Author Ehrlich received financial support from the Adolf-Messer Stiftung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Ehrlich JR, 2005, CARDIOVASC RES, V67, P520, DOI 10.1016/j.cardiores.2005.03.007; GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x; Husser D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P24, DOI 10.1161/CIRCEP.108.799098; Jaskolski F, 2005, J BIOL CHEM, V280, P22968, DOI 10.1074/jbc.M413166200; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; Kurokawa J, 2001, J MOL CELL CARDIOL, V33, P873, DOI 10.1006/jmcc.2001.1377; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Liu AP, 2005, ARCH BIOCHEM BIOPHYS, V443, P101, DOI 10.1016/j.abb.2005.09.007; Lundby A, 2010, HEART RHYTHM, V7, P708, DOI 10.1016/j.hrthm.2009.12.017; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Peroz D, 2009, J BIOL CHEM, V284, P5250, DOI 10.1074/jbc.M806459200; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Stryer L, 2002, BIOCHEMISTRY; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26967	10.1371/journal.pone.0026967	http://dx.doi.org/10.1371/journal.pone.0026967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073228	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200027
J	Lobanov, MY; Galzitskaya, OV				Lobanov, Michail Yu.; Galzitskaya, Oxana V.			Disordered Patterns in Clustered Protein Data Bank and in Eukaryotic and Bacterial Proteomes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; WEB SERVER; PREDICTION; REGIONS; REPEATS; SEARCH; TANDEM; ORDER	We have constructed the clustered Protein Data Bank and obtained clusters of chains of different identity inside each cluster, http://bioinfo.protres.ru/st_pdb/. We have compiled the largest database of disordered patterns (141) from the clustered PDB where identity between chains inside of a cluster is larger or equal to 75% (version of 28 June 2010) by using simple rules of selection. The results of these analyses would help to further our understanding of the physicochemical and structural determinants of intrinsically disordered regions that serve as molecular recognition elements. We have analyzed the occurrence of the selected patterns in 97 eukaryotic and in 26 bacterial proteomes. The disordered patterns appear more often in eukaryotic than in bacterial proteomes. The matrix of correlation coefficients between numbers of proteins where a disordered pattern from the library of 141 disordered patterns appears at least once in 9 kingdoms of eukaryota and 5 phyla of bacteria have been calculated. As a rule, the correlation coefficients are higher inside of the considered kingdom than between them. The patterns with the frequent occurrence in proteomes have low complexity (PPPPP, GGGGG, EEEED, HHHH, KKKKK, SSTSS, QQQQQP), and the type of patterns vary across different proteomes, http://bioinfo.protres.ru/fp/search_new_pattern.html.	[Lobanov, Michail Yu.; Galzitskaya, Oxana V.] Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences	Lobanov, MY (corresponding author), Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Pushchino 142292, Moscow Region, Russia.	ogalzit@vega.protres.ru	GALZITSKAYA, OXANA V/L-2664-2015		Russian Foundation for Basic Research [11-04-00763]; Russian Academy of Sciences [01200959110]; Federal Agency for Science and Innovations [02.740.11.0295, 16.512.11.2204]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI))	The work was supported by the Russian Foundation for Basic Research (grant No 11-04-00763), Russian Academy of Sciences (programs "Molecular and Cell Biology'' (01200959110) and "Fundamental Sciences to Medicine''), as well as a grant from the Federal Agency for Science and Innovations (#02.740.11.0295) and a grant from the Federal Agency for Science and Innovations (No16.512.11.2204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bogatyreva Natalya S., 2006, Journal of Bioinformatics and Computational Biology, V4, P597, DOI 10.1142/S0219720006002016; Bordelon T, 2004, J BIOL CHEM, V279, P43085, DOI 10.1074/jbc.M406139200; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P681, DOI 10.1142/S021972000800362X; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hecker J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S9; Hemmer B, 2000, INT IMMUNOL, V12, P375, DOI 10.1093/intimm/12.3.375; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Lobanov MY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P192, DOI 10.1134/S0006297910020094; Lobanov MY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035004; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; Lobanov MY, 2010, NUCLEIC ACIDS RES, V38, pD283, DOI 10.1093/nar/gkp963; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nikiforovich GV, 2002, P NATL ACAD SCI USA, V99, P10388, DOI 10.1073/pnas.162362199; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zbilut JP, 2006, FEBS LETT, V580, P4861, DOI 10.1016/j.febslet.2006.07.076	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27142	10.1371/journal.pone.0027142	http://dx.doi.org/10.1371/journal.pone.0027142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073276	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200039
J	Lopez-Rios, L; Novoa, FJ; Chirino, R; Varillas, F; Boronat-Cortes, M; Wagner, AM				Lopez-Rios, Laura; Novoa, Francisco J.; Chirino, Ricardo; Varillas, Francisco; Boronat-Cortes, Mauro; Waegner, Ana M.			Interaction between Cholesteryl Ester Transfer Protein and Hepatic Lipase Encoding Genes and the Risk of Type 2 Diabetes: Results from the Telde Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; IMPAIRED GLUCOSE-TOLERANCE; PLASMA-LIPID LEVELS; CETP GENE; PROMOTER POLYMORPHISM; TRIGLYCERIDE LIPASE; INSULIN-RESISTANCE; HEART-DISEASE; FATTY-ACIDS; ASSOCIATION	Background and Aim: Diabetic dyslipidaemia is common in type 2 diabetes (T2D) and insulin resistance and often precedes the onset of T2D. The Taq1B polymorphism in CETP (B1 and B2 alleles) (rs708272) and the G-250A polymorphism in LIPC (rs2070895) are associated with changes in enzyme activity and lipid concentrations. Our aim was to assess the effects of both polymorphisms on the risk of T2D. Methods and Results: In a case-control study from the population-based Telde cohort, both polymorphisms were analysed by PCR-based methods. Subjects were classified, according to an oral glucose tolerance test, into diabetic (N = 115) and pre-diabetic (N = 116); 226 subjects with normal glucose tolerance, matched for age and gender, were included as controls. Chi-square (comparison between groups) and logistic regression (identification of independent effects) were used for analysis. The B1B1 Taq1B CETP genotype frequency increased with worsening glucose metabolism (42.5%, 46.1% and 54.3% in control, IGR and diabetic group; p = 0.042). This polymorphism was independently associated with an increased risk of diabetes (OR: 1.828; IC 95%: 1.12-2.99; p = 0.016), even after adjusting by confounding variables, whereas the LIPC polymorphism was not. Regarding the interaction between both polymorphisms, in the B1B1 genotype carriers, the absence of the minor (A) allele of the LIPC polymorphism increased the risk of having diabetes. Conclusion: The presence of the B1B1 Taq1B CETP genotype contributes to the presence of diabetes, independently of age, sex, BMI and waist. However, among carriers of B1B1, the presence of GG genotype of the -250 LIPC polymorphism increases this risk further.	[Lopez-Rios, Laura; Novoa, Francisco J.; Boronat-Cortes, Mauro; Waegner, Ana M.] Complejo Hosp Univ Insular Maternoinfantil Gran C, Serv Endocrinol, Las Palmas Gran Canaria, Spain; [Lopez-Rios, Laura; Novoa, Francisco J.; Boronat-Cortes, Mauro; Waegner, Ana M.] Univ Las Palmas Gran Canaria, Dept Ciencias Med & Quirurg, Las Palmas Gran Canaria, Spain; [Chirino, Ricardo] Univ Las Palmas Gran Canaria, Dept Bioquim Biol Mol Fisiol Genet & Inmunol, Las Palmas Gran Canaria, Spain; [Varillas, Francisco] Hosp Gen Fuerteventura, Fuerteventura, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Lopez-Rios, L (corresponding author), Complejo Hosp Univ Insular Maternoinfantil Gran C, Serv Endocrinol, Las Palmas Gran Canaria, Spain.	awagner@dcmq.ulpgc.es	Boronat, Mauro/I-2851-2017; Wägner, Ana M/AAS-9601-2021; Chirino, Ricardo/ABB-1873-2021	Boronat, Mauro/0000-0001-8535-8543; Wägner, Ana M/0000-0002-7663-9308; Chirino, Ricardo/0000-0002-5681-8931	Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain); ULPGC; Ministerio de Ciencia e Innovacion [PI08/1113, PI10/2310]; European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk)	Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain); ULPGC; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk)(Novo NordiskJuvenile Diabetes Research Foundation)	This work has been supported in part by grants from Fundacion Canaria de Investigacion y Salud (FUNCIS, Spain; ref: Canarias Bioregion). LLR is being supported by a post-doctoral fellowship from ULPGC. FJN and AMW receive funding from Ministerio de Ciencia e Innovacion (PI08/1113 and PI10/2310) and the European Foundation for the Study of Diabetes (EFSD/JDRF/Novo Nordisk Programme 2008). No additional external funding was provided for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; BLADES B, 1993, ARTERIOSCLER THROMB, V13, P1227, DOI 10.1161/01.ATV.13.8.1227; Boekholdt SM, 2004, CURR OPIN LIPIDOL, V15, P393, DOI 10.1097/01.mol.0000137226.54278.60; Boronat M, 2006, DIABETIC MED, V23, P148, DOI 10.1111/j.1464-5491.2005.01739.x; Carr MC, 1999, ARTERIOSCL THROM VAS, V19, P2701, DOI 10.1161/01.ATV.19.11.2701; Corella D, 2000, ATHEROSCLEROSIS, V152, P367, DOI 10.1016/S0021-9150(99)00477-3; Deeb SS, 2000, J LIPID RES, V41, P155; DESPRES JP, 1989, ARTERIOSCLEROSIS, V9, P485, DOI 10.1161/01.ATV.9.4.485; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; Grarup N, 2008, J CLIN ENDOCR METAB, V93, P2294, DOI 10.1210/jc.2007-2815; Gudnason V, 1999, EUR J CLIN INVEST, V29, P116, DOI 10.1046/j.1365-2362.1999.00412.x; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Isaacs A, 2007, J CLIN ENDOCR METAB, V92, P2680, DOI 10.1210/jc.2007-0269; Jackson KG, 2000, AM J CLIN NUTR, V71, P13; KONDO I, 1989, CLIN GENET, V35, P49; LAGROST L, 1993, ARTERIOSCLER THROMB, V13, P815, DOI 10.1161/01.ATV.13.6.815; Lambert G, 1999, J LIPID RES, V40, P1294; Lindi V, 2008, NUTR METAB CARDIOVAS, V18, P88, DOI 10.1016/j.numecd.2006.09.008; Lopez-Rios L, 2009, NUTR METABO IN PRESS; Morton RE, 1999, CURR OPIN LIPIDOL, V10, P321, DOI 10.1097/00041433-199908000-00006; Noone E, 2000, BRIT J NUTR, V84, P203; Novoa FJ, 2005, DIABETES CARE, V28, P2388, DOI 10.2337/diacare.28.10.2388; Sandhofer A, 2008, OBESITY, V16, P919, DOI 10.1038/oby.2007.130; Smaoui M, 2006, NUTR METAB CARDIOVAS, V16, P44, DOI 10.1016/j.numecd.2005.05.011; Soyal SM, 2011, ATHEROSCLEROSIS, V216, P374, DOI 10.1016/j.atherosclerosis.2011.01.052; Tahvanainen E, 1998, J CLIN INVEST, V101, P956, DOI 10.1172/JCI1144; Thuren T, 2000, CURR OPIN LIPIDOL, V11, P277, DOI 10.1097/00041433-200006000-00008; Todorova B, 2004, J CLIN ENDOCR METAB, V89, P2019, DOI 10.1210/jc.2003-031325; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wu JH, 2001, ATHEROSCLEROSIS, V159, P451, DOI 10.1016/S0021-9150(01)00524-X; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zacharova J, 2005, J INTERN MED, V257, P185, DOI 10.1111/j.1365-2796.2004.01435.x; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zambon A, 1998, ARTERIOSCL THROM VAS, V18, P1723, DOI 10.1161/01.ATV.18.11.1723	35	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27208	10.1371/journal.pone.0027208	http://dx.doi.org/10.1371/journal.pone.0027208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073289	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000032
J	Ferrier, A; Charron, A; Sadozai, Y; Switaj, L; Szutenbach, A; Smith, PA				Ferrier, Andrew; Charron, Alexandra; Sadozai, Yama; Switaj, Lynn; Szutenbach, Anneliese; Smith, Pliny A.			Multiple Phenotypes Resulting from a Mutagenesis Screen for Pharynx Muscle Mutations in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; CELLULAR INTERACTIONS; GENE ENCODES; PROTEIN; ORGANOGENESIS; PHA-4/FOXA; WORMBASE; RESOURCE; HOMOLOG	We describe a novel screen to isolate pharyngeal cell morphology mutants in Caenorhabditis elegans using myo-2::GFP to rapidly identify abnormally shaped pharynxes in EMS (Ethyl Methanesulfonate) mutagenized worms. We observed over 83 C. elegans lines with distinctive pharyngeal phenotypes in worms surviving to the L1 larval stage, with phenotypes ranging from short pharynx, unattached pharynx, missing cells, asymmetric morphology, and non-adherent pharynx cells. Thirteen of these mutations have been chromosomally mapped using Single Nucleotide Polymorphisms (SNPs) and deficiency strain complementation. Our studies have focused on genetically mapping and functionally testing two phenotypes, the short pharynx and the loss of muscle cohesion phenotypes. We have also identified new alleles of sma-1, and our screen suggests many genes directing pharynx assembly and structure may be either pharynx specific or less critical in other tissues.	[Ferrier, Andrew; Charron, Alexandra; Sadozai, Yama; Switaj, Lynn; Szutenbach, Anneliese; Smith, Pliny A.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA		Ferrier, A (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	smith@lakeforest.edu			Lake Forest College; NIH National Center for Research Resources (NCRR)	Lake Forest College; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by Lake Forest College. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Ashleigh Porter, Elizabeth Pahamov, Carlos Becerra, Ejaz Ali, Ariel Nguyen, Victoria Egedus, former and current members of the Smith lab for their contributions to this research. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We acknowledge Dustin Updike for his insightful recommendations for using the PD4792 worm strain.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; AVERY L, 1993, GENETICS, V133, P897; BRENNER S, 1974, GENETICS, V77, P71; Broitman-Maduro G, 2006, DEVELOPMENT, V133, P3097, DOI 10.1242/dev.02475; Chanal P, 1997, GENETICS, V146, P207; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Christensen S, 1996, DEVELOPMENT, V122, P1373; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; DELONG L, 1993, GENETICS, V133, P875; ELLIS RE, 1991, GENETICS, V129, P79; Epstein HF, 1995, CAENORHABDITIS ELEGA, pxxi659; FERGUSON EL, 1985, GENETICS, V110, P17; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GREENWALD IS, 1980, GENETICS, V96, P147; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Jafari G, 2010, GENETICS, V186, P969, DOI 10.1534/genetics.110.120519; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao G, 2006, DEV BIOL, V290, P211, DOI 10.1016/j.ydbio.2005.11.026; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; MANGO SE, 1994, DEVELOPMENT, V120, P3019; McKeown C, 1998, DEVELOPMENT, V125, P2087; McMahon L, 2001, J CELL SCI, V114, P2265; Morck C, 2004, DEV BIOL, V272, P403, DOI 10.1016/j.ydbio.2004.05.011; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Praitis V, 2001, GENETICS, V157, P1217; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; PRUSS RM, 1981, CELL, V27, P419, DOI 10.1016/0092-8674(81)90383-4; Roy Chowdhuri S, 2006, DEV BIOL; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Smith PA, 2007, DEV BIOL, V302, P25, DOI 10.1016/j.ydbio.2006.08.023; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/PL00013816; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Takeda K, 2008, GENES CELLS, V13, P653, DOI 10.1111/j.1365-2443.2008.01195.x; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161	49	6	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26594	10.1371/journal.pone.0026594	http://dx.doi.org/10.1371/journal.pone.0026594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073173	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900025
J	Guo, F; Carter, DE; Mukhopadhyay, A; Leask, A				Guo, Fen; Carter, David E.; Mukhopadhyay, Anuradha; Leask, Andrew			Gingival Fibroblasts Display Reduced Adhesion and Spreading on Extracellular Matrix: A Possible Basis for Scarless Tissue Repair?	PLOS ONE			English	Article							TGF-BETA; MYOFIBROBLAST; CCN2; DIFFERENTIATION; FIBRONECTIN; CONTRACTION; EXPRESSION; FIBROSIS; DISEASE; KINASE	Unlike skin, oral gingiva do not scar in response to injury. The basis of this difference is likely to be revealed by comparing the responses of dermal and gingival fibroblasts to fibrogenic stimuli. Previously, we showed that, compared to dermal fibroblasts, gingival fibroblasts are less responsive to the potent pro-fibrotic cytokine TGF beta, due to a reduced production of endothelin-1 (ET-1). In this report, we show that, compared to dermal fibroblasts, human gingival fibroblasts show reduced expression of pro-adhesive mRNAs and proteins including integrins alpha 2 and alpha 4 and focal adhesion kinase (FAK). Consistent with these observations, gingival fibroblasts are less able to adhere to and spread on both fibronectin and type I collagen. Moreover, the enhanced production of ET-1 mRNA and protein in dermal fibroblasts is reduced by the FAK/src inhibitor PP2. Given our previous observations suggesting that fibrotic fibroblasts display elevated adhesive properties, our data suggest that scarring potential may be based, at least in part, on differences in adhesive properties among fibroblasts resident in connective tissue. Controlling adhesive properties may be of benefit in controlling scarring in response to tissue injury.	[Guo, Fen; Mukhopadhyay, Anuradha; Leask, Andrew] Univ Western Ontario, Dept Dent, London, ON, Canada; [Carter, David E.] Robarts Res Inst, London, ON, Canada; [Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Guo, F (corresponding author), Univ Western Ontario, Dept Dent, London, ON, Canada.	andrew.leask@schulich.uwo.ca	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institute of Health Research funded this paper. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham David J, 2007, Curr Rheumatol Rep, V9, P136, DOI 10.1007/s11926-007-0008-z; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P125, DOI 10.1007/s12079-011-0122-6; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Matsui S, 2011, J CLIN BIOCHEM NUTR, V48, P209, DOI 10.3164/jcbn.10-85; San Miguel SM, 2011, ARCH ORAL BIOL, V56, P812, DOI 10.1016/j.archoralbio.2011.01.001; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schor S L, 1996, Oral Dis, V2, P155; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29	26	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27097	10.1371/journal.pone.0027097	http://dx.doi.org/10.1371/journal.pone.0027097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073262	gold, Green Submitted, Green Published			2022-12-25	WOS:000297154900075
J	Singh, P; Yadav, GP; Gupta, S; Tripathi, AK; Ramachandran, R; Tripathi, RK				Singh, Pankaj; Yadav, Gaya Prasad; Gupta, Sudeepti; Tripathi, Anil Kumar; Ramachandran, Ravishankar; Tripathi, Raj Kamal			A Novel Dimer-Tetramer Transition Captured by the Crystal Structure of the HIV-1 Nef	PLOS ONE			English	Article							QUATERNARY STRUCTURE; PROTEIN; DOMAIN; SEQUENCES; COMPLEX; CELLS; CORE; GENE	HIV-1 Nef modulates disease progression through interactions with over 30 host proteins. Individual chains fold into membrane-interacting N-terminal and C-terminal core (Nef(core)) domains respectively. Nef exists as small oligomers near membranes and associates into higher oligomers such as tetramers or hexadecamers in the cytoplasm. Earlier structures of the Nef(core) in apo and complexed forms with the Fyn-kinase SH3 domain revealed dimeric association details and the role of the conserved PXXP recognition motif (residues 72-78) of Nef in SH3-domain interactions. The crystal structure of the tetrameric Nef reported here corresponds to the elusive cytoplasmic stage. Comparative analyses show that subunits of Nef(core) dimers (open conformation) swing out with a relative displacement of similar to 22 angstrom and rotation of similar to 174 degrees to form the 'closed' tetrameric structure. The changes to the association are around Asp125, a conserved residue important for viral replication and the important XR motif (residues 107-108). The tetramer associates through C4 symmetry instead of the 222 symmetry expected when two dimers associate together. This novel dimer-tetramer transition agrees with earlier solution studies including small angle X-ray scattering, analytical ultracentrifugation, dynamic laser light scattering and our glutaraldehyde cross-linking experiments. Comparisons with the Nef(core)-Fyn-SH3 domain complexes reveal that the PXXP motif that interacts with the SH3-domain in the dimeric form is sterically occluded in the tetramer. However the 151-180 loop that is distal to the PXXP motif and contains several protein interaction motifs remains accessible. The results suggest how changes to the oligomeric state of Nef can help it distinguish between protein partners.	[Singh, Pankaj; Gupta, Sudeepti; Tripathi, Raj Kamal] CSIR, Cent Drug Res Inst, Div Toxicol, Lucknow, Uttar Pradesh, India; [Yadav, Gaya Prasad; Ramachandran, Ravishankar] CSIR, Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Tripathi, Anil Kumar] Chatrapati Shahuji Maharaj Med Univ, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Singh, P (corresponding author), CSIR, Cent Drug Res Inst, Div Toxicol, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	r_ravishankar@cdri.res.in; rk_tripathi@cdri.res.in	yadav, gaya/AAA-3576-2021; Yadav, Gaya P/F-3720-2019	Yadav, Gaya P/0000-0002-4514-4679; Ramachandran, Ravishankar/0000-0002-0723-9861; Tripathi, Anil/0000-0001-9139-8701	Council of Scientific and Industrial Research (CSIR), India [MLP007, NWP034]; CSIR; Indian Council for Medical Research	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by grants MLP007 and NWP034 from the Council of Scientific and Industrial Research (CSIR), India. GY, SG and PS acknowledge fellowships from CSIR and Indian Council for Medical Research respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arold S, 2000, PROTEIN SCI, V9, P1137, DOI 10.1110/ps.9.6.1137; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; Carl S, 2000, J INFECT DIS, V181, P132, DOI 10.1086/315187; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; CORNISHBOWDEN AJ, 1971, J BIOL CHEM, V246, P3092; Dennis CA, 2005, PROTEINS, V60, P658, DOI 10.1002/prot.20544; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim WM, 2010, ACTA CRYSTALLOGR D, V66, P163, DOI 10.1107/S090744490904880X; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Klotz IM, 1975, PROTEINS, V1, P293; Kwak YT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-77; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Leslie AGW, 1992, NEWS LETT PROTEIN CR, V26; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Piguet V, STRUCTURE FUNCTION A, P448; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Roussel A, 1990, ACTA CRYSTALLOGR A, V46, pC66; Schorr J, 1996, J VIROL, V70, P9051, DOI 10.1128/JVI.70.12.9051-9054.1996; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3	37	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26629	10.1371/journal.pone.0026629	http://dx.doi.org/10.1371/journal.pone.0026629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073177	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900028
J	Xu, JL; Cao, SX; Wang, L; Xu, R; Chen, G; Xu, Q				Xu, Jianliang; Cao, Shaoxian; Wang, Lu; Xu, Rui; Chen, Gong; Xu, Qiang			VEGF Promotes the Transcription of the Human PRL-3 Gene in HUVEC through Transcription Factor MEF2C	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TYROSINE-PHOSPHATASE; COLORECTAL-CANCER; METASTASIS; EXPRESSION; GROWTH; DIFFERENTIATION; SUPPRESSES; CARCINOMA; MIGRATION	Phosphatase of regenerating liver 3 (PRL-3) is known to be overexpressed in many tumors, and its transcript level is high in the vasculature and endothelial cells of malignant tumor tissue. However, the mechanism(s) underlying its enhanced expression and its function in endothelial cells remain unknown. Here, we report that vascular endothelial growth factor (VEGF) can induce PRL-3 transcription in human umbilical vein endothelial cells (HUVEC). An analysis of its 5'UTR revealed that PRL-3 transcription is initiated from two distinct sites, which results in the formation of the two transcripts, PRL-3-iso1 and PRL-3-iso2, but only the latter is up-regulated in HUVEC by VEGF. The PRL-3-iso2 promoter region includes two functional MEF2 (myocyte enhancer factor2) binding sites. The over-expression of the constitutively active form of MEF2C promotes the abundance of the PRL-3-iso2 transcript in a number of human cell lines. The siRNA-induced knockdown of MEF2C abolished the stimulative effect of VEGF on PRL-3 transcript in HUVEC, indicating that the VEGF-induced promotion of PRL-3 expression requires the presence of MEF2C. Finally, blocking PRL-3 activity or expression suppresses tube formation by HUVEC. We suggest that PRL-3 functions downstream of the VEGF/MEF2C pathway in endothelial cells and may play an important role in tumor angiogenesis.	[Xu, Jianliang; Cao, Shaoxian; Wang, Lu; Xu, Rui; Chen, Gong; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Xu, JL (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	molpharm@163.com	Xu, Jianliang/AGG-2739-2022	Xu, Jianliang/0000-0003-4154-4322	National Science and Technology Major Project of China [2009ZX09303-001, 2009ZX09102-129]; Science Fund for Creative Research Groups [30821006]; Natural Science Foundation of Jiangsu Province [BK2008022]	National Science and Technology Major Project of China; Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was in part supported by National Science and Technology Major Project of China (No. 2009ZX09303-001 and 2009ZX09102-129), Science Fund for Creative Research Groups (No. 30821006) and Natural Science Foundation of Jiangsu Province (BK2008022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Ambler CA, 2003, DEV BIOL, V257, P205, DOI 10.1016/S0012-1606(03)00042-3; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Choi MS, 2011, BIOCHEM BIOPH RES CO, V406, P305, DOI 10.1016/j.bbrc.2011.02.037; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kong L, 2007, NEUROPATHOLOGY, V27, P516, DOI 10.1111/j.1440-1789.2007.00818.x; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YQ, 2008, ARCH PATHOL LAB MED, V132, P1307, DOI 10.1043/1543-2165(2008)132[1307:EOPORL]2.0.CO;2; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291	41	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27165	10.1371/journal.pone.0027165	http://dx.doi.org/10.1371/journal.pone.0027165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073279	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900083
J	Hartney, JM; Gustafson, CE; Bowler, RP; Pelanda, R; Torres, RM				Hartney, John M.; Gustafson, Claire E.; Bowler, Russell P.; Pelanda, Roberta; Torres, Raul M.			Thromboxane Receptor Signaling Is Required for Fibronectin-induced Matrix Metalloproteinase 9 Production by Human and Murine Macrophages and Is Attenuated by the Arhgef1 Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; NECROSIS-FACTOR-ALPHA; EXTRACELLULAR-MATRIX; PROSTAGLANDIN E-2; HUMAN MONOCYTES; LYSOPHOSPHATIDIC ACID; PROSTANOID RECEPTORS; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-MIGRATION	During an inflammatory response, resident and newly recruited tissue macrophages adhere to extracellular matrix and cell-bound integrin ligands. This interaction induces the expression of pro-inflammatory mediators that include matrix metalloproteinases (MMPs). Arhgef1 is an intracellular signaling molecule expressed by myeloid cells that normally attenuates murine macrophage MMP production in vivo and in vitro after cell culture on the extracellular matrix protein, fibronectin. In this study, we have extended the characterization of this fibronectin-induced Arhgef1-regulated signaling pathway in both human and murine myeloid cells. Our results show that MMP9 production by fibronectin-stimulated monocytes and macrophages depends on autocrine thromboxane receptor signaling and that under normal conditions, this signaling pathway is attenuated by Arhgef1. Finally, we show that the expression of ARHGEF1 by human peripheral blood monocytes varies between individuals and inversely correlates with fibronectin-mediated MMP9 production.	[Hartney, John M.; Gustafson, Claire E.; Pelanda, Roberta; Torres, Raul M.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Bowler, Russell P.] Univ Colorado, Sch Med, Denver, CO 80206 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Torres, RM (corresponding author), 1400 Jackson St,K810, Denver, CO 80206 USA.	torresr@njhealth.org			National Institutes of Health NIAID [T32-AI07045]; FAMRI; National Jewish Health Translational Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052157] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FAMRI; National Jewish Health Translational Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Training Grant T32-AI07045 (to J. M. H.). This work was also supported by a FAMRI Young Clinical Scientist Award (to J. M. H.), the Herman Dana Trust (to R. M. T.), and a National Jewish Health Translational Research Initiative award (to R. M. T.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; ALLAN CJ, 1994, J PHARMACOL EXP THER, V270, P446; ALTAVILLA D, 1995, EUR J PHARMACOL, V286, P31, DOI 10.1016/0014-2999(95)00431-J; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; BROWN GP, 1988, AM J PHYSIOL, V254, pC809, DOI 10.1152/ajpcell.1988.254.6.C809; Caughey GE, 1997, J IMMUNOL, V158, P351; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; CORCORAN ML, 1995, J BIOL CHEM, V270, P10365, DOI 10.1074/jbc.270.18.10365; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; FU JY, 1990, J BIOL CHEM, V265, P16737; Gelosa P, 2010, J PHARMACOL EXP THER, V334, P199, DOI 10.1124/jpet.110.165787; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; GUDEWICZ PW, 1994, J LEUKOCYTE BIOL, V55, P423, DOI 10.1002/jlb.55.4.423; GUDEWICZ PW, 1991, J CELL PHYSIOL, V149, P195, DOI 10.1002/jcp.1041490204; HALL RA, 1987, EUR J PHARMACOL, V135, P193, DOI 10.1016/0014-2999(87)90611-X; Harenberg A, 2005, EUR J IMMUNOL, V35, P1977, DOI 10.1002/eji.200425769; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Hartney JM, 2010, AM J PATHOL, V176, P1157, DOI 10.2353/ajpath.2010.090200; HARTUNG HP, 1983, J IMMUNOL, V130, P2861; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V103, P1054, DOI 10.1016/S0091-6749(99)70179-X; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Johnson JL, 1995, ARCH BIOCHEM BIOPHYS, V324, P26, DOI 10.1006/abbi.1995.9934; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KUHN DC, 1993, PROSTAG OTH LIPID M, V46, P195, DOI 10.1016/0090-6980(93)90003-P; Kuroda E, 2003, J IMMUNOL, V170, P757, DOI 10.4049/jimmunol.170.2.757; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lee M, 2009, AM J PHYSIOL-GASTR L, V297, pG641, DOI 10.1152/ajpgi.00191.2009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MORLEY J, 1979, PROSTAGLANDINS, V17, P729, DOI 10.1016/S0090-6980(79)80044-1; MORRIS DD, 1989, CIRC SHOCK, V28, P149; MUFSON RA, 1989, CELL IMMUNOL, V119, P182, DOI 10.1016/0008-8749(89)90234-7; MUROTA SI, 1978, BIOCHIM BIOPHYS ACTA, V528, P507; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; NICOLAOU KC, 1979, P NATL ACAD SCI USA, V76, P2566, DOI 10.1073/pnas.76.6.2566; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; SHAPIRO SD, 1993, J BIOL CHEM, V268, P8170; Shi H, 1998, EUR RESPIR J, V11, P624; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sun LK, 2001, INFLAMM RES, V50, P496, DOI 10.1007/PL00000224; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Thomas DW, 2003, J IMMUNOL, V171, P6389, DOI 10.4049/jimmunol.171.12.6389; WEIDEMANN MJ, 1978, FEBS LETT, V89, P136, DOI 10.1016/0014-5793(78)80539-0; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	65	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44521	44531		10.1074/jbc.M111.282772	http://dx.doi.org/10.1074/jbc.M111.282772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086927	hybrid, Green Published			2022-12-25	WOS:000298645500024
J	Riddle, RC; Leslie, JM; Gross, TS; Clemens, TL				Riddle, Ryan C.; Leslie, Julie M.; Gross, Ted S.; Clemens, Thomas L.			Hypoxia-inducible Factor-1 alpha Protein Negatively Regulates Load-induced Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; CANCER CELL-LINE; BETA-CATENIN; FLUID-FLOW; GROWTH-FACTOR; RAT ULNA; IN-VIVO; MC3T3-E1 OSTEOBLASTS; PROSTAGLANDIN E-2; MAMMALIAN TARGET	Mechanical loads induce profound anabolic effects in the skeleton, but the molecular mechanisms that transduce such signals are still poorly understood. In this study, we demonstrate that the hypoxia-inducible factor-1 alpha (Hif-1 alpha) is acutely up-regulated in response to exogenous mechanical stimuli secondary to prostanoid signaling and Akt/mTOR (mammalian target of rapamycin) activation. In this context, Hif-1 alpha associates with beta-catenin to inhibit Wnt target genes associated with bone anabolic activity. Mice lacking Hif-1 alpha in osteoblasts and osteocytes form more bone when subjected to tibia loading as a result of increased osteoblast activity. Taken together, these studies indicate that Hif-1 alpha serves as a negative regulator of skeletal mechanotransduction to suppress load-induced bone formation by altering the sensitivity of osteoblasts and osteocytes to mechanical signals.	[Riddle, Ryan C.; Leslie, Julie M.; Clemens, Thomas L.] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21205 USA; [Riddle, Ryan C.; Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA; [Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle	Riddle, RC (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, 1721 E Madison St,Ross 232, Baltimore, MD 21205 USA.	rriddle1@jhmi.edu			National Institutes of Health [AR049410]; Veterans Administration; Johns Hopkins University Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049410] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Johns Hopkins University Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AR049410 (to T. L. C.). This work was also supported by a Career Development Award from the Veterans Administration (to R. C. R).; Supported by a Pilot and Feasibility Grant from the Johns Hopkins University Center for Musculoskeletal Research. To whom correspondence should be addressed: Dept. of Orthopaedic Surgery, Johns Hopkins University School of Medicine, 1721 E. Madison St., Ross 232, Baltimore, MD 21205. Fax: 443287- 4428; E-mail: rriddle1@ jhmi. edu.	Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Lim JH, 2008, CANCER RES, V68, P5177, DOI 10.1158/0008-5472.CAN-07-6234; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Robling AG, 2001, J EXP BIOL, V204, P3389; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yang ZQ, 2010, J CELL PHYSIOL, V223, P435, DOI 10.1002/jcp.22057; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	58	28	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44449	44456		10.1074/jbc.M111.276683	http://dx.doi.org/10.1074/jbc.M111.276683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081627	Green Published, hybrid			2022-12-25	WOS:000298645500017
J	Bensmihen, S; de Billy, F; Gough, C				Bensmihen, Sandra; de Billy, Francoise; Gough, Clare			Contribution of NFP LysM Domains to the Recognition of Nod Factors during the Medicago truncatula/Sinorhizobium meliloti Symbiosis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; RHIZOBIUM-MELILOTI; ARABIDOPSIS-THALIANA; TRUNCATULA CONTROLS; NODULATION FACTORS; FACTOR PERCEPTION; HOST-SPECIFICITY; GENE; BINDING; PROTEIN	The root nodule nitrogen fixing symbiosis between legume plants and soil bacteria called rhizobia is of great agronomical and ecological interest since it provides the plant with fixed atmospheric nitrogen. The establishment of this symbiosis is mediated by the recognition by the host plant of lipo-chitooligosaccharides called Nod Factors (NFs), produced by the rhizobia. This recognition is highly specific, as precise NF structures are required depending on the host plant. Here, we study the importance of different LysM domains of a LysM-Receptor Like Kinase (LysM-RLK) from Medicago truncatula called Nod factor perception (NFP) in the recognition of different substitutions of NFs produced by its symbiont Sinorhizobium meliloti. These substitutions are a sulphate group at the reducing end, which is essential for host specificity, and a specific acyl chain at the non-reducing end, that is critical for the infection process. The NFP extracellular domain (ECD) contains 3 LysM domains that are predicted to bind NFs. By swapping the whole ECD or individual LysM domains of NFP for those of its orthologous gene from pea, SYM10 (a legume plant that interacts with another strain of rhizobium producing NFs with different substitutions), we showed that NFP is not directly responsible for specific recognition of the sulphate substitution of S. meliloti NFs, but probably interacts with the acyl substitution. Moreover, we have demonstrated the importance of the NFP LysM2 domain for rhizobial infection and we have pinpointed the importance of a single leucine residue of LysM2 in that step of the symbiosis. Together, our data put into new perspective the recognition of NFs in the different steps of symbiosis in M. truncatula, emphasising the probable existence of a missing component for early NF recognition and reinforcing the important role of NFP for NF recognition during rhizobial infection.	[Bensmihen, Sandra; de Billy, Francoise; Gough, Clare] INRA, LIPM, F-31326 Castanet Tolosan, France; [Bensmihen, Sandra; de Billy, Francoise; Gough, Clare] CNRS, LIPM, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bensmihen, S (corresponding author), INRA, LIPM, F-31326 Castanet Tolosan, France.	sandra.bensmihen@toulouse.inra.fr		bensmihen, sandra/0000-0003-1351-7220	French Agence Nationale de la Recherche [ANR-05-BLAN-0243-01]; European Community through a Marie Curie Research Training Network [MRTN-CT-2006-035546]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community through a Marie Curie Research Training Network	This work was funded by the French Agence Nationale de la Recherche (contract ANR-05-BLAN-0243-01 "NodBindsLysM") and by the European Community's Sixth Framework Programme through a Marie Curie Research Training Network (contract MRTN-CT-2006-035546 "NODPERCEPTION"). This work is part of the "Laboratoire d'Excellence (LABEX) entitled TULIP (ANR -10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bek AS, 2010, MOL PLANT MICROBE IN, V23, P58, DOI 10.1094/MPMI-23-1-0058; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Catoira R, 2001, DEVELOPMENT, V128, P1507; Charron D, 2004, PLANT PHYSIOL, V136, P3582, DOI 10.1104/pp.104.051110; Cronk Q, 2006, CURR OPIN PLANT BIOL, V9, P99, DOI 10.1016/j.pbi.2006.01.011; Cullimore J, 2003, SCIENCE, V302, P575, DOI 10.1126/science.1091269; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; DEBELLE F, 1988, J BACTERIOL, V170, P5718, DOI 10.1128/jb.170.12.5718-5727.1988; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; FAUCHER C, 1988, J BACTERIOL, V170, P5489, DOI 10.1128/jb.170.12.5489-5499.1988; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; STAEHELIN C, 1994, PLANT J, V5, P319, DOI 10.1111/j.1365-313X.1994.00319.x; Wais RJ, 2002, PLANT PHYSIOL, V129, P211, DOI 10.1104/pp.010690; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097	43	46	50	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26114	10.1371/journal.pone.0026114	http://dx.doi.org/10.1371/journal.pone.0026114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087221	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700003
J	Pieper, R; Zhang, QS; Clark, DJ; Huang, ST; Suh, MJ; Braisted, JC; Payne, SH; Fleischmann, RD; Peterson, SN; Tzipori, S				Pieper, Rembert; Zhang, Quanshun; Clark, David J.; Huang, Shih-Ting; Suh, Moo-Jin; Braisted, John C.; Payne, Samuel H.; Fleischmann, Robert D.; Peterson, Scott N.; Tzipori, Saul			Characterizing the Escherichia coli O157:H7 Proteome Including Protein Associations with Higher Order Assemblies	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; EXTRACELLULAR PROTEINS; STATISTICAL-MODEL; ABSOLUTE PROTEIN; MASS; IDENTIFICATION; O157-H7; EXPRESSION; MEMBRANE; SEQUENCE	Background: The recent outbreak of severe infections with Shiga toxin (Stx) producing Escherichia coli (STEC) serotype O104:H4 highlights the need to understand horizontal gene transfer among E. coli strains, identify novel virulence factors and elucidate their pathogenesis. Quantitative shotgun proteomics can contribute to such objectives, allowing insights into the part of the genome translated into proteins and the connectivity of biochemical pathways and higher order assemblies of proteins at the subcellular level. Methodology/Principal Findings: We examined protein profiles in cell lysate fractions of STEC strain 86-24 (serotype O157:H7), following growth in cell culture or bacterial isolation from intestines of infected piglets, in the context of functionally and structurally characterized biochemical pathways of E. coli. Protein solubilization in the presence of Triton X-100, EDTA and high salt was followed by size exclusion chromatography into the approximate M-r ranges greater than 280 kDa, 280-80 kDa and 80-10 kDa. Peptide mixtures resulting from these and the insoluble fraction were analyzed by quantitative 2D-LC-nESI-MS/MS. Of the 2521 proteins identified at a 1% false discovery rate, representing 47% of all predicted E. coli O157:H7 gene products, the majority of integral membrane proteins were enriched in the high Mr fraction. Hundreds of proteins were enriched in a Mr range higher than that predicted for a monomer supporting their participation in protein complexes. The insoluble STEC fraction revealed enrichment of aggregation-prone proteins, including many that are part of large structure/function entities such as the ribosome, cytoskeleton and O-antigen biosynthesis cluster. Significance: Nearly all E. coli O157:H7 proteins encoded by prophage regions were expressed at low abundance levels or not detected. Comparative quantitative analyses of proteins from distinct cell lysate fractions allowed us to associate uncharacterized proteins with membrane attachment, potential participation in stable protein complexes, and susceptibility to aggregation as part of larger structural assemblies.	[Pieper, Rembert; Clark, David J.; Huang, Shih-Ting; Suh, Moo-Jin; Braisted, John C.; Payne, Samuel H.; Fleischmann, Robert D.; Peterson, Scott N.] J Craig Venter Inst, Rockville, MD USA; [Zhang, Quanshun; Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Div Infect Dis, North Grafton, MA USA	J. Craig Venter Institute; Tufts University	Pieper, R (corresponding author), J Craig Venter Inst, Rockville, MD USA.	rpieper@jcvi.org	Suh, Moo-Jin/A-5436-2010; Payne, Samuel/AAC-6388-2021	Suh, Moo-Jin/0000-0003-0003-393X; Payne, Samuel/0000-0002-8351-1994; Clark, David/0000-0003-0527-8469	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [N01-AI-30050, N01-AI15447]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funder was the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funder was involved in the selection process of this White Paper research project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At Tufts University, the work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) under contract number N01-AI-30050. At the J Craig Venter Institute, the work was funded by the NIAID, NIH, under contract number N01-AI15447. The funders had no role in study design, data collection and analysis or preparation of the manuscript. Because the work was funded via two NIH contracts, the funder reserved the right to approve submission of the manuscript for publication, but the research teams made the decision to publish.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ARAKAWA T, 2001, CURR PROTOC PROTEIN, pCH20; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Asakura H, 2007, MICROBIOL IMMUNOL, V51, P875, DOI 10.1111/j.1348-0421.2007.tb03969.x; Bernsel A, 2009, TRENDS MICROBIOL, V17, P444, DOI 10.1016/j.tim.2009.07.005; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; COLE ST, 1988, J BACTERIOL, V170, P2448, DOI 10.1128/jb.170.6.2448-2456.1988; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Cornick NA, 2000, J INFECT DIS, V181, P242, DOI 10.1086/315172; Denamur E, 2011, CLIN MICROBIOL INFEC, V17, P1124, DOI 10.1111/j.1469-0691.2011.03620.x; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hyde R, 2011, LANCET, V377, P1991, DOI 10.1016/S0140-6736(11)60847-7; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kaberdin VR, 2009, RNA BIOL, V6, P402, DOI 10.4161/rna.6.4.9320; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; Kuntumalla S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-22; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Link AJ, 2002, TRENDS BIOTECHNOL, V20, pS8, DOI 10.1016/S1471-1931(02)00202-1; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PAGE WJ, 1988, J GEN MICROBIOL, V134, P2925; Pan JY, 2010, J PROTEOME RES, V9, P3730, DOI 10.1021/pr100301f; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; PICKERING LK, 1994, PEDIATR INFECT DIS J, V13, P459, DOI 10.1097/00006454-199406000-00001; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Pieper R, 2009, PROTEOMICS, V9, P5029, DOI 10.1002/pmic.200900196; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rudnick PA, 2010, MOL CELL PROTEOMICS, V9, P225, DOI 10.1074/mcp.M900223-MCP200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P545, DOI 10.1128/JB.108.1.545-552.1971; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P553, DOI 10.1128/JB.108.1.553-563.1971; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Swanson SK, 2005, DRUG DISCOV TODAY, V10, P719, DOI 10.1016/S1359-6446(05)03450-1; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; VOEGELE RT, 1993, J BACTERIOL, V175, P1087, DOI 10.1128/JB.175.4.1087-1094.1993; Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x; Whittam, 2006, ECMLST MULTILOCUS SE; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Xiong XL, 1996, J BACTERIOL, V178, P1213, DOI 10.1128/jb.178.4.1213-1215.1996; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhang J, 2007, PROTEOMICS, V7, P500, DOI 10.1002/pmic.200500880; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	83	14	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26554	10.1371/journal.pone.0026554	http://dx.doi.org/10.1371/journal.pone.0026554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087229	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700007
J	Armand, AS; Laziz, I; Djeghloul, D; Lecolle, S; Bertrand, AT; Biondi, O; De Windt, LJ; Chanoine, C				Armand, Anne-Sophie; Laziz, Iman; Djeghloul, Dounia; Lecolle, Sylvie; Bertrand, Anne T.; Biondi, Olivier; De Windt, Leon J.; Chanoine, Christophe			Apoptosis-Inducing Factor Regulates Skeletal Muscle Progenitor Cell Number and Muscle Phenotype	PLOS ONE			English	Article							GLUTAMATE CYSTEINE LIGASE; OXIDATIVE STRESS; SATELLITE CELLS; STEM-CELLS; FIBER-TYPE; MYONUCLEAR NUMBER; IN-VIVO; ATROPHY; REGENERATION; MOUSE	Apoptosis Inducing Factor (AIF) is a highly conserved, ubiquitous flavoprotein localized in the mitochondrial intermembrane space. In vivo, AIF provides protection against neuronal and cardiomyocyte apoptosis induced by oxidative stress. Conversely in vitro, AIF has been demonstrated to have a pro-apoptotic role upon induction of the mitochondrial death pathway, once AIF translocates to the nucleus where it facilitates chromatin condensation and large scale DNA fragmentation. Given that the aif hypomorphic harlequin (Hq) mutant mouse model displays severe sarcopenia, we examined skeletal muscle from the aif hypomorphic mice in more detail. Adult AIF-deficient skeletal myofibers display oxidative stress and a severe form of atrophy, associated with a loss of myonuclei and a fast to slow fiber type switch, both in "slow" muscles such as soleus, as well as in "fast" muscles such as extensor digitorum longus, most likely resulting from an increase of MEF2 activity. This fiber type switch was conserved in regenerated soleus and EDL muscles of Hq mice subjected to cardiotoxin injection. In addition, muscle regeneration in soleus and EDL muscles of Hq mice was severely delayed. Freshly cultured myofibers, soleus and EDL muscle sections from Hq mice displayed a decreased satellite cell pool, which could be rescued by pretreating aif hypomorphic mice with the manganese-salen free radical scavenger EUK-8. Satellite cell activation seems to be abnormally long in Hq primary culture compared to controls. However, AIF deficiency did not affect myoblast cell proliferation and differentiation. Thus, AIF protects skeletal muscles against oxidative stress-induced damage probably by protecting satellite cells against oxidative stress and maintaining skeletal muscle stem cell number and activation.	[Armand, Anne-Sophie; Laziz, Iman; Djeghloul, Dounia; Lecolle, Sylvie; Biondi, Olivier; Chanoine, Christophe] Univ Paris 05, Ctr Etude Sensori Motricite, Ctr Univ St Peres, UMR CNRS 8194, Paris, France; [Bertrand, Anne T.] Royal Netherlands Acad Sci, Hubrecht Inst, Utrecht, Netherlands; [Bertrand, Anne T.] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [De Windt, Leon J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	UDICE-French Research Universities; Universite Paris Cite; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University	Armand, AS (corresponding author), Univ Paris 05, Ctr Etude Sensori Motricite, Ctr Univ St Peres, UMR CNRS 8194, Paris, France.	christophe.chanoine@parisdescartes.fr	Bertrand, Anne/AAR-6751-2020; de Windt, Leon/AAO-6395-2020	de Windt, Leon/0000-0002-7793-2856; Bertrand, Anne/0000-0001-7153-848X; Armand, Anne-Sophie/0000-0002-0291-6421; chanoine, christophe/0000-0001-8155-2357	Fondation Bettencourt Schueller; Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Association Francaise contre les Myopathies; Netherlands Organization for Health Research and Development [912-04-054, 912-04-017, 917-863-72]; Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-005-018833/EUGeneHeart]; Fondation Leducq Transatlantic Network of Excellence	Fondation Bettencourt Schueller; Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation)	ATB was supported by a young investigator's award of the Fondation Bettencourt Schueller. OB held a doctoral fellowship from the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT). This work was supported by grants from the Association Francaise contre les Myopathies. This work was also supported by grants 912-04-054, 912-04-017 and a VIDI award 917-863-72 from The Netherlands Organization for Health Research and Development; grant NHS2007B167 from The Netherlands Heart Foundation; the European Union Contract No. LSHM-CT-005-018833/EUGeneHeart; and the Fondation Leducq Transatlantic Network of Excellence (to LJDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Armand AS, 2004, EXP CELL RES, V297, P27, DOI 10.1016/j.yexcr.2004.02.021; BALABAN RS, 2005, MITOCHONDRIA, V120, P483; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dupont-Versteegden EE, 1999, AM J PHYSIOL-CELL PH, V277, pC589, DOI 10.1152/ajpcell.1999.277.3.C589; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ishimura R, 2008, J NEUROSCI, V28, P4938, DOI 10.1523/JNEUROSCI.0229-08.2008; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Krzywanski DM, 2004, ARCH BIOCHEM BIOPHYS, V423, P116, DOI 10.1016/j.abb.2003.11.004; Launay T, 2001, J HISTOCHEM CYTOCHEM, V49, P887, DOI 10.1177/002215540104900709; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Perier C, 2010, ANN NEUROL, V68, P184, DOI 10.1002/ana.22034; PETERSON CA, 1995, J GERONTOL A-BIOL, V50, P142; Reimann J, 2004, CELL TISSUE RES, V315, P233, DOI 10.1007/s00441-003-0833-y; Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wang LC, 2001, J ANAT, V199, P631, DOI 10.1046/j.1469-7580.2001.19960631.x; Wigmore PM, 2002, INT REV CYTOL, V216, P175; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	61	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27283	10.1371/journal.pone.0027283	http://dx.doi.org/10.1371/journal.pone.0027283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076146	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200060
J	Strom, TS; Anur, P; Prislovsky, A				Strom, Ted S.; Anur, Praveen; Prislovsky, Amanda			A Numerical Analysis Model for Interpretation of Flow Cytometric Studies of Ex Vivo Phagocytosis	PLOS ONE			English	Article							MEDIATED PHAGOCYTOSIS; PLATELET	The study of ex vivo phagocytosis via flow cytometry requires that one distinguish experimentally between uptake and adsorption of fluorescently labeled targets by phagocytes. Removal of the latter quantity from the analysis is the most common means of analyzing such data. Because the probability of phagocytosis is a function of the probability of adsorption, and because partially quenched fluorescence after uptake often overlaps with that of negative controls, this approach is suboptimal at best. Here, we describe a numerical analysis model which overcomes these limitations. We posit that the random adsorption of targets to macrophages, and subsequent phagocytosis, is a function of three parameters: the ratio of targets to macrophages (m), the mean fluorescence intensity imparted to the phagocyte by the internalized target (alpha), and the probability of phagocytosis per adsorbed target (p). The potential values of these parameters define a parameter space and their values at any point in parameter space can be used to predict the fraction of adsorption(+) and [adsorption(-), phagocytosis(+)] cells that might be observed experimentally. By systematically evaluating the points in parameter space for the latter two values and comparing them to experimental data, the model arrives at sets of parameter values that optimally predict such data. Using activated THP-1 cells as macrophages and platelets as targets, we validate the model by demonstrating that it can distinguish between the effects of experimental changes in m, alpha, and p. Finally, we use the model to demonstrate that platelets from a congenitally thrombocytopenic WAS patient show an increased probability of ex vivo phagocytosis. This finding correlates with other evidence that rapid in vivo platelet consumption contributes significantly to the thrombocytopenia of WAS. Our numerical analysis method represents a useful and innovative approach to multivariate analysis.	[Strom, Ted S.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Strom, Ted S.; Prislovsky, Amanda] Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Anur, Praveen] Oregon Hlth & Sci Univ, Portland, OR USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Oregon Health & Science University	Strom, TS (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	tstrom@uthsc.edu			National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [1R21AI079757]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079757] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) award 1R21AI079757 (TS, PI) and by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam R, 2007, TRANSFUSION, V47, P2161, DOI 10.1111/j.1537-2995.2007.01441.x; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Dewey RA, 2006, EXP HEMATOL, V34, P1162, DOI 10.1016/j.exphem.2006.04.021; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Marathe BM, 2009, EXP HEMATOL, V37, P1353, DOI 10.1016/j.exphem.2009.08.007; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Prislovsky A, 2008, EXP HEMATOL, V36, pe915; Prislovsky A, 2008, EXP HEMATOL, V36, P906; Wiener E, 2003, EUR J HAEMATOL, V70, P67, DOI 10.1034/j.1600-0609.2003.00025.x; Zimring JC, 2005, BLOOD, V106, P1105, DOI 10.1182/blood-2005-03-1040	11	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26657	10.1371/journal.pone.0026657	http://dx.doi.org/10.1371/journal.pone.0026657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073181	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200016
J	Camorlinga-Ponce, M; Perez-Perez, G; Gonzalez-Valencia, G; Mendoza, I; Penaloza-Espinosa, R; Ramos, I; Kersulyte, D; Reyes-Leon, A; Romo, C; Granados, J; Munoz, L; Berg, DE; Torres, J				Camorlinga-Ponce, Margarita; Perez-Perez, Guillermo; Gonzalez-Valencia, Gerardo; Mendoza, Irma; Penaloza-Espinosa, Rosenda; Ramos, Irma; Kersulyte, Dangeruta; Reyes-Leon, Adriana; Romo, Carolina; Granados, Julio; Munoz, Leopoldo; Berg, Douglas E.; Torres, Javier			Helicobacter pylori Genotyping from American Indigenous Groups Shows Novel Amerindian vacA and cagA Alleles and Asian, African and European Admixture	PLOS ONE			English	Article							Y-CHROMOSOME POLYMORPHISMS; MITOCHONDRIAL-DNA; NATIVE-AMERICAN; NORTH-AMERICA; POPULATIONS; STRAINS; MEXICO; DIVERSITY; MTDNA; ASSOCIATION	It is valuable to extend genotyping studies of Helicobacter pylori to strains from indigenous communities across the world to better define adaption, evolution, and associated diseases. We aimed to genetically characterize both human individuals and their infecting H. pylori from indigenous communities of Mexico, and to compare them with those from other human groups. We studied individuals from three indigenous groups, Tarahumaras from the North, Huichols from the West and Nahuas from the center of Mexico. Volunteers were sampled at their community site, DNA was isolated from white blood cells and mtDNA, Y-chromosome, and STR alleles were studied. H. pylori was cultured from gastric juice, and DNA extracted for genotyping of virulence and housekeeping genes. We found Amerindian mtDNA haplogroups (A, B, C, and D), Y-chromosome DYS19T, and Amerindian STRs alleles frequent in the three groups, confirming Amerindian ancestry in these Mexican groups. Concerning H. pylori cagA phylogenetic analyses, although most isolates were of the Western type, a new Amerindian cluster neither Western nor Asian, was formed by some indigenous Mexican, Colombian, Peruvian and Venezuelan isolates. Similarly, vacA phylogenetic analyses showed the existence of a novel Amerindian type in isolates from Alaska, Mexico and Colombia. With hspA strains from Mexico and other American groups clustered within the three major groups, Asian, African or European. Genotyping of housekeeping genes confirmed that Mexican strains formed a novel Asian-related Amerindian group together with strains from remote Amazon Aborigines. This study shows that Mexican indigenous people with Amerindian markers are colonized with H. pylori showing admixture of Asian, European and African strains in genes known to interact with the gastric mucosa. We present evidence of novel Amerindian cagA and vacA alleles in indigenous groups of North and South America.	[Camorlinga-Ponce, Margarita; Gonzalez-Valencia, Gerardo; Mendoza, Irma; Ramos, Irma; Munoz, Leopoldo; Torres, Javier] Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Perez-Perez, Guillermo] NYU, Sch Med, New York, NY USA; [Penaloza-Espinosa, Rosenda] Inst Mexicano Seguro Social, Unidad Invest Genet Humana, Mexico City, DF, Mexico; [Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Reyes-Leon, Adriana; Romo, Carolina] Inst Nacl Pediat, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Nutr & Ciencias Med, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; New York University; Instituto Mexicano del Seguro Social; Washington University (WUSTL); Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Camorlinga-Ponce, M (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	jtorresl57@yahoo.com.mx	Perez, Guillermo Perez/AAJ-3761-2020	Perez Perez, Guillermo/0000-0002-0131-5798	CONACYT, Mexico; NYU Center for the Study of Asian American Health; National Institutes of Health Research Center of Excellence [P60 MD000538-05]; Fudacion IMSS, Mexico; US National Institutes of Health [R21 AI078237, R21 AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R21AI088337] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD000538] Funding Source: NIH RePORTER	CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NYU Center for the Study of Asian American Health; National Institutes of Health Research Center of Excellence; Fudacion IMSS, Mexico; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by CONACYT, Mexico, and by the NYU Center for the Study of Asian American Health, a National Institutes of Health Research Center of Excellence (P60 MD000538-05). JT was a recipient of a exclusivity scholarship from Fudacion IMSS, Mexico. DB received support from the US National Institutes of Health (grants R21 AI078237 and R21 AI088337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Azuma T, 2004, ALIMENT PHARM THER, V20, P7, DOI 10.1111/j.1365-2036.2004.01980.x; Barrot C, 2005, INT J LEGAL MED, V119, P111, DOI 10.1007/s00414-004-0488-6; Bonilla C, 2005, AM J PHYS ANTHROPOL, V128, P861, DOI 10.1002/ajpa.20227; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Gonzalez-Valencia G, 2000, J INFECT DIS, V182, P1450, DOI 10.1086/315864; Guardado-Estrada M, 2009, J HUM GENET, V54, P695, DOI 10.1038/jhg.2009.98; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lisker R, 1996, HUM BIOL, V68, P395; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Mazieres S, 2008, ANN HUM GENET, V72, P145, DOI 10.1111/j.1469-1809.2007.00392.x; McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Penaloza-Espinosa RI, 2007, HUM BIOL, V79, P313, DOI 10.1353/hub.2007.0042; Rangel-Villalobos H, 2008, AM J PHYS ANTHROPOL, V135, P448, DOI 10.1002/ajpa.20765; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; Reyes-Leon A, 2007, INFECT IMMUN, V75, P3445, DOI 10.1128/IAI.01951-06; Romo-Gonzalez C, 2009, INFECT IMMUN, V77, P2201, DOI 10.1128/IAI.01284-08; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Sanchez-Boiso A, 2011, RIC IN PRESS; Schauer K, 2010, J BACTERIOL, V192, P1231, DOI 10.1128/JB.01216-09; Spohn G, 2002, J BACTERIOL, V184, P2925, DOI 10.1128/JB.184.11.2925-2930.2002; Suzuki M, 2011, J BIOL CHEM, DOI 101074/jbc.M111.263715; Torres J, 2001, J CLIN MICROBIOL, V39, P1650, DOI 10.1128/JCM.39.4.1650-1651.2001; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; WALLACE DC, 1992, HUM BIOL, V64, P403; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	38	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27212	10.1371/journal.pone.0027212	http://dx.doi.org/10.1371/journal.pone.0027212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073291	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000033
J	Fuster-Matanzo, A; Llorens-Martin, M; de Barreda, EG; Avila, J; Hernandez, F				Fuster-Matanzo, Almudena; Llorens-Martin, Maria; Gomez de Barreda, Elena; Avila, Jesus; Hernandez, Felix			Different Susceptibility to Neurodegeneration of Dorsal and Ventral Hippocampal Dentate Gyrus: A Study with Transgenic Mice Overexpressing GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; TAU-PROTEIN; GSK-3-BETA; PHOSPHORYLATION; INHIBITORS; NEURONS; LITHIUM; HYPERPHOSPHORYLATION; 3-BETA	Dorsal hippocampal regions are involved in memory and learning processes, while ventral areas are related to emotional and anxiety processes. Hippocampal dependent memory and behaviour alterations do not always come out in neurodegenerative diseases at the same time. In this study we have tested the hypothesis that dorsal and ventral dentate gyrus (DG) regions respond in a different manner to increased glycogen synthase kinase-3 beta (GSK3 beta) levels in GSK3 beta transgenic mice, a genetic model of neurodegeneration. Reactive astrocytosis indicate tissue stress in dorsal DG, while ventral area does not show that marker. These changes occurred with a significant reduction of total cell number and with a significantly higher level of cell death in dorsal area than in ventral one as measured by fractin-positive cells. Biochemistry analysis showed higher levels of phosphorylated GSK3 beta in those residues that inactivate the enzyme in hippocampal ventral areas compared with dorsal area suggesting that the observed susceptibility is in part due to different GSK3 regulation. Previous studies carried out with this animal model had demonstrated impairment in Morris Water Maze and Object recognition tests point out to dorsal hippocampal atrophy. Here, we show that two tests used to evaluate emotional status, the light-dark box and the novelty suppressed feeding test, suggest that GSK3 beta mice do not show any anxiety-related disorder. Thus, our results demonstrate that in vivo overexpression of GSK3 beta results in dorsal but not ventral hippocampal DG neurodegeneration and suggest that both areas do not behave in a similar manner in neurodegenerative processes.	[Fuster-Matanzo, Almudena; Llorens-Martin, Maria; Gomez de Barreda, Elena; Avila, Jesus; Hernandez, Felix] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Avila, Jesus; Hernandez, Felix] Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Fuster-Matanzo, A (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	fhernandez@cbm.uam.es	Avila, Jesus/I-2610-2015; Hernandez, Felix/L-2114-2015; Llorens-Martin, Maria/R-4613-2017	Avila, Jesus/0000-0002-6288-0571; Hernandez, Felix/0000-0001-8753-8249; Llorens-Martin, Maria/0000-0001-9129-5198	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [SAF2010-15525, SAF 2006-02424]; Comunidad de Madrid (NEURODEGMODELS-CM) [SAL/0202/2006]; Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN) [PI 008-09]; Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER); Fundacion Botin; Fundacion Ramon Areces	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad de Madrid (NEURODEGMODELS-CM)(Comunidad de Madrid); Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN); Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER); Fundacion Botin; Fundacion Ramon Areces	This work was supported by grants from the Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT; SAF2010-15525, SAF 2006-02424), the Comunidad de Madrid (NEURODEGMODELS-CM, SAL/0202/2006), Fundacion Centro de Investigaciones de Enfermedades Neurologicas (Fundacion CIEN, PI 008-09), the Centro de Investigacion Biomedica en Red on Neurodegeneration (CIBER) and by institutional grants from Fundacion Botin and Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hetman M, 2000, J NEUROSCI, V20, P2567; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Ohm TG, 2007, PROG BRAIN RES, V163, P723, DOI 10.1016/S0079-6123(07)63039-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Paxinos G., 2001, MOUSE BRAIN; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	34	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27262	10.1371/journal.pone.0027262	http://dx.doi.org/10.1371/journal.pone.0027262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073301	Green Published, gold			2022-12-25	WOS:000297197000038
J	Goatley, CHR; Bellwood, DR				Goatley, Christopher H. R.; Bellwood, David R.			The Roles of Dimensionality, Canopies and Complexity in Ecosystem Monitoring	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; HABITAT COMPLEXITY; BENTHIC COMPOSITION; CARBONATE BUDGETS; HIGH DIVERSITY; CLIMATE-CHANGE; PHASE-SHIFTS; DISTURBANCE; ALGAE	Canopies are common among autotrophs, increasing their access to light and thereby increasing competitive abilities. If viewed from above canopies may conceal objects beneath them creating a 'canopy effect'. Due to complexities in collecting 3-dimensional data, most ecosystem monitoring programmes reduce dimensionality when sampling, resorting to planar views. The resultant 'canopy effects' may bias data interpretation, particularly following disturbances. Canopy effects are especially relevant on coral reefs where coral cover is often used to evaluate and communicate ecosystem health. We show that canopies hide benthic components including massive corals and algal turfs, and as planar views are almost ubiquitously used to monitor disturbances, the loss of vulnerable canopy-forming corals may bias findings by presenting pre-existing benthic components as an altered system. Our reliance on planar views in monitoring ecosystems, especially coral cover on reefs, needs to be reassessed if we are to better understand the ecological consequences of ever more frequent disturbances.	[Goatley, Christopher H. R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Goatley, CHR (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	christopher.goatley@jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	Lizard Island Reef Research Foundation; Australian Museum; Australian Research Council	Lizard Island Reef Research Foundation; Australian Museum; Australian Research Council(Australian Research Council)	This work was funded by the Lizard Island Reef Research Foundation and the Australian Museum through a Lizard Island Doctoral Fellowship (C.H.R.G.) and the Australian Research Council (D.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, MAR ECOL PROG SER, V165, P271, DOI 10.3354/meps165271; [Anonymous], AUSTR I MAR SCI REEF; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Booth DT, 2008, ENVIRON MANAGE, V42, P1091, DOI 10.1007/s00267-008-9110-x; Braun C, 2009, P 11 CORAL REEF S, V18, P865; Brooker RM, 2010, J FISH BIOL, V76, P2578, DOI 10.1111/j.1095-8649.2010.02644.x; Bythell JC, 2001, CORAL REEFS, V20, P193; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; CARPENTER RC, 1993, LIMNOL OCEANOGR, V38, P687, DOI 10.4319/lo.1993.38.3.0687; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Depczynski M, 2003, MAR ECOL PROG SER, V256, P183, DOI 10.3354/meps256183; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P153; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Done T.J., 1982, Proceedings of the International Coral Reef Symposium, P315; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Fox HE, 2003, MAR POLLUT BULL, V46, P1024, DOI 10.1016/S0025-326X(03)00246-7; GEHLBACH F R, 1975, Biological Conservation, V8, P79, DOI 10.1016/0006-3207(75)90033-6; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Harding DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023471; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; KOHN AJ, 1976, OECOLOGIA, V25, P199, DOI 10.1007/BF00345098; Korpela I, 2004, SILVA FENN, P1; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Madin JS, 2008, BIOL LETTERS, V4, P490, DOI 10.1098/rsbl.2008.0249; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Mallela J, 2007, CORAL REEFS, V26, P129, DOI 10.1007/s00338-006-0169-7; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; MCINTYRE GA, 1953, J ECOL, V41, P319, DOI 10.2307/2257044; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; ONEILL RV, 1991, LANDSCAPE ECOL, V5, P137, DOI 10.1007/BF00158061; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Perry CT, 2006, PALAEOGEOGR PALAEOCL, V242, P1, DOI 10.1016/j.palaeo.2006.05.006; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; SAVINO JF, 1989, ANIM BEHAV, V37, P311, DOI 10.1016/0003-3472(89)90120-6; SCHMID WD, 1965, ECOLOGY, V46, P816, DOI 10.2307/1934014; Seefeldt SS, 2006, ENVIRON MANAGE, V37, P703, DOI 10.1007/s00267-005-0016-6; Shuman CS, 2003, RESTOR ECOL, V11, P325, DOI 10.1046/j.1526-100X.2003.00182.x; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Vroom Peter S., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/164127; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	82	72	72	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27307	10.1371/journal.pone.0027307	http://dx.doi.org/10.1371/journal.pone.0027307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073311	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000297197000046
J	Luo, RT; Piovoso, MJ; Martinez-Picado, J; Zurakowski, R				Luo, Rutao; Piovoso, Michael J.; Martinez-Picado, Javier; Zurakowski, Ryan			Optimal Antiviral Switching to Minimize Resistance Risk in HIV Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRUCTURED TREATMENT INTERRUPTION; ACTIVE ANTIRETROVIRAL THERAPY; SOCIETY-USA PANEL; CD8(+) T-CELLS; INFECTED PATIENTS; DRUG-RESISTANCE; RANDOMIZED-TRIAL; TYPE-1; BENEFIT	The development of resistant strains of HIV is the most significant barrier to effective long-term treatment of HIV infection. The most common causes of resistance development are patient noncompliance and pre-existence of resistant strains. In this paper, methods of antiviral regimen switching are developed that minimize the risk of pre-existing resistant virus emerging during therapy switches necessitated by virological failure. Two distinct cases are considered; a single previous virological failure and multiple virological failures. These methods use optimal control approaches on experimentally verified mathematical models of HIV strain competition and statistical models of resistance risk. It is shown that, theoretically, order-of-magnitude reduction in risk can be achieved, and multiple previous virological failures enable greater success of these methods in reducing the risk of subsequent treatment failures.	[Luo, Rutao; Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Piovoso, Michael J.] Penn State Univ Great Valley, Dept Elect Engn, Malvern, PA USA; [Martinez-Picado, Javier] IrsiCaixa, Inst Recerca SIDA, Badalona, Spain; [Martinez-Picado, Javier] ICREA, Barcelona, Spain; [Zurakowski, Ryan] Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Luo, RT (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	ryanz@udel.edu	Martinez-Picado, Javier/G-5507-2012	Martinez-Picado, Javier/0000-0002-4916-2129; Zurakowski, Ryan/0000-0003-3726-3114	National Institute Of Allergy And Infectious Diseases [R21AI078842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078842] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	The project described was supported by Award Number R21AI078842 from the National Institute Of Allergy And Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Benson CA, 2006, J INFECT DIS, V194, P1309, DOI 10.1086/508289; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; Bonjoch A, 2008, HIV CLIN TRIALS, V9, P387, DOI 10.1310/hct0906-387; CARDOZO EF, 2011, P IEEE ENG MED BIOL, P116; Colgrove R, 1999, ANTIVIR RES, V41, P45, DOI 10.1016/S0166-3542(98)00062-X; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; Gray CM, 2000, AIDS RES HUM RETROV, V16, P1357, DOI 10.1089/08892220050140900; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang YX, 2006, BIOMETRICS, V62, P413, DOI 10.1111/j.1541-0420.2005.00447.x; Katlama C, 2004, AIDS, V18, P217, DOI 10.1097/00002030-200401230-00011; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Luo R, 2008, P AMER CONTR CONF, P2112, DOI 10.1109/ACC.2008.4586804; Luo R, 2010, P AMER CONTR CONF, P5155; Luo RT, 2011, J PROCESS CONTR, V21, P367, DOI 10.1016/j.jprocont.2010.11.010; Luo RT, 2009, P AMER CONTR CONF, P2295, DOI 10.1109/ACC.2009.5160358; Mansky LM, 1996, AIDS RES HUM RETROV, V12, P307, DOI 10.1089/aid.1996.12.307; Martinez-Picado J, 2003, ANN INTERN MED, V139, P81, DOI 10.7326/0003-4819-139-2-200307150-00007; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rosero-Garcia EE, 2010, P AMER CONTR CONF, P460; Ruiz L, 2001, AIDS, V15, pF19, DOI 10.1097/00002030-200106150-00001; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Wodarz D, 2001, J THEOR BIOL, V213, P447, DOI 10.1006/jtbi.2001.2426; Wong JK, 1997, J VIROL, V71, P2059, DOI 10.1128/JVI.71.3.2059-2071.1997; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996; ZURAKOWSKI R, 2007, P 46 IEEE C DEC CONT, P5174; Zurakowski R, 2011, P AMER CONTR CONF, P5418; Zurakowski R, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-40	39	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27047	10.1371/journal.pone.0027047	http://dx.doi.org/10.1371/journal.pone.0027047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073250	gold, Green Submitted, Green Published			2022-12-25	WOS:000297197000025
J	Ahmad, E; Rabbani, G; Zaidi, N; Singh, S; Rehan, M; Khan, MM; Rahman, SK; Quadri, Z; Shadab, M; Ashraf, MT; Subbarao, N; Bhat, R; Khan, RH				Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Singh, Saurabh; Rehan, Mohd; Khan, Mohd Moin; Rahman, Shah Kamranur; Quadri, Zainuddin; Shadab, Mohd.; Ashraf, Mohd Tashfeen; Subbarao, Naidu; Bhat, Rajiv; Khan, Rizwan Hasan			Stereo-Selectivity of Human Serum Albumin to Enantiomeric and Isoelectronic Pollutants Dissected by Spectroscopy, Calorimetry and Bioinformatics	PLOS ONE			English	Article							ARTIFICIAL PROTEIN; CRYSTAL-STRUCTURE; BINDING SITE; FLUORESCENCE; THERMODYNAMICS; SPECIFICITY	1-naphthol (1N), 2-naphthol (2N) and 8-quinolinol (8H) are general water pollutants. 1N and 2N are the configurational enantiomers and 8H is isoelectronic to 1N and 2N. These pollutants when ingested are transported in the blood by proteins like human serum albumin (HSA). Binding of these pollutants to HSA has been explored to elucidate the specific selectivity of molecular recognition by this multiligand binding protein. The association constants (K-b) of these pollutants to HSA were moderate (10(4)-10(5) M-1). The proximity of the ligands to HSA is also revealed by their average binding distance, r, which is estimated to be in the range of 4.39-5.37 nm. The binding free energy (Delta G) in each case remains effectively the same for each site because of enthalpy-entropy compensation (EEC). The difference observed between Delta C-p(exp) and Delta C-p(calc) are suggested to be caused by binding-induced flexibility changes in the HSA. Efforts are also made to elaborate the differences observed in binding isotherms obtained through multiple approaches of calorimetry, spectroscopy and bioinformatics. We suggest that difference in dissociation constants of pollutants by calorimetry, spectroscopic and computational approaches could correspond to occurrence of different set of populations of pollutants having different molecular characteristics in ground state and excited state. Furthermore, our observation of enhanced binding of pollutants (2N and 8H) in the presence of hemin signifies that ligands like hemin may enhance the storage period of these pollutants in blood that may even facilitate the ill effects of these pollutants.	[Ahmad, Ejaz; Rabbani, Gulam; Zaidi, Nida; Khan, Mohd Moin; Rahman, Shah Kamranur; Quadri, Zainuddin; Shadab, Mohd.; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Singh, Saurabh; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Rehan, Mohd; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Ashraf, Mohd Tashfeen] Gautam Buddha Univ, Sch Biotechnol, Greater Noida, India	Aligarh Muslim University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Gautam Buddha University	Ahmad, E (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Ahmad, Ejaz/L-1506-2013; Khan, Mohd Moin/GYQ-7170-2022; Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022; Subbarao, Prof Naidu/AAZ-1832-2020; Rehan, Mohd/H-9835-2012; Quadri, Zainuddin/GYD-5172-2022; Khan, Rizwan Hasan/F-8276-2014	Ahmad, Ejaz/0000-0002-5713-6713; Rabbani, Gulam/0000-0002-5293-8231; Subbarao, Prof Naidu/0000-0002-1720-2165; Quadri, Zainuddin/0000-0002-4068-6153; Khan, Rizwan Hasan/0000-0002-9965-8982; Shadab, Mohammad/0000-0003-4148-0365; Zaidi, Dr Nida/0000-0003-2579-2190; Rahman, Shah Kamranur/0000-0002-8835-7092; Rehan, Mohd/0000-0003-4898-6043; Mohd., Tashfeen Ashraf/0000-0003-1580-0003	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to E. Ahmad in the form of a Senior Research Fellowship was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1980, BIOCHEM J, V191, P95, DOI 10.1042/bj1910095; Alkilany AM, 2008, LANGMUIR, V24, P10235, DOI 10.1021/la8018343; Bevington PR, DATA REDUCTION ERROR; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; Bjelic S, 2008, J MOL RECOGNIT, V21, P289, DOI 10.1002/jmr.909; Brodersen R, 1982, BILIRUBIN, V1; CROSS AJ, 1986, BIOPHYS J, V50, P507, DOI 10.1016/S0006-3495(86)83488-9; Cyril L, BIOCH HDB; DeLano W.L., PYMOL MOL GRAPHICS S; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; DONOVAN JW, 1969, J BIOL CHEM, V244, P1961; DROGE JHM, 1985, BIOCHEM PHARMACOL, V34, P3299, DOI 10.1016/0006-2952(85)90349-1; Feng XZ, 1998, TALANTA, V47, P1223, DOI 10.1016/S0039-9140(98)00198-2; Fitzgerald MM, 1996, NAT STRUCT BIOL, V3, P626, DOI 10.1038/nsb0796-626; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gomez MA, 2003, EXCITED STATE PROPER; Hu YJ, 2005, J MOL STRUCT, V750, P174, DOI 10.1016/j.molstruc.2005.04.032; Hubbard SJ, NACCESS COMPUTER PRO; Il'ichev YV, 2002, J PHYS CHEM B, V106, P452, DOI 10.1021/jp012314u; Jelen F, 2009, J STRUCT BIOL, V165, P10, DOI 10.1016/j.jsb.2008.09.007; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; KRAGHHANSEN U, 1991, BIOCHEM J, V273, P641, DOI 10.1042/bj2730641; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Lakowicz J. R., PRINCIPLES FLUORESCE; Meeker JD, 2006, EPIDEMIOLOGY, V17, P61, DOI 10.1097/01.ede.0000190602.14691.70; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Musah RA, 2002, J MOL BIOL, V315, P845, DOI 10.1006/jmbi.2001.5287; Otosu T, 2010, J BIOCHEM, V147, P191, DOI 10.1093/jb/mvp175; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINKERTON TC, 1990, ANAL CHEM, V62, P2114, DOI 10.1021/ac00218a013; Privalov PL, 1987, METHOD ENZYMOL, V131, P4; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sahoo BK, 2008, BIOPHYS CHEM, V132, P81, DOI 10.1016/j.bpc.2007.10.007; Sharma R, 2008, J CHEM THERMODYN, V40, P1141, DOI 10.1016/j.jct.2008.02.009; Singh SK, 2006, J PHYS CHEM B, V110, P9728, DOI 10.1021/jp0608426; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X	49	120	120	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26186	10.1371/journal.pone.0026186	http://dx.doi.org/10.1371/journal.pone.0026186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073150	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900014
J	Fisher, R; Knowlton, N; Brainard, RE; Caley, MJ				Fisher, Rebecca; Knowlton, Nancy; Brainard, Russell E.; Caley, M. Julian			Differences among Major Taxa in the Extent of Ecological Knowledge across Four Major Ecosystems	PLOS ONE			English	Article							BIODIVERSITY; RESILIENCE; DIVERSITY; ASSEMBLAGES; RICHNESS; SYSTEMS; FUTURE; PLUS; FISH	Existing knowledge shapes our understanding of ecosystems and is critical for ecosystem-based management of the world's natural resources. Typically this knowledge is biased among taxa, with some taxa far better studied than others, but the extent of this bias is poorly known. In conjunction with the publically available World Registry of Marine Species database (WoRMS) and one of the world's premier electronic scientific literature databases (Web of Science (R)), a text mining approach is used to examine the distribution of existing ecological knowledge among taxa in coral reef, mangrove, seagrass and kelp bed ecosystems. We found that for each of these ecosystems, most research has been limited to a few groups of organisms. While this bias clearly reflects the perceived importance of some taxa as commercially or ecologically valuable, the relative lack of research of other taxonomic groups highlights the problem that some key taxa and associated ecosystem processes they affect may be poorly understood or completely ignored. The approach outlined here could be applied to any type of ecosystem for analyzing previous research effort and identifying knowledge gaps in order to improve ecosystem-based conservation and management.	[Fisher, Rebecca] Australian Inst Marine Sci, UWA Oceans Inst, Crawley, WA, Australia; [Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Brainard, Russell E.] Natl Marine Fisheries Serv, Coral Reef Ecosyst Div, Pacific Isl Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Honolulu, HI USA; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Australian Institute of Marine Science	Fisher, R (corresponding author), Australian Inst Marine Sci, UWA Oceans Inst, Crawley, WA, Australia.	r.fisher@aims.gov.au	Fisher, Rebecca/C-5459-2011; Caley, Julian/A-4042-2008	Fisher, Rebecca/0000-0001-5148-6731; Caley, Julian/0000-0001-5739-749X	BHP Billiton through CReefs Australia	BHP Billiton through CReefs Australia	This work was funded by BHP Billiton through CReefs Australia, a partnership between BHP Billiton, the Great Barrier Reef Foundation, the Census of Marine Life and the Australian Institute of Marine Science (AIMS). CReefs Australia is a node of the Census of Coral Reef Ecosystems (CReefs), a project of the Census of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Anderson MJ, 2005, J EXP MAR BIOL ECOL, V320, P35, DOI 10.1016/j.jembe.2004.12.023; Barnes RD, 1982, INVERTEBRATE ZOOLOGY, P104; Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Bowen W, 1997, MAR ECOL PROG SER, V158, P74; Boxshall G., 2010, HARPACTICOIDA; Burgess SC, 2010, GLOBAL ECOL BIOGEOGR, V19, P363, DOI 10.1111/j.1466-8238.2009.00516.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chapman AD, 2009, NUMBERS LIVING SPECI; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Fisher R, 2010, CONSERVATION LETT; GARFIELD E, 1990, CURR CONTENTS, V1, P3; GARFIELD E, 1990, CURR CONTENTS, V33, P5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harborne AR, 2006, ADV MARINE BIOL; HECK KL, 1995, J EXP MAR BIOL ECOL, V189, P205, DOI 10.1016/0022-0981(95)00012-G; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Kuiter RH, 2006, WORLD ATLAS MARINE F; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PEARSON DL, 1994, PHILOS T ROY SOC B, V345, P75, DOI 10.1098/rstb.1994.0088; Pinheiro J, 2001, MIXED EFFECTS MODELS; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; R Development Core Team, 2009, R FDN STAT COMP; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Zuur Alain F., 2009, P1	48	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26556	10.1371/journal.pone.0026556	http://dx.doi.org/10.1371/journal.pone.0026556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073172	Green Published, gold			2022-12-25	WOS:000297154900024
J	Stockl, AL; Petie, R; Nilsson, DE				Stockl, Anna Lisa; Petie, Ronald; Nilsson, Dan-Eric			Setting the Pace: New Insights into Central Pattern Generator Interactions in Box Jellyfish Swimming	PLOS ONE			English	Article							TRIPEDALIA-CYSTOPHORA; NERVOUS-SYSTEM; MEDUSAE; PACEMAKERS; RHOPALIA; CNIDARIA; CUBOZOA; MUSCLES; NEURONS; NERVES	Central Pattern Generators (CPGs) produce rhythmic behaviour across all animal phyla. Cnidarians, which have a radially symmetric nervous system and pacemaker centres in multiples of four, provide an interesting comparison to bilaterian animals for studying the coordination between CPGs. The box jellyfish Tripedalia cystophora is remarkable among cnidarians due to its most elaborate visual system. Together with their ability to actively swim and steer, they use their visual system for multiple types of behaviour. The four swim CPGs are directly regulated by visual input. In this study, we addressed the question of how the four pacemaker centres of this radial symmetric cnidarian interact. We based our investigation on high speed camera observations of the timing of swim pulses of tethered animals (Tripedalia cystophora) with one or four rhopalia, under different simple light regimes. Additionally, we developed a numerical model of pacemaker interactions based on the inter pulse interval distribution of animals with one rhopalium. We showed that the model with fully resetting coupling and hyperpolarization of the pacemaker potential below baseline fitted the experimental data best. Moreover, the model of four swim pacemakers alone underscored the proportion of long inter pulse intervals (IPIs) considerably. Both in terms of the long IPIs as well as the overall swim pulse distribution, the simulation of two CPGs provided a better fit than that of four. We therefore suggest additional sources of pacemaker control than just visual input. We provide guidelines for future research on the physiological linkage of the cubozoan CPGs and show the insight from bilaterian CPG research, which show that pacemakers have to be studied in their bodily and nervous environment to capture all their functional features, are also manifest in cnidarians.	[Stockl, Anna Lisa; Petie, Ronald; Nilsson, Dan-Eric] Lund Univ, Dept Biol, Vis Grp, Lund, Sweden	Lund University	Stockl, AL (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	stoeckl@bio.lmu.de		Stockl, Anna/0000-0002-0833-9995; Petie, Ronald/0000-0002-4092-4756	Swedish Research Council [G21-2010-3503]; Elite Network of Bavaria	Swedish Research Council(Swedish Research CouncilEuropean Commission); Elite Network of Bavaria	The study was funded by the Swedish Research Council (grant to D.-E. Nilsson, grant no. G21-2010-3503) and supported by the Elite Network of Bavaria (travel grant to Anna Stockl, no grant-no exists). http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. https://www.elitenetzwerk.bayern.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DEMONT ME, 1988, J EXP BIOL, V134, P333; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Grimmelikhuijzen C.J.P., 1995, Experientia Supplementum (Basel), V72, P7; HORRIDGE GA, 1955, J EXP BIOL, V32, P642; HORRIDGE GA, 1959, J EXP BIOL, V36, P72; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G, 1982, ZOOL JB ANAT, V108, P17; LERNER J, 1971, J EXP BIOL, V55, P177; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MURRAY MJ, 1977, J COMP PHYSIOL, V117, P63, DOI 10.1007/BF00605524; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Parkefelt L, 2005, J COMP NEUROL, V492, P251, DOI 10.1002/cne.20658; Parkefelt L, 2009, J COMP NEUROL, V516, P157, DOI 10.1002/cne.22072; PASSANO LM, 1965, AM ZOOL, V5, P465; Petie R, 2011, J EXP BIOL IN PRESS, V214; Prinz AA, 2006, CURR OPIN NEUROBIOL, V16, P615, DOI 10.1016/j.conb.2006.10.001; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Romanes G J, 1876, J Anat Physiol, V10, P707; ROMANES GJ, 1877, PHILOS T ROY SOC LON, V167, P659; SATTERLIE RA, 1979, J COMP PHYSIOL, V133, P357, DOI 10.1007/BF00661138; SATTERLIE RA, 1979, NATURE, V281, P141, DOI 10.1038/281141a0; Satterlie RA, 2001, J EXP BIOL, V204, P1413; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Shorten M, 2005, J ZOOL, V267, P371, DOI 10.1017/S0952836905007600; Spencer AN, 1995, AM ZOOL, V35, P520; Yatsu N., 1917, J COLL SCI IMP U TOK, V11, P1	36	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27201	10.1371/journal.pone.0027201	http://dx.doi.org/10.1371/journal.pone.0027201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073288	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900089
J	Slee, RB; Steiner, CM; Herbert, BS; Vance, GH; Hickey, RJ; Schwarz, T; Christan, S; Radovich, M; Schneider, BP; Schindelhauer, D; Grimes, BR				Slee, R. B.; Steiner, C. M.; Herbert, B-S; Vance, G. H.; Hickey, R. J.; Schwarz, T.; Christan, S.; Radovich, M.; Schneider, B. P.; Schindelhauer, D.; Grimes, B. R.			Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability	ONCOGENE			English	Article						pericentromeric heterochromatin; chromosome instability; JMJD2 demethylase	ALPHA-SATELLITE DNA; CENP-B BOX; HISTONE DEMETHYLASES; HUMAN KINETOCHORE; CHROMATIN; CENTROMERE; DISTINCT; OVEREXPRESSION; INACTIVATION; ORGANIZATION	Many tumors exhibit elevated chromosome mis-segregation termed chromosome instability (CIN), which is likely to be a potent driver of tumor progression and drug resistance. Causes of CIN are poorly understood but probably include prior genome tetraploidization, centrosome amplification and mitotic checkpoint defects. This study identifies epigenetic alteration of the centromere as a potential contributor to the CIN phenotype. The centromere controls chromosome segregation and consists of higher-order repeat (HOR) alpha-satellite DNA packaged into two chromatin domains: the kinetochore, harboring the centromere-specific H3 variant centromere protein A (CENP-A), and the pericentromeric heterochromatin, considered important for cohesion. Perturbation of centromeric chromatin in model systems causes CIN. As cancer cells exhibit widespread chromatin changes, we hypothesized that pericentromeric chromatin structure could also be affected, contributing to CIN. Cytological and chromatin immunoprecipitation and PCR (ChIP-PCR)-based analyses of HT1080 cancer cells showed that only one of the two HORs on chromosomes 5 and 7 incorporate CENP-A, an organization conserved in all normal and cancer-derived cells examined. Contrastingly, the heterochromatin marker H3K9me3 (trimethylation of H3 lysine 9) mapped to all four HORs and ChIP-PCR showed an altered pattern of H3K9me3 in cancer cell lines and breast tumors, consistent with a reduction on the kinetochore-forming HORs. The JMJD2B demethylase is overexpressed in breast tumors with a CIN phenotype, and overexpression of exogenous JMJD2B in cultured breast epithelial cells caused loss of centromere-associated H3K9me3 and increased CIN. These findings suggest that impaired maintenance of pericentromeric heterochromatin may contribute to CIN in cancer and be a novel therapeutic target. Oncogene (2012) 31, 3244-3253; doi:10.1038/onc.2011.502; published online 28 November 2011	[Slee, R. B.; Steiner, C. M.; Herbert, B-S; Vance, G. H.; Radovich, M.; Schneider, B. P.; Grimes, B. R.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Slee, R. B.; Herbert, B-S; Vance, G. H.; Hickey, R. J.; Schneider, B. P.; Grimes, B. R.] Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Hickey, R. J.; Schneider, B. P.] IUSM, Dept Med, Indianapolis, IN 46202 USA; [Schwarz, T.; Christan, S.; Schindelhauer, D.] Univ Munich, Dept Med Genet, Munich, Germany	Indiana University System; Indiana University Bloomington; University of Munich	Grimes, BR (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	brgrimes@iupui.edu			INGEN (Indiana Genomics Initiative); IUSM Cytogenetics Division; US DOD BCRP [W81XWH-09-1-0424]; American Cancer Society [IRG-84-002-24]; IUSM Biomedical Research Grants; NCI [N01 CN-43300]; Deutsche Forschungsgemeinschaft; Friedrich Baur Institute; Lilly Endowment; NIH [NRSA 1 T32 CA 111198]; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER	INGEN (Indiana Genomics Initiative); IUSM Cytogenetics Division; US DOD BCRP; American Cancer Society(American Cancer Society); IUSM Biomedical Research Grants; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich Baur Institute; Lilly Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kinya Yoda for advice with ChIP assays; Simone Schuffenhauer and Jan Murken for BF cells; Hunt Willard, Mariano Rocci and Theo Hulsebos for centromere plasmid probes; Tim Yen for CENP-E antibodies; Mervin Yoder for HUVEC samples; Virginia Thurston for advice on the patient BF sample and Andrew Ross, Nikki Collins, Janak Bhavsar, Tony Brown, Waylan Bessler and Laura Mead for technical assistance. This research was supported in part by INGEN (Indiana Genomics Initiative), the IUSM Cytogenetics Division and grants from the US DOD BCRP (W81XWH-09-1-0424) and American Cancer Society (IRG-84-002-24) awarded to BRG, IUSM Biomedical Research Grants awarded to RBS and an NCI grant (N01 CN-43300) to BSH. DS was supported by Deutsche Forschungsgemeinschaft and the Friedrich Baur Institute. INGEN is supported in part by Lilly Endowment. MR was supported by an NIH pre-doctoral fellowship (NRSA 1 T32 CA 111198 Cancer Biology Training Program).	Alonso A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-6; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Cardinale S, 2009, MOL BIOL CELL, V20, P4194, DOI 10.1091/mbc.E09-06-0489; David G, 2006, ONCOGENE, V25, P7354, DOI 10.1038/sj.onc.1209734; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Grimes BR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r89; Grimes BR, 2009, STEM CELLS DEV, V18, P717, DOI 10.1089/scd.2008.0255; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; HAAF T, 1994, HUM MOL GENET, V3, P697, DOI 10.1093/hmg/3.5.697; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Hochreiter AE, 2006, CLIN CANCER RES, V12, P3184, DOI 10.1158/1078-0432.CCR-05-2760; HULSEBOS T, 1988, CYTOGENET CELL GENET, V47, P144, DOI 10.1159/000132533; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; Malorni L, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.10621; Mitelman F., 1994, CATALOG CHROMOSOME A; Mravinac B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006602; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Radovich M, TRANSCRIPTIONA UNPUB; Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rosandic M, 2006, CHROMOSOME RES, V14, P735, DOI 10.1007/s10577-006-1078-x; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; SCHINDELHAUER D, 1995, GENOMICS, V28, P605, DOI 10.1006/geno.1995.1202; Schuffenhauer S, 1996, AM J MED GENET, V65, P56, DOI 10.1002/(SICI)1096-8628(19961002)65:1<56::AID-AJMG9>3.3.CO;2-X; Shin HJ, 2003, ONCOGENE, V22, P3853, DOI 10.1038/sj.onc.1206502; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; SULLIVAN BA, 1999, PRACT APPROACH SER, V200, P81; Sullivan LL, 2011, CHROMOSOME RES, V19, P457, DOI 10.1007/s10577-011-9208-5; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tomonaga T, 2003, CANCER RES, V63, P3511; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Warburton PE, 1996, HUMAN GENOME EVOLUTI, P121; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yoda K, 2004, METHOD ENZYMOL, V375, P253	61	72	72	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	27					3244	3253		10.1038/onc.2011.502	http://dx.doi.org/10.1038/onc.2011.502			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22081068				2022-12-25	WOS:000306113400004
J	Kiyohara, M; Nakatomi, T; Kurihara, S; Fushinobu, S; Suzuki, H; Tanaka, T; Shoda, S; Kitaoka, M; Katayama, T; Yamamoto, K; Ashida, H				Kiyohara, Masashi; Nakatomi, Takashi; Kurihara, Shin; Fushinobu, Shinya; Suzuki, Hideyuki; Tanaka, Tomonari; Shoda, Shin-ichiro; Kitaoka, Motomitsu; Katayama, Takane; Yamamoto, Kenji; Ashida, Hisashi			alpha-N-Acetylgalactosaminidase from Infant-associated Bifidobacteria Belonging to Novel Glycoside Hydrolase Family 129 Is Implicated in Alternative Mucin Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; MOLECULAR-CLONING; BIOSE-I; TRANSGLYCOSYLATION ACTIVITY; CLOSTRIDIUM-PERFRINGENS; DIPLOCOCCUS-PNEUMONIAE; METABOLIC PATHWAYS; GENOME SEQUENCE; BINDING PROTEIN; MUCUS LAYERS	Bifidobacteria inhabit the lower intestine of mammals including humans where the mucin gel layer forms a space for commensal bacteria. We previously identified that infant-associated bifidobacteria possess an extracellular membrane-bound endo-alpha-N-acetylgalactosaminidase (EngBF) that may be involved in degradation and assimilation of mucin-type oligosaccharides. However, EngBF is highly specific for core-1-type O-glycan (Gal beta 1-3GalNAc alpha 1-Ser/Thr), also called T antigen, which is mainly attached onto gastroduodenal mucins. By contrast, core-3-type O-glycans (GlcNAc beta 1-3GalNAc alpha 1-Ser/Thr) are predominantly found on the mucins in the intestines. Here, we identified a novel alpha-N-acetylgalactosaminidase (NagBb) from Bifidobacterium bifidum JCM 1254 that hydrolyzes the Tn antigen (GalNAc alpha 1-Ser/Thr). Sialyl and galactosyl core-3 (Gal beta 1-3/4GlcNAc beta 1-3(Neu5Ac alpha 2-6)GalNAc alpha 1-Ser/Thr), a major tetrasaccharide structure on MUC2 mucin primarily secreted from goblet cells in human sigmoid colon, can be serially hydrolyzed into Tn antigen by previously identified bifidobacterial extracellular glycosidases such as alpha-sialidase (SiaBb2), lacto-N-biosidase (LnbB), beta-galactosidase (BbgIII), and beta-N-acetylhexosaminidases (BbhI and BbhII). Because NagBb is an intracellular enzyme without an N-terminal secretion signal sequence, it is likely involved in intracellular degradation and assimilation of Tn antigen-containing polypeptides, which might be incorporated through unknown transporters. Thus, bifidobacteria possess two distinct pathways for assimilation of O-glycans on gastroduodenal and intestinal mucins. NagBb homologs are conserved in infant-associated bifidobacteria, suggesting a significant role for their adaptation within the infant gut, and they were found to form a new glycoside hydrolase family 129.	[Kiyohara, Masashi; Nakatomi, Takashi; Kurihara, Shin; Yamamoto, Kenji; Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Kiyohara, Masashi; Katayama, Takane; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Suzuki, Hideyuki; Tanaka, Tomonari] Kyoto Inst Technol, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 6068585, Japan; [Shoda, Shin-ichiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Kyoto University; Ishikawa Prefecture University; University of Tokyo; Kyoto Institute of Technology; Tohoku University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Ashida, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	ashida@lif.kyoto-u.ac.jp	Tanaka, Tomonari/GPP-2232-2022; Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019; Ashida, Hisashi/HCI-0293-2022	Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075; Tanaka, Tomonari/0000-0002-7050-9043	Program for Promotion of Basic Research Activities for Innovative Biosciences	Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Ashida H, 2000, ARCH BIOCHEM BIOPHYS, V373, P394, DOI 10.1006/abbi.1999.1565; Ashida H, 2000, ARCH BIOCHEM BIOPHYS, V384, P305, DOI 10.1006/abbi.2000.2114; Ashida H, 2001, CARBOHYD RES, V330, P487, DOI 10.1016/S0008-6215(01)00008-8; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Ashida H, 2010, GLYCOCONJUGATE J, V27, P125, DOI 10.1007/s10719-009-9247-8; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; ENDO Y, 1976, J BIOCHEM-TOKYO, V80, P1; FAN JQ, 1990, AGR BIOL CHEM TOKYO, V54, P233, DOI 10.1080/00021369.1990.10869928; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Goda HM, 2008, BIOCHEM BIOPH RES CO, V375, P541, DOI 10.1016/j.bbrc.2008.08.065; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P471, DOI 10.1007/s00253-008-1750-5; GUM JR, 1994, J BIOL CHEM, V269, P2440; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Tanaka T, 2008, CHEM COMMUN, P2016, DOI 10.1039/b801090k; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Zhao H, 2008, FEMS MICROBIOL LETT, V285, P278, DOI 10.1111/j.1574-6968.2008.01246.x	48	68	69	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					693	700		10.1074/jbc.M111.277384	http://dx.doi.org/10.1074/jbc.M111.277384			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090027	Green Published, hybrid			2022-12-25	WOS:000298682400067
J	Lok, HC; Rahmanto, YS; Hawkins, CL; Kalinowski, DS; Morrow, CS; Townsend, AJ; Ponka, P; Richardson, DR				Lok, Hiu Chuen; Rahmanto, Yohan Suryo; Hawkins, Clare L.; Kalinowski, Danuta S.; Morrow, Charles S.; Townsend, Alan J.; Ponka, Prem; Richardson, Des R.			Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC ACTIVATED MACROPHAGES; NITROGEN MONOXIDE; DRUG-RESISTANCE; INHIBITION; NO; PREECLAMPSIA; MOBILIZATION; METABOLISM; EXPRESSION; PROTECTION	Nitrogen monoxide (NO) plays a role in the cytotoxic mechanisms of activated macrophages against tumor cells by inducing iron release. We showed that NO-mediated iron efflux from cells required glutathione (GSH) (Watts, R. N., and Richardson, D. R. (2001) J. Biol. Chem. 276, 4724-4732) and that the GSH-conjugate transporter, multidrug resistance-associated protein 1 (MRP1), mediates this release potentially as a dinitrosyl-dithiol iron complex (DNIC; Watts, R. N., Hawkins, C., Ponka, P., and Richardson, D. R. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 7670-7675). Recently, glutathione S-transferase P1-1 (GST P1-1) was shown to bind DNICs as dinitrosyl-diglutathionyl iron complexes. Considering this and that GSTs and MRP1 form an integrated detoxification unit with chemotherapeutics, we assessed whether these proteins coordinately regulate storage and transport of DNICs as long lived NO intermediates. Cells transfected with GSTP1 (but not GSTA1 or GSTM1) significantly decreased NO-mediated Fe-59 release from cells. This NO-mediated Fe-59 efflux and the effect of GST P1-1 on preventing this were observed with NO-generating agents and also in cells transfected with inducible nitric oxide synthase. Notably, Fe-59 accumulated in cells within GST P1-1-containing fractions, indicating an alteration in intracellular Fe-59 distribution. Furthermore, electron paramagnetic resonance studies showed that MCF7-VP cells transfected with GSTP1 contain significantly greater levels of a unique DNIC signal. These investigations indicate that GST P1-1 acts to sequester NO as DNICs, reducing their transport out of the cell by MRP1. Cell proliferation studies demonstrated the importance of the combined effect of GST P1-1 and MRP1 in protecting cells from the cytotoxic effects of NO. Thus, the DNIC storage function of GST P1-1 and ability of MRP1 to efflux DNICs are vital in protection against NO cytotoxicity.	[Lok, Hiu Chuen; Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Hawkins, Clare L.] Heart Res Inst, Sydney, NSW 2042, Australia; [Morrow, Charles S.; Townsend, Alan J.] Wake Forest Univ, Dept Biochem, Winston Salem, NC 27157 USA; [Ponka, Prem] Lady Davis Inst, Montreal, PQ H3T 1E2, Canada	University of Sydney; University of Sydney; Heart Research Institute; Wake Forest University; Lady Davis Institute; McGill University	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Blackburn Bldg,D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Ponka, Prem/A-4123-2011; Hawkins, Clare/AAV-7424-2021; Townsend, Alan/AAE-9602-2019; Suryo Rahmanto, Yohan/K-8043-2018; Hawkins, Clare L/F-6696-2014	Hawkins, Clare/0000-0003-2738-5089; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Hawkins, Clare L/0000-0003-2738-5089; Ponka, Prem/0000-0001-5835-1477; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415; Kalinowski, Danuta/0000-0002-9303-7405	Australian Research Council [DP1092734]; Canadian Institute of Health research; Cancer Institute NSW [08/ECF/1-36, 08/ECF/1-30]; National Heart Foundation [CR08S 3959]; National Health and Medical Research Council of Australia [570829, 571123]	Australian Research Council(Australian Research Council); Canadian Institute of Health research(Canadian Institutes of Health Research (CIHR)); Cancer Institute NSW; National Heart Foundation(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092734 from the Australian Research Council (to D. R. R.) and a Canadian Institute of Health research grant (to P. P.).; Supported by Cancer Institute NSW Early Career Fellowship 08/ECF/1-36.; Supported by National Heart Foundation Fellowship CR08S 3959 and National Health and Medical Research Council of Australia Project Grant 570829.; Supported by Cancer Institute NSW Early Career Fellowship 08/ECF/1-30.; Supported by the National Health and Medical Research Council of Australia for Senior Principal Research Fellowship 571123 and project grants. To whom correspondence should be addressed: Blackburn Bldg. - D06, Dept. of Pathology, University of Sydney, NSW 2006, Australia. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	BASTIAN NR, 1994, J BIOL CHEM, V269, P5127; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Choi JW, 2002, ANN CLIN LAB SCI, V32, P257; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Depeille P, 2004, MOL PHARMACOL, V65, P897, DOI 10.1124/mol.65.4.897; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Harbottle A, 2001, INT J CANCER, V92, P777, DOI 10.1002/ijc.1283; Harrop TC, 2008, J AM CHEM SOC, V130, P15602, DOI 10.1021/ja8054996; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Richardson DR, 2008, BBA-GEN SUBJECTS, V1780, P638, DOI 10.1016/j.bbagen.2007.12.009; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; VANIN AF, 1991, FEBS LETT, V289, P1, DOI 10.1016/0014-5793(91)80894-9; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zaman K, 2004, BIOCHEM J, V380, P67, DOI 10.1042/BJ20031687	37	46	49	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					607	618		10.1074/jbc.M111.310987	http://dx.doi.org/10.1074/jbc.M111.310987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084240	Green Published, hybrid			2022-12-25	WOS:000298682400059
J	Wang, K; Lin, ZQ; Long, B; Li, JH; Zhou, J; Li, PF				Wang, Kun; Lin, Zhi-Qiang; Long, Bo; Li, Jian-Hui; Zhou, Jing; Li, Pei-Feng			Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; CARDIOMYOCYTE HYPERTROPHY; IN-VIVO; TRANSCRIPTION FACTOR; DOWN-REGULATION; DISEASE; APOPTOSIS; PHOSPHORYLATION; MYOCARDIN; TARGETS	MicroRNAs (miRNAs) are a class of small noncoding RNAs that mediate post-transcriptional gene silencing. Myocardial hypertrophy is frequently associated with the development of heart failure. A variety of miRNAs are involved in the regulation of cardiac hypertrophy, however, the molecular targets of miRNAs in the cardiac hypertrophic cascades remain to be fully identified. We produced miR-23a transgenic mice, and these mice exhibit exaggerated cardiac hypertrophy in response to the stimulation with phenylephrine or pressure overload by transverse aortic banding. The endogenous miR-23a is up-regulated upon treatment with phenylephrine, endothelin-1, or transverse aortic banding. Knockdown of miR-23a attenuates hypertrophic responses. To identify the downstream targets of miR-23a, we found that transcription factor Foxo3a is suppressed by miR-23a. Luciferase assay indicates that miR-23a directly inhibits the translation activity of Foxo3a 3' UTR. Introduction or knockdown of miR-23a leads to the alterations of Foxo3a protein levels. Enforced expression of the constitutively active form of Foxo3a counteracts the provocative effect of miR-23a on hypertrophy. Furthermore, we observed that miR-23a is able to alter the expression levels of manganese superoxide dismutase and the consequent reactive oxygen species, and this effect is mediated by Foxo3a. In addition, our results show that miR-23a and Foxo3a bi-transgenic mice exhibit a reduced hypertrophic response compared with the miR-23a transgenic mice alone. Our present study reveals that miR-23a can mediate the hypertrophic signal through regulating Foxo3a. They form an axis in hypertrophic machinery and can be targets for the development of hypertrophic treatment.	[Wang, Kun; Lin, Zhi-Qiang; Long, Bo; Li, Jian-Hui; Zhou, Jing; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Long, Bo/GQH-5131-2022; Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022; Long, Bo/AGX-8013-2022	Li, Peifeng/0000-0002-0969-9407; Lin, zhiqiang/0000-0002-2034-2492	National Natural Science Foundation of China [30730045, 30900761, 31010103911]; National Basic Research Program of China 973 Program [2007CB512000, 2011CB965300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045, 30900761, and 31010103911 and National Basic Research Program of China 973 Program Grants 2007CB512000 and 2011CB965300.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529; Amin JK, 2001, J MOL CELL CARDIOL, V33, P131, DOI 10.1006/jmcc.2000.1285; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen D, 2005, BIOCHEM PHARMACOL, V69, P1421, DOI 10.1016/j.bcp.2005.02.022; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Han MY, 2009, CIRCULATION, V120, pS732; Huang ZP, 2010, J CARDIOVASC TRANSL, V3, P212, DOI 10.1007/s12265-010-9165-y; Ikeda S, 2010, CURR DRUG TARGETS, V11, P913, DOI 10.2174/138945010791591304; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Markham DW, 2010, CIRC RES, V106, P1011, DOI 10.1161/CIRCRESAHA.110.219030; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Topkara VK, 2010, PERS MED, V7, P531, DOI 10.2217/PME.10.44; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437	53	92	96	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					589	599		10.1074/jbc.M111.266940	http://dx.doi.org/10.1074/jbc.M111.266940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084234	Green Published, hybrid			2022-12-25	WOS:000298682400057
J	Biggs, PJ; Fearnhead, P; Hotter, G; Mohan, V; Collins-Emerson, J; Kwan, E; Besser, TE; Cookson, A; Carter, PE; French, NP				Biggs, Patrick J.; Fearnhead, Paul; Hotter, Grant; Mohan, Vathsala; Collins-Emerson, Julie; Kwan, Errol; Besser, Thomas E.; Cookson, Adrian; Carter, Philip E.; French, Nigel P.			Whole-Genome Comparison of Two Campylobacter jejuni Isolates of the Same Sequence Type Reveals Multiple Loci of Different Ancestral Lineage	PLOS ONE			English	Article							MICROBIAL GENE IDENTIFICATION; RECOMBINATION; POLYMORPHISM; ANNOTATION; DIVERGENCE; ALIGNMENT; ORTHOMCL; ARTEMIS; CLONES; DNA	Campylobacter jejuni ST-474 is the most important human enteric pathogen in New Zealand, and yet this genotype is rarely found elsewhere in the world. Insight into the evolution of this organism was gained by a whole genome comparison of two ST-474, flaA SVR-14 isolates and other available C. jejuni isolates and genomes. The two isolates were collected from different sources, human (H22082) and retail poultry (P110b), at the same time and from the same geographical location. Solexa sequencing of each isolate resulted in similar to 1.659 Mb (H22082) and similar to 1.656 Mb (P110b) of assembled sequences within 28 (H22082) and 29 (P110b) contigs. We analysed 1502 genes for which we had sequences within both ST-474 isolates and within at least one of 11 C. jejuni reference genomes. Although 94.5% of genes were identical between the two ST-474 isolates, we identified 83 genes that differed by at least one nucleotide, including 55 genes with non-synonymous substitutions. These covered 101 kb and contained 672 point differences. We inferred that 22 (3.3%) of these differences were due to mutation and 650 (96.7%) were imported via recombination. Our analysis estimated 38 recombinant breakpoints within these 83 genes, which correspond to recombination events affecting at least 19 loci regions and gives a tract length estimate of similar to 2 kb. This includes a similar to 12 kb region displaying non-homologous recombination in one of the ST-474 genomes, with the insertion of two genes, including ykgC, a putative oxidoreductase, and a conserved hypothetical protein of unknown function. Furthermore, our analysis indicates that the source of this recombined DNA is more likely to have come from C. jejuni strains that are more closely related to ST-474. This suggests that the rates of recombination and mutation are similar in order of magnitude, but that recombination has been much more important for generating divergence between the two ST-474 isolates.	[Biggs, Patrick J.; Mohan, Vathsala; Collins-Emerson, Julie; Kwan, Errol; French, Nigel P.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Fearnhead, Paul] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Hotter, Grant] AgResearch, Hopkirk Res Inst, Anim Hlth Sect, Palmerston North, New Zealand; [Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Cookson, Adrian] AgResearch Ltd, Rumen Microbiol Anim Nutr & Hlth Capabil Grp, Palmerston North, New Zealand; [Carter, Philip E.] Inst Environm Sci & Res Ltd, Wellington, New Zealand	Massey University; Lancaster University; AgResearch - New Zealand; Washington State University; AgResearch - New Zealand; Institute of Environmental Science & Research (ESR) - New Zealand	Biggs, PJ (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	p.biggs@massey.ac.nz	Cookson, Adrian/R-6617-2019; Fearnhead, Paul/A-1653-2008; Fearnhead, Paul/A-5938-2015; Hotter, Georgina/R-1156-2018; Mohan, Vathsala/R-5017-2016; French, Nigel/F-5725-2011; Biggs, Patrick Jon/H-3355-2014	Fearnhead, Paul/0000-0002-9386-2341; Fearnhead, Paul/0000-0002-9386-2341; Mohan, Vathsala/0000-0003-4486-9368; French, Nigel/0000-0002-6334-0657; Biggs, Patrick Jon/0000-0002-0285-4101	Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North [RM12767]; Royal Society of New Zealand [MAU0802]	Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North; Royal Society of New Zealand(Royal Society of New Zealand)	This work was supported by the Building Research Capability in Strategically Relevant Areas (BRCSRA) fund, Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North (RM12767) and The Royal Society of New Zealand Marsden Fund (MAU0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson J, 2012, ZOONOSES PUBLIC HLTH, V59, P52, DOI 10.1111/j.1863-2378.2011.01418.x; Baker MG, 2007, EPIDEMIOL INFECT, V135, P163, DOI 10.1017/S0950268806006583; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2008, EMERG INFECT DIS, V14, P1620, DOI 10.3201/eid1410.071109; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; DONNELLY P, 2010, LONDON MATH SOC LECT, V378; Falush D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000627; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; Fearnhead P, 2002, J ROY STAT SOC B, V64, P657, DOI 10.1111/1467-9868.00355; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; GUERRY P, 1990, J BACTERIOL, V172, P1853, DOI 10.1128/jb.172.4.1853-1860.1990; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li N, 2003, GENETICS, V165, P2213; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Muellner P, 2011, PREV VET MED, V102, P242, DOI 10.1016/j.prevetmed.2011.07.011; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen Y, 2001, MICROB ECOL, V42, P635, DOI 10.1007/s00248-001-1012-x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; SEARS A, 2011, NZ EMERGING INFECT D, V17, P1007; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; Sheppard SK, 2011, MICROBIOL-SGM, V157, P1066, DOI 10.1099/mic.0.045153-0; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	63	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27121	10.1371/journal.pone.0027121	http://dx.doi.org/10.1371/journal.pone.0027121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096527	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000297553900023
J	Platt, B; Drever, B; Koss, D; Stoppelkamp, S; Jyoti, A; Plano, A; Utan, A; Merrick, G; Ryan, D; Melis, V; Wan, H; Mingarelli, M; Porcu, E; Scrocchi, L; Welch, A; Riedel, G				Platt, Bettina; Drever, Benjamin; Koss, David; Stoppelkamp, Sandra; Jyoti, Amar; Plano, Andrea; Utan, Aneli; Merrick, Georgina; Ryan, Duncan; Melis, Valeria; Wan, Hong; Mingarelli, Marco; Porcu, Emanuele; Scrocchi, Louise; Welch, Andy; Riedel, Gernot			Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1	PLOS ONE			English	Article							AMYLOID-BETA OLIGOMERS; INTRACELLULAR A-BETA; TRANSGENIC MICE; ANIMAL-MODELS; DISEASE; MEMORY; DEFICITS; IMMUNIZATION; ACCUMULATION; HIPPOCAMPUS	Late-stage neuropathological hallmarks of Alzheimer's disease (AD) are beta-amyloid (beta A) and hyperphosphorylated tau peptides, aggregated into plaques and tangles, respectively. Corresponding phenotypes have been mimicked in existing transgenic mice, however, the translational value of aggressive over-expression has recently been questioned. As controlled gene expression may offer animal models with better predictive validity, we set out to design a transgenic mouse model that circumvents complications arising from pronuclear injection and massive over-expression, by targeted insertion of human mutated amyloid and tau transgenes, under the forebrain-and neurone-specific CaMKII alpha promoter, termed PLB1(Double). Crossing with an existing presenilin 1 line resulted in PLB1(Triple) mice. PLB1(Triple) mice presented with stable gene expression and age-related pathology of intra-neuronal amyloid and hyperphosphorylated tau in hippocampus and cortex from 6 months onwards. At this early stage, pre-clinical (18)FDG PET/CT imaging revealed cortical hypometabolism with increased metabolic activity in basal forebrain and ventral midbrain. Quantitative EEG analyses yielded heightened delta power during wakefulness and REM sleep, and time in wakefulness was already reliably enhanced at 6 months of age. These anomalies were paralleled by impairments in long-term and short-term hippocampal plasticity and preceded cognitive deficits in recognition memory, spatial learning, and sleep fragmentation all emerging at similar to 12 months. These data suggest that prodromal AD phenotypes can be successfully modelled in transgenic mice devoid of fibrillary plaque or tangle development. PLB1(Triple) mice progress from a mild (MCI-like) state to a more comprehensive AD-relevant phenotype, which are accessible using translational tools such as wireless EEG and microPET/CT.	[Platt, Bettina; Drever, Benjamin; Koss, David; Stoppelkamp, Sandra; Jyoti, Amar; Plano, Andrea; Utan, Aneli; Merrick, Georgina; Ryan, Duncan; Melis, Valeria; Mingarelli, Marco; Porcu, Emanuele; Welch, Andy; Riedel, Gernot] Univ Aberdeen, Coll Life Sci & Med, Sch Med Sci, Aberdeen, Scotland; [Wan, Hong] Pfizer BioTherapeut, Translat & Mol Med, Collegeville, PA USA; [Scrocchi, Louise] Amorfix Life Sci, Mississauga, ON, Canada	University of Aberdeen; Pfizer	Platt, B (corresponding author), Univ Aberdeen, Coll Life Sci & Med, Sch Med Sci, Aberdeen, Scotland.	b.platt@abdn.ac.uk		Koss, David/0000-0002-8034-9880; Platt, Bettina/0000-0002-7852-0749	KHIDI (Korea Health Industry Development Institute) [A040147]; TMRI (Translational Medicine Research Initiative) [NS_AU_098]	KHIDI (Korea Health Industry Development Institute); TMRI (Translational Medicine Research Initiative)	Part-funding from KHIDI (Korea Health Industry Development Institute; Project A040147) and TMRI (Translational Medicine Research Initiative, NS_AU_098) is acknowledged (to BP and GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bliwise Donald L, 2004, Clin Cornerstone, V6 Suppl 1A, pS16, DOI 10.1016/S1098-3597(04)90014-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brankack J, 2009, PROG NEURO-PSYCHOPH, V33, P806, DOI 10.1016/j.pnpbp.2009.03.027; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cvetkovic B, 2000, J BIOL CHEM, V275, P1073, DOI 10.1074/jbc.275.2.1073; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Drever BD, 2007, J ALZHEIMERS DIS, V12, P319; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Echeverria V, 2004, J ALZHEIMERS DIS, V6, P209; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Hale G, 2005, BEHAV NEUROSCI, V119, P884, DOI 10.1037/0735-7044.119.4.884; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kessels RPC, 2010, AGING NEUROPSYCHOL C, V17, P556, DOI 10.1080/13825585.2010.481354; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Kuntner C, 2009, MOL IMAGING BIOL, V11, P236, DOI 10.1007/s11307-009-0198-z; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; LUO F, 2010, NEUROBIOL A IN PRESS; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Micheau J, 2004, BEHAV NEUROSCI, V118, P1022, DOI 10.1037/0735-7044.118.5.1022; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicholson RM, 2010, BRAIN RES, V1347, P179, DOI 10.1016/j.brainres.2010.05.084; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; Prichep LS, 2007, ANN NY ACAD SCI, V1097, P156, DOI 10.1196/annals.1379.008; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Riedel G, 2009, BEHAV BRAIN RES, V204, P217, DOI 10.1016/j.bbr.2009.06.012; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; STOPPELKAMP S, 2011, EXP NEUROL; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tampellini D, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00013; Tanghe A., 2010, INT J ALZHEIMERS DIS, V2010, DOI DOI 10.4061/2010/417314; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vale C, 2010, CELL MOL NEUROBIOL, V30, P577, DOI 10.1007/s10571-009-9482-3; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Woodruff-Pak DS, 2008, J ALZHEIMERS DIS, V15, P507; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhang B, 2005, AM J PATHOL, V167, P1361, DOI 10.1016/S0002-9440(10)61223-0; 2010, ANN NEUROL, V68, pA9	64	87	89	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27068	10.1371/journal.pone.0027068	http://dx.doi.org/10.1371/journal.pone.0027068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096518	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900018
J	Baron, D; Magot, A; Ramstein, G; Steenman, M; Fayet, G; Chevalier, C; Jourdon, P; Houlgatte, R; Savagner, F; Pereon, Y				Baron, Daniel; Magot, Armelle; Ramstein, Gerard; Steenman, Marja; Fayet, Guillemette; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Savagner, Frederique; Pereon, Yann			Immune Response and Mitochondrial Metabolism Are Commonly Deregulated in DMD and Aging Skeletal Muscle	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TRANSCRIPTIONAL LANDSCAPE; CALORIC RESTRICTION; OXIDATIVE DAMAGE; ATROPHY INVOLVE; RECEPTOR-ALPHA; RAINBOW-TROUT; MICROARRAY; AGE; DNA	Duchenne Muscular Dystrophy (DMD) is a complex process involving multiple pathways downstream of the primary genetic insult leading to fatal muscle degeneration. Aging muscle is a multifactorial neuromuscular process characterized by impaired muscle regeneration leading to progressive atrophy. We hypothesized that these chronic atrophying situations may share specific myogenic adaptative responses at transcriptional level according to tissue remodeling. Muscle biopsies from four young DMD and four AGED subjects were referred to a group of seven muscle biopsies from young subjects without any neuromuscular disorder and explored through a dedicated expression microarray. We identified 528 differentially expressed genes (out of 2,745 analyzed), of which 328 could be validated by an exhaustive meta-analysis of public microarray datasets referring to DMD and Aging in skeletal muscle. Among the 328 validated co-expressed genes, 50% had the same expression profile in both groups and corresponded to immune/fibrosis responses and mitochondrial metabolism. Generalizing these observed meta-signatures with large compendia of public datasets reinforced our results as they could be also identified in other pathological processes and in diverse physiological conditions. Focusing on the common gene signatures in these two atrophying conditions, we observed enrichment in motifs for candidate transcription factors that may coordinate either the immune/fibrosis responses (ETS1, IRF1, NF1) or the mitochondrial metabolism (ESRRA). Deregulation in their expression could be responsible, at least in part, for the same transcriptome changes initiating the chronic muscle atrophy. This study suggests that distinct pathophysiological processes may share common gene responses and pathways related to specific transcription factors.	[Baron, Daniel; Steenman, Marja; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Savagner, Frederique; Pereon, Yann] INSERM, UMR915, Nantes, France; [Baron, Daniel; Ramstein, Gerard; Steenman, Marja; Jourdon, Philippe; Houlgatte, Remi; Pereon, Yann] Univ Nantes, Nantes, France; [Baron, Daniel; Magot, Armelle; Steenman, Marja; Fayet, Guillemette; Chevalier, Catherine; Jourdon, Philippe; Houlgatte, Remi; Pereon, Yann] CHU Nantes, Inst Thorax, CIC, F-44035 Nantes 01, France; [Magot, Armelle; Fayet, Guillemette; Pereon, Yann] CHU Nantes, Lab Explorat Fonct, F-44035 Nantes 01, France; [Magot, Armelle; Fayet, Guillemette; Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Rares Enfant, F-44035 Nantes 01, France; [Ramstein, Gerard] Ecole Polytech, Lab Informat Nantes Atlantique LINA, Nantes, France; [Savagner, Frederique] INSERM, UMR 694, Angers, France; [Savagner, Frederique] Univ Angers, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers	Baron, D (corresponding author), INSERM, UMR915, Nantes, France.	daniel.baron@inserm.fr	chevalier, catherine/L-4803-2015; Steenman, Marja/D-3618-2015; Steenman, Marja/S-8433-2019; Houlgatte, Remi/P-3020-2017	Steenman, Marja/0000-0003-4547-4448; Steenman, Marja/0000-0003-4547-4448; Ramstein, Gerard/0000-0003-0239-3330	"Institut National de la Sante et de la Recherche Medicale'' (INSERM); "Association Francaise contre les Myopathies'' (AFM)	"Institut National de la Sante et de la Recherche Medicale'' (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Association Francaise contre les Myopathies'' (AFM)(Association Francaise contre les Myopathies)	Funding were provided by the "Institut National de la Sante et de la Recherche Medicale'' (INSERM) and the "Association Francaise contre les Myopathies'' (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aure K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Baron D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-113; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Cossu G, 2000, J CLIN INVEST, V105, P1669, DOI 10.1172/JCI10376; Danko CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-31; Deschenes MR, 2011, CURR AGING SCI  0429; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Fierro AC, 2008, CURR GENOMICS, V9, P525, DOI 10.2174/138920208786847935; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Flanigan KM, 1998, NEUROL CLIN, V16, P659, DOI 10.1016/S0733-8619(05)70087-6; French L, 2009, BIOINFORMATICS, V25, P1543, DOI 10.1093/bioinformatics/btp259; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; GUTMANN DH, 1995, DEV DYNAM, V202, P302, DOI 10.1002/aja.1002020309; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Jafari Peyman, 2006, BMC Med Inform Decis Mak, V6, P27, DOI 10.1186/1472-6947-6-27; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; Kossler N, 2011, HUM MOL GENET; Lamirault G, 2010, J CELL MOL MED, V14, P1443, DOI 10.1111/j.1582-4934.2009.00913.x; Le Meur N, 2004, NUCLEIC ACIDS RES, V32, P5349, DOI 10.1093/nar/gkh870; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lopez F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004001; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rhodes DR, 2002, CANCER RES, V62, P4427; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; Steenman M, 2005, EUR J HEART FAIL, V7, P157, DOI 10.1016/j.ejheart.2004.05.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trovo-Marqui AB, 2006, CLIN GENET, V70, P1, DOI 10.1111/j.1399-0004.2006.00639.x; TURNER PR, 1993, J MEMBRANE BIOL, V133, P243; Virtanen C, 2008, APPL PHYSIOL NUTR ME, V33, P124, DOI 10.1139/H07-150; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	66	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26952	10.1371/journal.pone.0026952	http://dx.doi.org/10.1371/journal.pone.0026952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096509	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800018
J	Besnard, V; Wert, SE; Ikegami, M; Xu, Y; Heffner, C; Murray, SA; Donahue, LR; Whitsett, JA				Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae; Whitsett, Jeffrey A.			Maternal Synchronization of Gestational Length and Lung Maturation	PLOS ONE			English	Article							SURFACTANT PROTEIN-C; GLUCOCORTICOID-RECEPTOR; TARGETED DISRUPTION; RESPIRATORY-FAILURE; LIQUID CLEARANCE; PRETERM BIRTH; NEWBORN MICE; C/EBP-ALPHA; SP-B; DIFFERENTIATION	Among all mammals, fetal growth and organ maturation must be precisely synchronized with gestational length to optimize survival at birth. Lack of pulmonary maturation is the major cause of infant mortality in preterm birth. Whether fetal or maternal genotypes influence the close relationship between the length of gestation and lung function at birth is unknown. Structural and biochemical indicators of pulmonary maturity were measured in two mouse strains whose gestational length differed by one day. Shorter gestation in C57BL/6J mice was associated with advanced morphological and biochemical pulmonary development and better perinatal survival when compared to A/J pups born prematurely. After ovarian transplantation, A/J pups were born early in C57BL/6J dams and survived after birth, consistent with maternal control gestational length. Expression of genes critical for perinatal lung function was assessed in A/J pups born after ovarian transfer. A subset of mRNAs important for perinatal respiratory adaptation was selectively induced in the A/J pups born after ovarian transfer. mRNAs precociously induced after ovarian transfer indicated an important role for the transcription factors C/EBP alpha and CREB in maternally induced lung maturation. We conclude that fetal lung maturation is determined by both fetal and maternal genotypes. Ovarian transfer experiments demonstrated that maternal genotype determines the timing of birth and can influence fetal lung growth and maturation to ensure perinatal survival.	[Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Perinatal Inst, Cincinnati, OH USA; [Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Sect Neonatol Perinatal & Pulm Biol, Cincinnati, OH USA; [Besnard, Valerie; Wert, Susan E.; Ikegami, Machiko; Xu, Yan; Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Heffner, Caleb; Murray, Stephen A.; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Jackson Laboratory	Besnard, V (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Perinatal Inst, Cincinnati, OH USA.	jeff.whitsett@cchmc.org		, Yan/0000-0003-2025-027X; Besnard, Valerie/0000-0002-2614-629X; Heffner, Caleb/0000-0002-2631-6201	March of Dimes (MOD) [MOD154, 6-FY109-235]; National Institutes of Health [HL095469, HL090156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL090156] Funding Source: NIH RePORTER	March of Dimes (MOD)(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the March of Dimes (MOD) [to YX, JAW, MI], MOD154 [to LRD], 6-FY109-235 from MOD [to MI], National Institutes of Health HL095469 [to MI]; and the National Institutes of Health HL090156 [to JAW, YX, SEW]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Beck S, 2009, B WORLD HEALTH ORGAN, V88, P31; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bird AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017843; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Heleve O, 2009, NEONATOLOGY, V95, P347; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; Nakatani T, 2004, J BIOL CHEM, V279, P16356, DOI 10.1074/jbc.M311740200; Oshika E, 1998, PEDIATR RES, V43, P305, DOI 10.1203/00006450-199803000-00001; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Ramachandrappa A, 2009, PEDIATR CLIN N AM, V56, P565, DOI 10.1016/j.pcl.2009.03.009; Sztein J, 1998, BIOL REPROD, V58, P1071, DOI 10.1095/biolreprod58.4.1071; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Wert SE, 2008, NORMAL ABNORMAL STRU, P783; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26682	10.1371/journal.pone.0026682	http://dx.doi.org/10.1371/journal.pone.0026682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096492	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800011
J	Valle, D; Clark, JS; Zhao, KG				Valle, Denis; Clark, James S.; Zhao, Kaiguang			Enhanced Understanding of Infectious Diseases by Fusing Multiple Datasets: A Case Study on Malaria in the Western Brazilian Amazon Region	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIAGNOSTIC-TESTS; GLOBAL DISTRIBUTION; HIGH PREVALENCE; DEFORESTATION; SPECIFICITY; SENSITIVITY; IMMUNITY; JOINT; STATE	Background: A common challenge to the study of several infectious diseases consists in combining limited cross-sectional survey data, collected with a more sensitive detection method, with a more extensive (but biased) syndromic sentinel surveillance data, collected with a less sensitive method. Our article describes a novel modeling framework that overcomes this challenge, resulting in enhanced understanding of malaria in the Western Brazilian Amazon. Methodology/Principal Findings: A cohort of 486 individuals was monitored using four cross-sectional surveys, where all participants were sampled regardless of symptoms (aggressive-active case detection), resulting in 1,383 microscopy and 1,400 polymerase chain reaction tests. Data on the same individuals were also obtained from the local surveillance facility (i.e., passive and active case detection), totaling 1,694 microscopy tests. Our model accommodates these multiple pathogen and case detection methods. This model is shown to outperform logistic regression in terms of interpretability of its parameters, ability to recover the true parameter values, and predictive performance. We reveal that the main infection determinant was the extent of forest, particularly during the rainy season and in close proximity to water bodies, and participation on forest activities. We find that time residing in Acrelandia (as a proxy for past malaria exposure) decreases infection risk but surprisingly increases the likelihood of reporting symptoms once infected, possibly because non-naive settlers are only susceptible to more virulent Plasmodium strains. We suggest that the search for asymptomatic carriers should focus on those at greater risk of being infected but lower risk of reporting symptoms once infected. Conclusions/Significance: The modeling framework presented here combines cross-sectional survey data and syndromic sentinel surveillance data to shed light on several aspects of malaria that are critical for public health policy. This framework can be adapted to enhance inference on infectious diseases whenever asymptomatic carriers are important and multiple datasets are available.	[Valle, Denis; Clark, James S.] Duke Univ, Univ Program Ecol, Durham, NC 27706 USA; [Clark, James S.; Zhao, Kaiguang] Duke Univ, Dept Biol, Durham, NC USA; [Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Valle, D (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27706 USA.	drv4@duke.edu	Valle, Denis/B-7650-2012; Zhao, Kaiguang/D-1172-2010	Zhao, Kaiguang/0000-0001-5858-4967; Valle, Denis/0000-0002-9830-8876	Duke Global Health Initiative	Duke Global Health Initiative	Denis Valle was partly supported by a pilot project grant from the Duke Global Health Initiative. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; BARKER RH, 1994, EXP PARASITOL, V79, P41, DOI 10.1006/expr.1994.1057; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Castro MC, 2001, MALARIA FOCI COLONIZ; Clark JS, 2009, BAYESIAN ANAL, V4, P337, DOI 10.1214/09-BA413; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Ferreira MU, 2010, J INFECT DEV COUNTR, V4, P533, DOI 10.3855/jidc.760; *FUNASA, 2001, MAN TER MAL; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; Hardnett FP, 2004, CLIN INFECT DIS, V38, pS121, DOI 10.1086/381602; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Katsuragawa TH, 2009, CAD SAUDE PUBLICA, V25, P1486, DOI 10.1590/S0102-311X2009000700006; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LASERSON KF, 1994, AM J TROP MED HYG, V50, P169, DOI 10.4269/ajtmh.1994.50.169; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Markus MB, 2011, PARASITOL RES, V108, P247, DOI 10.1007/s00436-010-2072-y; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; O'Meara WP, 2005, AM J TROP MED HYG, V73, P593, DOI 10.4269/ajtmh.2005.73.593; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Oliveira EC, 2011, MALARIA J, P10; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Olson SH, 2009, EMERG INFECT DIS, V15, P659, DOI 10.3201/eid1504.080822; Pruss-Ustun A., 2006, WORLD HEALTH; R Development Core Team, 2007, R LANG ENV STAT COMP; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Schwartz SL, 2010, STAT MED, V29, P1710, DOI 10.1002/sim.3900; Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002; Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021; Slasor P, 2003, STAT MED, V22, P2137, DOI 10.1002/sim.1439; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Su CL, 2004, STAT MED, V23, P2237, DOI 10.1002/sim.1809; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3	53	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27462	10.1371/journal.pone.0027462	http://dx.doi.org/10.1371/journal.pone.0027462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087321	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700048
J	Nguyen, NQN; Castermans, K; Berndt, S; Herkenne, S; Tabruyn, SP; Blacher, S; Lion, M; Noel, A; Martial, JA; Struman, I				Ngoc-Quynh-Nhu Nguyen; Castermans, Karolien; Berndt, Sarah; Herkenne, Stephanie; Tabruyn, Sebastien P.; Blacher, Silvia; Lion, Michelle; Noel, Agnes; Martial, Joseph A.; Struman, Ingrid			The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR-KAPPA-B; NONPRODUCTIVE ANGIOGENESIS; PERICYTE RECRUITMENT; UP-REGULATION; CELLS; ACTIVATION; EXPRESSION; THERAPY; CANCER	Background: Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role in tumor growth, invasion, and metastasis. 16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumor growth and metastasis by modifying tumor vessel morphology. Methodology/Principal Findings: Here we investigated the effect of 16K hPRL on tumor vessel maturation and on the related signaling pathways. We show that 16K hPRL treatment leads, in a murine B16-F10 tumor model, to a dysfunctional tumor vasculature with reduced pericyte coverage, and disruption of the PDGF-B/PDGFR-B, Ang/Tie2, and Delta/Notch pathways. In an aortic ring assay, 16K hPRL impairs endothelial cell and pericyte outgrowth from the vascular ring. In addition, 16K hPRL prevents pericyte migration to endothelial cells. This event was independent of a direct inhibitory effect of 16K hPRL on pericyte viability, proliferation, or migration. In endothelial cell-pericyte cocultures, we found 16K hPRL to disturb Notch signaling. Conclusions/Significance: Taken together, our data show that 16K hPRL impairs functional tumor neovascularization by inhibiting vessel maturation and for the first time that an endogenous antiangiogenic agent disturbs Notch signaling. These findings provide new insights into the mechanisms of 16K hPRL action and highlight its potential for use in anticancer therapy.	[Ngoc-Quynh-Nhu Nguyen; Castermans, Karolien; Herkenne, Stephanie; Tabruyn, Sebastien P.; Lion, Michelle; Martial, Joseph A.; Struman, Ingrid] Univ Liege, Unit Mol Biol & Genet Engn, GIGA Res, Liege, Belgium; [Berndt, Sarah; Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Biol Tumor & Dev, GIGA Res, Liege, Belgium	University of Liege; University of Liege	Nguyen, NQN (corresponding author), Univ Liege, Unit Mol Biol & Genet Engn, GIGA Res, Liege, Belgium.	I.Struman@ulg.ac.be		Herkenne, stephanie/0000-0002-2106-9360; Noel, Agnes/0000-0002-7670-6179; struman, ingrid/0000-0003-2550-3707	Fonds National de la Recherche Scientifique [FP7-HEALTH-2007-A, 201279]; Belgian Science Policy (Brussels, Belgium); Service Public de Wallonie [616476]; Belgian Foundation against Cancer	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Service Public de Wallonie; Belgian Foundation against Cancer	This work was supported by the "Fonds National de la Recherche Scientifique", FP7-HEALTH-2007-A, proposal No. 201279 "MICROENVIMET", the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium) and the Neoangio program #616476 of the "Service Public de Wallonie", the Belgian Foundation against Cancer. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentzien F, 2001, CANCER RES, V61, P7356; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berndt S, 2006, FASEB J, V20, P2630, DOI 10.1096/fj.06-5885fje; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Furuhashi M, 2004, CANCER RES, V64, P2725, DOI 10.1158/0008-5472.CAN-03-1489; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2010, J EXP MED, V207, P491, DOI 10.1084/jem.20091846; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kim J, 2003, CANCER RES, V63, P386; Kinet V, 2009, CANCER LETT, V284, P222, DOI 10.1016/j.canlet.2009.04.030; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Li JL, 2011, CANC RES; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Martini JF, 2000, MOL ENDOCRINOL, V14, P1536, DOI 10.1210/me.14.10.1536; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Nguyen NQN, 2007, MOL THER, V15, P2094, DOI 10.1038/sj.mt.6300294; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pan H, 2004, INVEST OPHTH VIS SCI, V45, P2413, DOI 10.1167/iovs.03-1001; Patel NS, 2006, CLIN CANCER RES, V12, P4836, DOI 10.1158/1078-0432.CCR-06-0285; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Real C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018323; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; Sun JZ, 2004, CANCER RES, V64, P3586, DOI 10.1158/0008-5472.CAN-03-2673; Tabruyn SP, 2007, MOL ENDOCRINOL, V21, P1422, DOI 10.1210/me.2007-0021; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381	57	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27318	10.1371/journal.pone.0027318	http://dx.doi.org/10.1371/journal.pone.0027318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087289	Green Published, Green Submitted, gold			2022-12-25	WOS:000297347700038
J	Riesch, R; Schlupp, I; Langerhans, RB; Plath, M				Riesch, Ruediger; Schlupp, Ingo; Langerhans, R. Brian; Plath, Martin			Shared and Unique Patterns of Embryo Development in Extremophile Poeciliids	PLOS ONE			English	Article							TOXIC HYDROGEN-SULFIDE; IMMIGRANTS MAINTAINS DIFFERENTIATION; DWELLING ATLANTIC MOLLIES; SEXUAL SELECTION; GENETIC DIFFERENTIATION; ECOLOGICAL SPECIATION; CAVEFISH ASTYANAX; MEXICAN CAVE; EVOLUTION; FISH	Background: Closely related lineages of livebearing fishes have independently adapted to two extreme environmental factors: toxic hydrogen sulphide (H2S) and perpetual darkness. Previous work has demonstrated in adult specimens that fish from these extreme habitats convergently evolved drastically increased head and offspring size, while cave fish are further characterized by reduced pigmentation and eye size. Here, we traced the development of these (and other) divergent traits in embryos of Poecilia mexicana from benign surface habitats ("surface mollies") and a sulphidic cave ("cave mollies"), as well as in embryos of the sister taxon, Poecilia sulphuraria from a sulphidic surface spring ("sulphur mollies"). We asked at which points during development changes in the timing of the involved processes (i.e., heterochrony) would be detectible. Methods and Results: Data were extracted from digital photographs taken of representative embryos for each stage of development and each type of molly. Embryo mass decreased in convergent fashion, but we found patterns of embryonic fat content and ovum/embryo diameter to be divergent among all three types of mollies. The intensity of yellow colouration of the yolk (a proxy for carotenoid content) was significantly lower in cave mollies throughout development. Moreover, while relative head size decreased through development in surface mollies, it increased in both types of extremophile mollies, and eye growth was arrested in mid-stage embryos of cave mollies but not in surface or sulphur mollies. Conclusion: Our results clearly demonstrate that even among sister taxa convergence in phenotypic traits is not always achieved by the same processes during embryo development. Furthermore, teleost development is crucially dependent on sufficient carotenoid stores in the yolk, and so we discuss how the apparent ability of cave mollies to overcome this carotenoid-dependency may represent another potential mechanism explaining the lack of gene flow between surface and cave mollies.	[Riesch, Ruediger; Langerhans, R. Brian] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Riesch, Ruediger; Langerhans, R. Brian] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Riesch, Ruediger; Schlupp, Ingo] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Plath, Martin] Goethe Univ Frankfurt, Dept Ecol & Evolut, Frankfurt, Germany	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Oklahoma System; University of Oklahoma - Norman; Goethe University Frankfurt	Riesch, R (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	rwriesch.evolutionarybiology@gmail.com	Riesch, Rüdiger/A-5787-2008; Schlupp, Ingo/C-3913-2012; Langerhans, R. Brian/ABE-6246-2021	Riesch, Rüdiger/0000-0002-6769-8808; Schlupp, Ingo/0000-0002-2460-5667; Riesch, Rudiger/0000-0002-0223-1254	National Science Foundation of the United States [NSF: DEB-0743406, DEB-0813783, DEB 0842364]; Deutsche Forschungsgemeinschaft [DFG: PL 470/3-1]	National Science Foundation of the United States(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the National Science Foundation of the United States (NSF: DEB-0743406, DEB-0813783, and DEB 0842364) and the Deutsche Forschungsgemeinschaft (DFG: PL 470/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez del Villar J., 1948, ANALES ESCUELA NACL, V5, P275; Anderson J., 1990, P21; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Beatty RA, 1941, J EXP BIOL, V18, P144; Berti R, 2001, CAN J ZOOL, V79, P1278, DOI 10.1139/cjz-79-7-1278; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; BURTON GW, 1989, J NUTR, V119, P109, DOI 10.1093/jn/119.1.109; CARTER G. S., 1931, JOUR LINN SOC LONDON ZOOL, V37, P327; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Coelho SG, 2006, PHOTOCHEM PHOTOBIOL, V82, P651, DOI 10.1562/2005-08-02-TSN-635; CRAIK JCA, 1985, AQUACULTURE, V47, P61, DOI 10.1016/0044-8486(85)90008-0; Culver DC, 1982, CAVE LIFE EVOLUTION; CZECZUGA B, 1970, Hydrobiologia, V36, P353, DOI 10.1007/BF00039794; DURAND JP, 1976, BIOL BULL, V151, P450, DOI 10.2307/1540499; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Feulner Philine G.D., 2009, Communicative & Integrative Biology, V2, P329; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; GORDON MALCOLM S., 1962, COPEIA, V2, P360; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; HAYNES JL, 1995, COPEIA, P147; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Hervant F, 1998, J CRUSTACEAN BIOL, V18, P717, DOI 10.2307/1549148; HEULETT ST, 1995, COPEIA, P97, DOI 10.2307/1446803; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HUBBS C, 1957, J EXP ZOOL, V134, P33, DOI 10.1002/jez.1401340103; HUBBS CLARK, 1958, PHYSIOL ZOOL, V31, P280; JAPPINEN P, 1990, BRIT J IND MED, V47, P824; Jeffery WR, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P141, DOI 10.1201/EBK1578086702-c6; Jeffery WR, 2009, CURR TOP DEV BIOL, V86, P191, DOI 10.1016/S0070-2153(09)01008-4; Korner KE, 2006, J FISH BIOL, V69, P54, DOI 10.1111/j.1095-8649.2006.01056.x; Kolluru GR, 2006, BIOL J LINN SOC, V89, P301, DOI 10.1111/j.1095-8312.2006.00675.x; KRAMER DL, 1978, CAN J ZOOL, V56, P717, DOI 10.1139/z78-101; Kueppop Kathrin, 2005, P4; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Li JC, 2006, RAFFLES B ZOOL, V54, P277; Malard F, 1999, FRESHWATER BIOL, V41, P1, DOI 10.1046/j.1365-2427.1999.00379.x; Marsh-Matthews E, 2011, P 3 INT S V IN PRESS; Marsh-Matthews Edie, 2011, P18; Martyn U, 2006, DEV DYNAM, V235, P617, DOI 10.1002/dvdy.20664; McCauley DW, 2004, EVOL DEV, V6, P209, DOI 10.1111/j.1525-142X.2004.04026.x; Miller R. R, 2005, FRESHWATER FISHES ME; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Morrongiello JR, 2010, J EVOLUTION BIOL, V23, P2718, DOI 10.1111/j.1420-9101.2010.02149.x; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Nyman T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-49; Ozgo M, 2008, EVOL ECOL RES, V10, P721; Parichy DM, 2001, BEYOND HETEROCHRONY, P229; Parzefali J, 1999, HDB REPTILIEN AMPHIB, V4, P57; Parzefall J, 2001, ENVIRON BIOL FISH, V62, P263, DOI 10.1023/A:1011899817764; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Plath M, 2004, BEHAV ECOL SOCIOBIOL, V55, P596, DOI 10.1007/s00265-003-0750-9; Plath M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-256; Plath M, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P281; Plath M, 2010, NATURWISSENSCHAFTEN, V97, P769, DOI 10.1007/s00114-010-0691-x; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; REZNICK D, 1981, EVOLUTION, V35, P941, DOI [10.2307/2407865, 10.1111/j.1558-5646.1981.tb04960.x]; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Riesch R, 2011, J EVOLUTION BIOL, V24, P596, DOI 10.1111/j.1420-9101.2010.02194.x; Riesch R, 2011, BIOL LETT IN PRESS; Riesch R, 2011, ENV BIOL FI IN PRESS; Riesch R, 2010, EVOL ECOL, V24, P789, DOI 10.1007/s10682-009-9335-z; Riesch R, 2010, ECOLOGY, V91, P1494, DOI 10.1890/09-1008.1; Riesch R, 2010, NATURWISSENSCHAFTEN, V97, P133, DOI 10.1007/s00114-009-0613-y; Riesch R, 2009, ENVIRON BIOL FISH, V84, P89, DOI 10.1007/s10641-008-9392-0; Roach KA, 2011, ECOLOGY IN PRESS; Ruehl CB, 2011, BIOL J LINN SOC, V103, P147, DOI 10.1111/j.1095-8312.2011.01626.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 2003, INT J DEV BIOL, V47, P613; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Tobler M, 2008, J FISH BIOL, V72, P523, DOI 10.1111/j.1095-8649.2007.01716.x; Tobler M, 2009, J EVOLUTION BIOL, V22, P2298, DOI 10.1111/j.1420-9101.2009.01844.x; Tobler M, 2008, BIOL J LINN SOC, V95, P517, DOI 10.1111/j.1095-8312.2008.01063.x; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler Michael, 2011, P120; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; WILKENS H, 1988, EVOL BIOL, V23, P271; Wilkens H, 2003, BIOL J LINN SOC, V80, P545, DOI 10.1111/j.1095-8312.2003.00230.x; Wilkens H, 2001, ENVIRON BIOL FISH, V62, P251, DOI 10.1023/A:1011897805681; Wilkens Horst, 2005, P241; WINEMILLER KO, 1989, COPEIA, P382; WOLFE DA, 1964, SCIENCE, V144, P1467, DOI 10.1126/science.144.3625.1467; Wourms J.P., 1988, P1; Wray GA, 2002, BRAIN BEHAV EVOLUT, V59, P327, DOI 10.1159/000063566	101	28	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27377	10.1371/journal.pone.0027377	http://dx.doi.org/10.1371/journal.pone.0027377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087302	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700046
J	Stamm, JA; Belloli, EA; Zhang, YZ; Bon, J; Sciurba, FC; Gladwin, MT				Stamm, Jason A.; Belloli, Elizabeth A.; Zhang, Yingze; Bon, Jessica; Sciurba, Frank C.; Gladwin, Mark T.			Elevated N-Terminal Pro-Brain Natriuretic Peptide Is Associated with Mortality in Tobacco Smokers Independent of Airflow Obstruction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; PULMONARY-DISEASE; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; BETA-BLOCKERS; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; FAILURE; RISK	Background: Tobacco use is associated with an increased prevalence of cardiovascular disease. N-terminal pro-brain natiuretic peptide (NT-proBNP), a widely available biomarker that is associated with cardiovascular outcomes in other conditions, has not been investigated as a predictor of mortality in tobacco smokers. We hypothesized that NT-proBNP would be an independent prognostic marker in a cohort of well-characterized tobacco smokers without known cardiovascular disease. Methods: Clinical data from 796 subjects enrolled in two prospective tobacco exposed cohorts was assessed to determine factors associated with elevated NT-proBNP and the relationship of these factors and NT-proBNP with mortality. Results: Subjects were followed for a median of 562 (IQR 252 - 826) days. Characteristics associated with a NT-proBNP above the median (>= 49 pg/mL) were increased age, female gender, and decreased body mass index. By time-to-event analysis, an NT-proBNP above the median (>= 49 pg/mL) was a significant predictor of mortality (log rank p = 0.02). By proportional hazard analysis controlling for age, gender, cohort, and severity of airflow obstruction, an elevated NT-proBNP level (>= 49 pg/mL) remained an independent predictor of mortality (HR = 2.19, 95% CI 1.07-4.46, p = 0.031). Conclusions: Elevated NT-proBNP is an independent predictor of mortality in tobacco smokers without known cardiovascular disease, conferring a 2.2 fold increased risk of death. Future studies should assess the ability of this biomarker to guide further diagnostic testing and to direct specific cardiovascular risk reduction inventions that may positively impact quality of life and survival.	[Stamm, Jason A.] Geisinger Med Ctr, Div Pulm & Crit Care Med, Danville, PA 17822 USA; [Belloli, Elizabeth A.] Univ Pittsburgh, Div Gen Internal Med, Med Ctr, Pittsburgh, PA USA; [Zhang, Yingze; Bon, Jessica; Sciurba, Frank C.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Med Ctr, Pittsburgh, PA USA; [Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Med Ctr, Pittsburgh, PA USA	Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stamm, JA (corresponding author), Geisinger Med Ctr, Div Pulm & Crit Care Med, Danville, PA 17822 USA.	gladwinmt@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Bon, Jessica/AAK-6714-2021	sciurba, frank/0000-0001-7468-2225	National Institutes of Health through the University of Pittsburgh SCCOR in COPD [NHLBI 1P50 HL084948, P50-CA90440]; Roche Diagnostics (Manheim, Germany); NIH [R01HL098032, RO1HL096973, PO1HL103455]; Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania; NATIONAL CANCER INSTITUTE [P50CA090440] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, R01HL096973, P01HL103455, R01HL098032] Funding Source: NIH RePORTER	National Institutes of Health through the University of Pittsburgh SCCOR in COPD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Roche Diagnostics (Manheim, Germany); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health through the University of Pittsburgh SCCOR in COPD [NHLBI 1P50 HL084948 and P50-CA90440] and through an investigator-initiated grant (Dr. Zhang) from Roche Diagnostics (Manheim, Germany). Dr. Gladwin receives research support from NIH grants R01HL098032, RO1HL096973, and PO1HL103455, the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen AK, 2006, AM J CARDIOL, V98, P525, DOI 10.1016/j.amjcard.2006.02.061; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Au DH, 2004, AM J MED, V117, P925, DOI 10.1016/j.amjmed.2004.07.043; BANG KM, 1993, CHEST, V103, P536, DOI 10.1378/chest.103.2.536; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; de Lemos JA, 2008, AM J CARDIOL, V101, p16A, DOI [10.1016/j.amjcard.2007.11.014, 10.1016/j.amjcard.2607.11.014]; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Dini FL, 2008, AM J CARDIOL, V102, P463, DOI 10.1016/j.amjcard.2008.03.083; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Galasko GIW, 2005, EUR HEART J, V26, P2269, DOI 10.1093/eurheartj/ehi410; Gerardi DA, 1996, EUR RESPIR J, V9, P431, DOI 10.1183/09031936.96.09030431; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; JAJICH CL, 1984, JAMA-J AM MED ASSOC, V252, P2831, DOI 10.1001/jama.252.20.2831; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Kruger S, 2002, J AM COLL CARDIOL, V40, P718, DOI 10.1016/S0735-1097(02)02032-6; Lorgis L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1605; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Otsuka T, 2010, AM J CARDIOL, V106, P1456, DOI 10.1016/j.amjcard.2010.06.075; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Rutten FH, 2007, EUR J HEART FAIL, V9, P651, DOI 10.1016/j.ejheart.2007.01.010; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Wu AHB, 2006, AM HEART J, V152, P828, DOI 10.1016/j.ahj.2006.08.021	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27416	10.1371/journal.pone.0027416	http://dx.doi.org/10.1371/journal.pone.0027416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087311	gold, Green Accepted, Green Published			2022-12-25	WOS:000297347700050
J	Harmidy, K; Tufenkji, N; Gruenheid, S				Harmidy, Kevin; Tufenkji, Nathalie; Gruenheid, Samantha			Perturbation of Host Cell Cytoskeleton by Cranberry Proanthocyanidins and Their Effect on Enteric Infections	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL ADHESION; SALMONELLA-TYPHIMURIUM; VACCINIUM-MACROCARPON; BIOFILM FORMATION; GROWTH; JUICE; PHYTOCHEMICALS; INHIBITION; EXPRESSION	Cranberry-derived compounds, including a fraction known as proanthocyanidins (PACs) exhibit anti-microbial, anti-infective, and anti-adhesive properties against a number of disease-causing organisms. In this study, the effect of cranberry proanthocyanidins (CPACs) on the infection of epithelial cells by two enteric bacterial pathogens, enteropathogenic Escherichia coli (EPEC) and Salmonella Typhimurium was investigated. Immunofluorescence data showed that actin pedestal formation, required for infection by enteropathogenic Escherichia coli (EPEC), was disrupted in the presence of CPACs. In addition, invasion of HeLa cells by Salmonella Typhimurium was significantly reduced, as verified by gentamicin protection assay and immunofluorescence. CPACs had no effect on bacterial growth, nor any detectable effect on the production of bacterial effector proteins of the type III secretion system. Furthermore, CPACs did not affect the viability of host cells. Interestingly, we found that CPACs had a potent and dose-dependent effect on the host cell cytoskeleton that was evident even in uninfected cells. CPACs inhibited the phagocytosis of inert particles by a macrophage cell line, providing further evidence that actin-mediated host cell functions are disrupted in the presence of cranberry CPACs. Thus, although CPAC treatment inhibited Salmonella invasion and EPEC pedestal formation, our results suggest that this is likely primarily because of the perturbation of the host cell cytoskeleton by CPACs rather than an effect on bacterial virulence itself. These findings have significant implications for the interpretation of experiments on the effects of CPACs on bacteria-host cell interactions.	[Harmidy, Kevin; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada; [Harmidy, Kevin; Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Harmidy, Kevin; Gruenheid, Samantha] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Harmidy, K (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	nathalie.tufenkji@mcgill.ca; samantha.gruenheid@mcgill.ca		Gruenheid, Samantha/0000-0002-0908-6715	NSERC; CRC; Hydro-Quebec Scholars Program; McGill University; Wisconsin Cranberry Board; Cranberry Institute	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Hydro-Quebec Scholars Program; McGill University; Wisconsin Cranberry Board; Cranberry Institute	The authors acknowledge the financial support of NSERC, the CRC Program, the Hydro-Quebec Scholars Program, the EUL Fund at McGill University, the Wisconsin Cranberry Board and the Cranberry Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Burger O, 2002, CRIT REV FOOD SCI, V42, P279, DOI 10.1080/10408390209351916; Camesano TA, 2007, AGRO FOOD IND HI TEC, V18, P24; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; de la Iglesia R, 2010, BIOFACTORS, V36, P159, DOI 10.1002/biof.79; Eydelnant IA, 2008, LANGMUIR, V24, P10273, DOI 10.1021/la801525d; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Guo ML, 2007, DALTON T, P4951, DOI 10.1039/b705136k; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P1532, DOI 10.1128/AEM.02201-10; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Howell AB, 1998, NEW ENGL J MED, V339, P1408; Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082; Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Kresty LA, 2008, J AGR FOOD CHEM, V56, P676, DOI 10.1021/jf071997t; Labrecque J, 2006, J ANTIMICROB CHEMOTH, V58, P439, DOI 10.1093/jac/dkl220; Lacombe A, 2010, INT J FOOD MICROBIOL, V139, P102, DOI 10.1016/j.ijfoodmicro.2010.01.035; LEVINE MM, 1978, LANCET, V1, P1119; Lipson SM, 2011, FOOD ENVIRON VIROL, V3, P46, DOI 10.1007/s12560-011-9055-8; Liu M, 2009, J AGR FOOD CHEM, V57, P762, DOI 10.1021/jf802780k; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Matsushima M, 2008, J GASTROEN HEPATOL, V23, pS175, DOI 10.1111/j.1440-1746.2008.05409.x; Mayer R, 2008, J AGR FOOD CHEM, V56, P6959, DOI 10.1021/jf800832r; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mckay DL, 2007, NUTR REV, V65, P490, DOI 10.1301/nr.2007.nov.490-502; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Narayansingh R, 2009, J SCI FOOD AGR, V89, P542, DOI 10.1002/jsfa.3471; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neto CC, 2008, MOL NUTR FOOD RES, V52, pS18, DOI 10.1002/mnfr.200700433; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Pinzon-Arango PA, 2009, J MED FOOD, V12, P259, DOI 10.1089/jmf.2008.0196; ROBSON HG, 1972, J INFECT DIS, V126, P378, DOI 10.1093/infdis/126.4.378; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Ruel G, 2007, MOL NUTR FOOD RES, V51, P692, DOI 10.1002/mnfr.200600286; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Souto FO, 2011, J NAT PROD, V74, P113, DOI 10.1021/np1003017; Su XW, 2010, FOOD MICROBIOL, V27, P985, DOI 10.1016/j.fm.2010.05.027; Suzuki T, 2011, J NUTR, V141, P87, DOI 10.3945/jn.110.125633; Tufenkji N, 2010, FOOD RES INT, V43, P922, DOI 10.1016/j.foodres.2009.10.022; Vikram A, 2010, J APPL MICROBIOL, V109, P515, DOI 10.1111/j.1365-2672.2010.04677.x; Vikram A, 2010, INT J FOOD MICROBIOL, V140, P109, DOI 10.1016/j.ijfoodmicro.2010.04.012; Wu VCH, 2008, LWT-FOOD SCI TECHNOL, V41, P1834, DOI 10.1016/j.lwt.2008.01.001; Zhang L, 2005, HELICOBACTER, V10, P139, DOI 10.1111/j.1523-5378.2005.00301.x	50	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27267	10.1371/journal.pone.0027267	http://dx.doi.org/10.1371/journal.pone.0027267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076143	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200057
J	Liskovykh, M; Chuykin, I; Ranjan, A; Safina, D; Popova, E; Tolkunova, E; Mosienko, V; Minina, JM; Zhdanova, NS; Mullins, JJ; Bader, M; Alenina, N; Tomilin, A				Liskovykh, Mikhail; Chuykin, Ilya; Ranjan, Ashish; Safina, Dina; Popova, Elena; Tolkunova, Elena; Mosienko, Valentina; Minina, Julia M.; Zhdanova, Natalia S.; Mullins, John J.; Bader, Michael; Alenina, Natalia; Tomilin, Alexey			Derivation, Characterization, and Stable Transfection of Induced Pluripotent Stem Cells from Fischer344 Rats	PLOS ONE			English	Article							GENE; GENERATION; MOUSE; EXPRESSION; MODELS; NANOG; LINES; TIME	The rat represents an important animal model that, in many respects, is superior to the mouse for dissecting behavioral, cardiovascular and other physiological pathologies relevant to humans. Derivation of induced pluripotent stem cells from rats (riPS) opens the opportunity for gene targeting in specific rat strains, as well as for the development of new protocols for the treatment of different degenerative diseases. Here, we report an improved lentivirus-based hit-and-run riPS derivation protocol that makes use of small inhibitors of MEK and GSK3. We demonstrate that the excision of proviruses does not affect either the karyotype or the differentiation ability of these cells. We show that the established riPS cells are readily amenable to genetic manipulations such as stable electroporation. Finally, we propose a genetic tool for an improvement of riPS cell quality in culture. These data may prompt iPS cell-based gene targeting in rat as well as the development of iPS cell-based therapies using disease models established in this species.	[Liskovykh, Mikhail; Safina, Dina; Tolkunova, Elena; Tomilin, Alexey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Chuykin, Ilya; Ranjan, Ashish; Popova, Elena; Mosienko, Valentina; Bader, Michael; Alenina, Natalia] Max Delbruck Ctr Mol Med, Berlin, Germany; [Minina, Julia M.; Zhdanova, Natalia S.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Mullins, John J.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Edinburgh	Liskovykh, M (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	alenina@mdc-berlin.de; antom@mail.cytspb.rssi.ru	Tomilin, Alexey N/C-3361-2014; Bader, Michael/K-2124-2013; Minina, Julia/AAZ-4280-2020; Mosienko, Valentina/AAN-5983-2020; Tomilin, Alexey/AAA-8774-2022; Tomilin, Alexey/AAK-3068-2021; Tolkunova, Elena/U-7174-2017	Tomilin, Alexey N/0000-0002-1137-7167; Minina, Julia/0000-0003-1504-9803; Tomilin, Alexey/0000-0002-1137-7167; Bader, Michael/0000-0003-4780-4164; Mosienko, Valentina/0000-0002-8562-532X; Tolkunova, Elena/0000-0003-1254-2619	Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany) [07-04-92281/HRJRG-024]; EURATRANS; European Union; Presidium of Russian Academy of Sciences; Russian Ministry of Education and Science [02.512.11.2253, 16.512.11.2085, 16.512.11.2242]; non-profit foundation Dynasty (Russia); DAAD [A0799669, A0890020]; BHF Centre of Research Excellence; Wellcome Trust	Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany)(Russian Foundation for Basic Research (RFBR)Helmholtz Association); EURATRANS; European Union(European Commission); Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); non-profit foundation Dynasty (Russia); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BHF Centre of Research Excellence; Wellcome Trust(Wellcome Trust)	This work was supported by joint Russian Foundation for Basic Research (Russia) - Helmholtz Society (Germany) to NA and AT (07-04-92281/HRJRG-024), by the EURATRANS integrated project funded by the Seventh Framework Programme of the European Union, by the Presidium of Russian Academy of Sciences program "Molecular and Cellular Biology" to AT, by the state contracts between AT and the Russian Ministry of Education and Science (02.512.11.2253, 16.512.11.2085, and 16.512.11.2242), by a studentship from the non-profit foundation Dynasty (Russia) to ML, by DAAD studentship to VM (A0799669) and to IC (A0890020). The authors acknowledge support from the BHF Centre of Research Excellence, and JJM was the recipient of a Wellcome Trust Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bader M, 2010, METHODS MOL BIOL, V597, P403, DOI 10.1007/978-1-60327-389-3_27; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Chuykin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009794; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kotnik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005124; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Minina Iu M, 2010, Tsitologiia, V52, P420; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; O'Brien SJ, 2006, ATLAS MAMMALIAN CHRO, pxlii; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Popova E, 2005, METH MOLEC MED, V108, P33; Popova E, 2005, TRANSGENIC RES, V14, P729, DOI 10.1007/s11248-005-7218-9; Popova E, 2008, TRANSGENIC RES, V17, P955, DOI 10.1007/s11248-008-9189-0; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sugawara A, 2006, COMPARATIVE MED, V56, P31; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27345	10.1371/journal.pone.0027345	http://dx.doi.org/10.1371/journal.pone.0027345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076153	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000297198200067
J	Viviani, R; Messina, I; Walter, M				Viviani, Roberto; Messina, Irene; Walter, Martin			Resting State Functional Connectivity in Perfusion Imaging: Correlation Maps with BOLD Connectivity and Resting State Perfusion	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; GLOBAL SIGNAL; FLUCTUATIONS; CORTEX; FMRI; ARCHITECTURE; SINGLE	Functional connectivity is a property of the resting state that may provide biomarkers of brain function and individual differences. Classically, connectivity is estimated as the temporal correlation of spontaneous fluctuations of BOLD signal. We investigated differences in connectivity estimated from the BOLD and CBF signal present in volumes acquired with arterial spin labeling technique in a large sample (N = 265) of healthy individuals. Positive connectivity was observable in both BOLD and CBF signal, and was present in the CBF signal also at frequencies lower than 0.009 Hz, here investigated for the first time. Negative connectivity was more variable. The validity of positive connectivity was confirmed by the existence of correlation across individuals in its intensity estimated from the BOLD and CBF signal. In contrast, there was little or no correlation across individuals between intensity of connectivity and mean perfusion levels, suggesting that these two biomarkers correspond to distinct sources of individual differences.	[Viviani, Roberto; Messina, Irene] Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Messina, Irene] Univ Padua, Dept Appl Psychol, Padua, Italy; [Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Clin Affect Neuroimaging Lab, Magdeburg, Germany	Ulm University; University of Padua; Otto von Guericke University	Viviani, R (corresponding author), Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany.	roberto.viviani@uni-ulm.de	Viviani, Roberto/A-8787-2015	Walter, Martin/0000-0001-7857-4483; Viviani, Roberto/0000-0002-7517-6006				Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aguirre GK, 2005, INT REV NEUROBIOL, V66, P213, DOI 10.1016/S0074-7742(05)66007-2; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alsop DC, 1998, RADIOLOGY, V208, P410, DOI 10.1148/radiology.208.2.9680569; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Detre JA, 1992, MAGN RESON MED, V3, P454; Drevets Wayne C., 1995, P1153; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Viviani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-30; Viviani R, 2009, NEUROIMAGE, V46, P12, DOI 10.1016/j.neuroimage.2009.01.041; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	47	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27050	10.1371/journal.pone.0027050	http://dx.doi.org/10.1371/journal.pone.0027050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073252	Green Published, gold			2022-12-25	WOS:000297198200031
J	Yeo, HC; Beh, TT; Quek, JJL; Koh, G; Chan, KKK; Lee, DY				Yeo, Hock Chuan; Beh, Thian Thian; Quek, Jovina Jia Ling; Koh, Geoffrey; Chan, Ken Kwok Keung; Lee, Dong-Yup			Integrated Transcriptome and Binding Sites Analysis Implicates E2F in the Regulation of Self-Renewal in Human Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FAMILY-MEMBERS; BETA-CATENIN; GENE; TARGET; EXPRESSION; ACTIVATION; NETWORK; NANOG; CYCLE	Rapid cellular growth and multiplication, limited replicative senescence, calibrated sensitivity to apoptosis, and a capacity to differentiate into almost any cell type are major properties that underline the self-renewal capabilities of human pluripotent stem cells (hPSCs). We developed an integrated bioinformatics pipeline to understand the gene regulation and functions involved in maintaining such self-renewal properties of hPSCs compared to matched fibroblasts. An initial genome-wide screening of transcription factor activity using in silico binding-site and gene expression microarray data newly identified E2F as one of major candidate factors, revealing their significant regulation of the transcriptome. This is underscored by an elevated level of its transcription factor activity and expression in all tested pluripotent stem cell lines. Subsequent analysis of functional gene groups demonstrated the importance of the TFs to self-renewal in the pluripotency-coupled context; E2F directly targets the global signaling (e. g. self-renewal associated WNT and FGF pathways) and metabolic network (e. g. energy generation pathways, molecular transports and fatty acid metabolism) to promote its canonical functions that are driving the self-renewal of hPSCs. In addition, we proposed a core self-renewal module of regulatory interplay between E2F and, WNT and FGF pathways in these cells. Thus, we conclude that E2F plays a significant role in influencing the self-renewal capabilities of hPSCs.	[Yeo, Hock Chuan; Beh, Thian Thian; Koh, Geoffrey; Chan, Ken Kwok Keung; Lee, Dong-Yup] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Quek, Jovina Jia Ling; Lee, Dong-Yup] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore	Yeo, HC (corresponding author), ASTAR, Bioproc Technol Inst, Singapore, Singapore.	kenkkc@hku.hk; cheld@nus.edu.sg	Lee, Dong-Yup/D-6650-2011	Lee, Dong-Yup/0000-0003-0901-708X; Yeo, Hock Chuan/0000-0001-5176-8800	Agency for Science, Technology and Research (A*STAR); National University of Singapore [R-279-000-328-112]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	The financial support of the Agency for Science, Technology and Research (A*STAR) is gratefully acknowledged. This work was also supported by the Academic Research Fund (R-279-000-328-112) from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2003, CELL CYCLE, V2, P538, DOI 10.4161/cc.2.6.550; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chan KKK, 2008, STEM CELLS DEV, V17, P825, DOI 10.1089/scd.2008.0233; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; DeGregori J, 2006, CURR MOL MED, V6, P739; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luciakova K, 2000, BIOCHEM J, V351, P251, DOI 10.1042/0264-6021:3510251; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stewart R, 2006, EUR J CANCER, V42, P1257, DOI 10.1016/j.ejca.2006.01.033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tashiro E, 2003, ONCOGENE, V22, P5630, DOI 10.1038/sj.onc.1206636; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Winn J, 2011, GENETICS, V188, P897, DOI 10.1534/genetics.111.128421; Wu SM, 2010, STEM CELL RES, V4, P38, DOI 10.1016/j.scr.2009.09.002; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	57	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27231	10.1371/journal.pone.0027231	http://dx.doi.org/10.1371/journal.pone.0027231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076139	gold, Green Submitted, Green Published			2022-12-25	WOS:000297198200053
J	Loucoubar, C; Goncalves, B; Tall, A; Sokhna, C; Trape, JF; Sarr, FD; Faye, J; Badiane, A; Ly, AB; Diop, A; Bar-Hen, A; Bureau, JF; Sakuntabhai, A; Paul, R				Loucoubar, Cheikh; Goncalves, Bronner; Tall, Adama; Sokhna, Cheikh; Trape, Jean-Francois; Sarr, Fatoumata Diene; Faye, Joseph; Badiane, Abdoulaye; Ly, Alioune Badara; Diop, Aliou; Bar-Hen, Avner; Bureau, Jean-Francois; Sakuntabhai, Anavaj; Paul, Richard			Impact of Changing Drug Treatment and Malaria Endemicity on the Heritability of Malaria Phenotypes in a Longitudinal Family-Based Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD INFECTION LEVELS; PLASMODIUM-FALCIPARUM; MISSING HERITABILITY; RESISTANCE; POPULATION; SUSCEPTIBILITY; TRANSMISSION; PROTECTION; PARASITES	Despite considerable success of genome wide association (GWA) studies in identifying causal variants for many human diseases, their success in unraveling the genetic basis to complex diseases has been more mitigated. Pathogen population structure may impact upon the infectious phenotype, especially with the intense short-term selective pressure that drug treatment exerts on pathogens. Rigorous analysis that accounts for repeated measures and disentangles the influence of genetic and environmental factors must be performed. Attempts should be made to consider whether pathogen diversity will impact upon host genetic responses to infection. We analyzed the heritability of two Plasmodium falciparum phenotypes, the number of clinical malaria episodes (PFA) and the proportion of these episodes positive for gametocytes (Pfgam), in a family-based cohort followed for 19 years, during which time there were four successive drug treatment regimes, with documented appearance of drug resistance. Repeated measures and variance components analyses were performed with fixed environmental, additive genetic, intra-individual and maternal effects for each drug period. Whilst there was a significant additive genetic effect underlying PFA during the first drug period of study, this was lost in subsequent periods. There was no additive genetic effect for Pfgam. The intra-individual effect increased significantly in the chloroquine period. The loss of an additive genetic effect following novel drug treatment may result in significant loss of power to detect genes in a GWA study. Prior genetic analysis must be a pre-requisite for more detailed GWA studies. The temporal changes in the individual genetic and the intra-individual estimates are consistent with those expected if there were specific host-parasite interactions. The complex basis to the human response to malaria parasite infection likely includes dominance/epistatic genetic effects encompassed within the intra-individual variance component. Evaluating their role in influencing the outcome of infection through host genotype by parasite genotype interactions warrants research effort.	[Loucoubar, Cheikh; Goncalves, Bronner; Bureau, Jean-Francois; Sakuntabhai, Anavaj; Paul, Richard] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France; [Loucoubar, Cheikh; Bar-Hen, Avner] Univ Paris 05, Lab Math Appl Paris 5, UMR 8145, Paris, France; [Loucoubar, Cheikh; Tall, Adama; Sarr, Fatoumata Diene; Faye, Joseph; Badiane, Abdoulaye; Ly, Alioune Badara] Univ Cheikh Anta Diop, Inst Pasteur Dakar, Unite Epidemiol Malad Infect, ED SEV,UR 172, Dakar, Senegal; [Loucoubar, Cheikh; Bar-Hen, Avner] Ecole Hautes Etud Sante Publ, Rennes, France; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, Dakar, Senegal; [Diop, Aliou] Univ Gaston Berger, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Sakuntabhai, Anavaj] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Mahidol University	Loucoubar, C (corresponding author), Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France.	rpaul@pasteur.fr		Paul, Richard/0000-0002-0665-5089; Bureau, Jean-Francois/0000-0003-1945-1883; DIOP, Aliou/0000-0002-0808-5622	Ecole des Hautes Etudes en Sante Publique	Ecole des Hautes Etudes en Sante Publique	Doctoral finances for Cheikh Loucoubar awarded by the Ecole des Hautes Etudes en Sante Publique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Barnes KI, 2005, ACTA TROP, V94, P230, DOI 10.1016/j.actatropica.2005.04.014; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Davila S, 2009, GENOME MED, V1, DOI 10.1186/gm19; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; [National Human Genome Research Institute National Institutes of Health], 2011, CAT PUBL GEN WID ASS; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Ntoumi F, 2007, AM J TROP MED HYG, V77, P270, DOI 10.4269/ajtmh.2007.77.270; Paul REL, 2003, ECOL LETT, V6, P866, DOI 10.1046/j.1461-0248.2003.00509.x; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; SAS, 2010, MIXED PROC SAS STAT; SAS, 2010, INBREED PROC SAS STA; SAS Institute Inc, 2010, GLIMMIX PROC SAS STA; Schneider P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-257; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26364	10.1371/journal.pone.0026364	http://dx.doi.org/10.1371/journal.pone.0026364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073159	gold, Green Published			2022-12-25	WOS:000297197000008
J	Nakano, A; Tsuji, D; Miki, H; Cui, Q; El Sayed, SM; Ikegame, A; Oda, A; Amou, H; Nakamura, S; Harada, T; Fujii, S; Kagawa, K; Takeuchi, K; Sakai, A; Ozaki, S; Okano, K; Nakamura, T; Itoh, K; Matsumoto, T; Abe, M				Nakano, Ayako; Tsuji, Daisuke; Miki, Hirokazu; Cui, Qu; El Sayed, Salah Mohamed; Ikegame, Akishige; Oda, Asuka; Amou, Hiroe; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Kagawa, Kumiko; Takeuchi, Kyoko; Sakai, Akira; Ozaki, Shuji; Okano, Kazuma; Nakamura, Takahiro; Itoh, Kohji; Matsumoto, Toshio; Abe, Masahiro			Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; SIDE POPULATION; GLUCOSE-METABOLISM; P-GLYCOPROTEIN; CANCER; PROTEIN; LINES	Cancer cells eventually acquire drug resistance largely via the aberrant expression of ATP-binding cassette (ABC) transporters, ATP-dependent efflux pumps. Because cancer cells produce ATP mostly through glycolysis, in the present study we explored the effects of inhibiting glycolysis on the ABC transporter function and drug sensitivity of malignant cells. Inhibition of glycolysis by 3-bromopyruvate (3BrPA) suppressed ATP production in malignant cells, and restored the retention of daunorubicin or mitoxantrone in ABC transporter-expressing, RPMI8226 (ABCG2), KG-1 (ABCB1) and HepG2 cells (ABCB1 and ABCG2). Interestingly, although side population (SP) cells isolated from RPMI8226 cells exhibited higher levels of glycolysis with an increased expression of genes involved in the glycolytic pathway, 3BrPA abolished Hoechst 33342 exclusion in SP cells. 3BrPA also disrupted clonogenic capacity in malignant cell lines including RPMI8226, KG-1, and HepG2. Furthermore, 3BrPA restored cytotoxic effects of daunorubicin and doxorubicin on KG-1 and RPMI8226 cells, and markedly suppressed subcutaneous tumor growth in combination with doxorubicin in RPMI8226-implanted mice. These results collectively suggest that the inhibition of glycolysis is able to overcome drug resistance in ABC transporter-expressing malignant cells through the inactivation of ABC transporters and impairment of SP cells with enhanced glycolysis as well as clonogenic cells.	[Nakano, Ayako; Miki, Hirokazu; Cui, Qu; Ikegame, Akishige; Oda, Asuka; Amou, Hiroe; Nakamura, Shingen; Harada, Takeshi; Fujii, Shiro; Kagawa, Kumiko; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Tsuji, Daisuke; Okano, Kazuma; Nakamura, Takahiro; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Med Biotechnol, Inst Med Res, Tokushima 770, Japan; [El Sayed, Salah Mohamed] Univ Tokushima, Grad Sch Med, Dept Pediat, Tokushima 770, Japan; [Takeuchi, Kyoko] Tokushima Univ Hosp, Div Transfus Med, Tokushima, Japan; [Sakai, Akira] Hiroshima Univ, Dept Hematol & Oncol, RIRBM, Hiroshima, Japan; [Ozaki, Shuji] Tokushima Prefectural Hosp, Div Internal Med, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Hiroshima University	Nakano, A (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan.	masabe@clin.med.tokushima-u.ac.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820	Ministry of Education, Culture, Science and Sports of Japan; National Cancer Center from the Ministry of Health, Labor and Welfare of Japan [21-8-5]	Ministry of Education, Culture, Science and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-aid for Scientific Research (A) to T. M., Grants-in-Aid for Scientific Research (C) to M. A. from the Ministry of Education, Culture, Science and Sports of Japan, and a National Cancer Center Research and Development Fund (21-8-5) to M. A. from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2000, CANCER RES, V60, P5761; Allen JD, 1999, CANCER RES, V59, P4237; Arai Fumio, 2008, STEMBOOK, DOI 10.3824/stembook.1.6.1; Asano J, 2011, LEUKEMIA, V25, P1182, DOI 10.1038/leu.2011.60; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Buda G, 2007, BRIT J HAEMATOL, V137, P454, DOI 10.1111/j.1365-2141.2007.06605.x; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hiasa M, 2009, BLOOD, V114, P4517, DOI 10.1182/blood-2009-04-215020; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hulleman E, 2009, BLOOD, V113, P2014, DOI 10.1182/blood-2008-05-157842; Kitazoe K, 2009, INT J HEMATOL, V89, P45, DOI 10.1007/s12185-008-0226-9; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Lin Q, 2008, GENE REGUL SYST BIO, V2, P43; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Minderman H, 2004, CLIN CANCER RES, V10, P1826, DOI 10.1158/1078-0432.CCR-0914-3; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	35	76	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27222	10.1371/journal.pone.0027222	http://dx.doi.org/10.1371/journal.pone.0027222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073292	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900091
J	Tseng, KY; Caballero, A; Dec, A; Cass, DK; Simak, N; Sunu, E; Park, MJ; Blume, SR; Sammut, S; Park, DJ; West, AR				Tseng, Kuei Y.; Caballero, Adriana; Dec, Alexander; Cass, Daryn K.; Simak, Natalie; Sunu, Elizabeth; Park, Michael J.; Blume, Shannon R.; Sammut, Stephen; Park, Diana J.; West, Anthony R.			Inhibition of Striatal Soluble Guanylyl Cyclase-cGMP Signaling Reverses Basal Ganglia Dysfunction and Akinesia in Experimental Parkinsonism	PLOS ONE			English	Article							NITRIC OXIDE/CGMP PATHWAY; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC-TRANSMISSION; OSCILLATORY ACTIVITY; NEOSTRIATAL NEURONS; PROJECTION NEURONS; FORELIMB AKINESIA; ACTIVITY STATES; RAT-BRAIN	Objective: There is clearly a necessity to identify novel non-dopaminergic mechanisms as new therapeutic targets for Parkinson's disease (PD). Among these, the soluble guanylyl cyclase (sGC)-cGMP signaling cascade is emerging as a promising candidate for second messenger-based therapies for the amelioration of PD symptoms. In the present study, we examined the utility of the selective sGC inhibitor 1H-[1,2,4] oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ) for reversing basal ganglia dysfunction and akinesia in animal models of PD. Methods: The utility of the selective sGC inhibitor ODQ for reversing biochemical, electrophysiological, histochemical, and behavioral correlates of experimental PD was performed in 6-OHDA-lesioned rats and mice chronically treated with MPTP. Results: We found that one systemic administration of ODQ is sufficient to reverse the characteristic elevations in striatal cGMP levels, striatal output neuron activity, and metabolic activity in the subthalamic nucleus observed in 6-OHDA-lesioned rats. The latter outcome was reproduced after intrastriatal infusion of ODQ. Systemic administration of ODQ was also effective in improving deficits in forelimb akinesia induced by 6-OHDA and MPTP. Interpretation: Pharmacological inhibition of the sGC-cGMP signaling pathway is a promising non-dopaminergic treatment strategy for restoring basal ganglia dysfunction and attenuating motor symptoms associated with PD.	[Tseng, Kuei Y.; Caballero, Adriana; Cass, Daryn K.; Simak, Natalie; Blume, Shannon R.] Rosalind Franklin Univ, Dept Cellular & Mol Pharmacol, Chicago Med Sch, N Chicago, IL USA; [Dec, Alexander; Sunu, Elizabeth; Park, Michael J.; Sammut, Stephen; Park, Diana J.; West, Anthony R.] Rosalind Franklin Univ, Dept Neurosci, Chicago Med Sch, N Chicago, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Tseng, KY (corresponding author), Rosalind Franklin Univ, Dept Cellular & Mol Pharmacol, Chicago Med Sch, N Chicago, IL USA.	kuei-yuan.tseng@rosalindfranklin.edu; Anthony.West@rosalindfranklin.edu	Sammut, Stephen/AAE-9787-2021	Caballero, Adriana/0000-0001-7052-7594; Sammut, Stephen/0000-0003-1507-5235	Parkinson's Disease Foundation; United States Public Health grants [NS047452, NS047452-S1]; Rosalind Franklin University; PRI;  [DA004093]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004093, R37DA004093] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; United States Public Health grants; Rosalind Franklin University; PRI; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Parkinson's Disease Foundation and United States Public Health grants NS047452 and NS047452-S1 to ARW, and DA004093, Rosalind Franklin University start-up funds, and PRI innovation grant to KYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1990, EUR J PHARMACOL, V181, P17; ARIANO MA, 1983, NEUROSCIENCE, V10, P707, DOI 10.1016/0306-4522(83)90212-9; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Calabresi P, 1999, J NEUROSCI, V19, P2489; Chalimoniuk M, 2007, NEUROCHEM INT, V50, P821, DOI 10.1016/j.neuint.2007.02.002; Chalimoniuk M, 2004, BIOCHEM BIOPH RES CO, V324, P118, DOI 10.1016/j.bbrc.2004.09.028; Chepkova AN, 2009, PFLUG ARCH EUR J PHY, V459, P131, DOI 10.1007/s00424-009-0714-7; COLWELL CS, 1995, J NEUROSCI, V15, P1704, DOI 10.1523/JNEUROSCI.15-03-01704.1995; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Ding JD, 2004, J COMP NEUROL, V472, P437, DOI 10.1002/cne.20054; Doreulee N, 2003, BRAIN RES, V964, P159, DOI 10.1016/S0006-8993(02)04121-5; Galati S, 2008, SYNAPSE, V62, P409, DOI 10.1002/syn.20510; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Giorgi M, 2008, EUR J NEUROSCI, V28, P941, DOI 10.1111/j.1460-9568.2008.06387.x; Hirsch EC, 2000, TRENDS NEUROSCI, V23, pS78, DOI 10.1016/S1471-1931(00)00021-5; HOFMANN M, 1977, J NEUROCHEM, V29, P395; Jouvert P, 2004, J NEUROSCI, V24, P10716, DOI 10.1523/JNEUROSCI.1398-04.2004; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; ODonnell P, 1997, NEUROSCIENCE, V76, P1; OLSSON M, 1995, J NEUROSCI, V15, P3863; Ondracek JM, 2008, EUR J NEUROSCI, V27, P1739, DOI 10.1111/j.1460-9568.2008.06157.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Roedter A, 2001, J COMP NEUROL, V432, P217, DOI 10.1002/cne.1098; Sammut S, 2007, J NEUROCHEM, V103, P1145, DOI 10.1111/j.1471-4159.2007.04811.x; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Stocchi F, 2008, MOVEMENT DISORD, V23, pS599, DOI 10.1002/mds.22052; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; Threlfell S, 2009, J PHARMACOL EXP THER, V328, P785, DOI 10.1124/jpet.108.146332; Tseng KY, 2006, BIOL PSYCHIAT, V60, P585, DOI 10.1016/j.biopsych.2006.03.030; Tseng KY, 2005, EUR J NEUROSCI, V22, P2579, DOI 10.1111/j.1460-9568.2005.04456.x; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; TSOU K, 1993, P NATL ACAD SCI USA, V90, P3462, DOI 10.1073/pnas.90.8.3462; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; West AR, 2010, US HDB BASAL GANGLIA, P187; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	46	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27187	10.1371/journal.pone.0027187	http://dx.doi.org/10.1371/journal.pone.0027187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073284	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900087
J	Zeng, S; Zhang, QY; Huang, JZ; Vedantham, S; Rosario, R; Ananthakrishnan, R; Yan, SF; Ramasamy, R; DeMatteo, RP; Emond, JC; Friedman, RA; Schmidt, AM				Zeng, Shan; Zhang, Qing Yin; Huang, Jianzhong; Vedantham, Srinivasan; Rosario, Rosa; Ananthakrishnan, Radha; Yan, Shi Fang; Ramasamy, Ravichandran; DeMatteo, Ronald P.; Emond, Jean C.; Friedman, Richard A.; Schmidt, Ann Marie			Opposing roles of RAGE and Myd88 signaling in extensive liver resection	FASEB JOURNAL			English	Article						nuclear factor-kappa B; Pim1; inflammation; proliferation; stat 3 phosphorylation	NF-KAPPA-B; SERINE/THREONINE KINASE PIM-1; MICE LACKING; IN-VIVO; C-MYC; REGENERATION; ACTIVATION; EXPRESSION; INTERLEUKIN-6; NECROSIS	In extensive liver resection secondary to primary or metastatic liver tumors, or in living donor liver transplantation, strategies to quell deleterious inflammatory responses and facilitate regeneration are essential. The receptor for advanced glycation end-products (RAGE) and myeloid differentiating factor 88 (Myd88) are implicated in the inflammatory response. To establish the contributions of RAGE vs. Myd88 signaling in extensive liver resection, we probed the effect of RAGE and/or Myd88, the latter primarily a key transducer of major toll-like receptors and also implicated in interleukin-1 (Il1) signaling, in a murine model of extensive (85%) hepatectomy. We report that, although Myd88 is thoroughly essential for survival via regulation of NF-kappa B and TNF-alpha, deletion of RAGE significantly improved survival compared to wild-type, Myd88-null, or RAGE-null/Myd88-null mice. RAGE opposes Myd88 signaling at multiple levels: by suppression of p65 levels, thereby reducing activation of NF-kappa B and consequent production of cyclin D1, and by suppression of Il6-mediated phosphorylation of Stat3, thereby down-regulating Pim1 and suppressing the hyperplastic response. Further, RAGE-dependent suppression of glyoxalase1, a detoxification pathway for pre-AGEs, enhances AGE levels and suppresses Il6 action. We conclude that blockade of RAGE may rescue liver remnants from the multiple signals that preclude adaptive proliferation triggered primarily by Myd88 signaling pathways.-Zeng, S., Zhang, Q. Y., Huang, J., Vedantham, S., Rosario, R., Ananthakrishnan, R., Yan, S. F., Ramasamy, R., DeMatteo, R. P., Emond, J. C., Friedman, R. A., Schmidt, A. M. Opposing roles of RAGE and Myd88 signaling in extensive liver resection. FASEB J. 26, 882-893 (2012). www.fasebj.org	[Zeng, Shan; DeMatteo, Ronald P.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Vedantham, Srinivasan; Rosario, Rosa; Ananthakrishnan, Radha; Yan, Shi Fang; Ramasamy, Ravichandran; Schmidt, Ann Marie] NYU, Div Endocrinol, Dept Med, Sch Med, New York, NY 10016 USA; [Zeng, Shan; Zhang, Qing Yin; Huang, Jianzhong; Emond, Jean C.] Columbia Univ, Dept Surg, Coll Phys & Surg, New York, NY USA; [Friedman, Richard A.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Coll Phys & Surg, New York, NY USA; [Friedman, Richard A.] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY USA	Memorial Sloan Kettering Cancer Center; New York University; Columbia University; Columbia University; Columbia University	Zeng, S (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10065 USA.	zengs@mskcc.org; annmarie.schmidt@nyumc.org		Ramasamy, Ravichandran/0000-0002-3666-3346	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068346] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068346] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Buckley AR, 2000, J NEUROIMMUNOL, V109, P40, DOI 10.1016/S0165-5728(00)00301-5; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Chen XG, 2010, J INTERF CYTOK RES, V30, P525, DOI 10.1089/jir.2009.0111; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CUYPERS HT, 1984, CELL, V37, P141; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Hanse EA, 2009, CELL CYCLE, V8, P2802, DOI 10.4161/cc.8.17.9465; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; Meloche J, 2011, ARTERIOSCL THROM VAS, V31, P2114, DOI 10.1161/ATVBAHA.111.230573; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; OHMORI S, 1987, J CHROMATOGR-BIOMED, V414, P149, DOI 10.1016/0378-4347(87)80033-6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Panis Y, 1997, SURGERY, V121, P142, DOI 10.1016/S0039-6060(97)90283-X; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Samstein B, 2001, ANNU REV MED, V52, P147, DOI 10.1146/annurev.med.52.1.147; Sowa JP, 2008, WORLD J GASTROENTERO, V14, P7093, DOI 10.3748/wjg.14.7093; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Yamada Y, 1998, AM J PATHOL, V152, P1577; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	42	25	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					882	893		10.1096/fj.11-192997	http://dx.doi.org/10.1096/fj.11-192997			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22075646	Green Published			2022-12-25	WOS:000300485700038
J	Palczewski, K				Palczewski, Krzysztof			Thematic Minireview Series on Focus on Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu			NATIONAL EYE INSTITUTE [R01EY008061, R01EY009339] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009339, R01 EY008061] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1610	1611		10.1074/jbc.R111.322347	http://dx.doi.org/10.1074/jbc.R111.322347			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074916	Green Published, hybrid			2022-12-25	WOS:000299321000001
J	Canals, M; Lane, JR; Wen, A; Scammells, PJ; Sexton, PM; Christopoulos, A				Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur			A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; FUNCTIONAL SELECTIVITY; PLAUSIBLE MODEL; DRUG DISCOVERY; 2-STATE MODEL; BINDING; ACTIVATION; LIGAND; AGONISTS; PHARMACOLOGY	The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors. Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands. We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M-1 muscarinic acetylcholine receptor (mAChR). Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high positive cooperativity with orthosteric agonists in a manner that correlated with efficacy but negative cooperativity with inverse agonists. The activity of BQCA was significantly increased at a constitutively active M-1 mAChR but abolished at an inactive mutant. Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway. This latter cellular property also determined the difference in magnitude of positive cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways. The lack of additional, pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast G(pa1) protein and human G alpha subunits. These findings define a chemical biological framework that can be applied to the study and classification of allosteric modulators across different GPCR families.	[Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, 399 Royal Pde, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Lane, J. Robert/0000-0002-7361-7875; Canals, Meritxell/0000-0002-7942-5006; Scammells, Peter/0000-0003-2930-895X	National Health and Medical Research Council [519461, APP1011796, APP1011920]; Australian Research Council [DP110100687]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was funded in part by National Health and Medical Research Council Program Grants 519461 (to A. C. and P. M. S.), APP1011796 (to M. C.), and APP1011920 (to J. R. L.) by and Australian Research Council Discovery Grant DP110100687 (A. C.).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Giraldo J, 2004, FEBS LETT, V556, P13, DOI 10.1016/S0014-5793(03)01404-2; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Lanzafame A, 1996, EUR J PHARMACOL, V316, P27, DOI 10.1016/S0014-2999(96)00639-5; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; PROSKA J, 1994, MOL PHARMACOL, V45, P709; Scholten D., 2011, BR J PHARM IN PRESS; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Stewart GD, 2010, ACS CHEM BIOL, V5, P365, DOI 10.1021/cb900276p; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; Thomas RL, 2008, J PHARMACOL EXP THER, V327, P365, DOI 10.1124/jpet.108.141788; TUCEK S, 1990, MOL PHARMACOL, V38, P674; Valant C, 2010, MOL PHARMACOL, V78, P444, DOI 10.1124/mol.110.064568; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	41	93	94	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					650	659		10.1074/jbc.M111.314278	http://dx.doi.org/10.1074/jbc.M111.314278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086918	Green Published, hybrid			2022-12-25	WOS:000298682400063
J	Goel, S; Krishnamurthy, S; Hampsey, M				Goel, Shivani; Krishnamurthy, Shankarling; Hampsey, Michael			Mechanism of Start Site Selection by RNA Polymerase II INTERPLAY BETWEEN TFIIB AND Ssl2/XPB HELICASE SUBUNIT OF TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION PREINITIATION COMPLEX; II INITIATION COMPLEX; PHOTO-CROSS-LINKING; N-TERMINAL REGION; SACCHAROMYCES-CEREVISIAE; GENE LOOPS; EXCISION-REPAIR; YEAST TFIIB; CHROMOSOME CONFORMATION; FUNCTIONAL INTERACTION	TFIIB is essential for transcription initiation by RNA polymerase II. TFIIB also cross-links to terminator regions and is required for gene loops that juxtapose promoter-terminator elements in a transcription-dependent manner. The Saccharomyces cerevisiae sua7-1 mutation encodes an altered form of TFIIB (E62K) that is defective for both start site selection and gene looping. Here we report the isolation of an ssl2 mutant, encoding an altered form of TFIIH, as a suppressor of the cold-sensitive growth defect of the sua7-1 mutation. Ssl2 (Rad25) is orthologous to human XPB and is a member of the SF2 family of ATP-dependent DNA helicases. The ssl2 suppressor allele encodes an arginine replacement of the conserved histidine residue (H508R) located within the DEVH-containing helicase domain. In addition to suppressing the TFIIB E62K growth defect, Ssl2 H508R partially restores both normal start site selection and gene looping. Moreover, Ssl2, like TFIIB, associates with promoter and terminator regions, and the diminished association of TFIIB E62K with the PMA1 terminator is restored by the Ssl2 H508R suppressor. These results define a novel, functional interaction between TFIIB and Ssl2 that affects start site selection and gene looping.	[Goel, Shivani; Krishnamurthy, Shankarling; Hampsey, Michael] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	michael.hampsey@umdnj.edu			National Institutes of Health [GM39484, GM068887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887, R29GM039484, R01GM039484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM39484 (to M. H.) and GM068887 (to Claire Moore (Tufts Medical School) and M. H.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Douziech M, 2000, MOL CELL BIOL, V20, P8168, DOI 10.1128/MCB.20.21.8168-8177.2000; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lee BS, 1998, GENETICS, V148, P1743; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PINTO I, 1994, J BIOL CHEM, V269, P30569; PINTO I, 1992, GENETICS, V132, P97; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh BN, 2009, METHODS, V48, P361, DOI 10.1016/j.ymeth.2009.02.018; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; SWEDER KS, 1994, J BIOL CHEM, V269, P1852; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu WH, 1999, GENETICS, V153, P643; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; [No title captured]	75	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					557	567		10.1074/jbc.M111.281576	http://dx.doi.org/10.1074/jbc.M111.281576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081613	Green Published, hybrid			2022-12-25	WOS:000298682400054
J	Li, Y; Martin, BR; Cravatt, BF; Hofmann, SL				Li, Yi; Martin, Brent R.; Cravatt, Benjamin F.; Hofmann, Sandra L.			DHHC5 Protein Palmitoylates Flotillin-2 and Is Rapidly Degraded on Induction of Neuronal Differentiation in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; REGGIE/FLOTILLIN PROTEINS; SACCHAROMYCES-CEREVISIAE; MEMBRANE MICRODOMAINS; AXON REGENERATION; S-ACYLATION; ENDOCYTOSIS; PSD-95; DOMAIN; REGGIE-1/FLOTILLIN-2	Post-translational palmitoylation of intracellular proteins is mediated by protein palmitoyltransferases belonging to the DHHC family, which share a common catalytic Asp-His-His-Cys (DHHC) motif. Several members have been implicated in neuronal development, neurotransmission, and synaptic plasticity. We previously observed that mice homozygous for a hypomorphic allele of the ZDHHC5 gene are impaired in context-dependent learning and memory. To identify potentially relevant protein substrates of DHHC5, we performed a quantitative proteomic analysis of stable isotope-labeled neuronal stem cell cultures from forebrains of normal and DHHC5-GT(gene-trapped) mice using the bioorthogonal palmitate analog 17-octadecynoic acid. We identified similar to 300 17-octadecynoic acid-modified and hydroxylamine-sensitive proteins, of which a subset was decreased in abundance in DHHC5-GT cells. Palmitoylation and oligomerization of one of these proteins (flotillin-2) was abolished in DHHC5-GT neuronal stem cells. In COS-1 cells, overexpression of DHHC5 markedly stimulated the palmitoylation of flotillin-2, strongly suggesting a direct enzyme-substrate relationship. Serendipitously, we found that down-regulation of DHHC5 was triggered within minutes following growth factor withdrawal from normal neural stem cells, a maneuver that is used to induce neural differentiation in culture. The effect was reversible for up to 4 h, and degradation was partially prevented by inhibitors of ubiquitin-mediated proteolysis. These findings suggest that protein palmitoylation can be regulated through changes in DHHC PAT levels in response to differentiation signals.	[Li, Yi; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Li, Yi; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Martin, Brent R.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Martin, Brent R.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; Scripps Research Institute	Hofmann, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.hofmann@utsouthwestern.edu	Martin, Brent/B-4370-2012	Martin, Brent/0000-0002-7136-2397	National Institutes of Health [R37 NS36867, K99CA151460]; Robert A. Welch Foundation [I-1187]; NATIONAL CANCER INSTITUTE [K99CA151460, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS36867 (to S. L. H.) and K99CA151460 (B. R. M.). This work was also supported by Robert A. Welch Foundation Grant I-1187 (to S. L. H.).	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Montoro AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016969; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; HESS DT, 1992, J NEUROSCI, V12, P4634; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim Ki-Bum, 2008, V424, P413, DOI 10.1007/978-1-60327-064-9_32; Kokkola T, 2011, FEBS LETT, V585, P2665, DOI 10.1016/j.febslet.2011.07.028; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin B. R., 2011, NAT METHODS IN PRESS; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schulte T, 1997, DEVELOPMENT, V124, P577; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Uechi Y, 2009, BIOCHEM BIOPH RES CO, V378, P732, DOI 10.1016/j.bbrc.2008.11.107; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107	55	93	97	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					523	530		10.1074/jbc.M111.306183	http://dx.doi.org/10.1074/jbc.M111.306183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081607	Green Published, hybrid			2022-12-25	WOS:000298682400051
J	Meng, H; Yuan, Y; Lee, VM				Meng, Hui; Yuan, Yuan; Lee, Vivian M.			Loss of Sphingosine Kinase 1/S1P Signaling Impairs Cell Growth and Survival of Neurons and Progenitor Cells in the Developing Sensory Ganglia	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; DORSAL-ROOT GANGLION; SPHINGOSINE 1-PHOSPHATE; IN-VIVO; LYSOPHOSPHOLIPID RECEPTORS; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; DEATH; EXPRESSION; DIFFERENTIATION	Background: Lysophospholipids such as lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are important signaling molecules that can regulate a wide range of cellular responses. We discovered that Sphingosine kinase 1 (Sphk1), a key enzyme that converts sphingosine to S1P, is expressed in neurons and progenitor cells in nascent trigeminal and dorsal root ganglia during mouse embryogenesis. Methods and Findings: Sphk1 null mouse embryos do not display overt deficits owing to compensation by Sphk2. Thus, we analyzed embryos that are deficient in both Sphk1 and Sphk2 (which essentially eliminates S1P function) in order to investigate the role(s) of Sphk1 during sensory ganglia formation. While animals lacking 1-3 alleles of Sphk1 and Sphk2 had no obvious phenotype, embryos without both genes displayed clear developmental defects. The complete absence of Sphk1 and Sphk2 resulted in trigeminal and dorsal root ganglia with fewer neurons and progenitor cells. The profound loss in cell number could be attributed to a decrease in cell proliferation as well as an increase in apoptosis. Furthermore, Sphk1/2 double mutants displayed an overall reduction in other sphingolipids as well as an imbalance of S1P/sphingosine and S1P/ceramide ratio, thereby favoring cell death and reducing cell growth. Conclusions: Together, these results provide strong in vivo evidence that sphingosine kinase/S1P signaling plays an important role in regulating early events during development of sensory ganglia.	[Meng, Hui; Lee, Vivian M.] Med Coll Wisconsin, Dept Pediat, Div Dev Biol, Milwaukee, WI 53226 USA; [Meng, Hui; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China	Medical College of Wisconsin; China Medical University	Meng, H (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Dev Biol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	leevivianm@gmail.com	Yuan, Yuan/GVS-5120-2022		March of Dimes Basil O'Connor	March of Dimes Basil O'Connor(March of Dimes)	This study was funded in part by a March of Dimes Basil O'Connor Starter Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agudo-Lopez A, 2010, NEUROSCI LETT, V470, P130, DOI 10.1016/j.neulet.2009.12.070; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dobrowsky RT, 1998, ANN NY ACAD SCI, V845, P32, DOI 10.1111/j.1749-6632.1998.tb09660.x; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hapner SJ, 2006, DEV BIOL, V297, P182, DOI 10.1016/j.ydbio.2006.05.007; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Kanno T, 2010, NEUROSCIENCE, V171, P973, DOI 10.1016/j.neuroscience.2010.10.021; Le Douarin NM, 1999, NEURAL CREST, V2; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Meng H, 2009, DEV DYNAM, V238, P487, DOI 10.1002/dvdy.21852; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Saba JD, 2004, J CELL BIOCHEM, V92, P967, DOI 10.1002/jcb.20128; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5	42	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27150	10.1371/journal.pone.0027150	http://dx.doi.org/10.1371/journal.pone.0027150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096531	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800031
J	Robson, LG; Di Foggia, V; Radunovic, A; Bird, K; Zhang, XY; Marino, S				Robson, Lesley G.; Di Foggia, Valentina; Radunovic, Aleksandar; Bird, Katy; Zhang, Xinyu; Marino, Silvia			Bmi1 Is Expressed in Postnatal Myogenic Satellite Cells, Controls Their Maintenance and Plays an Essential Role in Repeated Muscle Regeneration	PLOS ONE			English	Article							SELF-RENEWAL; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; PROLIFERATION; ORIGIN; MICE; SHOW; PROGENITORS; PROGRESSION; POPULATION	Satellite cells are the resident stem cell population of the adult mammalian skeletal muscle and they play a crucial role in its homeostasis and in its regenerative capacity after injury. We show here that the Polycomb group (PcG) gene Bmi1 is expressed in both the Pax7 positive (+)/Myf5 negative (-) stem cell population as well as the Pax7+/Myf5+ committed myogenic progenitor population. Depletion of Pax7+/Myf5- satellite cells with reciprocal increase in Pax7+/Myf5+ as well as MyoD positive (+) cells is seen in Bmi1-/- mice leading to reduced postnatal muscle fiber size and impaired regeneration upon injury. Bmi1-/- satellite cells have a reduced proliferative capacity and fail to re-enter the cell cycle when stimulated by high serum conditions in vitro, in keeping with a cell intrinsic defect. Thus, both the in vivo and in vitro results suggest that Bmi1 plays a crucial role in the maintenance of the stem cell pool in postnatal skeletal muscle and is essential for efficient muscle regeneration after injury especially after repeated muscle injury.	[Robson, Lesley G.; Di Foggia, Valentina; Bird, Katy; Zhang, Xinyu; Marino, Silvia] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Radunovic, Aleksandar] Barts & London NHS Trust, Neurosci Clin Acad Unit, London, England	University of London; Queen Mary University London; Barts Health NHS Trust	Robson, LG (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	s.marino@qmul.ac.uk	Radunovic, Aleksandar/D-2569-2012	Marino, Silvia/0000-0002-9612-2883	Medical Research Council UK; Muscular Dystrophy Campaign; MRC [G0802546] Funding Source: UKRI; Medical Research Council [G0802546] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Medical Research Council UK and Muscular Dystrophy Campaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; ASP P, 2011, P NATL AC SCI US; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; BOLDRIN L, 2010, J HISTOCHEM CYTOCHEM; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; GROUNDS MD, 1992, EXP CELL RES, V198, P357, DOI 10.1016/0014-4827(92)90391-K; Irintchev A, 1997, NEUROMUSCULAR DISORD, V7, P117, DOI 10.1016/S0960-8966(96)00422-1; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; MASSA R, 1994, ACTA NEUROPATHOL, V87, P377; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Menzel CL, 2011, J SURG RES, V166, pE149, DOI 10.1016/j.jss.2010.11.914; Nowak JA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-1; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Pavlath GK, 2003, AM J PATHOL, V162, P1685, DOI 10.1016/S0002-9440(10)64303-9; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Wilton SD, 1997, NEUROMUSCULAR DISORD, V7, P329, DOI 10.1016/S0960-8966(97)00058-8; Wilton SD, 1997, MUSCLE NERVE, V20, P728; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	47	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27116	10.1371/journal.pone.0027116	http://dx.doi.org/10.1371/journal.pone.0027116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096526	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800028
J	Cui, LB; Qi, YH; Li, HJ; Ge, YY; Zhao, KC; Qi, X; Guo, XL; Shi, ZY; Zhou, MH; Zhu, BL; Guo, Y; Li, J; Stratton, CW; Tang, YW; Wang, H				Cui, Lunbiao; Qi, Yuhua; Li, Haijing; Ge, Yiyue; Zhao, Kangchen; Qi, Xian; Guo, Xiling; Shi, Zhiyang; Zhou, Minghao; Zhu, Baoli; Guo, Yan; Li, Jun; Stratton, Charles W.; Tang, Yi-Wei; Wang, Hua			Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PLASMA; BIOMARKERS; IDENTIFICATION; DIAGNOSIS; CANCER	Altered circulating microRNA (miRNA) profiles have been noted in patients with microbial infections. We compared host serum miRNA levels in patients with hand-foot-and-mouth disease (HFMD) caused by enterovirus 71 (EV71) and coxsackievirus 16 (CVA16) as well as in other microbial infections and in healthy individuals. Among 664 different miRNAs analyzed using a miRNA array, 102 were up-regulated and 26 were down-regulated in sera of patients with enteroviral infections. Expression levels of ten candidate miRNAs were further evaluated by quantitative real-time PCR assays. A receiver operating characteristic (ROC) curve analysis revealed that six miRNAs (miR-148a, miR-143, miR-324-3p, miR-628-3p, miR-140-5p, and miR-362-3p) were able to discriminate patients with enterovirus infections from healthy controls with area under curve (AUC) values ranged from 0.828 to 0.934. The combined six miRNA using multiple logistic regression analysis provided not only a sensitivity of 97.1% and a specificity of 92.7% but also a unique profile that differentiated enterovirial infections from other microbial infections. Expression levels of five miRNAs (miR-148a, miR-143, miR-324-3p, miR-545, and miR-140-5p) were significantly increased in patients with CVA16 versus those with EV71 (p<0.05). Combination of miR-545, miR-324-3p, and miR-143 possessed a moderate ability to discrimination between CVA16 and EV71 with an AUC value of 0.761. These data indicate that sera from patients with different subtypes of enteroviral infection express unique miRNA profiles. Serum miRNA expression profiles may provide supplemental biomarkers for diagnosing and subtyping enteroviral HFMD infections.	[Cui, Lunbiao; Qi, Yuhua; Ge, Yiyue; Zhao, Kangchen; Qi, Xian; Guo, Xiling; Shi, Zhiyang; Zhou, Minghao; Zhu, Baoli; Wang, Hua] Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Peoples R China; [Cui, Lunbiao; Li, Haijing; Stratton, Charles W.; Tang, Yi-Wei] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Guo, Yan; Li, Jun] Nanjing Childrens Hosp, Nanjing, Peoples R China; [Stratton, Charles W.; Tang, Yi-Wei] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Cui, LB (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Peoples R China.	yiwei.tang@vanderbilt.edu; hua@jscdc.cn	ge, yiyue/AAW-9914-2021; cui, lunbiao/AAP-7931-2021; zhou, minghao/GZA-7244-2022		National Natural Science Foundation of China [30901285]; Important National Science and Technology Projects [2008ZX10004-002]; Natural Science Foundation of Jiangsu Province [BK2009434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science and Technology Projects; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The study was supported by the National Natural Science Foundation of China (30901285, www.nsfc.gov.cn), Important National Science and Technology Specific Projects during the eleventh five-year plan period (2008ZX10004-002, www.most.gov.cn) and the Natural Science Foundation of Jiangsu Province (BK2009434, www.jstd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIHRER V, 2011, AM J GASTROENTEROL; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cui LB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/425939; Deng XQ, 2003, J VIROL METHODS, V107, P141, DOI 10.1016/S0166-0934(02)00211-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Nuovo GJ, 2010, DIAGN MOL PATHOL, V19, P135, DOI 10.1097/PDM.0b013e3181c4daaa; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reid G., 2010, CRIT REV ONCOL HEMAT, DOI 10,1016/j.critrevonc.,2010.11.004; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; [The Chinese Center for Disease Control and Prevention The Office of the World HealthOrganization in China], 2008, REP HAND FOOT MOUTH; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	37	67	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27071	10.1371/journal.pone.0027071	http://dx.doi.org/10.1371/journal.pone.0027071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087245	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700014
J	Neiman, AB; Russell, DF; Rowe, MH				Neiman, Alexander B.; Russell, David F.; Rowe, Michael H.			Identifying Temporal Codes in Spontaneously Active Sensory Neurons	PLOS ONE			English	Article							SPIKE-TIMING PRECISION; INFORMATION-TRANSMISSION; DETECTION THRESHOLDS; STIMULI; SYSTEM; TRAINS; AFFERENTS; DYNAMICS; INTERNEURONS; VARIABILITY	The manner in which information is encoded in neural signals is a major issue in Neuroscience. A common distinction is between rate codes, where information in neural responses is encoded as the number of spikes within a specified time frame (encoding window), and temporal codes, where the position of spikes within the encoding window carries some or all of the information about the stimulus. One test for the existence of a temporal code in neural responses is to add artificial time jitter to each spike in the response, and then assess whether or not information in the response has been degraded. If so, temporal encoding might be inferred, on the assumption that the jitter is small enough to alter the position, but not the number, of spikes within the encoding window. Here, the effects of artificial jitter on various spike train and information metrics were derived analytically, and this theory was validated using data from afferent neurons of the turtle vestibular and paddlefish electrosensory systems, and from model neurons. We demonstrate that the jitter procedure will degrade information content even when coding is known to be entirely by rate. For this and additional reasons, we conclude that the jitter procedure by itself is not sufficient to establish the presence of a temporal code.	[Neiman, Alexander B.; Russell, David F.; Rowe, Michael H.] Ohio Univ, Neurosci Program, Athens, OH 45701 USA; [Neiman, Alexander B.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Russell, David F.; Rowe, Michael H.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Neiman, AB (corresponding author), Ohio Univ, Neurosci Program, Athens, OH 45701 USA.	rowe@ohio.edu	Neiman, Alexander B/G-2196-2010	Neiman, Alexander B/0000-0002-0906-9894	National Institutes of Health (NIH) [DC 04922, DC 05063]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004922, R01DC005063] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) DC 04922 and DC 05063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Aldworth ZN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002041; Aldworth ZN, 2005, J NEUROSCI, V25, P5323, DOI 10.1523/JNEUROSCI.0359-05.2005; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brichta AM, 2000, J NEUROPHYSIOL, V83, P1224, DOI 10.1152/jn.2000.83.3.1224; BRYANT HL, 1973, J NEUROPHYSIOL, V36, P205, DOI 10.1152/jn.1973.36.2.205; Butts DA, 2011, J NEUROSCI, V31, P11313, DOI 10.1523/JNEUROSCI.0434-11.2011; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Dayan P., 2001, THEORETICAL NEUROSCI; Engel TA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021919; Engelmann J, 2010, J NEUROPHYSIOL, V104, P1955, DOI 10.1152/jn.00503.2009; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Farkhooi F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021905; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Gabbiani F, 1996, NETWORK-COMP NEURAL, V7, P61, DOI 10.1080/0954898X.1996.11978655; Goldberg J M, 1991, Curr Opin Neurobiol, V1, P229, DOI 10.1016/0959-4388(91)90083-J; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Goldobin DS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.045201; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; HANGGI P, 1982, PHYS REP, V88, P207, DOI 10.1016/0370-1573(82)90045-X; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Koppl C, 1997, J NEUROSCI, V17, P3312; Lewis PAW, 1966, STAT ANAL SERIES EVE; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marsalek PR, 1997, P NATL ACAD SCI USA, V94, P735, DOI 10.1073/pnas.94.2.735; Massot C, 2011, J NEUROPHYSIOL, V105, P1798, DOI 10.1152/jn.00910.2010; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Neiman AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061915; Neiman AB, 2004, J NEUROPHYSIOL, V92, P492, DOI 10.1152/jn.00742.2003; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Nguyen H, 2010, EUR PHYS J-SPEC TOP, V187, P179, DOI 10.1140/epjst/e2010-01282-3; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1997, SPIKES EXPLORING NEU; Rokem A, 2006, J NEUROPHYSIOL, V95, P2541, DOI 10.1152/jn.00891.2005; Rowe MH, 2011, BRAIN RES, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Schleimer JH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.248105; Strong S P, 1998, Pac Symp Biocomput, P621; Teramae J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.204103; Teramae JN, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194102; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Tricas TC, 1998, J COMP PHYSIOL A, V182, P89; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Yoshimura K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.154101	56	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27380	10.1371/journal.pone.0027380	http://dx.doi.org/10.1371/journal.pone.0027380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087303	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700037
J	Bordonaro, M; Tewari, S; Cicco, CE; Atamna, W; Lazarova, DL				Bordonaro, Michael; Tewari, Shruti; Cicco, Catherine E.; Atamna, Wafa; Lazarova, Darina L.			A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells	PLOS ONE			English	Article							ACID PHENETHYL ESTER; HISTONE-DEACETYLASE ACTIVITY; RECEPTOR TYROSINE KINASES; BETA-CATENIN; IN-VITRO; COMPENSATORY PROLIFERATION; COLORECTAL-CANCER; UP-REGULATION; FOLD-CHANGE; APOPTOSIS	Butyrate, a fermentation product of fiber in the colon, acts as a histone deacetylase inhibitor (HDACi) and induces apoptosis in colon cancer (CC) cells in vitro. We have reported that the apoptotic effects of butyrate are dependent upon the hyperactivation of the Wnt/beta-catenin pathway. However, prolonged exposure of CC cells to increasing concentrations of butyrate results in the acquisition of resistance to the Wnt/beta-catenin- and apoptosis-inducing effects of this agent, as well as cross-resistance to structurally different HDACis. Here we report that one mechanism whereby HDACi resistance arises is through the increase of beta-catenin-independent (noncanonical) Wnt signaling. Compared to HDACi-sensitive HCT-116 CC cells, HDACi-resistant HCT-R cells exhibit higher levels of AKT/PKB cell survival signaling, which is in part induced by WNT5A and its receptor ROR2. The induction of AKT signaling by HDACis is also detected in other CC cell lines, albeit to a lesser extent than in the drug-resistant HCT-R cells. The observations suggested that the apoptotic effect of butyrate and other HDACis in CC cells can be augmented by inhibitors of pAKT. In agreement with the hypothesis, the combination of MK2206, a pAKT inhibitor, and a HDACi (butyrate or LBH589) induced higher apoptosis in CC cells compared to each agent alone. The exposure to both agents also re-sensitized the HCT-R cells to apoptosis. Finally, the concept of simultaneously inducing canonical Wnt activity and suppressing AKT signaling was translated into a combination of diet-derived agents. Diet-derived pAKT inhibitors (caffeic acid phethyl ester, sulforaphane, dilallyl trisulfide) suppressed the butyrate-induced levels of pAKT, and increased the apoptotic effects of butyrate in both drug-sensitive and drug-resistant CC cells. Our findings can be translated into (a) CC therapy employing combinations of synthetic HDACis and inhibitors of pAKT, as well as (b) CC prevention based upon diets that result in sufficient amounts of butyrate and pAKT inhibitors.	[Bordonaro, Michael; Tewari, Shruti; Cicco, Catherine E.; Atamna, Wafa; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Bordonaro, M (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	dlazarova@tcmedc.org			NIH/NCI [1R15CA152852-01]; Commonwealth Medical College (Scratnon, PA); AICR [09A002]; NIH/NCI-NIDDK [1R15CA149589-01]; NATIONAL CANCER INSTITUTE [R15CA152852, R15CA149589] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth Medical College (Scratnon, PA); AICR; NIH/NCI-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Darina Lazarova is supported by NIH/NCI grant #1R15CA152852-01 and institutional funds from The Commonwealth Medical College (Scratnon, PA). Michael Bordonaro is supported by AICR grant #09A002, NIH/NCI-NIDDK #1R15CA149589-01, and institutional funds from The Commonwealth Medical College (Scratnon, PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova MV, 2010, INT J BIOCHEM CELL B, V42, P1847, DOI 10.1016/j.biocel.2010.08.001; Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Barbier A, 2010, B CANCER, V97, pE9, DOI 10.1684/bdc.2010.1033; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; De Angelis Paula M, 2004, Mol Cancer, V3, P11, DOI 10.1186/1476-4598-3-11; Denlinger CE, 2005, J THORAC CARDIOV SUR, V130, P1422, DOI 10.1016/j.jtcvs.2005.06.051; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Feike AC, 2010, BIOCHEM BIOPH RES CO, V400, P500, DOI 10.1016/j.bbrc.2010.08.074; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; He X, 2011, CANCER LETT, V301, P168, DOI 10.1016/j.canlet.2010.11.012; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Izuishi K, 2000, CANCER RES, V60, P6201; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P159, DOI 10.1002/art.25017; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mahmoud NN, 2000, CARCINOGENESIS, V21, P921, DOI 10.1093/carcin/21.5.921; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyaki M, 1999, CANCER RES, V59, P4506; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; Sela U, 2008, NUTR CANCER, V60, P412, DOI 10.1080/01635580701733083; Shankar S, 2007, INT J ONCOL, V30, P905; Shen G, 2007, CANCER RES, V67, P9937, DOI 10.1158/0008-5472.CAN-07-1112; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; The Associations between Food Nutrition Physical Activitythe Risk of Colorectal Cancer, WCRF AICR SYST LIT R; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Weyant MJ, 2000, CLIN CANCER RES, V6, P949; Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; ZHENG ZS, 1995, ONCOL RES, V7, P445	69	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27308	10.1371/journal.pone.0027308	http://dx.doi.org/10.1371/journal.pone.0027308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073312	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000047
J	Mou, XZ; Wan, SY; Li, YF; Zhang, SS; Sun, MJ; Liu, FL; Fu, HY; Zhang, X; Liu, HY; Cao, Q; Ke, YH; Xiang, C				Mou, Xiaozhou; Wan, Shuying; Li, Yifei; Zhang, Shanshan; Sun, Mingjiao; Liu, Fanglong; Fu, Huiying; Zhang, Xue; Liu, Haiying; Cao, Qian; Ke, Yuehai; Xiang, Charlie			Phenotypic Pattern-Based Assay for Dynamically Monitoring Host Cellular Responses to Salmonella Infections	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; SENSOR ARRAYS; MOUSE MODEL; LABEL-FREE; INVASION; SECRETION; APOPTOSIS; DEATH; IDENTIFICATION	The interaction between mammalian host cells and bacteria is a dynamic process, and the underlying pathologic mechanisms are poorly characterized. Limited information describing the host-bacterial interaction is based mainly on studies using label-based endpoint assays that detect changes in cell behavior at a given time point, yielding incomplete information. In this paper, a novel, label-free, real-time cell-detection system based on electronic impedance sensor technology was adapted to dynamically monitor the entire process of intestinal epithelial cells response to Salmonella infection. Changes in cell morphology and attachment were quantitatively and continuously recorded following infection. The resulting impedance-based time-dependent cell response profiles (TCRPs) were compared to standard assays and showed good correlation and sensitivity. Biochemical assays further suggested that TCRPs were correlated with cytoskeleton-associated morphological dynamics, which can be largely attenuated by inhibitions of actin and microtubule polymerization. Collectively, our data indicate that cell-electrode impedance measurements not only provide a novel, real-time, label-free method for investigating bacterial infection but also help advance our understanding of host responses in a more physiological and continuous manner that is beyond the scope of current endpoint assays.	[Mou, Xiaozhou; Li, Yifei; Liu, Fanglong; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Wan, Shuying; Zhang, Shanshan; Sun, Mingjiao; Fu, Huiying; Zhang, Xue; Cao, Qian; Ke, Yuehai] Zhejiang Univ, Sch Med, Inst Mol Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Wan, Shuying; Zhang, Shanshan; Sun, Mingjiao; Fu, Huiying; Zhang, Xue; Cao, Qian; Ke, Yuehai] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Xiang, Charlie] Zhejiang California Int Nanosyst Inst ZCNI, Mol Diag Div, Hangzhou, Zhejiang, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China; [Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Mou, XZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yke@zju.edu.cn; cxiang@zju.edu.cn	fu, huiying/GZG-2399-2022		National Basic Research Program of China (973 program) [2007CB513001]; China's National Science and Technology Major Project [2008ZX10002-009]; Zhejiang University; Zhejiang Provincial TCM Administration [N20090004]; National Natural Science Foundation of China [30900849]	National Basic Research Program of China (973 program)(National Basic Research Program of China); China's National Science and Technology Major Project; Zhejiang University; Zhejiang Provincial TCM Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (973 program) No. 2007CB513001, China's National Science and Technology Major Project No. 2008ZX10002-009 and a Qiu Shi Professorship from Zhejiang University to C.X., and partly supported by the key program of Zhejiang Provincial TCM Administration N20090004 and National Natural Science Foundation of China 30900849 to Y.H.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2004, J IMMUNOL METHODS, V292, P195, DOI 10.1016/j.jim.2004.06.022; Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Atienza JM, 2006, J BIOMOL SCREEN, V11, P634, DOI 10.1177/1087057106289334; Baldwin DN, 2003, GENOME BIOL, V4; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Chowers Y, 2000, J IMMUNOL, V165, P2955, DOI 10.4049/jimmunol.165.6.2955; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; FINLAY BB, 1991, J CELL SCI, V99, P283; FINLAY BB, 1988, J CELL BIOL, V107, P221, DOI 10.1083/jcb.107.1.221; Fu HY, 2011, ANAL CHEM, V83, P6518, DOI 10.1021/ac201670e; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; Huang L, 2008, ANALYST, V133, P643, DOI 10.1039/b714384b; Ke N, 2010, ANAL CHEM, V82, P6495, DOI 10.1021/ac1007877; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kirstein SL, 2006, ASSAY DRUG DEV TECHN, V4, P545, DOI 10.1089/adt.2006.4.545; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sianina H, 2011, J MICROBIOL METH, V84, P101, DOI 10.1016/j.mimet.2010.11.004; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Steele-Mortimer Olivia, 2008, V431, P201; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005	46	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26544	10.1371/journal.pone.0026544	http://dx.doi.org/10.1371/journal.pone.0026544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073171	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000010
J	Suzuki, N; Furusawa, C; Kaneko, K				Suzuki, Narito; Furusawa, Chikara; Kaneko, Kunihiko			Oscillatory Protein Expression Dynamics Endows Stem Cells with Robust Differentiation Potential	PLOS ONE			English	Article							SELF-RENEWAL; GENE-EXPRESSION; NETWORK; PLURIPOTENCY; MOUSE; EMERGENCE; CIRCUITRY; NOISE; MODEL; FATE	The lack of understanding of stem cell differentiation and proliferation is a fundamental problem in developmental biology. Although gene regulatory networks (GRNs) for stem cell differentiation have been partially identified, the nature of differentiation dynamics and their regulation leading to robust development remain unclear. Herein, using a dynamical system modeling cell approach, we performed simulations of the developmental process using all possible GRNs with a few genes, and screened GRNs that could generate cell type diversity through cell-cell interactions. We found that model stem cells that both proliferated and differentiated always exhibited oscillatory expression dynamics, and the differentiation frequency of such stem cells was regulated, resulting in a robust number distribution. Moreover, we uncovered the common regulatory motifs for stem cell differentiation, in which a combination of regulatory motifs that generated oscillatory expression dynamics and stabilized distinct cellular states played an essential role. These findings may explain the recently observed heterogeneity and dynamic equilibrium in cellular states of stem cells, and can be used to predict regulatory networks responsible for differentiation in stem cell systems.	[Suzuki, Narito; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Suzuki, Narito; Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo, Japan; [Furusawa, Chikara] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Lab Multiscale Biosyst Dynam, Suita, Osaka, Japan	University of Tokyo; University of Tokyo; Osaka University; RIKEN	Suzuki, N (corresponding author), Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	kaneko@complex.c.u-tokyo.ac.jp	Furusawa, Chikara/ABB-6516-2021; Furusawa, Chikara/N-6103-2015	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975	people of Japan, via Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [21120004, 23650152]	people of Japan, via Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the people of Japan, via a Exploratory Research for Advanced Technology (ERATO) project from Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research (no. 21120004 and 23650152) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fujimori T, 2010, DEV GROWTH DIFFER, V52, P253, DOI 10.1111/j.1440-169X.2010.01172.x; Furusawa C, 1998, B MATH BIOL, V60, P659, DOI 10.1006/bulm.1997.0034; Furusawa C, 2001, J THEOR BIOL, V209, P395, DOI 10.1006/jtbi.2001.2264; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Goodwin B., 1963, TEMPORAL ORG CELLS; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirsch MW., 2003, DIFFERENTIAL EQUATIO, V2nd edn; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Huang S, 2007, PHYS REV LETT, V94; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kaneko K, 1997, B MATH BIOL, V59, P139, DOI 10.1016/S0092-8240(96)00044-4; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; KANEKO K, 1994, PHYSICA D, V75, P89, DOI 10.1016/0167-2789(94)90277-1; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lander Arthur D., 2009, Journal of Biology (London), V8, P70, DOI 10.1186/jbiol177; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MIZUGUCHI T, 1995, PHYS REV LETT, V75, P966, DOI 10.1103/PhysRevLett.75.966; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Newman SA, 2009, J BIOSCIENCES, V34, P553, DOI 10.1007/s12038-009-0074-7; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Waddington C., 1957, STRATEGY GENES; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427	55	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27232	10.1371/journal.pone.0027232	http://dx.doi.org/10.1371/journal.pone.0027232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073296	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000034
J	Vallejo, S; Romacho, T; Angulo, J; Villalobos, LA; Cercas, E; Leivas, A; Bermejo, E; Carraro, R; Sanchez-Ferrer, CF; Peiro, C				Vallejo, Susana; Romacho, Tania; Angulo, Javier; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Bermejo, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; OXIDATIVE STRESS; PLASMA VISFATIN; DIABETIC-RATS; DYSFUNCTION; EXPRESSION; CELLS; ATHEROSCLEROSIS; ASSOCIATION; NAMPT	Visfatin, also known as extracellular pre-B-cell colony-enhancing factor (PBEF) and nicotinamide phosphoribosyltransferase (Nampt), is an adipocytokine whose circulating levels are enhanced in metabolic disorders, such as type 2 diabetes mellitus and obesity. Circulating visfatin levels have been positively associated with vascular damage and endothelial dysfunction. Here, we investigated the ability of visfatin to directly impair vascular reactivity in mesenteric microvessels from both male Sprague-Dawley rats and patients undergoing non-urgent, non-septic abdominal surgery. The pre-incubation of rat microvessels with visfatin (50 and 100 ng/mL) did not modify the contractile response to noradrenaline (1 pmol/L to 30 mu mol/L), as determined using a small vessel myograph. However, visfatin (10 to 100 ng/mL) concentration-dependently impaired the relaxation to acetylcholine (ACh; 100 pmol/L to 3 mu mol/L), without interfering with the endothelium-independent relaxation to sodium nitroprusside (1 nmol/L to 3 mu mol/L). In both cultured human umbilical vein endothelial cells and rat microvascular preparations, visfatin (50 ng/mL) stimulated nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, as determined by lucigenin-derived chemiluminiscence. The relaxation to ACh impaired by visfatin was restored by the NADPH oxidase inhibitor apocynin (10 mu mol/L). Additionally, the Nampt inhibitor APO866 (10 mmol/L to 10 mu mol/L), but not an insulin receptor-blocking antibody, also prevented the stimulation of NADPH oxidase and the relaxation impairment elicited by visfatin. Accordingly, the product of Nampt activity nicotinamide mononucleotide (100 nmol/L to 1 mmol/L) stimulated endothelial NADPH oxidase activity and concentration-dependently impaired ACh-induced vasorelaxation. In human mesenteric microvessels pre-contracted with 35 mmol/L potassium chloride, the endothelium-dependent vasodilation to bradykinin (1 nmol/L to 3 mu mol/L) was equally impaired by visfatin and restored upon co-incubation with APO866. In conclusion, visfatin impairs endothelium-dependent relaxation through a mechanism involving NADPH oxidase stimulation and relying on Nampt enzymatic activity, and therefore arises as a potential new player in the development of endothelial dysfunction.	[Vallejo, Susana; Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain; [Angulo, Javier] IRYCIS, Dept Histol, Madrid, Spain; [Bermejo, Elena] Hosp Princesa, Serv Cirugia Gen & Digest, Madrid, Spain; [Carraro, Raffaele] Hosp Princesa, Serv Endocrinol, Unidad Obesidad, Madrid, Spain; [Carraro, Raffaele] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Leivas, Alejandra; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Hosp Princesa, Inst Invest Sanitaria, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Hospital de La Princesa; Autonomous University of Madrid; Hospital de La Princesa	Vallejo, S (corresponding author), Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain.	concha.peiro@uam.es	Romacho, Tania/B-2663-2016; Romacho, Tania/AAB-3306-2021; Peiro, Concepcion/B-9545-2017	Romacho, Tania/0000-0002-0962-7163; Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Leivas-Aldea, Alejandra/0000-0002-3950-9002; Carraro, Raffaele/0000-0002-5874-8076	Ministerio de Ciencia e Innovacion [SAF2008-01291, SAF2008-00942, SAF2011-28011, SAF2011-24648]; Instituto de Salud Carlos III (RETICEF) [RD06/0013, PI061779]; Ministerio de Educacion y Ciencia, Spain; CONACYT, Mexico	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (RETICEF)(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01291, SAF2008-00942, SAF2011-28011 and SAF2011-24648) and Instituto de Salud Carlos III (RETICEF RD06/0013, PI061779). T.R. and L.A.V. are the recipients of fellowships from Ministerio de Educacion y Ciencia, Spain, and CONACYT, Mexico, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Filippatos TD, 2007, J ENDOCRINOL INVEST, V30, P323, DOI 10.1007/BF03346300; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kang YS, 2010, KIDNEY INT, V78, P170, DOI 10.1038/ki.2010.98; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Malam Z, 2011, J IMMUNOL, V186, P6474, DOI 10.4049/jimmunol.1003706; Malyszko J, 2009, TRANSPL P, V41, P150, DOI 10.1016/j.transproceed.2008.10.086; Malyszko J, 2010, NEPHROLOGY, V15, P190, DOI 10.1111/j.1440-1797.2009.01180.x; Mu JA, 2011, J NEPHROL, V24, P177, DOI 10.5301/JN.2010.3488; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodriguez-Manas L, 2003, DIABETOLOGIA, V46, P556, DOI 10.1007/s00125-003-1056-1; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; TAYLOR R, 1987, BIOCHEM J, V242, P123, DOI 10.1042/bj2420123; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Yamawaki H, 2009, BIOCHEM BIOPH RES CO, V383, P503, DOI 10.1016/j.bbrc.2009.04.074; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727; Yilmaz MI, 2009, CLIN TRANSPLANT, V23, P241, DOI 10.1111/j.1399-0012.2008.00921.x	33	53	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27299	10.1371/journal.pone.0027299	http://dx.doi.org/10.1371/journal.pone.0027299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073309	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000044
J	Boonchawalit, S; Jullaksorn, D; Uttiyoung, J; Yowang, A; Krathong, N; Chautrakul, S; Yamashita, A; Ikuta, K; Roobsoong, A; Kanitvittaya, S; Sawanpanyalert, P; Kameoka, M				Boonchawalit, Samatchaya; Jullaksorn, Duangrat; Uttiyoung, Jiraporn; Yowang, Amara; Krathong, Nongkran; Chautrakul, Sununta; Yamashita, Akifumi; Ikuta, Kazuyoshi; Roobsoong, Amornsak; Kanitvittaya, Sangkom; Sawanpanyalert, Pathom; Kameoka, Masanori			Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; POSITIVE SELECTION; HYPERMUTATION; GP120; DNA; RESISTANCE; POPULATION; INFECTION	Background: The envelope glycoproteins (Env), gp120 and gp41, are the most variable proteins of human immunodeficiency virus type 1 (HIV-1), and are the major targets of humoral immune responses against HIV-1. A circulating recombinant form of HIV-1, CRF01_AE, is prevalent throughout Southeast Asia; however, only limited information regarding the immunological characteristics of CRF01_AE Env is currently available. In this study, we attempted to examine the evolutionary pattern of CRF01_AE Env under the selection pressure of host immune responses. Methodology/Principal Findings: Peripheral blood samples were collected periodically over 3 years from 15 HIV-1-infected individuals residing in northern Thailand, and amplified env genes from the samples were subjected to computational analysis. The V5 region of gp120 showed highest variability in several samples over 3 years, whereas the V1/V2 and/or V4 regions of gp120 also showed high variability in many samples. In addition, the N-terminal part of the C3 region of gp120 showed highest amino acid diversity among the conserved regions of gp120. Chronological changes in the numbers of amino acid residues in gp120 variable regions and potential N-linked glycosylation (PNLG) sites are involved in increasing the variability of Env gp120. Furthermore, the C3 region contained several amino acid residues potentially under positive selection, and APOBEC3 family protein-mediated G to A mutations were frequently detected in such residues. Conclusions/Significance: Several factors, including amino acid substitutions particularly in gp120 C3 and V5 regions as well as changes in the number of PNLG sites and in the length of gp120 variable regions, were revealed to be involved in the molecular evolution of CRF01_AE Env. In addition, a similar tendency was observed between CRF01_AE and subtype C Env with regard to the amino acid variation of gp120 V3 and C3 regions. These results may provide important information for understanding the immunological characteristics of CRF01_AE Env.	[Boonchawalit, Samatchaya; Kameoka, Masanori] Thailand Japan Res Collaborat Ctr Emerging & Re E, Nonthaburi, Thailand; [Jullaksorn, Duangrat; Sawanpanyalert, Pathom] Minist Publ Hlth MOPH, Natl Inst Hlth, Dept Med Sci DMSc, Nonthaburi, Thailand; [Uttiyoung, Jiraporn; Yowang, Amara; Kanitvittaya, Sangkom] MOPH, DMSc, Reg Med Sci Ctr Chiangrai, Chiangrai, Thailand; [Krathong, Nongkran; Chautrakul, Sununta; Roobsoong, Amornsak] Mae Soay Hosp, Chiangrai, Thailand; [Yamashita, Akifumi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Ikuta, Kazuyoshi; Kameoka, Masanori] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Ministry of Public Health - Thailand; Tohoku University; Osaka University	Boonchawalit, S (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Re E, Nonthaburi, Thailand.	mkameoka@biken.osaka-u.ac.jp		Kameoka, Masanori/0000-0001-5525-9915	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan; Department of Medical Sciences, Ministry of Public Health of Thailand	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) by the Ministry of Education, Cultures, Sports, Science and Technology of Japan, and the research budget of the Department of Medical Sciences, Ministry of Public Health of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archary D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-92; Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150; Bagnarelli P, 1999, J VIROL, V73, P3764, DOI 10.1128/JVI.73.5.3764-3777.1999; BALL JK, 1994, J GEN VIROL, V75, P867, DOI 10.1099/0022-1317-75-4-867; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Curran R, 2002, J MED VIROL, V67, P9, DOI 10.1002/jmv.2186; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Dieltjens T, 2009, AIDS RES HUM RETROV, V25, P1165, DOI 10.1089/aid.2008.0161; Frost SDW, 2001, VIROLOGY, V284, P250, DOI 10.1006/viro.2000.0887; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; GOUDSMIT J, 1988, AIDS, V2, P157; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Jullaksorn D, 2010, SE ASIAN J TROP MED, V41, P347; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; LAMERS SL, 1993, J VIROL, V67, P3951, DOI 10.1128/JVI.67.7.3951-3960.1993; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mens H, 2007, AIDS RES HUM RETROV, V23, P107, DOI 10.1089/aid.2006.0089; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; Utachee P, 2009, AIDS RES HUM RETROV, V25, P229, DOI 10.1089/aid.2008.0232; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	56	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27098	10.1371/journal.pone.0027098	http://dx.doi.org/10.1371/journal.pone.0027098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073263	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900076
J	He, NP; Han, XG; Yu, GR; Chen, QS				He, Nianpeng; Han, Xingguo; Yu, Guirui; Chen, Quansheng			Divergent Changes in Plant Community Composition under 3-Decade Grazing Exclusion in Continental Steppe	PLOS ONE			English	Article							LEYMUS-CHINENSIS GRASSLAND; TALLGRASS PRAIRIE; FIRE FREQUENCY; NITROGEN; LITTER; HETEROGENEITY; VARIABILITY; RESTORATION; STABILITY; ECOSYSTEM	An understanding of the factors controlling plant community composition will allow improved prediction of the responses of plant communities to natural and anthropogenic environmental change. Using monitoring data from 1980 to 2009, we quantified the changes in community composition in Leymus chinensis and Stipa grandis dominated grasslands in Inner Mongolia under long-term grazing-exclusion and free-grazing conditions, respectively. We demonstrated that the practice of long-term grazing exclusion has significant effects on the heterogeneity, the dominant species, and the community composition in the two grasslands. The community composition of L. chinensis and S. grandis grasslands exhibited directional changes with time under long-term grazing exclusion. Under free grazing, the L. chinensis community changed directionally with time, but the pattern of change was stochastic in the S. grandis community. We attributed the divergent responses to long-term grazing exclusion in the S. grandis and L. chinensis grasslands to litter accumulation and changes in the microenvironment after grazing exclusion, which collectively altered the growth and regeneration of the dominant species. The changes in the grazed grasslands were primarily determined by the selective feeding of sheep during long-term heavy grazing. Overall, the responses of the community composition of the Inner Mongolian grasslands to long-term grazing exclusion and heavy grazing were divergent, and depended primarily on the grassland type. Our findings provide new insights into the role of grazing in the maintenance of community structure and function and therefore have important implications for grassland management.	[He, Nianpeng; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [He, Nianpeng; Han, Xingguo; Chen, Quansheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	He, NP (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	henp@igsnrr.ac.cn	Han, Xingguo/K-7552-2016; Chen, Quansheng/AGH-8083-2022; 于, 贵瑞/C-1768-2014	Han, Xingguo/0000-0002-1836-975X; Chen, Quansheng/0000-0003-2498-3278; 于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	State Key Basic Research Development Program in China [2010CB833500]; Natural Science Foundation in China [31070431, 40803024]	State Key Basic Research Development Program in China; Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the State Key Basic Research Development Program in China (No. 2010CB833500) and by Natural Science Foundation in China (No. 31070431 and 40803024). The authors also declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON F. W., 1965, ECOLOGY, V46, P714, DOI 10.2307/1935011; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bao YJ, 2001, GRASSLAND CHINA, V22, P17; Bao YJ, 2000, GRASSLAND CHINA, V21, P1; Baoyin T, 2009, RANGELAND ECOL MANAG, V62, P314, DOI 10.2111/08-161.1; Burns CE, 2009, BIODIVERS CONSERV, V18, P2327, DOI 10.1007/s10531-009-9590-x; CARSON WP, 1990, OECOLOGIA, V85, P8, DOI 10.1007/BF00317337; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Chen Z., 2000, TYPICAL STEPPE ECOSY; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; COLLINS SL, 1987, ECOLOGY, V68, P1243, DOI 10.2307/1939208; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; COLLINS SL, 1992, ECOLOGY, V73, P2001, DOI 10.2307/1941450; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hobbs RJ, 2007, ECOL MONOGR, V77, P545, DOI 10.1890/06-1530.1; Jiang S., 1988, RES GRASSLAND ECOSYS, V3, P1; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Li YH, 1994, GRASSLAND CHINA, V20, P11; Li YH, 2008, RESTOR ECOL, V16, P572, DOI 10.1111/j.1526-100X.2007.00332.x; Liu P, 2010, OECOLOGIA, V162, P771, DOI 10.1007/s00442-009-1506-7; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; Miller R.H., 1982, CHEM MICROBIOLOGICAL, V2nd, P1; Veen GF, 2008, OIKOS, V117, P859, DOI [10.1111/j.2008.0030-1299.16515.x, 10.1111/j.0030-1299.2008.16515.x]; Vermeire LT, 2008, AGR ECOSYST ENVIRON, V125, P111, DOI 10.1016/j.agee.2007.12.003; Wang SP, 2001, ACTA ECOLOGICA SINIC, V21, P264; Wang SP, 2001, ACTA ECOLOGICA SINIC, V20, P951; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Yang Hao, 2009, Chinese Journal of Plant Ecology, V33, P499, DOI 10.3773/j.issn.1005-264x.2009.03.009; Yang YF, 1998, ACTA ECOLOGICA SINIC, V28, P567	32	33	44	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26506	10.1371/journal.pone.0026506	http://dx.doi.org/10.1371/journal.pone.0026506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073169	gold, Green Published			2022-12-25	WOS:000297154900022
J	Pratama, G; Vaghjiani, V; Tee, JY; Liu, YH; Chan, J; Tan, C; Murthi, P; Gargett, C; Manuelpillai, U				Pratama, Gita; Vaghjiani, Vijesh; Tee, Jing Yang; Liu, Yu Han; Chan, James; Tan, Charmaine; Murthi, Padma; Gargett, Caroline; Manuelpillai, Ursula			Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic Applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INDUCED EPITHELIOMESENCHYMAL TRANSITION; HUMAN FETAL MEMBRANES; IN-VITRO EXPANSION; STROMAL CELLS; ANIMAL SERUM; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; REGENERATION	Human amniotic epithelial cells (hAEC) isolated from term placenta have stem cell-like properties, differentiate into tissue specific cells and reduce lung and liver inflammation and fibrosis following transplantation into disease models established in mice. These features together with their low immunogenicity and immunosuppressive properties make hAEC an attractive source of cells for potential therapeutic applications. However, generation of large cell numbers required for therapies through serial expansion in xenobiotic-free media may be a limiting factor. We investigated if hAEC could be expanded in xenobiotic-free media and if expansion altered their differentiation capacity, immunophenotype, immunosuppressive properties and production of immunomodulatory factors. Serial expansion in xenobiotic-free media was limited with cumulative cell numbers and population doubling times significantly lower than controls maintained in fetal calf serum. The epithelial morphology of primary hAEC changed into mesenchymal-stromal like cells by passage 4-5 (P4-P5) with down regulation of epithelial markers CK7, CD49f, EpCAM and E-cadherin and elevation of mesenchymal-stromal markers CD44, CD105, CD146 and vimentin. The P5 hAEC expanded in xenobiotic-free medium differentiated into osteocyte and alveolar epithelium-like cells, but not chondrocyte, hepatocyte, a-and b-pancreatic-like cells. Expression of HLA Class IA, Class II and co-stimulatory molecules CD80, CD86 and CD40 remained unaltered. The P5 hAEC suppressed mitogen stimulated T cell proliferation, but were less suppressive compared with primary hAEC at higher splenocyte ratios. Primary and P5 hAEC did not secrete the immunosuppressive factors IL-10 and HGF, whereas TGF-beta 1 and HLA-G were reduced and IL-6 elevated in P5 hAEC. These findings suggest that primary and expanded hAEC may be suitable for different cellular therapeutic applications.	[Pratama, Gita; Vaghjiani, Vijesh; Tee, Jing Yang; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Liu, Yu Han; Chan, James] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Tan, Charmaine; Gargett, Caroline] Monash Univ, Dept Obstet & Gynecol, Monash Inst Med Res, Clayton, Vic, Australia; [Tan, Charmaine; Gargett, Caroline] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Clayton, Vic, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Murthi, Padma] Royal Womens Hosp, Pregnancy Res Ctr, Dept Perinatal Med, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Monash University; University of Melbourne	Pratama, G (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	ursula.manuelpillai@monash.edu	Gargett, Caroline E/Q-7911-2019; Pratama, Gita/AAX-8749-2021; Gargett, Caroline Eve/I-4895-2019; Tee, Jing Yang/F-2821-2013; Murthi, Padma/AAY-5395-2021	Gargett, Caroline E/0000-0002-3590-2077; Pratama, Gita/0000-0001-5626-1283; Tee, Jing Yang/0000-0003-1605-4938; Vaghjiani, Vijesh/0000-0001-8004-3876	Australian National Health & Medical Research Council (NHMRC) [606473, 465121, 545992, 509140, 436634]; Australian Partnership Scholarship, AusAID; Victorian Government	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Partnership Scholarship, AusAID; Victorian Government	UM is funded by: the Australian National Health & Medical Research Council (NHMRC) project grant #606473; CG by NHMRC Career Development Award #465121 and project grant #545992; PM by NHMRC project grant #509140; JC by NHMRC program grant #436634. GP was supported by an Australian Partnership Scholarship, AusAID. Study was supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Kollar Katarina, 2009, Int J Cell Biol, V2009, P904682, DOI 10.1155/2009/904682; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pera MF, 2000, J CELL SCI, V113, P5; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804; Tamagawa T, 2009, HUM CELL, V22, P55, DOI 10.1111/j.1749-0774.2009.00069.x; Terada S, 2000, CELL TRANSPLANT, V9, P701, DOI 10.1177/096368970000900518; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; YEAGER AM, 1985, AM J MED GENET, V22, P347, DOI 10.1002/ajmg.1320220219; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	43	93	106	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26136	10.1371/journal.pone.0026136	http://dx.doi.org/10.1371/journal.pone.0026136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073147	Green Published, gold			2022-12-25	WOS:000297154900005
J	Trenado, HP; Orilio, AF; Marquez-Martin, B; Moriones, E; Navas-Castillo, J				Trenado, Helena P.; Orilio, Anelise F.; Marquez-Martin, Belen; Moriones, Enrique; Navas-Castillo, Jesus			Sweepoviruses Cause Disease in Sweet Potato and Related Ipomoea spp.: Fulfilling Koch's Postulates for a Divergent Group in the Genus Begomovirus	PLOS ONE			English	Article							LEAF-CURL-VIRUS; STREAK VIRUS; DNA; INFECTION; CLONES; REPLICATION; INOCULATION; PROTEIN; CLONING; COPIES	Sweet potato (Ipomoea batatas) and related Ipomoea species are frequently infected by monopartite begomoviruses (genus Begomovirus, family Geminiviridae), known as sweepoviruses. Unlike other geminiviruses, the genomes of sweepoviruses have been recalcitrant to rendering infectious clones to date. Thus, Koch's postulates have not been fullfilled for any of the viruses in this group. Three novel species of sweepoviruses have recently been described in Spain: Sweet potato leaf curl Lanzarote virus (SPLCLaV), Sweet potato leaf curl Spain virus (SPLCSV) and Sweet potato leaf curl Canary virus (SPLCCaV). Here we describe the generation of the first infectious clone of an isolate (ES:MAL:BG30:06) of SPLCLaV. The clone consisted of a complete tandem dimeric viral genome in a binary vector. Successful infection by agroinoculation of several species of Ipomoea (including sweet potato) and Nicotiana benthamiana was confirmed by PCR, dot blot and Southern blot hybridization. Symptoms observed in infected plants consisted of leaf curl, yellowing, growth reduction and vein yellowing. Two varieties of sweet potato, 'Beauregard' and 'Promesa', were infected by agroinoculation, and symptoms of leaf curl and interveinal loss of purple colouration were observed, respectively. The virus present in agroinfected plants was readily transmitted by the whitefly Bemisia tabaci to I. setosa plants. The progeny virus population present in agroinfected I. setosa and sweet potato plants was isolated and identity to the original isolate was confirmed by sequencing. Therefore, Koch's postulates were fulfilled for the first time for a sweepovirus.	[Trenado, Helena P.; Orilio, Anelise F.; Marquez-Martin, Belen; Moriones, Enrique; Navas-Castillo, Jesus] CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Trenado, HP (corresponding author), CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain.	jnavas@eelm.csic.es	Navas-Castillo, Jesús/G-3894-2011; Orílio, Anelise/D-1235-2012; Navas-Castillo, Jesús/AAQ-2075-2021; MORIONES, ENRIQUE/Q-6090-2017	Navas-Castillo, Jesús/0000-0002-8616-6241; Navas-Castillo, Jesús/0000-0002-8616-6241; MORIONES, ENRIQUE/0000-0003-0295-7845	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain; Consejo Superior de Investigaciones Cientificas (CSIC), Spain [200440E119]	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas (CSIC), Spain	EM and JNC are members of the Research Group AGR-214, partially funded by Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain. HPT and AFO were funded by Consejo Superior de Investigaciones Cientificas (CSIC), Spain, through predoctoral fellowships (Proyecto Intramural Especial 200440E119 and JAE Program, respectively). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque LC, 2011, ARCH VIROL, V156, P1291, DOI 10.1007/s00705-011-1016-x; Banks G K, 1999, Plant Dis, V83, P486, DOI 10.1094/PDIS.1999.83.5.486B; BonillaRamirez GM, 1997, J GEN VIROL, V78, P947, DOI 10.1099/0022-1317-78-4-947; Briddon RW, 2006, PLANT PATHOL, V55, P286, DOI 10.1111/j.1365-3059.2005.01273.x; CHATANI M, 1991, J GEN VIROL, V72, P2325, DOI 10.1099/0022-1317-72-10-2325; CHUNG M-L, 1985, Plant Protection Bulletin (Taichung), V27, P333; Clark CA, 2006, PLANT DIS, V90, P83, DOI 10.1094/PD-90-0083; Cohen J, 1997, ANN APPL BIOL, V131, P273, DOI 10.1111/j.1744-7348.1997.tb05156.x; COHEN J, 1991, PLANT DIS, V75, P291, DOI 10.1094/PD-75-0291; Cuellar WJ, 2011, J GEN VIROL, V92, P1233, DOI 10.1099/vir.0.029975-0; DONSON J, 1988, VIROLOGY, V162, P248, DOI 10.1016/0042-6822(88)90416-3; ELMER JS, 1988, PLANT MOL BIOL, V10, P225, DOI 10.1007/BF00027399; Fauquet CM, 2003, ANN APPL BIOL, V142, P165, DOI 10.1111/j.1744-7348.2003.tb00241.x; Ferreira PDTDO, 2008, J VIROL METHODS, V147, P351, DOI 10.1016/j.jviromet.2007.10.001; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Fuentes S, 2003, PLANT DIS, V87, P9893; Gibson RW, 1997, ANN APPL BIOL, V130, P481, DOI 10.1111/j.1744-7348.1997.tb07676.x; Gibson RW, 2004, VIRUS RES, V100, P115, DOI 10.1016/j.virusres.2003.12.023; GRIMSLEY N, 1987, NATURE, V325, P177, DOI 10.1038/325177a0; HAYES RJ, 1988, J GEN VIROL, V69, P209, DOI 10.1099/0022-1317-69-1-209; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Kwak Hae-ryun, 2006, The Plant Pathology Journal, V22, P239; Lapidot M, 2007, J VIROL METHODS, V144, P143, DOI 10.1016/j.jviromet.2007.04.011; LIANG Y G, 1990, Plant Protection Bulletin (Taichung), V32, P136; Ling KS, 2010, CROP PROT, V29, P757, DOI 10.1016/j.cropro.2010.02.017; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Lotrakul P, 1998, PLANT DIS, V82, P1253, DOI 10.1094/PDIS.1998.82.11.1253; Lotrakul P., 1999, MOL PLANT PATHOL; Lotrakul Pongtharin, 2003, Revista Mexicana de Fitopatologia, V21, P128; Lozano G, 2009, J GEN VIROL, V90, P2550, DOI 10.1099/vir.0.012542-0; Luan YS, 2006, PLANT DIS, V90, P1111, DOI 10.1094/PD-90-1111C; Luan YS, 2007, VIRUS GENES, V35, P379, DOI 10.1007/s11262-007-0084-1; Miano DW, 2006, PLANT DIS, V90, P832, DOI 10.1094/PD-90-0832B; Osaki T., 1991, Bulletin of the University of Osaka Prefecture Series B Agriculture and Biology, V43, P17; Paprotka T, 2010, VIRUS RES, V149, P224, DOI 10.1016/j.virusres.2010.02.003; Prasanth G, 2008, PLANT DIS, V92, P311, DOI 10.1094/PDIS-92-2-0311B; Simmons AM, 2009, CROP PROT, V28, P1007, DOI 10.1016/j.cropro.2009.06.011; STANLEY J, 1990, P NATL ACAD SCI USA, V87, P6291, DOI 10.1073/pnas.87.16.6291; STANLEY J, 1986, NUCLEIC ACIDS RES, V14, P5981, DOI 10.1093/nar/14.15.5981; STANLEY J, 2005, VIRUS TAXONOMY, P301; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; Unseld S, 2004, VIROLOGY, V318, P90, DOI 10.1016/j.virol.2003.09.003; Valverde RA, 2004, VIRUS RES, V100, P123, DOI 10.1016/j.virusres.2003.12.020; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Wasswa P, 2011, PLANT PATHOL, V60, P1030, DOI 10.1111/j.1365-3059.2011.02464.x; Wu CY, 2008, J VIROL METHODS, V147, P355, DOI 10.1016/j.jviromet.2007.10.002	46	16	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27329	10.1371/journal.pone.0027329	http://dx.doi.org/10.1371/journal.pone.0027329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073314	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900099
J	Maruyama, S; Shibata, R; Kikuchi, R; Izumiya, Y; Rokutanda, T; Araki, S; Kataoka, Y; Ohashi, K; Daida, H; Kihara, S; Ogawa, H; Murohara, T; Ouchi, N				Maruyama, Sonomi; Shibata, Rei; Kikuchi, Ryosuke; Izumiya, Yasuhiro; Rokutanda, Taku; Araki, Satoshi; Kataoka, Yoshiyuki; Ohashi, Koji; Daida, Hiroyuki; Kihara, Shinji; Ogawa, Hisao; Murohara, Toyoaki; Ouchi, Noriyuki			Fat-derived Factor Omentin Stimulates Endothelial Cell Function and Ischemia-induced Revascularization via Endothelial Nitric Oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; GENE-EXPRESSION; TISSUE ISCHEMIA; ADIPOSE-TISSUE; OBESITY; AKT; ANGIOGENESIS; ADIPONECTIN; DISEASE	Obesity-related diseases are associated with vascular dysfunction and impaired revascularization. Omentin is a fat-derived secreted protein, which is down-regulated in association with obese complications. Here, we investigated whether omentin modulates endothelial cell function and revascularization processes in vitro and in vivo. Systemic delivery of an adenoviral vector expressing omentin (Ad-omentin) enhanced blood flow recovery and capillary density in ischemic limbs of wild-type mice in vivo, which were accompanied by increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS). In cultured human umbilical vein endothelial cells (HUVECs), a physiological concentration of recombinant omentin protein increased differentiation into vascular-like structures and decreased apoptotic activity under conditions of serum starvation. Treatment with omentin protein stimulated the phosphorylation of Akt and eNOS in HUVECs. Inhibition of Akt signaling by treatment with dominant-negative Akt or LY294002 blocked the stimulatory effects of omentin on differentiation and survival of HUVECs and reversed omentin-stimulated eNOS phosphorylation. Pretreatment with the NOS inhibitor also reduced the omentin-induced increase in HUVEC differentiation and survival. Omentin protein also stimulated the phosphorylation of AMP-activated protein kinase in HUVECs. Transduction with dominant-negative AMP-activated protein kinase diminished omentin-induced phosphorylation of Akt and omentin-stimulated increase in HUVEC differentiation and survival. Of importance, in contrast to wild-type mice, systemic administration of Ad-omentin did not affect blood flow in ischemic muscle in eNOS-deficient mice in vivo. These data indicate that omentin promotes endothelial cell function and revascularization in response to ischemia through its ability to stimulate an Akt-eNOS signaling pathway.	[Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Izumiya, Yasuhiro; Rokutanda, Taku; Araki, Satoshi; Ogawa, Hisao] Kumamoto Univ, Sch Med, Dept Cardiol, Kumamoto 8608556, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Maruyama, Sonomi; Daida, Hiroyuki] Juntendo Univ, Dept Cardiol, Sch Med, Tokyo 1138421, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Suita, Osaka 5650871, Japan	Nagoya University; Kumamoto University; Nagoya University; Juntendo University; Osaka University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014; Kikuchi, Ryosuke/AAX-4971-2021		Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation; Japan Heart Foundation/Novartis; Japan Heart Foundation and Astellas/Pfizer	Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; Japan Heart Foundation and Astellas/Pfizer	This work was supported by a grant-in-aid for Scientific Research and grants from the Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology, and the Uehara Memorial Foundation (to N. O.).; Supported by a grant-in-aid for Young Scientists B, the Uehara Memorial Foundation, Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology (2011), and the Japan Heart Foundation and Astellas/Pfizer grant for Research on Atherosclerosis Update. To whom correspondence may be addressed: Dept. of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 4668550, Japan. Tel.: 81-52-744-2427; Fax: 81-52-744-2427; E-mail: rshibata@med.nagoya-u.ac.jp.	Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; LIND L, 1993, AM HEART J, V125, P1494, DOI 10.1016/0002-8703(93)90446-G; Liu R, 2011, DIABETES RES CLIN PR, V93, P21, DOI 10.1016/j.diabres.2011.03.001; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Oshima Y, 2009, CIRCULATION, V120, P1606, DOI 10.1161/CIRCULATIONAHA.109.872200; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R., 2011, HYPERTENS RES; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; WARLEY A, 1995, DIABETOLOGIA, V38, P413, DOI 10.1007/s001250050300; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Zhang W, 2010, J NEUROENDOCRINOL, V22, P175, DOI 10.1111/j.1365-2826.2010.01953.x; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26	35	122	132	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					408	417		10.1074/jbc.M111.261818	http://dx.doi.org/10.1074/jbc.M111.261818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081609	Green Published, hybrid			2022-12-25	WOS:000298682400039
J	Singh, BN; Fu, JS; Srivastava, RK; Shankar, S				Singh, Brahma N.; Fu, Junsheng; Srivastava, Rakesh K.; Shankar, Sharmila			Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms	PLOS ONE			English	Article							GLI TRANSCRIPTION FACTORS; GENOMIC ANALYSES; SELF-RENEWAL; COLON-CANCER; PATHWAY; GROWTH; SURVIVAL; THERAPY; ACTIVATION; MEDULLOBLASTOMA	Background: Recent evidence from in vitro and in vivo studies has demonstrated that aberrant reactivation of the Sonic Hedgehog (SHH) signaling pathway regulates genes that promote cellular proliferation in various human cancer stem cells (CSCs). Therefore, the chemotherapeutic agents that inhibit activation of Gli transcription factors have emerged as promising novel therapeutic drugs for pancreatic cancer. GDC-0449 (Vismodegib), orally administrable molecule belonging to the 2-arylpyridine class, inhibits SHH signaling pathway by blocking the activities of Smoothened. The objectives of this study were to examine the molecular mechanisms by which GDC-0449 regulates human pancreatic CSC characteristics in vitro. Methodology/Principal Findings: GDC-0499 inhibited cell viability and induced apoptosis in three pancreatic cancer cell lines and pancreatic CSCs. This inhibitor also suppressed cell viability, Gli-DNA binding and transcriptional activities, and induced apoptosis through caspase-3 activation and PARP cleavage in pancreatic CSCs. GDC-0449-induced apoptosis in CSCs showed increased Fas expression and decreased expression of PDGFR alpha. Furthermore, Bcl-2 was down-regulated whereas TRAIL-R1/DR4 and TRAIL-R2/DR5 expression was increased following the treatment of CSCs with GDC-0449. Suppression of both Gli1 plus Gli2 by shRNA mimicked the changes in cell viability, spheroid formation, apoptosis and gene expression observed in GDC-0449-treated pancreatic CSCs. Thus, activated Gli genes repress DRs and Fas expressions, up-regulate the expressions of Bcl-2 and PDGFR alpha and facilitate cell survival. Conclusions/Significance: These data suggest that GDC-0499 can be used for the management of pancreatic cancer by targeting pancreatic CSCs.	[Singh, Brahma N.; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Singh, BN (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu						Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Altaba ARI, 2004, CANCER LETT, V204, P145, DOI 10.1016/S0304-3835(03)00451-8; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Hidalgo M, 2009, NEW ENGL J MED, V361, P2094, DOI 10.1056/NEJMcibr0905857; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Hwang JH, 2009, CANCER LETT, V273, P266, DOI 10.1016/j.canlet.2008.08.028; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lee J, 2007, CHEMBIOCHEM, V8, P1916, DOI 10.1002/cbic.200700403; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Liu Hailan, 2011, Chin J Cancer, V30, P13; Mantamadiotis T, 2011, FRONT BIOSCI-LANDMRK, V16, P598, DOI 10.2741/3708; Marchese R, 2006, PANCREAS, V32, P171, DOI 10.1097/01.mpa.0000202938.63084.e3; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Tang SC, 2011, INT J CANC; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vogt A, 2004, J EXP MED, V199, P753, DOI 10.1084/jem.20031190; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Vorechovsky I, 1999, EUR J CANCER, V35, P711; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; WARSHAW AL, 1991, AM J SURG, V161, P26, DOI 10.1016/0002-9610(91)90356-I; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoshikawa N, 2009, J SURG RES, V153, P246, DOI 10.1016/j.jss.2008.04.021	50	146	155	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27306	10.1371/journal.pone.0027306	http://dx.doi.org/10.1371/journal.pone.0027306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087285	gold, Green Published, Green Submitted			2022-12-25	WOS:000297349700028
J	Strom, M; Mortensen, EL; Henriksen, TB; Olsen, SF				Strom, Marin; Mortensen, Erik L.; Henriksen, Tine B.; Olsen, Sjurdur F.			Fish Consumption Measured during Pregnancy and Risk of Cardiovascular Diseases Later in Life: An Observational Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; N-3 FATTY-ACIDS; ACUTE MYOCARDIAL-INFARCTION; DIETARY-INTAKE; MORTALITY; ALCOHOL; OMEGA-3-FATTY-ACIDS; STROKE; HEALTH; LIPIDS	Previous studies have indicated a protective effect of long chain n-3 PUFAs against cardiovascular disease; however, the overall evidence remains uncertain, and there is a general lack of knowledge in the field of cardiovascular epidemiology in women. Therefore, the objective of this study was to explore the association between fish intake and cardiovascular disease among 7429 women from a prospective pregnancy cohort in Aarhus, Denmark, who were followed for 12-17 years. Exposure information derived from a questionnaire sent to the women in gestation week 16, and daily fish consumption was quantified based on assumptions of standard portion sizes and food tables. Information on admissions to hospital was obtained from the Danish National Patient Registry and diagnoses of hypertensive, cerebrovascular and ischaemic heart disease were used to define the outcome: cardiovascular disease. During the follow-up period 263 events of cardiovascular disease were identified. Overall, there was no association between cardiovascular disease and fish intake, confidence intervals for effect estimates in the different fish intake groups were wide, overlapped and for all but one they encompassed unity. Restricting the analysis to women who had reported the same fish intake in a questionnaire in gestation week 30 did not alter these findings. In conclusion, our data from a prospective cohort of relatively young and initially healthy women from Aarhus linked with information from registries could not substantiate a protective effect of fish intake against cardiovascular disease.	[Strom, Marin; Olsen, Sjurdur F.] Statens Serum Inst, Dept Epidemiol Res, Maternal Nutr Grp, DK-2300 Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Inst Publ Hlth, Dept Environm Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Dept Paediat, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen; Aarhus University	Strom, M (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Maternal Nutr Grp, DK-2300 Copenhagen, Denmark.	mrm@ssi.dk		Strom, Marin/0000-0003-1926-6610; Olsen, Sjurdur/0000-0003-3017-7096; Mortensen, Erik Lykke/0000-0002-6985-451X	Faroese Research Council; Fisheries Research Fund of the Faroe Islands; Danish Council for Strategic Research [2101-07-0025]	Faroese Research Council; Fisheries Research Fund of the Faroe Islands; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Financial support for this study was obtained from the Faroese Research Council (http://www.gransking.fo/), the Fisheries Research Fund of the Faroe Islands (http://www.fvg.fo/), and the strategic network funded by the Danish Council for Strategic Research: "Global maternal and fetal care in prevention of adult non-comunicable disease (2101-07-0025)" (http://www.fi.dk/raad-og-udvalg/det-strategiske-forskningsraad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Andersen LT, 1996, SCAND J NUTR, V40, pS129; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; Bierregaard LJ, 2010, EUR HEART J, V31, P29, DOI 10.1093/eurheartj/ehp375; BURR ML, 1989, LANCET, V2, P757; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; European Society of Cardiology Press Office, 2009, NEED GEND SPEC RES H; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Hjerteforeningen and Statens Institut for Folkesundhed, 2004, 2004 HJERT; Hooper L, 2004, Cochrane Database Syst Rev, pCD003177; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Kesmodel U, 2002, ALCOHOL ALCOHOLISM, V37, P87, DOI 10.1093/alcalc/37.1.87; Kesmodel U, 2000, EPIDEMIOLOGY, V11, P512, DOI 10.1097/00001648-200009000-00005; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kromhout D, 1996, INT J EPIDEMIOL, V25, P753, DOI 10.1093/ije/25.4.753; Levnedsmiddelstyrelsen, 1996, LEVN; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Marckmann P, 1999, EUR J CLIN NUTR, V53, P585, DOI 10.1038/sj.ejcn.1600832; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Oken E, 2008, AM J CLIN NUTR, V88, P789, DOI 10.1093/ajcn/88.3.789; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Olsen SF, 2002, BMJ-BRIT MED J, V324, P447, DOI 10.1136/bmj.324.7335.447; Osler M, 2003, J CLIN EPIDEMIOL, V56, P274, DOI 10.1016/S0895-4356(02)00600-5; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; SHEKELLE RB, 1985, NEW ENGL J MED, V313, P820; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Vanden Heuvel John P, 2004, Curr Atheroscler Rep, V6, P432, DOI 10.1007/s11883-004-0083-9	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27330	10.1371/journal.pone.0027330	http://dx.doi.org/10.1371/journal.pone.0027330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087293	gold, Green Submitted, Green Published			2022-12-25	WOS:000297349700032
J	Huda, A; Tyagi, E; Marino-Ramirez, L; Bowen, NJ; Jjingo, D; Jordan, IK				Huda, Ahsan; Tyagi, Eishita; Marino-Ramirez, Leonardo; Bowen, Nathan J.; Jjingo, Daudi; Jordan, I. King			Prediction of Transposable Element Derived Enhancers Using Chromatin Modification Profiles	PLOS ONE			English	Article							UCSC GENOME BROWSER; GENE-EXPRESSION; HISTONE MODIFICATIONS; HYPERSENSITIVE SITES; CAP ANALYSIS; SELFISH DNA; STEM-CELLS; EVOLUTION; IDENTIFICATION; MOUSE	Experimentally characterized enhancer regions have previously been shown to display specific patterns of enrichment for several different histone modifications. We modelled these enhancer chromatin profiles in the human genome and used them to guide the search for novel enhancers derived from transposable element (TE) sequences. To do this, a computational approach was taken to analyze the genome-wide histone modification landscape characterized by the ENCODE project in two human hematopoietic cell types, GM12878 and K562. We predicted the locations of 2,107 and 1,448 TE-derived enhancers in the GM12878 and K562 cell lines respectively. A vast majority of these putative enhancers are unique to each cell line; only 3.5% of the TE-derived enhancers are shared between the two. We evaluated the functional effect of TE-derived enhancers by associating them with the cell-type specific expression of nearby genes, and found that the number of TE-derived enhancers is strongly positively correlated with the expression of nearby genes in each cell line. Furthermore, genes that are differentially expressed between the two cell lines also possess a divergent number of TE-derived enhancers in their vicinity. As such, genes that are up-regulated in the GM12878 cell line and down-regulated in K562 have significantly more TE-derived enhancers in their vicinity in the GM12878 cell line and vice versa. These data indicate that human TE-derived sequences are likely to be involved in regulating cell-type specific gene expression on a broad scale and suggest that the enhancer activity of TE-derived sequences is mediated by epigenetic regulatory mechanisms.	[Huda, Ahsan; Tyagi, Eishita; Bowen, Nathan J.; Jjingo, Daudi; Jordan, I. King] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Marino-Ramirez, Leonardo] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Marino-Ramirez, Leonardo; Jordan, I. King] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [Bowen, Nathan J.] Georgia Inst Technol, Ovarian Canc Inst, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Georgia; Georgia Institute of Technology	Huda, A (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	king.jordan@biology.gatech.edu	Mariño-Ramírez, Leonardo/I-5759-2013; Mariño-Ramírez, Leonardo/N-5395-2019; Bowen, Nathan J./M-3202-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Bowen, Nathan J./0000-0002-1609-6698	Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology [BR-4839]; Georgia Institute of Technology; Integrated Cancer Research Center at the Georgia Institute of Technology; NIH, NLM, NCBI; Corporacion Colombiana de Investigacion Agropucuaria CORPOICA; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology(Alfred P. Sloan Foundation); Georgia Institute of Technology; Integrated Cancer Research Center at the Georgia Institute of Technology; NIH, NLM, NCBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Corporacion Colombiana de Investigacion Agropucuaria CORPOICA; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	IKJ and AH were supported by an Alfred P. Sloan Research Fellowship in Computational and Evolutionary Molecular Biology (BR-4839) (http://www.sloan.org/). Eishita Tyagi was supported by the Bioinformatics program at the Georgia Institute of Technology (http://www.bioinformatics.biology.gatech.edu/). NJB was supported by the Integrated Cancer Research Center at the Georgia Institute of Technology (http://ovariancancerinstitute.org/). This research was supported in part by the Intramural Research Program of the NIH, NLM, NCBI (http://www.ncbi.nlm.nih.gov/). LMR is supported by Corporacion Colombiana de Investigacion Agropucuaria CORPOICA (http://www.corpoica.org.co/SitioWeb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HICKEY DA, 1982, GENETICS, V101, P519; Huda A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-2; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marino-Ramirez L, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-20; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MILLER CJ, 2007, DESCRIPTION EXONMAP; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Silva JC, 2003, GENET RES, V82, P1, DOI 10.1017/S0016672303006268; Smit AFA, GREEN P REPEATMASKER; Sokal R. R., 1981, BIOMETRY; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891	41	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27513	10.1371/journal.pone.0027513	http://dx.doi.org/10.1371/journal.pone.0027513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087331	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700061
J	Korn, MJ; Koppel, SJ; Cramer, KS				Korn, Matthew J.; Koppel, Scott J.; Cramer, Karina S.			Astrocyte-Secreted Factors Modulate a Gradient of Primary Dendritic Arbors in Nucleus Laminaris of the Avian Auditory Brainstem	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCES; AFFERENT INFLUENCES; POTASSIUM CHANNEL; GLUTAMATE RECEPTORS; N-MAGNOCELLULARIS; COCHLEAR NUCLEI; SUPERIOR OLIVE; SYNAPTIC INPUT; PURKINJE-CELLS; DELAY-LINES	Neurons in nucleus laminaris (NL) receive binaural, tonotopically matched input from nucleus magnocelluaris (NM) onto bitufted dendrites that display a gradient of dendritic arbor size. These features improve computation of interaural time differences, which are used to determine the locations of sound sources. The dendritic gradient emerges following a period of significant reorganization at embryonic day 15 (E15), which coincides with the emergence of astrocytes that express glial fibrillary acidic protein (GFAP) in the auditory brainstem. The major changes include a loss of total dendritic length, a systematic loss of primary dendrites along the tonotopic axis, and lengthening of primary dendrites on caudolateral NL neurons. Here we have tested whether astrocyte-derived molecules contribute to these changes in dendritic morphology. We used an organotypic brainstem slice preparation to perform repeated imaging of individual dye-filled NL neurons to determine the effects of astrocyte-conditioned medium (ACM) on dendritic morphology. We found that treatment with ACM induced a decrease in the number of primary dendrites in a tonotopically graded manner similar to that observed during normal development. Our data introduce a new interaction between astrocytes and neurons in the auditory brainstem and suggest that these astrocytes influence multiple aspects of auditory brainstem maturation.	[Korn, Matthew J.; Koppel, Scott J.; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Korn, MJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	cramerk@uci.edu		Koppel, Scott/0000-0001-9001-4454; Cramer, Karina/0000-0003-3793-4862	National Institutes of Health (NIH) [R01DC010796, P30DC008369]; National Science Foundation (NSF) [IOB-0642346]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010796, P30DC008369] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) R01DC010796, NIH P30DC008369, and National Science Foundation (NSF) IOB-0642346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2004, NEUROSCIENCE, V127, P137, DOI 10.1016/j.neuroscience.2004.04.032; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; BENES FM, 1977, BRAIN RES, V122, P1, DOI 10.1016/0006-8993(77)90658-8; Blondel O, 2000, J NEUROSCI, V20, P8012; BOORD RL, 1963, J COMP NEUROL, V120, P463, DOI 10.1002/cne.901200305; Buard I, 2010, GLIA, V58, P538, DOI 10.1002/glia.20943; Burette A, 1998, MICROSC RES TECHNIQ, V41, P224, DOI 10.1002/(SICI)1097-0029(19980501)41:3<224::AID-JEMT6>3.0.CO;2-T; CANADY KS, 1992, J NEUROSCI, V12, P1001; CARR CE, 1990, J NEUROSCI, V10, P3227; Carr CE, 1996, J COMP NEUROL, V373, P467, DOI 10.1002/(SICI)1096-9861(19960930)373:4<467::AID-CNE1>3.0.CO;2-#; Cheng SM, 2007, DEV NEUROBIOL, V67, P1957, DOI 10.1002/dneu.20541; Cochran SL, 1999, J COMP NEUROL, V413, P271, DOI 10.1002/(SICI)1096-9861(19991018)413:2<271::AID-CNE8>3.0.CO;2-L; Cramer KS, 2000, J COMP NEUROL, V426, P270; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; DEITCH JS, 1989, J COMP NEUROL, V281, P234, DOI 10.1002/cne.902810207; DEITCH JS, 1989, J COMP NEUROL, V281, P259, DOI 10.1002/cne.902810208; Diaz C, 2009, EUR J NEUROSCI, V29, P213, DOI 10.1111/j.1460-9568.2008.06578.x; Feng J, 2010, J NEUROSCI RES, V88, P86, DOI 10.1002/jnr.22179; Feng JJ, 2006, HEARING RES, V216, P116, DOI 10.1016/j.heares.2006.01.012; Friauf E, 1999, CELL TISSUE RES, V297, P187, DOI 10.1007/s004410051346; Gorlich A, 2010, NEUROSCIENCE, V168, P564, DOI 10.1016/j.neuroscience.2010.04.002; Hendricks SJ, 2006, J COMP NEUROL, V498, P433, DOI 10.1002/cne.21031; JACKSON H, 1982, J COMP NEUROL, V210, P80, DOI 10.1002/cne.902100109; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Korn MJ, 2008, DEV NEUROBIOL, V68, P1093, DOI 10.1002/dneu.20645; KORN MJ, 2011, J COMP NEUR IN PRESS; Kubke MF, 2002, J NEUROSCI, V22, P7671; Kubke MF, 1998, MICROSC RES TECHNIQ, V41, P176; Kuenzel T, 2007, EUR J NEUROSCI, V25, P974, DOI 10.1111/j.1460-9568.2007.05343.x; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Kulesza RJ, 2011, BRAIN RES, V1367, P360, DOI 10.1016/j.brainres.2010.10.015; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lin JC, 2001, J NEUROSCI, V21, P159, DOI 10.1523/JNEUROSCI.21-01-00159.2001; LIPPE WR, 1980, BRAIN RES, V196, P43, DOI 10.1016/0006-8993(80)90715-5; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Lohmann C, 2005, NAT NEUROSCI, V8, P305, DOI 10.1038/nn1406; Lordkipanidze T, 2005, GLIA, V51, P229, DOI 10.1002/glia.20200; Lukose R, 2011, BRAIN RES, V1398, P102, DOI 10.1016/j.brainres.2011.05.013; LURIE DI, 1994, J COMP NEUROL, V346, P276, DOI 10.1002/cne.903460207; Lurie DI, 2000, J COMP NEUROL, V421, P199; Morrison ME, 1998, J NEUROSCI, V18, P3563; MURAI KK, 2011, GLIA; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; Parameshwaran S, 2001, J NEUROSCI, V21, P485, DOI 10.1523/JNEUROSCI.21-02-00485.2001; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; PARKS TN, 1987, J COMP NEUROL, V260, P312, DOI 10.1002/cne.902600211; PARKS TN, 1981, J COMP NEUROL, V202, P47, DOI 10.1002/cne.902020105; PARKS TN, 1979, J COMP NEUROL, V183, P665, DOI 10.1002/cne.901830313; Perney TM, 1997, J COMP NEUROL, V386, P178; Person AL, 2004, J NEUROBIOL, V60, P28, DOI 10.1002/neu.10330; Procko C, 2010, CURR OPIN CELL BIOL, V22, P560, DOI 10.1016/j.ceb.2010.07.005; RAKIC P, 1972, J COMP NEUROL, V146, P335, DOI 10.1002/cne.901460304; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; RUBEL EW, 1981, J COMP NEUROL, V202, P397, DOI 10.1002/cne.902020309; Sanchez JT, 2011, JOVE-J VIS EXP, DOI 10.3791/2527; Sanchez JT, 2010, J NEUROPHYSIOL, V104, P1774, DOI 10.1152/jn.00468.2010; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Seidl AH, 2010, MICROSC RES TECHNIQ, V73, P37, DOI 10.1002/jemt.20750; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; SMITH ZDJ, 1981, J COMP NEUROL, V203, P309, DOI 10.1002/cne.902030302; Sorensen SA, 2006, J NEUROSCI, V26, P1539, DOI 10.1523/JNEUROSCI.3807-05.2006; Sorensen SA, 2011, J COMP NEUROL, V519, P2838, DOI 10.1002/cne.22656; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; Tanaka M, 2009, NEUROCHEM RES, V34, P2078, DOI 10.1007/s11064-009-0073-y; Tang YZ, 2004, HEARING RES, V191, P79, DOI 10.1016/j.heares.2004.01.007; TAVOSANIS G, 2011, DEV NEUROBIOL; Taylor AR, 2007, NAT PROTOC, V2, P1499, DOI 10.1038/nprot.2007.208; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wang Y, 2008, NEUROSCIENCE, V154, P381, DOI 10.1016/j.neuroscience.2008.02.032; Yanni PA, 2002, GLIA, V38, P292, DOI 10.1002/glia.10071; YOUNG SR, 1983, J NEUROSCI, V3, P1373	85	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27383	10.1371/journal.pone.0027383	http://dx.doi.org/10.1371/journal.pone.0027383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087304	Green Published, gold			2022-12-25	WOS:000297347700047
J	Xu, HT; Li, XX; Zhang, ZZ; Qiu, MG; Mu, QW; Wu, Y; Tan, LW; Zhang, SX; Zhang, XM				Xu, Haotong; Li, Xiaoxiao; Zhang, Zhengzhi; Qiu, Mingguo; Mu, Qiwen; Wu, Yi; Tan, Liwen; Zhang, Shaoxiang; Zhang, Xiaoming			Visualization of the Left Extraperitoneal Space and Spatial Relationships to Its Related Spaces by the Visible Human Project	PLOS ONE			English	Article							PERITONEAL REFLECTIONS; SURGICAL-TREATMENT; SECTIONAL ANATOMY; ADRENAL-GLAND; CT	Background: The major hindrance to multidetector CT imaging of the left extraperitoneal space (LES), and the detailed spatial relationships to its related spaces, is that there is no obvious density difference between them. Traditional gross anatomy and thick-slice sectional anatomy imagery are also insufficient to show the anatomic features of this narrow space in three-dimensions (3D). To overcome these obstacles, we used a new method to visualize the anatomic features of the LES and its spatial associations with related spaces, in random sections and in 3D. Methods: In conjunction with Mimics (R) and Amira (R) software, we used thin-slice cross-sectional images of the upper abdomen, retrieved from the Chinese and American Visible Human dataset and the Chinese Virtual Human dataset, to display anatomic features of the LES and spatial relationships of the LES to its related spaces, especially the gastric bare area. The anatomic location of the LES was presented on 3D sections reconstructed from CVH2 images and CT images. Principal Findings: What calls for special attention of our results is the LES consists of the left sub-diaphragmatic fat space and gastric bare area. The appearance of the fat pad at the cardiac notch contributes to converting the shape of the anteroexternal surface of the LES from triangular to trapezoidal. Moreover, the LES is adjacent to the lesser omentum and the hepatic bare area in the anterointernal and right rear direction, respectively. Conclusion: The LES and its related spaces were imaged in 3D using visualization technique for the first time. This technique is a promising new method for exploring detailed communication relationships among other abdominal spaces, and will promote research on the dynamic extension of abdominal diseases, such as acute pancreatitis and intra-abdominal carcinomatosis.	[Xu, Haotong; Zhang, Zhengzhi; Wu, Yi; Tan, Liwen; Zhang, Shaoxiang] Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China; [Xu, Haotong; Mu, Qiwen] N Sichuan Med Coll, Nanchong Cent Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Li, Xiaoxiao] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Hlth Serv, Chongqing, Peoples R China; [Qiu, Mingguo] Third Mil Med Univ, Coll Bioengn & Med Imaging, Chongqing, Peoples R China; [Mu, Qiwen] Med Univ S Carolina, Ctr Adv Imaging Res, Charleston, SC 29425 USA; [Zhang, Xiaoming] N Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China	Army Medical University; North Sichuan Medical University; Army Medical University; Army Medical University; Medical University of South Carolina; North Sichuan Medical University	Xu, HT (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China.	zhangsx1021@yahoo.com; cjr.zhxm@vip.163.com		Xu, Haotong/0000-0001-6416-9970; Xu, Hao-tong/0000-0003-0352-1795	National Science Foundation of China [60871099]; Study on Key Science and Technology Program of Nanchong [N2008-ZC027]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Study on Key Science and Technology Program of Nanchong	This work was supported by the National Science Foundation of China (No. 60871099) URL: http://www.nsfc.gov.cn/Portal0/default124.htm. This work was also supported by the Study on Key Science and Technology Program of Nanchong (No. N2008-ZC027) URL: http://www.v86.org/unitsite/index.asp?unit_id=46532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Chen R, 2009, SURG RADIOL ANAT, V31, P129, DOI 10.1007/s00276-008-0417-3; CHEN Y, 2001, SICHUAN J ANATOMY, V9, P26; Congdon ED, 1941, ANAT REC, V80, P289, DOI 10.1002/ar.1090800303; DING GF, 1991, CHIN J CLIN ANAT, V9, P26; Henderson JM, 2000, BEST PRACT RES CL GA, V14, P911, DOI 10.1053/bega.2000.0138; Ikramuddin S, 2007, J GASTROINTEST SURG, V11, P217, DOI 10.1007/s11605-006-0028-4; [蒋穗斌 Jiang Suibin], 2008, [解剖学杂志, Chinese Journal of Anatomy], V31, P235; [李幼琼 LI Youqiong], 2007, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V33, P464; Lim JH, 1998, BRIT J RADIOL, V71, P450, DOI 10.1259/bjr.71.844.9659142; Liu ZY, 2008, EUR RADIOL, V18, P1611, DOI 10.1007/s00330-008-0935-8; LU QY, 2009, SHANGHAI MED IMAGING, V18, P139; Lyass S, 2005, AM SURGEON, V71, P738; Ma G, 2008, SURG RADIOL ANAT, V30, P271, DOI 10.1007/s00276-008-0308-7; MCCORT JJ, 1981, ABDOMINAL RADIOLOGY, P192; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; MEYERS MA, 2010, DYNAMIC RADIOLOGY AB; [闵鹏秋 Min Pengqiu], 2003, [中国医学影像学杂志, Chinese Journal of Medical Imaging], V11, P161; MIN PQ, 1992, RADIOLOGY, V182, P553, DOI 10.1148/radiology.182.2.1732980; Monig SP, 2001, HEPATO-GASTROENTEROL, V48, P1231; Parikh MS, 2005, SURG ENDOSC, V19, P1631, DOI 10.1007/s00464-005-0302-7; Raptopoulos V, 1997, RADIOLOGY, V205, P777, DOI 10.1148/radiology.205.3.9393535; Rowe PM, 1999, LANCET, V353, P46, DOI 10.1016/S0140-6736(05)74857-1; Sadat Umar, 2007, J Med Case Rep, V1, P12, DOI 10.1186/1752-1947-1-12; Spitzer VM, 1998, ANAT RECORD, V253, P49, DOI 10.1002/(SICI)1097-0185(199804)253:2<49::AID-AR8>3.0.CO;2-9; SPITZER VM, 1995, VISIBLE HUMAN PROJEC; Tonelli P., 1999, Annali Italiani di Chirurgia, V70, P405; TONELLI P, 1999, ANN ITAL CHIR, V70, P419; WALD H, 1983, ANN SURG, V197, P389, DOI 10.1097/00000658-198304000-00002; Wu B, 2007, ABDOM IMAGING, V32, P284, DOI 10.1007/s00261-006-9058-3; Wu Y, 2010, SURG RADIOL ANAT, V32, P629, DOI 10.1007/s00276-010-0625-5; XIA CL, 2007, J JILIN U MED EDITIO, V33, P898; Yepes H, 2010, J BONE JOINT SURG AM, V92A, P1215, DOI 10.2106/JBJS.I.00743; [张俐 Zhang L], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P8193; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273; Zhao ZM, 2005, J COMPUT ASSIST TOMO, V29, P430, DOI 10.1097/01.rct.0000164259.91057.af	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27166	10.1371/journal.pone.0027166	http://dx.doi.org/10.1371/journal.pone.0027166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087259	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700023
J	Mo, WK; Nicolson, T				Mo, Weike; Nicolson, Teresa			Both Pre- and Postsynaptic Activity of Nsf Prevents Degeneration of Hair-Cell Synapses	PLOS ONE			English	Article							LATERAL-LINE SYSTEM; NEUROTROPHIC FACTOR; SNARE-COMPLEX; BRAIN; ALPHA; BDNF; ORGANIZATION; POTENTIATION; REQUIREMENT; MAINTENANCE	Vesicle fusion contributes to the maintenance of synapses in the nervous system by mediating synaptic transmission, release of neurotrophic factors, and trafficking of membrane receptors. N-ethylmaleimide-sensitive factor (NSF) is indispensible for dissociation of the SNARE-complex following vesicle fusion. Although NSF function has been characterized extensively in vitro, the in vivo role of NSF in vertebrate synaptogenesis is relatively unexplored. Zebrafish possess two nsf genes, nsf and nsfb. Here, we examine the function of either Nsf or Nsfb in the pre- and postsynaptic cells of the zebrafish lateral line organ and demonstrate that Nsf, but not Nsfb, is required for maintenance of afferent synapses in hair cells. In addition to peripheral defects in nsf mutants, neurodegeneration of glutamatergic synapses in the central nervous system also occurs in the absence of Nsf function. Expression of an nsf transgene in a null background indicates that stabilization of synapses requires Nsf function in both hair cells and afferent neurons. To identify potential targets of Nsf-mediated fusion, we examined the expression of genes implicated in stabilizing synapses and found that transcripts for multiple genes including brain-derived neurotrophic factor (bdnf) were significantly reduced in nsf mutants. With regard to trafficking of BDNF, we observed a striking accumulation of BDNF in the neurites of nsf mutant afferent neurons. In addition, injection of recombinant BDNF protein partially rescued the degeneration of afferent synapses in nsf mutants. These results establish a role for Nsf in the maintenance of synaptic contacts between hair cells and afferent neurons, mediated in part via the secretion of trophic signaling factors.	[Mo, Weike] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Mo, WK (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	Nicolson@ohsu.edu	Mo, Weike/K-2066-2014		NIH [DC 006880]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006880] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported in part by NIH DC 006880 and by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, METHOD CELL BIOL, V77, P3; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; Becker T, 2001, MECH DEVELOP, V109, P37, DOI 10.1016/S0925-4773(01)00504-4; Berliocchi L, 2005, J CELL BIOL, V168, P607, DOI 10.1083/jcb.200406126; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Golby JA, 2001, GENETICS, V158, P265; Gorski JA, 2003, J NEUROSCI, V23, P6856; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Henshall TL, 2009, HUM MOL GENET, V18, P4830, DOI 10.1093/hmg/ddp455; KNUSEL B, 1992, J NEUROSCI, V12, P4391; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Kurrasch DM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-22; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nouvian R, 2011, NAT NEUROSCI, V14, P411, DOI 10.1038/nn.2774; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Sanyal S, 2001, NEUROREPORT, V12, P1363, DOI 10.1097/00001756-200105250-00015; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; WEBB JF, 1989, BRAIN BEHAV EVOLUT, V33, P34, DOI 10.1159/000115896; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Williamson LC, 1998, J NEUROSCI RES, V52, P569, DOI 10.1002/(SICI)1097-4547(19980601)52:5<569::AID-JNR9>3.0.CO;2-A; Woods IG, 2006, CURR BIOL, V16, P636, DOI 10.1016/j.cub.2006.02.067; Wright MA, 2010, J NEUROSCI, V30, P14513, DOI 10.1523/JNEUROSCI.4025-10.2010; Wu CL, 2010, ANN NY ACAD SCI, V1201, P8, DOI 10.1111/j.1749-6632.2010.05628.x; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27146	10.1371/journal.pone.0027146	http://dx.doi.org/10.1371/journal.pone.0027146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073277	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000029
J	Eastburn, A; Scherzer, R; Zolopa, AR; Benson, C; Tracy, R; Do, T; Bacchetti, P; Shlipak, M; Grunfeld, C; Tien, PC				Eastburn, Abigail; Scherzer, Rebecca; Zolopa, Andrew R.; Benson, Constance; Tracy, Russell; Do, Tri; Bacchetti, Peter; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.			Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ANTIRETROVIRAL THERAPY; FAT REDISTRIBUTION; METABOLIC-CHANGE; MARKERS; FRAM	Background: Whether HIV viremia, particularly at low levels is associated with inflammation, increased coagulation, and all-cause mortality is unclear. Methods: The associations of HIV RNA level with C-reactive protein (CRP), fibrinogen, interleukin (IL)-6 and mortality were evaluated in 1116 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. HIV RNA level was categorized as undetectable (i.e., "target not detected"), 1-19, 20-399, 400-9999, and >= 10,000 copies/ml. Covariates included demographics, lifestyle, adipose tissue, and HIV-related factors. Results: HIV RNA level had little association with CRP. Categories of HIV RNA below 10,000 copies/ml had similar levels of IL-6 compared with an undetectable HIV RNA level, while HIV RNA >= 10,000 copies/ml was associated with 89% higher IL-6 (p<0.001). This association was attenuated by similar to 50% after adjustment for CD4+ cell count. Higher HIV RNA was associated with higher fibrinogen. Compared to an undetectable HIV RNA level, fibrinogen was 0.6%, 1.9%, 4.5%, 4.6%, and 9.4% higher across HIV RNA categories, respectively, and statistically significant at the highest level (p = 0.0002 for HIV RNA >= 10,000 copies/ml). Higher HIV RNA was associated with mortality during follow-up in unadjusted analysis, but showed little association after adjustment for CD4+ cell count and inflammation. Conclusion: HIV RNA >= 10,000 copies/ml was associated with higher IL-6 and fibrinogen, but lower levels of viremia appeared similar, and there was little association with CRP. The relationship of HIV RNA with IL-6 was strongly affected by CD4 cell depletion. After adjustment for CD4+ cell count and inflammation, viremia did not appear to be substantially associated with mortality risk over 5 years.	[Eastburn, Abigail; Scherzer, Rebecca; Do, Tri; Bacchetti, Peter; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Scherzer, Rebecca; Shlipak, Michael; Grunfeld, Carl; Tien, Phyllis C.] Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Zolopa, Andrew R.] Stanford Univ, Stanford, CA 94305 USA; [Benson, Constance] Univ Calif San Diego, San Diego, CA 92103 USA; [Tracy, Russell] Univ Vermont, Burlington, VT USA; [Do, Tri] Roche Mol Diagnost, Pleasanton, CA USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Diego; University of Vermont; Roche Holding	Eastburn, A (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ptien@ucsf.edu			NIH [R01-DK57508, HL74814, HL53359, K23-AI66943, DK080645]; NIH center [M01-RR00036, RR00051, RR00052, RR00054, RR00083, RR0636, RR00865, UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054, M01RR000865, M01RR000036, M01RR000083, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053359, R01HL074814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI066943, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057508, K23DK080645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIH grants R01-DK57508, HL74814, and HL53359; K23-AI66943 and DK080645, and NIH center grants M01-RR00036, RR00051, RR00052, RR00054, RR00083, RR0636, RR00865, and UL1 RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HIV RNA testing of stored samples was supported by Roche Molecular Diagnostics.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Choi A, 2010, AM J KIDNEY DIS, V56, P872, DOI 10.1053/j.ajkd.2010.05.019; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Cockerham L, 2010, JAIDS-J ACQ IMM DEF, V53, P102, DOI 10.1097/QAI.0b013e3181b79d22; FRAM Study Investigators, J ACQUIR IMMUNE DEFI, V40, P121; Gilks WR, 1996, MARKOV CHAIN MONTE C; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2011, CLIN INFECT DIS, V52, P681, DOI 10.1093/cid/ciq202; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Madden E, 2008, AIDS, V22, P707, DOI 10.1097/QAD.0b013e3282f560d9; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Reingold JS, 2008, JAIDS-J ACQ IMM DEF, V48, P142, DOI 10.1097/QAI.0b013e3181685727; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Tien PC, 2006, AM J EPIDEMIOL, V163, P860, DOI 10.1093/aje/kwj111; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Zhang S, 2010, ANTIVIR THER, V15, P555, DOI 10.3851/IMP1564	21	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26320	10.1371/journal.pone.0026320	http://dx.doi.org/10.1371/journal.pone.0026320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073156	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900017
J	Chapman, KD; Ohlrogge, JB				Chapman, Kent D.; Ohlrogge, John B.			Compartmentation of Triacylglycerol Accumulation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COA-DIACYLGLYCEROL ACYLTRANSFERASE; COENZYME-A SYNTHETASE; FATTY-ACID SYNTHESIS; ENDOPLASMIC-RETICULUM; SEED OIL; LIPID-SYNTHESIS; MICROSOMAL PREPARATIONS; TRANSGENIC ARABIDOPSIS; DEVELOPING EMBRYOS; KEY ENZYME	Triacylglycerols from plants, familiar to most people as vegetable oils, supply 25% of dietary calories to the developed world and are increasingly a source for renewable biomaterials and fuels. Demand for vegetable oils will double by 2030, which can be met only by increased oil production. Triacylglycerol synthesis is accomplished through the coordinate action of multiple pathways in multiple subcellular compartments. Recent information has revealed an underappreciated complexity in pathways for synthesis and accumulation of this important energy-rich class of molecules.	[Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Ohlrogge, John B.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	University of North Texas System; University of North Texas Denton; Michigan State University	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA.	chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072	United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences) [DBI-0701919]; Great Lakes Bioenergy Research Center Department of Energy [DE-FC02-07ER64494]	United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences)(United States Department of Energy (DOE)); Great Lakes Bioenergy Research Center Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences); National Science Foundation Grant DBI-0701919; and Great Lakes Bioenergy Research Center Department of Energy Grant DE-FC02-07ER64494. This is the third article in the Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Allen DK, 2009, PLANT J, V58, P220, DOI 10.1111/j.1365-313X.2008.03771.x; Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; BAFOR M, 1990, BIOCHEM J, V272, P31, DOI 10.1042/bj2720031; Bao XM, 1999, PLANT PHYSIOL, V120, P1057, DOI 10.1104/pp.120.4.1057; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; BROWSE J, 1981, BIOCHEM J, V196, P347, DOI 10.1042/bj1960347; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Goffman FD, 2005, PLANT PHYSIOL, V138, P2269, DOI 10.1104/pp.105.063628; Hanson MR, 2011, PLANT PHYSIOL, V155, P1486, DOI 10.1104/pp.110.170852; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Kim HU, 2005, PLANT CELL, V17, P1073, DOI 10.1105/tpc.104.030403; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; Mietkiewska E, 2011, FEBS J, V278, P764, DOI 10.1111/j.1742-4658.2010.07995.x; Mongrand S, 2000, PLANT PHYSIOL, V122, P845, DOI 10.1104/pp.122.3.845; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Ohlrogge J., 2011, BIOCHEMISTRY-US, V33, P34, DOI [10.1042/BIO03302034, DOI 10.1042/BIO03302034]; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STYMNE S, 1983, BIOCHIM BIOPHYS ACTA, V752, P198, DOI 10.1016/0005-2760(83)90113-3; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vigeolas H, 2011, PLANT PHYSIOL, V155, P1435, DOI 10.1104/pp.110.166462; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x	71	296	330	7	100	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2288	2294		10.1074/jbc.R111.290072	http://dx.doi.org/10.1074/jbc.R111.290072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090025	hybrid, Green Published			2022-12-25	WOS:000300292300004
J	Jain, M; Zhang, LS; Patterson, EE; Kebebew, E				Jain, Meenu; Zhang, Lisa; Patterson, Erin E.; Kebebew, Electron			KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer	PLOS ONE			English	Article							PCNA-ASSOCIATED FACTOR; ADRENOCORTICAL TUMORS; HEPATOCELLULAR-CARCINOMA; EXPRESSION; GENE; MALIGNANCY; P15(PAF); PREDICTS; CELLS	Background: KIAA0101 is a proliferating cell nuclear antigen-associated factor that is overexpressed in some human malignancies. Adrenocortical neoplasm is one of the most common human neoplasms for which the molecular causes are poorly understood. Moreover, it is difficult to distinguish between localized benign and malignant adrenocortical tumors. For these reasons, we studied the expression, function and possible mechanism of dysregulation of KIAA0101 in human adrenocortical neoplasm. Methodology/Principal Findings: KIAA0101 mRNA and protein expression levels were determined in 112 adrenocortical tissue samples (21 normal adrenal cortex, 80 benign adrenocortical tumors, and 11 adrenocortical carcinoma (ACC). SiRNA knockdown was used to determine the functional role of KIAA0101 on cell proliferation, cell cycle, apoptosis, soft agar anchorage independent growth and invasion in the ACC cell line, NCI-H295R. In addition, we explored the mechanism of KIAA0101 dysregulation by examining the mutational status. KIAA0101 mRNA (9.7 fold) and protein expression were significantly higher in ACC (p<0.0001). KIAA0101 had sparse protein expression in only a few normal adrenal cortex samples, which was confined to adrenocortical progenitor cells. KIAA0101 expression levels were 84% accurate for distinguishing between ACC and normal and benign adrenocortical tumor samples. Knockdown of KIAA0101 gene expression significantly decreased anchorage independent growth by 80% and invasion by 60% (p = 0.001; p = 0.006). We found no mutations in KIAA0101 in ACC. Conclusions/Significance: KIAA0101 is overexpressed in ACC. Our data supports that KIAA0101 is a marker of cellular proliferation, promotes growth and invasion, and is a good diagnostic marker for distinguishing benign from malignant adrenocortical neoplasm.	[Jain, Meenu; Zhang, Lisa; Patterson, Erin E.; Kebebew, Electron] NCI, Endocrine Oncol Sect, Surg Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jain, M (corresponding author), NCI, Endocrine Oncol Sect, Surg Branch, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov			Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Collado M, 2007, CLIN CHEM, V53, P1860, DOI 10.1373/clinchem.2007.089201; Dunn JCY, 2009, J SURG RES, V156, P317, DOI 10.1016/j.jss.2009.04.021; Favia G, 1995, Minerva Endocrinol, V20, P95; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Guo ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-109; Hosokawa M, 2007, CANCER RES, V67, P2568, DOI 10.1158/0008-5472.CAN-06-4356; Icard P, 2001, ANN CHIR, V126, P249, DOI 10.1016/S0003-3944(01)00497-7; Kais Z, 2011, MOL CANC RES; KATO T, 2011, LUNG CANC; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; Kjellman M, 1996, CANCER RES, V56, P4219; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Lombardi CP, 2006, BIOMED PHARMACOTHER, V60, P186, DOI 10.1016/j.biopha.2006.03.006; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Mizutani K, 2005, CANCER-AM CANCER SOC, V103, P1785, DOI 10.1002/cncr.20988; Simpson F, 2006, EXP CELL RES, V312, P73, DOI 10.1016/j.yexcr.2005.09.020; Slater EP, 2006, EUR J ENDOCRINOL, V154, P587, DOI 10.1530/eje.1.02116; TURCHI L, 2009, CELL DEATH DIFFER; van Bueren KL, 2007, GENE EXPR PATTERNS, V7, P47, DOI 10.1016/j.modgep.2006.05.006; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113	30	44	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26866	10.1371/journal.pone.0026866	http://dx.doi.org/10.1371/journal.pone.0026866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096502	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900012
J	Francis, CD; Ortega, CP; Cruz, A				Francis, Clinton D.; Ortega, Catherine P.; Cruz, Alexander			Noise Pollution Filters Bird Communities Based on Vocal Frequency	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; ACOUSTIC COMMUNICATION; TRAFFIC NOISE; URBAN NOISE; BODY-MASS; IMPACT; SONG; ROADS; CONSEQUENCES; ADJUSTMENT	Background: Human-generated noise pollution now permeates natural habitats worldwide, presenting evolutionarily novel acoustic conditions unprecedented to most landscapes. These acoustics not only harm humans, but threaten wildlife, and especially birds, via changes to species densities, foraging behavior, reproductive success, and predator-prey interactions. Explanations for negative effects of noise on birds include disruption of acoustic communication through energetic masking, potentially forcing species that rely upon acoustic communication to abandon otherwise suitable areas. However, this hypothesis has not been adequately tested because confounding stimuli often co-vary with noise and are difficult to separate from noise exposure. Methodology/Principal Findings: Using a natural experiment that controls for confounding stimuli, we evaluate whether species vocal features or urban-tolerance classifications explain their responses to noise measured through habitat use. Two data sets representing nesting and abundance responses reveal that noise filters bird communities nonrandomly. Signal duration and urban tolerance failed to explain species-specific responses, but birds with low-frequency signals that are more susceptible to masking from noise avoided noisy areas and birds with higher frequency vocalizations remained. Signal frequency was also negatively correlated with body mass, suggesting that larger birds may be more sensitive to noise due to the link between body size and vocal frequency. Conclusions/Significance: Our findings suggest that acoustic masking by noise may be a strong selective force shaping the ecology of birds worldwide. Larger birds with lower frequency signals may be excluded from noisy areas, whereas smaller species persist via transmission of higher frequency signals. We discuss our findings as they relate to interspecific relationships among body size, vocal amplitude and frequency and suggest that they are immediately relevant to the global problem of increases in noise by providing critical insight as to which species traits influence tolerance of these novel acoustics.	[Francis, Clinton D.; Cruz, Alexander] Univ Colorado, Boulder, CO 80309 USA; [Ortega, Catherine P.] Ft Lewis Coll, San Juan Inst Nat & Cultural Resources, Durango, CO 81301 USA	University of Colorado System; University of Colorado Boulder	Francis, CD (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	clinton.francis@nescent.org	Vazquez-Dominguez, Guillermo GVD/L-7818-2014		National Science Foundation (NSF) [IOS 0910092]; United States Bureau of Land Management; ConocoPhillips; Williams Energy; U. Colorado Department of Ecology and Evolutionary Biology; the Animal Behavior Society; Southwestern Association of Naturalists; Colorado Field Ornithologists; Edna Bailey Sussman Foundation; Mountain Studies Institute; Wells Fargo Foundation; National Evolutionary Synthesis Center (NESCent) [NSF EF-0905606]	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Bureau of Land Management; ConocoPhillips; Williams Energy; U. Colorado Department of Ecology and Evolutionary Biology; the Animal Behavior Society; Southwestern Association of Naturalists; Colorado Field Ornithologists; Edna Bailey Sussman Foundation; Mountain Studies Institute; Wells Fargo Foundation; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was primarily supported by the National Science Foundation (NSF) Doctoral Dissertation Improvement Grants (DDIG) (# IOS 0910092), United States Bureau of Land Management, ConocoPhillips, Williams Energy, and U. Colorado Department of Ecology and Evolutionary Biology, plus the Animal Behavior Society, Southwestern Association of Naturalists, Colorado Field Ornithologists, Edna Bailey Sussman Foundation, Mountain Studies Institute, and an Ariel Appleton Research Fellowship with support from the Wells Fargo Foundation. Dr. Francis was supported by the National Evolutionary Synthesis Center (NESCent; NSF EF-0905606). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babisch W, 2003, Noise Health, V5, P1; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bertelli S, 2002, BIOL J LINN SOC, V77, P423, DOI 10.1046/j.1095-8312.2002.00112.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burnham KP, 2002, MULTIMODEL INFERENCE; Cardoso GC, 2010, J EVOLUTION BIOL, V23, P212, DOI 10.1111/j.1420-9101.2009.01883.x; Charif RA, 2010, RAVEN PRO 1 4 USERS; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Francis CD, 2011, BIOL LETTERS, V7, P850, DOI 10.1098/rsbl.2011.0359; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Goodwin SE, 2011, CONSERV BIOL, V25, P406, DOI 10.1111/j.1523-1739.2010.01602.x; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Ortega CP, ORNITHOLOGI IN PRESS; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Podos Jeffrey, 2004, P318, DOI 10.1016/B978-012473070-0/50014-1; Poole A, BIRDS N AM ONLINE; R Core Development Team, 2010, R LANG ENV STAT COMP; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Tubaro PL, 1998, CONDOR, V100, P54, DOI 10.2307/1369896; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6	40	75	78	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27052	10.1371/journal.pone.0027052	http://dx.doi.org/10.1371/journal.pone.0027052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096517	Green Published, Green Submitted, gold			2022-12-25	WOS:000297350800024
J	Ma, XQ; Yang, LF; Xiao, LB; Tang, M; Liu, LY; Li, ZJ; Deng, MY; Sun, LQ; Cao, Y				Ma, Xiaoqian; Yang, Lifang; Xiao, Lanbo; Tang, Min; Liu, Liyu; Li, Zijian; Deng, Mengyao; Sun, Lunquan; Cao, Ya			Down-Regulation of EBV-LMP1 Radio-Sensitizes Nasal Pharyngeal Carcinoma Cells via NF-kappa B Regulated ATM Expression	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; ENCODED LATENT MEMBRANE-PROTEIN-1; ATAXIA-TELANGIECTASIA CELLS; DNA-DAMAGE RESPONSE; NASOPHARYNGEAL CARCINOMA; IONIZING-RADIATION; BREAST-CANCER; C-JUN; PATHWAY; ALPHA	Background: The latent membrane protein 1 (LMP1) encoded by EBV is expressed in the majority of EBV-associated human malignancies and has been suggested to be one of the major oncogenic factors in EBV-mediated carcinogenesis. In previous studies we experimentally demonstrated that down-regulation of LMP1 expression by DNAzymes could increase radiosensitivity both in cells and in a xenograft NPC model in mice. Results: In this study we explored the molecular mechanisms underlying the radiosensitization caused by the down-regulation of LMP1 in nasopharyngeal carcinoma. It was confirmed that LMP1 could up-regulate ATM expression in NPCs. Bioinformatic analysis of the ATM ptomoter region revealed three tentative binding sites for NF-kappa B. By using a specific inhibitor of NF-kB signaling and the dominant negative mutant of IkappaB, it was shown that the ATM expression in CNE1-LMP1 cells could be efficiently suppressed. Inhibition of LMP1 expression by the DNAzyme led to attenuation of the NF-kappa B DNA binding activity. We further showed that the silence of ATM expression by ATM-targeted siRNA could enhance the radiosensitivity in LMP1 positive NPC cells. Conclusions: Together, our results indicate that ATM expression can be regulated by LMP1 via the NF-kappa B pathways through direct promoter binding, which resulted in the change of radiosensitivity in NPCs.	[Ma, Xiaoqian; Yang, Lifang; Xiao, Lanbo; Tang, Min; Liu, Liyu; Li, Zijian; Deng, Mengyao; Cao, Ya] Cent S Univ, Canc Res Inst, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Yang, Lifang; Sun, Lunquan] Cent S Univ, Ctr Mol Med, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Cao, Ya] Minist Hlth, Key Lab Carcinogenesis & Invas, Minist Educ, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Sun, Lunquan; Cao, Ya] Cent S Univ, Ctr Mol Imaging, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Ma, XQ (corresponding author), Cent S Univ, Cell Transplantat & Gene Therapy Inst, Xiangya Hosp 3, Changsha, Hunan, Peoples R China.	Lq-sun@hotmail.com; ycao98@vip.sina.com	Li, Zi-Jian/O-7703-2019	Li, Zi-Jian/0000-0002-6796-4176	National Natural Science Foundation of China [30873010, 81072220]; National High Technology Research and Development Program of China [2006AA02Z481, 2009AA02Z403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30873010, No. 81072220) and National High Technology Research and Development Program of China (2006AA02Z481 and 2009AA02Z403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim B, 2003, ONCOGENE, V22, P2260, DOI 10.1038/sj.onc.1206402; Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Allio T, 2000, MUTAT RES-FUND MOL M, V453, P5, DOI 10.1016/S0027-5107(00)00030-0; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Benimetskaya L, 1998, NUCLEIC ACIDS RES, V26, P5310, DOI 10.1093/nar/26.23.5310; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926; Deng L, 2003, CELL RES, V13, P187, DOI 10.1038/sj.cr.7290163; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Gueven N, 2001, J BIOL CHEM, V276, P8884, DOI 10.1074/jbc.M006190200; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; HAMMARSKJOLD ML, 1992, J VIROL, V66, P6496; Hatzivassiliou E, 2002, FRONT BIOSCI, V7, pD319, DOI 10.2741/hatziva; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; JUNG M, 1995, SCIENCE, V268, P1619, DOI 10.1126/science.7777860; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Lu ZX, 2008, CANCER LETT, V265, P226, DOI 10.1016/j.canlet.2008.02.019; Lu ZX, 2005, CANCER GENE THER, V12, P647, DOI 10.1038/sj.cgt.7700833; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Pandita Tej K, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006318; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Roy K, 2006, BIOCHEM BIOPH RES CO, V344, P821, DOI 10.1016/j.bbrc.2006.03.222; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; Song X, 2004, CELL SIGNAL, V16, P1153, DOI 10.1016/j.cellsig.2004.03.014; Truman JP, 2005, J BIOL CHEM, V280, P23262, DOI 10.1074/jbc.M503701200; Wu BY, 1997, J VIROL, V71, P3161, DOI 10.1128/JVI.71.4.3161-3167.1997; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yin LQ, 2001, CHINESE MED J-PEKING, V114, P718; Zhao Y, 2004, INT J BIOCHEM CELL B, V36, P1473, DOI 10.1016/j.biocel.2003.10.024	45	35	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e24647	10.1371/journal.pone.0024647	http://dx.doi.org/10.1371/journal.pone.0024647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096476	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800001
J	Daniels, CS; Rubinsky, B				Daniels, Charlotte S.; Rubinsky, Boris			Cryosurgery with Pulsed Electric Fields	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; ABLATION; CANCER; TISSUE; ELECTROCHEMOTHERAPY; MODEL	This study explores the hypothesis that combining the minimally invasive surgical techniques of cryosurgery and pulsed electric fields will eliminate some of the major disadvantages of these techniques while retaining their advantages. Cryosurgery, tissue ablation by freezing, is a well-established minimally invasive surgical technique. One disadvantage of cryosurgery concerns the mechanism of cell death; cells at high subzero temperature on the outer rim of the frozen lesion can survive. Pulsed electric fields (PEF) are another minimally invasive surgical technique in which high strength and very rapid electric pulses are delivered across cells to permeabilize the cell membrane for applications such as gene delivery, electrochemotherapy and irreversible electroporation. The very short time scale of the electric pulses is disadvantageous because it does not facilitate real time control over the procedure. We hypothesize that applying the electric pulses during the cryosurgical procedure in such a way that the electric field vector is parallel to the heat flux vector will have the effect of confining the electric fields to the frozen/cold region of tissue, thereby ablating the cells that survive freezing while facilitating controlled use of the PEF in the cold confined region. A finite element analysis of the electric field and heat conduction equations during simultaneous tissue treatment with cryosurgery and PEF (cryosurgery/PEF) was used to study the effect of tissue freezing on electric fields. The study yielded motivating results. Because of decreased electrical conductivity in the frozen/cooled tissue, it experienced temperature induced magnified electric fields in comparison to PEF delivered to the unfrozen tissue control. This suggests that freezing/cooling confines and magnifies the electric fields to those regions; a targeting capability unattainable in traditional PEF. This analysis shows how temperature induced magnified and focused PEFs could be used to ablate cells in the high subzero freezing region of a cryosurgical lesion.	[Daniels, Charlotte S.; Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Daniels, CS (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	daniels.charlotte@gmail.com			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	CD was supported by National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPS JJ, 1953, T AM I MIN MET ENG, V198, P327; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Baust JG, 2007, TECHNOL CANCER RES T, V6, P97, DOI 10.1177/153303460700600206; Baust JG, 2005, BJU INT, V95, P1187, DOI 10.1111/j.1464-410X.2005.05502.x; BISCHOF J, 1993, CRYOBIOLOGY, V30, P482, DOI 10.1006/cryo.1993.1049; Daniels CS, 2011, PLOS ONE, P6; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Diaz-Rivera RE, 2006, BIOMED MICRODEVICES, V8, P25, DOI 10.1007/s10544-006-6379-5; DIAZRIVERA R, 2000, THESIS UC BERKELEY; EDD JF, 2008, PHYSL MEASUREMENT, V29; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Fuchs KH, 2002, ENDOSCOPY, V34, P154, DOI 10.1055/s-2002-19857; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Gallo SA, 2002, BIOPHYS J, V82, P109, DOI 10.1016/S0006-3495(02)75378-2; Gilbert J, 1984, IEEE T BIOMEDICAL EN, P563; Ingebritsen SE, 1998, GEOL MAG, V136, P697, DOI [10.1017/S0016756899363329, DOI 10.1017/S0016756899363329]; Jaroszeski MJ, 1999, ADV DRUG DELIVER REV, V35, P131, DOI 10.1016/S0169-409X(98)00068-4; Jiang J, 2010, CRYOBIOLOGY, V61, P280, DOI 10.1016/j.cryobiol.2010.09.006; KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001; Kanduser Masa, 2008, P1, DOI 10.1007/978-0-387-79374-0_1; Koushafar H, 1997, UROLOGY, V49, P421, DOI 10.1016/S0090-4295(96)00572-9; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; MAZZOLENI AP, 1986, BIOELECTROMAGNETICS, V7, P95, DOI 10.1002/bem.2250070111; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 2002, BRIT J CANCER, V86, P1658, DOI 10.1038/sj.bjc.6600306; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; OKINO M, 1987, JPN J CANCER RES, V78, P1319; ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4; ONIK G, 1991, CANCER, V67, P901, DOI 10.1002/1097-0142(19910215)67:4<901::AID-CNCR2820670408>3.0.CO;2-Z; Onik G, 2007, TECHNOLOGY CANC RES, P6; Pakhomov AG, 2010, ADV ELECTROPORATION; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; RUBINSKY B, 1990, CRYOBIOLOGY, V27, P85, DOI 10.1016/0011-2240(90)90055-9; Rubinsky B, 1988, P ROYAL SOC LONDON, P234; Rubinsky B, 1976, J HEAT TRANSFER, P98; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Somiari S, 2000, MOL THER, V2, P178, DOI 10.1006/mthe.2000.0124; Tatsutani K, 1996, UROLOGY, V48, P441, DOI 10.1016/S0090-4295(96)00199-9; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; WJ Minkowycz, 2006, HDB NUMERICAL HEAT T	42	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26219	10.1371/journal.pone.0026219	http://dx.doi.org/10.1371/journal.pone.0026219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087224	gold, Green Published			2022-12-25	WOS:000297347700004
J	Nischalke, HD; Berger, C; Luda, C; Berg, T; Muller, T; Grunhage, F; Lammert, F; Coenen, M; Kramer, B; Korner, C; Vidovic, N; Oldenburg, J; Nattermann, J; Sauerbruch, T; Spengler, U				Nischalke, Hans Dieter; Berger, Cordula; Luda, Carolin; Berg, Thomas; Mueller, Tobias; Gruenhage, Frank; Lammert, Frank; Coenen, Martin; Kraemer, Benjamin; Koerner, Christian; Vidovic, Natascha; Oldenburg, Johannes; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich			The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis	PLOS ONE			English	Article							DOMAIN-CONTAINING 3; HEPATOCELLULAR-CARCINOMA; GENE VARIANT; DISEASE; I148M; ADIPONUTRIN; SEVERITY; FIBROSIS; CHILDREN; TRENDS	Background: An isoleucine. methionine mutation at position 148 in the PNPLA3 gene (p. I148M, rs738409) has recently been identified as a susceptibility factor for liver damage in steatohepatitis. Here, we studied whether the PNPLA3 rs738409 polymorphism also affects predisposition to hepatocellular carcinoma (HCC). Methods: We compared distributions of PNPLA3 genotypes in 80 and 81 Caucasian patients with alcoholic and hepatitis C virus (HCV)-associated HCC to 80 and 81 age- and sex-matched patients with alcohol-related and HCV-related cirrhosis without HCC, respectively. PNPLA3 genotypes in 190 healthy individuals from the same population served as reference. Potential confounders obesity, diabetes, HCV genotype and HBV co-infection were controlled by univariate and multivariate logistic regression with forward variable selection. Results: PNPLA3 genotypes were in Hardy-Weinberg equilibrium for all study groups. The frequency of the 148M allele was significantly (p<0.001) increased in alcoholic cirrhosis with (53.7%) and without HCC (36.2%) but was not different between healthy controls (22.9%) and patients with cirrhosis (25.3%; p = 0.545) and HCC (30.2%; p = 0.071) due to hepatitis C. HCC risk was highest in 148M/M homozygous patients with alcoholic liver disease (odds ratio (OR) 16.8 versus healthy controls; 95% confidence interval (CI) 6.68-42.43, p<0.001). Finally, multivariate regression confirmed 148M/M homozygosity (OR 2.8; 95%-CI: 1.24-6.42; p = 0.013) as HCC risk factor in alcoholic cirrhosis. In HCV-related cirrhosis only HCV genotype 1 was confirmed as a HCC risk factor (OR 4.2; 95%-CI: 1.50-11.52; p = 0.006). Conclusion: The PNPLA3 148M variant is a prominent risk factor for HCC in patients with alcoholic cirrhosis, while its effects are negligible in patients with cirrhosis due to HCV. This polymorphism provides an useful tool to identify individuals with particularly high HCC risk in patients with alcoholic liver disease that should be taken into account in future HCC prevention studies.	[Nischalke, Hans Dieter; Berger, Cordula; Luda, Carolin; Coenen, Martin; Kraemer, Benjamin; Koerner, Christian; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany; [Berg, Thomas] Univ Hosp Leipzig, Dept Gastroenterol, Leipzig, Germany; [Mueller, Tobias] Med Univ Charite Campus, Virchow Klinikum Berlin, Med Clin Hepatol & Gastroenterol, Berlin, Germany; [Gruenhage, Frank; Lammert, Frank] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany; [Vidovic, Natascha; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany	University of Bonn; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universitatsklinikum des Saarlandes; University of Bonn	Nischalke, HD (corresponding author), Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany.	ulrich.spengler@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020; Körner, Christian/ABB-8335-2020; Krämer, Benjamin/AAC-9618-2019	Körner, Christian/0000-0002-3431-7319; Krämer, Benjamin/0000-0002-1385-9709; Mueller, Tobias/0000-0003-3426-5421; Oldenburg, Johannes/0000-0002-1585-4100; Nischalke, Hans Dieter/0000-0002-3457-0023; Berg, Thomas/0000-0003-0003-6241	Deutsche Krebshilfe [107865]; Deutsche Forschungsgemeinschaft [SFB TR57 TP01, TP12]; BMBF Network [01KI0792]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF Network(Federal Ministry of Education & Research (BMBF))	This work was funded by the Deutsche Krebshilfe (grant 107865 to HDN and US, http://www.krebshilfe.de/english.html) and the SFB TR57 TP01 & TP12 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) to FL, JN and US. CK was supported by a grant of the BMBF Network "Susceptbility and Resistance to Hepatitis C" to US and JN (grant 01KI0792, http://www.bmbf.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Corradini SG, 2011, HEPATOLOGY, V53, P1776, DOI 10.1002/hep.24244; Falleti E, 2011, LIVER INT       0419; Goran MI, 2010, DIABETES, V59, P3127, DOI 10.2337/db10-0554; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Petit JM, 2010, J CLIN ENDOCR METAB, V95, pE430, DOI 10.1210/jc.2010-0814; Rae-Whitcombe SM, 2010, BIOCHEM BIOPH RES CO, V402, P767, DOI 10.1016/j.bbrc.2010.10.106; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Sanyal AJ, 2005, ALIMENT PHARM THER, V22, P48, DOI 10.1111/j.1365-2036.2005.02596.x; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, J HEPATOL       0218; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Yang JD, NAT REV GASTROENTERO, V7, P448	28	87	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27087	10.1371/journal.pone.0027087	http://dx.doi.org/10.1371/journal.pone.0027087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087248	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700016
J	Chang, LR; Lin, YH; Kuo, TBJ; Chang, HCW; Liu, CM; Liu, CC; Hwu, HG; Yang, CCH				Chang, Li-Ren; Lin, Yu-Hsuan; Kuo, Terry B. J.; Chang, Hung-Chieh Wu; Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo; Yang, Cheryl C. H.			Autonomic Modulation and Health-Related Quality of Life among Schizophrenic Patients Treated with Non-Intensive Case Management	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; NONLINEAR COMPLEXITY; NERVOUS-SYSTEM; QT VARIABILITY; RATE DYNAMICS; EQ-5D; VALIDATION; DEPRESSION; COMMUNITY; SEVERITY	Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.	[Chang, Li-Ren; Lin, Yu-Hsuan; Chang, Hung-Chieh Wu; Liu, Chih-Min] Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan; [Lin, Yu-Hsuan; Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Kuo, Terry B. J.] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Liu, Chih-Min; Liu, Chen-Chung; Hwu, Hai-Gwo] Natl Taiwan Univ, Dept Psychiat, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; National Taiwan University	Chang, LR (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan.	cchyang@ym.edu.tw		HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHEN-CHUNG/0000-0002-9290-110X; CHANG, LI-REN/0000-0003-0853-3904; LIU, CHIH-MIN/0000-0001-7016-8990	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL.99N015]; National Science Council (Taiwan) [NSC 99-2911-I-008-100]; Ministry of Education [100AC-B3]	National Taiwan University Hospital, Yun-Lin Branch; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education	This study was supported by a Grant (NTUHYL.99N015) from the National Taiwan University Hospital, Yun-Lin Branch, and a grant (NSC 99-2911-I-008-100) from the National Science Council (Taiwan) and by a grant (100AC-B3) from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bar KB, 2008, J CLIN PSYCHOPHARM, V28, P694, DOI 10.1097/JCP.0b013e31818a6d25; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021; Bar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bar KJ, 2007, J APPL PHYSIOL, V102, P1051, DOI 10.1152/japplphysiol.00811.2006; Bar KJ, 2005, J PSYCHIATR RES, V39, P519, DOI 10.1016/j.jpsychires.2004.12.007; Beck AT, 2013, SCHIZOPHRENIA BULL, V39, P43, DOI 10.1093/schbul/sbr040; Bobes J, 2005, EUR PSYCHIAT, V20, pS313, DOI 10.1016/S0924-9338(05)80182-8; Bobes J, 1997, QUALITY OF LIFE IN MENTAL DISORDERS, P165; Boettger S, 2006, CLIN NEUROPHYSIOL, V117, P2715, DOI 10.1016/j.clinph.2006.08.009; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Camm AJ, 1996, CIRCULATION, V93, P1043; Castro MN, 2008, SCHIZOPHR RES, V99, P294, DOI 10.1016/j.schres.2007.08.025; Chang JS, 2010, PROG NEURO-PSYCHOPH, V34, P924, DOI 10.1016/j.pnpbp.2010.04.017; Chang JS, 2009, PROG NEURO-PSYCHOPH, V33, P991, DOI 10.1016/j.pnpbp.2009.05.004; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Fujibayashi M, 2009, PSYCHIAT CLIN NEUROS, V63, P538, DOI 10.1111/j.1440-1819.2009.01983.x; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Isaac M, 2007, BRIT J PSYCHIAT, V191, pS71, DOI 10.1192/bjp.191.50.s71; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Kemp AH, 2011, BIOL PSYCHIAT, V69, pE25, DOI 10.1016/j.biopsych.2010.10.035; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim DH, 2006, J AM GERIATR SOC, V54, P1751, DOI 10.1111/j.1532-5415.2006.00940.x; Kim JH, 2004, PROG NEURO-PSYCHOPH, V28, P371, DOI 10.1016/j.pnpbp.2003.11.007; Konig HH, 2007, EUR PSYCHIAT, V22, P177, DOI 10.1016/j.eurpsy.2006.08.004; Koponen H, 2008, NORD J PSYCHIAT, V62, P342, DOI 10.1080/08039480801959323; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; Kuo TBJ, 2005, J CARDIOVASC ELECTR, V16, P864, DOI 10.1111/j.1540-8167.2005.40656.x; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lempp H, 2009, QUAL LIFE RES, V18, P699, DOI 10.1007/s11136-009-9486-y; Licht Carmilla M M, 2011, Biol Psychiatry, V69, pe3, DOI 10.1016/j.biopsych.2010.06.034; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Okada T, 2003, J CLIN PSYCHOPHARM, V23, P441, DOI 10.1097/01.jcp.0000088901.24613.b8; Penttila J, 2005, EUR J CLIN PHARMACOL, V61, P559, DOI 10.1007/s00228-005-0953-2; Prieto L, 2004, CURR MED RES OPIN, V20, P827, DOI 10.1185/030079904125003674; Prieto L, 2003, ACTA PSYCHIAT SCAND, V107, P24, DOI 10.1034/j.1600-0447.107.s416.6.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Shinagawa M, 2002, BLOOD PRESS MONIT, V7, P69, DOI 10.1097/00126097-200202000-00015; Silke B, 2002, J PSYCHOPHARMACOL, V16, P355, DOI 10.1177/026988110201600410; So SH, 2010, PSYCHOSOM MED, V72, P681, DOI 10.1097/PSY.0b013e3181e7cca6; Sowden GL, 2009, INT J CARDIOL, V132, P30, DOI 10.1016/j.ijcard.2008.10.002; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thornicroft G, 2004, BRIT J PSYCHIAT, V185, P283, DOI 10.1192/bjp.185.4.283; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; van Gestel AJR, 2011, RESPIROLOGY, V16, P939, DOI 10.1111/j.1440-1843.2011.01992.x; Voss A, 2011, PROG NEURO-PSYCHOPH, V35, P1131, DOI 10.1016/j.pnpbp.2011.03.015; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323	65	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26378	10.1371/journal.pone.0026378	http://dx.doi.org/10.1371/journal.pone.0026378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	850MH	22073161	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200008
J	Kus, V; Flachs, P; Kuda, O; Bardova, K; Janovska, P; Svobodova, M; Jilkova, ZM; Rossmeisl, M; Wang-Sattler, R; Yu, ZH; Illig, T; Kopecky, J				Kus, Vladimir; Flachs, Pavel; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Svobodova, Michaela; Jilkova, Zuzana Macek; Rossmeisl, Martin; Wang-Sattler, Rui; Yu, Zhonghao; Illig, Thomas; Kopecky, Jan			Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							HEPATIC INSULIN SENSITIVITY; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MARINE ORIGIN; GLYCOGEN-SYNTHESIS; LIPID CATABOLISM; INDUCED OBESITY; RECEPTOR	Combining pharmacological treatments and life style interventions is necessary for effective therapy of major diseases associated with obesity, which are clustered in the metabolic syndrome. Acting via multiple mechanisms, combination treatments may reduce dose requirements and, therefore, lower the risk of adverse side effects, which are usually associated with long-term pharmacological interventions. Our previous study in mice fed high-fat diet indicated additivity in preservation of insulin sensitivity and in amelioration of major metabolic syndrome phenotypes by the combination treatment using n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and rosiglitazone, i.e. an anti-diabetic drug of the thiazolidinedione (TZD) family. We investigated here whether pioglitazone, a TZD-drug in clinical use, could elicit the additive beneficial effects when combined with n-3 LC-PUFA. Adult male mice (C57BL/6N) were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various dietary treatments (i) cHF+F, cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids; (ii) cHF+ROSI, cHF with 10 mg rosiglitazone/kg diet; (iii) cHF+F+ROSI; (iv) cHF+PIO, cHF with 50 mg pioglitazone/kg diet; and (v) cHF+F+PIO, or chow-fed. Plasma concentrations of 163 metabolites were evaluated using a targeted metabolomics approach. Both TZDs preserved glucose homeostasis and normal plasma lipid levels while inducing adiponectin, with pioglitazone showing better effectiveness. The beneficial effects of TZDs were further augmented by the combination treatments. cHF+F+ROSI but not cHF+F+PIO counteracted development of obesity, in correlation with inducibility of fatty acid beta-oxidation, as revealed by the metabolomic analysis. By contrast, only cHF+F+PIO eliminated hepatic steatosis and this treatment also reversed insulin resistance in dietary obese mice. Our results reveal differential effects of rosiglitazone and pioglitazone, unmasked in the combination treatment with n-3 LC-PUFA, and support the notion that n-3 LC-PUFA could be used as add-on treatment to TZDs in order to improve diabetic patient's therapy.	[Kus, Vladimir; Flachs, Pavel; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Svobodova, Michaela; Jilkova, Zuzana Macek; Rossmeisl, Martin; Kopecky, Jan] Acad Sci Czech Republ Vvi, Dept Adipose Tissue Biol, Inst Physiol, Prague, Czech Republic; [Wang-Sattler, Rui; Yu, Zhonghao; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kus, V (corresponding author), Acad Sci Czech Republ Vvi, Dept Adipose Tissue Biol, Inst Physiol, Prague, Czech Republic.	kopecky@biomed.cas.cz	Flachs, Pavel/A-5341-2012; Kuda, Ondrej/B-7990-2012; Svobodova, Michaela/F-7783-2016; Janovska, Petra/E-7160-2013; Rossmeisl, Martin/C-1892-2012; Macek Jílková, Zuzana/N-4051-2014; Bardova, Kristina/C-3493-2015; Kopecky, Jan/B-8244-2012; Rossmeisl, Martin/CAF-0060-2022; Wang-Sattler, Rui/B-5354-2014	Kuda, Ondrej/0000-0001-7034-4536; Janovska, Petra/0000-0002-6154-2175; Rossmeisl, Martin/0000-0001-8534-4002; Macek Jílková, Zuzana/0000-0002-2553-5971; Bardova, Kristina/0000-0002-2297-5066; Kopecky, Jan/0000-0001-8072-2035; Rossmeisl, Martin/0000-0001-8534-4002; Wang-Sattler, Rui/0000-0002-8794-8229	Internal Grant Agency of the Ministry of Health of the Czech Republic [NS/10528-3]; European Union [244995]; EPAX AS (Norway); EFSD	Internal Grant Agency of the Ministry of Health of the Czech Republic; European Union(European Commission); EPAX AS (Norway); EFSD	The research leading to these results has received funding from the Internal Grant Agency of the Ministry of Health of the Czech Republic (NS/10528-3), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS), EPAX AS (Norway), and the EFSD New Horizons research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, END SOC STAT PROV SU; Bays HE, 2010, CURR MED RES OPIN, V26, P907, DOI 10.1185/03007991003645318; Bell DSH, 2011, DIABETES OBES METAB, V13, P313, DOI 10.1111/j.1463-1326.2010.01342.x; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Djaouti L, 2010, DIABETES-METAB RES, V26, P297, DOI 10.1002/dmrr.1081; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Higashi Y, 2010, J BIOL CHEM, V285, P36361, DOI 10.1074/jbc.M110.137661; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kim H, 2004, DIABETOLOGIA, V47, P2215, DOI 10.1007/s00125-004-1581-6; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kuda O, 2009, J PHYSIOL PHARMACOL, V60, P135; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Lankinen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005258; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Libby P, 2007, AM J CARDIOL, V99, p27B, DOI 10.1016/j.amjcard.2006.11.004; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PELIKANOVA T, 1993, ANN NY ACAD SCI, V683, P272; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Rabol R, 2010, DIABETES OBES METAB, V12, P806, DOI 10.1111/j.1463-1326.2010.01237.x; Reyes-Soffer G, 2011, EXPERT OPIN PHARMACO, V12, P1429, DOI 10.1517/14656566.2011.563506; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Ruxton CH, 2007, J HUM NUTR DIET, V17, P449; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Serhan CN, 2005, PHARMACOL THERAPEUT, V105, P7, DOI 10.1016/j.pharmthera.2004.09.002; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; van Schothorst EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-110; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; Whitehead JP, 2011, INT J BIOCHEM CELL B, V43, P1071, DOI 10.1016/j.biocel.2011.04.017; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yang KJ, 2010, LIFE SCI, V87, P405, DOI 10.1016/j.lfs.2010.08.002; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	61	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27126	10.1371/journal.pone.0027126	http://dx.doi.org/10.1371/journal.pone.0027126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073272	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000028
J	Liu, YC; Hsu, DH; Huang, CL; Liu, YL; Liu, GY; Hung, HC				Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Liu, Yi-Liang; Liu, Guang-Yaw; Hung, Hui-Chih			Determinants of the Differential Antizyme-Binding Affinity of Ornithine Decarboxylase	PLOS ONE			English	Article							METHOTREXATE-INDUCED APOPTOSIS; POLYAMINE METABOLISM; INTRACELLULAR DEGRADATION; CELL-GROWTH; ANALYTICAL ULTRACENTRIFUGATION; ODC ANTIZYME; C-MYC; PROTEIN; TARGET; EXPRESSION	Ornithine decarboxylase (ODC) is a ubiquitous enzyme that is conserved in all species from bacteria to humans. Mammalian ODC is degraded by the proteasome in a ubiquitin-independent manner by direct binding to the antizyme (AZ). In contrast, Trypanosoma brucei ODC has a low binding affinity toward AZ. In this study, we identified key amino acid residues that govern the differential AZ binding affinity of human and Trypanosoma brucei ODC. Multiple sequence alignments of the ODC putative AZ-binding site highlights several key amino acid residues that are different between the human and Trypanosoma brucei ODC protein sequences, including residue 119, 124,125, 129, 136, 137 and 140 (the numbers is for human ODC). We generated a septuple human ODC mutant protein where these seven bases were mutated to match the Trypanosoma brucei ODC protein sequence. The septuple mutant protein was much less sensitive to AZ inhibition compared to the WT protein, suggesting that these amino acid residues play a role in human ODC-AZ binding. Additional experiments with sextuple mutants suggest that residue 137 plays a direct role in AZ binding, and residues 119 and 140 play secondary roles in AZ binding. The dissociation constants were also calculated to quantify the affinity of the ODC-AZ binding interaction. The K-d value for the wild type ODC protein-AZ heterodimer ([ODC_WT]-AZ) is approximately 0.22 mu M, while the K-d value for the septuple mutant-AZ heterodimer ([ODC_7M]-AZ) is approximately 12.4 mu M. The greater than 50-fold increase in [ODC_7M]-AZ binding affinity shows that the ODC-7M enzyme has a much lower binding affinity toward AZ. For the mutant proteins ODC_7M(-Q119H) and ODC_7M(-V137D), the K-d was 1.4 and 1.2 mu M, respectively. These affinities are 6-fold higher than the WT_ODC K-d, which suggests that residues 119 and 137 play a role in AZ binding.	[Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yen-Chin; Hsu, Den-Hua; Huang, Chi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, YC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-99-2113-M-005-010]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	The authors acknowledge support of this work by the National Science Council, Republic of China (NSC-99-2113-M-005-010) and in part by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Coffino P, 1998, UBIQUITIN BIOL CELL, P411; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Feith DJ, 2006, CARCINOGENESIS, V27, P1090, DOI 10.1093/carcin/bgi343; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1992, MOL CELL BIOL, V12, P2178, DOI 10.1128/MCB.12.5.2178; GHODA L, 1990, J BIOL CHEM, V265, P11823; Hoffman DW, 2005, BIOCHEMISTRY-US, V44, P11777, DOI 10.1021/bi051081k; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019253; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURAKAMI Y, 1994, BIOCHEM J, V304, P183, DOI 10.1042/bj3040183; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; OBrien TG, 1997, CANCER RES, V57, P2630; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Seiler N, 1998, INT J ONCOL, V13, P993; Smithson DC, 2010, J BIOL CHEM, V285, P16771, DOI 10.1074/jbc.M109.081588; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; VANNIEUWENHOVE S, 1985, T ROY SOC TROP MED H, V79, P692, DOI 10.1016/0035-9203(85)90195-6; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26835	10.1371/journal.pone.0026835	http://dx.doi.org/10.1371/journal.pone.0026835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073206	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000014
J	Klinke, DJ				Klinke, David J., II			Age-Corrected Beta Cell Mass Following Onset of Type 1 Diabetes Mellitus Correlates with Plasma C-Peptide in Humans	PLOS ONE			English	Article							ORAL INSULIN; PANCREAS; RESERVE; TRIALS; COST	Background: The inability to produce insulin endogenously precipitates the clinical symptoms of type 1 diabetes mellitus. However, the dynamic trajectory of beta cell destruction following onset remains unclear. Using model-based inference, the severity of beta cell destruction at onset decreases with age where, on average, a 40% reduction in beta cell mass was sufficient to precipitate clinical symptoms at 20 years of age. While plasma C-peptide provides a surrogate measure of endogenous insulin production post-onset, it is unclear as to whether plasma C-peptide represents changes in beta cell mass or beta cell function. The objective of this paper was to determine the relationship between beta cell mass and endogenous insulin production post-onset. Methods and Findings: Model-based inference was used to compare direct measures of beta cell mass in 102 patients against contemporary measures of plasma C-peptide obtained from three studies that collectively followed 834 patients post-onset of clinical symptoms. An empirical Bayesian approach was used to establish the level of confidence associated with the model prediction. Age-corrected estimates of beta cell mass that were inferred from a series of landmark pancreatic autopsy studies significantly correlate (p>0.9995) with contemporary measures of plasma C-peptide levels following onset. Conclusions: Given the correlation between beta cell mass and plasma C-peptide following onset, plasma C-peptide may provide a surrogate measure of beta cell mass in humans. The clinical relevance of this study is that therapeutic strategies that provide an increase in plasma C-peptide over the predicted value for an individual may actually improve beta cell mass. The model predictions may establish a standard historical "control" group - a prior in a Bayesian context - for clinical trials.	[Klinke, David J., II] W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA; [Klinke, David J., II] W Virginia Univ, Dept Immunol Microbiol & Cell Biol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Klinke, DJ (corresponding author), W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938	National Science Foundation [1053490]; National Cancer Institute [R15CA132124]; National Institute of Allergy and Infectious Diseases [R56AI076221]; NATIONAL CANCER INSTITUTE [R15CA132124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076221] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Science Foundation CAREER 1053490, the National Cancer Institute R15CA132124, and the National Institute of Allergy and Infectious Diseases R56AI076221. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Science Foundation, the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for the Advancement of Science, 1990, SCI ALL AM; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2011, DIABETES, V60, P361, DOI 10.2337/db10-1506; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Daaboul J, 2003, REV ENDOCR METAB DIS, V4, P317, DOI 10.1023/A:1027308310837; FOULIS AK, 1987, DIABETOLOGIA, V30, P333, DOI 10.1007/BF00299027; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Frayn K., 2003, METABOLIC REGULATION; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Goke B, 2010, CURR PHARM DESIGN, V16, P1547, DOI 10.2174/138161210791164081; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kahn R, 2004, DIABETES CARE, V27, P2262; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Klinke DJ, 2008, BIOPHYS J, V94, P4249, DOI 10.1529/biophysj.107.120451; Klinke DJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-371; Komulainen J, 1997, DIABETIC MED, V14, P532, DOI 10.1002/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Larsen MO, 2006, AM J PHYSIOL-ENDOC M, V290, pE670, DOI 10.1152/ajpendo.00251.2005; MCCULLOCH DK, 1991, DIABETES, V40, P673, DOI 10.2337/diabetes.40.6.673; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Teuscher AU, 1998, DIABETES, V47, P324, DOI 10.2337/diabetes.47.3.324; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	31	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26873	10.1371/journal.pone.0026873	http://dx.doi.org/10.1371/journal.pone.0026873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073210	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900047
J	Soyiri, IN; Reidpath, DD; Sarran, C				Soyiri, Ireneous N.; Reidpath, Daniel D.; Sarran, Christophe			Asthma Length of Stay in Hospitals in London 2001-2006: Demographic, Diagnostic and Temporal Factors	PLOS ONE			English	Article							PATIENT SAFETY; ADMISSION; ATTENDANCE; MORTALITY; BURDEN; ADULTS; COST; CARE; NHS	Asthma is a condition of significant public health concern associated with morbidity, mortality and healthcare utilisation. This study identifies key determinants of length of stay (LOS) associated with asthma-related hospital admissions in London, and further explores their effects on individuals. Subjects were primarily diagnosed and admitted for asthma in London between 1(st) January 2001 and 31(st) December 2006. All repeated admissions were treated uniquely as independent cases. Negative binomial regression was used to model the effect(s) of demographic, temporal and diagnostic factors on the LOS, taking into account the cluster effect of each patient's hospital attendance in London. The median and mean asthma LOS over the period of study were 2 and 3 days respectively. Admissions increased over the years from 8,308 (2001) to 10,554 (2006), but LOS consistently declined within the same period. Younger individuals were more likely to be admitted than the elderly, but the latter significantly had higher LOS (p<0.001). Respiratory related secondary diagnoses, age, and gender of the patient as well as day of the week and year of admission were important predictors of LOS. Asthma LOS can be predicted by socio-demographic factors, temporal and clinical factors using count models on hospital admission data. The procedure can be a useful tool for planning and resource allocation in health service provision.	[Soyiri, Ireneous N.] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Clayton, Vic 3800, Australia; [Sarran, Christophe] Met Off, Exeter, Devon, England	University of Ghana; Monash University; Met Office - UK	Soyiri, IN (corresponding author), Univ Ghana, Sch Publ Hlth, Accra, Ghana.	soyiriin@yahoo.com	Soyiri, Ireneous N./H-4594-2011; Soyiri, Ireneous/AAE-7617-2019	Soyiri, Ireneous N./0000-0003-4697-5156; Soyiri, Ireneous/0000-0003-4697-5156; Reidpath, Daniel/0000-0002-8796-0420				ALT JE, 2000, POLITICAL ANAL, V0009; Arnold DH, 2011, EMERGENCY MED J; Arnold DH, 2008, AM J EMERG MED, V26, P473, DOI 10.1016/j.ajem.2007.05.026; Asthma-UK, 2010, KEY FACTS STAT ASTHM; Asthma-UK, 2007, ASTHM DIV IN EM CAR; Atienza N, 2008, STAT MED, V27, P1403, DOI 10.1002/sim.3029; Burg JG, 2001, MED VET ENTOMOL, V15, P413, DOI 10.1046/j.0269-283x.2001.00329.x; Callery P, 2010, ARCH DIS CHILD, V95, P341, DOI 10.1136/adc.2009.163261; Cameron AC, 2007, ESSENTIALS COUNT DAT, P331; DiSantostefano RL, 2011, AM J RESP CRIT CARE, V183; Gerrish K, 2000, J ADV NURS, V31, P918, DOI 10.1046/j.1365-2648.2000.01357.x; [GLA Demography-Team], 2011, MIDY POP EST; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Gray B, 2009, ENVIRON ECOL STAT, V17, P573; HES, 2008, HES US HLTH SOC CAR; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hodder R, 2010, CAN MED ASSOC J, V182, pE55, DOI 10.1503/cmaj.080072; Holgate ST, 1995, ASTHM OUTD AIR POLL; Kuan V, 2010, THORAX, V65, pA6, DOI 10.1136/thx.2010.150912.7; Long J. S., 2003, REGRESSION MODELS CA; Long JS, 2001, STATA J, V1, P51, DOI 10.1177/1536867X0100100103; Lyratzopoulos G, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-4; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Moloney ED, 2006, EMERG MED J, V23, P363, DOI 10.1136/emj.2005.028944; Morrison DS, 2001, THORAX, V56, P687, DOI 10.1136/thorax.56.9.687; Mulla ZD, 2007, EPIDEMIOL INFECT, V135, P868, DOI 10.1017/S0950268806007448; Paradis AR, 2009, AM J MED QUAL, V24, P53, DOI 10.1177/1062860608327610; Poulos Leanne M, 2005, Paediatr Respir Rev, V6, P20, DOI 10.1016/j.prrv.2004.11.004; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Rowe, 2010, ADMISSIONS CANADIAN; Schenkel S, 2000, ACAD EMERG MED, V7, P1204, DOI 10.1111/j.1553-2712.2000.tb00466.x; Scott IA, 2010, AUST HEALTH REV, V34, P317, DOI 10.1071/AH09821; Singh CH, 2010, EUR J HEALTH ECON, V11, P119, DOI 10.1007/s10198-009-0153-6; Sobota A, 2010, AM J HEMATOL, V85, P24, DOI 10.1002/ajh.21565; Stewart B, 2006, EMERG MED J, V23, P911, DOI 10.1136/emj.2006.039339; Watson L, 2007, INT J CLIN PRACT, V61, P1884, DOI 10.1111/j.1742-1241.2007.01559.x; Watson L, 2007, RESP MED, V101, P1659, DOI 10.1016/j.rmed.2007.03.006; Xiao J, 1999, SOCIOECONOMIC PLANNI, V33, P39, DOI DOI 10.1016/S0038-0121(98)00006-8	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27184	10.1371/journal.pone.0027184	http://dx.doi.org/10.1371/journal.pone.0027184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073282	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900086
J	Merino, D; Strasser, A; Bouillet, P				Merino, D.; Strasser, A.; Bouillet, P.			Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression	ONCOGENE			English	Article						Myc; bim; tumor suppression; lymphoma; apoptosis	B-CELL LYMPHOMAGENESIS; TRANSGENIC MICE; C-MYC; MEMBRANE PERMEABILIZATION; PROTEINS; DEATH; PUMA; EXPRESSION; LEUKEMIA; DRIVEN	Overexpression of the transcriptional regulator Myc is thought to be the cause or a contributing factor in the development of a large number of human lymphomas and certain other cancers. Apoptotic cell death constitutes a tumor suppressive mechanism, particularly in the context of Myc overexpression. Accordingly, lymphoma development in El-Myc transgenic mice, which mimic the Myc/ IgH chromosomal translocation that causes Burkitt lymphoma, is accelerated by concomitant overexpression of anti-apoptotic Bcl-2 family members or loss of proapoptotic BH3-only proteins, such as Bim. Bim binds with high affinity to all pro-survival Bcl-2-like proteins and can also interact with Bax/ Bak, but it remains unclear which of these interactions are critical for its tumor suppressive function. We have previously generated knock-in mutant mice in which the BH3 region of Bim has been exchanged with that for Bad, Noxa or Puma so that it can only bind to select pro-survival Bcl-2-like proteins: Bim(Bad) binding to Bcl-2, Bcl-xL and Bcl-w, but not Mcl-1 or A1; Bim(Noxa) binding only to Mcl-1 and A1 and as a control, Bim(Puma), which can still bind all pro-survival Bcl-2-like proteins. We have now inter-crossed these Bim mutant mice with El-Myc transgenic mice, and found that both the Bim(Bad) and the Bim(Noxa) mutations but not the Bim(Puma) mutation greatly accelerate Myc-induced lymphoma development and increase leukemic burden. These results demonstrate that for optimal tumor suppressive activity, Bim must be able to interact with all and not just select pro-survival Bcl-2 family members. Oncogene (2012) 31, 3392-3396; doi: 10.1038/onc.2011.508; published online 14 November 2011	[Merino, D.; Strasser, A.; Bouillet, P.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia; [Merino, D.; Strasser, A.; Bouillet, P.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Bouillet, P (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3010, Australia.	bouillet@wehi.edu.au	Strasser, Andreas/C-7581-2013; Merino, Delphine/L-9159-2017; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Merino, Delphine/0000-0002-8075-6275; Bouillet, Philippe/0000-0002-9012-6058	Australian National Health and Medical Research Council [461221]; National Cancer Institute [CA43540]; Australian Research Council; Leukemia and Lymphoma Society [7015]; Australian Government (IRISS); Victorian State Government (OIS); NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Research Council(Australian Research Council); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Government (IRISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government (OIS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Mikara Robati and Owen Siggs for help with experiments; Jerry Adams, Suzanne Cory, Clare Scott and Cyril Clybouw for insightful discussions; and Em-Myc mice, Bruno Helbert and Carley Young for mouse genotyping; Emily Sutherland and Giovanni Siciliano for mouse husbandry; and Jason Corbin for blood sample analysis. This work was supported by the Australian National Health and Medical Research Council (program grant 461221, Australia Fellowship (AS) and Career Development Award (PB)), the National Cancer Institute (CA43540), the Australian Research Council (DM), the Leukemia and Lymphoma Society (LLS Specialized Center of Research grant 7015) and operational infrastructure grants through the Australian Government (IRISS) and the Victorian State Government (OIS).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Frenzel A, 2010, BLOOD, V115, P995, DOI 10.1182/blood-2009-03-212670; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 1996, EMBO J, V15, P3823, DOI 10.1002/j.1460-2075.1996.tb00756.x; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Xiang ZF, 2010, J CLIN INVEST, V120, P2109, DOI 10.1172/JCI39964; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	22	17	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	28					3392	3396		10.1038/onc.2011.508	http://dx.doi.org/10.1038/onc.2011.508			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	973NT	22081075	Green Accepted			2022-12-25	WOS:000306367600008
J	Mahata, B; Sundqvist, A; Xirodimas, DP				Mahata, B.; Sundqvist, A.; Xirodimas, D. P.			Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner	ONCOGENE			English	Article						RPL11; nucleolar stress; NEDD8; Mdm2; p53	RIBOSOMAL-PROTEIN L11; P53 ACTIVATION; DNA-DAMAGE; ACTINOMYCIN-D; IN-VIVO; C-MYC; ACETYLATION; TRANSCRIPTION; UBIQUITIN; RNA	Ribosomal proteins (RPs) activate the p53 tumour-suppressor protein upon disruption of the nucleolus. However, the exact mechanisms for p53 transcriptional activation through RPs are not well understood. We show that the RPL11 is rapidly but transiently recruited at promoter sites of p53-regulated genes upon nucleolar stress induced by actinomycin D (ActD). Characterisation of molecular events at p53 promoter sites shows that L11 is required for the recruitment of p53 transcriptional co-activators p300/CBP and p53 K382 acetylation. We found that direct binding to Mdm2 E3 ligase and NEDDylation of L11 are critical regulators for L11 promoter recruitment. Our data suggest that binding of L11 to Mdm2 at the promoter results in relief from Mdm2-mediated transcriptional repression of p53. Analysis of chromatin and RNA polymerase II markers suggests that L11 is involved in the initiation step of transcriptional activation. Furthermore, analysis of 36 ActD-induced genes shows that L11 and NEDD8 are global regulators of the p53 activation response. The studies provide insights on how nucleolar stress through L11 and NEDD8 can activate the transcriptional activity of p53. Oncogene (2012) 31, 3060-3071; doi: 10.1038/onc.2011.482; published online 14 November 2011	[Xirodimas, D. P.] CNRS, Ctr Rech Biochim Macromol, UMR 5237, F-34293 Montpellier 5, France; [Mahata, B.; Sundqvist, A.; Xirodimas, D. P.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Dundee	Xirodimas, DP (corresponding author), CNRS, Ctr Rech Biochim Macromol, UMR 5237, F-34293 Montpellier 5, France.	dimitris.xirodimas@crbm.cnrs.fr		Mahata, Bidesh/0000-0002-4506-0184; Xirodimas, Dimitris/0000-0001-9275-1140	Association for International Cancer Research (AICR); INSERM	Association for International Cancer Research (AICR); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Our research in the DPX laboratory is supported by the Association for International Cancer Research (AICR) and INSERM. DPX is an AICR Research Fellow.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	48	52	55	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	25					3060	3071		10.1038/onc.2011.482	http://dx.doi.org/10.1038/onc.2011.482			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	964OP	22081073				2022-12-25	WOS:000305705900005
J	Garcia, BL; Summers, BJ; Lin, Z; Ramyar, KX; Ricklin, D; Kamath, DV; Fu, ZQ; Lambris, JD; Geisbrecht, BV				Garcia, Brandon L.; Summers, Brady J.; Lin, Zhuoer; Ramyar, Kasra X.; Ricklin, Daniel; Kamath, Divya V.; Fu, Zheng-Qing; Lambris, John D.; Geisbrecht, Brian V.			Diversity in the C3b Contact Residues and Tertiary Structures of the Staphylococcal Complement Inhibitor (SCIN) Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; IMMUNE EVASION; REVEALS; SYSTEM; RECOGNITION; ACTIVATION; INSIGHTS; SITE	To survive in immune-competent hosts, the pathogen Staphylococcus aureus expresses and secretes a sophisticated array of proteins that inhibit the complement system. Among these are the staphylococcal complement inhibitors (SCIN), which are composed of three active proteins (SCIN-A, -B, and -C) and one purportedly inactive member (SCIN-D or ORF-D). Because previous work has focused almost exclusively on SCIN-A, we sought to provide initial structure/function information on additional SCIN proteins. To this end we determined crystal structures of an active, N-terminal truncation mutant of SCIN-B (denoted SCIN-B18-85) both free and bound to the C3c fragment of complement component C3 at 1.5 and 3.4 angstrom resolution, respectively. Comparison of the C3c/SCIN-B18-85 structure with that of C3c/SCIN-A revealed that both proteins target the same functional hotspot on the C3b/C3c surface yet harbor diversity in both the type of residues and interactions formed at their C3b/C3c interfaces. Most importantly, these structures allowed identification of Arg(44) and Tyr(51) as residues key for SCIN-B binding to C3b and subsequent inhibition of the AP C3 convertase. In addition, we also solved several crystal structures of SCIN-D to 1.3 angstrom limiting resolution. This revealed an unexpected structural deviation in the N-terminal alpha helix relative to SCIN-A and SCIN-B. Comparative analysis of both electrostatic potentials and surface complementarity suggest a physical explanation for the inability of SCIN-D to bind C3b/C3c. Together, these studies provide a more thorough understanding of immune evasion by S. aureus and enhance potential use of SCIN proteins as templates for design of complement targeted therapeutics.	[Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Kamath, Divya V.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fu, Zheng-Qing] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Missouri System; University of Missouri Kansas City; University of Pennsylvania; United States Department of Energy (DOE); Argonne National Laboratory	Geisbrecht, BV (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	GeisbrechtB@umkc.edu	Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233	National Institutes of Health [AI071028, AI030040, AI068730, AI072106]; American Heart Association; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; SER-CAT Institutional Members website; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, R01AI072106, R01AI030040, N01AI030040, R01AI071028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SER-CAT Institutional Members website; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI071028, AI030040, AI068730, and AI072106 (to B. V. G. and J. D. L.). This work was also supported by an American Heart Association Predoctoral Fellowship (to B. L. G.).; We acknowledge the generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for use of the EnSpire plate reader. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory. A list of supporting member institutions may be found at the SER-CAT Institutional Members website.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Geisbrecht BV, 2008, ADV EXP MED BIOL, V632, P221, DOI 10.1007/978-0-387-78952-1_16; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Tedesco F, 2004, COMPLEMENT SYSTEM: NOVEL ROLES IN HEALTH AND DISEASE, P97, DOI 10.1007/1-4020-8056-5_6; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					628	640		10.1074/jbc.M111.298984	http://dx.doi.org/10.1074/jbc.M111.298984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086928	hybrid, Green Published			2022-12-25	WOS:000298682400061
J	Yao, DCI; Brune, DC; Vavilin, D; Vermaas, WFJ				Yao, Danny C. I.; Brune, Daniel C.; Vavilin, Dmitri; Vermaas, Wim F. J.			Photosystem II Component Lifetimes in the Cyanobacterium Synechocystis sp Strain PCC 6803 SMALL Cab-LIKE PROTEINS STABILIZE BIOSYNTHESIS INTERMEDIATES AND AFFECT EARLY STEPS IN CHLOROPHYLL SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN PRODUCTION; SP PCC-6803; CHLOROPHYLL; MEMBRANE; PHOTOINHIBITION; DEGRADATION; BINDING; REPAIR; POLYPEPTIDES; METABOLISM	To gain insight in the lifetimes of photosystem II (PSII) chlorophyll and proteins, a combined stable isotope labeling (N-15)/mass spectrometry method was used to follow both old and new pigments and proteins. Photosystem I-less Synechocystis cells were grown to exponential or post-exponential phase and then diluted in BG-11 medium with [N-15] ammonium and [N-15] nitrate. PSII was isolated, and the masses of PSII protein fragments and chlorophyll were determined. Lifetimes of PSII components ranged from 1.5 to 40 h, implying that at least some of the proteins and chlorophyll turned over independently from each other. Also, a significant amount of nascent PSII components accumulated in thylakoids when cells were in post-exponential growth phase. In a mutant lacking small Cab-like proteins (SCPs), most PSII protein lifetimes were unaffected, but the lifetime of chlorophyll and the amount of nascent PSII components that accumulated were decreased. In the absence of SCPs, one of the PSII biosynthesis intermediates, the monomeric PSII complex without CP43, was missing. Therefore, SCPs may stabilize nascent PSII protein complexes. Moreover, upon SCP deletion, the rate of chlorophyll synthesis and the accumulation of early tetrapyrrole precursors were drastically reduced. When [N-14] aminolevulinic acid (ALA) was supplemented to N-15-BG-11 cultures, the mutant lacking SCPs incorporated much more exogenous ALA into chlorophyll than the control demonstrating that ALA biosynthesis was impaired in the absence of SCPs. This illustrates the major effects that nonstoichiometric PSII components such as SCPs have on intermediates and assembly but not on the lifetime of PSII proteins.	[Vermaas, Wim F. J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Vermaas, WFJ (corresponding author), Arizona State Univ, Sch Life Sci, Box 874501, Tempe, AZ 85287 USA.	wim@asu.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-08ER15543]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-08ER15543.	Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Jansson S, 2000, PLANT MOL BIOL, V42, P345, DOI 10.1023/A:1006365213954; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kufryk G, 2008, PHOTOSYNTH RES, V95, P135, DOI 10.1007/s11120-007-9244-3; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Mattoo AK, 1999, PHYSIOL PLANTARUM, V107, P454, DOI 10.1034/j.1399-3054.1999.100412.x; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; MULLET JE, 1990, P NATL ACAD SCI USA, V87, P4038, DOI 10.1073/pnas.87.11.4038; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; PRASIL O, 1992, TOPICS PHOTOSYNTHESI, V2, P293; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Shalygo N, 2009, PLANT MOL BIOL, V71, P425, DOI 10.1007/s11103-009-9532-8; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH D, 1993, FEMS MICROBIOL LETT, V110, P341, DOI 10.1016/0378-1097(93)90126-M; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sonoike Kintake, 2006, V24, P657; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; Vavilin D, 2007, J BIOL CHEM, V282, P37660, DOI 10.1074/jbc.M707133200; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	48	44	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					682	692		10.1074/jbc.M111.320994	http://dx.doi.org/10.1074/jbc.M111.320994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090028	Green Published, hybrid			2022-12-25	WOS:000298682400066
J	Wermuth, PJ; Addya, S; Jimenez, SA				Wermuth, Peter J.; Addya, Sankar; Jimenez, Sergio A.			Effect of Protein Kinase C delta (PKC-delta) Inhibition on the Transcriptome of Normal and Systemic Sclerosis Human Dermal Fibroblasts In Vitro	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; GROWTH-FACTOR; CYTOKINE; CLASSIFICATION; LOCALIZATION; STIMULATION; FIBRONECTIN; SIGNATURES; ROTTLERIN	Previous studies demonstrated that protein kinase C-delta (PKC-delta) inhibition with the selective inhibitor, rottlerin, resulted in potent downregulation of type I collagen expression and production in normal human dermal fibroblasts and abrogated the exaggerated type I collagen production and expression in fibroblasts cultured from affected skin from patients with the fibrosing disorder systemic sclerosis (SSc). To elucidate the mechanisms involved in the ability of PKC-delta to regulate collagen production in fibroblasts, we examined the effects of PKC-delta inhibition on the transcriptome of normal and SSc human dermal fibroblasts. Normal and SSc human dermal fibroblasts were incubated with rottlerin (5 mu M), and their gene expression was analyzed by microarrays. Pathway analysis and gene ontology analysis of differentially expressed genes in each comparison were performed. Identification of significantly overrepresented transcriptional regulatory elements (TREs) was performed using the Promoter Analysis and Interaction Network Toolset (PAINT) program. PKC-delta activity was also inhibited using RNA interference (siRNA) and by treating fibroblasts with a specific PKC-delta inhibitory cell permeable peptide. Differential gene expression of 20 genes was confirmed using real time PCR. PKC-delta inhibition caused a profound change in the transcriptome of normal and SSc human dermal fibroblasts in vitro. Pathway and gene ontology analysis identified multiple cellular and organismal pathways affected by PKC-delta inhibition. Furthermore, both pathway and PAINT analyses indicated that the transcription factor NFkB played an important role in the transcriptome changes induced by PKC-delta inhibition. Multiple genes involved in the degradation of the extracellular matrix components were significantly reduced in SSc fibroblasts and their expression was increased by PKC-delta inhibition. These results indicate that isoform-specific inhibition of PKC-delta profibrotic effects may represent a novel therapeutic approach for SSc and other fibrotic diseases.	[Wermuth, Peter J.; Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; [Addya, Sankar] Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Wermuth, PJ (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.	sergio.jimenez@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Jimenez, Sergio/0000-0001-5213-1203	National Institutes of Health (NIH) [RO1 AR-019616]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [T-32 AR007583-15]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR019616, T32AR007583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant RO1 AR-019616 to SAJ. PJW was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Training Grant T-32 AR007583-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; CARPENTER D, 1987, NATURE, V325, P107, DOI 10.1038/325107a0; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; ESMON NL, 1983, J BIOL CHEM, V258, P2238; Fruchtman S, 2005, AM J PHYSIOL-GASTR L, V289, pG342, DOI 10.1152/ajpgi.00413.2004; Fuzii HT, 2008, CLIN EXP RHEUMATOL, V26, P866; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Iwata Y, 2009, J RHEUMATOL, V36, P976, DOI 10.3899/jrheum.080343; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; KIKKAWA U, 1987, FEBS LETT, V223, P212, DOI 10.1016/0014-5793(87)80291-0; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; LEROY EC, 1988, J RHEUMATOL, V15, P202; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Mochly-Rosen D, 1998, FASEB J, V12, P35; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; Newton Alexandra C, 2003, Methods Mol Biol, V233, P3; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; SELLERS A, 1981, INT REV CONNECT TISS, V9, P151; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Tan FK, 2005, ARTHRITIS RHEUM-US, V52, P865, DOI 10.1002/art.20871; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Vallee S, 2004, EXP CELL RES, V297, P165, DOI 10.1016/j.yexcr.2004.03.007; VARGA J, 1987, BIOCHEM BIOPH RES CO, V147, P1282, DOI 10.1016/S0006-291X(87)80209-7; WANG N, 1994, J BIOL CHEM, V269, P29308; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Zhang YH, 2007, J IMMUNOL, V179, P3297, DOI 10.4049/jimmunol.179.5.3297; Zohlman A, 2008, FASEB J, V22	53	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27110	10.1371/journal.pone.0027110	http://dx.doi.org/10.1371/journal.pone.0027110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096525	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900022
J	Tebruegge, M; Pantazidou, A; Clifford, V; Gonis, G; Ritz, N; Connell, T; Curtis, N				Tebruegge, Marc; Pantazidou, Anastasia; Clifford, Vanessa; Gonis, Gena; Ritz, Nicole; Connell, Tom; Curtis, Nigel			The Age-Related Risk of Co-Existing Meningitis in Children with Urinary Tract Infection	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PLEOCYTOSIS; ACUTE BACTERIAL-MENINGITIS; YOUNG INFANTS; FEBRILE INFANTS; ASEPTIC-MENINGITIS; BACTEREMIA	Objective: The primary aim of this study was to determine age-stratified rates of co-existing bacterial meningitis in children with urinary tract infection (UTI). The secondary aims of this study were to determine the causative pathogens of UTI, and the clinical features and outcome of children with co-existing meningitis. Methods: Analysis of data collected over a nine-year period at a tertiary pediatric hospital in Australia. Study population: children below 16 years of age with culture-confirmed UTI and a paired CSF sample. Results: A total of 748 episodes in 735 cases were included in the final analysis. The commonest pathogens causing UTI were Escherichia coli (67.4%), Enterococcus faecalis (8.4%), Klebsiella oxytoca (3.5%) and Klebsiella pneumoniae (3.5%). Only two (1.2%; 95% CI: 0.15-4.36%) of 163 neonates (between 0 and 28 days of age) with UTI had co-existing meningitis. Both presented with pyrexia, irritability and lethargy, and recovered uneventfully with antibiotic treatment. There were no cases of co-existing meningitis among 499 infants (between 29 days and 12 months of age) with UTI (95% CI: 0.00-0.74%), or any of the 86 children aged 12 months or over (95% CI: 0.00-4.20%). Conclusions: These findings indicate that clinicians should have a low threshold to perform a lumbar puncture in neonates with UTI, as the risk of co-existing meningitis is not insignificant in this age group. In contrast, beyond the neonatal period, the risk is small and a more selective approach is warranted.	[Tebruegge, Marc; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Tebruegge, Marc; Pantazidou, Anastasia; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic, Australia; [Tebruegge, Marc; Clifford, Vanessa; Ritz, Nicole; Connell, Tom; Curtis, Nigel] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Clifford, Vanessa; Gonis, Gena] Royal Childrens Hosp Melbourne, Dept Microbiol, Parkville, Vic, Australia	University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Tebruegge, M (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	marc.tebruegge@rch.org.au	Ritz, Nicole/L-1452-2019; Curtis, Nigel/B-3491-2012; Ritz, Nicole/G-2924-2015	Ritz, Nicole/0000-0002-1498-1685; Curtis, Nigel/0000-0003-3446-4594; Ritz, Nicole/0000-0002-1498-1685; Clifford, Vanessa/0000-0001-9758-867X	European Society for Paediatric Infectious Diseases; University of Melbourne; National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	European Society for Paediatric Infectious Diseases; University of Melbourne(University of Melbourne); National Institute for Health Research(National Institute for Health Research (NIHR))	No external funding was received for this study. MT and NR were supported by Fellowship awards from the European Society for Paediatric Infectious Diseases and International Research Scholarships provided by the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Shohet FC, 2003, PEDIATR INFECT DIS J, V22, P1039, DOI 10.1097/01.inf.0000100576.99266.07; [Anonymous], 2004, Paediatr Child Health, V9, P377; BACHUR R, 1995, PEDIATR EMERG CARE, V11, P280, DOI 10.1097/00006565-199510000-00004; BATNITZKY S, 1977, JAMA-J AM MED ASSOC, V237, P148, DOI 10.1001/jama.237.2.148; Bergman DA, 1999, PEDIATRICS, V103, P843; BERGSTRO.T, 1972, J PEDIATR-US, V80, P858; Bonsu Bema K, 2007, BMC Pediatr, V7, P24, DOI 10.1186/1471-2431-7-24; Connell T, 2005, ADV EXP MED BIOL, V568, P199; Dayan PS, 2004, PEDIATR EMERG CARE, V20, P85, DOI 10.1097/01.pec.0000113876.10140.9b; DELOUVOIS J, 1994, J ANTIMICROB CHEMOTH, V34, P61, DOI 10.1093/jac/34.suppl_A.61; ERICKSON RC, 1989, DIAGN MICR INFEC DIS, V12, P235, DOI 10.1016/0732-8893(89)90020-5; Finkelstein Y, 2001, PEDIATR INFECT DIS J, V20, P630, DOI 10.1097/00006454-200106000-00019; GINSBURG CM, 1982, PEDIATRICS, V69, P409; Goldman Ran D, 2003, CJEM, V5, P394; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Heath PT, 2003, ARCH DIS CHILD-FETAL, V88, P173; Hoberman A, 1997, PEDIATR INFECT DIS J, V16, P11, DOI 10.1097/00006454-199701000-00004; Honkinen O, 2000, PEDIATR INFECT DIS J, V19, P630, DOI 10.1097/00006454-200007000-00009; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; Joffe Ari R, 2007, J Intensive Care Med, V22, P194, DOI 10.1177/0885066607299516; Kestenbaum LA, 2010, PEDIATRICS, V125, P257, DOI 10.1542/peds.2009-1181; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Lin DS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e20; Magin EC, 2007, PEDIATR EMERG CARE, V23, P83, DOI 10.1097/PEC.0b013e3180302c47; National Institute for Health and Clinical Excellence UK, 2007, CLIN GUID UR TRACT I; Schnadower D, 2010, PEDIATRICS, V126, P1074, DOI 10.1542/peds.2010-0479; Shah SS, 2008, J PEDIATR, V153, P290, DOI 10.1016/j.jpeds.2008.02.044; Syrogiannopoulos GA, 2001, PEDIATR INFECT DIS J, V20, P927, DOI 10.1097/00006454-200110000-00003; Tebruegge M, 2011, ARCH DIS CHILD, V96, DOI 10.1136/adc.2011.215277; TEELE DW, 1981, NEW ENGL J MED, V305, P1079, DOI 10.1056/NEJM198110293051810; Vuillermin PJ, 2007, EMERG MED AUSTRALAS, V19, P464, DOI 10.1111/j.1742-6723.2007.01001.x; Wang Sue-Fan, 1994, Acta Paediatrica Sinica, V35, P294; Yam AOW, 2009, J PAEDIATR CHILD H, V45, P364, DOI 10.1111/j.1440-1754.2009.01502.x	33	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26576	10.1371/journal.pone.0026576	http://dx.doi.org/10.1371/journal.pone.0026576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096488	Green Published, gold, Green Accepted			2022-12-25	WOS:000297350800009
J	Marfe, G; Tafani, M; Fiorito, F; Pagnini, U; Iovane, G; De Martino, L				Marfe, Gabriella; Tafani, Marco; Fiorito, Filomena; Pagnini, Ugo; Iovane, Giuseppe; De Martino, Luisa			Involvement of FOXO Transcription Factors, TRAIL-FasL/Fas, and Sirtuin Proteins Family in Canine Coronavirus Type II-Induced Apoptosis	PLOS ONE			English	Article							CALORIE RESTRICTION; TNF SUPERFAMILY; SIR2 HOMOLOG; CELL-DEATH; DEACETYLASE; BIM; MITOCHONDRIA; EXPRESSION; RECEPTORS; BAX	In our previous study, we have shown that canine coronavirus type II (CCoV-II) activates both extrinsic and intrinsic apoptotic pathway in a canine fibrosarcoma cell line (A-72 cells). Herein we investigated the role of Sirtuin and Forkhead box O (FOXO) families in this experimental model using Nortern Blot and Western Blot analysis. Our results demonstrated that mitochondrial SIRT3 and SIRT4 protein expression increased from 12 and 24 h post infection (p.i.) onwards, respectively, whereas the nuclear SIRT1 expression increased during the first 12 h p.i. followed by a decrease after 36 h p.i., reaching the same level of control at 48 h p.i. Sirtuins interact with/and regulate the activity of FOXO family proteins, and we herein observed that FOXO3A and FOXO1 expression increased significantly and stably from 12 h p.i. onwards. In addition, CCoV-II induces a remarkable increase in the expression of TNF-related apoptosis-inducing ligand (TRAIL), while we observed a slight up-regulation of FasL/Fas at 36 p.i. with a decrease of both proteins at the end of infection. Furthermore, we found that virus infection increased both bax translocation into mitochondria and decreased bcl-2 expression in cytosol in a time-dependent manner. These data suggest that FOXO transcription factors mediate pro-apoptotic effects of CCoV-II, in part due to activation of extrinsic apoptosis pathway, while some Sirtuin family members (such as SIRT3 and SIRT4) may be involved in intrinsic apoptotic pathway. Moreover, these results propose that TRAIL is an important mediator of cell death induced by CCoV-II during in vitro infection.	[Marfe, Gabriella] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Tafani, Marco] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy; [Fiorito, Filomena; Pagnini, Ugo; Iovane, Giuseppe; De Martino, Luisa] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy	University of Rome Tor Vergata; IRCCS San Raffaele Pisana; University of Naples Federico II	Marfe, G (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy.	filomena.fiorito@unina.it	Fiorito, Filomena/O-2175-2016; Tafani, Marco/C-3275-2017; Tafani, Marco/U-7230-2019	Fiorito, Filomena/0000-0002-6658-7807; Tafani, Marco/0000-0001-7128-810X; Tafani, Marco/0000-0001-7128-810X	Ministry of Education, University and Research, Italy [2005071441_002]	Ministry of Education, University and Research, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants of Ministry of Education, University and Research, Italy (Prot. 2005071441_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; De Martino L, 2010, VET MICROBIOL, V141, P36, DOI 10.1016/j.vetmic.2009.09.001; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Law HKW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-35; Li W, 2003, AM J PHYSIOL-HEART C, V284, pH23, DOI 10.1152/ajpheart.00240.2002; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Pratelli A, 2004, J CLIN MICROBIOL, V42, P1797, DOI 10.1128/JCM.42.4.1797-1799.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ruggieri A, 2007, VET MICROBIOL, V121, P64, DOI 10.1016/j.vetmic.2006.12.016; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; WANG F, 2006, AGING CELL, V5, P630; Wendt J, 2005, ONCOGENE, V24, P4052, DOI 10.1038/sj.onc.1208580; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358	42	31	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27313	10.1371/journal.pone.0027313	http://dx.doi.org/10.1371/journal.pone.0027313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087287	Green Published, Green Submitted, gold			2022-12-25	WOS:000297349700030
J	Walshe, DP; Lehane, MJ; Haines, LR				Walshe, Deirdre P.; Lehane, Michael J.; Haines, Lee R.			Post Eclosion Age Predicts the Prevalence of Midgut Trypanosome Infections in Glossina	PLOS ONE			English	Article							MORSITANS-MORSITANS DIPTERA; TSETSE-FLIES; BRUCEI-RHODESIENSE; AFRICAN TRYPANOSOMES; PERITROPHIC MEMBRANE; CONGOLENSE; FLY; SUSCEPTIBILITY; FORMS; IDENTIFICATION	The teneral phenomenon, as observed in Glossina sp., refers to the increased susceptibility of the fly to trypanosome infection when the first bloodmeal taken is trypanosome-infected. In recent years, the term teneral has gradually become synonymous with unfed, and thus fails to consider the age of the newly emerged fly at the time the first bloodmeal is taken. Furthermore, conflicting evidence exists of the effect of the age of the teneral fly post eclosion when it is given the infected first bloodmeal in determining the infection prevalence. This study demonstrates that it is not the feeding history of the fly but rather the age (hours after eclosion of the fly from the puparium) of the fly when it takes the first (infective) bloodmeal that determines the level of fly susceptibility to trypanosome infection. We examine this phenomenon in male and female flies from two distinct tsetse clades (Glossina morsitans morsitans and Glossina palpalis palpalis) infected with two salivarian trypanosome species, Trypanosoma (Trypanozoon) brucei brucei and Trypanosoma (Nannomonas) congolense using Fisher's exact test to examine differences in infection rates. Teneral tsetse aged less than 24 hours post-eclosion (h. p. e.) are twice as susceptible to trypanosome infection as flies aged 48 h. p. e. This trend is conserved across sex, vector clade and parasite species. The life cycle stage of the parasite fed to the fly (mammalian versus insect form trypanosomes) does not alter this age-related bias in infection. Reducing the numbers of parasites fed to 48 h. p. e., but not to 24 h. p. e. flies, increases teneral refractoriness. The importance of this phenomenon in disease biology in the field as well as the necessity of employing flies of consistent age in laboratory-based infection studies is discussed.	[Walshe, Deirdre P.; Lehane, Michael J.; Haines, Lee R.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Walshe, DP (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	m.j.lehane@liv.ac.uk	Walshe, Deirdre/AAD-7716-2019; Haines, Lee/K-9264-2017	Walshe, Deirdre/0000-0001-5531-2368; Haines, Lee/0000-0001-8821-6479	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoda K, 2009, J MED ENTOMOL, V46, P1446, DOI 10.1603/033.046.0629; Akoda K, 2009, MED VET ENTOMOL, V23, P195, DOI 10.1111/j.1365-2915.2009.00799.x; ANDERSON M, 1973, J INSECT PHYSIOL, V19, P1989, DOI 10.1016/0022-1910(73)90193-5; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; BRUN R, 1979, ACTA TROP, V36, P289; BURTT E, 1946, ANN TROP MED PARASIT, V40, P18, DOI 10.1080/00034983.1946.11685259; DISTELMANS W, 1982, ANN SOC BELG MED TR, V62, P41; ELLIS DS, 1977, NATURE, V267, P834, DOI 10.1038/267834a0; EVANS DA, 1979, J PROTOZOOL, V26, P425, DOI 10.1111/j.1550-7408.1979.tb04648.x; Fairbairn H., 1950, Acta Tropica, V7, P19; FERRANTE A, 1983, PARASITE IMMUNOL, V5, P491, DOI 10.1111/j.1365-3024.1983.tb00763.x; FISH WR, 1989, BIOCHEMISTRY-US, V28, P5415, DOI 10.1021/bi00439a015; GINGRICH JB, 1982, T ROY SOC TROP MED H, V76, P479, DOI 10.1016/0035-9203(82)90142-0; GINGRICH JB, 1982, J MED ENTOMOL, V19, P268, DOI 10.1093/jmedent/19.3.268; GINGRICH JB, 1985, AM J TROP MED HYG, V34, P73, DOI 10.4269/ajtmh.1985.34.73; Haddow JD, 2002, INSECT BIOCHEM MOLEC, V32, P1045, DOI 10.1016/S0965-1748(02)00042-5; Haddow JD, 2004, THESIS U VICTORIA VI; Hao ZG, 2002, INSECT BIOCHEM MOLEC, V32, P1663, DOI 10.1016/S0965-1748(02)00106-6; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HARLEY JMB, 1966, B ENTOMOL RES, V56, P595, DOI 10.1017/S0007485300056613; HARLEY JMB, 1971, ANN TROP MED PARASIT, V65, P191, DOI 10.1080/00034983.1971.11686745; Hoof L.van, 1937, Annales de la Societe Belge de Medecine Tropicale, V17, P249; Hu YJ, 2005, INSECT BIOCHEM MOLEC, V35, P105, DOI 10.1016/j.ibmb.2004.10.007; JACKSON CHN, 1946, B ENTOMOL RES, V37, P291, DOI 10.1017/S0007485300022203; Kubi C, 2007, ONDERSTEPOORT J VET, V74, P223; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; LEHANE MJ, 1991, MED VET ENTOMOL, V5, P495, DOI 10.1111/j.1365-2915.1991.tb00578.x; MAKUMYAVIRI AM, 1984, ANN SOC BELG MED TR, V64, P365; Maudlin I., 1991, Advances in Disease Vector Research, V7, P117; MAUDLIN I, 1989, ANN TROP MED PARASIT, V83, P431, DOI 10.1080/00034983.1989.11812368; MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021; MOLOO SK, 1994, MED VET ENTOMOL, V8, P225, DOI 10.1111/j.1365-2915.1994.tb00503.x; MOSSER DM, 1982, EXP PARASITOL, V54, P310, DOI 10.1016/0014-4894(82)90040-6; Msangi AR, 1998, ACTA TROP, V70, P143, DOI 10.1016/S0001-706X(98)00013-8; MWANGELWA MI, 1987, INSECT SCI APPL, V8, P33, DOI 10.1017/S1742758400006913; OTIENO LH, 1983, ACTA TROP, V40, P113; PAGE W A, 1972, Tropical Animal Health and Production, V4, P41, DOI 10.1007/BF02357093; PAINDAVOINE P, 1986, PARASITOLOGY, V92, P31, DOI 10.1017/S0031182000063435; Rio RVM, 2006, P ROY SOC B-BIOL SCI, V273, P805, DOI 10.1098/rspb.2005.3399; Robertson M, 1913, PHILOS T R SOC LON B, V203, P161, DOI 10.1098/rstb.1913.0005; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Walshe DP, 2009, ADV INSECT PHYSIOL, V37, P119, DOI 10.1016/S0065-2806(09)37003-4; WELBURN SC, 1992, ANN TROP MED PARASIT, V86, P529, DOI 10.1080/00034983.1992.11812703; Wijers D. J. B., 1960, Annals of Tropical Medicine and Parasitology, V54, P341; WIJERS D. J. B., 1958, ANN TROP MED AND PARASITOL, V52, P385; Woolhouse MEJ, 1998, PARASITOLOGY, V116, P149, DOI 10.1017/S0031182097002047; YOUNG CJ, 1983, ANN TROP MED PARASIT, V77, P467, DOI 10.1080/00034983.1983.11811740	49	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e26984	10.1371/journal.pone.0026984	http://dx.doi.org/10.1371/journal.pone.0026984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087240	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000297349700012
J	Fabregat-Andres, O; Tierrez, A; Mata, M; Estornell-Erill, J; Ridocci-Soriano, F; Monsalve, M				Fabregat-Andres, Oscar; Tierrez, Alberto; Mata, Manuel; Estornell-Erill, Jordi; Ridocci-Soriano, Francisco; Monsalve, Maria			Induction of PGC-1 alpha Expression Can Be Detected in Blood Samples of Patients with ST-Segment Elevation Acute Myocardial Infarction	PLOS ONE			English	Article							RECEPTOR-GAMMA AGONIST; MITOCHONDRIAL BIOGENESIS; HEART-FAILURE; PIOGLITAZONE; ACTIVATION; MECHANISMS; GUIDELINES; UPDATE; MICE	Following acute myocardial infarction (MI), cardiomyocyte survival depends on its mitochondrial oxidative capacity. Cell death is normally followed by activation of the immune system. Peroxisome proliferator activated receptor gamma-coactivator 1 alpha (PGC-1 alpha) is a transcriptional coactivator and a master regulator of cardiac oxidative metabolism. PGC-1 alpha is induced by hypoxia and facilitates the recovery of the contractile capacity of the cardiac muscle following an artery ligation procedure. We hypothesized that PGC-1 alpha activity could serve as a good molecular marker of cardiac recovery after a coronary event. The objective of the present study was to monitor the levels of PGC-1 alpha following an ST-segment elevation acute myocardial infarction (STEMI) episode in blood samples of the affected patients. Analysis of blood mononuclear cells from human patients following an STEMI showed that PGC-1 alpha expression was increased and the level of induction correlated with the infarct size. Infarct size was determined by LGE-CMR (late gadolinium enhancement on cardiac magnetic resonance), used to estimate the percentage of necrotic area. Cardiac markers, maximum creatine kinase (CK-MB) and Troponin I (TnI) levels, left ventricular ejection function (LVEF) and regional wall motion abnormalities (RWMA) as determined by echocardiography were also used to monitor cardiac injury. We also found that PGC-1 alpha is present and active in mouse lymphocytes where its expression is induced upon activation and can be detected in the nuclear fraction of blood samples. These results support the notion that induction of PGC-1 alpha expression can be part of the recovery response to an STEMI and could serve as a prognosis factor of cardiac recovery.	[Fabregat-Andres, Oscar; Ridocci-Soriano, Francisco] Consorcio Hosp Gen Univ Valencia, Serv Cardiol, Valencia, Spain; [Tierrez, Alberto; Monsalve, Maria] Fdn Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Mata, Manuel] Fdn Hosp Gen Valencia, Valencia, Spain; [Estornell-Erill, Jordi] Consorcio Hosp Gen Univ Valencia, Unidad TAC & RMN, Valencia, Spain; [Monsalve, Maria] CSIC, Inst Invest Biol Alberto Sols, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Fabregat-Andres, O (corresponding author), Consorcio Hosp Gen Univ Valencia, Serv Cardiol, Valencia, Spain.	mpmonsalve@iib.uam.es	Morcillo, Esteban/I-1552-2015; Roig, Manuel Mata/G-4338-2015; Monsalve, Maria/K-4416-2014	Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Monsalve, Maria/0000-0003-2796-1453	Spanish Ministry of Science and Innovation [SAF2009-07599, CSD 2007-00020]; Juan de la Cierva postdoctoral; Fundacion Investigacion CHGUV; Spanish Cardiology Society; Pro-CNIC Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva postdoctoral; Fundacion Investigacion CHGUV; Spanish Cardiology Society; Pro-CNIC Foundation	This work was supported by the Spanish Ministry of Science and Innovation (http://www.micinn.es/) (grants SAF2009-07599 and CSD 2007-00020 to M.M.); a Juan de la Cierva postdoctoral contract to A.T.; two Intramural grants ("Beca de investigacion Intramural"), years 2008 and 2010, from the Fundacion Investigacion CHGUV (http://chguv.san.gva.es/Inicio/Paginas/default.aspx); and a "Beca para Proyecto de Investigacion Basica en Cardiologia, 2010" grant from the Spanish Cardiology Society (http://www.secardiologia.es/). The Centro Nacional de Investigaciones Cardiovasculares (CNIC) (http://www.cnic.es/es/index.php) is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bodi V, 2008, AM HEART J, V156, P1065, DOI 10.1016/j.ahj.2008.07.008; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Garcia C, 2010, DIABETES METAB, V36, P327, DOI 10.1016/j.diabet.2010.07.001; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Honda T, 2008, J MOL CELL CARDIOL, V44, P915, DOI 10.1016/j.yjmcc.2008.03.004; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ortolani P, 2008, EUR HEART J, V29, P1241, DOI 10.1093/eurheartj/ehm338; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Rohini A, PHARM RES, V61, P269; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Sun CK, 2007, INT HEART J, V48, P533, DOI 10.1536/ihj.48.533; Swedberg K, 2005, REV ESP CARDIOL, V58, P1062, DOI 10.1157/13078554; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Van de Werf F, 2009, REV ESP CARDIOL, V62, P293, DOI 10.1016/S1885-5857(09)71559-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yasuda S, 2009, CIRC J, V73, P2000, DOI 10.1253/circj.CJ-09-0655; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26913	10.1371/journal.pone.0026913	http://dx.doi.org/10.1371/journal.pone.0026913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087236	gold, Green Published, Green Submitted			2022-12-25	WOS:000297347700011
J	Gilchrist, CL; Darling, EM; Chen, J; Setton, LA				Gilchrist, Christopher L.; Darling, Eric M.; Chen, Jun; Setton, Lori A.			Extracellular Matrix Ligand and Stiffness Modulate Immature Nucleus Pulposus Cell-Cell Interactions	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; MAMMARY EPITHELIAL-CELLS; PROTEIN GENE-EXPRESSION; BASEMENT-MEMBRANE; NOTOCHORDAL CELLS; VISCOELASTIC PROPERTIES; PROTEOGLYCAN SYNTHESIS; STEM-CELLS; SUBSTRATE; DEGENERATION	The nucleus pulposus (NP) of the intervertebral disc functions to provide compressive load support in the spine, and contains cells that play a critical role in the generation and maintenance of this tissue. The NP cell population undergoes significant morphological and phenotypic changes during maturation and aging, transitioning from large, vacuolated immature cells arranged in cell clusters to a sparse population of smaller, isolated chondrocyte-like cells. These morphological and organizational changes appear to correlate with the first signs of degenerative changes within the intervertebral disc. The extracellular matrix of the immature NP is a soft, gelatinous material containing multiple laminin isoforms, features that are unique to the NP relative to other regions of the disc and that change with aging and degeneration. Based on this knowledge, we hypothesized that a soft, laminin-rich extracellular matrix environment would promote NP cell-cell interactions and phenotypes similar to those found in immature NP tissues. NP cells were isolated from porcine intervertebral discs and cultured in matrix environments of varying mechanical stiffness that were functionalized with various matrix ligands; cellular responses to periods of culture were assessed using quantitative measures of cell organization and phenotype. Results show that soft (<720 Pa), laminin-containing extracellular matrix substrates promote NP cell morphologies, cell-cell interactions, and proteoglycan production in vitro, and that this behavior is dependent upon both extracellular matrix ligand and substrate mechanical properties. These findings indicate that NP cell organization and phenotype may be highly sensitive to their surrounding extracellular matrix environment.	[Gilchrist, Christopher L.; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Darling, Eric M.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA; [Darling, Eric M.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Brown University; Brown University; Brown University; Duke University	Gilchrist, CL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	lori.setton@duke.edu	Darling, Eric/K-2529-2013	Darling, Eric/0000-0002-3932-8623; Setton, Lori/0000-0001-5992-4206	National Intitutes of Health (NIH) [AR054673, R01EB002263, R01AR047442, R01AR057410]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054673, R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	National Intitutes of Health (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Intitutes of Health (NIH) (AR054673 (Dr. Darling), R01EB002263, R01AR047442, and R01AR057410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1966, J CELL BIOL, V28, P473, DOI 10.1083/jcb.28.3.473; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; BASELGA J, 1987, MACROMOLECULES, V20, P3060, DOI 10.1021/ma00178a020; BAYLISS MT, 1988, SPINE, V13, P972, DOI 10.1097/00007632-198809000-00003; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Cao L, 2007, J ANAT, V211, P444, DOI 10.1111/j.1469-7580.2007.00784.x; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; CLOYD JM, 2007, EUR SPINE J; COTTEN A, 1994, SURG RADIOL ANAT, V16, P53, DOI 10.1007/BF01627921; Darling EM, 2005, TISSUE ENG, V11, P395, DOI 10.1089/ten.2005.11.395; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd; Evans ND, 2009, EUR CELLS MATER, V18, P1; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; GOTO S, 1986, ACTA ORTHOP SCAND, V57, P85, DOI 10.3109/17453678608993224; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hayes AJ, 1999, DEV DYNAM, V215, P179, DOI 10.1002/(SICI)1097-0177(199907)215:3<179::AID-AJA1>3.3.CO;2-H; Hertz H., 1881, REINE ANGEW MATH, V171, P156; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Hunter CJ, 2003, J ANAT, V202, P279, DOI 10.1046/j.1469-7580.2003.00162.x; Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368; Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009; Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18; LEHTONEN E, 1995, DIFFERENTIATION, V59, P43, DOI 10.1046/j.1432-0436.1995.5910043.x; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x; Oegema TR, 2002, BIOCHEM SOC T, V30, P839, DOI 10.1042/bst0300839; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; RUFAI A, 1995, ANAT EMBRYOL, V192, P53; Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	64	74	74	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27170	10.1371/journal.pone.0027170	http://dx.doi.org/10.1371/journal.pone.0027170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087260	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700024
J	Enayetallah, AE; Ziemek, D; Leininger, MT; Randhawa, R; Yang, JX; Manion, TB; Mather, DE; Zavadoski, WJ; Kuhn, M; Treadway, JL; Etages, SAGD; Gibbs, EM; Greene, N; Steppan, CM				Enayetallah, Ahmed E.; Ziemek, Daniel; Leininger, Michael T.; Randhawa, Ranjit; Yang, Jianxin; Manion, Tara B.; Mather, Dawn E.; Zavadoski, William J.; Kuhn, Max; Treadway, Judith L.; Etages, Shelly Ann G. des; Gibbs, E. Michael; Greene, Nigel; Steppan, Claire M.			Modeling the Mechanism of Action of a DGAT1 Inhibitor Using a Causal Reasoning Platform	PLOS ONE			English	Article							GENE-EXPRESSION; DIACYLGLYCEROL ACYLTRANSFERASE-1; LEPTIN SENSITIVITY; INSULIN-RESISTANCE; FAT DIET; MICE; OBESITY; OVEREXPRESSION; IDENTIFICATION; DYSLIPIDEMIA	Triglyceride accumulation is associated with obesity and type 2 diabetes. Genetic disruption of diacylglycerol acyltransferase 1 (DGAT1), which catalyzes the final reaction of triglyceride synthesis, confers dramatic resistance to high-fat diet induced obesity. Hence, DGAT1 is considered a potential therapeutic target for treating obesity and related metabolic disorders. However, the molecular events shaping the mechanism of action of DGAT1 pharmacological inhibition have not been fully explored yet. Here, we investigate the metabolic molecular mechanisms induced in response to pharmacological inhibition of DGAT1 using a recently developed computational systems biology approach, the Causal Reasoning Engine (CRE). The CRE algorithm utilizes microarray transcriptomic data and causal statements derived from the biomedical literature to infer upstream molecular events driving these transcriptional changes. The inferred upstream events (also called hypotheses) are aggregated into biological models using a set of analytical tools that allow for evaluation and integration of the hypotheses in context of their supporting evidence. In comparison to gene ontology enrichment analysis which pointed to high-level changes in metabolic processes, the CRE results provide detailed molecular hypotheses to explain the measured transcriptional changes. CRE analysis of gene expression changes in high fat habituated rats treated with a potent and selective DGAT1 inhibitor demonstrate that the majority of transcriptomic changes support a metabolic network indicative of reversal of high fat diet effects that includes a number of molecular hypotheses such as PPARG, HNF4A and SREBPs. Finally, the CRE-generated molecular hypotheses from DGAT1 inhibitor treated rats were found to capture the major molecular characteristics of DGAT1 deficient mice, supporting a phenotype of decreased lipid and increased insulin sensitivity.	[Enayetallah, Ahmed E.; Greene, Nigel] Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA; [Ziemek, Daniel; Randhawa, Ranjit] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA USA; [Leininger, Michael T.; Yang, Jianxin; Manion, Tara B.; Mather, Dawn E.; Zavadoski, William J.; Kuhn, Max; Treadway, Judith L.; Etages, Shelly Ann G. des; Gibbs, E. Michael; Steppan, Claire M.] Pfizer Inc, Cardiovasc Metab & Endocrine Dis Res Unit, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Enayetallah, AE (corresponding author), Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA.	Ahmed.Enayetallah@pfizer.com	yang, jian/HIK-0188-2022	Randhawa, Ranjit/0000-0003-1516-7674; Kuhn, Max/0000-0003-2402-136X	Pfizer Inc.	Pfizer Inc.(Pfizer)	The authors have read the journal's policy and have the following conflicts: The work has been funded by Pfizer Inc. as part of DGAT1 therapeutic targeting program and the authors are/were paid employee of the funder, Pfizer Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; [Anonymous], 2010, R LANG ENV STAT COMP; Archer KJ, 2006, BIOSTATISTICS, V7, P198, DOI 10.1093/biostatistics/kxj001; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Becker W, 2004, J MOL ENDOCRINOL, V32, P195, DOI 10.1677/jme.0.0320195; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen HC, 2002, ENDOCRINOLOGY, V143, P2893, DOI 10.1210/en.143.8.2893; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Jain AK., 1988, TECHNOMETRICS; Jia YZ, 2003, J BIOL CHEM, V278, P47232, DOI 10.1074/jbc.M306363200; Kawakami A, 2009, J ATHEROSCLER THROMB, V16, P6, DOI 10.5551/jat.E607; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Pollard Jack Jr, 2005, Diabetes Technol Ther, V7, P323, DOI 10.1089/dia.2005.7.323; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Sayers E.W., NUCL ACIDS RES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Vallejo SJH, 2009, AM J PHYSIOL-GASTR L, V296, pG782, DOI 10.1152/ajpgi.90324.2008; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; [No title captured]; [No title captured]; [No title captured]	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27009	10.1371/journal.pone.0027009	http://dx.doi.org/10.1371/journal.pone.0027009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073239	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200028
J	Pechnick, RN; Zonis, S; Wawrowsky, K; Cosgayon, R; Farrokhi, C; Lacayo, L; Chesnokova, V				Pechnick, Robert N.; Zonis, Svetlana; Wawrowsky, Kolja; Cosgayon, Rosemarie; Farrokhi, Catherine; Lacayo, Liliana; Chesnokova, Vera			Antidepressants Stimulate Hippocampal Neurogenesis by Inhibiting p21 Expression in the Subgranular Zone of the Hipppocampus	PLOS ONE			English	Article							NEURAL STEM-CELLS; FORCED SWIMMING TEST; ANIMAL-MODEL; SYNAPTIC PLASTICITY; DENTATE GYRUS; FACTOR LIF; ADULT; DEPRESSION; APOPTOSIS; RAT	The relationships among hippocampal neurogenesis, depression and the mechanism of action of antidepressant drugs have generated a considerable amount of controversy. The cyclin-dependent kinase (Cdk) inhibitor p21(Cip1) (p21) plays a crucial role in restraining cellular proliferation and maintaining cellular quiescence. Using in vivo and in vitro approaches the present study shows that p21 is expressed in the subgranular zone of the dentate gyrus of the hippocampus in early neuronal progenitors and in immature neurons, but not in mature neurons or astroglia. In vitro, proliferation is higher in neuronal progenitor cells derived from p2-/- mice compared to cells derived from wild-type mice. Proliferation is increased in neuronal progenitor cells after suppression of p21 using lentivirus expressing short hairpin RNA against p21. In vivo, chronic treatment with the non-selective antidepressant imipramine as well as the norepinephrine-selective reuptake inhibitor desipramine or the serotonin-selective reuptake inhibitor fluoxetine all decrease p21 expression, and this was associated with increased neurogenesis. Chronic antidepressant treatment did not affect the expression of other Cdk inhibitors. Untreated p2-/- mice exhibit a higher degree of baseline neurogenesis and decreased immobility in the forced swim test. Although chronic imipramine treatment increased neurogenesis and reduced immobility in the forced swim test in wild-type mice, it reduced neurogenesis and increased immobility in p21/- mice. These results demonstrate the unique role of p21 in the control of neurogenesis, and support the hypothesis that different classes of reuptake inhibitor-type antidepressant drugs all stimulate hippocampal neurogenesis by inhibiting p21 expression.	[Pechnick, Robert N.; Farrokhi, Catherine; Lacayo, Liliana] Cedars Sinai Med Ctr, Dept Psychiat & Behav Neurosci, Los Angeles, CA 90048 USA; [Zonis, Svetlana; Wawrowsky, Kolja; Cosgayon, Rosemarie; Chesnokova, Vera] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol, Los Angeles, CA 90048 USA; [Pechnick, Robert N.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Pechnick, RN (corresponding author), Cedars Sinai Med Ctr, Dept Psychiat & Behav Neurosci, Los Angeles, CA 90048 USA.	chesnokovav@cshs.org	Chesnokova, Vera/AAI-4168-2020		National Institutes of Health [MH079988]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH079988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant MH079988 and NARSAD Independent Investigator Award (to V. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Benmansour S, 1999, J NEUROSCI, V19, P10494; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; CHESNOKOVA V, 2005, PITUITARY, V19, P2371; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dou Q. Ping, 1998, Frontiers in Bioscience, V3, pD419; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Frazer A, 2002, MOL PSYCHIATR, V7, pS23, DOI 10.1038/sj.mp.4001015; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gartel A L, 1998, Prog Mol Subcell Biol, V20, P43; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Krampert M, 2010, MOL CELL BIOL, V30, P3685, DOI 10.1128/MCB.00434-09; LI P, 2004, CELL, V116, P57; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Lucki I, 2001, PSYCHOPHARMACOLOGY, V153, P395, DOI 10.1007/s002130000561; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pechnick RN, 2006, PSYCHOPHARMACOLOGY, V185, P76, DOI 10.1007/s00213-005-0258-2; Pechnick RN, 2004, NEUROPSYCHOPHARMACOL, V29, P770, DOI 10.1038/sj.npp.1300402; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Piccotti JR, 2005, DRUG CHEM TOXICOL, V28, P117, DOI 10.1081/DCT-200039743; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Xia ZL, 1999, J BIOCHEM MOL TOXIC, V13, P338, DOI 10.1002/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.3.CO;2-Z; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	45	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27290	10.1371/journal.pone.0027290	http://dx.doi.org/10.1371/journal.pone.0027290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076148	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200062
J	Adam, E; Hussong, A; Bindics, J; Wust, F; Viczian, A; Essing, M; Medzihradszky, M; Kircher, S; Schafer, E; Nagy, F				Adam, Eva; Hussong, Andrea; Bindics, Janos; Wuest, Florian; Viczian, Andras; Essing, Marcus; Medzihradszky, Matyas; Kircher, Stefan; Schaefer, Eberhard; Nagy, Ferenc			Altered Dark- and Photoconversion of Phytochrome B Mediate Extreme Light Sensitivity and Loss of Photoreversibility of the phyB-401 Mutant	PLOS ONE			English	Article							PLANT PHOTORECEPTORS PHYTOCHROME; ARABIDOPSIS PHYTOCHROMES; DISTINCT FUNCTIONS; EID1; ELONGATION; DEPENDENCE; DYNAMICS; QUALITY; DOMAIN; GENE	The phyB-401 mutant is 10(3) fold more sensitive to red light than its wild-type analogue and shows loss of photoreversibility of hypocotyl growth inhibition. The phyB-401 photoreceptor displays normal spectral properties and shows almost no dark reversion when expressed in yeast cells. To gain insight into the molecular mechanism underlying this complex phenotype, we generated transgenic lines expressing the mutant and wild-type phyB in phyB-9 background. Analysis of these transgenic lines demonstrated that the mutant photoreceptor displays a reduced rate of dark-reversion but normal P-fr to P-r photoconversion in vivo and shows an altered pattern of association/dissociation with nuclear bodies compared to wild-type phyB. In addition we show (i) an enhanced responsiveness to far-red light for hypocotyl growth inhibition and CAB2 expression and (ii) that far-red light mediated photoreversibility of red light induced responses, including inhibition of hypocotyl growth, formation of nuclear bodies and induction of CAB2 expression is reduced in these transgenic lines. We hypothesize that the incomplete photoreversibility of signalling is due to the fact that far-red light induced photoconversion of the chromophore is at least partially uncoupled from the P-fr to P-r conformation change of the protein. It follows that the phyB-401 photoreceptor retains a P-fr-like structure (P-r*) for a few hours after the far-red light treatment. The greatly reduced rate of dark reversion and the formation of a biologically active P-r* conformer satisfactorily explain the complex phenotype of the phyB-401 mutant and suggest that amino acid residues surrounding the position 564 G play an important role in fine-tuning phyB signalling.	[Adam, Eva; Viczian, Andras; Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Hussong, Andrea; Bindics, Janos; Wuest, Florian; Essing, Marcus; Medzihradszky, Matyas; Kircher, Stefan; Schaefer, Eberhard] Univ Freiburg, Inst Biol Bot 2, Freiburg, Germany; [Schaefer, Eberhard] Univ Freiburg, Ctr Biol Signalling BIOSS, Freiburg, Germany; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Freiburg; University of Freiburg; University of Edinburgh	Adam, E (corresponding author), Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary.	nagyf@brc.hu	Viczián, András/D-3118-2015; Nagy, Ferenc/D-3532-2015	Viczián, András/0000-0003-2055-3430; Nagy, Ferenc/0000-0002-6157-9269; Kircher, Stefan/0000-0002-8351-567X; Wust, Florian/0000-0002-9941-5550	DFG [SFB592]; FRSYS; BIOSS; OTKA [81399]; SULSA	DFG(German Research Foundation (DFG)); FRSYS; BIOSS; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); SULSA	Work in Freiburg was supported by a grant of the DFG (SFB592) to ES, FN, and SK; and a grant from FRSYS and BIOSS to ES. Work in Szeged was supported by a grant from OTKA (81399) to FN, and work in Edinburgh was supported by a SULSA professorial grant to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Beggs CJ, 1994, PHOTOMORPHOGENESIS P, P733; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Buche C, 2000, PLANT CELL, V12, P547, DOI 10.1105/tpc.12.4.547; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; Eichenberg K, 1999, J BIOL CHEM, V274, P354, DOI 10.1074/jbc.274.1.354; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Furuya M, 1996, TRENDS PLANT SCI, V1, P301; Gross J, 1984, TECHNIQUES PHOTOMORP, P131; Hennig L, 1999, PLANT PHYSIOL, V121, P571, DOI 10.1104/pp.121.2.571; Hennig L, 1999, PLANTA, V208, P257, DOI 10.1007/s004250050557; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hirschfeld M, 1998, GENETICS, V149, P523; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; JABBEN M, 1982, PHOTOCHEM PHOTOBIOL, V35, P709, DOI 10.1111/j.1751-1097.1982.tb02634.x; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kretsch T, 2000, PLANT J, V22, P177, DOI 10.1046/j.1365-313x.2000.00715.x; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Livak KJ, 1997, USER B, P11; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; Oka Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000158; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rausenberger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010721; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; SCHAFER E, 1974, PLANTA, V116, P257, DOI 10.1007/BF00390231; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Zhou YC, 2002, PLANT PHYSIOL, V128, P1098, DOI 10.1104/pp.010811	43	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27250	10.1371/journal.pone.0027250	http://dx.doi.org/10.1371/journal.pone.0027250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073299	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000037
J	Falik, O; Mordoch, Y; Quansah, L; Fait, A; Novoplansky, A				Falik, Omer; Mordoch, Yonat; Quansah, Lydia; Fait, Aaron; Novoplansky, Ariel			Rumor Has It ... : Relay Communication of Stress Cues in Plants	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; ABSCISIC-ACID; INDUCED RESISTANCE; INDUCED VOLATILES; WATER-STRESS; HERBIVORY; DEFENSE; RECOGNITION; BEHAVIOR; ECOLOGY	Recent evidence demonstrates that plants are able not only to perceive and adaptively respond to external information but also to anticipate forthcoming hazards and stresses. Here, we tested the hypothesis that unstressed plants are able to respond to stress cues emitted from their abiotically-stressed neighbors and in turn induce stress responses in additional unstressed plants located further away from the stressed plants. Pisum sativum plants were subjected to drought while neighboring rows of five unstressed plants on both sides, with which they could exchange different cue combinations. On one side, the stressed plant and its unstressed neighbors did not share their rooting volumes (UNSHARED) and thus were limited to shoot communication. On its other side, the stressed plant shared one of its rooting volumes with its nearest unstressed neighbor and all plants shared their rooting volumes with their immediate neighbors (SHARED), allowing both root and shoot communication. Fifteen minutes following drought induction, significant stomatal closure was observed in both the stressed plants and their nearest unstressed SHARED neighbors, and within one hour, all SHARED neighbors closed their stomata. Stomatal closure was not observed in the UNSHARED neighbors. The results demonstrate that unstressed plants are able to perceive and respond to stress cues emitted by the roots of their drought-stressed neighbors and, via 'relay cuing', elicit stress responses in further unstressed plants. Further work is underway to study the underlying mechanisms of this new mode of plant communication and its possible adaptive implications for the anticipation of forthcoming abiotic stresses by plants.	[Falik, Omer; Mordoch, Yonat; Novoplansky, Ariel] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Quansah, Lydia; Fait, Aaron] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Dryland, Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel	Ben Gurion University; Ben Gurion University	Falik, O (corresponding author), Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel.	anovopla@bgu.ac.il	Fait, Aaron/M-2869-2015; Quansah, Lydia/GPK-6126-2022	Fait, Aaron/0000-0002-9073-8441; Novoplansky, Ariel/0000-0003-0988-786X	Israel Science foundation [341/04]	Israel Science foundation(Israel Science Foundation)	The study was partially funded by grant no. 341/04 from the Israel Science foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	APHALO PJ, 1995, FUNCT ECOL, V9, P5, DOI 10.2307/2390084; Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bruin J, 2001, BIOCHEM SYST ECOL, V29, P1103, DOI 10.1016/S0305-1978(01)00053-9; Callaway RM, 2007, NATURE, V448, P145, DOI 10.1038/448145a; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; CHEPLICK GP, 1993, ECOLOGY, V74, P2161, DOI 10.2307/1940860; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Conrath U, 2009, ADV BOT RES, V51, P361, DOI 10.1016/S0065-2296(09)51009-9; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P1075, DOI 10.1016/S0305-1978(01)00051-5; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gomez S, 2006, OECOLOGIA, V147, P461, DOI 10.1007/s00442-005-0293-z; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Griffin AS, 2005, ANIM BEHAV, V70, P507, DOI 10.1016/j.anbehav.2004.11.023; Haisel D, 2006, PHOTOSYNTHETICA, V44, P606, DOI 10.1007/s11099-006-0079-5; Hartung W, 2005, AUST J AGR RES, V56, P1253, DOI 10.1071/AR05065; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Herben T, 2008, EVOL ECOL, V22, P337, DOI 10.1007/s10682-007-9214-4; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kegge W, 2010, TRENDS PLANT SCI, V15, P126, DOI 10.1016/j.tplants.2009.11.007; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; SACHS T, 1993, ANN BOT-LONDON, V71, P237, DOI 10.1006/anbo.1993.1030; *SPSS INC, 2000, SYSTAT WIND VERS 10; Trewavas A, 2009, PLANT CELL ENVIRON, V32, P606, DOI 10.1111/j.1365-3040.2009.01929.x; Trouverie J, 2003, J EXP BOT, V54, P2177, DOI 10.1093/jxb/erg234; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Wu JS, 2008, PLANTA, V227, P1161, DOI 10.1007/s00425-008-0690-8	52	46	47	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e23625	10.1371/journal.pone.0023625	http://dx.doi.org/10.1371/journal.pone.0023625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073135	Green Published, gold			2022-12-25	WOS:000297154900013
J	Donnini, S; Finetti, F; Terzuoli, E; Giachetti, A; Iniguez, MA; Hanaka, H; Fresno, M; Radmark, O; Ziche, M				Donnini, S.; Finetti, F.; Terzuoli, E.; Giachetti, A.; Iniguez, M. A.; Hanaka, H.; Fresno, M.; Radmark, O.; Ziche, M.			EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity	ONCOGENE			English	Article						prostaglandinE-2; mPGES-1; epidermal growth factor; Egr-1; E-cadherin; vimentin	EPIDERMAL-GROWTH-FACTOR; TRANSCRIPTION FACTOR EGR-1; FACTOR-RECEPTOR; LUNG-CANCER; COLORECTAL ADENOMAS; KAPPA-B; ACTIVATION; E-2; GENE; CYCLOOXYGENASE-2	In this report we describe the contribution of prostaglandin E-2 (PGE(2)) derived from the inducible microsomal PGE-synthase type-1 (mPGES-1) to the epidermal growth factor receptor (EGFR) oncogenic drive in tumor epithelial cells and in tumor-bearing mice. EGFR stimulation upregulated expression of mPGES-1 in HT-29, A431 and A549 cancer cells. Egr-1, a transcription factor induced by EGF, mediated this response. The Egr-1 rise provoked the overexpression of mPGES-1 messenger and protein, and enhanced PGE(2) formation. These changes were suppressed either by silencing Egr-1, or by upstream blockade of EGFR or ERK1/2 signals. Further, in a clonogenic assay on tumor cells, EGF induced a florid tumorigenic phenotype, which regressed when mPGES-1 was silenced or knocked down. EGF-induced mPGES-1 overexpression in epithelial cell reduced E-cadherin expression, whereas enhancing that of vimentin, suggesting an incipient mesenchymal phenotype. Additionally, inhibiting the EGFR in mice bearing the A431 tumor, the mPGES-1 expression and the tumor growth, exhibited a parallel decline. In conclusion, these findings provide novel evidence that a tight cooperation between the EGF/EGFR and mPGES-1 leads to a significant tumorigenic gain in epithelial cells, and provide clues for controlling the vicious association. Oncogene (2012) 31, 3457-3466; doi:10.1038/onc.2011.503; published online 14 November 2011	[Donnini, S.; Finetti, F.; Terzuoli, E.; Giachetti, A.; Ziche, M.] Univ Siena, Dept Biotechnol, Pharmacol Sect, I-53100 Siena, Italy; [Donnini, S.; Finetti, F.; Terzuoli, E.; Giachetti, A.; Ziche, M.] ITT, Siena, Italy; [Iniguez, M. A.; Fresno, M.] Univ Autonoma Madrid, CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Hanaka, H.; Radmark, O.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	University of Siena; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Karolinska Institutet	Ziche, M (corresponding author), Univ Siena, Dept Biotechnol, Pharmacol Sect, Via Aldo Moro 2, I-53100 Siena, Italy.	ziche@unisi.it	Finetti, Federica/J-9089-2016; Donnini, Sandra/K-9252-2019; Peña, Miguel Angel Iñiguez/J-8518-2012; Terzuoli, Erika/M-7346-2016	Donnini, Sandra/0000-0001-6617-1644; Peña, Miguel Angel Iñiguez/0000-0001-8262-6119; Ziche, Marina/0000-0002-9564-214X; Terzuoli, Erika/0000-0001-9248-4505; Fresno Escudero, Manuel/0000-0002-9223-5477	Associazione Italiana della Ricerca sul Cancro (AIRC) [IG10731]; Istituto Toscano Tumori (ITT); Comunidad de Madrid [S-SAL2006/0015]; Ministerio de Ciencia e Innovacion [SAF2010-18733, BFU2010-21055]; Ministerio de Ciencia e Innovacion	Associazione Italiana della Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank Dr MD Diaz-Munoz for the construction of mPGES-1 plasmids. This work has received financial support from the Associazione Italiana della Ricerca sul Cancro (AIRC) IG10731 (MZ), Istituto Toscano Tumori (ITT) (SD), Comunidad de Madrid S-SAL2006/0015, Ministerio de Ciencia e Innovacion SAF2010-18733 (MF), Ministerio de Ciencia e Innovacion BFU2010-21055 (MAI).	Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cheng S, 2004, J BIOL CHEM, V279, P22057, DOI 10.1074/jbc.M402828200; Choe MS, 2005, MOL CANCER THER, V4, P1448, DOI 10.1158/1535-7163.MCT-04-0251; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Dasari A, 2010, CLIN CANCER RES, V16, P3811, DOI 10.1158/1078-0432.CCR-09-2283; Deckmann K, 2010, BIOCHEM PHARMACOL, V80, P1365, DOI 10.1016/j.bcp.2010.07.032; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Golijanin D, 2004, CLIN CANCER RES, V10, P1024, DOI 10.1158/1078-0432.CCR-1032-3; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Johns TG, 2002, INT J CANCER, V98, P398, DOI 10.1002/ijc.10189; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lu D, 2012, ONCOGENE, V31, P842, DOI 10.1038/onc.2011.287; Mann JR, 2006, CANCER RES, V66, P6649, DOI 10.1158/0008-5472.CAN-06-1787; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Nah SS, 2010, RHEUMATOL INT, V30, P443, DOI 10.1007/s00296-009-0976-6; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wiesner GL, 2001, J NATL CANCER I, V93, P635, DOI 10.1093/jnci/93.8.635; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P3971; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669	38	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	29					3457	3466		10.1038/onc.2011.503	http://dx.doi.org/10.1038/onc.2011.503			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	976FN	22081067	Green Accepted			2022-12-25	WOS:000306566400006
J	Schroder, S; Cho, SY; Zeng, L; Zhang, Q; Kaehlcke, K; Mak, L; Lau, J; Bisgrove, D; Schnolzer, M; Verdin, E; Zhou, MM; Ott, M				Schroeder, Sebastian; Cho, Sungyoo; Zeng, Lei; Zhang, Qiang; Kaehlcke, Katrin; Mak, Lily; Lau, Joann; Bisgrove, Dwayne; Schnoelzer, Martina; Verdin, Eric; Zhou, Ming-Ming; Ott, Melanie			Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TEFB; HIV-1 TAT; 7SK SNRNA; INTERACTING DOMAIN; BRD4; CHROMATIN; ACETYLATION; RECOGNITION; HEXIM1; EQUILIBRIUM	The positive transcription elongation factor b (P-TEFb) exists in two forms in cells as follows: an inactive form where the core components cyclin T1 and CDK9 are incorporated in the 7SK small nuclear ribonucleoprotein complex containing the inhibitory molecule HEXIM1, and an active form, part of which associates with the bromodomain-containing protein BRD4. Here, we define a novel interaction between P-TEFb and BRD4 involving tri-acetylated cyclin T1 (acK380, acK386, and acK309) and the second bromodomain in BRD4. This interaction is observed with the short splice variant of BRD4 (amino acids 1-722) lacking a previously defined C-terminal P-TEFb-interacting domain (PID). Notably, P-TEFb complexes associated with short BRD4 contain HEXIM1 and 7SK snRNA, implicating the PID in the liberation of P-TEFb from the 7SK small nuclear ribonucleoprotein complex (7SK snPNP). Overexpression of the PID alone in cells dissociates HEXIM1 and 7SK snRNA from P-TEFb, but it is not sufficient to activate P-TEFb-dependent transcription of the HIV LTR. Our data support a model where two BRD4 domains, the second bromodomain and the PID, bind P-TEFb and are required for full transcriptional activation of P-TEFb response genes.	[Schroeder, Sebastian; Cho, Sungyoo; Kaehlcke, Katrin; Mak, Lily; Lau, Joann; Bisgrove, Dwayne; Verdin, Eric; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Cho, Sungyoo; Verdin, Eric; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Zeng, Lei; Zhang, Qiang; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Helmholtz Association; German Cancer Research Center (DKFZ)	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R01 AI081651]; GIVI-UCSF Center for AIDS Research; Boehringer Ingelheim Fonds; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081651, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIVI-UCSF Center for AIDS Research; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI081651 (to M. O.). This work was also supported by the GIVI-UCSF Center for AIDS Research (to S. C.) and Boehringer Ingelheim Fonds (to S. S.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; French CA, 2003, CANCER RES, V63, P304; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urano E, 2008, FEBS LETT, V582, P4053, DOI 10.1016/j.febslet.2008.10.047; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	41	123	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1090	1099		10.1074/jbc.M111.282855	http://dx.doi.org/10.1074/jbc.M111.282855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084242	hybrid, Green Published			2022-12-25	WOS:000299170300025
J	Baek, JY; Han, SH; Sung, SH; Lee, HE; Kim, YM; Noh, H; Bae, SH; Rhee, SG; Chang, TS				Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin			Sulfiredoxin Protein Is Critical for Redox Balance and Survival of Cells Exposed to Low Steady-state Levels of H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; HYDROGEN-PEROXIDE; ACTIVE-SITE; INTRACELLULAR MESSENGER; OXIDATIVE STRESS; TARGET GENE; PEROXIREDOXIN; REDUCTION; INACTIVATION; MITOCHONDRIA	Sulfiredoxin (Srx) is an enzyme that catalyzes the reduction of cysteine sulfinic acid of hyperoxidized peroxiredoxins (Prxs). Having high affinity toward H2O2, 2-Cys Prxs can efficiently reduce H2O2 at low concentration. We previously showed that Prx I is hyperoxidized at a rate of 0.072% per turnover even in the presence of low steady-state levels of H2O2. Here we examine the novel role of Srx in cells exposed to low steady-state levels of H2O2, which can be achieved by using glucose oxidase. Exposure of low steady-state levels of H2O2 (10-20 mu M) to A549 or wild-type mouse embryonic fibroblast (MEF) cells does not lead to any significant change in oxidative injury because of the maintenance of balance between H2O2 production and elimination. In contrast, loss-of-function studies using Srx-depleted A549 and Srx(-/-) MEF cells demonstrate a dramatic increase in extra-and intracellular H2O2, sulfinic 2-Cys Prxs, and apoptosis. Concomitant with hyperoxidation of mitochondrial Prx III, Srx-depleted cells show an activation of mitochondria-mediated apoptotic pathways including mitochondria membrane potential collapse, cytochrome c release, and caspaseactivation. Furthermore, adenoviralre-expressionofSrxin Srx-depleted A549 or Srx(-/-) MEF cells promotes the reactivation of sulfinic 2-Cys Prxs and results in cellular resistance to apoptosis, with enhanced removal of H2O2. These results indicate that Srx functions as a novel component to maintain the balance between H2O2 production and elimination and then protects cells from apoptosis even in the presence of low steady-state levels of H2O2.	[Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Chang, TS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Sci Bldg C,Rm 208,52 Ewhayeodae Gil, Seoul 120750, South Korea.	changts@ewha.ac.kr			Bio RD Program [M10642040002-07N4204-00210]; National Core Research Center through the National Research Foundation of Korea [2011-0006244]; Korea government (Ministry of Education, Science and Technology (MEST)); Brain Korea 21 Scholars Program	Bio RD Program; National Core Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Education, Science and Technology (MEST))(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Bio R&D Program Grant M10642040002-07N4204-00210, National Core Research Center Program Grant 2011-0006244 through the National Research Foundation of Korea funded by the Korea government (Ministry of Education, Science and Technology (MEST)), and the Brain Korea 21 Scholars Program (to J. Y. B., S. H. H., and Y. H. N.).	Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flohe Leopold, 2007, V44, P1; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim H, 2010, J BIOL CHEM, V285, P34419, DOI 10.1074/jbc.M110.126839; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Suzuki YJ, 1999, J MOL CELL CARDIOL, V31, P345, DOI 10.1006/jmcc.1998.0872; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	32	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					81	89		10.1074/jbc.M111.316711	http://dx.doi.org/10.1074/jbc.M111.316711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086924	Green Published, hybrid			2022-12-25	WOS:000298682400011
J	Ding, J; Polier, G; Kohler, R; Giaisi, M; Krammer, PH; Li-Weber, M				Ding, Jie; Polier, Gernot; Koehler, Rebecca; Giaisi, Marco; Krammer, Peter H.; Li-Weber, Min			Wogonin and Related Natural Flavones Overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein Resistance of Tumors by Down-regulation of c-FLIP Protein and Up-regulation of TRAIL Receptor 2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; IN-VITRO; MEDIATED APOPTOSIS; GENE-EXPRESSION; TARGET; DEATH; P53; PATHWAY	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent that kills various tumor cells without damaging normal tissues. However, many cancers remain resistant to TRAIL. To overcome TRAIL resistance, combination therapies using sensitizers of the TRAIL pathway would be an efficacious approach. To investigate potential sensitizers of TRAIL-induced apoptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T cell leukemia/lymphoma (ATL) cells as a model system. So far, HTLV-1-associated ATL is incurable by presently known therapies. Here, we show that wogonin and the structurally related natural flavones apigenin and chrysin break TRAIL resistance in HTLV-1-associated ATL by transcriptional down-regulation of c-FLIP, a key inhibitor of death receptor signaling, and by up-regulation of TRAIL receptor 2 (TRAIL-R2). This effect is mediated through transcriptional inhibition of the p53 antagonist murine double minute 2(Mdm2), leading to an increase in p53 levels and, consequently, to up-regulation of the p53 target gene TRAIL-R2. We also show that these flavones can sensitize to TNF alpha- and CD95-mediated cell death. Furthermore, we show that wogonin, apigenin, and chrysin also enhance TRAIL-mediated apoptosis in other human cancer cell lines including breast cancer cell line MDA-MB-231, colon cancer cell line HT-29, hepatocellular carcinoma cell line HepG2, melanoma cell line SK-MEL-37, and pancreatic carcinoma cell line Capan-1 by the same mechanism. Thus, our study suggests the potential use of these flavones as an adjuvant for TRAIL-mediated anticancer therapy.	[Ding, Jie; Polier, Gernot; Koehler, Rebecca; Giaisi, Marco; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de			Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association	Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association	This work was supported by the Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association.	Baumann S, 2008, BLOOD, V111, P2354, DOI 10.1182/blood-2007-06-096198; Baumbusch LO, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-47; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chung HY, 2008, INT J CANCER, V122, P816, DOI 10.1002/ijc.23182; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gomes NP, 2010, GENE DEV, V24, P111, DOI 10.1101/gad.1893610; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MIYOSHI I, 1981, GANN, V72, P978; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Osman F, 2008, J VIROL METHODS, V154, P69, DOI 10.1016/j.jviromet.2008.09.005; Peng J, 2009, J ETHNOPHARMACOL, V124, P257, DOI 10.1016/j.jep.2009.04.031; Polier G, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.66; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Proksch P, 2005, J IMMUNOL, V174, P7075, DOI 10.4049/jimmunol.174.11.7075; Qi Q, 2009, PHYTOTHER RES, V23, P417, DOI 10.1002/ptr.2645; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; ROWE T, 1995, LEUKEMIA RES, V19, P621, DOI 10.1016/0145-2126(95)00030-R; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Sun MM, 2008, ONCOL REP, V19, P177; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wang W, 2006, BIOL PHARM BULL, V29, P1132, DOI 10.1248/bpb.29.1132; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Wuchter C, 2001, LEUKEMIA, V15, P921, DOI 10.1038/sj.leu.2402131; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7	44	67	73	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					641	649		10.1074/jbc.M111.286526	http://dx.doi.org/10.1074/jbc.M111.286526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086925	Green Published, hybrid			2022-12-25	WOS:000298682400062
J	Nanou, E; Martinez, GQ; Scheuer, T; Catterall, WA				Nanou, Evanthia; Martinez, Gilbert Q.; Scheuer, Todd; Catterall, William A.			Molecular Determinants of Modulation of Ca(V)2.1 Channels by Visinin-like Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC CALCIUM CURRENT; TERM SYNAPTIC PLASTICITY; CA2+ CHANNELS; RAT-BRAIN; NEUROTRANSMITTER RELEASE; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; BINDING PROTEIN-1; CALMODULIN; P/Q	CaV2.1 channels, which conduct P/Q-type Ca2+ currents, initiate synaptic transmission at most synapses in the central nervous system. Ca2+/calmodulin-dependent facilitation and inactivation of these channels contributes to short-term facilitation and depression of synaptic transmission, respectively. Other calcium sensor proteins displace calmodulin (CaM) from its binding site, differentially regulate Ca(V)2.1 channels, and contribute to the diversity of short-term synaptic plasticity. The neuronal calcium sensor protein visinin-like protein 2 (VILIP-2) inhibits inactivation and enhances facilitation of Ca(V)2.1 channels. Here we examine the molecular determinants for differential regulation of Ca(V)2.1 channels by VILIP-2 and CaM by construction and functional analysis of chimeras in which the functional domains of VILIP-2 are substituted in CaM. Our results show that the N-terminal domain, including its myristoylation site, the central alpha-helix, and the C-terminal lobe containing EF-hands 3 and 4 of VILIP-2 are sufficient to transfer its regulatory properties to CaM. This regulation by VILIP-2 requires binding to the IQ-like domain of Ca(V)2.1 channels. Our results identify the essential molecular determinants of differential regulation of Ca(V)2.1 channels by VILIP-2 and define the molecular code that these proteins use to control short-term synaptic plasticity.	[Nanou, Evanthia; Martinez, Gilbert Q.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu			National Institutes of Health [R01 NS22625]; Swedish Research Council [524-2010-913]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01 NS22625 (to W. A. C.). This work was also supported by Postdoctoral Fellowship 524-2010-913 from the Swedish Research Council (to E. N.).	Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Igarashi M, 2007, NEUROSCI RES, V58, P226, DOI 10.1016/j.neures.2007.03.005; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Leal K., 2010, 40 ANN M SAN DIEG CA; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; TANAKA O, 1995, MOL BRAIN RES, V30, P1, DOI 10.1016/0169-328X(94)00265-G; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					504	513		10.1074/jbc.M111.292581	http://dx.doi.org/10.1074/jbc.M111.292581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074920	Green Published, hybrid			2022-12-25	WOS:000298682400049
J	Gilbert, RS; Kobayashi, R; Sekine, S; Fujihashi, K				Gilbert, Rebekah S.; Kobayashi, Ryoki; Sekine, Shinichi; Fujihashi, Kohtaro			Functional Transforming Growth Factor-beta Receptor Type II Expression by CD4(+) T Cells in Peyer's Patches Is Essential for Oral Tolerance Induction	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TGF-BETA; IMMUNE-RESPONSES; FOXP3 EXPRESSION; FOOD ALLERGY; CUTTING EDGE; ABSENCE; SUPPRESSION; MICE	Our previous studies have shown that Peyer's patches (PPs) play a key role in the induction of oral tolerance. Therefore, we hypothesized that PPs are an important site for Transforming Growth Factor (TGF)- beta signaling and sought to prove that this tissue is of importance in oral tolerance induction. We found that expression of TGF-beta type II receptor (TGF beta RII) by CD4(+) T cells increases and persists in the PPs of normal C57BL/6 mice after either high- or low-dose feeding of OVA when compared to mesenteric lymph nodes (MLNs) and spleen. Approximately one-third of these TGF beta RII+ CD4(+) T cells express the transcription factor Foxp3. Interestingly, the number of TGF beta RII+ CD4(+) T cells in PPs decreased when OVA-fed mice were orally challenged with OVA plus native cholera toxin (CT). In contrast, numbers of TGF beta RII+ CD4(+) T cells were increased in the intestinal lamina propria (iLP) of these challenged mice. Further, these PP CD4(+) TGF beta RII+ T cells upregulated Foxp3 within 2 hours after OVA plus CT challenge. Mice fed PBS and challenged with OVA plus CT did not reveal any changes in TGFbRII expression by CD4(+) T cells. In order to test the functional property of TGF beta RII in the induction of oral tolerance, CD4dnTGF beta RII transgenic mice, in which TGF beta RII signaling is abrogated from all CD4(+) T cells, were employed. Importantly, these mice could not develop oral tolerance to OVA. Our studies show a critical, dose-independent, role for TGF beta RII expression and function by CD4(+) T cells in the gut-associated lymphoid tissues, further underlining the vital role of PPs in oral tolerance.	[Gilbert, Rebekah S.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA; [Kobayashi, Ryoki; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Pediat Dent, Immunobiol Vaccine Ctr, Birmingham, AL USA; [Sekine, Shinichi] Osaka Univ, Dept Prevent Dent, Suita, Osaka, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University	Gilbert, RS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA.	kohtarof@uab.edu		Kobayashi, Ryoki/0000-0002-7909-8981	U.S. Public Health Service [DE012242, AG 025873]; DART (Dental Academic Research Training) [T35 DE0176707]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012242, R29DE012242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025873] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); DART (Dental Academic Research Training); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by U.S. Public Health Service Grants DE012242 and AG 025873 as well as DART (Dental Academic Research Training) grant no T35 DE0176707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2010, J CLIN GASTROENTEROL, V44, P391, DOI 10.1097/MCG.0b013e3181d7760b; Amendt C, 1998, ONCOGENE, V17, P25, DOI 10.1038/sj.onc.1202161; Barron L, 2008, J IMMUNOL, V180, P2762, DOI 10.4049/jimmunol.180.5.2762; Bottinger EP, 1997, CANCER RES, V57, P5564; Broere F, 2009, MUCOSAL IMMUNOL, V2, P254, DOI 10.1038/mi.2009.2; Burks AW, 2008, J ALLERGY CLIN IMMUN, V121, P1344, DOI 10.1016/j.jaci.2008.02.037; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; du Pre MF, 2011, ALLERGY, V66, P478, DOI 10.1111/j.1398-9995.2010.02519.x; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Fujihashi K, 1999, INT IMMUNOL, V11, P1907, DOI 10.1093/intimm/11.12.1907; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Fujihashi K, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P539, DOI 10.1016/B978-012491543-5/50032-2; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hauet-Broere F, 2003, EUR J IMMUNOL, V33, P2801, DOI 10.1002/eji.200324115; Huang XP, 2005, J IMMUNOL, V175, P4283, DOI 10.4049/jimmunol.175.7.4283; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kweon MN, 1998, J IMMUNOL, V160, P1687; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Maeda Y, 2001, IMMUNOBIOLOGY, V204, P442, DOI 10.1078/0171-2985-00054; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mestecky J, 2003, FUNDAMENTAL IMMUNOLO, P965; Mowat AM, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P487, DOI 10.1016/B978-012491543-5/50031-0; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Shiokawa A, 2009, IMMUNOL LETT, V125, P7, DOI 10.1016/j.imlet.2009.05.002; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.09.051, 10.1016/j.jaci.2008.12.1128]; Smith KM, 2000, AM J RESP CRIT CARE, V162, pS175, DOI 10.1164/ajrccm.162.supplement_3.15tac7; Song F, 2008, J AUTOIMMUN, V30, P230, DOI 10.1016/j.jaut.2007.10.002; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Strober W, 2008, MUCOSAL IMMUNOL, V1, P92, DOI 10.1038/mi.2007.22; Strober W, 1998, J CLIN IMMUNOL, V18, P1, DOI 10.1023/A:1023222003039; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsuji NM, 2003, INT IMMUNOL, V15, P525, DOI 10.1093/intimm/dxg051; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Walton KLW, 2006, CLIN EXP IMMUNOL, V143, P503, DOI 10.1111/j.1365-2249.2006.03019.x; Wardrop RM, 1999, INFLAMM RES, V48, P106; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	51	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27501	10.1371/journal.pone.0027501	http://dx.doi.org/10.1371/journal.pone.0027501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087328	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700060
J	Henriksen, K; Flores, C; Thomsen, JS; Bruel, AM; Thudium, CS; Neutzsky-Wulff, AV; Langenbach, GEJ; Sims, N; Askmyr, M; Martin, TJ; Everts, V; Karsdal, MA; Richter, J				Henriksen, Kim; Flores, Carmen; Thomsen, Jesper S.; Bruel, Anne-Marie; Thudium, Christian S.; Neutzsky-Wulff, Anita V.; Langenbach, Geerling E. J.; Sims, Natalie; Askmyr, Maria; Martin, Thomas J.; Everts, Vincent; Karsdal, Morten A.; Richter, Johan			Dissociation of Bone Resorption and Bone Formation in Adult Mice with a Non-Functional V-ATPase in Osteoclasts Leads to Increased Bone Strength	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; RESISTANT ACID-PHOSPHATASE; PARATHYROID-HORMONE; ANABOLIC ACTIONS; STRUCTURAL BASIS; GENE; CELLS; PHENOTYPE; GROWTH; ACIDIFICATION	Osteopetrosis caused by defective acid secretion by the osteoclast, is characterized by defective bone resorption, increased osteoclast numbers, while bone formation is normal or increased. In contrast the bones are of poor quality, despite this uncoupling of formation from resorption. To shed light on the effect of uncoupling in adult mice with respect to bone strength, we transplanted irradiated three-month old normal mice with hematopoietic stem cells from control or oc/oc mice, which have defective acid secretion, and followed them for 12 to 28 weeks. Engraftment levels were assessed by flow cytometry of peripheral blood. Serum samples were collected every six weeks for measurement of bone turnover markers. At termination bones were collected for mu CT and mechanical testing. An engraftment level of 98% was obtained. From week 6 until termination bone resorption was significantly reduced, while the osteoclast number was increased when comparing oc/oc to controls. Bone formation was elevated at week 6, normalized at week 12, and reduced onwards. mu CT and mechanical analyses of femurs and vertebrae showed increased bone volume and bone strength of cortical and trabecular bone. In conclusion, these data show that attenuation of acid secretion in adult mice leads to uncoupling and improves bone strength.	[Henriksen, Kim; Thudium, Christian S.; Neutzsky-Wulff, Anita V.; Karsdal, Morten A.] Nord Biosci AS, Herlev, Denmark; [Flores, Carmen; Askmyr, Maria; Richter, Johan] Lund Univ, Lund, Sweden; [Thomsen, Jesper S.; Bruel, Anne-Marie] Univ Aarhus, Inst Anat, Aarhus, Denmark; [Langenbach, Geerling E. J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Funct Anat, Amsterdam, Netherlands; [Langenbach, Geerling E. J.; Everts, Vincent] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands; [Sims, Natalie; Martin, Thomas J.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Everts, Vincent] Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands	Nordic Bioscience; Lund University; Aarhus University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; St. Vincent's Institute of Medical Research; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Henriksen, K (corresponding author), Nord Biosci AS, Herlev, Denmark.	kh@nordicbioscience.com	Sims, Natalie Ann/A-7192-2012; Bruel, Annemarie/AAT-2310-2020	Sims, Natalie Ann/0000-0003-1421-8468; Karsdal, Morten/0000-0001-5026-8740; Bruel, Annemarie/0000-0003-4833-0888; Flores Bjurstrom, Carmen/0000-0002-8673-9142; Neutzsky-Wulff, Anita Vibsig/0000-0002-0577-3374; Thomsen, Jesper Skovhus/0000-0001-9386-6679	Nordforsk; Danish Research Foundation; European Calcified Tissue Society; Swedish Childhood Cancer Foundation; Lund University Hospital; Magnus Bergvalls Foundation; Georg Danielsson Foundation; Foundations of Lund University Hospital; Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research	Nordforsk; Danish Research Foundation; European Calcified Tissue Society; Swedish Childhood Cancer Foundation(European Commission); Lund University Hospital; Magnus Bergvalls Foundation; Georg Danielsson Foundation; Foundations of Lund University Hospital; Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research	CST received funding from Nordforsk, AVNW received funding from the Danish Research Foundation, CF is supported by a PhD fellowship from European Calcified Tissue Society. JR was supported by grants from The Swedish Childhood Cancer Foundation, a Clinical Research Award from Lund University Hospital, Magnus Bergvalls Foundation, the Georg Danielsson Foundation and The Foundations of Lund University Hospital. The Lund Stem Cell Center is supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo SL, 2004, CLIN CHEM, V50, P883, DOI 10.1373/clinchem.2003.029355; Askmyr M, 2009, EXP HEMATOL, V37, P302, DOI 10.1016/j.exphem.2008.10.010; Blin-Wakkach C, 2004, LEUKEMIA, V18, P1505, DOI 10.1038/sj.leu.2403449; BOLLERSLEV J, 1993, BONE, V14, P865, DOI 10.1016/8756-3282(93)90316-3; BOLLERSLEV J, 1989, ENDOCR REV, V10, P45, DOI 10.1210/edrv-10-1-45; BOLLERSLEV J, 1989, BONE, V10, P19, DOI 10.1016/8756-3282(89)90142-7; Chavassieux P, 2007, ENDOCR REV, V28, P151, DOI 10.1210/er.2006-0029; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Fuller K, 2008, BONE, V42, P200, DOI 10.1016/j.bone.2007.09.044; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; GRAM J, 1991, CALCIFIED TISSUE INT, V48, P438, DOI 10.1007/BF02556458; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Jansen IDC, 2009, FASEB J, V23, P3470, DOI 10.1096/fj.08-122598; Johansson MK, 2007, BLOOD, V109, P5178, DOI 10.1182/blood-2006-12-061382; Karsdal MA, 2005, AM J PATHOL, V166, P467, DOI 10.1016/S0002-9440(10)62269-9; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Leeming DJ, 2009, OSTEOPOROSIS INT, V20, P1461, DOI 10.1007/s00198-009-0904-3; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0; Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; Neutzsky-Wulff AV, 2008, CALCIFIED TISSUE INT, V83, P425, DOI 10.1007/s00223-008-9185-7; Nielsen RH, 2007, BIOCHEM BIOPH RES CO, V360, P834, DOI 10.1016/j.bbrc.2007.06.145; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; Pennypacker B, J BONE MINER RES S1, V24; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Scott K, 2009, J BONE MINER RES S1, V24; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Segovia-Silvestre T, 2009, HUM GENET, V124, P561, DOI 10.1007/s00439-008-0583-8; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Sorensen MG, 2007, J BONE MINER RES, V22, P1640, DOI 10.1359/JBMR.070613; TAKAHASHI H, 1964, Surg Forum, V15, P437; Taranta A, 2003, AM J PATHOL, V162, P57, DOI 10.1016/S0002-9440(10)63798-4; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tondelli B, 2009, AM J PATHOL, V174, P727, DOI 10.2353/ajpath.2009.080688; Waguespack SG, 2002, J CLIN ENDOCR METAB, V87, P2212, DOI 10.1210/jc.87.5.2212; Waguespack SG, 2007, J CLIN ENDOCR METAB, V92, P771, DOI 10.1210/jc.2006-1986; WALKER DG, 1975, J EXP MED, V142, P651, DOI 10.1084/jem.142.3.651; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; WALKER DG, 1975, SCIENCE, V190, P785, DOI 10.1126/science.1198094; WIKTORJEDRZEJCZAK W, 1986, EXP HEMATOL, V14, P819; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Yuan FL, 2010, MOL BIOL REP, V37, P3561, DOI 10.1007/s11033-010-0004-7; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	70	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27482	10.1371/journal.pone.0027482	http://dx.doi.org/10.1371/journal.pone.0027482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087326	Green Published, gold			2022-12-25	WOS:000297347700058
J	Pardo, R; Enguix, N; Lasheras, J; Feliu, JE; Kralli, A; Villena, JA				Pardo, Rosario; Enguix, Natalia; Lasheras, Jaime; Feliu, Juan E.; Kralli, Anastasia; Villena, Josep A.			Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor gamma Coactivator-1 alpha	PLOS ONE			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; INDUCIBLE COACTIVATOR; BROWN ADIPOCYTES; SKELETAL-MUSCLE; MICE; FAT; PGC-1-ALPHA; PGC-1-BETA; METABOLISM	Background: Thiazolidinediones, a family of insulin-sensitizing drugs commonly used to treat type 2 diabetes, are thought to exert their effects in part by promoting mitochondrial biogenesis in white adipose tissue through the transcriptional coactivator PGC-1 alpha (Peroxisome Proliferator-Activated Receptor gamma Coactivator-1 alpha). Methodology/Principal Findings: To assess the role of PGC-1 alpha in the control of rosiglitazone-induced mitochondrial biogenesis, we have generated a mouse model that lacks expression of PGC-1 alpha specifically in adipose tissues (PGC-1 alpha-FAT-KO mice). We found that expression of genes encoding for mitochondrial proteins involved in oxidative phosphorylation, tricarboxylic acid cycle or fatty acid oxidation, was similar in white adipose tissue of wild type and PGC-1 alpha-FAT-KO mice. Furthermore, the absence of PGC-1 alpha did not prevent the positive effect of rosiglitazone on mitochondrial gene expression or biogenesis, but it precluded the induction by rosiglitazone of UCP1 and other brown fat-specific genes in white adipose tissue. Consistent with the in vivo findings, basal and rosiglitazone-induced mitochondrial gene expression in 3T3-L1 adipocytes was unaffected by the knockdown of PGC-1 alpha but it was impaired when PGC-1 beta expression was knockdown by the use of specific siRNA. Conclusions/Significance: These results indicate that in white adipose tissue PGC-1 alpha is dispensable for basal and rosiglitazone-induced mitochondrial biogenesis but required for the rosiglitazone-induced expression of UCP1 and other brown adipocyte-specific markers. Our study suggests that PGC-1 alpha is important for the appearance of brown adipocytes in white adipose tissue. Our findings also provide evidence that PGC-1 beta and not PGC-1 alpha regulates basal and rosiglitazone-induced mitochondrial gene expression in white adipocytes.	[Pardo, Rosario; Enguix, Natalia; Lasheras, Jaime; Feliu, Juan E.; Villena, Josep A.] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, E-08193 Barcelona, Spain; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Scripps Research Institute	Pardo, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, E-08193 Barcelona, Spain.	josep.villena@vhir.org	Villena, Josep A/H-1597-2015	Enguix, Natalia/0000-0002-7873-902X; Villena, Josep A/0000-0002-2200-2985	Ministerio de Ciencia e Innovacion (MICINN), Spain [SAF2008-03644, RYC-2006-002622, DK064951, BES-2009-013411]; Fundacio La Marato de TV3 [082610]	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3	This work was supported by grants SAF2008-03644 and RYC-2006-002622 from Ministerio de Ciencia e Innovacion (MICINN), Spain, to J.A.V. and DK064951 to A.K. J.A.V. is a researcher of the "Ramon y Cajal" program (MICINN), Spain. N.E. is a FPI predoctoral fellow (BES-2009-013411) from the MICINN. J.L. is supported by a grant from the "Fundacio La Marato de TV3" (082610) to J.A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; COUSIN B, 1992, J CELL SCI, V103, P931; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; DESAUTELS M, 1985, AM J PHYSIOL, V249, pE99, DOI 10.1152/ajpendo.1985.249.1.E99; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Phielix E, 2010, DIABETOLOGIA, V53, P1714, DOI 10.1007/s00125-010-1764-2; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Toseland CDN, 2001, DIABETES OBES METAB, V3, P163, DOI 10.1046/j.1463-1326.2001.00117.x; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752	67	70	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26989	10.1371/journal.pone.0026989	http://dx.doi.org/10.1371/journal.pone.0026989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087241	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700014
J	Kuhn, BF; Werdelin, L; Hartstone-Rose, A; Lacruz, RS; Berger, LR				Kuhn, Brian F.; Werdelin, Lars; Hartstone-Rose, Adam; Lacruz, Rodrigo S.; Berger, Lee R.			Carnivoran Remains from the Malapa Hominin Site, South Africa	PLOS ONE			English	Article							AUSTRALOPITHECUS-SEDIBA; DEPOSITS; GENUS; MACHAIRODONTINAE; REVISION; PLIOCENE; MAMMALIA; GAUTENG; KENYA; HOMO	Recent discoveries at the new hominin-bearing deposits of Malapa, South Africa, have yielded a rich faunal assemblage associated with the newly described hominin taxon Australopithecus sediba. Dating of this deposit using U-Pb and palaeomagnetic methods has provided an age of 1.977 Ma, being one of the most accurately dated, time constrained deposits in the Plio-Pleistocene of southern Africa. To date, 81 carnivoran specimens have been identified at this site including members of the families Canidae, Viverridae, Herpestidae, Hyaenidae and Felidae. Of note is the presence of the extinct taxon Dinofelis cf. D. barlowi that may represent the last appearance date for this species. Extant large carnivores are represented by specimens of leopard (Panthera pardus) and brown hyaena (Parahyaena brunnea). Smaller carnivores are also represented, and include the genera Atilax and Genetta, as well as Vulpes cf. V. chama. Malapa may also represent the first appearance date for Felis nigripes (Black-footed cat). The geochronological age of Malapa and the associated hominin taxa and carnivoran remains provide a window of research into mammalian evolution during a relatively unknown period in South Africa and elsewhere. In particular, the fauna represented at Malapa has the potential to elucidate aspects of the evolution of Dinofelis and may help resolve competing hypotheses about faunal exchange between East and Southern Africa during the late Pliocene or early Pleistocene.	[Kuhn, Brian F.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Kuhn, Brian F.; Berger, Lee R.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Hartstone-Rose, Adam] Penn State Univ Altoona, Altoona, PA USA; [Lacruz, Rodrigo S.] Univ So Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Witwatersrand; University of Witwatersrand; Swedish Museum of Natural History; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Southern California	Kuhn, BF (corresponding author), Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa.	brian.kuhn@wits.ac.za	Hartstone-Rose, Adam/I-3503-2016; Lacruz, Rodrigo/AGY-8090-2022; Hartstone-Rose, Adam/AAU-3332-2020; Berger, Lee Rogers/AAC-3484-2020	Hartstone-Rose, Adam/0000-0001-5307-5573; Berger, Lee Rogers/0000-0002-0367-7629; LACRUZ, RODRIGO/0000-0002-0776-6143	Swedish Research Council; Pennsylvania State University; South African Department of Science and Technology; South African National Research Foundation; Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Africa Array Program; Duke University; Texas AM University; University of Zurich; Nash family	Swedish Research Council(Swedish Research CouncilEuropean Commission); Pennsylvania State University; South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; Africa Array Program; Duke University; Texas AM University; University of Zurich; Nash family	Research by LW is funded by the Swedish Research Council. AHR is supported by the Pennsylvania State University. The South African Department of Science and Technology, the South African National Research Foundation, the Palaeontological Scientific Trust (PAST), the Andrew W. Mellon Foundation, the Africa Array Program, the United States Diplomatic Mission to South Africa, Duke University, the Ray A. Rothrock Fellowship of Texas A&M University, the Texas A&M Program to Enhance Scholarly and Creative Activities, the University of Zurich 2009 Field School, and Sir Richard Branson all provided substantial funding for the excavations and research conducted at Malapa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bernhard Zipfel for access to materials curated at the IHE and BPI at the University of the Witwatersrand. Stephany Potze for access to material housed at the Ditsong Museum, Pretoria. Job Kibii, Christine Steininger and Bonita de Klerk for aid in the early identification and sorting of specimens. Celeste Yates, Meshack Kgasi and Roseberry Languza for preparing the specimens. The South African Heritage Resource agency for the permits to work on the Malapa site and the Nash family for granting access to the Malapa site and continued support of research on their reserve.	ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bamford M. K., 2010, Palaeontologia Africana, V45, P23; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berger LR, 2003, S AFR J SCI, V99, P279; Broom R., 1937, S AFR J SCI, V33, P750; BROOM ROBERT, 1948, ANN TRANSVAAL MUS, V21, P1; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; COLLINS K, 2010, P 16 C PAL SOC SO AF; COOKE H B S, 1991, Palaeontologia Africana, V28, P9; de Ruiter DJ, 2009, J HUM EVOL, V56, P497, DOI 10.1016/j.jhevol.2009.01.009; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Ditchfield P, 1999, J HUM EVOL, V36, P123, DOI 10.1006/jhev.1998.0255; ESTES RD, 1991, BEHAV GUIDE AFRICAN; EWER R. F., 1956, PROC ZOOL SOC LONDON, V126, P97; EWER R. F., 1956, PROC ZOOL SOC LONDON, V126, P259; EWER R. F., 1955, PROC ZOOL SOC LONDON, V125, P587; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Gommery D., 2008, Annals of the Transvaal Museum, V45, P67; Hartstone-Rose A, 2010, J PALEONTOL, V84, P299, DOI 10.1666/09-124.1; HENDEY Q B, 1974, Annals of the Transvaal Museum, V29, P27; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Keyser AW, 2000, S AFR J SCI, V96, P193; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Lacruz Rodrigo, 2006, Annals of the Transvaal Museum, V43, P89; Leakey M.G., 1976, P302; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Macdonald David W., 2010, P3; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; MILLS MGL, 1976, P S END WILDL 1976 E, P36; Mills MGL, 1990, KALAHARI HYAENAS COM; O'Regan HJ, 2009, GEOBIOS-LYON, V42, P329, DOI 10.1016/j.geobios.2009.03.001; OREGAN HJ, 2009, J HUM EVOL, P212; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Savage R.J.G., 1978, P249; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Sliwa A, 2004, MAMM BIOL, V69, P96, DOI 10.1078/1616-5047-00124; Thackeray JF, 2002, S AFR J SCI, V98, P537; Turner A., 1997, Palaeontologia Africana, V34, P115; TURNER A, 1993, PRETORIA TRANSVAAL M, V7, P151; Von den Driesch A., 1976, ARCHAEOLOGY PEABODY, V1; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; WERDELIN L, 2008, CARNIVORA KOOBI FORA, V7; WERDELIN L, 2011, PALAEONTOLOGIA AFRIC, V28, P9; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	50	17	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26940	10.1371/journal.pone.0026940	http://dx.doi.org/10.1371/journal.pone.0026940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073222	gold, Green Published			2022-12-25	WOS:000297197000017
J	Xia, XM; Wang, FY; Zhou, J; Hu, KF; Li, SW; Zou, BB				Xia, Xian-Ming; Wang, Fang-Yu; Zhou, Ju; Hu, Kai-Feng; Li, Su-Wen; Zou, Bing-Bing			CXCR4 Antagonist AMD3100 Modulates Claudin Expression and Intestinal Barrier Function in Experimental Colitis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; EPITHELIAL BARRIER; CHARGE SELECTIVITY; IN-VITRO; ALPHA; CELLS; PERMEABILITY; RECEPTOR; MODEL; LOCALIZATION	Ulcerative colitis is a gastrointestinal disorder characterized by local inflammation and impaired epithelial barrier. Previous studies demonstrated that CXC chemokine receptor 4 (CXCR4) antagonists could reduce colonic inflammation and mucosal damage in dextran sulfate sodium (DSS)-induced colitis. Whether CXCR4 antagonist has action on intestinal barrier and the possible mechanism, is largely undefined. In the present study, the experimental colitis was induced by administration of 5% DSS for 7 days, and CXCR4 antagonist AMD3100 was administered intraperitoneally once daily during the study period. For in vitro study, HT-29/B6 colonic cells were treated with cytokines or AMD3100 for 24 h until assay. DSS-induced colitis was characterized by morphologic changes in mice. In AMD3100-treated mice, epithelial destruction, inflammatory infiltration, and submucosal edema were markedly reduced, and the disease activity index was also significantly decreased. Increased intestinal permeability in DSS-induced colitis was also significantly reduced by AMD3100. The expressions of colonic claudin-1, claudin-3, claudin-5, claudin-7 and claudin-8 were markedly decreased after DSS administration, whereas colonic claudin-2 expression was significantly decreased. Treatment with AMD3100 prevented all these changes. However, AMD3100 had no influence on claudin-3, claudin-5, claudin-7 and claudin-8 expression in HT-29/B6 cells. Cytokines as TNF-alpha, IL-6, and IFN-gamma increased apoptosis and monolayer permeability, inhibited the wound-healing and the claudin-3, claudin-7 and claudin-8 expression in HT-29/B6 cells. We suggest that AMD3100 acted on colonic claudin expression and intestinal barrier function, at least partly, in a cytokine-dependent pathway.	[Xia, Xian-Ming; Zhou, Ju; Hu, Kai-Feng; Li, Su-Wen] Anhui Med Univ, Affiliated Hosp 4, Dept Gastroenterol & Hepatol, Hefei, Anhui, Peoples R China; [Wang, Fang-Yu] Jinling Hosp, Dept Gastroenterol & Hepatol, Nanjing, Jiangsu, Peoples R China; [Zou, Bing-Bing] Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Xia, XM (corresponding author), Anhui Med Univ, Affiliated Hosp 4, Dept Gastroenterol & Hepatol, Hefei, Anhui, Peoples R China.	xiaxm2000@hotmail.com			Postdoctoral Science Foundation of China [20090451573]; Postdoctoral Science Foundation of Jiangsu Province [0902061C]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation)	This work was funded by projects from the Postdoctoral Science Foundation of China (grant no. 20090451573) and the Postdoctoral Science Foundation of Jiangsu Province (grant no. 0902061C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoghaibi MA, 2008, J DIGEST DIS, V9, P144, DOI 10.1111/j.1751-2980.2008.00336.x; Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bernasconi E, 2010, INFLAMM BOWEL DIS, V16, P428, DOI 10.1002/ibd.21072; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Ding ZQ, 2006, CRIT CARE MED, V34, P3011, DOI 10.1097/01.CCM.0000247719.37793.43; Dotan I, 2010, INFLAMM BOWEL DIS, V16, P583, DOI 10.1002/ibd.21106; Fernandez AL, 2007, ALCOHOL, V41, P371, DOI 10.1016/j.alcohol.2007.04.010; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Haas CS, 2005, ARTHRITIS RHEUM-US, V52, P3718, DOI 10.1002/art.21476; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; Mazzon E, 2007, SHOCK, V28, P192, DOI 10.1097/shk.0b013e318033eb29; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Menconi MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1007, DOI 10.1152/ajpgi.1997.272.5.G1007; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nakase H, 2009, INFLAMM BOWEL DIS, V15, P963, DOI 10.1002/ibd.20755; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Qin XF, 2008, SHOCK, V29, P372, DOI 10.1097/shk.0b013e3181453f4e; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shichijo K, 2008, DIGEST DIS SCI, V53, P2443, DOI 10.1007/s10620-007-0160-3; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Soriano FG, 2001, CRIT CARE MED, V29, P703, DOI 10.1097/00003246-200104000-00001; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Wu JH, 2010, WORLD J GASTROENTERO, V16, P3911, DOI 10.3748/wjg.v16.i31.3911; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2994, DOI 10.3748/wjg.v16.i24.2994; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007	48	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27282	10.1371/journal.pone.0027282	http://dx.doi.org/10.1371/journal.pone.0027282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073304	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000040
J	Hua, J; Liang, SW; Ma, X; Webb, TJ; Potter, JP; Li, ZP				Hua, Jing; Liang, Shuwen; Ma, Xiong; Webb, Tonya J.; Potter, James P.; Li, Zhiping			The Interaction between Regulatory T Cells and NKT Cells in the Liver: A CD1d Bridge Links Innate and Adaptive Immunity	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; HIGH-FAT DIET; VIRUS-INFECTION; TOLERANCE; HEPATITIS; TRANSPLANTATION; LYMPHOCYTES; ACTIVATION; BIOLOGY; DISEASE	Background/Aims: Regulatory T cells (Tregs) and natural killer T (NKT) cells are two distinct lymphocyte subsets that independently regulate hepatic adaptive and innate immunity, respectively. In the current study, we examine the interaction between Tregs and NKT cells to understand the mechanisms of cross immune regulation by these cells. Methods: The frequency and function of Tregs were evaluated in wild type and NKT cell deficient (CD1dko) mice. In vitro lymphocyte proliferation and apoptosis assays were performed with NKT cells co-cultured with Tregs. The ability of Tregs to inhibit NKT cells in vivo was examined by adoptive transfer of Tregs in a model of NKT cell mediated hepatitis. Results: CD1dko mice have a significant reduction in hepatic Tregs. Although, the Tregs from CD1dko mice remain functional and can suppress conventional T cells, their ability to suppress activation induced NKT cell proliferation and to promote NKT cell apoptosis is greatly diminished. These effects are CD1d dependent and require cell to cell contact. Adoptive transfer of Tregs inhibits NKT cell-mediated liver injury. Conclusions: NKT cells promote Tregs, and Tregs inhibit NKT cells in a CD1d dependent manner requiring cell to cell contact. These cross-talk immune regulations provide a linkage between innate and adaptive immunity.	[Hua, Jing; Liang, Shuwen; Ma, Xiong; Potter, James P.; Li, Zhiping] Jiaotong Univ, Shanghai Renji Hosp, Sch Med, Shanghai Inst Digest Dis, Shanghai, Peoples R China; [Hua, Jing; Liang, Shuwen; Ma, Xiong; Potter, James P.; Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Webb, Tonya J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Shanghai Jiao Tong University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Hua, J (corresponding author), Jiaotong Univ, Shanghai Renji Hosp, Sch Med, Shanghai Inst Digest Dis, Shanghai, Peoples R China.	zhipingli@jhmi.edu		Webb, Tonya/0000-0003-3086-6414; Ma, Xiong/0000-0001-9616-4672	NIH/NIDDK [R01DK075990]; Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases; NATIONAL CANCER INSTITUTE [R21CA162273, R21CA162277, K01CA131487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, R01DK075990] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from NIH/NIDDK R01DK075990 (ZL) and the Program of Shanghai Innovative Research Team in Immunity of Non-viral Liver Diseases (XM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2003, CANCER RES, V63, P4516; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Demirkiran A, 2006, LIVER TRANSPLANT, V12, P277, DOI 10.1002/lt.20612; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hallett WHD, 2008, BIOL BLOOD MARROW TR, V14, P1088, DOI 10.1016/j.bbmt.2008.08.001; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Jiang SP, 2003, AM J TRANSPLANT, V3, P516, DOI 10.1034/j.1600-6143.2003.00124.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Li WP, 2008, ACTA BIOCH BIOPH SIN, V40, P381, DOI 10.1111/j.1745-7270.2008.00410.x; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Nador RG, 2010, AM J TRANSPLANT, V10, P262, DOI 10.1111/j.1600-6143.2009.02942.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pillai AB, 2009, BLOOD, V113, P4458, DOI 10.1182/blood-2008-06-165506; QIAN SW, 1994, HEPATOLOGY, V19, P916, DOI 10.1002/hep.1840190418; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tupin E, 2006, METHOD ENZYMOL, V417, P185, DOI 10.1016/S0076-6879(06)17014-7; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; VELAOJEDA J, 2010, STEM CELLS DEV; Yang SQ, 2001, AM J PHYSIOL-GASTR L, V281, pG382, DOI 10.1152/ajpgi.2001.281.2.G382; YASSER O, 2000, J IMMUNOL, V30, P1919; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27038	10.1371/journal.pone.0027038	http://dx.doi.org/10.1371/journal.pone.0027038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073248	Green Published, Green Submitted, gold			2022-12-25	WOS:000297154900068
J	Wang, YJ; Zhang, Q; Chen, HQ; Li, X; Mai, WJ; Chen, KP; Zhang, SF; Lee, EYC; Lee, MYWT; Zhou, YJ				Wang, Yujue; Zhang, Qian; Chen, Huiqing; Li, Xiao; Mai, Weijun; Chen, Keping; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.; Zhou, Yajing			P50, the Small Subunit of DNA Polymerase Delta, Is Required for Mediation of the Interaction of Polymerase Delta Subassemblies with PCNA	PLOS ONE			English	Article							EUKARYOTIC REPLICATION FORK; CELL NUCLEAR ANTIGEN; SCHIZOSACCHAROMYCES-POMBE; CALF THYMUS; DAMAGE RESPONSE; P12 SUBUNIT; PROTEIN; REPAIR; IDENTIFICATION; CHROMATOGRAPHY	Mammalian DNA polymerase delta (pol delta), a four-subunit enzyme, plays a crucial and versatile role in DNA replication and various DNA repair processes. Its function as a chromosomal DNA polymerase is dependent on the association with proliferating cell nuclear antigen (PCNA) which functions as a molecular sliding clamp. All four of the pol delta subunits (p125, p50, p68, and p12) have been reported to bind to PCNA. However, the identity of the subunit of pol delta that directly interacts with PCNA and is therefore primarily responsible for the processivity of the enzyme still remains controversial. Previous model for the network of protein-protein interactions of the pol delta-PCNA complex showed that pol delta might be able to interact with a single molecule of PCNA homotrimer through its three subunits, p125, p68, and p12 in which the p50 was not included in. Here, we have confirmed that the small subunit p50 of human pol delta truthfully interacts with PCNA by the use of far-Western analysis, quantitative ELISA assay, and subcellular co-localization. P50 is required for mediation of the interaction between pol delta subassemblies and PCNA homotrimer. Thus, pol delta interacts with PCNA via its four subunits.	[Wang, Yujue; Zhang, Qian; Chen, Huiqing; Li, Xiao; Mai, Weijun; Chen, Keping; Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY USA	Jiangsu University; New York Medical College	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	yajingzhou@ujs.edu.cn	Wang, Yujue/HHN-4296-2022	Zhang, Sufang/0000-0003-3883-023X; Weijun, Mai/0000-0003-2636-9028	National Natural Science Foundation of China [30970612]; Jiangsu University for Advanced Professionals [09JDG002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University for Advanced Professionals; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Natural Science Foundation of China (30970612) and Startup Scientific Research Fund from Jiangsu University for Advanced Professionals (09JDG002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cardoso MC, 1999, J CELL BIOCHEM, P15; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Harlow E., 1988, ANTIBODIES LAB MANUA; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee M Y, 1981, Prog Nucleic Acid Res Mol Biol, V26, P83; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; Leonhardt H, 1998, J CELL BIOCHEM, P243, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<243::AID-JCB30>3.0.CO;2-6; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Pohler JRG, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-17; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shikata K, 2001, J BIOCHEM-TOKYO, V129, P699, DOI 10.1093/oxfordjournals.jbchem.a002909; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; TAN CK, 1986, J BIOL CHEM, V261, P2310; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	42	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27092	10.1371/journal.pone.0027092	http://dx.doi.org/10.1371/journal.pone.0027092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073260	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900074
J	Mainz, A; Bardiaux, B; Kuppler, F; Multhaup, G; Felli, IC; Pierattelli, R; Reif, B				Mainz, Andi; Bardiaux, Benjamin; Kuppler, Frank; Multhaup, Gerd; Felli, Isabella C.; Pierattelli, Roberta; Reif, Bernd			Structural and Mechanistic Implications of Metal Binding in the Small Heat-shock Protein alpha B-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; ZINC SUPEROXIDE-DISMUTASE; DESMIN-RELATED MYOPATHY; N-TERMINAL DOMAIN; SOLID-STATE NMR; MOLECULAR CHAPERONE; COMPLETE ASSIGNMENT; OXIDATIVE STRESS; PROTONLESS NMR; SPECTROSCOPY	The human small heat-shock protein alpha B-crystallin (alpha B) rescues misfolded proteins from irreversible aggregation during cellular stress. Binding of Cu(II) was shown to modulate the oligomeric architecture and the chaperone activity of alpha B. However, the mechanistic basis of this stimulation is so far not understood. We provide here first structural insights into this Cu(II)-mediated modulation of chaperone function using NMR spectroscopy and other biophysical approaches. We show that the alpha-crystallin domain is the elementary Cu(II)-binding unit specifically coordinating one Cu(II) ion with picomolar binding affinity. Putative Cu(II) ligands are His(83), His(104), His(111), and Asp(109) at the dimer interface. These loop residues are conserved among different metazoans, but also for human alpha A-crystallin, HSP20, and HSP27. The involvement of Asp109 has direct implications for dimer stability, because this residue forms a salt bridge with the disease-related Arg(120) of the neighboring monomer. Furthermore, we observe structural reorganization of strands beta 2-beta 3 triggered by Cu(II) binding. This N-terminal region is known to mediate both the intermolecular arrangement in alpha B oligomers and the binding of client proteins. In the presence of Cu(II), the size and the heterogeneity of alpha B multimers are increased. Atthesametime, Cu(II) increases the chaperone activity of alpha B toward the lens-specific protein beta(L)-crystallin. We therefore suggest that Cu(II) binding unblocks potential client binding sites and alters quaternary dynamics of both the dimeric building block as well as the higher order assemblies of alpha B.	[Reif, Bernd] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Mainz, Andi; Bardiaux, Benjamin; Reif, Bernd] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Mainz, Andi; Reif, Bernd] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Kuppler, Frank; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Felli, Isabella C.; Pierattelli, Roberta] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Felli, Isabella C.; Pierattelli, Roberta] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy	Technical University of Munich; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; University of Florence; University of Florence	Reif, B (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Lichtenbergstr 4, D-85747 Garching, Germany.	reif@tum.de	Felli, Isabella C./O-1751-2015; Bardiaux, Benjamin/AAN-2741-2021; Pierattelli, Roberta/F-9439-2012; Bardiaux, Benjamin/A-4799-2011	Felli, Isabella C./0000-0002-6018-9090; Bardiaux, Benjamin/0000-0003-4014-9195; Pierattelli, Roberta/0000-0001-7755-0885; Reif, Bernd/0000-0001-7368-7198	Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft; Deutsche Forschungsgemeinschaft [Re1435, SFB449, SFB740, SFB610]; EC [261863]; Center for Integrated Protein Science Munich	Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Center for Integrated Protein Science Munich	This work was supported by the Leibniz-Gemeinschaft, by the Helmholtz-Gemeinschaft, by the Deutsche Forschungsgemeinschaft (Grants Re1435, SFB449, SFB740, and SFB610), by access to research infrastructures activity in the 7th Framework Programme of the EC (project number 261863, Bio-NMR), and by the Center for Integrated Protein Science Munich.	Ahmad MF, 2008, J MOL BIOL, V382, P812, DOI 10.1016/j.jmb.2008.07.068; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bermel W, 2006, J MAGN RESON, V178, P56, DOI 10.1016/j.jmr.2005.08.011; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bermel W, 2003, J AM CHEM SOC, V125, P16423, DOI 10.1021/ja037676p; Bermel W, 2007, J MAGN RESON, V188, P301, DOI 10.1016/j.jmr.2007.07.004; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Bertini I, 2011, P NATL ACAD SCI USA, V108, P10396, DOI 10.1073/pnas.1103854108; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Biswas A, 2008, BIOCHEMISTRY-US, V47, P804, DOI 10.1021/bi7011965; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Ganadu ML, 2004, J INORG BIOCHEM, V98, P1103, DOI 10.1016/j.jinorgbio.2004.03.013; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh KS, 2011, BIOCHEMISTRY-US, V50, P3279, DOI 10.1021/bi200091q; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hawse JR, 2003, INVEST OPHTH VIS SCI, V44, P672, DOI 10.1167/iovs.02-0018; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hough MA, 1999, J MOL BIOL, V287, P579, DOI 10.1006/jmbi.1999.2610; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koretz JF, 1998, INT J BIOL MACROMOL, V22, P283, DOI 10.1016/S0141-8130(98)00026-9; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lawless MW, 2010, EXPERT OPIN THER TAR, V14, P1225, DOI 10.1517/14728222.2010.526933; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu LY, 2006, ANAL BIOCHEM, V350, P186, DOI 10.1016/j.ab.2005.12.019; Mainz A, 2009, J AM CHEM SOC, V131, P15968, DOI 10.1021/ja904733v; Moroz OV, 2003, ACTA CRYSTALLOGR D, V59, P859, DOI 10.1107/S0907444903004700; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narayanan S, 2006, FEBS LETT, V580, P5941, DOI 10.1016/j.febslet.2006.09.063; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Prabhu S, 2011, FREE RADICAL BIO MED, V51, P755, DOI 10.1016/j.freeradbiomed.2011.05.021; Reif B, 2007, TOP CURR CHEM, V272, P117, DOI 10.1007/128_066; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; SHAKA AJ, 1983, J MAGN RESON, V53, P313, DOI 10.1016/0022-2364(83)90035-5; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Srinivas V, 2005, MOL VIS, V11, P249; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISHART DS, 1994, J BIOMOL NMR, V4, P171	71	55	56	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1128	1138		10.1074/jbc.M111.309047	http://dx.doi.org/10.1074/jbc.M111.309047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22090033	Green Published, hybrid			2022-12-25	WOS:000299170300028
J	Morita, K; Tokuda, H; Nishiyama, K				Morita, Kazuhiro; Tokuda, Hajime; Nishiyama, Ken-ichi			Multiple SecA Molecules Drive Protein Translocation across a Single Translocon with SecG Inversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; EVERTED MEMBRANE-VESICLES; COLI PLASMA-MEMBRANE; DISTINCT ATP-BINDING; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; DEPENDENT STIMULATION; TOPOLOGY INVERSION; SECRETORY PROTEIN	SecA is a translocation ATPase that drives protein translocation. D209N SecA, a dominant-negative mutant, binds ATP but is unable to hydrolyze it. This mutant was inactive to proOmpA translocation. However, it generated a translocation intermediate of 18 kDa. Further addition of wild-type SecA caused its translocation into either mature OmpA or another intermediate of 28 kDa that can be translocated into mature by a proton motive force. The addition of excess D209N SecA during translocation caused a topology inversion of SecG. Moreover, an intermediate of SecG inversion was identified when wild-type and D209N SecA were used in the same amounts. These results indicate that multiple SecA molecules drive translocation across a single translocon with SecG inversion. Here, we propose a revised model of proOmpA translocation in which a single catalytic cycle of SecA causes translocation of 10-13 kDa with ATP binding and hydrolysis, and SecG inversion is required when the next SecA cycle begins with additional ATP hydrolysis.	[Morita, Kazuhiro; Tokuda, Hajime; Nishiyama, Ken-ichi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	University of Tokyo	Nishiyama, K (corresponding author), Iwate Univ, Cryobiofrontier Res Ctr, Fac Agr, Morioka, Iwate 0208550, Japan.	nishiyam@iwate-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21570110] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AKITA M, 1990, J BIOL CHEM, V265, P8164; AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; HANADA M, 1994, J BIOL CHEM, V269, P23625; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KATO M, 1993, J BIOL CHEM, V268, P3586; KIM YJ, 1994, CELL, V78, P845; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Nagamori S, 2000, J BIOCHEM-TOKYO, V128, P129, DOI 10.1093/oxfordjournals.jbchem.a022723; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHINKAI A, 1990, BIOCHEM BIOPH RES CO, V172, P1217, DOI 10.1016/0006-291X(90)91578-G; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; TANI K, 1991, FEBS LETT, V285, P127, DOI 10.1016/0014-5793(91)80741-K; TANI K, 1989, J BIOL CHEM, V264, P18582; TANI K, 1990, J BIOL CHEM, V265, P17341; TOKUDA H, 1993, BIOCHEM BIOPH RES CO, V195, P1415, DOI 10.1006/bbrc.1993.2201; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Slius EO, 2006, J BACTERIOL, V188, P1188, DOI 10.1128/JB.188.3.1188-1190.2006; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; WATANABE M, 1993, P NATL ACAD SCI USA, V90, P9011, DOI 10.1073/pnas.90.19.9011; YAMADA H, 1989, J BIOL CHEM, V264, P1723; YAMADA H, 1989, J BIOL CHEM, V264, P18577; YAMANE K, 1987, J BIOL CHEM, V262, P2358; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	55	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					455	464		10.1074/jbc.M111.301754	http://dx.doi.org/10.1074/jbc.M111.301754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074917	Green Published, hybrid			2022-12-25	WOS:000298682400044
J	Garbuz, DG; Astakhova, LN; Zatsepina, OG; Arkhipova, IR; Nudler, E; Evgen'ev, MB				Garbuz, David G.; Astakhova, Lubov N.; Zatsepina, Olga G.; Arkhipova, Irina R.; Nudler, Eugene; Evgen'ev, Michael B.			Functional Organization of hsp70 Cluster in Camel (Camelus dromedarius) and Other Mammals	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MOLECULAR CHAPERONES; STRESS-RESPONSE; GENES; ADAPTATION; EVOLUTION; PROTEINS; DIFFER; CELLS	Heat shock protein 70 (Hsp70) is a molecular chaperone providing tolerance to heat and other challenges at the cellular and organismal levels. We sequenced a genomic cluster containing three hsp70 family genes linked with major histocompatibility complex (MHC) class III region from an extremely heat tolerant animal, camel (Camelus dromedarius). Two hsp70 family genes comprising the cluster contain heat shock elements (HSEs), while the third gene lacks HSEs and should not be induced by heat shock. Comparison of the camel hsp70 cluster with the corresponding regions from several mammalian species revealed similar organization of genes forming the cluster. Specifically, the two heat inducible hsp70 genes are arranged in tandem, while the third constitutively expressed hsp70 family member is present in inverted orientation. Comparison of regulatory regions of hsp70 genes from camel and other mammals demonstrates that transcription factor matches with highest significance are located in the highly conserved 250-bp upstream region and correspond to HSEs followed by NF-Y and Sp1 binding sites. The high degree of sequence conservation leaves little room for putative camel-specific regulatory elements. Surprisingly, RT-PCR and 5'/3'-RACE analysis demonstrated that all three hsp70 genes are expressed in camel's muscle and blood cells not only after heat shock, but under normal physiological conditions as well, and may account for tolerance of camel cells to extreme environmental conditions. A high degree of evolutionary conservation observed for the hsp70 cluster always linked with MHC locus in mammals suggests an important role of such organization for coordinated functioning of these vital genes.	[Garbuz, David G.; Astakhova, Lubov N.; Zatsepina, Olga G.; Evgen'ev, Michael B.] RAS, Engelhardt Inst Mol Biol, Moscow 117901, Russia; [Arkhipova, Irina R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Nudler, Eugene] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Evgen'ev, Michael B.] RAS, Inst Cell Biophys, Pushchino, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Marine Biological Laboratory - Woods Hole; New York University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Garbuz, DG (corresponding author), RAS, Engelhardt Inst Mol Biol, Moscow 117901, Russia.	misha572001@yahoo.com	Garbuz, David/Q-7522-2016	Nudler, Evgeny/0000-0002-8811-3071; Arkhipova, Irina/0000-0002-4805-1339	Russian Foundation for Basic Research [09-04-00643, 09-04-00660]; "Genofond dynamics" program; Molecular and Cellular Biology RAN; Ministry of Education and Science of Russian Federation [14.740.11.0757]; Russia President Grant [MK-1418.2010.4]; Ministry of Education and Science [N16.552.11.7034]; Direct For Biological Sciences [0821956] Funding Source: National Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); "Genofond dynamics" program; Molecular and Cellular Biology RAN; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russia President Grant; Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Russian Foundation for Basic Research, project 09-04-00643 and 09-04-00660, project from "Genofond dynamics" program, and Grant of the Program of Molecular and Cellular Biology RAN to Dr. Evgen'ev; and by the Ministry of Education and Science of Russian Federation (State contract 14.740.11.0757 and Russia President Grant to young scientists MK-1418.2010.4. The research was supported by State Contract N16.552.11.7034 of Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Swailem AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010720; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Evgen'ev MB, 2004, CHROMOSOMA, V113, P223, DOI 10.1007/s00412-004-0312-6; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Freeman BC, 2000, METH MOL B, V99, P393; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; GLINSKI W, 1976, J CLIN INVEST, V57, P604, DOI 10.1172/JCI108316; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; Jensen ON, 1999, METH MOL B, V112, P513; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LYASHKO VN, 1994, P NATL ACAD SCI USA, V91, P12492, DOI 10.1073/pnas.91.26.12492; Margulis B, HEAT SHOCK PROTEINS, P305; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rozhkova E, 2010, ANN NY ACAD SCI, V1197, P94, DOI 10.1111/j.1749-6632.2009.05375.x; SALTERCID L, 1994, IMMUNOGENETICS, V39, P1; Sambrook J, 2001, MOL CLONING LAB MANU; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Schmidt-Nilsen K, 1972, ANIMALS DESERTS; Thayyullathil F, 2008, ANN NY ACAD SCI, V1138, P376, DOI 10.1196/annals.1414.039; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; ULMASOV HA, 1993, COMP BIOCHEM PHYS B, V106, P867, DOI 10.1016/0305-0491(93)90043-5; ULMASOV KA, 1992, P NATL ACAD SCI USA, V89, P1666, DOI 10.1073/pnas.89.5.1666; WALTER L, 1994, IMMUNOGENETICS, V40, P325, DOI 10.1007/BF01246673; Zatsepina OG, 2000, J EXP BIOL, V203, P1017	29	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27205	10.1371/journal.pone.0027205	http://dx.doi.org/10.1371/journal.pone.0027205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096537	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800037
J	Thomsen, MS; El-Sayed, M; Mikkelsen, JD				Thomsen, Morten S.; El-Sayed, Mona; Mikkelsen, Jens D.			Differential Immediate and Sustained Memory Enhancing Effects of Alpha7 Nicotinic Receptor Agonists and Allosteric Modulators in Rats	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; COGNITIVE IMPROVEMENT; IN-VITRO; ACTIVATION; DESENSITIZATION; SCHIZOPHRENIA; PERFORMANCE; EXPRESSION; DEFICITS; GTS-21	The alpha 7 nicotinic acetylcholine receptor (nAChR) is a potential target for the treatment of cognitive deficits in patients with schizophrenia, ADHD and Alzheimer's disease. Here we test the hypothesis that upregulation of alpha 7 nAChR levels underlies the enhanced and sustained procognitive effect of repeated administration of alpha 7 nAChR agonists. We further compare the effect of agonists to that of alpha 7 nAChR positive allosteric modulators (PAMs), which do not induce upregulation of the alpha 7 nAChR. Using the social discrimination test as a measure of short-term memory, we show that the alpha 7 nAChR agonist A582941 improves short-term memory immediately after repeated (76daily), but not a single administration. The alpha 7 nAChR PAMs PNU-120596 and AVL-3288 do not affect short-term memory immediately after a single or repeated administration. This demonstrates a fundamental difference in the behavioral effects of agonists and PAMs that may be relevant for clinical development. Importantly, A-582941 and AVL-3288 increase short-term memory 24 hrs after repeated, but not a single, administration, suggesting that repeated administration of both agonists and PAMs may produce sustained effects on cognitive performance. Subsequent [I-125]-bungarotoxin autoradiography revealed no direct correlation between alpha 7 nAChR levels in frontal cortical or hippocampal brain regions and short-term memory with either compound. Additionally, repeated treatment with A-582941 did not affect mRNA expression of RIC-3 or the lynx-like gene products lynx1, lynx2, PSCA, or Ly6H, which are known to affect nAChR function. In conclusion, both alpha 7 nAChR agonists and PAMs exhibit sustained pro-cognitive effects after repeated administration, and altered levels of the alpha 7 nAChR per se, or that of endogenous regulators of nAChR function, are likely not the major cause of this effect.	[Thomsen, Morten S.; El-Sayed, Mona; Mikkelsen, Jens D.] Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark; [Mikkelsen, Jens D.] Neurosearch AS, Ballerup, Denmark	University of Copenhagen	Thomsen, MS (corresponding author), Univ Copenhagen Hosp, Neurobiol Res Unit, DK-2100 Copenhagen, Denmark.	morten.s.thomsen@nru.dk	Hervig, Mona El-Sayed/E-4791-2019; Hervig, Mona El-Sayed/Q-3970-2019	Hervig, Mona El-Sayed/0000-0003-0969-1250; Hervig, Mona El-Sayed/0000-0003-0969-1250	Danish Medical Research Council; NOVO Nordisk Foundation; Lundbeck Foundation; Danish Ministry of Science, Technology and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science, Technology and Innovation	This work was supported by the Danish Medical Research Council, the NOVO Nordisk Foundation, the Lundbeck Foundation, and the Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla FA, 1996, PSYCHOPHARMACOLOGY, V124, P323, DOI 10.1007/BF02247437; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Bjugstad KB, 1996, DRUG DEVELOP RES, V39, P19; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Castner SA, 2011, BIOL PSYCHIAT, V69, P12, DOI 10.1016/j.biopsych.2010.08.006; Christensen DZ, 2010, J NEUROCHEM, V114, P1205, DOI 10.1111/j.1471-4159.2010.06845.x; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Deutsch SI, 2008, CLIN NEUROPHARMACOL, V31, P34, DOI [10.1097/WNF.0B013E31806462BA, 10.1097/wnf.0b013e31806462ba]; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; Faghih R, 2008, J MED CHEM, V51, P701, DOI 10.1021/jm070256g; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Keller JJ, 2005, BEHAV BRAIN RES, V162, P143, DOI 10.1016/j.bbr.2005.03.004; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Li JG, 2008, NEUROPSYCHOPHARMACOL, V33, P2820, DOI 10.1038/npp.2008.1; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Pei Q, 2003, NEUROSCIENCE, V121, P975, DOI 10.1016/S0306-4522(03)00504-9; Pepeu G, 2004, LEARN MEMORY, V11, P21, DOI 10.1101/lm.68104; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Reymond J-L, 2011, BIOCH PHARM IN PRESS; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Thomsen MS, 2011, CURR DRUG T IN PRESS; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Treinin Millet, 2008, Biotechnology Journal, V3, P1539, DOI 10.1002/biot.200800179; Werkheiser JL, 2011, NEUROSCIENCE, V186, P76, DOI 10.1016/j.neuroscience.2011.04.033; Woldbye DPD, 1996, BRAIN RES, V720, P111, DOI 10.1016/0006-8993(96)00158-8; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008	40	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27014	10.1371/journal.pone.0027014	http://dx.doi.org/10.1371/journal.pone.0027014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096516	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800023
J	Huang, T; Sun, LG; Stark, J; Wang, YH; Cheng, ZQ; Yang, QC; Sun, S				Huang, Tao; Sun, Liguang; Stark, John; Wang, Yuhong; Cheng, Zhongqi; Yang, Qichao; Sun, Song			Relative Changes in Krill Abundance Inferred from Antarctic Fur Seal	PLOS ONE			English	Article							STABLE-ISOTOPES; SOUTHERN-OCEAN; MIGRATION PATTERNS; MARINE ECOSYSTEMS; LAKE-SEDIMENTS; TROPHIC LEVELS; CLIMATE-CHANGE; ICE EXTENT; FOOD-WEB; DIET	Antarctic krill Euphausia superba is a predominant species in the Southern Ocean, it is very sensitive to climate change, and it supports large stocks of fishes, seabirds, seals and whales in Antarctic marine ecosystems. Modern krill stocks have been estimated directly by net hauls and acoustic surveys; the historical krill density especially the long-term one in the Southern Ocean, however, is unknown. Here we inferred the relative krill population changes along the West Antarctic Peninsula (WAP) over the 20th century from the trophic level change of Antarctic fur seal Arctocephalus gazella using stable carbon (delta C-13) and nitrogen (delta N-15) isotopes of archival seal hairs. Since Antarctic fur seals feed preferentially on krill, the variation of delta N-15 in seal hair indicates a change in the proportion of krill in the seal's diets and thus the krill availability in local seawater. For the past century, enriching fur seal delta N-15 values indicated decreasing krill availability. This is agreement with direct observation for the past similar to 30 years and suggests that the recently documented decline in krill populations began in the early parts of the 20th century. This novel method makes it possible to infer past krill population changes from ancient tissues of krill predators.	[Huang, Tao; Sun, Liguang; Wang, Yuhong; Yang, Qichao] Univ Sci & Technol China, Inst Polar Environm, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Stark, John] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Stark, John] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Wang, Yuhong; Sun, Song] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Cheng, Zhongqi] CUNY Brooklyn Coll, Brooklyn, NY 11210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Chinese Academy of Sciences; Institute of Oceanology, CAS; City University of New York (CUNY) System; Brooklyn College (CUNY)	Huang, T (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Sch Earth & Space Sci, Hefei 230026, Peoples R China.	slg@ustc.edu.cn	Cheng, Zhongqi/K-4148-2018	Cheng, Zhongqi/0000-0002-2486-9662; Huang, Tao/0000-0001-5035-1632	National Natural Science Foundation of China [40730107, 41106162]; Chinese Arctic and Antarctic Administration; Polar Research Institute of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Arctic and Antarctic Administration; Polar Research Institute of China	Funding for this work was provided by the National Natural Science Foundation of China (No. 40730107 and No. 41106162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Chinese Arctic and Antarctic Administration and Polar Research Institute of China for support in field, and all the people who provided help in field.	Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; APPLEBY PG, 1995, J PALEOLIMNOL, V13, P179, DOI 10.1007/BF00678106; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Casaux R, 1998, POLAR BIOL, V20, P424, DOI 10.1007/s003000050324; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Crosta X, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000565; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hodgson DA, 1997, NATURE, V387, P30, DOI 10.1038/387030a0; Hofmann EE, 2004, ANTARCT SCI, V16, P487, DOI 10.1017/S0954102004002275; Liu XD, 2004, PROG NAT SCI-MATER, V14, P786, DOI 10.1080/10020070412331344331; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; Miller DG, 1989, BIOMASS SCI SER, V9, P1; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reid K, 1999, MAR ECOL PROG SER, V177, P103, DOI 10.3354/meps177103; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Sun LG, 2000, NATURE, V407, P858, DOI 10.1038/35038163; Sun LG, 2004, POLAR BIOL, V27, P495, DOI 10.1007/s00300-004-0608-2; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; Yang QC, 2010, CHINESE SCI BULL, V55, P1084, DOI 10.1007/s11434-009-0581-9	29	21	29	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27331	10.1371/journal.pone.0027331	http://dx.doi.org/10.1371/journal.pone.0027331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087294	Green Published, gold			2022-12-25	WOS:000297347700042
J	Rosani, U; Varotto, L; Rossi, A; Roch, P; Novoa, B; Figueras, A; Pallavicini, A; Venier, P				Rosani, Umberto; Varotto, Laura; Rossi, Alberta; Roch, Philippe; Novoa, Beatriz; Figueras, Antonio; Pallavicini, Alberto; Venier, Paola			Massively Parallel Amplicon Sequencing Reveals Isotype-Specific Variability of Antimicrobial Peptide Transcripts in Mytilus galloprovincialis	PLOS ONE			English	Article							INNATE IMMUNITY; COPY NUMBER; MUSSELS; EXPRESSION; DEFENSE; INVOLVEMENT; MYTICIN; DNA; RESISTANCE; HEMOCYTES	Background: Effective innate responses against potential pathogens are essential in the living world and possibly contributed to the evolutionary success of invertebrates. Taken together, antimicrobial peptide (AMP) precursors of defensin, mytilin, myticin and mytimycin can represent about 40% of the hemocyte transcriptome in mussels injected with viral-like and bacterial preparations, and unique profiles of myticin C variants are expressed in single mussels. Based on amplicon pyrosequencing, we have ascertained and compared the natural and Vibrio-induced diversity of AMP transcripts in mussel hemocytes from three European regions. Methodology/Principal Findings: Hemolymph was collected from mussels farmed in the coastal regions of Palavas (France), Vigo (Spain) and Venice (Italy). To represent the AMP families known in M. galloprovincialis, nine transcript sequences have been selected, amplified from hemocyte RNA and subjected to pyrosequencing. Hemolymph from farmed (offshore) and wild (lagoon) Venice mussels, both injected with 10 7 Vibrio cells, were similarly processed. Amplicon pyrosequencing emphasized the AMP transcript diversity, with Single Nucleotide Changes (SNC) minimal for mytilin B/C and maximal for arthropod-like defensin and myticin C. Ratio of non-synonymous vs. synonymous changes also greatly differed between AMP isotypes. Overall, each amplicon revealed similar levels of nucleotidic variation across geographical regions, with two main sequence patterns confirmed for mytimycin and no substantial changes after immunostimulation. Conclusions/Significance: Barcoding and bidirectional pyrosequencing allowed us to map and compare the transcript diversity of known mussel AMPs. Though most of the genuine cds variation was common to the analyzed samples we could estimate from 9 to 106 peptide variants in hemolymph pools representing 100 mussels, depending on the AMP isoform and sampling site. In this study, no prevailing SNC patterns related to geographical origin or Vibrio injection emerged. Whether or not the contact with potential pathogens can increase the amount of AMP transcript variants in mussels requires additional study.	[Rosani, Umberto; Varotto, Laura; Rossi, Alberta; Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Roch, Philippe] Univ Montpellier 2, CNRS, IRD, Montpellier, France; [Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Pallavicini, Alberto] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Padua; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Trieste	Rosani, U (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	umberto.rosani@unipd.it; paola.venier@unipd.it	Venier, Paola/J-6302-2019; Pallavicini, Alberto/H-9281-2019; Figueras, Antonio/AAB-8921-2019; Pallavicini, Alberto/J-4158-2012; Figueras, Antonio/B-5133-2015; rosani, umbero/I-6007-2019; Novoa, Beatriz/K-3785-2014	Venier, Paola/0000-0001-9634-3662; Pallavicini, Alberto/0000-0001-7174-4603; Figueras, Antonio/0000-0002-0617-0030; Pallavicini, Alberto/0000-0001-7174-4603; Figueras, Antonio/0000-0002-0617-0030; rosani, umbero/0000-0003-0685-1618; Novoa, Beatriz/0000-0003-4888-8419	 [FOOD-CT-2005-007103];  [20084BEJ9F-PRIN08]	; 	This study was funded by the European project FOOD-CT-2005-007103 (http://imaquanim.dfvf.dk/info) and, in part, by the Italian Project 20084BEJ9F-PRIN08 (http://prin.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, MAR GENOM, V4, P61, DOI 10.1016/j.margen.2011.01.001; Akaishi FM, 2007, AQUAT TOXICOL, V82, P1, DOI 10.1016/j.aquatox.2007.01.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babarro JMF, 2008, COMP BIOCHEM PHYS A, V151, P108, DOI 10.1016/j.cbpa.2008.06.006; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; Benaglio P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013071; BERKOWITZ BA, 1990, BIOCHEM PHARMACOL, V39, P625, DOI 10.1016/0006-2952(90)90138-B; Bers AV, 2006, BIOFOULING, V22, P251, DOI 10.1080/08927010600901112; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Cellura C, 2007, FISH SHELLFISH IMMUN, V22, P340, DOI 10.1016/j.fsi.2006.06.007; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chen QX, 2010, ANESTHESIOLOGY, V112, P1428, DOI 10.1097/ALN.0b013e3181d968eb; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Francisco CJ, 2010, J PARASITOL, V96, P200, DOI 10.1645/GE-2064.1; Galler S, 2008, J MUSCLE RES CELL M, V29, P73, DOI 10.1007/s10974-008-9149-6; Gao B, 2010, DEV COMP IMMUNOL, V34, P659, DOI 10.1016/j.dci.2010.01.012; Gerard K, 2008, MOL PHYLOGENET EVOL, V49, P84, DOI 10.1016/j.ympev.2008.07.006; Gilg MR, 2003, EVOLUTION, V57, P1061, DOI 10.1111/j.0014-3820.2003.tb00316.x; Gomez DK, 2008, J INVERTEBR PATHOL, V97, P197, DOI 10.1016/j.jip.2007.10.012; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Hamilton CE, 2010, RNA BIOL, V7, P220, DOI 10.4161/rna.7.2.11344; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Lazzaro BP, 2011, SCIENCE, V332, P43, DOI 10.1126/science.1200486; Li H, 2010, FISH SHELLFISH IMMUN, V28, P640, DOI 10.1016/j.fsi.2009.12.022; Li H, 2009, DEV COMP IMMUNOL, V33, P974, DOI 10.1016/j.dci.2009.04.002; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Mitta G, 2000, J BIOL CHEM, V275, P12954, DOI 10.1074/jbc.275.17.12954; Mitta G, 2000, J CELL SCI, V113, P2759; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Pantzartzi C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000847; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Parisi MG, 2009, MOL IMMUNOL, V46, P384, DOI 10.1016/j.molimm.2008.10.009; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Rayyan A, 2006, DIS AQUAT ORGAN, V70, P251, DOI 10.3354/dao070251; Roch P, 2008, DEV COMP IMMUNOL, V32, P227, DOI 10.1016/j.dci.2007.05.006; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Rozen S, 2000, Methods Mol Biol, V132, P365; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Smith LC, 2010, DIS MODEL MECH, V3, P1; Sonthi M, 2011, MAR BIOTECHNOL, V13, P857, DOI 10.1007/s10126-010-9345-4; Sperstad SV, 2011, BIOTECHNOL IN PRESS; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031	64	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26680	10.1371/journal.pone.0026680	http://dx.doi.org/10.1371/journal.pone.0026680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087233	gold, Green Published			2022-12-25	WOS:000297347700008
J	Al-Alwan, M; Olabi, S; Ghebeh, H; Barhoush, E; Tulbah, A; Al-Tweigeri, T; Ajarim, D; Adra, C				Al-Alwan, Monther; Olabi, Safiah; Ghebeh, Hazem; Barhoush, Eman; Tulbah, Asma; Al-Tweigeri, Taher; Ajarim, Dahish; Adra, Chaker			Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules	PLOS ONE			English	Article							NF-KAPPA-B; MYOEPITHELIAL CELL LINEAGES; BUNDLING PROTEIN; GENE-EXPRESSION; CARCINOMA METASTASIS; ESTROGEN-RECEPTOR; PLASMINOGEN-ACTIVATOR; RELA/P65 SUBUNIT; TUMOR-METASTASIS; DENDRITIC CELLS	The actin-bundling protein, fascin, is a member of the cytoskeletal protein family that has restricted expression in specialized normal cells. However, many studies have reported the induction of this protein in various transformed cells including breast cancer cells. While the role of fascin in the regulation of breast cancer cell migration has been previously shown, the underlying molecular mechanism remained poorly defined. We have used variety of immunological and functional assays to study whether fascin regulates breast cancer metastasis-associated molecules. In this report we found a direct relationship between fascin expression in breast cancer patients and; metastasis and shorter disease-free survival. Most importantly, in vitro interference with fascin expression by loss or gain of function demonstrates a central role for this protein in regulating the cell morphology, migration and invasion potential. Our results show that fascin regulation of invasion is mediated via modulating several metastasis-associated genes. We show for the first time that fascin down-regulates the expression and nuclear translocation of a key metastasis suppressor protein known as breast cancer metastasis suppressor-1 (BRMS1). In addition, fascin up-regulates NF-kappa B activity, which is essential for metastasis. Importantly, fascin up-regulates other proteins that are known to be critical for the execution of metastasis such as urokinase-type plasminogen activator (uPA) and the matrix metalloproteases (MMP)-2 and MMP-9. This study demonstrates that fascin expression in breast cancer cells establishes a gene expression profile consistent with metastatic tumors and offers a potential therapeutic intervention in metastatic breast cancer treatment through fascin targeting.	[Al-Alwan, Monther; Olabi, Safiah; Ghebeh, Hazem; Barhoush, Eman; Adra, Chaker] King Faisal Specialist Hosp & Res Ctr, Stem Cell Therapy Program, Riyadh 11211, Saudi Arabia; [Tulbah, Asma] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Al-Tweigeri, Taher; Ajarim, Dahish] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia; [Adra, Chaker] Harvard Univ, Brigham & Womens Hosp, Sch Med, TRC, Boston, MA 02115 USA; [Adra, Chaker] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Al-Alwan, M (corresponding author), King Faisal Specialist Hosp & Res Ctr, Stem Cell Therapy Program, Riyadh 11211, Saudi Arabia.	MAlwan@kfshrc.edu.sa	Olabi, Safaih/AAG-8956-2020; Ghebeh, Hazem/AAR-1453-2021	Olabi, Safaih/0000-0002-2850-0475; Ghebeh, Hazem/0000-0002-3297-3996; Al-Alwan, Monther/0000-0003-2150-5297	Research Advisory Council, King Faisal Specialist Hospital and Research Centre [2060 016]	Research Advisory Council, King Faisal Specialist Hospital and Research Centre	This work was supported by the Research Advisory Council (proposal grant 2060 016), King Faisal Specialist Hospital and Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Bashyam MD, 2002, CANCER, V94, P1821, DOI 10.1002/cncr.10362; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Boecker W, 2003, CELL PROLIFERAT, V36, P73, DOI 10.1046/j.1365-2184.36.s.1.7.x; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DUH FM, 1994, DNA CELL BIOL, V13, P821, DOI 10.1089/dna.1994.13.821; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Frolova N, 2009, TUMOR BIOL, V30, P148, DOI 10.1159/000228908; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Gordon LA, 2003, INT J CANCER, V106, P8, DOI 10.1002/ijc.11172; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; JIANG P, 2009, CANC LETT; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mosialos G, 1996, AM J PATHOL, V148, P593; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Naffar-Abu-Amara S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001457; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Onodera M, 2009, LAB INVEST, V89, P1261, DOI 10.1038/labinvest.2009.89; Pinkus GS, 1997, AM J PATHOL, V150, P543; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Saaristo A, 2000, ONCOGENE, V19, P6122, DOI 10.1038/sj.onc.1203969; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Seraj MJ, 2000, CANCER RES, V60, P2764; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Tran J, 2007, MOL THER, V15, P1331, DOI 10.1038/sj.mt.6300184; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xie JJ, 2005, BIOCHEM BIOPH RES CO, V337, P355, DOI 10.1016/j.bbrc.2005.09.055; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	53	79	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27339	10.1371/journal.pone.0027339	http://dx.doi.org/10.1371/journal.pone.0027339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076152	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200066
J	Radpour, R; Barekati, Z; Kohler, C; Schumacher, MM; Grussenmeyer, T; Jenoe, P; Hartmann, N; Moes, S; Letzkus, M; Bitzer, J; Lefkovits, I; Staedtler, F; Zhong, XY				Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Schumacher, Martin M.; Grussenmeyer, Thomas; Jenoe, Paul; Hartmann, Nicole; Moes, Suzette; Letzkus, Martin; Bitzer, Johannes; Lefkovits, Ivan; Staedtler, Frank; Zhong, Xiao Yan			Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment	PLOS ONE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; MYELODYSPLASTIC SYNDROMES; POOR-PROGNOSIS; LUNG-CANCER; CELL-LINES; PHASE-III; IN-VIVO; EXPRESSION; METASTASIS	Background: The contribution of aberrant DNA methylation in silencing of tumor suppressor genes (TSGs) and microRNAs has been investigated. Since these epigenetic alterations are reversible, it became of interest to determine the effects of the 5-aza-2'-deoxycytidine (DAC) demethylation therapy in breast cancer at different molecular levels. Methods and Findings: Here we investigate a synoptic model to predict complete DAC treatment effects at the level of genes, microRNAs and proteins for several human breast cancer lines. The present study assessed an effective treatment dosage based on the cell viability, cytotoxicity, apoptosis and methylation assays for the investigated cell lines. A highly aggressive and a non-aggressive cell line were investigated using omics approaches such as MALDI-TOF MS, mRNA- and microRNA expression arrays, 2-D gel electrophoresis and LC-MS-MS. Complete molecular profiles including the biological interaction and possible early and late systematic stable or transient effects of the methylation inhibition were determined. Beside the activation of several epigenetically suppressed TSGs, we also showed significant dysregulation of some important oncogenes, oncomiRs and oncosuppressors miRNAs as well as drug tolerance genes/miRNAs/proteins. Conclusions: In the present study, the results denote some new molecular DAC targets and pathways based on the chemical modification of DNA methylation in breast cancer. The outlined approach might prove to be useful as an epigenetic treatment model also for other human solid tumors in the management of cancer patients.	[Radpour, Ramin; Barekati, Zeinab; Kohler, Corina; Zhong, Xiao Yan] Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland; [Schumacher, Martin M.; Hartmann, Nicole; Letzkus, Martin; Staedtler, Frank] Novartis Pharma AG, Biomarker Dev, Novartis Inst BioMed Res, Basel, Switzerland; [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Grussenmeyer, Thomas; Lefkovits, Ivan] Univ Basel Hosp, Dept Cardiac Surg, CH-4031 Basel, Switzerland; [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, Basel, Switzerland; [Bitzer, Johannes] Univ Basel, Dept Obstet & Gynecol, Womens Hosp, Basel, Switzerland	University of Basel; Novartis; University of Basel; University of Basel; University of Basel; University of Basel	Radpour, R (corresponding author), Univ Basel, Lab Gynecol Oncol, Womens Hosp, Dept Biomed, Basel, Switzerland.	ivan.lefkovits@unibas.ch; frank.staedtler@novartis.com; zhongx@uhbs.ch	Lefkovits, Ivan/B-9777-2009; Radpour, Ramin/J-4949-2014	Lefkovits, Ivan/0000-0003-1783-8881; Radpour, Ramin/0000-0002-5632-7833; Schumacher, Martin/0000-0001-9538-8682	Swiss National Science Foundation Basel, Switzerland [320000-119722/1, 320030_124958/1]	Swiss National Science Foundation Basel, Switzerland	This work was supported in part by Swiss National Science Foundation (320000-119722/1 and 320030_124958/1) Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; Barekati Z, 2010, HUM MOL GENET, V19, P2936, DOI 10.1093/hmg/ddq199; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Issa Jean-Pierre, 2003, Current Opinion in Oncology, V15, P446, DOI 10.1097/00001622-200311000-00007; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Li JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-354; Li Min, 2005, Archives of Gynecology and Obstetrics, V272, P48, DOI 10.1007/s00404-004-0708-9; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Moggs JG, 2004, TOXICOL APPL PHARM, V196, P422, DOI 10.1016/j.taap.2004.01.009; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; MUSGROVE EA, 1995, INT J CANCER, V63, P584, DOI 10.1002/ijc.2910630420; Plante I., 2010, ONCOGENE; POLLACK MS, 1981, J NATL CANCER I, V66, P1003, DOI 10.1093/jnci/66.6.1003; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016080; Radpour R, 2009, J PROTEOME RES, V8, P5264, DOI 10.1021/pr900591w; Radpour R, 2009, GENET TEST MOL BIOMA, V13, P565, DOI 10.1089/gtmb.2009.0060; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rivenbark AG, 2007, EXP MOL PATHOL, V83, P188, DOI 10.1016/j.yexmp.2007.03.008; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; SMITH HS, 1979, J NATL CANCER I, V62, P225; Subramaniam Deepa S, 2005, Curr Treat Options Oncol, V6, P147, DOI 10.1007/s11864-005-0022-1; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	70	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27355	10.1371/journal.pone.0027355	http://dx.doi.org/10.1371/journal.pone.0027355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076154	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200068
J	Ryman, SG; Gasparovic, C; Bedrick, EJ; Flores, RA; Marshall, AN; Jung, RE				Ryman, Sephira G.; Gasparovic, Chuck; Bedrick, Edward J.; Flores, Ranee A.; Marshall, Alison N.; Jung, Rex E.			Brain Biochemistry and Personality: A Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							N-ACETYLASPARTATE LEVELS; MAJOR DEPRESSION; CINGULATE CORTEX; INTELLIGENCE; EXTROVERSION; ANATOMY; NETWORK; MARKERS	To investigate the biochemical correlates of normal personality we utilized proton magnetic resonance spectroscopy (H-1-MRS). Our sample consisted of 60 subjects ranging in age from 18 to 32 (27 females). Personality was assessed with the NEO Five-Factor Inventory (NEO-FFI). We measured brain biochemistry within the precuneus, the cingulate cortex, and underlying white matter. We hypothesized that brain biochemistry within these regions would predict individual differences across major domains of personality functioning. Biochemical models were fit for all personality domains including Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness. Our findings involved differing concentrations of Choline (Cho), Creatine (Cre), and N-acetylaspartate (NAA) in regions both within (i.e., posterior cingulate cortex) and white matter underlying (i.e., precuneus) the Default Mode Network (DMN). These results add to an emerging literature regarding personality neuroscience, and implicate biochemical integrity within the default mode network as constraining major personality domains within normal human subjects.	[Ryman, Sephira G.; Gasparovic, Chuck; Flores, Ranee A.; Marshall, Alison N.; Jung, Rex E.] Univ New Mexico, Hlth Sci Ctr, MRN, Albuquerque, NM 87131 USA; [Bedrick, Edward J.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Marshall, Alison N.; Jung, Rex E.] Univ New Mexico, Hlth Sci Ctr, Dept Neurosurg, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Ryman, SG (corresponding author), Univ New Mexico, Hlth Sci Ctr, MRN, Albuquerque, NM 87131 USA.	rex.jung@gmail.com		Jung, Rex/0000-0003-3718-0597	John Templeton Foundation [22156]	John Templeton Foundation	This research was funded by grant number 22156 from the John Templeton Foundation entitled "The Neuroscience of Scientific Creativity." http://www.templeton.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; DeYoung C, CAMBRIDGE HDB INTELL; DeYoung CG, 2010, EUR J PERSONALITY, V24, P404; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dinzeo TJ, 2007, J NERV MENT DIS, V195, P421, DOI 10.1097/01.nmd.0000253795.69089.ec; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gjedde A, 1999, ADV EXP MED BIOL, V471, P67; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; Jung RE, 2005, NEUROIMAGE, V26, P965, DOI 10.1016/j.neuroimage.2005.02.039; Jung RE, 2002, BIOL PSYCHIAT, V51, P224, DOI 10.1016/S0006-3223(01)01224-0; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Jung RE, 2009, INTELLIGENCE, V37, P192, DOI 10.1016/j.intell.2008.10.009; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; McCrae R.R., 1993, IMAGIN COGN PERS, V13, P39, DOI [10.2190/H8H6-QYKR-KEU8-GAQ0, DOI 10.2190/H8H6-QYKR-KEU8-GAQ0]; Moore Gregory J, 2002, Psychopharmacol Bull, V36, P5; Moutafi J, 2006, PERS INDIV DIFFER, V40, P587, DOI 10.1016/j.paid.2005.08.004; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pfleiderer B, 2004, NEUROSCIENCE, V123, P1053, DOI 10.1016/j.neuroscience.2003.11.008; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rae C, 1996, P ROY SOC B-BIOL SCI, V263, P1061, DOI 10.1098/rspb.1996.0156; Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; ROSS BD, 1991, NMR BIOMED, V4, P59, DOI 10.1002/nbm.1940040205; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sundberg R, 2002, ENCY ENV; Valenzuela MJ, 2000, NEUROIMAGE, V12, P747, DOI 10.1006/nimg.2000.0629; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WIDIGER TA, 1994, J ABNORM PSYCHOL, V103, P78, DOI 10.1037/0021-843X.103.1.78; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	41	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26758	10.1371/journal.pone.0026758	http://dx.doi.org/10.1371/journal.pone.0026758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073190	Green Published, Green Submitted, gold			2022-12-25	WOS:000297197000012
J	Soria, A; Guerini, FR; Bandera, A; Bolognesi, E; Uglietti, A; Fusco, C; Zucchi, P; Maserati, R; Rizzardini, G; Clerici, M; Gori, A				Soria, Alessandro; Guerini, Franca Rosa; Bandera, Alessandra; Bolognesi, Elisabetta; Uglietti, Alessia; Fusco, Caterina; Zucchi, Patrizia; Maserati, Renato; Rizzardini, Giuliano; Clerici, Mario; Gori, Andrea			KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy	PLOS ONE			English	Article							COUNT RECOVERY; CELL RECOVERY; RECEPTOR; PROGRESSION; SUBTYPES; AIDS	Background: In HIV-infected individuals, mechanisms underlying unsatisfactory immune recovery during effective combination antiretroviral therapy (cART) have yet to be fully understood. We investigated whether polymorphism of genes encoding immune-regulating molecules, such as killer immunoglobulin-like receptors (KIR) and their ligands class I human leukocyte antigen (HLA), could influence immunological response to cART. Methods: KIR and HLA frequencies were analyzed in 154 HIV-infected and cART-treated patients with undetectable viral load divided into two groups: 'immunological non responders' (INR, N = 50, CD4(+) T-cell count <200/mm(3)) and full responders (FR, N = 104, CD4(+) T-cell count >350/mm(3)). Molecular KIR were typed using polymerase chain reaction-based genotyping. Comparisons were adjusted for baseline patient characteristics. Results: The frequency of KIR2DL3 allele was significantly higher in FR than in INR (83.7% vs. 62%, P = 0.005). The functional compound genotype HLA-C1(+)/KIR2DL3(+), even at multivariable analysis, when adjusted for nadir CD4(+) T-cell count, was associated with reduced risk of INR status: odds ratio (95% Confidence Intervals) 0.34 (0.13-0.88), P = 0.03. Conclusions: Reduced presence of the inhibitory KIR2DL3 genotype detected in INR might provoke an imbalance in NK function, possibly leading to increased immune activation, impaired killing of latently infected cells, and higher proviral burden. These factors would hinder full immune recovery during therapy.	[Soria, Alessandro; Bandera, Alessandra; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Guerini, Franca Rosa; Bolognesi, Elisabetta; Clerici, Mario] Don C Gnocchi Fdn IRCCS, Lab Mol Med & Biotechnol, Milan, Italy; [Uglietti, Alessia; Maserati, Renato] Fdn IRCCS San Matteo Hosp, Dept Infect Dis, Pavia, Italy; [Fusco, Caterina] AORN A Cardarelli, Immunohematol & Transfus Serv, Naples, Italy; [Zucchi, Patrizia; Rizzardini, Giuliano] Luigi Sacco Hosp, Div Infect Dis, Milan, Italy; [Clerici, Mario] Univ Milan, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione San Matteo; University of Milan; Luigi Sacco Hospital; University of Milan	Soria, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.soria@hsgerardo.org	Guerini, Franca R./G-8055-2012; Gori, Andrea/AAC-6078-2022; Zucchi, Patrizia/AFQ-5312-2022; Bandera, Alessandra/AAC-6081-2022; Bolognesi, Elisabetta/AAC-1629-2022; Bandera, Alessandra/D-6255-2015	Guerini, Franca R./0000-0001-9461-5927; SORIA, Alessandro/0000-0002-4447-2574; Clerici, Mario/0000-0001-5920-6191; Bolognesi, Elisabetta/0000-0001-5554-1697; Fusco, Caterina/0000-0001-8124-6376; BANDERA, ALESSANDRA/0000-0001-9440-4601; Bandera, Alessandra/0000-0003-1626-0328	Cariplo Foundation [2006.0687/10.4877]; "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Cariplo Foundation(Fondazione Cariplo); "Ermenegildo Zegna" Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	This work was supported by a grant from Cariplo Foundation (2006.0687/10.4877), "Ermenegildo Zegna" Foundation, Italy, and Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Boyton RJ, 2006, AM J RESP CRIT CARE, V173, P327, DOI 10.1164/rccm.200501-124OC; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferraris L, 2008, CLIN INFECT DIS, V46, P149, DOI 10.1086/524087; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; KLATT N, 2010, 17 C RETR OPP INF SA; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Wong AHW, 2010, AIDS RES HUM RETROV, V26, P459, DOI 10.1089/aid.2009.0176	24	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27349	10.1371/journal.pone.0027349	http://dx.doi.org/10.1371/journal.pone.0027349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073315	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000048
J	Vaknin, I; Kunis, G; Miller, O; Butovsky, O; Bukshpan, S; Beers, DR; Henkel, JS; Yoles, E; Appel, SH; Schwartz, M				Vaknin, Ilan; Kunis, Gilad; Miller, Omer; Butovsky, Oleg; Bukshpan, Shay; Beers, David R.; Henkel, Jenny S.; Yoles, Eti; Appel, Stanley H.; Schwartz, Michal			Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPPRESSOR-CELLS; IMMUNE-SYSTEM; INHERITED ALS; MOTOR-NEURONS; DISEASE; CANCER; MODEL; IMMUNOSUPPRESSION; NEUROPROTECTION	Background: Circulating immune cells including autoreactive T cells and monocytes have been documented as key players in maintaining, protecting and repairing the central nervous system (CNS) in health and disease. Here, we hypothesized that neurodegenerative diseases might be associated, similarly to tumors, with increased levels of circulating peripheral myeloid derived suppressor cells (MDSCs), representing a subset of suppressor cells that often expand under pathological conditions and inhibit possible recruitment of helper T cells needed for fighting off the disease. Methods and Findings: We tested this working hypothesis in amyotrophic lateral sclerosis (ALS) and its mouse model, which are characterized by a rapid progression once clinical symptoms are evident. Adaptive transfer of alternatively activated myeloid (M2) cells, which homed to the spleen and exhibited immune suppressive activity in G93A mutant superoxide dismutase-1 (mSOD1) mice at a stage before emergence of disease symptoms, resulted in earlier appearance of disease symptoms and shorter life expectancy. The same protocol mitigated the inflammation-induced disease model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), which requires circulating T cells for disease induction. Analysis of whole peripheral blood samples obtained from 28 patients suffering from sporadic ALS (sALS), revealed a two-fold increase in the percentage of circulating MDSCs (LIN(-/Low)HLA-DR(-)CD33(+)) compared to controls. Conclusions: Taken together, these results emphasize the distinct requirements for fighting the inflammatory neurodegenerative disease, multiple sclerosis, and the neurodegenerative disease, ALS, though both share a local inflammatory component. Moreover, the increased levels of circulating MDSCs in ALS patients indicates the operation of systemic mechanisms that might lead to an impairment of T cell reactivity needed to overcome the disease conditions within the CNS. This high level of suppressive immune cells might represent a risk factor and a novel target for therapeutic intervention in ALS at least at the early stage.	[Vaknin, Ilan; Kunis, Gilad; Miller, Omer; Butovsky, Oleg; Bukshpan, Shay; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Beers, David R.; Henkel, Jenny S.; Appel, Stanley H.] Methodist Hosp, Res Inst, Methodist Neurol Inst, Dept Neurol, Houston, TX 77030 USA; [Yoles, Eti] NeuroQuest Ltd, Misgav Venture Accelerator, Misgav, Israel	Weizmann Institute of Science; The Methodist Hospital System; The Methodist Hospital - Houston	Vaknin, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	sappel@tmhs.org; michal.schwartz@weizmann.ac.il	Butovsky, Oleg/ABG-9086-2020	Butovsky, Oleg/0000-0003-0186-8867	Israel Science Foundation (ISF) [710312020]; IsrA.L.S Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); IsrA.L.S Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Israel Science Foundation (ISF)-Legacy-Bio-Med program, grant No. 710312020, and was also supported by the IsrA.L.S Research Fund. The funders had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; nor the preparation, review, or approval of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Katchar K, 2001, SCAND J IMMUNOL, V54, P220, DOI 10.1046/j.1365-3083.2001.00923.x; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moline-Velazquez V, 2011, BRAIN PATHOL, V21, P678, DOI 10.1111/j.1750-3639.2011.00495.x; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SEKSENYAN A, 2009, J CELL MOL MED; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009	30	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26921	10.1371/journal.pone.0026921	http://dx.doi.org/10.1371/journal.pone.0026921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073221	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000016
J	Zhang, Z; Tao, LM; Chen, Z; Zhou, DZ; Kan, MY; Zhang, D; Li, C; He, L; Liu, Y				Zhang, Zhou; Tao, Liming; Chen, Zhuo; Zhou, Daizhan; Kan, Mengyuan; Zhang, Di; Li, Can; He, Lin; Liu, Yun			Association of Genetic Loci with Blood Lipids in the Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-DISEASE; RISK; CHOLESTEROL; TRIGLYCERIDES; POLYMORPHISM	Background: Recent genome-wide association (GWA) studies have identified a number of novel genetic determinants of blood lipid concentrations in Europeans. However, it is still unclear whether these loci identified in the Caucasian GWA studies also exert the same effect on lipid concentrations in the Chinese population. Methods and Results: We conducted a replication study assessing associations between SNPs at 15 loci and blood lipid and lipoprotein concentrations in two Chinese cohorts, comprising 2533 and 2105 individuals respectively. SNPs in APO(A1/C3/A4/A5), TIMD4-HAVCR1, DOCK7, TRIB1, ABCA1, and TOMM40-APOE showed strong associations with at least one lipids trait, and rs174546 in FADS1/2/3 showed modest association with triglyceride in the Chinese population. Conclusions: We successfully replicated 7 loci associated plasma lipid concentrations in the Chinese population. Our study confirmed the implication of APO(A1/C3/A4/A5), TOMM40-APOE, ABCA1, DOCK7, TIMD4-HAVCR1, TRIB1 and FADS1/2 in plasma lipid and lipoprotein concentrations in Chinese population.	[Zhang, Zhou; Tao, Liming; Chen, Zhuo; Zhou, Daizhan; Kan, Mengyuan; Zhang, Di] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Zhang, Zhou; He, Lin; Liu, Yun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Can; He, Lin] Shanghai Jiao Tong Univ, Key Lab Dev Genet & Neuropsychiat Dis, Minist Educ, Bio X Ctr, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Shanghai Jiao Tong University	Zhang, Z (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China.	helin@bio-x.cn; superliuyun@gmail.com	liming, tao/D-7969-2013; chen, zhuo/E-7041-2012		973 Program [2010CB529600, 2007CB947300, 2006CB910601]; 863 Program [2006AA02A407, 2009AA022701]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; National Key Project for Investigational New Drug [2008ZX09312-003]; Shanghai Leading Academic Discipline Project [B205]; National Natural Science Foundation of China [909190492, 30972529]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Shanghai Municipal Commission of Science and Technology Program; National Key Project for Investigational New Drug; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 Program (2010CB529600, 2007CB947300, 2006CB910601), the 863 Program (2006AA02A407, 2009AA022701), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the National Key Project for Investigational New Drug 2008ZX09312-003, and the Shanghai Leading Academic Discipline Project (B205), and the National Natural Science Foundation of China (No. 909190492, 30972529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Delgado-Lista J, 2010, J LIPID RES, V51, P63, DOI 10.1194/jlr.M800527-JLR200; Gomez P, 2010, J NUTR, V140, P773, DOI 10.3945/jn.109.115964; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Pan LA, 2009, CARDIOLOGY, V114, P174, DOI 10.1159/000226610; Park MH, 2011, J MED GENET, V48, P10, DOI 10.1136/jmg.2010.081000; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	22	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27305	10.1371/journal.pone.0027305	http://dx.doi.org/10.1371/journal.pone.0027305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073310	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000045
J	Coude, G; Ferrari, PF; Roda, F; Maranesi, M; Borelli, E; Veroni, V; Monti, F; Rozzi, S; Fogassi, L				Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Borelli, Eleonora; Veroni, Vania; Monti, Fabio; Rozzi, Stefano; Fogassi, Leonardo			Neurons Controlling Voluntary Vocalization in the Macaque Ventral Premotor Cortex	PLOS ONE			English	Article							LEARNED VOCAL COMMUNICATION; TRAINED TONGUE-PROTRUSION; FACE MOTOR CORTEX; MIRROR NEURONS; RHESUS-MONKEYS; REVERSIBLE INACTIVATION; FUNCTIONAL-PROPERTIES; CORTICAL CONNECTIONS; PREFRONTAL CORTEX; NONHUMAN PRIMATE	The voluntary control of phonation is a crucial achievement in the evolution of speech. In humans, ventral premotor cortex (PMv) and Broca's area are known to be involved in voluntary phonation. In contrast, no neurophysiological data are available about the role of the oro-facial sector of nonhuman primates PMv in this function. In order to address this issue, we recorded PMv neurons from two monkeys trained to emit coo-calls. Results showed that a population of motor neurons specifically fire during vocalization. About two thirds of them discharged before sound onset, while the remaining were time-locked with it. The response of vocalization-selective neurons was present only during conditioned (voluntary) but not spontaneous (emotional) sound emission. These data suggest that the control of vocal production exerted by PMv neurons constitutes a newly emerging property in the monkey lineage, shedding light on the evolution of phonation-based communication from a nonhuman primate species.	[Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Borelli, Eleonora; Veroni, Vania; Monti, Fabio; Rozzi, Stefano; Fogassi, Leonardo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Ferrari, Pier Francesco] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Fogassi, Leonardo] Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; [Coude, Gino; Ferrari, Pier Francesco; Roda, Francesca; Maranesi, Monica; Rozzi, Stefano; Fogassi, Leonardo] Ist Italiano Tecnol, Parma, Italy	University of Parma; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT	Coude, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	gino.coude@nemo.unipr.it	Ferrari, Pier Francesco/G-5547-2017; Borelli, Eleonora/AAU-9973-2021; Rozzi, Stefano/F-9915-2019; FOGASSI, Leonardo/K-3541-2018	Rozzi, Stefano/0000-0002-6147-1530; Borelli, Eleonora/0000-0002-3391-4437; FOGASSI, Leonardo/0000-0003-3348-039X; Maranesi, Monica/0000-0002-8090-3300; Roda', Francesca/0000-0003-4740-8743	European Program Neurocom [12738]; Italian Ministry of Education, Universities and Research [2004057380]	European Program Neurocom; Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by European Program Neurocom no. 12738 2005-2008 and by the Italian Ministry of Education, Universities and Research (Cofin) no. 2004057380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1979, BRAIN LANG, V8, P227, DOI 10.1016/0093-934X(79)90051-8; AITKEN PG, 1981, BRAIN LANG, V13, P171, DOI 10.1016/0093-934X(81)90137-1; Belmalih A, 2009, J COMP NEUROL, V512, P183, DOI 10.1002/cne.21892; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Buch ER, 2006, EXP BRAIN RES, V169, P69, DOI 10.1007/s00221-005-0130-y; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Egnor SER, 2006, AM J PRIMATOL, V68, P1183, DOI 10.1002/ajp.20317; Fant G., 1960, ACOUSTIC THEORY SPEE; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Fogassi L, 2007, CURR DIR PSYCHOL SCI, V16, P136, DOI 10.1111/j.1467-8721.2007.00491.x; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2008, CURR BIOL, V18, pR457, DOI 10.1016/j.cub.2008.03.030; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; HAKE DF, 1979, J EXP ANAL BEHAV, V32, P305, DOI 10.1901/jeab.1979.32-305; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hihara S, 2003, NEUROSCI RES, V45, P383, DOI 10.1016/S0168-0102(03)00011-7; HUANG CS, 1988, J NEUROPHYSIOL, V59, P796, DOI 10.1152/jn.1988.59.3.796; Izumi A, 2001, COGN AFFECT BEHAV NE, V1, P266, DOI 10.3758/CABN.1.3.266; JURGENS U, 1970, EXP BRAIN RES, V10, P532; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lal H., 1967, PSYCHON SCI, V8, P35; Lieberman P, 1998, BEHAV BRAIN SCI, V21, P520, DOI 10.1017/S0140525X98341266; LOUBOUNGOU M, 1987, PRIMATES, V28, P367, DOI 10.1007/BF02381019; MCGUINNESS E, 1980, J COMP NEUROL, V193, P591, DOI 10.1002/cne.901930302; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; MOLLIVER ME, 1963, J EXP ANAL BEHAV, V6, P197, DOI 10.1901/jeab.1963.6-197; Moran A, 2006, MOVEMENT DISORD, V21, P1425, DOI 10.1002/mds.20995; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; MURRAY GM, 1992, J NEUROPHYSIOL, V67, P775, DOI 10.1152/jn.1992.67.3.775; MURRAY GM, 1991, J NEUROPHYSIOL, V65, P511, DOI 10.1152/jn.1991.65.3.511; MYERS RE, 1976, ANN NY ACAD SCI, V280, P745, DOI 10.1111/j.1749-6632.1976.tb25537.x; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Pardo-Vazquez JL, 2008, J NEUROSCI, V28, P12396, DOI 10.1523/JNEUROSCI.3396-08.2008; PENFIELD WILDER, 1950; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; PIERCE J D JR, 1985, Primates, V26, P202, DOI 10.1007/BF02382019; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Rasmussen T., 1975, CEREBRAL LOCALIZATIO, P238, DOI DOI 10.1007/978-3-642-66204-1.J9; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P427; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; SALZINGER K, 1962, J EXP ANAL BEHAV, V5, P383, DOI 10.1901/jeab.1962.5-383; Seyfarth RM, 1997, ANIM LEARN BEHAV, V25, P249, DOI 10.3758/BF03199083; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Simoes CS, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00123; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; SINNOTT JM, 1975, J ACOUST SOC AM, V58, P412, DOI 10.1121/1.380685; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; SUTTON D, 1973, BRAIN RES, V52, P225, DOI 10.1016/0006-8993(73)90660-4; SUTTON D, 1974, BRAIN RES, V71, P61, DOI 10.1016/0006-8993(74)90191-7; WEST RA, 1995, J NEUROPHYSIOL, V74, P1856, DOI 10.1152/jn.1995.74.5.1856; Yamaguchi C, 2008, ORIGINS LANGUAGE UNR; YAMAGUCHI SI, 1972, BRAIN RES, V37, P109, DOI 10.1016/0006-8993(72)90350-2; Yoshino K, 1998, NEUROSCI RES, V30, P321, DOI 10.1016/S0168-0102(98)00014-5	71	103	103	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26822	10.1371/journal.pone.0026822	http://dx.doi.org/10.1371/journal.pone.0026822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073201	Green Published, gold			2022-12-25	WOS:000297154900041
J	Dejean, A; Cereghino, R; Carpenter, JM; Corbara, B; Herault, B; Rossi, V; Leponce, M; Orivel, J; Bonal, D				Dejean, Alain; Cereghino, Regis; Carpenter, James M.; Corbara, Bruno; Herault, Bruno; Rossi, Vivien; Leponce, Maurice; Orivel, Jerome; Bonal, Damien			Climate Change Impact on Neotropical Social Wasps	PLOS ONE			English	Article							EL-NINO; AMPHIBIAN EXTINCTIONS; DROUGHT; ECOLOGY; FOREST; SEASONALITY; RESPONSES; VESPIDAE; PRODUCTIVITY; TERRESTRIAL	Establishing a direct link between climate change and fluctuations in animal populations through long-term monitoring is difficult given the paucity of baseline data. We hypothesized that social wasps are sensitive to climatic variations, and thus studied the impact of ENSO events on social wasp populations in French Guiana. We noted that during the 2000 La Nina year there was a 77.1% decrease in their nest abundance along ca. 5 km of forest edges, and that 70.5% of the species were no longer present. Two simultaneous 13-year surveys (1997-2009) confirmed the decrease in social wasps during La Nina years (2000 and 2006), while an increase occurred during the 2009 El Nino year. A 30-year weather survey showed that these phenomena corresponded to particularly high levels of rainfall, and that temperature, humidity and global solar radiation were correlated with rainfall. Using the Self-Organizing Map algorithm, we show that heavy rainfall during an entire rainy season has a negative impact on social wasps. Strong contrasts in rainfall between the dry season and the short rainy season exacerbate this effect. Social wasp populations never recovered to their pre-2000 levels. This is probably because these conditions occurred over four years; heavy rainfall during the major rainy seasons during four other years also had a detrimental effect. On the contrary, low levels of rainfall during the major rainy season in 2009 spurred an increase in social wasp populations. We conclude that recent climatic changes have likely resulted in fewer social wasp colonies because they have lowered the wasps' resistance to parasitoids and pathogens. These results imply that Neotropical social wasps can be regarded as bio-indicators because they highlight the impact of climatic changes not yet perceptible in plants and other animals.	[Dejean, Alain; Orivel, Jerome] CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France; [Dejean, Alain; Cereghino, Regis] Univ Toulouse 3, F-31062 Toulouse, France; [Dejean, Alain; Cereghino, Regis] Univ Toulouse, Toulouse, France; [Cereghino, Regis] CNRS, UMR 5245, Lab Ecol Fonct & Environm EcoLab, Toulouse, France; [Carpenter, James M.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Corbara, Bruno] Univ Blaise Pascal, CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Corbara, Bruno] Univ Blaise Pascal, Clermont Univ, F-63000 Clermont Ferrand, France; [Herault, Bruno] Ecol Forets Guyane UMR UAG 43, Kourou, France; [Herault, Bruno] Univ Antilles Guyane, Kourou, France; [Rossi, Vivien] CIRAD, Kourou, France; [Rossi, Vivien] Ecol Forets Guyane UMR CIRAD 93, Kourou, France; [Leponce, Maurice] Royal Belgian Inst Nat Sci, Biol Evaluat Sect, Brussels, Belgium; [Bonal, Damien] INRA Nancy, UMR EEF, Nancy, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Royal Belgian Institute of Natural Sciences; INRAE; Universite de Lorraine	Dejean, A (corresponding author), CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France.	alain.dejean@wanadoo.fr	Rossi, Vivien/C-9721-2009; Hérault, Bruno/B-2765-2011; CEREGHINO, Regis/G-9500-2011	Rossi, Vivien/0000-0001-5458-1523; Hérault, Bruno/0000-0002-6950-7286; CORBARA, Bruno/0000-0003-4232-8234; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Cereghino, Regis/0000-0003-3981-3159; Carpenter, James/0000-0001-6754-8028	French Centre National de la Recherche Scientifique [2ID]; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Bouwma AM, 2005, BEHAV ECOL SOCIOBIOL, V59, P222, DOI 10.1007/s00265-005-0028-5; Bouwma AM, 2007, BIOTROPICA, V39, P719, DOI 10.1111/j.1744-7429.2007.00321.x; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Collins M, 2005, CLIM DYNAM, V24, P89, DOI 10.1007/s00382-004-0478-x; Colwell RK, ESTIMATES STAT ESTIM; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corbara B, 2009, CR BIOL, V332, P470, DOI 10.1016/j.crvi.2009.01.003; Cowling SA, 2004, PHILOS T R SOC B, V359, P539, DOI 10.1098/rstb.2003.1427; Dejean A, 1998, INSECT SOC, V45, P33, DOI 10.1007/s000400050066; Dejean A, 2010, CR BIOL, V333, P35, DOI 10.1016/j.crvi.2009.10.007; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diniz IR, 1998, REV BIOL TROP, V46, P109; Fonty E, 2009, GLOBAL CHANGE BIOL, V15, P2360, DOI 10.1111/j.1365-2486.2009.01923.x; Gaston AJ, 2005, AVIAN CONSERV ECOL, V1; Gergis J.L., 2006, ADV GEOSCI, V6, P173, DOI [10.5194/adgeo-6-173-2006, DOI 10.5194/ADGEO-6-173-2006, DOI 10.5194/ADGE0-6-173-2006]; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Grant PR, 2000, ECOLOGY, V81, P2442, DOI 10.2307/177466; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; Harrison RD, 2001, POPUL ECOL, V43, P63, DOI 10.1007/PL00012017; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heinrich B., 1996, THERMAL WARRIORS STR; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Howard KJ, 2004, INSECT SOC, V51, P179, DOI 10.1007/s00040-004-0730-8; Hunt JH, 1999, BIOTROPICA, V31, P192; Hunt JH, 2001, ANN ENTOMOL SOC AM, V94, P555, DOI 10.1603/0013-8746(2001)094[0555:OOTNSF]2.0.CO;2; IPCC, 2007, CLIM CHANG 2007 PHYS; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Jeanne RL, 1996, BEHAV ECOL, V7, P43, DOI 10.1093/beheco/7.1.43; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; Kayano MT, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006142; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Kumar A, 2009, BIOTROPICA, V41, P338, DOI 10.1111/j.1744-7429.2008.00483.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P1, DOI 10.1111/j.1442-9993.2007.01812.x; Li WH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006355; London KB, 1998, J KANSAS ENTOMOL SOC, V71, P175; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Meisel JE, 2006, ECOL APPL, V16, P913, DOI 10.1890/1051-0761(2006)016[0913:TEOTNA]2.0.CO;2; O'Donnell S, 2001, BIOTROPICA, V33, P727, DOI 10.1646/0006-3606(2001)033[0727:SACCIA]2.0.CO;2; ODONNELL S, 1990, J TROP ECOL, V6, P507, DOI 10.1017/S0266467400004958; Parks D, 2011, CLIMATE CHANGE CATER; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011325; Payne CD, 1986, GEN LINEAR INTERACTI; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Santos GMD, 2009, ENVIRON ENTOMOL, V38, P1613, DOI 10.1603/022.038.0613; Santos GMDM, 2007, NEOTROP ENTOMOL, V36, P180, DOI 10.1590/S1519-566X2007000200002; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; Tsonis AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022875; Van Bael SA, 2004, J TROP ECOL, V20, P625, DOI 10.1017/S0266467404001725; Vargas G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028812; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	62	30	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27004	10.1371/journal.pone.0027004	http://dx.doi.org/10.1371/journal.pone.0027004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073236	Green Published, gold			2022-12-25	WOS:000297154900061
J	Jain, S; Chang, TT; Hamilton, JP; Lin, SY; Lin, YJ; Evans, AA; Selaru, FM; Lin, PW; Chen, SH; Block, TM; Hu, CT; Song, W; Meltzer, SJ; Su, YH				Jain, Surbhi; Chang, Ting-Tsung; Hamilton, James P.; Lin, Selena Y.; Lin, Yih-Jyh; Evans, Alison A.; Selaru, Florin M.; Lin, Pin-Wen; Chen, Shun-Hua; Block, Timothy M.; Hu, Chi-Tan; Song, Wei; Meltzer, Stephen J.; Su, Ying-Hsiu			Methylation of the CpG Sites Only on the Sense Strand of the APC Gene Is Specific for Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; LUNG-CANCER PATIENTS; ISLAND HYPERMETHYLATION; PROMOTER METHYLATION; COLORECTAL-CANCER; ABERRANT METHYLATION; BREAST-CANCER; DNA; MARKERS; LIVER	Hypermethylation of the promoter of the tumor suppressor gene, adenomatous polyposis coli (APC), occurs in various malignancies, including hepatocellular carcinoma (HCC). However, reports on the specificity of the methylation of the APC gene for HCC have varied. To gain insight into how these variations occur, bisulfite PCR sequencing was performed to analyze the methylation status of both sense and antisense strands of the APC gene in samples of HCC tissue, matched adjacent non-HCC liver tissue, hepatitis, cirrhosis, and normal liver tissues. DNA derived from fetal liver and 12 nonhepatic normal tissue was also examined. These experiments revealed liver-specific, antisense strand-biased CpG methylation of the APC gene and suggested that, although methylation of the antisense strand of the APC gene exists in normal liver and other non-HCC disease liver tissue, methylation of the sense strand of the APC gene occurs predominantly in HCC. To determine the effect of the DNA strand on the specificity of the methylated APC gene as a biomarker for HCC detection, quantitative methylation-specific PCR assays for sense and antisense strand DNA were developed and performed on DNA isolated from HCC (n = 58), matched adjacent non-HCC (n = 58), cirrhosis (n = 41), and hepatitis (n = 39). Receiver operating characteristic curves were constructed. With the cutoff value set at the limit of detection, the specificity of sense and antisense strand methylation was 84% and 43%, respectively, and sensitivity was 67.2% and 72.4%, respectively. This result demonstrated that the identity of the methylated DNA strand impacted the specificity of APC for HCC detection. Interestingly, methylation of the sense strand of APC occurred in 40% of HCCs from patients with serum AFP levels less than 20 ng/mL, suggesting a potential role for APC as a biomarker to complement AFP in HCC screening.	[Jain, Surbhi; Lin, Selena Y.; Block, Timothy M.; Su, Ying-Hsiu] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Dept Med, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Hamilton, James P.; Selaru, Florin M.; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Lin, Yih-Jyh; Lin, Pin-Wen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Evans, Alison A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Chen, Shun-Hua] Natl Cheng Kung Univ, Coll Med, Dept Microbiol, Tainan 70101, Taiwan; [Hu, Chi-Tan] Buddhist Tzu Chi Gen Hosp, Dept Gen Med, Hualien, Taiwan; [Song, Wei] JBS Sci Inc, Philadelphia, PA USA	Drexel University; National Cheng Kung University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National Cheng Kung University; National Cheng Kung University Hospital; Drexel University; National Cheng Kung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Jain, S (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	Ying-hsiu.Su@drexelmed.edu	Evans, Alison/I-4970-2013	Selaru, Florin/0000-0001-7990-8238	National Institutes of Health [R01 CA125642, CA146799, CA133012, CA085069, DK087454, K08]; Johns Hopkins University School of Medicine; Prevent Cancer Foundation; Early Detection Research Network of The National Cancer Institute; Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA125642, U01CA085069, R01CA136607, R01CA133012, R01CA146799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454, K08DK090154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University School of Medicine(Johns Hopkins University); Prevent Cancer Foundation; Early Detection Research Network of The National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hepatitis B Foundation of America; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 CA125642 (Y-HS), CA146799(SM), CA133012 (SM), CA085069 (SM), DK087454 (SM), and K08 (JH); a Clinician-Scientist Award from Johns Hopkins University School of Medicine (JH); Prevent Cancer Foundation Postdoctoral Fellowship Award (SJ); The Early Detection Research Network grant of The National Cancer Institute (TB); The Hepatitis B Foundation of America (TB); and an appropriation from The Commonwealth of Pennsylvania (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2010, CANC FACTS FIG; An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Chang H, 2008, EXP MOL PATHOL, V85, P96, DOI 10.1016/j.yexmp.2008.07.001; Clement G, 2004, CANCER RES, V64, P6867, DOI 10.1158/0008-5472.CAN-03-2503; Csepregi A, 2008, J CANCER RES CLIN, V134, P579, DOI 10.1007/s00432-007-0321-y; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Esteller M, 2000, CANCER RES, V60, P4366; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 2001, CANCER RES, V61, P3225; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Glockner SC, 2009, CANCER RES, V69, P4691, DOI 10.1158/0008-5472.CAN-08-0142; Harder J, 2008, INT J CANCER, V122, P2800, DOI 10.1002/ijc.23433; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Iyer P, EXPT MOL PATHOLOGY, V88, P107; Iyer P, 2010, EXP MOL PATHOL, V88, P107, DOI 10.1016/j.yexmp.2009.09.012; Jain S, 2010, AM J TRANSL RES, V2, P105; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Katoh H, 2006, GENE CHROMOSOME CANC, V45, P1050, DOI 10.1002/gcc.20362; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lee TL, 2002, CLIN CANCER RES, V8, P1761; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Pao MM, 2001, HUM MOL GENET, V10, P903, DOI 10.1093/hmg/10.9.903; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Qu ZX, 2010, J BIOL CHEM, V285, P11786, DOI 10.1074/jbc.M109.086561; Ronneberg JA, 2008, CANCER RES, V68, P5562, DOI 10.1158/0008-5472.CAN-07-5828; Tsuchiya T, 2000, ONCOGENE, V19, P3642, DOI 10.1038/sj.onc.1203704; Uhlmann K, 2002, EVALUATION POTENTIAL, P4072; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Veeck J, 2010, J CLIN ONCOL, V28, pE563, DOI 10.1200/JCO.2010.30.1010; Wong IHN, 1999, CANCER RES, V59, P71; Wright LA, 2007, CANCER DETECT PREV, V31, P35, DOI 10.1016/j.cdp.2006.11.003; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4	46	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26799	10.1371/journal.pone.0026799	http://dx.doi.org/10.1371/journal.pone.0026799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073196	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900038
J	Landmann, C; Landi, SM; Grafton, ST; Della-Maggiore, V				Landmann, Claire; Landi, Sofia M.; Grafton, Scott T.; Della-Maggiore, Valeria			fMRI Supports the Sensorimotor Theory of Motor Resonance	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; MOVEMENT; PARIETAL; AREAS; RESPONSES; MODULATION; ACTIVATION; EXECUTION; REGIONS; EVENTS	The neural mechanisms mediating the activation of the motor system during action observation, also known as motor resonance, are of major interest to the field of motor control. It has been proposed that motor resonance develops in infants through Hebbian plasticity of pathways connecting sensory and motor regions that fire simultaneously during imitation or self movement observation. A fundamental problem when testing this theory in adults is that most experimental paradigms involve actions that have been overpracticed throughout life. Here, we directly tested the sensorimotor theory of motor resonance by creating new visuomotor representations using abstract stimuli (motor symbols) and identifying the neural networks recruited through fMRI. We predicted that the network recruited during action observation and execution would overlap with that recruited during observation of new motor symbols. Our results indicate that a network consisting of premotor and posterior parietal cortex, the supplementary motor area, the inferior frontal gyrus and cerebellum was activated both by new motor symbols and by direct observation of the corresponding action. This tight spatial overlap underscores the importance of sensorimotor learning for motor resonance and further indicates that the physical characteristics of the perceived stimulus are irrelevant to the evoked response in the observer.	[Landmann, Claire; Landi, Sofia M.; Della-Maggiore, Valeria] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Buenos Aires, DF, Argentina; [Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	University of Buenos Aires; University of California System; University of California Santa Barbara	Landmann, C (corresponding author), Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, Buenos Aires, DF, Argentina.	vdellamaggiore@fmed.uba.ar		Della-Maggiore, Valeria/0000-0001-9586-4255	National Institutes of Health [RO3 TW007815-01A1]; National Agency for the Promotion of Science and Technology [PICT 34312]; FOGARTY INTERNATIONAL CENTER [R03TW007815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Agency for the Promotion of Science and Technology(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Institutes of Health grant "Fogarty International Research Collaboration Award" (STG and VDM, RO3 TW007815-01A1, http://www.fic.nih.gov/programs/pages/research-collaboration.aspx) and by the National Agency for the Promotion of Science and Technology (VDM, PICT 34312, http://www.agencia.gov.ar/spip.php?article28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Buch ER, 2006, EXP BRAIN RES, V169, P69, DOI 10.1007/s00221-005-0130-y; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Engel A, 2008, SOC NEUROSCI, V3, P368, DOI 10.1080/17470910701612793; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PASSINGHAM RE, 1988, EXP BRAIN RES, V70, P590; PASSINGHAM RE, 1985, BEHAV BRAIN RES, V18, P175, DOI 10.1016/0166-4328(85)90073-7; PASSINGHAM RE, 1985, NEUROPSYCHOLOGIA, V23, P453, DOI 10.1016/0028-3932(85)90001-6; PASSINGHAM RE, 1989, BRAIN BEHAV EVOLUT, V33, P189, DOI 10.1159/000115927; Petroni A, 2010, J NEUROPHYSIOL, V104, P1867, DOI 10.1152/jn.00386.2010; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rothwell J. C, 2008, OXFORD HDB TRANSCRAN, P171; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; Talairach J., 1988, COPLANAR STEREOTAXIC; Thoenissen D, 2002, J NEUROSCI, V22, P9024; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Toni I, 2002, J COGNITIVE NEUROSCI, V14, P769, DOI 10.1162/08989290260138663; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	45	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26859	10.1371/journal.pone.0026859	http://dx.doi.org/10.1371/journal.pone.0026859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073209	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900046
J	Pringle, LM; Young, R; Quick, L; Riquelme, DN; Oliveira, AM; May, MJ; Chou, MM				Pringle, L. M.; Young, R.; Quick, L.; Riquelme, D. N.; Oliveira, A. M.; May, M. J.; Chou, M. M.			Atypical mechanism of NF-kappa B activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis	ONCOGENE			English	Article						TRE17; USP6; aneurysmal bone cyst; NF-kappa B; I kappa B	ANEURYSMAL BONE-CYST; IKK-BETA; P65 PHOSPHORYLATION; SIGNALING PATHWAY; ANGIOTENSIN-II; KINASE ALPHA; CANCER; SERINE-536; TRANSCRIPTION; UBIQUITIN	The NF-kappa B transcription factor has a central role in diverse processes, including inflammation, proliferation and cell survival, and its activity is dysregulated in diseases such as autoimmunity and cancer. We recently identified the TRE17/ubiquitin-specific protease 6 (USP6) oncogene as the first deubiquitinating enzyme to activate NF-kappa B. TRE17/USP6 is translocated and overexpressed in aneurysmal bone cyst (ABC), a pediatric tumor characterized by extensive bone degradation and inflammatory recruitment. In the current study, we explore the mechanism by which TRE17 induces activation of NF-kappa B, and find that it activates the classical NF-kappa B pathway through an atypical mechanism that does not involve I kappa B degradation. TRE17 co-precipitates with I kappa B kinase (IKK), and IKK activity is augmented in stable cell lines overexpressing TRE17, in a USP-dependent manner. Optimal activation of NF-kappa B by TRE17 requires both catalytic subunits of IKK, distinguishing its mechanism from the classical and non-canonical pathways, which require either IKK beta or IKK alpha, respectively. TRE17 stimulates phosphorylation of p65 at serine 536, a modification that has been associated with enhanced transcriptional activity and nuclear retention. Induction of S536 phosphorylation by TRE17 requires both IKK alpha and IKK beta, as well as the IKK gamma/NEMO regulatory subunit of IKK. We further demonstrate that TRE17(long) is highly tumorigenic when overexpressed in NIH3T3 fibroblasts, and that inhibition of NF-kappa B significantly attenuates tumor formation. In summary, these studies uncover an unexpected signaling mechanism for activation of classical NF-kappa B by TRE17. They further reveal a critical role for NF-kappa B in TRE17-mediated tumorigenesis, and suggest that NF-kappa B inhibitors may function as effective therapeutic agents in the treatment of ABC. Oncogene (2012) 31, 3525-3535; doi:10.1038/onc.2011.520; published online 14 November 2011	[Pringle, L. M.; Young, R.; Quick, L.; Riquelme, D. N.; Chou, M. M.] Childrens Hosp Philadelphia, Dept Pathol & Lab, Philadelphia, PA 19104 USA; [Pringle, L. M.; Young, R.; Quick, L.; Riquelme, D. N.; Chou, M. M.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Oliveira, A. M.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA; [Oliveira, A. M.] Mayo Fdn, Rochester, MN USA; [May, M. J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [May, M. J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Mayo Clinic; University of Pennsylvania; University of Pennsylvania	Chou, MM (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab, ARC 816E, Philadelphia, PA 19104 USA.	mmc@mail.med.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1 CA081415, P30 AS050950]; National Service Research Award Grant [F31CA126488]; NATIONAL CANCER INSTITUTE [F31CA126488, R01CA081415] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Service Research Award Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health Grant RO1 CA081415 (to MMC) and Grant P30 AS050950 (Penn Center for Musculoskeletal Disorders). This work was also supported by the National Service Research Award Grant F31CA126488 (to LMP).	BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Choudhary S, 2007, MOL ENDOCRINOL, V21, P2203, DOI 10.1210/me.2006-0465; Cottalorda J, 2007, ARCH ORTHOP TRAUM SU, V127, P105, DOI 10.1007/s00402-006-0223-5; Dobrovolskaia MA, 2005, CURR CANCER DRUG TAR, V5, P325, DOI 10.2174/1568009054629645; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hansberger MW, 2007, J VIROL, V81, P1360, DOI 10.1128/JVI.01860-06; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khandaker NA, 2004, J IMMUNOL, V173, P6965; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lau AW, 2010, J BIOL CHEM, V285, P37111, DOI 10.1074/jbc.M110.175133; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Liu S, 2008, CELL RES, V21, P6; Mankin HJ, 2005, J CLIN ONCOL, V23, P6756, DOI 10.1200/JCO.2005.15.255; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P311, DOI 10.1097/01.coc.0000204403.13451.52; NAKAMURA T, 1992, ONCOGENE, V7, P733; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Oliveira AM, 2004, CANCER RES, V64, P1920, DOI 10.1158/0008-5472.CAN-03-2827; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Saccomanni B, 2008, ARCH ORTHOP TRAUM SU, V128, P1145, DOI 10.1007/s00402-007-0477-6; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Sitcheran R, 2008, MOL CELL BIOL, V28, P5061, DOI 10.1128/MCB.00578-08; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116	48	48	49	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	30					3525	3535		10.1038/onc.2011.520	http://dx.doi.org/10.1038/onc.2011.520			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22081069	Green Submitted, Green Accepted			2022-12-25	WOS:000306844100005
J	Derocq, D; Prebois, C; Beaujouin, M; Laurent-Matha, V; Pattingre, S; Smith, GK; Liaudet-Coopman, E				Derocq, D.; Prebois, C.; Beaujouin, M.; Laurent-Matha, V.; Pattingre, S.; Smith, G. K.; Liaudet-Coopman, E.			Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis	ONCOGENE			English	Article						cancer; cathepsin D; LRP1; RIP; endocytosis; tyrosine phosphorylation	BREAST-CANCER CELLS; AMYLOID PRECURSOR PROTEIN; HUMAN PROCATHEPSIN-D; INTRACELLULAR DOMAIN; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; CORECEPTOR FUNCTION; CYTOPLASMIC DOMAIN; GENE-EXPRESSION; D INTERACTS	The aspartic protease cathepsin-D (cath-D) is a marker of poor prognosis in breast cancer that is overexpressed and hypersecreted by human breast cancer cells. Secreted pro-cath-D binds to the extracellular domain of the beta-chain of the LDL receptor-related protein-1 (LRP1) in fibroblasts. The LRP1 receptor has an 85-kDa transmembrane beta-chain and a noncovalently attached 515-kDa extracellular alpha-chain. LRP1 acts by (1) internalizing many ligands via its alpha-chain, (2) activating signaling pathways by phosphorylating the LRP1 beta-chain tyrosine and (3) modulating gene transcription by regulated intramembrane proteolysis (RIP) of its beta-chain. LRP1 RIP involves two cleavages: the first liberates the LRP1 ectodomain to give a membrane-associated form, LRP1 beta-CTF, and the second generates the LRP1 beta-intracellular domain, LRP1 beta-ICD, that modulates gene transcription. Here, we investigated the endocytosis of pro-cathD by LRP1 and the effect of pro-cath-D/LRP1 beta interaction on LRP1 beta tyrosine phosphorylation and/or LRP1 beta RIP. Our results indicate that pro-cath-D was partially endocytosed by LRP1 in fibroblasts. However, pro-cath-D and ectopic cath-D did not stimulate phosphorylation of the LRP1 beta-chain tyrosine. Interestingly, ectopic cath-D and its catalytically inactive (D231N)cath-D, and pro-(D231N)cath-D all significantly inhibited LRP1 RIP by preventing LRP1 beta-CTF production. Thus, cath-D inhibits LRP1 RIP independently of its catalytic activity by blocking the first cleavage. As cath-D triggers fibroblast outgrowth by LRP1, we propose that cath-D modulates the growth of fibroblasts by inhibiting LRP1 RIP in the breast tumor microenvironment. Oncogene (2012) 31, 3202-3212; doi:10.1038/onc.2011.501; published online 14 November 2011	[Liaudet-Coopman, E.] INSERM, U896, IRCM Val dAurelle Paul Lamarque, F-34298 Montpellier 5, France; [Derocq, D.; Prebois, C.; Beaujouin, M.; Laurent-Matha, V.; Pattingre, S.; Liaudet-Coopman, E.] IRCM, Montpellier, France; [Derocq, D.; Prebois, C.; Beaujouin, M.; Laurent-Matha, V.; Pattingre, S.; Liaudet-Coopman, E.] Univ Montpellier I, Montpellier, France; [Derocq, D.; Prebois, C.; Beaujouin, M.; Laurent-Matha, V.; Pattingre, S.; Liaudet-Coopman, E.] CRLC Val dAurelle Paul Lamarque, Montpellier, France; [Smith, G. K.] GlaxoSmithKline Inc, Screening & Compound Profiling, Res Triangle Pk, NC USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); GlaxoSmithKline	Liaudet-Coopman, E (corresponding author), INSERM, U896, IRCM Val dAurelle Paul Lamarque, F-34298 Montpellier 5, France.	emmanuelle.liaudet-coopman@inserm.fr	Liaudet-Coopman, Emmanuelle/N-4744-2017	Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Valerie, LAURENT-MATHA/0000-0002-3277-7397; Pattingre, Sophie/0000-0001-6284-6050	Institut National de la Sante et de la Recherche Medicale; University of Montpellier I; ANR Jeunes Chercheuses; Jeunes Chercheurs; Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; ANR Jeunes Chercheuses(French National Research Agency (ANR)); Jeunes Chercheurs; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank Francoise Berthet and Nadia Kerdjadj for secretarial assistance, and Jean-Yves Cance for the photographs. We also thank Vincent Cavailles for pertinent suggestions for the gene reporter experiments, Herve Emonard for helpful discussions and Owen Parkes for English corrections. This work was supported by the Institut National de la Sante et de la Recherche Medicale, University of Montpellier I, ANR Jeunes Chercheuses, Jeunes Chercheurs and the Ligue Nationale contre le Cancer; the Association pour la Recherche sur le Cancer provided a fellowship for Melanie Beaujouin.	Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; CAPONY F, 1987, J CELL BIOL, V104, P253, DOI 10.1083/jcb.104.2.253; CAPONY F, 1989, CANCER RES, V49, P3904; CAPONY F, 1994, EXP CELL RES, V215, P154, DOI 10.1006/excr.1994.1327; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Fears CY, 2005, CANCER RES, V65, P9338, DOI 10.1158/0008-5472.CAN-05-1560; Ferrandina G, 1997, BRIT J CANCER, V76, P661, DOI 10.1038/bjc.1997.442; Foekens JA, 1999, INT J CANCER, V84, P209, DOI 10.1002/(SICI)1097-0215(19990621)84:3<209::AID-IJC2>3.0.CO;2-9; FUSEK M, 1994, BIOCHEM J, V303, P775, DOI 10.1042/bj3030775; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; Laurent-Matha V, 2002, EXP CELL RES, V277, P210, DOI 10.1006/excr.2002.5556; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu CX, 2007, J BIOL CHEM, V282, P7504, DOI 10.1074/jbc.M608088200; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Ohri SS, 2008, INT J ONCOL, V32, P491; Ohri SS, 2007, CANCER BIOL THER, V6, P1081, DOI 10.4161/cbt.6.7.4325; Polavarapu R, 2008, AM J PATHOL, V172, P1355, DOI 10.2353/ajpath.2008.070975; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P23586; Rochefort H, 1999, APMIS, V107, P86, DOI 10.1111/j.1699-0463.1999.tb01530.x; Rodriguez J, 2005, INT J BIOL MARKER, V20, P103, DOI 10.1177/172460080502000204; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Selvais C, 2009, ENDOCRINOLOGY, V150, P3792, DOI 10.1210/en.2009-0015; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Vashishta A, 2007, INT J ONCOL, V30, P1223; VETVICKA V, 1994, CANCER LETT, V79, P131; VIGNON F, 1986, ENDOCRINOLOGY, V118, P1537, DOI 10.1210/endo-118-4-1537; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	59	27	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	26					3202	3212		10.1038/onc.2011.501	http://dx.doi.org/10.1038/onc.2011.501			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22081071	Green Accepted, Green Submitted			2022-12-25	WOS:000305934400008
J	Bian, WN; Bursac, N				Bian, Weining; Bursac, Nenad			Soluble miniagrin enhances contractile function of engineered skeletal muscle	FASEB JOURNAL			English	Article						synaptogenesis; myogenesis; twitch force; acetylcholine receptors	RECEPTOR EPSILON-SUBUNIT; ACETYLCHOLINE-RECEPTORS; AGRIN; EXPRESSION; DYSTROPHIN; UTROPHIN; MYOTUBES; FIBERS; CA2+; DYSTROGLYCAN	Neural agrin plays a pleiotropic role in skeletal muscle innervation and maturation, but its specific effects on the contractile function of aneural engineered muscle remain unknown. In this study, neonatal rat skeletal myoblasts cultured within 3-dimensional engineered muscle tissue constructs were treated with 10 nM soluble recombinant miniagrin and assessed using histological, biochemical, and functional assays. Depending on the treatment duration and onset time relative to the stage of myogenic differentiation, miniagrin was found to induce up to 1.7-fold increase in twitch and tetanus force amplitude. This effect was associated with the 2.3-fold up-regulation of dystrophin gene expression at 6 d after agrin removal and enhanced ACh receptor (AChR) cluster formation, but no change in cell number, expression of muscle myosin, or important aspects of intracellular Ca2+ handling. In muscle constructs with endogenous ACh levels suppressed by the application of alpha-NETA, miniagrin increased AChR clustering and twitch force amplitude but failed to improve intracellular Ca2+ handling and increase tetanus-to-twitch ratio. Overall, our studies suggest that besides its synaptogenic function that could promote integration of engineered muscle constructs in vivo, neural agrin can directly promote the contractile function of aneural engineered muscle via mechanisms distinct from those involving endogenous ACh.-Bian, W., Bursac, N. Soluble miniagrin enhances contractile function of engineered skeletal muscle. FASEB J. 26, 955-965 (2012). www.fasebj.org	[Bursac, Nenad] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Bian, Weining] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia & Med, Boston, MA 02115 USA; [Bian, Weining] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Duke University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bursac, N (corresponding author), Duke Univ, Dept Biomed Engn, 3000 Sci Dr,Hudson Hall 136, Durham, NC 27708 USA.	nbursac@duke.edu	Bursac, Nenad/AAU-5548-2021	Bursac, Nenad/0000-0002-5688-6061	Center for Biomolecular and Tissue Engineering at Duke University; U.S. National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Disease [AR055226]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055226] Funding Source: NIH RePORTER	Center for Biomolecular and Tissue Engineering at Duke University; U.S. National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Robert Dennis (University of North Carolina, Chapel Hill, NC, USA) for providing the force transducer and Dr. Hyung-Suk Kim (University of North Carolina, Chapel Hill) for designing qRT-PCR gene expression assays. The authors also acknowledge invaluable technical assistance from Mark Juhas, Dr. Wayne Pfeiler, and Dr. Dennis Himmel. This work was supported by Lew's fellowship from the Center for Biomolecular and Tissue Engineering at Duke University to W. B. and U.S. National Institutes of Health grant AR055226 from the National Institute of Arthritis and Musculoskeletal and Skin Disease to N.B.	Bach AD, 2003, CELL TISSUE RES, V314, P263, DOI 10.1007/s00441-003-0757-6; Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019; Bandi E, 2005, J PHYSIOL-LONDON, V568, P171, DOI 10.1113/jphysiol.2005.091439; Bandi E, 2008, AM J PHYSIOL-CELL PH, V294, pC66, DOI 10.1152/ajpcell.00248.2007; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Berthier C, 1997, BIOL CELL, V89, P413, DOI 10.1016/S0248-4900(97)89313-6; Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441; Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155; Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BRANDT PW, 1980, P NATL ACAD SCI-BIOL, V77, P4717, DOI 10.1073/pnas.77.8.4717; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; COGNARD C, 1993, DEVELOPMENT, V117, P1153; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736; Hamann M, 1995, J PHYSIOL-LONDON, V489, P791, DOI 10.1113/jphysiol.1995.sp021092; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062; Hopf C, 1996, J BIOL CHEM, V271, P5231; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985; Jurdana M, 2009, CELL MOL NEUROBIOL, V29, P123, DOI 10.1007/s10571-008-9304-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75; Lin S, 2000, DEV BRAIN RES, V119, P289, DOI 10.1016/S0165-3806(99)00165-0; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; MacIntosh BR, 2003, NEWS PHYSIOL SCI, V18, P222, DOI 10.1152/nips.01456.2003; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Radojevic V, 2000, CELL TISSUE RES, V300, P447, DOI 10.1007/s004410000213; Rimer M, 1997, MOL CELL NEUROSCI, V9, P254, DOI 10.1006/mcne.1997.0622; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SASTRY BVR, 1988, J PHARMACOL EXP THER, V245, P72; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Stavropoulos M. E., 2009, CURR PROTOC STEM CEL; Tourovskaia A, 2008, BIOPHYS J, V95, P3009, DOI 10.1529/biophysj.107.128173; Walker JS, 2010, J MUSCLE RES CELL M, V31, P59, DOI 10.1007/s10974-010-9208-7	50	41	41	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					955	965		10.1096/fj.11-187575	http://dx.doi.org/10.1096/fj.11-187575			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22075647	Green Published			2022-12-25	WOS:000300485700045
J	Pinto, MFS; Fensterseifer, ICM; Migliolo, L; Sousa, DA; de Capdville, G; Arboleda-Valencia, JW; Colgrave, ML; Craik, DJ; Magalhaes, BS; Dias, SC; Franco, OL				Pinto, Michelle F. S.; Fensterseifer, Isabel C. M.; Migliolo, Ludovico; Sousa, Daniel A.; de Capdville, Guy; Arboleda-Valencia, Jorge W.; Colgrave, Michelle L.; Craik, David J.; Magalhaes, Beatriz S.; Dias, Simoni C.; Franco, Octavio L.			Identification and Structural Characterization of Novel Cyclotide with Activity against an Insect Pest of Sugar Cane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALATA B1; PLANT CYCLOTIDES; CIRCULAR PROTEINS; TRYPSIN-INHIBITOR; CYCLOVIOLACIN O2; KNOTTED PROTEINS; PEPTIDES; DISCOVERY; POLYPEPTIDE; RECOGNITION	Cyclotides are a family of plant-derived cyclic peptides comprising six conserved cysteine residues connected by three intermolecular disulfide bonds that form a knotted structure known as a cyclic cystine knot (CCK). This structural motif is responsible for the pronounced stability of cyclotides against chemical, thermal, or proteolytic degradation and has sparked growing interest in this family of peptides. Here, we isolated and characterized a novel cyclotide from Palicourea rigida (Rubiaceae), which was named parigidin-br1. The sequence indicated that this peptide is a member of the bracelet subfamily of cyclotides. Parigidin-br1 showed potent insecticidal activity against neonate larvae of Lepidoptera (Diatraea saccharalis), causing 60% mortality at a concentration of 1 mu M but had no detectable antibacterial effects. A decrease in the in vitro viability of the insect cell line from Spodoptera frugiperda (SF-9) was observed in the presence of parigidin-br1, consistent with in vivo insecticidal activity. Transmission electron microscopy and fluorescence microscopy of SF-9 cells after incubation with parigidin-br1 or parigidin-br1-fluorescein isothiocyanate, respectively, revealed extensive cell lysis and swelling of cells, consistent with an insecticidal mechanism involving membrane disruption. This hypothesis was supported by in silico analyses, which suggested that parigidin-br1 is able to complex with cell lipids. Overall, the results suggest promise for the development of parigidin-br1 as a novel biopesticide.	[Pinto, Michelle F. S.; Fensterseifer, Isabel C. M.; Migliolo, Ludovico; Magalhaes, Beatriz S.; Dias, Simoni C.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Arboleda-Valencia, Jorge W.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [de Capdville, Guy; Arboleda-Valencia, Jorge W.] Embrapa Recursos Genet & Biotecnol, CENARGEN, Ctr Nacl Pesquisa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Livestock Ind, St Lucia, Qld 4067, Australia; [Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sousa, Daniel A.] Univ Brasilia, Programa Posgrad Patol Mol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Universidade de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia SGAN, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Quadra 916,Av W5 Norte, BR-70790160 Brasilia, DF, Brazil.	ocfranco@pos.ucb.br	MIGLIOLO, LUDOVICO/AAV-6913-2021; Franco, Octavio L/T-3020-2017; Craik, David/B-1695-2010; Sousa, Daniel/HHS-6778-2022; Colgrave, Michelle/A-5710-2012	MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Craik, David/0000-0003-0007-6796; Colgrave, Michelle/0000-0001-8463-805X; Franco, Octavio/0000-0001-9546-0525	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Pesquisa e Desenvolvimento; Fundacao de Amparo a Pesquisa do Distrito Federal; Fundacao de Amparo a Pesquisa de Minas Gerais; Universidade Catolica de Brasilia; Australian Research Council	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Catolica de Brasilia; Australian Research Council(Australian Research Council)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Pesquisa e Desenvolvimento, Fundacao de Amparo a Pesquisa do Distrito Federal, Fundacao de Amparo a Pesquisa de Minas Gerais, and Universidade Catolica de Brasilia. Work at the University of Queensland was supported in part by a grant from the Australian Research Council.	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Biello David, 2008, SCI AM          0207; BIGNAMI GS, 1993, TOXICON, V31, P817, DOI 10.1016/0041-0101(93)90389-Z; Bliss CI, 1934, SCIENCE, V79, P409, DOI 10.1126/science.79.2053.409; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Burman R, 2010, BIOPOLYMERS, V94, P626, DOI 10.1002/bip.21408; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Chen B, 2005, J BIOL CHEM, V280, P22395, DOI 10.1074/jbc.M501737200; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2010, ANTIMICROB AGENTS CH, V54, P2160, DOI 10.1128/AAC.01306-09; Craik DJ, 2010, TOXICON, V56, P1092, DOI 10.1016/j.toxicon.2010.02.021; Craik DJ, 2009, TRENDS PLANT SCI, V14, P328, DOI 10.1016/j.tplants.2009.03.003; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, LETT PEPT SCI, V8, P119, DOI 10.1007/BF02446507; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Desai PN, 2010, BIOTECHNOL ADV, V28, P427, DOI 10.1016/j.biotechadv.2010.01.005; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JOHNSON JA, 1995, J ECON ENTOMOL, V88, P734, DOI 10.1093/jee/88.3.734; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; Lindholm P, 2002, MOL CANCER THER, V1, P365; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Massatochi N., 2000, MOL EVOLUTION PHYLOG, P73; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Peters B, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-4; Plan MR, 2010, BIOPOLYMERS, V94, P647, DOI 10.1002/bip.21409; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Seydel P, 2007, APPL MICROBIOL BIOT, V77, P275, DOI 10.1007/s00253-007-1159-6; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Watts J. L., 2006, PERFORMANCE STANDARD, V28, P5; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	69	67	70	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					134	147		10.1074/jbc.M111.294009	http://dx.doi.org/10.1074/jbc.M111.294009			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074926	hybrid, Green Published			2022-12-25	WOS:000298682400016
J	Viola, IL; Reinheimer, R; Ripoll, R; Manassero, NGU; Gonzalez, DH				Viola, Ivana L.; Reinheimer, Renata; Ripoll, Rodrigo; Uberti Manassero, Nora G.; Gonzalez, Daniel H.			Determinants of the DNA Binding Specificity of Class I and Class II TCP Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; DOMAIN; GENES; COMPLEX; PROTEINS; GROWTH; SITES; TRANSFORMATION; INTERFERENCE	TCP proteins constitute a family of plant transcription factors with more than 20 members in angiosperms. They can be divided in two classes based on sequence homology and the presence of an insertion within the basic region of the TCP DNA binding and dimerization domain. Here, we describe binding site selection studies with the class I protein TCP16, showing that its DNA binding preferences are similar to those of class II proteins. Through sequence comparison and the analysis of mutants and chimeras of TCP16, TCP20 (class I), and TCP4 (class II), we established that the identity of residue 11 of the class I TCP domain or the equivalent residue 15 of the class II domain, whether it is Gly or Asp, determines a preference for a class I or a class II sequence, respectively. Footprinting analysis indicated that specific DNA contacts related to these preferences are established with one of the strands of DNA. The dimerization motif also influences the selectivity of the proteins toward class I and class II sequences and determines a requirement of an extended basic region in proteins with Asp-15. We postulate that differences in orientation of base-contacting residues brought about by the presence of either Gly or Asp are responsible for the binding site preferences of TCP proteins. Expression of repressor forms of TCP16 with Asp-11 or Gly-11 differently affects leaf development. TCP16-like proteins with Asp-11 in the TCP domain arose in rosids and may be related to developmental characteristics of this lineage of eudicots.	[Viola, Ivana L.; Ripoll, Rodrigo; Uberti Manassero, Nora G.; Gonzalez, Daniel H.] Univ Nacl Litoral, Inst Agrobiotecnol Litoral CONICET UNL, Catedra Biol Celular & Mol, Fac Bioquim & Ciencias Biol, RA-3000 Santa Fe, Argentina; [Reinheimer, Renata] Inst Bota Darwin, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Gonzalez, DH (corresponding author), Univ Nacl Litoral, Inst Agrobiotecnol Litoral CONICET UNL, Catedra Biol Celular & Mol, Fac Bioquim & Ciencias Biol, CC 242 Paraje El Pozo, RA-3000 Santa Fe, Argentina.	dhgonza@fbcb.unl.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Universidad Nacional del Litoral	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad Nacional del Litoral	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Universidad Nacional del Litoral.	Aggarwal P, 2010, PLANT CELL, V22, P1174, DOI 10.1105/tpc.109.066647; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Giraud E, 2010, PLANT CELL, V22, P3921, DOI 10.1105/tpc.110.074518; Gonzalez DH, 2007, PLANT J, V51, P105, DOI 10.1111/j.1365-313X.2007.03121.x; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Jain SS, 2008, NAT PROTOC, V3, P1092, DOI 10.1038/nprot.2008.72; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Navaud O, 2007, J MOL EVOL, V65, P23, DOI 10.1007/s00239-006-0174-z; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Reynolds A., 1997, CURRENT PROTOCOLS MO; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Silver J, 1995, PCR STRATEGIES, P179; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takeda T, 2006, PLANT MOL BIOL, V61, P165, DOI 10.1007/s11103-006-6265-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2008, PLANT J, V53, P42, DOI 10.1111/j.1365-313X.2007.03308.x; Uberti Manassero N. G., 2011, J EXP BOT       1020, DOI [10.1093/jxb/err305, DOI 10.1093/JXB/ERR305]; Viola IL, 2007, BIOCHEMISTRY-US, V46, P7416, DOI 10.1021/bi602657e; Viola IL, 2011, BIOCHEM J, V435, P143, DOI 10.1042/BJ20101019; Viola IL, 2009, BIOCHIMIE, V91, P974, DOI 10.1016/j.biochi.2009.04.021; Welchen E, 2006, PLANT PHYSIOL, V141, P540, DOI 10.1104/pp.105.075366	46	38	42	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					347	356		10.1074/jbc.M111.256271	http://dx.doi.org/10.1074/jbc.M111.256271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074922	Green Published, hybrid			2022-12-25	WOS:000298682400034
J	Zhang, WN; Wang, L; Wang, Q; Luo, X; Fang, DF; Chen, Y; Pan, X; Man, JH; Xia, Q; Jin, BF; Li, WH; Li, T; Liang, B; Chen, L; Gong, WL; Yu, M; Li, AL; Zhou, T; Li, HY				Zhang, Wei-Na; Wang, Li; Wang, Qiong; Luo, Xue; Fang, Di-Feng; Chen, Yuan; Pan, Xin; Man, Jiang-Hong; Xia, Qing; Jin, Bao-Feng; Li, Wei-Hua; Li, Tao; Liang, Bing; Chen, Liang; Gong, Wei-Li; Yu, Ming; Li, Ai-Ling; Zhou, Tao; Li, Hui-Yan			CUEDC2 (CUE Domain-containing 2) and SOCS3 (Suppressors of Cytokine Signaling 3) Cooperate to Negatively Regulate Janus Kinase 1/Signal Transducers and Activators of Transcription 3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TYROSINE PHOSPHORYLATION; STAT3 ACTIVATION; JAK/STAT PATHWAY; SH2 DOMAIN; RECEPTOR; PROTEIN; BINDING; DEGRADATION; INHIBITION	Janus kinase 1/signal transducers and activators of transcription 3 (JAK1/STAT3) pathway is one of the recognized oncogenic signaling pathways that frequently overactivated in a variety of human tumors. Despite rapid progress in elucidating the molecular mechanisms of activation of JAK/STAT pathway, the processes that regulate JAK/STAT deactivation need to be further clarified. Here we demonstrate that CUE domain-containing 2 (CUEDC2) inhibits cytokine-induced phosphorylation of JAK1 and STAT3 and the subsequent STAT3 transcriptional activity. Further analysis by a yeast two-hybrid assay showed that CUEDC2 could engage in a specific interaction with a key JAK/STAT inhibitor, SOCS3 (suppressors of cytokine signaling 3). The interaction between CUEDC2 and SOCS3 is required for the inhibitory effect of CUEDC2 on JAK1 and STAT3 activity. Additionally, we found CUEDC2 functions collaboratively with SOCS3 to inhibit JAK1/STAT3 signaling by increasing SOCS3 stability via enhancing its association with Elongin C. Therefore, our findings revealed a new biological activity for CUEDC2 as the regulator of JAK1/STAT3 signaling and paved the way to a better understanding of the mechanisms by which SOCS3 has been linked to suppression of the JAK/STAT pathway.	[Zhang, Wei-Na; Luo, Xue; Fang, Di-Feng; Chen, Yuan; Pan, Xin; Man, Jiang-Hong; Xia, Qing; Jin, Bao-Feng; Li, Wei-Hua; Li, Tao; Liang, Bing; Chen, Liang; Gong, Wei-Li; Yu, Ming; Li, Ai-Ling; Zhou, Tao; Li, Hui-Yan] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China; [Wang, Li] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Li, HY (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, 27 Tai Ping Rd, Beijing 100850, Peoples R China.	lihy@nic.bmi.ac.cn	FANG, DIFENG/G-7796-2018	FANG, DIFENG/0000-0003-2105-6743; Pan, Xin/0000-0002-1982-2261; Li, Tao/0000-0002-0746-8322; Man, Jianghong/0000-0001-6020-3537	National Basic Research Program of China [2012CB9100700]; National Natural Science Foundation of China [81130037, 30900754, 31100978]; National High Technology Research and Development Program of China [2009AA02Z103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China Grant 2012CB9100700, National Natural Science Foundation of China Grants 81130037, 30900754, and 31100978, and National High Technology Research and Development Program of China Grant 2009AA02Z103.	ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Komyod W, 2007, MOL CANCER RES, V5, P271, DOI 10.1158/1541-7786.MCR-06-0274; Krebs DL, 2000, J CELL SCI, V113, P2813; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leong H, 2009, BREAST CANCER RES TR, V117, P505, DOI 10.1007/s10549-008-0196-x; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Suzuki R, 1998, ONCOGENE, V17, P2271, DOI 10.1038/sj.onc.1202143; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	54	23	27	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					382	392		10.1074/jbc.M111.276832	http://dx.doi.org/10.1074/jbc.M111.276832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084247	Green Published, hybrid			2022-12-25	WOS:000298682400037
J	Rhodes, G; Lie, HC; Thevaraja, N; Taylor, L; Iredell, N; Curran, C; Tan, SQC; Carnemolla, P; Simmons, LW				Rhodes, Gillian; Lie, Hanne C.; Thevaraja, Nishta; Taylor, Libby; Iredell, Natasha; Curran, Christine; Tan, Shi Qin Claire; Carnemolla, Pia; Simmons, Leigh W.			Facial Attractiveness Ratings from Video-Clips and Static Images Tell the Same Story	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; MATING SUCCESS; HUMAN FACES; PREFERENCES; FEMALE	Most of what we know about what makes a face attractive and why we have the preferences we do is based on attractiveness ratings of static images of faces, usually photographs. However, several reports that such ratings fail to correlate significantly with ratings made to dynamic video clips, which provide richer samples of appearance, challenge the validity of this literature. Here, we tested the validity of attractiveness ratings made to static images, using a substantial sample of male faces. We found that these ratings agreed very strongly with ratings made to videos of these men, despite the presence of much more information in the videos (multiple views, neutral and smiling expressions and speech-related movements). Not surprisingly, given this high agreement, the components of video-attractiveness were also very similar to those reported previously for static-attractiveness. Specifically, averageness, symmetry and masculinity were all significant components of attractiveness rated from videos. Finally, regression analyses yielded very similar effects of attractiveness on success in obtaining sexual partners, whether attractiveness was rated from videos or static images. These results validate the widespread use of attractiveness ratings made to static images in evolutionary and social psychological research. We speculate that this validity may stem from our tendency to make rapid and robust judgements of attractiveness.	[Rhodes, Gillian; Taylor, Libby; Simmons, Leigh W.] Univ Western Australia, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia; [Rhodes, Gillian; Lie, Hanne C.; Thevaraja, Nishta; Taylor, Libby; Iredell, Natasha; Curran, Christine; Tan, Shi Qin Claire; Carnemolla, Pia; Simmons, Leigh W.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Rhodes, G (corresponding author), Univ Western Australia, ARC Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	gillian.rhodes@uwa.edu.au	Lie, Hanne Cathrine/AAL-8227-2020; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518; Lie, Hanne Cathrine/0000-0002-8370-5422	Australian Research Council [DP0877379]; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This work was supported by the Australian Research Council (DP0877379) and the Australian Research Council Centre of Excellence for Cognition and its Disorders (CE110001021. URL http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins DC, 2007, J FAM PSYCHOL, V21, P726, DOI 10.1037/0893-3200.21.4.726; BROWN TA, 1986, J SOC PSYCHOL, V126, P305, DOI 10.1080/00224545.1986.9713590; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; DUNTEMAN GH, 2005, GEN LINEAR MODELS IN; Lander K, 2008, ANIM BEHAV, V75, P817, DOI 10.1016/j.anbehav.2007.07.001; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Lie HC, 2010, ANIM BEHAV, V79, P903, DOI 10.1016/j.anbehav.2009.12.040; Little A. C., 2011, SCI SOCIAL VISION, P164; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Morrison ER, 2010, ETHOLOGY, V116, P1234, DOI 10.1111/j.1439-0310.2010.01839.x; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Penton-Voak I, 2008, J EVOLUTIONARY PSYCH, V6, P89, DOI DOI 10.1556/JEP.2008.1011; PENTONVOAK IS, 2011, OXFORD HDB FACE PERC, P653; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; REIS HT, 1990, EUR J SOC PSYCHOL, V20, P259, DOI 10.1002/ejsp.2420200307; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Roberts SC, 2009, ETHOLOGY, V115, P588, DOI 10.1111/j.1439-0310.2009.01640.x; Rubenstein AJ, 2005, PSYCHOL SCI, V16, P759, DOI 10.1111/j.1467-9280.2005.01610.x; Simmons LW, 2004, BEHAV ECOL, V15, P864, DOI 10.1093/beheco/arh099; TRACY JL, 2011, HAPPY GUYS FINISH LA; Valenzano DR, 2006, VISION RES, V46, P1282, DOI 10.1016/j.visres.2005.10.024; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz L.A., 2011, OXFORD HDB FACE PERC, P31, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0003	26	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26653	10.1371/journal.pone.0026653	http://dx.doi.org/10.1371/journal.pone.0026653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	855HG	22096491	gold, Green Submitted, Green Published			2022-12-25	WOS:000297553900006
J	Williams, R; Krkosek, M; Ashe, E; Branch, TA; Clark, S; Hammond, PS; Hoyt, E; Noren, DP; Rosen, D; Winship, A				Williams, Rob; Krkosek, Martin; Ashe, Erin; Branch, Trevor A.; Clark, Steve; Hammond, Philip S.; Hoyt, Erich; Noren, Dawn P.; Rosen, David; Winship, Arliss			Competing Conservation Objectives for Predators and Prey: Estimating Killer Whale Prey Requirements for Chinook Salmon	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; ORCINUS-ORCA; PACIFIC SALMON; FISHERIES; ABUNDANCE; SEA; POPULATIONS; FISH; DIET	Ecosystem-based management (EBM) of marine resources attempts to conserve interacting species. In contrast to single-species fisheries management, EBM aims to identify and resolve conflicting objectives for different species. Such a conflict may be emerging in the northeastern Pacific for southern resident killer whales (Orcinus orca) and their primary prey, Chinook salmon (Oncorhynchus tshawytscha). Both species have at-risk conservation status and transboundary (Canada-US) ranges. We modeled individual killer whale prey requirements from feeding and growth records of captive killer whales and morphometric data from historic live-capture fishery and whaling records worldwide. The models, combined with caloric value of salmon, and demographic and diet data for wild killer whales, allow us to predict salmon quantities needed to maintain and recover this killer whale population, which numbered 87 individuals in 2009. Our analyses provide new information on cost of lactation and new parameter estimates for other killer whale populations globally. Prey requirements of southern resident killer whales are difficult to reconcile with fisheries and conservation objectives for Chinook salmon, because the number of fish required is large relative to annual returns and fishery catches. For instance, a U. S. recovery goal (2.3% annual population growth of killer whales over 28 years) implies a 75% increase in energetic requirements. Reducing salmon fisheries may serve as a temporary mitigation measure to allow time for management actions to improve salmon productivity to take effect. As ecosystem-based fishery management becomes more prevalent, trade-offs between conservation objectives for predators and prey will become increasingly necessary. Our approach offers scenarios to compare relative influence of various sources of uncertainty on the resulting consumption estimates to prioritise future research efforts, and a general approach for assessing the extent of conflict between conservation objectives for threatened or protected wildlife where the interaction between affected species can be quantified.	[Williams, Rob; Hammond, Philip S.] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Rosen, David] Univ British Columbia, Dept Zool, Marine Mammal Res Unit, Fisheries Ctr, Vancouver, BC, Canada; [Krkosek, Martin] Univ Otago, Dept Zool, Dunedin, New Zealand; [Ashe, Erin] Oceans Initiat, Pearse Isl, BC, Canada; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Clark, Steve] SeaWorld, Orlando, FL USA; [Hoyt, Erich] Whale & Dolphin Conservat Soc, North Berwick, Scotland; [Noren, Dawn P.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Marine Mammal & Seabird Program, Seattle, WA USA; [Winship, Arliss] Dalhousie Univ, Dept Biol, Life Sci Ctr, Halifax, NS, Canada	University of St Andrews; University of British Columbia; University of Otago; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University	Williams, R (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	rmcw@st-andrews.ac.uk	Williams, Rob/C-5882-2011; Branch, Trevor/A-5691-2009	Williams, Rob/0000-0001-7496-453X; Ashe, Erin/0000-0001-9918-1419; Hoyt, Erich/0000-0001-6946-4055; Noren, Dawn/0000-0002-9544-4530; Hammond, Philip/0000-0002-2381-8302	University of Washington; Russell Family Foundation; British Columbia Marine Planning Fund; SeaWorld-Busch Gardens Conservation Fund; Natural Sciences and Engineering Research Council of Canada; Natural Environment Research Council [smru10001] Funding Source: researchfish	University of Washington(University of Washington); Russell Family Foundation; British Columbia Marine Planning Fund; SeaWorld-Busch Gardens Conservation Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Canada-United States Fulbright program (RW) at University of Washington, The Russell Family Foundation, the British Columbia Marine Planning Fund and SeaWorld-Busch Gardens Conservation Fund, and a Natural Sciences and Engineering Research Council of Canada Post Doctoral Fellowship (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Bax NJ, 1998, ICES J MAR SCI, V55, P997, DOI 10.1006/jmsc.1998.0350; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Boersma PD, 2001, BIOSCIENCE, V51, P643; Boyd IL, 2002, AQUAT CONSERV, V12, P119, DOI 10.1002/aqc.481; Brewer JF, 2011, ECOL SOC, V16; Clark ST, 1999, J MAMMAL, V80, P777, DOI 10.2307/1383247; Corkeron PJ, 2006, CONSERV BIOL, V20, P617, DOI 10.1111/j.1523-1739.2006.00436.x; Durban JW, 2006, MAR MAMMAL SCI, V22, P735, DOI 10.1111/j.1748-7692.2006.00068.x; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Fisheries and Oceans Canada (FOC), 2002, CAN OC STRAT; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2010, 2009101 DFO CAN SCI; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Grellier K, 2006, MF0319 DEP ENV FOOD; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; HARWOOD J, 1988, MAR MAMMAL SCI, V4, P13, DOI 10.1111/j.1748-7692.1988.tb00179.x; HARWOOD J, 1987, P ROY SOC EDINB B, V93, P535; Hauser DDW, 2007, MAR ECOL PROG SER, V351, P301, DOI 10.3354/meps07117; Healey M.C., 1991, P311; HOYT E, 1990, ORCA WHALE CALLED KI; ICES, 2008, REP ICES ADV COMM 20, P326; JONSGARD A, 1970, Nytt Magasin for Zoologi (Oslo), V18, P41; Kriete B., 1995, THESIS U BRIT COLUMB; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Lackey R.T., 2006, SALMON 2100 FUTURE W, P13; Larkin PA, 1996, REV FISH BIOL FISHER, V6, P139; Leaper Russell, 2007, Journal of Cetacean Research and Management, V9, P179; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Logerwell Elizabeth A., 2005, Aquatic Mammals, V31, P62, DOI 10.1578/AM.31.1.2005.62; Lusseau D, 2004, ECOL LETT, V7, P1068, DOI 10.1111/j.1461-0248.2004.00669.x; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Myers J, 1998, NOAA TECH MEMO, P443; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; NMFS, 2008, REC PLAN SO RES KILL; NMFS (National Marine Fisheries Service), 1999, EC BAS FISH MAN REP; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Northcote T.G., 1997, P199; Osborne RW, 1999, THESIS U VICTORIA VI, P262; Pacific Salmon Commission, 2009, ANN REP CATCH ESC PA; Pacific Salmon Commission, 2004, TCCHINOOK0404 PAC SA, P04; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinheiro J, MIXED EFFECTS MODELS; POC, 2003, AM LIV OC CHART COUR; Raymond B, 2011, J APPL ECOL, V48, P181, DOI 10.1111/j.1365-2664.2010.01916.x; Reynolds John E. III, 2009, Endangered Species Research, V7, P23, DOI 10.3354/esr00179; RICKER WE, 1976, J FISH RES BOARD CAN, V33, P1483, DOI 10.1139/f76-191; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Sharples RJ, 2009, MAR ECOL PROG SER, V390, P265, DOI 10.3354/meps08232; Sigler MF, 2006, J FISH BIOL, V69, P392, DOI 10.1111/j.1095-8649.2006.01096.x; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Southwell C, 2008, J APPL ECOL, V45, P622, DOI 10.1111/j.1365-2664.2007.01399.x; STEPHENSON RL, 1995, CAN J FISH AQUAT SCI, V52, P2051, DOI 10.1139/f95-796; Taylor BL, 2004, NMFSNWFSC62 NOAA; US Commission on Ocean Policy (USCOP), 2004, OC BLUEPR 21 CENT WA; Walters Carl, 1997, Conservation Ecology, V1, pUnpaginated; Waples R.S., 1991, MAR FISH REV, V53, P11; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281	72	60	61	3	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26738	10.1371/journal.pone.0026738	http://dx.doi.org/10.1371/journal.pone.0026738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096495	Green Published, gold			2022-12-25	WOS:000297350800012
J	Belete, HA; Hubmayr, RD; Wang, SH; Singh, RD				Belete, Hewan A.; Hubmayr, Rolf D.; Wang, Shaohua; Singh, Raman-Deep			The Role of Purinergic Signaling on Deformation Induced Injury and Repair Responses of Alveolar Epithelial Cells	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; INDUCED LIPID TRAFFICKING; MEMBRANE STRESS FAILURE; PLASMA-MEMBRANE; ATP RELEASE; CYCLIC STRETCH; NUCLEOTIDE RECEPTORS; MOLECULAR-MECHANISMS; EXTRACELLULAR ATP	Cell wounding is an important driver of the innate immune response of ventilator-injured lungs. We had previously shown that the majority of wounded alveolus resident cells repair and survive deformation induced insults. This is important insofar as wounded and repaired cells may contribute to injurious deformation responses commonly referred to as biotrauma. The central hypothesis of this communication states that extracellular adenosine-5' triphosphate (ATP) promotes the repair of wounded alveolus resident cells by a P2Y2-Receptor dependent mechanism. Using primary type 1 alveolar epithelial rat cell models subjected to micropuncture injury and/or deforming stress we show that 1) stretch causes a dose dependent increase in cell injury and ATP media concentrations; 2) enzymatic depletion of extracellular ATP reduces the probability of stretch induced wound repair; 3) enriching extracellular ATP concentrations facilitates wound repair; 4) purinergic effects on cell repair are mediated by ATP and not by one of its metabolites; and 5) ATP mediated cell salvage depends at least in part on P2Y2-R activation. While rescuing cells from wounding induced death may seem appealing, it is possible that survivors of membrane wounding become governors of a sustained pro-inflammatory state and thereby perpetuate and worsen organ function in the early stages of lung injury syndromes. Means to uncouple P2Y2-R mediated cytoprotection from P2Y2-R mediated inflammation and to test the preclinical efficacy of such an undertaking deserve to be explored.	[Belete, Hewan A.; Hubmayr, Rolf D.; Wang, Shaohua; Singh, Raman-Deep] Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Belete, HA (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA.	rhubmayr@mayo.edu	Takhter, Ramandeep/AAG-8977-2019	Takhter, Ramandeep/0000-0002-1441-2722	National Institutes of Health [HL 63178]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL 63178) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adriaensen D, 2004, CURR OPIN PHARMACOL, V4, P207, DOI 10.1016/j.coph.2004.01.010; Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Beigi RD, 2000, J IMMUNOL, V165, P7189, DOI 10.4049/jimmunol.165.12.7189; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Boitano S, 2004, AM J PHYSIOL-LUNG C, V287, pL455, DOI 10.1152/ajplung.00172.2004; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; da Cruz CM, 2006, BRIT J PHARMACOL, V147, P324, DOI 10.1038/sj.bjp.0706559; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Douillet CD, 2005, AM J RESP CELL MOL, V32, P52, DOI 10.1165/rcmb.2004-0177OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Gattinoni L, 2011, CURR OPIN CRIT CARE, V17, P18, DOI 10.1097/MCC.0b013e32834272d8; GODIN LM, 2011, AM J PHYSL LUNG CELL; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; Gozal E, 2001, FREE RADICAL BIO MED, V31, P679, DOI 10.1016/S0891-5849(01)00630-X; Green AS, 2004, J BIOMECH, V37, P661, DOI 10.1016/j.jbiomech.2003.09.024; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; Jung SR, 2004, AM J PHYSIOL-CELL PH, V286, pC573, DOI 10.1152/ajpcell.00350.2003; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; LEONARD RT, 1978, PLANT PHYSIOL, V61, P175, DOI 10.1104/pp.61.2.175; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu GJ, 2005, EUR J NEUROSCI, V21, P151, DOI 10.1111/j.1460-9568.2004.03831.x; Matsuyama H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-79; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2002, J CELL SCI, V115, P873; Nieuwenhuizen L, 2009, EUR J HAEMATOL, V82, P413, DOI 10.1111/j.1600-0609.2009.01238.x; Oeckler RA, 2007, CRIT CARE, V11, DOI 10.1186/cc6160; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Orihuela PA, 2006, J ENDOCRINOL, V188, P579, DOI 10.1677/joe.1.06448; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; RICE WR, 1995, AM J RESP CELL MOL, V12, P27, DOI 10.1165/ajrcmb.12.1.7811468; Rossi AH, 2007, AM J PHYSIOL-LUNG C, V292, pL92, DOI 10.1152/ajplung.00081.2006; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361, DOI 10.1152/jappl.2001.90.6.2361; Sugamoto Yoshiharu, 1999, Journal of Medical and Dental Sciences, V46, P83; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Vlahakis NE, 2005, AM J RESP CRIT CARE, V171, P1328, DOI 10.1164/rccm.200408-1036SO; Vlahakis NE, 2002, AM J RESP CRIT CARE, V166, P1282, DOI 10.1164/rccm.200203-207OC; Vlahakis NE, 2001, AM J PHYSIOL-LUNG C, V280, pL938, DOI 10.1152/ajplung.2001.280.5.L938; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; WANG S, 2011, AM J RESP CELL MOL B; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	70	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27469	10.1371/journal.pone.0027469	http://dx.doi.org/10.1371/journal.pone.0027469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087324	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700050
J	Hsu, SC; Endow, JK; Ruppel, NJ; Roston, RL; Baldwin, AJ; Inoue, K				Hsu, Shih-Chi; Endow, Joshua K.; Ruppel, Nicholas J.; Roston, Rebecca L.; Baldwin, Amy J.; Inoue, Kentaro			Functional Diversification of Thylakoidal Processing Peptidases in Arabidopsis thaliana	PLOS ONE			English	Article							I SIGNAL PEPTIDASE; LEADER PEPTIDASE; OUTER ENVELOPE; PROTEIN-IMPORT; REACTION SPECIFICITIES; POLYGLYCINE STRETCH; COMPLETE MATURATION; GENOME SEQUENCE; TRANSIT PEPTIDE; TRANSPORT	Thylakoidal processing peptidase (TPP) is responsible for removing amino-terminal thylakoid-transfer signals from several proteins in the thylakoid lumen. Three TPP isoforms are encoded by the nuclear genome of Arabidopsis thaliana. Previous studies showed that one of them termed plastidic type I signal peptidase 1 (Plsp1) was necessary for processing three thylakoidal proteins and one protein in the chloroplast envelope in vivo. The lack of Plsp1 resulted in seedling lethality, apparently due to disruption of proper thylakoid development. The physiological roles of the other two TPP homologs remain unknown. Here we show that the three A. thaliana TPP isoforms evolved to acquire diverse functions. Phylogenetic analysis revealed that TPP may have originated before the endosymbiotic event, and that there are two groups of TPP in seed plants: one includes Plsp1 and another comprises the other two A. thaliana TPP homologs, which are named as Plsp2A and Plsp2B in this study. The duplication leading to the two groups predates the gymnosperm-angiosperm divergence, and the separation of Plsp2A and Plsp2B occurred after the Malvaceae-Brassicaceae diversification. Quantitative reverse transcription-PCR assay revealed that the two PLSP2 genes were co-expressed in both photosynthetic tissues and roots, whereas the PLSP1 transcript accumulated predominantly in photosynthetic tissues. Both PLSP2 genes were expressed in the aerial parts of the plsp1-null mutant at levels comparable to those in wild-type plants. The seedling-lethal phenotype of the plsp1-null mutant could be rescued by a constitutive expression of Plsp1 cDNA but not by that of Plsp2A or Plsp2B. These results indicate that Plsp1 and Plsp2 evolved to function differently, and that neither of the Plsp2 isoforms is necessary for proper thylakoid development in photosynthetic tissues.	[Hsu, Shih-Chi; Endow, Joshua K.; Ruppel, Nicholas J.; Roston, Rebecca L.; Baldwin, Amy J.; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Hsu, SC (corresponding author), Boyce Thompson Inst Plant Res, Itacha, NY USA.	kinoue@ucdavis.edu	Roston, Rebecca/AAQ-5309-2020	Baldwin, Amy/0000-0002-2162-3771; Roston, Rebecca/0000-0002-3063-5002; Endow-Monteiro, Joshua/0000-0002-5845-0077	United States of America Department of Energy [DE-FG02-08ER15963]	United States of America Department of Energy	This work was supported by the Energy Biosciences Program at the United States of America Department of Energy DE-FG02-08ER15963 to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlos JL, 2000, J BIOL CHEM, V275, P38813, DOI 10.1074/jbc.M007093200; Chaal BK, 2003, PLANT MOL BIOL, V52, P463, DOI 10.1023/A:1023900100803; Chaal BK, 1998, J BIOL CHEM, V273, P689, DOI 10.1074/jbc.273.2.689; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coate JE, 2011, PLANT PHYSIOL, V155, P2081, DOI 10.1104/pp.110.169599; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; DATE T, 1983, J BACTERIOL, V154, P76, DOI 10.1128/JB.154.1.76-83.1983; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Endow JK, 2010, PLANT SIGNAL BEHAV, V5, P721, DOI 10.4161/psb.5.6.11662; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Firlej-Kwoka E, 2008, PLANT MOL BIOL, V68, P505, DOI 10.1007/s11103-008-9387-4; Green N, 2001, CO POSTTRANSLATIONAL, VXXII, P57; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; Howe C. J., 2001, CO POSTTRANSLATIONAL, VXXII, P101; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KIRWIN PM, 1987, J BIOL CHEM, V262, P16386; KIRWIN PM, 1988, J BIOL CHEM, V263, P18128; Lang D, 2005, PLANT BIOLOGY, V7, P238, DOI 10.1055/s-2005-837578; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mould RM, 1997, PLANT J, V11, P1051, DOI 10.1046/j.1365-313X.1997.11051051.x; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nohara T, 1996, BIOCHEM BIOPH RES CO, V224, P474, DOI 10.1006/bbrc.1996.1051; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Richter S, 2005, PHYSIOL PLANTARUM, V123, P362, DOI 10.1111/j.1399-3054.2005.00476.x; Robinson C, 2005, ANNU PLANT REV, V13, P180; Rodrigues RAO, 2011, PLANT J, V65, P600, DOI 10.1111/j.1365-313X.2010.04448.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnell DJ, 1997, TRENDS CELL BIOL, V7, P303, DOI 10.1016/S0962-8924(97)01111-2; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Schunemann D, 2007, BIOL CHEM, V388, P907, DOI 10.1515/BC.2007.111; SHACKLETON JB, 1991, J BIOL CHEM, V266, P12152; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Skalitzky CA, 2011, PLANT PHYSIOL, V155, P354, DOI 10.1104/pp.110.166546; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; Strittmatter P, 2010, METHODS MOL BIOL, V619, P307, DOI 10.1007/978-1-60327-412-8_18; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; WALLACE TP, 1990, FEBS LETT, V272, P141, DOI 10.1016/0014-5793(90)80468-X; WHATLEY JM, 1983, NEW PHYTOL, V94, P381, DOI 10.1111/j.1469-8137.1983.tb03452.x; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zhang YB, 1997, GENE, V194, P249, DOI 10.1016/S0378-1119(97)00198-4; Zhbanko M, 2005, J BACTERIOL, V187, P3071, DOI 10.1128/JB.187.9.3071-3078.2005	69	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27258	10.1371/journal.pone.0027258	http://dx.doi.org/10.1371/journal.pone.0027258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087276	Green Published, Green Accepted, gold			2022-12-25	WOS:000297347700032
J	Jakob, C; Aust, DE; Liebscher, B; Baretton, GB; Datta, K; Muders, MH				Jakob, Christiane; Aust, Daniela E.; Liebscher, Birgit; Baretton, Gustavo B.; Datta, Kaustubh; Muders, Michael H.			Lymphangiogenesis in Regional Lymph Nodes Is an Independent Prognostic Marker in Rectal Cancer Patients after Neoadjuvant Treatment	PLOS ONE			English	Article							COLORECTAL-CANCER; TUMOR-REGRESSION; VESSEL DENSITY; PREOPERATIVE CHEMORADIOTHERAPY; CHEMORADIATION THERAPY; MICROVESSEL DENSITY; BREAST-CARCINOMA; VEGF-C; METASTASIS; PREDICTOR	One of the major prognostic factors in rectal cancer is lymph node metastasis. The formation of lymph node metastases is dependent on the existence of a premetastatic niche. An important factor preceding metastasis are lymph vessels which are located in the lymph node. Accordingly, the occurrence of intranodal lymphangiogenesis is thought to indicate distant metastasis and worse prognosis. To evaluate the significance of lymph node lymphangiogenesis, we studied formalin fixed, paraffin embedded adenocarcinomas and regional lymph nodes of 203 rectal cancer patients who were treated with neoadjuvant radiochemotherapy and consecutive curative surgery with cancer free surgical margins (R0). Regional lymph node lymph vessels were detected by immunohistochemistry for podoplanin (D2-40). Our results show that the presence of lymphatic vessels in regional lymph nodes significantly affects the disease-free survival in univariate and multivariate analyses. In contrast, there was no correlation between peritumoral or intratumoral lymph vessel density and prognosis. Indeed, our study demonstrates the importance of lymphangiogenesis in regional lymph nodes after neoadjuvant radiochemotherapy and consecutive surgery as an independent prognostic marker. Staining for intranodal lymphangiogenesis and methods of intravital imaging of lymphangiogenesis and lymphatic flow may be a useful strategy to predict long-term outcome in rectal cancer patients. Furthermore, addition of VEGF-blocking agents to standardized neoadjuvant treatment schemes might be indicated in advanced rectal cancer.	[Jakob, Christiane; Aust, Daniela E.; Liebscher, Birgit; Baretton, Gustavo B.; Datta, Kaustubh; Muders, Michael H.] Tech Univ Dresden, Inst Pathol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany; [Datta, Kaustubh] Univ Nebraska Med Ctr, Dept Biochem, Omaha, NE USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Nebraska System; University of Nebraska Medical Center	Jakob, C (corresponding author), Tech Univ Dresden, Inst Pathol, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany.	kaustubh.datta@unmc.edu; michael.muders@uniklinikum-dresden.de	Muders, Michael/AAU-6443-2020		Wilhelm Sander Stiftung fur Krebsforschung; KD [R01-NIH, CA140432]; NATIONAL CANCER INSTITUTE [R01CA140432] Funding Source: NIH RePORTER	Wilhelm Sander Stiftung fur Krebsforschung; KD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	No current external sources fund this specific study. Generally, the work of the researchers was supported by grants to MHM (Wilhelm Sander Stiftung fur Krebsforschung) and KD (R01-NIH, CA140432).	Alabi AA, 2009, INT J COLORECTAL DIS, V24, P269, DOI 10.1007/s00384-008-0622-x; Caricato M, 2007, EJSO-EUR J SURG ONC, V33, P724, DOI 10.1016/j.ejso.2007.01.023; Chang GJ, 2009, CANCER, V115, P5432, DOI 10.1002/cncr.24622; Duff SE, 2007, COLORECTAL DIS, V9, P793, DOI 10.1111/j.1463-1318.2006.01199.x; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Gao J, 2009, DIGEST LIVER DIS, V41, P116, DOI 10.1016/j.dld.2008.07.315; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hirakawa S, 2009, AM J PATHOL, V175, P2235, DOI 10.2353/ajpath.2009.090420; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Jakob C, 2006, AM J SURG PATHOL, V30, P1169; Kaneko I, 2007, DIS COLON RECTUM, V50, P13, DOI 10.1007/s10350-006-0745-5; Klos CL, 2010, AM J SURG, V200, P440, DOI 10.1016/j.amjsurg.2010.03.013; Kurahara H, 2010, J SURG ONCOL, V102, P809, DOI 10.1002/jso.21744; Longatto A, 2008, VIRCHOWS ARCH, V452, P133, DOI 10.1007/s00428-007-0550-0; Matsumoto K, 2007, DIS COLON RECTUM, V50, P308, DOI 10.1007/s10350-006-0792-y; Muders MH, 2009, CANCER RES, V69, P6042, DOI 10.1158/0008-5472.CAN-09-0552; Omachi T, 2007, CANCER LETT, V246, P167, DOI 10.1016/j.canlet.2006.02.013; Perez RO, 2005, INT J COLORECTAL DIS, V20, P434, DOI 10.1007/s00384-004-0712-3; Rinaldo F, 2007, ONCOGENE, V26, P1731, DOI 10.1038/sj.onc.1209971; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Royston D, 2009, J PATHOL, V217, P608, DOI 10.1002/path.2517; Sauer R, 2003, Colorectal Dis, V5, P406; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Van den Eynden GG, 2007, CLIN CANCER RES, V13, P5391, DOI 10.1158/1078-0432.CCR-07-1230; Van der Auwera I, 2005, CLIN CANCER RES, V11, P7637, DOI 10.1158/1078-0432.CCR-05-1142; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yeo SG, 2010, ANN SURG, V252, P998, DOI 10.1097/SLA.0b013e3181f3f1b1	29	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27402	10.1371/journal.pone.0027402	http://dx.doi.org/10.1371/journal.pone.0027402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087309	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700048
J	Liu, L; Zhong, R; Wei, S; Yin, JY; Xiang, H; Zou, L; Chen, W; Chen, JG; Zheng, XW; Huang, LJ; Zhu, BB; Chen, Q; Duan, SY; Rui, R; Yang, BF; Sun, JW; Xie, DS; Xu, YH; Miao, XP; Nie, SF				Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Xiang, Hao; Zou, Li; Chen, Wei; Chen, Ji-Gui; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa			Interactions between Genetic Variants in the Adiponectin, Adiponectin Receptor 1 and Environmental Factors on the Risk of Colorectal Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA ADIPONECTIN; CIRCULATING ADIPONECTIN; CELL-PROLIFERATION; SERUM ADIPONECTIN; OBESITY; ASSOCIATION; COLON; INSULIN; ADIPOQ	Background: Metabolic syndrome traits play an important role in the development of colorectal cancer. Adipokines, key metabolic syndrome cellular mediators, when abnormal, may induce carcinogenesis. Methodology/Principal Findings: To investigate whether polymorphisms of important adipokines, adiponectin (ADIPOQ) and its receptors, either alone or in combination with environmental factors, are implicated in colorectal cancer, a two-stage case-control study was conducted. In the first stage, we evaluated 24 tag single nucleotide polymorphisms (tag SNPs) across ADIPOQ ligand and two ADIPOQ receptors (ADIPOR1 and ADIPOR2) among 470 cases and 458 controls. One SNP with promising association was then analyzed in stage 2 among 314 cases and 355 controls. In our study, ADIPOQ rs1063538 was consistently associated with increased colorectal cancer risk, with an odds ratio (OR) of 1.94 (95% CI: 1.48-2.54) for CC genotype compared with TT genotype. In two-factor gene-environment interaction analyses, rs1063538 presented significant interactions with smoking status, family history of cancer and alcohol use, with ORs of 4.52 (95% CI: 2.78-7.34), 3.18 (95% CI: 1.73-5.82) and 1.97 (95% CI: 1.27-3.04) for smokers, individuals with family history of cancer or drinkers with CC genotype compared with non-smokers, individuals without family history of cancer or non-drinkers with TT genotype, respectively. Multifactor gene-environment interactions analysis revealed significant interactions between ADIPOQ rs1063538, ADIPOR1 rs1539355, smoking status and BMI. Individuals carrying one, two and at least three risk factors presented 1.18-fold (95% CI: 0.89-fold to 1.58-fold), 1.87-fold (95% CI: 1.38-fold to2.54-fold) and 4.39-fold (95% CI: 2.75-fold to 7.01-fold) increased colorectal cancer risk compared with those who without risk factor, respectively (P-trend <0.0001). Conclusions/Significance: Our results suggest that variants in ADIPOQ may contribute to increased colorectal cancer risk in Chinese and this contribution may be modified by environmental factors, such as smoking status, family history of cancer and BMI.	[Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Zou, Li; Chen, Wei; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Liu, Li; Zhong, Rong; Wei, Sheng; Yin, Jie-Yun; Zou, Li; Chen, Wei; Zheng, Xia-Wen; Huang, Li-Juan; Zhu, Bei-Bei; Chen, Quan; Duan, Sheng-Yu; Rui, Rui; Yang, Bei-Fang; Sun, Jing-Wen; Xie, Duo-Shuang; Xu, Yi-Hua; Miao, Xiao-Ping; Nie, Shao-Fa] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xiang, Hao] Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China; [Chen, Ji-Gui] Eighth Hosp Wuhan, Dept Surg, Wuhan, Hubei, Peoples R China; [Xie, Duo-Shuang] Taihe Hosp, Dept Infect Control, Yunyang Med Coll, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	miaoxp@mail.hust.edu.cn; sf_nie@mails.tjmu.edu.cn	miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; chen, quan/0000-0002-8019-0857	National Natural Science Foundation of China [NSFC-30972534, NSFC-81001275, 81171878]; Program for New Century Excellent Talents in University [NCET-10-0388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China [NSFC-30972534 to N. S., NSFC-81001275 and 81171878 to M. X. http://www.nsfc.gov.cn/Portal0/default124.htm] and Program for New Century Excellent Talents in University [NCET-10-0388 to M. X. http://www.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DIABETIC MED, V25, P400, DOI 10.1111/j.1464-5491.2008.02396.x; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Bray MS, 2001, HUM MUTAT, V17, P296, DOI 10.1002/humu.27; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedland SJ, 2005, J UROLOGY, V174, P1266, DOI 10.1097/01.ju.0000173093.89897.97; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Gonullu G, 2010, INT J COLORECTAL DIS, V25, P205, DOI 10.1007/s00384-009-0828-6; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Holmes MD, 2004, AM J EPIDEMIOL, V159, P732, DOI 10.1093/aje/kwh112; Inoue K, 2011, INTERNAL MED, V50, P707, DOI 10.2169/internalmedicine.50.4600; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jurinke C, 2001, Methods Mol Biol, V170, P103; Kaklamani V, 2011, METABOLISM, V60, P1234, DOI 10.1016/j.metabol.2011.01.005; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; LeMarchand L, 1997, CANCER RES, V57, P4787; Li HJ, 2010, CLIN CHEM, V56, P34, DOI 10.1373/clinchem.2009.133272; Lin J, 2004, CANCER CAUSE CONTROL, V15, P581, DOI 10.1023/B:CACO.0000036168.23351.f1; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Loos RJF, 2007, AM J CLIN NUTR, V85, P26, DOI 10.1093/ajcn/85.1.26; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Meilleur KG, 2010, J CLIN ENDOCR METAB, V95, P3517, DOI 10.1210/jc.2009-2765; Mutoh M, 2011, GASTROENTEROLOGY, V140, p[2000, e2]; Nagel G, 2009, EUR HEART J, V30, P1885, DOI 10.1093/eurheartj/ehp180; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Otsuka F, 2009, J CARDIOL, V53, P219, DOI 10.1016/j.jjcc.2008.11.004; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Russo A, 1998, INT J CANCER, V78, P161, DOI 10.1002/(SICI)1097-0215(19981005)78:2&lt;161::AID-IJC7&gt;3.0.CO;2-X; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Sun YT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011987; Tang HW, 2011, CANCER EPIDEM BIOMAR, V20, P779, DOI 10.1158/1055-9965.EPI-10-0845; Wan De-Sen, 2009, Ai Zheng, V28, P897; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705	55	55	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27301	10.1371/journal.pone.0027301	http://dx.doi.org/10.1371/journal.pone.0027301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087284	Green Submitted, gold, Green Published			2022-12-25	WOS:000297347700037
J	Anez, G; Morales-Betoulle, ME; Rios, M				Anez, German; Morales-Betoulle, Maria E.; Rios, Maria			Circulation of Different Lineages of Dengue Virus Type 2 in Central America, Their Evolutionary Time-Scale and Selection Pressure Analysis	PLOS ONE			English	Article							MOLECULAR EVOLUTION; PHYLOGENETIC-RELATIONSHIPS; PUERTO-RICO; NICARAGUA; MICROEVOLUTION; GENOTYPE; BIOLOGY; MEXICO; PCR	Dengue is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Each serotype is genetically distant from the others, and each has been subdivided into different genotypes based on phylogenetic analysis. The study of dengue evolution in endemic regions is important since the diagnosis is often made by nucleic acid amplification tests, which depends upon recognition of the viral genome target, and natural occurring mutations can affect the performance of these assays. Here we report for the first time a detailed study of the phylogenetic relationships of DENV-2 from Central America, and report the first fully sequenced DENV-2 strain from Guatemala. Our analysis of the envelope (E) protein and of the open reading frame of strains from Central American countries, between 1999 and 2009, revealed that at least two lineages of the American/Asian genotype of DENV-2 have recently circulated in that region. In occasions the co-circulation of these lineages may have occurred and that has been suggested to play a role in the observed increased severity of clinical cases. Our time-scale analysis indicated that the most recent common ancestor for Central American DENV-2 of the American/Asian genotype existed about 19 years ago. Finally, we report positive selection in DENV-2 from Central America in codons of the genes encoding for C, E, NS2A, NS3, and NS5 proteins. Some of these identified codons are novel findings, described for the first time for any of the DENV-2 genotypes.	[Anez, German; Rios, Maria] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Morales-Betoulle, Maria E.] US Naval Med Res Unit 3 NAMRU 3, Cairo, Egypt	US Food & Drug Administration (FDA); Egyptian Knowledge Bank (EKB); Cairo University	Anez, G (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	German.Anez@fda.hhs.gov; Maria.Rios@fda.hhs.gov	Añez, Germán/H-4912-2019	Añez, Germán/0000-0001-5361-3001; Rios, Maria/0000-0001-5092-8403	Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration	Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration	This study was funded by Office of Blood Research and Review/Center for Biologics Evaluation and Research/Food and Drug Administration Internal Operational Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bennett SN, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P157; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Centers for Disease Control and Prevention (CDC), 1995, MMWR, V44, P21; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Droll D, 2001, TIMELINE DENGUE AM D; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; PAHO, 2011, DENG REG INF NUMB CA; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reyes M, 2010, AM J TROP MED HYG, V83, P683, DOI 10.4269/ajtmh.2010.10-0023; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633; Tamura K, 2011, MOL BIOL EV IN PRESS; Tang Y, 2011, VIRUS GENES; TRENT DW, 1989, VIROLOGY, V172, P523, DOI 10.1016/0042-6822(89)90195-5; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945; Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06; Vasilakis N, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P183; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0	44	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27459	10.1371/journal.pone.0027459	http://dx.doi.org/10.1371/journal.pone.0027459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076162	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200076
J	Mendez-Bravo, A; Calderon-Vazquez, C; Ibarra-Laclette, E; Raya-Gonzalez, J; Ramirez-Chavez, E; Molina-Torres, J; Guevara-Garcia, AA; Lopez-Bucio, J; Herrera-Estrella, L				Mendez-Bravo, Alfonso; Calderon-Vazquez, Carlos; Ibarra-Laclette, Enrique; Raya-Gonzalez, Javier; Ramirez-Chavez, Enrique; Molina-Torres, Jorge; Guevara-Garcia, Angel A.; Lopez-Bucio, Jose; Herrera-Estrella, Luis			Alkamides Activate Jasmonic Acid Biosynthesis and Signaling Pathways and Confer Resistance to Botrytis cinerea in Arabidopsis thaliana	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; N-ACYLETHANOLAMINES; SALICYLIC-ACID; NITRIC-OXIDE; GENE-EXPRESSION; HOMOSERINE-LACTONE; DEFENSE RESPONSES; PROTEIN; TRANSDUCTION; LIPOXYGENASE	Alkamides are fatty acid amides of wide distribution in plants, structurally related to N-acyl-L-homoserine lactones (AHLs) from Gram-negative bacteria and to N-acylethanolamines (NAEs) from plants and mammals. Global analysis of gene expression changes in Arabidopsis thaliana in response to N-isobutyl decanamide, the most highly active alkamide identified to date, revealed an overrepresentation of defense-responsive transcriptional networks. In particular, genes encoding enzymes for jasmonic acid (JA) biosynthesis increased their expression, which occurred in parallel with JA, nitric oxide (NO) and H2O2 accumulation. The activity of the alkamide to confer resistance against the necrotizing fungus Botrytis cinerea was tested by inoculating Arabidopsis detached leaves with conidiospores and evaluating disease symptoms and fungal proliferation. N-isobutyl decanamide application significantly reduced necrosis caused by the pathogen and inhibited fungal proliferation. Arabidopsis mutants jar1 and coi1 altered in JA signaling and a MAP kinase mutant (mpk6), unlike salicylic acid-(SA) related mutant eds16/sid2-1, were unable to defend from fungal attack even when N-isobutyl decanamide was supplied, indicating that alkamides could modulate some necrotrophic-associated defense responses through JA-dependent and MPK6-regulated signaling pathways. Our results suggest a role of alkamides in plant immunity induction.	[Mendez-Bravo, Alfonso; Raya-Gonzalez, Javier; Lopez-Bucio, Jose] Univ Michoacana, Inst Invest Quim Biol, Morelia, Michoacan, Mexico; [Mendez-Bravo, Alfonso; Calderon-Vazquez, Carlos; Ibarra-Laclette, Enrique; Herrera-Estrella, Luis] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez-Chavez, Enrique; Molina-Torres, Jorge] CINVESTAV, Dept Biotecnol & Bioquim, Unidad Irapuato, Guanajuato, Mexico; [Guevara-Garcia, Angel A.] UNAM, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Calderon-Vazquez, Carlos] IPN, Ctr Interdisciplinario Invest Desarrollo Integral, Guasave, Sinaloa, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Mendez-Bravo, A (corresponding author), Univ Michoacana, Inst Invest Quim Biol, Morelia, Michoacan, Mexico.	jbucio@umich.mx; lherrera@ira.cinvestav.mx	Calderon-Vazquez, Carlos/R-3601-2018; Herrera-Estrella, Luis/AAL-2472-2020; Torres, Jorge Molina/B-9325-2019; Herrera-Estrella, Luis/ABC-7431-2020; Estrella, Luis R Herrera/G-7351-2011	Calderon-Vazquez, Carlos/0000-0002-6674-2504; Herrera-Estrella, Luis/0000-0001-7936-3856; Estrella, Luis R Herrera/0000-0001-7936-3856; Mendez-Bravo, Alfonso/0000-0002-0991-5464; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Chavez, Enrique/0000-0003-1689-7759	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [C02-43978/330, 106725]; Coordinacion de la Investigacion Cientifica-UMSNH [CIC 2.26]; Consejo Estatal de Ciencia y Tecnologia (COECYT); DGAPA-UNAM [IN-217698]; Howard Hughes Medical Institute [Nbr55003677]; European Commission [ICA-4-CT2000-30017]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Coordinacion de la Investigacion Cientifica-UMSNH; Consejo Estatal de Ciencia y Tecnologia (COECYT); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Consejo Nacional de Ciencia y Tecnologia (CONACYT C02-43978/330 and 106725), the Coordinacion de la Investigacion Cientifica-UMSNH (CIC 2.26), the Consejo Estatal de Ciencia y Tecnologia (COECYT), the DGAPA-UNAM (IN-217698), the Howard Hughes Medical Institute (grant no. Nbr55003677), and the European Commission (grant no. ICA-4-CT2000-30017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2002, PLANTA, V214, P497, DOI 10.1007/s00425-001-0688-y; Binns SE, 2001, PHYTOCHEMISTRY, V57, P417, DOI 10.1016/S0031-9422(00)00444-1; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Bush SM, 2007, J EXP BOT, V58, P2181, DOI 10.1093/jxb/erm092; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chapman KD, 1999, PLANT PHYSIOL, V120, P1157, DOI 10.1104/pp.120.4.1157; Chapman KD, 1998, PLANT PHYSIOL, V116, P1163, DOI 10.1104/pp.116.3.1163; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; Dangl J.L., 2000, BIOCH MOL BIOL PLANT, P1044; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Dudler R, 2006, CURR OPIN BIOTECH, V17, P1; Gibson G., 2004, GENETIC ANAL COMPLEX, P251; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Goel V, 2002, INT IMMUNOPHARMACOL, V2, P381, DOI 10.1016/S1567-5769(01)00163-1; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hu XY, 2009, PLANT SIGNAL BEHAV, V4, P696, DOI 10.4161/psb.4.8.9181; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Keereetaweep J, 2010, FEBS LETT, V584, P3215, DOI 10.1016/j.febslet.2010.06.008; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Kunos G, 2000, CHEM PHYS LIPIDS, V108, P159, DOI 10.1016/S0009-3084(00)00194-8; Lait CG, 2003, P NATL ACAD SCI USA, V100, P7027, DOI 10.1073/pnas.1232474100; Laluk K, 2011, PLANT J, V68, P480, DOI 10.1111/j.1365-313X.2011.04702.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bucio J, 2007, PLANT PHYSIOL, V145, P1703, DOI 10.1104/pp.107.107953; Lopez-Bucio J, 2006, CURR OPIN PLANT BIOL, V9, P523, DOI 10.1016/j.pbi.2006.07.002; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mendez-Bravo A, 2010, PLANT CELL PHYSIOL, V51, P1612, DOI 10.1093/pcp/pcq117; Molina-Torres J, 2004, J AGR FOOD CHEM, V52, P4700, DOI 10.1021/jf034374y; Morquecho-Contreras A, 2010, PLANT PHYSIOL, V152, P1659, DOI 10.1104/pp.109.149989; MORQUECHOCONTRE.A, 2007, INT J PLANT DEV BIOL, V1, P34; Ortiz-Castro R, 2008, PLANT CELL ENVIRON, V31, P1497, DOI 10.1111/j.1365-3040.2008.01863.x; Paria BC, 2000, CHEM PHYS LIPIDS, V108, P211, DOI 10.1016/S0009-3084(00)00197-3; Pluskota WE, 2007, J EXP BOT, V58, P4071, DOI 10.1093/jxb/erm263; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ramirez-Chavez E, 2004, PLANT PHYSIOL, V134, P1058, DOI 10.1104/pp.103.034553; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rios-Chavez P, 2003, IN VITRO CELL DEV-PL, V39, P37, DOI 10.1079/IVP2002354; Romero FR, 2009, IN VITRO CELL DEV-PL, V45, P599, DOI 10.1007/s11627-008-9187-1; Rosario SL, 1996, PLANTA MED, V62, P376, DOI 10.1055/s-2006-957913; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schuhegger R, 2006, PLANT CELL ENVIRON, V29, P909, DOI 10.1111/j.1365-3040.2005.01471.x; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; von Rad U, 2008, PLANTA, V229, P73, DOI 10.1007/s00425-008-0811-4; Wendehenne D, 2006, PLANT CELL MONOGR, P35; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woo HR, 2002, PLANT J, V31, P331, DOI 10.1046/j.1365-313X.2002.01355.x; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zimmerli L, 2001, PLANT PHYSIOL, V126, P517, DOI 10.1104/pp.126.2.517	88	39	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27251	10.1371/journal.pone.0027251	http://dx.doi.org/10.1371/journal.pone.0027251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076141	Green Published, Green Submitted, gold			2022-12-25	WOS:000297198200055
J	Marquez, CMS; Ceux, T; Wenderoth, N				Marquez, Cinthia M. Saucedo; Ceux, Tanja; Wenderoth, Nicole			Attentional Demands of Movement Observation as Tested by a Dual Task Approach	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; MOTOR CORTEX EXCITABILITY; MAGNETIC STIMULATION; PREMOTOR CORTEX; AUTOMATIC IMITATION; CONTROLLED-TRIAL; MENTAL PRACTICE; CHRONIC STROKE; HUMAN BRAIN; BOTTOM-UP	Movement observation (MO) has been shown to activate the motor cortex of the observer as indicated by an increase of corticomotor excitability for muscles involved in the observed actions. Moreover, behavioral work has strongly suggested that this process occurs in a near-automatic manner. Here we further tested this proposal by applying transcranial magnetic stimulation (TMS) when subjects observed how an actor lifted objects of different weights as a single or a dual task. The secondary task was either an auditory discrimination task (experiment 1) or a visual discrimination task (experiment 2). In experiment 1, we found that corticomotor excitability reflected the force requirements indicated in the observed movies (i.e. higher responses when the actor had to apply higher forces). Interestingly, this effect was found irrespective of whether MO was performed as a single or a dual task. By contrast, no such systematic modulations of corticomotor excitability were observed in experiment 2 when visual distracters were present. We conclude that interference effects might arise when MO is performed while competing visual stimuli are present. However, when a secondary task is situated in a different modality, neural responses are in line with the notion that the observers motor system responds in a near-automatic manner. This suggests that MO is a task with very low cognitive demands which might be a valuable supplement for rehabilitation training, particularly, in the acute phase after the incident or in patients suffering from attention deficits. However, it is important to keep in mind that visual distracters might interfere with the neural response in M1.	[Marquez, Cinthia M. Saucedo; Ceux, Tanja; Wenderoth, Nicole] Katholieke Univ Leuven, Res Ctr Motor Control & Neuroplast, Dept Biomed Kinesiol, Grp Biomed Sci, Heverlee, Belgium	KU Leuven	Marquez, CMS (corresponding author), Katholieke Univ Leuven, Res Ctr Motor Control & Neuroplast, Dept Biomed Kinesiol, Grp Biomed Sci, Heverlee, Belgium.	nici.wenderoth@faber.kuleuven.be	Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386	Flanders Fund for Scientific Research [G.0749.09]	Flanders Fund for Scientific Research(FWO)	Support for this study was provided through a grant from the Flanders Fund for Scientific Research (G.0749.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2012, PSYCHOL RES-PSYCH FO, V76, P503, DOI 10.1007/s00426-011-0380-1; Alaerts K, 2010, NEUROPSYCHOLOGIA, V48, P2082, DOI 10.1016/j.neuropsychologia.2010.03.029; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P415, DOI 10.1016/j.neuropsychologia.2008.09.012; Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Andres M, 2007, J COGNITIVE NEUROSCI, V19, P563, DOI 10.1162/jocn.2007.19.4.563; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Engel A, 2008, SOC NEUROSCI, V3, P368, DOI 10.1080/17470910701612793; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Gazes Y, 2010, BEHAV BRAIN RES, V210, P229, DOI 10.1016/j.bbr.2010.02.036; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Goodale MA, 1998, NOVART FDN SYMP, V218, P21; Gowen E, 2010, BRAIN COGNITION, V74, P288, DOI 10.1016/j.bandc.2010.08.010; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Hiraga CY, 2009, BEHAV BRAIN RES, V205, P10, DOI 10.1016/j.bbr.2009.07.019; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jonas M, 2007, EXP BRAIN RES, V177, P255, DOI 10.1007/s00221-006-0660-y; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Langguth B, 2009, NEUROSCI LETT, V460, P32, DOI 10.1016/j.neulet.2009.05.034; Leon-Sarmiento FE, 2005, NEUROSCI LETT, V389, P17, DOI 10.1016/j.neulet.2005.06.061; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Press C, 2006, EUR J NEUROSCI, V24, P2415, DOI 10.1111/j.1460-9568.2006.05115.x; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2005, CURR OPIN NEUROBIOL, V15, P623, DOI 10.1016/j.conb.2005.10.018; RIZZOLATTI G, 1987, EXP BRAIN RES, V67, P220, DOI 10.1007/BF00269468; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; van Leeuwen ML, 2009, NEUROPSYCHOLOGIA, V47, P3265, DOI 10.1016/j.neuropsychologia.2009.06.005; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Wolfe P, 2001, BRAIN MATTERS TRANSL, P151	75	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27292	10.1371/journal.pone.0027292	http://dx.doi.org/10.1371/journal.pone.0027292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073307	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000043
J	Polito, A; Sonneville, R; Guidoux, C; Barrett, L; Viltart, O; Mattot, V; Siami, S; de la Grandmaison, GL; Chretien, F; Singer, M; Gray, F; Annane, D; Brouland, JP; Sharshar, T				Polito, Andrea; Sonneville, Romain; Guidoux, Celine; Barrett, Lucinda; Viltart, Odile; Mattot, Virginie; Siami, Shidasp; de la Grandmaison, Geoffroy Lorin; Chretien, Fabrice; Singer, Mervyn; Gray, Francoise; Annane, Djillali; Brouland, Jean-Philippe; Sharshar, Tarek			Changes in CRH and ACTH Synthesis during Experimental and Human Septic Shock	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; CECAL LIGATION; NITRIC-OXIDE; HYDROCORTISONE THERAPY; CORTISOL-LEVELS; VASOPRESSIN; SEPSIS; SECRETION; STRESS	Context: The mechanisms of septic shock-associated adrenal insufficiency remain unclear. This study aimed at investigating the synthesis of corticotropin-releasing hormone (CRH) and vasopressin (AVP) by parvocellular neurons and the antehypophyseal expression of ACTH in human septic shock and in an experimental model of sepsis. Objective: To test the hypothesis that ACTH secretion is decreased secondarily to alteration of CRH or AVP synthesis, we undertook a neuropathological study of the antehypophyseal system in patients who had died from septic shock and rats with experimental faecal peritonitis. Methods: Brains obtained in 9 septic shock patients were compared to 10 nonseptic patients (controls). Parvocellular expression of AVP and CRH mRNA were evaluated by in situ hybridization. Antehypophyseal expression of ACTH, vasopressin V1b and CRH R1 receptors and parvocellular expression of iNOS in the PVN were evaluated by immunohistochemistry. The same experiments were carried out in a fecal peritonitis-induced model of sepsis. Data from septic rats with (n = 6) or without (n = 10) early death were compared to sham-operated (n = 8) animals. Results: In patients and rats, septic shock was associated with a decreased expression of ACTH, unchanged expression of V1B receptor, CRHR1 and AVP mRNA, and increased expression of parvocellular iNOS compared to controls. Septic shock was also characterized by an increased expression of CRH mRNA in rats but not in patients, who notably had a greater duration of septic shock. Conclusion: The present study suggests that in humans and in rats, septic shock is associated with decreased ACTH synthesis that is not compensated by its two natural secretagogues, AVP and CRH. One underlying mechanism might be increased expression of iNOS in hypothalamic parvocellular neurons.	[Polito, Andrea; Siami, Shidasp; Annane, Djillali; Sharshar, Tarek] Hop Raymond Poincare, Dept Intens Care, Garches, France; [Polito, Andrea; Siami, Shidasp; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin Yvelines, Virginie EA4342, Lab Neuroendocrin Response Sepsis, Garches, France; [Sonneville, Romain; Guidoux, Celine; Gray, Francoise; Brouland, Jean-Philippe] Lariboisiere Hosp, Dept Pathol, Paris, France; [Sonneville, Romain; Chretien, Fabrice] Inst Pasteur, Dept Infect & Epidemiol, HISTO Human HiSTOpathol & Anim Models, Paris, France; [Barrett, Lucinda] UCL, Dept Intens Care, London, England; [Viltart, Odile] Inst Pasteur, CNRS, Dept Biol, UMR8161, F-59019 Lille, France; [Mattot, Virginie] Univ Nord France, INSERM, Dept Plast Postnatal Brain, U837, Lille, France; [de la Grandmaison, Geoffroy Lorin] Hop Raymond Poincare, Dept Pathol, Garches, France; [Singer, Mervyn] UCL, Dept Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; University of London; University College London	Polito, A (corresponding author), Hop Raymond Poincare, Dept Intens Care, Garches, France.	djillali.annane@rpc.aphp.fr	Singer, Mervyn/J-4425-2012; Chretien, fabrice B/D-4035-2018; Sharshar, Tarek/ABF-4117-2021; Singer, Mervyn/Q-6142-2019; Sonneville, Romain/AAE-7039-2020; Annane, Djillali/R-7947-2019	Singer, Mervyn/0000-0002-1042-6350; Chretien, fabrice B/0000-0002-2794-1383; Singer, Mervyn/0000-0002-1042-6350; Sonneville, Romain/0000-0003-0245-309X; Brouland, Jean Philippe/0000-0003-3475-0101	Fondation Garches; CORTICUS [NCT00147004]	Fondation Garches; CORTICUS	This study was funded by a grant from the Fondation Garches and also by CORTICUS (NCT00147004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bugajski J, 1999, BRAIN RES, V817, P220, DOI 10.1016/S0006-8993(98)01209-8; Carlson DE, 2006, CRIT CARE MED, V34, P1178, DOI 10.1097/01.CCM.0000207340.24290.3C; Carlson DE, 2007, EXP NEUROL, V205, P485, DOI 10.1016/j.expneurol.2007.03.015; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; DOHANICS J, 1990, PEPTIDES, V11, P51, DOI 10.1016/0196-9781(90)90109-I; FLESHNER M, 1995, BRAIN RES BULL, V37, P605, DOI 10.1016/0361-9230(95)00051-F; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Guzman JA, 2007, J CRIT CARE, V22, P319, DOI 10.1016/j.jcrc.2007.05.003; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Heuer JG, 2004, J SURG RES, V121, P178, DOI 10.1016/j.jss.2004.04.018; HOLMES MC, 1986, NATURE, V319, P326, DOI 10.1038/319326a0; Hsieh CH, 2010, NEUROSCIENCE, V165, P1191, DOI 10.1016/j.neuroscience.2009.12.003; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; IRVINE CHG, 1989, ENDOCRINOLOGY, V124, P3102, DOI 10.1210/endo-124-6-3102; Kapcala LP, 1995, ANN NY ACAD SCI, V771, P419, DOI 10.1111/j.1749-6632.1995.tb44699.x; LIGHTMAN SL, 1988, J PHYSIOL-LONDON, V403, P511, DOI 10.1113/jphysiol.1988.sp017261; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; Lolait SJ, 2007, ENDOCRINOLOGY, V148, P849, DOI 10.1210/en.2006-1309; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathiak G, 2000, BRIT J PHARMACOL, V131, P383, DOI 10.1038/sj.bjp.0703629; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Muller MB, 2001, ENDOCRINOLOGY, V142, P4150, DOI 10.1210/en.142.9.4150; Oliveira-Pelegrin GR, 2010, J NEUROIMMUNOL, V227, P80, DOI 10.1016/j.jneuroim.2010.06.019; Oliveira-Pelegrin GR, 2009, NEUROIMMUNOMODULAT, V16, P45, DOI 10.1159/000179666; Oppert M, 2000, INTENS CARE MED, V26, P1747, DOI 10.1007/s001340000685; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Polito A, 2011, CRIT CARE, V15, DOI 10.1186/cc10244; Rivier C, 2003, ANN NY ACAD SCI, V992, P72, DOI 10.1111/j.1749-6632.2003.tb03139.x; Rivier C, 1998, NEUROIMMUNOMODULAT, V5, P203, DOI 10.1159/000026338; Schroeder S, 2001, CRIT CARE MED, V29, P310, DOI 10.1097/00003246-200102000-00017; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sharshar T, 2010, INTENS CARE MED, V36, P1318, DOI 10.1007/s00134-010-1840-6; Sonneville R, 2010, BRAIN PATHOL, V20, P613, DOI 10.1111/j.1750-3639.2009.00355.x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Pancoto JAT, 2008, AUTON NEUROSCI-BASIC, V138, P57, DOI 10.1016/j.autneu.2007.10.006; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	41	33	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e25905	10.1371/journal.pone.0025905	http://dx.doi.org/10.1371/journal.pone.0025905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073145	gold, Green Published, Green Submitted			2022-12-25	WOS:000297197000006
J	Yamazaki, Y; Matsubara, T; Takahashi, T; Kurashige, T; Dohi, E; Hiji, M; Nagano, Y; Yamawaki, T; Matsumoto, M				Yamazaki, Yuu; Matsubara, Tomoyasu; Takahashi, Tetsuya; Kurashige, Takashi; Dohi, Eisuke; Hiji, Masanori; Nagano, Yoshito; Yamawaki, Takemori; Matsumoto, Masayasu			Granulovacuolar Degenerations Appear in Relation to Hippocampal Phosphorylated Tau Accumulation in Various Neurodegenerative Disorders	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE HIPPOCAMPUS; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; PICKS-DISEASE; CORTICOBASAL DEGENERATION; TDP-43 IMMUNOREACTIVITY; PRECURSOR PROTEIN; DEMENTED PATIENTS; ALPHA-SYNUCLEIN	Background: Granulovacuolar degeneration (GVD) is one of the pathological hallmarks of Alzheimer's disease (AD), and it is defined as electron-dense granules within double membrane-bound cytoplasmic vacuoles. Several lines of evidence have suggested that GVDs appear within hippocampal pyramidal neurons in AD when phosphorylated tau begins to aggregate into early-stage neurofibrillary tangles. The aim of this study is to investigate the association of GVDs with phosphorylated tau pathology to determine whether GVDs and phosphorylated tau coexist among different non-AD neurodegenerative disorders. Methods: An autopsied series of 28 patients with a variety of neurodegenerative disorders and 9 control patients were evaluated. Standard histological stains along with immunohistochemistry using protein markers for GVD and confocal microscopy were utilized. Results: The number of neurons with GVDs significantly increased with the level of phosphorylated tau accumulation in the hippocampal regions in non-AD neurodegenerative disorders. At the cellular level, diffuse staining for phosphorylated tau was detected in neurons with GVDs. Conclusions: Our data suggest that GVDs appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders, while the presence of phosphorylated tau in GVD-harbouring neurons in non-AD neurodegenerative disorders was indistinguishable from age-related accumulation of phosphorylated tau. Although GVDs in non-AD neurodegenerative disorders have not been studied thoroughly, our results suggest that they are not incidental findings, but rather they appear in relation to phosphorylated tau accumulation, further highlighting the role of GVD in the process of phosphorylated tau accumulation.	[Yamazaki, Yuu; Takahashi, Tetsuya; Kurashige, Takashi; Dohi, Eisuke; Hiji, Masanori; Nagano, Yoshito; Yamawaki, Takemori; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Matsubara, Tomoyasu] Aso Iizuka Hosp, Dept Gen Internal Med, Iizuka, Fukuoka, Japan; [Hiji, Masanori] Mifukai Viha Ra Hananosato Hosp, Dept Neurol, Miyoshi, Japan	Hiroshima University	Yamazaki, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	yyamazak@hiroshima-u.ac.jp	Kurashige, Takashi/N-1767-2014; Dohi, Eisuke/I-7197-2019; Takahashi, Tetsuya/ABG-8566-2021; Matsubara, Tomoyasu/AAB-4925-2021	Kurashige, Takashi/0000-0002-5206-5979; Takahashi, Tetsuya/0000-0001-6891-0842; Matsubara, Tomoyasu/0000-0002-7559-8284; Yamazaki, Yu/0000-0002-0806-4960; NAGANO, YOSHITO/0000-0002-7974-4824	Ministry of Education, Culture, Sports, Science and Technology (MEXT);  [21591085]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT: http://www.mext.go.jp/english/) and Grant-in-Aid for Scientific Research (C) (#21591085; Principle Investigator, Tetsuya Takahashi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; BALL MJ, 1978, ACTA NEUROPATHOL, V42, P73, DOI 10.1007/BF00690970; BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; BONDAREFF W, 1991, AM J PATHOL, V139, P641; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Chalmers KA, 2007, J NEUROPATH EXP NEUR, V66, P158, DOI 10.1097/nen.0b013e3180303b93; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; DICKSON DW, 1987, ACTA NEUROPATHOL, V73, P254, DOI 10.1007/BF00686619; EIDELBERG D, 1987, BRAIN, V110, P993, DOI 10.1093/brain/110.4.993; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; FLAMENT S, 1990, BRAIN RES, V516, P15, DOI 10.1016/0006-8993(90)90891-E; FUNK KE, 2010, NEUROPATHOL APPL NEU; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gertz HJ, 1996, EUR ARCH PSY CLIN N, V246, P132, DOI 10.1007/BF02189114; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ghanevati M, 2005, J MOL NEUROSCI, V25, P79, DOI 10.1385/JMN:25:1:079; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; GIBB WRG, 1989, BRAIN, V112, P1171, DOI 10.1093/brain/112.5.1171; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; HOF PR, 1992, ACTA NEUROPATHOL, V84, P45, DOI 10.1007/BF00427214; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; HOF PR, 1992, NEUROSCI LETT, V139, P10, DOI 10.1016/0304-3940(92)90846-Y; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4; Ikegami K, 1996, PSYCHIAT CLIN NEUROS, V50, P137, DOI 10.1111/j.1440-1819.1996.tb01678.x; Ishizawa T, 2003, AM J PATHOL, V163, P1057, DOI 10.1016/S0002-9440(10)63465-7; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Kannanayakal TJ, 2006, ACTA NEUROPATHOL, V111, P413, DOI 10.1007/s00401-006-0049-9; KIUCHI A, 1991, ACTA NEUROPATHOL, V82, P1, DOI 10.1007/BF00310916; Lagalwar S, 2007, ACTA NEUROPATHOL, V113, P63, DOI 10.1007/s00401-006-0159-4; Lagalwar S, 2006, J NEUROPATH EXP NEUR, V65, P455, DOI 10.1097/01.jnen.0000229236.98124.d8; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Lieberman AP, 1998, ANN NEUROL, V43, P259, DOI 10.1002/ana.410430218; LOVE S, 1988, J NEUROPATH EXP NEUR, V47, P393, DOI 10.1097/00005072-198807000-00001; Mena R, 1992, J Geriatr Psychiatry Neurol, V5, P132; MOLSA PK, 1987, ACTA NEUROL SCAND, V75, P376; OKAMOTO K, 1991, ACTA NEUROPATHOL, V82, P340, DOI 10.1007/BF00296544; SCHERRER VB, 1996, ACTA NEUROPATHOL, V91, P351; Schmidt ML, 1996, J NEUROPATH EXP NEUR, V55, P534, DOI 10.1097/00005072-199605000-00006; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Spillantini MG, 1999, ACTA NEUROPATHOL, V97, P585, DOI 10.1007/s004010051034; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Su JH, 2002, ACTA NEUROPATHOL, V104, P1, DOI 10.1007/s00401-002-0548-2; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; TOWFIGHI J, 1972, ACTA NEUROPATHOL, V21, P224, DOI 10.1007/BF00688501; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; VERMERSCH P, 1993, ANN NEUROL, V33, P445, DOI 10.1002/ana.410330506; WOODARD JS, 1962, J NEUROPATH EXP NEUR, V21, P85, DOI 10.1097/00005072-196201000-00007; XU M, 1992, ACTA NEUROPATHOL, V85, P1, DOI 10.1007/BF00304627; Yamazaki Y, 2010, NEUROSCI LETT, V477, P86, DOI 10.1016/j.neulet.2010.04.038	61	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e26996	10.1371/journal.pone.0026996	http://dx.doi.org/10.1371/journal.pone.0026996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073234	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000020
J	Connelly, JT; Mishra, A; Gautrot, JE; Watt, FM				Connelly, John T.; Mishra, Ajay; Gautrot, Julien E.; Watt, Fiona M.			Shape-Induced Terminal Differentiation of Human Epidermal Stem Cells Requires p38 and Is Regulated by Histone Acetylation	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSIT-AMPLIFYING CELLS; MAP KINASE; GENE-EXPRESSION; ACTIVATION; ACTIN; SRF; SURFACE; ROLES; HDAC1	Engineered model substrates are powerful tools for examining interactions between stem cells and their microenvironment. Using this approach, we have previously shown that restricted cell adhesion promotes terminal differentiation of human epidermal stem cells via activation of serum response factor (SRF) and transcription of AP-1 genes. Here we investigate the roles of p38 MAPK and histone acetylation. Inhibition of p38 activity impaired SRF transcriptional activity and shape-induced terminal differentiation of human keratinocytes. In addition, inhibiting p38 reduced histone H3 acetylation at the promoters of SRF target genes, FOS and JUNB. Although histone acetylation correlated with SRF transcriptional activity and target gene expression, treatment with the histone de-acetylase inhibitor, trichostatin A (TSA) blocked terminal differentiation on micro-patterned substrates and in suspension. TSA treatment simultaneously maintained expression of LRIG1, TP63, and ITGB1. Therefore, global histone de-acetylation represses stem cell maintenance genes independent of SRF. Our studies establish a novel role for extrinsic physical cues in the regulation of chromatin remodeling, transcription, and differentiation of human epidermal stem cells.	[Connelly, John T.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Mishra, Ajay; Watt, Fiona M.] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Gautrot, Julien E.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	University of London; Queen Mary University London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; Queen Mary University London; University of Cambridge	Connelly, JT (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	j.connelly@qmul.ac.uk	Watt, Fiona/AHB-0226-2022; Gautrot, Julien/S-7920-2016	Watt, Fiona/0000-0001-9151-5154; Gautrot, Julien/0000-0002-1614-2578; mishra, ajay/0000-0001-8201-4067; Connelly, John/0000-0002-5955-8848	Wellcome Trust; Medical Research Council; Cancer Research UK; European Union; Barts and the London Charity; National Institutes of Health	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Barts and the London Charity; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Wellcome Trust, Medical Research Council, Cancer Research UK, the European Union Framework 7, and Barts and the London Charity. JTC was the recipient of a National Institutes of Health postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Chen WX, 2000, MOL CARCINOGEN, V28, P196, DOI 10.1002/1098-2744(200008)28:4<196::AID-MC2>3.0.CO;2-C; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Murai K, 2002, MOL CELL BIOL, V22, P7083, DOI 10.1128/MCB.22.20.7083-7092.2002; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	39	43	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27259	10.1371/journal.pone.0027259	http://dx.doi.org/10.1371/journal.pone.0027259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073300	Green Published, gold			2022-12-25	WOS:000297154900095
J	Klemuk, SA; Riede, T; Walsh, EJ; Titze, IR				Klemuk, Sarah A.; Riede, Tobias; Walsh, Edward J.; Titze, Ingo R.			Adapted to Roar: Functional Morphology of Tiger and Lion Vocal Folds	PLOS ONE			English	Article							PHONATION THRESHOLD PRESSURE; FINITE-ELEMENT MODEL; VISCOELASTIC PROPERTIES; LAMINA PROPRIA; FUNDAMENTAL-FREQUENCY; STRESS-RELAXATION; ELASTICITY; TISSUE; BIOMATERIALS; GEOMETRY	Vocal production requires active control of the respiratory system, larynx and vocal tract. Vocal sounds in mammals are produced by flow-induced vocal fold oscillation, which requires vocal fold tissue that can sustain the mechanical stress during phonation. Our understanding of the relationship between morphology and vocal function of vocal folds is very limited. Here we tested the hypothesis that vocal fold morphology and viscoelastic properties allow a prediction of fundamental frequency range of sounds that can be produced, and minimal lung pressure necessary to initiate phonation. We tested the hypothesis in lions and tigers who are well-known for producing low frequency and very loud roaring sounds that expose vocal folds to large stresses. In histological sections, we found that the Panthera vocal fold lamina propria consists of a lateral region with adipocytes embedded in a network of collagen and elastin fibers and hyaluronan. There is also a medial region that contains only fibrous proteins and hyaluronan but no fat cells. Young's moduli range between 10 and 2000 kPa for strains up to 60%. Shear moduli ranged between 0.1 and 2 kPa and differed between layers. Biomechanical and morphological data were used to make predictions of fundamental frequency and subglottal pressure ranges. Such predictions agreed well with measurements from natural phonation and phonation of excised larynges, respectively. We assume that fat shapes Panthera vocal folds into an advantageous geometry for phonation and it protects vocal folds. Its primary function is probably not to increase vocal fold mass as suggested previously. The large square-shaped Panthera vocal fold eases phonation onset and thereby extends the dynamic range of the voice.	[Klemuk, Sarah A.; Titze, Ingo R.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Riede, Tobias] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Riede, Tobias; Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Walsh, Edward J.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Iowa; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Boys Town National Research Hospital	Klemuk, SA (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA.	u0629893@utah.edu	Riede, Tobias/J-9092-2012	Riede, Tobias/0000-0001-6875-0017; Walsh, Edward/0000-0002-6846-2872; Riede, Tobias/0000-0001-9606-0742	National Institutes of Health (NIH) [R01 DC008612, R01 DC04390, 1R01 DC010275]; National Science Foundation (NSF) [0823417]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010275, R01DC008612, R01DC004390] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work was provided in part by National Institutes of Health (NIH) Grants R01 DC008612, R01 DC04390, and 1R01 DC010275, and National Science Foundation (NSF) Grant 0823417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2000, J ACOUST SOC AM, V108, P3003, DOI 10.1121/1.1324678; Alipour F, 2011, J VOICE, V25, P130, DOI 10.1016/j.jvoice.2009.09.002; Alipoura F, 2008, J ACOUST SOC AM, V123, P4572, DOI 10.1121/1.2908289; Bevington PR., 2002, DATA REDUCTION ERROR; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516; Chan RW, 2003, ANN BIOMED ENG, V31, P482, DOI 10.1114/1.1561287; Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019; CICERO VL, 2008, CELL PROLIFERAT, V41, P460; *COMM LOW FREQ MAR, 1994, LOW FREQ SOUND MAR M; Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517; Goemmel Andreas, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P377, DOI 10.1080/10255840701550923; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Hahn MS, 2008, ANN OTO RHINOL LARYN, V117, P371, DOI 10.1177/000348940811700508; Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607; Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022; HAST MH, 1989, J ANAT, V163, P117; Hirano S, 2004, ANN OTO RHINOL LARYN, V113, P777, DOI 10.1177/000348940411301002; HOLBROOK KA, 1974, J INVEST DERMATOL, V62, P415, DOI 10.1111/1523-1747.ep12701670; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; Ishizaka K., 1968, J ACOUST SOC JPN, V24, P311, DOI [10.20697/jasj.24.5_311, DOI 10.20697/JASJ.24.5_311]; JIANG JJQ, 1994, J VOICE, V8, P132, DOI 10.1016/S0892-1997(05)80305-4; Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018; Klemuk SA, 2010, LARYNGOSCOPE, V120, P995, DOI 10.1002/lary.20877; Kurita S., 1983, VOCAL FOLD PHYSL CON, P3; Larom D, 1997, J EXP BIOL, V200, P421; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711; Peters G., 1978, SPIXIANA, V1, P1; Peters G, 2011, MAMMAL REV, V41, P54, DOI 10.1111/j.1365-2907.2010.00169.x; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Riede T, 2008, J EXP BIOL, V211, P2144, DOI 10.1242/jeb.017004; Riede T, 2011, J BIOMECH, V44, P1936, DOI 10.1016/j.jbiomech.2011.04.024; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Schaller G. B., 1972, SERENGETI LION; SCHRAG JL, 1977, T SOC RHEOL, V21, P399, DOI 10.1122/1.549445; Selbie WS, 1998, J ACOUST SOC AM, V103, P1115, DOI 10.1121/1.421223; Tayama N, 2002, ANN OTO RHINOL LARYN, V111, P83, DOI 10.1177/000348940211100114; Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299; Titze IR, 2011, J SPEECH LANG HEAR R, V54, P520, DOI 10.1044/1092-4388(2010/09-0284); Titze IR, 2010, J EXP BIOL, V213, P3866, DOI 10.1242/jeb.044982; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; WALSH EJ, 2011, 3 INT S AC COMM AN, P173; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	47	26	26	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27029	10.1371/journal.pone.0027029	http://dx.doi.org/10.1371/journal.pone.0027029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073246	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900066
J	Moore, TJ; Furberg, CD; Glenmullen, J; Maltsberger, JT; Singh, S				Moore, Thomas J.; Furberg, Curt D.; Glenmullen, Joseph; Maltsberger, John T.; Singh, Sonal			Suicidal Behavior and Depression in Smoking Cessation Treatments	PLOS ONE			English	Article							PSYCHIATRIC ADVERSE EVENTS; CONTROLLED CLINICAL-TRIALS; VARENICLINE; TOBACCO; RISK; METAANALYSIS; SYMPTOMS; COHORT	Background: Two treatments for smoking cessation-varenicline and bupropion-carry Boxed Warnings from the U. S. Food and Drug Administration (FDA) about suicidal/self-injurious behavior and depression. However, some epidemiological studies report an increased risk in smoking or smoking cessation independent of treatment, and differences between drugs are unknown. Methodology: From the FDA's Adverse Event Reporting System (AERS) database from 1998 through September 2010 we selected domestic, serious case reports for varenicline (n = 9,575), bupropion for smoking cessation (n = 1,751), and nicotine replacement products (n = 1,917). A composite endpoint of suicidal/self-injurious behavior or depression was defined as a case with one or more Preferred Terms in Standardized MedDRA Query (SMQ) for those adverse effects. The main outcome measure was the ratio of reported suicide/self-injury or depression cases for each drug compared to all other serious events for that drug. Results: Overall we identified 3,249 reported cases of suicidal/self-injurious behavior or depression, 2,925 (90%) for varenicline, 229 (7%) for bupropion, and 95 (3%) for nicotine replacement. Compared to nicotine replacement, the disproportionality results (OR (95% CI)) were varenicline 8.4 (6.8-10.4), and bupropion 2.9 (2.3-3.7). The disproportionality persisted after excluding reports indicating concomitant therapy with any of 58 drugs with suicidal behavior warnings or precautions in the prescribing information. An additional antibiotic comparison group showed that adverse event reports of suicidal/self-injurious behavior or depression were otherwise rare in a healthy population receiving short-term drug treatment. Conclusions: Varenicline shows a substantial, statistically significant increased risk of reported depression and suicidal/self-injurious behavior. Bupropion for smoking cessation had smaller increased risks. The findings for varenicline, combined with other problems with its safety profile, render it unsuitable for first-line use in smoking cessation.	[Moore, Thomas J.] Inst Safe Medicat Practices, Alexandria, VA USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA; [Glenmullen, Joseph] Harvard Univ, Sch Med, Dept Psychiat, Cambridge Hosp, Cambridge, MA 02138 USA; [Maltsberger, John T.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Singh, Sonal] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; McLean Hospital; Johns Hopkins University	Moore, TJ (corresponding author), Inst Safe Medicat Practices, Alexandria, VA USA.	tmoore@ismp.org	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X; Moore, Thomas/0000-0003-0994-836X				American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P328, DOI 10.1001/archpsyc.62.3.328; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Greenland S, 1998, DRUG SAFETY, V18, P297, DOI 10.2165/00002018-199818040-00005; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Harrison-Woolrych M, 2011, DRUG SAFETY, V34, P763, DOI 10.2165/11594450-000000000-00000; HATSUKAMI DK, 1988, PSYCHOPHARMACOLOGY, V94, P242; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hughes JR, 2007, NICOTINE TOB RES, V9, P443, DOI 10.1080/14622200701243185; Josefberg H, 2006, CLIN SAFETY REV APPL; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Levenson M., 2008, STAT REV EVALUATION; MedDRA Maintenance and Support Services Organization, 2010, INTR GUID MEDDRA VER; MedDRA Maintenance and Support Services Organization, 2010, INTR GUID STAND MEDD; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Moore TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015337; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Moore TJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4964; Moore TJ, 2011, SIGNALS VARENICLINE; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P25, DOI 10.1089/cap.2006.16.25; National Cancer Institute Centers for Disease Control and Prevention, 2009, NAT CANC I CTR DIS C; National Center for Chronic Disease Prevention and Health Promotion; Office on Smoking and Health (U.S.), 2010, TOB SMOK CAUS DIS BI; National Library of Medicine, 2010, UN MED LANG SYST UML; Pfizer Inc, 2010, CHANTIX VAR TARTR TA; Pollock M, 2008, SUICIDALITY VARENICL; Rouve N, 2011, EUR J CLIN IN PRESS; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; United States Department of Veterans Affairs Pharmacy Benefits Management Services, 2011, CLIN GUID VAR CRIT P; United States Food and Drug Administration, 2009, CHANT ZYB GET BOX WA; United States Food and Drug Administration, 2011, CHANT QUARTERWATCH A; United States Food and Drug Administration, 2010, ADV EV REP SYST AERS; Wallerstedt SM, 2009, PHARMACOEPIDEM DR S, V18, P858, DOI 10.1002/pds.1794; Winchell C, 2006, SUPERVISORY REV NDA	40	116	119	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27016	10.1371/journal.pone.0027016	http://dx.doi.org/10.1371/journal.pone.0027016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073240	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900064
J	Bruzzone, S; Ameri, P; Briatore, L; Mannino, E; Basile, G; Andraghetti, G; Grozio, A; Magnone, M; Guida, L; Scarfi, S; Salis, A; Damonte, G; Sturla, L; Nencioni, A; Fenoglio, D; Fiory, F; Miele, C; Beguinot, F; Ruvolo, V; Bormioli, M; Colombo, G; Maggi, D; Murialdo, G; Cordera, R; De Flora, A; Zocchi, E				Bruzzone, Santina; Ameri, Pietro; Briatore, Lucia; Mannino, Elena; Basile, Giovanna; Andraghetti, Gabriella; Grozio, Alessia; Magnone, Mirko; Guida, Lucrezia; Scarfi, Sonia; Salis, Annalisa; Damonte, Gianluca; Sturla, Laura; Nencioni, Alessio; Fenoglio, Daniela; Fiory, Francesca; Miele, Claudia; Beguinot, Francesco; Ruvolo, Vittorio; Bormioli, Mariano; Colombo, Giuseppe; Maggi, Davide; Murialdo, Giovanni; Cordera, Renzo; De Flora, Antonio; Zocchi, Elena			The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts	FASEB JOURNAL			English	Article						insulin; oral glucose tolerance test; glucose uptake; GLP-1; GLUT-4	HUMAN PANCREATIC-ISLETS; CYCLIC ADP-RIBOSE; KAPPA-B KINASE; INSULIN-RESISTANCE; RISK; INFLAMMATION; MUSCLE	The plant hormone abscisic acid (ABA) is released from glucose-challenged human pancreatic beta cells and stimulates insulin secretion. We investigated whether plasma ABA increased during oral and intravenous glucose tolerance tests (OGTTs and IVGTTs) in healthy human subjects. In all subjects undergoing OGTTs (n = 8), plasma ABA increased over basal values (in a range from 2- to 9-fold). A positive correlation was found between the ABA area under the curve (AUC) and the glucose AUC. In 4 out of 6 IVGTTs, little or no increase of ABA levels was observed. In the remaining subjects, the ABA increase was similar to that recorded during OGTTs. GLP-1 stimulated ABA release from an insulinoma cell line and from human islets, by similar to 10- and 2-fold in low and high glucose, respectively. Human adipose tissue also released ABA in response to high glucose. Nanomolar ABA stimulated glucose uptake, similarly to insulin, in rat L6 myoblasts and in murine 3T3-L1 cells differentiated to adipocytes, by increasing GLUT-4 translocation to the plasma membrane. Demonstration that a glucose load in humans is followed by a physiological rise of plasma ABA, which can enhance glucose uptake by adipose tissues and muscle cells, identifies ABA as a new mammalian hormone involved in glucose metabolism.-Bruzzone, S., Ameri, P., Briatore, L., Mannino, E., Basile, G., Andraghetti, G., Grozio, A., Magnone, M., Guida, L., Scarf, S., Salis, A., Damonte, G., Sturla, L., Nencioni, A., Fenoglio, D., Fiory, F., Miele, C., Beguinot, F., Ruvolo, V., Bormioli, M., Colombo, G., Maggi, D., Murialdo, G., Cordera, R., De Flora, A., Zocchi, E. The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts. FASEB J. 26, 1251-1260 (2012). www.fasebj.org	[Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Bruzzone, Santina; Mannino, Elena; Basile, Giovanna; Grozio, Alessia; Magnone, Mirko; Guida, Lucrezia; Scarfi, Sonia; Salis, Annalisa; Damonte, Gianluca; Sturla, Laura; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res CEBR, I-16132 Genoa, Italy; [Ameri, Pietro; Briatore, Lucia; Andraghetti, Gabriella; Maggi, Davide; Murialdo, Giovanni; Cordera, Renzo] Univ Genoa, Dept Endocrinol & Med Sci, I-16132 Genoa, Italy; [Nencioni, Alessio; Fenoglio, Daniela] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr CBA, Genoa, Italy; [Fiory, Francesca; Miele, Claudia; Beguinot, Francesco] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Ruvolo, Vittorio; Bormioli, Mariano; Colombo, Giuseppe] Santa Corona Hosp, Pietra Ligure, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Naples Federico II	Zocchi, E (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto XV 1, I-16132 Genoa, Italy.	ezocchi@unige.it	Fenoglio, Daniela/I-7220-2018; Scarfi, Sonia/AAJ-2387-2020; Nencioni, Alessio/K-3692-2018; Bruzzone, Santina/A-4264-2015; Cordera, Renzo/I-7229-2017; Ameri, Pietro/K-8556-2016; maggi, davide/AAL-4687-2020; Salis, Annalisa/R-9241-2018	Fenoglio, Daniela/0000-0001-9532-6473; Scarfi, Sonia/0000-0002-7079-6919; Bruzzone, Santina/0000-0003-2034-3716; Cordera, Renzo/0000-0002-5280-9691; Ameri, Pietro/0000-0001-7167-7287; NENCIONI, ALESSIO/0000-0001-5068-8884; MAGGI, DAVIDE CARLO/0000-0003-3928-1295; Salis, Annalisa/0000-0002-3082-2908	Juvenile Diabetes Research Foundation [31-2008-413]; Italian Ministry of Education, University and Scientific Research; University of Genova; Fondazione CARIGE; Compagnia di S. Paolo; Regione Liguria	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo); Regione Liguria(Regione Liguria)	Human islets were provided through the Juvenile Diabetes Research Foundation, award 31-2008-413 (ECIT Islet for Basic Research program). The authors are indebted to all the volunteers collaborating on this study. This work was supported in part by the Italian Ministry of Education, University and Scientific Research, by the University of Genova, by the Fondazione CARIGE, by the Compagnia di S. Paolo, and by Regione Liguria.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, J CELL PHYSIOL, V227, P2502, DOI 10.1002/jcp.22987; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Espinola-Klein C, 2011, FRONT BIOSCI-LANDMRK, V16, P1663, DOI 10.2741/3812; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Velasquez DA, 2010, VITAM HORM, V84, P303, DOI [10.1016/B978-0-12-381517-0.00011-4, 10.1016/S0083-6729(10)84007-5]; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984	26	65	69	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1251	1260		10.1096/fj.11-190140	http://dx.doi.org/10.1096/fj.11-190140			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22075645				2022-12-25	WOS:000300949300027
J	Mohamed, JS; Boriek, AM				Mohamed, Junaith S.; Boriek, Aladin M.			Loss of desmin triggers mechanosensitivity and up-regulation of Ankrd1 expression through Akt-NF-kappa B signaling pathway in smooth muscle cells	FASEB JOURNAL			English	Article						ankyrin repeat protein 1; cytoskeleton; signal transduction; mechanotransduction	ANKYRIN REPEAT PROTEIN; MICE LACKING DESMIN; INTERMEDIATE-FILAMENT PROTEIN; SPINAL MUSCULAR-ATROPHY; SKELETAL-MUSCLE; CONGENITAL MYOPATHY; GENE-EXPRESSION; TRANSCRIPTION; CARP; PHOSPHORYLATION	Muscle cells, including human airway smooth muscle cells (HASMCs) express ankyrin repeat protein 1 (Ankrd1), a member of ankyrin repeat protein family. Ankrd1 efficiently interacts with the type III intermediate filament desmin. Our earlier study showed that desmin is an intracellular load-bearing protein that influences airway compliance, lung recoil, and airway contractile responsiveness. These results suggest that Ankrd1 and desmin may play important roles on ASMC homeostasis. Here we show that small interfering (si) RNA-mediated knockdown of the desmin gene in HASMCs, recombinant HASMCs (reHASMCs), up-regulates Ankrd1 expression. Moreover, loss of desmin in HASMCs increases the phosphorylation of Akt, inhibitor of kappa B kinase (IKK)-alpha, and inhibitor of kappa B (I kappa B)-alpha proteins, leading to NF-kappa B activation. Treatment of reHASMCs with Akt, IKK alpha, I kappa B alpha, or NF-kappa B inhibitor inhibits the loss of desmin-induced Ankrd1 up-regulation, suggesting Akt/NF-kappa B-mediated Ankrd1 regulation. Transfection of reHASMCs with siRNA specific for p50 or p65 corroborates the NF-kappa B-mediated Ankrd1 regulation. Luciferase reporter assays show that NF-kappa B directly binds on Ankrd1 promoter and up-regulates Ankrd1 levels. Overall, our data provide a new link between desmin and Ankrd1 regulation, which may be important for ASMC homeostasis.-Mohamed, J. S., Boriek, A. M. Loss of desmin triggers mechanosensitivity and up-regulation of Ankrd1 expression through Akt-NF-kappa B signaling pathway in smooth muscle cells. FASEB J. 26, 757-765 (2012). www.fasebj.org	[Mohamed, Junaith S.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	boriek@bcm.tmc.edu	Mohamed, Junaith/AAC-4050-2020		National Science Foundation; Keck Foundation	National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation)	This work was supported by the National Science Foundation and the Keck Foundation.	Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Balogh J, 2002, CARDIOVASC RES, V53, P439, DOI 10.1016/S0008-6363(01)00500-4; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Boriek AM, 2001, AM J PHYSIOL-CELL PH, V280, pC46, DOI 10.1152/ajpcell.2001.280.1.C46; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; de Waard V, 2003, ARTERIOSCL THROM VAS, V23, P64, DOI 10.1161/01.ATV.0000042218.13101.50; Halayko AJ, 1996, AM J PHYSIOL-LUNG C, V270, pL1040, DOI 10.1152/ajplung.1996.270.6.L1040; Kanai H, 2001, CIRC RES, V88, P30, DOI 10.1161/01.RES.88.1.30; KAPANCI Y, 1992, J HISTOCHEM CYTOCHEM, V40, P1955, DOI 10.1177/40.12.1333502; Kumar A, 2004, FASEB J, V18, P1524, DOI 10.1096/fj.04-2414com; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Loufrani L, 2001, FASEB J, V15, P117, DOI 10.1096/fj.01-0505fje; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Matsuura K, 2007, HUM PATHOL, V38, P410, DOI 10.1016/j.humpath.2006.09.006; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Nakada C, 2003, PATHOL INT, V53, P653, DOI 10.1046/j.1440-1827.2003.01541.x; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Pardo PS, 2008, AM J PHYSIOL-CELL PH, V294, pC1056, DOI 10.1152/ajpcell.00270.2007; PARK S, 1986, J BIOL CHEM, V261, P5734; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Shardonofsky FR, 2006, AM J PHYSIOL-LUNG C, V290, pL890, DOI 10.1152/ajplung.00397.2005; Sjuve R, 1998, J MUSCLE RES CELL M, V19, P415, DOI 10.1023/A:1005353805699; Slats AM, 2008, J ALLERGY CLIN IMMUN, V121, P1196, DOI 10.1016/j.jaci.2008.02.017; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Wede OK, 2002, J PHYSIOL-LONDON, V540, P941, DOI 10.1113/jphysiol.2001.014910; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zolk O, 2003, CARDIOVASC RES, V59, P563, DOI 10.1016/S0008-6363(03)00476-0; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	43	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					757	765		10.1096/fj.10-160291	http://dx.doi.org/10.1096/fj.10-160291			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22085644				2022-12-25	WOS:000300485700027
J	Sun, Y; Dandekar, RD; Mao, YTS; Yin, HL; Wulfing, C				Sun, Yi; Dandekar, Radhika D.; Mao, Yuntao S.; Yin, Helen L.; Wuelfing, Christoph			Phosphatidylinositol (4,5) Bisphosphate Controls T Cell Activation by Regulating T Cell Rigidity and Organization	PLOS ONE			English	Article							PLASMA-MEMBRANE; IMMUNOLOGICAL SYNAPSE; CDC42 ACTIVITY; ERM PROTEINS; PIP KINASE; RECEPTOR; CYTOSKELETON; HYDROLYSIS; MOVEMENT; ADHESION	Here we investigate the role of Phosphatidylinositol (4,5) bisphosphate (PIP(2)) in the physiological activation of primary murine T cells by antigen presenting cells (APC) by addressing two principal challenges in PIP(2) biology. First, PIP(2) is a regulator of cytoskeletal dynamics and a substrate for second messenger generation. The relative importance of these two processes needs to be determined. Second, PIP(2) is turned over by multiple biosynthetic and metabolizing enzymes. The joint effect of these enzymes on PIP(2) distributions needs to be determined with resolution in time and space. We found that T cells express four isoforms of the principal PIP(2)-generating enzyme phosphatidylinositol 4-phosphate 5-kinase (PIP5K) with distinct spatial and temporal characteristics. In the context of a larger systems analysis of T cell signaling, these data identify the T cell/APC interface and the T cell distal pole as sites of differential PIP(2) turnover. Overexpression of different PIP5K isoforms, as corroborated by knock down and PIP(2) blockade, yielded an increase in PIP(2) levels combined with isoform-specific changes in the spatiotemporal distributions of accessible PIP(2). It rigidified the T cell, likely by impairing the inactivation of Ezrin Moesin Radixin, delayed and diminished the clustering of the T cell receptor at the cellular interface, reduced the efficiency of T cell proximal signaling and IL-2 secretion. These effects were consistently more severe for distal PIP5K isoforms. Thus spatially constrained cytoskeletal roles of PIP(2) in the control of T cell rigidity and spatiotemporal organization dominate the effects of PIP(2) on T cell activation.	[Sun, Yi; Dandekar, Radhika D.; Wuelfing, Christoph] UT SW Med Ctr, Dept Immunol, Dallas, TX USA; [Mao, Yuntao S.; Yin, Helen L.] UT SW Med Ctr, Dept Physiol, Dallas, TX USA; [Wuelfing, Christoph] UT SW Med Ctr, Dept Cell Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, Y (corresponding author), UT SW Med Ctr, Dept Immunol, Dallas, TX USA.	Christoph.Wuelfing@UTSouthwestern.edu	Mao, Yuntao/E-9168-2012	Wuelfing, Christoph/0000-0002-6156-9861	National Institutes of Health [R01 CA96733, P50-GM21681]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to C.W. (R01 CA96733) and H.L.Y. (P50-GM21681) and a Robert A. Welch Foundation grant to H.L.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Chao WT, 2010, J CELL BIOL, V190, P247, DOI 10.1083/jcb.200911110; Corbett-Nelson EF, 2006, J CELL BIOL, V174, P255, DOI 10.1083/jcb.200605044; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; INOKUCHI S, 1990, J BIOL CHEM, V265, P5983; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shaw AS, 2001, IMMUNITY, V15, P683, DOI 10.1016/S1074-7613(01)00237-0; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wernimont SA, 2010, J IMMUNOL, V185, P4714, DOI 10.4049/jimmunol.1001445; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yonemura S, 2002, J CELL SCI, V115, P2569; Zaru R, 2001, EUR J IMMUNOL, V31, P2438, DOI 10.1002/1521-4141(200108)31:8<2438::AID-IMMU2438>3.0.CO;2-P	41	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e27227	10.1371/journal.pone.0027227	http://dx.doi.org/10.1371/journal.pone.0027227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096541	Green Submitted, Green Published, gold			2022-12-25	WOS:000297553900027
J	Janebodin, K; Horst, OV; Ieronimakis, N; Balasundaram, G; Reesukumal, K; Pratumvinit, B; Reyes, M				Janebodin, Kajohnkiart; Horst, Orapin V.; Ieronimakis, Nicholas; Balasundaram, Gayathri; Reesukumal, Kanit; Pratumvinit, Busadee; Reyes, Morayma			Isolation and Characterization of Neural Crest-Derived Stem Cells from Dental Pulp of Neonatal Mice	PLOS ONE			English	Article							HUMAN BONE-MARROW; IN-VITRO CHONDROGENESIS; ADULT PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; SELF-RENEWAL; MOUSE; EXPRESSION; GENE; MUSCLE; ACTIVATION	Dental pulp stem cells (DPSCs) are shown to reside within the tooth and play an important role in dentin regeneration. DPSCs were first isolated and characterized from human teeth and most studies have focused on using this adult stem cell for clinical applications. However, mouse DPSCs have not been well characterized and their origin(s) have not yet been elucidated. Herein we examined if murine DPSCs are neural crest derived and determined their in vitro and in vivo capacity. DPSCs from neonatal murine tooth pulp expressed embryonic stem cell and neural crest related genes, but lacked expression of mesodermal genes. Cells isolated from the Wnt1-Cre/R26R-LacZ model, a reporter of neural crest-derived tissues, indicated that DPSCs were Wnt1-marked and therefore of neural crest origin. Clonal DPSCs showed multi-differentiation in neural crest lineage for odontoblasts, chondrocytes, adipocytes, neurons, and smooth muscles. Following in vivo subcutaneous transplantation with hydroxyapatite/tricalcium phosphate, based on tissue/cell morphology and specific antibody staining, the clones differentiated into odontoblast-like cells and produced dentin-like structure. Conversely, bone marrow stromal cells (BMSCs) gave rise to osteoblast-like cells and generated bone-like structure. Interestingly, the capillary distribution in the DPSC transplants showed close proximity to odontoblasts whereas in the BMSC transplants bone condensations were distant to capillaries resembling dentinogenesis in the former vs. osteogenesis in the latter. Thus we demonstrate the existence of neural crest-derived DPSCs with differentiation capacity into cranial mesenchymal tissues and other neural crest-derived tissues. In turn, DPSCs hold promise as a source for regenerating cranial mesenchyme and other neural crest derived tissues.	[Janebodin, Kajohnkiart; Reyes, Morayma] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Horst, Orapin V.] Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA; [Horst, Orapin V.] Univ Washington, Sch Dent, Dept Endodont, Seattle, WA 98195 USA; [Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma] Univ Washington, Sch Med, Dept Pathol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Janebodin, Kajohnkiart] Mahidol Univ, Dept Anat, Fac Dent, Bangkok 10700, Thailand; [Pratumvinit, Busadee] Mahidol Univ, Dept Clin Pathol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University	Janebodin, K (corresponding author), Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	morayma@uw.edu	Janebodin, Kajohnkiart/AFG-5639-2022	Pratumvinit, Busadee/0000-0002-5220-0552	National Institutes of Health [5R03AR054955]; Department of Pathology and Laboratory Medicine, University of Washington; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE022377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, University of Washington(University of Washington); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by funding from National Institutes of Health grant 5R03AR054955 to MR, and the Department of Pathology and Laboratory Medicine, University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Alliot-Licht B, 2001, ARCH ORAL BIOL, V46, P221, DOI 10.1016/S0003-9969(00)00115-1; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Balic A, BONE; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braut A, 2003, INT J DEV BIOL, V47, P281; Breyer A, 2006, EXP HEMATOL, V34, P1596, DOI 10.1016/j.exphem.2006.07.013; Carlile MJ, 2000, HISTOCHEM J, V32, P239, DOI 10.1023/A:1004055118334; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Conway SJ, 1997, DEVELOPMENT, V124, P505; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; Duband JL, 1995, ACTA ANAT, V154, P63; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; GAUNT SJ, 1993, DEVELOPMENT, V117, P769; Grabski AD, 2009, ARTERIOSCL THROM VAS, V29, P1644, DOI 10.1161/ATVBAHA.109.191965; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Hara-Kaonga B, 2006, TRANSGENIC RES, V15, P101, DOI 10.1007/s11248-005-2541-8; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Huang GTJ, 2006, J ENDODONT, V32, P1066, DOI 10.1016/j.joen.2006.05.009; Hunt DP, 2010, STEM CELLS DEV, V19, P1055, DOI 10.1089/scd.2009.0371; Ji XH, 2000, J BONE MINER METAB, V18, P132, DOI 10.1007/s007740050103; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kiernan JA., 2009, HISTOLOGICAL HISTOCH, V4; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Lovschall H, 2005, EUR J ORAL SCI, V113, P312, DOI 10.1111/j.1600-0722.2005.00221.x; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Marchionni C, 2009, INT J IMMUNOPATH PH, V22, P699, DOI 10.1177/039463200902200315; Meulemans D, 2005, J EXP ZOOL PART B, V304B, P298, DOI 10.1002/jez.b.21047; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Pavlov MI, 2003, BIOL CELL, V95, P75, DOI 10.1016/S0248-4900(03)00008-X; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Reyes M, 2005, BLOOD, V106, P3646, DOI 10.1182/blood-2004-12-4603; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sieber-Blum M, 2008, STEM CELL REV, V4, P256, DOI 10.1007/s12015-008-9042-0; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Sloan AJ, 2009, INT J PAEDIATR DENT, V19, P61, DOI 10.1111/j.1365-263X.2008.00964.x; Sommer B, 1996, BONE, V19, P371, DOI 10.1016/S8756-3282(96)00218-9; Stevens A, 2008, STEM CELLS DEV, V17, P1175, DOI 10.1089/scd.2008.0012; Stokowski A, 2007, STEM CELLS, V25, P156, DOI 10.1634/stemcells.2006-0373; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; THOMPSON TJ, 1989, J ANAT, V166, P55; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torreggiani E, 2011, J CELL MOL MED; Trowbridge Henry O, 2003, Aust Endod J, V29, P5; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; Wang WG, 2003, TISSUE CELL, V35, P69, DOI 10.1016/S0040-8166(02)00106-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x; Yoshida S, 1996, ANAT RECORD, V245, P313; Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013; Zhang JP, 2006, BIOL CELL, V98, P567, DOI 10.1042/BC20060012; Zhang P, J BIOL CHEM, V285, P9180; Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357	85	101	107	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27526	10.1371/journal.pone.0027526	http://dx.doi.org/10.1371/journal.pone.0027526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087335	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700057
J	Shen, MY; Liu, YJ; Don, MJ; Liu, HY; Chen, ZW; Mettling, C; Corbeau, P; Chiang, CK; Jang, YS; Li, TH; Young, P; Chang, CLT; Lin, YL; Yang, WC				Shen, Ming-Yi; Liu, Yan-Jun; Don, Ming-Jaw; Liu, Hsien-Yueh; Chen, Zeng-Weng; Mettling, Clement; Corbeau, Pierre; Chiang, Chih-Kang; Jang, Yu-Song; Li, Tzu-Hsuan; Young, Paul; Chang, Cicero L. T.; Lin, Yea-Lih; Yang, Wen-Chin			Combined Phytochemistry and Chemotaxis Assays for Identification and Mechanistic Analysis of Anti-Inflammatory Phytochemicals in Fallopia japonica	PLOS ONE			English	Article							POLYGONUM-CUSPIDATUM; CHEMOKINE RECEPTORS; KINASE INHIBITORS; EMODIN; INFLAMMATION; RESVERATROL; EXTRACT; ANGIOGENESIS; SEPARATION; STILBENES	Plants provide a rich source of lead compounds for a variety of diseases. A novel approach combining phytochemistry and chemotaxis assays was developed and used to identify and study the mechanisms of action of the active compounds in F. japonica, a medicinal herb traditionally used to treat inflammation. Based on a bioactivity-guided purification strategy, two anthranoids, emodin and physcion, were identified from F. japonica. Spectroscopic techniques were used to characterize its crude extract, fractions and phytochemicals. The crude extract, chloroform fraction, and anthranoids of F. japonica significantly inhibited CXCR4-mediated chemotaxis. Mechanistic studies showed that emodin and physcion inhibited chemotaxis via inactivating the MEK/ERK pathway. Moreover, the crude extract and emodin could prevent or treat type 1 diabetes in non-obese diabetic (NOD) mice. This study illustrates the applicability of a combinational approach for the study of anti-inflammatory medicine and shows the potential of F. japonica and its anthranoids for anti-inflammatory therapy.	[Shen, Ming-Yi; Liu, Yan-Jun; Chen, Zeng-Weng; Jang, Yu-Song; Li, Tzu-Hsuan; Young, Paul; Yang, Wen-Chin] Acad Sinica, Biotechnol Res Ctr, Taipei 115, Taiwan; [Liu, Yan-Jun; Yang, Wen-Chin] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Don, Ming-Jaw] Natl Res Inst Chinese Med, Taipei, Taiwan; [Liu, Hsien-Yueh; Chang, Cicero L. T.; Yang, Wen-Chin] Natl Chung Hsing Univ, Dept Vet Med, Dept Life Sci, Taichung 40227, Taiwan; [Mettling, Clement; Corbeau, Pierre; Lin, Yea-Lih] Inst Genet Humaine CNRS UPR 1142, Montpellier, France; [Chiang, Chih-Kang] Buddist Tzu Chi Gen Hosp, Dept Chinese Med, Hualien, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; National Chung Hsing University; Centre National de la Recherche Scientifique (CNRS); Buddhist Tzu Chi General Hospital	Shen, MY (corresponding author), Acad Sinica, Biotechnol Res Ctr, Taipei 115, Taiwan.	ltchang@nchu.edu.tw; ylin@igh.cnrs.fr; wcyang@gate.sinica.edu.tw	刘, 严君/GZL-5764-2022; Yang, Wen-Chin/D-3441-2015; liu, yan/HCI-5542-2022; Shen, Ming-Yi/L-6861-2019	Yang, Wen-Chin/0000-0001-6410-2581; Mettling, Clement/0000-0002-4963-2928; Shen, Ming-Yi/0000-0002-9351-1912; CHIANG, CHIH-KANG/0000-0001-9021-4616	Development Program of Industrialization for Agricultural Biotechnology (DPAB) [099S0030093-AA]	Development Program of Industrialization for Agricultural Biotechnology (DPAB)	This work was supported by the Development Program of Industrialization for Agricultural Biotechnology (DPAB 099S0030093-AA). M.Y. Shen is an Academia Sinica postdoc fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 2002, J CLIN INVEST, V110, P1611, DOI 10.1172/JCI200217311; Bachmann M, 1992, J Environ Pathol Toxicol Oncol, V11, P49; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; BOSCH R, 1987, MUTAT RES, V188, P161, DOI 10.1016/0165-1218(87)90085-1; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chang CLT, 2005, J BIOMED SCI, V12, P79, DOI 10.1007/s11373-004-8172-x; Chang LC, 1999, BIOCHEM PHARMACOL, V58, P49, DOI 10.1016/S0006-2952(99)00075-1; China PCoPsRo ed, 2000, PHARM PEOPL REP CHIN, P950; Chong BF, 2009, EXPERT OPIN THER TAR, V13, P1147, DOI 10.1517/14728220903196761; Chu X, 2005, J CHROMATOGR A, V1097, P33, DOI 10.1016/j.chroma.2005.08.008; Cui XR, 2008, CHEM PHARM BULL, V56, P497, DOI 10.1248/cpb.56.497; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Ding Y, 2008, EUR J PHARMACOL, V590, P377, DOI 10.1016/j.ejphar.2008.06.044; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Fan PH, 2009, J SEP SCI, V32, P2979, DOI 10.1002/jssc.200900057; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Ghanim H, 2011, J CLIN ENDOCR METAB, V96, P1409, DOI 10.1210/jc.2010-1812; Hegde VR, 2004, BIOORG MED CHEM LETT, V14, P2275, DOI 10.1016/j.bmcl.2004.02.006; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; JAYASURIYA H, 1992, J NAT PROD, V55, P696, DOI 10.1021/np50083a026; JAYATILAKE GS, 1993, J NAT PROD, V56, P1805, DOI 10.1021/np50100a021; Kaneshiro T, 2006, EUR J PHARMACOL, V553, P46, DOI 10.1016/j.ejphar.2006.09.026; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kucia M, 2004, J MOL HISTOL, V35, P233; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Kwak HJ, 2006, INT J CANCER, V118, P2711, DOI 10.1002/ijc.21641; LEMLI J, 1988, PHARMACOLOGY, V36, P126, DOI 10.1159/000138431; Leu YL, 2008, PHYTOTHER RES, V22, P552, DOI 10.1002/ptr.2324; Lin SY, 2009, ANTICANCER RES, V29, P327; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; MANNILA E, 1993, PHYTOCHEMISTRY, V33, P813, DOI 10.1016/0031-9422(93)85280-5; Martin-Blondel G, 2009, AIDS, V23, P2545, DOI 10.1097/QAD.0b013e32833365f4; Matsuda H, 2001, BIOORG MED CHEM LETT, V11, P1839, DOI 10.1016/S0960-894X(01)00318-3; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Murdoch C, 2000, BLOOD, V95, P3032; Park CS, 2004, VASC PHARMACOL, V40, P279, DOI 10.1016/j.vph.2004.01.003; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Vastano BC, 2000, J AGR FOOD CHEM, V48, P253, DOI 10.1021/jf9909196; Xiao K, 2002, CHEM PHARM BULL, V50, P605, DOI 10.1248/cpb.50.605; Yang CLH, 2009, J MED CHEM, V52, P6707, DOI 10.1021/jm9006164; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Zhang CN, 2009, PHYTOTHER RES, V23, P740, DOI 10.1002/ptr.2619; Zhang LS, 1998, ONCOGENE, V16, P2855, DOI 10.1038/sj.onc.1201813	45	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27480	10.1371/journal.pone.0027480	http://dx.doi.org/10.1371/journal.pone.0027480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087325	Green Published, gold			2022-12-25	WOS:000297349700051
J	Gorlatova, N; Chao, KL; Pal, LR; Araj, RH; Galkin, A; Turko, I; Moult, J; Herzberg, O				Gorlatova, Natalia; Chao, Kinlin; Pal, Lipika R.; Araj, Rawan Hanna; Galkin, Andrey; Turko, Illarion; Moult, John; Herzberg, Osnat			Protein Characterization of a Candidate Mechanism SNP for Crohn's Disease: The Macrophage Stimulating Protein R689C Substitution	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; BETA-CHAIN; FACTOR/SCATTER FACTOR; CRYSTAL-STRUCTURE; SEMA DOMAIN; STABILITY; RECEPTOR; GENE; RON	High throughput genome wide associations studies (GWAS) are now identifying a large number of genome loci related to risk of common human disease. Each such locus presents a challenge in identifying the relevant underlying mechanism. Here we report the experimental characterization of a proposed causal single nucleotide polymorphism (SNP) in a locus related to risk of Crohn's disease and ulcerative colitis. The SNP lies in the MST1 gene encoding Macrophage Stimulating Protein (MSP), and results in an R689C amino acid substitution within the beta-chain of MSP (MSP beta). MSP binding to the RON receptor tyrosine kinase activates signaling pathways involved in the inflammatory response. We have purified wild-type and mutant MSP beta proteins and compared biochemical and biophysical properties that might impact the MSP/RON signaling pathway. Surface plasmon resonance (SPR) binding studies showed that MSP beta R689C affinity to RON is approximately 10-fold lower than that of the wild-type MSP beta and differential scanning fluorimetry (DSF) showed that the thermal stability of the mutant MSP beta was slightly lower than that of wild-type MSP beta, by 1.6 K. The substitution was found not to impair the specific Arg483-Val484 peptide bond cleavage by matriptase-1, required for MSP activation, and mass spectrometry of tryptic fragments of the mutated protein showed that the free thiol introduced by the R689C mutation did not form an aberrant disulfide bond. Together, the studies indicate that the missense SNP impairs MSP function by reducing its affinity to RON and perhaps through a secondary effect on in vivo concentration arising from reduced thermodynamic stability, resulting in down-regulation of the MSP/RON signaling pathway.	[Gorlatova, Natalia; Chao, Kinlin; Pal, Lipika R.; Araj, Rawan Hanna; Galkin, Andrey; Turko, Illarion; Moult, John; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Turko, Illarion] NIST, Gaithersburg, MD 20899 USA; [Moult, John] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Gorlatova, N (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	jmoult@umd.edu; osnat@umd.edu	Ray, Lipika/N-1245-2019	Ray, Lipika/0000-0002-3390-110X; Moult, John/0000-0002-3012-2282; Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health (NIH) [R21-DA027024, R01-GM087922, R01LM007174]; HHMI (Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027024] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI (Howard Hughes Medical Institute)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health (NIH) grants R21-DA027024, R01-GM087922, R01LM007174 (URL: http://grants.nih.gov/grants/oer.htm). RHA was a recipient of an HHMI (Howard Hughes Medical Institute) undergraduate student award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Axe DD, 1999, J MOL BIOL, V286, P1471, DOI 10.1006/jmbi.1999.2569; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Beckly JB, 2008, INFLAMM BOWEL DIS, V14, P500, DOI 10.1002/ibd.20365; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carafoli F, 2005, FEBS J, V272, P5799, DOI 10.1111/j.1742-4658.2005.04968.x; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; KELLEY RF, 1989, BIOCHEMISTRY-US, V28, P4047, DOI 10.1021/bi00435a062; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kretschmann KL, 2010, CURR DRUG TARGETS, V11, P1157; Lehr RV, 2000, PROTEIN EXPRES PURIF, V19, P362, DOI 10.1006/prep.2000.1258; Loo T, 2002, PROTEIN EXPRES PURIF, V24, P90, DOI 10.1006/prep.2001.1555; Ma Q, 2010, INT J ONCOL, V36, P1551, DOI 10.3892/ijo_00000642; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; PANTOLIANO MW, 1989, BIOCHEMISTRY-US, V28, P7205, DOI 10.1021/bi00444a012; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	37	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27269	10.1371/journal.pone.0027269	http://dx.doi.org/10.1371/journal.pone.0027269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087277	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700033
J	Lu, MP; Chen, RX; Wang, ML; Zhu, XJ; Zhu, LP; Yin, M; Zhang, ZD; Cheng, L				Lu, Mei-Ping; Chen, Ruo-Xi; Wang, Mei-Lin; Zhu, Xin-Jie; Zhu, Lu-Ping; Yin, Min; Zhang, Zheng-Dong; Cheng, Lei			Association Study on IL4, IL13 and IL4RA Polymorphisms in Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population	PLOS ONE			English	Article							IL-4 RECEPTOR-ALPHA; SERUM IGE LEVELS; INTERLEUKIN-4 RECEPTOR; CEDAR POLLINOSIS; DUTCH POPULATION; BIRTH COHORT; ASTHMA; ATOPY; GENE; VARIANT	Background: The IL4, IL13, and IL4 receptor a chain (IL4RA) genes are candidate genes for atopic diseases. We hypothesized that the polymorphisms in these genes are associated with persistent allergic rhinitis (PER). Objective: To investigate the association of the potential functional polymorphisms in IL4, IL13, and IL4RA with PER induced by house dust mites in a Chinese population. Methods: Using the TaqMan method, we genotyped six single nucleotide polymorphisms (SNPs) including C-590T in IL4, C-1055T and Arg130Gln in IL13, and Ile50Val, Ser478Pro and Gln551Arg in IL4RA, in a case-control study of 265 patients with PER and 275 healthy controls. Results: We found that the CT/CC genotypes in IL4 C-590T were associated with a significantly decreased risk of mite-sensitized PER [adjusted odds ratio (OR) = 0.64, 95% confidence interval (CI) 0.45-0.92], compared to the TT genotype. Furthermore, PER patients with CT/CC genotypes had significantly lower serum levels of total IgE than those with TT genotype (P = 0.001). However, there was no significant association of the IL13 and IL4RA polymorphisms with mite-sensitized PER (P>0.05). Conclusions: Our results suggest that the C-590T polymorphism in IL4 may contribute to the susceptibility to mite-sensitized PER in a Chinese population.	[Lu, Mei-Ping; Chen, Ruo-Xi; Zhu, Xin-Jie; Zhu, Lu-Ping; Yin, Min; Cheng, Lei] Nanjing Med Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Nanjing, Peoples R China; [Wang, Mei-Lin; Zhang, Zheng-Dong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Peoples R China; [Yin, Min; Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Lu, MP (corresponding author), Nanjing Med Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Nanjing, Peoples R China.	zdzhang@njmu.edu.cn; jspent@126.com	zhang, zheng/HCH-9684-2022; Cheng, Lei/AAT-2690-2021	Cheng, Lei/0000-0001-6541-7702	Jiangsu Higher Education Institutions [PAPD 2010-2013]; Innovative Research Project of Jiangsu Province [CX10B_341Z]; Health Promotion Project of Jiangsu Province [XK200719, RC2007065, RC2011]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS), Ministry of Education, the People's Republic of China [2008-890]	Jiangsu Higher Education Institutions; Innovative Research Project of Jiangsu Province; Health Promotion Project of Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS), Ministry of Education, the People's Republic of China	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Innovative Research Project (CX10B_341Z) and the Health Promotion Project (XK200719, RC2007065 and RC2011) of Jiangsu Province, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS 2008-890), Ministry of Education, the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Black S, 2009, ALLERGY, V64, P1172, DOI 10.1111/j.1398-9995.2009.01988.x; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Celedon JC, 2002, CLIN EXP ALLERGY, V32, P387, DOI 10.1046/j.1365-2222.2002.01348.x; Cheng L, 2006, INT ARCH ALLERGY IMM, V139, P25, DOI 10.1159/000089519; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kim JJ, 2007, EUR ARCH OTO-RHINO-L, V264, P395, DOI 10.1007/s00405-006-0204-x; Kruse S, 2002, RESP RES, V3, DOI 10.1186/rr174; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Nguyen DP, 2004, OBSTET GYNECOL, V104, P293, DOI 10.1097/01.AOG.0000133486.85400.5e; Noguchi E, 1998, CLIN EXP ALLERGY, V28, P449; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peden DB, 2002, TOXICOLOGY, V181, P323, DOI 10.1016/S0300-483X(02)00301-3; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Settipane Russell A, 2007, Clin Allergy Immunol, V19, P23; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Toda M, 2002, IMMUNOLOGY, V106, P1, DOI 10.1046/j.1365-2567.2002.01407.x; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Walley AJ, 1996, J MED GENET, V33, P689, DOI 10.1136/jmg.33.8.689; Wang M, 2003, HUM GENET, V113, P387, DOI 10.1007/s00439-003-1001-x; Yabiku K, 2007, CLIN EXP IMMUNOL, V148, P425, DOI 10.1111/j.1365-2249.2007.03366.x; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	39	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27363	10.1371/journal.pone.0027363	http://dx.doi.org/10.1371/journal.pone.0027363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087298	Green Published, gold, Green Submitted			2022-12-25	WOS:000297347700044
J	Pell, MD; Kotz, SA				Pell, Marc D.; Kotz, Sonja A.			On the Time Course of Vocal Emotion Recognition	PLOS ONE			English	Article							UNIVERSAL FACIAL EXPRESSIONS; CATEGORICAL PERCEPTION; SPEECH-PERCEPTION; BRAIN POTENTIALS; PROSODY; ATTENTION; LANGUAGE; CUES; COMMUNICATION; JUDGMENTS	How quickly do listeners recognize emotions from a speaker's voice, and does the time course for recognition vary by emotion type? To address these questions, we adapted the auditory gating paradigm to estimate how much vocal information is needed for listeners to categorize five basic emotions (anger, disgust, fear, sadness, happiness) and neutral utterances produced by male and female speakers of English. Semantically-anomalous pseudo-utterances (e. g., The rivix jolled the silling) conveying each emotion were divided into seven gate intervals according to the number of syllables that listeners heard from sentence onset. Participants (n = 48) judged the emotional meaning of stimuli presented at each gate duration interval, in a successive, blocked presentation format. Analyses looked at how recognition of each emotion evolves as an utterance unfolds and estimated the "identification point" for each emotion. Results showed that anger, sadness, fear, and neutral expressions are recognized more accurately at short gate intervals than happiness, and particularly disgust; however, as speech unfolds, recognition of happiness improves significantly towards the end of the utterance (and fear is recognized more accurately than other emotions). When the gate associated with the emotion identification point of each stimulus was calculated, data indicated that fear (M = 517 ms), sadness (M = 576 ms), and neutral (M = 510 ms) expressions were identified from shorter acoustic events than the other emotions. These data reveal differences in the underlying time course for conscious recognition of basic emotions from vocal expressions, which should be accounted for in studies of emotional speech processing.	[Pell, Marc D.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Neurocognit Rhythm Commun, Leipzig, Germany	McGill University; Max Planck Society	Pell, MD (corresponding author), McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	marc.pell@mcgill.ca	Pell, Marc D./AAL-3121-2021	Pell, Marc D./0000-0002-9947-1552	Natural Sciences and Engineering Research Council of Canada [RGPIN/203708-2006]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was financed by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN/203708-2006 to M. D. Pell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Audibert N, 2007, P ICPHS, P2137; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; BOWER GH, 1987, BEHAV RES THER, V25, P443, DOI 10.1016/0005-7967(87)90052-0; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Brosch T, 2009, J COGNITIVE NEUROSCI, V21, P1670, DOI 10.1162/jocn.2009.21110; Calder AJ, 2004, BRAIN, V127, P1958, DOI 10.1093/brain/awh214; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Charash M, 2002, J ANXIETY DISORD, V16, P529, DOI 10.1016/S0887-6185(02)00171-8; Cisler JM, 2009, COGNITION EMOTION, V23, P675, DOI 10.1080/02699930802051599; Coles M. G. H., 1987, ADV PSYCHOPHYSIOLOGY, V2, P79; Cornew L, 2010, COGNITION EMOTION, V24, P1133, DOI 10.1080/02699930903247492; COSMIDES L, 1983, J EXP PSYCHOL HUMAN, V9, P864, DOI 10.1037/0096-1523.9.6.864; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; FRICK RW, 1986, AGGRESSIVE BEHAV, V12, P121, DOI 10.1002/1098-2337(1986)12:2<121::AID-AB2480120206>3.0.CO;2-F; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Greasley P, 2000, LANG SPEECH, V43, P355, DOI 10.1177/00238309000430040201; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; GROSJEAN F, 1985, PERCEPT PSYCHOPHYS, V38, P299, DOI 10.3758/BF03207159; Grosjean F, 1996, LANG COGNITIVE PROC, V11, P597, DOI 10.1080/016909696386999; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Hot P, 2006, BRAIN RES, V1122, P171, DOI 10.1016/j.brainres.2006.09.020; Ishii K, 2003, PSYCHOL SCI, V14, P39, DOI 10.1111/1467-9280.01416; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Jaywant A, SPEECH COMMUNICATION, V54, P1; JOHNSON WF, 1986, ARCH GEN PSYCHIAT, V43, P280; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; KRAMER E, 1964, J ABNORM SOC PSYCH, V68, P390, DOI 10.1037/h0042473; Kreifelts B, 2009, NEUROPSYCHOLOGIA, V47, P3059, DOI 10.1016/j.neuropsychologia.2009.07.001; Laukka P, 2005, EMOTION, V5, P277, DOI 10.1037/1528-3542.5.3.277; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Levitt E, 1964, COMMUNICATION EMOTIO, P87; MATSUMOTO D, 1992, J NONVERBAL BEHAV, V16, P85, DOI 10.1007/BF00990324; Mozziconacci SJL, 2001, USER MODEL USER-ADAP, V11, P297, DOI 10.1023/A:1011800417621; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Niedenthal P.M., 1994, HEARTS EYE EMOTIONAL, P87, DOI [10.1016/B978-0-12-410560-7.50011-9, DOI 10.1016/B978-0-12-410560-7.50011-9]; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; OHALA JJ, 1983, PHONETICA, V40, P1, DOI 10.1159/000261678; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2012, SPEECH COMMUN, V54, P92, DOI 10.1016/j.specom.2011.07.004; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Pell MD, 2008, SPEECH COMMUN, V50, P519, DOI 10.1016/j.specom.2008.03.006; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 2009, J NONVERBAL BEHAV, V33, P107, DOI 10.1007/s10919-008-0065-7; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Pell MD, 2005, J NONVERBAL BEHAV, V29, P45, DOI 10.1007/s10919-004-0889-8; Pell MD, 2001, J ACOUST SOC AM, V109, P1668, DOI 10.1121/1.1352088; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLLACK I, 1960, LANG SPEECH, V3, P121, DOI 10.1177/002383096000300301; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; SALASOO A, 1985, J MEM LANG, V24, P210, DOI 10.1016/0749-596X(85)90025-7; Sauter DA, 2007, MOTIV EMOTION, V31, P192, DOI 10.1007/s11031-007-9065-x; Scherer KR, 2009, PHILOS T R SOC B, V364, P3459, DOI 10.1098/rstb.2009.0141; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Simon-Thomas ER, 2009, EMOTION, V9, P838, DOI 10.1037/a0017810; Sobin C, 1999, J PSYCHOLINGUIST RES, V28, P347, DOI 10.1023/A:1023237014909; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; TYLER LK, 1985, PERCEPT PSYCHOPHYS, V38, P217, DOI 10.3758/BF03207148; VANBEZOOIJEN R, 1983, J CROSS CULT PSYCHOL, V14, P387, DOI 10.1177/0022002183014004001; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; WARREN P, 1987, PERCEPT PSYCHOPHYS, V41, P262, DOI 10.3758/BF03208224; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Williams CE, 1981, SPEECH EVALUATION PS, P221; Wurm LH, 2001, COGNITION EMOTION, V15, P831, DOI 10.1080/02699930143000086; ZUCKERMAN M, 1975, J PERS SOC PSYCHOL, V32, P1068, DOI 10.1037/0022-3514.32.6.1068	99	84	89	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e27256	10.1371/journal.pone.0027256	http://dx.doi.org/10.1371/journal.pone.0027256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	852HH	22087275	Green Published, gold			2022-12-25	WOS:000297347700031
J	Johnstone, CP; Lill, A; Reina, RD				Johnstone, Christopher P.; Lill, Alan; Reina, Richard D.			Response of the Agile Antechinus to Habitat Edge, Configuration and Condition in Fragmented Forest	PLOS ONE			English	Article							YELLOW-FOOTED ANTECHINUS; STUARTII MARSUPIALIA; SEXUAL SEGREGATION; SMALL MAMMALS; PHYSIOLOGICAL STRESS; PATERNITY SUCCESS; FIELD POPULATION; MICROHABITAT USE; BLOOD PARASITES; PREDATION RISK	Habitat fragmentation and degradation seriously threaten native animal communities. We studied the response of a small marsupial, the agile antechinus Antechinus agilis, to several environmental variables in anthropogenically fragmented Eucalyptus forest in south-east Australia. Agile antechinus were captured more in microhabitats dominated by woody debris than in other microhabitats. Relative abundances of both sexes were positively correlated with fragment core area. Male and female mass-size residuals were smaller in larger fragments. A health status indicator, haemoglobin-haematocrit residuals (HHR), did not vary as a function of any environmental variable in females, but male HHR indicated better health where sites' microhabitats were dominated by shrubs, woody debris and trees other than Eucalyptus. Females were trapped less often in edge than interior fragment habitat and their physiological stress level, indicated by the neutrophil/lymphocyte ratio in peripheral blood, was higher where fragments had a greater proportion of edge habitat. The latter trend was potentially due to lymphopoenia resulting from stress hormone-mediated leukocyte trafficking. Using multiple indicators of population condition and health status facilitates a comprehensive examination of the effects of anthropogenic disturbances, such as habitat fragmentation and degradation, on native vertebrates. Male agile antechinus' health responded negatively to habitat degradation, whilst females responded negatively to the proportion of edge habitat. The health and condition indicators used could be employed to identify conservation strategies that would make habitat fragments less stressful for this or similar native, small mammals.	[Johnstone, Christopher P.; Lill, Alan; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University	Johnstone, CP (corresponding author), Monash Univ, Sch Biol Sci, Clayton Campus, Clayton, Vic 3800, Australia.	christopher.johnstone@monash.edu; alan.lill@monash.edu; richard.reina@monash.edu	Reina, Richard/AAC-7017-2019		Holsworth Wildlife Research [HOLSWOGB08]	Holsworth Wildlife Research	The research was partly funded by Holsworth Wildlife Research grant scheme for post-graduate studies (ANZ Philanthropy Partners), Fund scheme code: HOLSWOGB08 (website: http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/). All other funds were provided by Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ATCHLEY WR, 1976, SYST ZOOL, V25, P137, DOI 10.2307/2412740; Banks PB, 2000, CAN J ZOOL, V78, P1775, DOI 10.1139/cjz-78-10-1775; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; BENNETT AF, 1990, AUST WILDLIFE RES, V17, P325, DOI 10.1071/WR9900325; BENNETT AF, 1993, WILDLIFE RES, V20, P267, DOI 10.1071/WR9930267; Berry L, 2002, WILDLIFE RES, V29, P341, DOI 10.1071/WR01022; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Blackwell GL, 2006, J MAMMAL, V87, P216, DOI 10.1644/05-MAMM-A-215R1.1; Bradbury J.W., 1981, P138; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; CAUGHLEY G, 1988, J ANIM ECOL, V57, P771, DOI 10.2307/5092; CHEAL PD, 1976, AUST J ZOOL, V24, P299, DOI 10.1071/ZO9760299; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; COCKBURN A, 1992, J ZOOL, V226, P657, DOI 10.1111/j.1469-7998.1992.tb07508.x; Colombelli-Negrel D, 2008, AUST J ZOOL, V56, P117, DOI 10.1071/ZO07072; Cox MP, 2004, BIOL CONSERV, V115, P175, DOI 10.1016/S0006-3207(03)00105-8; Crawley MJ., 2007, R BOOK; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Delehanty B, 2009, GEN COMP ENDOCR, V160, P176, DOI 10.1016/j.ygcen.2008.11.011; DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; DIAMOND J M, 1987, Conservation Biology, V1, P132, DOI 10.1111/j.1523-1739.1987.tb00022.x; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; DICKMAN CR, 1983, OECOLOGIA, V60, P127, DOI 10.1007/BF00379332; Dickman CR, 1998, AUST J ZOOL, V46, P1, DOI 10.1071/ZO97036; DICKMAN CR, 1989, AUST J ECOL, V14, P387, DOI 10.1111/j.1442-9993.1989.tb01449.x; DUFVA R, 1995, FUNCT ECOL, V9, P785, DOI 10.2307/2390253; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Figuerola J, 1999, FUNCT ECOL, V13, P594, DOI 10.1046/j.1365-2435.1999.00354.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FISHER JW, 1962, BLOOD, V19, P557, DOI 10.1182/blood.V19.5.557.557; Fletcher QE, 2006, J ZOOL, V270, P473, DOI 10.1111/j.1469-7998.2006.00153.x; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GILPIN ME, 1976, P NATL ACAD SCI USA, V73, P4130, DOI 10.1073/pnas.73.11.4130; Holland GJ, 2009, BIODIVERS CONSERV, V18, P2997, DOI 10.1007/s10531-009-9621-7; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P139, DOI 10.1007/s00360-011-0598-7; Johnstone CP, 2010, J MAMMAL, V91, P1332, DOI 10.1644/10-MAMM-A-034.1; Jorgensen EE, 2004, J MAMMAL, V85, P531, DOI 10.1644/BER-019; Kelly LT, 2008, WILDLIFE RES, V35, P128, DOI 10.1071/WR07088; Knight EH, 2000, AUST J ZOOL, V48, P577, DOI 10.1071/ZO00018; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; Kraaijeveld-Smit FJL, 2002, AUST J ZOOL, V50, P325, DOI 10.1071/ZO02010; Kraaijeveld-Smit FJL, 2002, J EVOLUTION BIOL, V15, P100, DOI 10.1046/j.1420-9101.2002.00367.x; Kraaijeveld-Smit FJL, 2002, BEHAV ECOL SOCIOBIOL, V52, P84, DOI 10.1007/s00265-002-0485-z; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; LAZENBYCOHEN KA, 1991, AUST J ECOL, V16, P301, DOI 10.1111/j.1442-9993.1991.tb01058.x; Lee AK., 1985, EVOL ECOL; Lewis S, 2006, DACIE LEWIS PRACTICA, V10th; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Lunney D, 2001, WILDLIFE RES, V28, P459, DOI 10.1071/WR00015; MAC ARTHUR ROBERT H., 1967; Mac Nally R., 2002, Animal Biodiversity and Conservation, V25, P41; Mac Nally R, 1996, AUST J ECOL, V21, P224; Marchesan D, 2008, LANDSCAPE ECOL, V23, P741, DOI 10.1007/s10980-008-9234-7; MARLOW B. J., 1961, AUSTRALIAN JOUR ZOOL, V9, P203, DOI 10.1071/ZO9610203; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Masello JF, 2009, COMP BIOCHEM PHYS A, V152, P176, DOI 10.1016/j.cbpa.2008.09.018; May SA, 1996, WILDLIFE RES, V23, P387, DOI 10.1071/WR9960387; Menkhorst P., 2004, FIELD GUIDE MAMMALS; Naylor R, 2008, J COMP PHYSIOL B, V178, P545, DOI 10.1007/s00360-007-0250-8; Oishi K, 1999, ACTA PHYSIOL SCAND, V165, P65; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shimmin GA, 1999, BIOL REPROD, V60, P1353, DOI 10.1095/biolreprod60.6.1353; Shnberloff D.S., 1974, Annual Rev Ecol Syst, V5, P161; SIEGEL HS, 1980, BIOSCIENCE, V30, P529, DOI 10.2307/1307973; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Stokes VL, 2004, BIOL CONSERV, V117, P331, DOI 10.1016/j.biocon.2003.12.012; Sutherland DR, 1999, AUST J ZOOL, V47, P1, DOI 10.1071/ZO98037; Teague CR, 2007, J PROTEOME RES, V6, P2080, DOI 10.1021/pr060412s; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Tyler RD, 1996, COMP HAEMATOL INT, V6, P1, DOI 10.1007/BF00368096; WOOD D H, 1970, Australian Journal of Zoology, V18, P185, DOI 10.1071/ZO9700185; WOOLLARD P, 1971, Australian Journal of Zoology, V19, P347, DOI 10.1071/ZO9710347; Zanette L, 2003, P ROY SOC B-BIOL SCI, V270, P799, DOI 10.1098/rspb.2002.2311; Zuur Alain F., 2009, P1	96	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27158	10.1371/journal.pone.0027158	http://dx.doi.org/10.1371/journal.pone.0027158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076129	gold, Green Published, Green Submitted			2022-12-25	WOS:000297198200041
J	Teng, CT; Li, Y; Stockton, P; Foley, J				Teng, Christina T.; Li, Yin; Stockton, Pat; Foley, Julie			Fasting Induces the Expression of PGC-1 alpha and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney	PLOS ONE			English	Article							ERYTHROPOIETIN-PRODUCING CELLS; HORMONE RESPONSE ELEMENT; ALPHA GENE-EXPRESSION; RECEPTOR-GAMMA; COACTIVATOR-1-ALPHA PGC-1-ALPHA; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; JUXTAMEDULLARY CORTEX; ESTROGEN-RECEPTOR; METABOLIC-CONTROL	Background: Peroxisome proliferator-activated receptor-gamma co-activator-1 alpha (PGC-1 alpha) is a member of the transcriptional coactivator family that plays a central role in the regulation of cellular energy metabolism under various physiological stimuli. During fasting, PGC-1 alpha is induced in the liver and together with estrogen-related receptor a and gamma (ERR alpha and ERR gamma, orphan nuclear receptors with no known endogenous ligand, regulate sets of genes that participate in the energy balance program. We found that PGC-1 alpha, ERR alpha and ERR gamma was highly expressed in human kidney HK2 cells and that PGC-1 alpha induced dynamic protein interactions on the ERR alpha chromatin. However, the effect of fasting on the expression of endogenous PG-C1 alpha, ERR alpha and ERR gamma in the kidney is not known. Methodology/Principal Findings: In this study, we demonstrated by qPCR that the expression of PGC-1 alpha, ERR alpha and ERR gamma was increased in the mouse kidney after fasting. By using immunohistochemistry (IHC), we showed these three proteins are co-localized in the outer stripe of the outer medulla (OSOM) of the mouse kidney. We were able to collect this region from the kidney using the Laser Capture Microdissection (LCM) technique. The qPCR data showed significant increase of PGC-1 alpha, ERR alpha and ERR gamma mRNA in the LCM samples after fasting for 24 hours. Furthermore, the known ERR alpha target genes, mitochondrial oxidative phosphorylation gene COX8H and the tricarboxylic acid (TCA) cycle gene IDH3A also showed an increase. Taken together, our data suggest that fasting activates the energy balance program in the OSOM of the kidney.	[Teng, Christina T.] NIEHS, Biomol Screening Branch, NIH, Res Triangle Pk, NC 27709 USA; [Li, Yin] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA; [Li, Yin] NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Stockton, Pat; Foley, Julie] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Teng, CT (corresponding author), NIEHS, Biomol Screening Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	teng1@niehs.nih.gov			National Institutes of Health; National Institute of Environmental Health Sciences [Z01-ES 070067]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the Intramural Research Program of the National Institutes of Health and by the National Institute of Environmental Health Sciences Project Z01-ES 070067 to C.T.T. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Araki M, 2006, FEBS J, V273, P1669, DOI 10.1111/j.1742-4658.2006.05183.x; ARNALL DA, 1988, AM J PHYSIOL, V254, pC560, DOI 10.1152/ajpcell.1988.254.4.C560; Blantz RC, 1998, KIDNEY INT, V53, P512, DOI 10.1046/j.1523-1755.2003_t01-1-00784.x; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; COMMITTEE NRN, 1999, CELL, V97, P161; Couchepin C, 2008, DIABETES CARE, V31, P1254, DOI 10.2337/dc07-2001; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Grasfeder LL, 2009, MOL ENDOCRINOL, V23, P1171, DOI 10.1210/me.2009-0024; GUYTON AC, 1964, CIRC RES, V15, P187; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Iversen BM, 1998, AM J PHYSIOL-RENAL, V274, pF365, DOI 10.1152/ajprenal.1998.274.2.F365; Jelinsky SA, 2003, ENDOCRINOLOGY, V144, P701, DOI 10.1210/en.2002-220728; Johkura K, 1998, J HISTOCHEM CYTOCHEM, V46, P1161, DOI 10.1177/002215549804601008; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333, DOI 10.1152/ajpendo.2001.281.6.E1333; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; OLSON JL, 1986, KIDNEY INT, V29, P849, DOI 10.1038/ki.1986.76; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ranhotra HS, 2009, MOL CELL BIOCHEM, V332, P59, DOI 10.1007/s11010-009-0174-6; Roald AB, 2002, AM J PHYSIOL-RENAL, V282, pF506, DOI 10.1152/ajprenal.00199.2001; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; RUNDLE SE, 1989, ENDOCRINOLOGY, V125, P1700, DOI 10.1210/endo-125-3-1700; SCHREIBER SN, 2003, J BIOL CHEM; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shigeta H, 1997, J MOL ENDOCRINOL, V19, P299, DOI 10.1677/jme.0.0190299; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Taketani Y, 1998, J BIOL CHEM, V273, P14575, DOI 10.1074/jbc.273.23.14575; Teng CT, 2002, MOL HUM REPROD, V8, P58, DOI 10.1093/molehr/8.1.58; Tremblay AM, 2010, MOL ENDOCRINOL, V24, P22, DOI 10.1210/me.2009-0254; TUCKER BJ, 1977, AM J PHYSIOL, V232, pF477, DOI 10.1152/ajprenal.1977.232.6.F477; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e26961	10.1371/journal.pone.0026961	http://dx.doi.org/10.1371/journal.pone.0026961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073226	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200026
J	Yi, QY; Zhao, XY; Huang, Y; Ma, TL; Zhang, YY; Hou, HL; Cooke, HJ; Yang, DQ; Wu, MA; Shi, QH				Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Yang, Da-Qing; Wu, Mian; Shi, Qinghua			p53 Dependent Centrosome Clustering Prevents Multipolar Mitosis in Tetraploid Cells	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; NUCLEOTIDE EXCHANGE FACTOR; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR GENE; RHO-ASSOCIATED KINASE; CANCER-CELLS; CHROMOSOMAL INSTABILITY; CYTOKINESIS FAILURE; GENOMIC INSTABILITY; ACTIN CYTOSKELETON	Background: p53 abnormality and aneuploidy often coexist in human tumors, and tetraploidy is considered as an intermediate between normal diploidy and aneuploidy. The purpose of this study was to investigate whether and how p53 influences the transformation from tetraploidy to aneuploidy. Principal Findings: Live cell imaging was performed to determine the fates and mitotic behaviors of several human and mouse tetraploid cells with different p53 status, and centrosome and spindle immunostaining was used to investigate centrosome behaviors. We found that p53 dominant-negative mutation, point mutation, or knockout led to a 2 similar to 33-fold increase of multipolar mitosis in N/TERT1, 3T3 and mouse embryonic fibroblasts (MEFs), while mitotic entry and cell death were not significantly affected. In p53(-/-) tetraploid MEFs, the ability of centrosome clustering was compromised, while centrosome inactivation was not affected. Suppression of RhoA/ROCK activity by specific inhibitors in p53(-/-) tetraploid MEFs enhanced centrosome clustering, decreased multipolar mitosis from 38% to 20% and 16% for RhoA and ROCK, respectively, while expression of constitutively active RhoA in p53(+/+) tetraploid 3T3 cells increased the frequency of multipolar mitosis from 15% to 35%. Conclusions: p53 could not prevent tetraploid cells entering mitosis or induce tetraploid cell death. However, p53 abnormality impaired centrosome clustering and lead to multipolar mitosis in tetraploid cells by modulating the RhoA/ROCK signaling pathway.	[Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Wu, Mian; Shi, Qinghua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Yi, Qiyi; Zhao, Xiaoyu; Huang, Yun; Ma, Tieliang; Zhang, Yingyin; Hou, Heli; Cooke, Howard J.; Wu, Mian; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Yang, Da-Qing] Univ S Dakota, Sioux Falls, SD USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Edinburgh; University of Edinburgh; University of South Dakota	Yi, QY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013; Huang, Yun/AGX-8953-2022	Huang, Yun/0000-0001-5987-1319; Wu, Mian/0000-0002-2714-0500; Yi, Qiyi/0000-0001-5143-8828	National Natural Science Foundation of China [30571030, 30671168, 30725013]; National High Technology Research and Development Program of China [2006AA02Z4B4]; Ministry of Education of China [20070358022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from National Natural Science Foundation of China (Grants 30571030, 30671168 and 30725013), National High Technology Research and Development Program of China (2006AA02Z4B4), and Doctoral Fund of Ministry of Education of China (20070358022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Andreassen PR, 2003, MUTAT RES-FUND MOL M, V532, P245, DOI 10.1016/j.mrfmmm.2003.08.020; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Boveri T, 1929, ORIGIN MALIGNANT TUM; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Brown N, 2009, CELL CYCLE, V8, P1997, DOI 10.4161/cc.8.13.8987; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; del Peso L, 1997, ONCOGENE, V15, P3047; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Eda M, 2001, J CELL SCI, V114, P3273; EYFJORD JE, 1995, CANCER RES, V55, P646; Fichter CD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-13; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gisselsson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001871; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; HARVEY M, 1993, ONCOGENE, V8, P2457; Ho CC, 2010, ONCOTARGET, V1, P583; Ianzini F, 2009, CANCER RES, V69, P2296, DOI 10.1158/0008-5472.CAN-08-3364; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Lozano G, 2000, NATURE, V404, P24, DOI 10.1038/35003670; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mizuarai S, 2006, CANCER RES, V66, P6319, DOI 10.1158/0008-5472.CAN-05-4629; MOSCOW JA, 1994, ONCOGENE, V9, P189; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nakamoto M, 2001, INT J ONCOL, V19, P971; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rihet S, 2001, J CANCER RES CLIN, V127, P733; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Schmidt S, 2010, CELL CYCLE, V9, P4469, DOI 10.4161/cc.9.22.13684; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Senovilla L, 2009, CELL CYCLE, V8, P1380, DOI 10.4161/cc.8.9.8305; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sigurdsson S, 2000, CANCER GENET CYTOGEN, V121, P150, DOI 10.1016/S0165-4608(00)00260-0; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Song YH, 2000, J CELL BIOCHEM, V80, P229; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Vitale I, 2010, CELL CYCLE, V9, P2823, DOI 10.4161/cc.9.14.12254; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wadhwa R, 1999, CELL RES, V9, P261, DOI 10.1038/sj.cr.7290025; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208	85	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27304	10.1371/journal.pone.0027304	http://dx.doi.org/10.1371/journal.pone.0027304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076149	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200063
J	Bakkali, M				Bakkali, Mohammed			Microevolution of cis-Regulatory Elements: An Example from the Pair-Rule Segmentation Gene fushi tarazu in the Drosophila melanogaster Subgroup	PLOS ONE			English	Article							PHYLOGENETIC FOOTPRINTING REVEALS; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; HAPLOTYPE RECONSTRUCTION; CONCERTED EVOLUTION; FUNCTIONAL-ANALYSIS; ENHANCER EVOLUTION; ADAPTIVE EVOLUTION; SEQUENCE ALIGNMENT; STATISTICAL-METHOD	The importance of non-coding DNAs that control transcription is ever noticeable, but the characterization and analysis of the evolution of such DNAs presents challenges not found in the analysis of coding sequences. In this study of the cis-regulatory elements of the pair rule segmentation gene fushi tarazu (ftz) I report the DNA sequences of ftz's zebra element (promoter) and a region containing the proximal enhancer from a total of 45 fly lines belonging to several populations of the species Drosophila melanogaster, D. simulans, D. sechellia, D. mauritiana, D. yakuba, D. teissieri, D. orena and D. erecta. Both elements evolve at slower rate than ftz synonymous sites, thus reflecting their functional importance. The promoter evolves more slowly than the average for ftz's coding sequence while, on average, the enhancer evolves more rapidly, suggesting more functional constraint and effective purifying selection on the former. Comparative analysis of the number and nature of base substitutions failed to detect significant evidence for positive/adaptive selection in transcription-factor-binding sites. These seem to evolve at similar rates to regions not known to bind transcription factors. Although this result reflects the evolutionary flexibility of the transcription factor binding sites, it also suggests a complex and still not completely understood nature of even the characterized cis-regulatory sequences. The latter seem to contain more functional parts than those currently identified, some of which probably transcription factor binding. This study illustrates ways in which functional assignments of sequences within cis-acting sequences can be used in the search for adaptive evolution, but also highlights difficulties in how such functional assignment and analysis can be carried out.	Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain	University of Granada	Bakkali, M (corresponding author), Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain.	mbakkali@ugr.es	Bakkali, Mohammed/M-1267-2014	Bakkali, Mohammed/0000-0002-9079-8452	Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [G19219] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Andolfatto P, 2011, GENOME BIOL EVOL, V3, P114, DOI 10.1093/gbe/evq086; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bakkali M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000741; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; Carey M, 2000, TRANSCRIPTIONAL REGU, P539; CVEKL A, 1992, GENE, V110, P225, DOI 10.1016/0378-1119(92)90652-6; DAVID JR, 1982, BIOCHEM GENET, V20, P747, DOI 10.1007/BF00483971; DEAROLF CR, 1990, BIOESSAYS, V12, P109, DOI 10.1002/bies.950120303; DEAROLF CR, 1989, GENE DEV, V3, P384, DOI 10.1101/gad.3.3.384; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER G, 1994, CURR BIOL, V4, P1165, DOI 10.1016/S0960-9822(00)00265-7; DOVER GA, 1993, METHOD ENZYMOL, V224, P525, DOI 10.1016/0076-6879(93)24039-W; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FU YX, 1993, GENETICS, V133, P693; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Ganley Austen R. D., 2007, V395, P367; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2008, BIOL LETTERS, V4, P438, DOI 10.1098/rsbl.2008.0174; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAN W, 1993, MOL CELL BIOL, V13, P5549, DOI 10.1128/MCB.13.9.5549; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; Hancock JM, 1999, MOL BIOL EVOL, V16, P253, DOI 10.1093/oxfordjournals.molbev.a026107; Heffer A, 2010, P NATL ACAD SCI USA, V107, P18040, DOI 10.1073/pnas.1010746107; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Ho MCW, 2009, INT J DEV BIOL, V53, P459, DOI 10.1387/ijdb.082647mh; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; INGHAM P, 1988, DEVELOPMENT, V104, P51; JEFFS PS, 1994, MOL BIOL EVOL, V11, P287; JENKINS DL, 1995, P ROY SOC B-BIOL SCI, V261, P203, DOI 10.1098/rspb.1995.0137; Jiao K, 2002, YEAST, V19, P99, DOI 10.1002/yea.800; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kauer M, 2002, GENETICS, V160, P247; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lemos B, 2004, GENOMICS, V84, P511, DOI 10.1016/j.ygeno.2004.05.009; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; LIN KC, 1995, J BIOCHEM BIOPH METH, V30, P85, DOI 10.1016/0165-022X(94)00066-M; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nasiadka A, 1999, DEVELOPMENT, V126, P1515; Nei M, 1987, MOL EVOLUTIONARY GEN; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Phinchongsakuldit J, 2004, MOL BIOL EVOL, V21, P348, DOI 10.1093/molbev/msh025; PICK L, 1990, GENE DEV, V4, P1224, DOI 10.1101/gad.4.7.1224; Potokina E, 2008, PLANT J, V56, P287, DOI 10.1111/j.1365-313X.2008.03601.x; POWELL JR, 1991, MOL BIOL EVOL, V8, P892; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Skaer N, 2000, DEV BIOL, V221, P148, DOI 10.1006/dbio.1999.9661; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stern David L, 2007, Novartis Found Symp, V284, P191; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOPOL J, 1991, GENE DEV, V5, P855, DOI 10.1101/gad.5.5.855; Tran DA, 2010, DNA CELL BIOL, V29, P499, DOI 10.1089/dna.2009.0994; TSAI CC, 1995, DEVELOPMENT, V121, P453; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wingender E, 1996, PACIFIC SYMPOSIUM ON BIOCOMPUTING '97, P477; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wratten NS, 2006, EVOL DEV, V8, P6, DOI 10.1111/j.1525-142X.2006.05070.x; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200	93	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27376	10.1371/journal.pone.0027376	http://dx.doi.org/10.1371/journal.pone.0027376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073317	Green Published, gold, Green Submitted			2022-12-25	WOS:000297197000049
J	Taylor, PD; Mackenzie, SA; Thurber, BG; Calvert, AM; Mills, AM; McGuire, LP; Guglielmo, CG				Taylor, Philip D.; Mackenzie, Stuart A.; Thurber, Bethany G.; Calvert, Anna M.; Mills, Alex M.; McGuire, Liam P.; Guglielmo, Christopher G.			Landscape Movements of Migratory Birds and Bats Reveal an Expanded Scale of Stopover	PLOS ONE			English	Article							NOCTURNAL PASSERINE MIGRANTS; SPRING MIGRATION; EUROPEAN ROBINS; NEW-WORLD; ORIENTATION; AUTUMN; FLIGHT; SANDPIPERS; DEPARTURE; DURATION	Many species of birds and bats undertake seasonal migrations between breeding and over-wintering sites. En-route, migrants alternate periods of flight with time spent at stopover - the time and space where individuals rest and refuel for subsequent flights. We assessed the spatial scale of movements made by migrants during stopover by using an array of automated telemetry receivers with multiple antennae to track the daily location of individuals over a geographic area similar to 20x40 km. We tracked the movements of 322 individuals of seven migratory vertebrate species (5 passerines, 1 owl and 1 bat) during spring and fall migratory stopover on and adjacent to a large lake peninsula. Our results show that many individuals leaving their capture site relocate within the same landscape at some point during stopover, moving as much as 30 km distant from their site of initial capture. We show that many apparent nocturnal departures from stopover sites are not a resumption of migration in the strictest sense, but are instead relocations that represent continued stopover at a broader spatial scale.	[Taylor, Philip D.; Calvert, Anna M.; Mills, Alex M.] Acadia Univ, Wolfville, NS B0P 1X0, Canada; [Taylor, Philip D.; Mackenzie, Stuart A.; Thurber, Bethany G.; Calvert, Anna M.; Mills, Alex M.] Bird Studies Canada, Port Rowan, ON, Canada; [Mackenzie, Stuart A.; Thurber, Bethany G.; McGuire, Liam P.; Guglielmo, Christopher G.] Univ Western Ontario, London, ON, Canada	Acadia University; Western University (University of Western Ontario)	Taylor, PD (corresponding author), Acadia Univ, Wolfville, NS B0P 1X0, Canada.	Philip.taylor@acadiau.ca	McGuire, Liam/CAE-8434-2022		National Sciences and Engineering Research Council; Environment Canada; Ontario Ministry of Natural Resources	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Ontario Ministry of Natural Resources	Funding for the study was provided by grants from the National Sciences and Engineering Research Council (Discovery Grants to PDT, CGG; Scholarships to SAM, BGT, LPM), Environment Canada (PDT) and the Ontario Ministry of Natural Resources (CGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 1996, BEHAV ECOL SOCIOBIOL, V38, P293, DOI 10.1007/s002650050245; Akesson S, 1996, J AVIAN BIOL, V27, P95, DOI 10.2307/3677138; Akesson S, 1999, ARDEA, V87, P129; ALERSTAM T, 1978, OIKOS, V30, P405, DOI 10.2307/3543491; Amelon Sybill K., 2009, P57; Bachler E, 2007, CONDOR, V109, P142, DOI 10.1650/0010-5422(2007)109[142:TEOPLE]2.0.CO;2; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Butler RW, 2002, WILSON BULL, V114, P485, DOI 10.1676/0043-5643(2002)114[0485:SFALMO]2.0.CO;2; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Chernetsov Nikita, 2000, Avian Ecology and Behaviour, V5, P27; Cochran William W., 2005, P274; ELLEGREN H, 1993, ORNIS SCAND, V24, P220, DOI 10.2307/3676737; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fair J., 2010, ORNITHOLOGICAL COUNC; Farmer AH, 1997, CONDOR, V99, P698, DOI 10.2307/1370481; Goymann W, 2010, BIOL LETTERS, V6, P478, DOI 10.1098/rsbl.2009.1028; Holberton Rebecca L., 2005, P290; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; Mills AM, 2011, CONDOR, V113, P597, DOI 10.1525/cond.2011.100186; Moore FR, 1996, AUK, V113, P949, DOI 10.2307/4088878; Moore Frank R., 1995, P121; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Richardson W.J., 1990, P78; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Sandberg R, 1996, BEHAV ECOL SOCIOBIOL, V39, P1, DOI 10.1007/s002650050261; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schmaljohann H, 2011, J ORNITHOL, V152, P439, DOI 10.1007/s10336-010-0604-y; Sprague AJ, 2008, AVIAN CONSERV ECOL, V3; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tsvey A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1665, DOI 10.1007/s00265-007-0397-z; WIEDNER DS, 1992, AUK, V109, P500; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Zehnder Susanna, 2002, Avian Science, V2, P103	39	98	102	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27054	10.1371/journal.pone.0027054	http://dx.doi.org/10.1371/journal.pone.0027054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073253	Green Submitted, Green Published, gold			2022-12-25	WOS:000297197000026
J	Ahn, JH; Keum, JW; Kim, DM				Ahn, Jin-Ho; Keum, Jung-Won; Kim, Dong-Myung			Expression Screening of Fusion Partners from an E. coli Genome for Soluble Expression of Recombinant Proteins in a Cell-Free Protein Synthesis System	PLOS ONE			English	Article							ESCHERICHIA-COLI; INITIATION CODON; HIGH-THROUGHPUT; TRANSLATION INITIATION; STEP PURIFICATION; GENE-EXPRESSION; AGGREGATION; EFFICIENCY; ENHANCEMENT; DOWNSTREAM	While access to soluble recombinant proteins is essential for a number of proteome studies, preparation of purified functional proteins is often limited by the protein solubility. In this study, potent solubility-enhancing fusion partners were screened from the repertoire of endogenous E. coli proteins. Based on the presumed correlation between the intracellular abundance and folding efficiency of proteins, PCR-amplified ORFs of a series of highly abundant E. coli proteins were fused with aggregation-prone heterologous proteins and then directly expressed for quantitative estimation of the expression efficiency of soluble translation products. Through two-step screening procedures involving the expression of 552 fusion constructs targeted against a series of cytokine proteins, we were able to discover a number of endogenous E. coli proteins that dramatically enhanced the soluble expression of the target proteins. This strategy of cell-free expression screening can be extended to quantitative, global analysis of genomic resources for various purposes.	[Ahn, Jin-Ho; Kim, Dong-Myung] Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Taejon, South Korea; [Keum, Jung-Won] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Chungnam National University; Seoul National University (SNU)	Ahn, JH (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	dmkim@cnu.ac.kr		Kim, Dong-Myung/0000-0001-7875-0694	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011K000841, 2011-0027901]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant numbers 2011K000841 and 2011-0027901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2005, BIOCHEM BIOPH RES CO, V337, P325, DOI 10.1016/j.bbrc.2005.09.061; Ahn JH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl917; Ahn JH, 2008, J PROTEOME RES, V7, P2107, DOI 10.1021/pr700856s; Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Bi Y, 2006, PROTEIN EXPRES PURIF, V47, P234, DOI 10.1016/j.pep.2005.10.023; Braun P, 2004, DRUG DISCOV TODAY, V9, pS1; Castillo V, 2011, BIOTECHNOL J, V6, P752, DOI 10.1002/biot.201100014; Chambers S, 2008, J BIOMOL SCREEN, V13, P719; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; ECKER DJ, 1989, J BIOL CHEM, V264, P7715; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Etchegaray JP, 1999, J BIOL CHEM, V274, P10079, DOI 10.1074/jbc.274.15.10079; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; Kwon YC, 2010, APPL ENVIRON MICROB, V76, P6295, DOI 10.1128/AEM.00029-10; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Ottosson J, 2006, MOL CELL PROTEOMICS, V5, pS40; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Son JM, 2006, ANAL BIOCHEM, V351, P187, DOI 10.1016/j.ab.2005.11.047; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Zhang G, 2009, PLOS ONE	39	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26875	10.1371/journal.pone.0026875	http://dx.doi.org/10.1371/journal.pone.0026875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073212	Green Submitted, Green Published, gold			2022-12-25	WOS:000297154900049
J	Dutra, RC; Claudino, RF; Bento, AF; Marcon, R; Schmidt, EC; Bouzon, ZL; Pianowski, LF; Calixto, JB				Dutra, Rafael C.; Claudino, Rafaela F.; Bento, Allisson F.; Marcon, Rodrigo; Schmidt, Eder C.; Bouzon, Zenilda L.; Pianowski, Luiz F.; Calixto, Joao B.			Preventive and Therapeutic Euphol Treatment Attenuates Experimental Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELL-ADHESION; SODIUM-INDUCED COLITIS; NF-KAPPA-B; P-SELECTIN; ULCERATIVE-COLITIS; NITRIC-OXIDE; INTESTINAL INFLAMMATION; PLANT-EXTRACTS; DEFICIENT MICE	Background: The tetracyclic triterpene euphol is the main constituent found in the sap of Euphorbia tirucalli. This plant is widely known in Brazilian traditional medicine for its use in the treatment of several kinds of cancer, including leukaemia, prostate and breast cancers. Here, we investigated the effect of euphol on experimental models of colitis and the underlying mechanisms involved in its action. Methodology/Principal Findings: Colitis was induced in mice either with dextran sulfate sodium (DSS) or with 2,4,6-trinitrobenzene sulfonic acid (TNBS), and the effect of euphol (3, 10 and 30 mg/kg) on colonic injury was assessed. Pro-inflammatory mediators and cytokines were measured by immunohistochemistry, enzyme-Linked immunoabsorbent assay (ELISA), real time-polymerase chain reaction (RT-PCR) and flow cytometry. Preventive and therapeutic oral administration of euphol attenuated both DSS- and TNBS-induced acute colitis as observed by a significant reduction of the disease activity index (DAI), histological/microscopic damage score and myeloperoxidase (MPO) activity in colonic tissue. Likewise, euphol treatment also inhibited colon tissue levels and expression of IL-1 beta, CXCL1/KC, MCP-1, MIP-2, TNF-alpha and IL-6, while reducing NOS2, VEGF and Ki67 expression in colonic tissue. This action seems to be likely associated with inhibition of activation of nuclear factor-kappa B (NF-kappa B). In addition, euphol decreased LPS-induced MCP-1, TNF-alpha, IL-6 and IFN-gamma, but increased IL-10 secretion from bone marrow-derived macrophages in vitro. Of note, euphol, at the same schedule of treatment, markedly inhibited both selectin (P- and E-selectin) and integrin (ICAM-1, VCAM-1 and LFA-1) expression in colonic tissue. Conclusions/Significance: Together, these results clearly demonstrated that orally-administered euphol, both preventive or therapeutic treatment were effective in reducing the severity of colitis in two models of chemically-induced mouse colitis and suggest this plant-derived compound might be a potential molecule in the management of inflammatory bowel diseases.	[Dutra, Rafael C.; Claudino, Rafaela F.; Bento, Allisson F.; Marcon, Rodrigo; Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil; [Schmidt, Eder C.; Bouzon, Zenilda L.] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, Cent Lab Elect Microscopy, Florianopolis, SC, Brazil; [Pianowski, Luiz F.] Pianowski & Pianowski Ltda, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Dutra, RC (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil.	calixto@farmaco.ufsc.br	Bento, Allisson/F-5603-2013; Dutra, Rafael C/F-8452-2012; Ibrahim, Essam Hassan/G-1960-2018; bouzon, zenilda/I-6673-2012	Dutra, Rafael C/0000-0002-6938-2161; Ibrahim, Essam Hassan/0000-0003-0130-2257; calixto, joao Batista/0000-0003-4041-7153	Amazonia Fitomedicamentos Ltda.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Programa de Apoio aos Nucleos de Excelencia; Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina; Amazonia Fitomedicamentos	Amazonia Fitomedicamentos Ltda.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia; Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina; Amazonia Fitomedicamentos	This work was supported by grants from the Amazonia Fitomedicamentos Ltda., Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Programa de Apoio aos Nucleos de Excelencia and the Fundacao de Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina, all of Brazil. R. C. D., A. F. B., R. M. and E. C. S. are Ph.D. students and receiving grants from CNPq. R. F. C. holds a postdoctoral fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Luiz Francisco Pianowski is proprietor of the contract research organization Pianowski & Pianowski Ltda. He has received consulting fees from Amazonia Fitomedicamentos. In addition, Luiz F. Pianowski performed previous chemical characterization of euphol and provided it for this study. Luiz Francisco Pianowski and Joao Batista Calixto are assigned in the patent on the analgesic action of euphol as inventors. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Arulampalam V, 2002, GUT, V50, P446, DOI 10.1136/gut.50.4.446; Baert F, 2004, ACTA CLIN BELG, V59, P304, DOI 10.1179/acb.2004.045; Bani S, 2007, J ETHNOPHARMACOL, V110, P92, DOI 10.1016/j.jep.2006.09.021; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Betancur-Galvis LA, 2002, MEM I OSWALDO CRUZ, V97, P541, DOI 10.1590/S0074-02762002000400017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Chavakis T, 2002, BIOCHEM SOC T, V30, P168, DOI 10.1042/BST0300168; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COOPER HS, 1993, LAB INVEST, V69, P238; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Cuzzocrea Salvatore, 2003, Expert Opin Emerg Drugs, V8, P339, DOI 10.1517/14728214.8.2.339; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; De Paula ML, 2008, INT IMMUNOPHARMACOL, V8, P1291, DOI 10.1016/j.intimp.2008.05.002; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Dutra R, 2011, BR J PHARM, P19; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Frenette P S, 1996, Immunol Today, V17, P205; FRIEDMAN S, 2001, HARRISONS PRINCIPLES, P1679; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; GERDES J, 1984, J IMMUNOL, V133, P1710; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hanauer Stephen B, 2003, Rev Gastroenterol Disord, V3, P81; HECKER E, 1968, CANCER RES, V28, P2338; Hokari R, 2001, FREE RADICAL BIO MED, V31, P153, DOI 10.1016/S0891-5849(01)00565-2; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kang SY, 2008, J PHARM PHARMACOL, V60, P1347, DOI 10.1211/jpp/60.10.0011; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kimball ES, 2004, NEUROGASTROENT MOTIL, V16, P811, DOI 10.1111/j.1365-2982.2004.00549.x; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Kumar A, 2010, ECOTOX ENVIRON SAFE, V73, P1671, DOI 10.1016/j.ecoenv.2010.08.003; LEY K, 1991, BLOOD, V77, P2553; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu M, 2008, INT IMMUNOPHARMACOL, V8, P1561, DOI 10.1016/j.intimp.2008.06.011; Lucas R, 1997, J LEUKOCYTE BIOL, V61, P551, DOI 10.1002/jlb.61.5.551; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Martin R, 2010, BIOCHEM PHARMACOL, V79, P198, DOI 10.1016/j.bcp.2009.08.002; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; NOLTE D, 1994, AM J PHYSIOL-HEART C, V267, pH1637, DOI 10.1152/ajpheart.1994.267.4.H1637; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Peterson CGB, 2007, SCAND J CLIN LAB INV, V67, P810, DOI 10.1080/00365510701452838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SANDERS WE, 1992, BLOOD, V80, P795; Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Soriano A, 2000, LAB INVEST, V80, P1541, DOI 10.1038/labinvest.3780164; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Stanley E R, 1997, Methods Mol Biol, V75, P301; Stocker CJ, 2000, J IMMUNOL, V164, P3309, DOI 10.4049/jimmunol.164.6.3309; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vestweber D, 1992, Semin Cell Biol, V3, P211; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wallace JL, 1998, AM J PHYSIOL-GASTR L, V274, pG802, DOI 10.1152/ajpgi.1998.274.5.G802; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; WELLER A, 1992, J BIOL CHEM, V267, P15176; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	75	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27122	10.1371/journal.pone.0027122	http://dx.doi.org/10.1371/journal.pone.0027122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073270	Green Submitted, gold, Green Published			2022-12-25	WOS:000297154900081
J	Kawai, K; Larson, BJ; Ishise, H; Carre, AL; Nishimoto, S; Longaker, M; Lorenz, HP				Kawai, Kenichiro; Larson, Barrett J.; Ishise, Hisako; Carre, Antoine Lyonel; Nishimoto, Soh; Longaker, Michael; Lorenz, H. Peter			Calcium-Based Nanoparticles Accelerate Skin Wound Healing	PLOS ONE			English	Article							PUTATIVE NANOBACTERIA; SERUM; COMPLEXES; DIFFERENTIATION; ARTERIES; CULTURE; CANCER	Introduction: Nanoparticles (NPs) are small entities that consist of a hydroxyapatite core, which can bind ions, proteins, and other organic molecules from the surrounding environment. These small conglomerations can influence environmental calcium levels and have the potential to modulate calcium homeostasis in vivo. Nanoparticles have been associated with various calcium-mediated disease processes, such as atherosclerosis and kidney stone formation. We hypothesized that nanoparticles could have an effect on other calcium-regulated processes, such as wound healing. In the present study, we synthesized pH-sensitive calcium-based nanoparticles and investigated their ability to enhance cutaneous wound repair. Methods: Different populations of nanoparticles were synthesized on collagen-coated plates under various growth conditions. Bilateral dorsal cutaneous wounds were made on 8-week-old female Balb/c mice. Nanoparticles were then either administered intravenously or applied topically to the wound bed. The rate of wound closure was quantified. Intravenously injected nanoparticles were tracked using a FLAG detection system. The effect of nanoparticles on fibroblast contraction and proliferation was assessed. Results: A population of pH-sensitive calcium-based nanoparticles was identified. When intravenously administered, these nanoparticles acutely increased the rate of wound healing. Intravenously administered nanoparticles were localized to the wound site, as evidenced by FLAG staining. Nanoparticles increased fibroblast calcium uptake in vitro and caused contracture of a fibroblast populated collagen lattice in a dose-dependent manner. Nanoparticles also increased the rate of fibroblast proliferation. Conclusion: Intravenously administered, calcium-based nanoparticles can acutely decrease open wound size via contracture. We hypothesize that their contraction effect is mediated by the release of ionized calcium into the wound bed, which occurs when the pH-sensitive nanoparticles disintegrate in the acidic wound microenvironment. This is the first study to demonstrate that calcium-based nanoparticles can have a therapeutic benefit, which has important implications for the treatment of wounds.	[Kawai, Kenichiro; Larson, Barrett J.; Carre, Antoine Lyonel; Longaker, Michael; Lorenz, H. Peter] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Kawai, Kenichiro; Ishise, Hisako; Nishimoto, Soh] Hyogo Coll Med, Dept Plast & Reconstruct Surg, Hyogo, Japan	Stanford University; Hyogo College of Medicine	Kawai, K (corresponding author), Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.	plorenz@stanford.edu			Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS [R01 GM087609]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087609] Funding Source: NIH RePORTER	Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Oak Foundation; Plastic Surgery Education Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIGMS: R01 GM087609 (HPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag K, 2006, BREAST J, V12, P287, DOI 10.1111/j.1075-122X.2006.00264.x; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Featherstone JD, 1982, CARIES RES, V15, P377; Folk R L, 1992, GEOL SOC AM ANN M, V24, P104; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Huang JS, 1999, EUR J BIOCHEM, V266, P943, DOI 10.1046/j.1432-1327.1999.00932.x; Jadali A, 2010, J BIOL CHEM, V285, P23385, DOI 10.1074/jbc.M110.105619; Jelic TM, 2007, J HEART VALVE DIS, V16, P101; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; KAJANDER EO, 1997, SPIE P, V3111, P420; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; Limova Marketa, 2003, Ostomy Wound Manage, V49, P26; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Martel J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010343; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Motta G J, 1989, Ostomy Wound Manage, V25, P52; O'Donoghue J M, 1997, Acta Chir Plast, V39, P53; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/nnm.11.24, 10.2217/NNM.11.24]; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2010, SURGERY, V147, P181, DOI 10.1016/j.surg.2009.07.009; Schwartz MK, 2008, FASEB J, V924, P17; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Wainwright M, 1999, MICROBIOL-SGM, V145, P2623, DOI 10.1099/00221287-145-10-2623; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417	32	75	77	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27106	10.1371/journal.pone.0027106	http://dx.doi.org/10.1371/journal.pone.0027106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073267	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900079
J	Kipson, S; Fourt, M; Teixido, N; Cebrian, E; Casas, E; Ballesteros, E; Zabala, M; Garrabou, J				Kipson, Silvija; Fourt, Maia; Teixido, Nuria; Cebrian, Emma; Casas, Edgar; Ballesteros, Enric; Zabala, Mikel; Garrabou, Joaquim			Rapid Biodiversity Assessment and Monitoring Method for Highly Diverse Benthic Communities: A Case Study of Mediterranean Coralligenous Outcrops	PLOS ONE			English	Article							SPECIES-AREA RELATIONSHIP; MASS MORTALITY EVENT; MULTIVARIATE-ANALYSIS; PERMUTATION TESTS; LIGURIAN SEA; HUMAN IMPACT; ASSEMBLAGES; PATTERNS; VARIABILITY; SIMILARITY	Increasing anthropogenic pressures urge enhanced knowledge and understanding of the current state of marine biodiversity. This baseline information is pivotal to explore present trends, detect future modifications and propose adequate management actions for marine ecosystems. Coralligenous outcrops are a highly diverse and structurally complex deep-water habitat faced with major threats in the Mediterranean Sea. Despite its ecological, aesthetic and economic value, coralligenous biodiversity patterns are still poorly understood. There is currently no single sampling method that has been demonstrated to be sufficiently representative to ensure adequate community assessment and monitoring in this habitat. Therefore, we propose a rapid non-destructive protocol for biodiversity assessment and monitoring of coralligenous outcrops providing good estimates of its structure and species composition, based on photographic sampling and the determination of presence/absence of macrobenthic species. We used an extensive photographic survey, covering several spatial scales (100s of m to 100s of km) within the NW Mediterranean and including 2 different coralligenous assemblages: Paramuricea clavata (PCA) and Corallium rubrum assemblage (CRA). This approach allowed us to determine the minimal sampling area for each assemblage (5000 cm(2) for PCA and 2500 cm(2) for CRA). In addition, we conclude that 3 replicates provide an optimal sampling effort in order to maximize the species number and to assess the main biodiversity patterns of studied assemblages in variability studies requiring replicates. We contend that the proposed sampling approach provides a valuable tool for management and conservation planning, monitoring and research programs focused on coralligenous outcrops, potentially also applicable in other benthic ecosystems.	[Kipson, Silvija; Teixido, Nuria; Casas, Edgar; Garrabou, Joaquim] Inst Ciencies Mar ICM CSIC, Barcelona, Catalonia, Spain; [Fourt, Maia; Garrabou, Joaquim] Univ Aix Marseille 2, Ctr Oceanol Marseille, DIMAR CNRS, Stn Marine Endoume,UMR 6540, Marseille, France; [Kipson, Silvija] Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia; [Cebrian, Emma] Univ Girona, Dept Ciencies Ambientals, Fac Ciencies, Girona, Catalonia, Spain; [Ballesteros, Enric] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Catalonia, Spain; [Teixido, Nuria; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Aix-Marseille Universite; University of Zagreb; Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Kipson, S (corresponding author), Inst Ciencies Mar ICM CSIC, Barcelona, Catalonia, Spain.	silvija.kipson@zg.htnet.hr	Fourt, Maïa/ACD-7367-2022; Cebrian, Emma/J-9640-2012; Ballesteros, Enric/K-6497-2012	Cebrian, Emma/0000-0001-7588-0135; Teixido, Nuria/0000-0001-9286-2852	Spanish International Cooperation Agency for Development (AECID); French Government (Service de cooperation et d'action culturelle); Spanish Ministry of Science and Innovation [CTM2009-08045]; Parc National de Port-Cros; French Agence Nationale pour la Recherche (ANR); Total Foundation	Spanish International Cooperation Agency for Development (AECID); French Government (Service de cooperation et d'action culturelle); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Parc National de Port-Cros; French Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Total Foundation(Total SA)	The research was funded by the Spanish International Cooperation Agency for Development (AECID) (S. Kipson, Research Fellowship 2009-11), the French Government (Service de cooperation et d'action culturelle) (S. Kipson, Fellowship 2007), the Spanish Ministry of Science and Innovation (E. Casas, Doctoral Fellowship), Parc National de Port-Cros, French Agence Nationale pour la Recherche (ANR) (MEDCHANGE Project), the Total Foundation (MedDiversa Project) and the Spanish Ministry of Science and Innovation (Biorock project ref. CTM2009-08045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunto S., 2001, BIOL MARINA MEDITERR, V8, P191; AGARDY T, 2005, MILLENNIUM ECOSYSTEM, P513; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Ballesteros E., 1986, OECOL AQUATICA, V8, P117; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; BOHNSACK JA, 1979, B MAR SCI, V29, P242; BOUDOURESQUE C-F, 1971, Tethys, V3, P79; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CAIN STANLEY A., 1938, AMER MIDI NAT, V19, P573, DOI 10.2307/2420468; Casellato S, 2008, MAR ECOL-EVOL PERSP, V29, P321, DOI 10.1111/j.1439-0485.2008.00236.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocito S, 2002, SCI MAR, V66, P175, DOI 10.3989/scimar.2002.66n2175; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Flos J, 1985, W MEDITERRANEAN, P60; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; GILI JM, 1985, PSZNI MAR ECOL, V6, P219, DOI 10.1111/j.1439-0485.1985.tb00323.x; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gili JM, 1984, ARXIUS SECCIO CIENCI, V73, P677; Gili Josep-Maria, 1992, Oecologia Aquatica, V10, P243; Giuliani S, 2005, SCI TOTAL ENVIRON, V353, P340, DOI 10.1016/j.scitotenv.2005.09.023; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HAWKINS SJ, 1980, ESTUAR COAST MAR SCI, V10, P201, DOI 10.1016/S0302-3524(80)80058-2; Hong J.-S., 1983, Bulletin of the Korean Fisheries Society, V16, P273; Hong J.-S., 1982, BULLETIN OF KOREA OCEAN RESEARCH & DEVELOPMENT INSTITUTE, V4, P27; Hong JS, 1980, THESIS U AIX MARSEIL; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KRONBERG I, 1987, MAR BIOL, V96, P555, DOI 10.1007/BF00397974; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA, P93; LABOREL J, 1961, STAT MAR ENDOUME REC, V23, P37; Laubier L, 1966, ANN I OCEANOGRAPHIQU, V43, P139; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; MARTIN D, 1993, ESTUAR COAST SHELF S, V36, P47, DOI 10.1006/ecss.1993.1004; Muxika I, 2007, J EXP MAR BIOL ECOL, V349, P323, DOI 10.1016/j.jembe.2007.05.026; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NIELL FX, 1977, INVEST PESQ, V41, P509; Parravicini V, 2009, ESTUAR COAST SHELF S, V81, P359, DOI 10.1016/j.ecss.2008.11.007; Parravicini V, 2010, J EXP MAR BIOL ECOL, V395, P21, DOI 10.1016/j.jembe.2010.08.005; Piazzi L, 2004, BOT MAR, V47, P105, DOI 10.1515/BOT.2004.010; Piazzi L, 2010, J NAT HIST, V44, P1, DOI 10.1080/00222930903377547; Rocchini D, 2010, J ENVIRON MONITOR, V12, P825, DOI 10.1039/b921835a; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Steinitz O, 2006, J BIOGEOGR, V33, P1044, DOI 10.1111/j.1365-2699.2006.01473.x; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; True MA, 1970, B I OCEANOGR MONACO, V60, P1; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT, P21; Virgilio M, 2006, CORAL REEFS, V25, P265, DOI 10.1007/s00338-006-0100-2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEINBERG S, 1978, MAR BIOL, V49, P33, DOI 10.1007/BF00390728; ZABALA M, 1989, Scientia Marina, V53, P3	69	54	55	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27103	10.1371/journal.pone.0027103	http://dx.doi.org/10.1371/journal.pone.0027103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073264	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900078
J	Brast, S; Grabner, A; Sucic, S; Sitte, HH; Hermann, E; Pavenstadt, H; Schlatter, E; Ciarimboli, G				Brast, Sabine; Grabner, Alexander; Sucic, Sonja; Sitte, Harald H.; Hermann, Edwin; Pavenstaedt, Hermann; Schlatter, Eberhard; Ciarimboli, Giuliano			The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization	FASEB JOURNAL			English	Article						hOCT2; site-directed mutagenesis; regulation	TRANSMEMBRANE ALPHA-HELICES; HUMAN SEROTONIN TRANSPORTER; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; INTERACTION DOMAIN; EXTRUSION FAMILY; LIVING CELLS; RAT-KIDNEY; CISPLATIN; IDENTIFICATION	Human organic cation transporter 2 (hOCT2) is involved in transport of many endogenous and exogenous organic cations, mainly in kidney and brain cells. Because the quaternary structure of transmembrane proteins plays an essential role for their cellular trafficking and function, we investigated whether hOCT2 forms oligomeric complexes, and if so, which part of the transporter is involved in the oligomerization. A yeast 2-hybrid mating-based split-ubiquitin system (mbSUS), fluorescence resonance energy transfer, Western blot analysis, cross-linking experiments, immunofluorescence, and uptake measurements of the fluorescent organic cation 4-(4-(dimethylamino) styryl)-N-methylpyridinium were applied to human embryonic kidney 293 (HEK293) cells transfected with hOCT2 and partly also to freshly isolated human proximal tubules. The role of cysteines for oligomerization and trafficking of the transporter to the plasma membranes was investigated in cysteine mutants of hOCT2. hOCT2 formed oligomers both in the HEK293 expression system and in native human kidneys. The cysteines of the large extracellular loop are important to enable correct folding, oligomeric assembly, and plasma membrane insertion of hOCT2. Mutation of the first and the last cysteines of the loop at positions 51 and 143 abolished oligomer formation. Thus, the cysteines of the extracellular loop are important for correct trafficking of the transporter to the plasma membrane and for its oligomerization.-Brast, S., Grabner, A., Sucic, S., Sitte, H. H., Hermann, E., Pavenstadt, H., Schlatter, E., and Ciarimboli, G. The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB J. 26, 976-986 (2012). www.fasebj.org	[Brast, Sabine; Grabner, Alexander; Pavenstaedt, Hermann; Schlatter, Eberhard; Ciarimboli, Giuliano] Univ Klinikum Munster, Med Klin & Poliklin D, D-48149 Munster, Germany; [Hermann, Edwin] Univ Klinikum Munster, Klin & Poliklin Urol, D-48149 Munster, Germany; [Sucic, Sonja; Sitte, Harald H.] Med Univ Wien, Inst Pharmakol, Vienna, Austria	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Medical University of Vienna	Ciarimboli, G (corresponding author), Univ Klinikum Munster, Med Klin & Poliklin D, Domagkstr 3A, D-48149 Munster, Germany.	gciari@uni-muenster.de	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Sucic, Sonja/0000-0001-5136-8022; Ciarimboli, Giuliano/0000-0002-4365-3656	Deutsche Forschungsgemeinschaft [CI 107/4-1, CI 107/4-2]; Austrian Science Foundation [SFB35]; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are grateful to Rita Schroter, Bernadette Gelschefarth, and Ute Neugebauer for excellent technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (CI 107/4-1 to 2) and the Austrian Science Foundation (SFB35 to H.H.S.).	Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Biermann J, 2006, AM J PHYSIOL-CELL PH, V290, pC1521, DOI 10.1152/ajpcell.00622.2005; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Chen Y, 2007, J PHARMACOL EXP THER, V322, P695, DOI 10.1124/jpet.107.123554; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Ciarimboli G, 2011, MOL PHARMACEUT, V8, P270, DOI 10.1021/mp100329u; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; Grefen C., 2007, CURR PROTOC NEUROSCI, V41, P5271; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Kimura N, 2005, PHARM RES-DORDR, V22, P255, DOI 10.1007/s11095-004-1193-3; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Koepsell H, 2004, REV PHYSIOL BIOCH P, V150, P36, DOI 10.1007/s10254-003-0017-x; Lazar A, 2006, CLIN EXP HYPERTENS, V28, P645, DOI 10.1080/10641960600946411; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; More SS, 2010, MOL CANCER THER, V9, P1058, DOI 10.1158/1535-7163.MCT-09-1084; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Neuhoff S, 2003, PHARMACEUT RES, V20, P1141, DOI 10.1023/A:1025032511040; Ogasawara M, 2006, J PHARMACOL SCI, V101, P24, DOI 10.1254/jphs.FMJ06001X6; Pelis RM, 2006, AM J PHYSIOL-RENAL, V290, pF1118, DOI 10.1152/ajprenal.00462.2005; Pelis RM, 2006, J BIOL CHEM, V281, P35272, DOI 10.1074/jbc.M606561200; Pietig G, 2001, J BIOL CHEM, V276, P33741, DOI 10.1074/jbc.M104617200; PIETRUCK F, 1995, KIDNEY INT, V47, P1647, DOI 10.1038/ki.1995.229; ROHLICEK V, 1994, RENAL PHYSIOL BIOCH, V17, P57; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Sallinen R, 2010, ANN MED, V42, P296, DOI 10.3109/07853891003777109; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Taubert D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000385; Walter JK, 2009, CELL MOL LIFE SCI, V66, P3655, DOI 10.1007/s00018-009-0150-z; Wilde S, 2009, CELL MOL LIFE SCI, V66, P1729, DOI 10.1007/s00018-009-9145-z; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346	45	39	40	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					976	986		10.1096/fj.11-180679	http://dx.doi.org/10.1096/fj.11-180679			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22085643	Green Accepted			2022-12-25	WOS:000300949300003
J	Liu, SB; Qiao, LP; He, HL; Zhang, Q; Chen, XL; Zhou, WZ; Zhou, BC; Zhang, YZ				Liu, Sheng-Bo; Qiao, Li-Ping; He, Hai-Lun; Zhang, Qian; Chen, Xiu-Lan; Zhou, Wei-Zhi; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Optimization of Fermentation Conditions and Rheological Properties of Exopolysaccharide Produced by Deep-Sea Bacterium Zunongwangia profunda SM-A87	PLOS ONE			English	Article							HYDROTHERMAL VENTS; GUM; ENVIRONMENTS; GROWTH; CARBON; ICE; EPS	Zunongwangia profunda SM-A87 isolated from deep-sea sediment can secrete large quantity of exopolysaccharide (EPS). Response surface methodology was applied to optimize the culture conditions for EPS production. Single-factor experiment showed that lactose was the best carbon source. Based on the Plackett-Burman design, lactose, peptone and temperature were selected as significant variables, which were further optimized by the steepest ascent (descent) method and central composite design. The optimal culture conditions for EPS production and broth viscosity were determined as 32.21 g/L lactose, 8.87 g/L peptone and an incubation temperature of 9.8 degrees C. Under these conditions, the maximum EPS yield and broth viscosity were 8.90 g/L and 6551 mPa.s, respectively, which is the first report of such high yield of EPS from a marine bacterium. The aqueous solution of the EPS displayed high viscosity, interesting shearing thinning property and great tolerance to high temperature, a wide range of pH, and high salinity.	[Liu, Sheng-Bo; Qiao, Li-Ping; He, Hai-Lun; Zhang, Qian; Chen, Xiu-Lan; Zhou, Wei-Zhi; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Liu, SB (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			National Natural Science Foundation of China [31025001, 40876072, 31070061]; Hi-Tech Research and Development program of China [2011AA090703]; Natural Science Foundation of Shandong Province, China [JQ200910, ZR2009DZ002]; Foundation for Young Excellent Scientists in Shandong Province, China [2007BS07007, BS2010SW015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Foundation for Young Excellent Scientists in Shandong Province, China	The work was supported by National Natural Science Foundation of China (31025001, 40876072, 31070061), Hi-Tech Research and Development program of China (2011AA090703), Natural Science Foundation of Shandong Province, China (JQ200910, ZR2009DZ002), Foundation for Young Excellent Scientists in Shandong Province, China (2007BS07007, BS2010SW015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achi OK, 2004, INT J FOOD SCI TECH, V39, P431, DOI 10.1111/j.1365-2621.2004.00801.x; Bramhachari PV, 2007, J MICROBIOL BIOTECHN, V17, P44; CONTI E, 1994, MICROBIOL-UK, V140, P1125, DOI 10.1099/13500872-140-5-1125; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; DREVETON E, 1994, J FERMENT BIOENG, V77, P642, DOI 10.1016/0922-338X(94)90147-3; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ENRIQUEZ LG, 1989, FOOD EMULSIFIERS CHE, P335; Guezennec J, 2002, J IND MICROBIOL BIOT, V29, P204, DOI 10.1038/sj.jim.7000298; Gutierrez T, 2009, BIOTECHNOL BIOENG, V103, P207, DOI 10.1002/bit.22218; JANNASCH HW, 1984, ANNU REV MICROBIOL, V38, P487, DOI 10.1146/annurev.mi.38.100184.002415; Katzbauer B, 1998, POLYM DEGRAD STABIL, V59, P81, DOI 10.1016/S0141-3910(97)00180-8; KOJIC M, 1992, APPL ENVIRON MICROB, V58, P4086, DOI 10.1128/AEM.58.12.4086-4088.1992; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Lampitt RS, 1997, DEEP-SEA RES PT I, V44, P1377, DOI 10.1016/S0967-0637(97)00020-4; Li HP, 2011, CARBOHYD POLYM, V84, P1117, DOI 10.1016/j.carbpol.2010.12.072; Li X, 2008, BIORESOURCE TECHNOL, V99, P5391, DOI 10.1016/j.biortech.2007.11.017; Lopez MJ, 2004, J FOOD ENG, V63, P111, DOI 10.1016/S0260-8774(03)00289-9; Maugeri TL, 2002, BIOTECHNOL LETT, V24, P515, DOI 10.1023/A:1014891431233; Miqueleto AP, 2010, BIORESOURCE TECHNOL, V101, P1324, DOI 10.1016/j.biortech.2009.09.026; Moriello VS, 2003, J IND MICROBIOL BIOT, V30, P95, DOI 10.1007/s10295-002-0019-8; MORIN A, 1998, POLYSACCHARIDES STRU, P275; Muralidhar RV, 2001, BIOCHEM ENG J, V9, P17, DOI 10.1016/S1369-703X(01)00117-6; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Nichols CM, 2005, APPL ENVIRON MICROB, V71, P3519, DOI 10.1128/AEM.71.7.3519-3523.2005; Nicolaus B, 2002, SYST APPL MICROBIOL, V25, P319, DOI 10.1078/0723-2020-00128; Papinutti L, 2010, BIORESOURCE TECHNOL, V101, P1941, DOI 10.1016/j.biortech.2009.09.076; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; Qin QL, 2007, FEMS MICROBIOL LETT, V271, P53, DOI 10.1111/j.1574-6968.2007.00694.x; Qin QL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-247, 10.1186/1471-2164-11-501]; QIN QL, 2010, ISME J; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Sahan T, 2010, BIORESOURCE TECHNOL, V101, P4520, DOI 10.1016/j.biortech.2010.01.105; Saravanan P, 2008, LETT APPL MICROBIOL, V46, P1, DOI 10.1111/j.1472-765X.2007.02215.x; Satpute SK, 2010, BIOTECHNOL ADV, V28, P436, DOI 10.1016/j.biotechadv.2010.02.006; Song XY, 2007, J BIOTECHNOL, V131, P209, DOI 10.1016/j.jbiotec.2007.06.012; STAUDT AK, 2011, ARCH MICROB IN PRESS; Sutherland I W, 1972, Adv Microb Physiol, V8, P143, DOI 10.1016/S0065-2911(08)60190-3; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Turley CM, 2002, DEEP-SEA RES PT I, V49, P815, DOI 10.1016/S0967-0637(01)00080-2; Velasco SE, 2009, J AGR FOOD CHEM, V57, P1827, DOI 10.1021/jf803065w; VINCENT P, 1994, APPL ENVIRON MICROB, V60, P4134, DOI 10.1128/AEM.60.11.4134-4141.1994; Wang X, 2007, J BIOTECHNOL, V128, P403, DOI 10.1016/j.jbiotec.2006.09.019; Wang X, 2006, APPL ENVIRON MICROB, V72, P3367, DOI 10.1128/AEM.72.5.3367-3374.2006; Xu H, 2008, BIOCHEM ENG J, V39, P66, DOI 10.1016/j.bej.2007.08.013; Zakaria MB, 1996, CARBOHYD POLYM, V29, P25, DOI 10.1016/0144-8617(95)00132-8; Zhao Y, 2006, J APPL POLYM SCI, V102, P2616, DOI 10.1002/app.23991; Zhou WZ, 2009, COLLOID SURFACE B, V72, P295, DOI 10.1016/j.colsurfb.2009.04.018; Zhou WW, 2010, BIOPROC BIOSYST ENG, V33, P657, DOI 10.1007/s00449-009-0330-0	49	41	44	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26825	10.1371/journal.pone.0026825	http://dx.doi.org/10.1371/journal.pone.0026825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096500	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900010
J	Lottaz, D; Maurer, CA; Noel, A; Blacher, S; Huguenin, M; Nievergelt, A; Niggli, V; Kern, A; Muller, S; Seibold, F; Friess, H; Becker-Pauly, C; Stocker, W; Sterchi, EE				Lottaz, Daniel; Maurer, Christoph A.; Noel, Agnes; Blacher, Silvia; Huguenin, Maya; Nievergelt, Alexandra; Niggli, Verena; Kern, Alexander; Mueller, Stefan; Seibold, Frank; Friess, Helmut; Becker-Pauly, Christoph; Stoecker, Walter; Sterchi, Erwin E.			Enhanced Activity of Meprin-alpha, a Pro-Migratory and Pro-Angiogenic Protease, in Colorectal Cancer	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HYDROLASE HUMAN MEPRIN; METALLOPROTEASE MEPRIN; BETA-SUBUNITS; MATRIX METALLOPROTEINASES; RECEPTOR EXPRESSION; EPITHELIAL-CELLS; PABA PEPTIDE; IN-VITRO; UROKINASE	Meprin-alpha is a metalloprotease overexpressed in cancer cells, leading to the accumulation of this protease in a subset of colorectal tumors. The impact of increased Meprin-alpha levels on tumor progression is not known. We investigated the effect of this protease on cell migration and angiogenesis in vitro and studied the expression of Meprin-alpha mRNA, protein and proteolytic activity in primary tumors at progressive stages and in liver metastases of patients with colorectal cancer, as well as inhibitory activity towards Meprin-alpha in sera of cancer patient as compared to healthy controls. We found that the hepatocyte growth factor (HGF)-induced migratory response of meprin-transfected epithelial cells was increased compared to wild-type cells in the presence of plasminogen, and that the angiogenic response in organ-cultured rat aortic explants was enhanced in the presence of exogenous human Meprin-alpha. In patients, Meprin-alpha mRNA was expressed in colonic adenomas, primary tumors UICC (International Union Against Cancer) stage I, II, III and IV, as well as in liver metastases. In contrast, the corresponding protein accumulated only in primary tumors and liver metastases, but not in adenomas. However, liver metastases lacked Meprin-alpha activity despite increased expression of the corresponding protein, which correlated with inefficient zymogen activation. Sera from cancer patients exhibited reduced Meprin-alpha inhibition compared to healthy controls. In conclusion, Meprin-alpha activity is regulated differently in primary tumors and metastases, leading to high proteolytic activity in primary tumors and low activity in liver metastases. By virtue of its pro-migratory and pro-angiogenic activity, Meprin-alpha may promote tumor progression in colorectal cancer.	[Lottaz, Daniel] Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Huguenin, Maya; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Maurer, Christoph A.] Kantonsspital Liestal, Dept Surg, CH-4410 Liestal, Switzerland; [Noel, Agnes; Blacher, Silvia] Univ Liege, Lab Biol Tumor & Dev, Grp Interdisciplinaire Genoprote Appl Rech GIGA C, Liege, Belgium; [Nievergelt, Alexandra; Niggli, Verena] Univ Bern, Inst Pathol, Bern, Switzerland; [Kern, Alexander] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Mueller, Stefan; Seibold, Frank] Univ Bern, Dept Gastroenterol, Bern, Switzerland; [Friess, Helmut] Tech Univ Munich, Dept Surg, Munich, Germany; [Becker-Pauly, Christoph] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany	University of Bern; University Hospital of Bern; University of Bern; Kantonsspital Baselland; University of Liege; University of Bern; Technische Universitat Dresden; University of Bern; Technical University of Munich; Johannes Gutenberg University of Mainz	Lottaz, D (corresponding author), Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland.	daniel.lottaz@insel.ch; erwin.sterchi@ibmm.unibe.ch	Becker-Pauly, Christoph/B-7569-2011; Stöcker, Walter/AAB-9704-2019	Stöcker, Walter/0000-0002-1515-6994; Noel, Agnes/0000-0002-7670-6179	Swiss National Foundation [3100A0-100772]; Bernese Cancer League; Deutsche Forschungsgemeinschaft (DFG) [BE 4086/1-1]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Bernese Cancer League; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss National Foundation (www.snf.ch, grant #3100A0-100772 to EES), the Bernese Cancer League (www.bernischekrebsliga.ch, grant to DL) and the Deutsche Forschungsgemeinschaft (www.dfg.de, DFG BE 4086/1-1 to CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; DELBALDO C, 1995, CANCER RES, V55, P4688; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; Hahn D, 2000, BIOCHEM J, V346, P83, DOI 10.1042/0264-6021:3460083; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Hirano M, 2005, J IMMUNOL, V175, P3177, DOI 10.4049/jimmunol.175.5.3177; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Illemann M, 2006, MOL CANCER RES, V4, P293, DOI 10.1158/1541-7786.MCR-06-0003; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; JEFFERSON T, 2011, J BIOL CHEM; Jiang WP, 2000, GENE, V248, P77, DOI 10.1016/S0378-1119(00)00143-8; KAUSHAL GP, 1994, J CELL BIOL, V126, P1319, DOI 10.1083/jcb.126.5.1319; Keller HU, 2000, INT J CANCER, V88, P195, DOI 10.1002/1097-0215(20001015)88:2<195::AID-IJC8>3.0.CO;2-W; Khan KMF, 2002, J BIOL CHEM, V277, P13778, DOI 10.1074/jbc.M111290200; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; MULCAHY HE, 1994, LANCET, V344, P583, DOI 10.1016/S0140-6736(94)91968-2; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; PEPPER MS, 1992, J BIOL CHEM, V267, P20493; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; SIER CFM, 1991, GASTROENTEROLOGY, V101, P1522, DOI 10.1016/0016-5085(91)90387-Z; SIER CFM, 1994, GASTROENTEROLOGY, V107, P1449, DOI 10.1016/0016-5085(94)90549-5; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Tait CR, 2004, J PATHOL, V203, P515, DOI 10.1002/path.1544; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e26450	10.1371/journal.pone.0026450	http://dx.doi.org/10.1371/journal.pone.0026450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096485	Green Published, Green Submitted, gold			2022-12-25	WOS:000297553900004
J	Beyers, RL; Hart, JA; Sinclair, ARE; Grossmann, F; Klinkenberg, B; Dino, S				Beyers, Rene L.; Hart, John A.; Sinclair, Anthony R. E.; Grossmann, Falk; Klinkenberg, Brian; Dino, Simeon			Resource Wars and Conflict Ivory: The Impact of Civil Conflict on Elephants in the Democratic Republic of Congo - The Case of the Okapi Reserve	PLOS ONE			English	Article							FOREST ELEPHANT; LOXODONTA-AFRICANA; WILDLIFE; CONSERVATION; DETERMINES; MOVEMENTS; STRIFE	Human conflict generally has substantial negative impacts on wildlife and conservation. The recent civil war (1995-2006) in the Democratic Republic of Congo (DRC) resulted in a significant loss of wildlife, including elephants, due to institutional collapse, lawlessness and unbridled exploitation of natural resources such as minerals, wood, ivory and bushmeat. We used data from distance sampling surveys conducted before and after the war in a protected forest, the Okapi Faunal Reserve, to document changes in elephant abundance and distribution. We employed Generalized Additive Models to relate changes in elephant distribution to human and environmental factors. Populations declined by nearly fifty percent coinciding with a major increase in elephant poaching as indicated by reports of ivory trade during the war. Our results suggest that humans influenced elephant distribution far more than habitat, both before and after the war, but post-war models explained more of the variation. Elephant abundance declined more, closer to the park boundary and to areas of intense human activity. After the war, elephant densities were relatively higher in the centre of the park where they were better protected, suggesting that this area may have acted as a refuge. In other sites in Eastern DRC, where no protection was provided, elephants were even more decimated. Post-war dynamics, such as weakened institutions, human movements and availability of weapons, continue to affect elephants. Survival of remaining populations and recovery will be determined by these persistent factors and by new threats associated with growing human populations and exploitation of natural resources. Prioritizing wildlife protection, curbing illegal trade in ivory and bushmeat, and strengthening national institutions and organizations in charge of conservation will be crucial to counter these threats.	[Beyers, Rene L.; Sinclair, Anthony R. E.] Univ British Columbia, Beatty Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada; [Hart, John A.; Dino, Simeon] Tshuapa Lomami Lualaba Project TL2, Kinshasa, DEM REP CONGO; [Grossmann, Falk] Wildlife Conservat Soc, Africa Programs, New York, NY USA; [Klinkenberg, Brian] Univ British Columbia, Dept Geog, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Wildlife Conservation Society; University of British Columbia	Beyers, RL (corresponding author), Univ British Columbia, Beatty Biodivers Ctr, Vancouver, BC V5Z 1M9, Canada.	beyers@zoology.ubc.ca			United States Fish and Wildlife Service (USFWS); United States Agency for International Development; United Nations Educational, Scientific and Cultural Organization (UNESCO); Institut Congolais pour la Conservation de la Nature (ICCN); Wildlife Conservation Society (WCS)	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); United States Agency for International Development(United States Agency for International Development (USAID)); United Nations Educational, Scientific and Cultural Organization (UNESCO); Institut Congolais pour la Conservation de la Nature (ICCN); Wildlife Conservation Society (WCS)	This work was funded by the United States Fish and Wildlife Service (USFWS), the United States Agency for International Development, Central African Regional Program (USAID/CARPE), the United Nations Educational, Scientific and Cultural Organization (UNESCO), the Institut Congolais pour la Conservation de la Nature (ICCN) and the Wildlife Conservation Society (WCS). The views expressed here do not necessarily represent those of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALERS MPT, 1992, AFR J ECOL, V30, P279, DOI 10.1111/j.1365-2028.1992.tb00504.x; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; BARNES RFW, 1995, J TROP ECOL, V11, P27, DOI 10.1017/S0266467400008361; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; BLANC JJ, 2007, 33 IUCN SPEC SURV CO; Blom A, 2004, AFR J ECOL, V42, P23, DOI 10.1111/j.0141-6707.2004.00441.x; BRAECKMAN C, 2009, MONDE DIPLOMATIQ SEP, P11; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; de Merode E, 2007, BIOL LETTERS, V3, P299, DOI 10.1098/rsbl.2007.0010; DEWEERDT S, 2008, WORLD WATCH MAGAZINE; Donovan D., 2007, Extreme conflict and tropical forests, P1; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Hall JS, 1997, AFR J ECOL, V35, P213, DOI 10.1111/j.1365-2028.1997.088-89088.x; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; Hart JA, 1996, CONSERV BIOL, V10, P316, DOI 10.1046/j.1523-1739.1996.10020316.x; Hart T, 1997, CONSERV BIOL, V11, P308, DOI 10.1046/j.1523-1739.1997.011002308.x; Hart T., 2001, ARMED CONFLICT BIODI; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; HART TB, 1994, BIODIVERSITY AFRICAN; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hunter Nigel, 2004, Pachyderm, V36, P116; Johnston K., 2001, USING ARCGIS GEOSTAT; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; McNeely J. A., 2007, Extreme conflict and tropical forests, P159; Mubalama Leonard, 2001, Pachyderm, V31, P36; Nchanji AC, 2001, AFR J ECOL, V39, P24, DOI 10.1046/j.1365-2028.2001.00265.x; Plumptre A, 2000, SCIENCE, V288, P617; PLUMPTRE A, 2001, IMPACT GUERRE CIVILE; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; TCHAMBA MN, 1992, MAMMALIA, V56, P155; Wasser S, 2010, SCIENCE, V327, P1331, DOI 10.1126/science.1187811; White L.J.T., 2000, CONSERVATION RES AFR; WILKIE DS, 1988, ECOL MODEL, V41, P307, DOI 10.1016/0304-3800(88)90034-8; Wilkie DS, 1998, ORYX, V32, P131, DOI 10.1017/S0030605300029872; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	46	51	52	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e27129	10.1371/journal.pone.0027129	http://dx.doi.org/10.1371/journal.pone.0027129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096529	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800030
J	Du, WW; Yang, BB; Yang, BL; Deng, ZQ; Fang, L; Shan, SW; Jeyapalan, Z; Zhang, YU; Seth, A; Yee, AJ				Du, William Weidong; Yang, Burton B.; Yang, Bing L.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Zhang, Yaou; Seth, Arun; Yee, Albert J.			Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; PG-M/VERSICAN; PRODUCT SECRETION; GLYCOSAMINOGLYCAN MODIFICATION; DRUG-RESISTANCE; MAMMARY-TUMOR; IN-VIVO; EXPRESSION	Overexpression of EGFR and versican has been reported in association with breast cancers. Considered oncogenic, these molecules may be attractive therapeutic targets. Possessing anti-apoptotic and drug resistant properties, overexpression of these molecules is accompanied by selective sensitization to the process of apoptosis. In this study, we exogenously expressed a versican G3 construct in breast cancer cell lines and analyzed the effects of G3 on cell viability in fetal bovine serum free conditioned media and evaluated the effects of apoptotic agent C2-ceramide, and chemotherapeutic agents including Docetaxel, Doxorubicin, and Epirubicin. Versican G3 domain enhanced tumor cell resistance to apoptosis when cultured in serum free medium, Doxorubicin, or Epirubicin by up-regulating pERK and GSK-3 beta (S9P). However, it could be prevented by selective EGFR inhibitor AG 1478 and selective MEK inhibitor PD 98059. Both AG 1478 and PD 98059 enhanced expression of pSAPK/JNK, while selective JNK inhibitor SP 600125 enhanced expression of GSK-3 beta (S9P). Versican G3 promoted cell apoptosis induced by C2-ceramide or Docetaxel by enhancing expression of pSAPK/JNK and decreasing expression of GSK-3 beta (S9P), an observation blocked by AG 1478 or SP 6000125. Inhibition of endogenous versican expression by siRNA or reduction of versican G3's expression by linking G3 with 3'UTR prevented G3 modulated cell apoptosis. The dual roles of G3 in modulating breast cancer cell resistance to chemotherapeutic agents may in part explain a potential mechanism for breast cancer cell resistance to chemotherapy and EGFR therapy. The apoptotic effects of chemotherapeutics depend upon the activation and balance of down stream signals in the EGFR pathway. GSK-3 beta (S9P) appears to function as a key checkpoint in this balance of apoptosis and anti-apoptosis. Investigation and potential consideration of targeting GSK-3 beta (S9P) merits further study.	[Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Du, William Weidong; Yang, Bing L.; Yee, Albert J.] Univ Toronto, Ctr Study Bone Metastasis, Odette Canc Ctr, Toronto, ON, Canada; [Du, William Weidong; Yang, Burton B.; Yang, Bing L.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Seth, Arun] Sunnybrook Res Inst, Toronto, ON, Canada; [Yang, Burton B.; Deng, Zhaoqun; Fang, Ling; Shan, Sze Wan; Jeyapalan, Zina; Seth, Arun] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Yaou] Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Du, WW (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada.	albert.yee@sunnybrook.ca	Xie, Huangming/B-2260-2012	SHAN, SW/0000-0001-6876-9914	National Sciences and Engineering Research Council of Canada [227937-01]; Heart and Stroke Foundation of Ontario [CI5958]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a grant from National Sciences and Engineering Research Council of Canada (227937-01) to Dr. Yang who is the recipient of a Career Investigator Award (CI5958) from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Arteaga CL, 2004, CANCER CELL, V5, P525, DOI 10.1016/j.ccr.2004.05.028; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Brock N, 1996, CANCER, V78, P542; Brown LF, 1999, CLIN CANCER RES, V5, P1041; BUICK RN, 1990, PROG CLIN BIOL RES, V354, P179; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Ciardiello FTT, 2005, PHASE 2 TRIAL GEFITI; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Flowers M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005342; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graham DL, 2005, PHASE 2 STUDY ERLOTI; Gu L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006220; Hambly RJ, 1997, BREAST CANCER RES TR, V43, P247, DOI 10.1023/A:1005756632293; HORWITZ KB, 1975, STEROIDS, V26, P785, DOI 10.1016/0039-128X(75)90110-5; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kaufmann SH, 1998, BBA-GENE STRUCT EXPR, V1400, P195, DOI 10.1016/S0167-4781(98)00136-5; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nahta R, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-1-5; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Navolanic PM, 2003, INT J ONCOL, V22, P237; Nitta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010767; Polychronis ASH, 2005, ANTIPROLIFERATIVE MO; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Pusztai L, 1999, CANCER TREAT REV, V25, P271, DOI 10.1053/ctrv.1999.0132; Recchia I, 2004, BONE, V34, P65, DOI 10.1016/j.bone.2003.06.004; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; SCHABEL FM, 1977, CANCER, V39, P2875, DOI 10.1002/1097-0142(197706)39:6<2875::AID-CNCR2820390675>3.0.CO;2-7; Schaller G, 1999, J CANCER RES CLIN, V125, P520, DOI 10.1007/s004320050311; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Shimizu-Hirota R, 2001, J AM SOC NEPHROL, V12, P2609, DOI 10.1681/ASN.V12122609; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Syrokou A, 1999, BIOCHIMIE, V81, P733, DOI 10.1016/S0300-9084(99)80131-X; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; WALKERNASIR E, 1982, JNCI-J NATL CANCER I, V69, P371; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2005, MATRIX BIOL, V24, P3, DOI 10.1016/j.matbio.2004.11.007; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Wu YJ, 2001, J BIOL CHEM, V276, P14178, DOI 10.1074/jbc.M100618200; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zheng PS, 2004, J CELL SCI, V117, P5887, DOI 10.1242/jcs.01516; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	72	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26396	10.1371/journal.pone.0026396	http://dx.doi.org/10.1371/journal.pone.0026396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096483	Green Published, gold, Green Submitted			2022-12-25	WOS:000297350800006
J	Xiong, AS; Peng, RH; Zhuang, J; Chen, JM; Zhang, B; Zhang, J; Yao, QH				Xiong, Ai-Sheng; Peng, Ri-He; Zhuang, Jing; Chen, Jian-Min; Zhang, Bin; Zhang, Jian; Yao, Quan-Hong			A Thermostable beta-Glucuronidase Obtained by Directed Evolution as a Reporter Gene in Transgenic Plants	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VITRO; MOLECULAR EVOLUTION; FIREFLY LUCIFERASE; RAPID EVOLUTION; GUS; EXPRESSION; ENZYMES; ARABIDOPSIS; UTILITY	A beta-glucuronidase variant, GUS-TR3337, that was obtained by directed evolution exhibited higher thermostability than the wild-type enzyme, GUS-WT. In this study, the utility of GUS-TR337 as an improved reporter was evaluated. The corresponding gus-tr3337 and gus-wt genes were independently cloned in a plant expression vector and introduced into Arabidopsis thaliana. With 4-MUG as a substrate, plants containing the gus-wt gene showed no detectable b-glucuronidase activity after exposure to 60 degrees C for 10 min, while those hosting the gus-tr3337 gene retained 70% or 50% activity after exposure to 80 degrees C for 10 min or 30 min, respectively. Similarly, in vivo b-glucuronidase activity could be demonstrated by using X-GLUC as a substrate in transgenic Arabidopsis plants hosting the gus-tr3337 gene that were exposed to 80 degrees C for up to 30 min. Thus, the thermostability of GUS-TR3337 can be exploited to distinguish between endogenous and transgenic beta-glucuronidase activity, which is a welcome improvement in its use as a reporter.	[Xiong, Ai-Sheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Hort, Nanjing, Peoples R China; [Peng, Ri-He; Zhang, Bin; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Zhuang, Jing; Zhang, Jian] Alberta Innovates Technol Futures, Vegreville, AB, Canada; [Chen, Jian-Min] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Nanjing Agricultural University; Shanghai Academy of Agricultural Sciences; Alberta Innovates; Yangzhou University	Xiong, AS (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Hort, Nanjing, Peoples R China.	Jian.Zhang@albertainnovates.ca; yaoquanhong@saas.sh.cn	ZHANG, JIAN/AAD-2686-2021	ZHANG, JIAN/0000-0003-1507-4718; Xiong, Ai-Sheng/0000-0002-7900-5001	Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China [2009ZX08002-011B]; International Scientific and Technological Cooperation [2010DFA62320]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China; International Scientific and Technological Cooperation	The research is supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions; National key Project of Transgenic Crops of China (2009ZX08002-011B); International Scientific and Technological Cooperation (2010DFA62320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva M, 2003, ORG BIOMOL CHEM, V1, P4133, DOI 10.1039/b311055a; Alwen Anna, 1992, Transgenic Research, V1, P63, DOI 10.1007/BF02513023; ANHALT S, 1992, PLANTA, V187, P83, DOI 10.1007/BF00201627; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; BEKKAOUI F, 1988, PLANT CELL REP, V7, P481, DOI 10.1007/BF00272736; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chartrain M, 2000, CURR OPIN BIOTECH, V11, P209, DOI 10.1016/S0958-1669(00)00081-1; Chirumamilla RR, 2001, MOL CELL BIOCHEM, V224, P159, DOI 10.1023/A:1011904405002; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dixon DP, 2003, J BIOL CHEM, V278, P23930, DOI 10.1074/jbc.M303620200; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Fior S, 2009, PLANT SCI, V176, P130, DOI 10.1016/j.plantsci.2008.10.001; Fior S, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-19; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; Geddie ML, 2004, J BIOL CHEM, V279, P26462, DOI 10.1074/jbc.M401447200; Gilissen LJW, 1998, TRANSGENIC RES, V7, P157, DOI 10.1023/A:1008832711805; Haseloff J, 2006, METHOD BIOCHEM ANAL, V47, P259; Hastings JW, 2006, METHOD BIOCHEM ANAL, V47, P15; HAWKSWORTH G, 1971, J MED MICROBIOL, V4, P451, DOI 10.1099/00222615-4-4-451; HODAL L, 1992, PLANT SCI, V87, P115, DOI 10.1016/0168-9452(92)90199-V; HU CY, 1990, PLANT CELL REP, V9, P1, DOI 10.1007/BF00232123; JEFFERSON RA, 1987, EMBO J, V6, P3901; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; LANGLEY SD, 1983, J BIOL CHEM, V258, P7416; Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Leeuwen W. van, 2000, Plant Molecular Biology Reporter, V18, P143, DOI 10.1007/BF02824024; LEVVY GA, 1959, ADV CARBOHYD CHEM, V14, P381; Lewy GA, 1954, BIOCHEM J, V56, P462; Locher CP, 2005, DNA CELL BIOL, V24, P256, DOI 10.1089/dna.2005.24.256; Mantis J, 2000, PLANT MOL BIOL REP, V18, P319, DOI 10.1007/BF02825059; Martin T., 1992, GUS protocols: using the GUS gene as a reporter of gene expression., P23; Martin T, 1992, PLANT MOL BIOL REP, V10, P37, DOI 10.1007/BF02669263; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Millar AJ, 1992, PLANT MOL BIOL REP, V10, P324, DOI 10.1007/BF02668909; Muhitch MJ, 1998, PHYSIOL PLANTARUM, V104, P423, DOI 10.1034/j.1399-3054.1998.1040318.x; Nam SH, 2003, PROTEIN ENG, V16, P1099, DOI 10.1093/protein/gzg146; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; PLEGT L, 1989, MOL GEN GENET, V216, P321, DOI 10.1007/BF00334371; Rowe LA, 2003, J MOL BIOL, V332, P851, DOI 10.1016/S0022-2836(03)00972-0; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki K, 2000, J BIOL CHEM, V275, P27466; SEBASTIANO M, 1986, GENETICS, V112, P459; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Sudan C, 2006, PLANTA, V224, P853, DOI 10.1007/s00425-006-0276-2; Taylor CB, 1997, PLANT CELL, V9, P273, DOI 10.1105/tpc.9.3.273; Tian YS, 2010, WORLD J MICROB BIOT, V26, P903, DOI 10.1007/s11274-009-0251-8; Verhees J, 2002, PLANT MOL BIOL, V50, P653, DOI 10.1023/A:1019922329081; Whalen RG, 2001, CURR OPIN MOL THER, V3, P31; WOZNIAK CA, 1994, PHYSIOL PLANTARUM, V90, P763, DOI 10.1111/j.1399-3054.1994.tb02535.x; Xiong AS, 2007, PROTEIN ENG DES SEL, V20, P319, DOI 10.1093/protein/gzm023; Xiong AS, 2007, APPL MICROBIOL BIOT, V74, P160, DOI 10.1007/s00253-006-0659-0; Xiong AS, 2010, IN VITRO MUTAGENESIS; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao HM, 2002, CURR OPIN BIOTECH, V13, P104, DOI 10.1016/S0958-1669(02)00291-4; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577	62	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26773	10.1371/journal.pone.0026773	http://dx.doi.org/10.1371/journal.pone.0026773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096498	gold, Green Published, Green Submitted			2022-12-25	WOS:000297350800014
J	Stewart, AD; Anand, RR; Laird, JS; Verrall, M; Ryan, CG; de Jonge, MD; Paterson, D; Howard, DL				Stewart, Aaron D.; Anand, Ravi R.; Laird, Jamie S.; Verrall, Michael; Ryan, Chris G.; de Jonge, Martin D.; Paterson, David; Howard, Daryl L.			Distribution of Metals in the Termite Tumulitermes tumuli (Froggatt): Two Types of Malpighian Tubule Concretion Host Zn and Ca Mutually Exclusively	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; BEETLE CHRYSOLINA-PARDALINA; GEMOC NUCLEAR MICROPROBE; GOLD EXPLORATION; TRACE-ELEMENTS; ACCUMULATION PATTERNS; ZINC DISTRIBUTION; DRYWOOD TERMITES; BERKHEYA-CODDII; PIXE	The aim of this study was to determine specific distribution of metals in the termite Tumulitermes tumuli (Froggatt) and identify specific organs within the termite that host elevated metals and therefore play an important role in the regulation and transfer of these back into the environment. Like other insects, termites bio-accumulate essential metals to reinforce cuticular structures and utilize storage detoxification for other metals including Ca, P, Mg and K. Previously, Mn and Zn have been found concentrated in mandible tips and are associated with increased hardness whereas Ca, P, Mg and K are accumulated in Malpighian tubules. Using high resolution Particle Induced X-Ray Emission (PIXE) mapping of whole termites and Scanning Electron Microscope (SEM) Energy Dispersive X-ray (EDX) spot analysis, localised accumulations of metals in the termite T. tumuli were identified. Tumulitermes tumuli was found to have proportionally high Mn concentrations in mandible tips. Malpighian tubules had significant enrichment of Zn (1.6%), Mg (4.9%), P (6.8%), Ca (2.7%) and K (2.4%). Synchrotron scanning X-ray Fluorescence Microprobe (XFM) mapping demonstrated two different concretion types defined by the mutually exclusive presence of Ca and Zn. In-situ SEM EDX realisation of these concretions is problematic due to the excitation volume caused by operating conditions required to detect minor amounts of Zn in the presence of significant amounts of Na. For this reason, previous researchers have not demonstrated this surprising finding.	[Stewart, Aaron D.; Anand, Ravi R.; Verrall, Michael] CSIRO Earth Sci & Resource Engn, Perth, WA, Australia; [Laird, Jamie S.; Ryan, Chris G.] Univ Melbourne, Sch Phys, CSIRO Earth Sci & Resource Engn, Melbourne, Vic, Australia; [Laird, Jamie S.; Ryan, Chris G.] Univ Tasmania, Ctr Excellence Ore Deposits CODES, Hobart, Tas, Australia; [de Jonge, Martin D.; Paterson, David; Howard, Daryl L.] Australian Synchrotron, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of Tasmania	Stewart, AD (corresponding author), CSIRO Earth Sci & Resource Engn, Perth, WA, Australia.	Aaron.Stewart@csiro.au	Laird, Jamie/A-7683-2011; Ryan, Chris G/A-6032-2011; de Jonge, Martin D/C-3400-2011; Laird, Jamie/AAG-3250-2021; Stewart, Aaron/C-3209-2009; Howard, Daryl/E-9107-2013	Ryan, Chris G/0000-0003-2891-3912; de Jonge, Martin D/0000-0001-7731-6175; laird, jamie/0000-0002-4981-975X; Stewart, Aaron/0000-0002-6195-4516; verrall, michael/0000-0001-8287-2504; Howard, Daryl/0000-0001-6071-2382	CSIRO OCE	CSIRO OCE(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was funded by an CSIRO OCE Postdoctoral Fellowship (http://www.csiro.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhin E, 2010, GEOCHEM-EXPLOR ENV A, V10, P401, DOI 10.1144/1467-7873/09-004; Augustyniak M, 2008, X-RAY SPECTROM, V37, P142, DOI 10.1002/xrs.1037; Augustyniak M, 2006, COMP BIOCHEM PHYS C, V144, P242, DOI 10.1016/j.cbpc.2006.09.003; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; BROWN BE, 1982, BIOL REV, V57, P621, DOI 10.1111/j.1469-185X.1982.tb00375.x; COVENTRY RJ, 1988, AUST J SOIL RES, V26, P375, DOI 10.1071/SR9880375; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P433, DOI 10.1007/s00114-008-0346-3; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Dallinger R., 1991, ECOTOXICOLOGY METALS, P245; DEBRUYN LAL, 1995, AUST J SOIL RES, V33, P179, DOI 10.1071/SR9950179; DESHMUKH I, 1989, SOCIOBIOLOGY, V15, P155; Fassil Kebede, 2005, Journal of African Earth Sciences, V40, P101; GLEESON CF, 1989, J GEOCHEM EXPLOR, V31, P253, DOI 10.1016/0375-6742(89)90105-2; Grzes IM, 2010, EUR J SOIL BIOL, V46, P350, DOI 10.1016/j.ejsobi.2010.09.004; JANSSEN MPM, 1991, ARCH ENVIRON CON TOX, V20, P305, DOI 10.1007/BF01064395; Judd TM, 2007, ANN ENTOMOL SOC AM, V100, P893, DOI 10.1603/0013-8746(2007)100[893:DOMISI]2.0.CO;2; Kramarz P, 1999, B ENVIRON CONTAM TOX, V63, P531, DOI 10.1007/s001289901013; Laker M.C., 1982, Fort Hare Papers, V7, P275; LEVY R, 1979, J NEMATOL, V11, P100; LEVY R, 1979, FLA ENTOMOL, V62, P260, DOI 10.2307/3494064; Mesjasz-Przybylowicz J, 2002, FRESEN ENVIRON BULL, V11, P78; Migula P, 2007, PLANT SOIL, V293, P197, DOI 10.1007/s11104-007-9231-7; Ohmura W, 2007, SOCIOBIOLOGY, V50, P1035; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; PRASAD EAV, 1984, CURR SCI INDIA, V53, P649; PRASAD EAV, 1987, CURR SCI INDIA, V56, P1219; Przybylowicz WJ, 2003, NUCL INSTRUM METH B, V210, P343, DOI 10.1016/S0168-583X(03)01029-2; RABITSCH WB, 1995, ENVIRON POLLUT, V90, P221, DOI 10.1016/0269-7491(94)00082-O; Rabitsch WB, 1997, ARCH ENVIRON CON TOX, V32, P172, DOI 10.1007/s002449900171; Rabitsch WB, 1997, J APPL ECOL, V34, P1455, DOI 10.2307/2405261; RUGGIERO RG, 1994, AFR J ECOL, V32, P222, DOI 10.1111/j.1365-2028.1994.tb00573.x; Ryan CG, 2002, NUCL INSTRUM METH B, V189, P400, DOI 10.1016/S0168-583X(01)01098-9; Ryan CG, 2001, NUCL INSTRUM METH B, V181, P12, DOI 10.1016/S0168-583X(01)00548-1; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; RYAN CG, 1995, NUCL INSTRUM METH B, V104, P157, DOI 10.1016/0168-583X(95)00404-1; Sako A, 2009, GEODERMA, V153, P217, DOI 10.1016/j.geoderma.2009.08.011; Scheifler R, 2002, CHEMOSPHERE, V48, P571, DOI 10.1016/S0045-6535(02)00116-9; Schofield RMS, 1997, J EXP BIOL, V200, P3235; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; Sileshi GW, 2010, J VEG SCI, V21, P923, DOI 10.1111/j.1654-1103.2010.01197.x; Silva AFD, 2006, SOCIOBIOLOGY, V47, P293; SOHAL RS, 1976, TISSUE CELL, V8, P447, DOI 10.1016/0040-8166(76)90005-7; Tylko G, 2006, MICROCHIM ACTA, V155, P301, DOI 10.1007/s00604-006-0560-7; WATERHOUSE DF, 1950, AUST J SCI RES SER B, V3, P76, DOI 10.1071/BI9500076; WATSON J. P., 1970, Trans. Instn Min. Metall. Sect. B., V79, P53; WESSING A, 1992, J INSECT PHYSIOL, V38, P543, DOI 10.1016/0022-1910(92)90080-W; WESSING A, 1992, J INSECT PHYSIOL, V38, P623, DOI 10.1016/0022-1910(92)90114-S; Wood T.G., 1978, International Biological Programme, P245; Yoshimura T, 2002, NUCL INSTRUM METH B, V189, P450, DOI 10.1016/S0168-583X(01)01123-5; Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m	51	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27578	10.1371/journal.pone.0027578	http://dx.doi.org/10.1371/journal.pone.0027578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087339	gold, Green Published			2022-12-25	WOS:000297349700061
J	Ghosh, A; Zhao, HM; Price, ND				Ghosh, Amit; Zhao, Huimin; Price, Nathan D.			Genome-Scale Consequences of Cofactor Balancing in Engineered Pentose Utilization Pathways in Saccharomyces cerevisiae	PLOS ONE			English	Article							XYLOSE ISOMERASE PATHWAYS; METABOLIC NETWORK; XYLITOL DEHYDROGENASE; ESCHERICHIA-COLI; SYSTEMS BIOLOGY; PICHIA-STIPITIS; FERMENTATION; ETHANOL; ARABINOSE; REDUCTASE	Biofuels derived from lignocellulosic biomass offer promising alternative renewable energy sources for transportation fuels. Significant effort has been made to engineer Saccharomyces cerevisiae to efficiently ferment pentose sugars such as Dxylose and L-arabinose into biofuels such as ethanol through heterologous expression of the fungal D-xylose and L-arabinose pathways. However, one of the major bottlenecks in these fungal pathways is that the cofactors are not balanced, which contributes to inefficient utilization of pentose sugars. We utilized a genome-scale model of S. cerevisiae to predict the maximal achievable growth rate for cofactor balanced and imbalanced D-xylose and L-arabinose utilization pathways. Dynamic flux balance analysis (DFBA) was used to simulate batch fermentation of glucose, D-xylose, and L-arabinose. The dynamic models and experimental results are in good agreement for the wild type and for the engineered D-xylose utilization pathway. Cofactor balancing the engineered D-xylose and L-arabinose utilization pathways simulated an increase in ethanol batch production of 24.7% while simultaneously reducing the predicted substrate utilization time by 70%. Furthermore, the effects of cofactor balancing the engineered pentose utilization pathways were evaluated throughout the genome-scale metabolic network. This work not only provides new insights to the global network effects of cofactor balancing but also provides useful guidelines for engineering a recombinant yeast strain with cofactor balanced engineered pathways that efficiently co-utilizes pentose and hexose sugars for biofuels production. Experimental switching of cofactor usage in enzymes has been demonstrated, but is a time-consuming effort. Therefore, systems biology models that can predict the likely outcome of such strain engineering efforts are highly useful for motivating which efforts are likely to be worth the significant time investment.	[Ghosh, Amit; Zhao, Huimin; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL USA; [Zhao, Huimin; Price, Nathan D.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Ghosh, Amit; Price, Nathan D.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ghosh, A (corresponding author), Inst Syst Biol, Seattle, WA USA.	zhao5@illinois.edu; nprice@systemsbiology.org	Ghosh, Amit/AAA-3490-2021	Ghosh, Amit/0000-0003-3514-885X; Price, Nathan/0000-0002-4157-0267	Energy Biosciences Institute (EBI); Beyond Petroleum	Energy Biosciences Institute (EBI); Beyond Petroleum	This work was supported by a grant from the Energy Biosciences Institute (EBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding received from Energy Biosciences Institute (EBI), funded by Beyond Petroleum (a commercial company), is not accompanied by any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products and does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Becker J, 2003, APPL ENVIRON MICROB, V69, P4144, DOI 10.1128/AEM.69.7.4144-4150.2003; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bengtsson O, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-9; Bertilsson M, 2008, BIOPROC BIOSYST ENG, V31, P369, DOI 10.1007/s00449-007-0169-1; Bettiga M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-40; Bettiga M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-16; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; dos Santos MM, 2004, METAB ENG, V6, P352, DOI 10.1016/j.ymben.2004.06.002; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Galafassi S, 2010, J IND MICROBIOL BIOT; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hahn-Hagerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776, DOI 10.1007/BF00167144; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Lee KH, 2007, BRAIN RES, V1171, P1, DOI 10.1016/j.brainres.2007.07.053; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Matsushika A, 2008, J BIOSCI BIOENG, V105, P296, DOI 10.1263/jbb.105.296; Milne Caroline B., 2009, Biotechnology Journal, V4, P1653, DOI 10.1002/biot.200900234; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Tyo KEJ, 2010, CURR OPIN MICROBIOL, V13, P255, DOI 10.1016/j.mib.2010.02.001; Wahlbom CF, 2003, FEMS YEAST RES, V3, P319, DOI 10.1016/S1567-1356(02)00206-4; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019	44	40	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27316	10.1371/journal.pone.0027316	http://dx.doi.org/10.1371/journal.pone.0027316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076150	Green Published, gold			2022-12-25	WOS:000297198200064
J	Mateus, AM; Arias, AM				Mateus, Ana Margarida; Arias, Alfonso Martinez			Patterned Cell Adhesion Associated with Tissue Deformations during Dorsal Closure in Drosophila	PLOS ONE			English	Article							MORPHOGENESIS; INTEGRIN	Cell shape changes within epithelia require the regulation of adhesive molecules that maintain tissue integrity. How remodelling of cell contacts is achieved while tissue integrity is maintained remains a fundamental question in morphogenesis. Dorsal Closure is a good system to study the dynamics of DE-Cadherin during morphogenesis. It relies on concerted cell shape changes of two epithelial sheets: amnioserosa cell contraction and epidermal cell elongation. To investigate the modulation of DE-Cadherin we performed antibody uptake experiments in live embryos during Dorsal Closure. We found that some antibodies access certain epitopes of the extracellular domain of native DE-Cadherin only in the amnioserosa and epidermal cells attached to the amnioserosa, which has never been observed in fixed DE-Cadherin in Drosophila embryos. These differences correlate with the different cell behaviour of these regions and therefore we suggest that DE-Cadherin exists in different forms that confer different adhesive strengths. We propose this to be a widespread mechanism for the differential modulation of adhesion during morphogenesis.	[Mateus, Ana Margarida; Arias, Alfonso Martinez] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Mateus, Ana Margarida] Gulbenkian PhD Programme Biomed, Oeiras, Portugal	University of Cambridge	Mateus, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ama11@hermes.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010; Tsai, Yu-Chen/B-5852-2008		Fundacao para a Ciencia e Tecnologia from Portugal; Wellcome Trust	Fundacao para a Ciencia e Tecnologia from Portugal(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome Trust)	This work was funded by Fundacao para a Ciencia e Tecnologia from Portugal (AMM) and the Wellcome Trust (AMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; BROADIE K, 1992, ROUX ARCH DEV BIOL, V201, P364, DOI 10.1007/BF00365124; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Duband JL, 1995, ACTA ANAT, V154, P63; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fung S, 2008, J COMP NEUROL, V506, P469, DOI 10.1002/cne.21539; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188; Hendersen DS, 2004, METHODS MOL BIOL; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Kasza KE, 2010, CURR OPIN CELL BIOL; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; MARSH EW, 1995, J CELL BIOL, V129, P1509, DOI 10.1083/jcb.129.6.1509; MARTINEZ ARIAS A., 1993, DEV PATTERNING LARVA; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oda H, 2001, J CELL SCI, V114, P493; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Sanders PGT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000169; Simone RP, 2010, DEVELOPMENT, V137, P1385, DOI 10.1242/dev.048520; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27159	10.1371/journal.pone.0027159	http://dx.doi.org/10.1371/journal.pone.0027159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076130	Green Submitted, Green Published, gold			2022-12-25	WOS:000297198200042
J	Gane, L; Power, S; Kushki, A; Chau, T				Gane, Luke; Power, Sarah; Kushki, Azadeh; Chau, Tom			Thermal Imaging of the Periorbital Regions during the Presentation of an Auditory Startle Stimulus	PLOS ONE			English	Article							LOCKED-IN SYNDROME	Infrared thermal imaging of the inner canthi of the periorbital regions of the face can potentially serve as an input signal modality for an alternative access system for individuals with conditions that preclude speech or voluntary movement, such as total locked-in syndrome. However, it is unknown if the temperature of these regions is affected by the human startle response, as changes in the facial temperature of the periorbital regions manifested during the startle response could generate false positives in a thermography-based access system. This study presents an examination of the temperature characteristics of the periorbital regions of 11 able-bodied adult participants before and after a 102 dB auditory startle stimulus. The results indicate that the startle response has no substantial effect on the mean temperature of the periorbital regions. This indicates that thermography-based access solutions would be insensitive to startle reactions in their user, an important advantage over other modalities being considered in the context of access solutions for individuals with a severe motor disability.	[Gane, Luke; Power, Sarah; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Gane, Luke; Power, Sarah; Kushki, Azadeh; Chau, Tom] Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto	Gane, L (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	tom.chau@utoronto.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Bloorview Research Institute	Bloorview Research Institute	Some funding was provided by the Bloorview Research Institute Graduate Student Scholarship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bakker MJ, 2009, CLIN NEUROPHYSIOL, V120, P424, DOI 10.1016/j.clinph.2008.11.014; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blain S, 2008, OPEN REHABILITATION, V1, P27, DOI DOI 10.2174/1874943700801010027; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bruno MA, 2009, PEDIATR NEUROL, V41, P237, DOI 10.1016/j.pediatrneurol.2009.05.001; DRUMMOND PD, 1987, BRAIN, V110, P793, DOI 10.1093/brain/110.3.793; Eder DN, 2009, INT J PSYCHOPHYSIOL, V71, P149, DOI 10.1016/j.ijpsycho.2008.09.001; Falk TH, 2011, IEEE T NEUR SYS REH, V19, P136, DOI 10.1109/TNSRE.2010.2078516; Falk TH, 2010, INT CONF ACOUST SPEE, P517, DOI 10.1109/ICASSP.2010.5495643; GHANBARI M, 1990, IEEE T COMMUN, V38, P950, DOI 10.1109/26.57512; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gray H, 1973, GRAYS ANATOMY; Gros DF, 2009, INT J PSYCHOPHYSIOL, V73, P207, DOI 10.1016/j.ijpsycho.2009.03.001; Jones BF, 2002, IEEE ENG MED BIOL, V21, P41, DOI 10.1109/MEMB.2002.1175137; Jones BF, 1998, IEEE T MED IMAGING, V17, P1019, DOI 10.1109/42.746635; Memarian N, 2011, DISABIL REHABIL-ASSI, V6, P179, DOI 10.3109/17483107.2010.498075; Memarian N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-38; Memarian N, 2009, J NEUROENG REHABIL, V6, DOI [10.1186/1743-0003-6-1, 10.1186/1743-0003-6-11]; Nhan BR, 2009, PHYSIOL MEAS, V30, pN23, DOI 10.1088/0967-3334/30/4/N01; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Palmieri RL, 2009, NURSING, V39, P29; Pavlidis I, 2002, IEEE ENG MED BIOL, V21, P56, DOI 10.1109/MEMB.2002.1175139; Pavlidis I, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P315, DOI 10.1109/ICIP.2001.958491; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Reilly T, 2009, J THERM BIOL, V34, pCP1, DOI 10.1016/j.jtherbio.2009.01.005; Schmajuk NA, 2009, BEHAV BRAIN RES, V197, P251, DOI 10.1016/j.bbr.2008.08.030; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sherwood L, 2009, HUMAN PHYSL CELLS SY; Tsiamyrtzis P, 2007, INT J COMPUT VISION, V71, P197, DOI 10.1007/s11263-006-6106-y; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861	32	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27268	10.1371/journal.pone.0027268	http://dx.doi.org/10.1371/journal.pone.0027268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073302	gold, Green Submitted, Green Published			2022-12-25	WOS:000297197000039
J	Abrahamczyk, S; Kluge, J; Gareca, Y; Reichle, S; Kessler, M				Abrahamczyk, Stefan; Kluge, Juergen; Gareca, Yuvinka; Reichle, Steffen; Kessler, Michael			The Influence of Climatic Seasonality on the Diversity of Different Tropical Pollinator Groups	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; PLANT-COMMUNITIES; SPECIES RICHNESS; FOREST; BUTTERFLIES; LEPIDOPTERA; PATTERNS; BIODIVERSITY; HYMENOPTERA; PHENOLOGY	Tropical South America is rich in different groups of pollinators, but the biotic and abiotic factors determining the geographical distribution of their species richness are poorly understood. We analyzed the species richness of three groups of pollinators (bees and wasps, butterflies, hummingbirds) in six tropical forests in the Bolivian lowlands along a gradient of climatic seasonality and precipitation ranging from 410 mm to 6250 mm. At each site, we sampled the three pollinator groups and their food plants twice for 16 days in both the dry and rainy seasons. The richness of the pollinator groups was related to climatic factors by linear regressions. Differences in species numbers between pollinator groups were analyzed by Wilcoxon tests for matched pairs and the proportion in species numbers between pollinator groups by correlation analyses. Species richness of hummingbirds was most closely correlated to the continuous availability of food, that of bees and wasps to the number of food plant species and flowers, and that of butterflies to air temperature. Only the species number of butterflies differed significantly between seasons. We were not able to find shifts in the proportion of species numbers of the different groups of pollinators along the study gradient. Thus, we conclude that the diversity of pollinator guilds is determined by group-specific factors and that the constant proportions in species numbers of the different pollinator groups constitute a general pattern.	[Abrahamczyk, Stefan; Kluge, Juergen; Kessler, Michael] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Kluge, Juergen] Univ Marburg, Fac Geog, Marburg, Germany; [Gareca, Yuvinka] Museo Hist Nat Alcide Orbigny, Cochabamba, Bolivia; [Reichle, Steffen] Torre B Multictr, Nat Conservancy, Bolivia Off, La Paz, Bolivia	University of Zurich; Philipps University Marburg	Abrahamczyk, S (corresponding author), Univ Zurich, Inst Systemat Bot, Zurich, Switzerland.	stefan.abrahamczyk@systbot.uzh.ch	Abrahamczyk, Stefan/D-7316-2011; Kluge, Jurgen/D-6200-2011; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Kessler, Michael/A-3605-2009	Kessler, Michael/0000-0003-4612-9937	Konrad-Adenauer-Stiftung; DFG (Deutsche Forschungsgemeinschaft); University of Zurich; National Herbarium at La Paz; Museo de Historia Natural Noel Kempff Mercado at Santa Cruz; Ministry of the Environment of Bolivia	Konrad-Adenauer-Stiftung; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Zurich; National Herbarium at La Paz; Museo de Historia Natural Noel Kempff Mercado at Santa Cruz; Ministry of the Environment of Bolivia	This study was funded by the Konrad-Adenauer-Stiftung, the DFG (Deutsche Forschungsgemeinschaft) and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank T. Delhotal for assistance in the field, A. Schmidt-Lebuhn, B. Bembe and G. Gerlach for information during field work preparation, C. Hamel, S. K. Herzog, D.N. Karger, C. Bomblat, V. Sandoval and J.Q. Vidoz for their support and advice during field work as well as D. Cicuzza for their help during data analysis, M. Schwerdtfeger for providing odour baits, B. Steudel for his help with organization, S. Willinghofer, S. Stiegel, M. C. Vargas Karger, P. Buschhorn, P. Gottleuber for identifying and preparing euglossine bees, C. Taylor, M. H. Nee, R. Vasquez, and J.R.I. Wood for their support with plant identification, O. Mielke, K. Willmott, R. K. Robbins for the identification of butterflies, and R. W. Soria-Auza for providing the climatic data and the precipitation map. We are grateful to the Botanical Garden in Santa Cruz, the University of Cochabamba, Prometa, the municipal governments of Villa Tunari and Rio Seco, and R. Clarke Gemuseus for the permission to work on their land, and to the National Herbarium at La Paz, the Museo de Historia Natural Noel Kempff Mercado at Santa Cruz, as well as the Ministry of the Environment of Bolivia for supporting our study.	Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; Abrahamczyk S, 2010, ENTOMOL EXP APPL, V137, P262, DOI 10.1111/j.1570-7458.2010.01063.x; Abrahamczyk S, 2010, J ORNITHOL, V151, P615, DOI 10.1007/s10336-010-0496-x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Araujo AC, 2003, FLORA, V198, P427, DOI 10.1078/0367-2530-00116; Azerefegne F, 2001, J ANIM ECOL, V70, P1032, DOI 10.1046/j.0021-8790.2001.00556.x; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BECCALONI GW, 1995, BIOL CONSERV, V71, P77, DOI 10.1016/0006-3207(94)00023-J; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cotton PA, 1998, IBIS, V140, P512, DOI 10.1111/j.1474-919X.1998.tb04613.x; Cotton PA, 2007, IBIS, V149, P135; DAILY GC, 1995, BIODIVERS CONSERV, V4, P35, DOI 10.1007/BF00115313; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; des Granges J.-L., 1979, Living Bird, V17, P199; Devoto M, 2009, AUSTRAL ECOL, V34, P848, DOI 10.1111/j.1442-9993.2009.01987.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Devy MS, 2003, AM J BOT, V90, P650, DOI 10.3732/ajb.90.4.650; Diniz IR, 1998, REV BIOL TROP, V46, P109; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Eriksen W, 1986, BEITRAGE PHYSISCHEN, P1; Erwin TL., 2009, INSECT BIODIVERSITY; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hennessey A. B., 2003, LISTA ANOTADA AVES B; Herrera MMP, 2005, THESIS U COCHABAMBA; Hickman JM, 1996, J ECON ENTOMOL, V89, P832, DOI 10.1093/jee/89.4.832; Hill C. J., 1992, Journal of the Lepidopterists' Society, V46, P173; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; JONES RE, 1987, BIOTROPICA, V19, P7, DOI 10.2307/2388454; KEIGHERY GJ, 1980, PLANT SYST EVOL, V135, P171, DOI 10.1007/BF00983185; Kessler M, 2000, PLANT BIOLOGY, V2, P659, DOI 10.1055/s-2000-16642; Kevan Peter G., 2003, Biodiversity (Ottawa), V4, P3; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Gonzalez AMM, 2009, J TROP ECOL, V25, P493, DOI 10.1017/S0266467409990034; Mata JR, 2006, BIRDS S AM NONPASSER; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; MICHENER DC, 2000, BEES WORLD; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Neild EFA, 1996, BUTTERFLIES VENEZUEL; Nemesio A, 2009, ZOOTAXA, P1; Nicholls CI, 2001, LANDSCAPE ECOL, V16, P133, DOI 10.1023/A:1011128222867; Ollerton J, 2002, OIKOS, V98, P340, DOI 10.1034/j.1600-0706.2002.980215.x; Orr AG, 1996, MONOG BIOL, V74, P125; Owen D.F., 1971, TROPICAL BUTTERFLIES; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips RD, 2010, PHILOS T R SOC B, V365, P517, DOI 10.1098/rstb.2009.0238; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pozo C, 2008, FLA ENTOMOL, V91, P407, DOI 10.1653/0015-4040(2008)91[407:SAPOTB]2.0.CO;2; Proctor M, 1996, NATURAL STORY POLLIN; R Development Core Team, 2007, R LANG ENV STAT COMP; Rahbek C, 2000, P ROY SOC B-BIOL SCI, V267, P2259, DOI 10.1098/rspb.2000.1277; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Roback PJ, 2005, CONSERV BIOL, V19, P261, DOI 10.1111/j.1523-1739.2005.00269.x; Roubik D.W., 1989, ECOLOGY NATURAL HIST, DOI DOI 10.1126/SCIENCE.248.4958.1026; Salvatierra Mercado LM, 2003, THESIS U SANTA CRUZ; Schneider C, 2003, ECOL ENTOMOL, V28, P219, DOI 10.1046/j.1365-2311.2003.00494.x; Shahabuddin G, 1999, J TROP ECOL, V15, P703, DOI 10.1017/S0266467499001121; Shapiro AM, 1975, DIAMAND ECOLOGY EVOL; Shapiro AM, 1986, WEST N AM NATURALIST, V46, P112; SMITH PARDO ALLAN, 2007, Acta biol.Colomb., V12, P43; Soria-Auza RW, 2010, ECOL MODEL, V221, P1221, DOI 10.1016/j.ecolmodel.2010.01.004; Srygley RB, 2010, GLOBAL CHANGE BIOL, V16, P936, DOI 10.1111/j.1365-2486.2009.01986.x; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; TEPEDINO VJ, 1981, OIKOS, V36, P35, DOI 10.2307/3544376; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tschapka M, 2004, J ZOOL, V263, P7, DOI 10.1017/S0952836903004734; Tudor O, 2004, BIOL CONSERV, V119, P397, DOI 10.1016/j.biocon.2004.01.002; Tylianakis JM, 2008, ECOL LETT, V9, P278; van Dulmen A, 2001, PLANT ECOL, V153, P73, DOI 10.1023/A:1017577305193; Williams MR, 2008, ENVIRON ENTOMOL, V37, P1313, DOI 10.1603/0046-225X(2008)37[1313:ADODLI]2.0.CO;2; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; [No title captured]	82	34	37	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27115	10.1371/journal.pone.0027115	http://dx.doi.org/10.1371/journal.pone.0027115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073268	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000297154900080
J	Coriat, R; Leconte, M; Kavian, N; Bedda, S; Nicco, C; Chereau, C; Goulvestre, C; Weill, B; Laurent, A; Batteux, F				Coriat, Romain; Leconte, Mahaut; Kavian, Niloufar; Bedda, Sassia; Nicco, Carole; Chereau, Christiane; Goulvestre, Claire; Weill, Bernard; Laurent, Alexis; Batteux, Federic			Mangafodipir Protects against Hepatic Ischemia-Reperfusion Injury in Mice	PLOS ONE			English	Article							FACTOR-KAPPA-B; SUPEROXIDE-DISMUTASE; REACTIVE OXYGEN; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; LIVER RESECTION; PRECONDITIONING PROTECTS; INFLOW OCCLUSION; FREE-RADICALS; MURINE LIVER	Introduction and Aim: Mangafodipir is a contrast agent used in magnetic resonance imaging that concentrates in the liver and displays pleiotropic antioxidant properties. Since reactive oxygen species are involved in ischemia-reperfusion damages, we hypothesized that the use of mangafodipir could prevent liver lesions in a mouse model of hepatic ischemia reperfusion injury. Mangafodipir (MnDPDP) was compared to ischemic preconditioning and intermittent inflow occlusion for the prevention of hepatic ischemia-reperfusion injury in the mouse. Methods: Mice were subjected to 70% hepatic ischemia (continuous ischemia) for 90 min. Thirty minutes before the ischemic period, either mangafodipir (10 mg/kg) or saline was injected intraperitoneally. Those experimental groups were compared with one group of mice preconditioned by 10 minutes' ischemia followed by 15 minutes' reperfusion, and one group with intermittent inflow occlusion. Hepatic ischemia-reperfusion injury was evaluated by measurement of serum levels of aspartate aminotransferase (ASAT) activity, histologic analysis of the livers, and determination of hepatocyte apoptosis (cytochrome c release, caspase 3 activity). The effect of mangafodipir on the survival rate of mice was studied in a model of total hepatic ischemia. Results: Mangafodipir prevented experimental hepatic ischemia-reperfusion injuries in the mouse as indicated by a reduction in serum ASAT activity (P<0.01), in liver tissue damages, in markers of apoptosis (P<0.01), and by higher rates of survival in treated than in untreated animals (P<0.001). The level of protection by mangafodipir was similar to that observed following intermittent inflow occlusion and higher than after ischemic preconditioning. Conclusions: Mangafodipir is a potential new preventive treatment for hepatic ischemia-reperfusion injury.	[Coriat, Romain; Leconte, Mahaut; Kavian, Niloufar; Bedda, Sassia; Nicco, Carole; Chereau, Christiane; Goulvestre, Claire; Weill, Bernard; Laurent, Alexis; Batteux, Federic] Univ Paris 05, EA1833, Immunol Lab, Fac Med,Hop Cochin,AP HP, Paris, France; [Coriat, Romain] Univ Paris 05, Serv Hepatogastroenterol, Fac Med, Hop Cochin,AP HP, Paris, France; [Leconte, Mahaut] Univ Paris 05, Serv Chirurg Digest, Fac Med, Hop Cochin,AP HP, Paris, France; [Kavian, Niloufar; Goulvestre, Claire; Batteux, Federic] Univ Paris 05, Lab Immunol Biol, Fac Med, Hop Cochin,AP HP, Paris, France; [Laurent, Alexis] Univ Paris 12, Hop Henri Mondor, Serv Chirurg Digest, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Coriat, R (corresponding author), Univ Paris 05, EA1833, Immunol Lab, Fac Med,Hop Cochin,AP HP, Paris, France.	frederic.batteux@cch.aphp.fr	Nicco, Carole/O-8169-2017; Batteux, Frederic/O-7889-2017; Nicco, Carole/X-6726-2019; Coriat, Romain/O-7902-2017; Laurent, Alexis/O-3657-2016	Nicco, Carole/0000-0001-8211-2556; Batteux, Frederic/0000-0002-1265-7996; Nicco, Carole/0000-0001-8211-2556; Laurent, Alexis/0000-0003-1372-0843	French Ministry for Research; Association pour la Recherche sur le Cancer (ARC); National Agency for Valorization of Research (ANVAR); Association Transhepate; Association Benoit Malassagne; Paris-Biotech	French Ministry for Research(Ministry of Research, France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); National Agency for Valorization of Research (ANVAR); Association Transhepate; Association Benoit Malassagne; Paris-Biotech	This work was supported by grants from: French Ministry for Research, Association pour la Recherche sur le Cancer (ARC), National Agency for Valorization of Research (ANVAR), Association Transhepate, Association Benoit Malassagne, and Paris-Biotech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2006, J NATL CANCER I, V98, P236, DOI 10.1093/jnci/djj049; ALI BH, 1993, GEN PHARMACOL, V24, P1279, DOI 10.1016/0306-3623(93)90381-7; ATALLA SL, 1985, TRANSPLANTATION, V40, P584, DOI 10.1097/00007890-198512000-00002; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Bedda S, 2003, J HEPATOL, V39, P765, DOI 10.1016/S0168-8278(03)00325-8; Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010; Calabrese V, 1996, DRUG EXP CLIN RES, V22, P17; Calabrese V, 1998, DRUG EXP CLIN RES, V24, P85; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; EZAKI T, 1992, BRIT J SURG, V79, P224, DOI 10.1002/bjs.1800790311; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; GOZZETTI G, 1995, BRIT J SURG, V82, P1105, DOI 10.1002/bjs.1800820833; Hassan-Khabbar S, 2010, BIOCHIMIE, V92, P405, DOI 10.1016/j.biochi.2009.12.009; Hirakawa A, 2003, J SURG RES, V111, P240, DOI 10.1016/S0022-4804(03)00091-X; JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K; KOO A, 1992, HEPATOLOGY, V15, P507, DOI 10.1002/hep.1840150325; Llacuna L, 2009, AM J PATHOL, V174, P1776, DOI 10.2353/ajpath.2009.080857; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; MATSUMATA T, 1993, CANCER, V72, P1866, DOI 10.1002/1097-0142(19930915)72:6<1866::AID-CNCR2820720613>3.0.CO;2-F; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; NAGASUE N, 1995, EUR J SURG, V161, P181; Nguyen WD, 1999, CRIT CARE, V3, P127, DOI 10.1186/cc358; Nieuwenhuijs VB, 2006, DIGEST DIS SCI, V51, P1087, DOI 10.1007/s10620-006-8014-y; Peralta C, 2002, TRANSPLANTATION, V73, P1203, DOI 10.1097/00007890-200204270-00004; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rudiger HA, 2003, J HEPATOL, V39, P972, DOI 10.1016/S0168-8278(03)00415-X; Rudiger HA, 2002, ANN SURG, V235, P400; Sasaki H, 1998, TRANSPLANT P, V30, P2958, DOI 10.1016/S0041-1345(98)00887-2; Schauer RJ, 2004, ANN SURG, V239, P220, DOI 10.1097/01.sla.0000110321.64275.95; Sindram D, 2002, J HEPATOL, V36, P78, DOI 10.1016/S0168-8278(01)00229-X; Skjold A, 2004, J MAGN RESON IMAGING, V20, P948, DOI 10.1002/jmri.20200; STEIN HJ, 1991, J SURG RES, V50, P398, DOI 10.1016/0022-4804(91)90209-5; Tejima K, 2004, GASTROENTEROLOGY, V127, P1488, DOI 10.1053/j.gastro.2004.07.023; Yabe Y, 2001, J PHARMACOL EXP THER, V298, P894; Yadav SS, 1998, TRANSPLANTATION, V65, P1433, DOI 10.1097/00007890-199806150-00004; Yuan GJ, 2005, WORLD J GASTROENTERO, V11, P1825; Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27005	10.1371/journal.pone.0027005	http://dx.doi.org/10.1371/journal.pone.0027005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073237	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900062
J	Quiros, S; Roos, WP; Kaina, B				Quiros, Steve; Roos, Wynand Paul; Kaina, Bernd			Rad51 and BRCA2-New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; MISMATCH REPAIR; TEMOZOLOMIDE; APOPTOSIS; METHYLTRANSFERASE; DAMAGE; MGMT; O-6-METHYLGUANINE	First line chemotherapeutics for brain tumors (malignant gliomas) are alkylating agents such as temozolomide and nimustine. Despite growing knowledge of how these agents work, patients suffering from this malignancy still face a dismal prognosis. Alkylating agents target DNA, forming the killing lesion O-6-alkylguanine, which is converted into DNA double-strand breaks (DSBs) that trigger apoptosis. Here we assessed whether inhibiting repair of DSBs by homologous recombination (HR) or non-homologous end joining (NHEJ) is a reasonable strategy for sensitizing glioma cells to alkylating agents. For down-regulation of HR in glioma cells, we used an interference RNA (iRNA) approach targeting Rad51 and BRCA2, and for NHEJ we employed the DNA-PK inhibitor NU7026. We also assessed whether inhibition of poly(ADP) ribosyltransferase (PARP) by olaparib would enhance the killing effect. The data show that knockdown of Rad51 or BRCA2 greatly sensitizes cells to DSBs and the induction of cell death following temozolomide and nimustine (ACNU). It did not sensitize to ionizing radiation (IR). The expression of O-6-methylguanine-DNA methyltransferase (MGMT) abolished all these effects, indicating that O-6-alkylguanine induced by these drugs is the primary lesion responsible for the formation of DSBs and increased sensitivity of glioma cells following knockdown of Rad51 and BRCA2. Inhibition of DNA-PK only slightly sensitized to temozolomide whereas a significant effect was observed with IR. A triple strategy including siRNA and the PARP inhibitor olaparib further improved the killing effect of temozolomide. The data provides evidence that down-regulation of Rad51 or BRCA2 is a reasonable strategy for sensitizing glioma cells to killing by O-6-alkylating anti-cancer drugs. The data also provide proof of principle that a triple strategy involving down-regulation of HR, PARP inhibition and MGMT depletion may greatly enhance the therapeutic effect of temozolomide.	[Quiros, Steve; Roos, Wynand Paul; Kaina, Bernd] Johannes Gutenberg Univ Mainz, Inst Toxicol, Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz	Quiros, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Toxicol, Med Ctr, D-6500 Mainz, Germany.	kaina@uni-mainz.de	Quiros, Steve/A-2969-2015; Kaina, Bernd/AAE-4692-2020; Roos, Wynand/B-4846-2008	Quiros, Steve/0000-0002-9377-0199; Roos, Wynand/0000-0002-0474-7414	Deutsche Forschungsgemeinschaft; German Cancer Research Fund; Deutscher Akademischer Austauschdienst [A/06/05736]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Fund; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	The Deutsche Forschungsgemeinschaft and German Cancer Research Fund supported this work. SQ was supported by the Deutscher Akademischer Austauschdienst (grant A/06/05736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Boudreau RL, 2010, BRAIN RES, V1338, P112, DOI 10.1016/j.brainres.2010.03.038; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Christmann M, 2010, INT J CANCER, V127, P2106, DOI 10.1002/ijc.25229; CITRON M, 1995, ONCOL RES, V7, P49; Fan S, 2006, BRIT J CANCER, V94, P407, DOI 10.1038/sj.bjc.6602935; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kaina B, 2010, CELL MOL LIFE SCI, V67, P3663, DOI 10.1007/s00018-010-0491-7; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Koch D, 2007, J NEURO-ONCOL, V82, P85, DOI 10.1007/s11060-006-9244-8; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Nikolova T, 2010, DNA REPAIR, V9, P1050, DOI 10.1016/j.dnarep.2010.07.005; Ochs K, 2000, CANCER RES, V60, P5815; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Shao CJ, 2008, J NEURO-ONCOL, V89, P27, DOI 10.1007/s11060-008-9592-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Weller M, 1998, INT J CANCER, V79, P640; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527	34	76	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27183	10.1371/journal.pone.0027183	http://dx.doi.org/10.1371/journal.pone.0027183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073281	gold, Green Submitted, Green Published			2022-12-25	WOS:000297154900085
J	Sachs, JL; Russell, JE; Hollowell, AC				Sachs, Joel L.; Russell, James E.; Hollowell, Amanda C.			Evolutionary Instability of Symbiotic Function in Bradyrhizobium japonicum	PLOS ONE			English	Article							RHIZOBIUM-LEGUMINOSARUM; GENETIC-STRUCTURE; TRANSMISSION; MUTUALISM; ISLAND; HOST; SOIL; ASSOCIATION; TRANSITIONS; SYSTEMATICS	Bacterial mutualists are often acquired from the environment by eukaryotic hosts. However, both theory and empirical work suggest that this bacterial lifestyle is evolutionarily unstable. Bacterial evolution outside of the host is predicted to favor traits that promote an independent lifestyle in the environment at a cost to symbiotic function. Consistent with these predictions, environmentally-acquired bacterial mutualists often lose symbiotic function over evolutionary time. Here, we investigate the evolutionary erosion of symbiotic traits in Bradyrhizobium japonicum, a nodulating root symbiont of legumes. Building on a previous published phylogeny we infer loss events of nodulation capability in a natural population of Bradyrhizobium, potentially driven by mutation or deletion of symbiosis loci. Subsequently, we experimentally evolved representative strains from the symbiont population under host-free in vitro conditions to examine potential drivers of these loss events. Among Bradyrhizobium genotypes that evolved significant increases in fitness in vitro, two exhibited reduced symbiotic quality, but no experimentally evolved strain lost nodulation capability or evolved any fixed changes at six sequenced loci. Our results are consistent with trade-offs between symbiotic quality and fitness in a host free environment. However, the drivers of loss-of-nodulation events in natural Bradyrhizobium populations remain unknown.	[Sachs, Joel L.; Russell, James E.; Hollowell, Amanda C.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Sachs, Joel L.; Hollowell, Amanda C.] Univ Calif Riverside, Inst Integrat Genom Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Sachs, JL (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	joels@ucr.edu	Sachs, Joel/AAB-9348-2019	Sachs, Joel/0000-0002-0221-9247	NSF [DEB-0816663]	NSF(National Science Foundation (NSF))	JLS and JER were supported by NSF DEB-0816663 to JLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR BU; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI 10.1016/j.femsle.2004.07.013; DJORDJEVIC MA, 1982, J BACTERIOL, V151, P560, DOI 10.1128/JB.151.2.560-568.1982; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUSSDANELL K, 1986, PLANT SOIL, V90, P407, DOI 10.1007/BF02277412; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Keeler K.H., 1985, P100; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; LAGUERRE G, 1993, CAN J MICROBIOL, V39, P1142, DOI 10.1139/m93-172; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Maddison WP, 2011, MESQUITE MODULAR SYS; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Mueller UG, 2010, ANTON LEEUW INT J G, V98, P195, DOI 10.1007/s10482-010-9427-3; Nishiguchi MK, 2003, INT J SYST EVOL MICR, V53, P2019, DOI 10.1099/ijs.0.02792-0; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Brien HE, 2005, EUR J PHYCOL, V40, P363, DOI 10.1080/09670260500342647; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Parker MA, 2000, SYST APPL MICROBIOL, V23, P585, DOI 10.1016/S0723-2020(00)80034-X; Pongsilp N, 2002, SYMBIOSIS, V33, P39; RAO JR, 1994, SOIL BIOL BIOCHEM, V26, P339, DOI 10.1016/0038-0717(94)90283-6; Sachs JL, 2006, J EVOLUTION BIOL, V19, P1415, DOI 10.1111/j.1420-9101.2006.01152.x; Sachs JL, 2010, J EVOLUTION BIOL, V23, P1075, DOI 10.1111/j.1420-9101.2010.01980.x; Sachs JL, 2009, APPL ENVIRON MICROB, V75, P4727, DOI 10.1128/AEM.00667-09; Sachs JL, 2008, OIKOS, V117, P961, DOI 10.1111/j.0030-1299.2008.16606.x; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sawada H, 2003, J GEN APPL MICROBIOL, V49, P155, DOI 10.2323/jgam.49.155; SEGOVIA L, 1991, APPL ENVIRON MICROB, V57, P426, DOI 10.1128/AEM.57.2.426-433.1991; SPRENT JI, 1987, PHILOS T R SOC B, V317, P111, DOI 10.1098/rstb.1987.0051; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P98, DOI 10.1093/oxfordjournals.molbev.a026041; ZURKOWSKI W, 1979, ARCH MICROBIOL, V123, P195, DOI 10.1007/BF00446820	49	41	44	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26370	10.1371/journal.pone.0026370	http://dx.doi.org/10.1371/journal.pone.0026370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073160	gold, Green Submitted, Green Published			2022-12-25	WOS:000297154900020
J	Wibisono, HT; Linkie, M; Guillera-Arroita, G; Smith, JA; Sunarto; Pusparini, W; Asriadi; Baroto, P; Brickle, N; Dinata, Y; Gemita, E; Gunaryadi, D; Haidir, IA; Herwansyah; Karina, I; Kiswayadi, D; Kristiantono, D; Kurniawan, H; Lahoz-Monfort, JJ; Leader-Williams, N; Maddox, T; Martyr, DJ; Maryati; Nugroho, A; Parakkasi, K; Priatna, D; Ramadiyanta, E; Ramono, WS; Reddy, GV; Rood, EJJ; Saputra, DY; Sarimudi, A; Salampessy, A; Septayuda, E; Suhartono, T; Sumantri, A; Susilo; Tanjung, I; Tarmizi; Yulianto, K; Yunus, M; Zulfahmi				Wibisono, Hariyo T.; Linkie, Matthew; Guillera-Arroita, Gurutzeta; Smith, Joseph A.; Sunarto; Pusparini, Wulan; Asriadi; Baroto, Pandu; Brickle, Nick; Dinata, Yoan; Gemita, Elva; Gunaryadi, Donny; Haidir, Iding A.; Herwansyah; Karina, Indri; Kiswayadi, Dedy; Kristiantono, Decki; Kurniawan, Harry; Lahoz-Monfort, Jose J.; Leader-Williams, Nigel; Maddox, Tom; Martyr, Deborah J.; Maryati; Nugroho, Agung; Parakkasi, Karmila; Priatna, Dolly; Ramadiyanta, Eka; Ramono, Widodo S.; Reddy, Goddilla V.; Rood, Ente J. J.; Saputra, Doddy Y.; Sarimudi, Ahmad; Salampessy, Adnun; Septayuda, Eka; Suhartono, Tonny; Sumantri, Ade; Susilo; Tanjung, Iswandri; Tarmizi; Yulianto, Koko; Yunus, Mohammad; Zulfahmi			Population Status of a Cryptic Top Predator: An Island-Wide Assessment of Tigers in Sumatran Rainforests	PLOS ONE			English	Article							MODELS	Large carnivores living in tropical rainforests are under immense pressure from the rapid conversion of their habitat. In response, millions of dollars are spent on conserving these species. However, the cost-effectiveness of such investments is poorly understood and this is largely because the requisite population estimates are difficult to achieve at appropriate spatial scales for these secretive species. Here, we apply a robust detection/non-detection sampling technique to produce the first reliable population metric (occupancy) for a critically endangered large carnivore; the Sumatran tiger (Panthera tigris sumatrae). From 2007-2009, seven landscapes were surveyed through 13,511 km of transects in 394 grid cells (17617 km). Tiger sign was detected in 206 cells, producing a naive estimate of 0.52. However, after controlling for an unequal detection probability (where p = 0.13 +/- 0.017; +/- S.E.), the estimated tiger occupancy was 0.72 +/- 0.048. Whilst the Sumatra-wide survey results gives cause for optimism, a significant negative correlation between occupancy and recent deforestation was found. For example, the Northern Riau landscape had an average deforestation rate of 9.8%/yr and by far the lowest occupancy (0.33 +/- 0.055). Our results highlight the key tiger areas in need of protection and have led to one area (Leuser-Ulu Masen) being upgraded as a 'global priority' for wild tiger conservation. However, Sumatra has one of the highest global deforestation rates and the two largest tiger landscapes identified in this study will become highly fragmented if their respective proposed roads networks are approved. Thus, it is vital that the Indonesian government tackles these threats, e. g. through improved land-use planning, if it is to succeed in meeting its ambitious National Tiger Recovery Plan targets of doubling the number of Sumatran tigers by 2022.	[Wibisono, Hariyo T.; Pusparini, Wulan; Baroto, Pandu; Brickle, Nick; Gunaryadi, Donny; Kristiantono, Decki; Salampessy, Adnun; Sumantri, Ade; Susilo; Tanjung, Iswandri] Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia; [Wibisono, Hariyo T.; Sunarto; Pusparini, Wulan; Baroto, Pandu; Dinata, Yoan; Gemita, Elva; Haidir, Iding A.; Herwansyah; Karina, Indri; Kiswayadi, Dedy; Kristiantono, Decki; Kurniawan, Harry; Martyr, Deborah J.; Maryati; Nugroho, Agung; Parakkasi, Karmila; Priatna, Dolly; Ramadiyanta, Eka; Salampessy, Adnun; Septayuda, Eka; Susilo; Tanjung, Iswandri; Tarmizi; Yunus, Mohammad] Forum HarimauKita, Bogor, Indonesia; [Linkie, Matthew; Dinata, Yoan; Gemita, Elva; Martyr, Deborah J.] Fauna & Flora Int, Cambridge, England; [Linkie, Matthew; Leader-Williams, Nigel] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.] Univ Kent, Sch Math Stat & Actuarial Sci, Natl Ctr Stat Ecol, Canterbury CT2 7NZ, Kent, England; [Smith, Joseph A.; Gemita, Elva; Maddox, Tom; Priatna, Dolly; Salampessy, Adnun] Zool Soc London Indonesia Programme, Bogor, Indonesia; [Smith, Joseph A.] Panthera, New York, NY USA; [Sunarto; Kurniawan, Harry; Parakkasi, Karmila; Septayuda, Eka; Yulianto, Koko; Zulfahmi] World Wide Fund Nat Indonesia, Jakarta, Indonesia; [Sunarto] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Kiswayadi, Dedy; Maryati; Nugroho, Agung; Rood, Ente J. J.; Saputra, Doddy Y.] Fauna & Flora Int Indonesia Programme, Jakarta, Indonesia; [Haidir, Iding A.; Suhartono, Tonny] Indonesian Minist Forestry, Jakarta, Indonesia; [Ramadiyanta, Eka; Reddy, Goddilla V.; Sarimudi, Ahmad; Tarmizi] Leuser Int Fdn, Medan, Indonesia; [Leader-Williams, Nigel] Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; [Ramono, Widodo S.] Rhino Fdn Indonesia, Bogor, Indonesia; [Yunus, Mohammad] Sumatran Tiger Conservat Program, Lampung, Indonesia	Wildlife Conservation Society - Indonesia; University of Kent; University of Kent; Virginia Polytechnic Institute & State University; Ministry of Environment & Forestry; University of Cambridge	Wibisono, HT (corresponding author), Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia.	matthew.linkie@fauna-flora.org	Guillera-Arroita, Gurutzeta/F-7461-2015; Wibisono, Hariyo T/I-7511-2019; Lahoz-Monfort, José J/O-3546-2017	Guillera-Arroita, Gurutzeta/0000-0002-8387-5739; Wibisono, Hariyo T/0000-0002-0311-3700; Lahoz-Monfort, José J/0000-0002-0845-7035; Pusparini, Wulan/0000-0001-9909-0920; Dinata, Yoan/0000-0001-5507-3379	United States Fish and Wildlife Service; National Fish and Wildlife Foundation; 21st Century Tiger; Multi-Donor trust Fund for Aceh and Nias Island; Rufford Small Grants; People's Trust for Endangered Species; Panthera; International Rhino Foundation; Darwin Initiative; World Wildlife Fund Networks; Critical Ecosystem Partnership Fund; Virginia Tech; Hurvis Family and Zoo Atlanta; Engineering and Physical Sciences Research Council/National Centre; EPSRC [EP/I000917/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000917/1] Funding Source: researchfish	United States Fish and Wildlife Service(US Fish & Wildlife Service); National Fish and Wildlife Foundation; 21st Century Tiger; Multi-Donor trust Fund for Aceh and Nias Island; Rufford Small Grants; People's Trust for Endangered Species; Panthera; International Rhino Foundation; Darwin Initiative; World Wildlife Fund Networks; Critical Ecosystem Partnership Fund; Virginia Tech; Hurvis Family and Zoo Atlanta; Engineering and Physical Sciences Research Council/National Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was provided by United States Fish and Wildlife Service, National Fish and Wildlife Foundation/Save the Tiger Fund, 21st Century Tiger, Multi-Donor trust Fund for Aceh and Nias Island, Rufford Small Grants, the People's Trust for Endangered Species, Panthera, International Rhino Foundation, Darwin Initiative, World Wildlife Fund Networks, Critical Ecosystem Partnership Fund, Virginia Tech, the Hurvis Family and Zoo Atlanta. The work of GG-A was supported by an Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATBC, 2011, RES OPP ROAD CONSTR; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; Government of Aceh, 2007, LOGG MOR TEMP CESS L; Government of Indonesia, 2008, KES BERS SEL GUB SUM; GTI, 2010, GLOB TIG IN NA UNPUB; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 2011, J APPL ECOL IN PRESS; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Linkie M, 2010, INTEGR ZOOL, V5, P342, DOI 10.1111/j.1749-4877.2010.00215.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Ministry of Forestry of Indonesia, 2010, NAT TIG REC PROGR RO; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Seidensticker J, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P295, DOI 10.1016/B978-0-8155-1570-8.00022-0; Sunquist M. E., 1981, SMITHSONIAN CONTRIB, V336, P1, DOI DOI 10.5479/SI.00810282.336; TILSON RL, 1994, SUMATRAN TIGER POPUL; Wibisono HT, 2010, INTEGR ZOOL, V5, P313, DOI 10.1111/j.1749-4877.2010.00219.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; WWF-Indonesia, 2010, SUM FOR THEIR UNPUB	22	51	52	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e25931	10.1371/journal.pone.0025931	http://dx.doi.org/10.1371/journal.pone.0025931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22087218	Green Published, gold			2022-12-25	WOS:000297154900004
J	Shah, PP; Fong, MY; Kakar, SS				Shah, P. P.; Fong, M. Y.; Kakar, S. S.			PTTG induces EMT through integrin alpha(V)beta(3)-focal adhesion kinase signaling in lung cancer cells	ONCOGENE			English	Article						PTTG; securin; lung cancer	TUMOR-TRANSFORMING GENE; EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASE-2 MMP-2; GROWTH-FACTOR-I; OVARIAN-CANCER; BREAST-CANCER; ALPHA-V-BETA-3 INTEGRIN; EXPRESSION; PROGRESSION; METASTASIS	Pituitary tumor transforming gene (PTTG) is a well-studied oncogene for its role in tumorigenesis and serves as a marker of malignancy in several cancer types including lung. In the present study, we defined the role of PTTG in actin cytoskeleton remodeling, cell migration and induction of epithelial mesenchymal transition (EMT) through the regulation of integrin alpha(V)beta(3)-FAK (focal adhesion kinase) signaling pathway. Overexpression of PTTG through an adenovirus vector resulted in a significant increase in the expression of integrins alpha(V) and beta(3), a process that was reversed with the downregulation of PTTG expression through the use of an adenovirus expressing PTTG-specific small interfering RNA (siRNA). Western blot analysis of cells infected with adenovirus PTTG cDNA resulted in increased FAK and enhanced expression of adhesion complex molecules paxillin, metavincullin, and talin. Furthermore, downstream signaling genes Rac1, RhoA, Cdc42 and DOCK180 showed upregulation upon PTTG overexpression. This process was dependent on integrin alpha(V), as blockage by antagonist echistatin (RGD peptide) or alpha(V)-specific siRNA resulted in a decrease in FAK and subsequent adhesion molecules. Actin cytoskeleton disruption was detected as a result of integrin-FAK signaling by PTTG as well as enhanced cell motility. Taken together, our results suggest for the first time an important role of PTTG in regulation of integrins alpha(V) and beta(3) and adhesion-complex proteins leading to induction of EMT. Oncogene (2012) 31, 3124-3135; doi:10.1038/onc.2011.488; published online 14 November 2011	[Fong, M. Y.; Kakar, S. S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40202 USA; [Shah, P. P.; Kakar, S. S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Kakar, SS (corresponding author), Univ Louisville, Dept Physiol & Biophys, 505 S Hancock St,CTRB 322, Louisville, KY 40202 USA.	sskaka01@louisville.edu			NCI [CA 124630]; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Stanley D'Souza for his critical input. The work was supported by a grant from NCI CA 124630 (SSK).	Agiostratidou G, 2007, J MAMMARY GLAND BIOL, V12, P127, DOI 10.1007/s10911-007-9044-6; Altun-Gultekin ZF, 1998, MOL CELL BIOL, V18, P3044, DOI 10.1128/MCB.18.5.3044; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Blanco D, 2004, LAB INVEST, V84, P999, DOI 10.1038/labinvest.3700129; Chamaon K, 2005, BIOCHEM BIOPH RES CO, V331, P86, DOI 10.1016/j.bbrc.2005.03.124; Chen XY, 2005, NEOPLASIA, V7, P271, DOI 10.1593/neo.04538; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Deng BQ, 2010, MOL CELL BIOCHEM, V340, P21, DOI 10.1007/s11010-010-0396-7; El-Naggar SM, 2007, INT J ONCOL, V31, P137; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Firrincieli D, 2010, GASTROEN CLIN BIOL, V34, P523, DOI 10.1016/j.gcb.2010.04.017; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Gong JG, 1997, CELL GROWTH DIFFER, V8, P83; Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Heaney AP, 1999, BEST PRACT RES CL EN, V13, P367, DOI 10.1053/beem.1999.0028; Hofmann UB, 2000, J INVEST DERMATOL, V115, P625, DOI 10.1046/j.1523-1747.2000.00114.x; Honda S, 2003, ANTICANCER RES, V23, P3775; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huveneers S, 2008, J BIOL CHEM, V283, P13243, DOI 10.1074/jbc.M800927200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jung CR, 2006, HEPATOLOGY, V43, P1042, DOI 10.1002/hep.21137; Kakar SS, 2006, INT J ONCOL, V29, P387; Kakar SS, 1999, CYTOGENET CELL GENET, V84, P211, DOI 10.1159/000015261; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lee IA, 1999, BIOCHEM MOL BIOL INT, V47, P891; Liang HS, 2010, INT J BIOL MARKER, V25, P38, DOI 10.1177/172460081002500106; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Martin KH, 2002, CELL MOTIL CYTOSKEL, V51, P76, DOI 10.1002/cm.10018; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Nakashima N, 1999, J BIOL CHEM, V274, P3001, DOI 10.1074/jbc.274.5.3001; Ning SC, 2010, CANCER RES, V70, P7591, DOI 10.1158/0008-5472.CAN-10-1639; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; ORLANDO RA, 1991, J BIOL CHEM, V266, P19543; Panguluri SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-577; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P99; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; Shibata Y, 2002, JPN J CLIN ONCOL, V32, P233, DOI 10.1093/jjco/hyf058; Solbach C, 2004, BREAST, V13, P80, DOI 10.1016/j.breast.2003.09.008; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; Tang Ming-hua, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1712; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tsai SJ, 2005, J CLIN ENDOCR METAB, V90, P3715, DOI 10.1210/jc.2004-2303; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yan S, 2009, CANCER RES, V69, P3283, DOI 10.1158/0008-5472.CAN-08-0367; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zheng DQ, 1999, CANCER RES, V59, P1655; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; ZUK A, 1994, DEV DYNAM, V201, P378, DOI 10.1002/aja.1002010409	82	57	59	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2012	31	26					3124	3135		10.1038/onc.2011.488	http://dx.doi.org/10.1038/onc.2011.488			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22081074	Green Accepted			2022-12-25	WOS:000305934400002
J	Nakao, S; Zandi, S; Faez, S; Kohno, R; Hafezi-Moghadam, A				Nakao, Shintaro; Zandi, Souska; Faez, Sepideh; Kohno, Ri-ichiro; Hafezi-Moghadam, Ali			Discontinuous LYVE-1 expression in corneal limbal lymphatics: dual function as microvalves and immunological hot spots	FASEB JOURNAL			English	Article						lymphangiogenesis; VE-cadherin; imaging; leukocyte recruitment	LYMPHEDEMA-DISTICHIASIS; LYMPHANGIOGENESIS; GROWTH; ANGIOGENESIS; VESSELS; NEOVASCULARIZATION; ENDOTHELIUM; MACROPHAGES; HYALURONAN; INDUCTION	LYVE-1(+) corneal lymphatics contribute to drainage and immunity. LYVE-1 is widely accepted as the most reliable lymphatic marker because of its continuous expression in lymphatic endothelium. LYVE-1 expression in corneal lymphatics has not been examined. In this study, we report intact CD31(+) corneal lymphatic capillary endothelial cells that do not express LYVE-1. The number of LYVE-1(-) gaps initially increased until 8 wk of age but was significantly reduced in aged mice. C57BL/6 mice showed a notably higher number of the LYVE-1(-)/CD31(+) lymphatic regions than BALB/c mice, which suggests a genetic predisposition for this histological feature. The LYVE-1(-) lymphatic gaps expressed podoplanin and VE-cadherin but not alpha SMA or FOXC2. Interestingly, the number of LYVE-1(-) gaps in FGF-2, but not VEGF-A, implanted corneas was significantly lower than in untreated corneas. Over 70% of the CD45(+) leukocytes were found in the proximity of the LYVE-1(-) gaps. Using a novel in vivo imaging technique for visualization of leukocyte migration into and out of corneal stroma, we showed reentry of extravasated leukocytes from angiogenic vessels into newly grown corneal lymphatics. This process was inhibited by VE-cadherin blockade. To date, existence of lymphatic valves in cornea is unknown. Electron microscopy showed overlapping lymphatic endothelial ends, reminiscent of microvalves in corneal lymphatics. This work introduces a novel corneal endothelial lymphatic phenotype that lacks LYVE-1. LYVE-1(-) lymphatic endothelium could serve as microvalves, supporting unidirectional flow, as well as immunological hot spots that facilitate reentry of stromal macropahges.-Nakao, S., Zandi, S., Faez, S., Kohno, R., Hafezi-Moghadam, A. Discontinuous LYVE-1 expression in corneal limbal lymphatics: dual function as microvalves and immunological hot spots. FASEB J. 26, 808-817 (2012). www.fasebj.org	[Nakao, Shintaro; Zandi, Souska; Hafezi-Moghadam, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Funct & Mol Imaging, Boston, MA 02115 USA; [Nakao, Shintaro; Zandi, Souska; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Nakao, Shintaro; Zandi, Souska; Faez, Sepideh; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA; [Nakao, Shintaro; Kohno, Ri-ichiro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 812, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Kyushu University	Hafezi-Moghadam, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Funct & Mol Imaging, 221 Longwood Ave,3rd Floor, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Zandi, Souska/0000-0001-9351-4278; Hafezi-Moghadam, Ali/0000-0002-5336-0697	U.S. National Institutes of Health NIH [AI050775]; Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society; Young Investigator Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	U.S. National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society; Young Investigator Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health NIH grants AI050775 (A.H.-M.), an overseas Research Fellowship Award from Bausch & Lomb, a Fellowship Award from the Japan Eye Bank Association and Tear Film and Ocular Surface Society, and a Young Investigator Fellowship (to S.N. under the mentorship of A.H.-M.). The authors thank the Malaysian Palm Oil Board and the American Health Assistance Foundation. The authors thank Alexander Schering and Rebecca C. Garland for their help with the preparation of the manuscript and Dr. David Jackson and Dr. Takayuki Hattori for helpful suggestions. S.N. and A.H.-M. designed research and organized the experiments; S.N., S.Z., S. F., and R. K. performed research and analyzed data; S.N. and A.H.-M. wrote the paper. The authors declare no conflicts of interest.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; COLLIN HB, 1970, INVEST OPHTH VISUAL, V9, P146; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Hagendoorn J, 2004, CIRC RES, V95, P204, DOI 10.1161/01.RES.0000135549.72828.24; Hos D, 2008, EXP EYE RES, V87, P427, DOI 10.1016/j.exer.2008.07.013; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; Nakao S, 2010, FASEB J, V24, P504, DOI 10.1096/fj.09-134056; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Singh D, 2003, J CATARACT REFR SURG, V29, P632, DOI 10.1016/S0886-3350(03)00161-5; SZEGHY G, 1963, LANCET, V1, P832; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Trzewik J, 2001, FASEB J, V15, P1711, DOI 10.1096/fj.01-0067com; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	24	19	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					808	817		10.1096/fj.11-183897	http://dx.doi.org/10.1096/fj.11-183897			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22090317	Green Published			2022-12-25	WOS:000300485700032
J	Verhalen, B; Ernst, S; Borsch, M; Wilkens, S				Verhalen, Brandy; Ernst, Stefan; Boersch, Michael; Wilkens, Stephan			Dynamic Ligand-induced Conformational Rearrangements in P-glycoprotein as Probed by Fluorescence Resonance Energy Transfer Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; ASYMMETRIC OCCLUDED STATE; ATP-BINDING; MULTIDRUG-RESISTANCE; CATALYTIC CYCLE; ABC TRANSPORTER; DRUG-BINDING; CASSETTE TRANSPORTER; MALTOSE TRANSPORTER; ELECTRON-MICROSCOPY	P-glycoprotein (Pgp), a member of the ATP-binding cassette transporter family, functions as an ATP hydrolysis-driven efflux pump torid the cell of toxic organic compounds, including a variety of drugs used in anticancer chemotherapy. Here, we used fluorescence resonance energy transfer (FRET) spectroscopy to delineate the structural rearrangements the two nucleotide binding domains (NBDs) are undergoing during the catalytic cycle. Pairs of cysteines were introduced into equivalent regions in the N- and C-terminal NBDs for labeling with fluorescent dyes for ensemble and single-molecule FRET spectroscopy. In the ensemble FRET, a decrease of the donor to acceptor (D/A) ratio was observed upon addition of drug and ATP. Vanadate trapping further decreased the D/A ratio, indicating close association of the two NBDs. One of the cysteine mutants was further analyzed using confocal single-molecule FRET spectroscopy. Single Pgp molecules showed fast fluctuations of the FRET efficiencies, indicating movements of the NBDs on a time scale of 10-100 ms. Populations of low, medium, and high FRET efficiencies were observed during drug-stimulated MgATP hydrolysis, suggesting the presence of at least three major conformations of the NBDs during catalysis. Under conditions of vanadate trapping, most molecules displayed high FRET efficiency states, whereas with cyclosporin, more molecules showed low FRET efficiency. Different dwell times of the FRET states were found for the distinct biochemical conditions, with the fastest movements during active turnover. The FRET spectroscopy observations are discussed in context of a model of the catalytic mechanism of Pgp.	[Verhalen, Brandy; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Ernst, Stefan; Boersch, Michael] Univ Jena, Single Mol Microscopy Grp, Jena Univ Hosp, D-07743 Jena, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Friedrich Schiller University of Jena	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Borsch, Michael/0000-0002-0634-2963	National Institutes of Health [CA100246, GM058600]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100246 and GM058600 (to S. W.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Borsch M, 2011, BIOL CHEM, V392, P135, DOI 10.1515/BC.2011.001; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cohen AE, 2005, P SOC PHOTO-OPT INS, V5699, P296, DOI 10.1117/12.598689; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Duser MG, 2008, J BIOL CHEM, V283, P33602, DOI 10.1074/jbc.M805170200; Eidne KA, 2002, TRENDS ENDOCRIN MET, V13, P415, DOI 10.1016/S1043-2760(02)00669-0; Ernst S., 2011, P SOC PHOTO-OPT INS, V7902; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Johnson KM, 2009, BIOPOLYMERS, V91, P830, DOI 10.1002/bip.21262; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1998, BIOCHEMISTRY-US, V37, P6503, DOI 10.1021/bi973031o; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schroder GF, 2003, J CHEM PHYS, V119, P9920, DOI 10.1063/1.1616511; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 2011, P NATL ACAD SCI USA, V108, P15015, DOI 10.1073/pnas.1111863108; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zarrabi N, 2005, PROC SPIE, V5699, P175, DOI 10.1117/12.597967; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	69	68	69	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1112	1127		10.1074/jbc.M111.301192	http://dx.doi.org/10.1074/jbc.M111.301192			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086917	Green Published, hybrid			2022-12-25	WOS:000299170300027
J	Glidden, EJ; Gray, LG; Vemuru, S; Li, D; Harris, TE; Mayo, MW				Glidden, Emily J.; Gray, Lisa G.; Vemuru, Suneil; Li, Duo; Harris, Thurl E.; Mayo, Marty W.			Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE-B; MTOR COMPLEX; GROWTH; ACTIVATION; AKT/PKB; INSULIN; DEACETYLASES; SIRTUINS; RECEPTOR	The serine/threonine protein kinase Akt is a critical regulator of cell growth and survival in response to growth factors. A key step in Akt activation is phosphorylation at Ser-473 by the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). Although Rictor is required for the stability and activity of mTORC2, little is known about functional regions or post-translational modifications within Rictor that are responsible for regulating mTORC2. Here, we demonstrate that Rictor contains two distinct central regions critical for mTORC2 function. One we refer to as the stability region because it is critical for interaction with Sin1.1 and LST8, and a second adjacent region is required for multisite acetylation. p300-mediated acetylation of Rictor increases mTORC2 activity toward Akt, whereas site-directed mutants within the acetylation region of Rictor exhibit reduced insulin-like growth factor 1 (IGF-1)-stimulated mTORC2 kinase activity. Inhibition of deacetylases, including the NAD(+)-dependent sirtuins, promotes Rictor acetylation and IGF-1-mediated Akt phosphorylation. These results suggest that multiple-site acetylation of Rictor signals for increased activation of mTORC2, providing a critical link between nutrientsensitive deacetylases and mTORC2 signaling to Akt.	[Glidden, Emily J.; Gray, Lisa G.; Vemuru, Suneil; Li, Duo; Mayo, Marty W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Mayo, MW (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733,Jordan Hall,Rm 6233, Charlottesville, VA 22908 USA.	mwm3y@virginia.edu			National Institutes of Health through the NCI [CA132580, CA104397]; National Institutes of Health through NIDDK [DK052753]; University of Virginia; NATIONAL CANCER INSTITUTE [R01CA104397, R01CA132580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052753] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through NIDDK; University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132580 and CA104397 through the NCI (to M. W. M.) and Grant DK052753 through the NIDDK (to T. E. H.).; Supported by the University of Virginia Tobacco Research Program, a gift of Philip Morris USA. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Genetics, Box 800733, Jordan Hall, Rm. 6233, University of Virginia, Charlottesville, VA 22908. Tel.: 1-434-924-2509; Fax: 1-434-924-5069; E-mail: mwm3y@virginia.edu.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Song H, 2011, BIOCHEM BIOPH RES CO, V404, P68, DOI 10.1016/j.bbrc.2010.11.064; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	67	67	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					581	588		10.1074/jbc.M111.304337	http://dx.doi.org/10.1074/jbc.M111.304337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084251	hybrid, Green Published			2022-12-25	WOS:000298682400056
J	Burnside, K; Lembo, A; Harrell, MI; Gurney, M; Xue, L; Tran, NTB; Connelly, JE; Jewell, KA; Schmidt, BZ; de los Reyes, M; Tao, WA; Doran, KS; Rajagopal, L				Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S.; Rajagopal, Lakshmi			Serine/Threonine Phosphatase Stp1 Mediates Post-transcriptional Regulation of Hemolysin, Autolysis, and Virulence of Group B Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL SIGNALING PATHWAYS; SERINE-THREONINE PHOSPHATASE; BRAIN-BARRIER PENETRATION; SER/THR PROTEIN-KINASE; LUNG EPITHELIAL-CELLS; EUKARYOTIC-TYPE; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; IN-VIVO; SUBSTRATE IDENTIFICATION	Elucidating how serine/threonine phosphatases regulate kinase function and bacterial virulence is critical for our ability to combat these infections. Group B streptococci (GBS) are beta-hemolytic Gram-positive bacteria that cause invasive infections in humans. To adapt to environmental changes, GBS encodes signaling mechanisms comprising two component systems and eukaryotic-like enzymes. We have previously described the importance of the serine/threonine kinase Stk1 to GBS pathogenesis. However, how the presence or absence of the cognate serine/threonine phosphatase Stp1 affects Stk1 function and GBS virulence is not known. Here, we show that GBS deficient only in Stp1 expression are markedly reduced for their ability to cause systemic infections, exhibit decreased beta-hemolysin/cytolysin activity, and show increased sensitivity to autolysis. Although transcription of genes important for beta-hemolysin/cytolysin expression and export is similar to the wild type (WT), 294 genes (excluding stp1) showed altered expression in the stp1 mutant and included autolysin genes. Furthermore, phosphopeptide enrichment analysis identified that 35 serine/threonine phosphopeptides, corresponding to 27 proteins, were unique to the stp1 mutant. This included phosphorylation of ATP synthase, DNA and RNA helicases, and proteins important for cell division and protein synthesis. Collectively, our results indicate that Stp1 is important for appropriate regulation of Stk1 function, hemolysin activity, autolysis, and GBS virulence.	[Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Rajagopal, Lakshmi] Univ Washington, Sch Med, Dept Pediat Infect Dis, Seattle, WA 98101 USA; [Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Rajagopal, Lakshmi] Seattle Childrens Hosp Res Inst, Seattle, WA 98101 USA; [Gurney, Michael; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gurney, Michael; Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Xue, Liang; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; California State University System; San Diego State University; California State University System; San Diego State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rajagopal, L (corresponding author), Univ Washington, Sch Med, Dept Pediat Infect Dis, Seattle, WA 98101 USA.	lakshmi.rajagopal@seattlechildrens.org	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020; Jewell, Kelsea/AGG-9303-2022	Tao, Weiguo/0000-0002-5535-5517; Xue, Liang/0000-0003-3606-4615	National Institutes of Health (NIH) [RO1AI070749, GM088317, 5 T32 HD007233-29]; NIH, NINDS [RO1NS051247]; National Science Foundation [CAREER CHE-0645020]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1AI070749 (to L. R.), NIH, NINDS, Grant RO1NS051247 (to K. S. D.), and NIH Grant GM088317 (to W. A. T.). This work was also supported by the National Science Foundation CAREER CHE-0645020 award (to W. A. T.).; Supported by National Institutes of Health Training Grant 5 T32 HD007233-29 (to Lisa Frenkel).	Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Baker C., 1995, INFECT DIS FETUS NEW, V4th ed., P980; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnside K, 2011, FUTURE MICROBIOL, V6, P747, DOI [10.2217/FMB.11.62, 10.2217/fmb.11.62]; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chaffin DO, 2005, J BACTERIOL, V187, P4615, DOI 10.1128/JB.187.13.4615-4626.2005; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; COLIGAN JE, 1998, CURRENT PROTOCOLS IM, V1; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Guo HH, 2011, J LIPID RES, V52, P908, DOI 10.1194/jlr.M013375; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hensler ME, 2005, J INFECT DIS, V191, P1287, DOI 10.1086/428946; HILLIER SL, 1991, AM J OBSTET GYNECOL, V165, P955, DOI 10.1016/0002-9378(91)90447-Y; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Iliuk Anton, 2009, V527, P117, DOI 10.1007/978-1-60327-834-8_10; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ochem AE, 2008, ARCH BIOCHEM BIOPHYS, V470, P1, DOI 10.1016/j.abb.2007.11.005; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pritchard DG, 2004, MICROBIOL-SGM, V150, P2079, DOI 10.1099/mic.0.27063-0; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Redbird RA, 2007, FASEB J, V21, pA986; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Ring A, 2002, J INFECT DIS, V185, P1745, DOI 10.1086/340818; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Shelver D, 2003, J BACTERIOL, V185, P6592, DOI 10.1128/JB.185.22.6592-6599.2003; Silvestroni A, 2009, J PROTEOME RES, V8, P2563, DOI 10.1021/pr900069n; Song JH, 2005, MOL CELLS, V19, P365; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Struglics A, 1998, BIOCHEM BIOPH RES CO, V243, P664, DOI 10.1006/bbrc.1998.8151; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WESSELS MR, 1989, P NATL ACAD SCI USA, V86, P8983, DOI 10.1073/pnas.86.22.8983; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Yang LQ, 2004, BIOCHEM BIOPH RES CO, V314, P622, DOI 10.1016/j.bbrc.2003.12.129	98	33	34	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44197	44210		10.1074/jbc.M111.313486	http://dx.doi.org/10.1074/jbc.M111.313486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22081606	hybrid, Green Published			2022-12-25	WOS:000298402300060
J	Lei, XH; Ning, LN; Cao, YJ; Liu, S; Zhang, SB; Qiu, ZF; Hu, HM; Zhang, HS; Liu, S; Duan, EK				Lei, Xiao-hua; Ning, Li-na; Cao, Yu-jing; Liu, Shuang; Zhang, Shou-bing; Qiu, Zhi-fang; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu; Duan, En-kui			NASA-Approved Rotary Bioreactor Enhances Proliferation of Human Epidermal Stem Cells and Supports Formation of 3D Epidermis-Like Structure	PLOS ONE			English	Article							MODELED MICROGRAVITY; DIFFERENTIATION; CULTURE; KERATINOCYTE; MICROCARRIERS	The skin is susceptible to different injuries and diseases. One major obstacle in skin tissue engineering is how to develop functional three-dimensional (3D) substitute for damaged skin. Previous studies have proved a 3D dynamic simulated microgravity (SMG) culture system as a "stimulatory'' environment for the proliferation and differentiation of stem cells. Here, we employed the NASA-approved rotary bioreactor to investigate the proliferation and differentiation of human epidermal stem cells (hEpSCs). hEpSCs were isolated from children foreskins and enriched by collecting epidermal stem cell colonies. Cytodex-3 micro-carriers and hEpSCs were co-cultured in the rotary bioreactor and 6-well dish for 15 days. The result showed that hEpSCs cultured in rotary bioreactor exhibited enhanced proliferation and viability surpassing those cultured in static conditions. Additionally, immunostaining analysis confirmed higher percentage of ki67 positive cells in rotary bioreactor compared with the static culture. In contrast, comparing with static culture, cells in the rotary bioreactor displayed a low expression of involucrin at day 10. Histological analysis revealed that cells cultured in rotary bioreactor aggregated on the micro-carriers and formed multilayer 3D epidermis structures. In conclusion, our research suggests that NASA-approved rotary bioreactor can support the proliferation of hEpSCs and provide a strategy to form multilayer epidermis structure.	[Lei, Xiao-hua; Ning, Li-na; Cao, Yu-jing; Liu, Shuang; Zhang, Shou-bing; Qiu, Zhi-fang; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu; Duan, En-kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Liu, Shuang; Zhang, Shou-bing; Hu, Hui-min; Zhang, Hui-shan; Liu, Shu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lei, XH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	duane@ioz.ac.cn	Qiu, Zhifang/P-8313-2014; Lei, Xiaohua/J-7020-2019	Lei, Xiaohua/0000-0001-8095-9008; Qiu, Zhifang/0000-0001-9196-032X	National Basic Research Program of China [2011CB710905]; Chinese Academy of Sciences [XDA01010202, KSCX2-YW-R-228, KJCX2-YW-L08]; National Natural Science Foundation of China [30971671]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China Grant (2011CB710905), Strategic Priority Research Program of the Chinese Academy of Sciences Grant (XDA01010202), National Natural Science Foundation of China Grants (30971671), and Chinese Academy of Sciences Knowledge Innovation Program Grant (KSCX2-YW-R-228) and (KJCX2-YW-L08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Charruyer A, 2009, SKIN PHARMACOL PHYS, V22, P55, DOI 10.1159/000178864; Chen JS, 2007, ARTIF ORGANS, V31, P722, DOI 10.1111/j.1525-1594.2007.00440.x; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Duray P H, 1997, Sci Med (Phila), V4, P46; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Egberts F, 2004, J CELL SCI, V117, P2295, DOI 10.1242/jcs.01075; Facer SR, 2005, J DENT RES, V84, P542, DOI 10.1177/154405910508400611; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; LEWIS ML, 1993, J CELL BIOCHEM, V51, P265, DOI 10.1002/jcb.240510305; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371; Meuli M, 1997, PEDIATR SURG INT, V12, P471, DOI 10.1007/BF01258705; Navran S, 2008, BIOTECHNOL ANN REV, V14, P275, DOI 10.1016/S1387-2656(08)00011-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Qiu Q, 1998, TISSUE ENG, V4, P19, DOI 10.1089/ten.1998.4.19; Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563; Watt FM, 2002, J DERMATOL SCI, V28, P173, DOI 10.1016/S0923-1811(02)00003-8; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294	37	59	65	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26603	10.1371/journal.pone.0026603	http://dx.doi.org/10.1371/journal.pone.0026603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096490	Green Submitted, Green Published, gold			2022-12-25	WOS:000297350800010
J	Schue, M; Fekete, A; Ortet, P; Brutesco, C; Heulin, T; Schmitt-Kopplin, P; Achouak, W; Santaella, C				Schue, Mathieu; Fekete, Agnes; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Schmitt-Kopplin, Philippe; Achouak, Wafa; Santaella, Catherine			Modulation of Metabolism and Switching to Biofilm Prevail over Exopolysaccharide Production in the Response of Rhizobium alamii to Cadmium	PLOS ONE			English	Article							HEAVY-METAL RESISTANCE; LEGUMINOSARUM BV VICIAE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; BRASSICA-NAPUS; GLUTATHIONE; MECHANISMS; STRAIN; SEQUESTRATION; NICKEL	Heavy metals such as cadmium (Cd2+) affect microbial metabolic processes. Consequently, bacteria adapt by adjusting their cellular machinery. We have investigated the dose-dependent growth effects of Cd2+ on Rhizobium alamii, an exopolysaccharide (EPS)-producing bacterium that forms a biofilm on plant roots. Adsorption isotherms show that the EPS of R. alamii binds cadmium in competition with calcium. A metabonomics approach based on ion cyclotron resonance Fourier transform mass spectrometry has showed that cadmium alters mainly the bacterial metabolism in pathways implying sugars, purine, phosphate, calcium signalling and cell respiration. We determined the influence of EPS on the bacterium response to cadmium, using a mutant of R. alamii impaired in EPS production (MS Delta GT). Cadmium dose-dependent effects on the bacterial growth were not significantly different between the R. alamii wild type (wt) and MSDGT strains. Although cadmium did not modify the quantity of EPS isolated from R. alamii, it triggered the formation of biofilm vs planktonic cells, both by R. alamii wt and by MS Delta GT. Thus, it appears that cadmium toxicity could be managed by switching to a biofilm way of life, rather than producing EPS. We conclude that modulations of the bacterial metabolism and switching to biofilms prevails in the adaptation of R. alamii to cadmium. These results are original with regard to the conventional role attributed to EPS in a biofilm matrix, and the bacterial response to cadmium.	[Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] CEA, Lab Ecol Microbienne Rhizosphere & Environm Extre, iBEB, DSV, St Paul Les Durance, France; [Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] CNRS, Unite Mixte Rech Biol Vegetale & Microbiol Enviro, UMR 6191, St Paul Les Durance, France; [Schue, Mathieu; Ortet, Philippe; Brutesco, Catherine; Heulin, Thierry; Achouak, Wafa; Santaella, Catherine] Univ Aix Marseille, St Paul Les Durance, France; [Fekete, Agnes; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Ecol Chem, Dept BioGeochem & Anal, Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Dept Chem, Tech Anal Res Ctr Weihenstephan Brewing & Food Qu, D-8050 Freising Weihenstephan, Germany	CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Schue, M (corresponding author), CNRS, UPR 9025, Lab Enzymol Interfaciale & Physiol Lipolyse, Marseille, France.	catherine.santaella@cea.fr	, HEULIN/C-1689-2010; Schmitt-Kopplin, Philippe/H-6271-2011; SANTAELLA, Catherine/J-7967-2016; Achouak, Wafa/AAX-8916-2021; Fekete, Agnes/C-8048-2019; ORTET, Philippe/T-8172-2018	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; SANTAELLA, Catherine/0000-0003-3878-2733; Achouak, Wafa/0000-0003-4297-6661; Fekete, Agnes/0000-0003-3058-7570; ORTET, Philippe/0000-0002-2648-8978	French inter organism program "Toxicologie Nucleaire Environnementale''	French inter organism program "Toxicologie Nucleaire Environnementale''	This work was supported by the French inter organism program "Toxicologie Nucleaire Environnementale'' (Environmental Nuclear Toxicology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKING H, 1984, APPL ENVIRON MICROB, V47, P374, DOI 10.1128/AEM.47.2.374-377.1984; Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; Pereira SIA, 2006, MICROB ECOL, V52, P176, DOI 10.1007/s00248-006-9057-5; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BLAKE RC, 1993, ENVIRON TOXICOL CHEM, V12, P1365, DOI 10.1002/etc.5620120806; Bouchelaghem W, 2006, ACTA CRYSTALLOGR E, V62, pI99, DOI 10.1107/S1600536806008397; CHEN JH, 1995, ENVIRON HEALTH PERSP, V103, P53, DOI 10.2307/3432013; Czajka DR, 1997, WATER RES, V31, P2827, DOI 10.1016/S0043-1354(97)00129-2; Dedieu K, 2006, ENVIRON CHEM, V3, P424, DOI 10.1071/EN06063; Figueira EMDP, 2005, CAN J MICROBIOL, V51, P7, DOI [10.1139/w04-101, 10.1139/W04-101]; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; Fujishige NA, 2006, BOT J LINN SOC, V150, P79, DOI 10.1111/j.1095-8339.2006.00492.x; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; Lima AIG, 2006, ENZYME MICROB TECH, V39, P763, DOI 10.1016/j.enzmictec.2005.12.009; HEBBAR KP, 1992, APPL MICROBIOL BIOT, V38, P248, DOI 10.1007/BF00174477; HIGHAM DP, 1984, SCIENCE, V225, P1043, DOI 10.1126/science.225.4666.1043; Holmes JD, 1997, MICROBIOL-UK, V143, P2521, DOI 10.1099/00221287-143-8-2521; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Lamelas C, 2006, CHEMOSPHERE, V65, P1362, DOI 10.1016/j.chemosphere.2006.04.021; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MITRA RS, 1975, J BACTERIOL, V121, P1180, DOI 10.1128/JB.121.3.1180-1188.1975; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Morgante C, 2007, SOIL BIOL BIOCHEM, V39, P1222, DOI 10.1016/j.soilbio.2006.11.022; NELSON YM, 1995, WATER RES, V29, P1934, DOI 10.1016/0043-1354(94)00351-7; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pacheco CC, 2008, ARCH MICROBIOL, V189, P271, DOI 10.1007/s00203-007-0316-8; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Pages D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001539; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Ron Eliora Z., 1992, Biodegradation, V3, P161, DOI 10.1007/BF00129081; Santaella C, 2008, ENVIRON MICROBIOL, V10, P2150, DOI 10.1111/j.1462-2920.2008.01650.x; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Slaveykova VI, 2010, ENVIRON POLLUT, V158, P2561, DOI 10.1016/j.envpol.2010.05.016; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; TRINICK MJ, 1995, PLANT SOIL, V172, P207, DOI 10.1007/BF00011323; Vicre M, 2005, PLANT PHYSIOL, V138, P998, DOI 10.1104/pp.104.051813; Villain-Simonnet A, 2000, INT J BIOL MACROMOL, V27, P65, DOI 10.1016/S0141-8130(99)00120-8; VOLESKY B, 1987, TRENDS BIOTECHNOL, V5, P96, DOI 10.1016/0167-7799(87)90027-8; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Zhou WZ, 2009, COLLOID SURFACE B, V72, P295, DOI 10.1016/j.colsurfb.2009.04.018	47	20	24	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2011	6	11							e26771	10.1371/journal.pone.0026771	http://dx.doi.org/10.1371/journal.pone.0026771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852II	22096497	Green Submitted, gold, Green Published			2022-12-25	WOS:000297350800013
J	Lin, DCH; Zhang, J; Zhuang, R; Li, F; Nguyen, K; Chen, M; Tran, T; Lopez, E; Lu, JYL; Li, XYNN; Tang, L; Tonn, GR; Swaminath, G; Reagan, JD; Chen, JL; Tian, H; Lin, YJ; Houze, JB; Luo, J				Lin, Daniel C. -H.; Zhang, Jane; Zhuang, Run; Li, Frank; Kathy Nguyen; Chen, Michael; Thanhvien Tran; Lopez, Edwin; Lu, Jenny Ying Lin; Li, Xiaoyan Nina; Tang, Liang; Tonn, George R.; Swaminath, Gayathri; Reagan, Jeff D.; Chen, Jin-Long; Tian, Hui; Lin, Yi-Jyun; Houze, Jonathan B.; Luo, Jian			AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROTEIN-COUPLED RECEPTORS; FATTY-ACID STIMULATION; OBESE FA/FA RATS; DISCOVERY; GENE; TOLERANCE; RELEASE; POTENT; MICE	Agonists of GPR40 (FFA1) have been proposed as a means to treat type 2 diabetes. Through lead optimization of a high throughput screening hit, we have identified a novel GPR40 agonist called AMG 837. The objective of these studies was to understand the preclinical pharmacological properties of AMG 837. The activity of AMG 837 on GPR40 was characterized through GTP gamma S binding, inositol phosphate accumulation and Ca2+ flux assays. Activity of AMG 837 on insulin release was assessed on isolated primary mouse islets. To determine the anti-diabetic activity of AMG 837 in vivo, we tested AMG 837 using a glucose tolerance test in normal Sprague-Dawley rats and obese Zucker fatty rats. AMG 837 was a potent partial agonist in the calcium flux assay on the GPR40 receptor and potentiated glucose stimulated insulin secretion in vitro and in vivo. Acute administration of AMG 837 lowered glucose excursions and increased glucose stimulated insulin secretion during glucose tolerance tests in both normal and Zucker fatty rats. The improvement in glucose excursions persisted following daily dosing of AMG 837 for 21-days in Zucker fatty rats. Preclinical studies demonstrated that AMG 837 was a potent GPR40 partial agonist which lowered post-prandial glucose levels. These studies support the potential utility of AMG 837 for the treatment of type 2 diabetes.	[Lin, Daniel C. -H.; Zhang, Jane; Zhuang, Run; Li, Frank; Kathy Nguyen; Chen, Michael; Thanhvien Tran; Lopez, Edwin; Lu, Jenny Ying Lin; Li, Xiaoyan Nina; Swaminath, Gayathri; Reagan, Jeff D.; Chen, Jin-Long; Tian, Hui; Lin, Yi-Jyun; Luo, Jian] Amgen Inc, Metab Disorders, San Francisco, CA USA; [Houze, Jonathan B.] Amgen Inc, Chem Res & Discovery, San Francisco, CA USA; [Tang, Liang; Tonn, George R.] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA	Amgen; Amgen; Amgen	Lin, DCH (corresponding author), Amgen Inc, Metab Disorders, San Francisco, CA USA.	dclin@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	This study was supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bharate SB, 2008, BIOORG MED CHEM LETT, V18, P6357, DOI 10.1016/j.bmcl.2008.10.085; Boneva NB, 2009, HIPPOCAMPUS; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Del Guerra S, 2010, NUTR METAB CARDIOVAS, V20, P22, DOI 10.1016/j.numecd.2009.02.008; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; IONESCU E, 1985, AM J PHYSIOL, V248, pE500, DOI 10.1152/ajpendo.1985.248.5.E500; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Madiraju SRM, 2007, ENDOCRINOLOGY, V148, P2598, DOI 10.1210/en.2007-0336; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Naik H., 2011, J CLIN PHARM; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Sasaki S, 2011, J MED CHEM, V54, P1365, DOI 10.1021/jm101405t; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; TERRETTAZ J, 1986, ENDOCRINOLOGY, V118, P674, DOI 10.1210/endo-118-2-674; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tomita T, 2005, BIOCHEM BIOPH RES CO, V338, P1788, DOI 10.1016/j.bbrc.2005.10.161; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Walker SD, 2011, ORG PROCESS RES DEV, V15, P570, DOI 10.1021/op1003055	37	64	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27270	10.1371/journal.pone.0027270	http://dx.doi.org/10.1371/journal.pone.0027270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087278	Green Published, gold, Green Submitted			2022-12-25	WOS:000297349700025
J	Neddens, J; Buonanno, A				Neddens, Joerg; Buonanno, Andres			Expression of the Neuregulin Receptor ErbB4 in the Brain of the Rhesus Monkey (Macaca mulatta)	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARVALBUMIN-POSITIVE INTERNEURONS; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; DIFFERENTIAL EXPRESSION; GABAERGIC INTERNEURONS; SEXUAL DEVELOPMENT; RETICULAR NUCLEUS; PREFRONTAL CORTEX; RAT HIPPOCAMPUS	We demonstrated recently that frontal cortical expression of the Neuregulin (NRG) receptor ErbB4 is restricted to interneurons in rodents, macaques, and humans. However, little is known about protein expression patterns in other areas of the brain. In situ hybridization studies have shown high ErbB4 mRNA levels in various subcortical areas, suggesting that ErbB4 is also expressed in cell types other than cortical interneurons. Here, using highly-specific monoclonal antibodies, we provide the first extensive report of ErbB4 protein expression throughout the cerebrum of primates. We show that ErbB4 immunoreactivity is high in association cortices, intermediate in sensory cortices, and relatively low in motor cortices. The overall immunoreactivity in the hippocampal formation is intermediate, but is high in a subset of interneurons. We detected the highest overall immunoreactivity in distinct locations of the ventral hypothalamus, medial habenula, intercalated nuclei of the amygdala and structures of the ventral forebrain, such as the islands of Calleja, olfactory tubercle and ventral pallidum, and medium expression in the reticular thalamic nucleus. While this pattern is generally consistent with ErbB4 mRNA expression data, further investigations are needed to identify the exact cellular and subcellular sources of mRNA and protein expression in these areas. In contrast to in situ hybridization in rodents, we detected only low levels of ErbB4-immunoreactivity in mesencephalic dopaminergic nuclei but a diffuse pattern of immunofluorescence that was medium in the dorsal striatum and high in the ventral forebrain, suggesting that most ErbB4 protein in dopaminergic neurons could be transported to axons. We conclude that the NRG-ErbB4 signaling pathway can potentially influence many functional systems throughout the brain of primates, and suggest that major sites of action are areas of the "corticolimbic" network. This interpretation is functionally consistent with the genetic association of NRG1 and ERBB4 with schizophrenia.	[Neddens, Joerg; Buonanno, Andres] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurobiol Sect, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Neddens, J (corresponding author), JSW Life Sci GmbH, Dept Histol, Grambach, Austria.	jneddens@jsw-lifesciences.com			Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institutes of Health. Neither institution had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Arabadzisz D, 1999, NEUROSCIENCE, V92, P27, DOI 10.1016/S0306-4522(98)00736-2; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bernstein HG, 2006, BRAIN RES BULL, V69, P546, DOI 10.1016/j.brainresbull.2006.02.017; Bin Kwon O, 2008, P NATL ACAD SCI USA, V105, P15587, DOI 10.1073/pnas.0805722105; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Burns LH, 1996, BEHAV NEUROSCI, V110, P60, DOI 10.1037/0735-7044.110.1.60; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Coyle Joseph T, 2010, Dialogues Clin Neurosci, V12, P359; Csillik B, 2005, J CHEM NEUROANAT, V30, P17, DOI 10.1016/j.jchemneu.2005.03.010; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Disney AA, 2008, J COMP NEUROL, V507, P1748, DOI 10.1002/cne.21616; Elman I, 2006, NEUROPSYCHOPHARMACOL, V31, P2091, DOI [10.1038/sj.npp.1301141, 10.1038/sj.npp.1301051]; Faure A, 2008, J NEUROSCI, V28, P7184, DOI 10.1523/JNEUROSCI.4961-07.2008; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Ganzel BL, 2010, PSYCHOL REV, V117, P134, DOI 10.1037/a0017773; Georgieva L, 2008, BIOL PSYCHIAT, V64, P419, DOI 10.1016/j.biopsych.2008.03.025; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Higo N, 2007, BRAIN RES, V1171, P30, DOI 10.1016/j.brainres.2007.07.054; Hou JW, 2002, ENDOCRINOLOGY, V143, P1901, DOI 10.1210/en.143.5.1901; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Krivosheya D, 2008, J BIOL CHEM; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Ma YJ, 1999, J NEUROSCI, V19, P9913; McMahon LL, 1998, J NEUROSCI, V18, P5640; Meyer D, 1997, DEVELOPMENT, V124, P3575; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Neddens J, 2011, BIOL PSYCHIAT, V70, P636, DOI 10.1016/j.biopsych.2011.04.016; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; PinkasKramarski R, 1997, ONCOGENE, V15, P2803, DOI 10.1038/sj.onc.1201466; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Prevot V, 2003, J NEUROSCI, V23, P230; Rosler TW, 2011, NEUROPHARMACOLOGY; Saleem KS, 2007, COMBINED MRI HISTOLO; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Sharif A, 2009, GLIA, V57, P362, DOI 10.1002/glia.20762; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Singec I, 2004, J COMP NEUROL, V479, P30, DOI 10.1002/cne.20302; SORIANO E, 1993, J COMP NEUROL, V333, P435, DOI 10.1002/cne.903330309; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; Swerdlow NR, 2010, CURR TOP BEHAV NEURO, V4, P555, DOI 10.1007/7854_2010_48; Thompson M, 2007, BRAIN RES, V1139, P95, DOI 10.1016/j.brainres.2006.11.047; Thuret S, 2004, J NEUROCHEM, V91, P1302, DOI 10.1111/j.1471-4159.2004.02809.x; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	69	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2011	6	11							e27337	10.1371/journal.pone.0027337	http://dx.doi.org/10.1371/journal.pone.0027337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HZ	22087295	gold, Green Published, Green Submitted			2022-12-25	WOS:000297349700033
J	Bhattacharjee, M; Sillanpaa, MJ				Bhattacharjee, Madhuchhanda; Sillanpaa, Mikko J.			A Bayesian Mixed Regression Based Prediction of Quantitative Traits from Molecular Marker and Gene Expression Data	PLOS ONE			English	Article							VARIABLE SELECTION; GENOMIC SELECTION; CROSS-VALIDATION; LASSO; MODELS	Both molecular marker and gene expression data were considered alone as well as jointly to serve as additive predictors for two pathogen-activity-phenotypes in real recombinant inbred lines of soybean. For unobserved phenotype prediction, we used a Bayesian hierarchical regression modeling, where the number of possible predictors in the model was controlled by different selection strategies tested. Our initial findings were submitted for DREAM5 (the 5th Dialogue on Reverse Engineering Assessment and Methods challenge) and were judged to be the best in sub-challenge B3 wherein both functional genomic and genetic data were used to predict the phenotypes. In this work we further improve upon this previous work by considering various predictor selection strategies and cross-validation was used to measure accuracy of in-data and out-data predictions. The results from various model choices indicate that for this data use of both data types (namely functional genomic and genetic) simultaneously improves out-data prediction accuracy. Adequate goodness-of-fit can be easily achieved with more complex models for both phenotypes, since the number of potential predictors is large and the sample size is not small. We also further studied gene-set enrichment (for continuous phenotype) in the biological process in question and chromosomal enrichment of the gene set. The methodological contribution of this paper is in exploration of variable selection techniques to alleviate the problem of over-fitting. Different strategies based on the nature of covariates were explored and all methods were implemented under the Bayesian hierarchical modeling framework with indicator-based covariate selection. All the models based in careful variable selection procedure were found to produce significant results based on permutation test.	[Bhattacharjee, Madhuchhanda] Univ Pune, Dept Stat, Pune, Maharashtra, India; [Sillanpaa, Mikko J.] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Sillanpaa, Mikko J.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Biol, Oulu, Finland	Savitribai Phule Pune University; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu	Bhattacharjee, M (corresponding author), Univ Pune, Dept Stat, Pune, Maharashtra, India.	chhanda.bhatta@gmail.com	Bhattacharjee, Madhuchhanda/ABI-3732-2020	Bhattacharjee, Madhuchhanda/0000-0002-8700-376X; Sillanpaa, Mikko J./0000-0003-2808-2768	Academy of Finland; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	This work was supported by a research grant from the Academy of Finland and the University of Helsinki's research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bhattacharjee M, 2004, BIOINFORMATICS, V20, P2943, DOI 10.1093/bioinformatics/bth338; Bhattacharjee M, 2008, GENOMICS, V92, P384, DOI 10.1016/j.ygeno.2008.06.006; Bhattacharjee M, 2009, METHODS MICROARRAY D, P15; Caruana R., 2003, Journal of Machine Learning Research, V3, P1245, DOI 10.1162/153244303322753652; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang LC, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-81; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Lee E, 2009, GENOMICS, V94, P269, DOI 10.1016/j.ygeno.2009.06.002; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lee SH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-22; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Mackay Trudy F C, 2009, J Biol, V8, P23, DOI 10.1186/jbiol133; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pinna A, 2011, BIOINFORMATICS, V27, P2459, DOI 10.1093/bioinformatics/btr407; Sillanpaa MJ, 2005, GENETICS, V169, P427, DOI 10.1534/genetics.104.032680; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; West M, 2006, GENOME RES, V16, P559, DOI 10.1101/gr.3851306; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2011	6	11							e26959	10.1371/journal.pone.0026959	http://dx.doi.org/10.1371/journal.pone.0026959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HH	22087238	Green Submitted, Green Published, gold			2022-12-25	WOS:000297347700013
J	Prakash, R; Raja, SB; Devaraj, H; Devaraj, SN				Prakash, Radhakrishnan; Raja, Subramaniya Bharathi; Devaraj, Halagowder; Devaraj, Sivasitambaram Niranjali			Up-Regulation of MUC2 and IL-1 beta Expression in Human Colonic Epithelial Cells by Shigella and Its Interaction with Mucins	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENTEROPATHOGENIC ESCHERICHIA-COLI; GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; IN-VITRO; PROINFLAMMATORY CYTOKINES; YERSINIA-ENTEROCOLITICA; HELICOBACTER-PYLORI; ADHESIVE PROPERTIES; INTESTINAL MUCINS	Background: The entire gastrointestinal tract is protected by a mucous layer, which contains complex glycoproteins called mucins. MUC2 is one such mucin that protects the colonic mucosa from invading microbes. The initial interaction between microbes and mucins is an important step for microbial pathogenesis. Hence, it was of interest to investigate the relationship between host (mucin) and pathogen interaction, including Shigella induced expression of MUC2 and IL-1 beta during shigellosis. Methods: The mucin-Shigella interaction was revealed by an in vitro mucin-binding assay. Invasion of Shigella dysenteriae into HT-29 cells was analyzed by Transmission electron microscopy. Shigella induced mucin and IL-1 beta expression were analyzed by RT-PCR and Immunofluorescence. Results: The clinical isolates of Shigella were found to be virulent by a congo-red binding assay. The in vitro mucin-binding assay revealed both Shigella dysenteriae and Shigella flexneri have binding affinity in the increasing order of: guinea pig small intestinal mucin, guinea pig colonic mucin, Human colonic mucin. Invasion of Shigella dysenteriae into HT-29 cells occurs within 2 hours. Interestingly, in Shigella dysenteriae infected conditions, significant increases in mRNA expression of MUC2 and IL-1 beta were observed in a time dependent manner. Further, immunofluorescence analysis of MUC2 shows more positive cells in Shigella dysenteriae treated cells than untreated cells. Conclusions: Our study concludes that the Shigella species specifically binds to guinea pig colonic mucin, but not to guinea pig small intestinal mucin. The guinea pig colonic mucin showed a greater binding parameter (R), and more saturable binding, suggesting the presence of a finite number of receptor binding sites in the colonic mucin of the host. In addition, modification of mucins with TFMS and sodium metaperiodate significantly reduced mucin-bacterial binding; suggesting that the mucin-Shigella interaction occurs through carbohydrate epitopes on the mucin backbones. Overproduction of MUC2 may alter adherence and invasion of Shigella dysenteriae into human colonic epithelial cells.	[Prakash, Radhakrishnan; Raja, Subramaniya Bharathi; Devaraj, Sivasitambaram Niranjali] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India; [Devaraj, Halagowder] Univ Madras, Dept Zool, Biochem Unit, Madras, Tamil Nadu, India	University of Madras; University of Madras	Prakash, R (corresponding author), Univ Madras, Dept Biochem, Guindy Campus, Madras, Tamil Nadu, India.	niranjali@yahoo.com	Subramaniya, Bharathi raja/A-7024-2012	S, BHARATHIRAJA/0000-0002-5680-7036	University Grants Commission (UGC), New Delhi, India	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	This work was supported by the University Grants Commission (UGC), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BUYSSE JM, 1987, J BACTERIOL, V169, P2561, DOI 10.1128/jb.169.6.2561-2569.1987; Dabbagh K, 1999, J IMMUNOL, V162, P6233; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; DEVARAJ H, 1993, ARCH BIOCHEM BIOPHYS, V302, P285, DOI 10.1006/abbi.1993.1212; DEVARAJ N, 1994, GLYCOBIOLOGY, V4, P307, DOI 10.1093/glycob/4.3.307; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; DUGUID JP, 1966, J PATHOL BACTERIOL, V92, P107, DOI 10.1002/path.1700920113; Duguid JP, 1980, BACTERIAL ADHERENC B, V6, P184; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; EMBAYE H, 1989, GASTROENTEROLOGY, V96, P1079, DOI 10.1016/0016-5085(89)91626-0; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; FORMAL SB, 1991, J INFECT DIS, V164, P533, DOI 10.1093/infdis/164.3.533; FORSTNER JF, 1978, DIGESTION, V17, P234, DOI 10.1159/000198115; FRETER R, 1976, INFECT IMMUN, V14, P246, DOI 10.1128/IAI.14.1.246-256.1976; Guthrie RD, 1962, METHODS CARBOHYDRATE, V1, P432; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kim YD, 2002, MOL PHARMACOL, V62, P1112, DOI 10.1124/mol.62.5.1112; Kim YD, 2000, BIOCHEM BIOPH RES CO, V274, P112, DOI 10.1006/bbrc.2000.3107; KNUTTON S, 1987, INFECT IMMUN, V55, P78, DOI 10.1128/IAI.55.1.78-85.1987; KRIVAN HC, 1988, ARCH BIOCHEM BIOPHYS, V260, P493, DOI 10.1016/0003-9861(88)90473-0; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Lin JH, 2000, J INFECT DIS, V182, P882, DOI 10.1086/315767; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; MANTLE M, 1994, INFECT IMMUN, V62, P1219, DOI 10.1128/IAI.62.4.1219-1227.1994; MANTLE M, 1989, INFECT IMMUN, V57, P3292, DOI 10.1128/IAI.57.11.3292-3299.1989; MOURICOUT MA, 1987, INFECT IMMUN, V55, P1216, DOI 10.1128/IAI.55.5.1216-1223.1987; Nutten S, 2002, MICROBES INFECT, V4, P1121, DOI 10.1016/S1286-4579(02)01636-2; PAL T, 1989, INFECT IMMUN, V57, P2580; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; RAMPHAL R, 1983, INFECT IMMUN, V41, P339, DOI 10.1128/IAI.41.1.339-344.1983; RINGLER NJ, 1987, BIOCHEMISTRY-US, V26, P5322, DOI 10.1021/bi00391a016; SANFORD BA, 1989, INFECT IMMUN, V57, P3735, DOI 10.1128/IAI.57.12.3735-3742.1989; SASAKAWA C, 1986, INFECT IMMUN, V54, P32, DOI 10.1128/IAI.54.1.32-36.1986; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Shuter J, 1996, INFECT IMMUN, V64, P310, DOI 10.1128/IAI.64.1.310-318.1996; Smirnova MG, 2001, EUR CYTOKINE NETW, V12, P119; Sudha PS, 2001, CURR MICROBIOL, V42, P381; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TZOUVELEKIS LS, 1991, INFECT IMMUN, V59, P4252, DOI 10.1128/IAI.59.11.4252-4254.1991; Udhayakumar G, 2007, MOL CARCINOGEN, V46, P807, DOI 10.1002/mc.20311; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VISHWANATH S, 1985, INFECT IMMUN, V48, P331, DOI 10.1128/IAI.48.2.331-335.1985; Weiss AA, 1996, J HISTOCHEM CYTOCHEM, V44, P1161, DOI 10.1177/44.10.8813081; WELLS CL, 1988, REV INFECT DIS, V10, P958; Woodward H, 1982, BIOCHEMISTRY-US, V21, P4905; Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452	57	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27046	10.1371/journal.pone.0027046	http://dx.doi.org/10.1371/journal.pone.0027046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22073249	Green Published, gold, Green Submitted			2022-12-25	WOS:000297198200030
J	Ramdarshan, A; Alloing-Seguier, T; Merceron, G; Marivaux, L				Ramdarshan, Anusha; Alloing-Seguier, Thomas; Merceron, Gildas; Marivaux, Laurent			The Primate Community of Cachoeira (Brazilian Amazonia): A Model to Decipher Ecological Partitioning among Extinct Species	PLOS ONE			English	Article							DENTAL MICROWEAR ANALYSIS; MOLAR MICROWEAR; LATE MIOCENE; IMAGE-ANALYSIS; HOWLER MONKEY; DIET; SURINAM; EXTANT; HABITAT; CANOPY	Dental microwear analysis is conducted on a community of platyrrhine primates from South America. This analysis focuses on the primate community of Cachoeira Porteira (Para, Brazil), in which seven sympatric species occur: Alouatta seniculus, Ateles paniscus, Cebus apella, Chiropotes satanas, Pithecia Pithecia, Saguinus midas, and Saimiri sciureus. Shearing quotients are also calculated for each taxon of this primate community. Dental microwear results indicate significant differences between taxa, but are somewhat insufficient when it comes to discriminating between ecologically similar taxa. The primates of Cachoeira Porteira all incorporate a certain amount of fruit in their diet, entailing a definite amount of interspecific competition as they must share food resources. Alouatta is the most folivorous taxon of this community, which is corroborated by dental microwear analysis. Ateles, although of a similar size to Alouatta, limits inter-specific competition by incorporating more fruit in its diet. Cebus has a very diverse omnivorous diet, which is highlighted in this study, as it compares to both fruit and leaf eating taxa. In some cases, microwear results need to be supplemented by other methods. For example, dental microwear seems insufficient to distinguish between Pithecia and Chiropotes, which eat foods with similar physical properties. However, other methods (i.e. shearing quotients and body mass) provide enough complimentary information to be able to highlight differences between the two taxa. On the other hand, dental microwear can highlight differences between primates which have similar diets, such as Saimiri and Saguinus. In this case, differences could be due to other exogenous factors.	[Ramdarshan, Anusha; Alloing-Seguier, Thomas; Marivaux, Laurent] Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Montpellier, France; [Merceron, Gildas] Univ Lyon 1, CNRS, ENS, Lab Geol Lyon Terre,UMR 5276, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ramdarshan, A (corresponding author), Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Cc 064, Montpellier, France.	Anusha.Ramdarshan@univ-montp2.fr	Habe, Neusa K/D-6316-2011; Merceron, Gildas/C-8648-2012	Merceron, Gildas/0000-0001-5777-7126	ANR- PALASIAFRICA [ANR-08-JCJC-0017]	ANR- PALASIAFRICA(French National Research Agency (ANR))	This study was funded by the ANR- PALASIAFRICA Program (ANR-08-JCJC-0017, ANR, ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; AYRES JM, 1989, J HUM EVOL, V18, P697, DOI 10.1016/0047-2484(89)90101-2; Bearder S. K., 2007, PRIMATES PERSPECTIVE; BOURLIERE F, 1985, INT J PRIMATOL, V6, P1, DOI 10.1007/BF02693694; Butler P.M., 2000, P201, DOI 10.1017/CBO9780511542626.014; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Calandra I, 2010, PALAEONTOL Z, V84, P205, DOI 10.1007/s12542-010-0054-0; CANNON CH, 1994, AM J PHYS ANTHROPOL, V93, P505, DOI 10.1002/ajpa.1330930409; Chivers DJ, 1984, FOOD ACQUISITION PRO; DAHL JF, 1988, AM J PHYS ANTHROPOL, V75, P201; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1245, DOI 10.1023/A:1008972901159; DUCKE A., 1953, ANAIS ACAD BRASIL CIENC, V25, P1; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Ganzhorn Jorg U., 1999, P141, DOI 10.1017/CBO9780511542381.009; GANZHORN JU, 1988, OECOLOGIA, V75, P436, DOI 10.1007/BF00376949; Garber Paul A., 1993, P273; GINGERICH P D, 1980, Zeitschrift fuer Morphologie und Anthropologie, V71, P135; Glander K.E., 1975, P37; GRINE FE, 1988, NATURE, V333, P765, DOI 10.1038/333765a0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; IZAWA K, 1979, Primates, V20, P57, DOI 10.1007/BF02373828; IZAWA K, 1978, Primates, V19, P633, DOI 10.1007/BF02373631; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; JUNGERS WL, 1984, J PHYS, V27, P73; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay R.F., 1984, FOOD ACQUISITION PRO, P467, DOI DOI 10.1007/978-1-4757-5244-1_21; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAYRF, 1977, J PHYS, V46, P327; King T, 1999, J HUM EVOL, V36, P3, DOI 10.1006/jhev.1998.0258; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Kirk EC, 2001, J HUM EVOL, V40, P203, DOI 10.1006/jhev.2000.0450; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Lima EM, 2003, FOLIA PRIMATOL, V74, P150, DOI 10.1159/000070648; LUCAS PW, 1994, P 12 C INT PRIM SOC, P125; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2007, GEODIVERSITAS, V29, P421; Merceron G, 2009, J HUM EVOL, V57, P732, DOI 10.1016/j.jhevol.2009.06.009; MITTERMEIER RA, 1981, FOLIA PRIMATOL, V36, P1, DOI 10.1159/000156007; Novello A, 2010, CR PALEVOL, V9, P471, DOI 10.1016/j.crpv.2010.10.001; Pack KS, 1999, FOLIA PRIMATOL, V70, P1, DOI 10.1159/000021668; Power Michael L., 1999, P225; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; ROSENBERGER AL, 1992, J HUM EVOL, V88, P525; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal R.R., 1995, BIOMETRY PRINCIPAL P; STRAIT SG, 1993, AM J PHYS ANTHROPOL, V92, P63, DOI 10.1002/ajpa.1330920106; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; TEAFORD MF, 1985, AM J PHYS ANTHROPOL, V66, P363, DOI 10.1002/ajpa.1330660403; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; VISCHER NOE, 1994, BINARY-COMPUT MICROB, V6, P160; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5	68	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2011	6	11							e27392	10.1371/journal.pone.0027392	http://dx.doi.org/10.1371/journal.pone.0027392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850MH	22076156	gold, Green Published			2022-12-25	WOS:000297198200070
J	Piccardi, C				Piccardi, Carlo			Finding and Testing Network Communities by Lumped Markov Chains	PLOS ONE			English	Article							COMPLEX NETWORKS; GRAPH; WEB	Identifying communities (or clusters), namely groups of nodes with comparatively strong internal connectivity, is a fundamental task for deeply understanding the structure and function of a network. Yet, there is a lack of formal criteria for defining communities and for testing their significance. We propose a sharp definition that is based on a quality threshold. By means of a lumped Markov chain model of a random walker, a quality measure called "persistence probability" is associated to a cluster, which is then defined as an "alpha-community" if such a probability is not smaller than alpha. Consistently, a partition composed of alpha-communities is an "alpha-partition." These definitions turn out to be very effective for finding and testing communities. If a set of candidate partitions is available, setting the desired alpha-level allows one to immediately select the alpha-partition with the finest decomposition. Simultaneously, the persistence probabilities quantify the quality of each single community. Given its ability in individually assessing each single cluster, this approach can also disclose single well-defined communities even in networks that overall do not possess a definite clusterized structure.	Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy	Polytechnic University of Milan	Piccardi, C (corresponding author), Politecn Milan, Dept Elect & Informat, I-20133 Milan, Italy.	carlo.piccardi@polimi.it		Piccardi, Carlo/0000-0002-8373-539X				[Anonymous], 2009, ENCY COMPLEXITY SYST; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BUCHHOLZ P, 1994, J APPL PROBAB, V31, P59, DOI 10.2307/3215235; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Everitt BS, 2011, CLUSTER ANAL, DOI [10.1002/9780470977811, DOI 10.1002/9780470977811]; Fagiolo G, 2008, PHYSICA A, V387, P3868, DOI 10.1016/j.physa.2008.01.050; Fenn DJ, 2009, CHAOS, V19, DOI 10.1063/1.3184538; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Hoffmann KH, 2009, APPL MATH LETT, V22, P1471, DOI 10.1016/j.aml.2009.03.016; HOLGERSSON M, 1978, PATTERN RECOGN, V10, P287, DOI 10.1016/0031-3203(78)90038-9; Hu YQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066106; Hu YQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026121; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Kannan R, 2004, J ACM, V51, P497, DOI 10.1145/990308.990313; Kemeny J.G., 1976, MARKOV CHAINS, V6; Kim Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016103; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Meyer CD., 2000, MATRIX ANAL APPL LIN, DOI [10.1137/1.9780898719512, DOI 10.1137/1.9780898719512]; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Piccardi C, 2010, PHYSICA A, V389, P5247, DOI 10.1016/j.physa.2010.06.038; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2006, PHYSICA D, V224, P20, DOI 10.1016/j.physd.2006.09.009; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Sima J, 2006, LECT NOTES COMPUT SC, V3831, P530; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Subelj L, 2011, PHYSICA A, V390, P2968, DOI 10.1016/j.physa.2011.03.036; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061901	55	39	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2011	6	11							e27028	10.1371/journal.pone.0027028	http://dx.doi.org/10.1371/journal.pone.0027028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850LV	22073245	gold, Green Submitted, Green Published			2022-12-25	WOS:000297197000024
J	Andreatta, M; Schafer-Nielsen, C; Lund, O; Buus, S; Nielsen, M				Andreatta, Massimo; Schafer-Nielsen, Claus; Lund, Ole; Buus, Soren; Nielsen, Morten			NNAlign: A Web-Based Prediction Method Allowing Non-Expert End-User Discovery of Sequence Motifs in Quantitative Peptide Data	PLOS ONE			English	Article							BINDING PREDICTIONS; SIGNAL PEPTIDES; CLASS-I; HLA-DR; MICROARRAYS; EPITOPE; IDENTIFICATION; GENERATION; AFFINITY; DNA	Recent advances in high-throughput technologies have made it possible to generate both gene and protein sequence data at an unprecedented rate and scale thereby enabling entirely new "omics"-based approaches towards the analysis of complex biological processes. However, the amount and complexity of data that even a single experiment can produce seriously challenges researchers with limited bioinformatics expertise, who need to handle, analyze and interpret the data before it can be understood in a biological context. Thus, there is an unmet need for tools allowing non-bioinformatics users to interpret large data sets. We have recently developed a method, NNAlign, which is generally applicable to any biological problem where quantitative peptide data is available. This method efficiently identifies underlying sequence patterns by simultaneously aligning peptide sequences and identifying motifs associated with quantitative readouts. Here, we provide a web-based implementation of NNAlign allowing non-expert end-users to submit their data (optionally adjusting method parameters), and in return receive a trained method (including a visual representation of the identified motif) that subsequently can be used as prediction method and applied to unknown proteins/peptides. We have successfully applied this method to several different data sets including peptide microarray-derived sets containing more than 100,000 data points. NNAlign is available online at http://www.cbs.dtu.dk/services/NNAlign.	[Andreatta, Massimo; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Schafer-Nielsen, Claus] Schafer N, Copenhagen, Denmark; [Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Andreatta, M (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	massimo@cbs.dtu.dk	Buus, Soren/F-5446-2010; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014; Andreatta, Massimo/AAA-4061-2020	Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Andreatta, Massimo/0000-0002-8036-2647; Buus, Soren/0000-0001-8363-1999	European Union [222773]; National Institute of Allergy and Infectious Diseases [HHSN 272 2009 00045C]	European Union(European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research leading to these results received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement n<SUP>o</SUP> 222773, and from the National Institute of Allergy and Infectious Diseases under contract n<SUP>o</SUP> HHSN 272 2009 00045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhasin M, 2004, BIOINFORMATICS, V20, P421, DOI 10.1093/bioinformatics/btg424; Bhushan KR, 2003, TETRAHEDRON LETT, V44, P8585, DOI 10.1016/j.tetlet.2003.09.155; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; Christensen JK, 2003, NEURAL COMPUT, V15, P2931, DOI 10.1162/089976603322518803; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Han XM, 2009, J BIOMOL SCREEN, V14, P256, DOI 10.1177/1087057108329348; Hasan A, 1997, TETRAHEDRON, V53, P4247, DOI 10.1016/S0040-4020(97)00154-3; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hoppe-Seyler F, 2004, CURR MOL MED, V4, P529, DOI 10.2174/1566524043360519; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; James William, 2001, Current Opinion in Pharmacology, V1, P540, DOI 10.1016/S1471-4892(01)00093-5; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lathe W., 2008, NAT ED, V1; Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Lundegaard C, 2010, IMMUNOLOGY, V130, P309, DOI 10.1111/j.1365-2567.2010.03300.x; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Petersen TN, 2000, PROTEINS, V41, P17, DOI 10.1002/1097-0134(20001001)41:1<17::AID-PROT40>3.0.CO;2-F; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Sompuram SR, 2006, AM J CLIN PATHOL, V125, P82, DOI 10.1309/6H0ARQF7K3Y608EH; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Uttamchandani M, 2008, CURR PHARM DESIGN, V14, P2428, DOI 10.2174/138161208785777450; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568	49	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26781	10.1371/journal.pone.0026781	http://dx.doi.org/10.1371/journal.pone.0026781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073191	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900034
J	Graham, JF; Kurian, D; Agarwal, S; Toovey, L; Hunt, L; Kirby, L; Pinheiro, TJT; Banner, SJ; Gill, AC				Graham, James F.; Kurian, Dominic; Agarwal, Sonya; Toovey, Lorna; Hunt, Lawrence; Kirby, Louise; Pinheiro, Teresa J. T.; Banner, Steven J.; Gill, Andrew C.			Na+/K+-ATPase Is Present in Scrapie-Associated Fibrils, Modulates PrP Misfolding In Vitro and Links PrP Function and Dysfunction	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; SIGNAL-TRANSDUCTION; RECOMBINANT PRP; FREE CONVERSION; BRAIN; IDENTIFICATION; NA,K-ATPASE; MOLECULES; STRAIN; MODEL	Transmissible spongiform encephalopathies are characterised by widespread deposition of fibrillar and/or plaque-like forms of the prion protein. These aggregated forms are produced by misfolding of the normal prion protein, PrPC, to the disease-associated form, PrPSc, through mechanisms that remain elusive but which require either direct or indirect interaction between PrPC and PrPSc isoforms. A wealth of evidence implicates other non-PrP molecules as active participants in the misfolding process, to catalyse and direct the conformational conversion of PrPC or to provide a scaffold ensuring correct alignment of PrPC and PrPSc during conversion. Such molecules may be specific to different scrapie strains to facilitate differential prion protein misfolding. Since molecular cofactors may become integrated into the growing protein fibril during prion conversion, we have investigated the proteins contained in prion disease-specific deposits by shotgun proteomics of scrapie-associated fibrils (SAF) from mice infected with 3 different strains of mouse-passaged scrapie. Concomitant use of negative control preparations allowed us to identify and discount proteins that are enriched non-specifically by the SAF isolation protocol. We found several proteins that co-purified specifically with SAF from infected brains but none of these were reproducibly and demonstrably specific for particular scrapie strains. The alpha-chain of Na+/K+-ATPase was common to SAF from all 3 strains and we tested the ability of this protein to modulate in vitro misfolding of recombinant PrP. Na+/K+-ATPase enhanced the efficiency of disease-specific conversion of recombinant PrP suggesting that it may act as a molecular cofactor. Consistent with previous results, the same protein inhibited fibrillisation kinetics of recombinant PrP. Since functional interactions between PrPC and Na+/K+-ATPase have previously been reported in astrocytes, our data highlight this molecule as a key link between PrP function, dysfunction and misfolding.	[Graham, James F.; Agarwal, Sonya; Toovey, Lorna; Kirby, Louise; Banner, Steven J.; Gill, Andrew C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Graham, James F.; Agarwal, Sonya; Toovey, Lorna; Kirby, Louise; Banner, Steven J.; Gill, Andrew C.] Univ Edinburgh, RD SVS, Neuropathogenesis Div, Edinburgh, Midlothian, Scotland; [Kurian, Dominic; Hunt, Lawrence] Inst Anim Hlth, Newbury, Berks, England; [Pinheiro, Teresa J. T.] Univ Warwick, Sch Biol Sci, Coventry CV4 7AL, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Warwick	Graham, JF (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	andrew.gill@roslin.ed.ac.uk	Gill, Andrew C/A-5219-2009; Gill, ANdrew/GRO-1248-2022	Gill, Andrew C/0000-0001-5201-9473; Kurian, Dominic/0000-0002-5924-665X; Banner, Steve/0000-0002-7852-9284	Biotechnology and Biological Sciences Research Council, UK; Institute Strategic Programme Grants; BBSRC [BB/C506356/1, BB/C506356/2, BB/C506356/3, BBS/E/D/05241338] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241338, BB/C506356/2, BB/C506356/1, BB/C506356/3] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme Grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (www.bbsrc.ac.uk) through a doctoral training account to JFG and Institute Strategic Programme Grants to RI and IAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Baumann MH, 1996, BIOCHEM BIOPH RES CO, V219, P238, DOI 10.1006/bbrc.1996.0211; Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Brimacombe DB, 1999, BIOCHEM J, V342, P605, DOI 10.1042/0264-6021:3420605; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; CALANDRIELLO L, 1995, MED HYPOTHESES, V44, P173, DOI 10.1016/0306-9877(95)90132-9; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dumpitak C, 2005, BIOL CHEM, V386, P1149, DOI 10.1515/BC.2005.131; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Giorgi A, 2009, PROTEOMICS, V9, P3802, DOI 10.1002/pmic.200900085; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Hasan MR, 2006, EXP CELL RES, V312, P1950, DOI 10.1016/j.yexcr.2006.02.023; Hnasko R, 2010, PRION, V4, P94, DOI 10.4161/pri.4.2.12622; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2006, J GEN VIROL, V87, P3747, DOI 10.1099/vir.0.82086-0; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Kleene R, 2007, J NEUROSCI, V27, P12331, DOI 10.1523/JNEUROSCI.1358-07.2007; Kralovicova S, 2009, MOL CELL NEUROSCI, V41, P135, DOI 10.1016/j.mcn.2009.02.002; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kurup RK, 2003, INT J NEUROSCI, V113, P971, DOI 10.1080/00207450390220312; Lazzari C, 2011, J NEUROCHEM, V116, P881, DOI 10.1111/j.1471-4159.2010.07015.x; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Liao LJ, 2009, NEURON, V63, P12, DOI 10.1016/j.neuron.2009.06.011; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Moore RA, 2010, PROTEOMICS; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nieznanski K, 2010, CELL MOL NEUROBIOL, V30, P653, DOI 10.1007/s10571-009-9491-2; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; Petrakis S, 2009, J PROTEOMICS, V72, P690, DOI 10.1016/j.jprot.2009.01.025; Petrakis S, 2006, PROTEOMICS, V6, P6476, DOI 10.1002/pmic.200600103; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sanghera N, 2008, BBA-PROTEINS PROTEOM, V1784, P873, DOI 10.1016/j.bbapap.2008.02.017; Sanghera N, 2009, BBA-BIOMEMBRANES, V1788, P2245, DOI 10.1016/j.bbamem.2009.08.005; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Somerville RA, 2005, J GEN VIROL, V86, P241, DOI 10.1099/vir.0.80251-0; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; Sproul Adrian, 2009, P53, DOI 10.1007/978-1-60327-579-8_4; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Tomasi Vittorio, 2010, Immun Ageing, V7 Suppl 1, pS5, DOI 10.1186/1742-4933-7-S1-S5; Walker SG, 1996, J CHROMATOGR B, V680, P91, DOI 10.1016/0378-4347(95)00452-1; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Watt NT, 2007, FREE RADICAL BIO MED, V43, P959, DOI 10.1016/j.freeradbiomed.2007.06.004; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	78	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26813	10.1371/journal.pone.0026813	http://dx.doi.org/10.1371/journal.pone.0026813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073199	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000297154900040
J	Kunik, D; Dion, C; Ozaki, T; Levin, LA; Costantino, S				Kunik, Dario; Dion, Carolyne; Ozaki, Tsuneyuki; Levin, Leonard A.; Costantino, Santiago			Laser-Based Single-Axon Transection for High-Content Axon Injury and Regeneration Studies	PLOS ONE			English	Article							DEGENERATION; CELL; MECHANISMS; WLD(S); MICROSURGERY; ABLATION	The investigation of the regenerative response of the neurons to axonal injury is essential to the development of new axoprotective therapies. Here we study the retinal neuronal RGC-5 cell line after laser transection, demonstrating that the ability of these cells to initiate a regenerative response correlates with axon length and cell motility after injury. We show that low energy picosecond laser pulses can achieve transection of unlabeled single axons in vitro and precisely induce damage with micron precision. We established the conditions to achieve axon transection, and characterized RGC-5 axon regeneration and cell body response using time-lapse microscopy. We developed an algorithm to analyze cell trajectories and established correlations between cell motility after injury, axon length, and the initiation of the regeneration response. The characterization of the motile response of axotomized RGC-5 cells showed that cells that were capable of repair or regrowth of damaged axons migrated more slowly than cells that could not. Moreover, we established that RGC-5 cells with long axons could not recover their injured axons, and such cells were much more motile. The platform we describe allows highly controlled axonal damage with subcellular resolution and the performance of high-content screening in cell cultures.	[Kunik, Dario; Dion, Carolyne; Ozaki, Tsuneyuki; Levin, Leonard A.; Costantino, Santiago] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Kunik, Dario; Costantino, Santiago] Univ Montreal, Inst Genie Biomed, Montreal, PQ, Canada; [Dion, Carolyne; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Quebec City, PQ, Canada; [Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Dept Ophtalmol, Montreal, PQ, Canada; [Levin, Leonard A.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison	Kunik, D (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	santiago.costantino@umontreal.ca	Ozaki, Tsuneyuki/B-3283-2012; Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Ozaki, Tsuneyuki/0000-0001-8857-3900	Fondation de l'Hopital Maisonneuve-Rosemont; National Sciences and Engineering Research Council (NSERC); Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT); Canadian Institutes of Health Research (CIHR); National Institutes of Health (NIH) [R21 EY017970]; HMR; NSERCf; NATIONAL EYE INSTITUTE [R21EY017970] Funding Source: NIH RePORTER	Fondation de l'Hopital Maisonneuve-Rosemont; National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HMR; NSERCf; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grants from the Fondation de l'Hopital Maisonneuve-Rosemont to SC, the National Sciences and Engineering Research Council (NSERC) and the Fonds Qubebecois de la Recherche sur la Nature et les Technologies (FQRNT) grants to SC and TO, the Canadian Institutes of Health Research (CIHR) to LAL and SC, and the National Institutes of Health (NIH) R21 EY017970 to LAL. DK is a recipient of a HMR postdoctoral fellowships and CD of a NSERCf postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra Mascaro Anna Letizia, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00021; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Beirowski B, 2008, EUR J NEUROSCI, V28, P1166, DOI 10.1111/j.1460-9568.2008.06426.x; Belisle JM, 2009, LAB CHIP, V9, P3580, DOI 10.1039/b911967a; Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d; Berns MW, 2007, METHOD CELL BIOL, V82, P3, DOI 10.1016/S0091-679X(06)82001-7; BERNS MW, 1981, SCIENCE, V213, P505, DOI 10.1126/science.7017933; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Bourgeois F, 2007, OPT EXPRESS, V15, P8521, DOI 10.1364/OE.15.008521; Chang WC, 2010, WIRES NANOMED NANOBI, V2, P151, DOI 10.1002/wnan.76; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; Magidson V, 2007, METHOD CELL BIOL, V82, P239, DOI 10.1016/S0091-679(06)82007-8; Mandolesi G, 2004, FASEB J; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Schwartz M, 1999, MOL MED TODAY, V5, P470, DOI 10.1016/S1357-4310(99)01592-0; Steinmeyer JD, 2010, NAT PROTOC, V5, P395, DOI 10.1038/nprot.2010.4; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Vogel A, 2007, BIOPHYS J, V93, P4481, DOI 10.1529/biophysj.106.102277; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wu T, 2012, J R SOC INTERFACE, V9, P535, DOI 10.1098/rsif.2011.0351; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e26832	10.1371/journal.pone.0026832	http://dx.doi.org/10.1371/journal.pone.0026832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073205	Green Published, gold, Green Submitted			2022-12-25	WOS:000297154900044
J	Loponen, H; Ylikoski, J; Albrecht, JH; Pirvola, U				Loponen, Heidi; Ylikoski, Jukka; Albrecht, Jeffrey H.; Pirvola, Ulla			Restrictions in Cell Cycle Progression of Adult Vestibular Supporting Cells in Response to Ectopic Cyclin D1 Expression	PLOS ONE			English	Article							MOUSE INNER-EAR; HAIR-CELLS; DNA-DAMAGE; IN-VIVO; CARDIOMYOCYTE PROLIFERATION; CENTROSOME AMPLIFICATION; CHROMOSOME CONDENSATION; RETINOBLASTOMA PROTEIN; BALANCE EPITHELIA; POSTMITOTIC STATE	Sensory hair cells and supporting cells of the mammalian inner ear are quiescent cells, which do not regenerate. In contrast, non-mammalian supporting cells have the ability to re-enter the cell cycle and produce replacement hair cells. Earlier studies have demonstrated cyclin D1 expression in the developing mouse supporting cells and its downregulation along maturation. In explant cultures of the mouse utricle, we have here focused on the cell cycle control mechanisms and proliferative potential of adult supporting cells. These cells were forced into the cell cycle through adenoviral-mediated cyclin D1 overexpression. Ectopic cyclin D1 triggered robust cell cycle re-entry of supporting cells, accompanied by changes in p27(Kip1) and p21(Cip1) expressions. Main part of cell cycle reactivated supporting cells were DNA damaged and arrested at the G2/M boundary. Only small numbers of mitotic supporting cells and rare cells with signs of two successive replications were found. Ectopic cyclin D1-triggered cell cycle reactivation did not lead to hyperplasia of the sensory epithelium. In addition, a part of ectopic cyclin D1 was sequestered in the cytoplasm, reflecting its ineffective nuclear import. Combined, our data reveal intrinsic barriers that limit proliferative capacity of utricular supporting cells.	[Loponen, Heidi; Pirvola, Ulla] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Ylikoski, Jukka] Helsinki Ear Inst, Helsinki, Finland; [Albrecht, Jeffrey H.] Hennepin Cty Med Ctr, Div Gastroenterol, Minneapolis, MN 55415 USA	University of Helsinki; Hennepin County Medical Center	Loponen, H (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	ulla.pirvola@helsinki.fi		Pirvola, Ulla/0000-0001-5285-4225	Academy of Finland; NIH [DK54921]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054921] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Academy of Finland (U.P.) and by the NIH grant DK54921 (J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 1999, DEVELOPMENT, V126, P1581; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Gu RD, 2007, EUR J NEUROSCI, V25, P1363, DOI 10.1111/j.1460-9568.2007.05414.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Montcouquiol M, 2001, J NEUROSCI, V21, P570, DOI 10.1523/JNEUROSCI.21-02-00570.2001; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Nelsen CJ, 2001, CANCER RES, V61, P8564; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Ono K, 2009, MOL CELL NEUROSCI, V42, P391, DOI 10.1016/j.mcn.2009.08.011; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Quint E, 1998, HEARING RES, V118, P157, DOI 10.1016/S0378-5955(98)00026-4; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Sulg M, 2010, J NEUROCHEM, V112, P1513, DOI 10.1111/j.1471-4159.2009.06563.x; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Van Hooser A, 1998, J CELL SCI, V111, P3497; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wilkinson DG, 1991, POSTIMPLANTATION MAM, P447; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	55	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2011	6	11							e27360	10.1371/journal.pone.0027360	http://dx.doi.org/10.1371/journal.pone.0027360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849WB	22073316	gold, Green Published, Green Submitted			2022-12-25	WOS:000297154900100
J	Lu, R; Zhang, XC; Huang, DP; Huang, B; Gao, N; Wang, ZC; Ge, J				Lu, Rong; Zhang, Xinchun; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian			Conjunctival Reconstruction with Progenitor Cell-Derived Autologous Epidermal Sheets in Rhesus Monkey	PLOS ONE			English	Article							AMNIOTIC MEMBRANE TRANSPLANTATION; MUCIN GENE-EXPRESSION; STEM-CELLS; OCULAR SURFACE; EPITHELIAL EQUIVALENT; CORNEAL EPITHELIUM; IN-VITRO; SKIN; IDENTIFICATION; CULTURE	Severe ocular surface diseases are some of the most challenging problems that the clinician faces today. Conventional management is generally unsatisfactory, and the long-term ocular consequences of these conditions are devastating. It is significantly important to find a substitute for conjunctival epithelial cells. This study was to explore the possibility of progenitor cell-derived epidermal sheets on denuded amniotic membrane to reconstruct ocular surface of conjunctiva damaged monkeys. We isolated epidermal progenitor cells of rhesus monkeys by type IV collagen adhesion, and then expanded progenitor cell-derived epidermal sheets on denuded amniotic membrane ex vivo. At 3 weeks after the conjunctiva injury, the damaged ocular surface of four monkeys was surgically reconstructed by transplanting the autologous cultivated epidermal progenitor cells. At 2 weeks after surgery, transplants were removed and examined with Hematoxylin-eosin staining, Periodic acid Schiff staining, immunofluorescent staining, scanning and transmission electron microscopy. Histological examination of transplanted sheets revealed that the cell sheets were healthy alive, adhered well to the denuded amniotic membrane, and had several layers of epithelial cells. Electron microscopy showed that the epithelial cells were very similar in appearance to those of normal conjunctival epithelium, even without goblet cell detected. Epithelial cells of transplants had numerous desmosomal junctions and were attached to the amniotic membrane with hemidesmosomes. Immunohistochemistry confirmed the presence of the conjunctival specific markers, mucin 4 and keratin 4, in the transplanted epidermal progenitor cells. In conclusion, our present study successfully reconstructed conjunctiva with autologous transplantation of progenitor cell-derived epidermal sheets on denuded AM in conjunctival damaged monkeys, which is the first step toward assessing the use of autologous transplantation of progenitor cells of nonocular surface origin. Epidermal progenitor cells could be provided as a new substitute for conjunctival epithelial cells to overcome the problems of autologous conjunctiva shortage.	[Lu, Rong; Huang, Danping; Huang, Bing; Gao, Nan; Wang, Zhichong; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xinchun] Sun Yat Sen Univ, Guanghua Coll Stomatol, Hosp Stomatol, Dept Prosthodont, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Lu, R (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	gejian@mail.sysu.edu.cn		Schmidtko, Achim/0000-0001-7270-5075	National Natural Science Foundation of China [30901634]; Natural Science Foundation of Guangdong Province [9151008901000210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (30901634) and the Natural Science Foundation of Guangdong Province (9151008901000210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Ang LPK, 2004, INVEST OPHTH VIS SCI, V45, P1789, DOI 10.1167/iovs.03-1361; Arora R, 2005, EYE, V19, P273, DOI 10.1038/sj.eye.6701490; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Berry M, 1996, INVEST OPHTH VIS SCI, V37, P2559; Bickenbach J R, 2000, Adv Dermatol, V16, P159; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Burman Sanghamitra, 2004, Cell and Tissue Banking, V5, P161, DOI 10.1023/B:CATB.0000046067.25057.0a; Chiou AGY, 1998, SURV OPHTHALMOL, V43, P19, DOI 10.1016/S0039-6257(98)00005-8; Corrales RM, 2003, Arch Soc Esp Oftalmol, V78, P375; Corrales RM, 2003, CURR EYE RES, V27, P323, DOI 10.1076/ceyr.27.5.323.17221; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013; Gao N, 2007, SCI CHINA SER C, V50, P101, DOI 10.1007/s11427-007-0006-4; GIPSON IK, 1992, INVEST OPHTH VIS SCI, V33, P218; Gonnering R S, 1987, Ophthalmic Plast Reconstr Surg, V3, P99, DOI 10.1097/00002341-198703020-00009; Grinnell KL, 2007, CELL PROLIFERAT, V40, P685, DOI 10.1111/j.1365-2184.2007.00464.x; Gunduz K, 2006, EYE, V20, P351, DOI 10.1038/sj.eye.6701890; Huang Bing, 2004, Zhonghua Yi Xue Za Zhi, V84, P838; Islam MS, 2007, EUR J DERMATOL, V17, P302, DOI 10.1684/ejd.2007.0204; Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156; Jones PH, 1996, CLIN SCI, V91, P141, DOI 10.1042/cs0910141; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Krenzer KL, 1997, INVEST OPHTH VIS SCI, V38, P142; KRUSE FE, 1998, OPHTHALMOLOGY, V122; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Li W, 2006, INVEST OPHTH VIS SCI, V47, P2381, DOI 10.1167/iovs.05-1491; Liu YC, 2008, INT J DERMATOL, V47, P551, DOI 10.1111/j.1365-4632.2008.03647.x; Lu R, 2011, INT J BIOCHEM CELL B, V43, P751, DOI 10.1016/j.biocel.2011.01.018; Lu Rong, 2005, Zhonghua Yi Xue Za Zhi, V85, P2554; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Pflugfelder SC, 2007, CURR OPIN ALLERGY CL, V7, P450, DOI 10.1097/ACI.0b013e3282ef69e3; Reiisi S, 2010, IN VITRO CELL DEV-AN, V46, P54, DOI 10.1007/s11626-009-9245-y; Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235; SHORE JW, 1992, OPHTHALMOLOGY, V99, P383; Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; WEISE RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1736, DOI 10.1001/archopht.1985.01050110132041; Yu CJ, 1996, ONCOLOGY, V53, P118; Zhang LL, 2011, INT J BIOCHEM CELL B, V43, P1383, DOI 10.1016/j.biocel.2011.06.003; Zhou JX, 2004, CELL BIOL INT, V28, P523, DOI 10.1016/j.cellbi.2004.04.007	51	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2011	6	11							e25713	10.1371/journal.pone.0025713	http://dx.doi.org/10.1371/journal.pone.0025713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HG	22096478	Green Published, gold, Green Submitted			2022-12-25	WOS:000297553900001
J	Chan, DSM; Lau, R; Aune, D; Vieira, R; Greenwood, DC; Kampman, E; Norat, T				Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Greenwood, Darren C.; Kampman, Ellen; Norat, Teresa			Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							DOSE-RESPONSE DATA; COLON-CANCER; RISK-FACTORS; PROSPECTIVE COHORT; RECTAL-CANCER; UNITED-STATES; NAT2 POLYMORPHISMS; NETHERLANDS COHORT; DIETARY PATTERNS; WOMENS HEALTH	Background: The evidence that red and processed meat influences colorectal carcinogenesis was judged convincing in the 2007 World Cancer Research Fund/American Institute of Cancer Research report. Since then, ten prospective studies have published new results. Here we update the evidence from prospective studies and explore whether there is a non-linear association of red and processed meats with colorectal cancer risk. Methods and Findings: Relevant prospective studies were identified in PubMed until March 2011. For each study, relative risks and 95% confidence intervals (CI) were extracted and pooled with a random-effects model, weighting for the inverse of the variance, in highest versus lowest intake comparison, and dose-response meta-analyses. Red and processed meats intake was associated with increased colorectal cancer risk. The summary relative risk (RR) of colorectal cancer for the highest versus the lowest intake was 1.22 (95% CI = 1.11-1.34) and the RR for every 100 g/day increase was 1.14 (95% CI = 1.04-1.24). Non-linear dose-response meta-analyses revealed that colorectal cancer risk increases approximately linearly with increasing intake of red and processed meats up to approximately 140 g/day, where the curve approaches its plateau. The associations were similar for colon and rectal cancer risk. When analyzed separately, colorectal cancer risk was related to intake of fresh red meat (RR (for 100 g/day increase) = 1.17, 95% CI = 1.05-1.31) and processed meat (RR (for 50 g/day increase) = 1.18, 95% CI = 1.10-1.28). Similar results were observed for colon cancer, but for rectal cancer, no significant associations were observed. Conclusions: High intake of red and processed meat is associated with significant increased risk of colorectal, colon and rectal cancers. The overall evidence of prospective studies supports limiting red and processed meat consumption as one of the dietary recommendations for the prevention of colorectal cancer.	[Chan, Doris S. M.; Lau, Rosa; Aune, Dagfinn; Vieira, Rui; Norat, Teresa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Greenwood, Darren C.] Univ Leeds, Biostat Unit, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Imperial College London; University of Leeds; Wageningen University & Research	Chan, DSM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	t.norat@imperial.ac.uk	Greenwood, Darren C/C-3220-2008; Kampman, E./H-8057-2014	Greenwood, Darren C/0000-0001-7035-3096; 	World Cancer Research Fund International [2007/SP01]	World Cancer Research Fund International(World Cancer Research Fund International (WCRF))	Funding: This work was funded by the World Cancer Research Fund International (Grant number: 2007/SP01) (http://www.wcrf-uk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this review are the opinions of the authors. They may not represent the views of WCRF International/AICR and may differ from those in their future updates of the evidence related to food, nutrition, physical activity and cancer risk.	Alexander DD, 2011, OBES REV, V12, pe472, DOI 10.1111/j.1467-789X.2010.00785.x; Alexander DD, 2010, EUR J CANCER PREV, V19, P328, DOI 10.1097/CEJ.0b013e32833b48fa; *AM I CANC RES WOR, 2003, FOOD NUTR PHYS ACT P; *AM I CANC RES WOR, 2009, POL ACT CANC PREV FO; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; Berndt SI, 2006, CANCER EPIDEM BIOMAR, V15, P2263, DOI 10.1158/1055-9965.EPI-06-0449; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; BONNETT R, 1975, J CHEM SOC CHEM COMM, P884, DOI 10.1039/c39750000884; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Brink M, 2005, BRIT J CANCER, V92, P1310, DOI 10.1038/sj.bjc.6602491; Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan AT, 2005, INT J CANCER, V115, P648, DOI 10.1002/ijc.20890; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Chen J, 1998, CANCER RES, V58, P3307; Chen K, 2003, WORLD J GASTROENTERO, V9, P99, DOI 10.3748/wjg.v9.i1.99; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; English DR, 2004, CANCER EPIDEM BIOMAR, V13, P1509; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Gaard M, 1996, EUR J CANCER PREV, V5, P445; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GOLDBOHM RA, 1994, CANCER RES, V54, P718; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jarvinen R, 2001, BRIT J CANCER, V85, P357, DOI 10.1054/bjoc.2001.1906; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Joosen AMCP, 2009, CARCINOGENESIS, V30, P1402, DOI 10.1093/carcin/bgp130; Kabat GC, 2007, BRIT J CANCER, V97, P118, DOI 10.1038/sj.bjc.6603837; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; KNEKT P, 1994, INT J CANCER, V59, P756, DOI 10.1002/ijc.2910590608; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SA, 2009, NUTR CANCER, V61, P194, DOI 10.1080/01635580802419780; Lin J, 2004, AM J EPIDEMIOL, V160, P1011, DOI 10.1093/aje/kwh319; Luchtenborg M, 2005, CANCER CAUSE CONTROL, V16, P1041, DOI 10.1007/s10552-005-0239-0; Ma J, 2001, J NATL CANCER I, V93, P1330, DOI 10.1093/jnci/93.17.1330; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Norat T, 2001, NUTR REV, V59, P37, DOI 10.1111/j.1753-4887.2001.tb06974.x; Oba S, 2006, CANCER LETT, V244, P260, DOI 10.1016/j.canlet.2005.12.037; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Parkin DM, 2009, EUR J CANCER PREV, V18, P179, DOI 10.1097/CEJ.0b013e32830c8d83; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Sato Y, 2006, EUR J CANCER PREV, V15, P211, DOI 10.1097/01.cej.0000197455.87356.05; Sellers TA, 1998, CANCER CAUSE CONTROL, V9, P357; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; SINHA R, 1994, CANCER RES, V54, P6154; Sorensen M, 2008, CANCER LETT, V266, P186, DOI 10.1016/j.canlet.2008.02.046; Spencer EA, 2010, CANCER CAUSE CONTROL, V21, P1417, DOI 10.1007/s10552-010-9569-7; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; Wu K, 2004, CANCER CAUSE CONTROL, V15, P853, DOI 10.1007/s10552-004-1809-2	72	547	563	2	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20456	10.1371/journal.pone.0020456	http://dx.doi.org/10.1371/journal.pone.0020456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674008	Green Published, gold			2022-12-25	WOS:000291356400005
J	Li, JS; Bi, YT; Dong, C; Yang, JF; Liang, WD				Li, Jin-song; Bi, Yun-tian; Dong, Cheng; Yang, Ji-feng; Liang, Wan-dong			Transcriptome Analysis of Adaptive Heat Shock Response of Streptococcus thermophilus	PLOS ONE			English	Article							GROWTH TEMPERATURE; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; CLPL; METABOLISM; BULGARICUS; REGULATORS; TOLERANCE; BACTERIA; SYSTEMS	Streptococcus thermophilus, a gram-positive facultative anaerobe, is one of the most important lactic acid bacteria widely used in the dairy fermentation industry. In this study, we have analyzed the global transcriptional profiling of S. thermophilus upon temperature change. During a temperature shift from 42 degrees C to 50 degrees C, it is found that 196 (10.4%) genes show differential expression with 102 up-regulated and 94 down-regulated at 50 degrees C. In particular, 1) Heat shock genes, such as DnaK, GroESL and clpL, are identified to be elevated at 50 degrees C; 2) Transcriptional regulators, such as HrcA, CtsR, Fur, MarR and MerR family, are differentially expressed, indicating the complex molecular mechanisms of S. thermophilus adapting to heat shock; 3) Genes associated with signal transduction, cell wall genes, iron homeostasis, ABC transporters and restriction-modification system were induced; 4) A large number of the differentially expressed genes are hypothetical genes of unknown function, indicating that much remains to be investigated about the heat shock response of S. thermophilus. Experimental investigation of selected heat shock gene ClpL shows that it plays an important role in the physiology of S. thermophilus at high temperature and meanwhile we confirmed ClpL as a member of the CtsR regulon. Overall, this study has contributed to the underlying adaptive molecular mechanisms of S. thermophilus upon temperature change and provides a basis for future in-depth functional studies.	[Li, Jin-song; Yang, Ji-feng; Liang, Wan-dong] Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Bi, Yun-tian] Wenzhou Med Coll, Sch Basic Med Sci, Wenzhou, Peoples R China; [Dong, Cheng] Harbin Med Univ, Hosp 4, Harbin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Harbin Medical University	Li, JS (corresponding author), Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	liliang2011@yahoo.com	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	Natural Science Foundation of Zhejiang Province [Y2090642]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2090642), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Herve-Jimenez L, 2009, APPL ENVIRON MICROB, V75, P2062, DOI 10.1128/AEM.01984-08; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suokko A, 2008, PROTEOMICS, V8, P1029, DOI 10.1002/pmic.200700925; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Varcamonti M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-6; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	28	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25777	10.1371/journal.pone.0025777	http://dx.doi.org/10.1371/journal.pone.0025777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000295978600030
J	Li, J; Ding, ZY; Wang, ZX; Lu, JF; Maity, SN; Navone, NM; Logothetis, CJ; Mills, GB; Kim, J				Li, Jin; Ding, Zhiyong; Wang, Zhengxin; Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Mills, Gordon B.; Kim, Jeri			Androgen Regulation of 5 alpha-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; DEPENDENT INHIBITION; SERUM TESTOSTERONE; GENE-EXPRESSION; MESSENGER-RNA; ADULT-RAT; FINASTERIDE; RECEPTOR; DUTASTERIDE; TYPE-1	The enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5 alpha-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5 alpha-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5 alpha-reductase isoenzymes in a cell type-specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5 alpha-reductase isoenzymes may confer response or resistance to 5 alpha-reductase inhibitors and thus may have importance in prostate cancer prevention.	[Li, Jin; Ding, Zhiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, J (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	jekim@mdanderson.org	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Prostate Cancer Research Program at MD Anderson Cancer Center and supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Fitzpatrick JM, 2009, BJU INT, V103, P864, DOI 10.1111/j.1464-410X.2008.08206.x; George FW, 1997, ENDOCRINOLOGY, V138, P871, DOI 10.1210/en.138.3.871; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Makridakis N, 2005, J MOL ENDOCRINOL, V34, P617, DOI 10.1677/jme.1.01725; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Reddy G Kesava, 2004, Clin Prostate Cancer, V2, P209; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Schatzl G, 2001, PROSTATE, V47, P52; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Steiner JF, 1996, CLIN PHARMACOKINET, V30, P16, DOI 10.2165/00003088-199630010-00002; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024; TITUS MA, 2009, 5ALPHA REDUCTASE I 2, P175; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; WILBERT DM, 1983, J CLIN ENDOCR METAB, V56, P113, DOI 10.1210/jcem-56-1-113; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wilson JD, 1996, PROSTATE, P88; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Yamana K, 2010, HORM MOL BIOL CLIN I, V2, P293, DOI 10.1515/HMBCI.2010.035; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhou ZF, 1999, MOL GENET METAB, V68, P410, DOI 10.1006/mgme.1999.2898; Zhu YS, 2009, ANN NY ACAD SCI, V1155, P43, DOI 10.1111/j.1749-6632.2009.04115.x	49	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28840	10.1371/journal.pone.0028840	http://dx.doi.org/10.1371/journal.pone.0028840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194926	Green Published, Green Submitted, gold			2022-12-25	WOS:000298369100109
